Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AAMDC "C11orf67, CK067, FLJ21035, PTD015" ENSG00000087884 "Adipogenesis associated Mth938 domain containing" Q9H7C9 11 77821109-77918432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 656.7" "Cell type enhanced" "Detected in all" "Theca cells: 385.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 143.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 280.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA037918, HPA037919" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA037918: AB_2675737, HPA037919: AB_2675738" "unprognostic (3.10e-2)" "unprognostic (9.04e-3)" "unprognostic (6.02e-2)" "unprognostic (4.67e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-1)" "unprognostic (7.08e-2)" "unprognostic (1.90e-1)" "unprognostic (2.08e-1)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "unprognostic (3.84e-2)" 75.8 180.9 30.1 13.0 35.8 21.0 62.5 35.2 42.6 51.0 31.4 66.6 37.4 41.4 27.9 24.6 47.5 23.4 178.9 30.5 31.7 56.0 57.9 46.9 13.8 37.2 34.4 56.7 34.4 27.4 28.6 21.7 35.9 46.0 29.2 20.1 36.6 34.6 656.7 55.4 47.5 40.2 31.9 31.7 62.4 42.2 34.3 23.7 42.2 173.0 13.6 48.1 42.7 42.7 30.3 24.3 37.2 26.5 106.0 73.3 10.0 49.2 33.4 43.8 54.1 280.1 44.6 20.3 46.5 83.0 43.2 16.9 56.4 32.9 51.9 47.1 45.3 19.5 43.5 52.4 52.2 11.2 17.1 98.3 22.2 46.0 24.2 40.2 131.3 27.0 23.1 32.0 93.2 35.6 23.8 44.3 17.3 84.5 41.4 22.3 63.6 19.6 58.2 18.1 13.1 49.2 62.4 26.7 36.0 55.1 41.2 21.1 138.2 45.5 24.7 87.5 16.5 34.2 58.4 37.8 17.7 18.0 26.2 143.1 28.9 33.3 14.6 17.7 18.8 18.3 28.4 24.2 32.6 25.2 24.8 18.4 16.9 35.9 17.5 33.8 47.3 16.3 30.1 35.8 35.2 42.6 30.5 31.7 37.2 34.4 35.9 31.9 34.3 42.7 68.4 83.3 25.4 19.6 10.0 64.2 82.7 51.0 24.5 10.0 58.7 67.2 114.1 62.9 42.5 79.1 4.2 29.1 11.8 70.2 144.8 60.0 100.1 37.7 27.8 55.7 22.7 19.1 6.9 73.1 43.1 64.5 39.3 35.8 41.2 53.4 93.9 122.2 46.9 11.8 8.9 48.7 44.7 29.9 35.9 36.3 68.3 22.5 83.6 8.4 56.2 101.3 16.5 18.1 24.8 70.2 132.2 64.3 10.2 46.6 160.3 200.8 50.1 13.9 46.0 53.5 65.8 154.0 85.4 29.2 100.7 15.7 14.8 385.5 61.0 71.2 AASDH "ACSF4, LYS2, NRPS998" ENSG00000157426 "Aminoadipate-semialdehyde dehydrogenase" Q4L235 4 56338287-56387508 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036472, HPA036473" Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "HPA036472: AB_2675142, HPA036473: AB_10673656" "unprognostic (1.95e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (5.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (8.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-3)" "unprognostic (1.59e-1)" "unprognostic (1.73e-1)" "unprognostic (4.52e-2)" "unprognostic (1.85e-3)" 4.3 4.9 3.9 4.7 4.6 4.5 8.4 6.1 4.2 5.8 4.0 4.5 4.5 6.4 8.1 4.6 7.0 4.4 3.7 3.6 4.2 6.7 6.5 4.5 6.4 4.5 4.5 8.4 3.8 7.2 4.2 5.0 4.6 6.4 5.8 11.8 5.6 5.4 4.2 7.1 4.2 5.7 4.1 5.9 4.7 5.0 4.3 6.2 7.1 4.2 6.7 4.3 4.3 5.3 5.0 3.3 8.6 6.6 12.8 14.7 5.3 6.2 7.5 6.3 5.4 3.8 10.2 10.9 5.7 6.8 4.8 3.1 6.3 6.3 7.0 4.4 6.3 5.1 6.3 4.9 11.4 9.4 3.7 8.5 10.2 6.7 10.0 9.1 9.8 6.9 11.9 5.4 7.2 4.9 11.1 7.8 4.8 9.1 4.8 8.2 4.2 5.1 9.0 4.2 5.7 5.5 7.1 11.2 7.2 8.1 8.9 6.0 6.7 4.2 5.6 4.4 4.5 4.3 3.6 7.1 6.6 8.4 4.6 0.0 2.0 1.6 2.8 2.5 3.7 2.4 2.8 2.4 2.2 3.0 4.0 3.0 0.4 2.8 1.6 1.9 2.9 1.3 3.9 4.6 6.1 4.2 3.6 4.2 4.5 4.5 4.6 4.1 4.3 5.3 14.1 6.4 16.2 59.4 17.3 10.1 13.9 26.0 13.6 38.7 21.7 21.2 10.1 14.3 17.3 18.4 27.1 40.7 22.8 9.4 25.4 9.9 26.0 22.0 28.6 13.9 12.1 24.0 26.9 7.6 19.4 17.9 14.8 21.0 20.3 26.4 19.6 21.9 15.4 35.3 36.7 14.7 22.4 17.6 8.7 5.2 16.8 12.6 10.6 19.7 21.5 31.3 20.6 36.2 39.1 6.0 13.4 18.0 9.9 14.2 8.0 29.2 11.2 56.4 6.6 22.5 11.9 43.3 35.0 13.6 15.6 23.9 16.5 23.8 15.9 8.1 ABCC10 "EST182763, MRP7, SIMRP7" ENSG00000124574 "ATP binding cassette subfamily C member 10" Q5T3U5 6 43427366-43450427 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041607, HPA045464" Approved NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 35: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "HPA041607: AB_2677579, HPA045464: AB_2679336" "unprognostic (2.41e-1)" "unprognostic (2.76e-1)" "unprognostic (1.85e-2)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-2)" "unprognostic (3.01e-3)" "unprognostic (1.85e-2)" "unprognostic (8.88e-2)" "unprognostic (2.64e-1)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.75e-1)" "unprognostic (3.85e-1)" "unprognostic (1.58e-1)" "unprognostic (2.80e-2)" 9.2 17.7 18.0 8.2 17.9 7.5 8.9 19.6 24.2 14.4 16.6 12.7 9.4 13.2 8.3 16.3 11.8 6.8 12.4 17.5 17.0 15.5 10.1 10.8 8.7 17.0 17.0 17.6 19.5 5.0 19.6 7.7 17.3 17.3 7.6 4.5 12.7 7.6 7.8 11.0 13.0 8.6 15.7 15.5 13.5 9.2 17.6 8.3 12.8 3.4 7.4 16.2 13.8 17.3 13.3 6.7 8.7 19.9 18.8 12.0 9.0 13.7 9.6 10.1 8.6 14.9 5.6 2.8 15.9 16.7 7.9 16.5 5.8 10.6 7.2 17.1 11.7 9.5 8.4 29.8 11.5 13.2 13.7 20.9 13.9 13.5 7.4 10.0 13.8 8.9 11.3 14.9 12.1 13.1 7.8 20.3 5.6 32.1 8.0 3.9 2.3 9.8 11.7 21.6 12.1 9.8 8.1 11.5 10.2 7.6 11.3 12.8 14.4 12.4 4.2 11.6 16.6 13.3 6.2 6.9 5.8 9.4 5.9 5.0 1.9 2.2 2.9 0.6 1.3 1.0 2.2 2.6 1.1 0.9 1.2 1.8 0.7 1.3 1.5 0.8 2.8 1.8 18.0 17.9 19.6 24.2 17.5 17.0 17.0 17.0 17.3 15.7 17.6 17.3 4.6 3.2 5.6 15.7 5.6 1.1 5.9 6.7 10.2 9.3 3.2 3.8 2.5 4.3 3.4 0.0 10.4 7.1 6.6 5.4 1.9 4.5 1.3 4.9 5.5 5.1 7.8 1.7 16.0 3.3 6.0 4.1 15.3 4.9 6.3 11.8 6.1 2.0 6.9 11.8 14.9 3.6 4.1 4.1 3.3 0.8 7.5 5.2 3.6 9.4 3.4 2.1 13.4 13.6 11.1 4.7 6.1 6.0 7.1 2.1 5.4 3.4 9.9 5.6 0.0 3.3 3.7 2.2 4.5 4.7 1.8 4.4 7.9 14.4 5.4 2.8 ABCD4 "EST352188, P70R, PMP69, PXMP1L" ENSG00000119688 "ATP binding cassette subfamily D member 4" O14678 14 74285269-74303055 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003396 Approved NA NA "Cluster 35: T-regs - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" "HPA003396: AB_1078078" "unprognostic (3.92e-2)" "unprognostic (3.02e-1)" "unprognostic (3.01e-3)" "unprognostic (5.86e-2)" "unprognostic (3.69e-1)" "unprognostic (1.67e-1)" "unprognostic (5.72e-2)" "unprognostic (4.34e-2)" "unprognostic (3.46e-2)" "unprognostic (4.63e-2)" "unprognostic (2.21e-3)" "unprognostic (5.26e-2)" "unprognostic (2.35e-2)" "unprognostic (1.25e-1)" "unprognostic (6.69e-2)" "unprognostic (7.45e-3)" "unprognostic (7.93e-3)" 6.6 4.7 3.0 3.9 3.4 4.6 6.4 4.0 5.4 5.8 2.9 5.4 8.8 4.9 2.1 4.8 8.5 7.7 6.0 3.0 3.3 5.4 7.7 5.8 6.6 4.2 3.4 6.9 6.0 3.8 3.9 7.4 3.7 3.6 4.0 3.3 4.0 3.5 3.9 4.1 8.7 5.2 2.8 6.2 4.5 3.4 3.6 5.5 7.2 2.0 3.8 4.5 4.3 4.5 2.6 3.1 7.9 6.2 6.4 4.3 9.8 3.9 5.6 5.8 6.0 6.5 13.7 4.3 7.4 5.9 3.2 9.2 6.0 5.4 3.0 3.9 3.8 2.3 5.1 5.2 2.1 2.9 4.4 10.4 2.4 4.1 2.8 3.0 9.9 5.4 4.3 1.9 4.5 4.3 7.1 5.6 3.0 5.0 5.9 9.7 11.4 6.3 8.6 8.5 3.7 7.3 5.4 5.3 5.5 3.7 12.3 1.7 9.7 3.6 7.0 3.2 2.5 4.4 4.5 3.3 5.1 4.3 4.5 6.0 1.3 1.8 2.6 1.2 1.7 1.9 2.2 2.9 2.1 1.8 1.2 1.8 1.1 2.6 1.0 4.0 5.2 1.4 3.0 3.4 4.0 5.4 3.0 3.3 4.2 3.4 3.7 2.8 3.6 4.5 50.0 28.9 18.6 32.3 16.7 15.6 14.8 23.0 12.0 46.5 21.4 14.2 9.7 34.3 21.2 20.2 64.6 51.6 28.9 31.4 9.8 25.3 10.3 27.9 23.5 50.2 12.0 9.9 29.6 11.3 19.9 23.0 13.7 20.1 20.3 43.2 44.6 23.3 51.1 32.0 34.7 15.7 18.3 24.8 27.1 7.7 40.4 19.5 21.4 20.6 22.8 36.4 32.0 23.6 38.1 17.9 19.4 25.2 13.3 12.6 60.1 23.9 19.5 55.5 32.9 23.3 19.1 35.8 27.2 10.6 10.7 28.5 23.4 27.9 22.9 16.7 ABCF1 "ABC50, EST123147" ENSG00000204574 "ATP binding cassette subfamily F member 1" Q8NE71 6 30571393-30597179 "Plasma proteins, Predicted intracellular proteins, Transporters" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017578 Approved Enhanced Cytosol NA NA 490000 "Cluster 39: Non-specific - mRNA processing" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA017578: AB_1844438" "unprognostic (5.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.49e-1)" "unprognostic (1.41e-3)" "unprognostic (4.31e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (5.50e-2)" "unprognostic (3.45e-2)" "unprognostic (1.70e-2)" "unprognostic (2.35e-1)" "unprognostic (2.77e-1)" "unprognostic (3.50e-2)" "unprognostic (1.65e-1)" "unprognostic (3.65e-1)" "unprognostic (1.68e-3)" "unprognostic (7.16e-2)" 31.6 27.5 4.5 6.7 5.0 25.5 28.3 4.4 6.4 29.6 3.5 34.0 2.0 34.3 7.4 32.4 24.6 6.8 35.0 4.3 4.9 28.1 32.6 29.9 7.4 5.1 4.8 26.2 32.7 13.5 24.7 10.5 5.0 28.3 11.4 11.1 30.4 5.4 107.0 39.9 32.3 10.2 4.5 30.7 32.4 35.0 5.3 14.7 29.3 4.1 11.3 32.4 30.0 5.6 46.2 33.5 29.4 39.7 40.0 24.5 4.2 30.1 37.6 49.0 53.6 104.8 16.4 33.8 27.1 34.3 51.9 33.3 61.7 39.5 56.2 34.2 65.2 43.0 47.6 14.5 5.5 9.4 5.6 33.6 33.7 68.6 6.4 4.0 5.6 16.9 77.2 4.5 35.3 8.5 9.3 15.5 7.5 31.2 9.4 64.5 7.5 63.3 32.2 52.4 10.2 42.9 20.1 55.3 6.6 5.0 6.1 24.4 28.2 59.0 6.9 3.8 6.2 35.7 47.5 52.8 1.3 43.3 62.2 1.7 5.5 1.5 10.1 4.7 9.3 6.2 7.2 10.2 4.7 5.1 6.3 6.3 1.8 8.0 4.9 5.4 4.1 6.1 4.5 5.0 4.4 6.4 4.3 4.9 5.1 4.8 5.0 4.5 5.3 5.6 42.5 51.3 84.4 7.2 67.9 86.2 100.3 54.2 49.5 48.9 45.5 30.1 87.3 42.9 65.2 58.8 66.7 100.3 77.5 103.3 60.7 93.9 105.0 67.0 95.4 57.2 50.7 50.9 6.8 87.6 139.4 52.6 53.5 115.2 86.9 27.0 36.0 125.4 49.5 55.5 7.4 80.6 28.5 47.4 43.0 176.4 38.8 52.1 35.6 2.8 63.2 39.3 116.4 2.0 9.2 105.9 73.8 51.9 61.8 92.1 66.2 99.0 44.0 112.9 72.3 58.7 54.3 132.5 104.2 50.2 84.8 166.1 70.5 48.2 72.3 87.1 AC019117.1 ENSG00000283321 "Novel protein" 7 17299295-17467234 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "cervix: 8.4;urinary bladder: 15.2" "Cell type enhanced" "Detected in some" "Ductal cells: 1.1;Early spermatids: 2.1;Endometrial ciliated cells: 1.4;Late spermatids: 1.2;Theca cells: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 55.3" HPA029722 Uncertain NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "HPA029722: AB_10599189" 0.1 0.1 0.1 0.2 0.1 0.7 0.1 0.0 0.1 8.4 0.0 0.1 0.3 1.6 0.4 0.2 2.0 0.8 0.0 0.1 0.0 0.1 0.1 1.9 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.3 0.7 0.9 0.3 0.0 0.5 0.1 0.4 0.0 0.2 1.1 0.4 0.1 0.1 0.1 0.0 0.1 15.2 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.5 0.1 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.5 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 55.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 11.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.1 2.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 AC091167.6 ENSG00000275674 "Novel protein" 15 90266317-90314499 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.2;pancreas: 1.1" "Cell type enriched" "Detected in single" 5 "Alveolar cells type 2: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.9;CACO-2: 1.0;U-266/84: 1.1" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" "unprognostic (1.02e-1)" "unprognostic (6.86e-2)" "unprognostic (7.11e-2)" "unprognostic (9.39e-2)" "unprognostic (4.70e-2)" "unprognostic (2.50e-2)" "unprognostic (6.17e-2)" "unprognostic (1.27e-1)" "unprognostic (1.23e-1)" "unprognostic (9.18e-2)" "unprognostic (4.73e-2)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" 0.0 0.0 0.8 0.0 0.5 0.0 0.1 0.2 0.7 0.1 0.0 0.2 1.2 0.1 0.1 0.0 0.2 0.0 0.0 0.5 0.8 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.3 0.2 0.0 0.1 0.1 0.0 0.3 0.5 0.2 0.1 0.0 0.7 0.2 0.1 0.0 0.4 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.3 0.2 0.0 0.0 1.9 0.1 0.0 0.1 0.1 1.0 0.3 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.5 0.1 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.3 0.2 0.1 0.1 0.4 1.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.5 0.2 0.7 0.5 0.8 0.1 0.1 0.1 0.1 0.4 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC118553.2 ENSG00000283761 "Novel protein" 1 99970011-100083321 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 4.1;Collecting duct cells: 1.8;Respiratory ciliated cells: 5.1" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA073681 Approved Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA073681: AB_2686625" 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.2 0.2 0.5 0.2 0.2 0.2 0.1 0.6 0.2 0.1 0.1 0.2 0.3 0.3 0.2 0.7 0.0 0.3 0.2 0.3 0.0 1.0 0.0 0.2 0.4 0.2 0.3 1.0 0.2 0.5 0.1 0.1 0.1 0.4 0.1 0.0 0.2 0.4 0.2 0.7 0.1 0.3 0.2 0.6 0.1 0.3 0.5 0.7 0.9 0.2 0.0 0.6 0.8 1.3 0.5 1.3 2.7 0.5 2.0 0.1 3.3 2.0 2.7 2.1 2.6 0.9 1.7 0.9 1.3 2.2 3.7 0.1 0.2 0.5 0.5 0.0 0.8 2.5 2.2 0.7 1.6 0.3 1.8 1.2 0.7 1.2 2.3 0.1 0.1 2.1 1.1 0.5 2.0 0.9 0.7 1.1 0.6 0.7 1.1 0.6 0.5 0.8 0.6 0.1 0.5 0.8 1.3 0.7 1.4 0.7 2.9 0.3 1.0 1.0 0.3 8.4 5.1 3.5 4.4 5.2 5.0 2.8 4.5 5.2 5.8 1.9 4.2 3.6 0.8 6.7 3.2 4.6 5.9 5.0 0.0 0.3 0.1 0.2 0.2 0.3 0.3 0.2 0.4 0.1 0.2 0.3 0.3 6.4 4.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 1.3 1.8 0.0 0.0 0.6 0.0 0.0 0.2 0.0 1.2 1.3 0.4 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 ACAD10 MGC5601 ENSG00000111271 "Acyl-CoA dehydrogenase family member 10" Q6JQN1 12 111686053-111757107 "Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA067222 Uncertain NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" "HPA067222: AB_2685805" "unprognostic (8.45e-2)" "unprognostic (1.36e-2)" "unprognostic (1.12e-1)" "unprognostic (2.15e-3)" "unprognostic (6.01e-2)" "unprognostic (5.74e-2)" "unprognostic (1.38e-1)" "unprognostic (1.38e-2)" "unprognostic (1.56e-2)" "unprognostic (1.68e-2)" "unprognostic (6.21e-3)" "unprognostic (6.21e-2)" "prognostic favorable (3.71e-6)" "unprognostic (2.37e-2)" "unprognostic (5.81e-2)" "unprognostic (6.45e-2)" "unprognostic (4.87e-2)" 7.5 14.7 4.1 6.6 5.6 9.1 8.2 6.7 5.5 8.2 11.4 13.4 16.0 7.6 10.8 9.0 9.8 7.9 15.1 5.0 4.5 19.3 22.7 6.3 8.7 5.2 4.7 10.3 13.4 18.7 12.1 7.5 5.7 9.7 11.1 9.1 10.6 8.0 13.0 11.9 14.8 7.8 3.7 9.3 12.5 7.7 5.3 10.0 12.9 9.0 8.6 8.5 8.3 8.6 6.8 18.7 7.9 10.3 12.2 15.9 14.2 6.0 9.5 6.5 5.0 6.9 11.2 5.0 6.3 7.0 6.1 15.8 7.4 6.4 3.4 11.8 10.4 8.0 13.7 9.1 12.4 6.7 10.0 18.3 11.5 9.4 9.3 13.7 7.3 11.6 5.6 10.1 5.9 9.5 8.1 10.6 12.4 9.7 12.7 8.7 4.0 14.3 12.6 15.1 7.5 12.0 7.0 12.5 19.1 10.6 28.7 13.0 4.5 5.9 4.5 9.3 5.8 12.8 6.4 8.6 8.8 9.4 9.2 6.9 6.2 3.6 3.6 6.9 3.9 4.0 3.6 3.6 6.1 3.3 3.5 3.5 6.7 4.8 8.6 3.5 5.0 3.6 4.1 5.6 6.7 5.5 5.0 4.5 5.2 4.7 5.7 3.7 5.3 8.6 3.7 6.4 11.6 19.6 7.2 1.9 3.4 5.6 5.7 11.7 5.5 5.5 17.1 7.2 5.7 3.7 25.0 9.4 5.2 9.3 0.0 5.0 12.2 5.7 5.6 5.1 11.4 1.3 11.8 4.7 5.2 4.1 14.3 5.1 2.5 15.0 5.0 14.8 5.7 10.1 14.7 10.6 4.1 6.7 2.3 8.7 5.9 5.8 1.8 9.4 8.0 7.0 3.1 14.1 22.9 3.7 7.8 3.0 5.4 3.4 17.1 12.1 6.1 23.7 0.0 5.5 5.5 11.3 11.7 4.5 2.8 5.6 4.8 10.2 12.9 2.1 ACCS "ACS, PHACS" ENSG00000110455 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive)" Q96QU6 11 44065925-44084237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018873, HPA021654" Approved Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA018873: AB_1855273, HPA021654: AB_1855274" "unprognostic (3.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.98e-1)" "unprognostic (1.86e-1)" "unprognostic (7.86e-3)" "unprognostic (2.01e-2)" "unprognostic (1.40e-1)" "unprognostic (7.57e-3)" "unprognostic (1.41e-1)" "unprognostic (3.38e-2)" "prognostic favorable (4.25e-4)" "unprognostic (6.51e-2)" "unprognostic (3.07e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-1)" "unprognostic (5.63e-3)" "unprognostic (1.92e-2)" 11.4 17.0 1.8 3.7 1.5 10.0 11.2 1.5 2.0 11.1 7.2 8.3 5.4 14.2 8.1 5.5 15.4 10.1 5.8 1.9 2.2 10.4 18.9 9.7 5.5 2.0 1.8 9.8 11.0 2.8 11.0 2.6 1.8 10.9 6.9 1.0 10.3 6.3 3.1 7.8 10.3 6.3 1.5 14.0 10.4 6.5 2.3 4.1 12.7 2.4 6.4 9.1 8.3 2.0 4.0 8.8 0.0 1.0 2.3 4.1 0.0 2.1 2.7 1.9 2.0 0.7 5.6 1.5 1.6 4.7 0.0 6.7 2.4 0.5 1.0 0.5 2.6 6.3 3.3 0.1 4.4 0.0 0.0 4.6 8.2 2.4 1.1 2.6 3.5 0.0 5.0 0.0 5.8 3.0 0.0 2.5 3.4 5.1 1.3 5.5 0.0 0.0 4.8 2.6 1.1 3.5 2.1 1.1 2.5 2.2 8.6 3.8 3.8 2.2 2.3 3.5 1.1 0.0 0.0 0.2 5.3 0.0 2.3 0.9 3.1 5.6 0.8 3.1 0.7 1.1 0.7 1.3 4.4 1.4 1.1 0.7 0.0 0.9 2.5 3.3 1.2 2.0 1.8 1.5 1.5 2.0 1.9 2.2 2.0 1.8 1.8 1.5 2.3 2.0 12.2 12.8 22.7 11.8 4.6 2.7 2.7 4.0 6.8 1.9 8.6 10.2 4.0 7.2 8.9 9.2 0.0 3.1 4.0 6.4 0.0 2.3 2.1 8.6 3.9 7.0 7.2 3.4 3.4 4.2 0.4 6.9 13.7 5.0 9.5 11.0 8.2 9.7 6.1 0.0 3.3 8.2 4.1 7.0 5.5 4.4 9.6 9.0 0.0 5.6 9.4 2.6 7.2 4.5 6.6 2.9 8.0 7.5 2.5 2.1 16.6 6.5 7.4 1.0 0.0 3.7 4.7 0.7 2.4 2.4 2.3 1.9 3.3 9.2 6.4 2.1 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453890-38493142 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.9;NTERA-2: 25.9;SuSa: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025115, HPA040384" Approved NA No "Cluster 54: Non-specific - Microtubule organization" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "CAB025115: , HPA040384: AB_2732484" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 1.1 2.8 3.2 0.6 3.2 0.2 1.7 5.2 2.8 1.9 1.0 1.5 0.9 1.7 1.7 0.7 1.9 0.6 1.4 2.6 3.0 1.8 2.2 1.3 0.7 2.6 3.2 2.9 2.5 3.3 2.0 2.5 2.6 1.3 1.1 6.5 1.7 1.3 6.0 0.7 1.1 0.9 2.3 1.0 1.5 2.5 2.9 4.1 1.6 2.8 0.6 1.4 1.4 3.6 1.1 1.8 20.9 1.8 0.8 0.5 11.2 0.4 0.7 0.4 0.9 3.1 1.4 0.1 1.6 0.5 0.6 1.3 8.1 1.3 1.1 3.2 5.2 5.6 3.5 4.6 1.0 4.0 2.0 0.8 1.2 0.6 2.3 1.3 1.4 8.0 9.4 1.8 0.4 1.7 6.9 2.5 25.9 1.1 0.9 2.2 7.0 1.4 1.3 2.6 4.9 8.5 0.6 3.2 3.0 14.7 1.7 5.2 1.2 0.7 3.3 0.5 1.8 5.0 7.3 1.2 0.7 3.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 3.2 5.2 2.8 2.6 3.0 2.6 3.2 2.6 2.3 2.9 3.6 7.0 6.4 6.1 9.4 0.7 4.0 4.6 2.1 4.0 23.0 5.2 5.0 15.0 2.8 3.6 0.0 22.9 8.5 1.3 3.1 0.0 3.6 11.3 8.7 7.0 7.5 7.2 0.4 12.6 3.8 7.6 3.8 2.6 5.3 1.3 17.9 7.9 8.7 2.6 21.9 17.0 4.1 0.0 2.2 6.4 15.8 11.8 2.4 7.2 5.6 0.7 7.6 0.0 15.1 17.2 3.2 5.3 7.9 1.4 5.2 4.8 3.1 7.1 25.4 0.0 9.7 7.7 11.4 17.9 1.8 4.0 6.2 2.6 7.4 4.4 3.9 ADAMTS12 ENSG00000151388 "ADAM metallopeptidase with thrombospondin type 1 motif 12" P58397 5 33523535-33892019 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 25.2;Fibroblasts: 22.9;Leydig cells: 22.1;Microglial cells: 73.1;Sertoli cells: 52.6;Theca cells: 55.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 47.4;hTERT-RPE1: 88.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA035973, HPA075079" Uncertain Approved Nucleoli,Mitochondria "Secreted to extracellular matrix" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 52: Non-specific - Transcription" Nucleoli Mitochondria "HPA035973: AB_10669663, HPA075079: AB_2732278" "unprognostic (6.18e-3)" "unprognostic (3.12e-4)" "unprognostic (1.05e-1)" "unprognostic (8.37e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-1)" "unprognostic (2.60e-2)" "unprognostic (3.49e-3)" "unprognostic (3.78e-3)" "unprognostic (3.39e-2)" "unprognostic (5.63e-3)" "unprognostic (1.45e-1)" "unprognostic (4.27e-7)" "unprognostic (4.45e-3)" "unprognostic (1.47e-1)" "unprognostic (5.85e-2)" "prognostic unfavorable (6.78e-4)" 9.0 5.2 0.9 1.6 0.7 0.0 7.8 0.5 0.4 2.7 1.7 2.5 0.5 3.8 0.5 0.9 3.2 4.0 1.6 0.2 0.4 1.3 1.4 5.6 0.9 1.2 0.9 2.7 0.6 0.5 0.6 3.9 1.0 1.3 1.0 0.7 0.9 1.4 0.8 1.5 1.1 6.5 1.5 0.5 1.2 2.0 1.3 0.3 1.9 0.7 0.6 2.2 2.0 3.3 28.7 0.9 25.5 0.0 35.9 17.2 0.0 13.3 33.1 16.8 19.5 0.0 0.0 0.0 0.0 9.0 29.1 0.8 0.7 16.7 24.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 13.8 0.0 47.4 12.2 88.0 0.0 0.0 0.0 0.1 26.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 29.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.0 0.0 28.0 36.2 0.3 7.9 4.4 3.5 0.0 23.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.5 0.4 0.2 0.4 1.2 0.9 1.0 1.5 1.3 3.3 6.4 0.0 0.0 1.3 0.5 0.8 0.0 0.0 0.0 0.1 1.5 2.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 4.9 1.2 25.2 2.1 0.0 0.0 3.0 0.2 0.4 22.9 0.0 0.6 0.0 3.3 11.4 0.2 0.6 0.0 6.2 0.0 0.0 0.3 2.1 3.0 22.1 0.2 7.2 73.1 0.0 5.3 0.0 0.5 7.8 0.1 0.0 17.7 0.0 0.1 0.0 2.4 0.7 0.2 52.6 1.7 19.1 0.4 4.7 0.1 0.9 0.8 0.3 55.4 0.0 0.1 ADAMTS14 ENSG00000138316 "ADAM metallopeptidase with thrombospondin type 1 motif 14" Q8WXS8 10 70672506-70762441 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.9;gallbladder: 6.7;placenta: 7.6" "Group enriched" "Detected in some" 5 "Oligodendrocytes: 44.8;Paneth cells: 14.6;Theca cells: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.1;K-562: 10.4;RH-30: 5.4;U-138 MG: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (5.98e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-3)" "unprognostic (2.40e-1)" "unprognostic (5.33e-3)" "unprognostic (2.35e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.98e-2)" "unprognostic (6.81e-2)" "unprognostic (3.84e-13)" "unprognostic (3.90e-2)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" "unprognostic (2.16e-2)" 0.8 0.2 2.6 3.2 5.9 0.6 0.3 2.0 5.4 1.0 0.4 2.7 2.3 0.7 0.4 1.0 0.5 6.7 0.7 2.9 3.7 0.5 0.3 1.7 1.1 3.2 4.3 0.2 0.2 0.0 0.1 7.6 3.2 0.6 1.8 0.0 0.8 0.1 0.1 1.3 3.2 2.2 1.4 0.4 1.4 0.5 10.9 0.4 0.2 0.3 0.7 2.5 0.4 9.9 0.0 0.0 0.1 0.3 0.2 4.0 0.0 1.0 3.2 0.3 1.7 0.0 9.1 0.0 0.7 1.7 0.4 0.7 0.0 0.0 0.1 3.6 0.0 0.3 0.0 0.2 0.0 0.0 2.4 0.3 0.1 0.8 0.2 1.0 0.0 0.0 10.4 0.0 1.3 0.0 0.0 0.9 0.3 0.1 0.0 0.0 5.4 0.2 0.0 0.0 3.4 0.5 0.0 0.1 0.3 0.1 0.0 0.0 0.0 8.9 0.1 0.7 0.5 0.8 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 5.9 2.0 5.4 2.9 3.7 3.2 4.3 3.2 1.4 10.9 9.9 0.1 0.0 0.0 0.3 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.1 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.1 0.5 0.1 0.3 0.0 2.1 0.3 0.0 0.1 2.1 0.0 0.2 4.5 0.1 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.8 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 2.0 44.8 0.1 14.6 0.0 0.1 0.0 0.7 0.0 1.4 0.0 0.0 1.8 1.1 0.0 0.0 0.2 0.1 0.4 0.0 17.9 0.5 0.1 ADAMTS7 "ADAM-TS7, DKFZp434H204" ENSG00000136378 "ADAM metallopeptidase with thrombospondin type 1 motif 7" Q9UKP4 15 78759206-78811464 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "heart muscle: 30.6" "Cell type enriched" "Detected in some" 4 "Theca cells: 44.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "HMC-1: 259.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA045284, HPA048453" Uncertain Supported Vesicles "Secreted to extracellular matrix" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Vesicles "HPA045284: AB_2679285, HPA048453: AB_2680399" "unprognostic (5.94e-3)" "unprognostic (9.94e-3)" "unprognostic (2.76e-2)" "unprognostic (7.09e-2)" "unprognostic (3.38e-1)" "unprognostic (1.93e-1)" "unprognostic (5.88e-4)" "unprognostic (3.34e-3)" "unprognostic (2.89e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-2)" "unprognostic (3.79e-1)" "unprognostic (1.34e-2)" "prognostic unfavorable (9.53e-4)" "unprognostic (1.59e-1)" "unprognostic (2.66e-2)" "unprognostic (8.86e-2)" 6.6 5.3 0.5 1.8 0.4 0.1 3.8 0.3 0.5 6.0 0.6 4.2 1.1 7.2 0.1 0.9 2.2 2.3 30.6 0.4 0.5 2.2 1.1 6.3 0.9 0.5 0.5 6.1 0.5 0.4 0.8 2.1 0.4 1.8 0.2 0.5 1.3 0.4 1.1 1.8 2.6 1.4 0.2 5.2 2.2 4.1 0.7 0.1 2.1 0.5 0.2 3.0 2.5 0.6 0.0 1.1 16.5 7.5 6.9 8.2 20.9 3.7 1.3 1.0 0.6 0.0 0.1 0.0 4.8 0.4 1.0 0.4 0.4 2.0 0.0 0.3 0.6 2.1 0.5 0.1 6.9 0.0 259.9 3.3 2.0 1.9 1.0 5.3 24.0 0.0 0.3 0.7 5.6 0.0 0.1 4.9 4.7 0.0 1.4 17.3 7.7 0.3 0.5 0.9 0.3 23.9 4.8 0.0 0.6 4.0 3.2 0.4 29.8 9.4 1.0 3.3 0.0 0.1 0.0 0.0 1.6 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.3 0.5 0.4 0.5 0.5 0.5 0.4 0.2 0.7 0.6 7.5 0.0 0.0 3.6 0.3 0.4 0.2 0.7 0.0 0.3 0.1 0.5 9.8 0.0 0.3 0.0 0.0 0.3 0.2 0.1 0.0 0.1 4.9 0.8 7.5 10.5 0.0 0.0 0.1 0.0 0.3 10.1 0.5 0.9 3.8 7.2 2.9 0.3 0.7 0.0 0.2 0.0 2.0 0.0 0.8 2.7 1.5 0.1 1.8 1.0 0.1 1.3 0.0 9.5 1.4 0.3 0.0 1.9 0.0 0.3 0.0 0.1 0.3 0.1 0.0 3.7 5.0 2.6 2.0 0.2 0.1 0.3 0.5 44.9 0.1 0.3 ADAR "ADAR1, G1P1, IFI4" ENSG00000160710 "Adenosine deaminase RNA specific" P55265 1 154581695-154628013 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing" "DNA-binding, Hydrolase, RNA-binding" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003890, HPA051519, CAB056157" Enhanced Enhanced Nucleoplasm,Nucleoli No No "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoli Nucleoplasm "CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520" "unprognostic (3.46e-1)" "unprognostic (8.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.83e-2)" "unprognostic (2.38e-1)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (2.90e-1)" "unprognostic (4.13e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.30e-5)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (9.00e-2)" "unprognostic (3.94e-2)" 41.9 44.7 30.4 57.2 29.9 47.1 41.1 18.0 35.1 49.4 16.3 42.9 46.4 50.2 26.3 37.9 50.3 45.6 36.1 31.5 40.0 51.7 56.1 54.6 66.1 32.1 33.8 54.9 40.6 62.8 53.9 46.5 34.8 42.8 44.4 47.9 59.4 43.0 18.8 39.9 52.8 56.6 39.2 73.5 40.3 34.4 37.8 85.2 47.1 27.6 65.0 50.5 40.0 25.5 93.2 103.1 84.4 104.8 87.4 88.5 97.8 59.5 132.7 209.8 183.4 87.8 85.3 162.6 97.7 98.7 112.4 85.4 111.9 115.5 109.8 159.1 52.3 84.9 66.2 48.4 96.7 122.8 83.8 86.2 84.7 100.4 104.1 81.2 104.5 112.4 82.4 111.6 72.0 107.8 165.0 43.3 139.7 125.5 74.6 140.1 74.2 131.2 67.6 106.1 84.8 100.2 104.4 167.9 126.2 128.1 113.4 148.2 94.3 67.5 68.5 58.8 71.5 132.9 179.0 177.6 70.2 78.4 81.0 7.8 8.1 15.0 10.8 9.9 10.2 9.0 10.6 11.2 7.8 5.8 9.8 10.0 29.1 8.6 9.4 6.3 9.1 7.4 30.4 29.9 18.0 35.1 31.5 40.0 32.1 33.8 34.8 39.2 37.8 25.5 73.3 83.3 51.2 37.5 80.5 33.3 39.4 39.9 32.5 94.5 43.6 36.6 22.1 45.8 44.0 47.8 95.9 41.2 103.0 73.3 9.8 49.2 4.2 48.9 61.0 86.7 63.1 45.2 44.8 66.9 57.8 49.1 56.6 52.4 62.1 88.6 84.9 93.8 53.5 168.2 53.2 53.9 34.6 104.1 43.9 13.1 73.7 78.0 19.6 32.8 110.2 37.9 126.7 38.2 39.7 69.6 62.7 59.0 87.5 61.1 86.7 42.5 50.0 80.2 52.6 40.1 45.2 11.4 35.0 37.9 40.3 31.5 85.6 66.5 56.2 53.8 AGO1 "EIF2C1, hAGO1" ENSG00000092847 "Argonaute RISC component 1" Q9UL18 1 35869808-35930532 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Repressor, Ribonucleoprotein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067849 Supported "Cytosol,Cytoplasmic bodies" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Cytoplasmic bodies" Cytosol "HPA067849: " "unprognostic (2.35e-1)" "unprognostic (3.14e-2)" "unprognostic (1.27e-2)" "unprognostic (8.66e-3)" "unprognostic (1.20e-1)" "unprognostic (3.71e-2)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.61e-2)" "unprognostic (6.08e-2)" "unprognostic (1.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.60e-4)" "unprognostic (7.52e-2)" "unprognostic (1.74e-1)" "unprognostic (7.57e-2)" "unprognostic (5.77e-3)" 6.2 6.6 10.7 7.6 9.5 6.5 6.5 7.1 8.6 7.0 7.5 6.5 6.7 7.1 5.0 5.8 6.6 4.8 7.2 8.9 9.3 6.2 4.7 6.4 6.7 9.1 9.7 8.0 5.7 10.1 5.1 5.1 9.1 8.1 7.0 6.7 6.5 8.6 8.6 11.0 7.4 7.9 11.3 8.9 6.4 5.2 8.4 9.0 6.0 7.9 8.4 5.1 4.4 9.1 14.2 9.4 21.1 18.7 14.4 8.6 23.2 7.3 11.1 12.6 11.9 19.2 9.9 16.0 9.0 14.6 8.7 7.5 30.4 11.7 15.3 14.9 10.0 32.4 15.4 16.8 6.4 19.4 12.5 7.1 5.5 21.3 10.9 8.0 18.2 13.7 24.0 8.9 10.3 10.9 20.4 10.0 47.6 19.1 8.0 15.3 15.9 6.8 5.5 17.8 26.1 11.6 25.6 10.5 8.4 23.7 8.5 7.7 14.9 9.8 21.6 13.7 13.9 9.1 7.9 7.4 10.3 11.6 12.7 1.9 3.8 1.8 1.9 5.1 1.7 1.6 1.4 1.7 1.6 1.4 1.6 1.5 2.4 1.4 4.1 1.6 1.3 4.5 10.7 9.5 7.1 8.6 8.9 9.3 9.1 9.7 9.1 11.3 8.4 9.1 10.1 3.2 9.3 11.4 11.8 13.9 7.2 6.4 17.6 34.0 13.0 9.9 15.8 12.8 9.1 14.7 39.6 5.2 25.4 12.6 1.9 11.5 5.2 11.6 12.4 13.3 25.9 5.5 15.3 13.2 4.7 10.6 9.7 7.7 16.5 12.5 10.0 13.4 13.3 35.3 15.6 15.5 6.1 30.5 20.0 6.7 14.9 19.2 5.4 4.7 23.9 12.9 20.6 13.6 14.5 11.3 11.1 20.7 7.9 10.6 29.4 10.1 11.4 30.5 13.1 13.1 15.5 12.7 16.8 10.8 14.5 2.3 10.7 14.7 16.2 7.2 AGO3 "EIF2C3, FLJ12765, hAGO3" ENSG00000126070 "Argonaute RISC catalytic component 3" Q9H9G7 1 35930718-36072500 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 155.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048342, HPA067849, HPA075436" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Cytoplasmic bodies" "Nucleoplasm, Cytosol" "HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750" "unprognostic (4.10e-2)" "unprognostic (7.10e-2)" "unprognostic (4.94e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (1.89e-2)" "unprognostic (2.12e-2)" "unprognostic (4.39e-4)" "unprognostic (5.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-1)" "unprognostic (4.97e-2)" "unprognostic (2.96e-2)" "unprognostic (9.28e-3)" "unprognostic (1.61e-1)" "unprognostic (4.45e-2)" "unprognostic (9.06e-2)" "unprognostic (1.81e-1)" 3.6 2.8 4.5 2.6 8.4 7.4 2.9 6.9 6.9 3.3 7.4 3.0 1.4 2.9 3.2 2.7 2.7 1.9 3.4 4.6 6.9 2.5 4.3 3.5 3.0 8.5 7.2 3.7 2.9 3.3 6.2 3.5 7.4 3.2 2.0 5.1 2.5 2.2 3.2 3.8 2.5 2.7 6.8 2.8 2.8 5.6 8.0 3.3 3.2 4.4 3.1 3.0 3.0 14.0 6.6 4.4 5.5 4.4 7.5 4.6 6.7 5.2 5.4 7.9 8.4 4.9 7.2 7.2 6.5 5.4 9.1 5.3 5.9 3.8 10.5 9.9 3.7 8.8 8.3 3.7 4.0 8.5 7.2 2.2 3.4 11.4 7.2 3.1 6.8 7.4 9.8 10.2 7.0 2.5 6.5 4.6 9.6 3.4 7.8 7.5 7.4 7.1 2.5 6.2 6.7 4.2 9.4 2.3 3.3 8.3 3.5 3.5 5.4 5.5 13.9 4.9 6.4 5.6 10.5 9.9 2.8 5.4 5.4 9.8 4.3 13.2 4.9 4.1 3.1 6.5 3.1 3.4 4.8 6.4 4.4 4.3 13.0 5.4 6.1 4.2 3.4 2.3 4.5 8.4 6.9 6.9 4.6 6.9 8.5 7.2 7.4 6.8 8.0 14.0 32.2 86.6 43.2 80.6 32.6 38.7 35.9 17.8 35.3 69.1 26.1 17.8 19.1 17.2 23.0 25.8 112.6 11.8 36.6 13.2 0.0 15.8 56.0 26.6 43.0 33.8 46.7 18.7 103.8 12.2 14.8 42.3 19.9 35.6 55.9 31.6 36.8 24.7 16.4 42.1 101.1 16.0 20.3 31.7 45.1 76.7 37.9 29.7 23.2 70.3 36.9 35.2 27.8 141.8 155.9 17.3 9.1 41.3 24.7 41.1 15.0 8.8 17.5 89.6 19.7 64.4 29.9 37.5 22.1 20.0 33.5 12.9 35.3 31.0 17.5 27.9 AKAP10 "D-AKAP2, MGC9414, PRKA10" ENSG00000108599 "A-kinase anchoring protein 10" O43572 17 19904302-19978343 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028901 Approved Supported "Plasma membrane,Cytosol" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA028901: AB_10602227" "unprognostic (2.17e-2)" "unprognostic (3.48e-2)" "unprognostic (5.33e-1)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-3)" "unprognostic (3.88e-1)" "unprognostic (7.69e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (3.21e-2)" "unprognostic (3.21e-2)" "unprognostic (2.49e-2)" "unprognostic (7.15e-2)" "unprognostic (2.16e-2)" "unprognostic (5.20e-2)" 11.4 13.3 10.5 12.3 12.4 10.6 12.3 11.4 13.6 11.5 15.1 11.4 9.5 12.4 8.8 10.6 10.4 10.7 7.4 11.3 11.6 13.1 8.1 11.0 16.0 9.9 10.7 13.5 8.4 15.1 7.5 12.2 10.6 10.9 11.6 15.3 9.8 11.7 7.2 9.5 10.1 13.3 10.4 14.9 11.1 14.2 13.8 14.1 15.1 9.4 12.5 11.3 10.2 14.7 18.1 21.3 13.9 9.7 18.0 22.5 25.7 20.6 21.9 22.4 26.7 23.2 10.6 15.4 13.6 16.4 19.4 18.8 18.1 17.2 30.4 12.8 15.4 13.2 20.2 11.4 17.0 9.7 20.7 19.1 21.1 20.5 25.1 25.0 18.3 18.5 8.6 7.5 23.6 13.1 18.1 14.3 9.1 25.1 7.2 11.8 45.5 8.1 18.7 11.3 4.7 14.1 23.6 11.0 19.7 84.8 26.7 10.7 16.1 17.2 14.2 14.8 19.3 9.3 10.7 18.8 22.8 11.5 17.0 4.9 9.7 12.6 8.6 14.4 8.0 8.4 8.4 9.4 8.5 9.2 10.0 8.9 33.8 7.6 13.9 6.3 7.1 4.3 10.5 12.4 11.4 13.6 11.3 11.6 9.9 10.7 10.6 10.4 13.8 14.7 13.4 3.2 12.3 71.2 24.4 7.0 9.7 8.9 10.2 24.6 11.1 9.0 8.4 21.5 11.9 5.5 16.7 14.9 16.8 15.8 1.9 9.9 12.8 11.0 14.8 12.6 7.2 15.2 55.1 7.2 11.1 11.7 14.8 10.8 10.1 18.0 16.8 13.6 16.5 33.7 54.6 9.9 12.2 35.1 10.5 13.9 15.2 21.4 5.4 61.8 32.3 11.7 25.7 51.8 78.5 7.9 15.2 13.9 11.2 15.6 14.6 5.7 15.3 23.2 19.7 10.5 11.2 23.1 23.6 11.0 7.7 14.0 19.0 15.6 11.8 12.1 AKAP17A "721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y" ENSG00000197976 "A-kinase anchoring protein 17A" Q02040 X 1591604-1602520 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043247, HPA051020" Supported Supported "Nuclear speckles,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA043247: AB_10964776, HPA051020: AB_2681314" "unprognostic (4.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.40e-4)" "unprognostic (5.38e-2)" "unprognostic (1.59e-2)" "unprognostic (9.73e-3)" "unprognostic (6.25e-2)" "unprognostic (2.09e-1)" "unprognostic (7.91e-3)" "prognostic favorable (2.42e-4)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.52e-7)" "unprognostic (1.86e-2)" "unprognostic (2.71e-1)" "unprognostic (4.03e-2)" "prognostic favorable (1.11e-5)" 35.2 46.9 13.7 33.8 15.0 44.6 37.3 12.3 15.2 45.6 15.1 38.6 30.9 35.2 20.1 38.5 39.5 16.5 34.9 13.0 11.9 39.3 70.1 51.5 36.0 16.4 14.1 73.0 66.4 12.6 46.6 17.3 13.5 50.7 9.9 7.5 41.5 15.9 17.4 35.6 49.4 7.6 12.1 83.0 41.3 31.8 16.3 27.2 62.7 9.2 20.1 32.2 38.0 20.3 23.8 29.8 23.4 26.5 11.3 14.4 57.1 25.1 10.2 19.8 16.6 33.3 21.3 35.5 15.8 12.6 27.9 20.4 14.3 12.6 11.8 29.3 49.2 44.3 32.6 31.3 24.1 17.3 71.3 12.8 22.8 14.8 16.4 23.6 13.8 17.7 28.2 21.8 11.7 15.6 38.5 74.4 35.0 5.5 25.6 28.9 27.9 30.0 13.2 16.3 26.1 38.1 19.7 31.5 31.5 19.2 20.6 31.3 26.9 30.8 14.0 26.9 22.1 93.7 17.0 49.1 12.5 27.7 8.4 4.5 0.5 0.9 0.3 0.2 0.4 0.9 0.4 0.7 0.3 0.5 0.3 0.3 1.9 0.7 0.4 0.8 0.2 0.2 13.7 15.0 12.3 15.2 13.0 11.9 16.4 14.1 13.5 12.1 16.3 20.3 41.2 25.6 25.3 1.3 53.5 44.4 36.1 10.6 36.5 24.1 41.5 29.8 12.0 12.8 19.4 12.9 10.4 25.1 67.0 39.9 13.7 21.2 52.1 29.6 32.7 35.1 22.6 14.5 0.8 15.5 32.4 31.5 39.3 41.1 25.4 49.8 32.2 21.3 22.8 16.8 0.8 38.7 12.2 25.7 54.5 18.9 38.8 37.4 40.9 0.0 38.0 21.5 54.6 2.0 2.7 24.4 35.9 31.6 65.0 41.9 22.6 7.9 14.4 15.4 0.0 28.4 23.2 20.6 27.6 31.7 47.2 72.7 51.1 131.7 28.6 46.2 AKT2 PKBβ ENSG00000105221 "AKT serine/threonine kinase 2" P31751 19 40230317-40285536 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Diabetes mellitus, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004204, HPA064521" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles, Cytosol" "CAB004204: AB_626659, HPA064521: AB_2685278" "unprognostic (6.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.85e-1)" "unprognostic (6.40e-3)" "unprognostic (9.59e-2)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (2.49e-2)" "unprognostic (3.02e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (1.30e-2)" "unprognostic (1.89e-1)" "unprognostic (3.28e-1)" "unprognostic (6.16e-2)" "unprognostic (2.00e-1)" 62.8 40.0 31.7 37.3 31.3 48.4 38.6 58.3 40.0 49.8 55.1 42.3 24.5 43.5 49.4 42.5 46.1 25.1 40.8 31.5 24.5 52.2 59.2 30.7 38.1 32.0 26.0 53.9 41.9 58.5 47.8 27.6 26.3 41.2 23.3 41.2 32.5 45.0 101.3 39.4 35.6 34.2 22.1 38.1 33.1 29.7 28.0 53.4 100.1 118.7 37.0 39.8 41.5 35.2 66.2 160.1 63.1 61.5 72.0 88.9 32.5 41.7 63.5 87.6 77.9 71.8 60.8 67.4 36.8 96.3 37.2 28.2 66.8 90.0 56.1 62.5 74.3 43.4 116.5 44.7 45.8 50.7 50.5 82.7 53.6 58.6 56.4 71.9 19.0 73.0 57.3 67.5 49.8 54.6 81.1 24.7 31.7 73.7 41.5 54.2 32.1 48.5 68.3 105.7 82.7 49.8 43.3 75.0 35.0 62.5 59.8 64.9 18.8 52.7 51.5 47.3 67.6 61.5 59.0 56.4 52.6 59.7 44.3 5.7 2.6 2.1 2.2 1.2 2.2 1.9 1.8 1.5 1.7 2.9 1.7 2.6 4.0 1.7 1.6 4.9 1.6 1.7 31.7 31.3 58.3 40.0 31.5 24.5 32.0 26.0 26.3 22.1 28.0 35.2 18.1 16.0 15.9 51.2 33.0 23.8 23.9 20.9 26.2 67.6 25.3 23.9 31.2 30.0 18.1 60.7 41.7 31.3 26.0 23.7 21.5 19.7 5.5 26.2 26.7 17.4 19.2 19.1 30.4 30.4 25.2 27.9 20.9 25.8 14.0 44.2 13.9 87.5 22.3 60.6 25.3 20.1 22.4 23.2 17.5 10.5 42.9 20.0 23.2 23.4 21.7 46.2 50.4 41.7 40.6 24.8 16.9 26.7 30.4 29.7 21.8 24.8 24.9 97.4 19.7 29.3 25.0 14.8 15.6 31.1 27.4 38.7 23.1 56.9 23.3 29.4 AL354822.1 ENSG00000278384 Unmapped 51867-54893 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 6.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 8.1;Granulosa cells: 9.1;Rod photoreceptor cells: 7.5;Theca cells: 8.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" 0.6 2.2 2.7 1.2 3.6 0.3 0.7 1.3 3.2 0.5 2.5 1.0 0.9 1.3 0.7 1.0 1.1 0.7 1.8 2.6 3.1 0.7 0.7 0.8 1.3 5.1 3.5 1.3 0.8 0.9 0.7 4.9 1.0 1.0 5.6 1.0 0.5 1.3 2.8 1.5 1.0 1.9 1.8 0.8 1.4 3.8 0.3 1.7 0.4 0.7 0.4 6.1 0.0 0.7 0.0 4.0 0.0 0.0 3.4 0.3 0.8 0.0 0.1 0.8 2.8 1.1 0.9 0.7 0.8 0.3 1.1 1.8 0.1 0.6 2.2 2.2 5.0 2.5 0.1 0.8 4.6 0.1 2.4 0.6 0.0 0.6 0.3 0.1 4.2 5.5 0.5 1.9 0.3 0.3 1.6 1.0 1.7 0.0 0.6 4.4 1.1 0.6 3.2 2.3 0.0 1.6 0.8 1.2 2.1 0.7 2.6 1.2 2.5 0.9 2.1 4.0 3.0 0.0 1.9 0.6 4.5 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.5 0.0 0.0 2.7 3.6 1.3 3.2 2.6 3.1 5.1 3.5 4.9 1.9 3.8 6.1 0.6 3.2 4.1 0.0 1.2 1.7 0.8 2.7 1.2 8.1 0.7 0.8 0.0 1.5 1.7 1.8 4.2 1.3 1.6 0.8 0.0 1.0 0.1 3.6 4.1 1.5 0.0 0.4 0.0 0.9 0.5 2.4 2.0 5.9 0.0 9.1 2.5 0.9 0.4 3.3 0.0 0.5 6.1 0.8 1.9 0.1 2.1 0.7 1.8 0.0 1.2 1.6 5.2 0.0 0.0 1.0 0.3 1.5 1.3 1.4 0.5 0.4 6.9 7.5 0.0 3.9 2.2 0.0 0.1 0.9 2.8 0.4 1.7 8.5 0.5 0.9 ALG10B KCR1 ENSG00000175548 "ALG10 alpha-1,2-glucosyltransferase B" Q5I7T1 12 38316762-38329721 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043329, HPA063387" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA043329: AB_2678432, HPA063387: AB_2685000" "unprognostic (4.55e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-1)" "unprognostic (1.25e-1)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (4.43e-2)" "unprognostic (8.58e-2)" "unprognostic (7.40e-2)" "unprognostic (8.40e-2)" "unprognostic (1.17e-1)" "unprognostic (2.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.30e-3)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (2.28e-1)" 2.9 3.5 2.1 3.0 2.3 4.3 5.2 3.1 2.5 2.8 1.8 2.1 2.4 3.7 3.7 1.8 3.4 2.6 2.2 1.8 2.0 3.3 3.7 2.5 4.6 2.5 2.3 5.0 2.9 3.7 1.1 5.0 2.6 3.4 2.6 9.1 2.8 2.2 1.5 4.3 2.6 2.5 2.6 4.6 3.7 2.6 2.2 4.0 4.2 2.4 3.7 1.5 1.4 3.1 5.1 4.6 6.1 6.2 3.0 5.5 6.3 4.0 2.0 5.3 4.6 1.7 15.2 8.0 7.2 2.3 4.1 5.3 5.7 4.4 7.6 5.2 6.8 8.4 8.4 3.5 3.5 11.3 6.1 3.1 5.7 7.5 5.5 4.7 4.2 10.4 9.6 4.6 4.8 3.9 7.5 8.9 7.8 0.5 4.6 2.5 13.2 6.3 4.4 6.4 1.8 6.3 7.1 2.3 5.0 6.6 10.6 4.6 3.3 5.5 6.6 4.9 5.2 3.6 10.1 12.5 4.7 7.7 7.3 0.3 0.4 0.6 0.3 0.5 0.5 0.4 0.3 0.4 0.3 1.3 0.5 0.7 0.1 0.4 0.4 0.7 1.2 0.3 2.1 2.3 3.1 2.5 1.8 2.0 2.5 2.3 2.6 2.6 2.2 3.1 7.1 6.4 13.9 9.1 2.6 2.0 3.4 3.3 4.0 14.9 5.0 3.8 3.9 0.0 7.0 3.7 33.3 16.1 2.1 0.9 7.9 4.3 0.3 6.5 6.2 5.7 0.0 2.5 4.8 5.8 9.6 4.8 2.0 4.6 1.3 9.5 6.8 7.1 4.8 10.1 5.7 1.9 4.1 1.6 2.0 1.8 4.1 3.1 1.8 10.3 2.5 8.0 1.0 9.0 9.1 4.5 2.0 5.7 1.6 2.0 2.6 2.6 5.2 14.5 6.6 6.5 3.2 10.7 4.7 3.1 1.8 8.1 3.0 4.6 2.3 2.3 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431672 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease variant, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 41.5;ovary: 33.1" "Group enriched" "Detected in some" 4 "granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "HEL: 40.1;K-562: 22.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 11 "hippocampal formation: 9.4" "HPA060228, HPA069636" Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 51: Non-specific - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" Vesicles "Nucleoplasm, Cytosol" "HPA060228: AB_2684227, HPA069636: AB_2686163" "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.6 41.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.4 0.1 0.5 0.0 0.3 0.0 0.9 0.4 0.0 0.0 0.2 33.1 12.5 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 4.2 0.1 0.1 0.0 0.0 5.7 0.7 9.1 0.5 0.0 0.0 1.8 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 40.1 0.0 0.8 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 22.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 3.5 2.6 0.0 0.1 1.5 0.0 4.2 0.1 2.1 0.1 2.7 0.0 0.1 26.0 36.1 11.4 0.3 0.1 0.0 0.0 0.0 0.0 1.2 0.0 2.5 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.1 0.3 0.0 0.0 0.3 0.8 94.9 0.1 0.0 ANAPC7 APC7 ENSG00000196510 "Anaphase promoting complex subunit 7" Q9UJX3 12 110372900-110403730 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009567 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "CAB009567: AB_2227137" "unprognostic (2.49e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.36e-2)" "unprognostic (2.02e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (3.20e-1)" "unprognostic (7.08e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.36e-10)" "unprognostic (1.45e-1)" "unprognostic (9.92e-2)" "unprognostic (3.08e-2)" "unprognostic (1.58e-2)" 14.4 19.0 11.8 14.0 14.3 12.6 15.7 12.7 16.1 20.1 11.8 18.8 10.6 21.4 16.7 36.2 18.0 11.4 22.7 13.0 12.9 18.6 13.3 13.7 18.0 12.3 11.7 16.7 14.1 24.9 14.7 8.5 12.4 18.5 16.2 13.2 20.5 17.5 33.8 18.0 14.5 21.1 12.4 16.6 15.7 30.1 12.1 24.0 20.2 24.9 20.7 19.0 24.8 12.8 49.7 66.8 47.8 40.9 48.8 24.6 27.4 33.9 30.6 61.1 42.2 68.5 30.8 78.6 33.5 45.8 35.2 49.1 71.8 46.5 61.8 42.0 57.8 69.3 46.0 57.3 35.5 62.5 31.6 27.0 32.7 53.0 35.0 43.6 60.1 55.2 110.7 16.4 48.7 53.0 95.6 46.7 42.0 48.1 57.6 72.8 47.2 93.1 41.4 62.5 61.8 35.4 53.2 41.2 57.3 41.9 87.1 56.0 38.2 36.3 34.1 32.6 40.6 27.4 59.5 105.6 40.5 52.6 42.9 20.2 12.1 20.5 18.2 17.2 21.7 14.3 19.6 17.7 20.1 18.7 16.1 17.5 9.3 24.3 15.9 10.9 26.1 14.4 11.8 14.3 12.7 16.1 13.0 12.9 12.3 11.7 12.4 12.4 12.1 12.8 13.1 16.0 18.4 17.6 12.9 10.1 19.6 16.5 13.1 18.5 12.8 11.6 17.5 10.0 22.6 12.9 20.9 12.4 10.7 9.2 11.7 16.9 7.6 22.8 18.6 15.7 10.8 33.6 28.1 15.2 10.1 16.9 16.3 15.3 15.8 42.5 11.7 13.4 22.4 21.9 22.6 10.8 32.6 17.9 6.6 12.7 18.3 12.5 17.8 13.1 14.7 16.1 11.3 22.6 29.3 16.2 8.9 21.8 11.4 20.0 7.3 15.0 18.4 22.9 13.1 15.9 16.2 74.1 42.2 38.3 13.4 7.3 14.0 32.4 14.9 17.5 ANKRD12 "FLJ20053, GAC-1, KIAA0874" ENSG00000101745 "Ankyrin repeat domain 12" Q6UB98 18 9136228-9285985 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 106.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040705 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA040705: AB_10673301" "unprognostic (2.20e-1)" "unprognostic (1.14e-1)" "unprognostic (3.59e-1)" "unprognostic (1.37e-1)" "unprognostic (1.46e-1)" "unprognostic (3.41e-3)" "unprognostic (7.25e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" "unprognostic (2.39e-2)" "unprognostic (4.62e-1)" "unprognostic (1.56e-1)" "unprognostic (3.03e-1)" "unprognostic (1.03e-2)" 15.8 9.3 17.1 20.5 21.4 20.5 13.7 59.9 26.0 11.1 2.2 13.0 12.9 11.8 9.5 14.4 6.2 14.6 11.9 13.9 18.4 13.0 13.8 11.5 22.4 11.2 13.4 14.1 11.9 10.5 5.9 14.1 13.2 12.2 12.0 29.8 12.3 10.6 26.7 20.2 13.4 9.1 10.4 19.9 14.5 27.7 15.8 11.4 16.4 12.3 18.5 13.5 8.0 32.3 10.1 6.7 9.0 6.0 14.2 14.5 7.3 15.3 14.2 5.4 7.4 6.1 7.6 13.9 8.7 10.6 16.4 9.1 6.8 6.0 14.5 14.8 8.1 6.4 4.7 9.0 10.5 15.0 19.7 7.6 13.1 7.7 12.4 12.2 9.2 8.0 14.7 106.4 13.2 5.7 10.1 10.2 3.4 24.7 6.8 9.0 12.6 51.1 7.1 15.8 20.9 7.7 15.0 7.4 11.1 8.0 9.2 12.4 19.9 39.5 18.1 32.1 14.4 30.8 52.0 25.9 19.4 7.9 15.2 102.0 26.4 85.1 42.4 24.1 47.9 63.6 54.9 42.0 19.2 56.2 55.9 43.4 157.3 30.4 37.2 60.6 44.0 18.3 17.1 21.4 59.9 26.0 13.9 18.4 11.2 13.4 13.2 10.4 15.8 32.3 235.1 278.9 261.5 198.5 246.9 108.2 205.9 83.3 116.7 301.0 87.5 108.5 138.6 94.4 137.7 68.0 523.3 46.3 267.2 163.1 19.6 99.7 204.9 144.3 91.9 136.8 92.7 90.7 172.1 83.5 41.1 126.8 64.2 292.9 187.2 76.3 121.7 74.0 67.8 286.0 218.1 90.4 107.8 99.7 126.2 230.9 134.8 149.3 90.7 161.1 178.2 125.5 244.1 184.5 347.4 93.0 147.1 141.4 210.1 196.8 126.1 37.0 88.5 315.4 111.7 173.2 150.0 239.5 152.8 70.9 96.0 78.1 298.3 63.0 71.0 170.7 ANKRD50 KIAA1223 ENSG00000151458 "Ankyrin repeat domain 50" Q9ULJ7 4 124664048-124712732 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 56.8;HUVEC TERT2: 58.2;TIME: 147.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044008 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA044008: AB_10961996" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (6.85e-3)" "unprognostic (5.90e-1)" "unprognostic (9.77e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (7.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (3.28e-4)" "unprognostic (1.67e-1)" "unprognostic (8.25e-2)" "unprognostic (5.55e-3)" "unprognostic (4.82e-2)" "unprognostic (8.23e-2)" "unprognostic (8.16e-3)" 6.0 2.6 3.2 4.2 4.5 4.5 5.7 1.3 3.1 11.4 2.6 4.7 3.1 7.6 2.5 6.4 2.8 8.5 5.0 3.7 6.2 4.4 5.8 9.6 2.3 4.3 4.2 6.5 3.3 5.7 1.0 14.8 3.8 8.9 5.6 1.8 3.9 6.2 1.4 11.0 3.9 8.9 2.1 3.1 7.4 15.1 7.2 4.6 7.4 3.6 1.9 14.2 5.6 2.0 6.3 11.6 32.0 14.9 25.0 15.8 3.2 15.9 13.4 8.1 5.2 5.0 8.1 0.0 4.8 22.8 7.3 5.7 21.3 12.3 14.1 0.0 4.6 5.3 15.3 5.0 17.8 8.8 6.6 16.0 16.4 12.8 56.8 15.2 58.2 5.7 9.6 11.0 15.5 14.3 11.1 3.2 6.7 9.2 16.9 9.0 9.9 1.4 10.2 25.7 9.2 11.5 11.0 6.9 12.9 13.3 7.4 7.4 147.7 17.1 13.3 8.5 13.8 8.0 0.1 2.1 7.8 3.7 20.0 0.0 0.5 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.0 0.1 3.2 4.5 1.3 3.1 3.7 6.2 4.3 4.2 3.8 2.1 7.2 2.0 18.3 32.1 24.6 10.7 0.9 40.4 21.7 17.9 24.5 2.8 12.2 7.1 9.0 12.8 12.5 5.5 0.0 2.9 2.7 7.3 0.0 9.3 41.0 6.6 14.2 21.5 8.4 5.0 15.1 20.1 29.0 16.5 11.7 7.7 5.1 20.4 29.6 8.8 5.3 21.9 42.2 3.7 18.3 13.4 13.0 55.6 6.8 12.6 10.6 30.9 12.8 2.7 0.0 30.7 13.4 15.1 2.8 12.0 0.6 11.7 3.7 4.7 11.0 0.9 0.0 10.9 17.5 17.2 11.2 33.0 30.7 4.1 1.2 33.7 5.3 18.0 ANKZF1 "FLJ10415, Vms1, ZNF744" ENSG00000163516 "Ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1" Q9H8Y5 2 219229783-219236679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035208 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Cytosol" "HPA035208: AB_10602229" "unprognostic (5.23e-2)" "unprognostic (2.23e-1)" "unprognostic (1.12e-3)" "unprognostic (8.27e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (3.87e-2)" "unprognostic (9.68e-3)" "unprognostic (7.82e-3)" "unprognostic (1.24e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.49e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.88e-3)" 9.1 9.2 7.8 8.8 8.6 7.8 10.8 9.9 9.8 13.8 9.6 13.1 9.6 10.1 3.2 15.2 13.5 6.1 14.1 7.9 8.0 13.9 14.4 10.7 13.7 10.1 8.5 16.0 15.6 6.4 12.5 5.9 9.3 15.1 5.2 8.2 15.3 5.6 16.9 17.3 15.2 4.6 7.9 18.1 14.2 7.9 8.7 11.9 11.9 8.1 8.3 12.4 15.0 10.5 31.6 6.1 8.1 11.8 10.6 8.8 32.5 10.1 10.0 13.6 17.2 14.9 13.2 6.6 18.0 4.3 15.3 22.7 10.5 17.5 10.0 13.9 11.0 14.6 19.1 13.9 10.6 9.6 13.7 8.9 33.1 10.1 15.9 22.6 9.4 17.0 24.8 14.9 6.9 13.6 14.1 24.1 13.5 13.7 10.9 14.3 9.9 21.4 7.6 7.9 10.3 10.5 11.9 23.9 19.8 19.5 6.4 23.7 10.3 11.4 8.7 10.1 13.3 31.6 19.9 12.9 19.4 13.8 5.1 9.9 9.1 11.0 16.1 9.0 17.4 13.0 16.3 16.2 9.4 13.3 19.0 18.0 12.3 24.4 14.0 9.8 17.1 13.6 7.8 8.6 9.9 9.8 7.9 8.0 10.1 8.5 9.3 7.9 8.7 10.5 10.2 16.0 17.2 24.2 28.0 9.3 14.5 28.9 9.6 39.8 14.4 13.6 9.2 11.5 24.8 12.9 31.3 10.5 32.7 17.3 13.7 20.5 4.4 28.2 9.7 11.8 9.6 19.6 19.0 12.6 27.2 8.9 17.9 13.0 21.6 21.4 8.6 13.1 7.7 32.0 21.0 19.1 20.3 8.2 5.3 4.0 23.9 10.9 10.6 6.5 15.6 18.0 43.3 13.6 25.3 14.2 16.0 16.6 17.7 13.6 25.2 16.5 65.1 55.4 6.6 13.2 12.8 10.1 17.0 8.3 9.9 11.6 30.0 21.3 17.6 11.1 AQR "fSAP164, IBP160, KIAA0560" ENSG00000021776 "Aquarius intron-binding spliceosomal factor" O60306 15 34851782-34969742 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040624, HPA055647" Enhanced Nucleoplasm No No "Cluster 46: Basophils - DNA binding" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA040624: AB_2677050, HPA055647: AB_2682874" "unprognostic (1.73e-1)" "unprognostic (3.71e-2)" "unprognostic (2.97e-1)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.65e-1)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "prognostic favorable (4.83e-4)" "unprognostic (2.97e-1)" "unprognostic (2.47e-1)" "unprognostic (3.84e-1)" "unprognostic (3.13e-2)" 3.7 3.9 4.5 3.4 5.7 4.0 5.9 7.8 5.2 5.7 3.9 4.2 3.4 4.5 4.1 3.5 4.4 3.1 2.7 4.7 5.0 5.2 4.0 3.6 4.2 4.1 4.7 5.0 4.1 5.2 2.5 4.4 4.5 4.0 4.2 8.0 3.3 3.7 2.8 4.2 3.6 3.8 4.5 4.7 3.8 5.6 4.9 7.0 5.4 3.5 4.7 4.0 3.5 5.8 5.3 13.5 8.7 9.3 11.6 10.7 4.5 6.4 8.1 8.3 7.4 6.1 3.2 4.3 4.0 10.8 5.4 8.2 14.8 9.1 9.1 6.1 6.0 13.8 11.4 5.6 6.6 11.3 6.2 8.4 5.9 6.5 6.9 7.7 7.1 3.3 9.9 4.2 8.3 3.6 6.6 7.5 8.7 12.2 5.5 8.9 15.0 4.3 8.3 9.2 9.5 7.4 10.3 9.7 2.3 7.6 6.9 8.7 9.3 6.1 3.4 4.3 5.7 5.0 6.6 8.5 7.7 9.6 6.3 3.6 2.0 1.2 2.6 2.2 2.3 1.6 2.3 2.6 1.7 2.3 2.3 2.6 1.0 2.1 1.4 2.3 2.0 1.4 4.5 5.7 7.8 5.2 4.7 5.0 4.1 4.7 4.5 4.5 4.9 5.8 27.0 12.8 26.0 45.4 27.9 9.6 13.7 17.0 15.4 28.6 19.9 15.6 14.7 17.2 28.1 14.7 114.7 16.4 31.4 18.2 3.9 13.4 38.2 20.6 26.7 24.1 13.2 21.0 39.8 14.3 14.4 18.6 20.4 22.1 24.1 28.8 31.1 18.5 14.9 25.2 44.0 19.1 12.2 18.6 5.1 8.4 20.8 21.8 16.0 29.0 27.9 14.3 22.6 42.3 42.2 18.5 12.1 18.4 22.9 18.8 17.4 12.9 27.1 41.1 6.6 42.8 16.9 19.4 22.2 22.4 9.7 13.3 27.0 46.5 21.6 13.5 AREL1 "FIEL1, KIAA0317" ENSG00000119682 "Apoptosis resistant E3 ubiquitin protein ligase 1" O15033 14 74653437-74713117 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051306 Uncertain NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA051306: AB_2681433" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-1)" "unprognostic (1.92e-3)" "unprognostic (1.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.58e-3)" "unprognostic (9.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (2.12e-1)" "prognostic favorable (4.67e-6)" "unprognostic (6.73e-2)" "unprognostic (3.14e-1)" "unprognostic (1.52e-1)" "unprognostic (7.18e-2)" 6.2 6.9 4.3 10.4 4.7 16.9 6.7 3.1 4.8 7.8 3.3 10.4 11.8 6.5 7.1 10.0 10.4 6.7 10.6 6.7 5.0 14.6 5.3 9.0 10.0 3.1 4.1 6.8 9.5 15.4 4.5 8.3 2.6 8.4 12.3 13.3 9.7 7.7 9.9 7.8 12.7 8.4 3.7 8.5 9.8 17.1 5.6 13.1 15.5 13.1 13.3 10.0 5.6 3.5 19.2 24.6 25.1 23.6 21.3 14.1 19.3 20.7 23.5 25.2 25.1 19.2 22.2 16.4 10.8 26.6 22.9 25.3 26.9 23.2 32.4 30.4 12.7 25.5 14.5 13.7 14.2 18.5 23.9 18.4 15.8 18.6 20.0 31.6 25.0 23.5 20.3 17.1 32.9 25.8 19.2 7.8 15.4 26.0 24.2 19.5 28.4 10.2 20.5 42.6 24.6 33.0 18.1 23.9 13.4 16.6 21.0 18.5 34.6 23.8 28.5 14.3 24.3 22.6 32.8 32.2 28.8 14.0 18.8 2.2 3.5 7.1 4.6 5.1 3.3 2.1 2.8 4.2 4.5 1.4 2.9 2.6 6.8 3.4 2.7 2.1 2.6 3.4 4.3 4.7 3.1 4.8 6.7 5.0 3.1 4.1 2.6 3.7 5.6 3.5 3.7 12.8 4.6 23.2 6.5 3.6 3.4 6.0 7.4 12.3 7.0 3.7 11.1 5.7 7.5 11.0 27.1 4.2 11.2 18.3 1.9 6.6 3.1 7.2 7.1 5.0 14.9 21.0 24.8 9.2 3.3 4.6 12.8 10.5 1.3 10.3 6.4 12.9 8.0 16.8 24.1 11.6 8.2 15.0 5.3 4.6 8.7 9.6 5.4 23.4 13.9 5.2 11.3 22.6 32.5 11.2 6.5 6.8 9.1 6.8 11.8 5.1 7.3 11.7 0.0 4.4 4.9 6.7 11.1 10.5 3.3 5.9 8.4 6.4 11.5 6.3 ARFGAP2 "FLJ14576, IRZ, Zfp289, ZNF289" ENSG00000149182 "ADP ribosylation factor GTPase activating protein 2" Q8N6H7 11 47164299-47177125 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016649, HPA018152" Enhanced Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA016649: AB_1844980, HPA018152: AB_1844979" "unprognostic (1.69e-2)" "unprognostic (9.11e-2)" "unprognostic (5.91e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-2)" "unprognostic (1.12e-1)" "unprognostic (4.81e-3)" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.41e-1)" "unprognostic (3.42e-2)" "unprognostic (7.00e-2)" "prognostic favorable (7.65e-7)" "unprognostic (2.05e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" "unprognostic (9.20e-2)" 38.0 51.4 62.1 36.3 63.9 82.2 41.7 63.2 68.3 42.3 57.2 49.4 40.0 43.3 35.5 60.8 49.3 32.1 58.7 62.5 60.1 47.6 76.8 40.7 51.9 65.1 61.8 44.6 69.7 48.2 38.7 39.9 61.8 51.4 39.4 38.9 56.1 41.7 115.9 78.7 43.8 38.8 60.6 51.2 55.7 30.7 63.1 49.8 47.4 81.4 50.5 44.7 43.3 70.3 55.7 36.4 54.9 43.3 45.9 37.3 51.6 51.2 48.1 64.1 48.4 41.3 45.3 91.3 32.4 58.7 40.8 82.3 47.2 74.6 40.3 45.0 46.1 77.6 85.5 50.8 53.7 107.0 84.4 56.7 82.3 33.3 71.1 46.1 60.4 65.6 111.8 67.8 58.5 102.5 50.8 87.8 43.6 98.3 48.4 78.8 94.8 116.8 60.3 79.3 53.0 47.0 58.7 81.7 38.8 26.1 126.8 78.8 48.7 55.2 43.3 50.5 68.6 58.6 60.7 78.3 38.6 81.2 56.4 108.5 69.1 92.8 74.0 77.3 66.6 59.0 57.1 66.2 65.9 63.1 63.0 63.4 41.8 69.2 98.4 35.4 71.8 108.1 62.1 63.9 63.2 68.3 62.5 60.1 65.1 61.8 61.8 60.6 63.1 70.3 23.8 35.3 45.9 25.1 46.5 22.2 31.4 22.1 29.6 73.6 30.9 25.8 13.0 20.0 41.2 31.3 114.7 64.3 40.7 38.6 25.4 38.7 2.7 20.3 26.4 29.8 45.4 47.1 16.2 36.6 47.1 29.7 34.1 27.0 60.8 44.9 31.1 44.0 36.8 74.0 15.1 35.0 38.7 33.6 25.4 6.6 34.2 28.6 28.4 15.9 58.1 51.1 71.1 13.0 23.7 39.2 45.0 26.4 31.7 26.4 41.0 26.3 34.1 115.4 39.5 33.0 28.0 24.7 35.9 30.3 26.7 91.8 43.7 40.3 36.3 34.0 ARFGEF1 "ARFGEP1, BIG1, DKFZP434L057, p200" ENSG00000066777 "ADP ribosylation factor guanine nucleotide exchange factor 1" Q9Y6D6 8 67173511-67343781 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023399, HPA023822" Supported Supported Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA023399: AB_1844981, HPA023822: AB_1844982" "prognostic unfavorable (8.76e-4)" "unprognostic (1.62e-1)" "unprognostic (4.60e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (4.52e-1)" "unprognostic (5.38e-2)" "unprognostic (4.67e-2)" "unprognostic (2.13e-3)" "unprognostic (1.31e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (1.62e-1)" "unprognostic (1.61e-2)" 11.4 10.3 5.6 14.6 5.3 27.5 13.6 8.2 6.8 14.2 10.1 19.2 16.9 10.5 11.0 15.2 11.8 12.5 9.6 4.6 5.5 22.8 15.2 13.8 15.4 6.2 6.5 10.3 17.5 28.0 5.4 14.4 6.7 13.0 17.2 36.5 14.8 12.1 12.8 13.7 17.5 10.8 5.2 13.8 19.6 28.3 6.4 22.2 22.4 14.0 17.2 19.7 7.9 7.3 31.8 20.4 19.3 7.3 21.9 29.8 22.5 21.4 24.3 21.7 22.0 12.6 30.0 23.9 8.9 27.6 26.2 22.2 23.5 30.4 26.6 28.3 16.0 40.2 12.0 13.5 18.6 20.9 37.3 18.4 21.6 19.2 31.8 22.3 31.5 24.6 24.5 25.3 25.5 7.2 48.1 9.7 42.5 34.5 18.5 22.4 13.9 4.8 35.8 58.2 7.6 14.9 14.1 33.9 19.5 29.5 58.5 18.3 38.6 14.4 19.3 19.5 16.4 20.4 22.6 17.5 23.6 20.8 14.2 6.1 1.6 4.3 2.8 2.3 3.6 1.2 1.8 2.3 1.6 1.3 3.0 2.6 5.1 2.5 0.9 2.2 3.9 0.9 5.6 5.3 8.2 6.8 4.6 5.5 6.2 6.5 6.7 5.2 6.4 7.3 38.5 44.8 23.1 73.1 32.7 23.7 34.0 23.8 19.9 36.8 32.7 18.9 33.1 18.6 31.9 38.6 139.7 20.0 47.0 43.2 11.7 29.7 25.4 42.5 34.7 28.5 29.4 16.2 119.0 25.6 15.4 22.9 57.6 53.0 15.2 40.0 23.2 19.6 15.8 43.7 146.3 27.9 14.2 31.3 20.4 36.0 40.0 35.2 17.8 105.9 47.1 22.9 46.4 151.8 126.6 40.1 25.7 30.1 29.8 38.2 30.8 24.7 33.9 100.8 6.6 23.6 26.5 69.4 50.7 26.0 29.5 24.9 42.4 32.1 28.0 60.4 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568137 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol No No "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: AB_2683236" "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favorable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favorable (7.34e-5)" 35.0 25.5 17.9 4.5 18.4 11.0 36.3 19.5 25.2 43.7 13.5 41.2 3.5 43.1 6.2 30.8 47.0 2.9 31.1 17.8 16.4 28.2 22.9 46.3 6.7 15.2 15.6 50.4 29.3 3.7 34.1 6.1 15.3 34.7 4.7 8.6 35.1 4.5 28.4 32.1 42.6 6.3 15.3 40.8 38.2 23.7 16.2 7.0 36.3 7.5 5.7 35.6 37.6 18.2 10.5 9.4 26.0 6.4 9.0 4.6 9.1 10.2 6.5 9.1 6.6 16.8 8.3 21.5 6.1 9.2 8.4 6.9 17.4 9.9 11.4 24.5 12.3 18.8 9.2 11.6 9.3 36.0 8.2 5.0 6.8 6.9 7.2 9.2 8.1 13.0 13.4 11.4 11.4 7.7 16.4 13.9 18.6 23.6 4.0 17.3 19.7 8.9 10.6 7.3 7.0 13.8 9.9 12.7 6.1 17.6 5.8 27.0 9.2 7.5 6.2 5.9 10.0 11.1 14.2 27.4 10.6 15.6 6.7 44.6 24.2 17.2 15.4 17.7 14.1 30.2 13.5 12.1 17.1 32.4 15.3 14.6 45.7 18.8 14.8 34.2 15.7 12.8 17.9 18.4 19.5 25.2 17.8 16.4 15.2 15.6 15.3 15.3 16.2 18.2 342.0 141.1 230.6 198.8 242.0 261.7 268.5 179.3 186.1 222.7 153.9 104.0 88.3 90.1 204.9 114.0 135.5 141.9 329.3 195.3 99.7 120.7 42.0 201.2 308.3 298.1 187.7 160.3 208.8 113.2 137.7 204.7 355.7 290.6 168.7 331.2 280.2 81.5 101.3 304.5 155.6 218.5 148.5 90.7 186.2 34.0 255.1 142.1 128.1 161.1 182.1 223.3 301.8 200.6 367.2 145.0 173.8 217.7 194.9 251.0 153.7 58.6 190.7 271.2 216.9 179.6 196.8 199.8 125.9 164.1 262.3 185.2 257.8 280.7 193.1 316.0 ARL17A "ARF1P2, ARL17P1" ENSG00000185829 "ADP ribosylation factor like GTPase 17A" Q8IVW1 17 46516702-46579691 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 54.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046814 Uncertain NA NA "Cluster 15: NK-cells - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "HPA046814: AB_2679821" "unprognostic (8.57e-4)" "unprognostic (7.48e-2)" "unprognostic (1.98e-1)" "unprognostic (2.72e-1)" "unprognostic (1.16e-1)" "unprognostic (6.57e-5)" "unprognostic (2.07e-1)" "unprognostic (2.61e-2)" "unprognostic (1.70e-1)" "unprognostic (4.01e-1)" "unprognostic (2.58e-2)" "unprognostic (4.12e-2)" "unprognostic (2.48e-4)" "unprognostic (1.04e-1)" "unprognostic (2.57e-1)" "unprognostic (1.43e-1)" "unprognostic (4.61e-2)" 7.6 7.0 4.1 8.1 4.6 8.1 8.8 15.3 6.9 15.0 4.8 9.9 3.6 9.6 10.2 8.8 11.5 3.2 7.5 5.3 4.9 7.2 5.8 9.1 9.5 4.7 4.3 12.8 9.5 6.5 13.4 4.0 5.8 11.5 6.7 14.7 11.4 4.9 10.5 11.2 9.4 6.2 2.2 9.8 9.1 7.1 6.5 5.7 11.7 3.5 7.3 9.5 12.0 8.1 4.6 5.4 9.5 8.2 3.8 4.6 4.2 5.8 2.1 2.8 3.6 12.5 6.9 16.3 4.1 2.7 9.1 7.0 5.1 3.7 5.9 13.8 17.5 5.5 23.0 10.3 2.4 8.5 6.1 4.1 7.1 3.7 4.9 6.0 5.4 10.3 7.2 8.9 5.0 1.9 10.5 10.1 4.2 2.0 3.4 14.7 14.1 4.3 3.2 6.8 7.1 4.6 4.1 2.0 1.8 5.4 12.2 7.4 9.3 16.2 8.6 5.2 4.2 10.9 14.8 5.4 4.1 9.9 5.5 4.1 1.6 1.2 3.1 1.2 1.8 2.4 2.2 2.6 1.4 3.4 2.2 2.8 1.4 3.0 1.6 3.2 2.1 0.7 4.1 4.6 15.3 6.9 5.3 4.9 4.7 4.3 5.8 2.2 6.5 8.1 5.8 22.4 11.8 17.6 10.7 6.0 8.7 9.7 8.0 19.1 7.3 5.5 8.3 4.3 8.1 16.5 54.2 6.4 11.1 5.3 9.8 6.7 8.6 4.2 7.6 5.8 6.7 2.1 24.5 2.6 4.2 6.5 2.6 5.3 6.3 15.2 9.7 4.3 6.4 15.2 26.5 7.9 10.2 9.0 6.9 5.4 13.1 6.0 3.6 14.0 14.2 5.9 2.1 29.7 36.4 3.2 4.6 9.1 3.5 4.9 5.6 6.3 10.6 30.3 13.1 11.1 7.0 12.2 6.1 2.9 8.4 3.6 9.6 9.4 9.1 7.5 ARMH4 "C14orf37, UT2" ENSG00000139971 "Armadillo like helical domain containing 4" Q86TY3 14 57999735-58298139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.8;kidney: 8.3" "Cell type enhanced" "Detected in some" "Adipocytes: 15.8;Collecting duct cells: 12.9;Endometrial ciliated cells: 10.2;Endometrial stromal cells: 7.7;Granulosa cells: 26.0;Theca cells: 44.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.7;AN3-CA: 6.1;fHDF/TERT166: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001580, HPA001789" Enhanced Approved "Plasma membrane" NA NA 1800000 "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Plasma membrane" "HPA001580: AB_2666366, HPA001789: AB_1078328" "unprognostic (2.56e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.97e-3)" "unprognostic (1.94e-1)" "unprognostic (7.84e-3)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (2.42e-1)" "unprognostic (1.01e-1)" "unprognostic (3.87e-8)" "unprognostic (5.22e-6)" "unprognostic (4.93e-2)" "unprognostic (8.74e-4)" "unprognostic (3.01e-4)" 1.2 2.5 2.3 0.6 3.6 0.7 0.8 8.5 3.5 1.8 0.0 0.7 0.5 3.0 1.8 0.8 2.1 1.8 3.1 2.6 2.1 8.3 0.8 0.7 0.4 11.5 5.1 4.3 1.0 3.6 1.3 0.4 12.8 1.6 1.0 1.2 0.7 1.4 0.2 1.0 0.7 2.3 1.0 0.5 1.4 2.2 1.6 0.2 1.5 1.9 0.3 1.2 0.9 0.7 0.0 0.0 9.7 6.1 4.7 1.7 0.0 1.9 1.5 0.3 0.3 0.5 0.1 0.0 0.6 10.8 1.2 0.0 2.9 0.0 0.4 0.1 1.0 0.0 0.0 0.5 0.2 0.0 4.8 1.8 0.0 0.2 0.2 2.7 0.5 0.8 0.1 0.3 1.2 0.3 0.0 0.0 4.5 0.0 2.0 1.4 0.3 2.5 3.9 0.3 1.1 0.0 0.1 0.0 0.3 2.7 0.2 0.2 0.1 1.3 3.5 0.5 2.6 0.3 0.2 0.0 3.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.6 8.5 3.5 2.6 2.1 11.5 5.1 12.8 1.0 1.6 0.7 15.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 12.9 0.0 0.2 0.7 0.0 0.0 2.1 0.0 10.2 7.7 2.3 0.0 0.0 0.0 1.3 0.4 3.0 0.0 2.4 0.0 26.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.3 0.3 44.5 0.0 0.0 ARX "CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS" ENSG00000004848 "Aristaless related homeobox" Q96QS3 X 25003694-25016420 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.4;ovary: 78.7;skeletal muscle: 26.7" "Group enriched" "Detected in some" 5 "Enteroendocrine cells: 83.7;Inhibitory neurons: 53.2;Leydig cells: 131.7;Peritubular cells: 70.0;Theca cells: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.9;PC-3: 3.9;THP-1: 1.7;U-266/70: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (8.28e-2)" "unprognostic (3.06e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (3.54e-7)" "unprognostic (9.85e-2)" "unprognostic (7.96e-3)" "unprognostic (1.18e-1)" "unprognostic (2.77e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-3)" "unprognostic (1.32e-1)" "unprognostic (1.06e-6)" "unprognostic (6.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.91e-1)" 0.0 0.1 7.6 0.0 10.1 0.0 0.3 0.0 17.4 0.0 0.0 0.9 3.5 0.0 0.1 0.1 1.1 0.0 0.0 10.1 6.0 0.1 0.0 0.4 0.0 0.0 0.0 78.7 1.4 1.8 0.3 0.0 0.1 0.7 0.9 0.0 0.2 0.0 26.7 0.0 0.7 0.0 0.0 0.2 5.5 7.2 0.4 0.0 0.2 1.9 0.4 0.0 0.2 8.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.9 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 3.9 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.1 0.0 0.0 8.3 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 10.1 0.0 17.4 10.1 6.0 0.0 0.0 0.1 0.0 0.4 8.0 0.0 0.0 0.0 14.0 0.3 0.0 2.5 0.5 0.0 0.0 0.3 0.0 0.5 0.0 2.2 0.0 0.0 0.2 0.1 1.9 0.0 0.0 1.2 0.0 0.0 0.1 83.7 0.0 0.2 0.0 2.4 4.7 4.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 53.2 3.6 4.1 0.0 0.0 3.6 131.7 0.2 0.0 3.7 0.0 0.0 0.0 3.5 0.6 0.3 0.8 70.0 0.9 1.3 0.1 0.1 11.3 0.0 0.0 1.5 0.3 0.5 0.3 0.0 0.0 0.1 0.3 66.8 1.9 1.6 ASH1L "ASH1, ASH1L1, huASH1, KMT2H" ENSG00000116539 "ASH1 like histone lysine methyltransferase" Q9NR48 1 155335268-155563162 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004806 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus" "HPA004806: AB_1845087" "unprognostic (2.98e-1)" "unprognostic (3.15e-2)" "unprognostic (1.10e-1)" "unprognostic (1.70e-2)" "unprognostic (2.05e-2)" "unprognostic (4.75e-2)" "unprognostic (1.42e-1)" "unprognostic (1.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (6.84e-2)" "prognostic favorable (3.80e-4)" "unprognostic (2.95e-1)" "unprognostic (1.62e-1)" "unprognostic (2.45e-2)" "unprognostic (1.94e-1)" 14.1 12.8 21.3 8.5 23.4 11.9 16.8 27.0 25.7 14.4 14.8 13.0 9.7 14.4 20.8 9.2 11.4 9.0 12.6 23.8 19.2 13.9 10.0 10.3 10.9 18.7 19.8 21.3 9.9 18.2 8.4 10.3 18.9 15.7 11.5 26.2 14.8 15.4 30.3 20.4 10.2 12.7 19.3 10.5 11.9 6.8 20.7 12.1 15.8 24.3 9.7 11.7 10.0 23.4 17.2 12.3 9.5 9.4 28.0 22.8 9.6 14.7 13.5 8.3 6.5 10.5 12.3 5.4 14.2 17.0 5.4 19.2 13.6 12.6 13.6 7.6 8.9 8.0 13.2 9.8 14.5 8.8 6.6 16.2 18.0 13.6 15.0 17.1 11.0 6.0 12.3 8.3 18.8 19.0 6.4 8.8 8.3 28.8 13.1 6.1 18.5 10.4 18.6 16.0 9.1 14.3 20.1 25.9 12.9 9.3 16.6 26.6 17.4 13.6 15.8 13.4 17.9 8.0 5.3 8.9 10.7 9.1 13.1 1.0 0.4 0.8 0.7 0.2 0.5 0.9 0.5 0.5 0.2 0.8 0.8 0.5 1.0 0.6 0.1 0.7 0.9 0.2 21.3 23.4 27.0 25.7 23.8 19.2 18.7 19.8 18.9 19.3 20.7 23.4 96.5 60.9 103.2 171.7 108.3 103.9 97.4 52.9 109.3 147.6 75.9 58.3 107.8 50.1 82.7 51.5 202.3 53.6 83.3 76.2 17.6 41.5 25.9 72.0 107.4 77.6 67.5 46.7 220.6 39.8 25.2 93.7 101.4 87.9 81.1 72.3 63.1 39.0 24.6 114.4 211.8 59.0 26.4 42.1 106.9 22.8 102.2 69.1 53.4 203.3 85.2 68.4 89.6 190.5 265.0 37.5 64.8 118.8 110.1 112.0 68.9 31.0 47.1 116.7 98.6 134.4 104.6 85.6 56.1 80.9 112.0 76.2 98.7 87.3 60.2 111.6 ATF7IP2 FLJ12668 ENSG00000166669 "Activating transcription factor 7 interacting protein 2" Q5U623 16 10326434-10483638 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 19.2" "Cell type enhanced" "Detected in all" "Spermatocytes: 145.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 14.2;THP-1: 13.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 3.3;hippocampal formation: 2.3" "HPA041156, HPA041228" Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "HPA041156: AB_10795536, HPA041228: AB_10795586" "prognostic favorable (4.98e-4)" "unprognostic (3.87e-2)" "unprognostic (1.35e-2)" "unprognostic (6.31e-2)" "unprognostic (7.56e-2)" "unprognostic (2.87e-1)" "prognostic favorable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (8.85e-2)" "unprognostic (2.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.10e-3)" "unprognostic (2.43e-1)" "unprognostic (2.99e-1)" "unprognostic (2.41e-2)" "prognostic favorable (8.57e-5)" 1.8 6.7 2.4 4.2 1.7 5.7 1.5 0.7 3.6 3.0 0.9 1.9 3.0 1.4 3.6 1.5 4.8 1.3 5.2 3.0 1.8 2.4 9.2 2.1 8.8 1.0 0.9 2.2 5.6 0.6 1.2 3.2 1.2 1.4 2.0 4.7 0.8 1.7 1.6 2.9 2.0 2.2 1.0 5.1 6.2 19.2 1.6 10.7 3.7 1.3 8.6 5.1 1.1 2.7 0.7 1.6 1.3 4.3 3.3 3.8 6.9 1.7 0.3 0.4 0.0 0.5 7.2 0.0 3.5 0.0 1.4 1.0 6.3 1.5 0.4 6.2 4.3 8.4 1.3 6.0 1.6 7.8 3.5 4.2 1.4 0.1 0.0 1.7 2.9 13.1 14.2 0.0 4.0 1.3 9.9 6.1 7.0 9.6 1.5 13.0 0.0 4.3 1.4 3.3 0.0 0.8 6.8 1.3 0.7 4.3 2.4 13.9 1.6 0.0 1.9 0.1 0.0 2.8 7.3 1.2 0.0 4.8 1.9 0.1 0.5 0.0 4.5 1.0 11.6 2.4 4.6 4.4 1.6 3.6 3.8 4.3 0.1 3.5 1.0 2.5 7.2 2.0 2.4 1.7 0.7 3.6 3.0 1.8 1.0 0.9 1.2 1.0 1.6 2.7 28.5 12.8 16.2 26.1 62.1 11.5 11.6 37.3 19.9 18.5 11.0 8.4 53.9 7.2 22.8 12.9 100.1 60.1 38.9 15.4 99.7 16.8 30.7 24.2 8.2 17.6 23.2 30.9 71.4 10.9 60.5 12.8 81.1 14.9 1.3 19.9 13.2 115.2 23.6 5.0 45.5 14.6 24.4 23.6 23.5 31.6 7.5 33.5 16.0 82.4 13.8 38.2 24.7 39.7 8.4 6.7 20.7 6.8 37.1 6.1 10.0 39.0 88.7 35.4 13.1 6.0 13.2 145.8 89.2 19.6 19.5 27.1 46.0 17.3 16.8 21.7 ATRX "JMS, MRX52, RAD54, XH2, XNP" ENSG00000085224 "ATRX chromatin remodeler" P46100 X 77504880-77786233 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001906, CAB009372, HPA064684, CAB068176" Supported Supported "Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "CAB009372: AB_2061023, CAB068176: AB_2665665, HPA001906: AB_1078249, HPA064684: AB_2685321" "unprognostic (1.77e-2)" "unprognostic (1.55e-1)" "unprognostic (6.65e-2)" "unprognostic (4.37e-2)" "unprognostic (1.67e-1)" "unprognostic (9.69e-2)" "unprognostic (8.11e-2)" "unprognostic (1.15e-2)" "unprognostic (6.04e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (5.80e-2)" "unprognostic (5.14e-3)" "unprognostic (1.50e-1)" "unprognostic (6.19e-2)" "unprognostic (1.76e-2)" "unprognostic (2.24e-1)" 18.0 15.9 17.3 17.6 20.4 29.9 18.1 32.9 20.4 18.0 21.4 12.7 11.2 21.2 14.8 13.3 11.8 14.7 15.5 19.2 19.8 16.9 13.2 13.4 22.6 15.0 20.1 24.9 13.4 23.2 8.5 16.6 16.6 19.2 13.5 26.8 14.0 14.8 19.1 15.6 10.9 15.6 16.4 22.8 16.5 6.6 22.6 25.7 20.0 26.9 18.6 14.1 9.9 19.7 36.0 55.1 60.1 45.0 31.8 38.1 21.2 29.4 27.3 21.8 25.9 19.6 30.7 48.5 29.9 32.5 39.9 30.0 44.6 18.1 37.5 27.3 30.8 29.3 67.2 16.2 16.1 38.4 10.2 25.5 20.2 32.2 30.4 29.4 41.9 30.3 34.9 53.3 29.3 27.6 30.2 25.0 42.0 17.6 42.5 48.6 76.3 26.0 25.6 46.4 33.1 55.5 60.5 23.1 21.9 37.2 18.6 20.8 55.8 32.8 76.1 34.4 21.0 16.3 52.9 42.1 23.0 30.9 27.8 44.0 10.5 22.7 26.0 13.3 25.2 31.2 24.0 20.9 8.1 32.4 24.6 20.1 33.2 23.2 20.0 20.7 22.2 9.7 17.3 20.4 32.9 20.4 19.2 19.8 15.0 20.1 16.6 16.4 22.6 19.7 201.0 160.3 230.1 157.4 176.6 92.4 112.2 71.3 114.9 220.1 87.8 86.7 277.8 60.1 101.5 71.7 212.7 72.2 176.9 49.0 23.5 91.8 4.7 103.1 195.5 162.8 126.8 105.8 197.8 83.1 51.0 134.3 114.2 137.3 113.1 261.4 97.8 56.7 70.9 158.2 246.9 78.0 69.2 87.0 101.6 12.7 162.4 113.1 62.2 195.8 149.0 112.3 183.4 202.5 237.1 92.0 47.6 208.0 183.9 120.8 49.2 37.2 102.6 245.4 92.1 174.7 160.0 19.8 52.8 78.7 84.4 59.8 158.0 312.4 73.3 112.0 ATXN2 "ATX2, SCA2, TNRC13" ENSG00000204842 "Ataxin 2" Q99700 12 111443485-111599676 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 209.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018295, HPA020339, HPA021146" Enhanced Enhanced Cytosol NA NA 9600 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132" "unprognostic (3.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (1.55e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (2.34e-1)" "unprognostic (2.77e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (4.58e-1)" "unprognostic (5.28e-2)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (3.40e-2)" 19.6 23.5 20.5 11.2 21.9 8.0 17.5 22.8 30.3 21.6 20.8 22.8 11.2 21.7 13.9 14.2 20.4 12.0 22.2 20.5 29.9 17.5 20.1 19.7 9.5 25.2 26.0 25.9 13.8 18.6 21.9 16.3 24.5 19.4 11.6 15.7 14.5 15.6 25.8 15.6 14.9 18.3 18.6 14.1 16.3 23.2 22.7 12.8 17.1 20.8 8.9 19.6 18.3 25.8 31.0 38.0 30.3 38.2 35.9 29.0 29.4 35.8 25.9 28.8 23.4 25.2 25.7 25.8 14.2 47.7 23.8 25.5 45.0 18.2 36.0 23.3 33.9 38.2 22.8 42.4 49.7 27.1 21.4 32.4 20.1 38.0 42.6 48.0 27.8 20.2 46.8 13.1 37.2 24.7 23.2 24.2 30.1 19.4 24.6 21.8 18.6 19.2 30.1 34.5 28.7 25.2 38.5 49.3 24.7 29.1 30.9 16.5 34.9 36.9 21.6 30.4 20.6 23.4 30.0 22.5 19.0 20.9 23.5 4.5 3.6 5.8 3.9 3.4 5.2 5.1 4.9 5.3 5.0 2.7 4.1 3.6 3.5 5.6 6.4 2.7 2.2 2.8 20.5 21.9 22.8 30.3 20.5 29.9 25.2 26.0 24.5 18.6 22.7 25.8 43.0 80.1 72.6 175.3 26.7 35.3 34.3 18.4 35.9 101.0 33.6 26.3 36.6 30.0 36.6 36.8 135.5 32.5 28.9 25.6 3.9 26.0 11.1 87.2 72.2 43.9 41.4 34.9 146.7 25.3 25.4 40.0 23.9 50.3 23.5 67.2 63.5 38.1 24.5 65.6 171.8 26.7 24.4 35.9 35.9 11.9 65.6 30.6 32.0 106.8 35.1 32.6 48.4 128.7 209.6 32.6 16.0 47.4 24.2 43.0 22.7 16.9 56.0 90.4 32.9 41.5 46.6 78.0 70.7 25.7 35.2 46.9 27.4 68.7 31.5 42.2 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106621 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124" "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 9.0 5.9 3.8 5.7 4.2 9.9 6.8 4.9 5.0 7.5 3.3 7.3 3.7 6.4 4.3 10.3 6.0 6.5 5.3 3.6 5.0 5.6 9.6 6.8 7.7 6.2 5.7 7.1 4.5 6.4 4.0 7.0 6.2 6.0 6.8 3.9 5.8 5.5 3.3 12.9 4.8 8.6 4.3 5.6 5.2 9.3 4.3 8.0 5.9 5.9 9.8 9.0 8.0 4.9 8.6 16.7 14.6 13.6 20.9 20.1 28.4 9.7 15.4 11.9 16.5 12.3 23.2 17.6 18.5 15.8 14.1 14.6 11.6 21.0 26.3 20.0 3.5 7.4 8.0 18.2 17.3 13.5 12.6 16.5 18.1 20.9 21.8 15.9 18.7 19.4 10.1 12.5 18.2 33.1 14.0 11.9 10.4 28.5 13.6 11.0 27.0 9.9 15.3 19.4 5.3 8.8 23.1 9.5 13.3 19.6 18.1 9.1 10.0 11.7 17.0 7.5 5.2 10.8 19.8 16.2 8.3 12.9 6.9 13.5 14.3 10.8 6.1 16.5 7.4 7.7 7.0 6.9 16.2 10.6 7.8 8.8 12.2 8.7 23.0 9.3 8.1 6.3 3.8 4.2 4.9 5.0 3.6 5.0 6.2 5.7 6.2 4.3 4.3 4.9 55.0 16.0 12.4 33.6 27.6 25.4 28.6 29.8 19.4 35.4 16.9 18.4 19.3 15.7 20.0 42.3 50.1 20.3 31.5 13.8 15.6 25.8 19.8 20.3 34.9 53.0 16.1 30.3 36.1 17.3 29.8 34.6 18.3 22.5 24.6 25.9 49.6 21.1 22.4 26.9 28.6 16.4 12.2 35.1 27.2 26.8 67.7 30.0 23.2 28.1 48.0 20.4 29.9 39.2 51.5 19.6 16.1 65.1 20.1 31.9 16.6 17.7 16.0 46.7 46.0 51.9 38.2 39.1 57.2 21.6 30.3 25.3 28.8 24.8 18.9 28.2 AVL9 KIAA0241 ENSG00000105778 "AVL9 cell migration associated" Q8NBF6 7 32495426-32588726 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 93.9;Inhibitory neurons: 92.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050957 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 45: Intestine - Brush border" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA050957: AB_2681289" "unprognostic (2.33e-2)" "unprognostic (8.75e-3)" "unprognostic (3.45e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-2)" "unprognostic (5.72e-3)" "unprognostic (5.14e-3)" "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (4.21e-2)" "unprognostic (9.03e-2)" "unprognostic (1.68e-2)" "unprognostic (3.68e-2)" "unprognostic (9.22e-2)" "unprognostic (4.40e-2)" "unprognostic (1.05e-1)" 7.5 9.0 9.3 10.2 11.4 9.4 10.7 8.6 10.2 9.0 9.2 15.9 13.3 8.2 12.2 8.0 8.5 7.6 5.2 12.0 10.1 10.5 8.3 8.0 10.6 7.6 8.6 8.2 11.0 9.3 7.0 10.8 9.1 9.5 17.9 22.4 9.2 7.1 8.0 7.6 13.3 8.3 5.4 8.6 12.2 7.0 11.8 12.7 13.2 6.2 11.3 9.1 7.0 9.2 19.6 17.0 17.4 23.6 10.3 14.8 12.1 17.3 22.8 16.7 22.3 13.4 25.8 24.7 0.3 15.3 64.4 15.8 16.7 17.1 28.1 10.8 10.3 18.5 11.8 14.6 37.8 31.8 23.3 16.1 16.5 21.4 24.3 18.5 25.0 19.6 45.9 22.1 52.9 20.2 12.9 26.5 19.6 27.1 14.8 12.4 19.3 18.9 17.8 32.7 37.4 23.8 14.6 35.5 15.4 23.2 25.4 28.8 19.2 17.3 20.2 13.8 15.2 50.6 47.4 38.8 34.2 29.5 38.6 21.0 15.0 23.3 13.8 11.8 11.7 12.9 11.5 13.1 11.5 16.0 14.1 12.8 37.9 7.0 11.5 13.6 11.5 16.2 9.3 11.4 8.6 10.2 12.0 10.1 7.6 8.6 9.1 5.4 11.8 9.2 11.0 6.4 11.7 85.5 23.8 11.5 12.4 12.4 13.6 31.6 16.2 8.1 9.5 15.7 15.2 12.9 62.6 16.2 21.4 46.7 3.9 12.8 5.8 14.9 11.6 13.1 22.3 9.0 93.9 17.2 15.7 11.1 28.5 19.4 17.7 25.5 16.8 13.4 15.1 32.0 92.6 27.6 6.1 24.6 14.2 2.8 10.2 17.8 12.4 78.7 18.3 12.5 19.6 56.8 88.6 24.5 24.8 9.4 22.3 21.1 22.5 15.8 18.4 36.8 6.6 9.7 12.7 9.9 8.4 12.2 10.5 17.5 16.6 15.7 29.0 23.3 B3GALT6 beta3GalT6 ENSG00000176022 "Beta-1,3-galactosyltransferase 6" Q96L58 1 1232237-1235041 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease variant, Dwarfism, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 69.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 14000 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "unprognostic (9.76e-2)" "unprognostic (6.97e-2)" "unprognostic (4.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.39e-1)" "unprognostic (4.62e-2)" "unprognostic (2.65e-3)" "unprognostic (1.86e-1)" "unprognostic (1.37e-1)" "unprognostic (2.66e-1)" "unprognostic (3.08e-2)" "unprognostic (2.40e-2)" "unprognostic (1.85e-1)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (9.89e-2)" 8.7 8.7 8.9 5.6 9.0 1.8 8.4 7.3 9.9 7.6 7.3 6.5 3.9 10.7 3.8 7.2 7.7 3.7 10.1 9.5 10.1 9.9 13.5 6.8 6.2 10.4 9.3 7.0 11.9 7.8 9.3 5.2 8.8 8.0 3.0 2.4 6.4 4.2 9.3 9.2 6.5 4.8 8.3 10.3 7.8 5.4 9.0 5.8 7.7 4.8 3.7 7.6 6.3 9.3 20.4 10.2 17.0 17.9 16.8 11.3 13.2 21.2 17.9 17.4 14.1 9.1 20.3 15.1 12.4 12.7 15.2 17.9 7.4 11.4 10.6 26.8 28.2 28.2 10.1 8.7 17.3 17.6 17.1 10.6 8.3 11.6 11.3 10.5 13.3 17.2 20.0 13.2 18.0 11.6 24.0 31.6 21.9 21.2 37.9 22.8 6.7 12.5 17.4 6.1 69.6 28.6 15.8 18.4 11.4 9.9 15.4 24.9 14.4 17.9 7.9 11.3 30.9 8.2 7.6 14.0 14.1 38.9 20.8 1.3 1.2 0.4 1.6 1.6 2.8 1.4 1.6 1.9 1.7 2.3 1.4 1.7 0.6 2.9 2.0 2.3 0.7 1.0 8.9 9.0 7.3 9.9 9.5 10.1 10.4 9.3 8.8 8.3 9.0 9.3 15.6 12.8 9.9 3.9 13.7 8.4 31.1 3.8 2.2 13.1 15.4 17.5 8.4 11.5 3.4 12.9 4.2 1.7 20.9 3.8 7.9 8.1 0.6 7.6 16.0 12.5 6.0 5.9 3.8 12.7 3.4 10.8 5.1 9.4 0.0 24.7 11.4 13.6 7.3 20.2 5.0 3.7 4.1 12.2 10.3 2.2 2.8 10.5 1.8 1.9 6.9 11.0 18.6 5.5 3.8 11.9 1.0 4.1 9.6 24.5 1.6 10.9 3.0 9.4 0.0 13.6 10.8 1.7 4.1 3.7 12.6 1.4 11.1 33.2 5.3 14.8 BCLAF1 "BTF, KIAA0164" ENSG00000029363 "BCL2 associated transcription factor 1" Q9NYF8 6 136256627-136289851 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 135.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006484, HPA006669, HPA027770" Enhanced Enhanced "Nuclear speckles" NA NA 21000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484" "prognostic unfavorable (1.64e-4)" "unprognostic (1.60e-1)" "prognostic favorable (3.44e-4)" "unprognostic (1.45e-1)" "unprognostic (9.46e-3)" "unprognostic (2.29e-1)" "unprognostic (2.13e-3)" "unprognostic (1.63e-1)" "unprognostic (5.07e-2)" "unprognostic (1.14e-1)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.20e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (7.93e-2)" "unprognostic (4.19e-3)" 24.4 22.3 14.3 26.9 17.3 135.0 32.9 23.6 18.6 21.4 19.7 29.5 18.8 23.2 24.0 24.3 21.3 14.8 16.7 15.9 19.2 21.5 27.4 24.6 28.2 11.1 12.9 24.4 25.5 33.4 18.0 21.3 12.0 21.2 28.4 34.8 21.2 20.5 27.5 21.8 21.1 28.3 14.7 24.8 27.9 21.3 16.7 35.2 30.4 24.3 32.9 23.0 19.3 19.3 82.4 70.0 162.5 136.2 50.4 42.6 82.3 153.0 94.4 100.6 106.5 100.4 54.4 172.7 92.8 117.9 112.8 78.0 183.5 101.1 125.5 95.1 114.2 213.7 96.0 110.3 58.6 362.6 131.0 58.3 49.2 142.8 88.6 37.2 90.9 77.6 193.6 82.3 107.0 97.4 145.3 40.2 120.2 55.2 72.0 130.3 203.2 76.4 76.3 155.0 137.2 94.5 150.0 71.3 60.4 60.6 66.9 71.5 125.7 79.2 116.7 95.9 151.2 69.5 134.8 227.9 47.2 113.3 94.2 32.6 27.1 42.1 32.4 33.2 32.7 36.6 29.9 28.1 42.3 32.9 37.7 34.5 57.9 49.5 35.3 24.7 25.5 24.5 14.3 17.3 23.6 18.6 15.9 19.2 11.1 12.9 12.0 14.7 16.7 19.3 165.3 205.1 178.7 68.9 174.3 68.2 118.9 99.5 104.2 129.7 86.9 71.5 88.4 65.8 131.6 57.0 210.6 111.9 173.3 86.3 33.2 96.8 12.6 157.2 173.5 117.5 118.9 134.6 80.5 65.2 99.4 138.0 128.0 169.8 156.4 130.5 74.3 60.0 74.0 102.6 82.6 106.0 93.6 92.5 88.9 13.8 122.1 121.8 69.4 56.2 136.9 91.6 118.4 63.3 93.4 77.5 81.4 109.4 197.8 128.6 83.3 42.9 147.1 139.9 111.7 259.8 130.7 102.2 129.7 121.4 71.2 128.3 174.8 154.8 101.6 123.8 BDP1 "HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR" ENSG00000145734 "B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB" A6H8Y1 5 71455651-71567820 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064166, HPA077984" Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 8: Non-specific - Mitochondria" "Cluster 17: WM-115 - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA064166: , HPA077984: " "unprognostic (4.96e-2)" "unprognostic (2.19e-1)" "unprognostic (6.65e-2)" "unprognostic (3.01e-1)" "unprognostic (3.47e-2)" "unprognostic (1.44e-2)" "unprognostic (7.72e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (8.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-1)" "unprognostic (7.83e-2)" "unprognostic (2.50e-2)" "unprognostic (5.86e-2)" 2.5 2.7 0.5 1.3 0.6 0.9 3.4 0.8 1.7 1.8 0.2 0.9 0.0 1.2 0.0 0.8 1.2 2.0 0.7 0.5 0.5 2.7 1.6 1.4 1.2 0.5 0.5 1.8 4.0 0.3 0.3 1.4 0.5 1.5 2.3 5.8 0.8 1.9 2.2 1.9 0.8 2.0 0.5 0.7 1.0 0.9 0.4 2.3 2.8 3.5 1.6 0.9 0.6 0.9 1.3 2.1 10.1 3.1 1.6 5.0 7.7 0.2 0.1 2.4 0.0 0.7 1.0 0.5 9.4 4.0 11.0 0.0 3.2 0.2 11.0 0.0 0.0 1.6 7.0 3.1 4.2 4.4 0.4 0.0 0.1 0.9 5.9 5.4 7.9 0.0 12.7 0.7 5.0 3.9 0.0 1.2 0.0 1.0 7.7 10.5 1.3 7.9 4.4 6.6 1.2 7.3 0.2 2.1 6.4 7.2 0.0 0.0 16.1 5.6 0.9 3.6 0.5 3.4 8.5 0.1 0.0 3.8 8.6 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.5 0.6 0.8 1.7 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.9 69.5 60.9 96.2 52.5 79.7 44.5 63.7 26.9 55.8 78.2 57.9 55.8 110.7 38.6 57.3 35.0 102.2 37.9 101.1 38.7 1.9 48.1 37.8 88.7 109.5 71.7 58.6 59.7 116.7 36.3 50.2 57.0 57.1 127.3 58.2 66.0 28.9 32.0 31.7 94.2 96.4 39.3 24.4 27.7 36.9 21.1 58.7 53.3 28.4 57.1 62.3 41.7 76.2 57.3 86.8 52.2 26.0 54.5 72.3 57.9 18.5 10.9 39.9 125.1 52.6 104.3 74.0 85.8 60.4 60.0 43.3 48.2 86.3 69.0 50.0 64.5 BFAR "BAR, RNF47" ENSG00000103429 "Bifunctional apoptosis regulator" Q9NZS9 16 14632931-14669236 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (4.88e-3)" "unprognostic (2.81e-2)" "unprognostic (3.15e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-2)" "unprognostic (2.11e-1)" "unprognostic (2.09e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (4.74e-5)" "unprognostic (3.22e-1)" "unprognostic (1.07e-2)" "unprognostic (2.31e-2)" "unprognostic (2.65e-1)" "unprognostic (3.42e-2)" "unprognostic (2.51e-2)" 36.3 24.4 12.2 14.8 13.6 17.2 32.6 14.2 12.5 25.7 14.1 27.2 19.8 25.9 14.5 18.3 23.2 17.3 24.7 11.8 12.6 25.0 22.7 35.5 20.6 13.7 12.9 28.4 46.3 16.2 16.8 25.3 13.7 20.7 15.4 19.4 22.7 13.6 45.6 24.8 25.3 17.5 12.5 22.5 28.3 15.7 13.1 21.3 22.5 26.5 17.5 27.1 23.7 14.2 29.4 37.4 37.3 42.4 35.3 50.6 26.0 44.2 54.9 39.3 41.7 24.3 43.2 47.8 81.9 53.6 33.8 41.1 65.0 41.7 51.4 29.0 25.4 32.2 33.2 78.0 54.7 49.9 36.0 58.4 44.7 37.7 52.4 41.9 61.8 31.2 43.4 36.9 46.0 41.6 34.6 42.1 71.6 26.9 16.0 58.7 48.7 51.1 49.2 33.1 45.9 45.1 36.5 38.7 113.0 37.1 38.4 42.3 49.9 66.3 31.8 35.7 35.7 49.2 54.7 45.4 37.8 44.4 43.7 6.2 7.1 8.4 11.5 9.4 13.4 11.2 9.8 12.0 9.1 8.4 9.4 10.0 4.0 9.8 8.3 6.9 14.7 6.3 12.2 13.6 14.2 12.5 11.8 12.6 13.7 12.9 13.7 12.5 13.1 14.2 49.3 44.8 58.0 10.1 47.2 39.4 39.7 30.8 43.9 34.2 30.0 33.9 20.8 31.5 26.8 23.9 37.5 44.6 55.1 32.0 31.3 49.9 9.4 28.7 36.6 45.8 33.0 37.0 11.2 92.9 81.1 37.3 35.2 54.6 47.5 54.1 46.4 25.3 38.8 25.2 12.9 49.9 28.5 58.6 25.2 7.9 30.1 41.6 19.6 12.2 46.3 29.6 44.3 13.0 13.0 62.1 35.6 26.7 37.2 30.7 47.5 50.6 17.7 37.1 26.3 27.8 31.9 45.4 42.1 30.7 19.7 44.1 47.3 53.8 39.5 36.6 BOD1 FAM44B ENSG00000145919 "Biorientation of chromosomes in cell division 1" Q96IK1 5 173607145-173616659 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036293 Uncertain NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 80: Striated muscle - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "HPA036293: AB_10673127" "unprognostic (2.85e-2)" "unprognostic (1.48e-1)" "unprognostic (4.04e-3)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.02e-4)" "prognostic unfavorable (2.49e-6)" "unprognostic (1.21e-1)" "unprognostic (7.66e-3)" "unprognostic (8.52e-2)" "unprognostic (2.34e-2)" "unprognostic (9.29e-2)" "unprognostic (1.00e-1)" "unprognostic (3.61e-1)" "unprognostic (1.93e-1)" "unprognostic (1.07e-2)" "unprognostic (2.51e-1)" 42.2 41.8 34.1 19.2 36.2 7.6 44.0 33.9 42.6 43.6 35.2 40.4 22.6 37.9 37.9 25.3 35.4 22.8 45.4 33.8 35.7 33.9 29.6 29.2 22.2 35.0 35.0 53.8 48.9 34.8 34.6 34.5 34.4 34.7 24.6 45.5 27.4 29.4 111.7 38.0 24.1 27.9 34.8 25.9 34.5 40.3 36.8 18.8 50.0 78.0 17.7 39.9 35.3 39.6 57.9 60.8 113.5 117.8 98.1 74.8 88.1 50.7 102.1 82.1 132.3 116.0 61.7 39.3 123.4 77.0 201.5 45.8 91.1 124.6 108.6 34.7 72.2 11.5 51.0 106.5 115.8 25.7 15.6 73.9 101.7 54.3 208.6 60.5 69.2 24.6 24.3 25.7 70.2 120.4 38.7 31.1 94.7 64.4 107.0 35.4 58.5 34.5 34.1 55.9 142.2 59.0 38.7 42.8 163.6 95.5 125.7 29.6 53.0 92.1 56.7 73.1 78.5 29.7 34.9 47.6 49.0 37.8 71.5 0.0 2.0 5.6 2.7 2.4 2.1 2.3 2.0 2.4 2.8 2.4 3.8 2.9 0.4 3.5 1.1 3.5 2.3 1.1 34.1 36.2 33.9 42.6 33.8 35.7 35.0 35.0 34.4 34.8 36.8 39.6 56.6 32.1 20.3 7.5 24.2 72.8 50.2 15.0 27.9 41.0 47.7 46.0 41.8 28.6 22.0 9.2 12.5 67.1 20.8 10.2 60.7 38.3 116.0 24.6 52.6 47.1 23.4 7.2 7.0 26.9 83.5 58.5 23.9 28.5 8.8 93.9 28.2 16.6 27.8 53.8 7.9 26.2 20.3 12.0 33.1 141.1 73.0 16.8 33.8 4.7 23.9 61.9 25.7 8.5 10.1 21.9 13.4 59.8 17.4 84.1 19.1 50.4 14.8 39.7 13.1 50.7 46.2 89.7 69.5 30.9 83.5 59.4 19.0 165.5 37.5 47.9 BOD1L1 "BOD1L, FAM44A, FLJ33215, KIAA1327" ENSG00000038219 "Biorientation of chromosomes in cell division 1 like 1" Q8NFC6 4 13568738-13627725 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036943, HPA037362, HPA041290" Approved Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (7.73e-2)" "unprognostic (2.29e-2)" "unprognostic (5.94e-2)" "unprognostic (6.15e-2)" "unprognostic (6.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-2)" "unprognostic (3.19e-1)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "prognostic favorable (3.48e-6)" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (6.60e-2)" 15.9 10.6 11.8 17.6 12.8 41.6 16.2 17.5 15.0 14.3 10.1 16.1 10.8 16.6 16.8 12.8 14.8 12.4 11.9 11.2 14.4 13.5 11.1 12.9 21.8 13.5 12.3 23.0 13.7 22.6 9.1 16.6 13.1 12.3 12.5 22.0 14.5 12.7 11.3 17.7 18.8 11.8 10.6 21.9 14.2 16.7 12.9 25.3 13.7 14.1 20.8 12.7 14.0 15.7 17.6 23.2 22.7 16.3 27.0 28.4 17.4 20.0 21.0 16.3 18.1 17.6 18.7 23.6 8.9 22.0 30.2 11.7 18.7 19.9 31.2 16.3 10.7 33.2 31.0 21.6 16.6 50.5 26.4 22.9 22.1 33.7 25.9 22.3 17.0 16.4 23.8 27.4 20.6 10.5 26.2 33.4 29.2 11.3 19.9 19.8 33.6 9.6 30.6 17.5 13.5 24.6 22.0 7.7 18.2 24.3 9.1 19.3 38.9 25.1 13.2 15.6 26.7 32.3 20.3 29.0 24.6 23.4 20.3 2.5 1.1 2.3 1.1 1.1 0.9 1.3 0.7 0.8 0.7 1.5 1.0 0.8 9.2 0.6 0.7 1.9 0.7 0.4 11.8 12.8 17.5 15.0 11.2 14.4 13.5 12.3 13.1 10.6 12.9 15.7 113.2 83.3 95.8 72.1 93.7 26.3 22.6 17.4 33.0 170.8 39.6 67.8 88.5 51.5 49.7 36.8 89.6 16.5 105.8 31.0 3.9 30.2 20.8 135.4 108.7 68.7 34.7 57.4 56.1 25.3 18.6 60.0 29.6 193.7 63.3 110.1 41.0 32.7 21.5 161.5 62.8 29.1 6.1 41.5 29.0 17.6 50.4 70.9 24.9 56.2 64.1 87.6 57.7 57.8 96.5 33.2 23.8 57.9 68.4 24.8 22.4 7.6 40.0 198.3 46.0 103.4 78.8 83.1 32.1 29.7 28.8 18.6 73.5 106.7 24.3 27.4 BPTF "FAC1, FALZ, NURF301" ENSG00000171634 "Bromodomain PHD finger transcription factor" Q12830 17 67825503-67984378 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029069, HPA048289" Approved Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA029069: AB_10602597, HPA048289: AB_2680342" "unprognostic (1.22e-1)" "unprognostic (6.53e-2)" "unprognostic (2.41e-2)" "unprognostic (3.74e-2)" "unprognostic (4.43e-2)" "unprognostic (1.10e-1)" "unprognostic (1.02e-2)" "unprognostic (2.30e-1)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (9.24e-2)" "prognostic favorable (8.46e-4)" "unprognostic (1.05e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" 25.5 23.7 24.1 25.4 29.5 32.0 25.5 88.1 26.3 30.3 10.9 27.9 15.7 27.9 28.7 26.6 29.6 19.1 20.7 21.0 38.2 27.9 20.7 22.6 43.7 26.4 21.9 38.1 22.9 27.4 34.6 22.2 24.3 25.2 22.2 44.0 25.2 16.7 25.9 37.5 28.5 19.6 17.6 31.4 23.6 32.1 22.6 52.9 27.4 22.3 39.2 24.4 27.7 34.3 42.2 52.8 76.3 38.7 41.6 39.0 42.2 32.0 29.4 37.1 31.8 49.6 29.0 167.7 22.4 35.4 28.5 32.2 74.4 34.5 60.0 24.2 72.5 64.9 50.4 68.8 19.8 97.3 49.9 28.6 37.3 36.9 27.6 34.0 70.2 52.9 75.1 46.1 32.3 64.0 99.1 47.3 58.9 37.9 47.8 70.3 91.0 33.6 32.5 50.6 56.5 65.6 42.8 117.4 46.4 91.4 49.1 53.7 49.6 56.2 43.7 20.7 39.7 39.3 42.0 97.9 26.9 45.1 22.0 20.3 4.2 8.5 7.2 2.4 5.7 6.2 5.9 5.7 3.0 11.8 6.1 6.3 9.2 10.7 5.7 10.9 4.5 1.6 24.1 29.5 88.1 26.3 21.0 38.2 26.4 21.9 24.3 17.6 22.6 34.3 118.7 115.4 148.2 192.3 130.9 75.2 55.3 37.8 87.0 216.8 76.2 78.5 136.0 61.5 92.0 58.8 143.9 39.4 170.3 64.1 7.9 63.8 26.6 147.7 174.5 108.1 126.1 114.6 124.4 63.1 30.8 94.8 88.2 165.9 121.4 124.9 71.0 46.4 42.2 198.5 136.4 68.9 48.8 56.3 54.4 25.7 108.7 84.7 64.0 109.6 88.0 129.3 146.2 231.8 262.7 65.4 64.5 111.3 129.2 62.1 37.7 17.4 80.8 202.6 65.7 167.3 92.3 144.9 101.3 82.6 75.6 38.7 128.8 126.6 85.8 60.7 BRAF BRAF1 ENSG00000157764 "B-Raf proto-oncogene, serine/threonine kinase" P15056 7 140719327-140924929 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 252.3;Inhibitory neurons: 242.4;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 202.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001328, CAB004552, HPA071048" Approved Approved Vesicles,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles Cytosol "CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336" "unprognostic (2.98e-3)" "unprognostic (5.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.66e-3)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.07e-2)" "unprognostic (4.23e-2)" "unprognostic (4.07e-2)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (1.91e-2)" "unprognostic (3.79e-3)" "unprognostic (2.08e-1)" "unprognostic (1.76e-1)" "unprognostic (8.01e-2)" "unprognostic (5.46e-2)" 8.8 5.8 6.3 5.6 7.7 15.9 8.8 12.5 8.7 8.2 5.4 8.6 4.7 8.3 8.3 7.5 8.0 5.8 7.6 8.3 6.7 7.6 6.6 9.9 6.9 4.0 3.6 9.8 8.3 11.5 9.0 7.2 4.6 8.2 5.4 17.0 7.2 5.9 8.6 10.4 6.9 6.0 3.1 6.7 7.8 13.7 5.2 8.7 10.2 8.4 6.4 9.9 8.5 6.7 6.3 5.2 7.7 9.4 9.1 11.8 12.3 6.8 7.5 5.4 7.6 5.7 6.7 10.8 5.0 7.3 8.4 3.4 6.8 5.5 10.0 9.8 5.4 7.1 5.1 5.2 7.6 11.7 6.8 7.9 6.1 6.0 12.0 8.2 6.6 7.7 11.3 19.1 9.8 3.3 15.6 12.0 6.9 6.2 3.1 10.1 6.5 8.9 5.3 11.9 8.9 7.3 7.9 4.9 7.3 7.5 4.5 7.8 9.7 5.9 4.3 12.9 5.5 21.6 12.9 16.7 9.7 11.3 6.6 1.9 1.0 4.1 1.5 0.9 1.0 1.3 1.5 1.2 0.8 1.1 2.6 1.3 2.0 3.5 1.3 1.0 1.5 0.6 6.3 7.7 12.5 8.7 8.3 6.7 4.0 3.6 4.6 3.1 5.2 6.7 43.4 22.4 45.7 151.1 58.4 21.5 24.6 6.0 23.3 29.7 31.2 21.2 19.8 10.0 18.7 25.8 35.5 15.7 73.5 8.8 7.9 14.3 68.6 50.6 37.4 23.4 19.2 14.9 252.3 9.8 12.9 22.0 21.9 69.2 24.7 45.5 9.3 9.6 9.4 25.2 242.4 9.8 8.2 13.6 37.1 36.5 16.4 30.1 16.0 126.5 14.6 11.3 15.5 206.1 202.6 15.4 8.1 10.1 48.7 23.8 8.0 13.4 20.0 33.0 6.6 24.1 24.7 43.8 26.0 14.5 24.0 75.5 41.4 30.9 8.7 33.4 BRAT1 "BAAT1, C7orf27, MGC22916" ENSG00000106009 "BRCA1 associated ATM activator 1" Q6PJG6 7 2537810-2555694 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029455, HPA076508" Approved Supported Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA029455: AB_10600761, HPA076508: AB_2686803" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.04e-3)" "unprognostic (6.07e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (2.03e-1)" "unprognostic (1.76e-1)" "unprognostic (2.46e-1)" "unprognostic (1.10e-3)" "unprognostic (4.69e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (5.37e-2)" "unprognostic (3.12e-2)" "unprognostic (8.88e-2)" "unprognostic (3.71e-2)" 17.4 31.0 10.7 6.8 10.9 7.9 17.8 10.4 14.3 22.5 9.6 16.2 8.8 19.4 2.2 15.1 19.2 3.7 14.5 10.4 11.2 15.2 20.7 12.2 7.2 13.5 11.4 21.6 20.2 5.2 19.8 4.5 10.1 24.5 1.3 0.9 17.4 6.6 14.8 21.6 16.6 2.5 10.6 21.1 19.6 31.5 11.2 5.0 18.7 3.7 2.1 17.6 18.8 10.5 35.1 31.1 7.5 27.2 6.8 6.3 24.5 11.7 6.5 10.1 8.5 22.5 21.5 26.3 18.1 7.8 19.4 35.1 8.8 13.7 1.6 10.4 44.4 12.2 23.5 14.3 8.7 16.5 18.2 10.6 9.5 10.2 3.0 5.8 11.4 20.2 39.1 9.6 7.1 50.0 11.8 77.9 35.3 8.8 47.0 28.6 21.9 25.5 6.5 11.3 19.5 30.2 17.1 29.8 12.9 3.5 26.5 33.4 11.8 13.8 43.3 28.5 23.2 20.7 17.3 19.0 15.2 32.8 33.2 5.1 30.8 17.5 21.9 28.2 19.3 18.6 19.8 22.6 32.4 15.2 16.3 17.9 25.4 15.9 27.1 22.7 18.4 22.8 10.7 10.9 10.4 14.3 10.4 11.2 13.5 11.4 10.1 10.6 11.2 10.5 10.1 12.8 6.4 19.9 11.1 7.8 17.5 22.6 16.5 12.8 11.3 8.9 6.8 15.7 14.8 9.2 12.5 21.1 15.0 14.8 15.6 10.6 20.8 7.1 12.3 13.0 11.4 10.3 14.2 13.8 12.9 12.8 26.0 7.5 14.0 34.9 15.4 15.3 34.2 3.3 16.2 14.8 8.2 13.1 6.7 9.4 22.7 13.3 7.2 12.2 17.6 14.4 9.2 13.6 11.3 12.0 12.1 22.2 14.4 9.1 15.0 16.6 8.1 11.9 6.6 9.4 10.7 28.8 39.5 8.0 6.8 14.6 11.9 31.7 17.9 7.6 BRD3 "KIAA0043, ORFX, RING3L" ENSG00000169925 "Bromodomain containing 3" Q15059 9 134030305-134068535 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 178.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051830 Approved Approved "Nuclear bodies" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "HPA051830: AB_2681627" "unprognostic (3.53e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (1.90e-1)" "unprognostic (6.20e-2)" "unprognostic (2.60e-2)" "unprognostic (2.98e-2)" "unprognostic (3.48e-2)" "unprognostic (1.11e-2)" "unprognostic (6.75e-2)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "prognostic favorable (2.71e-7)" "unprognostic (1.00e-1)" "unprognostic (4.71e-2)" "unprognostic (2.57e-2)" "unprognostic (1.42e-1)" 10.6 10.3 14.2 7.3 14.7 8.2 10.2 13.0 13.6 12.9 6.4 16.1 7.9 14.6 9.4 8.6 12.5 6.9 9.5 11.6 14.6 7.8 11.0 9.2 7.5 13.9 12.6 11.6 10.7 10.1 9.2 9.0 11.7 11.8 5.6 10.6 9.6 11.6 19.3 12.6 9.6 9.0 10.4 12.4 9.9 13.0 13.5 13.4 11.8 11.5 5.8 11.8 10.3 15.9 8.5 25.3 31.4 24.6 17.1 13.8 28.7 8.4 9.5 9.2 9.3 21.2 13.7 3.2 8.7 7.7 10.4 28.7 29.4 11.7 7.2 20.1 16.5 18.2 29.1 24.1 15.3 24.1 15.7 14.8 14.1 10.6 12.0 14.9 15.2 30.0 16.7 9.3 9.5 28.4 44.9 32.2 42.0 21.9 19.2 32.8 45.3 16.1 13.1 8.9 45.8 42.3 37.7 14.1 10.1 18.7 20.3 39.6 19.5 22.3 12.3 14.6 7.6 5.0 5.6 3.0 11.2 16.4 15.1 6.6 12.9 15.8 11.4 10.1 9.6 6.9 9.1 10.2 12.9 6.7 8.6 9.1 15.0 16.3 8.6 17.1 4.6 9.4 14.2 14.7 13.0 13.6 11.6 14.6 13.9 12.6 11.7 10.4 13.5 15.9 27.6 32.1 21.9 13.1 18.3 32.4 21.2 19.8 42.1 60.9 32.8 24.3 24.3 28.6 25.7 23.9 37.5 26.0 31.8 22.6 19.6 42.7 49.2 22.9 37.9 32.1 54.0 70.1 13.4 24.4 20.5 32.4 21.9 25.3 15.9 53.2 35.7 34.0 18.7 57.2 16.8 26.6 14.2 27.9 22.8 20.7 57.2 33.6 23.2 10.3 33.6 45.6 30.9 12.5 19.3 27.7 21.4 67.4 9.1 51.0 19.2 15.7 20.1 58.0 59.2 55.8 40.0 20.7 53.1 31.9 35.7 32.7 26.4 178.7 30.8 22.3 BRD7 "BP75, CELTIX1" ENSG00000166164 "Bromodomain containing 7" Q9NPI1 16 50313487-50368988 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042389, CAB046458, HPA060171" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214" "unprognostic (2.10e-2)" "unprognostic (9.52e-3)" "unprognostic (7.06e-2)" "unprognostic (3.39e-2)" "unprognostic (7.27e-2)" "unprognostic (1.62e-1)" "unprognostic (4.85e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.38e-4)" "unprognostic (2.15e-1)" "unprognostic (8.97e-2)" "unprognostic (9.46e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (3.59e-2)" "unprognostic (6.34e-2)" 32.6 34.1 50.8 33.6 55.8 65.9 36.0 53.4 69.4 36.0 49.2 42.8 31.1 36.8 47.0 49.3 34.3 26.7 36.4 49.5 55.3 40.3 30.6 35.3 46.6 55.4 53.4 33.3 47.8 56.0 30.8 43.1 54.8 32.7 38.5 49.6 35.0 33.1 54.4 43.4 35.1 34.5 52.4 37.4 39.5 57.0 53.3 57.2 40.1 44.3 50.0 35.5 35.6 57.6 78.4 67.8 116.4 69.7 48.2 47.7 76.6 62.8 61.7 96.9 43.8 114.3 77.5 116.1 64.2 56.0 60.4 70.7 107.6 63.3 111.1 53.2 89.1 79.0 54.2 159.2 56.7 110.0 83.5 34.9 93.2 49.9 85.5 58.8 65.6 113.0 115.8 36.2 59.9 51.0 125.2 147.0 91.5 82.0 63.5 151.8 109.2 84.8 85.6 54.5 90.0 73.1 76.3 73.2 53.6 99.0 43.9 98.5 66.8 61.3 74.4 51.0 62.0 17.0 7.1 196.9 48.1 78.5 62.2 6.2 5.1 7.6 6.4 4.4 4.9 6.1 6.4 6.0 4.1 6.2 7.1 8.7 2.9 9.8 4.1 8.5 6.9 3.0 50.8 55.8 53.4 69.4 49.5 55.3 55.4 53.4 54.8 52.4 53.3 57.6 73.7 38.5 64.4 16.0 54.6 50.7 41.1 16.9 20.5 89.0 63.4 63.8 35.7 52.9 29.6 49.7 66.7 70.6 124.6 51.1 107.6 22.3 47.4 75.1 62.9 42.0 36.0 76.4 14.6 23.0 49.5 41.3 40.2 89.1 15.2 84.3 38.6 45.8 29.9 90.9 15.8 46.6 20.3 40.3 24.5 22.5 32.6 45.9 26.6 17.8 38.4 81.2 82.4 30.2 32.7 23.9 36.4 28.2 74.2 62.2 32.0 72.3 36.7 120.6 52.6 78.4 46.5 203.6 157.2 44.8 63.2 72.4 55.7 59.3 46.1 66.6 BRD9 FLJ13441 ENSG00000028310 "Bromodomain containing 9" Q9H8M2 5 850291-892801 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 110.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021465, HPA023197" Uncertain Enhanced Nucleoplasm NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 70: Brain - Nervous system development" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA021465: AB_1845441, HPA023197: AB_2671106" "unprognostic (3.10e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-3)" "unprognostic (4.61e-2)" "unprognostic (5.89e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (5.88e-7)" "unprognostic (6.28e-2)" "unprognostic (7.53e-3)" "unprognostic (3.84e-2)" "unprognostic (8.82e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (2.37e-6)" "unprognostic (6.64e-2)" "unprognostic (1.07e-1)" "unprognostic (6.62e-3)" "unprognostic (1.02e-2)" 7.7 7.4 14.3 9.1 14.2 8.1 8.5 13.0 15.0 6.9 12.6 7.3 6.8 8.6 7.3 6.6 7.4 5.9 10.5 13.2 12.7 5.8 5.5 7.8 10.0 15.0 14.1 8.8 8.7 9.0 4.5 6.9 13.5 6.6 7.0 3.6 8.8 8.2 16.9 6.8 7.6 7.9 13.5 8.0 7.9 7.5 15.1 13.2 8.0 9.9 8.5 8.6 6.0 14.7 14.4 14.2 27.5 28.6 11.7 23.7 32.5 28.2 19.4 29.7 23.5 26.6 19.5 17.9 46.0 30.4 33.3 14.1 20.4 27.7 27.5 110.2 17.0 22.2 37.0 17.9 23.7 34.0 20.3 17.7 9.9 20.8 19.0 22.1 29.6 34.2 29.5 12.8 25.4 22.9 40.0 32.1 18.5 15.0 22.4 26.9 16.4 16.5 17.2 21.5 16.8 29.7 56.3 19.1 13.4 14.9 17.1 43.1 28.7 24.2 18.8 12.4 29.3 23.3 10.0 32.5 22.7 35.5 32.3 7.0 3.3 3.7 3.0 1.5 4.0 4.9 4.2 4.5 3.0 6.0 3.8 3.2 2.0 4.2 2.9 3.1 5.2 1.4 14.3 14.2 13.0 15.0 13.2 12.7 15.0 14.1 13.5 13.5 15.1 14.7 36.8 19.2 14.4 13.1 32.1 25.4 18.2 12.5 39.3 70.2 23.5 21.7 25.2 25.8 13.8 23.9 45.9 17.1 39.5 33.9 23.5 23.4 93.5 46.7 80.7 25.0 16.3 21.0 9.3 20.0 30.3 24.0 42.8 52.7 19.0 40.9 27.8 22.2 21.0 101.0 8.2 33.9 4.1 25.4 14.9 56.8 22.7 25.3 14.2 6.5 31.3 29.1 42.2 9.0 11.8 31.1 27.4 19.5 44.8 20.6 21.3 18.7 7.7 87.8 26.3 28.5 25.0 49.2 68.2 32.0 20.3 19.7 47.8 27.1 27.6 16.5 C19orf25 FLJ36666 ENSG00000119559 "Chromosome 19 open reading frame 25" Q9UFG5 19 1461143-1479219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050270, HPA067491" Approved Approved "Intermediate filaments" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" "HPA050270: AB_2681069, HPA067491: AB_2685849" "unprognostic (5.82e-2)" "unprognostic (3.87e-2)" "unprognostic (6.51e-2)" "prognostic favorable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (2.14e-3)" "prognostic unfavorable (3.81e-4)" "unprognostic (1.10e-2)" "unprognostic (1.36e-1)" "unprognostic (2.49e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.35e-2)" "prognostic favorable (9.20e-8)" "unprognostic (3.50e-3)" "unprognostic (8.01e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-3)" 14.4 23.5 33.3 8.8 33.2 7.8 15.9 31.1 43.8 17.7 29.3 18.0 15.6 15.8 5.3 20.4 15.7 8.1 21.2 31.6 30.0 31.0 29.5 14.8 15.0 35.3 33.1 15.9 19.9 15.6 27.1 8.6 32.0 22.1 5.2 6.9 17.6 8.1 16.2 17.3 17.7 6.1 32.7 23.4 17.8 22.0 34.0 9.7 23.8 7.4 7.0 17.5 15.6 36.7 25.0 19.2 11.6 18.3 11.0 10.0 23.4 24.4 16.8 25.5 23.5 27.4 12.1 14.2 18.7 13.0 12.1 30.1 17.9 15.0 6.0 44.7 27.1 17.3 12.2 32.3 23.6 27.5 33.5 9.2 33.2 10.7 17.2 18.3 13.2 29.3 46.1 32.7 16.6 13.9 25.6 21.8 36.2 15.2 29.5 41.4 16.0 36.5 17.8 16.7 19.8 26.5 18.0 23.0 28.5 6.0 33.4 31.8 16.3 19.8 22.4 40.6 23.4 46.3 26.7 24.2 20.4 27.4 35.1 50.1 32.1 59.1 41.3 33.0 33.5 36.6 37.9 35.7 23.4 45.6 38.2 30.9 52.0 30.5 27.7 47.6 52.6 38.6 33.3 33.2 31.1 43.8 31.6 30.0 35.3 33.1 32.0 32.7 34.0 36.7 24.2 16.0 8.7 10.4 44.3 19.2 30.5 27.3 18.8 62.7 28.9 29.7 10.3 21.5 19.9 51.5 64.6 41.5 45.2 68.1 49.0 40.1 6.2 14.7 21.0 23.0 50.6 17.2 14.5 46.1 33.3 21.7 31.1 19.3 11.4 30.4 29.3 18.2 35.9 97.6 11.5 33.7 34.6 27.9 24.9 7.3 26.4 26.4 24.9 8.4 56.7 49.2 82.4 14.1 20.6 52.6 52.0 21.8 26.7 33.5 83.2 35.5 15.3 87.8 46.0 20.0 24.1 33.8 33.0 14.8 19.7 52.9 47.3 36.1 38.2 33.6 C1QTNF4 "CTRP4, ZACRP4" ENSG00000172247 "C1q and TNF related 4" Q9BXJ3 11 47589667-47594411 "Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0;pituitary gland: 17.1" "Cell type enhanced" "Detected in many" "Late spermatids: 51.7;Leydig cells: 46.0;Muller glia cells: 54.5;Peritubular cells: 38.4;Spermatogonia: 44.5;Theca cells: 39.0" "Group enriched" "Detected in some" 4 "glioma: 1.7;ovarian cancer: 2.5;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "REH: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041032 Approved Uncertain "Golgi apparatus,Vesicles" "Secreted in brain" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 14: REH - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus, Vesicles" "HPA041032: AB_10671170" "unprognostic (1.84e-3)" "unprognostic (1.58e-1)" "unprognostic (8.98e-4)" "unprognostic (8.19e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-3)" "unprognostic (6.78e-2)" "unprognostic (6.11e-2)" "unprognostic (6.35e-2)" "unprognostic (4.00e-1)" "unprognostic (4.91e-4)" "unprognostic (1.22e-1)" "unprognostic (8.22e-6)" "unprognostic (6.02e-3)" "unprognostic (1.00e-1)" "unprognostic (2.80e-2)" "unprognostic (6.28e-2)" 1.7 1.5 7.9 0.0 33.0 1.1 2.2 13.2 17.6 5.3 0.0 3.9 0.1 5.8 0.0 0.5 4.2 0.0 1.0 7.5 1.1 1.4 0.9 0.7 0.0 6.0 4.9 12.0 0.4 0.7 17.1 0.0 2.1 2.8 0.0 0.1 1.1 0.1 0.9 1.8 1.5 0.1 1.0 1.0 1.5 5.8 6.7 0.0 1.5 0.0 0.0 1.3 2.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 33.0 13.2 17.6 7.5 1.1 6.0 4.9 2.1 1.0 6.7 3.4 2.4 0.0 0.0 18.9 0.0 2.4 6.5 0.2 0.0 15.8 1.3 25.8 0.7 1.5 0.3 3.7 16.7 1.3 0.1 0.2 3.9 0.1 11.3 0.8 21.2 4.5 0.0 2.5 15.5 0.2 2.7 20.7 0.5 0.6 0.0 31.3 2.5 0.2 3.3 5.0 17.8 0.1 0.0 0.3 3.0 51.7 46.0 0.7 10.6 4.7 0.0 54.5 0.0 5.0 8.0 0.1 0.1 38.4 0.0 4.3 0.1 0.6 0.6 24.7 26.3 12.8 8.5 13.5 44.5 0.3 1.8 3.6 0.6 39.0 0.2 2.4 C2CD6 "ALS2CR11, FLJ25351" ENSG00000155754 "C2 calcium dependent domain containing 6" Q53TS8 2 201487421-201619178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 39.9" "Cell type enriched" "Detected in some" 21 "Theca cells: 41.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.9;HSkMC: 2.0;hTEC/SVTERT24-B: 2.0;SCLC-21H: 2.3;THP-1: 2.0;U-2197: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 52: Non-specific - Transcription" "unprognostic (2.64e-1)" "unprognostic (1.14e-1)" "unprognostic (8.77e-3)" "unprognostic (7.13e-6)" "unprognostic (1.33e-1)" "unprognostic (4.38e-2)" "unprognostic (2.16e-1)" "unprognostic (4.81e-2)" "unprognostic (3.15e-2)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (2.10e-1)" "unprognostic (5.13e-10)" "unprognostic (1.95e-1)" "unprognostic (6.35e-2)" "unprognostic (2.00e-1)" "unprognostic (2.18e-1)" 0.6 0.7 1.5 0.0 2.2 0.0 0.3 2.3 1.2 0.1 0.8 0.1 0.1 0.2 0.1 0.2 0.1 0.4 1.2 0.5 2.2 0.1 0.1 0.3 0.2 5.5 2.6 0.7 0.0 0.0 0.7 0.1 4.5 0.3 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.2 4.3 0.1 0.0 39.9 2.3 0.0 0.1 0.0 0.0 0.1 0.1 6.6 0.0 0.0 0.0 0.0 0.2 1.9 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.2 0.1 0.0 2.0 0.0 0.0 0.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 2.2 2.3 1.2 0.5 2.2 5.5 2.6 4.5 4.3 2.3 6.6 0.3 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 C2orf49 "asw, MGC5509" ENSG00000135974 "Chromosome 2 open reading frame 49" Q9BVC5 2 105337532-105349211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043846, HPA060814" Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Mitochondria "HPA043846: AB_2678698, HPA060814: AB_2684372" "unprognostic (4.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.06e-1)" "unprognostic (6.16e-3)" "unprognostic (2.57e-3)" "unprognostic (8.75e-3)" "unprognostic (1.89e-3)" "unprognostic (6.51e-2)" "unprognostic (5.01e-2)" "unprognostic (2.07e-1)" "unprognostic (2.56e-1)" "unprognostic (5.94e-2)" "prognostic unfavorable (5.06e-5)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.04e-2)" 11.3 9.3 9.6 10.6 11.9 19.3 11.1 12.0 12.9 12.5 6.2 9.1 9.4 14.6 7.8 11.8 12.4 9.5 15.3 8.9 10.7 8.7 10.1 8.6 12.6 11.2 11.5 19.9 11.0 10.5 5.5 12.0 11.3 11.3 9.9 24.9 9.1 11.0 19.9 9.5 10.1 12.2 10.2 11.1 13.8 13.0 10.6 16.0 12.6 21.0 13.3 11.3 10.5 13.8 20.0 13.9 17.2 17.5 19.4 23.6 30.7 19.6 20.6 17.0 23.3 30.7 19.5 23.3 23.9 17.1 45.6 18.7 23.9 16.7 22.2 30.6 18.1 25.3 11.6 23.8 23.6 21.3 20.1 17.1 28.7 24.0 21.6 24.3 15.8 18.1 35.9 18.7 24.3 15.4 25.9 24.5 22.6 13.5 16.8 17.1 25.4 27.1 19.2 18.9 20.3 16.2 17.3 15.5 23.8 19.2 15.2 23.8 25.4 17.9 25.1 13.0 16.1 23.6 20.5 24.6 18.1 21.3 17.6 15.4 13.2 12.0 9.0 8.3 8.9 14.5 10.1 9.0 9.2 17.6 11.0 9.3 17.8 9.2 11.9 19.1 12.7 6.7 9.6 11.9 12.0 12.9 8.9 10.7 11.2 11.5 11.3 10.2 10.6 13.8 27.0 16.0 14.3 7.5 26.3 29.1 13.4 21.8 15.4 37.1 24.8 22.9 30.9 18.6 22.0 25.8 29.2 21.2 31.6 16.5 25.4 22.9 40.6 43.1 34.7 19.3 11.3 21.2 10.8 18.2 26.5 22.8 12.8 33.9 16.5 18.1 19.6 22.4 16.1 23.5 11.2 22.5 12.2 18.5 13.5 35.8 27.7 15.5 7.2 10.3 21.1 39.6 28.8 7.1 15.8 21.0 17.5 29.0 19.0 16.2 21.8 22.3 36.1 44.3 19.7 17.3 19.8 45.8 28.1 13.7 24.7 36.8 22.4 16.6 14.8 15.8 C2orf68 ENSG00000168887 "Chromosome 2 open reading frame 68" Q2NKX9 2 85605254-85612066 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051143 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane, Mitochondria" Nucleoli "HPA051143: AB_2681360" "unprognostic (1.71e-2)" "unprognostic (3.65e-2)" "unprognostic (1.07e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (9.34e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.76e-6)" "unprognostic (4.24e-3)" "unprognostic (8.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (1.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.70e-2)" "unprognostic (8.81e-3)" 11.0 9.4 8.8 10.0 11.6 10.5 12.6 15.4 9.9 18.7 10.7 13.6 11.0 15.7 12.2 12.1 15.2 6.6 12.3 8.6 9.4 12.8 11.7 14.0 14.2 11.7 10.8 20.4 17.2 8.5 14.0 12.5 11.0 16.4 10.9 20.0 16.4 10.7 21.8 16.3 16.6 9.9 9.8 16.9 14.3 9.5 10.2 13.7 16.3 9.8 13.9 13.6 15.4 15.2 8.8 7.9 15.7 11.5 14.2 7.6 10.2 4.3 5.6 6.7 8.7 7.1 10.6 12.4 6.0 7.3 6.0 10.4 7.9 7.5 7.2 6.8 19.1 21.1 13.8 8.5 11.2 12.3 11.4 11.3 9.7 4.4 12.7 10.6 10.1 14.7 10.7 12.4 6.3 9.3 13.3 13.4 6.9 10.2 7.3 14.8 27.8 11.5 8.5 10.1 19.8 14.2 6.5 8.5 9.0 8.7 9.1 6.5 7.0 4.8 12.8 5.9 4.2 17.9 11.8 10.8 7.2 12.9 6.0 32.7 30.5 59.0 22.4 21.8 21.3 14.6 21.1 21.0 22.4 20.7 30.5 28.2 49.2 31.2 27.0 15.2 17.7 16.7 8.8 11.6 15.4 9.9 8.6 9.4 11.7 10.8 11.0 9.8 10.2 15.2 8.2 64.1 63.1 15.0 18.6 5.9 18.2 10.0 9.6 17.4 16.0 12.3 10.7 37.1 24.3 35.0 35.5 47.2 24.4 24.6 17.6 17.9 4.8 9.4 8.7 13.9 19.2 19.5 2.7 19.8 17.7 12.9 17.9 9.6 34.7 15.6 17.9 25.3 23.3 25.2 6.8 16.9 12.2 34.9 14.3 12.8 24.2 26.0 14.2 15.0 31.4 12.3 38.1 10.1 16.9 19.4 14.0 13.5 13.6 14.4 32.7 26.6 21.0 27.0 19.7 13.7 8.5 37.2 20.1 27.4 9.8 24.9 18.1 10.0 15.8 19.2 CAD GATD4 ENSG00000084774 "Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase" P27708 2 27217369-27243943 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007781, HPA065158, HPA069341" Supported Supported Cytosol NA No 260000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Cytosol "CAB007781: AB_562057, HPA065158: , HPA069341: AB_2686125" "unprognostic (1.69e-1)" "unprognostic (7.34e-2)" "unprognostic (1.49e-1)" "unprognostic (4.71e-3)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.72e-11)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.94e-2)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (5.93e-3)" 15.0 13.5 12.7 12.4 14.1 9.0 14.9 12.7 15.5 19.8 12.2 16.5 8.5 23.8 9.9 19.2 19.3 7.7 11.6 12.3 12.8 18.0 27.8 12.3 14.9 13.8 13.5 22.3 22.3 5.9 18.7 7.5 14.5 15.2 7.8 5.0 12.3 8.8 10.3 18.7 16.1 11.9 12.7 20.1 14.0 22.2 14.2 11.6 15.8 5.9 10.5 16.9 15.8 15.2 75.2 66.4 28.9 58.4 46.1 37.6 22.9 31.0 21.4 38.3 27.0 75.7 29.2 66.4 27.4 28.5 29.6 41.4 85.7 41.1 28.5 43.8 69.2 95.2 55.0 40.0 23.0 75.7 46.2 28.8 33.1 55.7 63.0 17.8 41.6 60.6 68.3 36.0 34.2 74.8 48.7 112.0 69.7 31.3 49.7 84.0 86.5 69.5 28.6 37.6 57.9 29.1 43.3 30.5 37.4 21.3 23.9 31.3 37.7 57.7 47.5 45.5 63.5 74.0 51.8 135.2 23.3 71.7 51.0 0.0 0.8 0.4 3.1 1.5 2.5 3.4 4.4 5.2 1.9 3.1 2.8 2.8 0.5 2.7 0.9 3.4 5.9 2.0 12.7 14.1 12.7 15.5 12.3 12.8 13.8 13.5 14.5 12.7 14.2 15.2 4.2 3.2 3.9 12.7 5.3 3.7 4.3 5.0 5.7 10.6 7.1 8.6 8.3 10.0 4.7 1.8 16.7 5.9 3.9 3.9 0.0 6.1 1.5 2.9 7.9 5.1 6.6 9.7 5.6 3.7 6.6 7.0 6.1 4.3 4.5 16.9 3.3 6.6 7.7 6.7 5.7 5.8 0.0 3.0 1.9 1.9 6.2 3.6 3.6 6.5 4.7 4.1 5.2 8.5 7.4 5.9 1.9 9.8 7.3 8.0 2.5 2.0 3.5 6.8 0.0 8.2 5.2 5.6 12.1 6.2 3.4 2.2 5.1 9.7 7.5 2.2 CAND1 "DKFZp434M1414, KIAA0829, TIP120, TIP120A" ENSG00000111530 "Cullin associated and neddylation dissociated 1" Q86VP6 12 67269358-67319953 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055748, HPA062833, HPA069053" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 5900000 "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074" "unprognostic (1.50e-2)" "unprognostic (1.60e-1)" "unprognostic (1.39e-3)" "unprognostic (2.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.02e-2)" "unprognostic (2.17e-2)" "unprognostic (3.02e-1)" "unprognostic (3.38e-3)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" "unprognostic (2.88e-1)" "unprognostic (1.58e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" 18.4 23.1 19.6 19.9 21.4 22.6 25.9 25.3 21.8 21.4 15.9 19.8 19.5 21.2 27.8 22.5 19.2 18.3 12.6 20.9 21.7 24.3 27.4 16.8 27.5 18.8 19.0 25.0 18.7 28.3 19.3 23.2 21.2 22.4 20.6 37.5 16.5 20.0 9.9 29.3 18.5 21.6 19.5 19.1 18.2 27.8 19.5 38.8 26.0 11.4 30.8 23.3 19.3 19.5 62.1 62.6 93.1 66.6 69.7 54.3 62.4 60.2 51.6 62.0 54.2 58.4 34.5 132.9 51.0 60.6 38.9 57.8 101.1 68.3 70.6 50.8 60.5 75.1 46.5 55.7 45.7 89.5 40.9 51.5 51.0 56.8 51.9 75.8 58.7 63.9 60.4 72.3 67.7 61.0 81.6 60.3 98.8 47.4 43.1 78.4 79.8 56.3 57.3 103.9 95.2 47.3 74.9 68.0 49.9 77.8 73.2 40.7 50.3 49.0 31.5 34.1 46.1 23.5 31.1 111.5 58.3 52.2 51.4 9.3 6.4 7.4 14.0 7.4 17.0 10.9 16.8 15.3 10.0 14.7 17.7 14.9 2.7 19.0 14.0 8.6 19.3 5.7 19.6 21.4 25.3 21.8 20.9 21.7 18.8 19.0 21.2 19.5 19.5 19.5 37.6 60.9 36.3 38.5 61.2 58.1 50.2 51.6 57.5 92.4 51.4 40.6 17.0 42.9 42.0 44.1 116.7 37.4 61.5 47.3 13.7 30.7 3.9 45.2 53.9 44.6 45.4 34.9 48.8 28.6 42.7 47.7 41.3 51.1 7.6 71.0 40.4 49.8 31.3 87.5 61.7 50.4 34.6 42.4 52.4 11.0 69.0 35.9 33.8 32.8 54.6 53.8 48.4 49.8 63.5 35.2 28.6 60.9 55.1 56.6 59.8 32.3 55.3 115.3 26.3 52.1 50.7 82.5 47.7 47.1 63.9 44.6 59.3 66.4 46.5 64.2 CARF "ALS2CR8, FLJ21579, NYD-SP24" ENSG00000138380 "Calcium responsive transcription factor" Q8N187 2 202912214-202988263 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 66.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034557, HPA043191" Approved Approved "Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles "Nucleoli fibrillar center, Cytosol" "HPA034557: AB_10601663, HPA043191: AB_2732503" "unprognostic (4.63e-2)" "unprognostic (3.11e-1)" "unprognostic (1.30e-1)" "unprognostic (1.93e-2)" "unprognostic (6.09e-2)" "unprognostic (8.65e-3)" "unprognostic (1.12e-1)" "unprognostic (2.13e-3)" "unprognostic (4.39e-2)" "unprognostic (1.10e-1)" "unprognostic (7.58e-3)" "unprognostic (1.08e-1)" "unprognostic (6.12e-2)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.55e-2)" 4.5 5.3 4.2 5.7 8.6 5.4 7.7 6.4 5.1 5.9 2.5 5.2 4.5 9.4 9.9 5.5 6.8 6.0 4.9 4.4 5.0 6.8 4.5 5.1 8.8 5.9 6.0 7.9 3.9 7.8 5.1 4.7 6.5 6.7 6.0 16.1 4.6 6.4 4.5 7.4 4.9 6.6 4.6 7.5 6.0 21.5 5.5 9.4 10.6 5.4 7.8 5.7 5.0 12.3 2.5 2.4 6.1 5.4 4.5 9.5 4.7 3.7 4.7 3.8 3.4 2.8 6.2 3.8 1.6 4.3 4.6 4.5 3.2 2.7 4.3 3.0 1.7 5.9 3.0 1.7 3.8 3.5 2.9 7.8 5.2 3.3 8.6 9.6 2.3 13.9 2.5 15.5 5.9 4.9 7.2 5.6 2.6 1.6 3.5 5.1 4.2 3.1 6.9 2.6 4.3 4.6 4.0 2.2 1.7 7.7 3.6 6.5 2.7 7.1 1.8 4.6 2.4 13.7 8.4 4.2 6.1 4.1 4.4 1.4 1.0 0.8 2.2 1.9 2.4 2.0 2.2 2.1 1.2 2.4 3.1 2.2 0.4 8.8 1.1 1.9 4.7 0.6 4.2 8.6 6.4 5.1 4.4 5.0 5.9 6.0 6.5 4.6 5.5 12.3 5.6 9.6 15.7 28.7 14.6 3.2 3.9 5.5 5.2 33.5 6.7 5.5 6.6 7.2 14.1 14.7 18.8 4.2 9.2 2.7 11.7 4.4 19.0 7.1 5.0 5.6 1.8 7.6 21.5 2.4 9.3 7.4 5.6 2.9 20.3 19.6 8.2 3.2 3.9 26.9 25.0 4.7 6.1 8.2 3.7 16.7 10.8 4.9 1.8 16.9 5.9 9.6 18.6 39.2 66.1 2.9 3.2 9.4 4.0 2.0 9.5 5.8 17.7 31.1 6.6 7.1 5.6 37.2 8.6 4.4 2.7 1.8 10.2 10.5 6.2 2.7 CASP8AP2 "CED-4, FLASH, FLJ11208, KIAA1315, RIP25" ENSG00000118412 "Caspase 8 associated protein 2" 6 89829894-89874436 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.6" "Cell type enhanced" "Detected in many" "Spermatogonia: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053573 Approved "Nucleoli,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoli, Nuclear bodies" "HPA053573: AB_2682194" "unprognostic (7.80e-2)" "unprognostic (1.47e-1)" "unprognostic (6.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.64e-2)" "unprognostic (1.22e-2)" "unprognostic (1.75e-4)" "unprognostic (4.58e-1)" "unprognostic (4.36e-3)" "unprognostic (2.20e-2)" "unprognostic (1.11e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (2.35e-1)" "unprognostic (1.63e-1)" "unprognostic (4.16e-2)" "unprognostic (3.53e-1)" 0.6 0.3 0.4 0.4 1.0 0.2 0.5 2.6 1.2 0.7 0.3 0.9 0.0 0.7 0.0 0.4 0.6 0.1 0.4 0.6 0.4 0.4 0.2 0.5 0.4 0.5 0.5 0.5 0.5 0.1 0.4 0.1 0.8 0.5 0.1 0.0 0.4 0.0 0.8 0.4 0.5 0.2 0.8 0.4 0.3 0.3 0.7 0.6 0.6 0.7 0.2 0.6 0.5 1.9 0.4 1.0 1.3 1.0 0.1 0.4 0.3 2.1 0.2 0.7 0.5 0.8 0.5 2.4 0.7 1.0 0.8 0.7 2.5 0.6 0.7 3.7 3.5 4.0 3.0 0.0 0.0 2.6 1.1 0.2 0.2 1.6 0.6 0.2 0.8 1.4 4.4 1.3 0.6 0.7 1.6 0.0 0.2 0.2 1.3 3.3 3.8 0.9 0.0 3.2 1.4 0.8 1.8 0.0 0.5 0.5 0.4 1.2 1.6 0.3 0.5 1.6 1.6 0.2 2.8 1.3 0.5 1.4 1.4 14.4 1.5 5.6 6.2 2.6 5.9 5.5 7.1 6.5 1.9 6.3 5.4 5.6 3.1 12.6 2.3 4.9 6.6 2.3 0.4 1.0 2.6 1.2 0.6 0.4 0.5 0.5 0.8 0.8 0.7 1.9 27.3 32.1 14.5 26.1 26.8 0.0 9.1 0.0 13.6 19.5 13.3 16.4 47.5 7.2 11.8 7.3 6.2 20.5 21.4 12.7 3.9 15.1 5.9 9.6 22.1 21.1 2.4 35.7 32.3 12.3 15.8 21.4 11.7 13.7 15.8 31.8 9.7 6.9 12.4 35.3 33.5 11.7 0.0 11.5 0.0 4.7 23.0 16.1 0.0 33.7 26.9 18.1 34.0 23.6 38.2 9.3 10.3 25.9 14.4 13.2 11.8 7.2 13.8 25.5 19.7 30.6 25.1 47.2 74.2 15.7 0.0 10.9 24.7 16.7 14.6 9.1 CBWD3 bA561O23.1 ENSG00000196873 "COBW domain containing 3" Q5JTY5 9 68232003-68300035 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Uncertain Approved "Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.95e-1)" "unprognostic (9.71e-3)" "unprognostic (9.99e-2)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.05e-2)" "unprognostic (2.05e-2)" "unprognostic (1.05e-3)" "unprognostic (3.77e-2)" "unprognostic (1.67e-1)" "unprognostic (4.43e-3)" "unprognostic (5.16e-4)" 12.2 19.4 7.5 18.8 7.5 13.5 17.3 9.8 9.5 9.8 5.3 14.0 13.0 9.9 7.3 17.2 9.7 6.6 13.0 8.1 8.9 21.2 28.4 10.2 16.9 8.4 7.7 12.0 27.2 8.6 18.4 15.6 8.8 10.5 9.8 18.0 13.5 10.2 17.5 13.1 20.6 8.9 4.4 12.7 17.5 12.3 6.9 12.7 14.3 13.3 13.0 18.8 12.2 10.6 73.0 52.6 25.1 41.2 18.9 6.7 34.3 35.6 14.1 15.2 17.4 15.0 69.4 84.1 33.9 26.1 67.5 86.7 48.0 70.5 39.8 128.2 31.0 31.9 137.8 73.6 24.8 60.9 38.3 15.6 21.3 27.0 35.3 30.5 35.6 93.1 60.4 66.1 22.3 47.4 71.8 81.9 38.5 86.4 88.7 32.6 78.7 94.0 17.3 32.8 40.3 25.7 58.0 36.2 46.3 46.6 26.7 71.5 16.6 22.6 58.1 38.4 70.1 38.3 165.4 102.3 68.8 92.3 41.6 29.8 86.1 66.2 27.8 71.5 24.0 52.5 25.2 28.7 62.0 52.3 27.6 25.5 86.5 16.1 52.0 46.5 37.9 59.8 7.5 7.5 9.8 9.5 8.1 8.9 8.4 7.7 8.8 4.4 6.9 10.6 4.3 25.6 30.0 2.0 15.9 14.5 16.2 6.0 12.0 25.2 14.5 9.7 28.7 7.2 21.0 11.0 29.2 13.2 5.6 9.7 1.9 7.1 4.7 4.0 2.4 9.0 4.2 5.2 10.8 11.6 7.9 8.9 8.6 3.8 12.6 12.4 6.1 8.2 5.0 11.8 8.9 9.1 2.0 11.0 10.1 2.4 5.0 6.8 5.4 6.5 19.7 5.9 8.2 10.1 5.6 8.8 17.4 3.0 20.3 12.6 28.9 7.1 24.1 36.2 6.6 5.3 6.3 16.7 7.8 7.3 21.5 15.5 10.6 7.6 10.7 12.9 CBX7 ENSG00000100307 "Chromobox 7" O95931 22 39120167-39152680 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 37.2;U-266/70: 30.7" "Low region specificity" "Detected in all" "CAB011574, HPA048677, HPA056480" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "CAB011574: AB_726005, HPA048677: AB_2680490, HPA056480: AB_2683146" "prognostic favorable (6.18e-4)" "prognostic favorable (3.63e-4)" "prognostic unfavorable (3.73e-4)" "unprognostic (9.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.48e-3)" "unprognostic (4.76e-3)" "unprognostic (1.45e-2)" "unprognostic (3.86e-2)" "unprognostic (1.11e-3)" "prognostic favorable (1.04e-4)" "unprognostic (3.03e-3)" "prognostic favorable (2.45e-5)" "unprognostic (3.90e-1)" "unprognostic (1.26e-1)" "unprognostic (3.10e-1)" "unprognostic (1.63e-2)" 36.6 31.2 53.6 15.9 52.9 6.0 32.3 53.8 72.1 54.6 38.1 85.2 17.2 61.2 29.1 24.5 62.7 17.7 57.4 53.7 44.5 32.5 17.7 30.4 27.4 49.2 47.8 58.5 28.8 41.5 42.7 8.3 48.9 50.9 14.2 34.0 35.3 57.7 68.0 28.1 42.9 27.4 38.6 42.5 48.0 10.8 46.0 14.2 33.3 51.3 21.6 66.3 39.1 53.2 6.9 2.9 1.4 11.0 13.1 5.0 3.6 6.5 8.0 3.5 4.2 1.4 4.7 1.2 7.5 4.9 6.3 2.5 0.9 3.0 2.6 37.2 3.6 0.2 5.5 0.7 4.5 1.7 14.0 2.5 4.4 1.7 0.7 4.5 1.0 5.5 1.7 18.1 2.7 6.7 2.5 0.8 0.8 8.8 4.9 2.8 2.3 10.1 1.8 2.8 3.6 0.9 3.3 4.8 7.6 2.3 5.8 2.7 2.6 5.8 10.9 5.9 2.9 30.7 18.4 4.2 11.8 2.7 2.5 0.4 0.3 2.9 1.9 0.0 2.0 1.5 2.1 2.1 0.0 2.0 2.6 2.5 3.1 1.0 0.5 0.4 2.2 1.0 53.6 52.9 53.8 72.1 53.7 44.5 49.2 47.8 48.9 38.6 46.0 53.2 17.5 6.4 8.7 16.3 27.9 4.6 11.7 3.7 7.4 57.0 9.6 11.6 74.6 24.3 9.5 14.7 35.5 4.3 10.5 10.5 9.8 4.3 8.2 5.1 4.8 14.4 4.2 20.0 17.0 3.8 1.5 16.2 6.6 3.3 10.8 9.6 28.5 11.8 4.4 60.6 18.8 7.6 8.2 11.7 6.4 18.6 35.1 6.2 19.6 14.0 11.6 16.4 42.2 13.0 28.8 3.4 5.1 27.8 12.0 10.5 18.2 13.6 6.4 62.7 46.0 28.3 24.9 7.0 5.3 3.1 4.8 3.6 22.8 4.1 5.4 7.5 CCDC130 MGC10471 ENSG00000104957 "Coiled-coil domain containing 130" P13994 19 13731760-13763296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056977 Approved Approved Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA056977: AB_2683297" "unprognostic (6.54e-2)" "unprognostic (5.72e-3)" "unprognostic (2.13e-3)" "unprognostic (1.27e-3)" "unprognostic (2.71e-1)" "prognostic favorable (7.83e-5)" "unprognostic (7.04e-2)" "unprognostic (1.25e-2)" "unprognostic (2.47e-1)" "unprognostic (9.69e-2)" "prognostic favorable (2.34e-4)" "unprognostic (2.06e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.82e-4)" 24.4 20.9 17.3 20.5 21.1 23.1 26.2 18.3 24.8 30.4 21.2 24.8 17.1 27.3 3.6 22.5 28.9 11.7 26.8 17.3 20.7 26.9 24.7 27.2 23.4 22.9 20.1 37.5 25.8 13.1 28.9 15.0 22.1 27.2 7.5 13.4 24.3 10.6 28.2 26.4 29.6 10.9 17.9 31.3 25.0 20.4 21.2 16.5 32.6 11.6 12.2 25.5 27.1 28.7 14.9 10.1 19.3 19.7 12.5 9.7 11.9 15.6 13.2 14.3 13.5 9.5 10.2 12.6 11.3 12.5 11.4 14.4 8.9 8.0 4.6 21.6 26.2 9.7 34.3 14.5 24.4 9.5 24.9 13.8 17.3 17.6 12.0 15.2 16.6 23.2 9.9 22.9 9.0 11.1 25.8 21.1 13.2 7.7 20.1 22.1 9.4 17.1 11.4 16.8 11.8 15.5 10.0 10.4 25.0 9.7 8.3 22.5 13.7 23.2 9.6 27.9 20.4 36.5 14.8 10.3 20.2 22.6 16.2 18.3 12.9 20.3 13.2 11.3 16.4 15.2 14.2 14.1 13.1 18.0 13.0 14.8 13.5 14.4 15.2 10.8 12.8 11.3 17.3 21.1 18.3 24.8 17.3 20.7 22.9 20.1 22.1 17.9 21.2 28.7 25.5 9.6 17.9 21.5 29.0 13.4 15.4 20.2 15.4 30.3 18.6 18.4 14.5 8.6 18.6 29.5 27.1 17.3 31.4 25.6 7.9 17.6 40.2 22.7 24.8 22.4 18.7 16.0 19.8 15.7 19.1 19.5 53.0 26.9 24.6 34.9 17.5 10.8 18.0 26.9 24.9 18.1 24.4 18.6 33.8 24.4 19.0 21.9 24.9 15.0 24.9 26.0 17.5 14.1 30.3 18.1 25.5 17.0 27.3 12.8 32.1 18.9 23.0 41.7 26.3 16.6 23.6 35.5 20.3 19.2 15.6 35.0 31.0 31.8 17.5 11.0 CCDC186 "C10orf118, CCCP-1, FLJ10188, FLJ35301, golgin104" ENSG00000165813 "Coiled-coil domain containing 186" Q7Z3E2 10 114120862-114174232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 49.3" "Group enriched" "Detected in all" 4 "dendritic cells: 49.3;granulocytes: 26.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014569, HPA018019" Approved Approved "Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA014569: AB_2066352, HPA018019: AB_1845513" "unprognostic (1.66e-2)" "unprognostic (1.76e-2)" "unprognostic (9.14e-2)" "unprognostic (2.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.85e-3)" "unprognostic (2.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.06e-1)" "unprognostic (3.20e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "prognostic favorable (7.65e-8)" "unprognostic (8.45e-3)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" 7.4 7.3 2.8 9.0 3.3 32.8 12.5 8.6 5.4 8.5 9.2 12.4 15.4 7.5 9.6 12.5 8.2 6.8 9.4 2.8 5.9 14.9 7.2 10.8 9.1 3.4 2.9 8.0 21.1 13.1 7.1 9.4 3.7 15.1 11.9 14.1 15.6 9.2 7.1 12.6 16.1 6.2 2.5 11.0 16.7 16.6 4.8 12.0 14.7 9.2 10.2 7.7 6.8 4.3 17.9 6.1 6.0 6.9 6.8 7.9 7.8 11.0 13.2 5.1 8.1 11.2 18.3 4.2 7.0 9.1 6.3 14.1 7.1 9.8 9.8 21.9 7.3 3.3 7.0 6.6 6.3 9.6 14.6 5.9 11.1 6.0 16.9 12.6 7.7 11.1 6.1 13.5 6.0 6.5 8.8 5.3 3.5 10.6 3.9 8.4 20.7 6.6 9.0 10.9 4.2 4.4 9.7 13.4 6.6 9.7 8.6 4.1 11.2 3.9 7.8 3.9 9.3 7.6 13.3 8.4 4.1 0.1 3.0 26.5 3.3 11.7 8.6 3.8 8.5 7.9 6.6 7.8 4.0 8.6 6.4 6.4 19.9 5.8 3.7 49.3 8.7 2.6 2.8 3.3 8.6 5.4 2.8 5.9 3.4 2.9 3.7 2.5 4.8 4.3 63.2 141.1 85.7 23.8 46.7 0.0 79.5 0.0 63.2 63.8 73.5 49.0 57.4 38.6 57.6 77.3 62.6 94.9 174.6 107.1 66.5 78.2 221.9 98.4 40.6 41.3 64.6 33.1 53.0 70.7 40.7 43.7 48.9 108.9 24.7 28.1 21.0 20.9 21.4 107.7 49.9 78.9 0.0 25.0 0.0 143.6 50.1 37.1 0.0 33.7 40.0 31.7 70.0 25.6 27.7 74.9 89.9 44.4 77.8 94.8 91.4 84.0 64.1 74.0 26.3 61.7 28.3 83.7 69.2 56.1 0.0 113.6 62.1 32.5 53.7 120.3 CCDC194 ENSG00000269720 "Coiled-coil domain containing 194" A0A1B0GVG4 19 17390509-17394158 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 3.8;ovary: 2.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "ovarian cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "unprognostic (1.50e-3)" "unprognostic (1.37e-1)" "unprognostic (1.87e-4)" "unprognostic (2.75e-3)" "unprognostic (1.41e-1)" "unprognostic (1.28e-2)" "unprognostic (3.09e-1)" "unprognostic (9.87e-2)" "unprognostic (3.07e-1)" "unprognostic (5.84e-2)" "unprognostic (1.23e-1)" "unprognostic (2.64e-2)" "unprognostic (5.22e-14)" "unprognostic (1.04e-1)" "unprognostic (6.70e-3)" "unprognostic (2.60e-1)" "unprognostic (1.86e-2)" 0.2 0.3 0.9 0.0 0.7 0.0 0.1 0.4 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.3 0.1 0.1 0.1 0.0 1.0 0.5 2.2 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.2 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.4 3.8 0.4 0.3 1.0 0.5 0.8 1.2 1.1 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 CCDC28B "MGC1203, RP4-622L5.5" ENSG00000160050 "Coiled-coil domain containing 28B" Q9BUN5 1 32200595-32205453 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "skeletal muscle: 225.3;tongue: 75.0" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 90.1;monocytes: 65.5;NK-cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 124.9" "Low region specificity" "Detected in all" HPA028589 Uncertain NA NA "Cluster 24: B-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "HPA028589: AB_10602175" "prognostic favorable (2.92e-4)" "unprognostic (6.01e-3)" "unprognostic (1.04e-1)" "unprognostic (2.61e-2)" "unprognostic (2.59e-3)" "unprognostic (5.18e-2)" "unprognostic (7.50e-3)" "unprognostic (7.87e-2)" "unprognostic (5.15e-2)" "unprognostic (1.79e-2)" "prognostic favorable (1.10e-5)" "unprognostic (2.61e-2)" "unprognostic (1.22e-2)" "unprognostic (1.44e-2)" "unprognostic (1.67e-1)" "unprognostic (7.83e-2)" "unprognostic (1.07e-2)" 3.8 13.9 14.3 7.1 12.9 6.8 3.3 14.5 18.7 6.6 12.1 7.6 1.7 5.3 1.7 5.5 5.6 4.9 20.8 13.2 13.3 6.5 2.4 3.9 14.1 12.8 13.3 6.0 5.6 19.2 21.1 5.0 12.2 5.3 2.5 5.1 3.6 4.1 225.3 2.7 4.3 6.2 12.6 5.4 3.9 20.8 15.8 12.4 6.3 75.0 9.5 5.0 4.3 13.1 10.6 4.5 20.8 22.7 6.8 8.5 1.2 8.2 11.9 13.2 9.3 9.0 13.2 23.3 14.2 9.3 1.7 0.5 18.7 9.2 2.6 27.0 25.5 29.9 20.7 4.1 10.1 0.2 13.7 10.5 3.5 15.5 0.2 9.2 19.3 40.5 20.5 0.5 9.6 1.3 43.2 8.7 29.4 2.8 5.8 46.5 10.4 19.2 12.2 0.0 45.6 22.9 11.9 3.2 16.3 12.0 12.0 11.5 11.4 7.1 9.5 8.7 7.6 2.1 1.6 0.9 11.7 43.9 10.3 9.7 13.7 3.0 36.3 6.9 17.6 22.0 19.4 34.3 30.6 31.5 28.4 29.3 1.9 46.7 2.1 37.1 26.9 21.8 14.3 12.9 14.5 18.7 13.2 13.3 12.8 13.3 12.2 12.6 15.8 13.1 10.5 0.0 6.1 3.9 11.1 9.1 4.4 17.9 5.7 33.3 9.6 12.7 16.1 11.5 5.3 12.9 22.9 1.9 25.8 1.6 35.2 17.5 13.8 8.1 18.1 15.2 90.1 30.7 3.1 7.6 4.0 19.0 5.6 5.1 3.8 8.0 12.1 0.6 11.7 23.5 3.9 5.7 54.9 4.2 39.2 32.8 20.2 5.7 17.8 0.0 65.5 23.9 106.1 5.5 1.7 7.8 1.7 17.0 1.8 3.4 0.3 4.9 4.2 45.9 0.0 12.5 18.0 3.9 13.3 3.5 7.7 2.2 15.3 48.1 3.4 2.6 CCDC66 DKFZp686C0433 ENSG00000180376 "Coiled-coil domain containing 66" A2RUB6 3 56557161-56621837 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 202.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044185, HPA051937" Approved Supported "Cell Junctions,Midbody ring,Centriolar satellite,Cytosol" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Centriolar satellite" "Cell Junctions, Midbody ring, Cytosol" "HPA044185: AB_10965852, HPA051937: " "unprognostic (2.28e-2)" "unprognostic (7.74e-2)" "unprognostic (7.37e-2)" "unprognostic (2.90e-1)" "unprognostic (5.28e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.68e-3)" "unprognostic (2.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.05e-3)" "unprognostic (5.48e-3)" "unprognostic (6.85e-3)" "unprognostic (1.81e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-1)" "unprognostic (6.81e-3)" 2.7 3.1 3.8 3.6 3.7 3.0 5.2 3.7 4.3 4.8 4.2 4.0 3.0 4.1 5.3 2.5 5.7 3.4 2.9 3.7 4.2 4.1 2.0 3.6 4.9 3.8 3.7 6.0 3.3 5.4 4.5 3.3 3.9 4.0 4.1 7.8 3.3 3.6 4.5 2.5 2.8 4.9 3.8 4.3 3.2 3.7 3.7 5.1 4.9 2.6 4.9 3.7 3.1 3.8 5.6 2.0 5.8 3.7 8.9 5.2 4.6 6.8 6.4 9.1 7.8 4.3 4.3 15.6 1.6 3.8 5.8 2.8 3.4 6.5 10.1 5.6 4.0 9.5 9.0 4.6 6.2 12.8 3.3 4.9 8.8 7.7 5.1 8.0 6.0 7.7 9.3 2.4 7.2 4.7 10.0 7.5 9.7 4.8 7.5 3.4 5.2 8.6 5.3 1.9 2.2 4.2 8.7 5.5 5.2 4.9 1.9 5.2 3.1 6.6 5.2 6.3 9.9 4.7 5.3 8.0 4.9 14.3 5.5 10.0 1.5 3.5 4.1 2.0 5.4 2.7 7.0 5.0 1.1 1.6 8.0 5.8 0.3 5.1 2.4 1.0 14.8 2.6 3.8 3.7 3.7 4.3 3.7 4.2 3.8 3.7 3.9 3.8 3.7 3.8 39.7 22.4 22.6 42.7 41.3 28.2 20.1 30.5 15.9 68.5 18.5 21.0 30.5 30.0 29.0 22.0 108.4 23.0 51.5 7.7 29.4 23.7 202.5 58.1 33.5 28.8 21.0 40.8 93.2 10.5 14.6 29.9 18.8 13.9 34.2 38.3 37.9 8.5 18.4 52.2 95.8 11.4 22.4 35.8 27.9 109.6 54.0 20.7 26.6 51.5 56.1 36.8 105.0 70.9 96.7 14.1 9.8 47.8 28.1 25.5 11.5 20.3 51.5 111.5 32.9 38.6 30.9 55.8 46.8 12.1 29.5 16.4 51.7 33.6 14.5 11.4 CCDC93 FLJ10996 ENSG00000125633 "Coiled-coil domain containing 93" Q567U6 2 117915478-118014133 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054183 Approved Enhanced "Vesicles,Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" Vesicles "Plasma membrane" "HPA054183: AB_2682408" "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.02e-2)" "unprognostic (3.32e-2)" "unprognostic (2.47e-3)" "prognostic unfavorable (2.97e-6)" "unprognostic (2.51e-1)" "unprognostic (8.12e-2)" "unprognostic (8.99e-2)" "unprognostic (1.52e-3)" "unprognostic (8.56e-2)" "unprognostic (4.87e-1)" "unprognostic (1.79e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (2.40e-2)" 10.2 14.5 9.3 10.4 8.5 21.7 9.6 9.6 12.7 9.1 15.0 11.3 11.9 8.2 9.8 7.4 9.3 7.1 21.3 8.4 9.4 9.8 7.8 11.8 10.3 9.7 9.0 13.3 13.0 15.9 16.1 8.1 10.3 7.6 10.6 26.0 9.1 8.4 12.9 11.0 12.8 8.1 8.4 12.1 9.1 12.1 11.5 10.1 11.9 10.3 10.1 8.6 8.1 8.5 18.7 8.1 22.0 19.4 31.2 21.3 18.5 21.8 14.2 14.0 14.3 17.7 11.7 15.9 14.5 17.1 24.9 15.8 12.8 11.2 18.1 20.8 13.0 20.1 15.5 23.9 13.7 22.1 22.0 14.6 11.5 21.9 25.9 19.4 15.0 18.9 11.1 11.0 15.8 8.1 14.0 23.8 9.9 13.4 13.0 17.6 17.2 10.7 11.5 19.6 17.4 10.3 14.2 10.6 15.1 19.6 8.9 13.5 21.2 23.9 20.0 20.4 15.3 14.3 16.0 24.7 13.8 16.1 14.2 2.9 1.6 1.8 2.1 2.1 2.0 1.6 1.5 1.8 1.2 1.4 2.0 1.7 1.7 1.7 1.3 0.5 0.7 1.0 9.3 8.5 9.6 12.7 8.4 9.4 9.7 9.0 10.3 8.4 11.5 8.5 17.4 19.2 28.2 61.0 28.6 17.6 14.6 11.2 9.6 32.0 12.4 10.0 43.0 7.2 17.5 1.8 47.9 12.6 31.9 21.5 9.8 24.0 4.5 14.9 15.2 16.5 16.7 9.9 57.1 16.7 8.5 14.7 11.7 17.0 15.2 25.1 12.8 6.0 15.2 20.2 60.6 11.4 10.2 16.3 15.9 10.6 13.7 19.9 3.6 32.8 19.9 13.8 20.6 53.3 37.9 32.0 11.9 14.3 19.4 13.9 17.1 9.4 16.3 36.0 6.6 21.4 15.0 46.0 31.1 10.1 16.1 12.9 24.3 12.8 14.0 15.0 CCM2L "C20orf160, dJ310O13.5" ENSG00000101331 "CCM2 like scaffold protein" Q9NUG4 20 32010438-32032180 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 141.6" "Cell type enriched" "Detected in some" 5 "Theca cells: 248.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.2;HUVEC TERT2: 9.0;NTERA-2: 4.6;RH-30: 3.2;SCLC-21H: 7.7;TIME: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008434, HPA071063" Uncertain Supported Nucleoplasm NA NA "Cluster 64: Macrophages - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA008434: AB_1845671, HPA071063: AB_2686339" "unprognostic (1.71e-1)" "unprognostic (4.64e-2)" "unprognostic (2.43e-3)" "unprognostic (5.84e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (1.27e-3)" "unprognostic (2.37e-1)" "unprognostic (2.04e-1)" "unprognostic (4.34e-2)" "unprognostic (1.00e-3)" "unprognostic (7.84e-2)" "unprognostic (4.66e-3)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" 15.9 5.4 7.2 1.6 7.3 0.0 15.0 9.5 6.8 8.7 4.2 4.6 1.3 8.9 0.6 3.7 7.7 2.5 23.2 6.1 5.8 13.3 2.2 11.8 1.5 6.8 6.4 3.6 2.6 1.4 4.1 7.8 7.0 5.8 1.1 0.4 3.4 1.8 4.8 3.9 5.4 3.3 6.1 141.6 4.2 1.6 7.3 0.8 10.2 4.8 0.9 6.4 6.3 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.0 0.9 0.0 0.0 0.0 2.4 0.0 0.0 4.6 0.1 0.0 0.6 3.2 0.1 0.0 0.0 7.7 0.9 0.2 0.0 0.0 1.1 2.5 0.0 4.8 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 7.3 9.5 6.8 6.1 5.8 6.8 6.4 7.0 6.1 7.3 5.2 45.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.5 0.6 4.6 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.2 32.1 0.0 0.0 2.9 0.2 0.0 1.0 0.0 0.2 0.0 4.3 24.3 0.0 0.0 3.3 2.4 0.0 0.0 0.3 0.3 0.4 0.0 0.2 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.6 1.8 0.3 0.6 0.1 0.3 0.0 0.1 248.7 0.0 0.1 CCNL2 "ania-6b, CCNM, CCNS, HLA-ISO, PCEE, SB138" ENSG00000221978 "Cyclin L2" Q96S94 1 1385711-1399335 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053137 Supported Supported Nucleoplasm "Intracellular and membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA053137: AB_2682053" "unprognostic (3.08e-2)" "unprognostic (2.60e-1)" "unprognostic (1.14e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.59e-3)" "unprognostic (2.06e-1)" "unprognostic (3.91e-2)" "unprognostic (1.67e-2)" "unprognostic (1.15e-1)" "unprognostic (7.08e-3)" "unprognostic (2.91e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (4.61e-2)" "unprognostic (6.17e-2)" "unprognostic (3.71e-1)" "prognostic favorable (1.46e-7)" 65.1 79.9 16.3 29.6 17.5 33.3 74.0 24.1 21.5 101.8 27.8 76.9 36.0 88.7 30.9 67.2 86.6 26.4 57.9 16.9 14.2 65.6 100.5 62.1 32.2 16.9 15.7 104.3 90.2 31.7 73.4 34.4 18.4 76.0 22.8 22.9 78.1 31.9 49.7 73.7 75.8 26.6 15.7 62.1 71.3 31.1 17.0 31.6 91.4 18.4 28.1 77.0 82.5 26.6 30.1 24.5 72.5 29.7 39.2 63.9 37.1 63.8 33.8 32.1 31.6 27.5 57.9 30.6 35.3 42.8 27.7 68.4 26.8 40.9 24.6 14.7 68.9 38.4 142.0 43.8 47.8 19.9 42.8 81.1 29.0 31.4 48.5 94.6 34.9 41.0 37.3 32.4 37.6 32.1 25.1 78.7 23.7 21.2 48.5 48.8 17.6 39.1 56.5 37.1 45.4 63.0 40.7 60.6 37.5 42.8 48.8 30.3 60.1 70.8 32.5 29.4 25.2 64.9 12.1 53.7 35.0 50.7 18.5 5.4 6.1 8.5 7.4 4.6 5.0 7.2 7.2 7.9 7.1 9.0 8.3 7.4 5.8 6.6 7.3 6.7 4.3 2.9 16.3 17.5 24.1 21.5 16.9 14.2 16.9 15.7 18.4 15.7 17.0 26.6 66.4 35.3 107.5 76.7 46.6 45.5 36.6 48.3 50.7 31.7 50.8 56.4 37.2 40.0 58.1 29.5 47.9 43.2 48.7 43.1 21.5 30.6 22.4 49.0 82.1 56.0 50.6 26.5 44.7 26.7 33.8 49.9 78.5 55.2 43.1 81.4 37.5 45.6 24.7 60.6 41.2 41.5 52.9 22.9 34.0 14.6 51.3 31.0 32.0 48.7 27.2 35.5 47.4 31.2 52.5 40.2 40.7 32.7 46.7 31.1 33.9 18.4 58.6 39.4 59.2 56.8 59.9 45.1 30.6 40.3 44.0 63.8 46.4 73.6 34.6 39.0 CCNT2 ENSG00000082258 "Cyclin T2" O60583 2 134918235-134959342 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005559 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Plasma membrane, Cytosol" "HPA005559: AB_1078608" "unprognostic (2.49e-2)" "unprognostic (1.19e-1)" "unprognostic (9.57e-2)" "unprognostic (1.25e-1)" "unprognostic (4.92e-2)" "unprognostic (2.65e-3)" "unprognostic (1.85e-2)" "unprognostic (1.00e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.44e-4)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.33e-1)" "unprognostic (8.51e-2)" "unprognostic (9.94e-2)" "prognostic favorable (3.28e-4)" 13.4 12.1 10.1 12.2 10.2 29.0 15.6 13.7 12.4 16.4 10.6 13.0 13.4 13.5 14.8 12.8 14.0 9.4 11.7 9.9 10.8 10.9 18.3 14.9 15.5 10.4 10.0 17.4 19.8 15.0 15.1 12.0 10.8 13.5 12.1 19.0 13.0 10.7 10.3 15.4 14.4 8.5 11.1 15.6 14.8 12.3 10.5 14.4 14.5 9.7 14.1 15.0 16.3 14.4 9.0 4.4 28.0 10.5 13.6 13.7 21.3 12.2 9.9 11.2 13.9 11.9 10.1 14.6 8.9 10.0 5.4 11.4 17.0 9.1 16.3 7.9 11.5 15.8 11.9 16.9 13.3 14.3 13.4 12.6 17.6 11.1 13.5 14.4 16.8 10.8 13.4 14.6 13.2 6.1 16.0 21.2 22.8 7.4 9.0 15.2 10.0 11.7 17.4 24.4 19.1 15.8 8.9 10.3 14.2 20.3 10.8 17.3 15.3 14.4 15.9 6.2 9.0 10.2 6.7 15.1 9.0 11.2 12.5 3.8 1.6 2.0 1.7 2.0 2.1 1.6 1.9 2.1 2.1 1.2 3.3 2.6 2.1 2.8 1.0 1.9 2.6 1.3 10.1 10.2 13.7 12.4 9.9 10.8 10.4 10.0 10.8 11.1 10.5 14.4 27.1 25.6 26.0 49.6 38.0 15.0 28.8 17.9 26.7 34.7 21.6 15.4 23.5 14.3 21.8 14.7 33.3 11.9 35.3 22.4 7.9 16.2 5.5 20.2 30.2 21.5 18.5 20.0 73.6 14.9 9.6 23.7 46.9 33.1 11.4 31.1 18.9 20.9 10.1 42.1 70.1 16.4 6.1 15.7 22.1 14.6 14.0 25.2 8.8 52.5 23.6 12.9 19.6 76.9 81.8 14.2 19.0 22.2 26.5 35.4 19.1 7.0 12.4 34.5 19.7 17.7 24.2 17.7 23.6 25.3 18.2 13.7 29.0 25.2 17.1 50.5 CCZ1 "C7orf28A, CCZ1A, CGI-43" ENSG00000122674 "CCZ1 homolog, vacuolar protein trafficking and biogenesis associated" P86791 7 5898725-5926550 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045114, HPA050006" Uncertain Enhanced Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA045114: AB_2679219, HPA050006: AB_2680989" "unprognostic (1.91e-1)" "unprognostic (2.97e-3)" "unprognostic (3.15e-2)" "unprognostic (1.25e-2)" "unprognostic (1.82e-1)" "unprognostic (5.35e-2)" "unprognostic (3.74e-3)" "unprognostic (4.10e-1)" "unprognostic (9.25e-3)" "unprognostic (7.66e-2)" "unprognostic (6.64e-2)" "unprognostic (2.67e-2)" "unprognostic (5.27e-3)" "unprognostic (3.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-1)" "unprognostic (4.41e-1)" 32.5 55.8 10.7 12.8 10.9 26.9 30.2 12.2 13.7 28.7 12.9 31.1 13.0 29.7 9.4 40.8 25.2 10.3 31.3 11.4 10.5 27.3 27.3 26.0 15.4 10.7 10.4 23.0 27.3 29.9 24.9 12.2 10.6 24.6 16.0 12.6 32.1 11.9 43.2 30.3 26.9 13.9 10.5 31.5 29.0 22.1 11.0 20.5 25.5 13.0 16.2 31.7 28.9 11.6 52.2 29.8 30.3 27.1 41.8 35.4 15.3 15.6 30.1 23.1 25.0 9.1 27.2 42.8 4.8 40.8 61.9 27.8 16.6 26.7 26.5 16.2 37.3 18.1 30.2 16.8 38.0 13.1 7.1 40.5 42.4 15.6 19.5 42.5 57.2 25.4 52.4 29.7 38.8 26.9 16.8 56.9 39.5 26.4 28.3 36.0 13.8 28.9 21.1 38.3 23.9 31.9 15.3 36.6 13.6 57.9 26.1 21.0 27.7 28.8 57.4 18.7 25.7 13.6 24.6 58.0 9.6 30.8 41.6 3.1 1.9 2.7 1.8 2.3 1.4 1.3 2.2 2.2 1.8 1.3 1.5 1.6 3.4 3.0 2.4 1.8 4.6 0.7 10.7 10.9 12.2 13.7 11.4 10.5 10.7 10.4 10.6 10.5 11.0 11.6 30.7 3.2 23.5 15.7 26.3 45.2 30.6 21.2 9.6 59.2 29.5 20.2 11.0 24.3 24.0 31.3 62.6 45.0 47.2 38.0 31.3 61.0 6.5 18.7 18.1 35.0 29.9 26.7 20.2 71.4 35.9 26.7 11.2 21.3 15.8 21.1 76.4 17.6 35.7 23.5 20.5 30.8 50.8 39.0 61.6 4.9 37.9 27.5 46.2 8.4 80.8 41.5 72.1 15.6 28.7 74.0 30.1 36.1 14.3 26.2 40.2 21.9 32.9 69.2 78.9 19.4 32.0 40.6 34.5 11.0 54.1 34.9 32.8 38.2 34.4 33.7 CDAN1 "CDA-I, CDAI" ENSG00000140326 "Codanin 1" Q8IWY9 15 42723544-42737128 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Sertoli cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039404, HPA040787" Supported Enhanced "Plasma membrane,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Cytosol "Plasma membrane" "HPA039404: AB_10673530, HPA040787: AB_2677137" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.79e-3)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "unprognostic (7.71e-2)" "prognostic unfavorable (1.07e-4)" "unprognostic (7.17e-2)" "unprognostic (9.82e-2)" "unprognostic (1.24e-1)" "unprognostic (2.95e-2)" "unprognostic (1.26e-1)" "unprognostic (4.35e-3)" "unprognostic (2.05e-1)" "unprognostic (1.16e-1)" "unprognostic (9.20e-3)" "unprognostic (2.04e-1)" 4.0 5.0 2.1 3.6 2.2 8.1 4.3 4.3 3.1 7.7 3.2 4.5 2.8 5.9 4.4 4.1 6.1 2.5 2.9 2.1 0.9 3.2 4.0 3.5 4.2 3.0 1.5 11.3 4.8 3.5 5.1 3.2 2.7 6.9 2.5 2.6 5.4 3.5 4.2 4.9 4.2 2.8 0.7 4.6 4.5 6.3 1.4 5.2 5.1 2.8 3.4 5.8 5.6 2.6 8.1 5.4 7.2 10.4 6.3 5.4 8.6 10.4 4.3 9.9 7.2 13.6 4.2 3.9 11.2 5.8 9.7 15.5 7.7 4.7 2.9 9.9 7.2 14.5 10.3 5.3 4.7 10.8 13.2 7.4 5.2 6.3 4.5 6.1 7.6 13.0 18.9 5.7 8.2 4.5 8.4 14.2 3.6 7.7 8.5 11.9 9.0 3.4 3.1 7.9 5.9 6.8 8.2 11.3 1.7 4.6 8.6 15.9 5.6 10.4 9.2 8.6 12.1 11.2 12.7 8.7 5.4 15.8 8.6 1.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 2.1 2.2 4.3 3.1 2.1 0.9 3.0 1.5 2.7 0.7 1.4 2.6 2.0 0.0 3.7 4.6 2.4 1.9 2.0 1.5 1.8 3.3 3.2 1.8 2.2 2.8 1.5 7.3 4.2 3.0 2.6 1.9 0.0 1.5 0.4 2.0 2.8 2.3 4.8 1.7 7.6 1.8 1.6 2.9 3.6 2.0 1.3 9.0 3.9 3.6 2.1 1.7 6.3 1.6 4.1 2.5 0.9 1.2 4.4 1.6 0.0 4.7 1.5 4.5 2.1 5.5 3.8 1.6 0.5 4.9 2.5 2.3 2.2 1.3 1.9 4.7 19.7 3.4 2.4 5.4 2.1 2.8 1.3 2.2 2.5 4.6 2.6 1.7 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696354 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Yes Yes "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Midbody, Midbody ring" "HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favorable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favorable (3.63e-4)" 30.1 38.5 20.2 10.4 20.4 19.5 26.7 20.3 32.8 49.3 22.0 38.2 22.7 25.9 8.7 35.3 36.3 8.6 27.3 21.0 19.5 52.9 77.0 31.0 14.7 18.6 18.7 43.2 49.2 13.5 55.5 12.5 19.6 39.1 11.3 7.6 24.8 7.5 33.8 32.1 36.1 8.2 17.0 37.5 38.5 17.0 18.4 10.8 54.5 4.1 7.0 32.3 36.5 19.1 27.5 17.8 13.9 5.8 5.7 11.0 14.2 22.3 12.6 15.2 4.9 13.1 21.2 23.9 9.8 19.3 9.1 15.5 5.8 30.8 9.3 5.3 14.1 9.7 21.0 1.7 23.4 15.8 17.1 13.3 10.7 9.3 15.3 10.3 27.0 16.1 25.5 3.2 17.7 36.6 19.5 45.0 28.5 29.7 13.1 26.5 19.0 34.1 27.9 21.2 10.1 29.6 28.0 13.0 6.8 15.2 30.3 25.0 24.1 9.1 26.6 10.1 15.4 11.7 6.4 7.5 16.4 25.0 15.5 5.1 14.0 4.2 14.8 19.7 12.8 7.8 13.2 10.7 18.1 9.0 15.1 12.6 1.5 20.4 15.4 12.4 11.6 11.4 20.2 20.4 20.3 32.8 21.0 19.5 18.6 18.7 19.6 17.0 18.4 19.1 28.2 12.8 26.6 35.3 21.2 15.4 24.2 26.9 23.3 17.2 24.5 25.1 6.5 38.6 20.0 27.6 25.0 28.6 26.7 44.8 43.0 28.6 6.1 20.7 21.9 23.0 67.7 15.4 44.5 12.5 19.8 19.6 85.1 16.9 9.5 40.3 21.8 41.1 18.8 18.5 33.3 49.4 26.4 17.4 16.0 8.8 23.9 17.0 19.6 17.8 15.5 8.5 26.8 24.6 20.0 13.6 41.5 12.4 20.8 30.7 58.3 53.7 28.1 32.3 6.6 11.4 16.3 27.3 28.7 22.4 15.5 27.9 22.0 54.8 58.2 22.9 CDK13 "CDC2L, CDC2L5, CHED, KIAA1791" ENSG00000065883 "Cyclin dependent kinase 13" Q14004 7 39950121-40099580 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 179.0;Oligodendrocyte precursor cells: 171.9;Oligodendrocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059241 Uncertain Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Golgi apparatus, Cytosol" "HPA059241: AB_2683956" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (2.72e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-1)" "unprognostic (4.18e-3)" "unprognostic (3.42e-2)" "unprognostic (8.09e-2)" "unprognostic (1.13e-2)" "unprognostic (3.77e-2)" "unprognostic (8.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.21e-1)" "unprognostic (3.33e-2)" "unprognostic (3.53e-1)" "unprognostic (3.53e-2)" 11.4 10.2 8.8 14.6 10.8 28.1 11.1 19.3 9.9 12.8 6.7 11.9 10.5 13.6 14.2 14.7 15.0 12.7 10.4 8.1 10.7 12.7 15.9 12.1 21.7 10.5 8.5 20.1 12.8 17.2 8.0 13.6 8.6 11.2 13.6 19.7 12.9 11.8 11.2 12.0 12.0 12.0 7.2 16.6 12.3 19.0 10.1 19.6 20.6 14.0 20.2 13.4 10.0 14.9 28.4 16.6 28.2 27.0 24.9 24.1 19.3 22.1 23.8 19.8 24.6 17.8 19.1 51.0 12.6 23.4 34.8 33.6 23.4 19.4 29.0 25.3 17.3 22.8 20.0 16.0 23.7 34.8 23.5 14.3 25.5 22.6 30.0 22.6 23.6 23.1 39.0 34.3 20.7 14.7 28.0 24.9 40.8 20.0 19.1 30.5 18.5 20.5 18.5 28.1 20.0 28.8 27.6 59.8 19.9 36.7 24.6 43.0 28.3 27.0 26.0 17.6 30.5 28.3 26.0 41.2 19.8 30.9 35.4 7.8 2.2 4.0 4.1 1.9 2.8 6.4 3.8 3.0 1.3 10.5 3.8 3.9 5.9 4.3 3.1 3.3 3.9 1.3 8.8 10.8 19.3 9.9 8.1 10.7 10.5 8.5 8.6 7.2 10.1 14.9 47.6 44.8 72.0 131.6 49.7 21.4 18.5 15.9 29.0 47.8 36.7 27.7 30.9 25.8 37.1 31.3 70.9 13.7 91.0 23.1 7.9 20.4 13.9 54.3 51.4 30.9 18.7 5.9 179.0 15.4 9.1 31.7 30.1 72.6 17.1 95.5 19.2 23.7 13.2 37.0 166.2 17.6 14.2 23.8 17.4 9.2 26.1 31.6 14.2 145.2 27.9 22.4 53.5 171.9 199.6 28.6 12.9 17.7 50.1 21.8 15.2 12.7 32.8 69.4 6.6 38.5 32.0 36.1 33.4 34.7 26.1 12.2 49.7 56.8 20.1 25.0 CELF1 "BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR" ENSG00000149187 "CUGBP Elav-like family member 1" Q92879 11 47465933-47565569 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016114, HPA044597, CAB069989" Supported Enhanced Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012" "unprognostic (1.05e-1)" "unprognostic (7.54e-2)" "unprognostic (3.24e-2)" "unprognostic (7.64e-2)" "unprognostic (2.69e-1)" "unprognostic (4.08e-2)" "prognostic unfavorable (7.55e-4)" "unprognostic (3.84e-2)" "unprognostic (3.41e-2)" "unprognostic (1.59e-1)" "unprognostic (2.75e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-2)" "unprognostic (2.68e-1)" "unprognostic (9.58e-2)" "unprognostic (3.34e-2)" 27.3 32.2 36.5 31.9 44.8 46.0 25.8 59.0 37.3 29.7 35.4 34.5 22.4 31.7 23.9 32.0 28.4 24.4 30.1 34.7 31.5 26.9 56.1 32.1 39.4 24.1 26.0 26.0 28.0 48.0 23.4 27.6 20.7 23.6 25.8 29.2 26.1 22.6 74.3 30.7 30.6 29.0 20.2 34.6 26.6 29.8 30.3 28.9 28.8 58.0 38.5 29.4 29.4 24.9 48.6 84.4 68.8 71.0 52.9 55.8 58.5 51.0 52.5 62.9 65.4 72.3 56.0 127.6 34.6 55.2 75.6 70.6 107.5 72.3 104.9 53.5 46.9 39.2 117.3 52.2 51.3 62.2 41.4 43.0 43.7 68.5 82.5 44.4 58.0 54.2 75.0 50.5 40.6 64.8 64.5 49.3 96.5 60.0 49.3 65.5 54.8 49.9 54.3 85.4 64.3 54.3 67.9 62.0 41.1 70.0 87.8 40.5 67.0 71.3 69.7 69.1 70.0 42.9 42.2 99.7 57.6 29.2 59.3 13.9 11.6 22.8 12.5 10.2 15.8 14.4 13.3 14.6 13.1 15.0 14.0 11.9 14.9 7.9 17.7 8.0 10.1 9.5 36.5 44.8 59.0 37.3 34.7 31.5 24.1 26.0 20.7 20.2 30.3 24.9 56.2 54.5 41.9 90.8 74.6 107.7 78.0 82.1 79.6 82.4 78.8 59.3 51.1 72.9 56.2 79.1 95.9 52.6 84.1 51.6 21.5 57.3 16.3 76.5 68.4 73.2 85.6 81.0 134.4 56.1 48.8 48.8 57.1 94.4 21.5 92.6 92.4 233.5 72.4 127.9 108.5 62.3 52.9 123.2 98.2 12.4 52.8 81.3 42.7 91.8 106.2 52.2 98.9 76.4 65.8 86.5 53.7 55.3 55.3 103.5 46.2 43.5 106.1 42.9 52.6 52.3 72.0 50.1 69.7 70.2 109.1 36.0 68.8 50.2 70.0 101.1 CHD6 "CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB" ENSG00000124177 "Chromodomain helicase DNA binding protein 6" Q8TD26 20 41402083-41618384 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015543 Supported Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA015543: " "unprognostic (5.13e-3)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (1.27e-1)" "unprognostic (6.66e-2)" "unprognostic (1.36e-1)" "unprognostic (4.72e-3)" "prognostic favorable (3.42e-4)" "unprognostic (1.17e-1)" "unprognostic (3.17e-1)" "unprognostic (4.75e-2)" "unprognostic (1.14e-1)" "unprognostic (2.12e-3)" "unprognostic (6.66e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-1)" "unprognostic (1.14e-2)" 7.2 7.7 10.2 6.9 11.4 13.5 12.4 17.5 13.0 9.5 6.0 7.1 4.0 12.7 12.4 6.1 10.0 7.2 8.0 8.5 13.1 7.2 6.8 7.5 8.4 11.7 10.9 16.2 8.1 16.2 7.9 8.4 14.2 12.2 6.1 15.7 8.4 9.3 5.5 8.7 6.1 8.9 7.3 8.2 7.4 7.1 11.0 17.2 13.6 7.8 8.2 8.1 8.8 12.9 8.4 9.8 20.6 9.2 11.5 11.7 13.3 7.2 14.8 12.6 15.2 13.5 6.7 10.0 12.7 12.4 14.2 12.2 12.9 12.4 14.3 3.2 6.3 13.7 9.1 13.2 6.5 10.9 6.6 11.8 11.3 9.2 10.1 13.5 11.0 13.7 11.0 10.4 9.9 23.3 17.3 11.8 6.8 5.2 16.5 13.2 24.2 7.1 7.9 19.3 18.6 12.8 22.1 5.8 14.2 14.9 9.9 8.1 12.7 19.8 9.6 10.0 6.3 9.9 8.6 12.8 8.7 5.2 6.2 20.2 6.0 7.5 8.1 6.1 8.2 8.5 7.0 6.9 5.2 10.6 9.4 8.0 0.9 10.2 10.0 11.4 6.0 2.4 10.2 11.4 17.5 13.0 8.5 13.1 11.7 10.9 14.2 7.3 11.0 12.9 42.2 48.1 30.8 148.2 42.8 18.1 38.6 30.3 37.0 140.4 39.5 34.7 56.6 30.0 34.4 22.0 93.8 34.2 53.3 14.5 21.5 24.4 14.5 50.3 65.3 36.5 60.6 19.6 143.2 15.8 28.2 33.8 19.9 76.0 21.5 65.1 34.2 21.1 16.5 151.4 179.0 35.9 42.7 27.7 44.7 20.3 49.7 27.5 17.8 87.1 40.8 62.2 39.1 182.9 160.6 15.4 16.0 45.5 32.3 30.3 4.1 13.9 35.6 133.8 19.7 71.0 44.4 20.6 61.9 21.8 17.2 32.7 45.5 40.4 24.5 32.9 CHD8 "DUPLIN, HELSNF1, KIAA1564" ENSG00000100888 "Chromodomain helicase DNA binding protein 8" Q9HCK8 14 21385194-21456126 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052186, HPA076133" Enhanced Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA052186: AB_2681754, HPA076133: " "unprognostic (3.45e-1)" "unprognostic (9.71e-2)" "unprognostic (3.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.14e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.31e-2)" "unprognostic (9.22e-2)" "prognostic favorable (8.35e-4)" "unprognostic (1.64e-1)" "unprognostic (2.63e-2)" "unprognostic (2.54e-3)" "unprognostic (2.88e-1)" "unprognostic (9.24e-2)" "unprognostic (2.51e-1)" "unprognostic (8.07e-3)" 12.5 11.9 11.2 13.5 12.5 35.3 14.8 16.3 13.2 12.4 10.5 14.0 9.4 14.8 11.1 14.9 12.9 10.1 12.0 11.1 12.2 11.7 9.6 13.7 18.0 11.4 11.6 17.1 13.6 22.3 13.1 11.7 11.1 13.2 12.3 14.8 13.6 12.1 15.7 22.3 14.7 14.8 11.5 15.8 14.2 12.9 12.5 25.4 14.8 12.7 17.5 12.8 12.9 13.6 31.2 39.6 43.6 20.7 27.7 23.6 24.9 24.4 28.4 36.5 35.4 35.0 26.3 51.4 14.8 33.1 28.4 37.2 54.9 35.1 46.0 39.3 24.2 46.3 27.6 43.5 25.7 64.6 40.4 32.8 27.2 40.9 29.7 28.6 33.4 40.2 32.4 26.7 28.0 33.9 46.1 26.0 33.4 30.9 34.3 42.0 32.9 17.4 27.3 57.9 30.9 30.7 37.5 29.8 21.8 39.7 20.7 30.5 36.4 29.2 23.0 17.8 29.1 30.3 38.4 50.3 12.1 23.2 29.6 9.1 3.8 9.8 5.5 3.8 6.4 4.2 4.9 5.6 2.7 11.2 5.0 4.4 7.9 7.8 6.7 6.1 4.7 2.7 11.2 12.5 16.3 13.2 11.1 12.2 11.4 11.6 11.1 11.5 12.5 13.6 27.6 38.5 56.3 27.4 32.2 12.6 11.3 15.9 23.3 33.3 21.9 22.6 19.6 24.3 32.6 33.1 27.1 14.7 40.0 16.8 1.9 21.8 3.4 32.5 37.9 25.5 27.1 27.8 41.0 23.6 12.3 24.0 27.5 39.5 28.4 41.7 13.9 14.9 17.5 23.5 40.2 16.0 8.2 20.1 9.3 4.1 16.1 25.3 10.6 20.6 27.1 18.9 32.0 29.7 33.1 26.5 13.9 17.7 32.4 16.1 12.0 7.4 28.8 24.3 0.0 32.1 26.2 29.2 25.1 24.6 16.6 12.3 31.4 34.1 16.8 12.7 CLOCK "bHLHe8, KAT13D, KIAA0334" ENSG00000134852 "Clock circadian regulator" O15516 4 55427903-55546909 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001867, HPA027565" Supported Enhanced Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA001867: AB_1078537, HPA027565: AB_1846975" "unprognostic (1.30e-2)" "unprognostic (9.02e-2)" "unprognostic (4.25e-3)" "unprognostic (2.48e-1)" "unprognostic (3.94e-2)" "unprognostic (2.00e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (3.01e-2)" "unprognostic (5.96e-2)" "unprognostic (4.07e-2)" "unprognostic (8.31e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "unprognostic (7.16e-2)" 5.5 6.1 3.7 4.2 4.2 1.3 5.9 8.9 5.4 8.0 5.5 5.1 4.9 6.9 5.7 9.2 5.3 4.3 7.5 4.7 5.3 6.5 5.5 4.6 2.9 2.8 3.7 6.2 5.1 10.3 5.5 5.5 3.3 6.2 5.7 11.6 4.6 6.1 9.8 6.8 5.6 7.1 3.8 4.5 6.9 14.1 3.8 3.0 10.1 9.2 3.7 5.6 6.8 5.0 20.0 9.1 7.5 11.6 11.8 11.5 3.6 18.7 16.4 12.9 12.7 5.1 14.8 5.1 9.9 22.8 10.3 15.9 9.5 15.4 23.2 6.9 3.1 4.4 9.4 6.7 10.3 7.0 4.7 6.7 15.8 18.8 18.7 10.4 13.1 4.6 10.1 10.1 21.3 10.6 4.0 4.1 5.0 16.3 9.4 2.5 8.7 3.3 11.0 10.9 7.6 6.2 13.5 16.7 8.9 6.2 5.7 4.2 17.1 18.4 19.5 6.0 26.6 9.1 7.5 3.1 15.6 5.8 14.6 0.0 0.7 0.2 0.7 0.7 1.3 0.4 0.9 0.8 1.1 0.7 0.4 0.6 0.2 0.9 0.7 0.5 0.9 0.4 3.7 4.2 8.9 5.4 4.7 5.3 2.8 3.7 3.3 3.8 3.8 5.0 32.2 41.7 27.7 49.3 15.2 31.1 21.8 28.5 27.9 63.4 21.5 14.9 55.2 14.3 27.4 14.7 43.8 11.3 11.9 21.5 1.9 13.6 34.5 34.2 39.9 32.1 39.7 3.8 95.9 16.5 6.8 28.0 25.0 32.0 3.8 16.6 28.9 27.7 11.6 33.7 114.6 18.5 18.3 17.0 26.1 16.9 23.9 16.9 10.6 70.3 14.0 26.7 19.6 82.0 93.1 28.3 13.2 36.1 18.5 34.0 29.6 19.7 25.2 41.4 13.1 36.5 28.2 64.9 72.5 55.1 37.5 5.2 14.0 21.7 15.6 51.6 CMTR1 "FTSJD2, ISG95, KIAA0082, MTr1" ENSG00000137200 "Cap methyltransferase 1" Q8N1G2 6 37433219-37482827 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 253.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029954, HPA029979, HPA029980" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094" "unprognostic (1.33e-1)" "unprognostic (2.12e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.00e-1)" "unprognostic (3.72e-1)" "unprognostic (1.68e-2)" "unprognostic (6.43e-3)" "unprognostic (2.95e-2)" "unprognostic (9.17e-2)" "unprognostic (5.24e-3)" "unprognostic (1.50e-3)" "unprognostic (3.00e-3)" "unprognostic (3.27e-2)" "unprognostic (9.72e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-2)" 20.1 22.1 21.0 19.2 21.2 30.9 19.5 20.3 22.9 23.6 18.6 26.8 18.1 23.1 17.4 16.9 22.4 15.1 25.1 20.7 22.0 19.4 21.8 20.4 25.3 21.5 21.0 28.0 22.1 27.5 26.0 24.9 20.3 21.9 15.2 28.5 21.7 18.4 30.1 23.2 23.2 20.4 20.2 28.8 21.9 62.9 23.5 30.9 20.3 23.4 25.6 21.6 20.0 20.2 23.5 21.9 31.0 50.7 34.2 31.1 37.4 27.5 37.7 68.1 75.9 33.3 15.3 48.6 30.5 40.7 63.8 25.7 39.7 28.4 51.7 33.8 35.2 26.8 26.8 37.2 26.3 38.9 17.6 27.1 20.9 37.6 26.7 35.7 32.2 44.3 60.6 34.5 36.3 38.5 49.8 34.6 15.6 15.7 20.7 39.0 36.7 28.1 22.0 28.2 34.2 25.6 30.8 23.4 40.2 22.1 39.8 29.7 30.0 40.7 30.3 16.3 31.1 39.3 21.8 253.0 16.0 40.1 45.6 4.2 5.4 3.5 4.9 7.1 4.1 5.5 4.3 5.2 5.1 3.8 4.7 3.9 3.3 5.6 5.5 4.2 6.1 4.6 21.0 21.2 20.3 22.9 20.7 22.0 21.5 21.0 20.3 20.2 23.5 20.2 11.3 9.6 9.2 5.9 12.0 3.6 3.9 4.0 8.6 14.2 6.3 5.5 10.4 8.6 11.5 7.3 33.3 18.0 15.4 5.3 0.0 4.5 20.2 7.7 15.4 9.6 8.4 6.5 15.1 8.5 8.0 8.8 11.7 8.9 3.8 24.9 7.9 10.1 7.5 11.8 13.9 8.4 4.1 7.5 2.3 11.3 7.8 9.5 3.6 14.0 11.5 8.8 7.2 10.6 14.2 8.5 3.3 6.8 12.4 4.3 4.7 4.0 11.2 11.9 6.6 8.5 13.5 16.8 10.6 5.8 4.7 20.8 11.5 22.0 6.9 3.6 CMTR2 "AFT, FLJ11171, FTSJD1, MTr2" ENSG00000180917 "Cap methyltransferase 2" Q8IYT2 16 71281389-71289715 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 95.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041700, HPA048265" Uncertain Approved "Nuclear speckles,Cell Junctions" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Cell Junctions" "Nuclear speckles" "HPA041700: AB_2677623, HPA048265: AB_2680334" "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (2.94e-3)" "unprognostic (1.43e-1)" "unprognostic (6.30e-2)" "unprognostic (3.82e-2)" "unprognostic (1.93e-3)" "unprognostic (2.86e-2)" "unprognostic (7.93e-2)" "unprognostic (3.41e-1)" "unprognostic (1.85e-2)" "unprognostic (7.39e-2)" "prognostic favorable (4.97e-5)" "unprognostic (9.55e-2)" "unprognostic (5.99e-2)" "unprognostic (1.54e-1)" "unprognostic (5.34e-2)" 6.7 8.8 4.0 10.3 4.6 7.2 15.9 4.6 4.2 7.6 8.0 10.1 14.9 8.5 12.2 14.3 9.0 9.4 7.0 3.2 4.7 12.5 14.3 11.4 14.4 5.1 4.4 11.2 8.1 10.7 7.8 10.6 4.8 10.8 10.4 7.3 13.3 8.0 5.7 10.3 14.2 9.0 5.2 13.6 10.0 13.8 4.9 10.7 14.1 5.7 17.9 9.7 7.6 6.6 17.8 11.6 23.2 19.5 18.9 15.3 10.6 14.9 18.2 17.4 18.4 10.6 26.5 10.0 18.4 13.7 18.9 19.4 11.1 14.2 24.9 10.5 7.9 22.3 13.1 8.3 20.3 16.8 37.7 12.7 24.7 15.4 17.9 12.8 18.5 22.2 11.6 6.6 31.1 15.9 18.8 23.1 11.0 14.2 6.7 28.5 10.2 24.5 16.3 19.5 12.0 12.8 15.1 12.2 15.4 10.3 18.0 10.4 18.7 21.1 15.1 15.5 11.4 13.3 17.6 21.3 14.7 14.6 16.8 22.6 9.6 9.2 10.8 10.3 13.2 13.1 10.6 11.7 13.7 12.0 11.4 11.1 0.7 16.6 6.9 3.9 9.8 11.4 4.0 4.6 4.6 4.2 3.2 4.7 5.1 4.4 4.8 5.2 4.9 6.6 11.4 3.2 11.8 13.7 28.1 14.1 14.5 10.7 15.9 20.3 23.9 13.7 8.6 20.0 9.4 16.5 31.3 24.2 30.2 25.8 7.9 12.2 95.6 12.6 15.1 14.6 18.6 17.0 9.9 9.7 12.7 11.5 15.8 11.5 8.2 26.1 18.9 32.7 16.1 15.2 10.3 20.5 18.3 18.0 11.4 30.9 16.8 13.6 1.8 21.5 17.8 12.1 51.5 17.6 21.5 12.9 15.2 12.4 17.9 13.5 46.3 17.7 6.5 25.5 6.6 11.1 10.1 26.1 13.8 22.0 24.3 26.4 20.0 21.8 17.9 18.2 CNOT6 "CCR4, Ccr4a, KIAA1194" ENSG00000113300 "CCR4-NOT transcription complex subunit 6" Q9ULM6 5 180494379-180578358 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044568 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" Cytosol "HPA044568: AB_10797257" "unprognostic (9.41e-3)" "unprognostic (1.40e-1)" "unprognostic (2.03e-3)" "unprognostic (2.55e-1)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.35e-2)" "unprognostic (1.79e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-1)" "unprognostic (4.03e-2)" "unprognostic (3.57e-2)" 6.6 6.5 8.7 12.0 9.1 11.9 9.5 16.1 8.8 8.0 10.1 10.0 12.1 9.2 8.6 11.5 9.4 7.3 6.2 7.9 9.3 10.0 5.1 9.7 11.4 8.9 8.7 9.4 6.6 8.7 5.6 11.8 7.9 9.4 11.5 17.5 7.1 7.4 5.2 9.3 11.9 8.1 8.4 10.0 10.1 13.5 9.2 19.7 9.0 7.4 14.0 11.4 8.0 9.4 24.9 29.6 59.2 47.5 9.6 10.9 61.0 17.9 12.0 23.2 27.5 36.1 35.7 26.2 26.5 11.8 32.2 25.5 50.0 59.4 27.1 77.5 25.2 28.6 38.4 23.4 14.3 33.6 20.1 9.3 28.1 17.1 36.1 21.6 28.6 30.2 30.9 24.5 21.8 51.1 43.0 20.2 17.5 25.0 13.9 39.1 29.6 18.6 25.6 48.5 43.0 36.4 30.1 39.7 26.2 28.7 49.9 33.5 31.4 24.5 28.1 18.0 32.0 16.0 30.9 27.4 23.4 45.3 20.6 0.7 0.8 1.2 1.2 1.4 1.3 0.6 1.0 0.7 0.8 0.7 1.4 1.4 0.8 0.7 2.3 0.8 0.8 0.6 8.7 9.1 16.1 8.8 7.9 9.3 8.9 8.7 7.9 8.4 9.2 9.4 12.4 28.9 13.4 16.3 11.9 21.7 6.4 12.9 15.9 18.0 19.5 11.7 11.4 14.3 12.4 11.0 22.9 9.4 21.9 17.1 1.9 11.0 6.4 32.3 22.3 13.2 14.5 27.8 27.2 9.3 12.8 11.8 11.2 21.1 2.5 29.7 13.6 5.7 12.5 18.5 24.9 13.8 6.1 16.2 15.4 9.3 13.1 14.4 10.6 18.7 20.1 13.5 26.8 30.2 33.4 17.6 8.4 18.8 15.5 17.3 12.1 13.1 20.2 17.5 26.3 11.7 13.1 38.6 48.7 23.2 22.3 11.5 16.2 12.8 16.5 19.9 CNTLN "bA340N12.1, C9orf101, C9orf39, FLJ20276" ENSG00000044459 Centlein Q9NXG0 9 17134982-17503923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 91.8;Spermatocytes: 84.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.9" "Lineage enriched" "Detected in single" 5 "monocytes: 3.9" "Cell line enhanced" "Detected in many" "HEL: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007201, HPA036728, HPA036729" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" Centrosome "Nucleoplasm, Cytosol" "HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240" "unprognostic (1.97e-2)" "unprognostic (2.81e-3)" "unprognostic (1.81e-1)" "unprognostic (2.48e-1)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (7.71e-2)" "unprognostic (1.68e-1)" "unprognostic (7.71e-3)" "unprognostic (5.07e-3)" "unprognostic (1.06e-1)" "unprognostic (6.65e-2)" "unprognostic (2.47e-1)" "unprognostic (5.38e-2)" "unprognostic (3.35e-2)" "unprognostic (1.37e-1)" "unprognostic (5.80e-2)" 4.4 2.4 2.3 2.1 2.4 7.3 3.5 7.7 2.2 5.0 3.3 4.5 1.2 7.1 2.4 2.7 4.3 4.2 2.3 1.7 2.6 2.4 10.5 2.8 2.7 2.7 3.1 8.8 1.7 4.4 2.2 3.6 3.0 2.7 2.2 2.1 1.6 3.2 1.6 1.9 2.2 4.5 2.6 3.9 1.9 5.2 2.5 2.8 3.1 2.5 1.6 3.5 3.5 2.8 8.3 5.6 12.1 6.8 5.8 13.6 0.4 9.5 6.3 7.0 9.5 0.4 2.7 6.0 1.5 6.6 7.5 0.3 14.1 3.9 10.9 0.3 4.9 35.5 11.7 2.0 6.4 4.9 7.4 8.6 2.0 5.8 5.7 6.5 10.0 2.2 1.3 1.1 11.3 0.6 4.0 7.8 9.4 1.4 10.3 5.8 11.2 3.0 4.1 2.0 7.6 7.9 11.6 0.2 3.0 4.8 2.3 12.3 7.5 9.5 3.7 10.4 8.3 4.7 6.1 0.1 4.4 6.1 4.4 0.2 1.3 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.1 0.5 3.9 0.7 0.1 0.2 2.3 2.4 7.7 2.2 1.7 2.6 2.7 3.1 3.0 2.6 2.5 2.8 32.0 6.4 17.6 59.7 1.6 8.8 13.7 6.1 13.1 12.3 3.6 5.8 13.4 7.2 3.4 9.2 0.0 2.5 1.1 2.4 5.9 10.1 16.3 23.4 30.7 24.9 2.4 17.1 20.3 12.0 5.2 29.2 4.1 17.0 7.6 42.4 20.0 38.8 18.4 20.2 37.2 5.9 4.1 40.3 11.6 8.8 45.7 24.0 8.8 91.8 31.0 21.4 1.0 70.4 29.6 4.0 0.8 30.9 1.8 3.8 5.3 8.5 6.7 8.1 13.1 34.2 21.3 84.3 48.9 5.3 5.5 1.0 1.7 31.6 5.5 6.3 COG1 "KIAA1381, LDLB" ENSG00000166685 "Component of oligomeric golgi complex 1" Q8WTW3 17 73192632-73208507 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029224 Supported NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "HPA029224: AB_10600698" "unprognostic (8.93e-2)" "unprognostic (4.36e-2)" "unprognostic (2.44e-2)" "unprognostic (3.10e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (2.91e-6)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-3)" "unprognostic (5.31e-3)" "unprognostic (9.94e-3)" "unprognostic (2.63e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" "unprognostic (2.06e-1)" "unprognostic (2.21e-1)" 23.9 23.4 37.1 11.1 39.6 15.8 21.0 29.0 41.1 23.0 26.4 24.6 16.2 21.7 17.6 13.2 20.4 12.1 43.5 42.0 31.9 17.4 15.4 15.3 12.1 26.0 28.0 23.7 27.5 17.6 33.0 13.5 29.2 19.3 19.6 25.3 18.9 17.4 52.5 20.7 19.9 18.8 25.5 17.4 20.9 15.9 31.4 13.6 17.7 31.8 12.7 21.1 17.4 32.2 25.3 19.1 16.1 17.3 25.9 24.5 19.8 34.8 29.5 32.0 29.9 16.6 16.1 14.0 19.2 33.0 29.5 15.6 16.4 24.2 46.9 6.1 18.3 12.5 19.5 30.1 27.4 15.4 14.2 20.9 18.4 25.7 24.7 21.5 30.3 18.7 14.1 20.5 32.7 24.6 21.3 12.2 4.9 24.5 34.2 14.9 27.3 17.2 19.7 16.1 17.5 23.8 16.6 22.9 18.0 30.4 33.4 11.2 17.5 36.7 28.1 24.9 28.0 26.9 13.0 15.3 15.8 10.1 14.6 8.6 9.6 18.1 15.7 12.3 17.2 12.5 17.7 16.8 11.8 7.3 16.0 17.9 7.5 17.3 9.5 6.4 14.0 11.8 37.1 39.6 29.0 41.1 42.0 31.9 26.0 28.0 29.2 25.5 31.4 32.2 17.8 6.4 9.6 9.8 12.0 4.0 6.8 7.8 8.6 21.9 7.8 6.5 5.1 14.3 18.0 9.2 33.3 19.8 9.4 12.5 1.9 11.4 17.2 17.1 9.0 11.2 17.4 9.9 28.3 11.8 10.8 10.9 19.4 13.9 18.3 16.4 8.6 9.5 8.5 28.6 17.2 18.7 18.3 3.2 4.3 16.3 12.2 5.7 5.4 10.3 11.0 16.6 21.6 13.0 9.9 11.0 12.5 15.8 17.2 7.0 13.2 11.2 22.7 28.6 13.1 15.9 11.7 19.5 13.0 6.2 3.4 16.3 15.0 15.4 10.5 6.4 COX18 FLJ38991 ENSG00000163626 "Cytochrome c oxidase assembly factor COX18" Q8N8Q8 4 73052362-73069755 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046772, HPA049489" Approved NA NA "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 52: Non-specific - Transcription" "HPA046772: AB_2679799, HPA049489: AB_2680791" "unprognostic (3.32e-3)" "unprognostic (2.01e-1)" "prognostic favorable (6.31e-4)" "unprognostic (9.01e-3)" "unprognostic (2.43e-1)" "unprognostic (2.17e-1)" "unprognostic (3.81e-2)" "unprognostic (6.97e-2)" "unprognostic (2.92e-1)" "unprognostic (5.29e-3)" "unprognostic (1.58e-3)" "unprognostic (2.85e-2)" "prognostic favorable (8.22e-7)" "unprognostic (1.28e-2)" "unprognostic (2.94e-1)" "unprognostic (5.80e-2)" "unprognostic (1.22e-3)" 1.5 3.9 0.7 0.4 0.8 0.5 1.4 1.3 1.0 1.3 1.1 1.6 0.6 1.5 0.9 1.4 1.2 0.4 2.7 0.8 0.9 1.7 2.4 1.2 0.7 0.4 0.6 1.5 2.0 0.7 1.3 0.6 0.5 0.9 0.6 1.3 1.9 0.6 2.7 1.3 1.4 0.4 0.3 1.3 1.7 1.3 1.0 0.4 1.1 1.2 0.5 1.2 1.2 0.7 0.6 1.0 1.0 1.0 0.9 0.9 0.8 1.0 0.9 0.4 0.5 0.8 1.1 1.8 0.7 0.6 0.7 0.6 1.0 0.7 0.4 1.4 0.7 0.9 1.3 1.3 0.7 1.5 1.2 1.1 0.7 0.4 0.8 1.1 0.8 1.6 1.4 1.7 0.8 0.5 1.8 1.0 1.5 1.1 1.1 1.0 1.6 2.6 0.8 0.6 1.5 1.0 1.1 0.9 0.4 0.8 0.8 0.8 1.1 1.0 0.8 1.3 0.5 1.7 0.8 1.1 1.2 1.1 0.8 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.3 0.1 0.2 0.2 0.3 0.1 0.1 0.7 0.8 1.3 1.0 0.8 0.9 0.4 0.6 0.5 0.3 1.0 0.7 5.6 3.2 6.3 7.2 10.1 2.5 3.7 4.5 1.2 11.7 7.1 4.2 13.9 5.7 7.3 9.2 22.9 8.0 9.0 5.5 13.7 6.5 4.0 6.7 8.4 6.7 5.4 7.8 10.5 8.0 8.3 7.0 5.6 7.1 0.0 17.4 11.4 16.7 8.8 20.2 10.6 7.7 4.1 13.9 3.0 2.0 9.0 8.4 5.4 6.5 12.5 6.6 11.3 10.1 13.4 9.3 5.2 9.4 18.1 6.6 6.6 13.0 8.1 14.3 13.1 7.5 6.0 10.2 7.3 5.5 1.4 3.0 8.6 12.7 9.6 3.4 COX19 MGC104475 ENSG00000240230 "Cytochrome c oxidase assembly factor COX19" Q49B96 7 898778-975549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021226 Approved Supported Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Cytosol "HPA021226: AB_1847176" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (1.05e-2)" "unprognostic (3.76e-2)" "unprognostic (5.22e-2)" "unprognostic (1.05e-1)" "unprognostic (2.13e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-1)" "unprognostic (5.60e-2)" "unprognostic (4.79e-2)" "unprognostic (3.36e-2)" "unprognostic (2.37e-3)" "unprognostic (2.49e-2)" "unprognostic (1.64e-1)" "unprognostic (2.74e-1)" "unprognostic (9.14e-3)" 4.5 12.3 4.0 3.2 4.7 6.7 4.4 6.3 4.8 5.4 2.2 6.8 5.3 4.8 2.2 5.8 6.8 2.0 5.2 4.0 4.3 6.2 5.9 4.9 4.4 4.8 4.2 5.5 7.5 6.4 5.9 2.7 5.0 6.2 3.5 2.9 6.0 2.8 7.5 8.0 7.4 2.4 3.6 7.6 5.9 4.0 4.4 3.7 5.6 4.9 3.5 5.0 4.8 6.9 13.9 3.7 4.1 5.2 3.1 4.4 7.8 6.1 4.4 5.2 4.3 9.6 7.6 6.8 2.0 3.7 8.2 9.1 4.3 4.2 4.1 2.1 7.2 3.0 4.5 7.1 9.8 7.3 6.8 5.1 9.7 4.0 9.2 5.8 3.3 6.9 9.0 5.7 3.4 9.0 3.1 8.6 10.6 16.3 8.6 7.4 0.9 3.3 4.6 6.0 5.4 5.4 3.5 14.4 12.0 6.7 7.2 17.1 4.2 5.2 7.6 6.0 9.5 7.1 5.2 6.6 4.6 10.4 8.7 9.4 5.2 8.3 5.8 5.1 5.9 6.6 6.1 5.2 4.5 6.1 7.5 7.2 5.0 5.4 5.5 7.9 5.9 4.4 4.0 4.7 6.3 4.8 4.0 4.3 4.8 4.2 5.0 3.6 4.4 6.9 25.4 12.8 21.4 6.2 35.4 24.6 35.9 37.7 19.4 19.3 21.7 19.2 14.2 31.5 24.1 31.3 12.5 27.8 49.7 29.9 15.6 34.9 7.4 58.4 23.8 23.5 44.9 17.2 13.1 34.0 41.8 19.0 17.3 49.3 34.9 28.1 25.0 31.0 26.1 15.2 13.3 32.6 36.7 24.9 28.5 2.7 19.6 29.4 21.4 13.1 46.6 33.3 64.9 6.6 22.7 49.6 31.7 14.3 20.8 36.8 37.7 25.8 36.2 27.0 6.6 18.7 23.2 19.2 32.7 21.4 25.7 41.9 39.5 30.9 32.2 45.3 CPED1 "C7orf58, FLJ21986" ENSG00000106034 "Cadherin like and PC-esterase domain containing 1" A4D0V7 7 120988697-121297442 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 78.5" "Cell type enhanced" "Detected in many" "Fibroblasts: 48.4;Microglial cells: 229.5;Peritubular cells: 81.6;Theca cells: 94.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 10.8;intermediate monocyte: 11.3;myeloid DC: 25.2;non-classical monocyte: 7.6;plasmacytoid DC: 15.0" "Group enriched" "Detected in many" 9 "dendritic cells: 25.2;monocytes: 11.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 87.6;Hep G2: 51.6;K-562: 182.3;LHCN-M2: 60.0;U-138 MG: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012058 Uncertain Approved Nucleoplasm NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA012058: AB_1845761" "unprognostic (7.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (4.48e-4)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.52e-3)" "prognostic favorable (3.00e-4)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.48e-1)" "unprognostic (8.69e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.28e-3)" "unprognostic (5.05e-2)" "unprognostic (3.78e-1)" "unprognostic (6.54e-4)" 55.0 18.5 2.1 6.5 2.6 0.9 10.0 2.4 2.6 25.2 5.5 16.1 9.1 32.9 13.3 16.5 15.8 26.7 21.5 1.8 2.6 7.1 44.3 16.7 1.8 4.5 3.1 78.5 3.4 1.4 3.3 24.9 4.5 28.1 15.0 1.1 4.1 36.7 17.4 2.0 11.5 38.6 4.1 17.8 10.3 5.5 4.5 1.9 3.7 38.7 1.8 20.7 6.1 5.4 6.3 0.0 0.3 0.1 14.0 40.7 0.3 25.5 87.6 8.6 23.5 0.8 0.3 0.9 0.3 14.0 9.7 0.3 0.4 0.0 22.4 0.3 0.9 7.1 0.3 51.6 24.3 0.2 0.2 16.7 0.0 20.0 0.4 6.9 4.4 0.1 182.3 12.8 60.0 0.0 0.1 0.2 0.1 0.0 1.1 0.1 34.6 17.3 0.0 0.6 0.0 2.2 0.0 0.1 0.6 0.4 0.1 0.6 2.6 50.2 1.3 42.5 24.3 5.6 0.1 0.6 5.8 0.2 2.5 2.0 10.8 0.0 0.0 11.3 0.1 1.4 0.0 0.0 25.2 0.5 0.0 0.0 0.4 0.0 7.6 15.0 0.0 2.9 2.1 2.6 2.4 2.6 1.8 2.6 4.5 3.1 4.5 4.1 4.5 5.4 19.1 19.2 0.5 12.4 2.5 3.1 0.6 0.0 1.2 0.1 0.6 1.7 20.3 1.5 0.0 0.0 0.0 0.4 8.3 0.0 0.0 0.0 0.2 0.8 23.2 6.9 0.0 2.1 0.9 0.0 2.9 48.4 0.5 0.5 0.0 11.9 28.2 21.9 4.3 3.3 14.7 0.0 0.0 14.5 28.5 1.9 21.1 23.1 3.6 229.5 5.3 14.0 1.0 1.5 0.7 0.0 0.0 81.6 3.0 1.5 0.0 0.2 0.0 0.4 0.0 9.1 32.1 0.6 0.7 1.0 2.0 0.4 0.8 94.5 0.0 2.6 CRCP "C17, CGRP-RCP, POLR3I, RCP, RCP9" ENSG00000241258 "CGRP receptor component" O75575 7 66114604-66154568 "Metabolic proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006883, HPA007216" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane" "HPA006883: , HPA007216: AB_1856160" "unprognostic (2.36e-2)" "unprognostic (4.43e-1)" "unprognostic (2.32e-3)" "unprognostic (1.42e-3)" "unprognostic (3.38e-2)" "unprognostic (6.26e-2)" "unprognostic (2.67e-3)" "unprognostic (8.17e-2)" "unprognostic (1.77e-3)" "unprognostic (2.59e-3)" "unprognostic (8.49e-2)" "unprognostic (9.35e-2)" "unprognostic (1.39e-3)" "unprognostic (3.87e-2)" "unprognostic (4.81e-1)" "unprognostic (3.50e-1)" "unprognostic (2.06e-1)" 13.5 15.3 10.8 13.8 11.4 37.5 17.6 12.7 14.1 14.7 11.2 18.3 16.8 14.7 11.3 20.0 17.3 13.1 17.5 11.3 13.7 16.5 26.5 14.5 16.4 11.6 12.2 16.9 20.6 21.2 11.1 13.7 14.1 17.3 19.6 14.2 16.1 15.8 14.8 16.1 14.7 18.2 11.3 17.4 17.9 8.3 13.9 15.2 20.0 13.6 16.6 16.6 14.4 12.4 44.0 26.9 19.5 26.4 27.0 33.7 19.0 29.9 31.9 43.7 33.7 43.5 34.6 40.6 35.7 29.0 37.0 32.4 26.7 35.9 46.1 26.0 27.3 23.1 19.1 20.9 19.4 47.6 32.6 27.0 30.9 38.3 71.6 27.8 23.7 23.1 49.3 28.8 30.0 35.0 36.7 37.7 39.8 58.7 33.6 38.4 30.1 37.8 27.8 40.5 46.1 60.3 34.3 95.2 29.2 22.8 73.6 24.0 27.6 63.4 33.6 36.5 56.3 35.4 70.0 54.3 35.9 36.8 51.6 25.9 12.0 20.4 17.6 11.1 17.1 14.4 15.4 14.9 9.1 13.4 14.5 17.3 20.9 10.9 17.0 12.0 16.0 12.0 10.8 11.4 12.7 14.1 11.3 13.7 11.6 12.2 14.1 11.3 13.9 12.4 24.8 28.9 32.5 12.1 30.4 13.4 22.2 13.9 24.5 29.9 19.7 19.2 25.7 12.8 23.0 16.5 22.9 12.6 47.8 15.5 35.2 21.3 4.4 27.7 30.3 18.1 16.1 12.2 19.5 24.8 11.8 20.5 27.5 29.4 34.1 22.8 9.7 25.2 12.1 30.3 20.5 15.4 8.2 13.6 9.2 4.3 18.6 17.7 16.0 12.2 20.6 23.0 22.6 12.5 17.2 29.8 10.2 22.2 26.5 26.2 10.5 17.6 32.8 25.8 6.6 27.2 18.5 24.5 16.7 20.9 14.8 11.5 27.3 28.6 14.7 32.1 CREBZF ZF ENSG00000137504 "CREB/ATF bZIP transcription factor" Q9NS37 11 85657990-85682908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HeLa: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021526, HPA063652" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA021526: AB_2670738, HPA063652: AB_2685075" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (6.46e-2)" "unprognostic (2.23e-3)" "unprognostic (2.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.19e-2)" "unprognostic (4.51e-2)" "unprognostic (1.04e-3)" "unprognostic (2.23e-3)" "unprognostic (1.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.34e-2)" "unprognostic (2.38e-3)" 17.1 12.4 9.8 12.9 11.1 9.7 16.8 18.3 15.4 15.9 11.3 12.8 14.1 21.3 12.2 10.1 15.1 10.3 8.2 10.1 9.9 8.8 10.8 15.4 18.7 10.6 10.0 21.7 14.8 11.8 8.7 13.2 11.1 12.9 13.7 27.9 16.4 10.2 9.9 17.2 16.4 10.3 10.5 17.2 12.7 6.1 10.3 13.6 16.3 6.8 15.3 12.1 14.9 13.5 5.6 12.4 18.4 7.6 8.4 8.8 13.7 9.8 6.0 8.4 11.0 15.6 22.5 16.4 9.1 5.8 22.1 19.6 12.7 6.2 14.1 9.3 11.9 14.9 53.1 7.2 5.7 14.1 8.0 7.8 12.2 8.5 11.8 11.5 5.3 10.8 11.7 18.6 10.1 7.9 12.0 27.5 6.8 16.3 8.7 19.2 15.7 10.1 9.2 10.7 14.5 12.4 12.6 19.3 4.2 11.6 20.8 20.8 6.3 17.4 10.7 24.3 11.0 6.4 7.6 16.8 4.1 10.4 10.9 0.3 0.1 0.1 0.4 0.1 0.7 0.2 0.3 0.3 0.2 0.2 0.4 0.4 0.2 0.4 0.3 0.2 0.6 0.1 9.8 11.1 18.3 15.4 10.1 9.9 10.6 10.0 11.1 10.5 10.3 13.5 30.3 19.2 21.5 58.1 41.9 41.3 21.6 12.4 31.3 97.5 35.1 20.6 13.9 17.2 17.9 22.0 91.8 16.9 53.1 30.0 9.8 13.2 34.5 27.6 31.1 25.1 39.4 30.1 57.6 8.6 14.9 34.7 46.9 34.0 22.2 64.3 23.2 29.5 9.9 90.9 60.7 23.8 10.2 19.2 27.3 16.6 30.7 15.6 33.8 25.3 24.8 47.9 46.4 56.8 114.5 9.2 22.8 33.4 39.1 29.5 29.8 8.0 22.5 113.5 13.1 34.6 30.9 27.4 11.4 27.7 41.3 14.4 43.0 51.9 25.7 26.5 CRNKL1 "CLF, Clf1, CRN, SYF3" ENSG00000101343 "Crooked neck pre-mRNA splicing factor 1" Q9BZJ0 20 20034368-20056046 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "unprognostic (5.43e-2)" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (4.56e-1)" "unprognostic (2.06e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.06e-6)" "unprognostic (1.18e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-1)" "unprognostic (6.09e-2)" "unprognostic (1.43e-3)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.35e-1)" "unprognostic (2.78e-2)" 8.5 8.3 7.3 9.7 9.2 23.7 16.2 12.1 8.1 11.2 6.8 10.2 10.2 13.0 10.3 10.1 9.8 8.1 9.7 7.0 7.9 11.9 11.2 7.8 12.2 7.6 7.7 14.7 6.7 14.9 5.8 11.5 8.2 14.0 11.3 9.8 8.2 10.6 16.6 9.0 9.9 11.2 8.2 10.5 10.1 11.3 7.6 13.9 12.9 15.3 12.2 9.7 7.1 12.1 21.2 26.0 20.1 24.2 18.7 19.5 26.9 18.9 18.2 23.9 22.9 17.5 19.6 20.7 14.0 20.0 31.4 29.1 24.1 25.3 29.0 10.5 12.2 20.5 8.0 37.1 15.2 24.6 46.5 15.8 14.5 25.9 15.7 16.9 18.8 23.1 22.0 24.9 22.9 32.5 28.2 18.8 18.4 34.3 26.2 23.8 49.8 28.4 14.2 14.7 30.0 22.0 25.8 42.2 27.2 19.2 35.6 18.5 17.0 18.8 15.1 18.3 21.0 33.7 35.4 22.2 9.4 13.6 16.7 37.2 13.8 32.0 13.8 15.3 16.6 14.8 15.9 15.2 10.8 14.4 14.8 13.2 37.7 22.4 23.7 9.8 17.5 11.7 7.3 9.2 12.1 8.1 7.0 7.9 7.6 7.7 8.2 8.2 7.6 12.1 20.1 22.4 15.1 6.2 23.3 9.3 8.9 11.7 12.5 11.9 19.6 12.7 19.2 18.6 20.5 14.7 12.5 19.8 32.3 17.0 9.8 22.8 11.7 39.7 37.9 16.9 20.4 24.4 8.1 18.5 17.1 18.3 23.0 40.5 35.5 26.5 15.0 19.6 19.4 16.8 7.7 30.2 12.2 18.4 7.6 5.7 20.2 18.3 3.6 5.6 23.3 17.2 19.6 8.0 10.0 19.7 12.7 18.8 30.3 8.3 17.7 18.3 24.8 16.3 26.3 21.7 20.8 62.5 36.9 18.0 8.9 20.1 25.4 22.0 14.9 13.0 CSAD "CSD, PCAP" ENSG00000139631 "Cysteine sulfinic acid decarboxylase" Q9Y600 12 53157663-53180925 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 16.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 16.3" "Cell line enhanced" "Detected in all" "ASC diff: 84.5;T-47d: 52.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039487 Approved "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "HPA039487: AB_10672776" "unprognostic (1.00e-1)" "unprognostic (3.28e-2)" "prognostic unfavorable (9.50e-4)" "unprognostic (1.57e-1)" "unprognostic (7.99e-2)" "prognostic favorable (6.33e-4)" "prognostic favorable (1.37e-4)" "unprognostic (2.46e-2)" "unprognostic (7.87e-3)" "unprognostic (1.01e-1)" "prognostic favorable (3.39e-4)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.93e-6)" "unprognostic (4.59e-2)" "unprognostic (3.47e-1)" "unprognostic (1.38e-1)" "prognostic favorable (6.81e-6)" 68.0 28.3 24.3 15.9 25.4 39.1 62.4 25.2 25.7 54.9 33.8 34.3 17.3 31.2 52.3 29.3 41.5 19.2 25.2 24.0 24.5 39.2 101.7 30.8 19.1 26.1 23.0 54.0 35.9 14.9 40.9 13.0 24.8 50.3 16.0 16.8 34.7 19.8 19.6 59.6 28.5 19.6 20.2 37.5 31.9 27.7 24.7 14.2 36.0 7.7 14.1 25.8 37.6 36.7 3.7 6.8 16.0 6.8 84.5 34.4 5.7 14.5 3.2 6.0 5.0 4.1 8.8 4.9 10.6 7.7 2.0 12.6 7.1 11.2 3.5 6.6 8.6 7.8 19.4 8.8 7.6 3.3 4.9 42.6 13.8 9.0 11.2 30.8 5.6 10.4 8.4 42.8 5.7 30.8 1.8 9.2 3.1 1.9 6.3 6.6 1.0 11.4 8.0 9.6 8.0 6.3 14.3 19.9 5.7 9.9 52.7 6.5 12.6 17.5 3.4 5.2 4.2 12.2 3.4 2.6 14.7 8.3 7.1 3.7 2.0 2.5 1.3 1.1 0.8 1.1 1.8 0.8 1.0 1.8 2.4 1.4 16.3 1.6 1.3 2.3 3.4 0.5 24.3 25.4 25.2 25.7 24.0 24.5 26.1 23.0 24.8 20.2 24.7 36.7 23.5 3.2 22.0 40.1 15.6 16.6 28.3 18.3 4.0 29.0 27.9 43.4 8.9 20.0 17.4 23.9 16.7 12.2 18.5 19.3 3.9 12.6 0.7 11.6 20.4 22.5 14.4 0.4 47.0 9.1 6.9 23.0 19.4 14.3 9.5 22.0 21.4 38.2 8.4 26.9 51.1 21.3 14.2 11.9 12.8 3.5 27.1 11.1 14.2 30.0 15.6 18.3 20.6 34.2 62.4 10.0 25.5 30.9 6.9 28.8 22.5 5.1 15.4 30.0 39.5 22.5 27.9 48.0 64.4 5.5 18.3 8.9 13.0 17.9 15.4 24.2 CSNK2A1 "Cka1, Cka2" ENSG00000101266 "Casein kinase 2 alpha 1" P68400 20 472498-543835 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020680, HPA059206, HPA061698, CAB069395" Supported Supported Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (5.44e-2)" "unprognostic (8.28e-3)" "unprognostic (3.62e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (4.11e-6)" "unprognostic (4.08e-2)" "unprognostic (3.89e-1)" "unprognostic (6.88e-2)" "unprognostic (1.94e-2)" "unprognostic (1.16e-1)" "unprognostic (8.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.47e-1)" "unprognostic (9.53e-2)" "unprognostic (7.37e-2)" 36.1 32.6 20.9 38.6 23.2 34.0 35.9 28.2 29.6 36.5 29.3 48.3 39.1 35.8 26.6 50.0 39.9 31.3 54.0 25.7 21.0 41.0 31.8 31.6 41.2 20.6 21.1 41.5 46.9 59.1 21.2 42.4 21.1 35.8 40.7 32.9 41.1 37.7 110.5 34.2 40.5 39.1 18.8 30.2 49.5 65.2 22.3 51.6 39.6 86.4 46.6 47.4 28.5 27.3 209.5 170.4 152.9 96.0 61.1 103.8 103.5 117.9 116.1 125.8 139.5 178.5 120.0 179.1 74.2 90.1 179.1 147.8 162.1 167.4 187.2 62.6 57.7 247.3 44.7 177.7 102.5 228.1 51.3 99.5 173.3 105.8 316.0 122.2 139.5 146.4 248.9 112.6 123.8 64.2 262.0 73.7 227.4 173.4 97.6 149.8 140.5 140.9 112.9 128.5 163.9 132.3 97.2 184.0 174.8 120.7 120.4 83.9 142.7 136.0 118.4 90.0 178.5 120.6 311.8 174.1 65.8 119.5 138.6 40.5 23.8 28.7 18.2 32.3 22.4 23.0 18.0 17.6 31.5 22.5 17.9 17.4 14.9 25.1 33.5 25.7 20.4 20.8 20.9 23.2 28.2 29.6 25.7 21.0 20.6 21.1 21.1 18.8 22.3 27.3 50.7 64.1 84.6 51.9 46.1 41.0 40.0 43.8 45.5 49.4 42.1 36.1 59.4 41.5 75.8 44.1 31.3 42.2 50.5 43.5 41.1 68.5 135.5 67.6 77.0 44.5 35.2 59.3 65.6 50.6 54.4 46.3 40.2 75.7 63.8 108.6 27.1 31.1 33.2 60.6 69.3 41.8 46.8 39.2 30.3 140.0 41.0 45.3 14.2 51.5 61.7 38.6 37.0 73.9 73.6 66.6 34.4 36.9 49.6 57.2 43.2 68.8 65.5 27.8 52.6 43.6 56.8 94.2 68.7 52.3 50.2 61.4 38.9 81.2 40.6 59.4 CTIF KIAA0427 ENSG00000134030 "Cap binding complex dependent translation initiation factor" O43310 18 48539031-48863217 "Predicted intracellular proteins, Transporters" "Nonsense-mediated mRNA decay, Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 94.7;Excitatory neurons: 76.4;Inhibitory neurons: 80.6;Oligodendrocyte precursor cells: 75.9;Oligodendrocytes: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016865, HPA024801" Uncertain Supported Cytosol NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Cytosol "HPA016865: AB_1852311, HPA024801: AB_1852312" "unprognostic (5.84e-2)" "unprognostic (5.86e-2)" "unprognostic (2.27e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (1.44e-1)" "unprognostic (8.86e-2)" "unprognostic (1.95e-3)" "unprognostic (2.77e-3)" "unprognostic (1.35e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-1)" "unprognostic (2.34e-3)" "unprognostic (7.33e-3)" 35.3 20.0 15.7 3.3 13.9 2.0 24.3 10.7 23.2 14.0 0.0 26.0 2.5 21.5 2.6 11.4 16.3 7.5 24.8 16.0 15.5 11.1 24.8 14.3 1.3 20.7 17.4 28.0 9.8 4.6 12.4 4.3 23.3 13.9 1.6 7.4 11.0 5.4 15.8 14.0 9.9 7.0 9.1 6.7 19.6 7.3 19.0 1.4 10.7 4.3 1.0 26.1 12.6 16.7 3.2 3.4 4.5 5.8 11.3 6.0 2.5 15.9 13.2 12.4 11.2 3.5 1.9 0.0 3.5 22.0 5.2 6.7 3.3 9.0 5.3 0.0 2.7 1.4 7.9 8.4 21.6 2.6 4.5 8.4 14.5 7.8 13.8 8.9 8.9 4.1 4.0 9.8 8.0 1.7 0.9 2.0 2.2 3.4 2.8 1.6 5.2 4.2 3.7 4.3 9.6 9.7 5.6 6.0 4.5 3.8 3.8 3.1 18.1 11.4 10.5 3.4 2.9 3.3 4.2 0.0 10.1 1.6 5.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 13.9 10.7 23.2 16.0 15.5 20.7 17.4 23.3 9.1 19.0 16.7 7.3 35.3 3.7 94.7 1.9 3.3 2.1 3.5 2.8 25.6 11.2 8.4 16.0 5.7 5.6 7.3 16.7 1.9 0.8 4.6 7.9 5.1 11.1 1.7 7.7 8.5 3.5 0.4 76.4 4.8 2.8 13.1 7.1 3.6 4.5 19.5 7.5 23.0 4.2 11.8 80.6 3.5 4.1 6.4 2.7 19.3 25.1 5.0 3.6 30.0 1.5 3.6 3.1 75.9 59.7 5.7 2.7 50.8 4.8 3.0 5.9 5.8 4.7 8.8 6.6 8.8 9.4 2.3 1.8 3.5 2.3 1.2 0.7 34.7 3.3 3.3 CTNNAL1 "alpha-CATU, CLLP" ENSG00000119326 "Catenin alpha like 1" Q9UBT7 9 108942569-109013522 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 273.9" "Cell type enhanced" "Detected in all" "Theca cells: 616.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "unprognostic (2.93e-1)" "unprognostic (1.45e-1)" "unprognostic (2.10e-2)" "unprognostic (6.07e-3)" "unprognostic (2.14e-2)" "unprognostic (1.27e-3)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (2.05e-1)" "unprognostic (4.72e-2)" "unprognostic (3.55e-2)" "unprognostic (7.45e-2)" "unprognostic (2.26e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.53e-1)" "unprognostic (5.79e-3)" "unprognostic (1.67e-1)" 33.2 273.9 21.4 12.1 23.6 39.0 22.3 21.3 33.8 21.4 30.2 39.0 12.3 28.2 32.8 24.5 31.4 18.7 74.5 23.0 20.5 52.0 29.5 52.3 13.1 20.6 20.4 129.2 24.8 33.0 21.7 45.2 20.4 24.9 17.6 33.7 19.1 27.9 34.0 24.0 18.7 30.9 20.0 24.7 38.4 44.3 22.4 14.6 84.6 18.7 14.8 26.7 15.9 22.8 158.4 54.9 59.6 48.6 40.3 105.6 107.6 205.8 92.1 199.8 129.5 171.7 241.1 48.2 62.6 105.0 155.5 115.7 78.7 182.3 243.1 68.4 49.8 25.6 51.6 115.0 55.2 62.6 6.0 81.9 12.5 105.9 144.2 167.4 98.4 39.6 60.6 48.0 92.1 15.9 43.5 44.9 67.7 145.3 115.6 85.4 158.5 42.9 206.3 33.7 46.3 31.7 65.8 6.5 48.0 57.6 48.5 23.3 111.1 79.1 115.9 70.8 116.9 36.4 37.0 44.4 110.8 46.8 90.3 0.0 0.2 0.9 0.6 0.0 2.1 1.2 0.8 1.6 0.1 0.2 1.4 0.4 3.2 4.0 0.0 0.0 6.4 1.9 21.4 23.6 21.3 33.8 23.0 20.5 20.6 20.4 20.4 20.0 22.4 22.8 50.5 19.2 34.9 10.7 7.1 110.0 100.3 57.8 161.6 10.1 16.8 33.5 140.1 15.7 25.2 29.5 29.2 203.3 6.6 12.1 131.0 112.2 67.9 103.8 48.7 144.2 21.0 77.5 83.1 105.0 106.0 66.2 25.0 135.0 5.1 57.3 189.2 20.1 25.2 33.7 55.1 20.1 14.2 5.0 33.6 26.2 55.0 17.8 55.2 16.9 4.6 103.5 1.0 12.1 4.3 219.8 15.1 45.1 29.8 119.3 2.4 21.0 52.9 16.7 13.1 31.8 72.6 117.9 38.8 12.2 24.0 86.7 14.7 616.1 22.0 27.7 CUL7 "dJ20C7.5, KIAA0076" ENSG00000044090 "Cullin 7" Q14999 6 43037617-43053943 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015449, HPA030095, HPA030096" Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 51: Non-specific - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" "CAB015449: AB_629341, HPA030095: AB_10600659, HPA030096: AB_10600997" "unprognostic (2.32e-2)" "unprognostic (4.79e-2)" "unprognostic (1.01e-3)" "unprognostic (6.06e-2)" "unprognostic (5.41e-3)" "unprognostic (4.95e-2)" "unprognostic (3.72e-2)" "unprognostic (1.94e-2)" "unprognostic (1.01e-1)" "unprognostic (9.81e-2)" "unprognostic (2.13e-3)" "unprognostic (4.81e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (8.92e-2)" "unprognostic (6.78e-2)" "unprognostic (2.23e-1)" "unprognostic (3.35e-1)" 7.5 13.7 5.0 6.6 5.0 4.4 8.8 5.7 5.3 14.4 7.9 7.6 7.7 11.7 9.0 6.9 14.2 7.6 5.9 5.4 7.0 11.0 9.7 7.4 6.2 3.8 4.4 15.9 15.7 6.9 26.0 10.2 4.9 11.0 5.4 5.5 8.5 8.7 13.2 7.5 8.0 9.2 3.5 9.7 9.4 5.7 6.9 6.1 12.9 10.7 5.4 8.9 9.6 4.0 10.6 8.2 27.1 32.0 27.9 40.7 2.2 15.7 21.0 18.8 19.0 18.0 7.9 4.9 35.2 27.0 19.1 3.9 9.9 13.9 8.8 12.4 10.5 12.2 9.1 25.5 23.2 4.4 14.2 42.5 13.1 16.2 17.4 33.7 18.0 5.6 10.7 12.3 24.1 21.8 5.6 10.9 4.5 32.2 6.7 9.1 6.5 12.7 16.6 14.4 14.6 18.2 12.2 11.3 11.1 12.4 16.6 8.3 18.9 28.1 12.0 9.1 6.9 25.6 7.0 12.9 11.2 4.8 16.5 0.0 0.7 0.4 0.6 0.6 0.4 0.5 0.4 0.2 0.7 0.7 0.2 0.4 0.2 0.6 0.5 0.9 0.3 0.6 5.0 5.0 5.7 5.3 5.4 7.0 3.8 4.4 4.9 3.5 6.9 4.0 3.9 6.4 10.5 6.5 4.5 2.5 1.7 5.2 4.0 6.0 7.2 6.0 4.6 1.5 4.6 3.7 6.2 4.8 1.7 3.8 0.0 6.4 0.6 8.4 7.7 5.8 7.2 2.1 6.0 4.8 3.7 6.9 10.7 6.3 4.5 15.9 5.7 2.2 5.0 1.7 5.9 8.2 6.1 2.2 1.8 0.2 9.3 2.7 1.8 5.6 1.2 4.1 1.0 3.0 3.1 4.6 2.6 7.5 3.9 2.2 6.4 4.9 12.9 7.8 0.0 7.5 4.9 0.8 2.5 4.2 1.7 4.4 2.8 17.3 4.6 1.5 CWC25 "CCDC49, FLJ20291" ENSG00000273559 "CWC25 spliceosome associated protein homolog" Q9NXE8 17 38800441-38825355 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 28.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014874, HPA062997" Supported Enhanced "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB014874: , HPA062997: AB_2684917" "unprognostic (2.21e-1)" "unprognostic (4.30e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (4.75e-2)" "unprognostic (3.69e-2)" "unprognostic (1.01e-2)" "unprognostic (3.24e-2)" "unprognostic (3.43e-3)" "unprognostic (8.79e-3)" "unprognostic (4.17e-3)" "unprognostic (4.98e-2)" "unprognostic (1.32e-1)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (8.68e-3)" 13.3 12.6 7.9 9.9 8.9 62.2 12.3 8.5 9.7 11.6 8.8 11.1 10.3 10.3 5.4 12.5 11.9 7.6 9.0 8.2 8.5 11.6 16.2 13.0 12.6 8.7 8.5 11.2 12.6 7.2 11.0 6.7 8.5 11.7 6.1 8.6 10.9 4.5 12.7 17.4 13.1 6.8 8.0 16.8 11.6 18.4 8.5 14.2 11.3 7.1 9.0 10.9 11.5 9.4 11.2 13.1 8.2 14.1 10.9 7.1 8.3 11.5 7.9 12.0 11.0 8.4 11.7 12.7 7.8 9.2 9.2 25.3 8.2 7.7 14.5 12.0 8.7 9.9 14.9 10.4 10.8 25.2 15.6 8.4 12.3 11.8 9.7 12.7 9.8 13.5 15.5 15.0 10.2 6.2 26.4 25.6 8.5 8.2 6.4 20.0 12.1 11.4 12.0 10.7 9.3 8.2 10.7 7.6 13.8 12.2 12.0 19.8 10.2 10.8 9.9 14.3 17.9 11.9 9.3 18.8 11.4 12.1 10.9 18.0 4.1 10.6 4.6 3.9 4.0 4.5 4.3 4.8 3.5 6.0 4.9 3.7 28.7 5.9 8.1 1.7 2.9 3.0 7.9 8.9 8.5 9.7 8.2 8.5 8.7 8.5 8.5 8.0 8.5 9.4 50.7 57.7 69.5 10.4 54.2 63.9 61.2 45.9 39.9 37.2 40.8 31.2 18.3 21.5 46.3 23.9 83.4 35.1 60.6 56.6 29.4 27.5 118.4 63.8 51.7 45.3 41.8 34.5 10.0 23.6 35.2 43.8 52.0 100.2 58.9 23.8 37.9 27.2 28.6 26.9 7.9 51.9 26.4 27.0 37.9 31.9 37.3 38.2 26.6 5.6 38.7 30.1 41.2 5.5 8.1 29.3 70.9 34.6 43.2 51.4 61.5 27.2 41.9 43.4 39.5 57.0 45.7 93.9 33.6 30.5 76.7 79.1 54.6 28.8 32.6 72.4 CWF19L2 FLJ32343 ENSG00000152404 "CWF19 like cell cycle control factor 2" Q2TBE0 11 107326345-107457844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038166 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA038166: AB_10669518" "unprognostic (1.38e-1)" "unprognostic (9.41e-2)" "unprognostic (1.37e-1)" "unprognostic (7.35e-2)" "unprognostic (7.17e-2)" "unprognostic (6.42e-2)" "unprognostic (8.78e-2)" "unprognostic (1.63e-1)" "unprognostic (4.19e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (4.48e-2)" "unprognostic (1.26e-1)" "unprognostic (4.74e-2)" "unprognostic (1.76e-2)" 8.8 5.8 15.4 6.2 16.6 8.2 11.3 20.3 30.9 8.8 16.8 7.3 5.0 10.9 8.2 6.4 7.5 6.0 5.4 14.7 16.7 11.2 8.5 7.1 10.4 16.1 15.9 14.2 5.9 7.8 4.7 8.4 16.2 8.3 6.2 8.6 6.2 8.5 7.0 7.3 5.5 6.9 15.8 9.8 6.7 5.9 16.1 11.8 9.7 8.4 11.0 6.9 6.7 17.7 7.4 5.9 12.5 6.0 10.2 11.5 9.4 9.5 8.8 7.3 9.7 13.9 17.0 12.8 17.7 6.7 9.3 17.6 14.0 7.3 12.7 14.4 7.8 14.2 6.6 9.1 6.6 16.9 11.5 5.9 12.6 8.5 12.7 8.4 10.0 7.6 21.9 7.2 10.7 5.5 13.1 15.3 11.9 12.2 8.3 11.3 11.9 17.3 8.6 9.0 7.2 6.0 13.9 10.3 5.4 10.5 13.8 8.0 9.1 12.1 9.7 6.4 8.6 3.8 7.5 12.3 3.5 16.4 11.3 45.6 10.1 19.3 14.2 9.3 15.7 29.4 16.5 14.4 4.5 27.6 19.9 15.3 19.4 17.4 10.4 19.2 15.7 4.3 15.4 16.6 20.3 30.9 14.7 16.7 16.1 15.9 16.2 15.8 16.1 17.7 56.2 38.5 53.2 38.5 66.1 17.8 16.1 19.1 18.2 97.2 24.2 21.0 28.9 57.2 33.2 82.8 95.9 24.0 57.9 18.3 33.2 22.1 3.1 31.8 39.8 40.8 13.1 23.8 42.3 18.4 22.8 29.3 17.3 34.0 46.2 35.2 51.4 56.1 15.8 69.0 37.4 27.0 14.2 33.7 15.4 9.5 54.3 24.5 14.2 43.1 32.7 47.5 69.0 42.3 68.1 16.3 31.6 63.9 36.1 6.7 25.6 60.5 18.3 131.8 39.5 41.1 30.8 48.0 47.2 9.1 13.4 17.0 55.3 21.4 21.3 7.8 CYP17A1 "CPT7, CYP17, P450C17, S17AH" ENSG00000148795 "Cytochrome P450 family 17 subfamily A member 1" P05093 10 102830531-102837472 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Steroidogenesis "Lyase, Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 84 "adrenal gland: 8229.5" "Cell type enriched" "Detected in some" 17 "Theca cells: 1871.0" "Cancer enriched" "Detected in many" 5 "liver cancer: 22.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 3.0;SCLC-21H: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048533 Enhanced Approved Vesicles "Intracellular and membrane" NA NA "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Vesicles "HPA048533: AB_2680432" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (3.01e-2)" "unprognostic (9.08e-2)" "unprognostic (1.91e-1)" "unprognostic (6.29e-2)" "unprognostic (2.92e-3)" "unprognostic (2.39e-4)" "unprognostic (8.26e-2)" "unprognostic (2.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.13e-1)" "prognostic favorable (5.43e-7)" "unprognostic (1.07e-1)" "unprognostic (5.56e-2)" "unprognostic (1.66e-2)" "unprognostic (2.94e-4)" 0.4 8229.5 0.0 2.1 0.0 0.0 0.4 0.1 0.1 1.1 0.0 0.5 0.0 0.8 0.1 0.9 1.0 0.4 1.0 0.0 0.0 52.9 6.7 1.4 0.0 0.0 0.1 16.6 1.7 10.5 0.7 0.0 0.0 0.7 0.0 0.2 3.4 0.0 1.0 0.7 0.6 0.0 0.0 0.9 1.3 98.3 0.0 0.0 2.9 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.2 0.1 0.4 0.1 0.0 0.5 0.0 0.1 0.7 0.0 0.0 1.8 0.0 0.4 0.1 0.1 21.5 0.0 41.6 0.1 0.0 0.7 0.0 2.7 0.1 0.2 0.0 1.3 0.0 0.1 0.0 0.1 0.4 6.1 0.1 1.7 0.1 0.0 0.0 0.6 0.7 10.6 1.8 0.9 0.0 0.0 0.1 0.2 3.1 0.5 0.1 0.7 0.0 0.0 0.0 0.3 0.0 104.3 0.0 1.2 0.0 1.2 0.6 0.3 0.1 0.0 0.0 0.3 0.4 1871.0 0.0 0.1 DCAF17 "C2orf37, FLJ13096" ENSG00000115827 "DDB1 and CUL4 associated factor 17" Q5H9S7 2 171434217-171485052 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Deafness, Diabetes mellitus, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053339, HPA055040" Uncertain Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA053339: AB_2682119, HPA055040: AB_2682680" "unprognostic (1.60e-2)" "unprognostic (1.21e-1)" "unprognostic (4.05e-1)" "unprognostic (1.03e-2)" "unprognostic (1.60e-1)" "unprognostic (5.98e-2)" "unprognostic (5.60e-2)" "unprognostic (2.67e-2)" "unprognostic (2.30e-3)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (1.12e-2)" "unprognostic (1.41e-1)" "unprognostic (4.27e-1)" "prognostic unfavorable (7.10e-4)" "unprognostic (2.79e-2)" 3.9 4.5 5.2 5.4 6.6 3.4 6.4 6.6 6.1 6.1 4.3 5.6 4.5 6.2 6.3 4.4 4.6 3.8 3.5 5.1 5.7 5.6 4.5 3.8 7.2 5.5 5.2 7.1 5.0 6.0 3.8 5.3 5.8 5.0 4.6 13.9 4.3 4.5 3.9 7.2 4.7 4.6 5.5 6.4 4.4 5.7 6.9 7.8 10.2 4.3 6.0 5.6 5.4 10.6 8.5 6.9 8.9 10.6 11.0 11.7 13.6 7.3 7.5 7.3 6.8 8.3 5.5 24.4 5.4 9.1 5.5 8.2 9.1 9.0 9.9 11.4 6.2 11.3 6.2 15.0 11.2 16.2 7.9 9.2 11.6 9.3 20.7 8.6 8.0 7.6 17.9 8.2 10.1 5.2 17.9 14.9 13.2 6.2 4.3 13.4 11.7 13.4 6.2 7.6 7.8 11.3 6.9 5.8 7.4 8.3 4.5 8.3 9.6 8.4 7.6 4.8 6.4 12.4 18.3 20.5 8.9 8.2 8.8 1.1 1.3 0.5 2.3 1.5 3.4 1.3 1.8 1.7 1.0 1.8 2.0 2.5 0.0 1.1 1.3 0.8 1.8 1.6 5.2 6.6 6.6 6.1 5.1 5.7 5.5 5.2 5.8 5.5 6.9 10.6 5.8 0.0 7.5 17.9 8.9 4.7 4.7 4.2 8.6 10.1 7.8 6.0 5.0 7.2 3.1 7.3 12.5 6.5 6.0 4.4 9.8 4.8 2.2 6.2 10.7 5.2 10.2 6.9 18.0 3.9 5.7 5.8 8.2 4.9 3.8 8.2 2.5 7.7 5.6 8.4 23.5 4.5 6.1 8.4 4.6 3.6 6.2 5.0 3.6 15.0 4.4 8.8 5.2 24.6 56.5 6.6 2.0 6.0 6.4 6.3 5.5 6.2 6.1 15.2 0.0 6.7 7.2 13.5 17.1 8.7 5.1 5.6 7.5 9.0 4.3 5.0 DCAF7 "HAN11, SWAN-1, WDR68" ENSG00000136485 "DDB1 and CUL4 associated factor 7" P61962 17 63550477-63594279 "Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022948, HPA022962" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA022948: AB_1858820, HPA022962: AB_1858821" "unprognostic (7.75e-2)" "unprognostic (3.31e-1)" "unprognostic (1.37e-3)" "unprognostic (3.78e-2)" "unprognostic (1.03e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.86e-1)" "unprognostic (2.28e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.40e-2)" "unprognostic (1.97e-1)" "unprognostic (9.95e-2)" "unprognostic (4.18e-2)" 12.4 13.6 23.3 22.6 23.1 9.0 15.5 20.1 21.0 19.8 17.8 23.9 25.9 16.7 18.8 17.5 19.3 16.7 18.1 22.2 23.0 26.5 14.3 21.6 29.1 22.7 22.7 16.5 18.4 37.4 12.4 26.7 22.8 21.9 25.7 29.9 18.1 23.3 13.3 14.0 25.0 18.9 24.9 25.4 20.8 14.8 23.6 37.2 22.1 15.3 32.4 22.3 12.8 23.2 33.2 46.4 79.6 51.0 26.9 22.2 20.9 32.6 28.7 35.3 29.7 34.2 35.2 61.2 25.7 32.7 36.9 34.7 67.0 45.8 45.0 23.7 42.7 79.9 29.3 40.3 27.7 89.7 44.4 18.6 29.7 20.6 46.8 42.5 55.8 50.9 85.7 27.8 45.3 40.9 97.7 43.0 25.9 57.5 61.7 77.1 94.5 34.9 51.4 49.7 76.4 141.0 29.4 56.2 38.9 70.0 41.5 72.1 59.3 58.0 26.4 29.6 54.4 28.9 39.6 32.2 33.0 57.1 35.2 10.9 11.3 12.6 11.2 13.1 9.0 8.1 7.7 8.7 10.6 8.3 6.9 7.5 4.7 8.9 16.2 7.8 5.9 8.6 23.3 23.1 20.1 21.0 22.2 23.0 22.7 22.7 22.8 24.9 23.6 23.2 28.5 44.8 45.9 30.3 57.4 31.4 30.5 49.8 46.7 55.4 29.3 25.1 30.8 38.6 38.1 68.0 77.2 51.7 49.0 47.2 23.5 50.1 95.5 30.5 38.0 43.1 72.0 62.6 42.3 45.2 47.7 33.8 31.1 30.1 60.2 67.1 48.9 40.2 55.4 65.6 41.1 49.0 52.9 64.3 45.2 27.6 35.1 61.9 26.6 43.1 72.9 53.1 69.0 36.2 40.5 55.0 41.2 38.0 45.0 45.3 67.7 52.0 43.7 54.0 59.2 23.2 35.8 96.5 35.0 51.6 34.8 21.6 53.1 49.8 57.2 47.6 DCLRE1C "A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C" ENSG00000152457 "DNA cross-link repair 1C" Q96SD1 10 14897359-14954432 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069295 Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Golgi apparatus" "HPA069295: AB_2686112" "unprognostic (8.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.66e-2)" "unprognostic (2.40e-2)" "unprognostic (1.36e-2)" "prognostic favorable (1.30e-4)" "unprognostic (8.02e-4)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic favorable (7.98e-4)" "unprognostic (1.91e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (9.03e-8)" "unprognostic (2.43e-2)" "unprognostic (2.32e-1)" "unprognostic (2.51e-1)" "unprognostic (5.45e-3)" 4.2 3.3 2.2 8.0 3.2 14.0 6.1 5.7 3.4 4.5 3.7 4.3 5.2 4.4 3.8 7.1 3.7 4.0 2.3 2.2 2.2 3.5 2.6 4.9 14.1 2.8 2.7 4.5 3.1 3.8 2.2 4.4 3.1 4.0 5.2 4.9 4.5 3.7 3.0 6.9 5.4 3.9 2.5 10.4 5.9 1.9 2.9 12.3 5.5 2.7 12.8 5.4 5.1 3.7 16.2 7.8 6.9 13.8 6.4 8.2 6.6 9.7 5.3 13.0 13.5 8.9 13.4 21.7 3.8 7.6 9.2 13.7 7.6 5.1 10.9 13.4 8.0 16.7 8.9 6.0 5.1 10.0 18.4 6.6 4.8 12.7 5.3 8.2 7.4 13.9 10.5 17.4 8.6 7.4 14.9 9.9 4.7 14.4 3.5 17.2 9.2 12.1 6.5 6.0 3.6 6.9 10.7 10.2 27.5 5.3 12.8 18.5 6.0 8.3 11.6 17.1 10.8 9.9 19.1 21.5 8.1 10.5 11.8 27.4 13.9 20.0 12.1 18.9 14.5 25.1 14.1 15.0 20.9 28.1 12.2 13.2 13.2 11.0 17.5 22.4 11.9 8.9 2.2 3.2 5.7 3.4 2.2 2.2 2.8 2.7 3.1 2.5 2.9 3.7 6.6 3.2 6.9 17.9 27.6 17.3 20.8 10.9 5.7 24.8 7.8 4.3 4.4 11.5 26.1 14.7 62.6 15.1 21.8 10.9 3.9 9.9 26.8 8.5 8.6 8.2 6.7 22.7 12.4 11.1 21.9 10.2 7.1 13.1 6.3 14.1 10.4 1.9 10.2 32.0 10.6 7.3 10.2 19.8 20.6 2.3 12.5 13.3 19.6 16.9 21.8 10.4 35.0 12.5 11.9 14.9 15.5 11.3 13.4 21.5 12.3 2.7 22.3 47.9 19.7 18.1 11.9 13.9 18.5 7.3 21.2 5.1 14.8 12.4 8.6 41.4 DDHD2 "KIAA0725, SAMWD1, SPG54" ENSG00000085788 "DDHD domain containing 2" O94830 8 38225218-38275558 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015202, HPA023143, HPA023147" Supported Supported "Centriolar satellite,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Cytosol "Centriolar satellite" "CAB015202: , HPA023143: AB_1847534, HPA023147: AB_1847535" "unprognostic (1.49e-3)" "unprognostic (2.40e-1)" "unprognostic (1.40e-1)" "unprognostic (1.04e-1)" "unprognostic (2.64e-1)" "prognostic favorable (7.72e-4)" "unprognostic (4.54e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (2.63e-2)" "unprognostic (1.04e-1)" "unprognostic (4.49e-2)" "unprognostic (3.01e-3)" "unprognostic (3.21e-2)" "unprognostic (2.46e-1)" "unprognostic (7.88e-2)" "unprognostic (1.49e-1)" 28.9 18.1 27.3 14.4 32.1 14.9 19.4 33.8 39.7 22.0 23.5 20.1 19.6 20.9 23.3 20.9 19.1 17.5 27.7 30.1 29.3 21.6 12.1 16.9 19.8 32.1 27.7 28.9 22.2 21.1 18.3 15.2 35.1 22.6 16.7 31.7 18.3 29.3 32.0 16.8 22.2 18.2 30.7 17.2 15.0 22.7 32.4 19.5 18.7 35.8 22.3 17.6 17.7 38.8 57.7 26.1 58.3 28.3 21.8 30.6 18.4 18.1 33.0 42.5 38.4 30.8 22.6 22.8 24.1 32.8 26.3 22.7 33.9 34.1 64.9 19.8 22.6 83.0 36.0 29.9 19.6 9.6 12.8 16.0 26.4 26.4 26.8 27.0 51.5 31.2 59.6 24.5 27.3 12.3 66.6 14.7 13.2 9.5 15.1 34.0 50.1 16.5 22.5 34.8 21.2 32.0 44.4 21.9 22.2 18.2 26.3 26.1 46.6 24.8 31.1 24.3 28.4 25.7 25.8 54.0 39.5 18.4 35.3 2.5 3.9 4.7 10.6 4.9 11.8 9.8 9.6 11.9 6.5 15.2 10.2 7.5 0.3 16.5 3.5 3.8 15.6 7.3 27.3 32.1 33.8 39.7 30.1 29.3 32.1 27.7 35.1 30.7 32.4 38.8 15.4 22.4 7.0 20.5 17.3 13.8 10.6 8.2 14.2 27.9 12.7 7.4 23.9 8.6 8.4 20.2 18.8 12.1 16.2 7.2 23.5 11.6 4.5 9.7 13.4 13.8 15.7 25.2 51.3 11.0 11.5 13.6 12.8 12.4 21.0 22.8 12.5 5.5 7.4 53.8 51.2 9.3 6.1 8.4 11.2 10.8 20.2 7.7 19.6 21.5 13.0 19.9 16.5 35.7 46.9 16.2 6.2 20.7 24.0 10.2 23.8 10.0 5.4 5.9 6.6 17.6 13.6 30.9 35.3 8.7 10.7 6.4 17.9 13.4 8.9 7.7 DDX17 P72 ENSG00000100201 "DEAD-box helicase 17" Q92841 22 38483438-38507660 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024908, HPA063142" Supported Supported "Nuclear speckles" "Intracellular and membrane" NA NA 420000 "Cluster 1: Neutrophils - Mixed function" "Cluster 51: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB024908: , HPA063142: AB_2684949" "unprognostic (1.46e-2)" "unprognostic (5.99e-3)" "unprognostic (4.24e-3)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.06e-4)" "unprognostic (1.17e-1)" "unprognostic (5.51e-1)" "unprognostic (2.52e-2)" "unprognostic (2.73e-2)" "unprognostic (1.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.76e-1)" "unprognostic (4.31e-2)" "unprognostic (3.19e-3)" 181.2 172.4 142.0 124.3 160.1 74.5 198.5 150.9 178.4 248.7 174.8 233.8 107.8 216.1 255.3 150.4 248.1 121.1 168.7 143.5 152.1 247.2 152.8 202.2 186.4 152.8 149.4 298.8 214.0 144.7 309.9 158.8 155.3 234.4 114.2 342.0 188.4 123.3 184.8 197.0 227.2 119.7 146.8 293.0 192.1 91.1 148.2 215.2 300.0 106.6 158.2 204.4 201.5 196.5 122.0 79.9 237.6 141.8 148.2 166.0 120.7 104.3 85.9 118.3 121.2 89.0 100.5 225.8 65.8 119.5 82.9 133.2 212.5 127.9 145.9 202.5 142.1 140.4 175.8 133.5 153.4 192.9 170.8 122.3 183.7 86.8 142.9 211.7 153.3 109.6 139.7 255.3 116.0 75.6 128.7 164.0 148.0 172.1 51.6 218.0 122.9 137.1 141.2 132.6 134.1 75.3 155.0 125.9 161.2 180.5 110.0 148.4 140.8 125.7 77.6 80.0 79.3 203.7 130.3 183.4 156.7 123.1 154.2 6.7 8.1 9.5 7.6 7.9 8.9 9.0 7.1 7.3 7.0 7.2 5.7 6.8 16.6 5.1 8.7 10.5 9.1 6.0 142.0 160.1 150.9 178.4 143.5 152.1 152.8 149.4 155.3 146.8 148.2 196.5 252.6 214.7 325.5 483.8 241.9 223.6 206.1 129.3 158.2 448.3 300.7 195.3 147.2 180.1 223.5 283.3 352.3 127.6 297.5 172.8 33.2 111.7 44.4 280.0 293.4 250.4 236.1 177.1 198.9 90.2 99.9 207.5 216.1 234.2 200.7 505.3 233.8 205.3 113.9 321.4 242.1 191.6 146.5 200.6 194.8 49.1 323.7 197.7 154.7 253.9 235.1 223.4 304.9 334.3 553.3 104.7 153.1 278.7 213.1 193.5 154.8 89.8 270.8 559.4 289.3 260.5 213.6 136.4 74.2 120.4 279.9 139.4 218.6 293.7 147.0 255.3 DDX19A "DDX19L, FLJ11126" ENSG00000168872 "DEAD-box helicase 19A" Q9NUU7 16 70346861-70373383 "Enzymes, Predicted intracellular proteins, Transporters" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045252, HPA066668" Approved Uncertain Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA045252: AB_10961128, HPA066668: " "unprognostic (3.11e-2)" "unprognostic (1.93e-1)" "unprognostic (9.07e-2)" "unprognostic (3.95e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (2.38e-4)" "prognostic unfavorable (8.05e-5)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (1.67e-1)" "unprognostic (1.30e-1)" "unprognostic (5.87e-2)" "unprognostic (1.24e-1)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (3.01e-2)" "unprognostic (6.68e-3)" 20.1 19.1 11.3 14.2 12.0 12.6 17.6 12.5 12.6 16.3 12.6 21.4 10.3 20.8 14.1 19.8 17.2 16.0 22.9 11.1 12.4 17.5 21.8 15.6 19.1 12.2 12.2 21.7 17.3 24.8 11.9 23.6 12.6 15.4 15.0 12.6 14.5 20.8 58.4 16.4 14.0 26.9 12.1 15.2 16.9 7.4 12.7 21.0 20.3 38.5 20.5 22.3 14.5 12.5 36.5 39.9 42.4 43.8 60.8 41.7 39.6 45.8 46.7 70.0 54.1 60.9 27.5 60.4 41.8 49.2 34.1 41.6 75.3 45.2 60.4 20.0 41.1 31.7 32.0 75.5 55.0 56.9 26.3 51.0 31.7 65.3 49.8 35.1 46.3 43.5 77.6 15.6 42.6 53.0 62.2 47.8 68.6 43.6 24.6 79.2 27.9 84.8 42.3 23.0 35.1 45.8 115.3 25.4 35.6 43.8 47.4 35.5 31.0 49.0 39.2 31.4 43.9 44.6 70.5 132.7 32.8 50.8 50.5 9.3 8.6 4.7 7.3 8.0 6.7 5.3 6.4 7.2 10.5 5.8 7.0 7.4 0.8 7.1 7.6 5.9 6.0 7.0 11.3 12.0 12.5 12.6 11.1 12.4 12.2 12.2 12.6 12.1 12.7 12.5 14.8 16.0 20.7 15.3 19.1 9.9 21.2 8.6 14.8 35.0 10.4 11.0 18.0 22.8 17.5 11.0 33.3 23.0 12.7 8.2 9.8 14.7 3.2 14.7 18.6 15.6 14.4 21.0 23.4 13.8 16.3 16.0 7.1 15.2 17.7 18.0 12.5 19.5 14.0 23.5 25.7 10.1 2.0 14.2 9.5 2.0 26.1 11.2 10.6 2.8 19.2 15.6 27.8 8.5 10.9 14.0 9.5 12.4 19.8 23.0 8.7 13.3 12.8 32.3 26.3 14.7 15.1 14.7 15.7 16.3 10.2 17.2 16.3 18.0 13.6 16.0 DDX39B "BAT1, D6S81E, UAP56" ENSG00000198563 "DExD-box helicase 39B" Q13838 6 31530219-31542448 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 352.9;hTERT-HME1: 244.9;K-562: 255.5;NB-4: 254.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034012, HPA055334, HPA058450" Enhanced Enhanced "Nuclear speckles" NA NA 270000 "Cluster 32: T-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721" "unprognostic (2.78e-2)" "unprognostic (1.30e-2)" "unprognostic (6.86e-3)" "unprognostic (3.44e-2)" "unprognostic (3.22e-2)" "unprognostic (5.13e-3)" "unprognostic (2.89e-2)" "unprognostic (1.19e-2)" "unprognostic (4.89e-3)" "unprognostic (1.25e-1)" "unprognostic (2.81e-2)" "unprognostic (3.53e-3)" "prognostic unfavorable (1.11e-6)" "unprognostic (2.85e-1)" "unprognostic (1.72e-1)" "unprognostic (1.90e-2)" "prognostic favorable (1.43e-5)" 130.5 138.3 11.9 23.7 12.3 5.5 125.0 12.8 13.1 147.7 12.0 126.6 3.0 127.6 103.5 105.9 133.9 6.2 141.8 11.4 12.4 123.0 125.9 117.5 34.5 14.4 12.5 173.0 187.5 7.9 125.0 14.6 12.6 141.8 16.6 34.3 103.1 30.3 181.6 104.3 134.1 9.5 13.5 178.1 117.0 59.8 12.0 40.1 133.4 60.4 26.4 118.6 113.2 14.6 9.0 130.9 37.7 19.7 121.4 78.1 24.7 9.6 11.5 28.8 25.4 13.3 17.8 24.3 75.0 145.0 106.3 16.5 42.8 223.1 26.7 8.1 352.9 19.9 14.3 28.7 13.2 35.1 18.8 129.0 117.8 28.9 244.9 131.0 18.3 157.0 255.5 7.1 24.1 6.3 22.7 254.1 17.2 18.3 13.0 17.9 41.6 10.8 143.5 11.8 18.4 151.2 26.3 9.0 15.6 35.7 6.5 36.5 10.3 3.7 13.9 3.6 26.7 68.2 78.9 229.9 2.3 39.5 16.6 2.5 6.4 4.8 4.8 7.6 6.4 4.2 6.9 6.7 9.3 6.2 10.2 8.8 4.3 5.2 4.6 7.7 7.1 5.6 11.9 12.3 12.8 13.1 11.4 12.4 14.4 12.5 12.6 13.5 12.0 14.6 31.5 22.4 36.9 0.0 43.9 14.4 41.9 13.2 35.9 21.3 21.8 15.7 4.0 5.7 22.2 3.7 22.9 13.9 58.1 15.2 5.9 9.7 1.4 23.0 37.8 26.5 17.3 26.3 0.0 8.2 11.8 28.0 64.2 32.4 37.2 58.3 13.2 6.9 9.8 15.2 0.0 11.7 12.2 14.8 14.4 2.6 16.1 34.9 8.8 0.0 17.1 8.5 66.9 0.0 0.0 10.4 11.7 11.7 44.5 23.0 17.5 5.1 31.5 27.2 26.3 57.9 35.2 6.4 6.7 44.2 13.5 17.0 50.3 79.6 12.7 33.9 DDX46 "FLJ25329, KIAA0801, Prp5, PRPF5" ENSG00000145833 "DEAD-box helicase 46" Q7L014 5 134758771-134855133 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036554, HPA057501" Supported Supported "Nucleoli fibrillar center,Nuclear speckles" NA NA 13000 "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Nucleoli fibrillar center" "HPA036554: AB_10673621, HPA057501: AB_2683449" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "prognostic favorable (9.01e-6)" "unprognostic (7.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.71e-2)" "unprognostic (2.04e-3)" "unprognostic (1.07e-1)" "unprognostic (1.60e-2)" "unprognostic (5.05e-2)" "unprognostic (9.21e-2)" "unprognostic (6.02e-2)" "unprognostic (9.70e-3)" "unprognostic (4.36e-2)" "unprognostic (4.35e-2)" "unprognostic (1.64e-2)" "unprognostic (4.50e-2)" 16.5 14.6 7.6 23.9 8.8 23.1 17.7 16.1 10.8 16.3 11.4 17.3 17.0 19.8 12.3 17.5 15.0 13.4 13.4 6.8 11.2 18.8 17.7 15.8 25.6 10.0 8.4 18.5 20.8 18.4 11.1 15.7 9.2 15.5 20.7 18.0 16.8 12.1 35.2 19.4 18.7 17.6 5.4 20.6 20.0 16.3 10.0 32.1 18.7 22.9 26.6 18.2 15.6 10.3 87.1 78.0 54.4 71.1 20.8 23.2 75.0 56.8 43.7 58.8 65.6 119.2 61.7 108.9 47.7 38.3 62.3 52.5 80.9 54.2 68.7 73.8 73.3 131.0 84.7 48.5 18.0 120.5 67.8 21.0 28.9 62.1 34.8 24.9 47.3 85.9 113.6 45.3 44.1 41.5 104.2 46.9 75.2 50.1 34.8 89.7 142.0 54.8 32.0 73.9 64.2 61.3 79.4 37.2 42.7 63.0 58.3 68.0 59.0 61.8 43.2 47.9 114.0 35.6 103.2 140.2 42.8 112.0 40.0 55.6 31.9 48.2 30.7 29.2 28.0 38.1 30.4 31.3 25.3 43.4 30.9 31.5 55.9 32.3 27.5 38.5 29.7 17.8 7.6 8.8 16.1 10.8 6.8 11.2 10.0 8.4 9.2 5.4 10.0 10.3 102.4 76.9 131.5 35.9 123.6 113.8 121.5 102.7 68.9 131.5 80.6 79.4 69.3 64.3 94.9 103.0 83.4 133.7 142.3 91.3 56.7 100.5 53.4 111.4 155.8 104.7 92.2 90.6 38.7 107.9 160.4 85.1 69.3 115.9 101.2 122.3 76.8 113.1 94.4 121.1 41.2 112.4 63.1 119.3 113.2 26.7 111.9 103.4 56.9 21.5 178.5 79.9 194.7 28.1 57.6 130.7 62.6 113.2 134.7 139.5 79.2 84.1 74.5 176.0 98.6 114.9 115.2 246.3 275.7 81.0 137.0 157.2 131.8 114.5 112.7 144.1 DDX5 "G17P1, HLR1, p68" ENSG00000108654 "DEAD-box helicase 5" P17844 17 64498254-64508199 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005868, HPA020043, HPA071154" Supported Supported Nucleoplasm,Nucleoli No No 310000 "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: " "unprognostic (6.64e-2)" "unprognostic (6.98e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.94e-2)" "unprognostic (5.08e-2)" "unprognostic (9.85e-2)" "unprognostic (5.80e-2)" "unprognostic (1.61e-2)" "unprognostic (3.17e-2)" "unprognostic (4.71e-2)" "unprognostic (3.03e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-1)" "unprognostic (2.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.17e-1)" "unprognostic (9.28e-3)" 202.9 124.0 75.2 75.7 80.0 219.5 163.4 93.4 91.3 190.4 122.8 176.8 36.1 181.7 61.9 136.9 181.2 186.4 109.8 83.6 83.8 113.6 157.5 185.9 124.7 85.5 79.7 134.2 83.3 177.7 118.9 119.4 79.0 122.8 157.7 211.7 112.0 144.8 165.7 130.6 116.3 274.6 65.4 127.5 137.1 88.7 83.2 272.5 172.8 107.5 157.5 228.2 128.9 100.2 204.7 85.5 353.1 144.4 316.2 316.7 134.1 221.4 349.8 306.9 300.3 98.2 105.3 299.7 102.0 364.8 238.1 87.1 361.6 291.5 428.2 107.7 76.0 211.2 84.5 81.6 216.6 383.9 186.3 301.4 306.8 270.2 264.1 241.5 362.2 303.6 174.3 247.3 284.0 108.7 520.4 44.8 159.5 294.5 32.0 310.1 286.7 239.1 201.8 145.6 151.0 305.7 181.5 167.6 284.0 326.5 138.5 132.1 158.2 123.0 146.3 170.0 207.3 112.2 283.9 622.0 166.6 140.5 184.2 232.6 160.6 170.0 117.2 143.3 149.8 111.5 105.4 125.4 148.5 106.3 107.6 109.4 86.6 112.2 197.1 85.5 135.9 319.9 75.2 80.0 93.4 91.3 83.6 83.8 85.5 79.7 79.0 65.4 83.2 100.2 990.8 535.2 690.9 200.8 909.4 879.5 1536.4 837.0 618.1 403.5 433.3 393.7 249.6 346.0 855.7 369.6 335.7 439.9 1284.6 521.5 334.6 476.2 603.0 1021.9 987.2 767.7 664.1 309.7 187.9 419.2 371.3 733.5 452.1 1288.8 874.3 647.9 528.7 254.3 445.8 420.6 165.7 475.9 801.5 577.8 629.4 136.9 415.4 833.2 432.2 280.1 800.2 587.1 777.5 291.6 325.7 464.2 598.6 437.8 661.5 537.7 552.6 287.5 737.9 550.4 493.0 1437.7 961.5 407.6 399.1 466.4 746.0 887.3 1043.4 745.0 424.7 1056.4 DDX51 ENSG00000185163 "DEAD-box helicase 51" Q8N8A6 12 132136594-132144319 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039503 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 50: Non-specific - Ribosome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" Cytosol "HPA039503: AB_10796328" "unprognostic (2.84e-3)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (8.66e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (4.88e-1)" "unprognostic (3.05e-3)" "unprognostic (5.31e-2)" "unprognostic (3.97e-2)" "unprognostic (2.48e-1)" "unprognostic (4.69e-2)" "unprognostic (3.28e-1)" "unprognostic (1.65e-3)" 8.5 7.1 4.6 1.9 4.7 4.3 8.6 4.5 5.8 9.7 3.3 8.6 1.6 8.5 2.4 7.2 10.5 1.0 6.8 4.8 4.0 9.3 6.9 6.8 2.5 4.5 4.3 12.9 11.2 1.9 8.7 1.3 4.7 8.7 1.4 2.6 6.9 2.3 9.7 12.0 8.0 1.7 4.2 9.6 8.1 6.7 4.2 2.3 8.5 1.4 1.9 9.3 8.0 5.1 4.1 6.5 2.7 3.4 2.5 2.4 5.0 3.1 1.8 4.5 1.9 4.0 2.0 7.2 2.6 1.9 1.0 4.2 6.7 5.0 2.2 1.7 6.5 8.5 3.8 1.3 3.0 6.0 4.7 2.1 3.6 2.5 2.3 5.0 2.4 7.8 6.4 2.3 1.3 4.1 7.4 12.2 4.7 3.4 11.0 8.6 3.6 7.9 3.1 3.2 6.5 3.4 3.4 4.8 3.5 2.2 4.2 5.5 4.2 1.7 5.1 4.1 7.2 6.4 4.0 8.2 3.5 4.5 4.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.1 4.6 4.7 4.5 5.8 4.8 4.0 4.5 4.3 4.7 4.2 4.2 5.1 9.5 3.2 17.3 5.2 8.4 12.5 10.1 2.9 7.4 28.5 9.9 10.4 4.5 10.0 9.0 3.7 25.0 6.7 12.9 7.6 1.9 4.1 1.0 6.4 9.2 8.6 8.4 5.0 22.1 5.3 6.4 9.5 9.7 8.8 6.3 18.2 6.8 7.3 5.6 33.7 17.1 11.1 0.0 6.3 8.0 1.1 8.4 6.4 10.6 11.2 4.6 11.7 11.3 8.0 9.0 6.0 8.0 8.2 8.4 11.3 3.3 3.4 4.4 28.0 0.0 17.7 9.1 7.0 11.1 6.3 14.1 4.1 11.1 17.2 12.8 6.8 DENND6A "AFI1A, FAM116A, FLJ34969" ENSG00000174839 "DENN domain containing 6A" Q8IWF6 3 57625454-57693077 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 66.9;Inhibitory neurons: 65.4;Oligodendrocytes: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 18.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 18.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062618, HPA069725, HPA071711" Approved Supported Vesicles NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles "HPA062618: AB_2684809, HPA069725: AB_2686184, HPA071711: AB_2686435" "unprognostic (6.20e-2)" "unprognostic (3.86e-2)" "prognostic favorable (9.21e-4)" "unprognostic (1.76e-1)" "unprognostic (7.75e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (6.36e-4)" "unprognostic (7.16e-2)" "unprognostic (1.17e-2)" "unprognostic (2.28e-3)" "unprognostic (5.97e-3)" "unprognostic (1.12e-1)" "prognostic favorable (7.77e-6)" "unprognostic (3.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.61e-3)" "unprognostic (2.94e-1)" 11.6 7.3 3.4 8.8 4.6 12.6 12.9 12.9 7.1 11.8 3.8 10.7 7.1 12.7 9.9 11.4 10.3 8.3 8.0 3.0 5.5 8.9 7.7 10.5 12.6 4.2 4.8 20.9 5.3 11.4 6.6 11.8 5.3 9.9 9.2 10.0 8.4 11.7 7.1 8.6 9.2 11.3 4.7 12.9 9.7 8.0 4.7 11.8 14.0 9.8 10.5 10.7 10.5 8.4 16.8 13.5 18.0 11.0 9.4 10.6 10.2 8.6 11.0 10.5 8.2 8.7 18.4 19.9 3.6 8.9 9.2 8.8 14.4 18.2 8.9 5.1 12.9 15.7 15.1 6.7 9.0 12.1 8.9 11.3 13.0 7.2 18.7 10.6 15.2 21.1 10.8 21.1 7.6 7.3 26.2 14.9 10.2 10.6 9.3 10.9 10.7 14.8 12.8 28.1 6.1 22.0 17.1 13.9 12.5 7.7 9.1 14.7 16.7 12.7 6.8 13.6 22.8 15.7 22.2 20.7 14.8 19.9 18.9 18.7 1.0 1.4 2.4 1.1 2.9 0.8 2.3 2.4 1.3 1.2 3.4 2.6 1.5 1.9 1.4 1.0 1.3 1.0 3.4 4.6 12.9 7.1 3.0 5.5 4.2 4.8 5.3 4.7 4.7 8.4 28.8 19.2 8.2 31.3 14.5 12.9 11.8 10.6 12.0 16.2 9.9 9.1 20.8 11.5 10.0 5.5 8.4 6.4 21.4 5.7 3.9 8.1 22.2 10.1 25.6 16.0 3.0 16.2 66.9 10.9 4.4 15.7 10.2 17.1 2.5 24.1 20.7 11.1 11.1 10.1 65.4 5.5 12.2 34.3 9.9 11.3 11.8 16.8 3.6 47.8 16.8 10.2 20.6 42.3 74.3 18.9 3.5 14.3 9.5 8.4 6.5 8.9 8.0 14.5 6.6 19.2 18.3 13.3 5.0 14.1 10.7 2.3 19.6 16.7 6.1 13.0 DEPDC5 "DEP.5, KIAA0645" ENSG00000100150 "DEP domain containing 5, GATOR1 subcomplex subunit" O75140 22 31753867-31908033 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 31.9;Inhibitory neurons: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 34.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 34.8" "Cell line enhanced" "Detected in all" "U-698: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054969, HPA055619" Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "HPA054969: AB_2682655, HPA055619: AB_2682864" "unprognostic (5.68e-2)" "unprognostic (1.16e-2)" "unprognostic (8.98e-3)" "unprognostic (8.83e-2)" "unprognostic (5.60e-2)" "unprognostic (7.87e-3)" "unprognostic (5.93e-2)" "unprognostic (1.12e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" "unprognostic (4.59e-3)" "unprognostic (6.64e-2)" "prognostic favorable (2.46e-5)" "unprognostic (5.66e-2)" "unprognostic (7.88e-2)" "unprognostic (1.26e-1)" "prognostic favorable (4.86e-5)" 6.3 7.7 6.4 5.1 6.5 4.4 5.6 8.7 10.8 8.7 5.8 7.4 3.0 6.0 3.4 7.2 6.6 3.5 4.8 6.5 6.3 5.5 9.9 5.3 6.3 6.0 5.8 11.3 4.2 4.9 6.2 3.6 6.2 5.5 5.2 4.0 6.0 3.0 5.9 6.4 8.5 3.7 5.3 9.4 6.2 7.4 6.5 4.9 5.7 3.8 9.7 6.6 7.1 8.6 5.7 5.0 9.1 5.7 4.5 4.7 7.4 3.9 6.4 5.1 6.8 6.8 3.4 13.0 1.5 5.5 4.1 5.8 6.3 6.3 9.1 6.7 5.8 6.1 6.1 6.7 4.4 20.6 19.0 5.2 3.2 9.6 4.8 4.3 9.3 4.8 4.3 3.9 7.3 5.5 5.8 5.8 4.6 9.9 2.1 11.2 10.0 7.4 6.0 12.0 6.0 6.7 7.8 4.2 5.2 6.6 4.4 11.5 8.0 5.0 6.0 5.2 3.8 5.8 5.7 31.5 5.5 6.0 5.1 34.8 2.9 15.2 2.6 3.4 3.0 6.8 1.9 1.5 2.5 4.2 3.0 3.8 1.8 4.2 3.7 1.8 2.3 1.3 6.4 6.5 8.7 10.8 6.5 6.3 6.0 5.8 6.2 5.3 6.5 8.6 4.7 0.0 3.9 20.5 12.0 2.7 1.8 3.0 5.2 4.9 4.5 2.9 4.3 2.8 5.5 7.3 2.1 3.8 4.5 10.4 3.9 5.1 1.3 4.2 6.1 5.1 13.2 2.1 31.9 4.9 3.1 4.3 6.6 6.5 5.7 18.2 4.2 4.9 3.5 16.8 29.6 6.2 6.1 3.1 2.2 2.2 1.8 6.9 3.6 24.4 3.9 4.2 5.2 23.1 24.3 4.7 5.6 2.6 4.4 1.6 4.7 2.8 5.2 5.6 6.6 3.1 3.1 4.8 5.2 4.3 2.3 2.3 5.3 11.4 5.0 1.8 DET1 FLJ10103 ENSG00000140543 "DET1 partner of COP1 E3 ubiquitin ligase" Q7L5Y6 15 88494440-88546681 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA048873: AB_2680541" "unprognostic (9.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (3.17e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (6.64e-2)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (2.82e-3)" "unprognostic (2.62e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (4.67e-2)" 3.7 5.2 2.5 2.0 2.8 1.2 3.6 2.7 2.7 6.0 3.2 4.2 3.5 6.7 5.4 2.2 5.6 3.0 5.6 2.5 2.6 3.2 2.7 2.1 2.9 2.7 2.5 10.3 3.6 3.7 3.7 3.5 2.8 4.1 3.2 5.0 4.1 3.8 9.7 2.6 3.2 5.5 2.4 2.5 3.4 1.5 2.6 5.6 4.1 11.7 3.0 4.5 3.3 3.2 1.7 6.2 8.6 6.0 3.4 6.0 1.1 5.4 6.1 4.5 5.1 1.0 4.8 3.3 4.1 7.3 4.5 2.4 8.7 1.3 3.9 0.2 5.9 6.9 3.1 1.5 6.7 2.5 1.1 5.0 5.9 1.9 6.9 4.4 3.8 2.9 8.5 3.8 6.7 2.6 3.2 2.8 3.6 2.6 1.8 4.2 6.9 3.8 2.4 5.3 3.0 4.9 6.5 2.0 14.9 5.6 2.9 5.2 3.0 5.1 3.7 4.8 5.4 2.3 1.4 2.1 5.4 4.3 4.5 0.0 2.3 1.6 2.2 3.4 1.4 1.8 1.7 1.9 3.7 2.2 2.6 1.9 0.3 1.4 2.3 1.9 2.4 1.3 2.5 2.8 2.7 2.7 2.5 2.6 2.7 2.5 2.8 2.4 2.6 3.2 3.5 3.2 2.7 6.8 3.5 0.6 2.0 3.7 4.6 11.5 4.3 3.8 2.3 1.5 2.1 3.7 10.4 7.2 1.7 2.1 1.9 3.4 1.2 3.4 6.1 2.3 3.0 5.5 5.7 3.9 6.3 4.9 2.0 2.4 0.0 10.6 2.2 2.8 4.4 6.7 6.8 2.7 2.0 1.6 2.2 0.6 4.4 2.5 3.6 3.7 4.7 7.1 2.1 6.0 9.5 3.1 1.0 3.8 1.6 1.5 3.1 2.6 3.1 7.9 0.0 5.6 4.5 8.1 9.9 1.5 1.3 4.1 2.7 8.4 3.3 1.4 DGCR8 "C22orf12, DGCRK6, Gy1, pasha" ENSG00000128191 "DGCR8 microprocessor complex subunit" Q8WYQ5 22 20080232-20111877 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.3;Rod photoreceptor cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076916, HPA079351" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Cytosol" "HPA076916: , HPA079351: " "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" "unprognostic (2.75e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.34e-1)" "unprognostic (5.72e-3)" "unprognostic (2.83e-1)" "unprognostic (1.09e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.02e-2)" "unprognostic (4.20e-1)" "unprognostic (4.68e-2)" "unprognostic (2.26e-2)" 5.2 4.4 5.3 6.1 5.2 7.7 4.8 9.4 5.6 6.8 5.0 7.0 5.0 8.5 3.6 7.1 6.9 4.7 5.2 5.3 4.6 4.7 4.5 5.3 6.3 5.1 5.1 8.4 6.2 6.4 5.2 11.6 5.6 5.5 5.0 6.5 7.2 5.6 14.8 7.5 6.7 6.0 4.7 5.9 6.1 15.2 5.3 9.5 6.0 9.3 5.9 6.8 5.7 6.2 22.7 15.7 20.1 11.9 7.7 12.4 25.5 21.3 12.6 14.1 9.9 17.0 11.3 20.1 11.6 20.0 9.4 21.4 18.4 17.8 12.2 19.7 27.4 21.7 17.4 14.0 20.3 40.7 17.5 10.0 21.6 14.8 10.7 12.9 12.6 12.1 78.7 14.1 16.5 14.6 24.7 12.1 19.4 16.5 11.8 29.0 21.2 6.8 8.5 20.9 22.3 14.3 19.4 11.3 13.0 12.0 10.9 17.2 18.8 20.5 17.1 13.0 21.9 7.8 11.5 19.9 15.3 18.2 20.3 0.0 1.1 0.6 2.0 0.9 1.5 0.7 0.9 2.1 1.3 0.6 0.9 1.2 0.2 1.6 3.6 1.5 1.2 1.5 5.3 5.2 9.4 5.6 5.3 4.6 5.1 5.1 5.6 4.7 5.3 6.2 8.1 6.4 7.9 11.8 6.0 9.6 5.2 6.8 10.2 37.1 9.1 8.0 4.2 11.5 7.3 5.5 39.6 13.6 6.9 9.6 0.0 6.1 61.3 5.5 8.3 10.2 7.3 10.3 12.4 10.2 11.2 7.3 12.8 7.3 3.8 19.2 9.7 14.4 5.3 43.7 12.7 10.3 4.1 8.4 6.5 39.2 18.3 5.0 5.4 6.5 7.2 10.9 11.3 9.5 14.0 10.9 5.8 10.5 9.3 8.6 6.2 3.4 8.1 60.7 6.6 9.7 8.1 25.2 17.5 10.4 9.2 13.5 9.3 15.1 9.7 5.6 DHX38 "DDX38, hPrp16, KIAA0224, PRP16, PRPF16" ENSG00000140829 "DEAH-box helicase 38" Q92620 16 72093613-72112912 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041347, HPA041604" Uncertain Supported Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA041347: AB_10796571, HPA041604: AB_2677577" "unprognostic (2.38e-1)" "unprognostic (1.89e-1)" "unprognostic (1.24e-2)" "unprognostic (3.25e-2)" "unprognostic (1.07e-1)" "unprognostic (1.01e-1)" "unprognostic (6.32e-3)" "unprognostic (8.50e-3)" "unprognostic (6.97e-2)" "unprognostic (1.45e-1)" "unprognostic (7.92e-2)" "unprognostic (1.28e-3)" "unprognostic (4.20e-3)" "unprognostic (2.68e-1)" "unprognostic (9.46e-2)" "unprognostic (2.40e-1)" "unprognostic (2.40e-2)" 25.8 18.7 22.4 22.8 24.4 39.7 23.8 22.2 24.7 25.1 25.9 24.8 19.6 25.5 10.7 24.2 23.8 15.0 27.0 21.5 21.6 19.6 24.0 23.9 27.8 23.2 23.2 30.6 20.2 22.9 19.3 18.6 22.5 20.9 16.1 13.2 21.1 14.4 39.9 27.6 27.3 17.6 22.2 30.4 22.5 21.3 23.5 24.2 22.8 21.4 23.1 23.7 22.9 25.0 38.5 55.0 39.4 21.9 33.4 25.8 51.1 33.6 32.6 49.1 37.8 66.4 37.5 50.5 29.2 50.9 27.0 48.6 46.3 45.8 38.0 25.3 50.0 38.7 48.9 92.5 30.8 46.9 66.7 35.6 41.2 66.1 47.4 25.9 42.9 35.7 58.9 22.9 30.6 112.8 43.9 53.1 49.7 23.9 30.9 55.8 27.1 49.9 24.0 35.6 35.6 38.9 43.8 20.3 24.5 22.5 36.8 38.4 49.4 46.6 40.8 34.8 37.3 56.2 47.6 96.7 43.9 32.1 37.5 7.1 6.2 7.1 11.3 8.3 9.8 8.1 6.8 8.2 6.2 6.0 7.4 7.9 6.4 8.8 5.1 5.5 8.6 5.5 22.4 24.4 22.2 24.7 21.5 21.6 23.2 23.2 22.5 22.2 23.5 25.0 22.5 25.6 34.3 13.7 24.4 12.2 11.0 9.5 20.5 30.7 12.0 13.6 8.6 20.0 22.0 14.7 16.7 15.0 33.3 28.5 0.0 14.5 9.0 19.3 23.0 22.3 30.5 16.8 6.7 20.6 14.3 17.1 28.1 23.6 43.0 24.0 15.0 13.6 14.9 30.3 6.1 24.8 6.1 15.2 13.9 11.0 28.9 20.3 8.8 5.6 16.9 17.9 19.6 8.0 11.1 23.7 17.1 25.2 22.4 12.7 21.1 8.6 19.0 35.3 19.7 25.6 19.1 25.5 17.8 18.5 12.8 20.4 28.2 20.6 23.4 12.6 DHX40 "ARG147, DDX40, FLJ22060, PAD" ENSG00000108406 "DEAH-box helicase 40" Q8IX18 17 59565558-59608345 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 103.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044350 Uncertain Approved Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA044350: AB_10960560" "unprognostic (1.58e-2)" "unprognostic (3.10e-1)" "prognostic favorable (4.05e-5)" "unprognostic (4.09e-2)" "unprognostic (5.23e-2)" "unprognostic (2.84e-1)" "unprognostic (4.57e-3)" "unprognostic (7.53e-3)" "unprognostic (2.86e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (3.08e-1)" "unprognostic (9.48e-3)" "unprognostic (2.22e-1)" "unprognostic (1.25e-2)" "unprognostic (1.11e-1)" "unprognostic (3.10e-1)" 17.9 22.0 14.9 12.9 15.7 26.5 26.9 16.9 16.6 22.1 25.1 15.4 14.6 25.7 21.1 17.4 27.3 17.1 18.2 14.3 17.7 32.9 14.9 18.7 16.3 15.1 16.9 32.3 21.1 57.7 21.7 19.7 16.0 21.3 17.1 21.5 17.0 21.6 17.4 21.2 13.9 20.8 15.5 15.5 16.7 29.8 15.1 25.0 30.6 22.3 18.4 19.2 13.5 20.9 28.7 51.7 64.0 42.5 39.4 39.5 36.0 25.3 48.2 37.9 42.8 20.5 28.0 37.7 69.3 37.2 40.0 20.9 46.5 36.2 58.6 29.9 68.8 34.3 35.1 23.4 30.7 42.3 15.3 31.2 33.1 32.3 31.4 62.3 42.0 36.2 29.3 33.9 26.5 53.5 51.8 26.4 24.8 36.0 37.8 48.8 45.1 42.3 39.0 22.9 45.5 113.5 45.7 18.4 48.6 31.3 58.4 24.8 34.5 45.8 56.3 16.6 25.2 41.2 47.5 23.9 53.5 28.9 32.0 9.2 6.8 11.6 7.9 6.6 10.3 4.7 5.6 5.6 7.1 4.9 5.5 6.6 19.4 4.5 4.9 3.7 6.2 7.5 14.9 15.7 16.9 16.6 14.3 17.7 15.1 16.9 16.0 15.5 15.1 20.9 27.3 9.6 20.9 10.1 19.7 19.4 10.4 16.7 26.2 12.6 31.9 26.7 24.3 28.6 25.3 47.8 18.8 8.8 35.5 14.2 11.7 18.4 43.0 68.8 37.8 22.4 18.5 29.8 10.9 16.9 9.3 21.1 20.9 41.8 3.8 41.8 27.5 25.0 9.2 50.5 14.3 19.0 8.2 21.6 14.7 16.7 25.1 18.8 19.6 3.7 14.8 21.7 14.4 7.1 14.6 13.2 11.9 26.7 18.0 13.4 12.6 46.2 57.7 14.6 32.9 17.4 22.8 103.9 51.4 15.3 22.0 12.6 19.1 36.5 17.8 10.9 DHX8 "DDX8, Dhr2, HRH1, PRP22, PRPF22" ENSG00000067596 "DEAH-box helicase 8" Q14562 17 43483865-43610338 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049285 Approved Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA049285: AB_2680698" "unprognostic (2.99e-1)" "unprognostic (4.42e-2)" "unprognostic (5.64e-2)" "unprognostic (9.02e-2)" "unprognostic (1.25e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-3)" "unprognostic (9.43e-2)" "unprognostic (2.58e-1)" "unprognostic (3.40e-2)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (4.04e-1)" "unprognostic (5.08e-3)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" 20.4 18.5 25.9 18.0 25.8 55.0 20.5 24.7 36.7 22.4 22.8 21.4 17.3 19.9 26.1 26.9 16.7 16.4 21.8 25.4 24.8 20.3 18.6 20.0 23.7 25.6 25.2 17.0 17.0 27.5 20.8 20.9 25.5 21.6 23.9 16.8 20.8 20.4 22.6 33.7 20.6 23.6 23.4 25.8 19.5 24.3 25.8 35.1 19.0 19.4 29.6 23.0 21.7 25.5 29.2 81.7 43.3 52.4 42.3 42.5 24.0 30.2 62.0 64.9 61.7 37.4 28.1 40.3 27.0 59.4 46.6 38.0 65.9 53.1 74.8 40.8 51.9 33.8 61.2 56.7 35.8 59.8 49.5 21.1 44.1 53.0 58.4 31.4 57.4 52.1 38.8 35.2 51.2 32.0 75.9 52.7 35.5 35.4 31.0 46.2 82.4 40.2 44.3 60.6 37.3 56.0 33.9 18.6 27.3 50.9 44.1 58.3 40.0 50.3 26.9 36.3 45.8 27.5 36.6 44.7 41.2 36.8 41.2 30.2 17.4 20.4 16.0 25.2 14.7 12.2 12.7 15.5 17.0 11.0 10.6 11.5 21.8 11.0 26.1 10.3 12.8 11.4 25.9 25.8 24.7 36.7 25.4 24.8 25.6 25.2 25.5 23.4 25.8 25.5 17.1 6.4 15.0 6.5 18.6 11.9 7.1 12.4 12.0 16.9 16.3 13.0 13.2 7.2 19.2 22.0 18.8 9.1 23.6 13.4 13.7 16.2 19.4 18.3 26.2 17.6 26.7 13.7 10.7 17.7 8.8 14.5 14.8 23.9 14.5 15.3 16.1 14.7 11.1 6.7 10.5 15.3 10.2 14.8 11.5 10.6 12.5 18.4 17.8 14.0 24.8 10.6 21.6 9.5 15.8 21.2 16.0 10.9 20.0 9.4 10.1 12.4 13.7 19.8 19.7 20.3 14.4 27.9 16.8 17.2 13.4 21.2 20.9 11.1 10.8 14.3 DIDO1 "BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333" ENSG00000101191 "Death inducer-obliterator 1" Q9BTC0 20 62877738-62937952 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004374, HPA049904" Supported Approved Nucleoplasm,Vesicles,Cytosol No No "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Vesicles, Cytosol" "CAB004374: AB_2093108, HPA049904: AB_2680944" "unprognostic (9.56e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-1)" "unprognostic (7.47e-2)" "unprognostic (2.68e-1)" "prognostic favorable (5.13e-4)" "unprognostic (9.92e-3)" "unprognostic (4.57e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "prognostic favorable (3.88e-4)" "unprognostic (2.20e-2)" "unprognostic (1.50e-3)" "unprognostic (1.06e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-2)" "unprognostic (9.82e-2)" 30.4 20.1 15.7 21.5 17.6 29.1 31.0 22.4 17.8 33.8 23.3 36.3 19.6 38.2 26.8 27.1 36.8 17.5 27.6 15.4 17.2 25.5 24.7 30.9 31.6 16.4 16.4 39.5 24.6 28.5 28.1 24.8 16.6 34.0 19.7 19.9 33.2 24.9 32.5 39.5 36.5 20.9 14.0 35.9 28.8 27.9 17.3 30.8 33.0 22.8 26.9 32.6 31.5 22.2 29.6 22.5 36.7 21.0 18.4 22.6 19.6 21.9 18.5 79.4 22.8 96.4 29.9 29.0 29.4 26.9 46.1 45.2 33.8 42.4 51.1 16.1 22.9 41.9 40.2 69.6 23.5 37.8 41.6 23.3 57.0 27.5 15.4 18.1 22.1 54.6 41.7 25.8 20.5 28.7 76.9 33.1 29.4 35.7 32.2 53.7 47.0 18.5 13.1 26.0 45.2 26.7 43.8 41.9 28.9 21.9 41.8 42.7 27.8 64.3 44.8 21.7 31.5 17.1 11.9 38.2 29.3 18.8 23.7 32.6 7.2 20.2 15.0 9.5 15.9 11.7 13.4 14.8 5.1 9.8 17.6 16.5 10.6 13.8 7.6 10.7 11.8 9.6 15.7 17.6 22.4 17.8 15.4 17.2 16.4 16.4 16.6 14.0 17.3 22.2 24.8 25.6 30.1 37.9 28.4 24.2 35.3 17.8 25.6 25.6 23.1 19.6 27.5 22.8 23.8 25.8 33.3 28.6 49.0 32.3 23.5 18.0 42.8 32.1 26.1 26.2 19.2 21.0 44.9 13.8 15.7 24.2 30.1 34.3 22.8 33.8 20.7 19.6 14.5 38.7 46.0 23.2 14.2 16.8 13.7 13.0 35.1 20.2 21.4 32.8 26.8 16.7 42.2 40.7 47.4 22.2 20.2 33.8 30.0 26.3 25.3 9.6 45.8 23.4 6.6 35.4 23.4 26.1 32.1 26.0 25.6 19.7 32.1 25.6 21.1 34.4 DIRAS3 "ARHI, NOEY2" ENSG00000162595 "DIRAS family GTPase 3" O95661 1 68045886-68051631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 143.9;ovary: 60.1;pituitary gland: 52.5" "Group enriched" "Detected in many" 5 "Distal tubular cells: 64.6;Theca cells: 206.2" "Group enriched" "Detected in many" 4 "endometrial cancer: 4.3;glioma: 16.3;pancreatic cancer: 5.6;thyroid cancer: 13.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 8.2;HSkMC: 17.2;TIME: 11.2;U-251 MG: 9.1;U-87 MG: 16.9" "Low region specificity" "Detected in all" "HPA028483, HPA028557, HPA029384" Approved Approved "Nuclear membrane,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "Nuclear membrane, Cytosol" "HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343" "prognostic favorable (9.21e-4)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (1.69e-2)" "unprognostic (1.15e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (7.86e-2)" "unprognostic (8.35e-2)" "unprognostic (4.33e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.34e-1)" "unprognostic (4.99e-1)" "unprognostic (1.24e-2)" "unprognostic (5.07e-3)" 1.4 20.1 25.3 0.5 18.7 0.1 5.0 2.2 11.5 5.2 3.0 3.3 7.5 2.5 10.6 1.7 3.3 10.2 11.3 7.0 143.9 6.9 9.5 5.1 0.2 39.6 49.2 60.1 20.0 7.5 52.5 0.6 18.5 2.9 0.8 4.0 2.3 2.6 1.1 2.1 1.4 1.2 7.8 2.5 4.2 5.5 104.7 1.6 3.8 1.9 0.3 3.1 6.4 8.0 0.0 1.5 1.6 0.0 5.2 3.9 0.6 4.6 1.6 0.3 1.2 0.0 0.8 0.0 0.2 4.8 0.1 0.2 0.2 0.0 0.3 0.0 0.2 0.0 0.6 0.0 8.2 0.0 0.0 17.2 0.1 0.7 0.0 0.0 1.0 0.2 0.3 0.0 5.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.0 0.1 0.5 0.1 0.0 11.2 0.0 0.5 0.2 9.1 2.7 0.0 0.0 16.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 25.3 18.7 2.2 11.5 7.0 143.9 39.6 49.2 18.5 7.8 104.7 8.0 0.3 0.0 1.8 5.2 0.0 3.2 25.0 0.6 0.6 1.1 5.4 6.5 5.9 7.2 2.5 3.7 10.4 1.1 0.0 0.4 64.6 3.7 0.1 0.7 0.7 1.7 16.2 0.0 2.2 18.7 0.1 10.3 4.1 1.8 0.0 0.8 3.3 3.9 0.1 0.0 8.8 2.3 0.0 0.0 4.8 0.8 6.8 0.3 5.4 0.0 0.0 0.7 1.0 5.0 0.2 2.9 0.1 1.5 0.0 5.3 0.1 11.1 0.9 6.1 0.0 16.9 1.7 0.0 1.4 1.7 2.8 0.4 0.7 206.2 0.7 2.4 DIS3L "DIS3L1, FLJ38088, KIAA1955, MGC4562" ENSG00000166938 "DIS3 like exosome 3'-5' exoribonuclease" Q8TF46 15 66293217-66333898 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041805 Approved Supported "Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" Centrosome "HPA041805: AB_10796783" "unprognostic (2.57e-1)" "unprognostic (5.37e-2)" "unprognostic (1.12e-1)" "unprognostic (3.99e-2)" "unprognostic (3.16e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.59e-3)" "unprognostic (1.86e-1)" "unprognostic (3.42e-3)" "unprognostic (2.66e-1)" "unprognostic (6.18e-2)" "unprognostic (9.58e-2)" "unprognostic (3.40e-1)" 11.0 11.8 7.9 6.2 9.8 7.6 9.3 8.9 8.6 10.3 7.7 11.1 5.1 11.1 9.5 7.5 9.6 5.5 12.7 8.0 9.1 8.3 11.0 5.9 7.6 8.7 9.4 11.1 12.8 15.8 10.0 5.4 9.6 8.7 6.0 11.4 8.9 9.0 23.2 7.4 7.7 8.8 8.8 8.7 9.0 9.8 8.9 7.8 11.0 28.3 7.2 9.6 8.1 12.2 14.0 32.6 10.6 14.1 12.2 16.4 12.4 9.5 11.1 14.3 13.2 17.6 10.1 51.6 10.3 13.4 14.9 23.3 25.7 9.2 9.2 12.0 24.1 26.7 25.1 20.1 9.5 27.7 10.1 6.9 9.7 4.5 14.8 9.7 13.1 17.7 18.6 12.6 14.4 12.3 13.8 17.3 15.4 12.7 20.0 18.3 42.1 30.0 5.7 18.9 17.1 15.7 22.3 7.6 11.4 10.0 10.6 21.8 14.4 18.7 16.8 7.4 18.7 10.1 36.9 24.0 6.4 35.9 7.8 8.5 5.1 4.3 7.6 6.1 10.2 6.5 7.7 10.0 8.5 7.8 8.8 7.3 0.6 11.7 13.2 6.7 8.0 6.7 7.9 9.8 8.9 8.6 8.0 9.1 8.7 9.4 9.6 8.8 8.9 12.2 7.1 6.4 16.2 22.5 14.6 4.2 5.5 4.0 17.1 15.6 9.4 7.6 30.3 15.7 7.1 3.7 4.2 17.0 9.6 5.0 5.9 6.5 7.1 8.3 14.6 10.2 3.0 24.2 11.4 3.5 4.5 12.4 10.7 7.3 16.5 25.1 7.1 19.2 9.6 10.1 17.2 10.6 8.2 12.3 7.8 9.9 19.9 10.1 1.8 13.1 14.4 17.7 12.3 22.6 23.1 3.3 5.1 20.3 18.4 4.8 5.4 9.8 8.1 23.2 19.7 9.5 10.1 28.5 17.2 12.1 5.4 3.7 16.0 16.5 14.0 3.8 DMTF1 "DMP1, DMTF, hDMP1, MRUL" ENSG00000135164 "Cyclin D binding myb like transcription factor 1" Q9Y222 7 87152409-87196337 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 132.7;Oligodendrocytes: 176.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023846 Supported Supported Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA023846: AB_1847779" "unprognostic (3.86e-2)" "unprognostic (1.88e-1)" "unprognostic (9.82e-2)" "unprognostic (8.54e-2)" "unprognostic (3.13e-1)" "unprognostic (2.26e-3)" "unprognostic (9.77e-3)" "unprognostic (2.53e-3)" "unprognostic (6.89e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (6.39e-2)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-3)" 20.2 15.7 17.5 16.2 23.3 28.6 20.6 21.7 22.8 24.4 17.2 23.2 16.8 26.0 37.8 13.6 22.7 15.3 16.0 16.8 20.4 21.5 11.5 21.2 20.2 21.4 19.3 29.0 17.1 16.7 23.4 18.0 20.3 19.5 19.4 36.2 15.9 17.4 12.1 19.5 21.3 19.8 16.5 20.4 15.9 50.0 20.2 21.1 27.5 12.9 18.6 20.1 19.6 30.8 27.7 13.3 58.9 50.5 17.1 28.8 25.6 33.6 13.6 19.2 30.3 12.2 25.8 34.3 23.3 20.7 23.2 15.1 40.2 22.9 37.2 17.8 20.4 24.3 40.4 18.6 16.9 23.2 26.3 26.9 19.0 37.4 37.8 32.3 26.2 35.2 44.2 39.8 32.2 25.4 40.5 29.0 45.9 18.0 23.6 34.6 31.3 21.0 18.7 23.1 40.6 50.5 41.6 17.8 29.6 74.1 25.2 15.0 32.8 35.7 18.1 47.0 30.5 29.6 45.4 59.9 20.6 18.7 32.1 14.6 3.5 7.1 7.4 4.0 6.9 8.4 5.7 5.3 2.9 6.5 6.8 6.2 5.3 5.3 4.2 4.6 7.6 3.1 17.5 23.3 21.7 22.8 16.8 20.4 21.4 19.3 20.3 16.5 20.2 30.8 20.9 22.4 31.7 91.1 38.0 13.0 16.6 8.7 12.5 28.5 11.3 9.4 11.8 17.2 16.4 3.7 37.5 15.0 43.8 20.5 3.9 10.0 24.5 15.3 26.6 20.9 19.7 12.6 82.6 8.2 8.8 21.7 23.0 23.0 37.2 42.9 20.0 9.7 11.0 18.5 88.6 14.1 12.2 19.2 11.7 14.1 23.3 18.7 0.0 81.5 20.7 10.4 30.9 132.7 176.5 9.4 20.4 22.6 33.8 21.6 17.8 5.3 21.6 25.6 32.9 18.0 17.8 51.5 19.5 11.1 12.6 7.7 34.4 16.5 11.1 18.1 DMWD "D19S593E, DMR-N9, gene59" ENSG00000185800 "DM1 locus, WD repeat containing" Q09019 19 45782947-45792845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068172, HPA069843" Approved Approved "Plasma membrane,Actin filaments" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Actin filaments" "HPA068172: AB_2685964, HPA069843: AB_2686212" "unprognostic (6.49e-2)" "unprognostic (3.35e-1)" "unprognostic (1.03e-2)" "unprognostic (1.65e-3)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.47e-4)" "unprognostic (5.11e-3)" "unprognostic (7.61e-2)" "unprognostic (7.26e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (1.18e-2)" "unprognostic (4.59e-2)" 24.6 19.1 27.7 12.3 23.4 7.3 23.0 10.5 31.7 29.1 10.8 40.3 9.7 39.6 6.7 18.2 29.4 11.8 43.1 30.0 18.6 18.7 10.2 22.6 11.2 17.5 19.9 29.1 18.1 10.3 29.6 15.0 15.1 25.2 7.4 11.9 17.1 12.2 44.0 15.5 18.3 14.8 8.9 17.0 25.0 36.5 20.2 10.3 23.1 20.1 7.1 30.6 23.2 14.5 31.6 34.3 30.4 21.2 18.1 22.9 23.3 26.9 18.8 23.5 21.2 20.6 17.1 13.2 15.4 30.4 28.8 23.4 16.1 13.4 12.3 38.6 30.0 11.4 37.3 18.2 22.4 1.4 17.6 21.5 16.2 22.0 31.2 26.7 20.3 8.3 28.2 28.9 18.6 25.8 16.0 9.0 13.8 20.6 22.2 16.3 11.0 14.5 14.6 29.7 30.4 33.6 28.9 22.2 19.5 13.4 19.4 7.7 43.3 27.0 26.6 18.1 40.7 41.1 27.4 15.0 28.1 2.1 31.8 0.6 0.2 0.2 1.4 0.6 1.1 0.6 1.2 1.1 0.2 1.4 0.4 0.8 0.6 1.8 0.8 0.2 0.7 0.3 27.7 23.4 10.5 31.7 30.0 18.6 17.5 19.9 15.1 8.9 20.2 14.5 18.8 6.4 4.7 8.1 6.9 8.4 13.9 4.5 2.2 34.5 11.8 9.8 28.5 10.0 4.4 9.2 60.5 7.3 10.6 10.4 5.9 7.3 17.2 12.4 18.9 16.2 26.3 9.3 8.1 10.6 9.6 15.3 6.1 11.2 11.4 23.3 20.0 4.6 2.0 52.2 7.5 7.9 10.2 4.8 11.4 57.7 17.1 2.6 5.4 5.6 0.9 23.3 14.4 10.1 5.8 13.8 7.2 17.0 6.8 11.5 5.6 7.1 8.9 41.2 13.1 24.5 19.0 10.8 15.7 4.6 7.0 5.5 9.0 20.6 8.1 11.5 DNAJB14 FLJ14281 ENSG00000164031 "DnaJ heat shock protein family (Hsp40) member B14" Q8TBM8 4 99896248-99946618 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036016 Approved NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 1: Thyroid gland - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "HPA036016: AB_10670594" "unprognostic (1.90e-2)" "unprognostic (1.68e-1)" "unprognostic (9.04e-3)" "unprognostic (5.33e-2)" "unprognostic (2.10e-1)" "unprognostic (1.71e-1)" "unprognostic (2.35e-2)" "unprognostic (4.34e-2)" "unprognostic (2.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (2.75e-2)" "prognostic favorable (2.12e-6)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (5.02e-2)" "unprognostic (1.01e-2)" 13.4 11.6 9.0 9.6 12.1 17.7 11.6 7.4 15.3 10.8 5.4 13.8 9.4 11.5 10.7 9.8 7.8 10.3 7.8 14.3 13.7 13.8 10.9 12.2 15.3 9.7 11.1 11.9 7.9 14.8 8.5 16.5 11.9 12.0 9.8 18.5 8.3 10.3 5.0 10.2 9.8 10.2 7.7 14.3 12.0 4.4 11.8 11.2 17.3 6.2 10.9 10.8 8.5 13.7 14.4 36.9 12.6 14.0 22.6 23.8 12.5 35.6 21.2 11.2 10.3 25.2 33.0 13.8 19.7 15.5 7.2 12.0 9.5 15.7 18.2 35.2 11.3 22.3 21.8 20.7 20.0 19.6 32.9 19.6 18.2 12.0 12.2 19.6 22.0 14.7 20.2 18.8 26.1 30.2 23.0 11.4 7.0 9.3 18.6 21.6 14.6 12.0 20.5 28.7 7.1 16.4 19.4 28.0 19.4 11.2 15.6 9.2 31.6 19.6 16.6 13.8 12.1 23.4 55.1 18.4 16.4 8.2 23.6 39.0 14.5 17.5 18.6 16.2 16.7 16.8 14.7 17.1 13.1 17.5 16.9 15.5 22.3 16.3 25.6 15.1 20.1 13.6 9.0 12.1 7.4 15.3 14.3 13.7 9.7 11.1 11.9 7.7 11.8 13.7 78.6 64.1 57.5 61.0 76.5 45.0 50.8 40.3 44.9 92.3 36.7 35.1 20.9 37.1 46.5 40.5 54.2 47.2 100.1 50.9 33.2 31.0 4.4 32.2 60.0 55.0 35.4 15.8 125.4 30.1 31.0 54.9 36.2 42.2 41.1 45.0 47.5 30.3 31.5 111.0 114.8 30.3 30.5 52.7 76.8 4.2 49.7 49.4 44.4 53.4 68.3 64.5 64.9 70.9 107.5 32.1 36.5 53.4 55.7 63.5 34.3 41.8 31.5 95.3 26.3 69.0 54.3 20.3 14.1 32.7 36.9 48.2 83.4 43.0 27.4 54.7 DNAJC7 "TPR2, TTC2" ENSG00000168259 "DnaJ heat shock protein family (Hsp40) member C7" Q99615 17 41976421-42021376 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023015, HPA052395" Approved Supported Nucleoplasm,Cytosol NA NA 22000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA023015: AB_1847804, HPA052395: AB_2681811" "unprognostic (3.21e-2)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (8.40e-2)" "unprognostic (1.16e-1)" "unprognostic (5.31e-3)" "prognostic unfavorable (3.35e-4)" "unprognostic (7.71e-2)" "unprognostic (2.58e-2)" "unprognostic (1.90e-2)" "unprognostic (2.48e-2)" "unprognostic (8.37e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (2.32e-2)" "unprognostic (8.93e-3)" 41.7 50.5 122.8 43.5 126.4 40.4 39.6 125.0 204.0 39.5 124.2 46.5 37.3 28.3 50.5 66.7 33.8 26.2 85.3 126.8 128.6 65.4 67.0 38.9 53.4 127.6 127.1 43.0 54.9 54.5 55.2 35.9 127.2 37.4 45.4 49.2 39.2 25.0 99.8 48.2 38.1 27.6 124.1 45.1 49.1 46.0 125.5 56.5 38.2 73.0 67.7 40.7 41.3 128.1 99.2 129.6 130.8 100.1 68.5 106.5 120.0 103.6 98.8 139.7 110.6 143.5 93.9 142.0 118.2 113.2 118.4 140.6 192.3 127.9 169.7 123.6 220.1 102.6 116.0 189.7 100.8 185.0 102.7 92.4 82.3 131.5 104.4 101.5 114.8 122.4 160.7 98.9 122.2 66.5 210.8 155.0 139.4 92.3 87.1 124.0 175.4 123.6 116.9 104.8 117.7 104.7 84.9 243.6 126.1 128.7 139.3 177.8 110.3 80.1 105.0 100.1 163.3 72.0 159.4 122.9 103.0 124.0 97.1 49.7 55.9 35.9 30.9 57.8 35.2 39.6 36.3 36.1 57.7 41.9 33.4 32.6 19.8 49.4 59.8 98.5 43.8 38.8 122.8 126.4 125.0 204.0 126.8 128.6 127.6 127.1 127.2 124.1 125.5 128.1 62.2 35.3 38.3 39.2 87.1 65.4 94.4 107.8 37.5 80.5 46.7 43.4 57.6 61.5 54.0 66.2 135.5 108.6 139.0 81.1 115.4 107.6 108.3 83.7 77.8 71.8 111.4 52.4 33.9 132.5 103.8 50.9 38.7 70.6 57.0 105.5 71.4 56.4 102.4 63.9 37.3 63.4 67.1 102.1 99.6 52.3 67.4 94.6 48.0 34.7 166.5 100.0 121.5 36.7 142.0 125.2 62.1 61.3 79.7 77.4 79.2 155.8 61.7 143.5 46.0 78.9 78.5 104.7 111.9 49.3 68.8 126.8 81.9 127.2 79.1 94.6 DPP9 ENSG00000142002 "Dipeptidyl peptidase 9" Q86TI2 19 4675224-4724673 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 203.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036059 Approved Supported Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA036059: AB_10671240" "prognostic favorable (4.96e-4)" "unprognostic (4.16e-2)" "unprognostic (2.03e-1)" "prognostic favorable (6.21e-5)" "unprognostic (5.67e-2)" "unprognostic (8.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.23e-1)" "unprognostic (8.85e-2)" "unprognostic (6.38e-2)" "unprognostic (1.93e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (3.38e-8)" "prognostic favorable (7.72e-5)" "unprognostic (1.55e-1)" "unprognostic (4.22e-1)" "unprognostic (1.80e-1)" 19.6 16.2 12.2 24.5 13.8 32.8 19.4 12.9 13.7 20.1 25.0 24.2 20.1 20.3 5.9 24.5 16.3 13.5 32.2 13.2 11.7 16.9 57.2 27.4 24.9 14.8 14.3 17.3 20.6 10.1 12.7 12.9 14.3 18.9 13.8 9.5 17.7 12.8 71.0 23.8 26.3 15.3 12.3 28.4 21.1 9.0 16.1 17.9 16.9 23.0 17.1 23.2 20.2 15.4 77.5 60.4 17.6 27.5 26.2 36.3 31.7 44.3 58.5 73.1 47.4 54.3 58.2 36.5 32.8 57.7 49.1 51.7 35.9 203.9 44.5 47.3 34.8 26.8 33.6 47.2 40.0 47.2 55.8 27.9 46.6 114.4 67.2 62.2 66.8 25.0 37.4 78.3 64.1 21.2 54.2 30.0 36.0 30.4 89.0 34.0 37.4 42.4 38.3 52.5 24.8 22.2 38.2 67.8 29.5 18.1 18.8 38.2 54.5 64.9 28.0 101.6 89.6 54.6 62.3 36.8 63.4 53.7 55.7 10.8 7.1 7.7 10.6 8.3 7.9 8.0 4.7 8.5 7.1 4.8 4.5 7.3 3.7 11.4 6.5 3.3 9.7 7.7 12.2 13.8 12.9 13.7 13.2 11.7 14.8 14.3 14.3 12.3 16.1 15.4 21.8 28.9 25.8 14.4 18.8 7.9 13.6 10.2 10.8 18.6 12.2 12.3 14.6 10.0 11.2 3.7 37.5 11.7 22.7 37.4 3.9 12.4 2.0 12.7 14.6 19.4 12.5 7.6 10.1 12.8 18.3 10.7 36.2 22.8 17.1 13.3 17.2 39.5 19.0 23.5 10.2 21.3 6.1 20.4 17.6 3.9 9.9 22.0 5.4 16.9 42.2 9.0 25.7 7.5 13.7 26.6 28.4 9.4 32.9 15.6 20.1 5.1 9.5 30.8 19.7 21.7 12.4 7.5 6.9 12.4 5.5 15.6 21.2 12.8 20.6 16.7 DPY19L4 ENSG00000156162 "Dpy-19 like 4" Q7Z388 8 94719703-94793836 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024339, HPA024780" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Plasma membrane" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA024339: , HPA024780: AB_10600869" "unprognostic (1.45e-1)" "unprognostic (2.89e-3)" "unprognostic (3.41e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.28e-1)" "unprognostic (5.54e-2)" "unprognostic (4.94e-2)" "unprognostic (7.17e-2)" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (4.72e-2)" "unprognostic (9.38e-2)" "unprognostic (2.25e-1)" "unprognostic (1.48e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-2)" "unprognostic (1.55e-1)" 11.5 12.3 7.3 6.6 10.5 5.1 12.5 9.7 9.4 13.6 8.0 8.6 6.7 12.3 10.5 7.6 11.2 10.0 15.4 6.5 10.1 14.5 15.8 9.1 6.9 9.9 9.0 16.7 9.4 26.4 6.4 12.6 10.3 11.6 9.0 13.0 10.2 9.0 7.2 9.4 7.9 9.5 9.6 11.1 13.1 9.6 8.9 7.0 16.1 9.3 5.8 8.6 8.5 14.4 24.4 15.5 26.1 16.4 25.9 33.3 14.4 21.5 20.3 19.8 19.4 7.3 35.0 5.4 25.8 20.8 13.3 25.0 16.0 16.9 32.7 12.2 12.8 25.3 15.1 12.2 30.1 10.9 5.1 22.2 14.0 16.8 16.2 23.2 24.3 16.0 18.0 9.0 23.3 15.3 20.9 20.5 10.2 27.9 17.2 14.8 17.9 10.9 19.1 18.9 12.8 28.7 17.2 3.6 16.8 15.9 22.8 13.6 24.0 20.5 12.6 23.1 18.1 9.9 13.1 14.8 15.4 18.7 29.6 0.7 0.5 0.0 1.0 0.6 1.4 1.2 1.0 1.6 1.0 0.3 1.1 1.4 0.4 1.4 0.6 1.2 0.4 0.7 7.3 10.5 9.7 9.4 6.5 10.1 9.9 9.0 10.3 9.6 8.9 14.4 21.1 16.0 16.3 20.5 6.3 9.8 14.1 11.6 15.9 19.6 16.2 12.1 26.0 11.5 13.0 40.5 4.2 16.7 3.7 8.5 1.9 8.9 2.1 13.7 20.3 19.0 7.3 9.7 13.2 10.0 11.9 20.4 12.2 13.7 3.8 23.1 65.0 27.5 9.6 13.5 18.3 11.5 10.2 14.8 11.9 5.0 17.4 8.3 10.6 25.3 5.5 11.9 9.2 23.6 39.7 13.0 6.4 18.4 7.9 15.6 10.7 10.7 18.8 17.6 6.6 13.4 14.9 11.9 9.8 16.6 12.1 9.2 7.8 32.6 12.0 14.1 DYNC1H1 "CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22" ENSG00000197102 "Dynein cytoplasmic 1 heavy chain 1" Q14204 14 101964573-102056443 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Motor protein" "Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003742, CAB010443" Enhanced Supported Centrosome,Cytosol NA NA 490000 "Cluster 11: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Centrosome, Cytosol" "CAB010443: AB_2093483, HPA003742: AB_1078713" "unprognostic (2.58e-1)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (4.65e-2)" "unprognostic (4.66e-2)" "unprognostic (5.49e-2)" "prognostic unfavorable (3.03e-7)" "unprognostic (8.93e-2)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.09e-6)" "unprognostic (1.63e-2)" "unprognostic (8.73e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-3)" 22.4 19.3 7.8 4.9 7.2 9.2 18.2 16.1 10.9 17.2 0.0 29.1 3.6 24.6 5.0 18.5 17.5 4.0 29.7 9.2 1.1 12.6 9.4 19.9 4.4 5.2 4.3 21.0 15.8 2.0 20.9 3.0 9.0 14.5 3.1 13.2 19.9 2.9 53.1 27.6 19.2 3.1 0.6 14.2 19.7 13.0 2.1 2.0 17.6 1.2 2.4 23.4 18.0 9.2 3.3 6.6 5.0 4.6 3.0 5.0 3.2 3.0 1.8 5.1 4.5 2.6 4.5 4.2 3.4 5.4 4.9 4.0 8.2 5.3 3.6 3.4 3.5 4.1 15.1 3.3 2.7 3.6 6.4 6.4 6.3 14.1 4.9 3.2 3.9 8.0 3.0 8.9 4.5 4.2 5.6 4.1 5.1 2.1 10.2 4.6 3.3 1.6 5.2 7.6 8.4 2.8 3.2 2.2 3.4 4.9 2.5 1.5 11.5 6.8 4.1 11.5 5.1 4.3 7.6 4.9 9.1 2.9 3.0 1.3 0.6 0.8 0.6 0.4 0.5 0.4 0.4 0.4 0.6 0.5 0.3 0.5 1.2 0.4 0.6 0.6 0.4 0.3 7.8 7.2 16.1 10.9 9.2 1.1 5.2 4.3 9.0 0.6 2.1 9.2 102.1 125.0 84.7 83.9 55.9 52.4 46.4 75.0 51.2 126.4 63.1 55.5 182.9 31.5 89.1 77.3 139.7 49.6 106.3 94.2 13.7 112.6 14.8 123.6 131.0 93.7 71.3 38.1 127.3 81.2 42.9 86.5 86.6 134.6 33.5 117.9 46.1 36.7 40.2 183.4 131.0 68.0 75.3 52.7 123.6 16.8 70.5 90.7 71.2 51.5 99.2 63.3 73.2 51.8 93.3 131.3 73.6 71.5 100.0 47.6 82.6 48.5 90.7 115.4 85.5 81.4 106.1 87.1 72.2 59.2 64.1 37.4 91.3 86.1 64.4 46.5 EBLN2 ENSG00000255423 "Endogenous Bornavirus like nucleoprotein 2" Q6P2I7 3 73061659-73063337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA062510, HPA068795" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" Nucleoplasm "HPA062510: AB_2684787, HPA068795: AB_2686038" "unprognostic (1.23e-2)" "unprognostic (3.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.29e-3)" "unprognostic (7.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.81e-2)" "unprognostic (5.24e-3)" "unprognostic (2.89e-1)" "unprognostic (8.19e-3)" "unprognostic (8.38e-6)" "unprognostic (1.54e-1)" "unprognostic (1.47e-1)" "unprognostic (6.06e-2)" "unprognostic (1.12e-1)" 2.3 1.2 0.5 2.3 1.7 15.4 2.3 1.0 1.1 2.5 1.9 1.8 1.3 2.6 2.4 1.6 2.6 1.3 1.9 0.6 1.2 0.9 1.7 2.7 2.0 1.7 0.9 3.7 2.2 0.7 1.2 2.0 1.9 1.5 2.4 2.7 2.7 0.8 1.4 2.2 2.1 1.5 0.8 2.4 1.9 1.1 1.3 1.5 2.1 0.3 1.7 1.8 2.5 4.4 0.6 0.4 2.6 2.3 0.6 1.4 1.9 1.0 0.2 0.6 0.5 1.3 2.1 1.7 0.4 1.4 0.6 0.9 1.0 1.1 1.3 0.6 0.6 1.1 3.0 1.1 0.3 2.2 2.4 1.4 0.8 1.3 1.3 1.2 0.9 1.4 0.8 2.5 0.7 1.4 1.0 3.0 1.6 0.5 0.7 2.7 0.6 1.0 0.7 2.8 0.6 1.2 0.6 1.1 0.3 1.8 1.7 0.8 1.7 0.7 1.4 2.0 1.6 2.5 1.3 1.3 0.7 2.3 1.3 0.1 0.7 3.3 1.6 0.2 1.3 0.7 1.4 1.4 0.2 1.2 1.2 1.7 1.5 0.5 0.3 1.0 1.9 0.1 0.5 1.7 1.0 1.1 0.6 1.2 1.7 0.9 1.9 0.8 1.3 4.4 4.3 0.0 2.2 0.0 5.8 5.7 12.6 6.7 1.8 5.3 3.2 3.0 1.1 12.8 6.2 3.7 8.4 9.7 5.9 6.8 0.0 3.2 1.8 4.0 4.4 4.6 4.2 6.1 0.0 1.6 6.2 3.9 4.1 7.4 1.3 9.2 10.8 5.1 2.8 3.3 0.0 4.0 4.1 5.1 11.5 0.8 8.4 5.4 1.8 0.0 5.2 2.0 5.2 0.0 0.0 3.9 4.1 3.8 5.2 9.3 6.2 0.5 6.3 6.0 6.6 8.0 4.8 3.5 5.0 1.1 6.3 14.6 6.8 6.7 5.1 13.2 EFCC1 "C3orf73, CCDC48, FLJ12057" ENSG00000114654 "EF-hand and coiled-coil domain containing 1" Q9HA90 3 129001629-129040742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 5.6" "Cell type enhanced" "Detected in some" "Adipocytes: 7.1;Endothelial cells: 6.5;Enteroendocrine cells: 9.5;Fibroblasts: 10.7;Microglial cells: 9.4;Peritubular cells: 7.5;Sertoli cells: 6.6;Theca cells: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 1.3;HL-60: 3.7;U-266/84: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042798, HPA050888" Uncertain NA NA "Cluster 14: B-cells - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "HPA042798: AB_2678173, HPA050888: AB_2681263" "unprognostic (1.74e-1)" "unprognostic (5.16e-3)" "unprognostic (1.65e-1)" "unprognostic (1.49e-3)" "unprognostic (1.95e-1)" "unprognostic (2.54e-2)" "unprognostic (1.66e-3)" "unprognostic (7.23e-3)" "unprognostic (1.57e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.70e-4)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (1.82e-1)" "unprognostic (2.20e-1)" 1.7 0.4 0.8 0.4 0.2 0.1 1.8 1.8 1.0 1.2 0.0 3.5 1.9 1.9 0.1 0.9 1.6 0.5 2.3 2.2 1.4 1.2 0.5 5.6 0.1 1.7 1.0 3.4 0.5 0.1 1.3 0.3 1.8 2.0 0.4 0.0 0.7 0.2 1.0 1.1 2.5 0.1 0.5 2.7 2.1 0.4 1.1 0.2 2.2 0.5 0.0 2.0 1.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 1.8 1.0 2.2 1.4 1.7 1.0 1.8 0.5 1.1 0.0 7.1 0.0 1.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 1.3 1.0 1.5 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.1 1.4 0.2 0.3 6.5 9.5 3.6 1.3 0.6 0.0 10.7 0.0 0.2 0.0 0.4 3.6 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.8 5.3 4.7 0.1 1.8 9.4 0.0 0.0 2.1 0.0 0.1 0.1 0.0 7.5 0.0 0.1 0.0 0.2 0.0 0.0 6.6 1.1 2.4 0.2 0.4 0.0 0.4 0.1 0.3 22.0 0.2 0.1 EHMT2 "BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a" ENSG00000204371 "Euchromatic histone lysine methyltransferase 2" Q96KQ7 6 31879759-31897687 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 13.3;NTERA-2: 19.3;U-266/84: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050550, HPA060259" Supported Supported "Nucleoplasm,Nuclear speckles" "Intracellular and membrane" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Nucleoplasm "HPA050550: AB_2681170, HPA060259: AB_2684234" "unprognostic (3.11e-2)" "unprognostic (2.72e-1)" "unprognostic (4.39e-2)" "unprognostic (1.92e-2)" "unprognostic (5.44e-2)" "unprognostic (3.51e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (3.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.89e-2)" "unprognostic (1.88e-1)" "unprognostic (9.78e-3)" "unprognostic (8.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.25e-1)" "unprognostic (9.03e-2)" 8.6 9.6 0.5 0.3 0.4 1.0 8.7 0.4 0.5 15.1 0.2 12.9 2.4 19.8 1.7 10.1 12.8 0.0 5.7 0.4 0.4 7.1 4.6 7.3 1.0 0.4 0.5 16.1 7.8 0.6 12.8 0.7 0.4 10.3 0.3 0.6 9.5 1.3 5.5 9.3 10.5 1.4 0.4 11.5 9.4 12.6 0.5 1.5 10.3 0.4 1.0 13.1 11.3 0.4 0.0 4.5 7.8 0.0 3.4 1.8 5.0 3.5 2.8 3.9 3.2 0.0 0.0 0.0 7.6 5.7 4.0 0.0 0.0 8.6 1.8 5.4 11.8 0.0 0.0 0.1 0.0 13.3 0.0 4.6 1.4 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 9.4 0.0 19.3 0.0 0.0 8.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.3 6.5 3.1 0.0 0.0 3.8 4.1 3.1 6.9 0.0 11.0 16.1 3.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.4 0.4 0.5 0.4 0.4 0.4 0.5 0.4 0.4 0.5 0.4 16.9 16.0 12.0 22.9 20.3 8.4 6.3 11.9 26.2 60.6 15.9 17.8 6.6 17.2 18.9 25.8 41.7 24.6 13.4 9.2 7.9 15.7 41.5 10.1 19.1 16.1 22.6 19.3 16.6 12.2 15.0 16.0 13.3 11.8 14.5 33.8 22.1 7.5 16.3 38.7 24.4 16.4 12.2 12.9 7.3 60.0 27.4 12.1 19.6 9.4 19.9 26.8 25.7 20.1 23.9 10.8 9.1 23.0 16.5 6.2 12.5 10.1 10.8 48.2 26.3 16.3 15.0 20.8 33.7 23.5 11.1 5.6 18.3 19.9 19.0 5.2 ELMOD3 "DFNB88, FLJ21977, RBED1, RBM29" ENSG00000115459 "ELMO domain containing 3" Q96FG2 2 85354394-85391752 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012126 Approved Uncertain Nucleoplasm,Mitochondria NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA012126: AB_1848130" "unprognostic (1.90e-1)" "unprognostic (9.80e-3)" "unprognostic (1.42e-3)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (1.60e-2)" "unprognostic (1.35e-2)" "unprognostic (1.52e-2)" "unprognostic (4.62e-2)" "unprognostic (5.63e-2)" "prognostic favorable (6.16e-6)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.09e-6)" "unprognostic (5.71e-2)" "unprognostic (1.53e-1)" "unprognostic (9.51e-2)" "prognostic favorable (2.85e-5)" 11.1 8.2 7.0 3.7 7.4 2.7 8.7 6.6 8.0 7.2 5.1 7.6 4.9 5.6 5.9 5.0 6.9 6.1 5.3 5.9 6.4 6.0 8.8 4.9 5.4 6.9 6.8 6.5 6.0 8.9 6.6 6.1 6.2 8.4 4.9 3.1 6.2 7.0 12.1 5.1 5.6 6.7 6.4 6.6 7.1 2.7 6.7 5.4 6.3 10.2 5.0 7.3 6.3 7.0 4.9 6.0 6.7 10.0 20.9 9.2 4.0 8.6 6.7 12.6 11.7 5.0 2.4 3.7 6.7 7.2 15.9 5.1 9.7 11.9 11.4 13.0 6.7 6.5 3.4 3.7 10.9 4.9 8.2 9.6 10.6 12.1 13.6 10.6 9.1 7.4 6.6 4.2 11.9 3.9 7.2 2.9 3.3 9.8 6.4 5.2 13.9 3.5 5.8 3.0 6.3 3.3 5.3 7.3 7.9 7.6 4.0 3.5 4.8 9.1 4.9 7.9 8.0 5.0 9.9 4.9 9.1 5.7 9.4 6.5 2.7 8.0 5.0 1.9 2.7 3.1 3.2 2.0 3.2 2.6 2.7 4.8 2.5 5.0 4.5 0.9 5.5 2.8 7.0 7.4 6.6 8.0 5.9 6.4 6.9 6.8 6.2 6.4 6.7 7.0 9.0 6.4 8.4 36.9 15.7 4.7 10.0 13.0 8.6 27.2 10.7 7.6 5.2 10.0 16.7 11.0 29.2 15.2 9.8 17.3 7.9 8.6 5.6 4.6 6.9 9.5 8.4 7.4 24.3 9.1 5.9 10.0 12.8 4.0 8.9 20.7 12.5 7.5 8.6 30.3 21.4 11.4 14.2 10.0 9.3 5.6 19.3 9.5 17.8 18.7 16.5 14.1 28.8 28.6 49.7 10.4 15.3 23.7 7.7 10.8 24.9 7.1 11.7 30.9 19.7 10.0 8.0 19.7 10.9 6.7 6.5 12.4 14.0 18.3 12.7 9.4 ELP6 "C3orf75, FLJ20211, TMEM103" ENSG00000163832 "Elongator acetyltransferase complex subunit 6" Q0PNE2 3 47495640-47513712 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046358, HPA064545" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" Centrosome "HPA046358: AB_10961011, HPA064545: AB_2685282" "unprognostic (2.00e-3)" "unprognostic (2.27e-1)" "unprognostic (7.41e-3)" "unprognostic (2.41e-2)" "unprognostic (2.67e-1)" "unprognostic (8.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (1.24e-2)" "unprognostic (2.07e-2)" "unprognostic (5.38e-2)" "prognostic favorable (3.42e-6)" "unprognostic (1.54e-1)" "unprognostic (9.05e-2)" "unprognostic (2.30e-1)" "unprognostic (6.29e-2)" 13.5 27.0 21.3 14.3 22.8 11.5 15.8 23.6 23.6 14.5 24.3 16.2 15.2 17.2 23.1 15.5 16.9 14.7 19.6 21.0 21.6 17.5 21.3 12.1 21.9 22.8 22.2 21.7 14.8 21.1 15.1 14.4 22.7 19.4 13.9 8.7 16.4 17.7 35.6 16.6 13.4 18.0 22.2 15.7 15.7 21.1 22.9 24.6 19.3 29.0 20.5 16.0 13.3 23.7 37.6 36.4 45.3 46.8 34.9 32.0 26.5 43.4 29.7 54.2 48.6 35.1 38.4 68.7 27.1 37.6 51.3 22.1 43.6 62.5 33.0 39.9 34.4 62.6 55.5 40.4 38.5 49.1 38.5 34.9 33.2 61.4 38.3 31.5 47.3 58.8 67.1 21.7 54.1 44.0 59.8 56.7 55.1 35.4 57.9 29.2 22.3 42.2 38.4 33.9 40.3 40.9 36.9 29.8 25.8 36.0 40.8 41.1 32.8 57.3 41.9 28.9 56.9 44.8 63.5 64.9 28.4 58.8 58.4 19.7 20.4 15.1 31.8 18.9 25.2 33.4 29.4 32.9 25.9 35.2 28.3 28.9 2.8 35.3 13.7 33.9 38.5 25.6 21.3 22.8 23.6 23.6 21.0 21.6 22.8 22.2 22.7 22.2 22.9 23.7 19.3 6.4 12.3 8.8 24.9 8.4 15.2 35.7 19.4 21.7 20.3 22.4 23.0 24.3 20.0 33.1 14.6 44.0 27.8 16.0 60.7 28.1 8.3 15.3 19.4 22.6 17.4 30.3 9.4 23.6 39.6 23.4 17.9 14.0 22.2 56.3 30.0 28.5 28.6 38.7 11.9 15.0 40.7 14.5 8.3 14.5 23.0 17.4 16.0 9.4 21.7 43.7 48.4 5.5 11.7 21.3 12.7 30.5 23.1 10.9 22.9 51.1 15.7 26.0 6.6 14.2 22.6 47.2 22.4 15.6 8.4 26.8 23.9 58.4 21.7 10.4 EME2 "FLJ00151, SLX2B" ENSG00000197774 "Essential meiotic structure-specific endonuclease subunit 2" A4GXA9 16 1772810-1781708 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 3.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 14.1;Gastric mucus-secreting cells: 15.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 7.5;REH: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045770 Uncertain NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA045770: AB_2679447" "unprognostic (2.67e-2)" "unprognostic (1.77e-1)" "unprognostic (2.07e-1)" "unprognostic (2.94e-1)" "unprognostic (5.83e-2)" "prognostic favorable (2.86e-4)" "unprognostic (4.83e-2)" "unprognostic (4.46e-2)" "unprognostic (9.67e-3)" "unprognostic (1.92e-1)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (6.76e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "prognostic favorable (6.32e-5)" 0.7 1.1 0.5 0.5 0.7 0.2 0.8 0.4 0.9 0.8 0.2 0.9 0.6 1.1 0.1 1.2 0.9 0.0 0.4 0.8 0.2 0.8 0.4 0.7 0.2 0.9 0.3 0.5 0.8 0.1 3.9 0.1 0.9 2.1 0.0 0.0 1.0 0.4 0.4 0.9 1.2 0.0 0.0 1.1 1.1 0.9 0.3 0.1 1.7 0.0 0.0 0.9 0.8 0.1 0.5 0.1 0.0 0.4 0.1 0.0 1.1 1.8 0.0 0.1 0.1 0.4 0.8 1.8 1.1 0.0 0.0 1.9 0.0 0.0 0.0 2.4 7.5 0.4 0.8 0.1 0.0 0.9 2.1 0.0 0.3 0.0 0.0 0.0 0.2 0.7 2.4 0.1 0.0 0.2 0.5 0.6 1.0 0.1 1.0 4.1 0.3 2.1 0.1 0.1 3.4 0.6 1.7 0.8 0.2 0.0 1.2 0.7 1.2 0.2 1.1 0.5 0.9 2.5 0.8 2.1 0.0 0.4 0.5 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.2 0.3 0.2 0.2 0.5 0.7 0.4 0.9 0.8 0.2 0.9 0.3 0.9 0.0 0.3 0.1 2.8 3.2 8.2 0.3 4.5 2.7 1.2 2.4 2.2 14.1 4.3 3.9 1.3 0.0 6.0 3.7 8.4 2.1 3.3 8.9 0.0 1.6 2.1 2.7 2.8 2.2 6.7 0.8 0.0 2.2 1.2 2.7 15.3 3.1 0.0 4.2 2.5 2.7 3.6 5.0 0.0 3.6 0.0 5.5 2.3 1.4 1.2 4.6 3.6 0.0 4.4 2.4 3.1 0.0 0.1 3.6 1.7 1.5 2.7 2.0 5.6 1.5 3.0 7.1 0.0 4.0 2.4 1.5 1.9 4.6 2.8 2.5 3.6 8.5 6.7 1.4 EMID1 "EMI5, EMU1, hEmu1" ENSG00000186998 "EMI domain containing 1" Q96A84 22 29205896-29259597 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5;lymphoid tissue: 54.8" "Cell type enhanced" "Detected in many" "Astrocytes: 92.1;Granulosa cells: 32.7;Oligodendrocyte precursor cells: 51.8;Theca cells: 151.0" "Group enriched" "Detected in all" 4 "endometrial cancer: 23.1;glioma: 7.8;ovarian cancer: 10.9;thyroid cancer: 7.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HEL: 28.8;NB-4: 102.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000592 Uncertain "Secreted in other tissues" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "HPA000592: AB_1078737" "unprognostic (2.20e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-2)" "unprognostic (7.80e-3)" "unprognostic (2.40e-2)" "unprognostic (1.42e-1)" "unprognostic (3.46e-1)" "unprognostic (6.25e-3)" "unprognostic (3.75e-2)" "unprognostic (2.33e-1)" "unprognostic (5.24e-3)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.59e-1)" "unprognostic (1.76e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-1)" 2.6 29.0 34.5 4.2 35.0 14.8 2.5 27.7 49.5 6.5 24.4 5.7 5.1 10.0 1.7 1.3 10.4 4.8 2.3 36.8 29.4 15.0 3.3 13.0 7.5 30.1 30.4 7.0 14.0 12.4 2.0 4.9 28.3 6.1 3.4 0.3 3.6 3.9 0.8 6.3 8.3 2.3 27.0 54.8 7.7 2.3 27.8 4.8 13.2 0.3 2.3 4.9 2.2 32.4 0.0 0.2 4.9 10.5 0.0 0.0 0.7 0.0 0.0 0.4 0.3 5.7 0.7 0.0 4.7 0.1 0.0 0.0 2.5 0.1 0.0 11.5 8.6 28.8 0.1 1.1 0.7 4.1 2.2 0.3 0.2 0.2 0.0 0.0 0.0 6.4 2.5 0.0 0.0 8.0 0.2 102.0 1.1 0.1 0.4 0.0 0.2 11.3 0.0 0.1 13.2 6.3 0.4 0.1 0.2 0.8 4.2 5.4 0.0 0.0 8.0 0.0 0.1 0.5 0.0 0.0 0.0 14.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 34.5 35.0 27.7 49.5 36.8 29.4 30.1 30.4 28.3 27.0 27.8 32.4 0.4 0.0 2.5 92.1 0.1 2.8 1.0 0.1 0.0 1.7 5.3 3.9 0.7 4.3 0.6 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.2 10.8 22.6 6.2 0.0 18.5 5.6 1.3 0.1 11.8 0.5 20.0 11.4 32.7 11.4 2.1 0.3 0.0 6.2 0.4 0.0 0.3 5.2 0.5 3.1 0.6 0.0 10.3 0.6 1.1 0.0 51.8 1.0 0.4 0.0 1.9 1.0 1.9 0.1 1.9 0.0 0.4 0.0 17.5 4.0 0.1 1.5 0.0 2.0 0.3 1.1 151.0 0.3 0.4 ENDOV FLJ35220 ENSG00000173818 "Endonuclease V" Q8N8Q3 17 80415165-80438086 "Predicted intracellular proteins" "DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" "prognostic favorable (4.24e-5)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.40e-4)" "unprognostic (1.27e-1)" "unprognostic (2.08e-1)" "unprognostic (9.12e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-1)" "unprognostic (7.37e-2)" "unprognostic (1.51e-2)" "unprognostic (1.10e-2)" "unprognostic (2.00e-2)" "unprognostic (3.14e-2)" "unprognostic (1.40e-1)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (3.09e-3)" 9.7 8.4 11.1 5.4 11.0 5.0 10.1 12.9 13.2 13.3 8.3 11.0 6.3 11.1 11.6 9.2 11.6 6.4 6.7 11.0 8.5 15.6 15.0 9.7 5.3 9.2 7.9 10.6 10.5 5.8 9.3 4.3 9.0 13.0 4.7 26.3 10.4 6.5 12.6 15.0 9.2 5.0 7.2 13.5 9.5 23.8 8.7 5.3 9.1 5.5 3.7 9.3 10.5 10.5 18.9 25.2 7.9 13.3 13.2 12.2 7.2 8.2 9.1 4.8 10.5 5.8 21.4 0.9 4.7 8.7 13.6 12.2 2.1 3.8 3.9 8.8 18.7 1.8 8.8 10.0 13.6 2.8 3.8 13.5 8.5 9.4 9.5 11.2 8.1 13.1 2.9 15.8 4.0 36.2 5.4 4.4 8.6 11.7 20.3 6.2 7.8 11.1 10.7 9.0 8.6 28.0 9.6 9.3 23.9 9.2 33.4 24.2 8.2 33.5 17.8 22.8 3.6 19.7 3.6 2.0 18.1 7.6 6.4 15.2 12.5 11.0 4.8 12.9 6.0 11.8 5.2 5.1 20.1 18.6 4.4 5.4 8.3 9.5 5.8 26.5 5.6 6.5 11.1 11.0 12.9 13.2 11.0 8.5 9.2 7.9 9.0 7.2 8.7 10.5 15.8 16.0 13.4 13.7 18.1 11.6 23.8 28.0 6.2 35.1 21.7 18.5 7.9 24.3 18.7 27.6 79.2 18.8 22.1 38.2 29.4 26.7 15.3 15.6 15.0 21.9 29.9 3.0 11.5 19.6 13.2 15.9 29.0 12.9 8.9 43.6 27.8 13.5 12.9 37.0 10.8 26.6 26.4 23.6 17.1 15.0 30.1 14.8 14.2 2.8 23.6 28.4 17.5 7.5 11.9 22.4 22.6 21.4 8.2 21.9 59.4 28.9 26.3 87.9 39.5 21.3 18.0 46.3 49.5 9.7 15.2 23.4 14.9 29.9 27.7 19.4 ENTPD4 "KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase" ENSG00000197217 "Ectonucleoside triphosphate diphosphohydrolase 4" Q9Y227 8 23385783-23457695 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017655 Supported Approved Vesicles NA NA 82000 "Cluster 2: Granulocytes - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Vesicles "HPA017655: AB_1848181" "unprognostic (2.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (5.06e-2)" "unprognostic (7.86e-3)" "unprognostic (2.00e-2)" "unprognostic (2.99e-3)" "unprognostic (2.07e-2)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-1)" "unprognostic (6.62e-2)" "unprognostic (3.72e-2)" 16.3 11.5 8.6 24.2 10.5 30.5 14.8 11.1 16.2 17.0 8.1 19.8 18.1 16.8 17.3 12.6 13.7 14.6 21.2 10.8 12.3 12.2 13.7 20.0 29.3 13.1 9.2 13.5 21.4 27.2 18.3 17.2 12.8 16.8 20.3 32.7 22.0 13.4 15.2 12.4 26.2 16.5 7.6 25.4 20.3 19.9 12.5 14.5 14.7 15.9 29.8 16.7 16.6 11.6 20.8 28.7 34.0 23.5 29.0 36.8 35.0 33.1 30.4 21.3 33.2 40.3 26.4 35.5 22.9 32.8 32.9 24.5 15.8 29.0 40.3 8.6 11.5 18.4 18.1 14.2 23.7 9.8 34.8 22.8 34.7 28.4 29.9 51.9 31.2 26.7 13.2 30.6 36.4 9.3 14.8 11.9 20.1 26.2 10.2 14.3 34.6 10.8 27.0 24.1 27.2 26.6 12.0 17.0 23.7 67.0 12.9 13.6 38.6 39.1 38.3 43.7 24.1 24.7 11.5 45.5 51.3 11.5 39.4 17.0 5.7 13.4 7.4 8.6 8.8 8.7 7.3 8.1 7.5 6.5 9.2 7.3 14.4 4.8 7.0 6.8 6.3 6.9 8.6 10.5 11.1 16.2 10.8 12.3 13.1 9.2 12.8 7.6 12.5 11.6 15.9 19.2 34.5 10.7 25.8 6.5 12.0 17.6 8.6 32.1 11.4 8.6 24.6 7.2 27.3 14.7 14.6 16.1 33.4 25.1 0.0 15.6 8.6 13.6 21.6 15.8 17.3 10.3 31.4 16.9 16.9 16.9 23.9 23.9 17.7 18.9 12.1 11.5 12.3 47.1 37.4 19.7 20.3 14.2 15.5 19.2 7.2 18.2 12.4 19.7 19.4 15.2 18.6 23.1 23.1 21.8 13.3 8.6 46.9 18.9 18.8 5.0 15.0 35.9 13.1 14.3 14.6 21.5 22.8 9.5 5.5 20.2 21.3 11.7 12.4 18.9 EPM2AIP1 "FLJ11207, KIAA0766" ENSG00000178567 "EPM2A interacting protein 1" Q7L775 3 36985043-36993131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "unprognostic (7.24e-2)" "prognostic favorable (2.70e-4)" "unprognostic (6.24e-2)" "unprognostic (5.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.17e-2)" "unprognostic (2.28e-1)" "unprognostic (5.32e-3)" "unprognostic (1.71e-2)" "unprognostic (4.07e-2)" "unprognostic (1.22e-2)" "unprognostic (7.73e-2)" "unprognostic (4.30e-3)" "unprognostic (1.03e-2)" "unprognostic (1.35e-1)" "unprognostic (3.91e-2)" "unprognostic (2.25e-3)" 8.1 11.1 12.0 11.2 11.0 13.5 12.2 18.7 13.1 12.4 9.8 9.0 7.8 14.0 16.3 7.1 12.4 6.7 13.1 10.8 18.0 9.5 10.2 10.1 12.5 13.4 12.0 18.0 8.0 13.1 14.4 8.1 13.6 15.0 8.8 28.4 9.7 10.5 12.6 8.7 10.1 10.4 10.8 14.4 8.7 8.1 15.9 15.3 21.4 10.5 11.9 8.6 10.0 14.9 5.8 5.5 26.6 0.1 11.7 16.6 6.2 12.7 8.4 9.0 10.7 4.8 10.0 17.1 5.3 9.5 10.2 12.2 7.7 7.9 10.7 8.7 7.4 13.5 30.2 10.3 7.4 15.9 7.9 18.9 7.1 10.5 6.3 14.3 9.0 18.9 13.5 34.4 12.7 5.7 9.8 11.5 3.9 4.6 6.6 7.7 18.8 9.1 8.5 14.2 11.1 14.0 14.9 18.6 4.1 8.8 31.6 9.9 10.8 13.5 11.1 10.2 9.4 18.7 12.0 10.6 9.1 12.1 7.8 5.7 2.9 5.6 3.0 3.9 3.6 4.4 4.7 2.8 3.1 4.9 4.4 3.8 2.8 4.9 8.7 4.6 2.9 1.4 12.0 11.0 18.7 13.1 10.8 18.0 13.4 12.0 13.6 10.8 15.9 14.9 24.9 41.7 34.3 5.5 50.0 20.3 33.1 15.9 26.7 68.4 26.8 23.0 39.9 31.5 23.7 35.0 41.7 20.3 36.5 16.6 11.7 10.2 7.6 14.2 35.3 25.7 34.3 24.8 7.5 10.0 7.4 36.2 16.8 14.5 26.0 40.4 30.4 28.4 13.0 69.0 10.6 21.7 22.4 29.5 32.8 6.4 41.0 29.9 24.9 5.6 24.7 45.9 44.3 6.6 9.8 9.0 16.6 37.2 42.2 25.0 15.4 12.9 17.0 61.0 13.1 47.2 32.9 25.5 18.5 24.2 26.9 8.9 39.7 43.5 19.0 18.6 ERMP1 "FLJ23309, FXNA, KIAA1815" ENSG00000099219 "Endoplasmic reticulum metallopeptidase 1" Q7Z2K6 9 5765076-5833117 "Enzymes, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 50.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 73.5;Granulosa cells: 53.4;Oligodendrocytes: 88.8;Urothelial cells: 66.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 76.8;RT4: 154.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055582 Approved NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "HPA055582: " "unprognostic (1.93e-2)" "unprognostic (3.40e-1)" "unprognostic (2.76e-2)" "unprognostic (5.93e-2)" "unprognostic (2.97e-1)" "unprognostic (8.59e-2)" "unprognostic (4.30e-3)" "unprognostic (2.81e-1)" "unprognostic (5.46e-2)" "unprognostic (4.83e-3)" "unprognostic (3.14e-2)" "unprognostic (2.88e-2)" "prognostic favorable (5.83e-10)" "unprognostic (1.41e-1)" "unprognostic (4.00e-1)" "unprognostic (5.77e-2)" "unprognostic (1.36e-1)" 3.9 7.9 4.2 3.7 10.4 2.0 6.3 10.9 3.7 10.8 14.4 11.3 4.4 5.6 2.6 14.9 6.4 11.3 10.0 2.9 6.1 24.9 4.6 6.3 3.5 10.1 10.3 4.5 3.9 50.1 1.5 7.8 8.8 6.0 11.4 2.2 19.1 4.1 7.6 9.3 6.5 3.8 6.5 3.1 13.3 4.7 8.9 4.6 26.6 9.9 6.4 17.1 4.8 13.1 45.1 43.1 1.8 5.2 22.6 20.7 22.6 5.1 11.1 2.3 1.9 10.4 27.2 10.7 19.2 8.4 25.9 32.2 9.6 29.4 3.3 55.6 7.6 56.2 20.0 20.4 4.8 16.0 21.3 10.5 12.9 2.1 13.3 28.6 30.1 4.6 6.9 9.9 2.8 20.7 0.6 6.2 6.6 28.0 8.4 1.7 5.3 14.1 76.8 154.6 9.9 3.3 7.1 52.2 8.1 24.5 33.7 20.5 18.0 1.5 5.0 3.4 16.1 8.9 13.6 5.5 6.7 13.0 4.1 0.2 0.1 0.3 0.4 0.1 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 1.6 0.0 0.1 0.1 0.1 4.2 10.4 10.9 3.7 2.9 6.1 10.1 10.3 8.8 6.5 8.9 13.1 3.4 6.4 1.1 24.8 2.2 2.9 18.3 13.3 2.8 4.0 11.1 5.8 13.7 12.8 22.8 73.5 10.4 6.8 5.2 32.1 0.0 4.6 22.3 11.4 10.9 6.3 11.4 6.3 21.0 3.0 7.1 4.6 13.7 13.8 8.9 53.4 2.9 6.1 5.7 3.3 32.8 8.9 10.2 1.6 2.2 41.8 3.1 4.5 1.8 24.4 2.1 3.0 8.2 22.1 88.8 3.5 22.5 4.9 4.1 7.0 9.2 3.3 16.6 2.9 6.6 5.8 4.3 8.8 4.6 17.5 4.5 4.1 5.9 39.8 15.7 66.9 ERV3-1 "envR, ERV-R, ERV3, H-PLK, HERV-R" ENSG00000213462 "Endogenous retrovirus group 3 member 1, envelope" Q14264 7 64990356-65006743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 27.7" "HPA017209, HPA046508" Enhanced Approved Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA017209: AB_2732419, HPA046508: AB_2732525" "unprognostic (2.74e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (1.27e-2)" "unprognostic (4.48e-1)" "unprognostic (2.03e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" "unprognostic (4.05e-3)" "unprognostic (3.55e-1)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "unprognostic (4.27e-3)" "unprognostic (2.11e-1)" "unprognostic (2.19e-1)" "unprognostic (9.39e-2)" "unprognostic (1.88e-2)" 22.8 33.0 4.8 8.5 4.5 9.3 15.0 4.1 6.4 10.0 5.1 5.7 3.5 10.0 32.5 15.2 8.0 16.4 6.2 4.7 6.2 4.8 3.2 9.7 5.7 6.2 7.9 7.3 5.3 15.3 8.2 13.4 5.4 7.3 5.7 13.5 12.1 7.5 3.6 12.3 4.5 7.6 4.8 6.9 6.3 8.7 5.9 6.6 7.6 1.8 7.4 6.2 11.5 5.1 3.3 1.0 17.4 27.7 11.3 4.7 12.4 5.7 6.3 2.0 4.6 1.2 20.5 5.5 5.3 2.2 4.0 3.9 2.6 1.5 3.2 4.1 1.5 2.8 1.6 11.5 1.0 6.7 3.7 5.1 1.6 1.8 0.6 10.4 11.6 6.0 12.7 10.3 8.1 8.1 4.9 5.0 5.1 10.8 1.2 11.4 0.7 3.7 3.5 6.8 3.6 16.8 6.2 1.9 0.7 18.9 4.7 16.4 9.2 6.7 1.0 5.1 2.8 3.2 7.8 1.6 5.7 20.8 4.1 0.0 1.0 2.4 0.6 1.8 0.5 0.4 0.1 0.4 0.8 0.5 0.3 0.4 7.0 1.1 0.5 0.4 1.2 0.6 4.8 4.5 4.1 6.4 4.7 6.2 6.2 7.9 5.4 4.8 5.9 5.1 7.1 3.2 13.1 17.9 32.5 4.2 15.6 17.0 7.4 24.8 13.7 10.4 2.1 24.3 25.5 16.5 29.2 16.5 21.6 4.4 9.8 14.4 7.3 6.2 8.6 10.9 13.8 19.4 12.2 17.9 12.7 8.3 12.8 5.9 8.2 20.4 13.6 3.6 9.7 18.5 13.0 9.1 16.2 21.8 16.5 4.8 11.5 19.8 10.6 14.0 16.7 11.3 36.0 24.1 14.0 17.6 7.8 9.8 10.0 12.5 15.4 4.9 14.0 21.4 6.6 7.6 8.7 12.2 11.8 8.6 5.7 40.2 20.5 10.7 6.7 31.1 ESCO1 "EFO1, ESO1, KIAA1911" ENSG00000141446 "Establishment of sister chromatid cohesion N-acetyltransferase 1" Q5FWF5 18 21529284-21600884 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042497 Approved NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "HPA042497: AB_10794278" "unprognostic (8.12e-2)" "unprognostic (2.90e-2)" "unprognostic (1.91e-1)" "unprognostic (2.50e-1)" "unprognostic (6.26e-2)" "unprognostic (3.43e-3)" "unprognostic (1.38e-2)" "unprognostic (1.25e-2)" "unprognostic (1.29e-2)" "unprognostic (1.81e-3)" "unprognostic (1.72e-3)" "unprognostic (6.80e-3)" "unprognostic (9.29e-2)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.48e-1)" "unprognostic (3.72e-2)" 6.0 5.3 5.8 6.1 6.4 16.3 10.4 10.0 8.8 8.0 5.3 6.7 6.3 6.8 10.1 7.5 5.6 5.2 5.7 5.4 7.3 8.0 9.9 5.3 10.1 6.1 6.2 7.4 7.2 10.1 9.0 8.7 6.5 7.2 5.9 7.8 8.0 6.6 10.3 7.8 7.0 4.8 5.9 8.3 6.9 20.2 6.3 11.1 7.3 5.3 9.9 6.9 7.2 7.0 9.3 4.3 9.3 4.7 8.3 8.8 9.6 5.6 10.7 7.9 11.1 8.8 6.3 16.3 12.5 7.1 8.7 13.3 11.6 7.9 10.9 17.1 7.8 12.7 6.1 14.9 13.5 21.3 12.3 7.4 16.6 6.1 15.9 10.4 10.9 11.9 17.7 16.4 10.9 10.7 15.9 22.4 19.3 17.7 9.9 10.2 11.9 18.3 15.7 13.9 14.4 10.3 10.5 13.2 24.3 14.6 9.7 14.4 6.1 10.1 10.2 7.4 7.0 38.8 24.0 18.8 10.0 12.2 10.1 4.9 0.5 3.9 3.3 1.1 2.8 2.2 2.7 3.1 1.1 1.9 2.6 3.3 3.2 2.2 0.9 0.8 3.1 1.0 5.8 6.4 10.0 8.8 5.4 7.3 6.1 6.2 6.5 5.9 6.3 7.0 29.1 12.8 29.5 29.0 35.5 10.7 21.0 24.4 17.1 43.1 22.6 17.4 36.2 10.0 24.2 11.0 20.9 26.0 47.0 15.8 19.6 26.2 14.4 28.6 23.9 18.5 11.4 13.7 48.8 13.4 16.2 20.1 27.5 36.7 29.2 24.4 16.8 7.6 13.7 30.3 55.2 19.4 24.4 9.5 12.4 9.2 21.1 21.3 16.0 31.9 24.1 17.0 46.4 35.7 50.1 18.8 23.6 22.6 31.6 23.5 19.9 15.7 19.7 35.5 26.3 23.1 20.4 119.1 93.6 15.7 12.5 37.6 38.4 37.4 14.1 27.3 EXOC1L ENSG00000250821 "Exocyst complex component 1 like" A0A1B0GW35 4 55819790-55837489 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "Theca cells: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 20 "NK-cell: 1.9" "Lineage enriched" "Detected in single" 20 "NK-cells: 1.9" "Cell line enhanced" "Detected in single" "HEK 293: 1.5" "Region enriched" "Detected in single" 4 "pons and medulla: 2.8" "Not detected" "Not detected" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 EXOG "ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b" ENSG00000157036 "Exo/endonuclease G" Q9Y2C4 3 38496127-38542161 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 59.8;Rod photoreceptor cells: 78.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012531, HPA071050" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA012531: AB_2732403, HPA071050: " "unprognostic (2.88e-1)" "unprognostic (5.81e-3)" "unprognostic (3.55e-3)" "unprognostic (2.77e-1)" "unprognostic (8.32e-3)" "unprognostic (8.90e-3)" "unprognostic (4.78e-4)" "unprognostic (3.59e-2)" "unprognostic (3.99e-2)" "unprognostic (3.10e-2)" "prognostic favorable (1.92e-5)" "prognostic unfavorable (4.90e-4)" "unprognostic (6.51e-2)" "unprognostic (1.64e-2)" "unprognostic (4.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" 3.9 5.1 5.5 4.0 5.4 3.9 3.4 7.9 7.0 5.2 3.4 4.9 2.0 4.7 3.5 2.6 3.8 3.5 12.9 5.9 5.1 3.7 3.4 3.8 6.0 5.1 5.7 3.9 3.9 3.3 5.6 2.9 4.5 4.8 3.2 5.3 3.2 3.6 3.2 1.9 4.4 4.5 4.1 5.5 3.6 3.9 5.9 5.0 4.5 3.2 4.7 4.4 3.5 6.4 4.3 7.6 8.7 7.6 5.7 8.4 3.5 13.9 8.7 11.6 12.9 6.8 4.3 15.1 3.5 5.5 3.3 4.3 11.0 4.7 9.8 17.5 10.2 11.4 12.7 7.6 7.0 12.7 9.5 6.4 5.2 10.3 5.4 5.5 16.2 8.6 5.2 9.9 18.2 2.9 8.6 4.2 8.3 3.7 9.8 5.8 4.6 6.7 6.0 5.5 4.0 2.0 8.5 2.1 3.8 3.9 2.9 6.1 13.3 9.5 7.2 10.8 11.2 5.7 10.3 13.3 7.4 10.9 7.1 0.9 10.0 4.5 26.6 9.8 23.8 60.3 25.8 26.4 7.2 47.1 25.9 25.2 0.6 27.8 11.6 14.4 12.9 5.5 5.5 5.4 7.9 7.0 5.9 5.1 5.1 5.7 4.5 4.1 5.9 6.4 9.8 6.4 4.5 15.3 24.9 2.9 6.5 13.4 8.0 49.9 4.4 3.7 33.0 7.2 5.8 11.0 56.3 12.3 23.8 5.4 0.0 8.5 3.7 3.2 9.7 12.9 16.9 13.7 23.5 5.3 2.1 10.8 4.6 3.6 1.3 14.0 9.7 5.7 7.0 40.4 29.1 7.5 10.2 8.3 6.2 3.7 27.1 6.0 12.4 15.0 16.0 13.0 59.8 31.7 23.5 6.4 7.4 17.7 19.1 5.5 4.3 4.0 8.0 78.3 13.1 11.6 9.5 36.5 28.0 4.6 1.0 1.9 22.9 14.0 9.7 6.3 FAM111A "FLJ22794, KIAA1895" ENSG00000166801 "Family with sequence similarity 111 member A" Q96PZ2 11 59142748-59155039 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" "DNA-binding, Hydrolase, Protease" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039529, HPA040176" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli fibrillar center" "HPA039529: AB_10795149, HPA040176: AB_10793958" "unprognostic (4.12e-3)" "unprognostic (8.47e-2)" "unprognostic (7.80e-3)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (5.83e-3)" "unprognostic (1.81e-1)" "unprognostic (9.88e-2)" "unprognostic (5.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.15e-5)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (1.76e-2)" "prognostic favorable (4.39e-4)" 14.8 18.9 7.0 23.1 7.0 20.3 16.0 6.7 9.6 20.8 12.9 17.1 22.5 13.8 17.3 12.8 16.5 18.7 11.6 6.6 7.6 23.7 17.9 25.2 36.1 9.0 7.7 14.6 15.0 16.9 14.3 19.5 8.1 33.2 19.3 9.1 19.0 10.7 5.5 18.8 27.6 10.9 7.8 42.5 22.5 7.1 8.2 42.3 26.6 4.1 30.1 14.8 17.4 8.4 66.0 16.2 7.9 7.5 16.9 21.4 5.1 91.6 50.8 38.5 56.3 24.9 59.0 94.3 37.1 29.7 51.2 21.9 26.9 40.4 47.4 86.0 1.2 36.3 22.7 7.6 17.8 58.7 45.7 14.5 9.6 36.2 11.1 22.0 37.7 57.2 4.8 76.7 42.2 18.0 85.6 36.9 3.5 19.5 17.5 59.9 28.7 22.8 25.4 57.6 0.2 2.3 48.6 38.5 17.5 4.1 80.1 24.7 37.0 61.9 55.5 42.5 42.7 39.0 43.4 15.3 34.3 39.5 75.9 6.0 5.0 4.8 4.2 3.4 5.3 2.6 2.7 3.2 4.6 2.6 2.4 2.5 5.4 5.0 1.9 1.2 3.1 2.2 7.0 7.0 6.7 9.6 6.6 7.6 9.0 7.7 8.1 7.8 8.2 8.4 38.9 64.1 43.7 14.4 27.4 8.5 10.7 21.3 26.2 1.7 24.2 24.3 5.5 14.3 24.7 16.5 0.0 11.1 40.5 20.8 9.8 13.8 0.2 31.5 26.0 25.9 6.0 42.5 0.2 7.7 1.4 22.7 30.5 20.7 27.8 83.9 30.0 8.1 28.2 0.0 0.2 24.8 22.4 31.3 19.5 1.8 13.1 39.2 7.2 21.5 40.2 25.2 47.4 12.1 3.9 7.5 17.6 6.8 29.7 14.2 19.4 10.3 36.9 7.3 0.0 17.0 14.3 0.4 2.1 24.3 8.8 4.4 41.3 48.8 18.6 14.0 FAM126B "HYCC2, MGC39518" ENSG00000155744 "Family with sequence similarity 126 member B" Q8IXS8 2 200973718-201071671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 164.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in all" 4 "neutrophil: 25.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 25.7" "Cell line enhanced" "Detected in all" "U-266/84: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036166, HPA036167, HPA067307" Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Cell Junctions" Nucleoplasm "HPA036166: AB_10696651, HPA036167: AB_2674982, HPA067307: AB_2685821" "unprognostic (7.47e-3)" "unprognostic (5.54e-2)" "unprognostic (2.52e-1)" "unprognostic (9.08e-2)" "unprognostic (8.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.11e-2)" "unprognostic (2.61e-3)" "unprognostic (1.34e-1)" "unprognostic (1.48e-2)" "unprognostic (1.79e-2)" "unprognostic (1.90e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" 7.8 4.5 4.7 6.3 5.2 17.4 4.8 15.9 8.1 4.0 2.3 7.2 6.8 3.9 4.0 8.2 3.2 4.3 3.4 6.5 3.1 7.8 7.4 5.4 5.9 3.3 3.2 3.8 4.9 4.9 3.8 5.0 3.3 3.7 6.4 10.4 4.3 2.7 3.0 7.1 6.6 3.9 0.6 6.8 7.5 4.5 5.2 5.9 6.9 3.6 6.1 3.8 4.4 6.1 5.4 2.8 3.9 4.2 4.0 5.3 8.2 5.0 3.0 4.0 3.7 7.2 6.2 4.9 4.8 5.1 3.7 6.5 8.1 3.1 6.0 7.1 4.9 14.3 7.6 6.7 3.3 17.6 11.9 2.3 3.9 5.5 3.3 3.1 3.9 5.2 13.4 17.6 4.1 3.3 10.5 11.4 2.8 3.5 4.7 6.1 5.9 4.6 3.7 5.9 7.7 3.8 5.3 6.0 4.7 5.1 4.2 7.7 7.9 7.5 5.3 3.7 4.6 13.1 58.8 10.5 4.3 6.7 5.4 2.6 1.8 6.3 3.8 2.4 4.0 2.6 3.2 3.0 1.6 2.7 3.1 3.7 25.7 3.1 2.7 1.1 2.4 1.9 4.7 5.2 15.9 8.1 6.5 3.1 3.3 3.2 3.3 0.6 5.2 6.1 21.5 28.9 23.9 45.1 29.3 52.6 10.7 17.0 23.3 52.9 16.3 9.4 17.2 27.1 20.4 20.2 164.7 16.6 38.3 59.1 17.6 10.6 9.1 12.7 16.4 22.7 37.1 23.1 113.4 10.5 10.1 15.9 24.5 16.2 24.7 19.9 35.3 21.0 12.0 26.9 98.3 23.4 22.4 33.9 51.6 6.6 31.7 21.1 30.2 45.0 41.5 20.3 73.2 57.8 64.6 21.3 31.1 25.6 34.0 13.2 47.3 16.4 23.1 42.7 19.7 14.8 15.9 32.8 22.9 31.6 74.2 17.4 35.6 15.3 22.0 19.6 FAM160B1 "bA106M7.3, KIAA1600" ENSG00000151553 "Family with sequence similarity 160 member B1" Q5W0V3 10 114821744-114899832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043624 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA043624: AB_10797145" "unprognostic (2.61e-1)" "unprognostic (2.47e-2)" "unprognostic (2.62e-1)" "unprognostic (8.45e-3)" "unprognostic (6.43e-2)" "unprognostic (9.87e-3)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (2.29e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (4.02e-6)" "unprognostic (3.41e-3)" "unprognostic (3.35e-1)" "unprognostic (2.10e-1)" "unprognostic (1.25e-2)" 15.0 11.7 8.7 10.0 8.4 53.3 11.9 6.1 8.4 12.1 6.1 10.7 12.7 16.0 10.0 7.3 12.3 10.5 14.2 7.8 6.5 7.9 19.0 11.6 12.6 5.6 6.5 14.3 9.8 11.9 7.4 14.9 6.1 10.5 8.1 11.5 8.5 11.3 20.3 8.6 13.2 16.9 5.3 11.4 10.1 18.8 6.9 11.2 11.7 12.3 9.6 11.9 10.0 5.2 16.7 8.9 9.6 14.3 22.9 26.0 11.2 29.7 28.8 16.8 13.4 3.1 6.3 9.9 9.1 27.2 4.3 11.0 4.7 11.9 19.8 36.2 10.2 3.9 16.5 7.2 16.7 10.6 12.8 20.4 11.3 12.5 20.2 36.0 22.9 20.0 5.6 24.4 31.7 7.7 19.0 10.5 6.3 4.8 6.6 16.3 16.3 6.6 11.3 9.9 2.1 8.6 13.2 13.6 15.5 11.3 5.4 6.0 23.1 10.4 6.6 30.7 10.4 10.0 3.0 11.2 13.4 26.0 10.0 19.9 3.2 4.7 5.4 2.4 4.0 3.7 7.4 9.2 3.6 3.6 4.0 5.5 15.2 4.9 2.8 3.7 10.5 2.7 8.7 8.4 6.1 8.4 7.8 6.5 5.6 6.5 6.1 5.3 6.9 5.2 25.9 16.0 8.1 20.5 10.9 7.0 7.9 8.0 14.8 13.9 9.4 6.7 19.5 4.3 8.4 3.7 12.5 12.7 14.1 9.0 1.9 10.2 26.7 12.0 26.2 19.8 7.8 9.9 26.5 9.6 10.2 19.2 23.0 16.8 2.5 29.6 23.9 31.3 6.3 10.1 27.4 9.2 4.1 15.6 6.8 36.0 28.6 11.3 3.6 25.3 11.4 8.3 25.7 28.1 13.8 15.1 3.7 22.2 20.1 19.5 20.8 6.6 8.7 16.9 6.6 13.2 14.4 14.9 6.4 8.9 4.8 12.6 17.5 15.0 5.8 14.8 FAM193A "C4orf8, RES4-22" ENSG00000125386 "Family with sequence similarity 193 member A" P78312 4 2536647-2732573 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043116 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA043116: AB_10795767" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (1.17e-3)" "unprognostic (1.97e-1)" "unprognostic (3.66e-3)" "unprognostic (6.34e-3)" "unprognostic (1.02e-1)" "unprognostic (7.16e-2)" "unprognostic (4.84e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.38e-2)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (3.47e-2)" "unprognostic (5.55e-2)" "unprognostic (4.96e-3)" 14.3 11.7 9.7 7.6 9.3 13.0 13.2 15.1 11.5 14.8 9.6 13.4 7.9 13.8 6.8 9.6 12.9 6.0 9.7 9.5 9.7 11.9 11.6 10.1 9.6 9.8 9.0 15.0 11.1 9.2 15.5 7.6 9.3 12.1 6.0 8.9 10.1 7.0 15.1 13.2 12.3 8.0 6.9 12.0 10.5 21.1 10.5 12.4 12.2 8.7 6.7 11.5 11.2 11.8 8.7 10.7 20.0 11.3 12.0 12.2 10.5 13.1 11.3 12.7 10.8 10.9 13.9 17.1 7.7 14.7 15.7 7.4 14.0 9.4 10.8 10.3 8.9 25.7 14.3 11.5 14.4 15.8 17.2 13.3 9.8 12.7 13.0 11.6 12.8 10.0 18.2 18.5 10.8 9.4 25.5 25.6 15.9 8.9 11.8 24.7 10.3 8.4 8.7 11.1 17.1 14.6 11.2 7.8 11.3 10.9 14.3 15.9 17.4 19.2 11.3 10.5 17.5 18.0 14.5 16.1 10.7 12.8 13.8 3.3 0.9 0.8 0.8 0.6 0.6 0.6 0.7 1.2 0.6 0.9 0.7 1.1 1.8 1.3 3.1 1.7 0.6 0.5 9.7 9.3 15.1 11.5 9.5 9.7 9.8 9.0 9.3 6.9 10.5 11.8 21.8 12.8 18.2 62.7 11.2 9.4 6.7 6.5 9.1 25.7 10.5 9.0 14.7 4.3 15.6 1.8 47.9 7.3 20.0 12.9 1.9 9.4 8.9 19.8 21.8 19.4 14.4 17.9 62.4 7.5 7.1 13.2 15.8 27.1 8.8 30.2 11.0 6.3 8.7 15.2 70.8 11.1 8.2 7.6 11.6 13.4 17.1 15.9 14.2 51.5 11.1 15.8 11.3 45.8 58.3 10.1 11.0 14.7 12.4 11.3 11.4 2.8 5.6 26.2 6.6 20.5 17.5 36.2 32.4 9.6 9.9 5.6 14.4 13.6 9.6 9.2 FAM217B "C20orf177, dJ551D2.5" ENSG00000196227 "Family with sequence similarity 217 member B" Q9NTX9 20 59933764-59948680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041021, HPA056698" Approved Enhanced Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA041021: AB_10959734, HPA056698: AB_2683212" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "unprognostic (2.88e-2)" "unprognostic (1.32e-2)" "unprognostic (9.43e-2)" "unprognostic (5.05e-2)" "unprognostic (9.04e-8)" "unprognostic (2.78e-3)" "unprognostic (4.51e-2)" "unprognostic (1.56e-1)" "unprognostic (1.17e-1)" "unprognostic (9.89e-2)" "unprognostic (1.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (2.63e-2)" 4.8 4.0 8.6 6.3 10.3 13.6 4.9 5.7 17.3 4.8 0.1 4.2 5.1 6.8 5.6 4.6 5.5 4.1 9.9 10.8 6.7 5.3 2.0 5.3 9.3 6.1 6.9 10.7 3.0 3.8 6.9 6.3 6.4 7.5 3.5 8.2 4.3 9.0 15.5 3.5 5.9 4.5 5.9 6.3 4.6 9.5 7.4 9.4 6.8 17.4 8.8 3.6 3.1 12.1 9.1 6.1 14.0 9.6 6.6 9.8 11.2 12.7 10.8 13.8 9.9 31.9 19.4 20.0 21.0 5.3 11.1 21.9 15.2 10.6 13.4 11.1 9.6 18.7 15.5 18.5 4.2 30.2 24.3 5.7 12.9 10.2 3.3 5.6 4.1 23.8 13.6 8.2 9.0 16.6 53.0 16.4 13.6 8.5 12.5 12.7 13.8 19.5 5.3 14.1 14.2 16.9 17.0 21.8 18.9 12.9 21.2 21.1 5.8 11.4 13.3 11.8 6.8 14.0 25.7 23.9 15.8 19.4 7.6 9.3 5.9 8.2 8.5 3.7 10.3 4.9 8.0 7.7 6.5 5.7 8.2 8.8 11.1 8.0 3.6 5.2 7.6 6.0 8.6 10.3 5.7 17.3 10.8 6.7 6.1 6.9 6.4 5.9 7.4 12.1 16.0 16.0 19.4 25.5 18.5 5.4 5.4 13.6 10.2 35.6 16.4 16.0 34.9 10.0 12.1 11.0 22.9 23.4 22.2 11.7 17.6 5.5 29.9 8.4 15.5 16.7 8.4 11.3 33.5 8.2 12.0 18.0 7.1 6.6 29.1 19.3 17.2 5.0 19.1 60.6 32.6 5.3 8.2 34.0 13.4 24.9 17.4 13.2 12.4 12.2 32.4 24.4 44.3 22.6 27.9 8.1 5.1 10.1 16.8 9.6 26.3 14.5 17.5 32.0 32.9 36.2 16.6 52.4 16.2 11.0 5.4 6.8 23.3 13.1 9.5 9.7 FAM234A "C16orf9, DKFZP761D0211, FLJ32603, ITFG3" ENSG00000167930 "Family with sequence similarity 234 member A" Q9H0X4 16 234521-272183 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA 5300000 "Cluster 14: Monocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.00e-1)" "unprognostic (1.85e-2)" "unprognostic (3.49e-1)" "unprognostic (4.80e-2)" "unprognostic (5.51e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-2)" "unprognostic (2.55e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.16e-1)" "unprognostic (3.28e-2)" "unprognostic (2.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" 59.5 57.9 22.5 25.1 38.7 19.9 46.5 41.1 30.5 38.3 41.3 71.2 101.2 52.5 21.5 59.7 40.8 37.6 116.8 21.9 25.7 57.7 51.5 36.6 19.2 59.0 37.2 39.5 68.4 48.2 58.1 38.6 54.8 52.5 30.1 9.8 41.2 39.4 175.7 49.1 64.7 40.6 35.7 30.2 59.8 45.1 37.1 16.7 50.5 77.0 15.0 60.1 38.3 71.1 29.5 67.1 72.3 152.1 110.2 66.3 39.2 71.5 92.7 41.9 54.2 67.6 76.9 30.2 104.2 90.8 37.3 55.2 27.6 48.4 35.7 40.5 48.5 35.7 38.8 53.2 81.0 21.4 22.5 74.4 58.7 67.1 48.1 119.8 74.1 39.1 42.1 6.0 44.9 140.0 22.1 25.2 89.1 44.2 31.1 66.5 48.0 120.5 73.9 29.6 83.1 73.9 107.9 58.3 61.5 63.3 81.5 31.4 63.3 76.7 25.2 43.8 21.3 15.6 7.1 37.6 54.4 30.1 104.9 11.7 17.7 13.3 10.1 17.7 5.2 7.1 8.9 10.0 18.0 9.5 10.0 11.3 6.1 15.8 17.2 6.5 9.4 13.9 22.5 38.7 41.1 30.5 21.9 25.7 59.0 37.2 54.8 35.7 37.1 71.1 20.2 9.6 12.6 0.0 7.4 0.0 11.3 0.0 9.6 8.9 23.9 19.7 0.0 21.5 5.0 31.3 25.0 58.7 8.8 25.2 7.9 49.4 27.9 22.2 26.8 18.1 35.2 14.5 0.0 26.1 48.8 21.0 23.4 33.2 8.8 59.2 22.9 23.5 25.7 10.1 0.0 26.4 0.0 14.4 0.0 78.1 16.8 10.9 0.0 0.0 39.6 11.1 10.3 0.0 0.0 18.4 41.5 21.8 5.7 14.8 102.1 18.6 6.6 12.0 19.7 16.9 20.1 29.2 30.8 18.2 0.0 66.2 6.8 73.3 40.4 10.7 FAM98A DKFZP564F0522 ENSG00000119812 "Family with sequence similarity 98 member A" Q8NCA5 2 33583660-33599382 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036250, HPA036251" Uncertain Approved Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Vesicles "HPA036250: AB_2675020, HPA036251: AB_10673124" "unprognostic (7.25e-2)" "unprognostic (9.92e-2)" "unprognostic (1.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (2.42e-2)" "prognostic unfavorable (4.86e-7)" "unprognostic (1.07e-1)" "unprognostic (2.29e-1)" "unprognostic (2.78e-2)" "unprognostic (1.01e-1)" "unprognostic (3.51e-1)" "unprognostic (2.02e-2)" "unprognostic (2.38e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (8.18e-5)" "unprognostic (6.01e-2)" 29.2 21.5 21.4 20.5 26.5 7.2 16.3 28.6 30.4 21.7 27.9 20.7 13.6 19.1 19.3 19.9 12.2 15.7 40.6 30.8 25.7 27.4 25.5 11.5 18.4 25.1 24.5 16.5 14.6 51.2 20.5 20.6 29.5 23.0 17.1 17.2 28.0 16.7 61.3 14.9 12.1 36.4 27.7 14.3 19.8 49.4 26.4 17.4 19.2 62.4 22.6 27.5 12.9 39.7 93.4 47.2 25.5 43.9 99.4 108.3 41.9 224.1 81.6 62.3 80.2 49.8 18.8 144.5 41.3 101.8 55.3 41.3 84.8 60.8 84.2 67.7 56.3 119.7 46.9 69.3 47.2 95.5 44.7 56.1 42.2 83.9 52.1 63.5 83.3 15.5 84.4 43.8 108.7 46.1 53.3 28.5 64.4 83.2 59.9 41.1 82.5 51.9 65.0 72.2 45.6 26.1 60.0 89.5 27.0 40.7 36.2 15.6 135.7 39.5 66.1 82.9 89.2 80.2 106.6 142.4 91.2 68.2 56.8 1.3 4.1 2.3 6.4 7.2 6.9 10.7 5.4 5.8 6.1 5.5 6.9 5.7 0.1 4.0 4.6 3.5 9.0 4.1 21.4 26.5 28.6 30.4 30.8 25.7 25.1 24.5 29.5 27.7 26.4 39.7 19.0 22.4 11.5 6.8 17.4 20.4 19.0 12.2 18.8 16.8 15.0 14.0 74.6 11.5 19.8 7.3 2.1 25.5 9.8 6.9 25.4 20.3 14.9 16.7 29.9 21.1 5.4 12.8 22.8 29.2 33.2 31.9 17.9 18.9 2.5 44.4 17.2 23.4 16.4 47.1 15.7 15.1 8.2 7.7 11.8 13.8 22.4 8.7 8.8 6.5 5.9 17.4 16.5 9.0 36.1 26.0 8.7 21.8 40.3 22.6 9.3 46.2 16.5 15.7 0.0 21.7 27.1 41.5 40.1 26.1 20.5 40.0 13.7 54.9 12.1 23.4 FAM98B FLJ38426 ENSG00000171262 "Family with sequence similarity 98 member B" Q52LJ0 15 38454127-38487710 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008320, HPA008502" Enhanced Supported Nucleoplasm,Vesicles NA NA 20000 "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA008320: AB_1848419, HPA008502: AB_1848420" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-2)" "unprognostic (1.54e-2)" "unprognostic (3.09e-2)" "unprognostic (9.25e-3)" "unprognostic (1.74e-1)" "unprognostic (4.69e-2)" "unprognostic (2.18e-1)" "unprognostic (3.15e-1)" "unprognostic (3.15e-2)" "unprognostic (1.51e-2)" "unprognostic (2.26e-1)" "unprognostic (4.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" 12.7 11.4 9.5 12.8 10.2 9.8 12.9 16.4 12.6 9.7 7.2 15.4 9.6 13.3 9.0 9.0 8.1 7.0 12.4 10.8 10.9 13.1 7.8 8.1 13.8 9.4 9.7 11.2 6.1 19.3 6.4 12.0 10.0 12.1 11.6 19.8 6.3 10.0 13.8 8.8 10.0 9.5 10.1 11.2 9.5 8.5 9.6 28.6 11.7 16.3 13.3 11.9 7.0 12.6 30.7 16.2 77.7 40.0 14.1 25.7 37.9 38.6 28.2 37.4 37.5 35.8 14.4 21.1 41.4 32.2 37.9 31.8 47.4 39.5 52.2 21.8 25.7 62.6 33.9 27.8 20.4 59.8 34.6 23.9 24.1 33.3 38.5 27.4 38.9 45.7 45.6 25.7 36.0 13.8 50.7 31.8 42.0 34.8 22.3 53.3 42.0 17.7 32.8 39.9 47.8 48.9 42.5 27.0 19.8 34.6 33.0 36.6 32.7 42.1 51.5 28.2 44.0 47.6 46.1 78.3 23.1 38.9 44.8 2.3 0.5 1.4 2.8 0.4 2.4 1.6 2.8 2.3 0.6 1.9 3.4 2.6 0.4 2.2 0.6 1.4 1.9 0.4 9.5 10.2 16.4 12.6 10.8 10.9 9.4 9.7 10.0 10.1 9.6 12.6 17.9 16.0 21.4 16.3 16.8 14.7 12.7 14.1 14.2 36.8 15.2 11.6 48.9 12.8 18.1 16.5 16.7 30.6 16.4 11.0 7.9 16.4 3.4 19.1 21.5 16.9 12.6 16.6 22.5 19.8 22.4 16.6 16.8 17.0 13.3 18.4 16.8 13.1 12.6 20.2 20.5 22.6 12.2 15.8 12.2 2.5 12.5 10.9 5.4 18.7 21.4 18.5 21.6 12.1 23.8 14.3 9.8 17.0 18.2 12.4 11.1 12.7 18.8 27.9 6.6 21.5 16.2 27.2 17.1 19.7 14.8 21.5 15.3 14.7 19.3 14.1 FDXR "ADR, ADXR" ENSG00000161513 "Ferredoxin reductase" P22570 17 74862497-74873031 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Oxidoreductase "Deafness, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "adrenal gland: 343.1" "Group enriched" "Detected in many" 7 "Granulosa cells: 329.3;Theca cells: 794.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 89.5;Hep G2: 173.5" "Low region specificity" "Detected in all" "CAB008597, CAB009818, HPA044393, HPA053673" Enhanced Enhanced Mitochondria NA NA "Cluster 15: NK-cells - Transcription" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 52: Non-specific - Transcription" Mitochondria "CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225" "unprognostic (2.69e-2)" "unprognostic (1.17e-3)" "unprognostic (7.51e-2)" "prognostic favorable (2.38e-4)" "unprognostic (3.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" "unprognostic (1.68e-2)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (6.30e-2)" "unprognostic (1.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.03e-2)" "unprognostic (2.13e-1)" 3.9 343.1 6.9 2.4 8.4 2.2 3.8 7.8 8.1 7.8 8.6 9.7 4.6 6.7 5.1 26.0 12.9 4.1 6.0 6.6 6.7 6.5 14.9 5.3 2.9 7.6 7.9 20.5 12.9 5.9 4.1 3.0 7.5 6.7 3.2 0.5 7.1 4.4 7.7 16.4 5.6 2.3 7.4 33.9 7.6 45.6 7.0 4.7 6.0 1.7 2.5 6.2 10.5 7.5 12.5 65.6 9.6 10.8 6.8 9.1 89.5 14.8 15.9 8.6 17.1 18.3 10.8 29.6 2.6 6.2 4.8 24.9 6.9 18.4 2.5 27.9 15.2 22.6 10.6 173.5 19.0 5.0 75.1 29.2 20.3 9.1 3.1 7.0 43.9 10.9 36.1 4.8 13.4 53.4 19.7 10.6 5.5 11.8 14.5 10.6 16.4 16.2 7.1 21.0 5.2 12.1 10.0 21.7 11.2 10.9 47.4 4.7 20.5 5.9 51.9 9.4 7.4 12.7 2.3 6.5 16.1 7.7 20.6 1.7 6.0 5.0 5.6 4.5 5.0 4.8 5.1 6.8 7.3 2.4 4.4 5.4 2.0 10.3 3.4 1.4 15.4 5.2 6.9 8.4 7.8 8.1 6.6 6.7 7.6 7.9 7.5 7.4 7.0 7.5 4.0 3.2 3.9 7.5 8.2 9.7 17.8 42.6 17.1 4.9 6.6 8.4 3.8 5.7 23.3 9.2 4.2 53.2 2.8 18.6 5.9 11.1 6.5 28.2 4.3 4.6 7.1 4.0 1.4 7.9 18.9 12.9 13.7 3.5 5.7 329.3 12.5 13.9 23.1 3.3 2.2 13.1 36.7 6.2 2.7 14.9 5.9 4.6 5.4 1.0 3.9 11.4 8.2 3.0 1.3 9.0 16.9 4.5 7.1 5.2 24.9 21.7 73.6 5.1 0.0 6.2 18.3 6.3 6.1 33.7 18.2 46.1 8.6 794.1 20.3 17.4 FHOD1 FHOS ENSG00000135723 "Formin homology 2 domain containing 1" Q9Y613 16 67229387-67247481 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 88.1;skeletal muscle: 127.0" "Cell type enhanced" "Detected in many" "granulocytes: 40.6;Theca cells: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HMC-1: 112.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024468 Approved Supported Cytosol NA NA 1300000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Cytosol "HPA024468: AB_1848568" "unprognostic (6.53e-3)" "prognostic unfavorable (9.57e-4)" "unprognostic (5.42e-2)" "unprognostic (2.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.18e-2)" "unprognostic (1.62e-1)" "unprognostic (1.81e-1)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.27e-2)" "prognostic unfavorable (1.90e-8)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-3)" "unprognostic (4.70e-2)" 16.9 16.9 3.6 9.6 3.5 6.2 13.2 3.5 4.0 9.6 4.6 9.3 5.9 8.5 1.6 4.5 7.9 5.5 10.4 3.4 3.3 10.5 3.3 26.6 8.5 4.1 4.0 14.7 7.7 3.7 5.4 8.9 3.9 8.8 4.2 0.3 8.4 3.9 127.0 6.2 9.7 5.8 4.0 88.1 7.2 5.0 4.8 4.1 16.8 29.8 5.9 7.4 6.7 3.8 12.0 31.6 11.8 9.8 46.1 27.9 39.2 24.9 19.8 27.2 26.3 22.3 15.7 14.1 17.5 18.0 8.8 14.7 13.5 20.0 13.5 11.3 21.7 63.1 13.9 24.5 12.2 26.3 112.1 34.8 2.6 42.2 4.1 24.3 43.0 19.9 32.9 9.3 17.6 41.0 18.1 48.3 17.6 11.0 10.0 20.3 25.9 33.8 8.7 4.9 3.7 19.2 38.2 22.4 22.5 11.7 23.8 21.1 51.6 37.4 22.0 24.0 20.3 29.9 32.0 20.7 76.1 24.7 34.7 0.3 0.7 0.1 0.2 0.2 0.3 0.0 0.3 0.2 0.4 0.1 0.1 0.1 0.5 0.3 0.2 0.2 0.3 0.6 3.6 3.5 3.5 4.0 3.4 3.3 4.1 4.0 3.9 4.0 4.8 3.8 18.0 12.8 21.6 4.6 7.2 5.7 1.8 2.0 3.4 1.8 11.5 8.0 13.8 10.0 5.9 5.5 8.4 8.7 11.4 16.9 0.0 3.6 1.1 3.5 8.1 22.3 9.1 8.6 2.5 5.9 4.7 10.9 5.6 4.7 40.6 12.0 25.0 0.8 17.1 1.7 2.2 13.1 2.0 20.3 19.7 1.1 10.5 19.8 3.6 17.8 18.9 2.9 10.3 2.0 0.6 7.4 6.1 10.9 7.1 3.1 6.3 1.4 3.9 1.2 26.3 4.2 15.7 19.0 12.3 5.6 3.7 1.9 13.3 40.3 13.8 1.7 FIGNL1 ENSG00000132436 "Fidgetin like 1" Q6PIW4 7 50444128-50542535 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA055542 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "HPA055542: AB_2682841" "unprognostic (4.62e-2)" "unprognostic (8.76e-2)" "unprognostic (3.99e-3)" "unprognostic (1.18e-2)" "unprognostic (1.18e-1)" "unprognostic (8.73e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.15e-1)" "prognostic unfavorable (4.82e-4)" "unprognostic (3.62e-2)" "unprognostic (3.11e-1)" "unprognostic (4.79e-2)" "prognostic unfavorable (9.54e-7)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" 4.5 4.1 4.0 8.4 4.9 8.7 8.8 6.2 5.3 5.4 1.6 6.2 6.8 8.5 4.7 9.0 4.8 4.5 3.9 4.3 4.2 3.5 4.7 3.3 10.3 4.4 3.9 11.3 2.7 3.8 2.5 5.2 4.9 5.9 6.4 9.7 3.8 4.4 6.5 8.6 6.3 9.9 3.9 7.7 4.2 7.2 4.4 10.2 3.7 8.0 13.3 3.6 4.9 5.7 12.9 25.8 33.0 36.1 7.4 13.3 21.1 43.8 22.3 46.0 50.9 40.6 28.5 49.1 22.9 13.1 38.3 43.6 35.3 21.9 73.0 42.0 26.5 21.8 53.7 14.2 4.5 52.5 33.4 6.1 10.7 30.4 15.6 7.3 48.8 22.1 51.5 30.0 35.3 19.1 32.1 38.8 30.2 48.6 30.4 29.8 28.5 17.9 14.3 32.7 37.6 29.2 16.3 35.5 16.6 15.4 34.8 17.4 19.0 0.1 19.2 55.9 36.4 50.5 56.5 38.1 14.7 47.2 73.4 0.0 1.1 0.8 1.7 2.0 3.0 3.4 2.0 3.4 1.2 4.0 3.0 2.9 0.6 3.8 6.1 1.2 4.1 1.5 4.0 4.9 6.2 5.3 4.3 4.2 4.4 3.9 4.9 3.9 4.4 5.7 3.4 0.0 0.5 3.9 7.8 4.1 1.9 3.2 8.6 10.8 4.3 3.9 17.2 2.8 2.3 1.8 6.2 7.0 6.0 1.7 3.9 3.0 1.1 3.3 5.6 4.4 0.0 17.9 11.0 1.2 9.8 5.7 2.6 6.0 2.5 21.3 3.9 2.1 4.6 10.1 7.6 1.3 4.1 2.9 4.2 1.4 11.5 2.9 3.6 4.7 4.4 6.0 7.2 6.6 11.1 2.3 2.8 9.4 8.6 0.7 1.5 2.2 0.8 14.9 0.0 6.0 4.3 27.6 20.4 7.7 3.0 1.4 5.5 9.9 4.0 1.2 FNBP4 KIAA1014 ENSG00000109920 "Formin binding protein 4" Q8N3X1 11 47716494-47767443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039485, HPA040029" Supported Enhanced "Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA039485: AB_2676536, HPA040029: AB_2676808" "unprognostic (2.49e-2)" "unprognostic (3.95e-1)" "unprognostic (5.50e-2)" "unprognostic (2.78e-1)" "unprognostic (1.19e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (7.33e-5)" "unprognostic (5.58e-3)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.60e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (6.35e-4)" "prognostic unfavorable (1.91e-8)" "unprognostic (3.54e-1)" "unprognostic (1.60e-1)" "unprognostic (3.58e-1)" "prognostic favorable (7.23e-5)" 38.0 34.4 5.8 12.1 6.1 19.6 36.6 9.9 7.4 46.7 8.4 35.4 8.9 38.9 9.4 33.8 40.6 8.2 29.9 5.7 6.8 29.5 31.3 39.1 15.9 5.9 6.2 48.8 39.2 7.5 29.2 9.6 5.8 36.3 8.8 14.9 32.7 8.2 51.0 40.5 42.8 9.0 5.3 50.6 31.6 16.5 6.4 14.0 42.8 7.0 14.2 34.2 40.2 7.8 10.6 8.5 17.7 12.5 10.0 11.6 12.0 12.3 12.7 11.1 12.9 8.4 14.0 23.2 6.0 14.0 9.3 21.2 15.8 10.0 16.4 18.2 24.1 17.5 28.1 14.3 14.1 19.5 16.6 14.2 16.4 9.7 22.0 16.2 13.1 14.1 19.2 19.2 10.7 9.7 30.0 22.6 16.7 9.4 7.8 21.2 16.8 12.9 10.9 12.8 7.9 13.1 18.5 15.2 10.5 13.2 12.3 9.1 14.4 13.1 13.8 19.0 17.3 18.6 13.4 26.1 9.5 11.9 9.1 3.8 2.1 3.4 3.7 1.5 2.9 5.1 2.6 2.6 1.3 5.4 2.7 2.9 2.0 1.8 2.2 5.6 3.9 0.9 5.8 6.1 9.9 7.4 5.7 6.8 5.9 6.2 5.8 5.3 6.4 7.8 65.0 51.3 71.7 82.6 114.7 70.9 112.5 45.9 112.7 95.1 57.0 49.0 38.2 27.1 63.6 25.8 108.4 48.9 122.0 46.1 5.9 39.9 5.5 94.3 121.9 59.7 36.5 59.1 86.7 37.8 37.4 70.6 89.2 165.4 57.6 95.5 48.2 27.0 28.4 67.3 93.6 46.5 34.6 37.2 58.3 8.0 89.5 59.2 39.2 71.2 62.1 28.1 83.4 100.5 108.3 50.8 39.4 62.1 102.4 120.8 36.6 11.3 60.5 103.2 46.0 70.5 61.6 37.3 28.1 96.0 69.9 82.9 105.7 93.4 42.6 168.0 GABPB2 MGC29891 ENSG00000143458 "GA binding protein transcription factor subunit beta 2" Q8TAK5 1 151070578-151125542 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028471, HPA058483" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA028471: AB_10602319, HPA058483: AB_2683730" "unprognostic (1.21e-1)" "unprognostic (7.03e-3)" "unprognostic (2.76e-2)" "unprognostic (9.95e-2)" "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" "unprognostic (4.65e-2)" "unprognostic (7.71e-2)" "unprognostic (1.98e-2)" "unprognostic (8.02e-2)" "unprognostic (1.75e-2)" "unprognostic (1.61e-2)" "unprognostic (2.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.90e-3)" 5.5 4.9 4.4 4.2 6.4 7.0 4.5 6.9 5.3 5.8 3.8 5.5 3.5 5.1 3.8 4.9 5.8 3.6 6.4 4.2 4.9 4.8 3.8 4.4 5.5 5.5 5.2 9.3 4.1 5.1 5.8 3.2 5.2 5.3 4.8 5.3 4.3 3.7 5.1 7.2 4.7 3.9 3.9 5.4 4.9 11.7 5.7 9.8 5.4 3.7 5.1 5.7 5.5 7.9 9.2 3.2 2.2 2.7 7.6 11.2 2.9 8.4 5.2 4.7 3.3 0.9 6.7 9.6 3.0 8.0 2.5 7.8 4.8 4.3 6.9 3.6 1.8 2.6 5.3 0.1 5.1 10.6 5.2 6.1 4.9 6.5 9.7 3.7 1.7 10.0 6.6 6.5 5.7 13.1 14.6 1.9 1.0 5.3 3.4 4.3 3.6 4.5 4.0 2.5 3.8 1.6 10.7 3.7 3.1 2.1 9.3 11.2 5.3 1.2 4.0 8.5 6.8 3.5 1.8 33.9 3.8 7.9 5.7 1.5 0.9 0.5 1.4 1.1 0.8 1.0 1.5 1.2 0.8 1.3 1.3 1.4 1.4 0.8 1.8 1.6 0.6 1.0 4.4 6.4 6.9 5.3 4.2 4.9 5.5 5.2 5.2 3.9 5.7 7.9 9.4 9.6 16.8 21.2 10.0 11.5 9.3 9.6 10.2 26.3 8.9 10.3 22.4 17.2 14.8 12.9 25.0 5.8 18.0 12.3 9.8 5.7 36.3 13.5 15.4 11.0 9.6 14.9 18.4 5.8 4.6 16.2 9.7 9.7 7.0 11.7 15.7 7.1 8.2 33.7 25.3 15.6 4.1 13.4 9.7 17.1 22.4 11.3 8.8 15.9 14.3 10.9 33.0 11.6 39.3 5.3 8.5 21.4 8.1 6.9 10.7 4.6 20.8 36.5 6.6 38.5 15.4 75.6 55.7 9.6 10.1 4.5 16.3 15.6 16.8 7.0 GALR3 ENSG00000128310 "Galanin receptor 3" O60755 22 37823382-37825485 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Glandular and luminal cells: 1.2;Late spermatids: 1.7;Paneth cells: 1.1;Theca cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 52: Non-specific - Transcription" "unprognostic (4.45e-2)" "unprognostic (1.45e-2)" "unprognostic (4.60e-3)" "unprognostic (7.07e-2)" "unprognostic (7.63e-2)" "unprognostic (8.17e-2)" "unprognostic (4.18e-2)" "unprognostic (2.16e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-1)" "unprognostic (1.66e-2)" "unprognostic (7.37e-2)" "unprognostic (8.35e-2)" "unprognostic (4.45e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.4 0.1 0.5 0.1 0.2 0.2 0.1 0.8 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.9 0.0 0.3 0.4 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.5 0.0 0.0 0.0 1.5 0.2 0.1 GATAD1 "FLJ22489, ODAG, RG083M05.2" ENSG00000157259 "GATA zinc finger domain containing 1" Q8WUU5 7 92447482-92460075 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 234.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006105, HPA072785" Enhanced Nucleoplasm Yes No "Cluster 17: Basophils - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA006105: AB_1078956, HPA072785: AB_2686556" "unprognostic (8.37e-2)" "unprognostic (1.01e-1)" "unprognostic (7.31e-3)" "unprognostic (6.24e-2)" "unprognostic (6.03e-2)" "unprognostic (1.36e-1)" "unprognostic (8.65e-3)" "unprognostic (6.43e-2)" "unprognostic (5.16e-2)" "unprognostic (4.30e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.91e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-1)" "unprognostic (3.44e-2)" "unprognostic (1.98e-3)" 22.7 22.1 9.5 7.3 12.8 6.2 22.2 10.1 10.9 26.8 9.7 22.3 11.2 21.4 18.3 14.6 26.5 11.8 16.2 9.6 10.5 21.4 20.1 20.1 8.7 12.1 11.5 33.6 29.4 15.5 23.1 12.4 12.4 23.9 11.3 13.2 18.4 12.4 10.8 14.0 18.6 11.7 10.4 20.2 21.6 10.2 12.0 6.7 26.0 5.7 7.3 22.0 20.2 16.0 12.3 7.5 15.3 16.1 19.7 22.4 12.1 11.9 17.8 12.4 16.9 8.5 18.5 9.1 15.9 8.9 28.9 14.3 10.7 8.1 13.0 15.8 11.3 11.6 8.0 11.6 27.4 14.1 30.0 16.8 19.3 9.5 27.4 22.3 14.2 6.6 24.2 19.0 13.8 17.7 5.5 20.2 20.8 19.9 14.4 7.2 18.1 12.1 13.6 13.4 13.4 21.4 15.7 16.5 23.7 19.0 9.2 18.8 13.0 19.7 14.9 30.0 15.5 15.2 5.5 10.0 16.6 9.0 27.6 2.9 1.1 1.2 0.7 0.7 0.7 0.9 0.5 0.5 0.6 1.4 0.6 0.9 1.0 0.9 0.8 1.2 0.6 0.4 9.5 12.8 10.1 10.9 9.6 10.5 12.1 11.5 12.4 10.4 12.0 16.0 59.0 48.1 64.6 98.9 26.5 13.3 37.8 14.6 26.7 79.0 33.3 35.1 16.3 24.3 26.6 47.8 70.9 25.7 28.8 30.2 3.9 22.4 3.8 46.7 48.3 34.7 16.8 24.6 77.8 22.0 23.4 38.1 30.5 51.6 53.2 115.1 37.1 21.7 24.6 62.2 70.4 33.3 2.0 30.8 23.7 5.0 45.4 40.2 21.4 54.4 25.8 65.3 32.0 108.6 234.9 27.0 30.7 35.0 13.6 45.9 33.2 18.2 36.1 114.1 19.7 54.3 36.7 14.1 10.4 23.6 17.8 20.7 24.7 56.0 31.9 35.7 GATC "15E1.2, FLJ37000" ENSG00000257218 "Glutamyl-tRNA amidotransferase subunit C" O43716 12 120446444-120463749 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" Ligase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 22: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "unprognostic (2.10e-1)" "unprognostic (3.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.04e-2)" "unprognostic (2.22e-1)" "unprognostic (8.46e-2)" "prognostic unfavorable (4.21e-5)" "unprognostic (1.68e-1)" "unprognostic (2.94e-2)" "unprognostic (1.02e-1)" "unprognostic (1.64e-1)" "unprognostic (1.02e-1)" "unprognostic (4.10e-3)" "unprognostic (1.32e-1)" "unprognostic (1.70e-1)" "unprognostic (1.12e-1)" "unprognostic (5.92e-2)" 10.0 10.3 11.6 8.4 13.2 7.5 12.0 15.2 15.1 11.1 10.2 10.2 11.7 8.3 10.9 8.7 7.7 7.3 6.6 12.1 12.6 15.3 16.4 8.6 10.2 13.2 12.9 9.9 37.8 13.0 7.9 9.2 13.6 8.6 10.7 12.8 10.5 7.9 8.5 9.5 10.2 7.7 12.8 9.2 9.6 4.6 13.1 11.9 11.6 8.0 11.8 10.0 8.3 15.8 12.7 40.7 19.4 22.6 23.4 23.1 13.8 16.1 15.0 17.5 12.9 37.9 9.3 25.2 17.6 14.7 15.5 20.4 30.7 17.6 17.1 19.4 28.7 24.1 25.3 25.4 25.8 23.4 13.6 21.7 18.8 13.7 24.4 24.0 24.8 23.4 33.3 12.9 17.9 20.0 26.3 25.8 12.3 19.0 25.7 17.6 22.5 33.9 20.7 21.5 35.7 17.3 28.8 15.1 21.0 15.3 26.8 12.9 21.9 14.6 13.5 19.8 12.6 18.4 32.6 32.5 19.8 14.5 23.5 7.0 5.3 4.0 6.1 3.6 5.9 6.2 4.7 3.6 3.9 5.9 4.3 5.0 3.7 4.7 5.5 6.2 5.4 5.4 11.6 13.2 15.2 15.1 12.1 12.6 13.2 12.9 13.6 12.8 13.1 15.8 14.8 3.2 19.1 11.4 13.0 9.4 20.6 4.4 16.5 17.6 13.4 12.4 6.2 18.6 13.8 18.4 16.7 13.3 16.4 18.3 11.7 17.8 3.2 14.6 19.5 17.2 27.0 10.1 14.0 24.4 12.3 12.5 11.2 18.2 24.1 17.6 18.5 22.8 11.3 18.5 12.8 15.5 6.1 14.9 4.2 1.9 14.6 14.6 3.6 4.7 18.5 12.0 11.3 13.6 13.6 29.4 14.1 20.3 13.9 25.8 19.8 22.4 7.5 14.1 6.6 20.0 12.0 11.7 8.0 15.3 9.9 14.9 12.6 11.7 19.3 22.0 GCC2 "GCC185, KIAA0336" ENSG00000135968 "GRIP and coiled-coil domain containing 2" Q8IWJ2 2 108449191-108509415 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035849, HPA035850" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoplasm "HPA035849: AB_10671941, HPA035850: AB_2674821" "unprognostic (1.35e-1)" "unprognostic (1.29e-2)" "unprognostic (2.45e-2)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.59e-1)" "unprognostic (3.11e-2)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (6.53e-2)" "unprognostic (6.53e-3)" "unprognostic (3.99e-1)" "unprognostic (4.71e-1)" "unprognostic (9.61e-2)" "unprognostic (1.64e-2)" 9.0 12.7 3.4 17.6 5.1 25.2 17.4 0.0 5.5 12.5 26.2 19.2 21.7 15.3 41.7 7.5 15.0 21.4 8.4 3.2 3.8 16.6 10.7 14.8 21.5 2.5 4.2 15.5 12.5 15.0 4.1 13.7 2.8 19.6 20.8 17.3 15.2 17.1 2.3 7.9 22.9 9.4 0.9 18.8 26.4 16.6 1.4 18.9 20.5 9.4 16.3 14.1 3.6 6.0 12.5 10.4 12.6 5.5 14.2 22.6 27.4 17.6 26.8 9.2 12.9 18.4 17.2 14.9 22.3 16.0 16.7 10.4 10.0 14.1 15.8 16.9 13.6 18.7 16.3 15.8 12.7 26.4 14.3 29.1 13.3 23.1 16.3 20.0 13.6 13.9 25.3 12.4 17.4 7.1 13.6 18.1 21.9 11.5 12.0 11.7 17.9 16.1 12.2 20.1 13.6 12.5 21.1 16.7 18.7 18.2 8.3 12.8 21.3 13.3 20.2 12.4 6.7 18.0 26.9 18.2 17.2 7.0 9.8 47.3 8.9 25.9 25.5 8.0 25.1 27.0 28.2 27.8 7.3 24.3 38.2 33.5 35.6 14.9 17.6 31.8 23.0 8.2 3.4 5.1 0.0 5.5 3.2 3.8 2.5 4.2 2.8 0.9 1.4 6.0 92.6 150.6 103.3 44.1 125.2 23.8 68.6 54.8 29.6 155.9 60.3 57.5 85.6 75.8 95.7 104.8 139.7 44.2 157.6 152.1 50.9 114.5 73.9 253.3 85.1 68.1 85.6 39.5 104.9 81.6 56.3 74.2 65.7 118.6 82.2 113.9 65.0 36.7 37.0 70.7 73.6 152.6 52.9 49.8 39.3 39.9 71.4 66.0 33.8 62.8 88.5 59.0 134.9 50.8 66.1 116.1 125.2 82.8 108.7 91.7 134.0 63.1 259.7 127.2 52.6 61.4 66.2 163.0 120.7 21.0 17.5 65.0 139.1 138.0 88.3 114.5 GIGYF1 "GYF1, PERQ1" ENSG00000146830 "GRB10 interacting GYF protein 1" O75420 7 100679507-100694250 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 100.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020999, HPA023995" Enhanced Approved Vesicles,Microtubules NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Vesicles Microtubules "HPA020999: AB_2111744, HPA023995: AB_1855221" "unprognostic (3.82e-3)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (2.67e-2)" "unprognostic (7.46e-2)" "prognostic favorable (7.42e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.43e-2)" "unprognostic (8.06e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.35e-5)" "unprognostic (3.66e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (1.89e-1)" "unprognostic (2.79e-1)" "unprognostic (2.67e-3)" 25.7 25.9 21.1 15.6 21.1 30.5 26.9 27.7 24.1 36.1 21.3 26.5 15.8 34.9 11.0 19.1 30.2 10.4 22.4 19.5 17.3 27.3 23.1 22.6 18.9 20.9 18.8 43.4 36.1 13.5 41.9 11.4 18.7 28.5 8.0 8.8 29.6 13.7 26.5 33.5 30.7 11.2 16.2 39.1 25.1 32.2 21.4 17.2 32.8 16.7 11.3 23.5 23.6 24.0 16.5 16.8 26.1 38.2 12.3 9.6 46.6 15.3 12.4 9.4 10.8 9.8 27.6 22.9 19.2 11.1 19.0 19.4 12.9 15.3 5.8 24.4 26.4 15.9 48.5 14.3 12.2 18.1 26.1 15.1 12.2 12.0 17.0 15.3 9.5 26.4 44.8 21.9 8.7 37.5 32.1 100.1 32.0 6.5 20.1 51.2 13.9 23.1 6.9 14.8 23.3 36.7 19.8 31.2 18.2 17.6 14.2 30.2 14.7 26.8 32.9 44.7 14.2 17.8 8.4 12.3 15.6 35.9 16.2 2.2 1.3 1.2 2.4 1.2 1.8 1.3 1.6 1.5 0.5 1.9 1.4 1.5 4.5 1.3 1.3 2.0 0.9 0.5 21.1 21.1 27.7 24.1 19.5 17.3 20.9 18.8 18.7 16.2 21.4 24.0 26.5 3.2 7.8 19.9 18.1 31.7 11.0 5.8 8.0 25.5 25.5 20.6 8.3 32.9 5.8 18.4 18.8 12.0 31.2 19.5 15.6 11.5 1.0 12.2 24.3 17.5 18.6 9.9 18.1 9.4 10.7 17.8 18.8 17.5 5.7 26.5 22.5 19.0 11.4 52.2 17.7 22.8 6.1 25.5 19.8 3.8 24.5 15.6 17.8 29.0 12.5 15.3 20.6 14.6 22.6 11.8 18.0 18.0 10.5 16.7 20.4 9.9 5.0 28.0 32.9 33.2 19.6 16.4 36.0 6.8 22.4 16.3 20.5 12.9 16.1 10.2 GIN1 "FLJ20125, GIN-1, TGIN1, ZH2C2" ENSG00000145723 "Gypsy retrotransposon integrase 1" Q9NXP7 5 103086000-103120138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037402, HPA061362" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "HPA037402: AB_10672790, HPA061362: AB_2684491" "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (3.02e-2)" "unprognostic (4.66e-2)" "unprognostic (3.01e-2)" "unprognostic (9.60e-3)" "unprognostic (1.20e-1)" "prognostic favorable (1.63e-4)" "unprognostic (1.89e-1)" "unprognostic (4.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.08e-2)" 2.2 4.0 1.8 2.9 2.0 0.6 4.3 3.0 3.5 3.4 1.3 2.5 2.5 3.2 3.6 2.2 3.2 1.7 6.7 1.7 2.3 4.3 4.3 2.3 3.6 2.2 2.1 5.4 2.9 5.2 1.1 2.4 2.1 3.5 3.2 7.2 3.0 3.6 7.8 2.4 2.5 2.8 2.2 3.0 3.2 4.7 2.2 4.2 4.1 6.9 3.5 2.7 1.7 3.2 4.0 4.7 5.8 4.0 2.8 7.1 4.4 5.6 3.8 4.0 3.6 2.6 5.3 2.5 5.0 2.2 3.5 4.7 5.4 7.9 5.3 3.3 4.4 3.5 4.2 3.1 5.5 3.5 2.3 2.6 8.7 3.6 7.3 4.8 3.0 4.1 3.3 3.6 6.4 2.9 4.6 2.3 4.6 3.3 7.0 4.0 6.4 6.0 5.3 3.4 5.1 3.2 4.3 2.8 5.6 4.1 8.7 5.9 2.4 4.0 2.5 4.4 4.2 4.4 3.5 3.6 5.3 5.6 3.5 0.4 1.4 2.8 1.7 1.8 2.0 2.6 2.4 2.6 1.7 2.6 2.8 3.0 2.1 2.3 4.0 1.7 4.4 1.4 1.8 2.0 3.0 3.5 1.7 2.3 2.2 2.1 2.1 2.2 2.2 3.2 5.4 9.6 5.3 11.4 6.1 0.9 4.7 12.5 4.0 9.4 3.5 4.4 18.7 2.8 6.5 5.5 0.0 7.7 3.6 2.9 23.5 8.0 1.6 4.3 6.5 3.9 4.2 1.7 9.1 4.3 4.9 4.7 4.1 3.1 16.5 6.1 3.3 4.5 5.5 0.0 12.2 4.0 10.2 3.5 2.0 0.7 5.0 4.8 0.0 4.7 4.8 9.3 5.2 23.1 23.7 4.0 4.7 6.8 2.6 3.6 4.5 8.8 7.6 13.4 6.6 4.0 6.5 23.8 12.2 2.7 2.0 8.2 6.1 5.7 3.6 3.0 GIT2 "KIAA0148, PKL" ENSG00000139436 "GIT ArfGAP 2" Q14161 12 109929802-109996389 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004681 Approved Approved Microtubules NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Microtubules "CAB004681: AB_425820" "unprognostic (1.07e-1)" "unprognostic (2.61e-1)" "unprognostic (3.67e-3)" "unprognostic (3.44e-2)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (3.87e-2)" "unprognostic (1.50e-1)" "unprognostic (1.87e-1)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "unprognostic (8.71e-2)" "unprognostic (2.41e-2)" 16.6 18.0 12.1 25.5 18.1 60.2 13.0 20.3 17.0 14.0 9.8 15.0 11.2 14.1 10.8 11.5 12.1 15.4 17.4 16.4 12.1 11.7 11.8 16.9 33.1 16.2 13.9 17.8 17.2 14.1 13.8 22.9 16.5 12.8 13.8 9.1 13.5 12.8 14.7 13.1 19.0 19.8 12.1 36.0 10.7 13.9 15.3 37.0 16.4 15.6 32.1 16.3 12.8 16.2 20.6 24.6 16.6 18.4 28.6 26.3 11.9 42.1 41.3 37.0 23.2 12.5 10.8 49.8 16.3 51.7 14.6 14.9 14.5 18.8 38.1 42.1 14.3 32.7 15.0 14.6 18.1 47.7 49.6 22.0 17.4 34.9 18.7 34.0 39.5 28.5 17.2 12.4 46.0 13.1 42.0 66.4 11.7 11.7 17.7 34.5 41.7 27.9 18.2 17.1 10.1 14.9 27.1 12.5 16.6 17.0 17.9 39.3 37.3 25.0 12.6 20.0 22.0 25.0 22.8 49.3 21.5 34.9 21.2 85.6 76.4 172.9 42.7 72.0 41.6 42.4 42.3 43.9 74.7 49.4 36.0 32.2 165.1 49.3 71.3 30.6 46.5 63.7 12.1 18.1 20.3 17.0 16.4 12.1 16.2 13.9 16.5 12.1 15.3 16.2 26.3 19.2 15.3 24.8 44.8 9.6 6.4 11.3 11.4 24.7 10.8 10.0 7.8 14.3 12.2 27.6 8.4 13.1 37.7 9.9 3.9 16.0 6.5 7.6 16.9 24.0 7.8 19.4 73.2 14.0 11.3 15.3 14.8 11.1 14.5 36.1 24.7 13.7 35.1 33.7 82.2 6.7 8.2 65.5 32.0 5.2 18.6 45.1 14.2 66.5 64.5 9.3 61.8 28.6 39.8 18.4 8.6 19.9 26.1 4.3 22.8 7.2 12.4 18.7 13.1 29.4 14.5 36.1 20.1 11.8 11.4 6.2 36.5 19.1 9.9 7.4 GLG1 "CFR-1, ESL-1, MG-160" ENSG00000090863 "Golgi glycoprotein 1" Q92896 16 74447427-74607144 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010815 Supported Supported "Golgi apparatus" NA NA 2100000 "Cluster 32: T-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA010815: AB_2232486" "unprognostic (3.70e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (7.42e-2)" "unprognostic (3.30e-2)" "unprognostic (1.90e-1)" "unprognostic (5.02e-3)" "unprognostic (5.13e-3)" "unprognostic (9.45e-3)" "unprognostic (8.46e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (8.85e-2)" "prognostic favorable (1.56e-7)" "unprognostic (3.54e-2)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.97e-4)" 42.7 36.8 25.0 17.4 26.3 9.0 40.3 24.0 25.7 53.3 17.3 44.5 17.3 57.8 22.4 30.9 46.7 20.4 50.5 24.7 27.5 42.6 25.6 38.2 16.3 27.0 29.0 69.0 58.1 34.3 38.9 24.9 25.2 37.5 18.7 20.3 36.1 24.9 53.8 35.2 36.4 29.9 25.0 35.1 36.3 40.6 29.5 20.0 43.1 16.4 18.9 42.3 40.8 30.0 38.4 52.2 44.7 43.3 113.7 113.2 42.8 45.0 64.2 48.6 68.3 34.4 116.0 22.8 59.8 102.9 35.8 71.1 30.1 62.1 80.1 10.3 26.1 17.9 37.8 54.3 70.5 29.3 12.6 68.0 32.8 63.6 66.3 91.3 100.8 54.8 19.0 24.9 44.2 70.0 14.1 26.0 34.7 81.2 20.6 33.9 32.6 59.5 31.6 17.1 15.8 23.3 87.3 24.9 25.0 47.7 28.2 36.5 79.1 46.1 40.9 48.2 30.3 47.4 51.2 41.1 86.3 22.5 46.6 3.2 16.7 13.3 19.1 15.7 19.2 11.6 23.8 20.9 18.5 10.1 28.2 22.6 7.3 15.4 19.9 18.4 21.0 19.0 25.0 26.3 24.0 25.7 24.7 27.5 27.0 29.0 25.2 25.0 29.5 30.0 52.8 64.1 50.7 114.3 46.4 27.1 27.2 33.0 55.8 68.5 35.6 35.6 79.5 77.2 39.7 51.5 146.0 78.0 75.6 33.5 7.9 39.9 39.7 49.2 79.3 62.0 38.6 25.0 133.4 42.5 43.6 101.4 38.7 58.0 3.8 91.0 75.3 40.7 50.1 70.7 155.3 31.9 24.4 68.8 42.1 28.1 96.9 44.4 42.7 62.8 64.8 59.6 111.2 97.5 137.3 40.8 28.8 114.3 100.2 33.6 47.8 44.2 44.3 57.9 92.1 84.6 59.9 89.2 87.9 30.5 21.6 75.2 72.4 72.4 32.9 26.4 GLI1 GLI ENSG00000111087 "GLI family zinc finger 1" P08151 12 57459785-57472268 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 11.1" "Cell type enhanced" "Detected in some" "Fibroblasts: 6.5;Leydig cells: 29.5;Peritubular cells: 42.9;Sertoli cells: 13.1;Theca cells: 7.8" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "AN3-CA: 24.2;BJ hTERT+: 16.9;NTERA-2: 14.0;RH-30: 60.6;U-266/70: 16.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009460, HPA065172, HPA068903" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122" "unprognostic (4.97e-4)" "unprognostic (5.53e-2)" "unprognostic (1.26e-1)" "unprognostic (5.58e-3)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.00e-2)" "unprognostic (1.88e-1)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-8)" "unprognostic (4.59e-3)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-2)" 2.4 1.2 1.3 1.7 1.6 0.5 1.5 3.5 1.9 11.1 0.4 3.0 2.5 9.5 6.6 0.6 3.7 5.5 2.1 1.0 2.1 1.4 0.8 1.6 0.7 1.9 2.4 1.5 0.8 0.0 1.0 0.5 1.7 4.2 4.1 0.0 1.5 2.8 0.6 1.7 3.3 2.4 1.7 0.9 1.9 4.7 4.2 0.3 2.3 1.8 1.0 4.4 3.1 1.1 0.1 9.8 3.2 24.2 0.7 0.1 0.3 0.9 16.9 2.1 2.3 0.3 0.7 3.1 0.0 0.5 2.3 1.7 1.8 1.1 0.4 2.7 0.3 0.1 1.2 0.2 2.7 0.7 1.4 0.8 0.4 3.1 1.0 4.2 0.3 2.2 0.4 7.8 1.0 0.0 0.7 0.5 14.0 0.8 0.9 1.2 60.6 1.7 2.7 0.0 0.1 0.1 0.2 0.1 0.4 2.4 0.0 0.3 0.1 2.2 7.7 0.6 0.3 16.7 1.0 5.7 2.0 1.3 3.8 0.8 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 1.9 0.0 0.0 0.1 0.2 0.0 1.3 1.6 3.5 1.9 1.0 2.1 1.9 2.4 1.7 1.7 4.2 1.1 0.4 0.0 0.0 2.0 0.7 0.1 0.4 0.3 0.0 0.0 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.1 3.5 0.5 0.0 0.0 0.1 0.0 0.1 6.5 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.4 2.5 29.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.9 0.1 0.2 0.0 1.3 0.0 0.0 13.1 1.9 1.6 0.3 1.1 0.2 0.6 0.1 0.5 7.8 0.1 0.1 GMEB1 "P96PIF, PIF96" ENSG00000162419 "Glucocorticoid modulatory element binding protein 1" Q9Y692 1 28668778-28719353 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044811, HPA052975" Supported Enhanced Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA044811: AB_10959666, HPA052975: AB_2682003" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" "unprognostic (2.49e-2)" "prognostic favorable (1.94e-4)" "unprognostic (2.71e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.91e-7)" "unprognostic (1.42e-2)" "unprognostic (1.41e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (3.38e-2)" "unprognostic (8.41e-2)" "unprognostic (4.79e-3)" "unprognostic (3.44e-1)" "unprognostic (1.75e-1)" "unprognostic (1.13e-2)" 4.7 3.0 2.3 5.7 2.2 13.6 4.3 5.9 3.1 5.1 3.1 4.4 2.9 4.9 3.0 5.2 4.4 4.2 3.1 2.5 1.9 3.6 3.4 4.3 6.7 2.5 2.2 5.6 4.1 3.3 3.7 5.7 2.5 3.5 4.4 5.6 3.4 3.1 5.3 5.0 4.4 4.8 1.9 5.5 4.1 6.0 2.6 10.6 3.5 4.4 8.0 4.3 4.4 3.1 12.1 8.5 14.1 12.9 4.6 8.5 10.0 12.5 9.0 7.9 11.7 2.7 9.4 22.1 6.5 11.7 4.7 4.6 12.7 9.7 10.2 25.4 7.9 20.4 8.9 5.2 6.9 17.1 10.2 6.8 6.8 19.2 12.3 6.9 11.1 10.8 12.6 17.1 9.6 10.5 10.7 5.7 18.9 8.0 5.7 7.2 9.7 10.3 6.0 9.6 10.4 8.6 12.1 8.0 8.1 9.4 6.1 8.7 11.2 5.4 13.1 9.3 17.0 7.6 13.8 12.1 6.6 15.8 8.7 8.1 5.4 9.9 6.7 7.0 5.1 4.0 6.5 7.9 6.3 6.0 5.3 5.5 7.6 7.5 9.0 4.6 6.0 4.6 2.3 2.2 5.9 3.1 2.5 1.9 2.5 2.2 2.5 1.9 2.6 3.1 12.9 6.4 20.0 3.9 20.5 17.0 19.9 8.6 8.6 23.6 9.0 10.2 4.0 10.0 11.0 14.7 12.5 14.1 17.7 12.7 5.9 10.9 13.3 10.1 12.5 13.2 7.8 26.7 7.0 11.1 16.6 10.0 9.2 16.3 28.5 12.8 16.8 6.1 10.7 25.2 5.9 13.1 10.2 13.4 7.9 2.8 9.6 12.2 1.8 4.7 14.8 17.5 29.9 5.0 9.2 11.5 14.1 7.9 11.5 12.4 8.5 5.7 7.1 24.7 19.7 18.3 13.0 34.8 28.6 8.3 16.8 32.3 19.5 13.2 11.0 19.6 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530183-54621521 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 4.6 3.6 2.0 7.0 3.6 8.9 4.8 2.6 2.7 4.8 3.1 4.7 3.9 4.7 3.7 5.7 4.7 4.7 7.2 2.7 2.6 4.4 3.9 5.0 7.6 3.1 3.6 3.8 5.0 5.7 2.3 5.6 3.2 3.7 6.1 3.8 4.0 4.4 7.1 5.7 4.7 7.3 2.7 6.9 5.3 2.3 3.4 8.3 8.5 7.8 8.5 6.7 3.5 5.4 20.7 49.1 9.5 20.9 10.2 8.3 15.2 9.8 8.7 13.4 9.9 43.4 16.6 26.9 21.3 18.2 15.1 18.7 34.6 14.9 19.0 15.9 16.4 30.0 34.0 17.2 7.9 42.6 26.0 10.0 7.1 31.0 17.4 5.7 13.4 16.4 19.2 27.0 14.0 36.5 25.5 11.8 29.6 13.0 26.7 27.7 23.9 27.8 10.3 28.8 17.1 8.4 39.7 24.3 11.7 20.9 30.9 11.4 20.0 22.6 22.1 21.8 18.4 19.9 25.7 35.9 12.8 34.6 27.8 23.6 14.4 15.0 16.5 12.8 15.0 15.1 14.8 13.8 11.1 16.0 10.6 11.7 19.2 21.5 15.0 10.2 9.3 12.5 2.0 3.6 2.6 2.7 2.7 2.6 3.1 3.6 3.2 2.7 3.4 5.4 9.2 12.8 18.5 14.4 15.3 1.3 3.6 3.9 9.6 10.2 6.1 3.9 8.5 8.6 11.8 3.7 12.5 7.1 14.1 7.4 3.9 9.4 0.4 8.2 17.2 9.4 3.5 12.0 14.8 8.7 6.4 7.4 10.7 9.6 10.8 10.9 7.1 4.6 4.9 8.4 14.8 4.7 8.2 9.4 4.2 0.0 5.6 9.4 0.0 14.0 12.0 3.4 25.7 16.1 23.2 9.8 3.9 3.0 10.0 4.2 6.8 5.3 7.8 9.3 6.6 8.5 7.1 1.1 7.7 6.6 2.0 5.5 11.9 9.5 7.6 3.6 GOLGA8A "CFAP286, FAP286, GM88, GOLGIN-67" ENSG00000175265 "Golgin A8 family member A" A7E2F4 15 34379068-34437466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 211.5;Oligodendrocyte precursor cells: 146.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 48.0;HeLa: 80.1" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (4.80e-2)" "unprognostic (1.26e-2)" "unprognostic (4.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.42e-2)" "unprognostic (2.10e-2)" "unprognostic (8.11e-3)" "prognostic favorable (7.58e-4)" "unprognostic (2.74e-2)" "unprognostic (4.37e-1)" "unprognostic (2.63e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "prognostic favorable (5.68e-6)" 24.5 18.6 16.1 10.4 11.7 7.9 32.4 18.5 21.4 56.3 11.0 32.7 10.5 31.6 31.8 31.2 37.6 7.3 23.6 13.1 10.0 33.2 6.8 22.4 14.0 17.8 8.8 62.5 22.9 6.3 22.8 2.2 11.9 37.8 2.2 26.4 26.8 10.2 7.6 36.8 38.2 3.2 7.0 48.1 30.3 40.0 12.8 1.2 56.8 1.0 2.1 33.0 40.2 12.2 2.4 13.4 3.7 12.5 0.1 0.0 2.8 20.3 0.1 3.4 1.5 23.3 0.0 0.1 3.6 2.4 6.9 21.7 9.5 6.8 5.3 20.1 7.6 48.0 80.1 15.0 1.3 18.4 12.6 0.0 19.5 2.3 0.5 2.3 0.3 7.0 46.0 40.0 9.2 4.3 4.7 34.6 6.9 6.4 7.2 19.6 11.2 16.2 7.7 13.8 17.1 8.2 13.6 9.2 2.2 0.1 3.6 11.4 10.5 15.7 3.5 0.0 3.6 37.5 13.4 5.5 4.7 38.9 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.1 11.7 18.5 21.4 13.1 10.0 17.8 8.8 11.9 7.0 12.8 12.2 37.3 211.5 71.6 82.9 16.1 26.1 10.9 13.4 7.4 95.3 36.1 41.9 35.0 5.7 127.6 1.8 100.1 2.9 21.1 6.5 0.0 4.2 37.5 17.6 83.9 18.4 16.1 2.5 114.4 2.6 5.0 17.4 13.7 52.3 13.9 39.3 14.6 1.5 2.4 84.1 91.8 11.9 14.2 6.8 20.1 8.4 31.4 8.5 23.2 38.4 1.7 14.8 6.2 146.8 62.5 4.7 6.9 21.1 19.3 8.5 6.6 0.9 52.0 117.6 0.0 26.7 22.4 33.0 23.5 7.8 21.6 3.3 32.9 39.9 11.7 9.4 GOLGA8B ENSG00000215252 "Golgin A8 family member B" A8MQT2 15 34525207-34588503 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 228.4" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 192.3;Excitatory neurons: 133.4;Inhibitory neurons: 126.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 14.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.4;Hep G2: 16.2;NB-4: 24.5" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 25: Pancreas - Digestion" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (2.12e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.89e-1)" "unprognostic (2.43e-1)" "unprognostic (4.06e-2)" "unprognostic (7.90e-3)" "unprognostic (9.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.06e-1)" "unprognostic (1.60e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (2.14e-1)" "unprognostic (5.31e-3)" "unprognostic (2.31e-1)" "prognostic favorable (5.79e-4)" 16.5 28.8 10.9 7.2 11.0 18.4 20.8 13.8 15.0 28.7 10.8 18.6 0.9 16.8 11.9 10.0 27.9 6.9 15.5 11.0 11.1 41.1 41.8 23.8 19.6 11.2 10.9 55.6 228.4 0.7 60.6 3.0 10.9 37.8 1.4 8.0 18.1 10.6 10.1 13.4 25.2 2.0 10.9 38.5 28.7 43.2 11.1 2.8 113.8 1.3 7.4 19.7 13.4 11.2 2.6 2.8 0.3 5.3 2.8 5.4 7.3 2.3 0.7 2.5 4.0 2.8 3.5 0.0 4.7 2.5 0.3 2.1 0.9 2.4 1.9 3.6 8.4 0.4 20.4 16.2 3.9 2.3 2.5 7.8 3.3 1.5 4.5 2.7 2.6 4.0 0.9 0.2 2.3 1.2 1.2 24.5 3.2 5.0 4.6 0.1 0.0 0.4 2.2 4.9 3.8 5.8 1.3 0.4 3.2 3.9 2.2 4.8 0.0 3.7 8.8 1.1 4.0 1.8 1.7 3.9 1.2 1.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 11.0 13.8 15.0 11.0 11.1 11.2 10.9 10.9 10.9 11.1 11.2 19.0 192.3 66.5 95.0 34.8 21.9 8.8 10.9 33.0 53.6 30.9 34.3 37.4 20.0 74.7 31.3 73.0 7.6 30.6 2.8 1.9 9.2 53.8 17.3 27.1 11.0 7.2 13.0 133.4 13.0 5.4 12.7 20.4 24.5 9.5 36.4 11.0 28.7 1.5 45.4 126.1 10.1 12.2 6.6 9.9 10.8 39.4 5.0 21.4 12.2 6.4 9.3 32.0 112.1 24.2 16.8 4.9 37.6 45.1 7.6 7.1 5.8 39.9 67.8 13.1 13.5 13.8 48.9 28.4 10.0 14.8 2.9 49.8 22.0 9.4 6.6 GOLGB1 "GCP, GCP372, giantin, GOLIM1" ENSG00000173230 "Golgin B1" Q14789 3 121663199-121749767 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011008, HPA011555" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 51: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA011008: AB_1079011, HPA011555: AB_1079010" "unprognostic (2.56e-2)" "unprognostic (7.69e-2)" "unprognostic (1.46e-1)" "unprognostic (6.57e-2)" "unprognostic (5.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (6.58e-2)" "unprognostic (7.49e-2)" "unprognostic (3.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-1)" "unprognostic (9.90e-3)" "unprognostic (9.05e-2)" 19.9 25.2 11.0 7.1 12.7 14.1 24.1 15.0 12.9 21.9 26.5 18.8 12.2 17.4 32.1 15.1 15.8 13.3 18.5 13.2 10.5 18.6 17.9 15.3 8.4 8.5 9.9 21.9 27.1 20.7 25.0 13.4 9.0 25.8 17.1 31.0 25.2 19.9 14.2 20.2 19.0 10.0 9.6 16.6 19.7 14.6 9.3 11.3 21.0 11.1 9.8 16.3 15.7 11.5 19.9 15.7 15.3 9.9 28.8 31.0 9.6 12.6 27.5 11.9 13.4 13.8 7.1 4.3 10.4 23.6 11.9 9.0 9.2 13.7 14.1 6.3 17.5 12.2 20.1 19.2 17.2 13.7 16.0 25.4 31.9 7.5 18.7 25.8 15.3 7.3 5.8 9.6 12.7 14.3 4.1 9.9 9.9 19.1 16.4 5.4 12.0 10.3 17.7 20.2 10.8 12.0 15.5 11.0 16.7 17.3 13.6 15.2 21.5 11.4 6.9 4.9 9.2 17.8 11.4 7.2 15.3 6.6 4.3 1.6 4.1 4.3 4.3 2.2 3.5 3.4 3.5 3.3 2.6 2.8 3.3 3.6 15.4 3.9 1.7 5.5 3.9 1.6 11.0 12.7 15.0 12.9 13.2 10.5 8.5 9.9 9.0 9.6 9.3 11.5 118.9 291.7 233.9 101.2 97.3 51.6 89.1 62.1 96.8 101.4 110.2 130.3 274.8 74.4 179.2 53.3 123.0 78.7 134.7 148.6 11.7 104.3 56.0 247.9 186.4 102.7 91.9 36.8 72.9 111.0 53.0 135.5 144.8 284.0 115.6 220.7 74.3 68.9 34.5 69.0 80.2 176.8 65.1 47.2 48.3 23.8 198.5 82.1 33.8 68.4 76.8 82.1 54.6 50.3 72.8 100.2 95.7 199.0 176.0 74.9 79.9 29.3 165.7 193.6 85.5 165.9 120.5 155.0 66.8 70.2 45.7 150.8 102.6 197.7 101.7 88.3 GPALPP1 "AD029, bA245H20.2, KIAA1704, LSR7" ENSG00000133114 "GPALPP motifs containing 1" Q8IXQ4 13 44989529-45037669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038966, HPA058739" Approved Approved "Nucleoplasm,Nucleoli rim" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 71: Testis - DNA repair" "Cluster 14: REH - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoli rim" Nucleoplasm "HPA038966: AB_10672656, HPA058739: AB_2683804" "unprognostic (4.99e-2)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (8.81e-2)" "unprognostic (3.65e-2)" "unprognostic (2.63e-2)" "unprognostic (8.86e-2)" "unprognostic (6.08e-2)" "unprognostic (2.72e-2)" "unprognostic (1.39e-2)" "unprognostic (1.06e-1)" "unprognostic (4.56e-2)" "unprognostic (1.41e-3)" "unprognostic (3.37e-2)" "unprognostic (6.38e-2)" "unprognostic (5.88e-2)" "unprognostic (3.94e-2)" 6.2 6.6 2.4 3.2 2.2 6.5 5.3 4.8 3.2 6.9 0.7 6.1 3.0 6.7 3.0 5.8 6.1 2.1 5.5 2.3 2.2 6.9 5.0 5.2 4.3 1.0 1.6 8.0 4.9 1.8 6.0 3.6 1.2 5.7 2.9 5.6 5.3 2.5 4.3 4.5 5.2 2.6 0.3 5.6 5.6 5.3 1.6 3.2 6.1 1.8 3.6 6.5 6.4 3.3 4.7 3.8 6.2 4.6 2.6 5.3 6.3 6.1 3.8 6.1 5.8 7.8 9.1 10.9 4.3 4.1 5.8 9.6 6.6 5.1 5.7 9.2 9.2 8.1 6.3 5.4 3.9 10.9 4.5 3.3 2.9 4.8 3.2 3.7 4.9 8.5 7.2 2.4 4.0 5.5 11.0 9.3 5.7 11.9 4.4 11.0 5.3 4.5 3.5 4.6 3.2 5.1 5.8 4.0 3.5 4.5 4.0 11.0 7.9 4.0 3.3 4.6 5.1 4.0 4.0 11.5 4.1 6.7 5.2 2.4 3.9 6.7 4.0 3.1 3.2 4.8 4.1 2.7 4.4 6.2 4.7 4.2 2.9 4.0 3.3 5.7 3.1 2.5 2.4 2.2 4.8 3.2 2.3 2.2 1.0 1.6 1.2 0.3 1.6 3.3 18.5 32.1 34.2 26.1 19.1 7.1 15.6 11.6 15.4 24.4 13.7 13.6 16.2 15.7 22.3 23.9 18.8 27.9 19.6 6.8 23.5 13.0 7.0 15.2 26.1 17.3 18.0 14.7 65.0 13.3 13.1 19.0 9.2 17.2 21.5 27.7 16.8 17.3 15.5 23.5 57.3 11.3 12.2 14.2 7.6 5.1 26.8 12.9 12.4 24.4 15.6 18.5 29.9 53.3 42.6 11.4 11.1 26.7 10.5 10.0 10.7 21.0 22.3 26.1 26.3 20.1 23.1 48.7 26.7 16.7 9.2 18.2 16.2 22.9 12.6 11.8 GPATCH2L "C14orf118, FLJ10033, FLJ20689" ENSG00000089916 "G-patch domain containing 2 like" Q9NWQ4 14 76151916-76254342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018856 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA018856: AB_1845553" "unprognostic (5.98e-2)" "unprognostic (1.44e-2)" "unprognostic (7.07e-2)" "unprognostic (1.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.59e-2)" "unprognostic (6.63e-3)" "unprognostic (1.81e-2)" "unprognostic (2.89e-2)" "unprognostic (2.70e-1)" "unprognostic (2.05e-2)" "unprognostic (5.60e-2)" "unprognostic (5.81e-2)" "unprognostic (7.79e-2)" "unprognostic (2.14e-1)" "unprognostic (8.09e-2)" "unprognostic (1.81e-1)" 9.9 8.9 7.5 12.1 10.1 37.5 9.7 10.7 9.7 8.9 11.4 9.9 8.5 10.5 9.5 11.3 8.0 12.2 13.3 7.8 10.2 8.9 6.8 10.7 12.1 9.9 8.9 10.4 8.7 9.2 6.9 11.3 9.4 9.8 10.8 15.5 8.2 9.8 12.1 9.0 9.2 11.9 9.9 10.8 9.3 13.8 8.8 11.6 9.7 14.0 12.1 10.5 9.3 12.8 18.7 24.0 19.2 15.3 11.0 17.0 15.7 21.7 15.0 20.7 20.1 16.0 30.8 22.2 12.6 16.8 16.8 22.0 23.4 14.2 36.6 24.7 12.9 19.5 26.1 10.1 14.2 13.7 27.6 17.6 12.6 17.8 23.0 16.2 21.9 18.1 20.6 30.6 18.6 30.6 18.3 17.7 24.2 11.1 17.5 20.3 23.2 11.5 14.7 37.0 15.5 19.2 24.5 21.6 12.0 19.7 25.2 21.2 24.0 26.7 15.3 14.9 16.5 30.7 31.3 29.2 21.4 18.4 28.0 5.3 7.3 7.9 3.5 6.6 3.0 6.3 1.9 5.2 7.2 5.3 4.2 3.0 5.6 5.6 4.8 5.6 4.5 3.7 7.5 10.1 10.7 9.7 7.8 10.2 9.9 8.9 9.4 9.9 8.8 12.8 35.3 16.0 18.2 48.0 30.2 23.3 37.4 26.0 22.2 100.0 19.9 21.2 46.3 18.6 25.2 18.4 104.3 16.2 36.8 18.8 3.9 20.0 151.4 28.9 46.2 38.2 47.8 17.1 76.0 13.3 12.7 36.6 21.9 54.5 43.7 48.2 29.3 11.6 25.2 158.2 67.0 19.3 24.4 43.0 48.9 138.9 24.8 43.5 23.2 59.0 47.7 42.3 43.3 82.0 75.0 30.4 29.4 37.6 24.6 56.9 40.2 13.5 24.4 122.7 26.3 55.0 41.7 56.6 27.2 18.7 27.3 17.4 31.2 34.9 20.6 42.6 GPR52 ENSG00000203737 "G protein-coupled receptor 52" Q9Y2T5 1 174447964-174449545 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 13.0;cerebellum: 3.2;cerebral cortex: 3.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "basal ganglia: 103.7" "Region enhanced" "Detected in all" "basal ganglia: 31.6" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.60e-2)" "unprognostic (2.61e-2)" "unprognostic (3.65e-1)" "unprognostic (2.27e-1)" "unprognostic (4.49e-1)" 0.0 0.0 1.2 0.0 13.0 0.5 0.0 3.2 3.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 13.0 3.2 3.5 0.9 1.0 0.0 0.3 0.1 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 GSE1 KIAA0182 ENSG00000131149 "Gse1 coiled-coil protein" Q14687 16 85169525-85676204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 146.0;Syncytiotrophoblasts: 182.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 24.4" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 174.6;K-562: 205.4;T-47d: 200.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036365, HPA042090" Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" Mitochondria Nucleoplasm "HPA036365: AB_10601762, HPA042090: " "unprognostic (1.12e-2)" "unprognostic (6.29e-2)" "unprognostic (1.12e-1)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (1.63e-1)" "unprognostic (1.76e-1)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (6.41e-2)" "prognostic favorable (5.20e-4)" "unprognostic (2.29e-3)" "unprognostic (1.32e-3)" "unprognostic (8.41e-2)" "unprognostic (8.46e-2)" "unprognostic (3.81e-1)" "unprognostic (1.88e-1)" 27.2 15.2 1.4 14.2 0.7 31.9 22.0 24.4 7.9 16.9 0.0 17.9 15.9 15.1 5.0 12.7 15.9 10.6 23.2 3.9 3.0 12.3 14.2 17.7 11.3 4.5 5.8 23.7 23.4 38.6 28.0 31.7 2.1 12.7 11.5 14.4 30.3 13.6 37.9 18.8 14.8 14.2 0.0 18.4 20.8 14.7 2.0 40.7 19.3 9.3 8.7 13.0 14.1 0.7 19.3 33.6 22.0 55.5 13.9 12.7 174.6 25.3 17.4 13.9 5.2 29.0 25.6 11.2 29.9 28.9 12.5 17.9 35.1 9.7 7.0 21.2 29.7 82.4 33.6 36.5 17.9 38.5 44.8 23.7 22.7 14.9 7.1 14.5 3.7 65.7 205.4 2.0 4.6 129.9 138.1 33.9 38.4 20.7 9.9 89.7 7.4 29.1 12.6 7.2 142.7 99.3 49.8 91.8 4.7 19.9 200.7 94.6 6.4 28.3 35.5 7.9 6.9 30.0 19.5 65.3 16.2 23.8 25.4 2.8 0.7 2.2 1.4 1.3 1.4 1.6 0.5 0.9 1.2 1.5 0.2 1.0 0.6 0.9 3.3 0.0 0.0 0.6 1.4 0.7 24.4 7.9 3.9 3.0 4.5 5.8 2.1 0.0 2.0 0.7 52.9 67.3 68.1 30.3 16.6 14.0 7.3 11.6 21.1 65.0 39.6 16.8 37.0 25.8 24.1 38.6 146.0 52.9 25.5 33.6 1.9 14.9 4.3 48.8 34.7 27.0 59.7 65.6 53.2 12.4 75.9 21.7 39.3 61.6 43.6 80.9 17.2 34.7 12.3 35.3 45.4 67.5 20.3 15.1 24.0 5.5 47.2 17.5 10.6 19.7 12.2 7.1 35.0 14.1 13.7 17.9 20.9 61.3 18.6 14.3 12.6 6.2 30.5 62.3 6.6 15.5 10.1 2.3 18.3 33.5 30.0 182.2 21.5 55.8 25.7 12.3 GTF2H2C ENSG00000183474 "GTF2H2 family member C" Q6P1K8 5 69560191-69595221 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 10.1" "Cell line enhanced" "Detected in many" "U-266/84: 37.5" HPA047001 Approved "Nuclear speckles" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA047001: AB_2679899" "unprognostic (3.70e-1)" "unprognostic (3.46e-2)" "unprognostic (2.11e-2)" "unprognostic (1.95e-1)" "unprognostic (5.97e-2)" "unprognostic (4.33e-2)" "unprognostic (8.59e-3)" "unprognostic (5.34e-2)" "unprognostic (7.12e-2)" "unprognostic (6.03e-2)" "unprognostic (6.08e-2)" "unprognostic (1.56e-1)" "unprognostic (1.86e-1)" "unprognostic (7.52e-2)" "unprognostic (2.68e-1)" "unprognostic (2.40e-3)" "unprognostic (2.55e-1)" 7.4 6.9 3.0 4.0 3.6 2.9 7.2 4.6 4.4 9.0 2.0 8.0 1.4 8.2 3.0 5.4 8.2 1.7 6.1 3.2 3.2 13.0 11.3 8.3 4.0 3.7 3.5 8.6 10.6 2.8 6.4 1.5 4.0 6.0 2.0 4.4 6.8 2.3 6.0 4.9 7.2 3.7 2.4 7.9 7.2 9.8 3.3 3.8 9.9 1.3 1.1 7.1 6.8 6.8 8.0 5.8 4.6 5.7 2.7 3.9 6.5 13.2 5.1 8.7 10.0 8.6 4.8 19.7 15.3 4.0 3.1 3.2 6.9 7.5 13.5 20.2 11.0 21.8 4.7 9.0 4.3 13.6 6.7 1.5 2.0 4.7 3.9 3.5 2.7 8.5 16.1 10.5 0.8 8.2 17.8 6.5 7.2 0.7 4.3 6.5 19.5 19.0 10.5 7.5 6.4 13.0 17.9 4.8 9.3 3.8 6.4 8.7 12.7 7.3 4.5 5.2 18.0 7.4 37.5 14.7 7.4 16.6 13.3 10.1 1.6 2.1 0.9 1.4 1.7 1.5 1.0 1.6 1.3 1.7 1.2 2.4 5.0 1.5 1.2 1.4 1.8 1.2 3.0 3.6 4.6 4.4 3.2 3.2 3.7 3.5 4.0 2.4 3.3 6.8 4.9 9.6 10.9 6.8 14.3 3.6 4.9 8.6 6.8 10.6 7.5 3.9 8.2 14.3 10.4 14.7 12.5 4.9 4.9 5.9 9.8 7.1 16.2 15.7 10.3 6.3 2.4 12.4 9.6 5.7 2.9 8.1 8.6 15.4 0.0 7.7 7.9 6.9 4.3 18.5 10.5 4.1 14.2 6.3 3.3 17.8 9.0 7.6 3.6 5.6 3.5 6.5 13.4 5.5 9.8 5.9 4.0 11.7 8.7 6.1 5.8 14.2 10.8 14.6 0.0 3.2 7.1 32.5 23.5 7.2 4.1 1.4 7.1 6.7 5.4 7.4 GTF2IRD2 "FLJ37938, GTF2IRD2A" ENSG00000196275 "GTF2I repeat domain containing 2" Q86UP8 7 74796144-74851551 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 59.0" "HPA056679, HPA056680" Supported Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA056679: AB_2683205, HPA056680: AB_2683206" "unprognostic (7.91e-5)" "unprognostic (3.90e-3)" "unprognostic (1.43e-2)" "unprognostic (5.35e-2)" "unprognostic (2.02e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" "unprognostic (6.80e-3)" "unprognostic (1.22e-1)" "unprognostic (6.11e-2)" "unprognostic (4.43e-5)" "unprognostic (3.18e-2)" "unprognostic (8.97e-3)" "unprognostic (2.58e-1)" "unprognostic (6.35e-2)" "unprognostic (1.19e-1)" "unprognostic (1.59e-4)" 11.6 12.7 6.5 4.6 7.5 8.5 12.6 7.3 7.1 16.8 7.6 16.3 5.9 13.0 5.0 9.6 15.5 4.6 18.7 6.5 7.7 13.2 17.4 9.1 5.7 7.3 7.5 19.6 15.3 6.7 13.0 3.8 7.6 15.4 6.5 7.7 11.9 6.8 38.7 9.3 9.7 7.4 6.9 8.9 15.1 7.4 7.4 8.2 13.5 17.8 5.5 14.0 11.3 10.0 16.6 5.4 7.3 10.6 10.2 6.6 5.6 5.6 5.7 6.4 7.3 1.5 13.9 4.3 1.3 9.1 11.0 3.3 0.1 3.4 5.5 2.1 1.3 3.5 8.3 7.9 9.6 5.8 0.7 6.3 5.3 1.8 4.9 8.0 6.6 3.3 10.3 8.8 5.8 14.6 2.3 16.5 11.5 18.2 3.8 4.3 2.6 15.8 15.7 14.6 5.1 16.7 22.8 59.0 13.3 6.3 12.5 11.3 6.0 9.8 2.5 1.7 8.9 6.6 3.0 4.7 8.0 3.9 20.9 12.3 7.1 7.8 3.2 4.1 4.7 18.9 7.2 9.5 7.3 11.6 8.7 5.5 1.0 5.5 3.6 13.0 7.1 7.6 6.5 7.5 7.3 7.1 6.5 7.7 7.3 7.5 7.6 6.9 7.4 10.0 6.7 19.2 27.4 23.5 20.7 3.2 11.7 6.9 15.4 27.4 15.8 13.1 11.7 21.5 15.5 12.9 56.3 7.2 11.2 18.1 3.9 21.4 20.3 15.5 10.6 7.2 27.0 3.8 4.5 28.1 7.4 14.3 17.9 11.1 14.0 32.0 18.5 9.6 4.7 37.0 8.5 19.9 6.1 7.9 4.6 5.2 43.8 6.8 10.6 3.7 11.7 12.4 26.8 14.6 20.5 28.8 18.0 25.9 8.5 12.3 15.0 6.7 22.5 40.7 13.1 29.2 13.2 2.8 2.6 11.2 4.3 6.4 12.0 18.2 21.1 8.0 GTF3C3 "TFIIIC102, TFiiiC2-102" ENSG00000119041 "General transcription factor IIIC subunit 3" Q9Y5Q9 2 196763035-196799725 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069179 Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" "HPA069179: AB_2686099" "unprognostic (1.44e-1)" "unprognostic (2.63e-2)" "unprognostic (1.89e-1)" "unprognostic (4.52e-2)" "unprognostic (5.88e-2)" "unprognostic (3.64e-2)" "prognostic unfavorable (1.26e-6)" "unprognostic (1.92e-1)" "unprognostic (9.28e-2)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (5.62e-2)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.72e-1)" "unprognostic (1.70e-1)" "unprognostic (3.08e-2)" 11.0 10.9 18.1 9.6 20.4 36.8 19.5 25.1 23.1 10.9 23.8 10.8 10.2 12.2 15.1 11.4 11.9 19.6 10.0 19.8 19.9 9.5 12.9 10.5 18.8 21.7 19.0 13.8 13.1 13.6 9.0 12.5 25.9 10.2 13.1 18.6 9.7 10.0 13.6 20.9 10.8 14.3 17.9 13.8 12.1 13.9 19.5 13.4 15.1 7.3 10.9 11.6 9.4 31.8 14.4 19.2 28.4 22.2 13.1 19.4 28.0 26.2 16.3 24.7 25.0 41.4 23.0 29.8 15.9 15.7 24.1 19.2 24.4 23.3 28.7 35.0 26.6 37.2 59.9 38.6 21.8 32.8 28.9 25.8 21.4 17.8 25.0 21.9 22.6 25.7 45.6 54.6 14.9 34.0 28.6 29.2 16.9 16.9 29.3 24.4 20.7 19.8 17.6 43.2 22.6 20.5 16.7 14.6 17.8 35.9 15.4 21.1 15.0 21.2 15.1 16.7 19.3 26.0 34.4 22.2 21.8 24.4 16.9 8.4 4.7 4.4 3.9 3.1 3.5 4.8 3.5 4.0 2.8 6.8 4.2 4.0 4.4 4.8 5.8 4.3 4.8 2.3 18.1 20.4 25.1 23.1 19.8 19.9 21.7 19.0 25.9 17.9 19.5 31.8 17.4 22.4 16.0 19.2 11.6 4.0 12.2 16.6 10.2 18.1 8.8 8.8 35.8 7.2 21.4 14.7 18.8 15.3 18.1 7.7 13.7 12.4 4.4 18.2 17.4 17.0 12.5 19.1 24.7 12.3 12.6 12.9 11.2 13.3 14.0 24.7 12.8 8.2 13.5 0.0 29.8 10.1 16.2 12.7 5.0 4.6 13.4 11.8 7.2 27.2 22.0 12.5 9.2 23.1 38.5 14.7 6.4 10.9 16.3 8.4 12.9 10.9 37.2 15.6 6.6 10.1 13.6 44.7 24.8 11.6 5.5 15.7 12.2 18.2 11.9 9.4 GTF3C5 "TFiiiC2-63, TFIIIC63, TFIIICepsilon" ENSG00000148308 "General transcription factor IIIC subunit 5" Q9Y5Q8 9 133030675-133058503 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067063, HPA069805" Supported Enhanced Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA067063: AB_2685773, HPA069805: AB_2686201" "unprognostic (1.07e-2)" "unprognostic (1.78e-3)" "unprognostic (5.58e-2)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-1)" "unprognostic (7.97e-3)" "unprognostic (4.01e-2)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (1.10e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-3)" "unprognostic (4.55e-3)" "unprognostic (1.13e-2)" "unprognostic (1.33e-1)" "unprognostic (8.73e-2)" 26.5 33.6 26.3 20.6 30.4 42.4 29.1 35.1 35.8 36.2 23.9 28.8 26.4 31.7 22.3 39.0 32.0 17.5 39.1 26.9 27.5 27.5 32.9 23.7 27.7 28.1 28.6 44.6 33.6 24.5 36.0 24.6 29.0 34.3 19.2 13.7 29.1 20.7 47.9 38.6 30.3 21.6 26.2 32.1 28.5 29.4 28.5 44.5 28.6 32.3 25.3 29.2 33.2 36.6 44.1 77.5 67.3 63.3 35.9 32.5 93.2 42.0 45.4 78.6 55.4 83.5 71.8 72.7 38.7 47.1 63.2 103.9 79.8 76.3 40.2 74.9 69.1 86.8 90.3 78.7 55.9 66.2 176.0 45.0 49.9 83.5 57.7 38.0 69.1 235.1 112.5 66.0 42.1 142.1 107.9 92.4 87.5 100.6 79.7 113.9 69.5 89.2 52.4 50.2 80.4 59.7 71.2 73.4 43.8 38.1 96.5 95.6 46.0 92.0 71.3 59.1 71.8 25.8 57.3 78.0 44.8 49.8 62.4 54.2 16.0 22.5 15.8 18.9 23.0 14.6 16.3 20.7 17.2 13.6 18.1 16.4 9.5 20.7 16.3 16.6 19.4 17.8 26.3 30.4 35.1 35.8 26.9 27.5 28.1 28.6 29.0 26.2 28.5 36.6 16.0 9.6 19.0 17.3 21.0 12.4 16.5 21.7 30.7 14.2 25.2 21.6 29.3 14.3 17.2 16.5 8.4 42.1 20.0 30.4 29.4 25.5 3.4 16.2 15.4 16.4 14.4 22.3 9.0 30.3 38.4 19.7 18.3 19.9 16.5 50.1 18.5 17.2 22.5 15.2 7.9 15.9 34.6 15.7 9.9 4.3 17.4 15.8 16.0 8.4 14.8 18.8 15.5 6.0 16.6 27.2 25.4 21.4 17.4 13.9 27.3 11.7 14.6 20.8 46.0 17.2 19.4 20.5 31.9 26.1 16.6 41.6 17.6 34.0 25.7 19.4 GVQW3 ENSG00000179240 "GVQW motif containing 3" Q3ZCU0 11 76381303-76414619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 14.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.9;Distal tubular cells: 9.8;granulocytes: 3.8;Granulosa cells: 7.0;Proximal tubular cells: 6.7;Theca cells: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057405 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Centrosome" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Centrosome" "Endoplasmic reticulum" "HPA057405: AB_2683429" "unprognostic (8.90e-2)" "unprognostic (1.16e-1)" "unprognostic (8.27e-2)" "unprognostic (1.92e-1)" "unprognostic (9.04e-3)" "unprognostic (8.56e-2)" "unprognostic (8.87e-2)" "unprognostic (2.91e-2)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (4.05e-4)" "unprognostic (7.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.28e-2)" "unprognostic (2.13e-1)" 1.1 1.5 1.5 1.4 1.6 1.1 1.9 3.2 2.1 1.7 4.4 1.3 1.4 1.8 1.9 0.4 2.0 0.7 1.0 1.4 0.8 1.4 0.7 0.9 1.9 0.5 0.1 2.2 6.5 1.0 2.4 0.8 0.6 1.2 1.5 14.2 1.9 0.8 1.1 1.4 1.3 0.9 0.0 1.7 1.4 3.4 1.2 2.4 1.9 0.6 1.6 0.9 1.3 1.5 1.1 1.2 4.4 3.2 1.2 1.6 1.5 0.6 0.5 1.1 1.1 3.0 2.0 3.6 1.2 0.5 1.3 2.6 1.9 0.8 1.9 2.0 1.2 1.9 5.0 1.3 0.7 2.5 1.2 0.7 1.2 1.4 0.8 1.0 0.9 4.9 1.2 2.3 0.4 1.3 2.4 3.8 0.9 0.9 1.4 3.7 2.9 1.9 0.7 0.8 6.5 2.9 1.2 0.7 0.7 1.7 2.1 0.8 0.6 2.1 2.2 3.2 0.7 2.1 1.6 4.6 0.8 1.7 1.1 1.5 0.3 0.4 0.4 0.2 0.3 0.5 0.6 0.5 0.2 0.6 0.6 0.6 1.0 0.8 0.2 0.3 0.8 0.2 1.5 1.6 3.2 2.1 1.4 0.8 0.5 0.1 0.6 0.0 1.2 1.5 2.1 0.0 3.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 2.3 0.0 0.0 2.5 1.8 0.0 1.1 1.7 0.0 9.8 1.2 0.0 2.4 2.5 0.8 0.0 0.0 0.0 0.6 0.6 1.4 0.0 0.6 3.8 7.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.7 2.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.9 5.5 0.0 0.0 HACD3 "B-ind1, HSPC121, PTPLAD1" ENSG00000074696 "3-hydroxyacyl-CoA dehydratase 3" Q9P035 15 65530418-65578349 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014837, HPA060347" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA014837: AB_1855914, HPA060347: AB_2684260" "unprognostic (1.51e-2)" "unprognostic (2.89e-1)" "unprognostic (2.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.52e-1)" "unprognostic (1.92e-2)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (3.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.57e-1)" "prognostic favorable (3.09e-5)" "unprognostic (3.44e-2)" "unprognostic (5.33e-2)" "unprognostic (1.10e-2)" "unprognostic (2.04e-2)" 23.1 84.1 56.1 18.5 57.1 17.3 74.4 64.6 67.5 40.2 73.2 30.0 28.9 29.9 43.0 19.2 32.4 34.1 11.8 54.3 87.8 79.6 119.1 30.3 18.8 68.3 79.6 47.8 29.8 61.5 44.2 37.2 87.2 41.6 34.3 54.0 28.6 34.3 6.9 27.7 29.2 28.1 70.0 21.2 68.7 34.6 88.3 29.0 70.8 7.8 20.3 43.0 17.8 75.8 88.9 194.4 211.3 106.2 130.3 78.0 99.8 95.9 82.4 106.6 119.6 149.9 129.1 110.8 81.8 104.7 132.6 237.9 344.4 80.1 94.8 61.9 191.8 88.1 88.7 165.3 65.9 110.6 64.9 80.3 58.7 73.3 52.5 102.7 105.5 65.1 117.5 40.8 174.3 105.6 82.5 86.0 180.6 235.3 65.4 91.8 178.9 125.0 152.1 151.2 126.8 111.9 103.6 114.9 110.5 197.5 117.1 57.9 84.2 134.4 117.6 66.9 134.9 79.1 251.2 154.5 89.7 105.8 82.6 8.5 7.5 2.5 31.7 11.2 36.1 23.7 28.6 30.2 13.2 22.2 33.0 32.9 1.0 23.2 12.7 17.4 24.6 22.7 56.1 57.1 64.6 67.5 54.3 87.8 68.3 79.6 87.2 70.0 88.3 75.8 63.6 64.1 64.8 84.5 18.7 0.0 60.5 0.0 76.2 121.3 94.8 64.5 9.9 62.9 27.9 176.6 100.1 189.1 23.8 6.1 25.4 71.3 107.2 62.8 76.2 51.8 43.7 67.3 57.5 46.3 124.4 62.7 73.4 39.8 16.4 127.0 42.1 165.2 51.2 139.7 97.1 26.3 0.0 23.1 0.0 32.5 87.3 22.2 0.0 29.0 5.2 89.8 16.5 57.8 66.7 32.1 18.2 88.4 28.9 71.5 28.3 56.2 36.5 83.7 78.9 40.9 41.9 156.9 110.3 54.3 0.0 113.1 22.3 136.2 45.1 78.7 HGSNAT "FLJ32731, HGNAT, TMEM76" ENSG00000165102 "Heparan-alpha-glucosaminide N-acetyltransferase" Q68CP4 8 43140464-43202855 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease variant, Mucopolysaccharidosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029578 Approved NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "HPA029578: AB_10602423" "unprognostic (5.35e-2)" "unprognostic (4.61e-2)" "unprognostic (4.31e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.46e-4)" "unprognostic (3.94e-3)" "unprognostic (1.10e-1)" "unprognostic (6.54e-3)" "unprognostic (5.02e-2)" "prognostic favorable (6.33e-5)" "unprognostic (2.55e-2)" "unprognostic (5.48e-3)" "unprognostic (2.03e-1)" "unprognostic (1.27e-2)" "unprognostic (1.55e-1)" "unprognostic (1.72e-1)" "unprognostic (3.45e-2)" 32.3 20.0 13.1 17.5 13.0 21.7 27.8 10.6 13.5 35.0 13.8 25.4 18.4 30.1 30.6 24.0 29.0 25.9 23.3 13.3 17.6 20.0 26.6 24.5 11.7 13.3 12.0 35.9 29.9 22.7 30.7 28.4 13.2 26.9 17.2 12.5 25.9 23.3 14.4 35.4 20.9 25.1 11.4 17.6 23.2 7.6 15.8 11.3 26.9 17.6 15.7 25.2 28.7 13.0 27.4 36.0 8.9 18.0 71.7 53.8 13.3 30.5 36.2 21.8 19.3 5.1 39.2 14.8 20.5 42.9 15.2 15.5 4.0 18.5 12.7 6.4 6.9 16.3 22.2 8.1 23.0 3.7 2.5 36.2 25.9 11.7 24.9 34.5 39.2 7.0 7.5 22.1 40.4 10.0 14.8 7.2 8.0 16.3 5.4 1.6 16.1 7.7 36.1 22.8 4.7 14.0 39.0 12.6 17.4 19.0 43.7 20.9 46.3 33.2 5.4 20.9 12.7 17.9 18.2 6.1 26.8 6.3 20.8 0.2 8.8 9.4 2.7 5.4 3.0 1.9 2.3 2.8 15.8 2.1 1.7 1.9 3.2 8.8 8.6 2.0 1.7 5.0 13.1 13.0 10.6 13.5 13.3 17.6 13.3 12.0 13.2 11.4 15.8 13.0 39.1 16.0 31.9 48.0 26.7 18.0 19.5 22.6 8.6 50.6 23.9 21.7 10.5 28.6 17.8 51.5 50.1 39.2 30.1 27.2 3.9 26.7 0.5 23.5 42.1 37.8 24.1 15.3 61.8 28.1 39.4 34.3 32.6 36.5 8.2 51.2 49.6 23.5 29.2 25.2 76.3 28.0 18.3 34.3 58.8 3.2 35.1 43.3 19.6 44.0 33.5 13.5 34.0 50.8 43.8 29.9 17.0 31.6 19.8 20.7 31.4 9.9 23.5 39.6 26.3 30.2 28.2 1.1 3.0 22.3 21.2 30.1 25.0 37.4 21.7 17.7 HMGXB3 "HMGX3, KIAA0194, SMF" ENSG00000113716 "HMG-box containing 3" Q12766 5 150000046-150053142 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "parathyroid gland: 117.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005967 Approved Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Nucleoli "HPA005967: AB_1080044" "unprognostic (3.66e-2)" "unprognostic (3.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (3.37e-5)" "unprognostic (9.72e-2)" "unprognostic (3.36e-1)" "unprognostic (3.89e-3)" "unprognostic (3.74e-2)" "unprognostic (2.11e-1)" "unprognostic (3.24e-3)" "unprognostic (1.30e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-2)" 13.9 17.0 10.4 9.5 11.4 20.0 17.3 10.2 12.0 14.1 14.2 11.8 8.0 14.2 15.3 10.6 14.5 12.4 12.7 11.0 10.6 14.6 13.5 16.5 11.8 10.5 11.4 15.3 13.6 117.1 17.1 12.5 10.3 20.2 11.0 11.6 13.3 12.5 14.6 15.2 11.6 11.4 10.1 16.1 14.1 14.3 12.9 14.9 16.0 13.3 12.0 12.4 11.8 12.3 23.5 27.2 19.4 30.6 27.2 22.6 32.8 22.2 41.1 33.0 41.7 39.7 28.5 22.3 25.4 31.3 70.7 17.0 36.9 39.9 29.0 20.9 26.0 19.4 30.8 20.1 38.3 38.0 42.8 30.1 29.3 48.9 39.1 42.6 24.5 17.8 26.2 23.2 36.4 19.5 23.5 20.9 14.4 16.1 41.2 20.6 26.1 21.9 20.8 29.6 24.1 24.6 19.3 48.2 51.4 16.8 22.3 25.6 20.5 49.3 21.0 24.2 42.2 27.0 27.0 31.5 57.2 29.2 26.0 3.5 2.5 2.3 3.3 3.1 2.6 3.0 2.8 2.4 3.2 2.6 2.1 2.4 0.2 1.2 2.1 2.5 4.4 2.1 10.4 11.4 10.2 12.0 11.0 10.6 10.5 11.4 10.3 10.1 12.9 12.3 34.8 9.6 12.8 14.0 22.0 11.3 27.0 14.2 17.6 29.5 33.2 26.7 8.0 11.5 17.0 9.2 35.5 16.3 36.1 13.3 21.5 22.2 6.2 47.7 37.5 24.7 15.5 12.8 20.4 21.9 12.6 23.9 30.1 47.5 18.3 36.7 15.0 12.6 27.9 72.3 20.0 12.8 6.1 11.9 13.7 3.1 13.4 18.9 3.6 16.9 23.5 19.8 29.9 15.1 18.5 34.3 8.4 12.4 29.5 41.1 7.4 13.8 24.7 43.1 13.1 23.5 19.5 28.9 24.4 15.6 12.1 15.5 23.3 42.8 15.6 29.4 HMGXB4 "HMG2L1, THC211630" ENSG00000100281 "HMG-box containing 4" Q9UGU5 22 35257452-35295807 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000725, HPA076681" Approved Approved Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA000725: AB_1079073, HPA076681: " "unprognostic (2.22e-1)" "unprognostic (1.12e-1)" "prognostic favorable (3.24e-5)" "unprognostic (4.81e-2)" "unprognostic (1.93e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (4.79e-4)" "unprognostic (2.85e-2)" "unprognostic (8.25e-3)" "unprognostic (6.67e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.62e-1)" "unprognostic (8.71e-3)" "unprognostic (1.13e-1)" "unprognostic (1.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.54e-2)" 7.9 4.7 5.1 7.8 6.5 23.4 8.1 6.5 7.2 6.7 3.7 6.6 6.4 11.6 3.7 8.6 7.6 7.0 6.5 5.3 5.8 4.1 5.1 5.6 7.5 5.9 5.3 14.0 7.0 8.2 2.2 9.0 5.8 7.4 7.4 8.5 6.7 6.2 7.2 6.7 6.7 9.5 4.9 6.3 5.0 7.9 6.1 11.3 6.7 7.2 7.7 8.6 5.3 8.2 22.6 4.9 37.6 17.6 9.3 16.4 9.9 22.3 31.6 22.1 20.1 4.3 8.9 27.5 10.2 23.3 13.4 13.0 14.9 18.3 26.2 23.3 18.6 24.6 6.5 5.3 11.2 56.8 25.1 15.8 14.0 18.5 14.2 13.3 16.8 21.0 19.7 21.6 17.1 11.0 35.1 15.1 15.7 15.6 14.2 25.3 32.5 10.7 13.8 17.5 22.1 23.0 19.6 15.6 16.5 10.6 9.6 16.1 13.3 20.1 41.9 24.1 19.5 26.1 25.5 34.8 17.1 15.9 31.7 34.5 12.5 16.9 13.4 14.8 11.7 10.4 13.1 14.3 9.8 13.3 8.4 9.6 19.0 9.6 13.8 10.8 12.1 5.9 5.1 6.5 6.5 7.2 5.3 5.8 5.9 5.3 5.8 4.9 6.1 8.2 30.6 12.8 18.5 18.3 30.9 20.9 52.3 33.3 16.5 60.6 26.0 25.1 14.4 34.3 29.7 27.6 35.5 48.0 30.1 31.5 29.4 40.4 14.7 22.2 35.5 32.4 16.9 56.6 17.7 29.3 54.5 34.8 27.5 31.9 52.1 51.9 36.8 24.1 31.8 67.3 20.5 31.9 28.5 26.4 17.6 12.7 53.7 29.1 8.8 7.5 32.1 21.0 34.0 17.1 31.5 35.3 27.4 56.8 21.2 58.1 26.4 21.0 15.6 73.5 39.5 46.4 32.9 67.0 82.9 28.0 22.6 64.7 30.4 33.1 32.3 57.8 HOMER3 HOMER-3 ENSG00000051128 "Homer scaffold protein 3" Q9NSC5 19 18929201-18941261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 125.1" "Cell type enhanced" "Detected in many" "Hofbauer cells: 76.4;Muller glia cells: 72.6;Proximal tubular cells: 84.2;Theca cells: 322.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 15.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 353.6;THP-1: 420.0;U-266/84: 375.4" "Region enriched" "Detected in all" 6 "cerebellum: 189.2" "Low region specificity" "Detected in all" "CAB032656, HPA040999, CAB079015" Enhanced Supported Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Cytosol "Plasma membrane, Cytoplasmic bodies" "CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242" "unprognostic (3.41e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.24e-5)" "unprognostic (1.19e-1)" "unprognostic (2.06e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (4.93e-5)" "unprognostic (1.07e-1)" "unprognostic (8.88e-2)" "unprognostic (5.78e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-2)" "unprognostic (5.99e-2)" "unprognostic (3.76e-2)" "unprognostic (2.33e-1)" "unprognostic (1.41e-1)" "unprognostic (4.11e-2)" 33.1 29.6 33.3 9.9 41.9 22.3 26.2 76.9 44.6 31.7 41.1 27.0 7.0 24.6 6.4 15.3 16.7 16.5 25.0 40.4 35.1 52.2 6.1 25.6 7.9 42.3 40.9 20.1 12.4 37.5 8.6 14.7 42.8 21.9 6.0 5.9 27.6 9.4 114.5 35.4 14.4 10.6 39.4 125.1 17.0 9.2 41.6 7.4 49.3 18.6 3.8 29.7 26.0 45.5 112.1 28.5 53.1 44.4 48.3 48.6 26.2 108.1 94.9 106.4 53.4 14.6 41.8 0.9 49.9 122.1 76.1 68.6 18.4 140.4 58.9 4.0 11.0 0.1 9.7 27.5 44.9 21.5 1.7 39.3 89.4 59.0 79.1 113.0 130.3 7.9 3.2 28.6 78.1 30.3 1.9 353.6 27.3 6.1 115.5 55.2 16.2 53.4 38.2 28.3 0.2 44.8 26.6 31.2 78.5 10.2 14.0 420.0 105.3 94.0 42.0 114.5 132.2 274.2 375.4 93.6 148.0 270.6 69.8 0.1 15.0 2.9 0.1 5.3 0.0 2.3 0.8 0.3 1.3 2.7 0.1 0.0 5.8 0.0 1.6 0.2 0.8 4.2 33.3 41.9 76.9 44.6 40.4 35.1 42.3 40.9 42.8 39.4 41.6 45.5 21.7 3.2 0.0 9.4 9.3 11.9 22.4 24.4 6.8 2.2 14.3 22.5 4.1 2.8 8.0 12.9 0.0 1.0 0.6 0.1 11.7 22.9 2.0 4.3 18.7 38.0 1.8 0.4 0.3 13.6 2.4 20.5 0.0 6.3 10.2 34.8 21.8 0.7 76.4 1.7 3.9 0.9 22.4 16.2 7.6 1.7 13.7 32.2 12.4 1.9 8.3 72.6 0.0 1.0 13.4 42.0 0.0 10.9 13.8 25.2 0.0 84.2 3.6 4.1 0.0 14.4 27.8 4.7 6.7 4.2 14.5 1.1 2.5 322.4 0.3 21.4 HPS4 "BLOC3S2, KIAA1667, LE" ENSG00000100099 "HPS4 biogenesis of lysosomal organelles complex 3 subunit 2" Q9NQG7 22 26443423-26483837 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 86.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033106, HPA050189" Approved Approved Centrosome NA NA "Cluster 46: Basophils - DNA binding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 52: Non-specific - Transcription" Centrosome "CAB033106: AB_2264349, HPA050189: AB_2681046" "unprognostic (1.55e-2)" "unprognostic (1.02e-1)" "unprognostic (9.82e-2)" "unprognostic (5.30e-3)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (1.83e-3)" "unprognostic (1.59e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (2.23e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (6.46e-2)" 6.6 8.9 10.4 6.5 11.4 10.3 6.7 11.1 10.5 9.0 12.2 6.7 5.4 6.9 7.7 9.9 9.2 6.1 4.5 10.3 11.5 8.6 8.5 6.5 8.5 10.9 10.8 12.1 12.7 12.1 11.0 5.6 11.2 8.3 5.5 7.6 6.6 7.7 4.6 14.0 7.3 7.1 10.7 9.0 8.1 13.1 11.4 13.0 9.8 5.0 9.6 6.9 8.4 10.5 16.3 7.5 15.5 15.9 11.5 13.6 8.2 9.7 18.8 21.4 19.1 7.9 7.8 15.4 7.5 11.8 12.1 13.2 14.9 21.0 19.3 11.4 15.4 15.6 6.3 13.3 20.5 18.4 17.0 13.3 17.1 19.5 34.5 18.1 14.2 25.5 17.4 19.0 15.7 6.9 31.2 6.2 9.3 15.0 8.0 86.3 18.3 20.4 9.9 10.1 17.6 13.0 9.4 10.6 46.7 11.6 11.5 13.9 8.8 24.8 46.2 12.4 12.2 28.1 23.4 50.5 16.2 11.8 16.3 10.8 3.2 3.1 4.8 2.3 4.5 5.5 3.9 4.1 4.3 4.7 4.5 5.0 1.1 7.2 2.1 5.7 2.8 4.7 10.4 11.4 11.1 10.5 10.3 11.5 10.9 10.8 11.2 10.7 11.4 10.5 16.6 12.8 32.4 28.7 38.7 12.5 28.3 28.9 17.1 52.6 14.4 12.4 6.3 17.2 25.5 42.3 114.7 21.7 31.7 11.6 17.6 20.4 24.3 16.3 17.2 18.6 26.5 48.1 18.4 27.1 19.4 14.1 28.1 14.1 42.4 40.6 22.5 14.2 24.8 43.7 31.1 20.1 44.7 18.3 12.2 24.3 32.6 19.1 48.0 19.7 14.9 23.7 21.6 32.6 36.4 45.0 13.6 19.9 25.1 29.4 18.0 15.7 28.1 119.3 0.0 16.0 12.2 32.3 46.6 11.1 14.9 20.0 20.6 23.6 21.4 26.9 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 56 "adrenal gland: 2174.8" "Group enriched" "Detected in some" 4 "Granulosa cells: 40.6;Proximal enterocytes: 38.8;Theca cells: 68.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.4" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" Yes NA "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.2 2174.8 0.3 2.1 0.8 0.0 0.1 0.0 0.7 0.2 0.0 7.7 0.0 0.2 0.0 0.2 0.4 0.0 0.3 0.2 0.0 0.9 1.0 0.5 0.0 0.0 0.0 0.9 0.5 0.0 0.1 3.6 0.1 0.4 1.0 0.0 1.0 0.0 0.1 0.2 38.7 0.1 0.0 0.2 0.3 2.9 0.2 0.5 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 3.5 0.0 0.0 0.0 40.6 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 38.8 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 68.9 1.7 0.0 ICE1 KIAA0947 ENSG00000164151 "Interactor of little elongation complex ELL subunit 1" Q9Y2F5 5 5420664-5490220 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054452, HPA061934" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA054452: AB_2682492, HPA061934: AB_2684641" "unprognostic (1.45e-2)" "unprognostic (9.73e-2)" "unprognostic (6.92e-2)" "unprognostic (2.39e-3)" "unprognostic (4.42e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.16e-1)" "unprognostic (4.29e-1)" "unprognostic (1.78e-1)" "unprognostic (3.51e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (4.59e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-2)" "unprognostic (2.33e-1)" 8.7 6.9 8.1 9.1 8.8 13.7 10.2 11.3 8.4 8.7 4.4 9.0 7.2 11.6 9.0 7.6 8.2 7.1 8.1 10.2 7.0 10.0 7.1 8.1 11.5 6.2 5.7 13.9 9.2 14.1 7.5 12.7 6.4 7.8 7.8 12.8 7.5 8.8 16.5 8.7 7.5 10.3 4.5 10.0 7.7 7.5 7.1 14.5 10.2 15.5 11.3 9.5 6.6 8.1 17.9 22.1 24.8 23.9 23.6 23.1 32.0 15.1 18.0 17.8 19.5 17.1 12.9 24.1 20.6 21.8 35.1 16.5 34.4 17.7 29.8 33.4 17.5 19.5 68.9 12.5 14.3 44.5 15.4 18.5 18.6 21.3 32.8 17.7 22.3 18.0 28.1 19.5 18.8 15.6 32.6 15.9 21.0 11.4 18.6 37.7 22.6 16.3 15.0 19.9 16.0 16.6 52.5 16.9 20.2 23.8 14.7 13.9 25.4 23.0 29.4 29.9 23.9 21.1 26.9 39.6 19.3 32.9 19.9 0.4 0.5 1.1 0.9 0.7 1.1 0.9 0.8 0.9 0.5 0.8 0.7 0.9 0.1 1.1 0.4 1.1 1.1 0.3 8.1 8.8 11.3 8.4 10.2 7.0 6.2 5.7 6.4 4.5 7.1 8.1 29.8 22.4 29.5 42.1 30.3 0.0 17.7 0.0 26.2 40.2 20.1 26.3 33.0 14.3 14.2 16.5 31.3 35.6 35.1 10.8 25.4 22.6 5.8 19.5 37.4 27.5 9.0 23.5 68.2 22.7 22.4 25.0 19.9 25.7 11.4 28.6 15.4 13.8 15.7 45.4 57.3 11.6 0.0 13.8 0.0 5.2 22.4 19.9 0.0 36.5 26.1 24.6 17.5 39.7 62.1 23.0 6.4 22.2 37.5 24.1 11.1 14.8 6.6 34.7 6.6 50.5 27.8 51.6 47.0 25.9 0.0 10.9 33.9 36.4 11.4 16.9 ICE2 "BRCC1, FLJ11896, NARG2" ENSG00000128915 "Interactor of little elongation complex ELL subunit 2" Q659A1 15 60419609-60479160 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 34.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040058 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA040058: AB_10795686" "unprognostic (3.80e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-1)" "unprognostic (5.59e-3)" "unprognostic (8.78e-3)" "unprognostic (2.71e-1)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (8.39e-3)" "unprognostic (1.68e-1)" "unprognostic (3.45e-1)" "unprognostic (3.56e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (5.74e-2)" 5.5 5.5 3.0 6.2 4.0 5.5 8.4 4.5 3.2 5.0 5.8 4.8 4.4 8.0 5.5 6.6 6.4 6.5 5.3 2.6 3.2 6.5 7.0 4.9 9.1 3.9 3.3 9.9 6.3 34.6 4.2 7.9 4.2 6.6 7.1 4.8 6.0 5.4 4.4 5.0 5.4 6.4 3.4 7.7 5.3 6.8 3.2 12.7 9.3 5.1 9.8 6.1 3.6 6.7 14.7 25.5 21.1 20.3 15.6 16.9 11.0 8.5 13.1 13.3 14.4 20.0 10.6 25.5 18.3 9.2 25.2 27.2 28.3 11.4 18.3 30.9 12.6 25.8 17.4 11.8 8.4 28.8 17.6 8.5 13.6 11.0 19.7 17.7 22.2 24.9 39.9 23.3 16.7 6.3 22.9 7.6 26.3 26.8 17.1 27.1 16.7 22.4 10.7 18.0 23.8 22.8 12.0 12.2 15.1 24.8 19.7 14.6 10.5 18.4 16.0 15.8 26.5 11.0 31.6 37.7 12.1 32.4 17.4 4.0 4.5 5.3 5.7 6.3 9.7 7.6 7.0 7.6 5.9 10.5 9.3 9.1 0.7 4.2 5.8 4.9 8.1 6.0 3.0 4.0 4.5 3.2 2.6 3.2 3.9 3.3 4.2 3.4 3.2 6.7 32.5 19.2 19.6 34.6 30.6 0.0 20.4 0.0 16.5 31.3 24.4 27.7 20.2 15.7 17.3 20.2 39.6 22.7 32.4 8.8 21.5 12.2 15.5 25.6 27.5 25.1 19.2 28.0 39.9 10.4 14.9 21.1 25.0 21.8 29.8 70.6 29.6 20.6 14.0 30.3 42.6 16.1 0.0 16.8 0.0 17.4 25.4 21.1 0.0 49.6 25.3 19.6 25.7 49.3 83.6 14.6 13.7 17.7 15.9 23.0 11.6 18.1 19.7 33.3 0.0 31.4 17.5 22.1 34.8 21.3 0.0 14.6 31.3 39.3 19.4 19.2 ING5 "FLJ23842, p28ING5" ENSG00000168395 "Inhibitor of growth family member 5" Q8WYH8 2 241687085-241729478 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 21.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042685 Approved NA NA "Cluster 38: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "HPA042685: AB_10797507" "unprognostic (1.87e-2)" "unprognostic (3.66e-1)" "unprognostic (1.65e-3)" "unprognostic (9.15e-3)" "unprognostic (1.79e-1)" "unprognostic (1.07e-3)" "prognostic unfavorable (2.86e-5)" "unprognostic (8.25e-2)" "unprognostic (2.30e-2)" "unprognostic (7.87e-2)" "prognostic favorable (1.60e-4)" "unprognostic (2.15e-1)" "unprognostic (5.88e-2)" "unprognostic (8.43e-2)" "unprognostic (5.01e-2)" "unprognostic (5.90e-2)" "unprognostic (4.74e-3)" 12.4 11.3 16.7 8.9 17.1 12.1 12.6 20.5 18.2 19.4 15.3 13.8 9.6 15.0 15.8 13.8 18.8 7.3 12.6 16.4 16.6 14.8 17.1 12.2 12.9 14.7 13.9 25.2 24.0 10.7 24.6 7.9 15.5 21.9 9.1 10.1 19.8 9.8 14.3 18.7 15.4 8.1 11.7 15.7 16.8 9.7 15.5 12.0 23.2 9.5 10.8 14.4 16.2 18.0 12.0 10.9 24.4 14.9 18.5 21.1 30.4 13.2 10.5 13.0 10.4 11.5 11.6 12.0 4.6 12.4 14.0 17.7 22.9 11.8 15.8 12.9 21.6 28.7 17.2 35.0 15.7 30.6 18.2 18.1 18.7 12.8 20.8 15.2 14.4 19.9 28.1 8.0 12.4 20.2 24.6 42.5 28.6 20.5 8.0 42.9 30.1 11.0 12.2 19.2 31.4 19.0 7.0 13.7 18.8 16.0 9.4 20.3 10.2 17.3 18.7 11.2 14.5 17.7 6.7 33.8 12.4 18.4 13.0 21.5 4.0 8.8 2.5 3.2 3.0 3.3 4.2 3.4 2.3 3.7 4.6 3.1 3.9 2.5 3.5 3.7 5.8 2.8 16.7 17.1 20.5 18.2 16.4 16.6 14.7 13.9 15.5 11.7 15.5 18.0 13.4 44.8 33.7 25.1 25.4 9.4 34.6 10.0 21.1 14.7 24.6 26.4 13.9 14.3 19.5 18.4 14.6 20.4 21.3 15.1 31.3 9.3 26.7 23.4 31.6 12.4 8.4 11.3 24.2 10.1 15.3 17.6 13.3 25.1 15.8 22.9 13.6 12.3 7.2 15.2 22.6 16.7 16.2 7.7 7.0 10.4 17.1 11.6 8.8 4.7 8.8 16.3 6.2 18.6 26.9 8.9 9.4 11.3 20.1 26.4 11.6 17.7 11.5 18.8 19.7 22.5 17.4 7.5 11.9 18.1 14.2 17.4 19.9 17.3 15.6 17.7 INO80 "hINO80, INO80A, INOC1, KIAA1259" ENSG00000128908 "INO80 complex ATPase subunit" Q9ULG1 15 40978880-41116280 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Actin-binding, DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041484, HPA048601" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" Cytosol "HPA041484: AB_2677506, HPA048601: " "unprognostic (5.39e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (3.92e-2)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.93e-1)" "unprognostic (6.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.69e-2)" "prognostic favorable (6.30e-4)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.72e-2)" "unprognostic (1.47e-2)" 9.3 6.5 5.4 7.3 5.7 15.7 8.8 10.1 5.9 8.3 5.3 9.3 7.3 8.9 4.7 9.6 7.7 5.7 6.9 5.3 5.2 7.9 7.8 9.4 9.7 5.9 5.2 9.1 6.9 10.0 5.5 6.8 5.6 7.9 8.6 5.7 7.3 6.6 15.7 10.9 8.7 8.2 5.0 8.9 7.9 7.0 5.8 10.8 8.5 9.6 10.4 9.1 8.5 7.5 13.1 12.9 10.6 10.7 16.5 13.8 11.4 12.2 18.8 17.3 15.0 14.8 10.4 14.0 8.8 17.6 21.6 24.3 19.5 20.7 19.0 17.5 10.0 18.9 17.7 11.8 15.2 17.9 16.2 13.5 18.4 13.8 36.9 11.1 16.8 14.5 20.5 11.6 12.3 10.6 13.2 11.2 11.3 20.6 13.5 19.1 11.2 11.0 12.7 26.1 14.5 9.6 9.6 18.5 7.3 10.4 10.5 19.9 19.2 14.3 11.1 17.3 19.0 12.4 9.6 22.2 16.1 24.7 11.7 0.3 1.0 0.2 0.8 0.5 0.9 1.3 0.8 0.8 0.7 1.1 1.0 1.1 0.3 2.1 0.2 0.6 0.7 0.4 5.4 5.7 10.1 5.9 5.3 5.2 5.9 5.2 5.6 5.0 5.8 7.5 23.7 9.6 25.7 27.4 27.6 8.5 16.2 7.5 23.3 30.4 18.1 15.9 25.1 14.3 16.4 16.5 22.9 13.5 25.4 17.3 7.9 17.6 2.2 17.2 21.5 17.6 13.1 23.8 54.1 13.3 12.0 16.0 32.6 28.9 15.8 18.4 13.2 10.0 9.8 26.9 47.5 11.8 2.0 14.4 6.8 3.3 14.6 18.6 7.2 25.3 20.8 12.9 19.6 43.2 53.3 15.2 16.1 15.8 19.8 21.7 9.5 11.3 16.3 33.0 6.6 28.1 21.3 19.2 24.7 28.2 12.8 19.2 25.8 25.1 13.9 15.1 INSL3 "MGC119818, MGC119819, RLF, RLNL" ENSG00000248099 "Insulin like 3" P51460 19 17816512-17821574 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" Hormone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 409.3" "Cell type enriched" "Detected in some" 19 "Theca cells: 24080.8" "Cancer enriched" "Detected in many" 21 "testis cancer: 39.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.7;PC-3: 2.6;SCLC-21H: 5.2;SH-SY5Y: 4.7" HPA028615 Enhanced "Secreted to blood" NA NA 566000 "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "HPA028615: AB_10600717" "unprognostic (3.25e-1)" "unprognostic (2.25e-4)" "unprognostic (3.50e-5)" "unprognostic (7.04e-2)" "unprognostic (1.74e-4)" "unprognostic (4.60e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.44e-1)" "unprognostic (1.73e-1)" "unprognostic (4.46e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-10)" "unprognostic (6.80e-3)" "unprognostic (1.41e-1)" "unprognostic (8.85e-2)" "unprognostic (1.09e-5)" 0.5 1.6 1.2 4.8 1.3 1.8 0.5 2.3 1.5 0.1 1.3 0.5 1.5 0.3 0.8 0.6 0.8 0.4 0.2 1.4 1.5 0.5 0.4 0.9 2.9 1.2 1.3 29.6 0.2 0.0 0.2 0.3 1.4 0.6 0.0 0.1 0.6 0.0 0.2 0.3 1.7 0.0 1.2 5.2 0.8 409.3 1.5 0.5 0.3 0.4 1.2 0.4 0.3 1.3 0.2 0.6 0.1 0.5 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 1.1 0.1 1.4 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.5 0.0 0.2 0.0 0.0 1.2 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 1.0 0.2 1.1 0.0 1.1 2.6 0.9 0.0 0.1 0.1 0.3 5.2 4.7 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.4 2.1 0.1 0.1 1.3 0.0 0.4 0.2 0.0 0.7 0.4 0.7 0.0 0.9 0.9 0.1 1.1 0.7 1.0 2.2 0.5 0.1 0.1 0.8 0.5 1.2 1.3 2.3 1.5 1.4 1.5 1.2 1.3 1.4 1.2 1.5 1.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.1 6.8 0.0 0.1 3.4 0.0 0.0 0.3 0.0 0.4 42.3 0.0 0.0 0.0 0.9 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 257.1 1240.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 998.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 2.9 5.7 0.0 0.0 0.5 0.8 24080.8 0.0 0.0 INSR CD220 ENSG00000171105 "Insulin receptor" P06213 19 7112255-7294414 "CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Carbohydrate metabolism" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.5" "Cell line enhanced" "Detected in many" "Karpas-707: 54.9;U-266/70: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036302, HPA036303" Uncertain Approved "Vesicles,Plasma membrane" NA Yes 190000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 52: Non-specific - Transcription" Vesicles "Plasma membrane" "HPA036302: AB_2675048, HPA036303: " "unprognostic (4.64e-2)" "unprognostic (2.42e-1)" "unprognostic (9.65e-3)" "unprognostic (9.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.15e-2)" "unprognostic (2.58e-1)" "unprognostic (5.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.05e-1)" "unprognostic (9.29e-2)" "unprognostic (1.86e-1)" "unprognostic (6.33e-2)" "unprognostic (3.45e-3)" "unprognostic (2.43e-1)" "unprognostic (2.75e-1)" "unprognostic (8.82e-2)" 13.0 22.6 12.5 2.8 16.8 5.6 13.0 17.3 12.8 14.6 18.8 15.0 10.0 18.4 6.3 4.1 16.9 8.2 26.3 10.0 12.2 21.8 33.0 7.2 2.3 18.3 16.3 39.9 64.2 13.0 16.3 7.4 18.7 15.2 10.4 6.5 16.9 9.9 23.5 11.5 12.2 11.5 14.1 48.2 12.5 5.4 16.6 2.7 14.5 13.3 3.5 12.3 9.2 22.5 6.2 3.2 3.6 5.7 18.8 6.1 11.1 3.5 2.9 1.6 1.6 8.4 7.0 9.0 8.2 6.8 4.0 1.6 8.9 1.4 1.2 0.0 6.4 0.0 2.3 22.6 8.2 4.3 6.7 10.0 4.5 0.2 4.9 4.2 3.8 4.8 9.5 54.9 1.8 3.2 3.1 7.8 3.3 3.8 5.2 29.0 2.1 7.6 0.1 27.8 6.6 5.2 6.5 3.8 3.3 6.4 1.4 21.6 3.6 3.4 2.1 8.2 5.1 40.4 23.9 20.2 4.3 7.3 0.0 2.7 8.6 5.9 0.2 8.8 0.3 0.8 0.3 0.1 9.8 1.1 0.7 0.1 1.9 1.0 12.5 8.2 0.0 1.6 12.5 16.8 17.3 12.8 10.0 12.2 18.3 16.3 18.7 14.1 16.6 22.5 75.6 48.1 34.7 64.9 10.6 64.9 63.6 34.7 8.0 40.4 134.0 76.2 92.1 137.2 83.3 62.5 79.2 17.8 6.7 124.1 15.6 55.1 4.7 26.8 106.8 123.9 163.6 25.0 68.3 78.7 53.7 43.7 20.4 42.1 3.8 168.4 255.2 246.0 9.2 38.7 100.8 97.3 32.6 49.0 31.1 9.0 96.3 35.0 51.6 62.8 24.2 31.6 0.0 62.8 183.5 50.7 68.8 245.3 21.8 107.9 122.9 114.1 65.3 23.6 59.2 37.6 44.2 5.2 3.6 3.2 68.8 38.3 4.7 81.4 65.2 130.0 INTS3 "C1orf60, FLJ21919, INT3, SOSS-A" ENSG00000143624 "Integrator complex subunit 3" Q68E01 1 153728050-153774808 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074391 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA074391: AB_2686685" "unprognostic (2.36e-1)" "unprognostic (1.94e-2)" "unprognostic (8.75e-3)" "unprognostic (6.97e-3)" "unprognostic (3.26e-1)" "unprognostic (4.48e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (5.42e-4)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.21e-1)" "unprognostic (1.85e-1)" "unprognostic (1.18e-3)" "unprognostic (8.29e-2)" 14.3 18.7 1.7 10.8 2.0 2.9 14.7 0.5 3.2 16.8 0.9 16.1 4.2 18.3 13.4 12.1 20.7 9.7 13.0 2.2 2.1 15.9 11.8 14.9 8.6 2.7 0.9 23.3 13.0 8.2 17.8 9.6 1.3 11.9 6.5 3.6 12.1 11.3 14.9 12.2 12.9 9.4 0.0 13.2 16.7 12.8 4.4 6.7 15.3 8.3 7.7 13.6 14.4 1.5 26.2 15.8 14.0 19.2 21.3 17.4 19.1 18.2 8.7 21.7 17.4 8.5 24.5 21.3 37.8 24.2 11.8 27.0 28.0 18.7 10.2 24.6 23.0 15.4 37.7 3.8 13.8 18.8 20.5 12.3 7.5 9.5 11.7 17.5 14.4 13.8 19.2 14.6 9.0 8.5 18.6 10.0 23.6 25.5 26.8 24.5 6.4 13.1 8.1 24.7 11.8 15.5 18.9 39.7 11.4 18.4 13.3 25.3 6.1 22.7 6.7 18.1 18.1 17.1 13.7 19.5 24.9 8.9 11.3 0.0 0.8 0.9 0.9 0.5 0.8 0.3 0.3 0.5 1.2 0.3 0.2 0.5 0.8 0.7 2.9 0.3 0.5 0.2 1.7 2.0 0.5 3.2 2.2 2.1 2.7 0.9 1.3 0.0 4.4 1.5 29.1 22.4 22.8 59.7 11.9 10.5 9.5 10.4 15.9 23.7 20.2 22.4 4.6 10.0 11.7 31.3 20.9 13.9 11.6 9.2 0.0 11.9 13.1 39.3 29.4 21.5 12.1 10.9 30.8 8.4 13.4 16.3 23.9 38.8 5.7 32.9 26.7 13.9 12.2 21.9 26.1 16.5 8.2 9.1 22.0 7.6 9.6 14.6 7.2 30.0 17.6 15.4 14.4 27.2 29.7 9.9 14.9 12.0 11.6 10.6 9.8 13.3 25.9 22.4 26.3 11.2 16.5 10.2 12.2 13.9 10.2 10.3 10.0 20.2 14.0 12.2 INTS4 "INT4, MGC16733, MST093" ENSG00000149262 "Integrator complex subunit 4" Q96HW7 11 77878720-77994671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042378 Uncertain Supported "Nucleoli rim" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoli rim" "HPA042378: AB_10797388" "unprognostic (2.72e-1)" "unprognostic (1.93e-1)" "unprognostic (4.07e-2)" "unprognostic (9.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (2.04e-2)" "unprognostic (1.17e-2)" "unprognostic (5.59e-2)" "unprognostic (1.60e-2)" "unprognostic (1.77e-1)" "unprognostic (4.20e-2)" "unprognostic (5.44e-2)" "unprognostic (4.20e-1)" "prognostic favorable (9.66e-4)" "unprognostic (9.39e-2)" 12.8 16.8 13.6 12.8 15.7 18.5 13.4 19.1 14.8 16.7 13.6 13.7 9.5 12.9 11.9 13.7 13.6 9.2 12.8 13.5 15.0 14.3 18.0 12.7 16.7 15.9 14.9 17.0 17.7 11.5 13.1 11.4 16.6 15.7 11.9 14.5 13.2 9.6 11.5 14.2 15.6 10.8 15.8 21.0 13.9 9.9 15.2 17.8 13.8 7.8 16.9 14.4 14.8 21.9 11.1 18.2 23.2 27.3 18.7 16.8 19.1 13.0 14.5 16.6 14.6 37.8 30.0 19.2 27.0 23.3 25.5 27.2 25.6 25.8 26.5 28.0 16.2 29.8 24.2 22.2 17.1 30.5 17.2 17.1 13.9 33.9 29.4 18.1 26.6 20.6 28.9 28.3 25.6 23.2 28.5 49.7 22.1 40.4 19.8 27.2 21.5 36.5 20.8 22.0 16.6 24.0 23.1 15.2 9.9 26.8 28.2 16.3 17.7 22.7 30.4 60.0 16.9 30.7 32.2 40.7 8.1 20.5 22.7 12.6 14.0 7.7 12.3 15.3 17.7 12.2 12.8 14.5 15.1 13.1 17.1 13.3 3.5 17.0 14.0 6.0 17.2 11.3 13.6 15.7 19.1 14.8 13.5 15.0 15.9 14.9 16.6 15.8 15.2 21.9 5.6 9.6 3.1 18.3 15.1 4.8 7.1 8.2 8.6 13.4 5.4 6.3 5.6 10.0 6.0 5.5 16.7 13.4 18.7 5.5 5.9 7.5 5.0 6.8 5.4 7.0 1.8 9.1 20.0 4.0 11.5 7.3 8.2 5.5 12.7 12.8 5.0 3.1 10.2 5.0 19.4 6.4 6.1 8.1 4.5 4.2 6.5 7.9 7.2 20.6 14.8 7.8 13.4 26.2 30.8 6.0 7.8 4.9 7.3 4.4 11.0 6.6 8.6 16.9 6.6 10.0 11.1 12.1 17.7 7.1 2.4 11.5 13.5 8.1 6.4 5.3 IPO9 "FLJ10402, Imp9" ENSG00000198700 "Importin 9" Q96P70 1 201829149-201884291 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059540 Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 70000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Cytosol Vesicles "HPA059540: " "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (7.44e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (4.11e-5)" "unprognostic (8.92e-3)" "unprognostic (2.23e-3)" "unprognostic (2.52e-1)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (5.05e-2)" "unprognostic (2.57e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (5.78e-4)" 17.0 18.2 17.8 12.0 17.8 10.1 16.5 18.0 22.5 18.9 16.4 15.9 9.2 19.2 18.2 15.7 15.2 9.2 15.9 18.8 17.6 17.4 26.9 17.9 13.7 17.3 16.7 17.2 17.9 14.8 20.7 14.5 16.8 17.5 13.9 23.7 12.3 10.8 14.0 17.7 15.1 16.7 15.0 19.6 14.3 14.4 17.8 16.2 19.3 10.7 16.7 16.6 15.0 17.1 45.4 46.9 63.0 51.4 35.7 24.1 47.1 34.2 34.3 55.6 53.8 75.6 38.4 26.8 18.9 32.9 48.8 41.0 43.0 47.2 47.9 24.5 38.1 20.0 75.2 57.2 27.2 26.2 31.4 26.7 21.3 60.2 48.5 37.1 56.7 36.0 40.5 24.6 40.4 45.1 30.5 34.2 63.4 40.6 15.2 32.2 65.8 26.6 30.7 71.0 53.3 60.5 37.5 58.7 30.8 96.6 43.1 32.8 31.1 52.1 46.6 29.5 63.5 18.1 12.0 31.5 25.9 30.5 39.8 10.1 10.1 8.7 9.9 13.2 8.6 9.5 9.5 10.9 12.6 8.5 7.6 8.3 2.3 10.2 13.8 6.6 9.5 7.8 17.8 17.8 18.0 22.5 18.8 17.6 17.3 16.7 16.8 15.0 17.8 17.1 25.7 22.4 45.6 48.0 22.1 15.8 14.9 14.3 13.6 57.9 14.5 14.7 23.6 10.0 20.4 7.3 60.5 27.8 17.6 7.5 1.9 16.9 8.0 9.2 28.9 27.3 11.3 28.6 60.1 18.7 20.8 25.4 16.3 11.2 11.4 32.6 23.2 18.1 19.5 75.7 60.7 16.3 10.2 17.6 21.5 8.8 20.2 13.3 14.2 36.5 21.6 38.1 26.8 46.8 50.6 17.6 10.6 28.2 18.2 16.4 8.9 9.0 10.5 56.5 39.5 35.4 26.1 42.0 37.3 16.4 14.2 22.6 17.0 26.0 17.0 12.5 IREB2 IRP2 ENSG00000136381 "Iron responsive element binding protein 2" P48200 15 78437431-78501453 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" RNA-binding "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032885, HPA040371, HPA068982" Uncertain Approved "Cell Junctions,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Cell Junctions" Cytosol "CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064" "unprognostic (1.00e-2)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (3.44e-2)" "unprognostic (3.39e-2)" "unprognostic (2.29e-1)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (7.30e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (6.51e-2)" "unprognostic (3.85e-3)" "unprognostic (4.09e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-2)" "unprognostic (9.40e-2)" 17.1 25.2 7.5 18.2 7.7 27.7 18.8 16.3 9.3 15.2 8.4 17.4 17.9 17.9 11.8 15.2 14.6 14.9 12.5 7.4 10.5 18.3 23.1 14.9 22.8 7.0 7.2 22.0 11.4 17.8 8.2 21.8 7.1 16.5 20.3 19.4 10.6 15.4 18.8 14.4 18.4 16.1 7.0 24.8 16.4 15.1 9.5 29.7 28.7 23.5 20.9 13.4 11.7 8.8 19.9 34.9 52.8 33.2 45.5 29.7 35.5 33.3 26.0 29.7 26.9 34.6 33.8 73.1 22.1 28.0 20.3 37.8 124.7 33.2 26.1 23.4 43.0 63.6 35.0 24.4 23.8 69.4 65.7 31.5 22.4 22.9 27.7 30.2 35.4 42.6 67.9 25.4 25.5 29.7 42.8 35.2 69.1 24.1 12.4 49.6 53.0 20.8 32.4 54.2 31.7 47.3 45.1 31.4 35.7 59.2 29.5 59.7 28.9 30.3 20.8 16.8 29.2 31.5 74.8 41.7 21.8 63.1 22.2 3.8 2.5 2.0 2.4 3.3 3.1 2.7 2.6 2.4 3.5 2.6 2.5 3.5 2.8 3.0 2.6 4.0 2.3 1.4 7.5 7.7 16.3 9.3 7.4 10.5 7.0 7.2 7.1 7.0 9.5 8.8 24.3 22.4 40.7 33.0 37.5 14.1 16.6 19.3 14.8 55.6 23.1 18.4 24.9 25.8 26.1 23.9 66.7 35.0 56.2 45.3 0.0 19.9 18.1 19.3 38.2 26.6 31.9 42.3 52.3 19.6 23.7 27.7 32.1 21.2 17.7 66.2 38.9 41.8 26.1 79.1 55.6 31.0 18.3 61.3 18.4 10.8 32.9 37.7 14.2 28.1 52.9 22.4 54.6 50.3 49.0 26.3 49.8 30.5 28.5 33.7 49.1 19.6 25.7 51.1 6.6 29.5 23.2 33.9 29.6 24.5 18.6 30.6 33.9 56.3 36.0 29.6 IRF9 ISGF3G ENSG00000213928 "Interferon regulatory factor 9" Q00978 14 24161265-24166565 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 73.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 76.6;BJ hTERT+ SV40 Large T+ RasG12V: 58.9;GAMG: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001862 Approved Supported Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Cytosol "HPA001862: AB_1079153" "unprognostic (4.96e-3)" "unprognostic (4.91e-2)" "unprognostic (6.84e-3)" "unprognostic (8.17e-3)" "unprognostic (5.32e-2)" "unprognostic (2.51e-2)" "unprognostic (2.00e-1)" "unprognostic (1.77e-2)" "unprognostic (4.50e-1)" "unprognostic (9.10e-2)" "unprognostic (4.08e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (7.58e-8)" "unprognostic (1.56e-1)" "unprognostic (4.44e-2)" "unprognostic (4.40e-2)" "prognostic favorable (9.92e-4)" 25.2 27.1 16.0 25.0 17.4 25.4 22.5 16.3 15.9 31.6 13.3 29.3 17.6 27.7 13.1 21.8 25.0 24.2 19.1 14.7 17.9 29.1 25.9 28.2 25.2 22.0 17.9 25.0 14.1 11.6 22.1 12.8 17.5 22.1 9.9 3.6 36.4 12.7 9.0 20.7 26.8 17.6 22.2 48.5 25.3 8.3 18.0 22.7 22.8 8.8 20.4 27.0 22.5 21.2 3.9 2.4 2.5 0.9 15.9 17.6 1.6 7.3 37.5 76.6 58.9 5.2 22.5 5.0 7.7 20.3 48.5 6.0 1.6 1.5 19.3 24.3 0.0 11.6 2.1 6.1 25.3 1.1 14.2 17.2 5.3 9.1 1.9 15.1 8.3 1.0 1.7 32.6 10.0 4.5 2.0 4.8 0.4 2.8 7.4 0.8 2.5 3.0 17.2 2.6 0.4 2.6 6.6 3.5 38.9 5.1 1.1 9.7 16.1 8.1 5.7 4.8 1.7 32.4 24.9 4.7 9.4 1.8 7.3 197.2 80.5 112.3 73.4 103.1 58.1 93.3 72.4 62.0 61.7 88.7 64.0 58.4 202.8 74.8 103.9 75.1 103.0 103.4 16.0 17.4 16.3 15.9 14.7 17.9 22.0 17.9 17.5 22.2 18.0 21.2 37.9 25.6 15.1 21.2 22.8 2.3 8.6 6.1 6.2 6.6 8.0 10.3 0.2 10.0 9.7 5.5 8.4 1.5 32.0 6.1 0.0 4.9 0.2 9.0 19.4 21.0 1.8 7.4 5.0 5.5 21.9 14.8 20.9 9.4 24.6 42.0 11.0 1.7 7.0 8.4 4.9 5.3 10.2 8.2 8.0 1.0 12.8 13.4 5.4 26.2 13.4 11.2 73.2 32.2 9.5 6.2 10.9 6.8 13.2 8.4 21.8 2.6 32.3 4.3 13.1 33.7 15.1 1.3 1.7 3.7 2.7 1.6 26.1 24.9 4.9 12.4 IRS1 HIRS-1 ENSG00000169047 "Insulin receptor substrate 1" P35568 2 226731312-226799820 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 75.4;Theca cells: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005261, HPA046433" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 52: Non-specific - Ribosome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005261: AB_649615, HPA046433: AB_2732524" "unprognostic (2.20e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.59e-2)" "unprognostic (3.86e-3)" "unprognostic (1.61e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-3)" "unprognostic (5.47e-2)" "unprognostic (2.24e-2)" "unprognostic (5.48e-3)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.46e-2)" "unprognostic (6.92e-2)" "unprognostic (3.23e-2)" "unprognostic (7.55e-3)" 7.6 9.7 1.7 2.9 1.6 0.5 11.7 5.2 3.1 14.7 1.8 10.3 3.9 17.4 1.9 3.6 15.0 5.6 5.0 1.6 1.0 3.4 10.5 5.0 1.7 1.8 1.6 20.9 3.5 3.3 1.5 9.5 1.2 7.8 2.7 1.5 3.0 7.0 28.0 5.2 5.1 10.3 2.0 2.0 5.3 0.8 1.6 8.1 20.0 2.9 1.3 11.6 6.6 1.5 5.7 26.0 18.6 0.7 25.0 14.8 0.0 15.6 12.2 20.4 13.0 15.0 14.4 2.3 2.5 10.6 14.0 10.0 1.2 15.0 11.5 5.9 1.0 0.1 1.7 7.1 12.5 0.5 0.1 20.7 8.1 16.1 14.5 12.3 0.0 2.3 3.0 22.7 14.0 22.6 4.9 6.6 7.5 3.6 14.3 1.1 24.1 0.1 9.3 18.9 3.2 0.5 5.0 3.6 8.4 14.9 13.7 0.3 1.3 26.8 24.2 20.9 15.1 10.6 4.6 3.4 26.5 0.5 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 5.2 3.1 1.6 1.0 1.8 1.6 1.2 2.0 1.6 1.5 1.7 19.2 4.6 5.9 2.7 35.4 31.9 29.7 19.4 19.3 36.9 28.1 13.4 14.3 12.8 0.0 0.0 6.4 0.0 13.2 17.6 15.4 1.6 22.1 28.4 2.1 2.4 0.0 17.3 11.4 0.6 28.3 2.0 24.3 0.0 75.4 1.8 57.4 1.7 20.2 31.3 6.5 24.4 1.3 4.6 1.8 22.7 3.6 16.0 15.0 0.8 8.4 0.0 26.7 1.7 11.1 8.2 14.7 9.5 14.5 23.4 3.0 8.1 1.7 13.1 9.5 22.8 1.0 1.2 4.2 23.7 18.3 1.2 110.3 7.7 22.8 ITFG2 "FGGAP1, MDS028" ENSG00000111203 "Integrin alpha FG-GAP repeat containing 2" Q969R8 12 2812622-2859791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038664, HPA038665" Uncertain Uncertain "Endoplasmic reticulum" NA No "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA038664: AB_10672722, HPA038665: AB_2676138" "unprognostic (5.70e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (2.96e-1)" "unprognostic (2.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-2)" "unprognostic (3.64e-2)" "unprognostic (1.60e-2)" "unprognostic (4.36e-2)" "unprognostic (5.05e-3)" "unprognostic (8.40e-2)" "unprognostic (2.60e-1)" "unprognostic (4.24e-1)" "unprognostic (5.89e-1)" "unprognostic (4.35e-2)" "unprognostic (7.43e-2)" 12.8 15.6 6.0 11.4 8.1 14.4 14.0 10.2 8.1 17.7 10.7 14.2 12.4 18.7 14.5 13.1 17.1 8.9 12.1 5.9 9.2 16.4 12.2 15.0 15.9 7.7 7.9 28.9 22.1 28.1 14.1 14.5 8.1 13.9 15.0 8.1 17.9 15.6 8.3 11.7 14.5 13.4 6.2 19.6 16.1 5.1 8.0 18.1 26.7 9.7 15.8 14.7 14.9 11.8 7.3 10.6 11.9 9.7 10.2 11.6 11.0 15.9 9.0 18.9 13.8 22.7 17.6 16.5 4.4 15.0 9.4 9.1 18.5 15.9 14.1 14.7 10.6 23.1 12.7 9.1 18.8 21.7 12.0 15.7 18.4 17.3 26.4 15.5 13.1 15.6 12.8 17.3 10.9 21.9 31.3 12.6 24.6 16.5 8.0 15.6 13.3 9.5 11.3 12.3 5.7 18.3 19.5 17.1 7.2 16.2 10.6 9.9 13.4 12.4 7.4 12.0 30.8 2.2 1.4 25.0 8.0 12.4 12.8 4.0 16.6 8.4 19.2 22.2 18.0 25.8 14.7 19.0 19.6 24.2 19.8 18.6 1.9 23.4 35.6 14.6 13.2 16.5 6.0 8.1 10.2 8.1 5.9 9.2 7.7 7.9 8.1 6.2 8.0 11.8 11.1 12.8 17.9 12.7 35.9 3.3 9.8 9.3 10.2 39.8 16.5 15.6 17.1 18.6 12.1 12.9 64.6 28.1 27.6 13.0 11.7 9.2 46.3 13.0 19.1 10.5 9.5 17.9 13.6 7.2 8.9 15.0 23.0 13.2 6.3 18.7 12.1 11.3 13.4 32.0 15.2 15.2 8.2 12.0 5.1 12.1 16.8 11.0 1.8 8.4 16.8 10.0 42.2 10.1 25.8 7.2 14.4 13.2 19.6 9.1 20.5 6.1 8.7 56.0 6.6 11.7 16.9 13.2 20.0 14.3 4.0 17.4 24.3 22.2 19.5 5.9 IVD ACAD2 ENSG00000128928 "Isovaleryl-CoA dehydrogenase" P26440 15 40405485-40435947 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 135.0;Theca cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041391, HPA044250" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 35: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Mitochondria Nucleoplasm "HPA041391: AB_2677449, HPA044250: AB_2678875" "unprognostic (9.30e-2)" "unprognostic (3.31e-1)" "unprognostic (1.36e-2)" "unprognostic (4.24e-2)" "unprognostic (7.53e-2)" "unprognostic (1.74e-1)" "prognostic favorable (1.95e-5)" "unprognostic (1.50e-2)" "unprognostic (2.53e-1)" "unprognostic (2.84e-2)" "unprognostic (4.08e-2)" "unprognostic (2.31e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (1.14e-1)" "unprognostic (5.46e-3)" 25.8 80.5 35.1 14.5 40.8 15.9 45.3 35.6 40.8 29.4 39.5 31.6 24.3 26.4 29.0 16.0 35.0 21.5 61.7 34.0 41.5 59.1 145.4 24.3 19.6 40.2 38.8 43.3 27.4 39.2 58.3 15.3 37.5 42.1 27.2 13.0 31.8 36.8 55.7 8.6 26.8 23.8 37.9 27.9 46.7 25.0 44.5 16.8 119.2 55.4 19.5 31.1 20.8 45.3 20.9 11.9 22.9 38.9 35.9 32.9 1.0 27.6 32.7 39.4 24.0 36.5 16.0 0.8 57.7 43.4 32.6 20.8 45.9 46.6 30.1 36.4 34.0 52.1 36.2 38.9 64.6 22.0 48.5 45.3 18.5 23.5 55.3 46.3 38.8 60.4 2.5 2.4 42.1 27.1 27.3 38.9 17.8 1.3 33.0 41.2 32.6 27.9 45.2 51.6 37.3 21.5 38.2 83.4 18.7 21.5 69.0 117.6 27.6 29.9 20.2 23.6 24.9 54.5 38.5 1.0 30.9 22.8 28.4 17.0 24.8 36.7 33.3 36.1 31.0 27.5 18.5 26.6 58.8 27.6 18.5 26.7 2.3 39.4 73.1 89.2 26.9 24.3 35.1 40.8 35.6 40.8 34.0 41.5 40.2 38.8 37.5 37.9 44.5 45.3 13.1 28.9 54.5 27.4 19.0 2.3 21.0 17.3 13.1 26.0 27.5 22.2 88.0 45.8 29.9 44.1 14.6 20.3 34.0 17.9 95.9 19.7 5.4 21.4 31.0 18.6 19.7 21.3 15.3 14.9 7.3 20.2 29.6 19.9 34.7 46.5 21.4 135.0 28.1 16.8 16.6 24.4 14.2 18.3 6.2 7.4 20.5 18.6 5.4 21.5 28.8 26.0 26.8 25.1 21.4 14.8 9.4 24.8 10.0 16.6 22.0 97.3 29.3 19.9 19.7 25.0 18.2 16.1 3.7 17.4 0.6 9.9 18.0 105.7 35.4 11.9 JRK "jerky, JH8" ENSG00000234616 "Jrk helix-turn-helix protein" O75564 8 142657460-142681968 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052675 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" No No "Cluster 46: Basophils - DNA binding" "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA052675: AB_2681910" "unprognostic (3.65e-2)" "unprognostic (5.30e-2)" "unprognostic (9.67e-2)" "unprognostic (3.90e-3)" "unprognostic (1.27e-1)" "unprognostic (1.84e-2)" "unprognostic (6.58e-6)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.90e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (7.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.53e-1)" "unprognostic (1.22e-2)" "unprognostic (1.69e-2)" 3.7 4.5 5.9 4.1 6.1 2.1 4.0 7.9 7.4 7.4 4.0 5.9 3.0 6.7 3.4 4.9 5.5 2.5 5.9 5.8 4.7 7.9 4.0 3.9 5.4 6.2 5.2 8.5 5.4 4.6 6.4 3.0 5.5 6.2 2.8 3.8 4.7 4.0 7.5 6.0 5.3 3.7 4.3 7.2 5.7 6.6 6.2 5.1 6.9 4.7 5.9 5.7 4.7 6.8 6.5 6.9 8.0 6.4 7.6 10.8 4.8 10.4 4.2 11.9 6.8 6.3 13.1 11.0 4.1 8.2 8.2 8.7 7.0 6.2 6.0 8.5 12.0 11.2 25.3 7.2 3.1 8.6 7.5 7.2 5.4 7.6 4.3 6.0 6.8 13.1 12.0 4.8 10.1 11.1 10.1 4.8 6.8 4.6 9.6 13.1 5.0 6.2 4.1 11.1 14.5 9.6 18.1 7.3 4.3 5.0 7.3 5.2 8.1 9.1 19.5 9.1 5.5 6.3 7.6 6.3 6.9 10.7 9.0 1.0 0.7 0.9 0.9 0.5 0.5 0.4 1.0 0.9 0.7 1.2 1.3 1.0 0.8 0.6 0.2 0.6 0.6 0.4 5.9 6.1 7.9 7.4 5.8 4.7 6.2 5.2 5.5 4.3 6.2 6.8 3.5 6.4 1.1 8.5 4.8 0.0 2.5 0.0 2.2 14.7 4.5 3.3 11.5 4.3 0.6 7.3 20.9 4.4 8.6 3.2 3.9 2.8 1.9 1.4 4.9 6.5 9.1 12.0 11.3 2.5 2.7 3.7 6.6 2.1 1.3 15.5 8.2 2.6 3.0 10.1 11.0 3.1 0.0 6.6 0.0 2.2 11.5 3.4 0.0 8.4 4.5 4.4 12.3 9.5 9.5 5.6 1.4 11.7 4.3 3.7 2.7 2.7 0.7 10.0 0.0 5.8 4.8 9.1 19.4 3.2 0.0 2.2 2.5 6.8 4.2 4.5 KANSL1 "CENP-36, DKFZP727C091, KIAA1267, MSL1v1, NSL1" ENSG00000120071 "KAT8 regulatory NSL complex subunit 1" Q7Z3B3 17 46029916-46225389 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 334.6;Inhibitory neurons: 326.7;Microglial cells: 327.9;Oligodendrocyte precursor cells: 313.6;Oligodendrocytes: 346.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006874, HPA007208" Approved Supported Nucleoplasm No No "Cluster 22: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA006874: AB_1852393, HPA007208: AB_1852395" "unprognostic (2.46e-1)" "unprognostic (2.55e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-2)" "unprognostic (4.45e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (1.54e-2)" "unprognostic (9.28e-2)" "unprognostic (7.79e-3)" "unprognostic (2.01e-1)" "unprognostic (1.16e-1)" "unprognostic (2.84e-2)" "unprognostic (6.13e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (1.33e-2)" 12.3 9.2 3.7 7.6 4.4 12.9 11.3 13.8 6.7 14.2 2.1 11.7 4.2 15.3 9.1 12.9 11.7 4.1 7.3 4.1 4.0 8.4 5.8 9.4 7.6 4.2 4.7 15.2 12.4 11.9 9.0 7.2 5.4 9.1 8.4 9.4 11.1 4.5 16.4 17.2 12.0 9.8 3.6 9.2 10.0 17.5 4.8 16.9 12.0 9.0 9.7 12.7 13.1 5.8 3.1 2.4 11.2 5.1 2.5 4.0 7.0 3.0 5.8 5.4 6.4 11.6 0.9 11.8 4.9 12.5 16.2 6.7 22.6 8.1 10.7 14.9 11.3 1.6 5.8 14.3 17.3 1.3 4.3 4.1 17.2 12.2 19.6 7.6 13.4 18.6 5.1 12.3 12.1 4.5 42.5 2.9 3.4 2.8 14.1 24.3 21.9 20.2 8.3 7.4 5.7 13.8 15.3 0.5 9.8 29.8 17.4 21.5 11.8 23.2 13.5 9.0 3.2 20.6 15.2 17.6 6.4 6.4 16.2 0.0 0.1 0.3 0.2 0.1 0.2 0.4 0.3 0.5 0.0 0.1 0.3 0.2 0.3 0.3 0.1 0.2 0.3 0.2 3.7 4.4 13.8 6.7 4.1 4.0 4.2 4.7 5.4 3.6 4.8 5.8 53.4 32.1 36.7 226.9 47.7 27.1 19.7 22.4 42.7 68.1 57.4 39.5 13.2 20.0 18.2 47.8 102.2 15.0 95.5 35.0 1.9 37.1 162.9 58.2 80.2 40.9 31.8 22.1 334.6 25.4 20.4 33.3 33.1 85.9 24.1 111.4 30.4 25.3 21.1 69.0 326.7 29.2 28.5 41.7 25.3 136.6 34.8 38.1 21.4 327.9 52.3 23.6 60.8 313.6 346.4 40.8 27.2 30.1 60.1 33.7 28.9 12.7 18.9 78.5 26.3 42.0 43.7 29.4 50.9 48.9 30.1 14.6 70.6 71.6 27.2 32.7 KAT2A "GCN5, GCN5L2, PCAF-b" ENSG00000108773 "Lysine acetyltransferase 2A" Q92830 17 42113111-42121367 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 84.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048958 Uncertain NA NA "Cluster 30: Non-specific - Translation" "Cluster 72: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "HPA048958: AB_2680571" "unprognostic (1.71e-1)" "unprognostic (9.08e-2)" "unprognostic (1.66e-1)" "unprognostic (2.31e-1)" "unprognostic (3.41e-1)" "unprognostic (9.07e-2)" "unprognostic (1.91e-3)" "unprognostic (3.87e-2)" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "prognostic favorable (3.57e-4)" "unprognostic (2.78e-2)" "prognostic unfavorable (1.41e-8)" "unprognostic (3.97e-2)" "unprognostic (2.90e-1)" "unprognostic (1.89e-1)" "unprognostic (2.29e-3)" 14.1 20.8 11.3 6.5 11.9 4.2 13.2 7.7 18.9 20.3 3.1 15.4 6.7 17.2 1.7 14.7 21.0 3.1 10.1 10.8 12.7 13.1 15.7 9.7 5.3 10.8 10.4 28.4 16.9 5.8 14.4 4.6 10.0 16.9 4.0 1.0 10.0 4.3 11.8 15.9 13.5 3.4 5.3 17.4 13.0 10.8 14.0 4.7 14.6 2.1 4.6 15.5 16.4 12.4 24.7 46.6 6.8 25.3 9.3 7.6 29.7 15.7 8.3 34.0 16.7 31.9 19.5 48.1 38.6 12.1 25.6 36.0 27.9 25.0 12.1 27.0 58.0 12.0 29.8 28.8 9.7 32.3 30.8 9.0 20.8 19.1 11.9 9.2 13.8 11.9 30.7 8.9 9.1 26.4 77.7 23.5 14.5 60.9 0.0 18.3 13.3 31.9 9.2 24.4 32.4 14.2 16.8 36.2 13.2 5.1 26.9 15.3 10.7 17.1 17.4 25.1 28.2 23.8 24.5 26.9 12.5 27.5 9.7 0.0 0.1 0.0 0.2 0.0 0.4 0.5 0.5 0.6 0.4 0.3 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.2 11.3 11.9 7.7 18.9 10.8 12.7 10.8 10.4 10.0 5.3 14.0 12.4 21.5 12.8 11.5 84.5 19.0 12.2 12.6 6.8 26.2 16.5 18.9 22.7 7.1 18.6 6.6 18.4 10.4 25.1 10.7 7.9 3.9 9.2 1.3 5.9 11.3 18.4 15.7 6.7 39.6 8.0 20.5 12.1 17.3 8.2 11.4 25.8 22.5 20.2 12.1 10.1 41.0 10.1 6.1 10.9 6.8 3.7 32.6 9.8 7.2 32.8 5.2 3.7 5.2 41.7 28.3 6.7 7.3 29.0 7.2 10.9 4.0 4.1 5.4 7.8 13.1 15.1 10.8 5.2 18.2 18.7 13.9 11.2 7.8 26.4 20.2 9.1 KDM4B "JMJD2B, KIAA0876, TDRD14B" ENSG00000127663 "Lysine demethylase 4B" O94953 19 4969113-5153598 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.1;dendritic cells: 1.7;granulocytes: 4.7" "Cell line enhanced" "Detected in all" "T-47d: 61.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071568 Supported Nucleoplasm,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA071568: " "prognostic favorable (7.39e-4)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.74e-4)" "prognostic favorable (4.25e-7)" "unprognostic (5.95e-2)" "unprognostic (7.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.89e-2)" "unprognostic (8.24e-3)" "unprognostic (5.14e-3)" "unprognostic (8.66e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-1)" "unprognostic (4.14e-2)" "unprognostic (5.44e-2)" 12.4 19.4 7.8 8.9 9.4 13.5 16.8 15.8 10.0 23.4 5.1 14.7 6.6 18.4 6.7 17.0 20.2 4.7 16.0 9.3 5.3 10.4 21.2 12.5 11.7 9.2 7.3 17.8 13.7 6.6 18.4 9.5 7.5 25.6 2.9 14.7 14.1 7.4 32.2 21.7 13.8 4.9 4.7 22.1 12.6 16.1 8.8 8.8 29.4 8.3 7.2 13.4 18.2 11.9 16.1 5.5 12.8 15.4 7.3 7.2 25.7 7.9 5.8 6.8 8.5 9.6 4.4 22.4 8.2 9.1 5.5 8.9 7.8 9.3 4.2 10.1 19.9 7.5 9.9 8.0 13.6 7.6 16.7 11.2 9.9 5.6 4.7 12.3 9.3 12.4 18.7 13.3 6.2 8.3 8.8 11.5 11.3 5.8 13.6 14.7 9.7 19.0 6.8 10.5 23.7 18.1 10.3 11.2 12.5 12.3 61.5 19.7 13.5 10.1 5.7 12.5 8.0 36.5 16.4 17.1 20.0 15.1 6.0 1.5 0.6 1.9 0.3 0.2 0.2 4.2 0.2 0.2 0.3 5.1 0.4 0.5 4.7 0.8 0.3 1.7 0.4 0.3 7.8 9.4 15.8 10.0 9.3 5.3 9.2 7.3 7.5 4.7 8.8 11.9 15.3 6.4 10.4 18.9 73.2 7.4 14.1 10.8 7.4 72.5 36.1 22.2 15.3 10.0 9.4 7.3 98.0 25.7 25.5 15.3 7.9 10.5 17.0 25.4 18.7 16.4 8.4 9.4 33.6 7.6 26.2 14.6 26.5 30.2 8.2 34.3 15.4 30.9 9.0 74.0 30.6 16.7 16.2 14.2 7.8 12.1 18.3 15.8 10.6 27.2 17.0 23.5 19.6 29.7 28.7 18.0 14.1 23.3 23.9 19.3 7.4 6.6 11.7 69.2 6.6 23.1 13.7 25.2 9.1 14.1 15.3 24.1 13.9 29.7 9.5 12.9 KIAA0319L "AAVR, KIAA1837" ENSG00000142687 "KIAA0319 like" Q8IZA0 1 35433492-35557950 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 47.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072692 Supported Supported "Nucleoli,Golgi apparatus" NA NA 1100000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoli "HPA072692: AB_2686549" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (4.23e-3)" "unprognostic (1.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.92e-5)" "unprognostic (3.41e-3)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.79e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.47e-1)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (1.84e-1)" 14.3 26.6 28.3 13.0 28.0 15.9 27.8 23.4 28.0 25.6 28.9 25.6 26.3 14.4 26.2 18.3 35.1 21.3 44.5 28.0 27.6 38.2 34.2 30.9 17.7 26.9 29.2 14.9 42.1 45.6 26.9 30.6 25.5 34.9 30.0 34.1 33.5 18.5 37.7 20.1 24.8 14.4 24.8 20.1 34.4 17.1 32.4 17.8 41.4 40.1 16.8 15.8 15.1 24.9 13.5 19.6 39.8 31.5 52.7 36.9 37.8 17.9 37.8 25.5 37.5 21.2 52.9 15.0 48.0 19.6 38.1 26.1 29.7 28.8 28.9 23.8 21.7 20.3 23.4 23.6 41.3 16.9 26.8 52.3 36.2 29.5 38.0 84.3 42.2 18.1 27.2 21.0 35.2 13.6 10.1 14.3 45.3 37.4 11.7 11.3 33.8 18.7 41.8 32.4 8.7 24.6 25.8 30.6 53.3 86.9 32.3 23.1 43.6 17.4 18.7 14.9 28.0 31.1 26.7 9.8 44.3 21.8 17.7 8.8 19.4 9.4 5.0 6.1 4.8 3.4 4.1 4.7 5.6 4.1 5.5 4.0 47.2 9.8 4.0 3.7 4.0 8.7 28.3 28.0 23.4 28.0 28.0 27.6 26.9 29.2 25.5 24.8 32.4 24.9 24.2 73.7 74.1 85.2 18.3 7.9 14.4 16.5 15.4 74.8 33.9 26.0 55.0 47.1 42.4 35.0 108.4 33.3 16.6 35.4 3.9 19.2 9.6 21.0 17.7 24.6 21.6 14.7 93.2 32.5 22.5 19.4 28.5 30.8 21.5 42.7 28.9 47.4 19.1 63.9 95.2 59.5 16.2 31.4 7.6 7.5 17.4 19.2 14.2 62.8 31.4 30.5 29.9 115.1 99.3 30.3 27.6 17.3 17.2 26.0 36.8 17.5 45.4 61.9 6.6 24.5 15.7 22.5 21.2 17.8 9.2 31.2 21.9 30.1 31.2 14.8 KIAA2026 FLJ20375 ENSG00000183354 KIAA2026 Q5HYC2 9 5881596-6008482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002109 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No "Cluster 37: B-cells - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" "Vesicles, Cytosol" Nucleoplasm "HPA002109: AB_1078071" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (8.74e-2)" "unprognostic (6.86e-2)" "unprognostic (9.19e-2)" "unprognostic (8.41e-3)" "unprognostic (6.49e-2)" "unprognostic (1.52e-1)" "prognostic favorable (8.34e-4)" "unprognostic (2.41e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" 6.8 5.1 13.5 5.6 17.2 6.4 6.2 24.1 11.7 7.8 25.1 6.4 4.8 7.9 5.8 6.1 6.4 5.7 5.7 9.9 12.1 6.1 4.9 5.9 6.7 11.6 13.3 10.2 5.2 8.6 6.2 6.9 11.9 6.2 5.0 10.4 6.1 5.4 9.5 8.2 5.6 6.3 10.3 8.1 6.5 11.5 12.6 8.3 8.4 9.5 5.9 6.2 7.1 17.0 7.1 3.5 7.2 4.6 5.4 8.5 3.2 4.6 6.8 4.4 4.0 2.3 4.0 8.8 1.7 5.8 5.5 3.5 4.2 3.9 6.5 19.2 3.0 26.5 8.4 3.7 4.2 9.4 11.6 5.3 5.0 3.9 6.4 8.3 6.9 5.7 2.8 16.2 5.5 2.2 5.1 17.2 4.0 4.1 2.8 5.3 4.6 4.5 4.8 4.9 9.3 5.3 4.3 4.0 3.7 4.9 4.1 12.6 7.8 8.4 4.7 4.2 5.3 11.1 9.5 8.8 4.3 4.3 2.3 5.0 2.3 7.0 4.2 1.9 4.8 5.9 4.1 3.8 0.9 3.8 4.5 4.8 6.0 4.8 4.5 2.9 2.6 0.8 13.5 17.2 24.1 11.7 9.9 12.1 11.6 13.3 11.9 10.3 12.6 17.0 47.8 44.8 34.0 99.9 40.3 44.6 29.9 21.4 37.5 89.0 33.5 25.5 53.7 42.9 22.1 38.6 79.2 17.1 51.9 31.0 7.9 18.2 33.0 28.3 40.9 39.7 38.5 18.7 97.8 13.4 10.6 33.2 31.1 46.7 20.2 43.5 29.3 18.7 16.9 45.4 119.1 34.7 16.2 25.5 28.8 17.2 70.5 31.9 23.2 113.4 55.1 47.7 95.8 116.1 170.1 18.4 29.1 76.3 35.4 34.4 30.1 11.9 18.2 81.5 46.0 45.8 40.1 127.7 121.2 38.3 52.4 30.0 45.1 38.7 28.5 42.0 KLHDC8B MGC35097 ENSG00000185909 "Kelch domain containing 8B" Q8IXV7 3 49171598-49176486 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 128.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 60.7;Sertoli cells: 98.6;Theca cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 28.8" "Group enriched" "Detected in many" 10 "granulocytes: 28.8;monocytes: 8.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008463, HPA014467" Approved Enhanced Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Cytosol "HPA008463: AB_1852563, HPA014467: AB_1852565" "unprognostic (1.66e-2)" "unprognostic (1.42e-1)" "unprognostic (5.31e-2)" "unprognostic (8.50e-3)" "unprognostic (2.66e-1)" "unprognostic (5.03e-3)" "unprognostic (1.71e-3)" "prognostic favorable (1.47e-4)" "unprognostic (6.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" "unprognostic (4.30e-2)" "unprognostic (1.02e-3)" "unprognostic (4.78e-2)" "unprognostic (5.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" 29.1 128.7 13.5 5.6 14.0 6.1 24.9 9.4 14.8 20.2 24.8 56.1 7.2 26.2 10.6 31.1 26.5 16.7 70.5 12.4 21.2 16.3 12.6 17.3 9.9 12.4 14.2 70.1 9.4 10.4 10.1 12.3 16.1 16.9 3.6 2.3 14.1 13.5 29.6 28.1 14.0 14.2 11.6 13.2 16.7 15.5 19.1 4.3 26.6 13.4 6.8 29.4 22.5 10.3 2.5 5.5 22.4 11.4 13.5 8.0 6.9 8.4 4.7 8.2 6.6 3.6 7.4 0.0 4.6 14.0 2.3 0.1 5.6 5.1 2.1 4.6 1.5 15.1 15.2 9.6 25.6 0.0 8.5 13.3 23.9 10.6 0.8 18.4 21.2 5.3 23.7 0.2 6.3 0.7 1.6 16.7 7.4 1.3 13.1 2.3 2.1 0.7 6.1 1.3 0.9 25.2 6.7 0.2 17.0 4.7 6.8 7.3 9.3 6.2 17.1 11.2 2.6 2.1 0.7 0.3 4.5 0.0 3.1 0.0 5.4 28.8 1.0 8.0 0.4 0.0 0.5 0.7 0.5 0.1 1.8 1.0 9.7 0.0 8.3 0.8 0.2 2.4 13.5 14.0 9.4 14.8 12.4 21.2 12.4 14.2 16.1 11.6 19.1 10.3 14.1 9.6 10.9 5.9 0.9 7.6 11.5 16.4 10.8 2.2 10.8 9.0 60.7 11.5 14.3 7.3 2.1 10.9 2.4 1.0 17.6 14.3 7.2 6.8 6.9 20.5 6.7 6.5 3.8 5.9 8.5 22.3 2.6 3.3 1.3 7.7 37.1 7.5 41.7 0.0 4.6 3.0 18.3 12.0 2.2 7.7 15.2 10.5 12.4 6.5 2.5 29.4 0.0 3.5 0.7 8.6 1.7 14.3 0.6 8.3 0.7 13.4 4.0 2.7 98.6 28.3 31.1 9.2 8.6 15.5 9.8 49.8 1.5 55.5 1.7 7.9 KLHL17 ENSG00000187961 "Kelch like family member 17" Q6TDP4 1 960584-965719 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031251 Approved Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" Nucleoplasm "HPA031251: AB_10601539" "unprognostic (1.28e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.18e-1)" "unprognostic (8.55e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (3.09e-2)" "unprognostic (1.51e-1)" "unprognostic (8.53e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.70e-6)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-1)" "unprognostic (7.73e-2)" 5.3 5.8 5.2 3.8 5.4 3.8 6.0 6.1 8.3 9.7 5.3 6.9 3.5 7.3 0.6 12.3 6.7 2.3 4.8 5.4 4.7 9.0 7.9 7.1 3.7 5.7 5.0 1.9 7.1 2.3 10.4 2.2 5.6 8.2 0.7 1.7 7.5 1.9 2.8 9.5 7.6 1.2 4.6 12.0 7.5 12.4 5.8 3.0 6.5 0.8 1.6 8.2 8.6 5.5 6.8 7.5 9.2 22.1 3.2 3.3 10.1 13.1 3.5 7.2 7.0 9.9 10.1 2.4 9.0 5.8 6.9 14.4 8.5 5.4 1.1 13.9 20.7 4.4 32.2 14.3 2.1 5.1 13.4 2.8 2.6 7.1 2.0 9.0 4.5 14.0 14.9 4.3 3.2 8.0 8.4 17.8 10.0 2.7 11.0 13.5 3.7 4.8 4.0 2.7 22.3 21.0 3.8 11.8 12.4 2.8 6.4 8.9 7.8 13.7 18.5 12.1 11.1 8.5 3.2 5.9 7.9 11.4 6.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 5.4 6.1 8.3 5.4 4.7 5.7 5.0 5.6 4.6 5.8 5.5 2.2 0.0 3.1 6.2 1.7 2.5 1.0 1.2 3.4 5.7 2.6 2.8 3.7 0.0 0.7 3.7 2.1 1.2 4.0 1.1 0.0 1.0 1.3 1.8 4.1 1.2 3.0 0.0 5.9 0.8 1.9 1.8 7.7 2.0 0.0 1.4 3.3 0.7 1.2 6.7 4.6 1.6 0.0 1.0 1.8 2.0 0.3 2.1 3.6 2.8 1.4 1.2 1.0 1.5 2.1 2.0 0.3 1.5 2.2 0.9 1.2 1.2 1.1 6.2 0.0 0.8 2.0 4.7 5.3 1.9 3.0 0.8 2.2 0.2 1.4 1.4 KMT2A "ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1" ENSG00000118058 "Lysine methyltransferase 2A" Q03164 11 118436490-118526832 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Apoptosis, Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017794, CAB024270, HPA044910" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "CAB017794: , CAB024270: , HPA044910: AB_2679141" "unprognostic (6.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.83e-1)" "unprognostic (4.56e-1)" "unprognostic (4.96e-2)" "unprognostic (1.72e-3)" "unprognostic (4.52e-3)" "unprognostic (6.07e-2)" "unprognostic (1.61e-1)" "unprognostic (8.46e-2)" "unprognostic (3.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.91e-3)" "unprognostic (7.90e-2)" "unprognostic (3.73e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" 9.9 6.7 8.0 8.5 8.6 19.5 9.9 21.2 9.3 10.3 1.6 10.8 5.4 10.7 8.2 6.8 10.3 6.4 6.5 7.4 9.6 6.7 6.0 10.5 12.4 6.3 6.3 21.2 11.1 9.8 10.2 5.6 6.6 9.2 6.4 23.9 9.4 8.4 7.4 10.4 9.8 7.6 3.2 9.7 8.2 5.3 7.0 14.1 9.9 8.4 11.3 10.7 9.3 11.9 17.9 8.6 20.1 14.5 11.1 16.1 6.2 8.7 11.8 9.0 9.6 17.3 11.4 23.1 15.9 10.8 14.6 16.0 22.9 7.2 17.9 26.0 10.0 45.7 8.9 9.3 6.1 28.5 7.8 7.2 7.4 20.3 24.0 8.9 12.8 13.3 32.8 18.8 9.2 12.7 18.2 12.7 13.6 6.6 13.7 13.8 21.9 6.9 9.8 13.8 18.0 11.8 22.0 6.7 3.9 9.8 11.9 9.1 20.4 14.1 12.7 9.4 14.7 5.1 4.4 15.6 4.7 17.6 8.3 2.1 0.6 1.9 1.6 0.6 1.6 2.5 1.8 1.5 0.3 1.8 1.8 1.2 0.5 2.0 0.7 1.4 1.7 0.4 8.0 8.6 21.2 9.3 7.4 9.6 6.3 6.3 6.6 3.2 7.0 11.9 87.1 70.5 65.8 93.4 83.4 86.9 67.6 29.4 64.9 158.1 76.8 73.9 44.5 40.0 32.2 38.6 152.2 13.9 81.0 26.2 3.9 33.0 10.1 62.1 101.4 74.4 66.4 67.3 146.0 25.6 10.2 65.6 44.4 85.2 29.0 57.5 60.0 27.3 16.8 195.2 170.1 29.6 20.3 37.0 63.7 5.8 66.8 44.8 42.7 62.8 49.9 98.9 78.2 106.6 131.9 28.2 20.1 78.6 83.3 88.3 22.7 10.5 52.7 152.4 65.7 113.4 84.6 25.5 30.7 46.3 80.6 6.0 102.8 55.8 30.6 64.8 KMT2B "CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7" ENSG00000272333 "Lysine methyltransferase 2B" Q9UMN6 19 35717973-35738878 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease variant, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 64.5;Rod photoreceptor cells: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006487 Approved Nucleoplasm,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA006487: AB_1080587" "unprognostic (1.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.41e-2)" "unprognostic (7.95e-2)" "unprognostic (9.92e-2)" "unprognostic (3.53e-3)" "unprognostic (2.33e-2)" "unprognostic (4.57e-2)" "unprognostic (7.28e-2)" "unprognostic (2.07e-2)" "unprognostic (3.13e-3)" "unprognostic (2.63e-3)" "unprognostic (9.47e-3)" "unprognostic (2.10e-1)" "unprognostic (2.37e-1)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" 11.6 10.1 15.4 9.8 15.7 14.3 11.8 17.2 22.9 12.9 12.2 13.6 9.8 14.1 4.4 12.8 13.1 6.8 8.4 14.7 14.8 10.3 10.0 12.1 14.5 15.4 14.4 16.1 16.0 5.1 14.5 5.8 14.7 13.4 3.9 5.8 13.3 5.8 16.1 18.8 14.5 4.5 12.4 15.6 12.7 22.5 15.9 9.3 16.6 5.0 6.8 12.6 12.0 16.0 16.7 36.7 11.1 17.3 6.0 4.3 11.0 6.7 4.7 7.3 5.0 25.3 7.4 15.5 11.8 5.1 8.5 10.8 11.3 5.2 4.2 21.2 13.6 29.7 20.2 24.4 8.6 17.4 26.1 6.9 9.4 8.9 10.7 6.9 5.7 13.5 22.5 15.8 6.4 34.1 15.9 24.4 12.0 18.8 9.2 19.8 8.9 7.6 7.8 21.3 14.0 10.0 13.5 20.6 11.3 7.9 11.8 21.3 12.5 16.3 17.0 10.5 17.4 22.2 15.7 12.4 8.5 18.8 12.2 0.3 0.4 0.4 1.0 0.1 0.5 0.4 0.6 0.7 0.3 0.7 0.6 0.9 1.8 0.5 0.2 2.1 0.8 0.4 15.4 15.7 17.2 22.9 14.7 14.8 15.4 14.4 14.7 12.4 15.9 16.0 24.6 9.6 15.4 13.7 18.6 12.7 10.0 6.2 9.6 64.5 16.1 14.6 9.2 8.6 6.3 9.2 52.1 6.5 27.4 25.2 0.0 6.4 2.8 17.9 31.6 15.6 20.3 7.4 11.7 7.7 6.1 12.4 27.5 26.0 5.1 30.5 11.0 11.2 8.4 35.3 11.8 14.1 6.1 11.8 7.1 4.7 8.1 13.4 5.4 7.5 9.5 25.7 19.6 7.5 10.0 8.4 16.7 12.4 17.9 19.6 13.9 5.0 6.7 71.2 0.0 25.0 17.3 26.5 38.5 11.9 12.9 9.4 20.6 30.7 16.3 14.8 KRBOX4 "FLJ20344, ZNF673" ENSG00000147121 "KRAB box domain containing 4" Q5JUW0 X 46447292-46497422 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 43.2;Oligodendrocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA065295 Approved Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA065295: AB_2685456" "unprognostic (4.12e-1)" "unprognostic (6.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.64e-2)" "unprognostic (1.17e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (2.87e-6)" "prognostic favorable (4.67e-5)" "unprognostic (1.73e-2)" "unprognostic (2.61e-3)" "unprognostic (3.27e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (1.98e-7)" "unprognostic (7.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.17e-4)" 13.1 10.0 20.1 9.6 19.5 6.4 14.3 19.1 22.5 18.4 19.6 14.0 6.7 18.1 22.6 7.4 13.2 11.9 10.2 19.3 20.8 11.4 16.5 11.6 14.6 18.8 18.2 18.2 8.8 13.8 13.1 17.6 18.9 15.7 9.1 14.6 8.8 11.5 8.3 11.5 9.8 15.0 17.6 18.5 9.3 5.5 23.7 14.4 14.7 9.0 12.8 12.3 11.2 20.0 23.0 13.2 20.1 15.6 19.6 20.1 12.3 21.8 19.8 19.9 18.0 11.3 20.8 12.7 14.1 19.4 32.9 16.0 25.1 12.2 23.4 12.7 10.7 10.9 29.7 11.0 20.9 16.3 16.8 22.7 13.6 27.1 22.8 17.7 18.7 19.7 11.7 13.8 18.0 13.2 16.6 8.1 18.3 9.1 23.4 11.6 18.6 16.0 13.2 9.4 7.3 14.3 18.6 9.2 21.5 34.2 15.3 15.9 17.2 22.0 22.0 29.2 17.9 15.1 18.3 18.5 19.1 0.8 20.6 18.0 7.2 15.5 12.7 9.0 13.4 13.6 13.9 12.5 7.1 18.6 17.3 13.1 4.3 15.6 10.3 13.4 13.1 9.4 20.1 19.5 19.1 22.5 19.3 20.8 18.8 18.2 18.9 17.6 23.7 20.0 16.9 6.4 6.1 25.1 11.8 2.2 4.5 7.4 14.2 6.4 5.6 7.0 6.6 8.6 5.1 5.5 4.2 15.2 10.5 1.9 9.8 7.5 0.2 4.9 10.1 15.4 1.2 7.2 22.4 4.5 8.0 10.5 5.6 3.6 7.6 8.8 16.8 5.3 9.5 10.1 22.2 3.9 4.1 6.3 2.6 1.3 7.8 5.1 7.2 20.6 5.5 8.9 13.4 43.2 36.9 3.6 6.5 11.3 8.3 3.8 3.1 5.8 5.1 8.4 13.1 6.4 8.1 4.3 5.4 4.2 2.7 13.5 10.9 11.1 3.6 1.9 LAMB1 CLM ENSG00000091136 "Laminin subunit beta 1" P07942 7 107923799-108003213 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 185.6;Fibroblasts: 99.6;Peritubular cells: 141.8;Theca cells: 174.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 593.0;ASC TERT1: 815.3;HSkMC: 779.6;TIME: 547.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004056, HPA004132, CAB004256" Enhanced "Secreted to extracellular matrix" NA NA 250000000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" "CAB004256: AB_627867, HPA004056: AB_1079226, HPA004132: AB_1079225" "unprognostic (2.39e-1)" "unprognostic (6.45e-3)" "unprognostic (2.01e-1)" "unprognostic (6.75e-2)" "unprognostic (3.45e-3)" "unprognostic (8.26e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (3.77e-2)" "unprognostic (1.04e-2)" "unprognostic (2.04e-2)" "unprognostic (3.44e-1)" "unprognostic (5.01e-2)" "unprognostic (2.87e-2)" "unprognostic (4.50e-3)" "unprognostic (1.75e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-1)" 141.4 21.8 1.2 26.5 1.6 0.1 74.1 0.9 1.7 46.4 23.0 87.0 29.3 78.9 3.3 25.2 44.1 53.4 53.9 2.4 0.7 81.4 14.7 104.3 9.4 0.0 0.8 29.4 48.2 12.1 11.8 154.3 0.2 18.1 40.4 0.7 24.6 29.7 20.4 39.3 67.5 73.2 0.1 42.4 49.5 11.4 1.4 19.7 43.5 40.6 5.2 53.5 31.0 0.4 94.5 148.6 77.3 3.6 593.0 815.3 291.9 103.5 182.5 68.6 72.1 306.7 166.6 0.0 127.7 200.3 90.8 41.9 24.8 143.6 49.9 0.1 24.8 4.8 52.6 87.9 364.3 0.0 2.8 779.6 49.0 175.9 193.4 409.2 450.0 2.8 17.0 0.0 126.5 29.9 0.1 0.5 42.9 54.9 103.6 0.4 51.9 0.3 238.5 96.0 24.3 142.1 75.1 100.9 68.5 180.2 37.6 1.1 547.1 179.9 44.3 60.2 133.1 0.0 0.2 0.4 89.9 0.0 301.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.9 1.7 2.4 0.7 0.0 0.8 0.2 0.1 1.4 0.4 81.8 0.0 5.6 2.9 2.2 8.9 5.2 16.7 10.8 12.1 2.0 9.5 16.3 15.7 7.6 27.6 4.2 85.5 3.5 10.5 3.9 18.0 2.0 22.6 185.6 57.8 19.2 0.0 51.6 11.2 27.1 99.6 2.6 34.6 2.5 2.9 20.7 3.5 10.1 8.4 23.7 8.0 8.2 2.8 3.8 4.7 71.1 2.4 8.8 11.2 2.0 2.1 5.2 6.0 3.2 21.6 17.0 141.8 0.4 3.6 9.5 11.6 2.9 8.6 52.6 10.2 54.4 5.5 5.1 4.7 6.7 32.6 3.2 174.7 19.2 2.1 LAMC3 DKFZp434E202 ENSG00000050555 "Laminin subunit gamma 3" Q9Y6N6 9 131009174-131094473 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 48.7" "Group enriched" "Detected in many" 4 "Leydig cells: 118.4;Peritubular cells: 364.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.0;EFO-21: 17.3;Hep G2: 6.1;SiHa: 6.7;U-2 OS: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022814 Enhanced "Secreted to extracellular matrix" NA NA 1100000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 28: Placenta - Pregnancy" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" "HPA022814: AB_2670960" "unprognostic (9.77e-2)" "unprognostic (1.90e-1)" "unprognostic (9.55e-3)" "unprognostic (2.09e-1)" "unprognostic (2.15e-1)" "unprognostic (1.22e-2)" "unprognostic (1.38e-2)" "unprognostic (2.28e-3)" "unprognostic (6.27e-2)" "unprognostic (1.83e-1)" "unprognostic (1.58e-1)" "unprognostic (3.38e-1)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (1.63e-1)" "unprognostic (3.34e-1)" "unprognostic (7.83e-2)" 1.5 13.5 1.3 0.3 1.8 0.0 1.5 1.3 2.4 22.3 1.9 1.6 0.4 3.3 3.5 1.7 1.1 2.7 1.2 1.4 1.2 9.2 4.9 23.3 0.0 1.4 1.3 1.7 3.5 0.9 11.6 48.7 1.2 4.2 0.1 0.0 1.4 3.8 0.3 8.6 0.3 0.3 1.2 11.3 0.5 19.0 1.7 0.2 1.2 1.1 0.0 15.0 8.2 2.0 0.0 0.5 4.0 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 17.3 0.0 0.3 0.0 0.3 0.0 0.0 0.0 2.2 0.0 1.5 6.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 2.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.4 0.1 6.7 0.0 2.6 0.4 0.0 0.7 0.0 0.0 5.3 0.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.3 1.8 1.3 2.4 1.4 1.2 1.4 1.3 1.2 1.2 1.7 2.0 1.5 0.0 0.0 1.0 0.0 6.8 0.0 0.0 0.0 0.0 0.4 0.4 1.3 0.0 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.1 1.9 1.6 48.5 1.7 0.0 0.0 1.7 0.0 0.8 20.7 0.0 1.1 0.0 27.8 3.6 0.1 1.5 0.0 4.1 0.2 0.0 0.0 10.2 12.6 118.4 0.5 10.6 36.5 0.1 0.0 0.0 0.0 1.0 0.1 0.0 364.1 0.0 0.2 0.0 0.2 0.0 0.0 46.0 0.1 10.0 1.0 3.5 0.0 4.4 1.0 0.8 38.1 0.0 0.1 LDB1 "CLIM2, NLI" ENSG00000198728 "LIM domain binding 1" Q86U70 10 102106489-102120368 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034488 Approved Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA034488: AB_10669783" "unprognostic (8.83e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-3)" "unprognostic (4.54e-2)" "unprognostic (1.35e-1)" "unprognostic (5.01e-3)" "unprognostic (1.55e-2)" "unprognostic (1.04e-3)" "unprognostic (2.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-3)" "unprognostic (8.25e-2)" "unprognostic (2.54e-1)" "unprognostic (3.19e-1)" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (1.26e-2)" 41.3 38.0 48.0 42.9 51.2 122.4 44.0 42.8 57.4 89.1 55.8 73.8 31.1 81.5 38.1 54.1 68.9 49.1 60.6 49.4 47.0 40.5 20.5 46.6 61.5 42.1 42.2 117.9 29.4 55.6 52.3 49.1 40.0 58.4 27.5 41.6 65.6 71.6 52.5 149.9 51.7 52.8 38.2 60.8 44.4 30.6 45.8 59.3 49.5 31.6 55.3 65.4 72.4 48.5 42.6 53.5 105.8 128.0 41.3 44.6 52.7 43.8 70.2 48.7 42.3 38.3 36.3 64.8 60.8 56.7 23.0 85.8 48.9 87.3 25.9 55.7 46.9 208.2 62.7 38.6 49.0 56.1 67.8 97.4 70.0 40.2 46.3 177.3 52.0 59.7 128.3 69.1 38.6 41.9 101.1 89.5 52.1 20.4 26.4 112.0 68.4 46.9 46.7 47.3 42.6 103.8 30.9 34.1 51.6 69.0 162.5 36.3 53.8 29.5 60.0 26.8 37.3 58.7 54.4 44.3 49.7 125.7 27.2 2.9 2.0 1.9 2.1 2.9 1.3 2.0 1.5 2.1 1.3 2.4 2.0 1.6 4.8 2.0 4.9 1.4 1.6 1.3 48.0 51.2 42.8 57.4 49.4 47.0 42.1 42.2 40.0 38.2 45.8 48.5 6.4 32.1 11.0 5.2 8.1 22.8 2.8 4.6 17.6 18.5 8.4 7.9 9.1 2.8 6.9 3.7 4.2 4.8 11.7 3.2 0.0 7.7 2.1 7.7 11.1 6.9 8.3 17.0 9.8 5.6 6.3 7.0 5.6 9.3 9.5 9.5 5.3 2.2 8.9 15.2 10.4 1.4 4.1 5.4 7.5 3.0 6.2 7.3 3.6 12.2 4.0 11.8 6.2 5.5 6.6 7.5 2.0 6.4 7.7 2.7 1.9 1.4 3.5 6.1 0.0 6.9 8.2 7.6 7.3 10.7 21.2 7.8 10.0 10.3 2.6 2.0 LHCGR "HHG, LCGR, LGR2, LHR, ULG5" ENSG00000138039 "Luteinizing hormone/choriogonadotropin receptor" P22888 2 48686774-48755730 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.2;ovary: 2.1;testis: 2.2" "Cell type enriched" "Detected in some" 22 "Theca cells: 143.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB009814 Uncertain NA NA "Cluster 21: Non-specific - Transcription" "Cluster 52: Non-specific - Transcription" "CAB009814: AB_2135467" "unprognostic (8.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.14e-2)" "unprognostic (2.97e-2)" "unprognostic (2.24e-2)" "unprognostic (5.22e-2)" 1.3 0.8 0.3 0.0 0.4 0.0 0.7 0.9 0.5 0.0 0.7 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.1 0.0 3.2 0.7 2.1 0.0 0.0 0.5 0.0 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.1 2.2 0.8 0.2 0.6 0.1 0.0 0.3 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.9 0.5 0.2 0.6 3.2 0.7 2.0 1.6 0.8 1.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 5.3 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.3 1.0 1.2 0.1 0.0 6.5 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 143.2 0.0 0.0 LHX9 ENSG00000143355 "LIM homeobox 9" Q9NQ69 1 197911902-197935478 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.2;ovary: 9.2" "Group enriched" "Detected in some" 6 "Leydig cells: 157.5;Peritubular cells: 50.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "midbrain: 17.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "fHDF/TERT166: 272.7" "Group enriched" "Detected in many" 4 "hippocampal formation: 6.3;midbrain: 17.3;thalamus: 12.2" "Group enriched" "Detected in many" 5 "midbrain: 16.8;pons: 6.7;thalamus: 14.5" HPA009695 Uncertain Approved Nucleoplasm NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA009695: AB_1079251" "unprognostic (8.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.38e-4)" "unprognostic (1.43e-1)" "unprognostic (5.68e-3)" "unprognostic (3.55e-1)" "unprognostic (1.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.63e-2)" "unprognostic (3.26e-2)" "unprognostic (5.15e-2)" "unprognostic (2.62e-3)" "unprognostic (6.35e-3)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" 0.1 0.0 2.5 0.0 0.4 0.0 0.0 0.6 0.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.6 4.1 0.0 0.4 1.4 0.0 1.8 17.2 9.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 15.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 27.4 4.3 7.2 0.6 0.0 0.0 0.0 0.1 272.7 0.1 0.0 6.7 0.0 2.3 0.0 0.5 0.0 7.6 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.6 0.1 8.1 7.7 3.1 0.0 0.0 0.0 0.0 6.7 0.0 2.4 1.3 11.7 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.4 0.6 0.7 0.6 4.1 1.8 17.2 2.5 0.6 15.4 1.4 0.0 3.2 15.4 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.9 0.1 1.1 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 157.5 0.2 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 50.4 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.5 2.5 0.9 0.0 0.0 0.1 0.1 0.1 0.2 0.1 LIG4 ENSG00000174405 "DNA ligase 4" P49917 13 108207439-108218368 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Cancer-related genes, Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001334, HPA057325" Approved Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Cytoplasmic bodies" "HPA001334: AB_1078689, HPA057325: AB_2732608" "unprognostic (9.93e-2)" "unprognostic (1.56e-1)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (1.40e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.21e-3)" "unprognostic (1.94e-2)" "unprognostic (3.04e-1)" "unprognostic (1.82e-1)" "unprognostic (1.50e-2)" "unprognostic (9.03e-3)" 7.2 8.3 6.3 8.6 6.5 3.9 5.6 6.1 9.0 4.0 8.7 5.7 7.2 4.4 8.5 4.2 4.5 6.8 6.7 7.1 10.2 8.2 12.0 6.9 11.0 6.8 6.6 5.8 3.8 11.3 5.2 5.8 6.8 5.6 6.6 23.1 4.6 5.2 7.1 5.3 7.0 6.6 6.1 8.3 7.8 9.8 7.1 21.8 7.7 6.5 8.3 6.9 2.3 7.9 15.5 5.8 15.3 10.2 12.4 13.3 5.4 14.9 11.2 11.2 13.3 6.9 6.7 26.0 11.9 9.8 13.7 6.3 10.2 9.9 19.2 15.4 9.8 12.3 13.8 3.6 14.8 16.6 12.5 12.3 16.3 10.8 9.6 10.7 13.5 47.0 4.4 4.7 17.4 8.3 27.7 12.1 3.9 12.6 3.6 25.1 6.0 4.2 14.6 9.7 9.6 9.9 3.3 9.0 11.7 11.7 7.7 25.4 20.1 6.6 7.2 7.5 13.5 12.4 8.7 41.7 25.4 9.4 15.2 0.6 1.6 4.8 1.1 2.5 1.6 1.6 1.2 1.2 1.4 2.2 1.2 1.7 2.2 1.9 8.3 1.0 1.8 1.0 6.3 6.5 6.1 9.0 7.1 10.2 6.8 6.6 6.8 6.1 7.1 7.9 5.6 9.6 9.5 13.4 9.2 2.7 2.8 4.9 3.4 10.7 4.9 2.8 11.6 1.5 10.0 1.8 8.4 2.3 7.3 7.9 9.8 5.3 11.6 8.3 5.7 4.3 9.6 0.4 16.6 7.5 1.0 4.2 7.7 6.0 3.8 3.6 4.6 9.8 5.8 18.5 16.1 5.3 2.0 7.5 3.9 5.1 2.8 7.4 1.8 10.3 9.3 7.3 4.1 13.6 24.9 8.9 6.3 6.0 6.2 2.5 3.5 6.3 21.9 13.6 13.1 4.6 3.8 19.1 4.4 4.0 5.7 1.8 4.1 8.7 2.9 3.7 LONP2 "LONP, LONPL, MGC4840" ENSG00000102910 "Lon peptidase 2, peroxisomal" Q86WA8 16 48244300-48363122 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008862 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 85: Liver - Metabolism" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 52: Non-specific - Transcription" "HPA008862: AB_2137156" "unprognostic (8.08e-3)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.75e-2)" "unprognostic (2.33e-2)" "unprognostic (6.08e-2)" "unprognostic (1.60e-2)" "unprognostic (7.59e-3)" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (3.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.71e-7)" "unprognostic (6.53e-2)" "unprognostic (1.49e-1)" "unprognostic (5.60e-2)" "unprognostic (1.33e-1)" 21.8 19.2 20.4 14.8 22.8 13.5 46.0 23.0 24.7 19.5 27.9 16.7 20.3 19.3 25.9 16.8 22.2 14.8 22.4 23.0 21.2 20.1 86.9 14.6 15.6 20.5 19.8 24.4 22.1 38.2 25.3 13.9 21.8 29.6 18.7 39.0 20.9 22.2 23.7 17.9 18.4 20.9 21.3 17.3 20.0 9.1 20.4 17.1 32.6 22.5 16.4 19.3 16.0 23.5 24.3 33.1 18.3 25.5 42.1 34.6 30.9 30.4 23.1 28.0 12.8 17.3 12.4 11.0 29.2 30.9 14.1 29.8 33.4 33.6 38.7 18.0 21.7 16.1 20.1 38.2 25.8 27.5 20.7 32.2 36.6 26.2 24.4 33.8 21.1 20.7 27.6 12.6 29.2 22.4 26.5 13.6 13.7 22.8 32.5 34.0 33.1 35.1 31.7 16.1 28.6 17.7 34.6 38.1 31.6 22.8 17.6 20.5 28.3 28.7 16.9 25.2 23.7 25.6 22.8 18.0 33.7 18.5 21.3 6.8 11.6 8.0 10.6 12.0 11.7 10.5 12.9 11.2 11.4 11.7 12.3 11.4 4.4 8.4 12.7 8.5 10.7 10.7 20.4 22.8 23.0 24.7 23.0 21.2 20.5 19.8 21.8 21.3 20.4 23.5 33.0 57.7 66.3 70.8 44.6 34.9 43.1 38.3 40.5 104.5 51.0 39.1 62.7 75.8 52.0 27.6 85.5 40.1 37.9 31.9 13.7 35.0 30.8 43.7 48.2 34.2 49.7 23.4 97.2 30.7 29.0 43.3 39.8 53.6 30.4 65.2 42.5 194.6 30.5 85.8 95.4 36.8 38.7 53.8 42.7 10.1 59.0 38.3 39.2 60.0 45.1 63.9 32.0 73.9 87.6 31.3 38.9 54.5 41.5 52.3 40.9 30.0 56.3 141.7 39.5 67.2 42.5 22.0 17.0 36.7 36.8 64.0 39.8 41.4 41.2 45.8 LRCH3 MGC4126 ENSG00000186001 "Leucine rich repeats and calponin homology domain containing 3" Q96II8 3 197791226-197888436 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 139.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 38.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 38.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012380, HPA017299" Uncertain Enhanced Cytosol "Intracellular and membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" Cytosol "HPA012380: AB_1853260, HPA017299: AB_2669576" "unprognostic (1.25e-1)" "unprognostic (4.92e-1)" "unprognostic (1.43e-1)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (8.26e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.29e-1)" "unprognostic (4.13e-1)" "unprognostic (9.85e-2)" "unprognostic (1.64e-1)" "unprognostic (2.06e-2)" "unprognostic (1.79e-3)" "unprognostic (3.29e-2)" "unprognostic (2.67e-1)" "unprognostic (5.59e-2)" "unprognostic (1.32e-1)" 13.1 10.2 7.7 12.0 11.9 8.0 11.4 18.7 9.1 16.2 7.3 16.3 7.0 15.5 7.7 10.7 13.7 10.2 14.6 7.7 12.5 8.2 10.3 11.9 17.0 9.8 8.1 18.8 9.5 12.2 12.3 10.1 8.5 13.9 10.2 19.2 12.0 12.1 19.3 10.8 12.8 14.8 6.0 13.9 11.2 13.1 10.1 15.5 9.7 11.5 18.7 14.8 13.8 15.7 30.5 10.0 28.8 17.5 28.9 35.2 11.0 21.5 25.6 25.3 31.5 26.0 15.5 16.1 33.5 24.9 40.7 19.1 25.7 21.2 34.5 13.3 14.4 29.8 16.2 19.2 18.9 21.4 19.3 25.0 10.9 24.7 31.9 23.0 30.7 14.7 18.1 27.5 23.4 25.1 15.9 7.8 19.3 15.8 22.3 16.0 17.6 10.6 11.3 19.4 14.2 14.4 28.5 18.5 20.1 26.4 39.0 17.1 30.1 19.4 12.0 24.4 22.2 24.5 26.9 15.2 19.8 28.0 20.3 38.9 4.7 10.1 7.4 6.9 6.0 9.3 5.8 6.3 4.1 6.6 5.3 7.5 2.3 7.1 6.9 3.5 6.1 5.4 7.7 11.9 18.7 9.1 7.7 12.5 9.8 8.1 8.5 6.0 10.1 15.7 19.2 32.1 27.0 64.6 29.7 10.6 18.1 11.4 8.0 56.0 11.6 8.5 15.4 14.3 17.0 9.2 56.3 8.5 25.8 10.4 1.9 10.1 12.8 12.2 22.9 20.8 6.0 11.1 69.8 9.9 6.6 23.8 10.7 16.4 11.4 23.0 34.6 14.2 9.0 38.7 86.1 11.0 8.2 17.6 17.9 9.6 25.1 14.6 17.8 66.5 30.8 19.8 27.8 102.1 139.2 14.1 9.5 28.6 15.1 15.9 7.1 5.2 15.1 43.1 19.7 31.7 22.8 18.0 17.2 9.4 10.5 6.0 19.9 17.0 11.0 14.7 LRIG2 KIAA0806 ENSG00000198799 "Leucine rich repeats and immunoglobulin like domains 2" O94898 1 113073198-113132260 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015538 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 2100000 "Cluster 17: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 18: U-2197 - ECM organization" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoplasm "HPA015538: AB_2250170" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (9.08e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (4.72e-2)" "unprognostic (1.27e-3)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (3.27e-2)" "unprognostic (5.95e-2)" "unprognostic (1.03e-2)" "unprognostic (1.03e-2)" "unprognostic (1.27e-2)" "unprognostic (2.34e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 2.6 2.2 3.1 2.1 4.6 1.0 2.7 4.7 3.4 3.2 3.2 2.9 2.8 3.1 3.8 2.3 2.5 1.4 2.4 2.8 3.6 2.2 2.0 2.0 2.6 4.2 3.8 3.8 2.6 2.9 2.9 2.4 3.9 2.5 2.1 6.4 2.4 2.2 3.9 4.5 3.0 1.7 3.8 3.0 2.3 1.7 3.9 2.9 3.4 2.1 2.4 2.5 2.7 6.8 2.6 1.3 3.8 2.9 3.6 3.6 2.1 1.6 2.4 1.9 3.2 2.0 1.6 2.6 2.8 2.0 1.1 2.8 2.6 1.7 3.2 1.8 1.5 2.8 2.9 1.0 3.6 3.4 1.3 3.6 3.1 3.0 4.0 2.9 2.5 3.6 3.4 2.4 2.4 1.9 3.5 3.5 3.5 1.0 2.3 3.1 4.8 1.3 1.9 1.7 2.6 2.1 2.8 1.8 3.6 3.1 1.4 3.8 3.9 3.5 1.9 4.9 2.6 2.6 1.3 2.6 3.8 2.1 3.3 1.9 0.7 0.5 0.8 0.6 1.0 0.9 1.0 0.9 0.6 1.4 1.1 1.0 0.4 1.4 0.7 0.7 0.8 0.5 3.1 4.6 4.7 3.4 2.8 3.6 4.2 3.8 3.9 3.8 3.9 6.8 9.4 0.0 15.5 14.4 12.7 8.4 3.1 5.7 8.0 21.0 7.0 7.2 11.6 7.2 7.1 14.7 37.5 7.8 14.6 13.5 0.0 3.2 1.3 6.9 14.6 9.4 5.4 5.5 22.9 2.6 5.1 10.2 13.7 8.0 5.7 22.0 6.1 5.4 4.8 18.5 23.8 8.7 0.0 8.2 5.6 0.9 18.3 6.4 7.2 19.7 11.9 20.6 17.5 25.1 40.9 3.3 7.5 16.1 7.8 5.5 8.9 4.4 10.8 23.4 0.0 12.6 8.2 11.1 16.1 5.5 6.7 5.3 10.3 20.4 9.8 3.3 LRRC42 MGC8974 ENSG00000116212 "Leucine rich repeat containing 42" Q9Y546 1 53946085-53968168 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047458, HPA050537, HPA064581" Uncertain Enhanced Nucleoplasm NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA047458: , HPA050537: AB_2681161, HPA064581: AB_2685292" "unprognostic (3.13e-1)" "unprognostic (1.32e-1)" "unprognostic (5.88e-2)" "unprognostic (9.97e-3)" "unprognostic (4.01e-2)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.88e-5)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.13e-1)" "unprognostic (2.24e-2)" "unprognostic (9.08e-2)" "unprognostic (7.36e-3)" "unprognostic (1.67e-2)" 15.6 29.0 10.5 9.7 10.7 11.8 14.8 9.7 13.6 16.2 14.9 16.4 12.3 18.7 15.3 21.8 16.6 12.5 14.7 10.4 11.7 15.2 24.3 15.3 11.4 10.8 10.4 17.2 13.2 15.4 24.1 22.4 10.0 15.1 13.2 8.6 16.7 14.8 17.6 21.9 11.8 18.1 10.4 9.2 16.7 19.4 12.2 16.4 23.6 15.7 14.4 18.7 18.3 10.8 73.3 26.9 66.0 38.9 34.0 45.9 45.2 56.7 78.7 74.4 100.4 90.8 48.0 41.4 44.4 70.6 88.0 63.5 57.0 81.4 85.4 32.7 35.5 38.2 40.4 57.9 61.7 23.9 35.2 41.8 110.6 64.5 69.5 54.1 47.6 37.7 48.8 10.6 73.2 25.5 45.1 33.1 56.6 53.5 42.0 75.9 70.2 28.8 53.1 54.1 39.3 42.3 76.5 42.7 63.4 103.1 63.4 28.3 39.6 56.1 71.7 50.1 35.9 29.4 36.4 61.7 54.3 24.8 30.4 0.0 3.1 5.7 4.9 3.1 4.3 4.2 4.2 5.9 3.9 2.3 4.2 3.2 4.8 4.9 2.3 6.9 4.8 2.9 10.5 10.7 9.7 13.6 10.4 11.7 10.8 10.4 10.0 10.4 12.2 10.8 7.8 12.8 5.8 3.6 6.7 51.6 36.4 46.6 29.6 4.4 15.9 14.1 10.5 30.0 24.2 11.0 4.2 43.8 5.4 14.9 19.6 35.0 2.9 16.2 17.0 11.1 68.2 16.0 8.0 16.7 31.4 22.6 17.3 16.8 0.0 19.8 8.2 15.0 17.8 10.1 4.9 9.6 30.5 5.7 11.7 3.5 23.9 8.5 10.6 7.5 10.6 28.7 9.2 5.5 8.4 32.6 13.3 17.7 16.7 46.4 9.9 17.6 19.2 3.6 13.1 15.5 22.7 21.9 48.5 25.5 39.1 57.5 7.9 75.7 14.6 41.0 LRRC58 ENSG00000163428 "Leucine rich repeat containing 58" Q96CX6 3 120324509-120349354 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057574 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA057574: AB_2683474" "unprognostic (7.87e-3)" "unprognostic (6.84e-3)" "unprognostic (3.20e-1)" "unprognostic (2.67e-3)" "unprognostic (8.73e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (4.41e-2)" "unprognostic (1.30e-2)" "unprognostic (3.67e-2)" "unprognostic (2.73e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.18e-4)" "unprognostic (1.06e-1)" 10.6 22.8 8.4 8.8 11.9 9.0 12.0 11.0 9.3 9.0 9.5 7.7 7.5 10.2 8.3 9.2 6.6 7.4 5.5 7.1 8.6 14.9 11.2 7.4 10.2 11.8 11.3 14.6 10.3 13.7 4.1 9.6 12.6 9.7 7.5 7.2 8.5 8.6 5.0 10.9 7.4 9.7 10.8 9.1 7.3 4.5 9.7 12.2 14.2 5.8 8.8 7.4 6.5 14.8 52.6 18.1 12.2 15.6 27.5 26.1 19.3 18.5 16.0 19.2 23.8 17.0 15.8 34.1 22.4 19.9 27.3 22.4 22.7 18.1 36.5 13.3 14.0 36.5 23.5 19.9 18.5 59.8 18.0 19.3 22.7 23.4 29.9 12.4 11.5 21.5 21.0 42.6 20.9 23.9 47.2 19.1 12.3 23.1 32.8 10.4 32.6 22.1 14.6 19.1 15.6 20.6 32.4 21.9 46.2 8.5 24.1 26.7 17.2 32.0 35.7 21.7 23.5 36.3 44.9 70.6 32.2 44.2 27.4 1.4 2.7 1.1 1.9 2.4 2.7 2.5 2.3 2.4 2.6 2.3 3.5 2.7 1.5 1.6 1.9 2.9 2.6 1.9 8.4 11.9 11.0 9.3 7.1 8.6 11.8 11.3 12.6 10.8 9.7 14.8 26.0 73.7 59.9 18.3 30.8 50.9 20.7 15.9 32.5 32.3 34.0 25.8 17.3 24.3 29.0 18.4 56.3 17.3 33.3 17.9 11.7 22.0 7.8 24.4 48.8 24.1 16.8 34.3 23.8 31.0 28.2 50.0 18.3 27.0 35.4 33.9 27.1 43.0 28.7 25.2 27.1 24.3 12.2 49.0 33.9 7.3 55.9 34.4 33.8 14.0 42.3 46.5 30.9 25.1 34.8 28.8 18.6 73.0 33.0 37.0 24.8 39.6 32.3 26.5 26.3 52.7 33.9 19.5 22.8 31.2 57.0 13.5 28.7 94.6 32.3 17.5 LUC7L "hLuc7B1, Luc7, LUC7B1" ENSG00000007392 "LUC7 like" Q9NQ29 16 188969-229463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056424, HPA069321" Supported Approved Nucleoplasm,Mitochondria NA NA 14000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm Mitochondria "HPA056424: AB_2683126, HPA069321: AB_2686119" "unprognostic (9.55e-3)" "unprognostic (2.01e-1)" "unprognostic (3.23e-2)" "unprognostic (5.61e-2)" "unprognostic (7.81e-2)" "unprognostic (2.60e-2)" "unprognostic (8.01e-3)" "unprognostic (4.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.30e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (1.33e-1)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (2.02e-3)" 32.9 47.3 46.0 16.5 46.5 24.0 32.2 47.8 62.9 58.9 46.4 42.8 17.1 40.8 28.2 31.8 40.8 19.4 33.5 46.8 47.1 54.6 43.0 31.9 27.6 45.6 44.9 48.3 48.9 14.9 58.8 18.4 45.4 68.6 13.8 19.6 27.4 18.5 23.3 26.0 40.7 16.2 43.8 63.7 39.2 41.8 45.6 20.3 72.9 12.9 16.9 34.7 36.7 48.3 14.6 62.5 65.1 25.0 24.0 18.8 29.2 26.2 19.7 40.6 29.7 65.8 16.7 27.1 33.5 14.8 22.2 18.5 77.5 23.5 41.2 46.7 53.9 31.7 48.2 77.7 27.4 37.8 34.2 17.0 26.8 33.9 13.3 35.3 31.8 22.1 38.7 16.9 33.8 68.6 60.4 63.8 98.1 32.2 30.0 52.3 28.6 27.8 59.1 15.4 38.8 43.1 28.3 19.6 25.9 38.4 25.2 20.3 27.2 30.5 45.6 13.1 32.2 18.2 25.6 28.2 9.3 26.4 28.1 0.3 9.3 3.9 6.3 11.0 5.1 6.4 6.1 6.4 10.2 2.8 3.5 2.7 1.1 4.5 13.3 11.4 7.5 5.9 46.0 46.5 47.8 62.9 46.8 47.1 45.6 44.9 45.4 43.8 45.6 48.3 64.2 51.3 67.9 59.4 46.9 53.2 39.9 36.4 47.8 48.9 33.1 32.8 22.3 12.8 46.7 23.9 37.5 30.1 63.1 27.2 11.7 35.8 56.7 48.9 81.6 48.2 42.3 26.9 56.7 21.1 42.9 44.4 52.5 55.5 41.1 66.9 26.0 12.7 24.3 45.4 54.0 26.0 28.5 16.6 54.9 21.5 32.6 34.0 39.2 30.0 32.2 24.4 17.5 54.8 40.6 25.8 28.0 32.4 47.4 43.5 27.9 15.5 34.6 59.7 26.3 50.0 50.4 82.1 56.7 29.3 54.3 49.9 45.4 42.5 26.2 37.6 LUC7L3 "CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18" ENSG00000108848 "LUC7 like 3 pre-mRNA splicing factor" O95232 17 50719565-50756219 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018475, HPA018484, HPA020017" Enhanced Enhanced "Nuclear speckles" NA NA 15000 "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249" "unprognostic (3.90e-1)" "unprognostic (4.71e-2)" "unprognostic (2.15e-1)" "unprognostic (1.05e-1)" "unprognostic (8.47e-2)" "unprognostic (2.99e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (1.39e-2)" "unprognostic (1.24e-2)" "unprognostic (1.18e-2)" "prognostic favorable (6.07e-4)" "unprognostic (1.16e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (7.23e-2)" "unprognostic (1.49e-1)" "unprognostic (1.67e-1)" "prognostic favorable (5.35e-5)" 86.8 108.2 128.2 91.1 134.2 75.9 96.4 165.6 193.2 172.2 131.4 163.3 99.4 144.8 88.1 98.3 157.5 63.8 102.8 126.1 138.7 112.7 90.8 119.0 132.4 131.3 128.4 223.5 111.6 63.6 172.0 78.5 132.5 141.3 75.1 175.8 94.8 73.4 151.9 105.3 131.2 65.8 124.6 133.6 113.7 73.7 133.5 84.1 144.0 43.2 88.4 130.1 136.5 148.4 176.7 114.3 222.8 143.1 91.5 87.9 105.5 162.8 63.0 77.0 92.1 214.5 132.4 212.5 171.1 65.2 87.5 148.8 149.4 67.5 132.2 226.6 242.5 251.5 445.3 174.9 50.5 223.4 136.0 84.2 94.5 84.2 48.7 193.7 79.9 164.9 202.9 188.0 99.1 99.1 221.4 218.0 146.2 125.3 83.4 238.2 208.4 224.0 105.5 109.8 158.1 163.2 96.8 121.5 179.3 192.6 196.3 164.9 113.7 170.9 146.3 72.8 171.5 167.8 191.7 265.1 108.1 152.5 123.9 49.1 32.3 32.6 32.0 24.0 28.2 67.3 35.7 27.6 21.2 55.4 37.1 30.5 47.8 23.3 19.8 64.7 29.6 12.1 128.2 134.2 165.6 193.2 126.1 138.7 131.3 128.4 132.5 124.6 133.5 148.4 129.7 150.6 194.2 231.8 177.8 216.2 200.9 99.4 200.3 512.3 121.1 129.5 111.5 70.1 148.3 93.8 229.4 104.8 237.1 130.8 74.3 102.6 18.9 111.1 171.8 151.9 207.8 191.2 121.5 85.3 108.5 149.8 99.4 144.8 148.0 364.8 94.2 83.1 76.4 380.2 145.9 151.8 81.4 87.4 122.5 48.4 394.5 105.1 96.0 107.7 184.2 207.8 197.8 181.5 239.1 86.5 158.0 355.0 134.5 151.2 157.8 56.2 130.1 402.2 236.7 204.5 172.3 122.2 159.3 135.7 177.0 99.9 162.8 253.1 141.7 191.7 LZTR1 "BTBD29, LZTR-1" ENSG00000099949 "Leucine zipper like transcription regulator 1" Q8N653 22 20982269-20999032 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067852, HPA068772, HPA071248" Approved Approved Nucleoplasm,Centrosome,Cytosol No No "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Centrosome, Cytosol" "HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372" "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (9.81e-2)" "unprognostic (3.55e-1)" "unprognostic (3.78e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.16e-3)" "unprognostic (4.29e-2)" "unprognostic (1.65e-1)" "unprognostic (6.25e-2)" "unprognostic (1.25e-2)" 18.4 15.2 9.0 8.9 9.7 6.0 17.3 8.9 10.1 20.1 7.2 20.1 9.9 23.3 4.4 12.6 18.5 9.4 13.4 9.1 9.1 15.8 12.0 16.0 7.3 10.3 9.5 19.5 12.4 11.5 24.7 9.8 10.8 16.2 6.4 3.4 13.0 8.6 14.7 13.6 15.9 11.3 8.1 18.3 13.9 8.2 8.9 6.5 18.8 8.0 5.7 18.1 15.8 9.3 10.3 8.4 12.2 15.0 27.6 18.9 9.6 20.8 14.6 11.6 15.8 4.9 4.2 11.0 7.6 23.4 10.7 13.7 9.3 17.1 4.7 20.5 21.0 11.8 11.8 7.4 14.6 6.4 14.9 17.5 8.5 14.7 10.6 18.4 22.9 10.0 49.8 18.5 13.4 6.3 11.5 6.0 3.8 12.6 9.1 13.4 17.8 4.4 9.2 13.9 11.9 17.9 11.3 19.5 12.4 7.4 9.1 11.7 20.6 27.0 13.3 12.3 11.5 8.0 7.4 3.2 12.2 6.2 13.5 0.0 0.5 0.0 0.7 0.7 0.4 0.4 0.3 0.8 0.4 0.1 0.4 0.3 0.0 0.3 1.0 0.3 0.1 0.5 9.0 9.7 8.9 10.1 9.1 9.1 10.3 9.5 10.8 8.1 8.9 9.3 12.4 12.8 8.6 20.5 7.9 2.2 1.8 3.7 4.0 9.5 7.5 7.6 11.7 5.7 5.2 9.2 6.2 4.1 11.9 10.7 1.9 7.0 0.9 5.5 12.7 10.1 9.1 2.5 14.2 4.9 4.0 10.9 11.2 8.4 5.7 14.7 12.1 8.5 7.7 3.3 13.2 10.0 6.1 8.8 3.5 1.6 8.7 7.1 7.2 14.0 5.0 5.6 5.2 8.0 17.6 6.1 8.9 9.8 9.2 2.3 7.0 7.6 7.3 9.8 0.0 7.0 11.6 4.5 1.5 5.9 3.7 3.6 7.7 10.1 6.7 1.4 MAN2C1 "MANA, MANA1" ENSG00000140400 "Mannosidase alpha class 2C member 1" Q9NTJ4 15 75355207-75368612 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040627, HPA067407" Uncertain Enhanced Nucleoplasm NA NA 110000 "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA040627: AB_10795490, HPA067407: AB_2685834" "unprognostic (4.68e-2)" "unprognostic (1.95e-1)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (3.85e-1)" "unprognostic (3.00e-2)" "unprognostic (1.26e-2)" "unprognostic (6.26e-2)" "unprognostic (2.47e-1)" "unprognostic (5.02e-2)" "unprognostic (1.06e-2)" "unprognostic (3.40e-2)" "unprognostic (4.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.33e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-3)" 49.3 66.1 20.2 23.9 21.1 37.6 49.3 17.7 28.8 52.1 18.6 41.8 25.5 49.3 12.1 29.9 50.5 16.4 55.6 20.0 17.8 52.8 50.0 50.3 20.3 22.8 18.1 58.5 49.1 26.3 56.6 21.1 20.9 49.4 14.9 14.8 37.3 19.5 58.5 36.8 41.6 18.6 17.5 54.7 46.0 34.8 19.8 17.1 64.8 24.5 12.7 45.7 41.5 22.0 11.0 25.5 21.3 15.7 23.8 20.4 27.1 25.3 23.5 12.9 10.9 20.3 38.3 5.7 14.6 18.6 11.8 33.0 11.7 17.1 8.4 30.8 26.1 34.0 58.5 18.1 35.3 23.1 5.7 25.3 17.0 12.3 15.3 27.3 30.9 16.9 20.5 27.4 10.7 22.1 11.9 25.2 9.0 13.2 11.8 16.0 11.0 34.6 16.8 49.8 13.2 22.7 16.4 23.9 11.5 15.6 26.1 26.1 61.5 27.1 18.7 19.0 25.5 27.9 7.1 9.3 17.6 25.9 27.6 4.0 19.8 3.5 9.2 23.0 9.1 3.2 6.9 6.8 22.6 2.6 9.5 6.9 2.2 6.0 18.9 9.2 10.2 14.3 20.2 21.1 17.7 28.8 20.0 17.8 22.8 18.1 20.9 17.5 19.8 22.0 34.1 22.4 51.7 29.0 12.5 13.5 15.2 13.0 11.4 30.7 18.2 16.3 2.8 5.7 19.2 9.2 54.2 17.2 17.2 22.4 3.9 11.4 10.4 10.1 18.3 23.2 34.2 7.6 28.9 8.7 10.9 20.4 39.3 12.7 31.7 46.8 32.5 22.4 20.4 28.6 23.8 19.5 12.2 29.8 20.2 14.0 23.3 26.3 16.0 15.0 31.4 17.3 19.6 18.1 19.5 11.2 20.0 12.4 12.9 16.0 27.9 15.9 19.3 52.4 26.3 25.6 16.3 21.1 10.4 14.9 8.5 21.2 16.2 17.0 24.0 15.3 MAP2K7 "Jnkk2, MKK7, PRKMK7" ENSG00000076984 "Mitogen-activated protein kinase kinase 7" O14733 19 7903843-7914478 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001633, CAB004262, HPA064711" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "Golgi apparatus" "CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331" "unprognostic (1.77e-1)" "unprognostic (5.04e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-1)" "unprognostic (4.24e-2)" "prognostic favorable (8.54e-5)" "unprognostic (1.80e-3)" "unprognostic (2.55e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-2)" "unprognostic (1.27e-3)" "unprognostic (1.56e-1)" "unprognostic (3.54e-2)" "unprognostic (3.71e-2)" "unprognostic (6.05e-2)" "unprognostic (1.73e-2)" "prognostic favorable (1.56e-4)" 19.1 17.0 17.9 11.7 17.8 19.4 19.5 16.8 19.0 25.1 10.4 24.4 13.1 26.1 3.7 20.2 20.5 5.9 20.8 14.8 15.2 18.7 24.7 17.1 11.7 17.3 17.3 23.2 21.6 9.6 23.4 9.2 17.1 21.0 4.6 5.6 19.2 7.9 52.4 27.9 20.1 6.2 15.1 24.5 18.8 17.5 17.3 10.9 19.0 16.4 6.1 22.0 22.4 19.9 25.8 14.4 12.2 20.2 9.7 9.3 22.8 16.5 8.0 11.0 11.3 20.9 15.2 30.5 25.9 8.8 10.7 22.9 10.7 12.8 4.3 24.7 53.3 21.4 20.9 15.6 12.4 20.1 26.0 10.8 16.1 8.7 9.8 14.5 10.0 21.9 31.9 38.5 6.5 13.4 28.8 48.6 21.7 13.6 32.0 28.5 13.4 31.0 9.8 21.0 22.4 22.5 11.3 19.4 23.9 7.3 21.0 22.7 15.3 33.2 19.0 23.7 22.7 55.5 27.7 28.8 16.6 29.2 13.6 0.0 0.8 0.6 0.6 0.8 0.4 0.7 0.5 0.6 0.4 1.0 0.5 0.7 1.5 1.0 0.5 0.8 0.2 0.4 17.9 17.8 16.8 19.0 14.8 15.2 17.3 17.3 17.1 15.1 17.3 19.9 15.4 25.6 18.1 11.1 27.0 38.6 37.2 22.7 22.2 52.9 23.5 16.5 14.4 24.3 14.5 20.2 77.2 28.3 27.8 31.1 13.7 22.8 4.8 16.2 20.3 19.5 36.5 23.6 9.9 19.0 31.1 18.5 16.3 24.8 10.8 33.3 21.4 22.2 18.6 57.2 11.0 24.0 32.6 22.2 17.1 11.7 28.9 20.5 32.0 6.5 25.3 23.9 46.4 9.0 15.0 25.7 20.8 12.4 30.4 39.8 38.7 18.4 15.3 65.7 32.9 30.2 22.1 17.7 36.4 22.7 42.6 49.3 30.3 30.3 27.6 33.2 MAP3K15 "ASK3, bA723P2.3, FLJ16518" ENSG00000180815 "Mitogen-activated protein kinase kinase kinase 15" Q6ZN16 X 19360056-19515261 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 10.8;choroid plexus: 13.1" "Cell type enhanced" "Detected in some" "Collecting duct cells: 5.5;Cone photoreceptor cells: 4.2;Granulosa cells: 7.5;Theca cells: 29.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.0;HAP1: 4.9;HEK 293: 4.1;JURKAT: 2.5;REH: 2.6;SuSa: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA004006 Approved Vesicles NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA004006: AB_1079358" "unprognostic (2.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.21e-2)" "unprognostic (6.56e-8)" "unprognostic (3.47e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-3)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-2)" "unprognostic (1.30e-2)" "unprognostic (8.95e-2)" "unprognostic (2.77e-3)" "unprognostic (4.00e-1)" "unprognostic (2.37e-1)" "unprognostic (3.98e-2)" "unprognostic (8.20e-2)" 0.0 10.8 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.6 1.1 0.0 0.3 0.0 0.0 0.3 0.4 0.5 0.7 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.0 4.9 0.0 0.0 0.8 4.1 1.7 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.1 0.0 1.1 1.3 0.0 0.5 2.6 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.6 0.0 0.3 0.4 0.0 0.2 0.0 0.2 0.0 3.1 0.3 0.0 0.1 0.5 0.0 0.0 1.0 0.2 0.6 2.9 0.0 0.0 5.5 4.2 0.0 0.1 0.2 3.9 0.0 0.4 0.3 0.3 0.1 0.0 0.4 2.6 0.0 0.3 0.4 0.0 0.3 0.0 7.5 0.4 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 1.0 0.0 0.3 0.0 0.5 1.1 0.1 0.0 1.2 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.3 0.2 0.6 1.4 0.0 0.0 0.1 0.2 29.8 0.1 0.0 MARK3 "CTAK1, KP78, PAR-1A" ENSG00000075413 "Microtubule affinity regulating kinase 3" P27448 14 103385377-103503831 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 32 "eosinophil: 101.5" "Lineage enriched" "Detected in all" 32 "granulocytes: 101.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024652 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "HPA024652: AB_1853582" "unprognostic (6.86e-2)" "unprognostic (2.93e-1)" "unprognostic (7.70e-2)" "unprognostic (3.48e-2)" "unprognostic (8.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.31e-3)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (2.29e-3)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.34e-1)" "unprognostic (1.33e-2)" "unprognostic (1.60e-1)" 34.6 52.5 14.9 23.0 15.9 53.2 27.5 16.0 22.1 29.8 15.1 34.8 20.4 31.3 26.7 39.8 36.8 20.8 71.5 14.5 14.8 38.7 30.8 38.3 24.9 15.1 15.0 33.7 46.7 33.8 32.0 22.8 16.2 30.5 21.3 23.2 29.2 24.2 71.0 27.3 31.8 30.8 15.0 42.6 46.5 38.4 14.7 31.0 33.2 42.7 26.2 32.1 28.5 15.6 28.1 33.3 52.8 34.7 64.3 43.6 40.9 54.9 56.8 66.3 62.4 23.3 46.2 36.3 31.9 52.5 27.0 51.5 58.3 56.6 81.2 39.4 28.0 46.8 34.9 30.8 123.5 53.4 27.2 56.1 51.5 53.1 105.0 51.9 61.0 33.0 45.4 77.1 51.2 61.6 34.9 38.4 42.0 57.7 56.0 44.9 56.2 30.1 54.1 52.3 44.5 43.1 59.0 36.6 52.1 58.7 50.8 47.1 50.2 34.8 23.4 62.1 48.4 44.4 67.0 42.1 41.5 40.8 48.0 0.3 1.5 101.5 1.4 1.1 0.9 1.5 2.2 2.8 1.8 0.6 2.4 1.6 2.3 1.4 1.1 1.2 3.1 0.7 14.9 15.9 16.0 22.1 14.5 14.8 15.1 15.0 16.2 15.0 14.7 15.6 38.0 57.7 79.1 154.1 43.6 44.2 57.2 28.7 33.0 78.7 26.3 21.7 74.6 47.1 45.2 38.6 162.6 33.3 47.9 36.6 11.7 46.8 38.0 47.5 63.7 50.9 31.2 187.1 153.5 42.0 31.0 47.3 52.0 62.1 48.2 128.7 63.9 30.1 30.2 58.9 145.0 32.3 30.5 40.4 63.0 52.4 60.9 42.6 37.4 70.3 57.5 34.4 61.8 138.2 172.3 60.4 34.0 59.0 55.9 67.4 34.6 21.5 36.8 86.7 32.9 38.9 44.1 74.6 72.4 36.1 52.1 49.1 54.8 98.9 33.7 114.6 MATN2 ENSG00000132561 "Matrilin 2" O00339 8 97868840-98036724 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 201.0;Peritubular cells: 258.8;Theca cells: 297.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "MAIT T-cell: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Cell line enhanced" "Detected in many" "BJ: 72.5;BJ hTERT+ SV40 Large T+: 78.6;BJ hTERT+ SV40 Large T+ RasG12V: 106.7;HaCaT: 114.4;HBF TERT88: 100.6;SuSa: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033879 Approved "Secreted to extracellular matrix" NA NA 1500000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "CAB033879: AB_2141502" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (2.14e-1)" "unprognostic (4.98e-1)" "unprognostic (5.35e-2)" "unprognostic (7.18e-2)" "unprognostic (5.22e-2)" "unprognostic (2.77e-1)" "unprognostic (2.07e-3)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (6.31e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (6.65e-2)" 54.4 51.0 24.3 30.2 22.5 1.8 43.6 17.6 23.2 194.4 19.3 67.5 58.5 147.0 101.6 32.8 46.9 40.1 110.2 20.0 23.4 39.3 24.6 15.2 18.0 24.1 30.5 116.4 11.3 28.0 9.9 177.9 26.3 104.9 57.8 45.7 42.6 171.9 4.0 62.8 80.6 98.1 18.3 5.9 23.7 31.2 23.4 4.9 271.4 28.5 15.4 103.0 139.2 30.8 24.1 10.8 23.3 2.5 60.7 3.6 15.0 72.5 17.6 78.6 106.7 13.0 8.4 0.1 7.0 29.2 3.5 114.4 2.3 4.4 100.6 0.0 2.9 0.8 6.1 0.9 14.0 0.0 0.0 13.6 9.5 16.1 0.8 22.1 0.5 1.3 0.1 0.2 4.1 11.2 0.0 0.7 7.1 0.3 3.7 0.0 2.4 11.4 5.7 5.3 16.0 1.5 11.5 0.2 19.8 67.3 10.9 1.4 0.6 5.2 31.5 16.1 11.0 0.9 0.2 0.2 18.8 0.4 5.9 0.0 0.1 0.1 0.2 0.4 5.2 0.0 0.7 0.9 0.8 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 24.3 22.5 17.6 23.2 20.0 23.4 24.1 30.5 26.3 18.3 23.4 30.8 27.8 3.2 1.3 11.1 0.3 37.3 10.1 6.2 80.2 6.3 3.8 45.8 29.1 18.6 3.0 16.5 54.2 1.2 0.2 20.6 0.0 9.9 86.0 4.2 22.6 32.4 23.4 3.2 6.4 0.0 1.1 113.1 5.1 5.0 0.0 43.5 201.0 11.0 1.6 0.0 11.5 25.4 0.0 5.0 7.7 108.6 103.5 0.9 28.4 19.7 2.0 8.1 0.0 86.0 59.8 3.2 18.2 258.8 0.0 6.5 118.7 3.4 1.6 52.9 13.1 97.2 17.1 2.5 2.6 7.3 8.5 2.5 2.0 297.5 27.4 1.8 MAU2 "KIAA0892, mau-2, MAU2L, MGC75361, SCC4" ENSG00000129933 "MAU2 sister chromatid cohesion factor" Q9Y6X3 19 19320829-19358754 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059897 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA059897: AB_2684154" "unprognostic (3.53e-1)" "unprognostic (2.94e-2)" "unprognostic (1.18e-1)" "unprognostic (9.57e-3)" "unprognostic (1.87e-1)" "prognostic favorable (3.90e-5)" "unprognostic (1.68e-2)" "unprognostic (3.49e-3)" "unprognostic (5.56e-3)" "unprognostic (3.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.28e-1)" "unprognostic (4.27e-3)" "unprognostic (2.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 16.2 15.9 15.9 12.6 19.1 21.2 15.8 16.4 19.4 18.8 15.1 17.9 13.1 18.4 11.8 20.2 18.4 10.6 19.6 15.1 15.2 15.1 14.3 14.2 14.6 20.1 17.4 23.4 16.5 13.4 21.1 12.2 18.7 17.6 7.6 10.9 15.5 12.1 36.0 21.7 16.5 11.2 15.7 22.2 15.0 19.7 17.6 17.4 17.0 17.6 12.0 16.5 17.2 26.1 13.6 10.4 18.0 16.1 14.5 15.1 24.9 12.7 12.9 16.8 15.1 14.8 18.9 16.9 26.7 13.7 8.5 15.9 15.5 12.8 7.8 9.0 39.3 13.0 16.5 13.2 16.8 23.7 19.5 16.7 14.4 12.1 13.8 17.4 16.3 15.0 18.0 20.3 11.3 15.5 24.3 32.5 15.8 18.7 29.1 27.1 11.6 18.2 11.8 17.6 26.0 23.8 15.7 16.2 16.1 9.1 14.0 32.9 14.8 25.9 6.0 25.7 19.3 26.1 23.5 16.9 12.8 24.8 19.9 3.1 5.8 4.3 6.0 5.0 6.8 4.6 5.3 5.7 5.1 4.5 5.6 5.4 10.4 6.5 11.1 4.9 5.4 6.1 15.9 19.1 16.4 19.4 15.1 15.2 20.1 17.4 18.7 15.7 17.6 26.1 16.4 19.2 18.3 33.6 17.3 6.2 5.5 8.5 18.8 30.4 13.1 15.2 19.1 11.5 10.5 11.0 54.2 10.4 16.4 15.8 3.9 8.2 9.7 16.5 17.0 13.4 14.4 17.4 26.1 9.4 7.1 13.0 15.8 14.5 10.1 26.0 14.6 8.6 8.8 50.5 31.8 11.9 4.1 13.8 6.4 12.3 15.2 13.9 10.6 14.0 15.4 12.0 20.6 26.7 55.3 11.8 10.7 13.9 12.8 10.5 13.7 6.2 21.0 29.3 6.6 17.2 14.8 31.9 12.6 11.8 9.7 15.2 13.6 21.1 13.1 8.6 MBTPS2 "KFSD, S2P" ENSG00000012174 "Membrane bound transcription factor peptidase, site 2" O43462 X 21839617-21885423 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Metalloprotease, Protease" "Disease variant, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005494, CAB009486" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 85: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria, Cytosol" "CAB009486: AB_2140370, HPA005494: AB_1079329" "unprognostic (7.97e-3)" "unprognostic (9.12e-2)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (7.22e-2)" "unprognostic (3.32e-1)" "unprognostic (9.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (8.38e-2)" "unprognostic (7.76e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (3.05e-2)" 8.6 10.6 3.5 5.2 4.0 1.7 8.8 7.8 4.9 7.5 4.5 5.1 5.2 9.7 6.0 5.8 7.3 6.7 7.7 3.7 4.1 9.4 18.7 5.5 5.0 4.4 4.1 12.5 7.3 11.0 3.8 11.6 4.9 10.5 6.0 8.8 6.6 8.5 7.1 3.7 4.2 10.1 4.1 4.8 5.8 4.1 4.2 4.9 9.0 9.1 4.7 6.8 4.0 6.1 16.9 34.5 16.1 16.5 19.8 24.4 7.7 24.4 24.7 22.7 19.7 13.8 22.5 14.6 12.4 26.2 44.4 15.4 22.4 14.0 27.9 10.9 17.8 7.2 19.7 11.4 27.1 15.6 6.8 23.2 14.8 34.3 25.1 23.0 17.8 8.4 20.3 15.8 26.1 10.5 6.4 8.1 15.0 8.8 25.1 7.9 29.8 16.4 15.7 8.4 3.9 32.8 34.3 21.5 30.5 21.3 28.9 13.2 21.2 28.4 6.6 41.9 18.5 19.1 26.0 6.9 31.6 6.4 28.0 0.0 2.2 0.8 2.2 2.5 2.0 1.9 1.6 2.0 3.6 1.7 2.2 2.6 0.2 2.6 2.6 2.4 3.2 1.7 3.5 4.0 7.8 4.9 3.7 4.1 4.4 4.1 4.9 4.1 4.2 6.1 5.5 9.6 11.5 16.6 5.8 5.5 4.8 7.0 8.0 11.8 7.5 5.1 13.3 8.6 7.1 7.3 18.8 7.0 2.2 3.8 0.0 5.9 0.3 4.0 11.5 5.6 2.4 2.1 16.8 8.9 7.1 10.8 6.1 3.7 10.8 14.5 7.5 18.7 9.4 30.3 25.0 3.4 12.2 9.2 4.0 1.9 10.5 4.8 10.6 11.2 5.0 7.3 3.1 21.6 22.2 6.1 2.4 13.2 9.1 7.4 4.9 7.2 10.7 14.5 0.0 8.6 8.3 2.7 1.5 6.5 2.7 4.8 5.1 12.3 4.3 4.9 MDM4 "HDMX, MDMX" ENSG00000198625 "MDM4 regulator of p53" O15151 1 204516379-204558120 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018919, HPA048821" Approved Supported Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA018919: AB_1853694, HPA048821: AB_2680531" "unprognostic (4.63e-2)" "unprognostic (3.73e-1)" "unprognostic (6.38e-2)" "unprognostic (1.50e-1)" "unprognostic (3.84e-2)" "unprognostic (1.68e-3)" "unprognostic (2.33e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-2)" "unprognostic (2.34e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (9.87e-4)" "prognostic unfavorable (7.06e-6)" "unprognostic (1.20e-1)" "unprognostic (1.73e-1)" "unprognostic (2.49e-2)" "prognostic favorable (2.49e-4)" 13.7 10.5 9.2 13.4 18.7 56.1 14.3 16.3 12.1 17.6 35.0 12.4 5.8 12.0 18.6 11.5 13.6 6.7 11.4 10.6 17.8 14.4 14.8 16.3 18.8 17.5 14.6 18.9 18.8 5.3 16.3 10.1 17.5 14.6 9.6 25.2 11.9 7.3 10.5 20.7 16.7 7.1 10.5 22.6 13.2 19.9 15.9 30.4 15.8 4.2 17.4 12.1 13.7 36.0 6.5 12.7 12.5 17.3 8.6 9.4 58.7 4.8 4.9 6.1 8.9 6.6 8.7 22.4 4.5 6.7 5.1 6.8 8.5 7.2 8.2 6.8 6.0 17.8 32.0 7.6 6.5 14.0 16.9 9.4 4.5 9.9 17.4 6.3 6.0 14.2 10.4 31.5 5.4 21.9 8.6 12.3 17.3 2.4 5.3 10.1 10.2 7.5 6.0 31.1 5.6 12.6 4.9 9.1 9.1 12.4 18.0 8.1 6.1 6.8 12.1 4.5 7.9 15.8 6.2 18.2 4.7 5.9 10.1 7.5 4.3 5.8 5.7 4.2 4.9 7.9 4.4 4.1 3.6 11.9 6.1 5.4 6.4 4.1 3.8 7.8 2.6 2.5 9.2 18.7 16.3 12.1 10.6 17.8 17.5 14.6 17.5 10.5 15.9 36.0 73.6 28.9 56.9 76.0 118.1 61.6 48.2 31.0 22.8 96.0 55.2 33.7 38.5 47.1 51.2 69.9 168.9 52.0 135.7 35.5 13.7 29.9 82.3 39.6 74.2 54.5 65.0 64.4 61.8 26.7 26.1 53.0 36.7 63.2 65.9 82.6 87.1 61.0 35.5 42.1 65.7 48.3 54.9 96.4 128.3 160.2 80.2 62.0 42.7 83.4 81.8 40.1 90.6 106.6 170.3 26.5 42.3 54.2 81.0 66.3 49.0 18.6 32.0 192.7 52.6 99.6 50.5 75.7 64.8 23.0 68.3 60.9 73.7 58.2 51.1 48.3 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642498-89819794 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.5;Inhibitory neurons: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 24.7;NTERA-2: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 4.2 4.6 3.4 1.9 3.6 4.2 4.3 4.4 3.3 4.5 1.7 4.4 1.2 5.6 2.1 4.9 5.0 1.2 4.9 3.1 3.3 4.4 9.1 3.9 2.6 3.3 3.1 7.6 5.9 3.0 4.6 1.2 3.7 3.6 1.8 3.0 3.9 1.5 8.3 7.1 5.0 1.7 2.2 4.5 4.6 6.5 3.3 2.8 6.0 3.4 2.5 4.2 4.3 5.7 4.2 4.1 4.1 3.8 6.6 6.3 4.1 2.8 2.1 3.1 3.8 9.4 1.5 12.5 3.1 2.9 3.3 3.6 10.7 3.8 5.5 4.9 7.1 13.5 5.6 6.1 2.5 17.7 3.2 3.9 3.1 8.3 7.6 1.9 5.6 5.6 24.7 2.9 3.1 5.0 2.8 6.6 22.7 3.4 3.5 5.5 7.8 3.1 2.7 5.8 7.5 3.3 3.9 2.3 2.5 5.4 1.6 7.7 7.2 2.1 3.8 2.8 6.5 3.3 3.9 5.9 2.8 9.8 3.7 3.2 0.3 0.6 0.7 0.2 0.6 1.0 1.0 0.8 0.2 1.3 1.3 1.0 0.0 1.1 0.3 3.0 0.4 0.1 3.4 3.6 4.4 3.3 3.1 3.3 3.3 3.1 3.7 2.2 3.3 5.7 13.2 28.9 19.1 55.2 19.2 29.3 8.2 6.0 30.7 24.4 14.0 11.0 39.2 11.5 16.9 14.7 25.0 5.5 25.2 6.6 0.0 6.3 7.5 20.1 21.9 15.0 7.7 58.5 82.5 8.1 7.2 13.3 19.4 25.2 6.3 26.4 6.4 48.5 6.6 18.5 79.5 7.7 6.1 6.3 9.5 4.3 7.2 8.6 12.4 33.7 6.6 8.0 9.2 35.7 74.8 6.9 3.7 8.6 26.0 18.1 4.7 2.5 12.9 18.7 0.0 33.1 12.7 37.5 50.1 26.1 30.1 3.4 19.4 17.4 10.3 8.5 MED17 "CRSP6, CRSP77, DRIP80, SRB4, TRAP80" ENSG00000042429 "Mediator complex subunit 17" Q9NVC6 11 93784227-93814963 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 4 "cerebellum: 2.3;cerebral cortex: 1.3;white matter: 1.7" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046619 Approved "Nuclear speckles,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA046619: " "prognostic unfavorable (4.94e-4)" "unprognostic (2.92e-1)" "unprognostic (2.72e-3)" "unprognostic (1.38e-1)" "unprognostic (6.71e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.48e-3)" "unprognostic (7.73e-2)" "unprognostic (1.41e-1)" "unprognostic (4.59e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-1)" "unprognostic (2.22e-1)" "unprognostic (5.56e-3)" "unprognostic (1.48e-1)" 1.3 0.9 0.2 1.5 0.4 1.5 1.0 2.3 1.3 1.4 1.2 1.5 0.4 1.8 1.0 1.0 1.5 0.6 1.7 0.3 0.2 0.9 0.5 1.1 1.1 0.4 0.2 1.6 1.4 0.5 0.8 1.3 0.3 1.0 0.5 1.1 1.0 0.7 1.6 1.1 2.1 1.0 0.1 2.3 1.7 0.9 0.4 1.3 0.9 1.1 1.0 1.0 1.0 1.7 3.3 1.1 2.7 5.9 3.3 0.4 5.3 7.3 2.5 4.7 2.8 5.9 6.6 5.3 11.6 0.6 1.3 9.8 2.5 1.4 1.3 6.5 2.9 6.0 3.7 1.7 1.7 10.5 10.1 1.3 3.4 3.5 2.1 1.1 1.9 1.4 5.5 3.4 2.7 1.0 12.3 3.1 5.1 0.7 0.8 9.5 7.8 4.4 2.8 2.3 9.7 12.3 5.8 4.7 2.8 0.6 7.2 2.5 6.5 7.2 5.7 9.9 6.3 4.9 10.1 3.9 1.9 7.2 8.5 3.3 3.0 7.6 4.0 3.7 4.5 8.2 5.1 5.0 3.8 5.8 5.2 2.9 3.3 6.7 2.2 4.5 5.3 3.5 0.2 0.4 2.3 1.3 0.3 0.2 0.4 0.2 0.3 0.1 0.4 1.7 7.7 6.4 9.3 16.3 32.1 30.1 39.6 19.4 25.6 24.6 10.1 4.6 15.5 14.3 19.5 7.3 16.7 39.3 25.5 12.4 1.9 15.8 1.0 9.3 14.9 14.2 26.8 9.7 25.8 9.7 27.4 17.2 17.3 13.6 10.8 22.9 16.8 8.6 14.5 15.2 27.7 13.4 16.2 15.5 27.0 3.0 15.8 12.8 14.2 19.7 18.4 13.4 23.7 22.1 25.1 10.4 14.8 21.4 25.6 26.9 13.8 2.7 19.4 43.9 65.7 19.3 16.4 23.1 16.3 18.1 25.7 34.1 28.1 10.4 17.6 36.3 MED23 "CRSP130, CRSP3, DRIP130, MRT18, Sur2" ENSG00000112282 "Mediator complex subunit 23" Q9ULK4 6 131573966-131628242 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 72.0;Inhibitory neurons: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070341 Approved Nucleoplasm,Vesicles NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA070341: AB_2686257" "unprognostic (1.11e-2)" "unprognostic (4.66e-2)" "unprognostic (5.51e-3)" "unprognostic (1.80e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (6.62e-3)" "unprognostic (4.47e-1)" "unprognostic (1.64e-1)" "unprognostic (6.81e-3)" "unprognostic (1.44e-2)" "unprognostic (3.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (2.21e-1)" "unprognostic (2.44e-2)" "unprognostic (2.53e-2)" 7.7 10.5 3.4 11.5 3.7 22.0 14.3 9.8 5.0 12.0 3.7 10.6 11.4 13.3 10.6 8.5 11.0 8.9 6.5 3.5 3.6 10.3 7.9 9.9 14.8 2.4 2.8 14.2 10.7 18.3 6.0 11.0 3.1 11.7 12.4 11.5 12.7 11.6 7.4 11.5 10.6 10.4 2.7 12.8 11.6 10.5 3.5 18.0 14.4 10.1 15.3 10.1 7.8 6.4 7.2 7.8 18.2 23.0 22.1 16.8 16.7 17.6 19.8 16.0 23.0 8.2 9.8 15.9 12.5 18.2 15.4 12.6 9.9 11.4 24.7 18.1 13.8 16.6 14.9 14.0 16.0 27.8 27.1 14.9 13.3 17.7 17.8 18.6 20.1 16.9 21.7 16.2 17.0 11.0 21.3 17.4 8.7 12.3 7.8 18.9 11.4 9.6 12.2 10.4 13.6 12.3 12.6 17.4 11.6 20.9 4.8 19.3 20.4 11.8 13.3 19.0 16.2 17.0 12.3 22.6 14.5 12.6 16.1 4.9 4.5 7.6 5.5 4.6 8.3 4.7 5.5 6.2 5.6 4.2 5.5 5.1 3.6 12.9 3.3 2.9 6.6 3.9 3.4 3.7 9.8 5.0 3.5 3.6 2.4 2.8 3.1 2.7 3.5 6.4 16.3 19.2 9.6 24.8 21.5 9.2 6.3 11.9 13.6 23.7 15.5 10.9 6.5 8.6 15.7 23.9 16.7 8.7 23.7 15.5 3.9 7.6 2.1 14.8 14.7 13.9 14.4 12.0 72.0 7.7 6.8 12.5 14.3 16.6 14.0 18.3 14.3 12.4 8.1 11.8 67.1 17.4 6.1 17.6 9.5 3.2 14.3 12.8 5.4 36.5 16.9 7.7 21.6 42.3 60.8 9.1 14.9 10.1 19.4 10.7 14.7 8.5 13.4 24.4 13.1 13.8 10.2 13.5 5.3 12.0 8.7 7.8 20.7 14.6 14.3 12.8 MED6 NY-REN-28 ENSG00000133997 "Mediator complex subunit 6" O75586 14 70581257-70600690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030764, HPA069039" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA030764: AB_2673601, HPA069039: AB_2686070" "unprognostic (1.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (6.93e-2)" "unprognostic (2.86e-1)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (3.15e-2)" 13.0 14.9 13.3 14.0 13.3 21.6 17.2 22.5 17.3 14.8 10.6 13.2 11.8 14.8 17.7 17.2 15.0 12.2 14.6 12.6 13.8 11.5 16.8 13.0 24.3 10.3 11.6 19.0 11.2 12.2 12.1 15.3 10.8 11.2 13.0 22.0 12.3 12.4 23.2 18.6 12.2 14.4 10.1 15.0 12.4 13.7 12.9 24.3 14.8 22.6 26.5 16.4 13.9 13.3 81.0 43.5 56.1 24.2 29.6 32.0 44.9 39.6 42.7 60.8 60.3 43.8 48.9 60.9 22.7 34.6 36.0 37.9 67.5 41.0 64.4 44.0 35.7 44.8 31.6 59.5 36.0 39.5 34.4 36.1 47.2 43.1 39.7 26.7 48.1 45.8 42.3 37.4 45.2 60.3 56.7 53.2 41.9 56.7 53.7 46.5 51.9 32.0 37.8 42.4 37.9 40.3 41.8 44.3 47.0 32.6 69.2 49.1 37.7 49.7 71.2 24.8 37.3 39.2 63.7 85.8 43.1 34.1 34.7 19.1 16.2 24.6 17.6 18.9 20.9 17.9 23.1 20.3 18.5 20.2 21.3 21.7 15.8 22.6 22.9 13.9 23.4 14.1 13.3 13.3 22.5 17.3 12.6 13.8 10.3 11.6 10.8 10.1 12.9 13.3 36.7 19.2 25.7 16.0 48.7 19.4 34.2 50.3 28.5 73.5 23.0 21.1 7.4 12.8 34.5 18.4 79.2 39.1 49.4 13.9 5.9 30.3 7.6 22.7 24.9 27.6 22.1 22.5 27.1 23.1 44.3 30.1 24.5 30.5 46.3 29.5 25.4 15.0 26.2 26.9 24.2 14.0 20.3 19.2 15.4 6.3 27.1 21.4 17.8 16.9 30.4 38.5 47.4 18.6 18.6 27.2 19.5 29.3 41.6 38.3 22.5 14.1 37.2 97.7 26.3 28.0 26.4 25.3 37.7 23.5 20.0 49.0 44.7 25.2 14.8 39.2 MEGF8 "C19orf49, EGFL4, FLJ22365, SBP1" ENSG00000105429 "Multiple EGF like domains 8" Q7Z7M0 19 42325609-42378769 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 38.7;Cone photoreceptor cells: 77.2;Horizontal cells: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049248 Approved NA NA 510000000 "Cluster 11: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "HPA049248: AB_2680691" "unprognostic (5.52e-3)" "unprognostic (1.52e-1)" "unprognostic (5.35e-2)" "unprognostic (1.66e-2)" "unprognostic (1.20e-1)" "unprognostic (4.63e-2)" "unprognostic (3.25e-2)" "unprognostic (8.58e-2)" "unprognostic (9.25e-2)" "unprognostic (3.64e-2)" "prognostic favorable (6.03e-4)" "unprognostic (4.33e-2)" "prognostic favorable (2.17e-7)" "unprognostic (1.18e-1)" "unprognostic (7.34e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" 13.0 12.3 23.4 4.3 20.9 2.3 10.0 11.1 30.6 10.4 6.7 11.8 4.8 11.9 7.0 7.3 9.7 4.6 16.6 21.7 18.0 11.3 6.9 6.8 3.9 16.1 19.7 13.5 8.7 20.5 12.3 6.1 17.4 10.0 4.3 10.9 8.5 8.1 10.2 6.8 8.6 6.7 12.1 9.1 9.3 7.9 23.0 3.8 10.7 6.8 3.3 10.2 7.9 17.3 12.7 21.1 22.2 5.5 48.6 23.1 8.2 10.6 14.8 6.0 9.3 4.2 11.6 10.7 22.4 14.7 7.9 6.6 16.2 13.8 6.0 13.1 14.1 8.0 10.3 6.9 18.7 10.9 9.5 28.0 13.6 7.3 10.9 39.9 20.7 3.1 11.8 4.7 11.3 8.3 2.5 6.6 11.3 11.5 3.5 10.4 20.0 2.4 16.1 16.6 11.5 29.3 13.0 6.8 14.4 23.8 7.2 24.3 31.1 12.7 12.3 4.0 14.6 10.9 6.4 5.9 13.8 6.5 31.2 0.4 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.1 23.4 20.9 11.1 30.6 21.7 18.0 16.1 19.7 17.4 12.1 23.0 17.3 6.2 6.4 10.8 13.7 3.2 2.2 2.4 7.3 4.6 38.7 5.7 6.3 15.9 2.8 10.3 7.3 77.2 3.7 3.2 8.4 0.0 7.2 3.4 7.9 9.8 7.0 13.2 1.7 24.4 3.7 1.5 9.2 4.6 6.7 3.8 26.2 7.1 8.9 5.9 40.4 27.2 6.7 6.1 4.7 3.9 1.2 12.8 3.2 8.8 8.4 4.0 13.1 2.1 10.1 10.0 4.6 3.1 14.3 3.2 2.6 5.4 4.4 7.2 16.3 0.0 11.9 8.9 5.9 4.2 5.7 1.0 2.3 2.5 18.9 10.9 1.4 METTL16 "METT10D, MGC3329" ENSG00000127804 "Methyltransferase like 16" Q86W50 17 2405562-2511891 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020352, HPA059798" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA020352: AB_1853828, HPA059798: AB_2684128" "unprognostic (4.94e-3)" "unprognostic (2.86e-2)" "unprognostic (2.29e-2)" "unprognostic (5.66e-3)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (3.35e-2)" "unprognostic (1.88e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-1)" "prognostic favorable (3.06e-4)" "unprognostic (5.35e-2)" "unprognostic (4.85e-3)" "unprognostic (2.91e-2)" "unprognostic (2.32e-1)" "unprognostic (1.61e-1)" "unprognostic (2.68e-2)" 6.8 6.2 4.4 6.6 6.2 8.8 7.8 5.1 5.2 7.2 4.3 6.0 5.3 9.5 5.7 5.9 9.1 4.9 7.2 4.0 4.4 6.3 3.8 7.0 8.3 4.7 5.2 12.3 7.5 10.1 4.5 4.2 4.9 7.4 5.8 7.7 6.6 7.0 6.6 6.4 5.2 8.5 5.0 6.9 4.7 5.4 4.8 10.4 9.3 7.4 8.3 6.4 5.3 7.9 9.0 25.3 12.7 12.9 9.7 12.1 12.3 11.8 9.6 12.4 10.3 34.5 6.1 28.1 11.9 10.1 13.3 12.5 30.2 15.3 16.8 11.0 20.7 14.2 21.2 16.0 10.8 13.3 11.0 10.2 14.0 17.3 24.9 8.5 13.0 16.1 19.1 14.8 8.4 11.0 19.1 7.8 14.9 10.9 10.1 31.8 13.8 12.7 9.2 8.3 6.8 11.4 16.7 9.3 9.0 13.5 11.9 8.6 10.2 11.6 7.3 16.3 16.3 8.3 11.3 19.4 15.5 11.1 15.8 1.6 2.1 0.8 3.5 1.4 4.4 3.5 3.3 3.4 1.5 2.9 4.9 3.7 0.0 1.3 1.0 2.0 2.3 1.4 4.4 6.2 5.1 5.2 4.0 4.4 4.7 5.2 4.9 5.0 4.8 7.9 17.5 12.8 33.5 19.2 25.7 11.5 21.4 12.6 9.6 28.7 14.9 14.1 15.8 15.7 25.8 7.3 45.9 8.9 19.3 11.8 13.7 9.9 20.8 18.8 21.7 13.9 20.4 6.3 20.9 10.8 9.1 18.9 15.3 15.0 24.7 25.5 17.5 9.2 10.4 26.9 21.6 13.7 10.2 10.0 5.9 7.6 14.9 11.6 8.8 17.8 13.7 20.2 30.9 23.6 42.2 9.7 6.3 12.8 14.5 20.1 23.2 9.0 26.3 37.4 6.6 28.0 21.3 11.8 16.7 14.7 12.8 6.0 25.5 28.7 16.8 17.0 MFSD8 "CLN7, MGC33302" ENSG00000164073 "Major facilitator superfamily domain containing 8" Q8NHS3 4 127917799-127966034 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044802 Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Vesicles Nucleoplasm "HPA044802: AB_10963221" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (8.10e-2)" "unprognostic (1.57e-1)" "unprognostic (4.12e-2)" "unprognostic (1.18e-1)" "unprognostic (8.99e-2)" "unprognostic (2.19e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (3.44e-2)" "unprognostic (3.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.61e-3)" "unprognostic (3.14e-1)" "prognostic favorable (2.21e-4)" 4.6 5.7 1.3 6.8 1.3 2.6 6.9 1.9 1.6 6.2 1.1 6.8 10.0 5.6 3.9 5.4 5.5 4.8 3.8 1.1 1.7 6.4 10.0 4.8 5.4 1.4 1.3 6.8 8.1 9.1 7.1 5.9 1.5 5.5 8.2 4.6 5.8 4.4 3.7 5.9 7.6 5.8 1.1 7.3 6.4 3.9 0.8 5.2 7.0 4.4 7.9 5.3 5.9 2.2 10.9 7.3 9.5 4.6 7.2 6.9 7.0 8.3 10.3 10.2 10.5 5.2 14.3 5.2 14.5 14.3 14.8 7.8 10.2 7.4 14.4 10.8 7.9 5.7 9.1 8.0 9.4 6.0 6.6 8.3 2.7 8.6 7.7 5.0 10.6 6.6 9.5 5.9 14.6 8.9 5.0 1.9 1.7 11.8 5.2 5.3 0.6 4.7 7.5 13.9 8.5 2.9 9.0 12.0 3.5 6.4 5.6 5.1 6.7 2.9 3.1 10.7 7.8 12.5 22.1 9.6 10.3 5.3 8.8 1.9 1.6 2.8 2.5 2.4 2.4 2.5 2.7 2.2 1.6 1.1 2.4 2.6 2.5 2.4 3.7 2.2 3.4 1.2 1.3 1.3 1.9 1.6 1.1 1.7 1.4 1.3 1.5 1.1 0.8 2.2 9.5 12.8 14.1 17.0 18.8 3.2 4.9 8.5 10.2 17.2 8.1 5.3 3.0 5.7 14.0 16.5 20.9 12.5 17.9 7.2 1.9 8.5 10.4 7.7 7.2 7.2 4.2 3.8 32.1 7.0 7.3 8.6 11.7 8.2 12.7 18.4 8.9 10.1 7.6 11.8 34.9 6.8 10.2 8.5 3.3 14.7 9.3 6.5 3.6 27.2 10.5 8.6 20.6 20.6 24.6 7.8 9.5 9.4 19.9 5.4 11.1 6.3 12.1 24.9 6.6 5.8 6.6 12.6 8.4 8.9 5.7 22.0 13.7 11.4 7.3 4.8 MGA "FLJ12634, KIAA0518, MAD5, MXD5" ENSG00000174197 "MAX dimerization protein MGA" Q8IWI9 15 41621224-41773081 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.6" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042278, HPA058183" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA042278: AB_10794647, HPA058183: AB_2683632" "unprognostic (5.78e-2)" "unprognostic (7.97e-2)" "unprognostic (2.97e-1)" "unprognostic (7.20e-2)" "unprognostic (6.26e-3)" "unprognostic (5.82e-3)" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (1.90e-2)" "unprognostic (3.96e-3)" "unprognostic (3.71e-1)" "unprognostic (3.80e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-1)" "unprognostic (3.93e-1)" "unprognostic (2.50e-1)" "unprognostic (3.89e-1)" 3.9 5.2 7.0 5.4 12.1 8.7 7.2 33.6 8.5 7.3 0.0 4.5 3.7 7.4 6.0 4.5 5.8 4.2 4.5 4.9 11.6 5.2 4.6 4.3 7.6 6.4 6.9 12.0 5.0 6.0 3.9 6.9 8.8 5.7 5.1 7.0 5.1 5.5 5.1 6.2 3.9 5.7 3.8 6.8 4.6 8.7 8.6 11.6 7.5 7.8 7.6 5.4 3.9 17.3 2.4 13.5 16.6 10.9 12.8 10.1 13.3 6.7 6.8 7.8 7.7 14.5 7.8 16.2 11.8 7.8 14.2 9.3 25.9 5.9 10.7 7.7 8.5 34.3 22.1 12.8 11.3 31.9 16.4 7.7 7.2 10.9 10.7 3.2 10.3 15.5 40.7 7.2 7.1 6.7 19.4 12.3 10.3 7.0 6.9 21.7 16.9 8.5 4.1 9.8 15.7 15.3 24.0 8.2 4.3 12.1 6.6 20.1 11.0 9.5 13.3 9.8 8.0 9.8 15.7 15.3 6.0 11.9 4.8 3.6 1.4 1.6 2.5 1.0 2.5 2.8 2.1 2.9 1.4 3.0 2.1 2.4 0.6 5.8 3.3 2.4 1.1 1.0 7.0 12.1 33.6 8.5 4.9 11.6 6.4 6.9 8.8 3.8 8.6 17.3 18.5 22.4 19.8 56.5 28.1 7.9 10.9 7.2 13.6 25.5 11.1 8.9 29.5 5.7 16.2 12.9 33.3 18.1 23.6 9.7 7.9 11.8 16.7 16.8 35.4 18.6 7.8 28.6 62.4 5.3 12.0 20.5 18.8 24.9 14.5 32.9 15.0 9.3 11.8 13.5 60.1 10.0 8.2 11.9 8.8 7.0 20.8 17.1 8.8 44.0 13.2 16.0 25.7 64.8 122.6 8.1 13.5 20.7 16.4 16.2 7.6 5.2 14.9 23.6 39.5 35.6 19.2 45.4 40.4 11.7 11.2 26.0 27.5 23.5 11.3 10.7 MGRN1 "KIAA0544, RNF156" ENSG00000102858 "Mahogunin ring finger 1" O60291 16 4616493-4690974 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 16.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007653, HPA008033" Approved Supported "Endoplasmic reticulum,Vesicles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 52: Non-specific - Transcription" Vesicles "Endoplasmic reticulum" "HPA007653: AB_1846304, HPA008033: " "unprognostic (2.27e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (4.24e-1)" "unprognostic (1.26e-2)" "unprognostic (9.96e-2)" "unprognostic (1.70e-1)" "unprognostic (4.03e-2)" "unprognostic (9.47e-2)" "unprognostic (6.41e-2)" "unprognostic (2.32e-1)" "unprognostic (9.06e-2)" "unprognostic (1.79e-1)" "unprognostic (5.04e-2)" 23.3 34.3 18.6 25.0 20.6 32.6 22.8 11.9 25.4 28.3 4.9 30.6 28.9 36.9 6.8 20.4 32.1 19.7 26.9 26.4 11.4 24.0 53.5 30.3 18.1 14.1 10.4 30.5 34.6 18.5 33.2 18.5 8.8 30.1 10.9 9.0 25.6 20.5 52.1 23.0 29.9 17.5 8.1 37.7 35.3 18.0 12.0 11.7 28.8 16.7 10.9 28.2 20.6 24.3 13.6 63.9 32.4 33.2 19.0 18.4 44.0 28.7 20.0 23.6 20.0 42.5 31.4 40.0 36.2 35.0 17.6 21.4 26.0 23.6 7.0 56.0 28.8 22.0 45.2 59.6 34.7 32.1 52.3 34.2 15.0 33.0 14.1 17.0 23.0 26.0 32.7 28.6 16.4 59.7 33.3 42.9 48.0 19.2 27.4 60.7 17.0 54.3 20.8 39.3 51.8 42.8 47.6 50.6 28.2 14.8 30.7 31.4 40.8 43.7 24.1 124.3 25.0 44.6 37.8 27.2 18.6 31.8 32.0 5.4 3.5 3.8 2.5 3.9 2.3 1.3 1.4 2.3 2.4 1.5 3.2 1.9 16.2 1.4 2.6 4.1 1.7 3.7 18.6 20.6 11.9 25.4 26.4 11.4 14.1 10.4 8.8 8.1 12.0 24.3 14.7 25.6 34.0 24.2 22.2 9.2 29.5 10.0 6.2 27.3 15.8 11.0 11.4 22.8 9.6 18.4 43.8 23.5 28.2 27.7 5.9 18.6 16.2 20.1 24.2 16.9 37.0 13.7 26.6 22.7 17.7 19.0 44.9 24.5 14.0 30.4 15.0 34.8 30.4 25.2 25.0 23.5 4.1 30.1 21.4 27.2 26.8 27.0 21.4 8.4 36.5 20.8 23.7 18.6 29.8 32.0 15.8 24.8 29.0 23.7 31.7 13.9 11.1 35.2 0.0 20.4 17.6 9.3 12.5 11.9 16.3 34.2 24.0 29.8 23.1 27.8 MIA3 "FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077" ENSG00000154305 "MIA SH3 domain ER export factor 3" Q5JRA6 1 222618097-222668007 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA055922, HPA056816" Supported Enhanced Vesicles NA NA 1400000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" Vesicles "HPA055922: AB_2682971, HPA056816: AB_2683243" "unprognostic (1.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.43e-1)" "unprognostic (6.60e-2)" "unprognostic (1.86e-2)" "unprognostic (8.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (5.65e-2)" "unprognostic (6.73e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.57e-2)" "unprognostic (1.83e-1)" "unprognostic (8.62e-3)" "unprognostic (3.26e-1)" 25.6 22.0 11.0 23.4 13.1 33.2 21.4 12.9 14.9 23.9 13.2 24.3 23.9 23.7 29.2 13.7 16.0 20.6 20.6 10.9 13.6 21.1 74.5 21.5 26.9 10.8 12.3 25.4 38.7 30.1 15.2 23.1 11.7 39.3 29.5 24.4 33.2 22.1 23.7 17.4 25.9 23.8 10.7 27.3 45.0 36.5 11.5 25.7 31.7 20.5 26.2 21.0 14.1 12.8 24.8 18.8 26.5 42.5 92.8 47.1 46.5 34.8 49.4 36.2 43.1 16.6 26.2 24.0 33.0 41.8 20.5 39.9 28.5 31.3 37.8 38.1 21.6 27.7 21.5 31.5 88.6 50.7 34.7 45.2 35.0 35.9 60.8 44.8 41.4 28.9 34.8 44.4 30.7 15.9 34.3 33.8 33.2 76.8 27.5 24.4 70.8 47.8 23.1 22.8 30.4 31.3 38.6 36.2 30.4 36.2 38.2 37.5 31.7 27.5 17.9 44.5 41.3 48.4 30.9 23.8 36.7 25.4 37.5 26.8 15.6 36.5 17.6 22.4 17.7 20.7 14.7 17.5 11.7 18.6 16.4 17.8 27.1 22.5 26.0 13.2 19.2 13.5 11.0 13.1 12.9 14.9 10.9 13.6 10.8 12.3 11.7 10.7 11.5 12.8 48.5 70.5 49.6 31.3 46.9 18.7 26.8 20.4 29.0 60.9 24.3 35.3 65.0 25.8 47.1 5.5 31.3 28.6 73.8 35.2 0.0 25.1 37.0 34.9 72.5 36.4 60.4 26.3 51.4 34.8 17.0 53.0 79.5 42.0 17.7 44.2 25.4 63.3 20.4 45.4 58.0 95.3 32.6 22.0 14.0 24.9 37.0 32.9 19.6 35.6 32.1 31.8 44.3 41.2 29.1 26.4 25.8 48.9 54.4 39.0 41.3 19.4 44.7 41.5 19.7 57.9 46.6 55.7 42.1 21.9 16.1 35.8 47.8 70.2 24.6 29.4 MIGA2 "C9orf54, FAM73B, FLJ00199, FLJ14596" ENSG00000148343 "Mitoguardin 2" Q7L4E1 9 129036621-129072082 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 18.7;Theca cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041363 Approved Approved "Cell Junctions,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Cytosol "Cell Junctions" "HPA041363: AB_10794664" "unprognostic (2.10e-1)" "unprognostic (4.82e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (1.01e-1)" "unprognostic (3.93e-2)" "unprognostic (3.07e-3)" "unprognostic (2.90e-2)" "prognostic favorable (3.04e-6)" "unprognostic (1.12e-2)" "unprognostic (1.44e-3)" "unprognostic (8.57e-3)" "unprognostic (1.25e-1)" "unprognostic (4.63e-2)" "unprognostic (4.15e-3)" 6.7 13.6 7.5 5.3 7.6 12.6 5.8 8.4 8.1 6.2 5.1 11.8 15.2 7.2 2.9 11.9 6.7 3.9 17.3 7.0 8.4 7.8 7.8 4.8 4.6 10.4 8.3 6.8 4.7 6.6 8.1 1.6 9.1 9.3 3.1 2.3 7.3 6.9 9.8 10.1 14.0 4.3 7.0 7.0 10.1 4.6 9.1 4.4 9.2 7.7 3.6 9.3 6.3 7.6 4.8 9.7 2.9 14.9 7.9 4.1 6.5 8.4 6.3 9.5 6.0 8.4 9.8 7.2 3.7 6.6 8.3 22.3 4.0 6.3 1.4 6.6 5.9 5.2 20.4 6.3 8.7 6.0 11.5 5.8 4.9 8.6 4.4 3.1 6.6 6.7 7.7 2.9 5.2 12.7 6.0 12.3 6.7 11.4 13.9 12.2 8.7 12.0 5.0 9.2 9.3 6.6 9.4 14.7 5.2 1.7 10.6 6.4 6.7 6.1 7.0 10.4 6.5 4.0 6.2 6.7 8.7 4.7 7.4 7.2 1.5 1.4 1.5 1.6 3.3 1.2 1.1 2.0 1.6 1.3 1.1 0.7 2.5 0.6 0.9 2.2 1.0 1.2 7.5 7.6 8.4 8.1 7.0 8.4 10.4 8.3 9.1 7.0 9.1 7.6 7.1 3.2 7.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 7.1 7.2 0.0 0.0 3.1 7.3 0.0 3.3 8.1 0.0 1.9 5.4 0.0 4.2 4.4 1.8 0.0 0.0 0.0 4.7 2.6 2.4 0.0 7.3 0.0 18.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 5.8 0.0 0.0 1.8 0.0 0.0 4.5 2.9 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 5.6 3.0 22.1 0.0 0.0 MPG MDG ENSG00000103152 "N-methylpurine DNA glycosylase" P29372 16 77007-85851 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006531 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA006531: AB_1854075" "unprognostic (1.78e-2)" "unprognostic (8.48e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.82e-5)" "unprognostic (8.54e-2)" "unprognostic (3.27e-1)" "unprognostic (2.75e-2)" "unprognostic (1.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-2)" "unprognostic (1.83e-2)" "unprognostic (1.39e-2)" "unprognostic (1.86e-3)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 45.6 63.1 28.6 24.5 28.4 32.8 45.8 28.3 43.8 45.5 25.8 43.0 23.7 46.6 9.4 39.8 40.4 27.5 59.7 28.1 28.7 33.6 66.9 44.6 40.4 27.4 27.5 43.1 59.2 11.9 44.4 21.2 27.4 50.3 7.6 2.0 55.6 21.2 69.2 37.9 37.1 14.7 28.3 53.0 46.8 16.2 29.5 14.2 46.6 21.1 15.1 46.7 38.4 28.5 50.2 70.4 18.1 54.9 34.1 77.2 51.9 78.0 95.1 44.1 49.3 44.2 61.5 40.2 65.0 39.8 20.5 64.7 13.1 30.4 6.7 67.6 59.3 25.3 34.3 67.1 99.3 25.4 141.9 75.4 41.9 50.0 20.4 57.4 80.0 39.9 56.1 58.6 57.8 167.5 43.6 118.1 36.4 27.3 86.1 84.2 25.7 140.5 37.5 17.1 15.5 42.5 41.0 36.2 91.9 8.3 54.1 119.4 80.6 34.1 47.9 49.4 34.4 67.7 23.6 49.6 67.8 71.2 129.9 47.3 75.3 80.9 60.6 56.6 55.0 92.5 57.1 60.3 80.3 85.9 42.5 43.7 38.9 130.2 47.6 110.3 90.8 67.0 28.6 28.4 28.3 43.8 28.1 28.7 27.4 27.5 27.4 28.3 29.5 28.5 72.6 3.2 25.6 14.0 73.9 35.8 82.9 102.9 47.8 13.8 76.8 80.4 1.3 37.1 63.0 40.5 4.2 78.7 74.2 59.1 33.2 76.4 9.9 33.5 63.1 59.3 49.8 39.9 14.2 114.2 89.4 78.7 43.8 36.1 56.3 57.1 62.8 55.6 89.8 10.1 13.9 92.5 83.4 69.4 43.7 5.0 65.9 55.6 56.9 10.3 77.9 39.8 66.9 14.1 12.9 134.8 78.6 57.9 80.1 110.6 83.1 67.7 43.5 11.4 85.5 51.5 73.3 15.1 36.7 53.9 41.1 61.8 59.8 197.2 68.3 114.0 MPHOSPH8 "HSMPP8, mpp8" ENSG00000196199 "M-phase phosphoprotein 8" Q99549 13 19633659-19673441 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039701, HPA040035" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane, Cytosol" "HPA039701: AB_10805484, HPA040035: AB_10794207" "unprognostic (4.22e-1)" "unprognostic (5.58e-2)" "unprognostic (2.66e-1)" "unprognostic (4.01e-3)" "unprognostic (3.05e-2)" "unprognostic (1.86e-1)" "unprognostic (2.81e-3)" "unprognostic (4.90e-2)" "unprognostic (4.55e-2)" "unprognostic (1.59e-1)" "unprognostic (3.52e-3)" "unprognostic (3.40e-2)" "unprognostic (6.49e-2)" "unprognostic (3.86e-2)" "unprognostic (4.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.02e-1)" 29.0 32.5 32.4 30.0 31.9 27.9 28.7 36.5 48.7 38.6 31.1 39.7 22.5 36.1 31.6 23.3 34.0 23.4 36.1 31.6 40.2 22.9 21.1 28.7 39.2 31.8 35.7 51.4 28.2 26.3 31.6 25.4 31.5 31.2 24.4 36.9 32.3 31.2 23.4 33.6 33.3 26.6 26.8 39.9 28.3 21.5 33.6 23.2 32.9 18.5 26.4 32.3 31.7 36.5 26.0 16.4 23.9 39.0 30.3 38.2 42.2 38.2 27.5 23.6 20.1 25.1 44.5 40.8 29.7 23.1 36.6 42.2 44.4 26.7 30.2 51.1 22.7 65.7 27.8 30.8 27.0 47.8 51.4 22.8 33.8 18.6 26.1 35.8 31.6 32.5 32.5 25.5 22.2 25.1 36.8 39.9 23.4 48.0 18.1 29.3 55.2 32.6 40.7 19.8 32.7 20.0 35.7 32.3 35.3 39.8 19.7 39.1 37.3 18.1 16.4 34.8 19.6 17.2 19.2 40.1 13.8 43.4 28.7 133.6 23.4 42.5 31.5 18.2 28.1 64.3 35.6 31.1 11.4 54.1 42.5 34.8 69.2 30.4 27.8 35.8 30.9 9.9 32.4 31.9 36.5 48.7 31.6 40.2 31.8 35.7 31.5 26.8 33.6 36.5 117.3 93.0 110.6 42.1 129.7 69.0 102.1 99.0 97.3 201.0 74.8 95.0 94.4 110.1 92.2 103.0 83.4 151.1 132.0 95.1 49.0 57.6 84.3 82.3 129.2 109.0 58.8 78.9 94.7 54.6 83.7 118.8 62.7 118.8 144.2 101.0 133.2 81.3 72.9 210.3 89.4 113.2 67.1 74.5 55.5 37.9 179.3 71.4 67.6 51.5 99.8 114.9 166.9 56.3 78.7 48.2 99.7 157.2 118.5 80.8 100.5 61.6 66.6 219.0 177.5 111.5 118.5 211.0 203.7 57.9 74.0 58.7 142.7 105.3 86.8 65.3 MRI1 "MGC3207, MRDI, mtnA, Ypr118w" ENSG00000037757 "Methylthioribose-1-phosphate isomerase 1" Q9BV20 19 13764522-13774282 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042744, CAB045988" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No 880000 "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "CAB045988: AB_2145566, HPA042744: AB_2678141" "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-3)" "unprognostic (1.61e-1)" "unprognostic (8.98e-2)" "unprognostic (1.50e-3)" "unprognostic (1.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.77e-1)" "unprognostic (1.28e-1)" 15.8 19.2 7.9 9.0 8.2 9.5 18.5 9.3 8.5 24.8 7.0 17.3 9.6 21.6 4.1 20.5 21.8 5.3 12.9 7.6 7.5 22.3 23.8 15.8 10.5 8.9 7.7 24.4 19.6 7.8 18.0 11.9 8.7 19.3 6.4 5.3 20.5 8.8 11.6 26.0 21.1 5.2 7.1 23.1 18.3 3.6 8.4 7.8 23.0 4.4 8.7 17.6 22.4 10.9 14.7 9.3 5.5 13.1 6.1 9.5 13.0 17.9 9.3 13.8 12.4 9.9 11.5 7.9 6.5 6.6 7.3 25.4 24.5 15.5 10.8 12.6 39.3 6.6 18.5 12.0 4.7 20.3 14.8 9.9 9.4 7.1 6.0 14.3 13.7 7.9 11.6 0.6 7.4 18.7 21.9 14.3 9.1 6.0 27.2 20.5 7.6 17.4 8.1 11.4 10.4 9.9 6.6 13.9 14.5 7.7 11.1 8.2 8.2 8.2 7.6 29.3 8.8 11.0 11.3 2.4 6.8 22.5 9.7 3.4 1.8 0.7 1.7 1.7 1.8 1.5 1.7 2.2 1.4 1.6 1.3 1.1 1.6 1.8 1.1 2.7 1.5 1.3 7.9 8.2 9.3 8.5 7.6 7.5 8.9 7.7 8.7 7.1 8.4 10.9 9.2 9.6 19.8 15.0 10.8 11.1 8.9 10.8 6.8 4.3 9.0 8.4 0.9 8.6 13.4 16.5 8.4 13.2 17.2 8.1 5.9 9.2 0.7 11.5 14.4 13.8 9.1 13.3 22.3 12.7 8.7 12.3 14.3 14.2 13.3 9.9 12.8 10.0 7.2 1.7 19.6 9.3 6.1 7.2 8.4 1.7 17.4 7.4 1.8 9.4 10.5 5.0 17.5 18.1 15.2 6.8 11.0 15.1 13.3 4.7 16.5 10.5 19.2 9.3 26.3 10.8 13.3 0.3 4.5 13.3 11.4 5.3 16.0 22.2 9.8 6.8 MTMR4 "KIAA0647, ZFYVE11" ENSG00000108389 "Myotubularin related protein 4" Q9NYA4 17 58489529-58517905 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (3.07e-1)" "unprognostic (6.52e-2)" "unprognostic (4.87e-3)" "unprognostic (1.68e-2)" "unprognostic (1.54e-1)" "unprognostic (6.42e-2)" "unprognostic (4.97e-2)" "unprognostic (3.45e-3)" "unprognostic (6.82e-2)" "unprognostic (2.21e-1)" "prognostic favorable (5.09e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.45e-1)" "unprognostic (2.13e-1)" "unprognostic (1.59e-2)" "unprognostic (2.92e-2)" 11.1 12.0 17.8 13.3 16.1 19.1 13.7 21.2 24.0 10.8 9.4 13.9 21.4 11.9 18.3 11.5 11.8 8.0 10.3 19.1 22.5 17.0 41.7 9.6 17.6 49.5 20.0 15.1 13.1 16.0 13.3 12.2 51.6 12.4 17.2 21.1 10.9 10.2 8.2 14.9 21.7 10.9 12.0 15.8 12.2 18.7 24.6 17.2 16.2 10.3 22.6 11.6 10.3 27.7 21.5 23.0 34.3 33.4 20.8 20.8 26.6 12.7 21.6 32.8 30.2 22.5 13.8 44.6 17.6 13.2 25.8 12.3 37.2 21.9 34.9 46.3 25.8 30.4 18.4 30.1 23.0 32.1 26.6 21.8 17.4 22.5 35.7 21.5 24.0 29.7 26.6 31.4 16.6 32.2 63.6 21.3 8.3 40.7 23.1 40.3 25.6 22.0 15.4 44.7 54.4 52.3 12.5 14.7 17.0 17.6 28.6 22.0 13.0 50.9 32.3 14.7 15.6 25.9 30.8 32.7 81.8 24.0 15.7 2.6 3.0 5.8 2.2 3.8 2.0 4.3 2.7 2.5 3.6 4.4 2.9 3.0 3.6 2.0 4.9 2.1 2.8 2.3 17.8 16.1 21.2 24.0 19.1 22.5 49.5 20.0 51.6 12.0 24.6 27.7 10.4 9.6 7.4 30.3 29.3 7.6 12.3 9.3 21.6 0.0 16.1 14.1 11.4 17.2 9.8 3.7 0.0 12.8 9.5 38.2 0.0 9.7 5.1 8.9 15.1 10.7 17.3 23.1 35.0 6.4 21.4 10.0 12.8 10.2 6.3 21.8 12.1 65.7 13.8 0.0 43.9 20.1 2.0 14.2 26.4 6.4 14.3 10.5 12.4 17.8 29.4 0.0 21.6 24.6 39.7 9.1 21.4 17.3 14.6 17.4 48.6 12.0 4.0 0.0 0.0 10.8 13.9 5.3 4.8 13.8 8.2 49.8 15.0 17.5 18.4 9.3 MTX3 ENSG00000177034 "Metaxin 3" Q5HYI7 5 79976716-79991262 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047858, HPA062061" Approved Approved Mitochondria NA NA "Cluster 30: Non-specific - Translation" "Cluster 51: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA047858: AB_2680185, HPA062061: AB_2684672" "unprognostic (2.56e-2)" "unprognostic (2.32e-1)" "unprognostic (2.47e-2)" "unprognostic (4.21e-2)" "unprognostic (4.59e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (5.08e-5)" "unprognostic (4.02e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (8.58e-2)" "unprognostic (8.46e-2)" "unprognostic (5.08e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-2)" "unprognostic (3.09e-2)" "unprognostic (2.28e-1)" 6.8 10.0 5.9 6.2 6.8 6.4 8.1 6.0 7.1 8.2 4.8 8.6 4.4 9.2 6.7 7.9 8.3 3.9 7.7 6.9 5.9 6.9 5.6 5.5 8.3 6.2 6.1 12.5 7.2 11.8 7.3 4.5 6.7 7.8 4.9 11.9 8.3 6.8 8.7 7.6 9.6 6.1 5.4 8.3 7.4 5.1 6.8 3.8 8.8 5.5 7.9 7.9 7.6 6.2 8.6 4.9 13.1 7.1 6.3 11.3 3.3 8.2 5.9 6.6 7.3 2.1 9.1 13.6 2.4 7.7 11.0 9.9 0.0 18.1 12.4 3.6 8.0 5.7 14.7 6.8 11.8 0.0 6.7 9.0 18.0 11.4 20.1 9.3 4.6 0.0 3.0 7.5 11.3 9.2 0.0 0.1 13.4 2.8 5.1 0.0 19.7 5.8 6.0 9.7 17.1 13.2 10.8 7.4 15.9 10.1 12.1 9.7 5.3 11.9 9.7 9.2 18.0 10.5 10.8 11.9 17.8 0.0 15.0 0.3 0.2 0.2 0.6 0.2 0.4 0.8 0.6 0.5 0.1 0.5 0.8 0.6 0.2 0.4 0.1 0.2 0.4 0.2 5.9 6.8 6.0 7.1 6.9 5.9 6.2 6.1 6.7 5.4 6.8 6.2 7.6 28.9 5.3 18.9 8.4 1.5 4.9 2.7 9.6 0.0 9.8 6.7 9.4 15.7 8.0 12.9 0.0 5.1 6.2 2.5 5.9 3.9 2.7 9.2 16.4 7.2 0.0 3.8 27.1 2.5 3.2 9.9 5.1 8.6 1.3 20.6 10.8 7.9 3.2 0.0 24.5 4.4 4.1 3.5 1.7 4.1 12.8 3.4 0.0 5.6 2.8 0.0 5.2 23.6 25.0 5.3 5.3 12.4 5.1 8.7 3.9 8.6 12.5 0.0 13.1 13.4 9.8 8.8 7.5 11.5 3.4 1.8 8.1 15.5 6.0 5.8 MYSM1 KIAA1915 ENSG00000162601 "Myb like, SWIRM and MPN domains 1" Q5VVJ2 1 58643440-58700077 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Immunity, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054291, HPA057306" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 6: Non-specific - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA054291: AB_2682438, HPA057306: " "unprognostic (2.95e-3)" "unprognostic (3.64e-2)" "unprognostic (3.20e-2)" "unprognostic (8.68e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.09e-5)" "unprognostic (8.12e-3)" "unprognostic (9.63e-3)" "unprognostic (5.72e-3)" "unprognostic (3.74e-1)" "unprognostic (2.25e-1)" "unprognostic (4.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.22e-2)" "unprognostic (1.83e-1)" "unprognostic (8.45e-2)" "unprognostic (1.44e-2)" 11.2 7.5 4.0 4.4 3.9 12.5 12.0 4.3 5.9 11.9 4.2 11.8 5.4 10.6 6.2 10.0 10.2 3.1 10.5 4.1 3.9 7.2 8.0 10.1 6.3 3.9 3.7 13.2 12.1 5.9 8.7 4.4 3.9 9.6 4.4 8.4 11.8 4.1 10.0 10.5 12.6 3.6 3.7 11.4 9.9 4.4 3.9 5.3 11.5 3.1 4.9 9.3 11.1 4.4 10.1 2.6 5.0 6.7 6.0 7.2 10.5 5.9 5.6 5.1 3.9 5.3 4.2 10.3 1.8 3.8 4.8 7.4 7.7 2.1 11.0 6.2 4.3 11.3 2.1 5.1 7.4 19.6 9.7 5.4 5.9 7.5 3.8 6.1 1.2 4.2 12.6 6.3 6.8 2.6 7.8 16.3 11.4 3.5 3.5 7.3 16.4 6.1 4.6 3.8 5.8 6.6 4.4 9.4 13.9 9.0 3.1 10.6 4.9 9.3 4.6 6.4 11.3 10.8 5.8 13.9 5.8 13.7 11.6 0.9 0.3 0.1 0.3 0.4 0.2 0.4 0.3 0.3 0.1 0.3 0.5 0.4 1.0 0.1 0.5 0.4 0.4 0.1 4.0 3.9 4.3 5.9 4.1 3.9 3.9 3.7 3.9 3.7 3.9 4.4 36.5 22.4 33.7 47.7 26.0 19.1 22.8 13.5 30.7 19.5 25.6 21.0 28.2 10.0 35.1 11.0 25.0 8.4 36.6 22.1 15.6 8.8 3.9 22.1 34.8 25.4 16.2 14.1 87.4 9.4 5.7 20.8 19.9 36.9 56.3 30.1 23.9 16.3 11.3 18.5 58.2 17.0 24.4 13.9 14.2 6.3 12.8 22.2 8.8 35.6 21.3 12.7 22.6 58.3 106.9 12.7 13.1 17.3 29.5 19.3 19.2 8.8 21.2 27.8 26.3 28.8 21.5 15.5 20.6 25.0 18.5 11.4 30.8 22.0 18.5 26.4 N4BP2L2 "CG005, PFAAP5" ENSG00000244754 "NEDD4 binding protein 2 like 2" Q92802 13 32432417-32538885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039338, HPA039434, HPA059327" Approved Approved Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 52: Non-specific - Ribosome" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA039338: AB_2676453, HPA039434: AB_10673143, HPA059327: AB_2683981" "unprognostic (1.13e-1)" "unprognostic (1.72e-1)" "unprognostic (3.15e-1)" "unprognostic (5.81e-2)" "unprognostic (6.83e-2)" "unprognostic (6.51e-2)" "unprognostic (8.95e-2)" "unprognostic (6.29e-3)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (2.71e-3)" "unprognostic (2.67e-2)" "unprognostic (4.73e-3)" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (4.03e-3)" 29.0 28.4 29.7 19.9 33.1 26.4 40.9 39.3 36.3 28.7 25.8 26.0 17.9 39.1 37.8 23.3 27.3 29.0 42.7 26.6 29.2 30.8 36.8 34.9 28.4 28.3 28.4 47.5 18.1 33.7 23.0 23.4 29.4 36.1 28.2 38.0 24.0 30.3 65.3 29.2 24.9 31.6 30.0 31.7 26.1 20.0 27.9 33.0 36.6 60.8 25.0 31.5 19.8 37.0 18.1 13.7 35.0 25.4 31.6 39.1 29.7 34.0 31.8 28.3 25.7 24.1 44.7 19.4 18.2 37.4 44.7 30.2 36.1 32.6 37.7 46.7 17.9 35.6 30.9 29.4 50.1 46.0 20.3 42.4 42.4 26.1 31.2 47.7 43.9 34.4 28.6 18.2 39.8 24.1 36.1 44.5 31.4 79.2 15.6 29.7 32.0 21.5 36.2 24.9 12.8 32.1 22.2 25.0 48.4 39.9 27.6 64.7 33.5 15.4 17.1 17.1 16.4 17.3 19.6 16.4 21.2 30.5 25.7 35.4 13.7 29.3 17.1 16.4 23.7 18.1 20.3 18.0 13.0 16.1 23.4 20.1 20.3 21.2 23.0 16.6 20.1 12.2 29.7 33.1 39.3 36.3 26.6 29.2 28.3 28.4 29.4 30.0 27.9 37.0 269.4 173.1 174.2 321.3 275.3 137.9 319.5 236.5 166.8 222.0 167.1 144.8 186.6 138.7 180.1 217.0 248.1 182.4 311.3 208.5 92.0 132.9 132.3 164.3 180.6 199.5 175.8 118.9 354.5 74.7 81.8 189.0 175.8 139.2 212.8 256.3 198.5 134.6 119.1 249.0 386.1 173.0 217.7 161.6 129.6 140.2 370.0 175.9 124.5 244.5 308.4 108.4 382.1 367.4 586.4 116.7 282.3 301.7 187.9 253.3 338.7 92.3 175.1 335.8 315.5 234.5 197.3 187.6 89.8 89.3 137.7 191.5 292.6 180.5 122.4 275.1 NAA16 "FLJ22054, MGC40612, NARG1L, PRO2435" ENSG00000172766 "N-alpha-acetyltransferase 16, NatA auxiliary subunit" Q6N069 13 41311267-41377030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 23.5;pancreas: 20.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039761, HPA040157" Approved Enhanced Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA039761: AB_10795112, HPA040157: AB_10793917" "unprognostic (2.09e-2)" "unprognostic (2.86e-2)" "unprognostic (2.95e-1)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "unprognostic (4.45e-2)" "unprognostic (1.60e-1)" "unprognostic (4.47e-3)" "unprognostic (1.09e-2)" "unprognostic (2.90e-1)" "unprognostic (3.04e-2)" "unprognostic (3.50e-2)" "unprognostic (1.36e-2)" "unprognostic (7.94e-2)" "unprognostic (5.81e-2)" "unprognostic (1.58e-1)" "unprognostic (3.34e-2)" 3.2 2.7 1.8 5.0 2.1 23.5 3.9 4.9 2.2 5.0 1.6 2.8 4.3 6.3 2.7 4.2 4.3 3.5 2.4 1.5 2.4 3.1 2.9 3.7 6.5 1.8 2.0 5.9 20.5 3.5 1.9 3.8 2.0 4.7 3.2 5.9 3.9 3.8 4.4 4.1 4.1 3.7 1.1 4.5 4.8 7.5 2.2 5.9 3.7 4.5 4.0 3.9 3.5 3.4 7.3 6.0 14.9 10.8 5.1 6.5 5.7 8.9 7.4 8.6 7.5 7.1 5.6 12.1 4.1 7.2 3.5 10.0 7.7 5.7 10.5 7.5 15.5 15.0 6.3 7.2 5.5 16.8 9.7 4.5 4.2 3.6 6.8 5.8 8.6 11.7 6.8 6.5 5.6 6.0 17.5 4.8 12.6 10.1 8.1 12.9 6.1 10.1 6.8 6.6 5.0 11.6 8.0 7.7 3.3 8.6 4.7 9.3 6.2 5.8 4.9 9.3 7.0 4.5 5.4 14.0 7.5 7.2 7.1 4.4 1.5 3.1 2.3 0.8 2.1 1.0 2.6 2.4 0.8 1.6 4.5 4.7 0.8 3.4 1.2 1.6 2.0 1.3 1.8 2.1 4.9 2.2 1.5 2.4 1.8 2.0 2.0 1.1 2.2 3.4 15.0 9.6 16.7 34.0 19.6 17.7 21.9 9.5 18.8 27.9 10.3 10.2 12.0 10.0 12.4 9.2 14.6 8.8 20.2 5.6 1.9 12.5 17.9 17.2 26.7 16.7 7.7 15.4 53.5 20.5 7.8 18.8 19.9 22.1 3.8 18.9 13.6 8.7 19.1 38.7 66.9 5.5 4.1 8.5 11.7 26.3 30.1 14.3 14.2 45.0 12.0 11.3 21.6 68.9 57.1 13.1 6.9 19.9 28.3 20.0 7.3 7.0 17.3 33.6 19.7 17.0 24.7 39.2 28.8 17.0 14.6 2.9 31.7 17.1 9.7 21.2 NAGPA "APAA, UCE" ENSG00000103174 "N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase" Q9UK23 16 5024844-5034141 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064055 Approved NA NA 7800000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 52: Non-specific - Transcription" "HPA064055: AB_2685183" "unprognostic (9.93e-2)" "unprognostic (1.61e-2)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (7.12e-3)" "unprognostic (3.30e-3)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.05e-2)" "unprognostic (2.98e-2)" "unprognostic (1.35e-1)" "unprognostic (9.51e-3)" "unprognostic (9.41e-2)" "prognostic unfavorable (2.67e-5)" "unprognostic (1.26e-1)" "unprognostic (6.09e-2)" "unprognostic (7.47e-2)" "unprognostic (1.02e-1)" 6.3 7.0 20.3 5.7 21.6 6.2 5.5 17.9 29.6 5.5 17.6 8.8 6.5 6.6 2.6 6.4 4.8 3.4 5.4 23.6 18.3 8.2 9.0 5.7 6.4 19.2 18.0 3.6 6.2 4.8 5.4 4.1 18.5 5.7 3.0 0.6 5.4 3.3 6.1 6.7 9.8 3.4 17.8 11.8 9.4 3.3 19.6 3.5 5.7 2.4 2.8 6.4 5.1 20.9 2.5 9.7 1.6 10.4 4.0 5.0 10.8 7.1 12.7 9.3 11.2 8.0 19.9 1.0 8.8 9.6 15.8 7.3 4.4 7.8 2.6 11.8 13.3 3.6 5.7 53.1 12.7 8.8 14.6 7.7 8.1 6.0 2.7 11.0 14.6 8.8 11.5 14.1 5.5 11.3 4.0 23.6 5.0 6.3 10.2 10.4 3.7 19.3 5.8 3.9 4.0 5.6 5.6 14.2 15.1 1.4 9.7 10.5 11.0 9.9 7.2 24.0 5.3 6.9 6.3 2.3 4.6 13.1 8.3 3.9 39.3 10.4 17.9 35.0 14.2 17.3 17.1 15.4 50.5 14.2 14.0 13.2 1.2 10.6 23.6 12.9 16.3 20.1 20.3 21.6 17.9 29.6 23.6 18.3 19.2 18.0 18.5 17.8 19.6 20.9 8.1 0.0 2.7 7.8 15.0 2.9 4.7 4.5 7.4 14.7 5.2 5.1 3.1 8.6 4.7 5.5 31.3 13.3 10.2 21.8 1.9 11.3 0.4 3.0 3.7 8.4 1.2 9.1 44.5 8.5 14.9 4.6 28.1 4.1 1.3 8.9 9.7 7.7 27.2 16.8 21.5 13.6 2.0 24.9 8.6 1.0 8.1 20.6 3.6 2.8 24.0 4.5 18.6 4.0 6.9 9.5 18.4 6.4 13.2 4.1 28.9 9.0 3.2 13.8 0.0 4.3 4.8 4.4 8.4 8.8 2.4 9.4 12.1 5.8 12.4 3.2 NAT9 DKFZP564C103 ENSG00000109065 "N-acetyltransferase 9 (putative)" Q9BTE0 17 74770529-74776367 "Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021820, HPA057149" Approved Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA021820: AB_1847958, HPA057149: AB_2683350" "unprognostic (7.53e-2)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.40e-1)" "unprognostic (2.18e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.25e-5)" "unprognostic (1.27e-1)" "unprognostic (5.77e-2)" "unprognostic (1.41e-1)" "prognostic favorable (3.21e-5)" "unprognostic (6.50e-3)" "prognostic unfavorable (6.26e-6)" "prognostic favorable (7.80e-4)" "unprognostic (8.50e-2)" "unprognostic (8.64e-2)" "unprognostic (1.03e-3)" 18.2 57.5 24.0 11.4 24.6 13.5 18.1 25.8 27.6 23.3 25.0 17.3 8.0 18.7 23.2 16.3 21.5 8.9 19.4 23.6 24.2 25.1 29.9 17.6 13.6 25.2 24.9 31.0 25.2 18.0 29.4 14.2 25.2 27.7 9.8 11.5 17.1 12.5 16.4 16.0 15.8 11.1 24.4 20.8 19.3 20.9 24.5 13.7 24.4 11.0 11.3 21.7 18.2 25.6 20.9 30.0 18.7 17.2 29.9 37.4 22.3 39.5 34.2 40.7 35.1 51.3 22.8 57.4 14.7 31.2 26.2 22.8 25.6 42.9 25.9 12.0 37.0 37.0 24.6 46.2 34.9 19.1 22.9 34.2 31.9 40.5 61.2 33.7 44.7 36.2 46.8 17.6 30.2 19.9 38.9 15.6 14.5 40.5 42.8 25.6 55.7 33.4 29.2 33.5 27.0 35.7 16.5 48.1 78.0 25.5 44.4 24.7 26.2 47.0 37.7 20.4 37.5 24.1 9.4 32.0 19.4 12.9 30.5 20.4 16.2 7.4 9.2 24.0 18.9 20.7 16.7 13.8 19.9 30.5 28.5 21.1 4.2 16.7 13.9 15.2 9.8 12.0 24.0 24.6 25.8 27.6 23.6 24.2 25.2 24.9 25.2 24.4 24.5 25.6 15.3 6.4 14.5 15.7 22.6 35.1 41.7 25.9 12.5 39.5 24.7 18.9 5.6 5.7 16.4 18.4 47.9 23.3 20.3 14.5 7.9 14.9 5.5 7.6 13.3 14.3 26.4 10.3 24.4 19.5 19.2 17.3 17.3 13.1 1.3 33.0 9.3 9.9 18.0 45.4 20.2 17.7 20.3 14.1 21.0 4.0 29.5 16.8 10.6 5.6 20.7 11.3 18.6 15.6 16.4 18.3 17.0 17.0 15.8 43.7 11.8 14.5 13.5 46.4 6.6 15.1 16.1 20.5 26.4 9.0 29.7 22.2 14.3 23.7 20.8 39.0 NCKAP5L KIAA1602 ENSG00000167566 "NCK associated protein 5 like" Q9HCH0 12 49791146-49828750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 112.6;Leydig cells: 68.3;Peritubular cells: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041034 Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" "HPA041034: AB_10796235" "unprognostic (3.35e-2)" "unprognostic (1.68e-3)" "unprognostic (2.87e-3)" "unprognostic (1.06e-1)" "unprognostic (4.79e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (2.07e-4)" "unprognostic (2.51e-2)" "unprognostic (8.65e-2)" "unprognostic (1.85e-2)" "prognostic favorable (4.87e-4)" "unprognostic (2.94e-1)" "prognostic unfavorable (1.16e-5)" "unprognostic (3.29e-2)" "unprognostic (3.80e-1)" "unprognostic (5.94e-2)" "unprognostic (1.15e-1)" 13.3 27.6 9.9 6.4 12.1 3.1 11.2 9.8 14.1 14.7 8.6 12.3 2.9 12.4 1.4 6.3 11.9 5.4 22.2 10.0 9.9 12.8 10.9 16.2 4.4 13.7 11.4 14.6 7.9 5.0 14.0 9.0 11.7 15.0 1.0 2.6 8.3 4.6 10.0 6.6 6.7 4.7 9.1 13.1 8.7 15.7 12.8 5.8 14.0 4.6 1.9 11.6 10.3 15.7 5.3 8.9 15.5 15.4 9.7 7.2 20.6 8.9 9.6 12.8 10.6 12.4 1.6 3.2 15.0 9.1 4.9 1.8 6.4 9.4 3.4 3.3 9.0 11.7 11.3 12.1 24.4 4.6 24.4 17.0 10.8 13.8 6.4 16.1 15.1 11.7 11.4 0.1 8.3 12.9 12.0 16.5 18.7 1.7 9.9 14.5 16.0 0.9 9.9 7.3 5.4 24.3 13.6 14.6 25.4 8.4 25.6 9.4 11.9 11.9 12.5 6.1 4.3 0.3 0.0 4.1 9.6 5.3 3.6 0.0 0.6 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.2 0.2 0.4 0.5 0.0 0.3 9.9 12.1 9.8 14.1 10.0 9.9 13.7 11.4 11.7 9.1 12.8 15.7 18.0 6.4 1.1 16.6 7.6 12.7 8.2 8.4 22.8 44.6 19.2 15.6 2.7 5.7 6.2 11.0 112.6 10.6 19.2 1.2 0.0 5.3 1.2 15.6 16.9 11.6 9.0 1.7 10.0 3.8 12.9 17.4 3.1 8.6 0.0 29.5 10.8 4.6 15.9 30.3 13.2 1.3 8.2 12.9 24.8 4.8 68.3 20.7 5.4 13.1 12.4 7.0 7.2 13.0 21.8 3.2 0.4 82.8 2.2 5.7 0.2 2.4 6.6 25.2 0.0 49.3 15.5 3.0 4.8 8.2 7.2 2.5 10.0 43.2 1.6 3.5 NCOR1 "hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1" ENSG00000141027 "Nuclear receptor corepressor 1" O75376 17 16029157-16218185 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043246, HPA050288, HPA051168, CAB072830" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370" "unprognostic (1.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.10e-1)" "unprognostic (7.38e-2)" "unprognostic (3.59e-2)" "unprognostic (2.55e-2)" "unprognostic (4.27e-2)" "unprognostic (4.87e-2)" "unprognostic (4.06e-2)" "unprognostic (7.07e-2)" "unprognostic (1.52e-2)" "prognostic favorable (7.92e-5)" "unprognostic (4.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-1)" "unprognostic (5.42e-2)" 22.1 18.3 37.8 28.1 39.7 42.8 29.0 60.8 84.7 27.3 41.0 44.0 47.1 30.7 20.3 30.6 25.1 26.4 23.4 39.3 34.7 33.6 46.2 26.9 29.9 32.7 35.7 33.5 34.2 42.3 17.1 28.3 31.0 27.6 40.6 41.4 22.4 31.4 42.0 31.6 38.2 29.7 28.2 29.3 42.7 32.4 35.4 51.9 34.8 39.9 34.7 28.8 18.3 43.4 68.0 110.6 77.7 65.1 62.4 47.1 38.6 48.9 54.8 52.4 47.1 59.8 30.3 70.9 33.6 85.9 39.3 50.4 96.4 59.2 77.3 95.6 71.1 70.7 96.3 71.1 60.8 45.3 80.7 48.5 60.6 81.2 94.4 45.2 73.9 98.0 63.0 28.8 52.3 44.3 79.3 29.1 38.6 118.6 29.9 78.1 78.5 33.5 54.9 76.0 26.5 43.8 80.7 34.7 37.7 197.5 33.5 50.3 65.5 53.7 32.6 39.9 68.3 19.7 25.0 40.4 51.0 52.4 47.0 408.4 104.8 240.4 126.9 86.0 106.7 188.4 144.0 141.0 76.3 191.4 139.8 139.0 205.2 139.9 112.3 130.3 144.7 98.8 37.8 39.7 60.8 84.7 39.3 34.7 32.7 35.7 31.0 28.2 35.4 43.4 90.9 80.1 113.2 116.2 130.0 67.8 106.2 91.3 86.0 150.3 76.8 60.8 91.5 82.9 86.9 53.3 158.4 102.1 121.7 198.1 35.2 95.5 69.7 75.7 109.5 88.4 87.9 132.1 127.0 96.5 101.7 77.1 149.4 103.7 87.3 88.9 67.5 126.4 76.1 129.5 122.2 118.8 81.4 81.9 76.7 43.6 101.5 96.7 37.4 107.7 172.8 83.1 197.8 123.1 151.4 111.7 148.3 121.5 88.5 95.6 194.4 46.7 63.8 167.1 92.1 106.0 106.2 98.7 90.2 78.0 68.2 87.6 142.1 89.5 153.0 122.9 NCOR2 "CTG26, SMRT, SMRTE, TNRC14, TRAC-1" ENSG00000196498 "Nuclear receptor corepressor 2" Q9Y618 12 124324415-124567589 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 6.0;non-classical monocyte: 2.5" "Group enriched" "Detected in many" 4 "granulocytes: 6.0;monocytes: 2.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001928 Approved Supported Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA001928: AB_1079454" "unprognostic (9.51e-3)" "unprognostic (7.37e-3)" "unprognostic (4.66e-2)" "unprognostic (2.55e-3)" "unprognostic (2.14e-1)" "unprognostic (7.37e-2)" "unprognostic (3.19e-2)" "unprognostic (8.86e-2)" "unprognostic (2.21e-2)" "unprognostic (2.90e-3)" "unprognostic (6.42e-3)" "unprognostic (1.96e-1)" "unprognostic (9.86e-2)" "unprognostic (6.26e-2)" "unprognostic (1.59e-1)" "unprognostic (7.56e-2)" "unprognostic (8.90e-2)" 48.1 51.1 41.2 34.3 15.8 29.9 49.7 27.2 45.6 62.9 13.6 56.2 25.2 58.6 9.0 33.3 49.0 21.4 56.7 61.3 12.6 37.6 27.5 62.8 19.5 56.4 29.2 70.8 49.3 18.1 84.1 20.2 53.0 57.7 10.9 20.7 55.1 22.0 109.2 56.2 36.8 22.5 5.4 35.7 45.8 26.1 26.4 19.9 40.5 19.9 11.2 47.4 43.9 27.0 78.6 143.6 40.4 38.7 23.0 31.1 120.4 79.3 39.0 45.2 20.1 76.9 56.3 78.7 57.0 65.1 40.7 72.6 16.2 84.7 18.5 83.6 31.5 63.6 142.1 48.0 46.0 48.3 77.5 50.1 30.9 56.6 33.4 69.2 43.7 35.5 83.3 22.9 41.2 67.4 174.3 55.5 56.4 29.8 139.0 55.8 67.1 40.2 21.6 89.9 106.0 77.1 97.3 81.1 47.7 30.2 66.3 59.8 212.0 104.5 178.9 104.3 170.5 43.5 48.0 48.1 59.4 35.4 100.1 6.0 0.4 1.0 1.0 0.2 0.3 0.3 0.3 0.8 0.2 0.1 0.3 0.2 0.9 0.1 2.5 0.9 0.0 0.3 41.2 15.8 27.2 45.6 61.3 12.6 56.4 29.2 53.0 5.4 26.4 27.0 30.6 115.4 58.9 46.4 14.7 33.3 24.6 22.2 33.0 95.3 33.3 28.3 30.4 18.6 38.8 18.4 39.6 8.8 27.4 39.1 3.9 22.1 2.2 28.0 53.4 28.2 18.7 11.6 61.9 27.2 39.7 50.6 37.8 32.4 42.3 43.5 18.5 19.0 28.4 121.1 37.0 20.3 4.1 50.0 48.7 7.1 62.1 44.8 16.0 51.5 27.0 28.0 20.6 70.9 65.9 38.0 22.2 65.1 22.6 23.7 25.4 8.0 16.8 65.9 6.6 63.0 35.5 1.8 11.6 17.7 24.4 12.6 25.1 69.4 21.9 23.1 NECAP1 DKFZP566B183 ENSG00000089818 "NECAP endocytosis associated 1" Q8NC96 12 8076939-8097881 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053980, HPA063300" Uncertain Approved Vesicles,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" Vesicles Cytosol "HPA053980: AB_2682331, HPA063300: AB_2684981" "unprognostic (1.73e-2)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-3)" "unprognostic (1.03e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (5.79e-3)" "unprognostic (5.72e-3)" "unprognostic (1.03e-1)" "unprognostic (1.72e-2)" "unprognostic (1.89e-2)" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (5.94e-2)" 11.7 23.7 25.4 11.8 23.2 8.0 13.6 19.3 39.6 14.9 1.0 17.8 15.6 10.2 8.7 12.1 15.5 9.9 12.7 25.5 44.0 15.8 14.4 11.2 8.0 13.0 11.1 16.1 22.3 27.5 24.7 15.9 17.8 15.7 16.9 42.5 15.9 12.4 7.9 9.4 15.6 11.4 13.8 10.1 16.1 13.6 15.2 14.2 12.6 12.2 10.4 16.9 10.1 15.9 20.4 18.8 12.6 17.6 29.6 22.0 28.2 41.8 26.6 36.1 36.2 40.9 23.1 9.2 7.3 20.9 26.2 14.0 35.2 23.1 31.2 28.2 27.4 11.6 21.2 21.4 26.9 10.7 29.2 28.7 26.3 40.4 48.0 27.7 26.2 15.0 27.3 14.8 38.8 25.8 17.3 2.8 35.1 57.2 15.4 6.8 32.0 9.7 24.6 32.0 20.7 14.3 21.3 29.7 15.9 40.7 10.1 8.9 26.6 16.9 33.3 20.3 30.1 9.4 18.4 19.9 30.6 11.7 26.0 28.8 16.6 36.4 10.9 15.7 12.7 9.8 10.3 11.2 11.9 10.2 12.1 11.0 28.7 10.6 22.7 7.2 16.8 13.0 25.4 23.2 19.3 39.6 25.5 44.0 13.0 11.1 17.8 13.8 15.2 15.9 18.9 38.5 24.0 11.4 36.1 25.5 22.0 16.0 25.6 49.0 17.5 10.5 10.4 7.2 18.7 23.9 27.1 14.6 32.9 19.8 25.4 15.3 25.4 11.3 20.9 18.1 16.2 17.0 29.4 16.7 14.5 17.9 17.3 16.1 29.2 33.5 15.4 15.2 13.8 28.6 28.4 16.1 12.2 19.8 39.0 13.7 23.3 22.4 28.4 11.2 14.8 30.7 20.6 14.6 21.3 19.0 16.0 14.7 33.7 21.8 23.9 17.8 13.1 46.3 6.6 17.7 21.3 17.4 22.3 21.0 21.3 22.4 35.6 25.2 14.1 22.0 NEMF "FLJ10051, NY-CO-1, SDCCAG1" ENSG00000165525 "Nuclear export mediator factor" O60524 14 49782083-49852821 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004160 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 830000 "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA004160: AB_1079884" "unprognostic (9.92e-2)" "unprognostic (6.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.65e-1)" "unprognostic (9.15e-3)" "unprognostic (7.62e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.50e-1)" "unprognostic (1.12e-1)" "prognostic favorable (2.85e-4)" "unprognostic (3.61e-1)" "unprognostic (2.36e-1)" "unprognostic (8.98e-2)" "unprognostic (1.81e-2)" 16.5 13.8 9.5 18.0 13.0 42.1 14.7 18.1 14.7 16.2 5.9 13.6 10.0 16.2 13.5 22.5 12.2 13.2 17.7 7.9 10.6 14.9 11.9 13.8 17.9 11.8 11.6 15.2 15.2 24.8 10.3 18.2 11.9 16.0 14.5 14.7 14.6 15.8 23.0 14.3 13.6 15.7 10.9 15.5 14.1 10.7 10.7 16.3 18.5 21.5 17.9 18.0 11.6 18.4 34.3 39.2 35.9 24.1 37.3 31.0 32.1 42.0 28.3 27.6 27.3 23.2 35.3 13.3 32.0 35.7 21.2 47.5 34.1 26.7 42.2 38.9 22.7 38.7 40.3 29.1 23.8 50.7 33.4 26.8 19.6 29.9 27.2 36.3 39.8 23.8 47.3 36.2 37.7 30.6 31.2 17.9 21.9 28.6 36.8 32.6 35.5 20.8 33.7 44.8 23.6 22.2 41.6 40.4 39.2 37.2 37.6 31.1 47.2 39.2 34.4 26.6 28.9 24.5 47.6 40.9 14.7 23.9 35.5 76.4 38.9 45.8 45.7 36.9 44.8 83.7 47.1 44.4 33.9 86.7 55.6 59.1 61.3 47.8 54.4 79.7 46.1 20.3 9.5 13.0 18.1 14.7 7.9 10.6 11.8 11.6 11.9 10.9 10.7 18.4 66.2 41.7 76.7 65.3 81.1 34.4 67.4 81.6 29.6 92.1 31.7 43.1 97.2 34.3 74.4 44.1 100.1 85.8 78.4 51.8 37.2 57.0 13.9 52.2 60.1 65.2 54.0 57.0 75.7 39.1 58.1 53.0 41.8 60.7 89.3 68.0 49.6 28.1 58.9 131.2 80.7 48.9 71.2 48.7 57.0 13.1 65.9 57.9 24.9 62.8 79.4 54.8 82.4 56.8 99.5 46.4 68.5 67.4 50.0 66.1 59.4 29.9 82.4 90.0 72.3 65.7 70.7 83.0 58.3 32.5 34.1 108.4 66.9 64.1 54.6 88.6 NFATC2IP "ESC2, FLJ14639, NIP45, RAD60" ENSG00000176953 "Nuclear factor of activated T cells 2 interacting protein" Q8NCF5 16 28950807-28967097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053587 Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 2: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA053587: AB_2682202" "unprognostic (6.01e-2)" "unprognostic (1.41e-2)" "unprognostic (8.48e-2)" "unprognostic (1.33e-1)" "unprognostic (4.90e-1)" "unprognostic (7.09e-2)" "unprognostic (8.82e-3)" "unprognostic (1.15e-2)" "unprognostic (8.95e-2)" "unprognostic (5.80e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (5.23e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (8.00e-2)" "unprognostic (3.85e-2)" "unprognostic (3.25e-1)" "unprognostic (5.94e-2)" 20.9 16.6 10.4 27.6 10.5 48.6 21.7 15.6 11.0 25.2 9.9 30.6 21.1 23.3 14.4 29.0 24.5 14.3 20.9 11.0 9.1 26.0 27.9 25.8 36.6 11.1 10.6 24.1 22.7 20.0 15.0 15.5 11.1 23.9 32.2 26.6 24.3 15.5 25.7 32.5 36.9 22.8 9.8 45.4 25.9 30.3 12.1 34.3 22.0 15.8 38.5 26.0 23.5 11.7 38.6 27.2 36.5 36.7 21.7 22.8 46.0 36.7 27.6 42.1 53.7 32.0 47.0 41.1 27.0 26.4 25.6 44.8 44.3 40.3 56.9 35.0 32.4 37.5 81.2 39.8 13.9 34.1 55.0 16.1 32.1 45.9 27.6 20.8 34.3 40.9 34.4 49.5 37.8 47.9 44.9 60.2 35.9 30.9 32.0 77.0 32.4 37.5 30.2 34.2 28.0 20.0 24.7 37.7 14.4 29.6 39.1 25.2 38.1 46.3 26.1 36.5 28.1 36.5 51.5 49.7 25.6 55.5 27.8 5.0 1.5 1.8 1.9 2.0 1.8 1.5 1.4 2.3 0.9 1.5 2.3 2.0 1.1 2.8 1.2 3.2 2.4 0.7 10.4 10.5 15.6 11.0 11.0 9.1 11.1 10.6 11.1 9.8 12.1 11.7 40.9 35.3 52.2 15.7 43.1 31.7 23.0 19.1 33.0 63.1 29.4 25.7 17.4 21.5 29.8 29.5 100.1 30.1 69.8 51.3 19.6 21.9 6.3 28.3 43.6 35.1 40.9 77.2 21.3 22.9 30.5 23.3 50.0 37.6 36.7 69.5 38.9 26.0 23.2 43.7 27.0 63.1 18.3 38.8 32.2 7.6 29.5 37.8 23.2 26.2 56.7 15.3 57.7 19.6 18.2 44.6 31.6 20.3 55.4 40.4 40.7 17.8 21.7 84.5 39.5 26.7 26.6 95.0 92.2 35.7 30.3 26.1 51.4 38.3 53.0 42.1 NHLRC2 "DKFZp779F115, FLJ20147, FLJ25621, FLJ33312, MGC45492" ENSG00000196865 "NHL repeat containing 2" Q8NBF2 10 113854661-113917194 "Disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038493, HPA057564" Approved Approved Nucleoplasm NA NA 120000 "Cluster 14: Monocytes - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA038493: AB_10672519, HPA057564: AB_2683469" "unprognostic (7.09e-2)" "unprognostic (7.33e-2)" "unprognostic (3.00e-1)" "unprognostic (4.74e-2)" "unprognostic (5.15e-2)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.49e-1)" "unprognostic (1.36e-1)" "unprognostic (4.88e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (8.60e-2)" "unprognostic (1.68e-2)" 5.9 5.6 4.4 4.9 5.1 4.2 6.2 5.8 5.2 7.0 7.6 6.5 5.4 6.2 6.9 4.7 5.7 4.1 16.5 3.5 4.3 5.4 8.7 6.6 5.9 5.1 4.8 7.2 7.9 10.5 5.3 6.4 5.1 8.8 5.8 10.1 6.7 4.8 10.6 7.0 6.2 5.2 4.2 7.2 6.4 3.8 4.6 4.6 7.6 7.5 5.5 6.2 6.2 6.0 10.8 6.8 13.1 10.8 4.7 8.4 8.3 7.4 8.8 6.3 6.9 4.7 10.3 5.8 5.2 7.5 5.5 9.4 10.8 6.1 10.7 7.0 5.4 6.2 5.7 6.7 7.1 8.9 6.8 5.8 7.4 7.0 14.4 12.2 7.7 4.1 7.4 6.5 8.6 5.0 5.1 6.9 3.9 6.6 3.4 4.7 18.8 3.4 7.8 5.9 3.4 6.9 5.8 7.3 9.1 6.1 5.3 6.6 9.9 7.5 7.6 4.8 11.3 4.4 2.3 5.7 6.2 14.0 5.1 0.9 0.5 0.7 0.6 0.4 0.6 0.6 0.4 0.7 0.6 0.6 0.4 0.5 0.3 0.6 0.9 0.8 0.5 0.3 4.4 5.1 5.8 5.2 3.5 4.3 5.1 4.8 5.1 4.2 4.6 6.0 22.4 19.2 21.3 40.5 13.7 7.9 13.1 8.9 11.4 20.8 15.2 9.7 74.4 18.6 18.8 36.8 14.6 16.8 8.3 8.5 7.9 10.9 5.4 15.6 24.1 19.4 10.3 27.6 45.5 12.3 12.9 19.3 16.3 14.4 10.8 23.3 19.2 28.2 10.1 28.6 34.7 15.8 10.2 17.6 6.7 8.6 18.0 13.7 7.2 44.0 13.2 20.6 13.4 58.3 55.2 11.1 15.4 26.4 9.1 17.3 12.4 11.8 8.9 25.7 65.7 29.1 19.1 16.0 11.4 9.9 8.4 18.2 10.9 18.7 12.3 14.1 NHLRC3 ENSG00000188811 "NHL repeat containing 3" Q5JS37 13 39038306-39050109 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013738 Uncertain "Secreted to blood" NA NA 310000 "Cluster 27: Non-specific - Gene expression" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "HPA013738: AB_1854455" "unprognostic (7.92e-2)" "unprognostic (3.51e-2)" "unprognostic (5.96e-2)" "unprognostic (3.90e-1)" "unprognostic (2.92e-2)" "unprognostic (1.22e-1)" "unprognostic (2.99e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-1)" "unprognostic (8.88e-2)" "unprognostic (2.28e-2)" "unprognostic (4.83e-2)" "unprognostic (3.21e-1)" "unprognostic (1.58e-2)" "unprognostic (2.99e-2)" "unprognostic (1.66e-1)" "unprognostic (7.81e-2)" 18.5 12.0 7.8 10.9 8.6 7.4 15.2 7.6 10.5 12.1 9.7 12.9 11.6 13.5 20.6 7.4 10.7 13.0 10.2 7.9 8.5 16.7 25.9 13.9 14.3 10.1 8.1 15.8 13.4 8.4 11.4 19.4 9.5 11.0 16.6 12.9 12.2 9.8 10.8 12.0 12.3 11.8 8.6 16.1 16.7 8.7 8.5 8.1 16.9 10.4 12.0 10.1 9.8 10.4 5.1 3.1 13.5 6.5 15.4 16.0 20.9 7.8 9.7 8.2 10.9 9.8 22.6 13.9 14.5 5.2 10.3 10.5 5.4 4.5 7.1 20.3 5.8 11.1 6.9 11.2 9.8 11.1 15.8 13.0 5.8 5.7 5.5 12.3 5.2 11.2 4.0 16.9 7.6 3.8 8.7 17.2 3.7 11.8 3.2 9.2 36.2 7.8 12.6 10.1 3.1 5.6 5.0 6.9 18.4 7.5 9.0 17.5 6.0 11.2 5.4 14.7 8.3 13.5 12.3 5.5 14.9 11.9 8.2 1.5 6.8 0.8 4.5 6.9 5.0 4.1 3.2 3.7 6.0 3.0 3.3 4.8 0.6 4.5 6.8 5.4 4.1 3.7 7.8 8.6 7.6 10.5 7.9 8.5 10.1 8.1 9.5 8.6 8.5 10.4 20.6 12.8 20.2 22.9 36.7 8.4 16.9 40.8 15.9 70.8 22.2 13.5 13.0 18.6 35.8 35.0 56.3 78.4 52.5 22.5 9.8 21.0 6.7 14.1 25.3 22.4 13.8 23.3 37.4 16.5 14.9 21.8 17.9 14.6 15.8 76.7 42.5 34.5 43.6 79.1 45.8 28.6 42.7 57.6 27.0 4.6 61.2 35.2 17.8 27.2 47.7 33.5 102.0 40.2 131.7 17.2 25.0 41.8 30.7 10.2 34.8 16.3 32.1 93.1 59.2 14.2 18.7 51.1 41.0 9.0 8.9 24.2 30.5 50.2 28.4 11.7 NIPAL3 "DJ462O23.2, NPAL3" ENSG00000001461 "NIPA like domain containing 3" Q6P499 1 24415802-24472976 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 88.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 110.5;Oligodendrocytes: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 101.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039978 Approved Approved Nucleoplasm NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 70: Brain - Nervous system development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA039978: AB_10697712" "unprognostic (9.36e-2)" "unprognostic (7.63e-2)" "unprognostic (2.88e-2)" "unprognostic (1.19e-2)" "unprognostic (5.96e-2)" "unprognostic (5.38e-2)" "unprognostic (3.72e-3)" "unprognostic (3.60e-2)" "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (2.79e-1)" "unprognostic (3.14e-1)" "prognostic favorable (3.03e-7)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (3.95e-4)" "unprognostic (2.85e-1)" 8.4 7.4 49.6 8.4 67.3 8.4 12.9 67.7 58.5 9.6 25.8 13.8 11.3 6.2 11.7 15.9 14.6 8.9 12.8 43.6 58.1 13.8 3.5 13.9 11.6 61.8 58.6 7.2 17.1 21.9 7.3 3.5 65.0 55.9 14.4 27.7 15.2 7.6 5.9 14.0 12.7 12.3 56.1 7.8 14.8 4.9 65.0 13.2 29.2 11.9 13.1 8.0 10.4 88.5 32.4 12.1 1.1 4.2 18.9 20.7 4.5 101.8 71.7 35.0 26.2 4.5 36.4 15.4 30.2 55.2 7.3 31.5 12.5 37.1 37.3 29.5 38.1 16.0 18.5 5.4 17.7 14.2 14.4 20.7 36.1 22.3 75.7 34.8 12.2 27.5 9.5 9.7 22.4 7.2 11.5 6.6 8.3 15.4 34.0 5.5 0.1 17.1 41.6 10.1 44.6 4.3 13.1 19.5 26.9 8.6 26.0 10.6 17.9 31.5 6.7 10.9 22.9 29.4 24.1 5.4 21.4 26.8 28.8 16.9 5.8 7.9 16.7 5.7 16.9 22.1 28.8 22.5 11.2 20.1 38.9 24.8 2.5 15.6 4.2 14.6 31.8 16.0 49.6 67.3 67.7 58.5 43.6 58.1 61.8 58.6 65.0 56.1 65.0 88.5 17.1 48.1 27.5 8.8 15.4 9.2 13.5 25.7 14.8 50.3 15.9 12.2 25.9 15.7 24.7 40.5 110.5 3.8 32.1 25.0 3.9 13.1 3.6 11.0 3.5 10.2 18.7 26.1 29.3 15.5 4.7 7.4 16.8 18.3 13.3 10.5 9.3 3.8 4.5 13.5 32.2 16.7 16.2 7.0 7.8 8.0 4.1 5.5 14.2 10.3 8.6 18.7 23.7 24.6 91.8 22.6 22.6 5.3 16.0 34.5 33.2 4.5 16.5 53.6 0.0 4.4 5.9 2.6 6.0 20.0 16.3 4.2 25.3 8.2 17.2 20.9 NKTR p104 ENSG00000114857 "Natural killer cell triggering receptor" P30414 3 42600655-42648735 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022120, HPA051576" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Cluster 42: Non-specific - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Plasma membrane, Cytosol" "HPA022120: AB_1854513, HPA051576: AB_2681540" "unprognostic (2.73e-3)" "unprognostic (3.11e-1)" "unprognostic (2.33e-1)" "unprognostic (2.06e-1)" "unprognostic (5.27e-3)" "prognostic favorable (1.26e-4)" "unprognostic (4.62e-2)" "unprognostic (5.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (6.01e-4)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.82e-1)" "unprognostic (4.57e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.05e-5)" 17.4 19.2 16.4 17.6 18.7 46.5 19.3 22.3 17.1 28.4 17.9 17.7 13.2 18.4 22.4 17.0 23.0 11.4 17.8 15.0 20.3 18.2 21.1 23.9 22.1 20.5 16.4 29.0 22.1 10.6 36.5 11.1 17.6 23.2 13.4 41.3 17.5 10.5 19.5 32.6 25.4 10.7 14.0 36.7 16.3 18.0 18.2 15.4 25.4 10.4 20.0 18.3 22.6 27.8 15.1 7.7 32.3 15.6 16.6 19.3 14.9 22.8 6.8 9.9 12.9 14.7 13.3 25.9 10.7 9.1 9.0 12.6 16.1 8.4 19.2 11.0 13.1 31.4 30.5 24.6 7.3 25.4 19.9 9.6 12.2 18.4 10.5 19.1 17.4 7.1 30.3 20.2 18.6 6.9 17.8 35.5 23.1 7.6 12.3 17.3 12.0 10.5 15.7 12.7 9.4 8.5 24.1 11.1 4.8 16.3 17.5 17.8 28.0 18.0 13.1 21.4 23.2 17.2 21.7 17.7 10.1 30.0 11.3 7.8 3.6 7.5 5.7 4.6 5.3 5.5 5.6 4.9 2.9 5.3 5.6 4.9 5.3 7.0 6.8 5.1 5.3 2.3 16.4 18.7 22.3 17.1 15.0 20.3 20.5 16.4 17.6 14.0 18.2 27.8 221.8 109.0 141.4 169.4 129.5 59.0 60.3 57.8 66.0 200.0 76.3 69.8 68.7 65.8 73.2 88.3 246.0 72.5 156.0 60.3 17.6 47.3 23.9 114.4 125.5 166.2 71.8 76.6 143.5 38.8 51.1 83.3 86.6 132.4 96.8 210.0 110.7 58.6 45.9 132.9 170.0 70.2 61.1 53.8 70.2 21.8 167.7 78.9 51.6 194.9 97.4 101.9 163.7 180.0 267.2 47.6 59.2 134.3 131.3 77.5 106.8 17.0 53.3 279.9 92.1 103.5 88.9 246.2 186.1 42.4 57.3 31.3 164.4 104.5 75.0 54.2 NOL8 "C9orf34, FLJ20736, Nop132" ENSG00000198000 "Nucleolar protein 8" Q76FK4 9 92297358-92325636 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044440, HPA062922" Uncertain Supported "Nucleoli,Mitotic chromosome" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoli "Mitotic chromosome" "HPA044440: AB_10963212, HPA062922: " "unprognostic (3.44e-2)" "unprognostic (1.67e-1)" "unprognostic (9.72e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (9.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.85e-1)" "unprognostic (6.16e-3)" "unprognostic (5.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.69e-2)" "unprognostic (5.38e-2)" "unprognostic (4.58e-1)" "unprognostic (5.53e-2)" 8.6 5.8 4.2 8.0 5.8 6.8 10.0 5.0 5.3 8.2 5.2 8.6 6.0 9.8 7.4 8.7 7.4 6.5 6.8 4.1 5.3 7.2 5.5 6.9 12.0 5.6 5.4 11.2 7.1 12.6 3.2 7.6 5.6 7.4 8.3 5.8 7.8 8.5 6.3 7.2 5.9 9.9 4.6 9.8 6.2 6.1 6.0 12.6 10.5 6.2 12.6 8.6 5.1 7.1 18.9 27.1 13.4 24.2 28.5 24.3 19.8 19.7 14.9 20.9 18.7 11.2 18.5 54.2 16.3 20.1 33.8 39.9 43.5 25.8 22.3 36.3 21.4 37.1 25.9 22.4 20.3 63.2 30.5 24.0 23.5 22.0 31.6 16.7 23.7 16.3 60.7 17.1 22.5 29.7 42.7 24.8 21.4 28.4 26.8 29.8 37.9 23.0 10.6 13.4 23.0 12.3 25.3 25.1 18.0 17.3 9.5 21.2 24.9 18.3 14.0 26.7 25.0 17.7 37.5 26.7 18.5 37.4 26.6 18.9 8.3 11.3 11.4 10.8 15.8 13.0 11.3 11.8 12.1 12.9 13.3 11.7 3.1 13.2 15.7 10.2 13.8 7.1 4.2 5.8 5.0 5.3 4.1 5.3 5.6 5.4 5.6 4.6 6.0 7.1 25.4 19.2 33.4 15.7 33.8 13.0 18.4 15.3 21.1 17.9 14.7 20.6 28.4 14.3 19.8 11.0 10.4 19.5 37.7 10.1 15.6 23.5 13.9 17.9 46.2 23.9 9.0 37.6 12.1 12.9 20.1 25.8 23.9 20.8 52.4 30.6 16.1 11.5 26.5 28.6 12.5 16.9 6.1 17.7 12.1 9.4 32.0 23.9 10.6 18.7 34.5 12.4 43.3 15.6 25.9 16.1 11.2 23.7 36.5 23.3 10.3 15.8 21.2 17.7 6.6 29.3 21.5 73.3 50.2 25.4 15.9 14.6 30.1 33.4 20.3 12.2 NOMO3 ENSG00000103226 "NODAL modulator 3" P69849 16 16232506-16300806 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 30.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 9.3" "HPA046697, HPA061174" Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" "HPA046697: AB_2679758, HPA061174: AB_2684444" "unprognostic (1.21e-1)" "unprognostic (1.41e-2)" "unprognostic (6.46e-2)" "unprognostic (2.31e-1)" "unprognostic (3.99e-2)" "unprognostic (1.33e-1)" "unprognostic (9.81e-2)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (8.02e-2)" "unprognostic (6.25e-2)" "unprognostic (8.43e-2)" "unprognostic (7.86e-3)" "unprognostic (1.82e-1)" "unprognostic (1.65e-1)" "unprognostic (1.10e-2)" "unprognostic (1.22e-1)" 5.7 5.8 3.1 0.7 3.2 2.7 5.2 4.4 4.6 5.2 1.6 6.5 0.7 7.7 0.8 4.8 5.5 0.3 20.3 3.4 3.0 4.3 4.4 6.7 0.4 3.0 2.8 5.4 30.0 0.5 4.3 0.8 3.3 3.8 1.0 3.1 5.5 0.4 22.1 5.1 5.1 0.4 2.4 4.0 8.7 3.5 3.5 0.5 4.9 0.1 0.7 6.6 4.5 4.3 1.3 2.9 0.8 2.8 0.6 2.6 1.2 1.9 1.8 2.4 1.3 1.1 1.5 1.3 9.3 1.0 0.4 1.0 2.7 1.7 1.9 1.3 1.9 1.3 3.5 6.6 0.9 1.6 7.0 1.0 6.1 3.4 0.8 1.5 0.8 2.0 1.1 2.1 1.0 5.9 0.5 3.0 0.8 0.4 1.9 2.2 2.6 4.7 0.7 1.1 1.1 1.8 1.3 2.0 1.3 1.5 1.8 1.3 1.5 1.1 1.8 1.9 1.1 2.4 1.9 1.7 2.4 3.0 1.7 0.0 0.2 0.3 0.2 0.3 0.1 0.4 0.3 0.4 0.4 0.1 0.1 0.3 0.2 0.3 0.1 0.2 0.3 0.3 3.1 3.2 4.4 4.6 3.4 3.0 3.0 2.8 3.3 2.4 3.5 4.3 1.3 3.2 4.1 2.9 3.3 10.5 3.7 3.0 2.2 5.7 2.8 1.8 8.2 8.6 4.3 3.7 12.5 2.0 5.2 2.0 0.0 1.2 1.8 2.2 2.2 3.6 3.5 4.0 4.4 1.5 1.4 3.1 5.1 2.2 4.5 8.7 5.3 2.9 1.6 6.7 5.4 1.5 2.0 4.9 4.4 2.2 2.1 2.7 1.8 2.8 3.3 1.1 7.2 5.0 7.2 1.8 1.6 1.2 3.2 2.9 2.1 1.0 6.1 5.2 6.6 4.3 2.3 8.2 6.6 1.5 11.2 2.5 3.5 5.2 1.9 3.2 NOX5 "NOX5A, NOX5B" ENSG00000255346 "NADPH oxidase 5" Q96PH1 15 68930525-69062762 "Predicted membrane proteins, Transporters" "Angiogenesis, Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 8.8;testis: 2.2" "Cell type enhanced" "Detected in some" "Early spermatids: 17.6;Excitatory neurons: 6.4;Inhibitory neurons: 5.4;Late spermatids: 11.2;Theca cells: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 64: Macrophages - Immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (2.33e-1)" "unprognostic (1.63e-2)" "unprognostic (6.11e-2)" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (4.91e-3)" "unprognostic (6.80e-2)" "unprognostic (5.50e-3)" "unprognostic (3.48e-2)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (8.21e-2)" "unprognostic (4.58e-3)" "unprognostic (2.71e-3)" "unprognostic (4.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.9 0.2 0.3 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.3 0.2 0.1 0.7 0.0 0.5 0.0 0.2 0.0 0.1 0.2 0.8 0.0 8.8 0.2 2.2 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.5 0.2 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.0 1.7 0.4 0.3 1.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 17.6 0.4 0.3 0.6 0.0 0.0 6.4 0.0 0.1 0.7 0.0 0.1 0.0 0.6 0.0 0.0 0.5 0.0 5.4 0.0 0.0 0.0 0.0 11.2 0.6 0.1 0.0 1.9 0.0 0.4 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.3 0.1 5.0 2.3 0.0 0.0 1.8 0.0 31.0 0.0 0.1 NPEPL1 "bA261P9.2, FLJ11583" ENSG00000215440 "Aminopeptidase like 1" Q8NDH3 20 58689131-58719238 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 23.9;classical monocyte: 18.5;eosinophil: 7.2;intermediate monocyte: 13.0;myeloid DC: 11.4;neutrophil: 13.7;non-classical monocyte: 18.8" "Group enriched" "Detected in all" 5 "dendritic cells: 11.4;granulocytes: 23.9;monocytes: 18.8" "Cell line enhanced" "Detected in many" "MCF7: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004986, CAB017025, HPA036356" Approved Approved Nucleoplasm,Cytosol NA NA 14000 "Cluster 14: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082" "unprognostic (1.68e-1)" "unprognostic (5.87e-3)" "unprognostic (8.28e-2)" "unprognostic (2.78e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (2.86e-3)" "unprognostic (3.11e-2)" "unprognostic (4.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.62e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.87e-9)" "unprognostic (7.97e-2)" "unprognostic (1.64e-1)" "unprognostic (2.21e-1)" "prognostic favorable (5.73e-4)" 31.9 24.8 20.6 9.4 21.5 19.9 28.1 20.2 28.9 20.4 22.5 40.8 15.9 24.8 3.9 26.9 23.2 15.8 30.7 20.7 19.0 40.6 20.6 26.6 13.6 22.6 20.3 23.6 24.1 16.7 27.0 10.0 20.9 29.3 4.4 2.5 29.7 15.2 66.3 23.7 25.4 8.6 19.7 40.1 27.1 23.1 22.1 7.7 39.2 28.8 6.1 39.2 22.1 21.0 22.5 31.2 5.5 4.5 11.8 21.7 1.7 8.5 0.7 26.6 14.9 18.0 16.6 1.0 44.6 15.7 0.3 24.0 7.5 10.4 2.6 20.0 7.5 8.0 26.0 8.3 29.6 8.1 13.0 21.3 31.7 9.3 0.0 9.8 22.6 6.1 1.1 3.5 10.6 106.6 3.3 21.2 8.3 13.1 33.8 6.6 2.6 12.6 11.1 14.8 10.1 3.2 22.4 6.1 41.8 3.0 23.4 15.3 25.3 6.7 5.4 14.0 4.4 11.7 4.3 0.7 9.8 15.2 2.7 23.9 18.5 7.2 2.5 13.0 3.1 1.4 1.5 1.7 11.4 0.9 0.9 1.8 13.7 3.2 18.8 0.5 3.7 6.3 20.6 21.5 20.2 28.9 20.7 19.0 22.6 20.3 20.9 19.7 22.1 21.0 23.6 9.6 15.6 0.0 3.5 9.2 8.2 17.1 10.8 19.0 17.2 16.0 16.7 10.0 16.4 27.6 25.0 15.0 11.8 7.6 13.7 14.8 2.3 11.9 8.1 13.6 12.0 3.0 0.0 9.2 7.8 16.1 18.8 6.4 2.5 32.3 15.0 9.1 11.2 8.4 0.0 10.2 20.3 16.7 12.0 8.5 22.1 15.1 7.2 0.0 16.3 20.1 6.2 0.0 0.0 10.8 14.3 14.7 8.4 4.4 17.6 19.9 19.0 8.5 19.7 14.9 15.2 6.7 3.0 16.9 11.2 8.9 9.0 9.7 13.1 7.7 NPHP3 "CFAP31, FLJ30691, FLJ36696, KIAA2000, MKS7, NPH3, SLSN3" ENSG00000113971 "Nephrocystin 3" Q7Z494 3 132680609-132722414 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Ciliopathy, Disease variant, Meckel syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009150 Uncertain NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "HPA009150: AB_1078086" "unprognostic (1.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.56e-2)" "unprognostic (2.79e-1)" "unprognostic (2.22e-1)" "unprognostic (8.24e-3)" "unprognostic (2.36e-5)" "unprognostic (8.02e-3)" "unprognostic (6.51e-2)" "unprognostic (1.96e-2)" "unprognostic (9.42e-3)" "unprognostic (2.92e-2)" "prognostic unfavorable (8.28e-9)" "unprognostic (2.61e-2)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" 7.0 6.0 3.7 4.1 5.6 2.8 7.6 4.0 4.5 9.2 4.4 5.5 3.3 12.9 10.8 4.0 8.1 7.3 5.6 3.5 5.6 4.4 2.9 7.2 5.0 5.6 5.0 15.9 4.5 3.6 3.6 7.4 5.4 6.8 4.1 3.1 5.3 6.0 3.7 8.0 4.1 7.8 4.2 6.2 4.0 3.4 5.2 3.7 6.4 5.2 2.8 5.3 5.4 7.9 4.7 2.5 12.2 8.3 9.0 15.1 5.6 13.9 11.3 6.3 7.6 3.6 2.1 0.6 6.0 13.9 5.4 4.2 5.1 6.3 7.2 2.6 3.5 3.8 2.9 4.0 9.1 0.7 4.1 12.2 3.8 7.2 10.2 13.5 9.5 2.9 1.8 3.8 18.0 4.4 0.6 4.6 5.9 3.0 3.8 1.5 11.3 5.2 7.9 3.2 0.3 9.3 9.1 2.5 10.5 10.5 3.9 2.2 11.5 9.6 6.2 11.7 5.8 3.1 1.2 1.2 10.7 1.1 9.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.5 0.3 0.1 0.5 0.0 0.7 0.2 0.3 0.0 3.7 5.6 4.0 4.5 3.5 5.6 5.6 5.0 5.4 4.2 5.2 7.9 25.5 28.9 18.6 0.0 12.4 19.1 15.9 10.5 7.4 20.8 21.5 27.6 20.9 12.8 8.9 16.5 56.3 18.7 13.5 9.4 0.0 6.8 2.4 14.0 20.1 24.7 12.7 7.4 0.0 4.9 11.7 25.2 4.1 11.0 7.6 25.6 52.1 14.6 9.7 26.9 0.0 11.6 4.1 18.5 17.2 4.3 60.0 9.8 14.2 0.0 13.2 13.2 10.3 0.0 0.0 8.1 5.4 40.3 5.6 15.8 14.8 5.2 14.3 34.1 32.9 26.6 20.6 14.1 5.5 6.9 18.8 9.2 14.0 15.1 13.4 9.1 NR5A1 "AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1" ENSG00000136931 "Nuclear receptor subfamily 5 group A member 1" Q13285 9 124481236-124507420 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 188.3;lymphoid tissue: 142.8" "Group enriched" "Detected in some" 8 "Granulosa cells: 47.9;Theca cells: 180.1" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6" "Region enriched" "Detected in some" 9 "thalamus: 18.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 82.9;Hep G2: 59.2;K-562: 20.6" "Region enriched" "Detected in single" 52 "hypothalamus: 5.2" "Region enriched" "Detected in single" 8 "hypothalamus: 1.2" HPA079181 Supported Nucleoplasm,Cytosol NA NA "Cluster 64: Macrophages - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA079181: " "unprognostic (1.66e-1)" "unprognostic (3.08e-1)" "unprognostic (6.13e-5)" "unprognostic (2.32e-7)" "unprognostic (3.95e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (1.60e-2)" "unprognostic (9.74e-2)" "unprognostic (4.14e-2)" "unprognostic (4.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" 0.1 188.3 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 2.0 0.0 0.1 0.0 0.1 0.0 0.0 35.8 0.0 0.0 21.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 142.8 0.1 14.1 18.3 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 82.9 0.0 59.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.2 2.0 0.0 0.0 0.3 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 11.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 1.4 0.3 0.2 0.0 0.0 0.0 0.0 180.1 0.0 0.0 NRDE2 "C14orf102, FLJ14051" ENSG00000119720 "NRDE-2, necessary for RNA interference, domain containing" Q9H7Z3 14 90267860-90331969 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, DNA damage, Mitosis, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 111.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047050, HPA050583" Uncertain Supported Nucleoplasm,Mitochondria NA NA "Cluster 11: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA047050: AB_2679917, HPA050583: AB_2681182" "unprognostic (1.24e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-1)" "unprognostic (3.02e-1)" "unprognostic (4.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.60e-2)" "unprognostic (8.91e-3)" "unprognostic (1.10e-1)" "unprognostic (4.88e-3)" "unprognostic (3.26e-3)" "unprognostic (1.35e-2)" "unprognostic (2.31e-3)" "unprognostic (8.27e-2)" "unprognostic (6.56e-2)" "unprognostic (3.13e-2)" "unprognostic (3.49e-2)" 1.0 1.0 2.1 1.4 3.0 3.5 1.2 7.3 2.9 1.3 2.3 1.3 2.5 1.6 1.3 1.1 1.2 0.9 1.2 2.1 2.8 1.1 1.7 1.2 1.2 2.5 2.1 1.5 1.2 1.4 1.8 1.1 2.4 1.3 1.0 3.1 1.4 0.9 1.6 2.0 1.5 1.1 1.8 1.6 1.3 0.9 2.8 1.7 1.7 1.0 1.1 1.1 1.2 3.6 0.7 1.4 2.0 1.2 0.3 1.0 1.4 1.4 0.9 1.0 1.1 1.8 1.3 1.3 0.7 1.4 1.3 1.9 1.1 1.9 1.9 2.5 1.7 1.7 5.0 1.3 0.5 4.6 2.2 1.8 1.3 1.0 0.6 2.1 0.9 3.3 0.8 2.0 0.9 1.4 2.1 1.9 0.7 0.6 1.1 1.8 2.9 0.5 0.6 2.9 1.8 2.1 0.6 3.8 1.0 0.7 1.7 1.9 1.2 1.5 0.7 0.9 0.6 1.6 1.9 1.3 1.4 0.8 1.8 1.6 0.8 1.0 0.8 0.5 0.6 0.8 0.5 0.6 0.4 1.0 0.5 0.6 1.3 0.7 0.4 1.1 0.5 0.2 2.1 3.0 7.3 2.9 2.1 2.8 2.5 2.1 2.4 1.8 2.8 3.6 18.2 35.3 29.7 11.4 21.6 5.9 7.0 13.3 17.1 79.4 19.7 14.9 13.2 37.1 18.8 18.4 87.6 19.1 26.4 23.3 7.9 16.6 8.6 15.2 23.8 20.8 24.7 13.7 10.0 14.6 13.0 16.7 18.8 18.0 38.6 24.7 28.2 42.1 11.8 53.8 12.2 24.2 14.2 17.6 6.7 9.7 23.6 12.8 8.8 4.7 25.1 30.4 30.9 15.1 18.8 14.0 17.7 33.1 9.4 8.0 36.5 18.6 11.4 111.3 0.0 26.6 16.5 24.3 39.4 9.3 6.3 25.2 18.6 18.3 23.7 5.5 NSD1 "ARA267, FLJ22263, KMT3B, STO" ENSG00000165671 "Nuclear receptor binding SET domain protein 1" Q96L73 5 177133025-177300213 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048431, HPA070333, HPA073705" Supported Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Plasma membrane" "HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239" "unprognostic (3.48e-2)" "unprognostic (7.46e-2)" "unprognostic (7.14e-3)" "unprognostic (2.64e-3)" "unprognostic (1.38e-1)" "unprognostic (9.67e-2)" "unprognostic (2.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.68e-3)" "unprognostic (8.04e-2)" "unprognostic (1.48e-1)" "unprognostic (2.09e-1)" "unprognostic (7.77e-3)" "unprognostic (3.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.51e-2)" "unprognostic (7.32e-2)" 8.7 7.2 8.9 12.0 13.4 21.2 10.9 26.2 10.4 11.1 9.8 10.1 8.4 11.5 10.3 11.4 10.1 8.0 9.1 7.7 10.0 10.6 6.6 9.2 13.7 9.7 10.8 12.3 11.3 12.8 9.0 10.7 12.2 9.3 10.8 11.9 10.4 9.6 13.6 12.0 9.4 12.0 6.6 11.3 8.9 23.2 12.0 20.2 15.5 11.5 14.7 9.3 7.9 17.5 20.5 25.9 26.0 22.8 12.5 16.1 0.9 18.2 17.9 24.6 22.8 5.7 16.6 41.7 19.9 24.8 22.7 17.0 41.9 40.0 29.7 72.9 25.9 18.6 29.5 0.2 20.7 40.4 21.2 15.2 23.6 29.4 27.3 17.5 36.4 26.0 25.9 14.3 25.2 42.3 28.3 13.1 28.5 13.7 22.5 31.0 3.4 12.9 15.9 24.4 31.6 21.9 46.7 20.1 13.8 24.1 20.2 33.0 27.4 17.1 25.0 11.0 22.6 16.7 15.7 29.5 9.9 19.3 18.7 14.7 9.0 10.5 7.2 6.1 6.0 8.5 6.1 5.0 7.2 10.3 7.5 6.0 18.6 11.3 12.2 9.4 6.4 3.4 8.9 13.4 26.2 10.4 7.7 10.0 9.7 10.8 12.2 6.6 12.0 17.5 37.4 22.4 31.4 84.9 71.7 17.0 32.8 27.2 34.1 94.4 29.8 25.7 44.5 34.3 35.0 55.2 150.1 43.6 66.1 19.7 17.6 27.8 31.9 27.1 65.7 36.4 41.9 48.3 107.0 21.2 23.7 32.7 41.8 41.9 41.7 64.0 33.5 19.9 27.7 89.2 110.3 25.6 12.2 36.8 25.7 50.3 51.0 47.1 16.0 115.2 75.0 29.2 95.8 140.8 157.5 23.7 31.0 33.1 55.8 29.4 33.6 19.2 17.3 112.3 52.6 42.9 36.1 83.7 62.1 41.8 20.6 35.4 62.0 55.9 28.2 30.0 NSG1 "D4S234E, NEEP21, P21" ENSG00000168824 "Neuronal vesicle trafficking associated 1" P42857 4 4348140-4419058 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.7;pituitary gland: 135.1;skin 1: 120.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 222.4;Cytotrophoblasts: 120.2;Granulosa cells: 128.8;Melanocytes: 291.7;Suprabasal keratinocytes: 178.2" "Cancer enriched" "Detected in many" 4 "melanoma: 61.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 45.2;MAIT T-cell: 61.9;memory CD4 T-cell: 42.2;memory CD8 T-cell: 37.1;naive CD8 T-cell: 27.6" "Lineage enriched" "Detected in many" 57 "T-cells: 61.9" "Cell line enhanced" "Detected in many" "HAP1: 84.7;SCLC-21H: 168.6;SH-SY5Y: 82.5;SK-MEL-30: 80.9;TIME: 204.6;U-698: 75.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "unprognostic (3.21e-3)" "unprognostic (2.33e-1)" "unprognostic (5.29e-3)" "unprognostic (7.60e-2)" "unprognostic (8.06e-2)" "unprognostic (1.49e-1)" "unprognostic (1.32e-3)" "unprognostic (3.47e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-3)" "prognostic favorable (9.49e-4)" "unprognostic (2.50e-1)" "unprognostic (6.85e-2)" "unprognostic (4.21e-2)" "unprognostic (7.33e-2)" "unprognostic (2.85e-1)" "unprognostic (7.41e-2)" 5.0 25.3 29.0 4.2 33.1 1.0 6.0 59.6 50.7 17.1 5.3 7.9 6.8 7.8 2.1 30.7 20.1 1.3 5.9 18.4 95.7 4.4 0.5 1.5 3.2 57.1 64.8 46.3 1.8 0.1 135.1 18.3 58.8 22.8 7.1 32.3 6.7 18.2 0.7 120.9 5.8 6.9 24.2 2.2 8.0 16.0 45.4 9.5 0.5 3.0 3.5 13.3 30.1 24.2 0.2 0.1 0.8 0.5 0.0 0.0 14.6 0.3 0.0 0.2 0.0 1.3 0.4 0.0 10.4 0.5 3.3 2.4 84.7 5.5 0.4 0.0 3.0 0.0 0.2 0.0 4.1 0.0 0.0 0.1 12.0 0.0 2.3 0.0 14.6 22.3 0.0 0.1 1.3 0.0 6.8 0.5 10.1 0.1 0.4 0.1 0.0 0.4 0.0 4.8 168.6 82.5 0.6 0.2 80.9 7.0 0.9 0.3 204.6 0.0 13.0 0.2 0.3 0.1 0.4 75.9 0.1 0.2 0.4 0.2 0.1 0.1 45.2 0.1 61.9 0.1 42.2 37.1 0.1 0.1 10.4 27.6 1.0 0.9 0.2 0.1 4.5 15.7 29.0 33.1 59.6 50.7 18.4 95.7 57.1 64.8 58.8 24.2 45.4 24.2 1.6 9.6 0.0 5.9 0.4 86.8 83.4 47.9 31.3 222.4 0.7 24.3 0.0 0.0 13.2 0.0 4.2 120.2 6.0 0.0 0.0 0.0 31.2 10.3 1.4 2.1 2.4 0.0 16.6 0.0 15.2 24.9 0.0 16.4 1.3 128.8 1.8 0.0 8.2 8.4 32.2 0.0 4.1 0.0 13.6 44.2 3.1 1.3 291.7 6.5 0.4 6.4 20.6 1.5 4.0 0.1 0.2 5.7 0.7 19.9 0.0 20.4 1.7 24.3 0.0 0.2 10.8 2.9 14.4 44.8 178.2 76.8 17.0 96.0 0.3 77.0 NSL1 "C1orf48, DC8, DKFZP566O1646, MIS14" ENSG00000117697 "NSL1 component of MIS12 kinetochore complex" Q96IY1 1 212726153-212791782 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045761, HPA053721" Enhanced Supported "Nuclear speckles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA045761: AB_2679444, HPA053721: AB_2682240" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "unprognostic (8.08e-2)" "unprognostic (2.67e-2)" "unprognostic (2.58e-2)" "unprognostic (1.78e-2)" "unprognostic (8.22e-3)" "unprognostic (3.55e-1)" "unprognostic (4.78e-2)" "unprognostic (6.09e-3)" "unprognostic (3.44e-3)" "unprognostic (1.58e-1)" "unprognostic (3.10e-3)" "unprognostic (2.59e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (6.66e-2)" 16.7 14.5 13.8 19.4 16.9 19.1 11.2 17.1 17.5 12.8 15.0 13.3 17.5 14.5 8.0 15.3 13.9 15.0 24.9 13.4 14.9 16.0 19.3 12.5 27.0 18.0 14.9 16.8 12.5 13.9 11.0 17.6 17.5 12.8 10.1 12.6 13.9 10.0 22.5 8.8 17.5 13.1 17.3 19.4 11.7 13.5 14.8 22.7 15.0 15.6 16.7 13.6 10.1 21.3 39.7 44.3 45.0 43.3 18.9 19.5 59.4 32.5 22.1 38.7 33.2 37.3 42.2 55.6 29.4 18.7 21.6 28.4 35.6 29.9 20.1 102.9 33.6 37.0 31.2 61.8 21.7 62.5 34.9 20.2 14.6 39.6 19.8 17.8 28.8 62.9 83.0 45.7 24.6 23.1 80.6 24.6 82.9 20.6 32.8 69.2 68.1 61.5 31.3 19.8 41.1 57.0 46.0 22.3 55.7 33.3 65.6 44.9 33.3 39.4 34.1 36.4 54.5 26.4 76.3 73.8 33.7 42.2 50.7 21.8 49.3 63.1 35.9 62.3 43.0 59.0 38.8 39.2 55.6 47.4 46.7 41.9 49.6 45.3 64.3 53.8 51.2 60.7 13.8 16.9 17.1 17.5 13.4 14.9 18.0 14.9 17.5 17.3 14.8 21.3 39.4 16.0 20.7 25.5 43.5 14.8 21.2 51.4 31.3 34.1 22.8 26.8 22.4 31.5 28.1 18.4 14.6 64.0 40.9 14.7 43.0 32.2 29.2 19.9 29.0 32.0 21.7 50.7 50.2 21.1 62.2 28.9 13.3 15.1 15.2 31.6 29.6 27.9 61.6 33.7 50.1 14.1 30.5 68.2 28.5 15.2 34.8 44.6 19.6 33.7 56.0 37.1 35.0 36.2 68.9 22.7 15.9 32.7 26.7 10.5 32.5 58.5 25.6 32.7 59.2 30.2 32.6 48.7 65.5 22.7 16.2 20.9 36.6 27.0 18.5 10.3 NSUN5 "FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL" ENSG00000130305 "NOP2/Sun RNA methyltransferase 5" Q96P11 7 73302516-73308826 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020536, HPA045590, HPA046867" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847" "unprognostic (3.94e-1)" "unprognostic (1.12e-1)" "unprognostic (3.79e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (3.54e-1)" "unprognostic (2.46e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-2)" 13.9 11.6 9.8 9.7 11.3 33.4 14.1 11.7 12.9 15.3 9.1 18.6 8.9 18.7 3.2 17.7 15.5 4.2 17.7 9.8 10.9 17.4 16.2 12.1 14.2 12.8 10.8 13.0 24.0 6.6 12.8 6.1 11.7 15.5 4.3 3.2 14.6 6.3 37.9 19.7 17.7 6.2 11.6 24.4 16.3 20.7 11.0 13.0 13.6 8.1 9.4 18.6 14.7 13.3 34.7 46.4 12.3 29.3 4.8 6.3 48.4 15.3 9.1 23.6 25.3 63.0 24.3 55.3 10.6 7.7 34.6 28.9 23.7 15.2 8.1 36.6 57.0 20.7 35.8 36.4 20.0 45.9 26.0 8.3 25.7 20.0 17.3 5.2 3.1 40.4 71.0 12.7 10.8 83.2 39.3 91.6 52.1 24.9 34.9 48.9 9.5 79.8 10.1 17.1 33.2 54.6 27.9 72.5 36.4 12.8 47.9 37.1 5.3 0.2 34.8 34.7 11.1 49.6 73.8 80.8 0.5 65.6 2.5 23.7 21.5 24.0 19.6 19.6 15.7 32.2 22.3 20.4 25.0 46.2 31.0 26.5 27.4 26.8 14.8 31.5 26.9 23.2 9.8 11.3 11.7 12.9 9.8 10.9 12.8 10.8 11.7 11.6 11.0 13.3 11.1 6.4 7.4 14.4 38.2 17.0 20.0 32.8 14.8 27.5 23.0 25.0 20.4 27.1 21.3 36.8 12.5 37.7 27.3 18.3 37.2 35.8 17.4 18.1 12.7 8.9 3.6 19.1 9.2 33.0 48.9 17.2 21.4 15.5 26.6 50.5 5.3 21.0 36.6 32.0 9.3 18.3 26.4 21.0 10.8 21.6 29.2 20.2 21.4 3.7 39.9 13.2 36.0 10.1 12.1 29.1 20.5 20.7 24.9 12.6 28.4 25.1 21.8 23.1 6.6 20.8 16.8 64.2 56.7 15.1 21.3 21.8 24.9 16.2 23.1 14.3 NUP160 "FLJ22583, KIAA0197" ENSG00000030066 "Nucleoporin 160" Q12769 11 47778087-47848555 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 15000 "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "unprognostic (8.72e-2)" "unprognostic (1.11e-1)" "unprognostic (3.22e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (3.23e-1)" "unprognostic (3.59e-3)" "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.94e-1)" "unprognostic (3.78e-2)" "unprognostic (3.14e-2)" "unprognostic (2.22e-2)" "unprognostic (1.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" 13.3 9.5 5.1 17.3 6.6 20.0 16.5 9.4 6.5 13.5 8.6 12.1 11.8 17.6 11.4 11.0 15.5 10.9 8.7 5.1 6.2 14.2 14.5 14.0 20.6 6.4 6.2 19.6 14.7 16.3 9.9 20.7 6.1 12.7 14.9 15.2 11.7 11.5 11.1 12.6 11.5 16.5 5.8 15.1 10.8 14.5 5.9 30.9 16.9 9.3 21.6 14.6 11.7 9.2 24.4 31.7 52.2 36.6 30.3 34.8 67.3 30.7 22.7 40.8 46.8 40.3 36.2 33.2 20.3 28.0 41.0 52.1 96.5 30.4 45.3 29.1 66.7 36.6 131.3 44.1 20.2 108.1 24.0 27.4 18.7 29.0 56.5 16.6 32.5 52.9 103.7 45.5 22.0 41.9 72.9 47.6 78.4 53.7 33.1 86.2 78.3 29.8 20.9 42.2 43.0 49.0 72.8 35.6 27.6 45.7 44.6 41.1 22.1 44.6 38.4 75.2 41.7 19.7 19.9 83.8 22.0 45.2 45.2 8.6 7.5 13.3 9.9 9.5 13.6 15.3 11.7 10.8 12.3 14.8 15.4 11.5 4.3 9.7 6.8 16.3 9.8 7.1 5.1 6.6 9.4 6.5 5.1 6.2 6.4 6.2 6.1 5.8 5.9 9.2 15.0 22.4 18.8 39.5 31.0 22.9 35.7 18.6 20.5 24.8 14.8 11.2 7.8 12.8 19.4 20.2 43.8 33.1 31.4 10.3 15.6 17.7 27.6 17.9 16.3 17.9 19.2 19.6 35.2 16.7 30.4 19.2 15.3 20.3 19.7 23.3 19.2 12.0 15.2 6.7 50.1 14.6 20.3 10.1 19.8 11.5 24.2 14.4 10.6 44.0 15.7 19.7 24.7 61.9 53.8 16.4 8.6 21.8 21.8 32.9 10.9 10.5 15.0 48.4 19.7 19.6 17.2 18.2 22.0 16.4 27.7 30.8 25.3 20.5 15.7 34.8 OPA3 "FLJ22187, MGA3" ENSG00000125741 "Outer mitochondrial membrane lipid metabolism regulator OPA3" Q9H6K4 19 45527427-45602212 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044881 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Cytosol Nucleoplasm "HPA044881: AB_10964052" "unprognostic (3.37e-1)" "unprognostic (3.89e-2)" "unprognostic (2.66e-1)" "unprognostic (5.71e-3)" "unprognostic (1.24e-2)" "unprognostic (2.87e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (3.14e-3)" "unprognostic (4.53e-2)" "unprognostic (8.06e-3)" "unprognostic (1.72e-3)" "unprognostic (8.73e-2)" "prognostic favorable (9.30e-12)" "unprognostic (5.85e-2)" "unprognostic (1.94e-1)" "unprognostic (3.82e-2)" "unprognostic (1.81e-1)" 4.8 7.2 3.3 4.7 3.4 4.0 3.5 4.4 5.2 3.0 3.7 4.6 4.0 4.9 3.0 5.8 3.4 3.3 10.5 3.2 3.1 7.4 7.8 4.4 4.7 4.9 4.0 3.4 4.4 12.0 6.0 4.4 5.0 3.8 3.9 6.4 4.0 4.1 11.1 5.8 5.0 4.7 2.5 5.8 4.9 8.9 5.5 4.6 4.6 12.9 4.7 4.1 3.5 3.2 15.2 18.9 7.4 7.3 4.8 5.9 11.3 9.7 8.9 10.1 10.7 8.8 10.5 13.0 6.9 9.8 11.5 12.0 12.5 13.3 8.9 24.0 12.6 20.1 10.8 9.1 8.8 14.1 25.0 8.9 10.1 11.2 12.2 5.8 7.3 7.6 17.5 14.2 6.9 9.3 11.3 5.8 6.5 12.6 12.9 10.9 6.7 7.1 8.0 26.9 5.5 6.6 12.4 11.3 5.2 6.6 6.3 8.0 15.9 8.5 9.7 7.1 16.7 9.5 19.1 10.6 8.2 10.1 13.1 5.6 5.3 2.9 3.6 7.8 3.6 4.4 3.2 3.1 5.6 3.9 3.9 4.0 4.7 7.8 10.5 5.1 4.8 3.6 3.3 3.4 4.4 5.2 3.2 3.1 4.9 4.0 5.0 2.5 5.5 3.2 11.0 12.8 11.7 8.5 23.0 18.7 22.4 14.6 13.1 22.8 9.2 7.9 25.4 17.2 11.6 11.0 52.1 25.6 15.7 18.8 25.4 18.4 18.5 12.8 13.8 15.2 13.8 5.7 9.5 21.1 29.8 10.6 14.3 20.1 15.9 8.9 11.4 21.9 16.3 20.2 10.2 14.5 16.2 11.4 28.3 20.2 6.2 17.4 14.2 4.7 19.0 15.1 11.3 3.0 8.1 18.2 19.2 6.4 11.9 15.8 21.2 16.8 10.7 36.0 0.0 23.3 23.6 23.9 13.1 11.2 19.6 36.3 14.4 19.5 16.6 16.7 OR52H1 ENSG00000181616 "Olfactory receptor family 52 subfamily H member 1" Q8NGJ2 11 5544489-5548533 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "Cluster 52: Non-specific - Transcription" "unprognostic (2.87e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.4 0.5 0.3 0.4 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 ORMDL1 ENSG00000128699 "ORMDL sphingolipid biosynthesis regulator 1" Q9P0S3 2 189770267-189784364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA065643 Supported "Endoplasmic reticulum" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 51: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA065643: AB_2685525" "unprognostic (1.45e-1)" "unprognostic (5.34e-3)" "unprognostic (1.05e-1)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (1.80e-1)" "unprognostic (4.85e-3)" "unprognostic (1.86e-2)" "unprognostic (6.70e-3)" "prognostic favorable (3.04e-5)" "unprognostic (5.90e-3)" "unprognostic (2.16e-2)" "prognostic unfavorable (5.84e-9)" "unprognostic (2.62e-1)" "unprognostic (1.14e-1)" "unprognostic (2.87e-2)" "prognostic favorable (1.49e-5)" 60.0 66.2 27.0 50.3 28.6 51.7 54.9 34.2 33.2 67.9 36.2 60.7 41.1 56.5 99.5 46.1 55.3 47.4 37.8 28.4 33.1 55.2 68.7 66.9 75.2 27.3 27.7 50.8 84.5 42.3 79.3 63.1 28.2 62.2 50.1 82.0 66.1 47.3 41.5 84.3 84.9 43.9 30.4 131.2 64.0 58.8 28.8 44.2 62.9 23.9 69.4 50.3 51.7 32.8 31.4 20.5 68.0 54.8 88.2 100.4 70.3 64.9 61.7 71.0 71.5 41.9 51.7 57.8 44.7 49.9 36.7 52.1 43.4 42.0 77.5 65.6 55.2 82.3 106.2 61.9 102.6 65.8 63.8 113.1 51.6 61.8 70.6 99.0 58.4 57.9 48.3 85.9 72.9 28.6 58.6 127.0 60.7 32.4 86.4 46.4 50.2 78.7 87.4 49.3 43.6 51.4 33.8 32.0 74.3 78.3 38.7 73.3 61.6 70.1 48.1 44.9 65.7 82.9 66.6 55.4 76.4 68.7 38.6 49.4 32.7 39.8 35.8 39.5 33.7 37.9 39.3 36.5 26.7 35.4 45.0 40.9 13.3 29.4 48.3 46.1 46.1 33.5 27.0 28.6 34.2 33.2 28.4 33.1 27.3 27.7 28.2 30.4 28.8 32.8 80.4 80.1 50.2 41.4 90.9 56.3 55.1 95.6 26.7 138.3 69.8 76.7 34.4 41.5 65.5 36.8 175.2 212.4 141.2 36.0 33.2 58.7 42.8 58.0 63.9 61.8 42.4 38.7 53.6 67.3 73.0 58.1 24.5 47.3 45.6 84.3 47.5 37.4 86.9 65.6 60.1 37.2 101.7 126.8 60.9 18.9 74.3 83.3 39.2 33.7 96.4 107.7 117.4 57.8 49.4 66.5 48.3 48.5 83.5 79.1 62.8 45.9 66.3 217.2 52.6 55.4 63.8 186.8 145.0 32.5 60.7 218.1 104.5 117.4 46.3 51.5 OSGEPL1 "OSGEPL, Qri7" ENSG00000128694 "O-sialoglycoprotein endopeptidase like 1" Q9H4B0 2 189746660-189763227 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Sertoli cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030693 Uncertain Supported Mitochondria NA NA "Cluster 30: Non-specific - Translation" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA030693: AB_10601978" "unprognostic (1.10e-1)" "unprognostic (8.72e-2)" "unprognostic (8.19e-2)" "unprognostic (6.70e-2)" "unprognostic (6.07e-2)" "unprognostic (6.38e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (4.18e-3)" "unprognostic (1.06e-3)" "prognostic favorable (3.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.80e-2)" "unprognostic (3.34e-2)" "unprognostic (2.68e-1)" "unprognostic (1.51e-2)" "unprognostic (6.39e-2)" "unprognostic (1.55e-3)" 3.9 8.2 3.6 3.5 5.0 1.9 7.2 6.1 5.0 4.5 3.0 3.5 3.3 5.7 5.6 4.0 5.2 3.2 8.9 3.4 4.0 8.4 7.9 3.9 6.5 4.3 4.5 8.7 3.1 4.7 2.7 4.0 4.5 4.1 3.9 9.8 4.7 3.7 12.3 6.1 3.5 5.0 4.3 5.4 3.1 6.4 3.9 5.6 5.2 11.0 6.3 3.6 3.0 6.1 7.1 3.8 16.7 12.7 12.9 7.1 9.8 10.8 7.5 14.9 15.9 4.5 7.1 4.7 11.7 4.5 8.2 10.1 15.0 12.7 16.9 12.3 11.5 15.3 9.0 5.9 6.7 8.8 7.6 7.8 10.6 11.5 5.5 10.2 11.3 11.8 5.6 7.2 9.8 3.9 6.8 9.9 8.1 9.5 17.4 7.5 13.4 8.1 9.7 3.8 10.1 11.2 7.3 12.8 23.9 20.6 10.1 9.9 4.7 9.6 8.5 14.3 6.8 7.3 6.6 7.4 12.7 11.0 10.7 0.5 2.7 2.3 7.5 2.7 10.6 7.7 7.7 8.6 3.8 9.8 11.3 10.5 0.4 7.6 2.4 6.6 6.6 3.1 3.6 5.0 6.1 5.0 3.4 4.0 4.3 4.5 4.5 4.3 3.9 6.1 3.6 6.4 3.6 6.8 8.4 1.9 2.8 5.9 5.2 8.9 4.0 4.8 8.6 8.6 2.8 0.0 12.5 10.6 7.3 0.4 7.9 3.0 1.4 3.5 5.5 4.1 0.0 5.2 6.6 2.3 7.3 4.5 1.5 2.3 3.8 6.8 3.6 2.9 4.4 10.1 10.0 1.1 2.0 2.4 1.7 0.8 11.1 4.1 1.8 5.6 1.8 12.0 13.4 10.1 17.0 2.0 1.0 8.2 1.9 1.1 1.7 10.2 6.0 11.8 26.3 5.8 8.4 9.6 13.7 4.4 2.0 2.2 6.0 11.8 2.2 1.0 PABPC1L "C20orf119, dJ1069P2.3, ePAB, PABPC1L1" ENSG00000101104 "Poly(A) binding protein cytoplasmic 1 like" Q4VXU2 20 44910060-44959035 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 24.6;Collecting duct cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA066650 Approved "Nuclear bodies,Cytosol" NA Yes "Cluster 50: Neutrophils - Cellular senescence" "Cluster 18: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Cytosol "Nuclear bodies" "HPA066650: AB_2685698" "unprognostic (4.98e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (1.73e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (1.77e-3)" "unprognostic (4.92e-3)" "unprognostic (3.69e-2)" "unprognostic (2.44e-1)" "unprognostic (2.28e-3)" "unprognostic (7.96e-2)" "prognostic unfavorable (4.00e-15)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (8.63e-2)" "prognostic favorable (8.84e-4)" 2.1 2.3 1.7 2.0 1.8 4.1 2.9 1.1 2.1 4.0 2.5 1.7 0.8 1.5 3.4 2.1 3.4 1.4 1.3 1.7 1.8 6.1 5.9 2.9 3.3 1.4 1.8 6.6 6.1 0.5 6.1 0.6 1.4 5.2 0.6 0.4 2.5 0.9 0.5 2.1 2.9 0.6 1.3 4.4 2.8 1.9 2.5 3.0 7.9 0.1 1.9 1.9 1.9 1.7 2.0 3.4 1.9 4.1 0.4 2.6 8.9 3.7 0.3 1.4 0.4 8.4 3.4 2.2 7.3 0.2 1.2 4.7 0.5 1.3 0.9 1.9 4.0 1.9 8.1 7.2 2.1 1.6 0.5 0.5 6.4 1.2 1.5 1.1 0.0 3.1 3.0 2.2 0.3 8.0 2.8 4.9 1.2 3.0 7.6 3.7 0.6 2.2 0.7 2.6 2.0 3.0 1.6 5.7 6.7 1.8 9.7 1.8 0.2 5.2 5.7 3.4 1.6 5.4 8.8 1.8 1.7 0.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 1.8 1.1 2.1 1.7 1.8 1.4 1.8 1.4 1.3 2.5 1.7 1.3 6.4 24.6 11.8 7.0 1.9 3.3 3.3 6.2 0.5 7.6 9.9 1.5 7.2 15.6 20.2 0.0 6.7 4.7 2.8 0.0 3.3 0.6 9.5 6.8 1.5 4.2 1.7 5.3 0.5 4.4 4.2 12.8 11.1 3.8 10.3 0.4 5.7 3.0 0.0 2.3 3.0 2.0 0.8 1.6 0.6 1.8 3.3 0.0 1.9 2.3 1.4 3.1 11.1 3.2 1.8 2.4 1.9 5.1 3.5 1.5 1.5 10.1 1.3 0.0 2.1 2.6 0.9 2.1 4.9 1.7 3.8 7.0 2.1 4.4 2.9 PAN2 "hPAN2, KIAA0710, USP52" ENSG00000135473 "Poly(A) specific ribonuclease subunit PAN2" Q504Q3 12 56316223-56334053 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "unprognostic (2.43e-1)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (2.55e-1)" "unprognostic (1.67e-1)" "unprognostic (9.10e-3)" "unprognostic (1.03e-1)" "unprognostic (7.28e-2)" "unprognostic (7.35e-3)" "unprognostic (3.80e-1)" "unprognostic (1.74e-3)" "unprognostic (4.23e-3)" "prognostic unfavorable (2.77e-4)" "unprognostic (4.19e-1)" "unprognostic (3.87e-1)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" 6.6 8.7 4.2 5.8 6.1 7.4 7.4 6.0 6.0 8.3 6.9 8.0 9.9 9.1 14.1 5.0 9.7 6.6 7.1 4.1 4.5 7.6 16.0 7.3 8.5 5.3 5.2 12.7 10.0 14.1 11.6 8.2 5.4 6.7 8.2 16.0 7.9 8.2 6.9 8.3 8.7 7.5 4.7 10.1 9.5 13.5 5.7 16.8 14.8 6.7 10.0 7.0 6.7 7.9 4.3 6.4 15.5 4.9 13.3 15.0 10.1 3.2 4.4 7.1 3.2 3.9 8.3 11.8 12.2 6.3 3.8 8.8 18.6 12.3 4.0 5.2 8.8 15.1 6.6 3.8 11.7 3.3 7.8 14.0 16.3 7.6 22.0 18.7 5.4 24.2 10.3 28.4 4.2 9.4 11.3 7.9 5.2 7.2 4.2 9.7 11.0 21.5 7.0 3.4 12.1 11.0 6.2 7.9 8.0 17.2 10.2 6.4 2.3 7.0 7.0 3.3 3.0 23.9 10.3 7.8 8.7 6.8 6.2 3.2 3.3 1.3 1.3 4.4 1.9 1.6 1.1 1.9 4.2 1.3 2.2 2.7 0.2 2.3 2.2 1.7 1.7 2.0 4.2 6.1 6.0 6.0 4.1 4.5 5.3 5.2 5.4 4.7 5.7 7.9 9.7 9.6 17.0 19.2 11.1 5.1 5.4 3.8 6.8 27.4 9.5 10.2 9.8 2.8 8.3 5.5 27.1 8.2 7.9 5.4 1.9 3.7 1.8 8.6 9.4 9.4 14.4 13.3 11.0 2.2 4.8 7.2 18.3 13.7 6.3 15.0 10.4 18.3 5.4 15.2 13.9 10.8 4.1 7.0 5.0 2.6 11.1 8.2 1.8 9.4 5.2 7.3 3.1 10.1 32.1 2.8 8.7 6.4 9.2 4.1 7.3 3.5 13.4 17.1 6.6 11.4 6.9 26.9 7.6 7.1 3.8 5.1 6.6 12.6 9.5 3.6 PARN DAN ENSG00000140694 "Poly(A)-specific ribonuclease" O95453 16 14435700-14632728 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006314, CAB011673, HPA012010" Supported Supported "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976" "unprognostic (2.54e-1)" "unprognostic (3.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.99e-3)" "unprognostic (5.07e-2)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.52e-1)" "unprognostic (3.25e-2)" "unprognostic (2.46e-1)" "unprognostic (3.10e-3)" "unprognostic (1.09e-2)" 16.6 20.2 10.8 13.9 12.1 9.2 15.9 11.7 11.4 17.2 12.0 19.3 11.8 19.1 24.7 15.6 16.0 13.4 14.8 10.6 14.0 12.7 16.4 14.2 21.2 11.7 11.9 16.4 16.5 21.1 16.3 15.6 11.9 16.1 16.8 7.0 15.3 17.1 16.8 17.9 16.1 18.0 11.3 15.7 16.2 18.1 12.6 21.6 20.6 9.7 23.4 19.3 16.0 13.5 28.0 39.9 17.6 22.9 32.9 33.2 20.3 24.4 32.4 29.8 28.3 21.9 28.7 56.2 63.1 32.3 25.3 30.4 46.7 32.3 41.0 42.9 29.4 28.8 24.2 53.2 35.5 46.0 36.2 32.5 38.5 32.0 43.1 25.5 22.5 32.6 28.5 29.9 32.5 44.9 36.7 33.1 26.0 28.2 16.7 56.2 36.1 57.1 23.1 17.1 18.7 16.9 53.4 29.6 36.3 28.6 31.6 28.0 21.2 31.5 15.8 16.4 26.9 32.5 31.0 63.5 34.6 30.8 35.8 8.9 8.0 15.8 8.6 13.2 7.7 16.0 10.4 12.4 13.6 9.4 14.2 14.4 6.2 15.0 15.6 8.3 19.1 7.1 10.8 12.1 11.7 11.4 10.6 14.0 11.7 11.9 11.9 11.3 12.6 13.5 18.0 32.1 39.1 37.9 26.2 7.1 7.8 9.7 21.6 13.0 13.4 14.0 22.3 7.2 11.8 11.0 8.4 29.2 24.7 13.6 11.7 14.2 14.1 15.2 20.5 15.2 14.9 20.4 48.0 12.9 23.2 19.5 21.9 21.7 2.5 19.2 11.7 15.6 14.8 8.4 48.2 14.3 6.1 14.2 5.8 6.3 21.1 18.2 10.6 54.4 35.8 10.3 52.5 38.2 72.4 15.2 10.6 17.7 23.0 7.1 12.2 10.8 19.2 10.8 19.7 13.1 15.0 70.5 70.5 20.0 8.2 22.4 21.5 20.1 13.4 4.8 PAXBP1 "C21orf66, fSAP105, GCFC, GCFC1" ENSG00000159086 "PAX3 and PAX7 binding protein 1" Q9Y5B6 21 32733899-32771792 "Plasma proteins, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 155.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003757 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA003757: AB_10600796" "unprognostic (8.21e-2)" "unprognostic (7.50e-2)" "unprognostic (1.04e-1)" "unprognostic (1.67e-1)" "unprognostic (6.53e-2)" "unprognostic (2.03e-3)" "unprognostic (2.38e-3)" "unprognostic (2.54e-2)" "unprognostic (6.89e-2)" "unprognostic (2.65e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (9.43e-4)" "prognostic unfavorable (1.50e-5)" "unprognostic (3.16e-1)" "unprognostic (3.78e-2)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" 5.8 6.2 7.3 6.4 8.4 28.6 7.2 10.1 9.8 7.4 8.5 6.8 10.2 8.3 7.2 5.8 7.4 4.9 4.6 7.0 9.2 6.7 6.6 6.3 9.4 8.5 8.1 10.9 6.9 4.7 5.8 6.3 8.5 5.8 7.6 13.0 5.7 5.2 9.3 8.0 7.9 5.3 7.7 7.4 5.5 8.3 8.0 10.1 6.2 6.7 8.0 6.3 6.0 10.5 14.5 11.5 24.4 19.7 9.2 7.4 32.0 10.4 7.0 13.7 10.0 24.3 12.8 16.9 7.9 6.2 10.9 14.1 23.7 9.8 14.5 14.0 18.2 29.6 19.7 17.9 4.5 33.6 17.1 3.9 14.5 16.0 7.5 9.7 9.5 18.4 34.3 15.9 10.3 12.6 23.1 19.8 64.5 16.4 11.0 21.1 22.0 25.0 11.0 13.1 19.3 11.2 15.2 17.3 12.1 15.1 11.3 18.7 8.2 10.5 13.7 11.8 16.5 15.5 19.8 31.0 7.8 30.0 10.7 0.0 0.3 0.1 0.6 0.1 0.8 0.5 0.7 0.5 0.4 0.6 0.7 0.7 0.0 0.2 0.2 0.3 0.4 0.1 7.3 8.4 10.1 9.8 7.0 9.2 8.5 8.1 8.5 7.7 8.0 10.5 28.9 12.8 21.6 62.3 22.0 25.5 21.5 5.6 31.3 50.6 26.0 20.2 12.3 21.5 15.3 20.2 62.6 16.7 39.2 19.4 5.9 7.4 36.8 47.8 51.6 22.3 22.1 17.9 61.6 8.0 12.1 27.1 30.1 45.6 12.0 42.4 15.4 12.7 10.2 21.9 66.1 23.7 6.1 13.9 19.3 32.8 14.6 24.3 21.4 55.3 14.1 28.6 24.7 117.6 155.4 6.8 12.8 17.0 29.1 25.1 17.4 7.9 24.5 81.6 32.9 51.5 23.5 32.2 18.2 26.5 25.4 17.8 29.4 26.3 21.7 32.4 PAXIP1 "CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2" ENSG00000157212 "PAX interacting protein 1" Q6ZW49 7 154943687-155003124 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 12.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006694, HPA016950" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA006694: AB_1855011, HPA016950: AB_2669489" "unprognostic (2.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.14e-2)" "unprognostic (2.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (7.39e-3)" "unprognostic (2.65e-2)" "unprognostic (1.34e-3)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (3.28e-2)" "unprognostic (4.99e-3)" "unprognostic (3.98e-1)" "unprognostic (2.44e-3)" "unprognostic (2.30e-1)" 4.3 3.9 2.3 5.8 2.5 9.8 5.4 12.0 2.6 4.8 2.7 4.9 4.8 4.6 4.8 5.4 4.2 4.4 3.9 2.3 2.4 4.6 5.7 4.2 8.8 2.8 2.6 5.7 4.4 6.2 3.8 6.1 2.9 4.4 4.9 3.9 5.7 3.6 5.9 6.5 5.7 3.7 2.5 5.6 5.2 8.7 2.6 26.6 5.5 4.6 6.0 5.3 4.7 2.8 17.7 14.2 18.4 31.2 7.8 6.5 16.4 7.6 8.0 10.3 11.9 15.7 13.6 22.9 9.4 9.1 21.3 13.6 23.7 12.1 12.7 23.0 18.4 17.4 10.7 13.6 5.5 23.9 22.3 6.3 9.0 10.3 4.2 5.8 9.9 22.8 24.3 15.1 10.4 24.3 51.1 19.9 29.8 17.1 9.5 28.8 18.7 24.8 10.7 14.6 14.6 9.4 20.3 14.9 9.5 16.6 11.4 20.1 5.1 8.6 1.5 12.3 18.6 15.2 9.5 31.0 21.1 27.7 23.6 0.2 0.9 0.5 0.9 1.1 1.4 0.5 1.5 1.1 1.0 0.9 2.4 0.7 0.5 1.3 1.3 1.2 1.2 0.9 2.3 2.5 12.0 2.6 2.3 2.4 2.8 2.6 2.9 2.5 2.6 2.8 5.2 6.4 6.3 18.9 5.8 6.4 5.1 4.7 4.0 18.9 8.9 6.6 6.9 7.2 7.1 9.2 10.4 9.0 3.8 6.8 5.9 3.9 2.3 5.5 6.9 5.2 2.4 10.3 21.4 3.3 8.0 6.9 5.6 6.5 2.5 8.8 5.0 9.2 4.4 3.3 24.2 8.4 2.0 6.1 7.1 2.8 8.7 4.8 3.6 15.9 6.3 8.0 7.2 27.2 27.4 4.4 4.3 9.4 4.9 8.0 5.2 4.2 4.3 12.3 0.0 11.1 5.1 22.6 18.7 8.9 7.0 6.2 4.9 6.3 9.8 4.5 PDRG1 "C20orf126, dJ310O13.3" ENSG00000088356 "P53 and DNA damage regulated 1" Q9NUG6 20 31944337-31952046 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 55.4" "Cell type enhanced" "Detected in all" "Spermatocytes: 86.8;Theca cells: 170.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047084, HPA063542" Approved Approved "Actin filaments" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" "Actin filaments" "HPA047084: AB_2679925, HPA063542: AB_2685035" "unprognostic (2.17e-1)" "unprognostic (9.77e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (8.51e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.62e-5)" "unprognostic (1.01e-1)" "unprognostic (1.70e-1)" "unprognostic (1.59e-1)" "unprognostic (3.82e-3)" "unprognostic (2.44e-2)" "unprognostic (1.30e-1)" "unprognostic (1.22e-1)" "unprognostic (3.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.00e-2)" 9.0 12.7 17.7 7.7 18.1 17.0 11.0 20.6 19.2 10.1 19.0 11.1 8.3 8.9 12.8 13.8 10.0 5.7 11.8 18.2 18.2 15.7 14.3 8.2 11.8 19.9 18.3 9.5 9.8 55.4 11.3 11.1 19.9 11.6 6.9 9.6 8.7 15.1 15.2 11.5 8.9 7.6 18.8 13.2 9.7 38.0 18.3 12.3 10.4 15.9 12.5 10.0 10.1 20.0 36.6 29.2 17.8 19.7 10.0 7.4 32.9 28.8 16.1 42.3 23.8 107.7 17.9 36.4 21.6 13.6 31.1 23.2 37.8 28.9 34.1 13.4 25.2 50.8 21.7 37.8 25.3 29.3 20.2 9.1 20.9 29.8 30.5 17.9 17.8 37.9 51.7 18.2 17.8 44.3 38.3 34.3 36.7 37.6 61.0 29.6 53.6 19.2 27.8 19.5 42.1 20.2 87.2 27.8 53.6 18.3 48.5 35.5 16.3 34.2 40.3 31.7 36.8 13.3 14.9 40.0 22.9 103.4 22.9 13.4 10.4 16.7 19.0 14.9 18.4 35.4 20.2 20.8 15.8 36.2 27.0 23.6 4.3 28.7 21.6 29.9 21.2 18.2 17.7 18.1 20.6 19.2 18.2 18.2 19.9 18.3 19.9 18.8 18.3 20.0 22.9 19.2 9.7 4.2 23.4 25.5 16.1 14.0 23.9 21.2 26.7 22.7 17.6 14.3 9.1 11.0 14.6 45.8 29.4 9.6 33.2 24.8 11.8 16.7 20.2 22.9 22.0 13.9 6.3 21.2 26.7 22.3 6.6 18.8 33.0 27.7 12.5 7.9 26.2 16.8 5.9 12.6 10.2 9.1 17.8 17.4 16.1 12.4 12.4 5.6 37.4 23.2 13.4 4.0 5.9 23.8 15.0 17.0 14.8 17.8 13.9 19.3 10.0 21.2 26.3 17.2 22.7 86.8 38.1 18.0 28.6 20.4 18.4 170.9 13.4 14.7 PEG3 "KIAA0287, ZKSCAN22, ZNF904, ZSCAN24" ENSG00000198300 "Paternally expressed 3" Q9GZU2 19 56810077-56840728 "Predicted intracellular proteins, Transcription factors" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 76.9;brain: 218.4;choroid plexus: 177.0;ovary: 260.1;placenta: 135.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 345.8;Granulosa cells: 224.1;Horizontal cells: 148.0;Syncytiotrophoblasts: 477.1;Theca cells: 395.9" "Cancer enhanced" "Detected in many" "testis cancer: 9.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 103.6;Hep G2: 218.1;RH-30: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026070 Approved Approved Nucleoplasm NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA026070: AB_10603328" "unprognostic (1.38e-2)" "unprognostic (1.90e-2)" "unprognostic (1.20e-1)" "unprognostic (7.12e-2)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (4.84e-2)" "unprognostic (4.44e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (9.92e-2)" "unprognostic (2.48e-5)" "unprognostic (6.92e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.56e-4)" "unprognostic (6.68e-3)" 2.4 76.9 76.5 1.5 56.5 0.1 10.9 4.4 41.2 8.7 177.0 5.1 0.6 22.8 5.8 2.2 12.9 1.9 3.5 28.7 218.4 3.4 4.5 1.8 0.5 51.9 105.8 260.1 2.5 9.9 28.8 135.1 95.6 3.0 1.7 17.9 5.4 4.9 0.7 1.5 1.4 9.2 27.4 0.8 2.1 33.6 130.4 1.0 5.7 1.8 6.2 3.5 3.3 42.8 0.0 0.0 4.0 0.0 0.0 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 218.1 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.6 0.0 71.7 0.1 0.1 0.1 0.2 6.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 7.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 76.5 56.5 4.4 41.2 28.7 218.4 51.9 105.8 95.6 27.4 130.4 42.8 4.1 0.0 4.6 0.0 0.2 4.8 1.9 0.0 4.0 31.0 10.9 17.8 17.2 1.5 1.8 1.8 8.4 345.8 1.6 0.0 1.9 0.9 32.0 1.3 35.0 3.5 0.0 0.0 0.0 0.0 45.4 56.9 0.0 1.6 0.0 224.1 4.6 4.3 34.3 148.0 0.0 0.0 0.0 0.6 1.7 19.4 58.7 1.2 14.2 0.0 0.0 17.0 0.0 0.0 0.0 0.3 0.0 109.9 0.0 2.0 0.0 1.1 2.2 13.7 13.1 29.5 17.0 53.0 36.2 2.0 2.6 477.1 0.2 395.9 0.0 0.7 PEX1 "ZWS, ZWS1" ENSG00000127980 "Peroxisomal biogenesis factor 1" O43933 7 92487020-92528520 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis, Protein transport, Transport" "Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020235 Approved Supported Peroxisomes NA NA "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Peroxisomes "HPA020235: AB_1855224" "unprognostic (4.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.55e-2)" "unprognostic (1.53e-2)" "unprognostic (4.85e-1)" "unprognostic (2.41e-2)" "unprognostic (7.81e-2)" "unprognostic (9.79e-3)" "unprognostic (2.17e-2)" "unprognostic (6.39e-2)" "unprognostic (1.68e-2)" "unprognostic (3.61e-2)" "unprognostic (2.95e-3)" "unprognostic (1.59e-1)" "unprognostic (2.49e-1)" "unprognostic (5.35e-3)" "unprognostic (4.90e-2)" 5.8 6.9 2.6 6.0 4.7 4.1 8.7 4.6 4.3 6.4 2.5 8.6 6.6 6.7 11.2 6.1 5.6 4.7 8.9 2.4 3.1 14.2 13.0 5.3 6.9 3.5 3.5 6.8 8.8 11.7 6.3 4.2 4.1 7.8 9.5 13.2 9.1 7.0 9.1 7.9 8.1 5.4 2.8 6.0 8.2 6.7 3.0 7.9 8.6 9.9 6.7 5.6 5.8 6.3 8.3 8.9 14.4 24.6 8.9 7.6 13.0 5.4 7.1 6.3 9.1 5.5 8.7 12.2 12.0 6.3 9.6 8.4 11.0 9.9 10.0 12.7 9.7 5.8 9.5 7.0 6.2 10.6 6.4 8.2 8.6 9.4 12.7 8.0 9.9 12.6 21.9 17.2 10.1 15.5 21.3 10.4 10.0 12.3 8.3 15.0 16.0 15.3 8.8 12.0 10.6 17.1 12.4 34.3 10.8 20.2 7.1 4.4 8.1 6.0 8.1 23.0 5.7 18.9 15.9 16.7 5.7 6.2 9.8 0.8 1.1 1.8 2.5 1.8 2.5 3.0 2.6 2.8 1.2 2.8 2.9 3.3 0.9 4.7 2.2 0.7 2.8 1.1 2.6 4.7 4.6 4.3 2.4 3.1 3.5 3.5 4.1 2.8 3.0 6.3 14.2 28.9 18.4 26.1 14.1 5.9 8.4 8.1 10.8 43.5 11.7 12.6 29.7 5.7 13.1 5.5 35.5 9.0 13.6 17.2 9.8 6.6 7.3 22.6 14.7 11.6 13.9 12.4 30.0 7.5 3.9 11.6 21.9 14.2 8.8 20.5 8.2 14.2 5.4 40.4 45.7 12.0 8.2 7.6 3.1 4.8 14.3 8.4 7.2 13.1 12.7 14.2 14.4 23.6 55.2 6.0 11.3 15.1 11.6 9.6 16.5 19.2 32.4 42.9 6.6 15.5 12.6 36.6 14.4 11.2 7.7 8.3 12.0 11.8 15.2 7.7 PEX6 "PAF-2, PXAAA1" ENSG00000124587 "Peroxisomal biogenesis factor 6" Q13608 6 42963865-42979181 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 76.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025924, HPA074179" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA025924: AB_1855230, HPA074179: " "unprognostic (7.32e-3)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (9.16e-2)" "unprognostic (9.18e-2)" "unprognostic (3.27e-1)" "unprognostic (8.88e-2)" "unprognostic (5.92e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "unprognostic (7.24e-3)" "unprognostic (5.31e-2)" "unprognostic (3.79e-3)" "unprognostic (1.86e-1)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (1.55e-1)" 11.6 20.5 24.9 9.2 25.2 9.5 12.1 23.9 27.7 19.1 25.5 16.3 9.3 15.5 7.7 16.4 22.7 9.6 18.7 25.1 25.5 16.5 27.7 10.0 14.5 27.2 25.5 26.1 76.2 15.2 24.3 9.6 24.2 21.6 7.8 9.9 14.8 11.4 23.4 14.0 16.3 9.6 23.9 17.5 16.3 16.2 25.1 14.7 19.8 15.0 10.4 17.3 15.7 25.2 35.0 16.4 8.1 30.6 29.6 28.3 8.4 6.0 9.4 4.8 10.0 10.5 10.1 14.1 8.2 14.3 20.5 32.2 28.7 31.1 5.0 27.6 15.2 4.7 24.4 6.2 20.0 4.8 9.4 35.5 35.5 19.9 5.5 39.1 24.7 18.9 25.2 14.1 10.7 3.9 12.7 15.8 10.0 78.8 14.3 26.8 14.3 5.8 12.3 10.0 25.4 11.1 5.6 21.9 32.7 13.1 43.2 21.2 14.0 15.2 2.9 7.5 14.0 21.0 19.8 19.7 5.2 24.6 12.4 1.3 1.3 2.1 1.2 1.1 2.1 1.0 1.8 2.5 1.9 1.9 2.2 2.1 0.8 2.0 0.7 1.0 0.9 1.1 24.9 25.2 23.9 27.7 25.1 25.5 27.2 25.5 24.2 23.9 25.1 25.2 5.6 6.4 2.6 19.9 5.6 5.0 10.2 6.2 10.8 15.2 11.8 12.7 4.1 10.0 5.6 7.3 2.1 11.4 5.4 10.2 13.7 2.8 2.5 17.6 10.6 5.8 5.4 1.7 24.6 1.5 6.7 9.2 11.2 9.1 0.0 19.8 8.6 14.1 5.8 21.9 22.4 8.5 6.1 9.7 3.2 3.6 14.6 5.4 8.8 9.4 4.5 11.8 9.2 13.0 16.6 1.9 10.4 9.4 3.1 6.3 15.1 13.9 14.3 7.0 0.0 13.0 6.6 7.3 2.6 6.3 5.5 7.4 7.8 26.1 10.5 6.6 PFAS "FGARAT, GATD8, KIAA0361, PURL" ENSG00000178921 "Phosphoribosylformylglycinamidine synthase" O15067 17 8247618-8270491 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 49.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022140, HPA022886" Enhanced Approved Vesicles NA NA 670000 "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA022140: AB_1855232, HPA022886: AB_1855233" "unprognostic (1.90e-1)" "unprognostic (9.21e-2)" "unprognostic (2.12e-1)" "unprognostic (5.19e-3)" "unprognostic (2.59e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (9.19e-4)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (5.47e-3)" "unprognostic (1.08e-3)" "unprognostic (9.51e-3)" "unprognostic (3.63e-2)" "unprognostic (6.57e-2)" "unprognostic (2.88e-3)" "unprognostic (3.85e-1)" 8.4 9.9 4.7 7.8 5.1 9.8 8.2 6.2 5.8 7.8 2.8 6.7 4.8 9.0 2.6 8.4 8.0 2.8 6.3 5.1 3.3 11.0 10.1 5.8 9.8 3.9 3.9 9.7 10.3 5.6 5.5 5.2 4.6 6.9 5.6 5.8 6.4 4.7 6.4 6.8 7.7 6.8 3.3 11.0 7.8 7.8 3.9 7.5 7.8 3.2 8.2 7.6 6.2 6.0 15.6 67.0 33.8 50.2 12.1 10.0 38.7 19.4 7.4 35.1 26.4 32.9 13.7 69.8 30.8 11.4 12.4 35.1 78.5 25.6 25.8 30.6 64.0 40.0 63.2 41.9 10.4 32.9 28.3 9.5 6.2 40.5 25.5 9.9 29.5 36.6 54.8 10.1 13.7 23.0 58.1 28.4 55.7 8.5 29.9 86.0 35.2 32.6 16.1 25.5 20.4 31.7 24.1 15.3 22.2 17.9 15.3 14.9 20.9 19.2 25.0 35.7 49.0 11.8 23.5 33.7 21.0 45.4 32.9 20.2 5.1 12.7 6.8 4.5 8.7 14.8 8.8 7.9 4.4 16.7 10.9 8.6 49.1 5.2 3.7 12.9 5.0 2.3 4.7 5.1 6.2 5.8 5.1 3.3 3.9 3.9 4.6 3.3 3.9 6.0 2.9 0.0 7.9 3.9 6.0 2.4 1.7 1.9 1.8 8.1 4.5 3.7 4.3 1.5 4.1 3.7 6.2 5.2 3.2 2.1 0.0 3.7 2.1 2.4 5.9 3.6 0.0 9.2 5.8 3.0 4.3 4.0 5.6 3.7 1.3 9.7 2.5 4.2 4.6 1.7 5.4 3.5 2.0 2.5 1.4 1.1 5.3 3.4 3.6 4.7 4.5 1.6 4.1 6.6 3.9 1.9 4.9 1.5 5.3 2.9 0.8 2.7 5.1 7.3 0.0 5.1 3.2 5.6 8.8 3.9 2.0 3.1 3.3 7.7 6.2 1.4 PGBD4 "FLJ32638, FLJ37497" ENSG00000182405 "PiggyBac transposable element derived 4" Q96DM1 15 34102083-34108686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.9" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.9" "Low cell line specificity" "Detected in many" "HPA040896, HPA059823" Uncertain Approved Nucleoplasm,Centrosome NA NA "Cluster 34: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" Nucleoplasm Centrosome "HPA040896: AB_10805831, HPA059823: AB_2684134" "unprognostic (9.54e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (7.43e-3)" "unprognostic (2.61e-2)" "unprognostic (1.10e-1)" "unprognostic (2.35e-2)" "unprognostic (6.47e-2)" "unprognostic (6.66e-2)" "unprognostic (1.32e-3)" "unprognostic (9.70e-2)" "unprognostic (6.68e-2)" "unprognostic (2.14e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-2)" "unprognostic (7.73e-2)" 0.8 0.8 2.5 1.6 2.4 2.8 1.1 3.1 3.2 0.6 2.2 0.9 1.1 0.7 1.3 0.8 1.1 0.7 1.5 2.4 2.6 1.1 1.3 0.7 2.0 3.5 2.4 0.9 1.0 1.5 0.6 0.6 3.5 0.9 1.1 2.4 0.7 0.8 5.3 1.6 1.1 0.6 1.9 1.4 1.4 1.8 2.4 1.3 1.1 1.3 1.5 0.6 0.6 3.1 1.0 1.9 1.3 2.2 3.9 2.5 0.8 1.7 1.6 1.0 1.3 1.3 1.4 2.2 1.3 1.3 2.1 3.0 0.8 1.9 1.3 2.4 2.0 3.7 4.2 1.0 1.6 1.2 3.2 1.9 2.2 1.4 2.5 1.8 1.1 4.1 2.6 2.6 2.2 0.8 2.1 2.9 0.5 2.2 1.4 3.1 1.8 1.1 1.4 2.3 1.9 1.7 0.8 1.9 0.6 1.6 1.8 1.9 1.3 3.2 1.8 1.7 1.1 3.1 2.1 1.2 2.8 2.9 1.9 3.9 0.5 0.6 0.4 0.4 0.3 0.5 0.6 0.4 0.3 0.9 0.9 0.8 1.1 0.6 0.3 0.6 0.5 0.2 2.5 2.4 3.1 3.2 2.4 2.6 3.5 2.4 3.5 1.9 2.4 3.1 1.4 0.0 3.2 2.0 4.1 0.8 2.5 1.8 3.4 5.6 1.9 1.3 5.8 2.8 2.9 0.0 6.2 2.0 5.6 3.1 9.8 1.2 11.6 2.0 3.8 2.1 0.0 2.5 2.7 0.7 0.6 1.8 3.6 2.3 1.3 1.8 3.6 2.2 1.3 10.1 3.1 2.5 4.1 2.8 0.4 11.5 1.2 2.2 0.0 1.0 2.1 2.1 3.1 2.0 3.9 2.1 2.5 0.4 1.6 2.0 3.6 1.4 3.9 6.9 13.1 3.9 1.9 7.6 1.6 2.3 0.3 3.3 4.6 2.7 2.9 1.5 PGRMC1 HPR6.6 ENSG00000101856 "Progesterone receptor membrane component 1" O00264 X 119236245-119244466 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 677.4" "Cell type enhanced" "Detected in all" "Hepatocytes: 520.4;Theca cells: 907.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002877, HPA064724" Enhanced Supported "Nucleoli,Endoplasmic reticulum" NA NA 1200000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" Nucleoli "HPA002877: AB_1079602, HPA064724: " "unprognostic (6.97e-2)" "unprognostic (1.99e-1)" "unprognostic (1.72e-1)" "unprognostic (4.35e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.58e-3)" "unprognostic (9.28e-2)" "unprognostic (4.66e-2)" "unprognostic (6.20e-2)" "unprognostic (3.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-3)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 108.0 171.3 97.9 37.5 102.5 25.1 106.0 83.8 115.5 135.4 96.3 98.2 109.3 154.5 273.3 57.0 149.0 56.9 38.6 102.3 127.0 235.4 677.4 62.1 27.6 97.2 109.3 93.3 40.2 113.9 59.1 44.9 126.1 127.6 87.3 80.5 71.4 200.4 15.7 53.2 131.9 85.2 106.1 41.4 77.1 46.5 112.8 33.4 89.0 27.0 29.3 77.3 65.0 116.9 165.6 102.4 196.3 227.7 414.2 196.9 127.1 243.0 281.0 126.1 155.7 124.5 196.6 47.3 259.5 253.8 147.3 128.3 216.5 102.1 168.8 50.8 248.7 53.7 88.5 141.0 69.0 88.4 27.5 204.7 56.5 153.8 79.2 93.5 82.6 55.7 57.2 28.8 150.3 176.5 66.9 64.7 515.8 179.4 170.3 78.5 123.1 68.5 168.7 123.9 182.9 81.7 178.1 291.7 98.9 188.2 67.4 56.2 64.2 87.6 127.7 312.6 233.6 29.9 59.2 51.0 238.8 138.6 170.6 21.0 20.1 20.4 8.7 19.9 11.8 5.8 12.0 12.9 17.0 5.5 12.0 10.1 9.1 8.8 18.4 12.0 13.4 50.2 97.9 102.5 83.8 115.5 102.3 127.0 97.2 109.3 126.1 106.1 112.8 116.9 109.1 125.0 91.4 16.0 19.0 94.1 131.3 67.4 81.4 199.1 110.8 95.1 17.1 120.1 76.7 73.5 68.8 88.2 25.8 170.5 68.4 93.0 4.2 119.7 264.2 81.9 57.7 37.6 36.5 73.0 138.6 153.1 50.4 122.4 40.5 197.0 66.4 520.4 51.8 65.6 58.5 85.0 81.4 35.0 51.2 9.0 172.1 111.1 103.2 15.0 26.5 109.8 18.6 108.6 91.3 68.9 144.7 181.7 22.6 118.8 375.5 295.1 105.4 92.4 105.2 99.2 111.1 68.2 77.2 69.3 87.7 62.1 32.1 907.9 137.6 127.9 PGS1 DKFZP762M186 ENSG00000087157 "Phosphatidylglycerophosphate synthase 1" Q32NB8 17 78378649-78425114 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022526 Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "HPA022526: AB_1855271" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (1.86e-3)" "unprognostic (1.35e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (5.76e-3)" "unprognostic (3.17e-2)" "unprognostic (8.46e-3)" "prognostic favorable (7.33e-5)" "prognostic unfavorable (9.94e-4)" "prognostic unfavorable (1.16e-5)" "unprognostic (9.94e-2)" "unprognostic (5.60e-2)" "unprognostic (1.33e-1)" "unprognostic (2.72e-2)" 16.1 10.0 12.6 17.9 14.9 39.6 15.4 13.3 25.3 14.2 15.8 13.0 11.7 14.9 6.0 10.8 14.0 13.2 11.1 13.0 16.6 13.8 7.0 23.5 16.9 18.0 15.4 13.9 10.9 11.5 11.5 19.7 15.6 12.4 7.8 6.6 11.9 10.8 13.5 11.5 14.7 10.3 12.9 19.8 11.4 8.9 18.8 14.0 16.4 7.6 11.6 14.5 12.0 18.1 19.9 16.7 17.8 13.5 14.6 23.0 18.8 18.3 17.2 19.3 21.2 17.8 15.8 20.2 10.8 10.8 19.4 15.5 19.8 12.5 15.1 30.3 24.1 22.2 25.0 17.5 15.2 17.7 16.9 23.6 16.1 14.6 12.6 19.1 37.8 15.9 26.0 14.2 13.2 10.8 39.5 19.5 17.4 8.5 15.9 19.4 29.6 16.8 21.0 19.5 21.4 33.2 15.4 16.4 18.5 17.8 17.4 23.8 22.8 24.9 16.6 13.5 15.4 16.0 9.5 15.2 19.1 19.0 18.7 2.1 17.7 19.3 11.0 15.0 13.6 10.3 11.6 11.7 20.6 11.9 14.5 10.6 33.9 11.2 7.2 9.4 15.1 12.0 12.6 14.9 13.3 25.3 13.0 16.6 18.0 15.4 15.6 12.9 18.8 18.1 25.9 12.8 16.8 10.1 11.6 4.5 12.0 16.3 7.4 13.0 6.4 8.8 5.8 4.3 12.0 12.9 2.1 20.2 11.2 7.7 3.9 5.8 20.0 9.0 8.7 21.5 4.2 5.5 14.8 7.0 8.1 9.7 12.2 6.7 7.6 13.3 15.0 3.9 15.4 20.2 15.0 6.1 6.1 13.9 8.3 10.8 10.5 19.2 5.4 17.8 12.1 11.0 10.3 11.6 20.4 7.2 15.6 8.6 9.4 9.2 8.0 5.2 14.4 11.4 32.9 6.8 10.8 17.9 18.4 5.8 3.8 19.3 10.8 14.7 8.5 10.9 PHF3 ENSG00000118482 "PHD finger protein 3" Q92576 6 63635802-63779336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024676, HPA025763" Approved Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA024676: AB_10599736, HPA025763: AB_10600987" "unprognostic (4.33e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.23e-2)" "unprognostic (2.89e-1)" "unprognostic (6.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.19e-2)" "unprognostic (1.76e-2)" "unprognostic (1.84e-2)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (3.37e-1)" 19.6 18.2 12.5 16.9 18.9 39.5 21.4 32.2 15.3 20.6 11.7 16.7 16.0 22.8 17.5 12.8 16.7 16.1 13.7 11.0 15.4 19.7 28.0 16.0 21.6 17.4 13.7 32.2 18.4 23.8 12.2 24.3 19.4 18.2 17.6 27.7 15.2 15.9 20.3 16.5 16.1 15.5 14.5 21.3 18.3 14.3 14.7 30.6 26.1 22.9 18.1 15.4 16.8 30.5 35.8 17.5 28.1 17.0 27.3 29.6 28.6 23.0 32.5 16.9 22.3 24.0 16.6 44.0 19.3 20.7 24.4 15.3 27.7 23.9 27.8 35.2 23.3 52.5 21.7 38.2 24.7 45.3 20.7 21.4 21.2 24.0 34.1 29.1 19.8 23.0 58.4 39.9 17.4 21.2 19.5 23.9 16.3 22.9 10.4 33.7 25.6 21.2 20.5 21.0 30.8 22.7 27.7 12.5 20.1 30.7 21.3 41.2 28.2 25.9 30.4 20.0 27.6 33.9 37.6 41.0 11.9 35.6 20.3 15.5 6.2 7.1 7.6 8.0 7.4 7.3 7.1 6.1 5.5 8.9 10.0 7.6 14.4 5.0 11.5 6.7 5.5 4.4 12.5 18.9 32.2 15.3 11.0 15.4 17.4 13.7 19.4 14.5 14.7 30.5 87.9 157.0 133.2 76.0 108.0 54.9 62.1 42.2 71.7 67.9 49.4 56.8 95.2 34.3 88.6 46.0 47.9 47.6 91.2 50.1 15.6 48.4 40.5 68.8 93.7 61.1 43.1 63.1 71.1 37.6 31.5 77.2 60.6 84.3 103.0 85.5 41.7 47.1 28.8 50.5 80.5 46.1 28.5 46.2 33.2 26.5 81.1 65.3 23.2 70.3 69.6 47.4 74.2 76.9 129.8 29.8 40.5 56.8 92.4 64.1 55.5 36.4 72.9 66.8 59.2 103.7 58.5 103.0 69.3 48.4 42.9 31.2 97.1 114.2 49.4 51.0 PHIP "BRWD2, DCAF14, FLJ20705, ndrp, WDR11" ENSG00000146247 "Pleckstrin homology domain interacting protein" Q8WWQ0 6 78934419-79078254 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019140, HPA019838" Approved Supported Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA019140: AB_2670073, HPA019838: AB_2670287" "unprognostic (1.58e-1)" "unprognostic (1.60e-1)" "unprognostic (9.43e-2)" "unprognostic (8.47e-3)" "unprognostic (1.05e-1)" "unprognostic (2.01e-3)" "unprognostic (3.50e-3)" "unprognostic (5.03e-2)" "unprognostic (4.03e-2)" "unprognostic (6.40e-3)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.55e-2)" 8.5 5.7 7.6 8.4 9.9 29.4 12.0 18.8 9.3 11.0 6.0 8.5 5.8 11.1 8.4 6.2 9.8 6.3 6.6 6.6 9.0 6.1 4.8 8.8 11.0 8.8 8.7 11.7 8.4 8.5 9.4 7.9 9.2 8.7 7.7 20.5 8.5 7.0 9.7 8.9 7.9 7.1 8.3 9.9 8.1 6.4 8.5 13.1 7.8 8.4 9.1 8.4 9.2 14.0 13.6 10.8 25.2 24.6 9.6 13.7 14.6 14.3 11.3 12.0 15.1 13.4 8.2 22.3 11.1 9.0 10.1 12.2 19.1 9.1 20.1 32.2 13.9 25.0 20.7 10.0 4.4 28.2 15.4 8.4 7.9 14.4 14.3 10.1 12.9 14.0 25.5 20.8 11.7 9.1 11.0 21.0 15.9 7.0 11.8 18.9 32.3 9.7 12.9 18.0 24.7 15.8 19.0 14.4 9.2 16.0 11.2 37.6 15.2 13.9 9.8 6.8 23.8 14.2 14.9 12.3 5.9 17.9 21.2 10.0 4.2 7.7 4.4 3.0 4.7 6.1 5.3 5.0 2.9 6.6 5.8 4.6 14.4 4.6 5.7 5.3 4.8 2.1 7.6 9.9 18.8 9.3 6.6 9.0 8.8 8.7 9.2 8.3 8.5 14.0 64.4 70.5 109.9 181.8 92.5 63.2 88.9 56.7 48.9 183.4 53.7 52.2 58.6 54.3 95.9 55.2 152.2 85.4 95.3 52.1 1.9 71.6 33.8 94.6 75.1 74.5 72.7 80.4 168.9 47.2 91.0 77.3 59.7 58.4 115.2 76.6 71.0 21.3 51.0 181.7 196.4 58.2 71.2 83.8 75.6 17.2 101.2 83.3 49.8 154.6 134.7 84.4 83.4 154.3 346.1 58.1 49.1 87.6 124.8 81.5 46.7 19.0 148.4 174.1 52.6 97.9 87.4 127.3 53.6 50.1 56.4 102.1 92.9 50.5 62.1 104.5 PHYKPL "AGXT2L2, MGC15875" ENSG00000175309 "5-phosphohydroxy-L-lysine phospho-lyase" Q8IUZ5 5 178208471-178232802 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036461, HPA063608" Approved Approved Mitochondria Yes No 160000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA036461: AB_10670717, HPA063608: AB_2685059" "unprognostic (3.29e-3)" "unprognostic (2.60e-1)" "unprognostic (5.51e-2)" "unprognostic (9.75e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-2)" "unprognostic (3.29e-1)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "prognostic unfavorable (3.82e-5)" "unprognostic (3.66e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-1)" "unprognostic (2.41e-3)" 23.2 10.6 7.4 16.4 8.2 14.9 14.0 6.8 8.6 12.3 8.3 23.9 20.7 14.3 15.8 11.1 13.9 14.4 15.5 6.7 8.3 17.5 42.2 15.8 24.5 11.4 8.3 12.5 15.6 13.7 5.2 16.3 10.0 13.7 30.8 3.4 13.8 12.0 19.6 10.7 24.8 18.5 7.6 17.2 15.5 5.9 9.5 25.1 19.7 18.7 23.6 13.7 9.6 11.7 9.6 3.8 9.0 3.6 21.6 17.4 13.9 5.6 6.2 7.6 11.8 9.7 11.7 13.0 18.4 17.6 9.7 6.2 7.7 14.3 8.5 24.0 8.7 15.6 18.0 7.1 35.1 9.2 11.4 19.6 15.0 9.3 22.4 14.9 24.9 18.6 11.8 26.7 11.3 13.1 13.1 5.5 1.9 11.5 12.4 9.1 4.3 25.0 13.4 8.3 5.7 5.4 9.2 5.2 9.4 10.2 5.5 7.4 9.9 7.8 7.0 5.1 6.2 18.8 5.5 7.2 2.2 9.2 5.2 16.7 41.7 36.9 20.3 46.8 20.4 28.4 22.2 22.9 53.4 26.3 27.3 22.2 9.2 23.7 47.2 70.9 28.6 33.2 7.4 8.2 6.8 8.6 6.7 8.3 11.4 8.3 10.0 7.6 9.5 11.7 23.1 19.2 14.3 31.6 63.0 10.7 43.1 16.1 25.0 21.9 17.2 14.5 17.4 37.1 13.0 23.9 25.0 18.4 72.5 96.1 19.6 24.6 21.7 13.2 27.7 26.2 19.2 30.7 20.7 18.6 20.2 33.4 76.9 13.8 12.7 38.4 31.1 30.1 31.7 15.2 17.9 40.8 6.1 37.1 22.9 55.3 42.6 43.3 24.9 36.5 61.1 25.0 70.0 29.1 45.2 15.1 64.5 25.2 51.4 30.3 119.2 43.1 13.6 26.4 13.1 34.5 23.6 37.2 25.9 14.6 10.4 22.0 58.9 36.3 39.2 36.6 PIGG "FLJ20265, GPI7, LAS21" ENSG00000174227 "Phosphatidylinositol glycan anchor biosynthesis class G" Q5H8A4 4 499210-540200 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015997 Uncertain NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 51: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "HPA015997: AB_2164679" "unprognostic (3.87e-2)" "unprognostic (5.32e-2)" "unprognostic (5.78e-3)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.20e-3)" "unprognostic (3.48e-2)" "unprognostic (4.68e-1)" "unprognostic (2.64e-1)" "unprognostic (7.01e-3)" "unprognostic (6.61e-3)" "unprognostic (9.09e-2)" "unprognostic (1.83e-2)" "unprognostic (1.51e-1)" "unprognostic (4.27e-3)" "unprognostic (2.97e-2)" 12.7 13.7 6.0 11.4 6.7 9.4 12.8 6.0 6.9 10.6 7.8 12.9 14.2 11.5 20.5 11.4 11.6 12.9 8.1 7.5 5.5 9.5 8.9 11.6 13.4 6.7 6.1 15.4 14.1 17.5 15.2 12.6 7.0 12.1 12.0 10.7 14.7 11.2 8.1 20.3 13.5 9.8 6.0 13.1 13.2 8.8 6.8 10.8 14.9 4.1 11.3 12.9 11.5 10.3 18.7 20.2 18.2 15.2 33.0 23.1 28.7 24.0 28.8 25.1 29.7 21.5 42.4 7.8 17.4 30.8 46.0 25.0 17.2 23.5 23.1 7.3 19.1 19.4 24.7 17.0 22.6 27.3 27.6 26.2 38.9 23.2 12.7 27.4 19.4 14.9 21.4 16.5 22.6 11.6 15.3 23.9 29.6 20.2 28.2 16.9 11.2 11.5 24.2 25.4 18.2 23.2 17.7 18.3 17.6 17.3 29.2 24.1 30.0 25.6 12.0 13.3 37.7 13.5 19.4 12.3 21.7 19.9 32.7 20.5 5.1 4.2 5.9 6.5 6.7 3.5 4.5 5.7 8.1 2.8 4.8 3.9 3.8 7.8 4.9 7.2 8.3 3.9 6.0 6.7 6.0 6.9 7.5 5.5 6.7 6.1 7.0 6.0 6.8 10.3 14.4 16.0 12.6 21.9 12.6 8.9 10.9 17.7 12.5 10.8 11.4 9.3 8.6 7.2 23.0 9.2 4.2 16.7 14.8 14.9 0.0 15.8 2.4 16.4 15.4 13.1 10.8 11.2 23.2 17.8 14.8 10.2 22.4 20.2 12.7 19.8 8.9 10.1 9.1 8.4 15.1 8.5 16.2 11.5 6.5 0.7 13.7 9.5 8.8 24.4 13.6 11.6 17.5 16.6 26.0 18.4 12.8 12.8 14.9 13.7 13.1 5.6 19.9 10.5 19.7 10.4 11.5 9.9 8.2 10.1 6.3 23.1 14.2 13.0 9.7 14.2 PIP4K2B "PIP5K2B, PIP5KIIB, PIP5KIIbeta" ENSG00000276293 "Phosphatidylinositol-5-phosphate 4-kinase type 2 beta" P78356 17 38765691-38800126 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062220 Supported Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 80: Striated muscle - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA062220: AB_2684715" "unprognostic (7.77e-2)" "unprognostic (8.37e-2)" "unprognostic (3.74e-2)" "unprognostic (1.13e-1)" "unprognostic (2.67e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.64e-1)" "unprognostic (2.33e-1)" "unprognostic (1.50e-2)" "unprognostic (6.10e-3)" "unprognostic (3.79e-1)" "unprognostic (4.82e-3)" "unprognostic (3.38e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.36e-4)" "unprognostic (2.48e-1)" 19.9 27.0 82.5 15.5 85.6 7.3 20.8 62.3 93.9 30.1 43.3 24.2 10.3 28.8 23.3 15.4 29.1 16.3 30.2 90.7 75.2 20.1 14.4 21.4 20.5 65.9 65.7 49.8 16.4 16.6 25.2 22.8 67.1 22.2 14.0 36.0 16.9 25.3 99.0 24.6 17.3 29.5 63.2 23.2 16.4 13.0 80.4 23.4 20.3 75.6 20.4 22.9 20.9 81.4 18.1 40.2 66.0 69.9 56.7 45.5 12.2 31.6 38.2 43.1 35.0 28.2 18.4 44.8 17.2 59.8 36.3 35.9 44.9 28.7 41.4 27.8 17.2 38.4 27.3 40.7 26.2 43.7 23.5 40.0 34.2 33.7 24.2 59.2 36.3 48.6 34.2 22.3 46.8 14.2 44.0 34.0 32.0 20.7 15.8 44.6 63.7 25.6 31.3 22.3 34.0 46.1 30.9 13.9 34.5 68.5 43.6 44.5 33.4 35.8 21.6 29.4 28.9 27.4 36.5 19.7 42.0 36.8 32.9 1.3 1.9 0.6 3.4 1.6 3.5 2.3 2.9 3.3 2.4 2.3 3.2 2.9 1.8 2.8 1.4 2.2 3.0 3.3 82.5 85.6 62.3 93.9 90.7 75.2 65.9 65.7 67.1 63.2 80.4 81.4 15.8 19.2 11.4 21.5 6.7 6.1 3.5 4.6 7.4 31.6 11.5 13.3 23.4 4.3 7.5 5.5 10.4 7.0 14.8 3.7 1.9 5.3 9.2 10.8 17.7 17.3 11.5 9.0 33.5 4.9 5.0 13.8 5.6 9.0 1.3 22.6 18.2 12.7 8.8 43.7 29.1 7.4 2.0 11.3 4.9 21.1 15.2 8.6 1.8 18.7 6.9 14.8 10.3 22.1 24.0 6.0 4.1 16.6 6.2 4.9 5.4 7.7 6.4 14.0 6.6 13.8 13.2 4.6 7.4 9.9 4.4 2.5 8.1 17.3 7.2 2.7 PKDCC "SgK493, Vlk" ENSG00000162878 "Protein kinase domain containing, cytoplasmic" Q504Y2 2 42048021-42058517 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Differentiation, Osteogenesis, Protein transport, Transport" "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 85.5" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 71.9;Fibroblasts: 55.4;Leydig cells: 137.6;Peritubular cells: 112.1;Rod photoreceptor cells: 95.9;Theca cells: 135.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 85.9;ASC diff: 61.7;CACO-2: 101.0;HHSteC: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026427, HPA026442, HPA026526" Approved "Secreted to blood" NA NA 80000 "Cluster 59: Non-specific - Translation" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" "HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416" "unprognostic (6.77e-2)" "unprognostic (3.35e-1)" "unprognostic (1.04e-2)" "unprognostic (3.59e-3)" "unprognostic (8.31e-2)" "unprognostic (1.11e-1)" "unprognostic (2.18e-2)" "unprognostic (5.79e-3)" "unprognostic (1.04e-2)" "unprognostic (1.32e-1)" "unprognostic (3.20e-1)" "unprognostic (6.09e-2)" "unprognostic (2.14e-2)" "unprognostic (9.08e-2)" "unprognostic (2.62e-1)" "unprognostic (4.73e-3)" "unprognostic (2.58e-3)" 25.7 11.3 3.1 4.9 3.8 0.8 16.1 0.8 6.2 31.8 6.4 20.3 10.7 25.7 2.1 2.2 24.2 3.3 37.6 4.8 1.0 10.7 6.9 16.5 2.1 1.5 1.6 50.1 7.0 1.1 6.8 3.6 1.3 12.2 5.7 5.3 20.7 5.8 85.5 3.8 13.7 9.8 1.4 9.6 9.6 14.8 2.1 6.4 5.1 27.7 1.4 32.5 17.4 4.7 0.0 5.5 14.0 85.9 61.7 0.7 5.3 0.2 0.0 1.2 1.5 101.0 0.2 0.0 0.3 1.7 1.8 0.0 1.3 0.0 0.0 8.1 3.5 0.2 3.3 27.0 53.7 0.0 1.2 5.7 0.3 0.2 0.0 0.6 0.7 0.0 1.2 0.0 0.3 0.3 0.0 0.3 23.8 6.8 1.7 0.0 27.3 0.0 0.0 0.0 2.8 5.1 1.3 0.0 0.2 16.3 0.1 0.7 0.0 0.6 2.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.8 0.8 6.2 4.8 1.0 1.5 1.6 1.3 1.4 2.1 4.7 28.8 19.2 0.5 4.2 0.3 3.2 0.2 0.0 0.0 4.7 1.3 2.0 9.2 1.5 0.0 1.8 16.7 0.5 0.6 22.8 0.0 2.1 1.1 6.0 31.4 3.1 71.9 0.0 22.8 1.3 1.3 55.4 2.6 26.3 0.0 4.5 2.9 2.7 0.6 0.0 3.3 18.6 0.0 0.6 3.1 5.4 137.6 0.6 1.8 3.7 0.0 21.3 0.0 10.1 1.8 1.9 16.0 112.1 0.0 0.8 15.2 3.9 0.0 95.9 13.1 14.2 15.1 0.7 1.7 0.0 1.8 0.3 0.8 135.4 35.9 0.1 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 80.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 80.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 19.3 16.5 9.3 17.6 14.2 48.7 24.1 20.7 10.9 16.4 17.0 23.9 30.5 23.6 25.0 24.7 18.1 17.1 14.1 9.5 9.7 16.9 20.5 20.4 18.2 12.3 10.4 31.2 15.5 22.3 10.1 24.7 12.7 20.3 30.0 26.7 16.3 15.4 9.8 20.3 30.8 18.5 10.1 19.0 20.9 10.5 12.6 17.8 26.1 13.4 17.4 21.3 15.4 17.6 61.1 23.8 45.2 27.3 29.8 33.6 29.6 35.3 32.2 38.5 39.8 25.3 42.5 23.9 41.0 33.6 47.3 46.7 44.7 26.6 52.4 8.6 33.0 17.7 49.3 21.4 26.2 17.6 5.1 27.7 27.1 30.2 36.3 30.6 44.7 18.6 29.9 16.8 42.2 12.2 20.5 15.2 22.8 23.1 27.1 19.3 68.8 9.8 34.3 117.9 22.0 14.5 52.7 29.8 45.7 33.9 22.5 15.7 42.2 32.5 29.2 42.1 37.2 9.2 8.6 16.6 13.6 17.1 12.6 15.3 9.9 16.6 5.7 5.9 5.1 8.0 5.1 5.3 5.0 9.3 6.6 5.6 80.5 3.5 8.0 8.6 4.6 2.7 9.3 14.2 20.7 10.9 9.5 9.7 12.3 10.4 12.7 10.1 12.6 17.6 104.7 41.7 57.8 102.5 52.5 48.4 44.3 33.3 75.1 85.4 60.2 67.9 50.8 38.6 47.9 69.9 89.6 42.9 48.1 101.5 11.7 61.2 2.6 63.7 68.7 59.5 44.3 57.7 134.2 60.7 33.1 53.1 85.6 84.6 15.8 107.0 47.5 39.4 24.2 65.6 130.8 64.3 32.6 35.8 27.9 6.6 54.3 44.9 32.0 178.0 57.3 50.5 22.6 117.1 146.4 77.6 98.1 48.2 54.8 64.7 84.0 26.7 49.1 150.5 39.5 62.8 55.5 43.6 34.6 83.0 52.4 37.4 44.8 90.2 65.0 124.2 PLAG1 ZNF912 ENSG00000181690 "PLAG1 zinc finger" Q6DJT9 8 56160909-56211324 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 32.0;Microglial cells: 28.1;Rod photoreceptor cells: 27.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 16.0;ASC TERT1: 20.9;hTERT-HME1: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA072290 Supported "Nucleoplasm,Nuclear speckles,Centrosome,Cytosol" NA NA "Cluster 30: Non-specific - Translation" "Cluster 77: Retina - Visual perception" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "Centrosome, Cytosol" "HPA072290: AB_2686508" "unprognostic (1.89e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-3)" "unprognostic (1.63e-4)" "unprognostic (6.81e-2)" "unprognostic (1.07e-1)" "unprognostic (5.63e-3)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (7.99e-2)" "unprognostic (3.42e-2)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (2.83e-2)" "unprognostic (3.94e-1)" "unprognostic (1.21e-2)" "unprognostic (6.14e-2)" 0.7 1.4 0.8 1.0 1.2 0.9 0.9 2.5 1.1 3.0 0.6 0.8 1.4 1.4 4.1 0.7 3.1 0.7 3.1 0.7 1.0 1.3 0.3 1.9 1.8 1.5 1.4 4.9 0.8 1.2 3.8 1.6 1.8 1.3 0.6 7.7 3.0 1.8 0.4 1.4 2.3 0.4 1.2 2.6 1.3 2.4 1.3 2.8 1.3 1.4 2.3 1.3 3.0 2.0 2.0 0.0 11.9 0.1 16.0 20.9 3.7 5.4 6.9 2.5 1.1 0.8 6.2 0.2 5.1 2.9 0.7 0.4 3.4 7.1 2.5 0.2 7.4 8.0 0.8 1.8 3.3 2.5 2.3 14.9 3.9 1.4 15.6 6.9 4.7 5.3 3.4 0.1 5.3 0.1 0.7 4.7 3.4 0.5 1.8 6.1 0.8 4.9 3.2 0.7 0.1 0.0 0.1 0.1 0.4 8.0 0.1 2.4 7.2 3.6 4.6 5.9 1.4 1.8 1.5 2.9 4.1 0.9 1.0 0.6 0.0 0.4 0.1 0.0 0.1 1.3 0.4 0.2 0.0 0.7 1.8 1.8 0.4 0.3 0.2 0.1 0.1 0.4 0.8 1.2 2.5 1.1 0.7 1.0 1.5 1.4 1.8 1.2 1.3 2.0 2.6 6.4 3.2 2.9 13.0 1.0 2.5 6.2 1.8 23.6 1.6 0.6 12.2 4.3 6.7 5.5 25.0 8.3 2.0 1.0 0.0 0.7 6.2 3.0 2.3 3.7 5.4 5.0 16.8 1.3 4.2 4.0 2.6 4.2 1.3 0.4 15.7 0.7 5.8 32.0 12.3 3.6 6.1 2.9 2.2 6.7 15.2 2.8 16.0 28.1 1.2 16.3 4.1 2.0 19.2 1.4 4.1 10.1 6.3 5.0 5.1 0.8 9.1 27.8 0.0 2.4 1.4 9.0 8.8 1.1 0.9 7.1 4.5 0.9 3.6 12.9 PLK5 "PLK5P, SgK384ps" ENSG00000185988 "Polo like kinase 5 (inactive)" Q496M5 19 1508023-1536046 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.1;cervix: 9.6;testis: 7.2" "Cell type enhanced" "Detected in some" "Astrocytes: 14.7;Leydig cells: 36.4;Muller glia cells: 9.4;Peritubular cells: 67.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enhanced" "Detected in many" "cerebellum: 16.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.1" "Region enhanced" "Detected in all" "cerebellum: 42.0" "Group enriched" "Detected in many" 5 "cerebellum: 36.9;cerebral cortex: 10.6;hippocampal formation: 13.9" HPA035024 Enhanced NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 21: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "HPA035024: AB_2674418" "unprognostic (4.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (7.69e-2)" "unprognostic (1.11e-2)" "unprognostic (1.33e-1)" "unprognostic (2.69e-1)" "unprognostic (8.38e-2)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" "unprognostic (3.36e-2)" "unprognostic (9.94e-3)" "unprognostic (2.18e-3)" "unprognostic (3.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.54e-2)" "unprognostic (4.01e-4)" 0.1 0.2 4.4 0.0 2.2 0.4 0.5 16.1 4.8 9.6 2.2 0.4 0.1 2.9 2.1 0.6 2.5 0.0 0.1 6.5 0.6 0.1 0.1 0.0 0.1 0.4 1.2 0.5 0.1 0.1 0.8 0.0 1.2 0.9 0.0 0.6 0.2 1.0 0.2 0.4 0.2 1.0 0.1 0.0 0.1 7.2 1.3 0.0 0.1 0.0 0.0 0.1 3.7 0.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.9 0.2 0.1 0.2 0.1 0.0 4.4 2.2 16.1 4.8 6.5 0.6 0.4 1.2 1.2 0.1 1.3 0.7 0.3 0.0 0.0 14.7 0.0 0.1 0.1 0.0 0.6 2.7 0.9 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.1 0.0 0.0 2.4 0.0 0.0 1.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.0 36.4 0.4 1.8 0.0 0.0 9.4 0.0 1.0 0.3 0.0 0.0 67.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.4 0.1 1.9 0.4 0.1 0.1 0.0 0.1 0.0 0.1 PNISR "bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130" ENSG00000132424 "PNN interacting serine and arginine rich protein" Q8TF01 6 99397629-99425331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038796, HPA075076" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 51: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Plasma membrane, Cytosol" "HPA038796: AB_10672652, HPA075076: " "unprognostic (2.95e-1)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "unprognostic (9.72e-3)" "unprognostic (1.68e-2)" "unprognostic (8.55e-3)" "unprognostic (4.41e-2)" "unprognostic (1.58e-3)" "unprognostic (5.82e-2)" "unprognostic (4.32e-3)" "prognostic favorable (5.27e-4)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (3.43e-2)" "unprognostic (2.59e-1)" "unprognostic (8.89e-2)" "prognostic favorable (1.09e-4)" 68.2 68.8 56.9 52.0 55.4 106.8 75.3 78.4 89.8 103.1 67.5 114.5 51.4 79.7 93.6 51.8 93.2 38.2 84.6 54.3 56.4 67.1 62.2 74.4 78.7 56.7 54.7 123.0 66.0 38.4 112.0 36.4 52.9 91.2 49.4 102.1 76.6 48.1 89.4 64.1 94.1 49.4 49.3 90.6 77.1 39.4 56.9 51.4 114.5 31.2 54.9 81.6 80.3 60.1 26.7 19.5 98.8 72.0 35.3 46.8 45.8 44.1 22.8 25.6 29.9 33.3 49.2 85.8 26.6 25.3 28.7 41.9 49.3 33.3 45.2 75.0 48.8 52.6 105.0 30.6 22.2 73.0 67.9 51.8 50.0 27.4 37.5 95.7 34.2 44.8 59.3 52.5 31.3 25.2 31.8 71.2 55.2 24.5 15.3 62.1 29.6 32.4 47.1 47.1 43.4 51.9 21.7 23.6 35.3 75.4 32.8 58.6 45.0 25.2 28.9 25.7 37.2 35.9 24.3 70.5 37.5 68.3 27.0 12.3 10.8 11.9 12.5 6.4 13.0 19.3 12.0 10.4 5.0 25.8 17.9 16.6 30.0 23.5 7.7 19.6 12.4 3.7 56.9 55.4 78.4 89.8 54.3 56.4 56.7 54.7 52.9 49.3 56.9 60.1 175.8 185.9 237.6 356.2 375.8 195.3 357.3 250.5 165.6 546.2 143.9 192.5 121.2 137.2 215.7 178.4 446.2 158.3 336.4 152.4 74.3 130.8 17.0 132.2 185.7 210.7 247.8 194.4 241.5 104.5 102.1 240.1 100.9 140.5 190.5 344.5 135.7 109.4 99.7 498.0 257.4 129.6 199.4 128.0 236.8 47.9 593.3 152.1 167.2 193.9 261.6 223.6 375.9 270.4 252.6 133.1 176.2 441.2 209.8 293.6 205.8 58.6 179.6 419.9 249.8 288.7 236.3 342.6 181.3 115.5 173.6 180.9 283.8 363.3 151.3 352.4 PNKP PNK ENSG00000039650 "Polynucleotide kinase 3'-phosphatase" Q96T60 19 49859882-49878351 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006782 Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "HPA006782: AB_1855496" "prognostic favorable (9.18e-4)" "unprognostic (1.87e-1)" "unprognostic (4.31e-2)" "unprognostic (4.23e-1)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (4.55e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.24e-2)" "unprognostic (3.68e-3)" 18.9 45.1 12.0 21.0 12.9 26.4 21.2 12.8 16.2 21.1 24.2 21.6 16.0 21.3 13.5 19.4 22.9 10.6 23.9 14.4 11.9 27.3 22.4 22.2 17.5 14.0 14.0 23.7 28.6 16.7 36.8 11.1 14.3 25.3 13.1 10.1 21.6 12.4 18.5 17.8 22.8 11.5 12.8 37.2 25.0 21.2 13.3 12.3 31.9 7.8 15.3 19.4 18.0 14.1 27.5 17.4 19.1 27.2 15.8 13.4 28.6 43.4 21.2 18.7 17.7 17.5 34.2 18.4 13.6 13.6 11.3 23.5 6.1 25.9 10.9 22.3 27.2 30.0 36.7 14.8 12.2 25.8 36.3 13.2 13.0 17.9 11.0 16.9 26.3 23.4 14.9 34.3 24.7 18.8 28.7 23.5 16.0 28.3 37.4 24.3 15.9 34.7 21.0 68.5 20.6 33.4 19.3 52.5 9.2 14.5 10.2 14.8 36.0 37.6 24.9 9.6 35.8 38.7 16.5 13.0 33.8 12.3 30.8 1.8 12.3 16.7 9.2 11.5 7.9 9.1 7.8 7.3 9.8 12.2 5.7 5.0 23.4 3.9 18.1 5.5 9.1 5.8 12.0 12.9 12.8 16.2 14.4 11.9 14.0 14.0 14.3 12.8 13.3 14.1 23.6 16.0 23.6 5.9 47.2 13.4 35.4 29.9 25.6 40.9 28.1 23.7 11.1 21.5 19.1 20.2 81.3 44.5 37.7 40.0 23.5 42.5 15.0 25.2 28.5 26.6 30.5 17.1 6.0 39.9 35.1 19.1 31.6 28.0 29.1 54.6 35.0 20.1 39.5 33.7 6.0 31.7 24.4 27.7 19.0 32.9 59.4 26.8 14.2 8.4 46.1 18.4 96.8 6.0 5.7 44.6 22.3 44.8 40.4 33.6 27.1 36.1 33.8 73.9 19.7 17.9 20.1 19.4 28.9 23.3 13.1 49.3 39.2 83.0 34.1 35.6 PNMA8B "KIAA1183, PNMAL2" ENSG00000204851 "PNMA family member 8B" Q9ULN7 19 46486906-46495879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 14.7;brain: 41.6" "Group enriched" "Detected in some" 4 "Adipocytes: 8.3;Granulosa cells: 5.3;Theca cells: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.4;AN3-CA: 1.8;SH-SY5Y: 1.4" "Low region specificity" "Detected in all" HPA054810 Enhanced NA NA "Cluster 65: Brain - Ion transport" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA054810: AB_2682609" "unprognostic (1.31e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-2)" "unprognostic (3.38e-3)" "unprognostic (2.90e-1)" "unprognostic (1.35e-1)" "unprognostic (4.15e-1)" "unprognostic (4.19e-3)" "unprognostic (4.26e-4)" "unprognostic (7.30e-2)" "unprognostic (5.57e-3)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (3.38e-1)" "unprognostic (1.32e-2)" 2.7 14.7 32.8 0.3 31.1 0.0 2.4 0.0 41.6 1.9 0.0 1.5 0.3 1.7 0.5 0.5 1.6 1.0 1.9 20.1 25.3 0.7 0.4 0.7 0.4 22.5 15.0 3.9 0.9 0.2 7.3 0.3 27.3 1.6 0.1 2.1 1.5 1.0 0.5 2.3 0.9 0.6 2.1 1.9 0.9 0.8 18.5 3.5 0.8 0.4 0.1 1.1 1.6 19.0 0.0 0.0 1.4 1.8 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 31.1 0.0 41.6 20.1 25.3 22.5 15.0 27.3 2.1 18.5 19.0 8.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.3 0.0 0.5 0.9 0.8 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.1 0.0 5.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 12.4 0.0 0.0 PNN memA ENSG00000100941 "Pinin, desmosome associated protein" Q9H307 14 39175183-39183220 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001378 Supported Supported "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA001378: AB_1079648" "unprognostic (9.28e-3)" "unprognostic (5.07e-2)" "unprognostic (5.46e-2)" "unprognostic (3.91e-1)" "unprognostic (7.38e-3)" "unprognostic (7.40e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (1.65e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.51e-3)" "unprognostic (1.25e-1)" "unprognostic (1.53e-1)" "unprognostic (1.00e-1)" "unprognostic (4.30e-2)" 57.8 60.6 42.7 68.0 46.6 135.9 60.2 50.6 48.1 82.2 77.8 83.1 56.5 81.5 129.5 74.0 77.0 41.8 54.9 42.9 51.4 87.6 124.8 61.4 87.6 47.5 45.1 84.5 78.5 40.8 90.7 53.8 47.2 83.8 63.1 76.0 65.6 48.4 59.9 67.7 90.5 48.0 43.9 103.6 70.7 58.5 47.1 65.6 88.4 27.0 69.5 69.2 73.3 50.9 152.4 72.0 193.2 94.0 45.5 37.4 141.4 116.6 35.4 82.4 81.2 112.3 232.6 229.1 72.7 53.2 69.7 156.4 153.3 85.5 138.5 105.1 109.0 158.6 243.7 246.0 39.1 201.0 107.6 55.8 73.5 80.1 65.1 115.5 57.3 119.0 149.1 128.2 65.8 122.6 145.5 170.3 126.6 76.2 114.3 188.4 137.0 64.2 65.6 219.3 93.8 50.5 126.2 90.5 69.1 133.2 114.4 117.5 92.7 115.9 90.9 52.7 142.2 102.5 87.8 194.0 59.5 167.3 70.6 9.2 13.7 22.0 17.0 11.4 16.1 22.2 12.1 10.9 11.8 25.5 17.2 16.6 27.6 15.4 16.4 22.1 14.2 6.1 42.7 46.6 50.6 48.1 42.9 51.4 47.5 45.1 47.2 43.9 47.1 50.9 105.6 192.3 125.0 40.8 170.5 126.2 244.5 84.4 153.1 203.1 77.5 87.5 63.4 61.5 164.8 60.7 56.3 113.2 230.9 129.3 35.2 89.4 59.0 155.0 178.9 127.9 136.2 121.1 33.1 58.3 100.0 117.1 101.9 289.4 142.5 273.5 69.3 67.8 62.3 153.1 35.6 96.6 71.2 69.3 72.5 53.7 156.3 93.9 49.8 25.3 89.2 138.0 193.6 41.2 54.6 76.7 126.3 151.6 116.7 172.1 82.9 28.9 111.7 172.4 151.2 166.2 161.3 212.8 149.3 145.0 112.0 99.6 170.6 211.8 123.7 245.4 POGK "BASS2, KIAA15131, KRBOX2, LST003" ENSG00000143157 "Pogo transposable element derived with KRAB domain" Q9P215 1 166839447-166856359 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007838, HPA031630, HPA075919" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: " "unprognostic (3.48e-2)" "unprognostic (2.03e-2)" "unprognostic (4.31e-2)" "unprognostic (3.18e-3)" "unprognostic (4.20e-2)" "unprognostic (2.59e-1)" "prognostic unfavorable (5.93e-4)" "unprognostic (4.85e-1)" "unprognostic (6.09e-2)" "unprognostic (1.02e-2)" "unprognostic (2.19e-2)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.22e-1)" "unprognostic (9.74e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" 11.3 9.1 33.8 13.5 38.4 11.0 14.2 32.4 39.2 14.9 25.0 12.3 9.5 15.7 10.9 14.7 11.9 11.2 10.5 30.4 30.8 13.9 11.1 19.5 13.5 34.2 36.5 17.3 13.7 19.5 8.3 14.1 34.8 10.5 13.7 26.5 11.6 13.0 6.8 18.8 11.3 15.2 34.2 14.3 14.0 6.3 34.7 12.3 11.7 9.5 16.9 17.5 11.5 43.4 33.4 27.4 29.5 36.5 30.5 25.2 17.1 22.6 22.7 28.1 21.2 21.0 27.4 37.3 33.1 23.3 23.8 32.6 37.1 29.7 25.6 46.3 25.4 14.9 25.2 15.0 26.0 52.8 39.7 19.2 46.1 31.7 44.9 24.8 25.4 33.9 51.0 24.3 27.0 15.7 33.0 13.2 48.5 38.5 32.2 37.2 16.5 32.9 29.4 79.4 38.4 46.5 32.1 43.6 41.7 43.5 41.7 48.3 24.1 29.7 29.7 23.9 41.2 34.2 47.7 47.8 16.7 25.9 28.7 2.2 6.0 5.1 4.7 7.5 5.1 6.7 4.6 5.1 7.8 3.9 4.2 4.6 0.8 7.5 9.0 3.7 4.3 4.9 33.8 38.4 32.4 39.2 30.4 30.8 34.2 36.5 34.8 34.2 34.7 43.4 11.7 54.5 19.5 12.4 20.2 21.9 26.2 13.0 18.8 30.7 17.8 12.8 10.1 11.5 19.4 12.9 10.4 10.8 15.3 9.8 1.9 16.9 2.8 9.8 19.9 16.0 9.0 5.9 14.7 16.3 12.3 15.4 13.3 15.2 24.1 23.4 15.0 13.4 16.0 48.8 15.7 11.9 4.1 20.1 17.5 1.6 10.8 18.7 8.8 8.4 21.6 16.5 10.3 23.1 27.8 15.0 11.9 18.0 11.6 31.9 9.2 7.3 11.1 29.5 13.1 19.8 17.1 1.0 3.3 25.4 24.0 9.0 13.7 7.8 15.6 28.0 POLM Tdt-N ENSG00000122678 "DNA polymerase mu" Q9NP87 7 44072062-44082530 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 63.0" "Lineage enriched" "Detected in all" 6 "granulocytes: 63.0" "Cell line enhanced" "Detected in all" "HBEC3-KT: 67.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058900, HPA066007" Approved Nucleoplasm NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA058900: AB_2683848, HPA066007: AB_2685595" "unprognostic (2.44e-2)" "unprognostic (8.18e-2)" "unprognostic (2.21e-3)" "unprognostic (3.93e-2)" "unprognostic (5.40e-2)" "unprognostic (1.83e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (3.91e-1)" "unprognostic (9.36e-2)" "unprognostic (8.26e-2)" "unprognostic (2.46e-3)" "unprognostic (6.31e-2)" "unprognostic (1.47e-1)" "unprognostic (2.87e-1)" "unprognostic (3.87e-3)" 8.0 5.9 4.0 4.4 4.0 4.5 7.8 4.4 4.1 8.8 4.0 6.6 5.6 6.1 3.7 8.4 6.4 4.4 7.5 3.5 3.7 10.2 9.7 5.9 7.6 4.4 5.2 8.9 8.5 4.4 6.0 2.8 4.5 8.4 3.4 4.3 7.5 6.7 7.9 8.9 9.0 3.5 3.9 13.1 9.1 3.8 5.1 9.8 10.5 4.9 7.2 7.6 7.8 4.0 1.8 2.5 2.6 5.8 3.6 4.2 7.5 6.1 6.2 4.5 2.5 3.2 4.2 18.1 5.6 4.7 5.5 5.3 2.7 67.0 2.6 6.3 6.0 2.3 2.8 1.1 4.8 5.8 7.7 6.1 6.0 3.7 4.4 8.6 8.1 18.5 2.7 9.2 3.8 4.1 10.5 4.7 5.4 5.5 14.2 9.6 1.6 7.3 4.7 2.9 2.7 4.8 2.9 11.3 5.6 4.0 6.7 10.2 5.7 3.1 4.4 3.2 8.6 14.1 7.5 13.9 5.6 5.2 6.9 23.9 3.5 10.7 6.3 4.3 6.5 7.9 5.5 5.6 3.3 11.1 7.9 6.3 63.0 7.4 3.3 9.5 5.8 2.9 4.0 4.0 4.4 4.1 3.5 3.7 4.4 5.2 4.5 3.9 5.1 4.0 8.3 3.2 7.8 13.1 33.4 4.5 11.2 8.3 11.4 24.5 10.3 6.2 5.6 15.7 11.4 12.9 29.2 12.3 19.9 11.1 1.9 7.6 0.6 5.0 7.1 8.7 5.4 3.0 4.0 9.4 9.4 7.1 27.5 6.0 24.1 11.1 12.5 9.2 10.2 18.5 4.3 8.5 10.2 11.1 5.0 0.7 14.0 9.9 10.6 6.5 14.4 11.9 23.7 3.5 5.7 8.3 22.5 10.1 15.6 16.6 19.4 5.6 7.4 48.3 0.0 6.9 9.0 17.5 14.3 6.5 5.1 9.7 18.8 13.5 12.1 15.0 POLR2B RPB2 ENSG00000047315 "RNA polymerase II subunit B" P30876 4 56977722-57031158 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037506 Approved Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA037506: AB_10672597" "unprognostic (9.88e-3)" "unprognostic (4.38e-2)" "unprognostic (1.83e-3)" "unprognostic (7.51e-2)" "unprognostic (2.30e-2)" "unprognostic (4.21e-3)" "unprognostic (1.24e-3)" "unprognostic (3.51e-1)" "unprognostic (6.39e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-1)" "unprognostic (1.95e-1)" "prognostic favorable (7.17e-4)" "unprognostic (1.91e-1)" "unprognostic (1.51e-1)" "unprognostic (3.43e-1)" "unprognostic (7.35e-2)" 28.2 29.1 11.8 38.3 14.0 34.1 34.1 21.0 17.6 32.9 16.9 34.7 32.6 34.9 26.5 30.0 32.9 30.2 48.1 14.2 16.0 35.7 30.0 27.7 49.9 14.1 11.8 31.6 28.3 50.3 17.8 32.9 15.4 32.5 36.3 36.8 30.6 32.4 64.7 28.0 30.9 38.3 12.8 36.5 31.1 39.8 12.8 61.2 37.6 56.7 51.3 42.4 19.8 17.6 78.9 64.3 110.5 98.2 89.3 80.3 61.2 94.6 101.3 98.3 91.1 82.9 80.1 126.5 86.1 94.3 71.4 52.2 140.5 77.2 139.8 54.2 66.3 96.9 70.0 71.5 102.2 156.0 100.6 86.8 76.1 114.3 68.5 81.0 119.5 95.0 145.4 100.0 115.9 56.8 142.3 60.5 92.0 101.5 77.9 105.9 75.7 68.4 66.8 90.7 95.3 106.8 67.5 120.3 89.6 90.7 65.8 88.3 91.2 74.4 95.2 75.8 132.2 77.3 75.5 172.8 82.4 83.1 92.4 51.9 17.0 22.8 27.7 17.0 29.5 27.9 26.6 28.8 22.2 18.9 25.9 30.8 14.4 26.5 19.8 17.6 30.9 19.8 11.8 14.0 21.0 17.6 14.2 16.0 14.1 11.8 15.4 12.8 12.8 17.6 39.5 28.9 52.0 26.8 61.5 41.3 60.9 60.3 39.9 45.5 31.5 26.5 35.7 35.8 56.3 36.8 43.8 49.2 77.1 36.9 19.6 60.9 5.9 53.4 52.7 39.5 29.9 50.5 31.1 55.0 30.7 42.8 59.1 45.8 58.2 36.8 30.7 30.8 29.1 45.4 32.0 36.9 50.8 45.8 36.8 8.8 57.5 42.5 44.4 33.7 74.3 26.7 115.4 23.6 40.4 54.0 36.2 38.0 50.5 59.4 36.6 32.7 80.6 49.0 72.3 46.5 45.7 74.0 63.6 32.7 39.9 41.0 75.2 46.2 35.4 74.6 POLR2J2 RPB11b1 ENSG00000228049 "RNA polymerase II subunit J2" Q9GZM3 7 102665368-102671629 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 5.3" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 20.0;RT4: 14.0;U-2 OS: 13.6" HPA046970 Approved Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA046970: AB_2679882" 1.7 1.9 0.5 3.8 0.7 2.2 2.5 0.8 5.3 2.2 0.3 2.4 3.1 1.8 2.3 3.1 1.7 2.7 1.8 0.7 0.0 2.9 2.6 2.6 3.1 0.6 0.2 2.3 3.0 3.3 2.4 1.2 1.1 2.4 1.8 4.1 2.3 1.1 4.7 3.8 4.5 0.6 0.0 4.7 2.5 1.4 1.0 1.2 3.1 1.0 4.3 1.9 2.6 1.3 2.7 2.2 1.6 1.9 3.5 5.0 3.1 3.0 0.7 1.7 1.8 1.8 5.4 2.8 0.5 2.0 1.0 2.5 1.1 0.8 4.8 2.0 3.1 1.5 4.0 1.1 1.7 6.5 2.8 0.9 0.5 1.3 2.6 0.8 0.7 1.7 2.9 6.9 1.3 1.0 20.0 2.0 1.2 0.9 0.6 2.5 0.5 2.5 1.1 14.0 1.5 1.8 2.5 1.4 1.2 2.4 0.8 1.0 1.1 3.9 13.6 0.6 2.3 3.1 2.4 2.4 1.8 2.8 1.4 11.0 2.8 2.2 3.9 1.6 2.6 4.1 4.0 2.9 1.3 5.2 4.3 3.3 2.2 2.2 2.5 4.3 2.6 1.0 0.5 0.7 0.8 5.3 0.7 0.0 0.6 0.2 1.1 0.0 1.0 1.3 2.0 6.4 2.6 8.1 4.6 1.7 4.0 1.6 0.6 6.9 2.1 1.5 0.0 5.7 1.1 9.2 10.4 6.9 8.8 2.2 5.9 4.4 0.1 1.2 2.4 3.8 3.6 5.7 15.9 0.8 4.2 2.5 4.6 1.3 1.3 5.6 6.4 2.2 3.6 5.0 12.9 2.7 4.1 5.9 1.5 0.4 9.0 3.6 0.0 6.5 7.5 2.4 15.5 9.5 10.0 1.6 1.2 3.4 2.9 2.3 8.5 4.0 2.5 11.9 0.0 5.4 3.1 8.2 11.9 0.5 1.3 7.8 4.8 5.4 2.0 3.4 POLR2J3 ENSG00000285437 "RNA polymerase II subunit J3" 7 102562133-102572583 "Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 84.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 243.5;Cone photoreceptor cells: 354.5;Rod photoreceptor cells: 343.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046970 Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA046970: AB_2679882" 9.7 16.7 21.2 16.0 18.9 37.8 11.5 28.4 74.7 2.1 15.3 26.2 15.8 18.2 22.0 14.0 3.5 8.0 3.4 21.3 24.8 18.4 19.8 8.0 15.9 26.0 21.1 11.5 7.2 17.7 8.6 18.5 8.6 14.7 44.3 5.2 8.1 84.7 15.6 14.3 4.0 11.2 16.6 12.8 12.2 22.3 34.6 8.1 40.6 11.9 12.9 25.6 49.6 6.2 67.8 60.6 3.3 13.7 26.1 68.1 2.6 14.4 4.2 22.9 37.9 22.2 32.4 11.9 35.0 31.0 8.9 16.7 44.1 2.9 10.5 52.2 90.5 69.1 9.4 89.4 49.4 15.1 19.6 7.7 5.7 38.7 19.8 40.9 46.4 128.3 6.2 25.0 126.1 38.9 20.6 62.5 1.9 58.7 60.9 64.4 19.4 62.0 32.5 48.6 53.6 53.1 53.2 76.1 20.7 50.0 21.3 89.9 40.8 79.2 56.0 57.5 93.7 143.0 49.7 60.0 55.4 41.9 24.9 36.9 20.6 22.4 18.8 29.4 27.0 23.8 22.2 25.3 23.1 22.5 24.9 20.9 33.1 33.7 27.9 22.6 21.2 18.9 28.4 74.7 21.3 24.8 26.0 21.1 18.5 11.2 22.3 25.6 2.6 6.4 2.6 49.0 58.0 12.2 97.8 32.5 21.6 243.5 4.0 1.3 15.9 105.8 19.9 7.3 354.5 0.0 63.3 55.3 1.9 0.4 8.3 2.2 2.4 43.1 58.4 65.0 43.4 0.4 0.0 23.6 46.9 1.9 13.4 0.3 137.0 43.9 0.0 178.4 40.4 44.1 26.4 85.9 19.0 11.2 90.7 24.6 24.9 30.0 58.9 53.0 178.2 29.1 35.6 0.9 46.5 51.6 25.7 69.3 79.3 3.5 16.6 343.4 26.3 97.3 33.9 84.4 111.1 22.3 14.8 0.0 59.1 0.4 42.5 105.0 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320883 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.5" "Cell type enhanced" "Detected in many" "Astrocytes: 27.1;Oligodendrocytes: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 43: Testis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 5.8 12.4 13.2 4.1 14.9 2.5 5.7 13.5 13.4 8.0 12.5 6.7 2.6 6.7 9.8 5.5 5.8 4.0 7.9 12.7 13.1 10.8 9.3 5.6 1.8 14.6 14.6 6.1 8.8 8.6 12.6 7.0 13.4 7.8 3.3 5.6 6.3 6.9 19.1 4.7 4.9 4.6 13.7 5.6 5.9 37.5 14.4 2.9 10.9 8.4 1.9 7.9 5.3 15.4 15.6 19.4 18.6 21.1 13.0 10.3 14.8 13.4 10.8 19.3 16.6 9.6 13.6 4.6 10.6 12.6 27.1 17.1 8.8 13.3 13.5 6.9 12.1 2.8 8.9 7.9 15.8 3.2 8.9 10.5 13.9 18.3 17.8 13.6 11.5 4.5 7.4 10.5 13.0 30.7 5.4 15.0 5.3 21.4 16.2 5.3 18.0 4.1 20.4 11.3 15.6 15.2 8.7 14.6 11.3 12.0 15.1 6.5 9.6 14.6 22.8 17.1 12.0 6.8 14.5 2.1 7.4 4.8 13.2 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.1 13.2 14.9 13.5 13.4 12.7 13.1 14.6 14.6 13.4 13.7 14.4 15.4 3.2 6.4 2.8 27.1 2.0 3.1 2.7 3.4 2.8 7.5 7.2 7.6 4.3 4.3 1.6 1.8 16.7 6.0 1.2 6.5 0.0 7.6 14.3 5.8 6.7 3.1 18.0 0.0 12.9 7.5 10.2 6.1 4.1 7.0 2.5 6.4 2.5 5.7 5.5 8.4 14.5 3.2 2.0 2.2 2.6 17.2 1.8 2.4 1.8 9.4 2.3 5.9 0.0 20.1 30.5 5.5 3.2 4.1 2.1 5.2 2.5 3.6 5.1 15.1 0.0 6.2 5.0 11.3 8.2 5.2 1.8 5.7 1.2 13.9 3.6 1.9 PPP1R3E FLJ00089 ENSG00000235194 "Protein phosphatase 1 regulatory subunit 3E" Q9H7J1 14 23295652-23302859 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 47.0" "Cell type enhanced" "Detected in all" "Early spermatids: 111.9;Late spermatids: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 41.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061600 Approved Approved "Microtubules,Mitotic spindle,Mitochondria" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Microtubules, Mitochondria" "Mitotic spindle" "HPA061600: AB_2684566" "unprognostic (3.45e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.89e-5)" "unprognostic (4.05e-1)" "unprognostic (2.85e-2)" "unprognostic (1.29e-2)" "unprognostic (7.12e-2)" "prognostic favorable (3.10e-4)" "unprognostic (1.73e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-3)" "unprognostic (2.41e-1)" "unprognostic (8.67e-3)" "unprognostic (8.46e-2)" "unprognostic (2.88e-1)" "unprognostic (8.12e-2)" "unprognostic (5.46e-2)" 5.8 8.0 15.2 5.7 17.9 3.9 6.4 17.9 23.8 10.2 9.7 7.4 6.3 6.4 10.1 6.0 9.5 3.3 6.2 15.0 15.3 11.6 11.2 5.7 9.5 18.5 16.5 12.5 10.6 5.7 19.3 2.7 19.4 12.1 5.9 47.0 8.5 6.2 14.9 10.9 13.3 3.4 13.8 15.1 9.0 14.7 17.7 8.2 14.9 5.4 8.2 7.9 8.5 23.3 1.1 3.0 3.6 2.5 6.9 2.9 1.7 1.2 2.2 2.0 1.7 1.7 5.8 11.2 0.8 1.6 2.2 7.6 2.1 1.2 2.5 4.0 2.1 2.0 6.9 4.0 1.8 2.3 4.4 2.5 4.5 1.2 6.1 3.3 0.9 6.0 1.9 9.8 1.7 2.6 2.1 3.6 0.9 3.6 2.8 3.4 2.5 7.2 1.1 2.5 4.5 1.2 1.8 1.6 1.2 1.8 1.9 0.8 1.7 2.4 1.3 4.1 0.9 41.1 4.6 5.1 1.9 4.0 1.5 0.2 0.4 0.2 0.5 1.4 0.6 1.0 0.1 0.2 0.3 0.6 0.5 0.3 0.4 0.2 1.8 0.3 0.4 0.3 15.2 17.9 17.9 23.8 15.0 15.3 18.5 16.5 19.4 13.8 17.7 23.3 5.8 3.2 4.8 30.0 25.4 5.6 9.0 5.3 11.4 59.4 7.8 11.6 8.8 7.2 5.0 20.2 37.5 8.2 12.8 8.0 5.9 2.1 111.9 3.7 6.6 7.2 8.4 7.2 25.0 3.3 2.0 6.1 20.4 4.3 3.8 9.4 7.5 7.2 7.4 32.0 33.0 7.7 4.1 9.5 9.6 62.9 27.4 9.2 10.6 15.9 8.1 20.4 26.8 16.1 56.1 2.4 11.6 25.9 11.9 6.7 19.5 9.5 4.8 38.1 13.1 3.5 5.4 36.5 13.9 8.4 9.1 5.2 15.7 7.2 9.6 8.6 PPP2R2D "B55D, B55delta, MDS026" ENSG00000175470 "Protein phosphatase 2 regulatory subunit Bdelta" Q66LE6 10 131901008-131959834 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042122, HPA042770" Approved Approved Cytosol NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (7.75e-3)" "unprognostic (7.11e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.40e-1)" "unprognostic (3.57e-1)" "unprognostic (9.64e-3)" "unprognostic (1.83e-1)" "unprognostic (3.13e-2)" "unprognostic (1.76e-2)" "unprognostic (8.74e-2)" "unprognostic (8.46e-2)" "unprognostic (8.04e-2)" "unprognostic (4.41e-3)" "unprognostic (1.10e-1)" "unprognostic (6.57e-2)" "unprognostic (6.66e-2)" "unprognostic (1.90e-2)" 1.5 3.0 4.5 1.2 5.4 0.0 1.4 7.0 5.8 2.1 3.8 2.8 2.1 1.6 2.0 1.6 1.6 1.6 3.3 4.9 4.1 1.8 1.6 2.3 2.4 4.1 4.1 3.6 15.9 3.2 2.3 1.9 4.1 1.8 1.9 2.8 3.3 1.9 2.8 2.7 2.4 1.3 3.6 1.8 2.1 1.3 4.6 1.7 2.2 2.9 1.5 2.3 1.9 4.9 4.4 3.8 2.4 1.8 3.3 2.6 3.4 1.5 3.1 2.9 3.1 3.1 3.6 1.8 1.0 1.8 1.8 7.9 3.2 0.7 3.1 4.5 4.2 3.0 3.7 1.8 1.1 3.2 3.4 0.9 6.7 3.2 4.5 4.6 2.0 2.6 3.9 0.8 3.2 2.1 1.5 7.3 1.5 1.5 3.4 2.0 1.6 0.5 2.3 0.6 1.9 2.6 1.9 1.6 1.8 2.5 1.4 2.4 2.8 1.6 0.7 2.3 8.1 2.8 1.6 2.3 1.4 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 5.4 7.0 5.8 4.9 4.1 4.1 4.1 4.1 3.6 4.6 4.9 26.8 19.2 14.3 22.2 20.0 37.3 37.4 6.4 20.5 55.0 25.8 23.6 36.3 14.3 10.2 9.2 10.4 10.6 36.1 27.6 19.6 9.8 12.7 21.5 24.8 19.0 10.7 18.7 43.0 17.7 13.6 21.8 19.9 32.3 6.3 33.1 13.2 23.2 14.1 52.2 37.5 18.2 8.2 12.0 17.6 6.4 17.4 23.3 12.4 26.2 10.5 28.3 18.6 29.7 38.1 16.8 18.0 20.7 20.3 39.1 20.0 29.6 5.7 32.6 26.3 29.2 23.2 14.3 20.1 18.8 34.0 11.8 24.4 39.5 19.1 39.6 PRKACA PKACa ENSG00000072062 "Protein kinase cAMP-activated catalytic subunit alpha" P17612 19 14091688-14118084 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cushing syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 310.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 116.8;Theca cells: 100.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010361, HPA071185" Approved Approved "Cytokinetic bridge,Cytosol" Yes NA 170000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 52: Non-specific - Transcription" Cytosol "Cytokinetic bridge" "CAB010361: AB_2268772, HPA071185: AB_2686356" "unprognostic (1.08e-1)" "prognostic favorable (6.28e-6)" "unprognostic (2.09e-2)" "prognostic unfavorable (6.26e-5)" "unprognostic (1.38e-2)" "unprognostic (2.95e-1)" "unprognostic (1.64e-1)" "unprognostic (9.36e-3)" "unprognostic (7.01e-2)" "unprognostic (3.41e-1)" "prognostic favorable (6.47e-4)" "unprognostic (2.86e-1)" "unprognostic (1.17e-1)" "unprognostic (4.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.66e-2)" "unprognostic (6.14e-3)" 62.7 126.5 46.6 27.6 47.6 18.9 53.9 39.9 64.2 53.2 29.5 59.0 20.9 56.9 28.5 41.8 53.7 14.2 204.8 49.2 53.3 35.4 78.4 46.1 15.9 56.8 54.5 94.1 34.0 21.6 71.2 17.3 55.3 41.2 13.0 25.2 42.3 20.8 310.9 42.3 36.3 21.8 40.7 71.6 40.2 57.2 50.3 18.2 39.6 122.1 13.4 50.6 44.2 46.6 37.5 16.3 40.3 74.4 36.2 30.8 9.9 30.5 23.6 32.7 27.5 21.6 15.0 13.8 26.2 49.2 22.9 25.4 26.7 26.6 32.3 23.1 17.7 27.7 20.6 24.4 36.8 21.9 33.5 33.8 18.1 30.0 11.1 26.6 29.7 19.0 29.1 47.3 36.7 48.1 46.3 31.9 21.5 38.7 45.0 38.0 47.8 36.7 41.7 13.5 36.5 24.2 34.2 31.3 23.8 18.1 37.2 26.5 37.7 71.7 20.3 100.7 39.6 31.9 24.9 23.6 49.6 28.0 32.7 0.1 1.5 0.2 0.8 2.7 0.3 0.8 0.3 0.5 1.1 0.5 0.5 0.7 3.2 0.4 2.5 0.6 0.3 0.6 46.6 47.6 39.9 64.2 49.2 53.3 56.8 54.5 55.3 40.7 50.3 46.6 39.5 6.4 3.4 9.4 7.0 8.8 6.8 6.4 2.2 42.2 19.2 19.0 116.8 22.8 4.7 14.7 27.1 6.9 9.0 24.6 7.9 12.4 32.4 11.7 22.9 26.7 17.5 2.5 16.9 19.1 5.7 22.6 8.6 12.9 0.0 15.9 26.4 39.7 34.5 3.3 21.6 11.8 2.0 49.4 50.8 15.7 49.0 37.1 14.2 9.4 37.8 26.1 9.2 10.1 10.7 15.6 11.6 51.9 3.3 6.4 20.7 11.8 7.0 23.9 19.7 23.3 23.5 26.4 6.9 10.1 11.2 8.1 10.0 100.6 14.4 6.6 PROK1 "EGVEGF, PK1, PRK1" ENSG00000143125 "Prokineticin 1" P58294 1 110451149-110457358 "Predicted secreted proteins" Angiogenesis "Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ovary: 197.1;placenta: 50.2;testis: 59.1" "Group enriched" "Detected in some" 8 "Leydig cells: 173.1;Peritubular cells: 668.0" "Cancer enhanced" "Detected in many" "testis cancer: 4.7" "Region enhanced" "Detected in many" "medulla oblongata: 5.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "ASC diff: 22.6" "Region enriched" "Detected in single" 11 "pons and medulla: 1.4" "Low region specificity" "Detected in many" "Secreted to blood" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "unprognostic (2.66e-1)" "unprognostic (2.71e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.26e-1)" "unprognostic (1.86e-1)" "unprognostic (3.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.24e-2)" "unprognostic (3.74e-2)" "unprognostic (7.39e-3)" "unprognostic (1.90e-1)" "unprognostic (2.61e-1)" "unprognostic (2.38e-1)" 4.0 9.8 0.4 0.4 0.3 0.0 5.1 0.4 0.7 14.1 0.2 0.3 0.1 0.3 0.1 1.2 3.5 0.4 2.7 1.1 0.4 0.1 0.2 0.3 0.0 5.5 1.3 197.1 0.3 0.0 0.7 50.2 1.2 12.8 0.0 0.1 0.5 9.9 1.3 2.4 0.2 0.0 1.8 1.5 0.4 59.1 0.9 0.1 0.2 0.0 0.0 4.5 25.1 1.5 0.0 0.0 0.0 0.1 22.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.7 1.1 0.4 5.5 1.3 1.2 1.8 0.9 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.6 16.4 0.1 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.3 0.0 1.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 23.4 173.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 668.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.7 1.1 0.0 0.0 1.0 0.1 52.3 0.0 0.1 PRPF4B "KIAA0536, PR4H, Prp4" ENSG00000112739 "Pre-mRNA processing factor 4B" Q13523 6 4021267-4064983 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020638 Approved Supported "Nuclear speckles" NA NA "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA020638: AB_1855774" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (4.95e-2)" "unprognostic (2.20e-1)" "unprognostic (3.59e-3)" "unprognostic (1.21e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (8.68e-3)" "unprognostic (3.41e-2)" "unprognostic (4.45e-3)" "unprognostic (2.17e-1)" "unprognostic (1.07e-1)" "unprognostic (9.50e-3)" "unprognostic (8.90e-2)" "unprognostic (2.34e-1)" "unprognostic (7.63e-3)" "prognostic favorable (6.82e-5)" 9.1 7.2 4.8 11.3 5.4 27.3 8.1 7.5 6.7 5.8 5.2 8.6 10.2 9.9 10.1 8.4 4.4 6.1 5.0 4.7 5.1 4.2 4.3 6.8 14.2 5.4 5.5 8.4 6.8 4.2 3.3 7.6 5.3 6.3 8.6 15.9 8.4 5.5 16.3 13.3 9.0 5.6 4.9 11.2 8.1 3.8 5.5 8.8 6.5 4.5 10.0 6.7 7.0 6.9 6.0 3.9 14.4 12.1 8.3 7.3 12.3 7.7 3.4 4.7 5.2 6.9 7.1 8.1 5.7 5.1 4.8 12.8 10.1 6.8 7.1 4.4 11.1 6.7 19.1 11.5 3.6 11.2 10.6 5.7 6.9 5.4 6.6 11.0 5.1 6.5 11.6 3.1 7.4 2.7 7.2 26.3 6.0 3.8 4.3 9.9 6.1 11.2 8.4 10.2 7.9 7.3 4.7 3.9 5.5 16.9 9.6 7.9 7.3 11.2 6.5 4.3 8.2 7.5 7.9 6.9 3.2 7.6 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 5.4 7.5 6.7 4.7 5.1 5.4 5.5 5.3 4.9 5.5 6.9 122.4 109.0 103.2 35.6 110.5 83.5 64.0 43.1 69.4 88.6 80.4 49.5 79.1 61.5 75.1 97.5 89.6 61.8 151.3 94.9 72.4 64.4 15.6 115.9 143.5 85.8 75.3 79.1 42.8 56.8 49.9 78.7 88.2 113.4 90.5 96.2 61.1 85.8 41.1 106.0 49.8 88.8 50.8 71.6 49.4 20.6 98.8 71.4 35.6 49.6 97.4 81.2 118.4 50.8 68.1 62.8 61.5 89.1 101.9 62.8 55.5 89.5 71.7 184.0 59.2 105.3 85.8 66.1 76.5 66.7 91.4 63.6 106.2 93.1 87.7 65.2 PRPF6 "ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K" ENSG00000101161 "Pre-mRNA processing factor 6" O94906 20 63981132-64033100 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047106 Supported Supported "Nuclear speckles" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA047106: AB_10963084" "unprognostic (1.29e-1)" "unprognostic (9.96e-3)" "unprognostic (7.02e-2)" "unprognostic (9.36e-3)" "unprognostic (1.80e-1)" "unprognostic (2.34e-1)" "unprognostic (1.66e-3)" "unprognostic (3.37e-2)" "unprognostic (1.44e-2)" "unprognostic (1.14e-1)" "unprognostic (5.76e-3)" "unprognostic (2.18e-1)" "unprognostic (3.16e-3)" "unprognostic (6.16e-2)" "unprognostic (8.04e-2)" "unprognostic (7.19e-2)" "unprognostic (5.39e-3)" 44.0 32.2 33.6 30.8 37.4 33.3 40.1 44.9 37.1 38.5 34.5 39.9 30.0 43.5 27.9 38.9 49.3 27.2 39.0 32.9 34.7 35.3 29.8 32.1 40.9 37.7 35.5 50.6 44.2 37.2 36.7 30.9 37.1 34.5 25.9 36.4 38.3 36.4 64.6 58.3 38.1 29.7 34.6 40.9 37.3 41.0 35.5 44.4 36.2 37.1 40.5 40.5 36.2 46.8 72.8 86.5 62.3 66.3 69.5 48.6 81.5 56.1 62.8 167.9 74.6 233.6 86.2 90.9 133.4 74.5 107.1 110.0 101.2 116.1 88.7 44.0 59.0 76.8 112.7 213.3 76.7 105.3 102.3 55.2 81.4 77.5 89.2 59.9 63.3 83.7 76.2 76.6 56.8 89.2 106.8 131.0 55.4 114.4 106.7 116.0 53.0 87.3 64.4 71.9 61.8 72.4 108.6 110.0 74.1 43.2 108.0 135.5 90.1 96.2 55.1 77.4 104.6 63.7 66.5 94.6 70.3 62.5 76.3 90.8 59.7 73.7 67.0 62.7 93.3 67.1 82.3 72.5 58.6 58.4 95.8 80.9 50.3 130.5 77.8 54.5 79.7 92.3 33.6 37.4 44.9 37.1 32.9 34.7 37.7 35.5 37.1 34.6 35.5 46.8 60.7 60.9 62.6 19.2 69.3 38.4 45.3 50.7 63.2 81.6 54.2 59.8 70.5 34.3 71.6 62.5 37.5 72.5 53.2 43.8 82.2 59.3 49.1 70.3 66.8 55.7 52.7 43.5 12.5 56.7 47.6 51.2 38.7 62.0 91.2 49.0 63.9 55.2 46.3 42.1 14.8 60.6 57.0 44.8 34.1 28.7 58.1 49.9 48.0 5.6 79.7 86.5 57.7 12.5 17.8 65.9 43.9 52.6 67.8 33.5 58.0 65.8 87.7 112.7 59.2 68.2 61.9 120.6 118.9 59.8 46.3 94.5 60.0 32.6 47.7 34.3 PRPS2 ENSG00000101911 "Phosphoribosyl pyrophosphate synthetase 2" P11908 X 12791355-12824222 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 147.8;parathyroid gland: 182.0" "Group enriched" "Detected in many" 7 "Leydig cells: 1431.5;Peritubular cells: 1995.0;Sertoli cells: 624.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051269, HPA067599, CAB070417" Enhanced Approved "Nuclear speckles,Vesicles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Vesicles "Nuclear speckles" "CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869" "unprognostic (7.50e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.09e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-2)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (4.75e-2)" "unprognostic (6.98e-2)" "unprognostic (2.64e-3)" "unprognostic (4.44e-3)" "unprognostic (1.81e-1)" "unprognostic (7.83e-2)" "unprognostic (2.20e-1)" "unprognostic (1.50e-1)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" 11.0 46.0 6.3 24.5 7.3 24.2 19.7 1.9 12.0 54.5 2.5 30.3 14.0 32.8 26.5 16.1 29.7 28.1 5.4 6.9 2.9 28.0 26.1 13.1 36.8 3.0 6.5 147.8 62.8 182.0 3.4 6.1 2.2 21.9 31.3 1.3 27.9 84.0 2.1 21.9 15.8 24.3 4.4 15.6 32.5 131.1 8.8 44.6 18.1 4.2 31.5 22.5 21.2 6.4 114.2 63.7 22.1 40.3 26.7 31.8 14.6 54.4 26.8 53.1 51.1 46.3 78.7 34.9 24.2 23.5 45.3 79.9 43.1 53.7 61.5 89.7 108.0 41.7 49.6 43.3 24.7 77.3 38.9 30.5 35.0 39.1 51.7 26.9 22.1 86.8 30.4 39.8 45.2 68.5 117.6 34.7 49.9 81.0 107.3 61.5 102.7 79.5 33.0 81.7 46.1 33.6 64.9 2.1 38.9 30.2 58.8 32.4 24.9 41.8 32.0 162.5 55.5 103.6 41.3 76.8 44.4 39.4 67.4 25.9 20.1 9.4 17.2 19.4 19.9 27.8 25.0 16.4 28.2 30.6 31.7 23.0 8.0 24.3 12.3 19.9 22.6 28.2 6.3 7.3 1.9 12.0 6.9 2.9 3.0 6.5 2.2 4.4 8.8 6.4 12.2 3.2 8.7 0.7 25.4 64.0 48.5 16.2 41.5 0.6 53.1 15.9 2.0 11.5 12.4 55.2 0.0 1.1 18.5 21.1 72.4 19.3 12.1 24.7 62.5 14.5 21.8 28.4 14.8 39.2 7.3 25.8 31.1 26.4 27.9 16.2 10.4 13.7 24.4 0.0 6.3 27.9 8.2 21.4 44.3 65.8 1431.5 20.7 40.9 3.7 18.2 1.2 18.6 3.5 5.1 24.6 17.4 1995.0 30.7 52.2 6.0 10.4 20.3 0.2 624.5 9.4 19.2 10.3 8.1 29.2 43.8 0.4 27.2 179.2 50.2 36.9 PRR14L "C22orf30, MGC50372" ENSG00000183530 "Proline rich 14 like" Q5THK1 22 31676256-31750140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062645 Uncertain Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA062645: AB_2684817" "unprognostic (2.87e-1)" "unprognostic (1.34e-1)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.42e-2)" "unprognostic (2.13e-1)" "unprognostic (1.37e-2)" "unprognostic (4.10e-2)" "unprognostic (8.86e-3)" "unprognostic (1.80e-1)" "unprognostic (2.10e-1)" "unprognostic (4.90e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.48e-2)" "unprognostic (4.14e-3)" 3.8 3.6 3.1 5.4 4.1 8.6 5.6 5.8 3.8 4.5 8.5 6.3 4.3 4.3 4.2 5.7 5.1 3.3 3.2 3.5 2.4 4.3 4.2 4.5 6.9 2.0 2.1 6.9 4.1 6.6 4.7 5.3 1.9 4.0 7.0 4.9 4.2 3.7 2.8 6.9 4.7 5.0 0.6 5.6 5.9 5.5 3.7 7.6 5.3 4.6 7.2 4.8 4.0 6.5 11.4 10.8 11.6 11.5 10.4 9.7 12.0 6.1 7.2 9.4 8.7 9.9 4.1 12.9 5.8 12.0 7.0 11.0 22.9 9.1 9.7 17.3 9.7 7.8 9.7 8.0 8.8 24.3 16.2 8.7 9.0 13.0 11.2 8.1 13.3 10.1 12.0 8.3 9.9 10.8 8.6 7.7 13.4 16.3 4.1 12.8 18.5 7.4 7.8 12.8 16.0 9.4 14.2 8.5 7.8 13.6 7.5 9.6 12.7 5.7 11.4 7.7 8.4 12.8 16.4 9.5 8.9 11.7 8.9 9.1 4.3 5.4 2.9 5.1 2.6 3.5 1.8 2.4 3.3 3.1 2.6 2.8 8.1 2.9 11.8 3.7 2.7 1.8 3.1 4.1 5.8 3.8 3.5 2.4 2.0 2.1 1.9 0.6 3.7 6.5 18.1 22.4 20.3 31.0 18.1 7.5 13.4 18.5 16.5 11.9 16.0 12.3 22.2 10.0 28.7 11.0 20.9 19.0 21.1 29.5 9.8 19.3 7.4 25.9 27.3 16.2 10.2 14.3 48.0 17.1 14.2 15.6 25.0 24.4 26.6 56.6 11.7 18.4 14.6 15.2 38.8 19.4 10.2 21.3 9.2 5.9 14.9 21.2 1.8 35.6 24.7 12.1 20.6 21.6 46.7 24.6 13.9 8.2 12.4 19.3 20.3 11.9 23.2 11.7 13.1 21.9 15.6 14.0 18.4 19.9 9.7 22.2 14.4 27.9 18.5 20.3 PRRC2C "BAT2D1, BAT2L2, KIAA1096, XTP2" ENSG00000117523 "Proline rich coiled-coil 2C" Q9Y520 1 171485551-171593511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025766, HPA028659" Approved Enhanced Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA025766: AB_1845277, HPA028659: AB_10600786" "unprognostic (4.16e-1)" "unprognostic (2.40e-2)" "unprognostic (6.66e-3)" "unprognostic (8.71e-2)" "unprognostic (6.07e-3)" "unprognostic (1.85e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-2)" "unprognostic (2.28e-1)" "unprognostic (8.19e-3)" "unprognostic (5.56e-2)" "prognostic unfavorable (7.76e-6)" "unprognostic (7.03e-2)" "unprognostic (2.62e-1)" "unprognostic (1.82e-1)" "unprognostic (4.34e-2)" 30.9 21.0 26.8 33.3 25.8 72.5 32.7 32.1 35.0 34.0 19.0 27.0 21.6 30.2 37.5 36.7 29.7 26.2 22.7 22.9 34.2 28.8 31.1 35.8 44.8 27.5 27.1 34.3 28.9 33.8 25.7 34.2 27.6 28.2 31.9 34.5 30.3 27.1 25.7 39.7 34.0 25.4 20.3 36.0 28.9 29.3 26.4 49.6 27.8 23.7 43.4 38.5 34.4 30.7 84.9 64.3 88.1 58.4 61.0 70.5 65.2 47.8 67.7 54.8 49.7 99.1 59.0 123.9 73.1 70.4 44.3 73.8 96.5 76.1 83.8 70.1 51.4 94.2 51.2 69.5 63.3 154.4 73.8 68.6 57.1 92.7 137.3 49.3 80.9 66.6 126.8 66.6 63.0 40.3 92.8 65.2 116.8 67.5 110.5 69.3 65.5 60.7 77.8 93.3 56.7 58.3 72.6 85.4 56.0 115.8 58.2 107.0 101.6 61.9 57.0 60.7 100.4 55.5 63.4 175.3 39.4 74.7 56.7 2.2 1.3 0.7 1.3 1.2 1.3 1.7 1.2 1.2 0.6 2.0 1.1 1.3 3.4 2.5 1.4 2.0 1.0 0.6 26.8 25.8 32.1 35.0 22.9 34.2 27.5 27.1 27.6 20.3 26.4 30.7 233.8 298.1 224.7 81.0 272.5 167.0 270.8 107.5 198.6 164.6 105.4 104.6 115.7 133.0 198.3 86.5 139.7 204.0 325.0 190.0 25.4 174.0 63.9 228.0 246.7 214.5 165.1 139.0 101.5 151.3 210.1 189.1 157.0 378.3 263.2 132.8 130.3 119.0 128.9 138.0 108.6 162.3 57.0 142.8 183.0 36.5 139.1 211.0 96.0 91.8 227.9 120.4 269.8 87.9 143.2 223.1 145.2 96.3 281.8 294.3 99.6 40.1 132.1 170.4 78.9 218.1 184.2 247.7 160.8 178.0 145.9 476.8 317.3 178.5 168.5 335.5 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952408 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.6;fallopian tube: 7.6;parathyroid gland: 15.3;pituitary gland: 11.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 17.2;MCF7: 23.1;SK-BR-3: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 83000 "Cluster 32: T-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Plasma membrane" Nucleoplasm "HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 0.9 1.8 3.9 1.1 5.0 1.5 1.2 10.1 11.6 1.3 0.3 1.3 0.4 1.2 1.2 1.2 7.6 1.1 1.1 4.4 1.1 1.3 0.4 0.9 1.2 5.1 1.9 1.3 1.8 15.3 11.0 0.3 5.3 2.5 0.3 2.2 2.3 1.7 1.4 2.3 0.9 0.9 0.0 0.9 1.1 2.1 3.6 1.3 2.2 0.2 1.3 1.8 1.1 4.8 0.4 1.0 3.6 4.7 17.2 2.3 1.2 1.8 3.4 2.0 4.5 0.3 3.4 2.0 0.4 4.2 2.1 0.3 1.3 4.5 0.9 9.8 2.0 0.7 1.9 0.2 1.7 0.4 1.7 4.4 0.3 1.7 0.7 9.7 0.8 6.0 1.0 4.7 2.5 23.1 4.4 0.4 8.5 0.1 2.1 2.8 0.4 1.9 1.0 0.4 6.6 4.4 1.8 33.6 0.7 1.4 9.1 0.4 0.7 0.4 4.6 0.9 1.3 6.1 6.6 0.6 10.9 0.3 1.3 0.5 0.2 0.2 1.2 0.1 1.4 0.5 1.3 1.2 0.0 0.6 1.4 1.3 0.3 0.7 0.1 0.6 0.2 0.4 3.9 5.0 10.1 11.6 4.4 1.1 5.1 1.9 5.3 0.0 3.6 4.8 3.3 0.0 2.0 3.9 2.9 2.7 3.8 3.7 3.4 22.8 7.4 6.2 3.0 7.2 3.4 11.0 14.6 0.7 4.4 4.5 3.9 2.9 4.3 5.0 5.4 3.3 11.3 2.1 14.7 5.0 0.5 5.2 5.6 4.9 1.3 7.9 2.2 2.9 3.8 15.2 10.8 5.4 2.0 2.5 2.6 3.5 5.6 2.2 1.8 2.8 11.3 8.6 11.3 5.5 3.7 3.1 1.0 2.6 2.2 4.2 6.4 8.0 12.4 21.6 0.0 7.2 5.3 10.4 6.4 3.4 2.3 0.4 5.6 7.8 4.7 3.0 PSIP1 "DFS70, LEDGF, p52, p75, PSIP2" ENSG00000164985 "PC4 and SFRS1 interacting protein 1" O75475 9 15464066-15510995 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 279.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 860.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013718, HPA019697" Enhanced Enhanced Nucleoplasm NA NA 24000 "Cluster 26: Non-specific - Mitochondria" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB013718: , HPA019697: AB_1852779" "unprognostic (8.54e-2)" "unprognostic (3.70e-2)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (2.89e-3)" "unprognostic (5.10e-2)" "unprognostic (5.93e-2)" "unprognostic (2.53e-2)" "unprognostic (6.49e-3)" "unprognostic (5.49e-2)" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (2.99e-1)" "unprognostic (7.14e-2)" "unprognostic (1.39e-1)" 32.9 40.9 67.8 46.9 72.1 62.0 27.4 83.9 89.1 45.8 52.6 40.8 23.1 57.5 36.0 26.2 42.9 30.8 34.4 71.5 79.2 32.6 22.3 32.8 80.7 65.2 66.4 86.0 17.1 30.3 52.2 39.5 64.4 36.3 30.9 154.4 19.1 41.0 38.6 26.0 34.4 43.2 65.1 54.7 28.5 81.6 68.1 129.7 37.1 29.5 69.3 31.2 32.3 72.2 117.5 76.5 254.7 187.4 54.0 65.2 56.7 138.3 98.1 121.7 143.6 32.1 59.5 248.1 31.4 73.5 68.2 32.0 160.1 75.0 174.9 164.8 96.6 860.4 194.9 60.8 65.1 101.7 91.7 54.8 21.0 102.1 74.4 121.0 108.0 115.2 144.4 134.1 80.2 42.8 211.5 250.9 395.2 2.7 117.2 194.7 138.8 50.7 68.3 40.5 161.1 176.7 123.7 54.0 67.1 157.5 54.5 134.9 76.7 88.0 88.6 66.7 133.2 57.1 85.3 221.8 70.2 100.8 51.6 13.7 2.6 5.4 6.1 2.0 7.7 11.0 12.5 8.8 3.0 17.5 18.7 11.6 8.4 9.5 5.7 3.1 12.9 2.4 67.8 72.1 83.9 89.1 71.5 79.2 65.2 66.4 64.4 65.1 68.1 72.2 93.7 54.5 31.9 27.4 98.1 31.9 49.1 8.1 48.9 231.0 22.0 35.6 57.8 31.5 23.1 47.8 66.7 122.7 82.1 24.7 62.6 9.5 95.5 92.9 62.5 84.8 38.1 160.1 73.4 8.5 76.2 74.8 23.0 35.1 15.2 104.2 65.3 18.0 32.1 138.0 76.9 34.1 2.0 36.5 45.9 58.5 125.9 45.8 40.9 20.6 47.9 162.2 83.4 49.8 67.6 3.6 20.6 134.3 60.4 19.6 14.1 54.5 42.1 279.1 124.9 85.2 89.8 217.9 243.8 34.5 21.2 41.3 111.6 68.6 45.8 20.3 PTAR1 ENSG00000188647 "Protein prenyltransferase alpha subunit repeat containing 1" Q7Z6K3 9 69709522-69760011 "Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021248 Uncertain Approved "Centriolar satellite,Rods & Rings" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 17: WM-115 - Nervous system development" "Cluster 52: Non-specific - Transcription" "Centriolar satellite" "Rods & Rings" "HPA021248: AB_1855872" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.18e-2)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-2)" "unprognostic (1.23e-1)" "unprognostic (9.47e-2)" "unprognostic (9.40e-2)" "unprognostic (1.71e-1)" "unprognostic (4.16e-1)" "unprognostic (6.99e-2)" "prognostic favorable (4.65e-4)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" 9.7 6.6 11.8 9.7 9.8 33.8 12.8 9.5 10.9 10.9 11.3 10.6 6.9 11.2 7.4 8.3 9.7 8.0 8.9 10.3 8.6 14.1 13.3 11.3 11.6 12.5 12.0 12.6 11.0 15.4 6.7 9.8 9.2 7.2 12.8 21.4 10.4 5.7 14.4 10.0 10.6 8.4 8.5 11.3 7.6 9.6 16.1 20.1 10.0 11.7 8.9 9.2 10.8 13.5 11.8 11.9 18.7 9.1 16.4 21.2 10.4 27.2 17.5 8.1 8.9 3.8 7.7 12.2 12.5 20.9 8.1 18.0 39.4 10.2 19.3 11.1 10.7 18.8 24.3 10.8 18.0 16.7 16.2 14.1 9.4 14.4 22.7 16.9 14.6 19.9 11.7 24.7 23.3 3.2 14.5 6.5 24.9 12.2 9.9 13.1 29.6 9.2 23.4 10.3 13.7 17.2 16.6 8.0 15.5 17.4 5.5 8.3 27.3 22.3 20.4 18.5 22.3 17.2 18.2 7.4 15.0 16.1 41.6 5.6 2.3 4.2 2.8 3.3 2.6 1.9 2.5 2.2 2.0 1.6 2.8 2.9 7.3 2.9 2.0 1.1 4.3 1.4 11.8 9.8 9.5 10.9 10.3 8.6 12.5 12.0 9.2 8.5 16.1 13.5 26.0 35.3 21.6 104.8 26.3 16.7 19.4 17.7 21.6 29.1 21.1 18.5 19.1 40.0 17.9 33.1 81.3 20.1 28.5 29.2 15.6 13.3 19.2 17.0 24.8 24.5 11.4 23.8 21.7 7.7 14.6 21.6 12.2 16.8 17.7 28.7 20.0 32.6 12.7 33.7 33.0 28.6 36.7 31.1 18.3 22.1 31.1 22.9 32.0 51.5 28.6 31.8 26.8 82.0 62.2 12.5 21.3 23.0 22.1 23.2 14.7 41.4 18.8 56.2 26.3 26.1 21.1 57.0 10.3 19.5 15.3 9.6 26.0 21.6 22.2 25.5 PTCD3 "DKFZp666K071, FLJ20758" ENSG00000132300 "Pentatricopeptide repeat domain 3" Q96EY7 2 86106223-86142157 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041154, HPA041382" Supported Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA041154: AB_10795488, HPA041382: AB_10795695" "unprognostic (1.16e-2)" "unprognostic (4.47e-2)" "unprognostic (1.37e-2)" "unprognostic (9.30e-3)" "unprognostic (2.40e-2)" "unprognostic (2.54e-1)" "unprognostic (4.92e-3)" "unprognostic (2.06e-2)" "unprognostic (4.78e-2)" "unprognostic (3.78e-1)" "unprognostic (7.42e-3)" "unprognostic (5.49e-3)" "unprognostic (1.26e-1)" "prognostic favorable (6.77e-4)" "unprognostic (3.69e-1)" "unprognostic (7.79e-2)" "prognostic favorable (6.86e-4)" 10.0 15.8 13.1 7.6 14.2 14.7 9.9 15.2 15.9 11.6 16.3 12.6 10.1 11.7 10.2 10.7 11.7 6.4 26.2 13.3 14.5 12.4 16.5 9.6 11.8 13.6 14.0 15.1 10.7 13.1 14.8 9.2 14.7 10.4 13.5 13.2 9.8 7.5 32.8 10.3 11.9 9.0 13.7 12.0 11.8 16.6 13.5 10.5 12.0 36.3 11.1 10.3 10.7 16.7 16.2 37.6 22.0 18.5 16.1 16.6 26.2 32.6 13.8 18.0 18.0 69.9 15.1 39.7 11.8 17.1 18.6 28.9 44.7 17.7 22.9 17.8 37.0 31.8 23.0 59.2 16.3 26.0 23.1 19.8 12.8 13.7 24.4 18.8 15.7 28.6 33.5 14.8 16.0 15.0 21.7 31.0 20.2 31.5 23.9 28.8 30.9 30.6 24.6 31.7 23.9 14.7 15.2 25.0 30.4 20.6 13.2 15.7 11.3 14.2 15.1 14.6 19.2 33.7 47.6 31.6 13.8 29.4 11.1 4.4 9.6 7.6 12.4 7.0 14.6 15.3 11.2 13.2 10.6 16.4 15.1 11.3 0.3 14.3 14.1 10.7 13.9 8.8 13.1 14.2 15.2 15.9 13.3 14.5 13.6 14.0 14.7 13.7 13.5 16.7 17.1 57.7 33.5 50.3 31.0 26.0 26.3 27.7 34.7 61.7 19.2 16.8 105.7 18.6 37.4 23.9 66.7 53.0 30.6 21.7 25.4 18.8 34.8 27.5 33.3 23.5 31.1 39.5 52.9 11.9 27.0 30.5 30.1 24.2 33.6 47.5 21.4 41.7 21.7 37.0 53.1 25.3 20.3 19.6 13.3 22.4 27.1 17.7 8.8 21.5 22.7 49.8 28.8 48.7 53.4 15.0 19.2 19.5 26.4 23.7 23.2 30.1 26.2 65.3 13.1 36.3 21.3 98.3 62.4 28.7 24.7 36.7 31.8 47.9 38.5 20.4 PTCH1 "BCNS, NBCCS, PTCH" ENSG00000185920 "Patched 1" Q13635 9 95442980-95517057 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, Disease variant, Holoprosencephaly, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 26.7" "Cell type enhanced" "Detected in many" "Late spermatids: 237.5;Leydig cells: 191.0;Peritubular cells: 444.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 6.1" "Lineage enriched" "Detected in single" 9 "T-cells: 6.1" "Cell line enhanced" "Detected in many" "NTERA-2: 29.6;WM-115: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013717, HPA075072" Uncertain Approved "Golgi apparatus" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "CAB013717: , HPA075072: AB_2686733" "unprognostic (1.46e-1)" "unprognostic (1.06e-1)" "unprognostic (3.16e-1)" "unprognostic (1.79e-2)" "unprognostic (3.22e-2)" "unprognostic (9.01e-2)" "unprognostic (2.13e-1)" "unprognostic (3.54e-3)" "unprognostic (2.63e-1)" "unprognostic (8.66e-3)" "unprognostic (1.52e-2)" "unprognostic (2.82e-1)" "unprognostic (1.13e-6)" "unprognostic (8.63e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-1)" "unprognostic (2.82e-1)" 3.0 3.5 9.5 4.0 11.6 0.7 2.8 24.6 5.6 26.7 2.7 11.3 8.1 15.6 2.7 2.9 7.1 8.1 2.9 4.7 17.8 4.6 2.2 5.5 2.2 16.0 12.7 5.0 6.4 2.5 2.1 3.8 8.0 6.8 12.3 8.3 7.5 4.0 3.0 3.2 11.6 2.4 7.0 3.3 12.5 14.5 24.0 2.1 4.7 4.8 3.0 7.2 2.9 4.5 10.1 4.7 20.3 12.9 3.0 5.0 11.4 1.9 1.7 2.2 1.4 4.9 4.8 8.0 3.3 3.8 4.4 22.3 11.7 1.6 1.4 7.9 7.8 0.0 4.8 2.3 2.7 0.2 4.2 4.7 2.4 2.2 1.4 4.3 4.2 3.5 7.3 9.1 1.0 1.9 0.1 3.2 29.6 7.2 1.8 0.0 15.5 4.2 1.6 1.5 13.8 7.0 7.1 6.8 2.9 18.8 1.8 2.1 1.1 2.6 12.9 13.6 1.5 18.0 16.8 5.3 3.8 3.9 71.0 0.0 0.0 0.0 6.1 0.0 3.3 0.7 1.1 2.5 0.0 0.2 1.9 2.2 0.0 0.3 0.0 0.0 1.2 1.7 9.5 11.6 24.6 5.6 4.7 17.8 16.0 12.7 8.0 7.0 24.0 4.5 6.0 0.0 6.4 49.0 3.0 4.0 2.7 3.0 4.6 20.3 3.5 4.6 5.9 25.8 2.7 0.0 41.7 3.0 11.8 2.0 5.9 3.5 88.4 12.2 89.8 5.4 21.7 0.4 15.2 4.2 1.9 27.2 1.1 11.0 1.3 2.6 6.4 2.9 0.8 20.2 10.7 11.0 4.1 0.9 1.2 237.5 191.0 1.4 12.4 4.7 0.8 55.6 54.6 39.7 20.5 2.4 3.1 444.5 3.1 4.9 3.1 1.6 5.5 13.4 39.5 4.8 9.4 4.4 35.5 3.0 4.4 1.4 6.5 71.7 4.7 1.4 PTCH2 ENSG00000117425 "Patched 2" Q9Y6C5 1 44819844-44843253 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ovary: 24.6;parathyroid gland: 59.1;salivary gland: 75.2;testis: 25.6" "Cell type enhanced" "Detected in many" "Leydig cells: 107.8;Peritubular cells: 68.1;Plasma cells: 67.1;Theca cells: 138.7" "Cancer enhanced" "Detected in many" "testis cancer: 9.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA046839 Supported "Nucleoli,Plasma membrane" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Plasma membrane" Nucleoli "HPA046839: " "unprognostic (6.54e-5)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (3.65e-3)" "unprognostic (3.89e-1)" "unprognostic (7.42e-3)" "unprognostic (3.01e-1)" "unprognostic (2.94e-2)" "unprognostic (1.51e-1)" "unprognostic (8.67e-2)" "prognostic favorable (5.74e-5)" "unprognostic (2.92e-1)" "unprognostic (5.74e-6)" "unprognostic (1.55e-2)" "unprognostic (4.86e-2)" "unprognostic (6.31e-2)" "unprognostic (6.81e-2)" 4.2 3.1 6.1 0.8 3.5 9.4 3.4 6.8 6.8 5.1 3.6 3.6 1.0 6.4 1.6 0.9 4.3 2.5 1.3 3.1 4.4 1.3 1.3 1.0 2.3 2.9 4.8 24.6 1.0 59.1 9.9 0.3 2.0 3.0 0.9 3.6 75.2 1.3 2.0 3.6 1.8 1.2 1.6 2.4 2.0 25.6 6.5 0.8 4.6 0.8 0.7 3.1 3.4 4.8 0.2 0.3 1.0 2.5 0.8 0.9 1.0 0.8 1.6 0.5 0.4 0.2 0.4 1.1 0.4 0.4 0.5 0.0 1.1 0.0 0.2 2.1 1.9 0.6 1.0 0.8 0.3 0.7 1.1 0.3 0.4 1.0 0.1 1.7 0.1 1.0 0.7 1.1 0.0 0.5 1.4 2.1 0.3 0.1 0.4 1.0 0.2 0.5 0.2 0.0 1.5 0.6 0.3 0.4 0.8 0.5 0.2 1.2 0.1 0.2 0.5 1.3 0.5 1.9 11.6 3.2 0.6 3.0 0.4 2.5 1.9 0.1 0.5 0.9 1.0 1.0 0.6 0.6 1.2 1.4 0.7 0.6 0.6 0.9 0.9 3.6 0.3 0.2 6.1 3.5 6.8 6.8 3.1 4.4 2.9 4.8 2.0 1.6 6.5 4.8 2.8 0.0 1.1 14.0 13.4 0.5 0.7 1.0 0.6 0.8 4.8 8.0 1.0 7.2 1.0 1.8 2.1 2.4 6.8 7.8 0.0 5.5 2.3 9.3 13.5 2.7 11.5 1.3 23.7 1.8 1.6 14.3 28.1 8.5 0.0 4.4 0.7 7.9 6.7 8.4 27.3 4.9 2.0 24.5 2.2 8.0 107.8 17.3 0.0 5.6 3.9 2.4 2.1 9.5 2.6 2.1 2.5 68.1 67.1 0.8 13.6 0.2 1.7 1.2 13.1 5.4 5.6 5.0 3.6 0.6 1.6 2.3 7.5 138.7 5.5 0.2 PTGDS "L-PGDS, PGDS" ENSG00000107317 "Prostaglandin D2 synthase" P41222 9 136975092-136981742 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Mast cell degranulation, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 4898.3;testis: 3242.2" "Group enriched" "Detected in many" 11 "Leydig cells: 38051.3;Peritubular cells: 65156.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 27 "plasmacytoid DC: 1386.8" "Lineage enriched" "Detected in many" 27 "dendritic cells: 1386.8" "Group enriched" "Detected in some" 6 "HHSteC: 518.7;HSkMC: 252.0" "HPA004938, CAB009916, HPA067456" Uncertain "Secreted to blood" NA NA 2500000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "CAB009916: AB_2174617, HPA004938: AB_1855745, HPA067456: " "unprognostic (2.79e-2)" "unprognostic (3.96e-3)" "unprognostic (9.70e-2)" "unprognostic (5.71e-3)" "unprognostic (6.50e-2)" "unprognostic (1.43e-3)" "unprognostic (2.85e-1)" "unprognostic (2.01e-2)" "unprognostic (6.50e-2)" "unprognostic (1.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.19e-7)" "unprognostic (8.49e-3)" "unprognostic (1.18e-1)" "unprognostic (2.44e-1)" "unprognostic (3.21e-2)" 391.1 297.1 1849.2 247.1 2423.8 9.9 121.1 2440.1 2559.6 1675.5 1508.4 84.8 31.5 320.4 735.9 172.5 492.1 396.7 4898.3 1760.9 2034.8 466.5 80.2 607.8 824.1 2339.4 2228.2 66.8 113.2 9.1 398.4 227.8 2318.0 727.0 17.7 146.1 97.8 813.1 108.3 164.9 205.9 99.7 1999.6 317.5 93.0 3242.2 2264.9 127.4 55.1 60.0 306.0 230.3 1181.0 2580.3 0.1 0.0 0.1 0.0 5.4 16.7 8.8 0.3 0.0 0.0 0.0 0.0 0.2 0.6 4.0 24.0 0.0 0.8 0.6 0.2 0.0 0.0 0.0 0.0 1.4 0.3 518.7 0.3 1.3 252.0 0.1 0.0 0.0 1.8 0.0 0.0 0.6 1.0 0.2 0.0 0.0 6.6 0.9 8.2 0.0 0.1 0.2 1.6 0.0 0.0 1.6 2.0 0.0 0.6 0.0 0.1 0.6 68.3 0.7 0.2 0.2 2.1 0.1 0.3 0.0 0.1 3.9 0.0 0.9 0.0 0.3 0.4 50.5 1.0 3.4 0.3 4.3 6.3 1.8 0.2 0.9 9.9 2.3 3.8 0.2 1386.8 1.4 11.2 1849.2 2423.8 2440.1 2559.6 1760.9 2034.8 2339.4 2228.2 2318.0 1999.6 2264.9 2580.3 29.3 0.0 0.6 665.0 1.5 70.4 3.2 0.1 5.7 46.8 6.6 14.7 333.6 8.6 0.1 138.0 52.1 14.4 1863.6 0.2 68.4 0.3 215.9 29.7 1156.5 167.8 0.0 13.5 4.0 0.0 55.0 1584.0 1.1 20.1 1.3 0.3 46.1 1.6 57.3 21.9 12.8 0.0 0.0 3.4 161.8 1230.9 38051.3 57.0 209.9 176.1 4.6 4625.8 583.9 63.3 850.4 1.7 0.0 65156.8 6.0 20.7 0.0 1.1 0.0 130.3 164.3 787.4 124.8 130.7 111.1 12.0 80.1 35.4 61.3 0.1 0.0 14.5 PTRH1 "C9orf115, PTH1" ENSG00000187024 "Peptidyl-tRNA hydrolase 1 homolog" Q86Y79 9 127690348-127724873 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 125.4;Theca cells: 460.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021223 Uncertain NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA021223: AB_1845798" "unprognostic (6.58e-2)" "unprognostic (7.01e-3)" "unprognostic (3.46e-3)" "unprognostic (2.53e-2)" "unprognostic (7.05e-2)" "unprognostic (1.30e-1)" "unprognostic (2.44e-1)" "unprognostic (3.90e-2)" "unprognostic (1.74e-1)" "unprognostic (6.58e-3)" "unprognostic (8.67e-2)" "unprognostic (4.08e-2)" "unprognostic (5.98e-3)" "unprognostic (5.74e-4)" "unprognostic (1.38e-2)" "unprognostic (1.91e-1)" "unprognostic (1.72e-2)" 16.6 25.5 9.0 5.0 9.1 4.3 15.7 8.0 13.7 11.9 6.8 12.1 4.3 12.7 9.5 10.4 15.1 3.8 18.3 9.1 7.8 26.7 18.1 12.7 3.3 6.7 6.9 8.3 20.9 7.7 17.7 2.7 6.8 13.6 2.3 2.8 11.5 5.3 19.9 24.8 7.6 3.5 6.0 12.6 14.5 17.4 8.2 4.1 20.1 3.3 2.5 12.9 9.6 8.3 28.4 11.7 2.2 7.5 3.9 5.1 20.3 18.6 5.0 7.0 3.9 5.2 10.1 9.4 24.3 8.0 9.2 31.0 2.4 13.3 2.5 15.4 3.5 4.0 15.4 11.8 11.2 6.3 12.0 4.2 13.1 8.6 8.9 3.5 13.4 14.2 11.8 8.2 7.8 24.4 12.7 7.9 3.5 23.5 52.9 10.0 5.5 22.9 13.2 5.6 11.9 10.7 18.7 23.0 14.4 2.0 20.3 3.0 15.8 9.2 13.9 36.0 11.1 23.5 14.1 7.1 13.2 4.2 11.8 8.5 31.1 14.0 67.5 37.2 69.3 21.7 34.3 68.5 28.0 17.1 24.8 57.0 4.0 28.1 20.1 25.3 37.2 31.6 9.0 9.1 8.0 13.7 9.1 7.8 6.7 6.9 6.8 6.0 8.2 8.3 17.4 3.2 9.1 2.0 8.6 17.0 41.2 27.4 9.1 28.3 26.5 23.1 0.3 21.5 13.8 47.8 45.9 13.1 13.4 11.2 66.5 60.5 86.6 54.9 25.2 19.7 30.1 10.8 1.3 33.6 23.7 20.1 10.7 25.5 17.2 15.8 18.5 28.1 46.6 16.8 1.0 25.8 32.6 11.3 13.9 18.7 22.1 11.6 16.0 1.0 15.4 22.2 22.6 2.0 1.0 48.1 13.4 94.0 8.8 85.3 14.6 125.4 43.8 59.0 0.0 15.2 17.0 24.6 9.2 14.4 21.2 18.7 16.0 460.9 17.5 34.8 PUS7L DKFZP434G1415 ENSG00000129317 "Pseudouridine synthase 7 like" Q9H0K6 12 43718992-43758793 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056203, HPA058750" Uncertain Approved "Nucleoli,Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Nucleoli "HPA056203: AB_2683064, HPA058750: AB_2683807" "unprognostic (3.41e-3)" "unprognostic (1.03e-1)" "unprognostic (2.51e-3)" "unprognostic (1.83e-1)" "unprognostic (3.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.87e-4)" "unprognostic (1.11e-1)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.49e-1)" "unprognostic (2.54e-2)" "unprognostic (1.80e-3)" "unprognostic (1.32e-1)" "unprognostic (2.56e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" 2.7 3.1 3.3 4.9 3.6 3.5 5.4 6.8 5.2 4.1 0.3 3.8 3.8 3.6 3.7 4.8 2.9 3.8 2.7 2.9 2.6 3.1 3.2 2.4 5.7 2.6 2.0 4.7 4.3 4.4 4.1 4.0 2.7 4.0 4.5 11.7 4.0 3.5 1.7 3.7 3.6 3.1 1.1 3.4 3.9 3.0 3.2 5.1 5.7 1.7 5.9 3.4 2.7 3.7 11.2 8.3 7.2 4.1 4.9 17.4 12.8 9.6 8.1 12.6 9.6 29.9 7.9 25.7 11.9 11.9 7.3 9.9 10.5 9.7 21.5 7.9 6.5 18.8 9.2 11.2 6.1 30.3 11.7 7.2 7.1 13.1 13.5 11.6 9.2 14.9 33.3 10.9 29.7 4.5 15.8 7.8 13.3 0.0 8.8 14.7 16.9 15.4 5.6 8.5 12.1 3.9 11.9 12.8 5.1 8.5 15.1 8.4 6.7 12.8 8.4 15.0 15.2 9.6 17.7 25.5 11.8 49.1 4.3 6.4 1.9 2.2 2.1 1.7 2.7 2.1 2.3 2.3 2.1 2.8 2.0 2.9 1.3 2.5 1.6 2.3 1.0 1.5 3.3 3.6 6.8 5.2 2.9 2.6 2.6 2.0 2.7 1.1 3.2 3.7 30.5 9.6 17.2 29.0 41.1 11.6 19.0 30.8 22.8 68.9 24.2 16.0 12.3 14.3 21.2 25.8 68.8 34.3 34.4 13.5 41.1 20.4 2.5 14.9 28.5 23.3 19.3 25.2 49.5 23.2 23.3 26.5 28.5 18.9 17.1 43.7 16.8 20.8 20.4 43.7 79.5 25.2 18.3 25.0 10.5 4.2 20.2 20.3 12.4 15.0 24.6 33.1 35.0 41.7 51.2 18.2 17.0 26.7 48.7 16.9 19.6 22.7 9.2 106.1 19.7 28.1 18.1 25.2 35.3 19.9 11.1 24.2 32.7 36.3 30.0 13.9 RAB34 "NARR, RAB39, RAH" ENSG00000109113 "RAB34, member RAS oncogene family" "P0DI83, Q9BZG1" 17 28714281-28718429 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Peritubular cells: 169.7;Theca cells: 182.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 51.0;intermediate monocyte: 47.2;myeloid DC: 76.3;non-classical monocyte: 23.4;plasmacytoid DC: 46.6" "Group enriched" "Detected in all" 5 "dendritic cells: 76.3;monocytes: 51.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021366 Approved NA NA 1100000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "HPA021366: AB_1856003" "unprognostic (1.29e-3)" "unprognostic (1.77e-1)" "unprognostic (7.87e-2)" "unprognostic (2.38e-1)" "unprognostic (2.35e-2)" "unprognostic (7.75e-2)" "unprognostic (1.33e-1)" "unprognostic (1.36e-3)" "unprognostic (2.21e-1)" "unprognostic (5.62e-2)" "unprognostic (8.77e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (1.64e-7)" "unprognostic (1.31e-3)" "unprognostic (7.72e-2)" "prognostic favorable (1.06e-5)" "unprognostic (5.05e-2)" 50.4 86.3 24.7 25.0 24.5 21.3 45.4 23.9 26.6 96.1 31.8 76.8 13.4 80.5 60.2 32.1 74.6 54.2 52.3 22.8 23.7 77.1 7.2 43.6 26.2 26.9 24.6 104.6 7.1 66.2 30.8 32.7 24.7 70.6 21.4 3.8 28.4 78.2 11.0 37.9 31.1 75.0 24.6 30.2 37.6 11.0 25.9 25.9 52.9 17.8 23.5 78.6 60.5 23.4 143.2 203.2 109.4 314.4 129.9 206.3 38.2 184.1 299.0 200.3 166.9 1.7 51.1 0.4 171.5 310.1 69.6 87.7 1.9 104.6 159.7 10.8 94.7 99.2 141.0 11.3 152.0 1.0 0.7 187.7 63.3 151.8 127.9 237.7 138.8 0.4 0.5 1.2 201.6 0.0 0.6 0.2 108.9 0.1 53.7 20.2 261.9 0.7 189.6 73.5 26.8 0.2 134.2 0.6 227.2 93.1 79.0 55.2 31.5 144.0 192.4 132.1 181.9 0.2 0.9 1.5 158.3 0.6 144.8 7.0 51.0 3.1 3.0 47.2 0.7 11.4 5.4 4.2 76.3 11.8 11.7 10.5 1.7 1.1 23.4 46.6 5.8 21.7 24.7 24.5 23.9 26.6 22.8 23.7 26.9 24.6 24.7 24.6 25.9 23.4 37.0 35.3 44.7 42.1 9.7 52.9 105.1 145.0 33.0 2.6 31.2 65.9 8.7 10.0 56.2 57.0 0.0 49.8 12.8 0.2 95.9 3.9 1.1 49.8 79.5 29.3 0.0 12.6 0.1 3.8 102.3 124.2 2.0 34.1 71.5 84.1 25.4 0.3 41.7 1.7 1.2 0.5 59.0 60.5 82.9 5.6 148.8 43.5 65.8 5.6 40.5 25.3 1.0 6.0 0.1 2.0 0.0 169.7 4.6 82.1 0.1 44.6 45.3 2.5 32.9 81.1 98.3 1.9 4.6 20.6 35.4 58.8 10.8 182.1 0.4 59.0 RAB3GAP2 "DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69" ENSG00000118873 "RAB3 GTPase activating non-catalytic protein subunit 2" Q9H2M9 1 220148293-220272453 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Cataract, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026273, HPA027299" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Cytosol "Plasma membrane" "HPA026273: AB_1856007, HPA027299: AB_1856008" "prognostic unfavorable (3.05e-4)" "unprognostic (2.80e-3)" "unprognostic (1.76e-2)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (7.00e-2)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (4.63e-2)" "unprognostic (2.13e-1)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.17e-1)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 10.1 9.0 6.3 9.6 6.7 10.2 11.2 11.4 7.8 8.7 23.5 8.8 7.8 9.4 8.4 9.0 7.0 7.9 9.3 7.3 9.3 11.7 10.0 8.6 12.6 6.7 6.9 9.6 8.6 18.6 6.2 11.5 9.0 8.5 8.3 18.1 9.2 7.9 8.7 7.9 7.8 9.3 5.7 9.2 9.4 6.6 7.5 13.1 12.8 12.2 14.4 9.1 6.0 9.1 21.3 15.8 18.9 14.3 21.2 25.1 21.4 21.4 20.3 18.9 22.2 14.7 17.3 26.4 14.8 20.9 14.3 19.9 19.8 16.4 21.8 22.1 12.9 20.6 21.5 13.8 27.9 29.8 20.3 20.0 18.4 18.5 28.5 21.2 17.6 11.4 36.2 16.6 21.6 6.0 23.0 10.5 40.8 11.4 9.3 12.5 26.0 23.7 16.1 17.3 18.8 22.7 22.2 21.4 35.3 20.3 22.4 28.0 25.7 20.6 9.6 14.4 23.2 14.6 19.2 22.8 17.7 24.6 24.8 10.0 2.8 5.6 4.8 3.6 5.9 4.8 4.7 6.2 3.8 3.8 4.1 4.9 1.8 2.8 3.9 2.4 6.0 3.3 6.3 6.7 11.4 7.8 7.3 9.3 6.7 6.9 9.0 5.7 7.5 9.1 28.5 41.7 21.9 60.7 30.4 11.6 13.6 15.8 17.6 57.9 18.9 16.3 34.8 32.9 23.4 25.8 68.8 18.5 30.6 23.8 5.9 17.4 4.3 21.4 27.7 22.3 35.4 18.7 106.8 16.7 13.5 23.4 20.4 28.5 19.6 40.8 28.9 24.2 25.4 42.1 105.1 22.1 16.2 29.0 9.4 2.8 18.0 22.2 14.2 68.4 25.2 39.8 26.8 82.0 81.5 21.7 14.2 25.9 24.7 21.0 19.4 14.9 17.2 50.5 6.6 24.1 20.4 17.7 13.6 17.5 9.8 23.1 27.1 23.6 19.3 13.2 RAD54L2 "ARIP4, KIAA0809, SRISNF2L" ENSG00000164080 "RAD54 like 2" Q9Y4B4 3 51541144-51668667 "Enzymes, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035004, HPA039992, HPA077351" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: " "unprognostic (1.46e-2)" "unprognostic (3.67e-2)" "unprognostic (2.61e-1)" "unprognostic (5.01e-2)" "unprognostic (1.15e-1)" "unprognostic (4.38e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-2)" "unprognostic (9.24e-2)" "unprognostic (2.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.71e-5)" "unprognostic (3.72e-2)" "unprognostic (3.19e-1)" "unprognostic (3.30e-2)" "unprognostic (6.63e-2)" 4.6 4.8 5.6 3.7 6.1 6.1 4.6 6.5 5.6 4.8 2.9 5.8 2.5 5.6 4.2 4.0 4.6 2.7 4.4 5.0 5.2 4.0 7.8 4.9 4.2 5.5 5.7 5.3 5.3 3.8 4.5 4.8 5.5 4.4 3.4 7.5 4.5 3.9 7.1 5.5 5.0 4.1 5.3 5.2 5.2 5.0 6.3 6.2 4.6 5.3 5.2 4.8 4.3 6.2 6.6 5.1 12.8 12.7 7.0 5.0 6.7 5.5 7.8 7.4 6.9 9.1 3.8 17.4 1.5 9.7 7.8 5.0 20.5 6.8 9.1 9.2 4.6 14.9 11.5 6.0 6.4 16.8 8.5 5.8 5.4 11.3 10.9 4.6 8.3 14.8 10.3 9.1 5.9 5.1 15.0 7.6 10.2 3.2 5.5 6.9 9.9 2.3 3.8 8.4 5.2 10.0 8.7 8.2 5.7 7.7 5.4 9.9 10.9 7.7 8.9 8.0 10.8 9.8 10.7 16.8 8.3 9.2 10.0 3.1 2.2 2.2 3.3 2.6 3.5 1.8 2.9 2.8 2.3 2.9 1.9 2.3 0.9 3.0 3.5 2.3 2.9 2.2 5.6 6.1 6.5 5.6 5.0 5.2 5.5 5.7 5.5 5.3 6.3 6.2 10.8 9.6 14.4 31.3 11.3 9.2 8.6 6.7 3.4 33.8 8.7 8.0 11.0 15.7 7.8 9.2 31.3 19.3 12.2 7.7 1.9 9.3 7.5 9.5 12.0 15.1 16.3 3.8 54.9 10.4 8.7 9.6 9.2 19.8 18.3 14.2 10.4 21.9 8.9 47.1 54.3 8.1 4.1 9.1 8.4 3.1 15.2 9.4 14.2 26.2 13.2 9.1 30.9 42.7 42.3 13.9 9.7 17.0 11.3 12.4 4.6 4.4 9.5 29.9 13.1 17.1 11.6 43.9 36.4 5.5 8.9 29.7 12.5 10.1 7.9 12.5 RANBP6 ENSG00000137040 "RAN binding protein 6" O60518 9 6011025-6015625 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043748, HPA052684" Approved Supported Vesicles NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" Vesicles "HPA043748: AB_10796796, HPA052684: AB_2681913" "unprognostic (1.47e-2)" "unprognostic (8.86e-2)" "unprognostic (1.70e-1)" "unprognostic (6.01e-2)" "unprognostic (3.63e-2)" "unprognostic (1.30e-1)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.89e-2)" "prognostic favorable (1.34e-7)" "unprognostic (2.42e-1)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (2.61e-1)" 8.6 11.4 8.3 12.9 8.8 31.0 11.4 11.5 12.4 7.7 18.4 7.1 7.5 8.8 7.0 7.9 7.3 7.6 12.4 9.3 10.8 13.4 15.2 8.4 17.0 11.2 9.7 9.6 7.8 13.6 5.0 8.9 11.9 9.7 7.1 21.6 8.6 8.5 16.3 9.9 8.6 10.3 9.2 13.1 11.1 5.9 10.0 19.6 12.0 16.1 16.2 8.7 5.6 10.3 25.1 13.6 27.2 23.4 23.6 18.6 14.6 30.9 21.9 26.8 21.6 7.5 7.7 33.5 8.4 24.7 13.1 14.0 24.2 28.2 29.7 80.1 13.9 88.3 53.0 15.6 13.9 34.2 17.9 20.2 15.2 16.5 16.3 21.1 31.3 30.1 6.9 27.3 25.8 8.4 24.3 54.8 12.3 9.0 11.0 25.6 16.7 15.7 28.1 17.6 13.2 19.9 14.7 11.0 8.7 22.3 17.7 23.0 37.6 25.1 14.9 12.4 29.4 16.3 27.8 31.5 14.4 19.8 9.3 5.1 4.5 3.7 2.6 6.3 2.5 2.5 3.8 2.8 2.7 1.9 4.4 4.2 1.3 2.8 5.2 3.1 5.2 2.9 8.3 8.8 11.5 12.4 9.3 10.8 11.2 9.7 11.9 9.2 10.0 10.3 11.3 9.6 8.1 8.8 11.5 10.3 6.6 10.1 13.1 18.0 8.1 5.6 24.4 8.6 16.3 11.0 2.1 8.8 12.0 4.1 7.9 8.6 1.6 12.2 16.5 13.1 9.5 8.6 15.9 10.9 4.1 8.3 16.8 17.7 10.8 10.1 10.0 13.7 4.4 11.8 19.0 3.2 2.0 10.5 6.0 1.2 6.5 7.2 1.8 8.4 7.2 15.9 9.2 3.0 20.5 7.5 3.8 6.8 11.8 5.7 1.8 12.5 8.7 23.1 0.0 11.6 10.2 10.1 9.3 9.8 9.5 6.6 13.3 12.7 4.8 7.3 RBAK ZNF769 ENSG00000146587 "RB associated KRAB zinc finger" Q9NYW8 7 5045821-5069487 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071231 Supported Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA071231: AB_2686370" "unprognostic (2.82e-2)" "unprognostic (1.98e-2)" "unprognostic (7.40e-2)" "unprognostic (1.85e-2)" "unprognostic (5.04e-1)" "unprognostic (4.32e-1)" "unprognostic (2.62e-1)" "unprognostic (2.32e-1)" "unprognostic (4.67e-2)" "unprognostic (5.91e-2)" "unprognostic (6.84e-2)" "unprognostic (5.10e-2)" "unprognostic (1.28e-1)" "unprognostic (2.50e-1)" "unprognostic (3.66e-2)" "unprognostic (6.12e-3)" "unprognostic (5.75e-2)" 4.3 3.8 4.1 4.4 4.0 3.7 5.8 6.7 5.4 4.7 3.7 4.6 4.5 5.2 4.7 5.8 4.4 3.7 4.3 3.8 4.5 4.4 6.5 4.0 6.4 4.5 5.0 4.8 5.5 6.9 3.9 4.5 4.4 4.7 4.9 8.4 4.6 4.7 4.2 6.0 5.1 4.4 4.2 5.1 5.0 2.9 4.8 5.6 5.5 6.1 6.7 4.1 4.6 4.8 8.9 6.7 9.2 17.0 6.6 6.1 7.5 5.5 4.3 5.3 6.3 8.3 5.4 10.5 4.5 6.4 10.0 10.8 10.4 8.5 8.2 2.3 7.4 7.7 9.2 6.9 7.0 12.9 8.9 5.9 9.9 5.3 11.8 7.7 5.3 6.1 16.2 3.7 6.7 15.7 3.2 11.9 14.5 3.0 7.0 5.3 14.9 7.7 6.1 11.3 9.4 15.4 7.7 12.6 11.5 11.7 7.7 15.3 4.5 6.3 10.0 7.3 9.1 11.4 9.7 9.2 6.3 9.5 8.2 0.0 0.2 0.4 0.5 0.4 0.7 0.3 0.4 0.3 0.3 0.3 0.5 0.4 0.0 0.5 0.1 0.4 0.3 0.1 4.1 4.0 6.7 5.4 3.8 4.5 4.5 5.0 4.4 4.2 4.8 4.8 7.4 0.0 8.2 0.0 6.5 4.2 3.4 4.7 5.2 8.2 6.1 3.9 13.4 7.2 7.3 0.0 10.4 2.8 7.9 5.1 1.9 5.9 1.1 7.5 10.1 6.1 4.9 11.6 0.0 5.8 2.2 6.7 8.6 6.9 5.7 11.7 7.9 5.3 3.7 21.9 0.0 5.6 2.0 8.2 4.0 1.4 8.1 5.2 3.6 0.0 5.7 6.0 5.2 0.0 0.0 6.0 3.8 8.6 6.7 5.9 5.6 3.7 8.8 8.2 0.0 8.8 7.0 5.0 3.2 7.5 7.0 1.9 6.4 9.1 6.1 4.2 RBM12B ENSG00000183808 "RNA binding motif protein 12B" Q8IXT5 8 93729356-93741017 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 15.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024398, HPA053050" Uncertain Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA024398: AB_1856109, HPA053050: AB_2682026" "unprognostic (4.57e-2)" "unprognostic (7.72e-2)" "unprognostic (3.39e-1)" "unprognostic (3.57e-2)" "unprognostic (1.78e-1)" "unprognostic (2.66e-2)" "unprognostic (2.40e-3)" "unprognostic (3.05e-1)" "unprognostic (3.92e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (2.54e-2)" "unprognostic (1.84e-3)" "unprognostic (9.15e-2)" "unprognostic (4.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.62e-2)" 6.6 7.2 3.2 14.8 4.3 9.2 11.7 15.2 5.2 11.4 3.5 8.9 9.1 14.3 8.9 8.5 11.7 8.4 9.3 3.1 6.6 8.9 6.4 8.5 19.8 4.0 2.1 21.8 7.8 9.4 5.6 13.4 2.8 13.0 9.4 24.7 10.2 8.4 5.5 8.5 9.0 8.3 1.5 13.6 10.6 17.6 2.5 16.3 15.9 6.2 16.9 8.4 7.1 10.8 26.0 19.3 48.3 34.4 11.7 22.3 23.4 21.4 15.8 23.9 24.9 14.6 34.6 45.5 33.2 12.0 25.4 26.0 42.3 11.3 26.7 32.3 21.8 59.0 48.2 12.6 13.7 22.2 28.7 14.6 14.2 15.7 15.5 15.8 16.4 26.6 49.4 37.0 21.3 15.0 41.3 17.3 0.2 19.6 20.4 30.2 34.2 15.0 12.3 21.9 31.6 25.0 23.0 7.2 17.8 33.0 27.5 16.7 32.0 22.2 33.3 16.3 22.3 43.0 34.2 38.3 15.8 31.0 38.0 15.0 2.3 4.4 2.3 2.0 3.5 1.5 3.0 2.4 2.2 2.1 4.1 3.5 3.3 3.0 2.4 2.9 3.8 2.1 3.2 4.3 15.2 5.2 3.1 6.6 4.0 2.1 2.8 1.5 2.5 10.8 16.8 6.4 8.1 23.2 17.9 4.0 7.1 7.2 11.4 31.8 9.9 9.1 11.8 10.0 6.6 12.9 43.8 7.9 13.7 5.5 3.9 6.9 1.4 11.3 21.4 12.8 15.7 17.7 23.7 4.8 4.8 13.5 7.7 12.8 0.0 30.3 11.4 8.4 4.7 45.4 26.6 9.2 8.2 11.1 5.8 2.4 12.5 8.9 5.4 21.5 15.9 21.9 17.5 32.6 40.2 6.8 7.1 10.1 8.7 8.8 5.9 5.0 12.5 32.1 19.7 23.2 13.1 19.1 10.9 7.3 4.3 4.0 11.8 13.5 8.0 4.9 RBM23 "CAPERbeta, FLJ10482, RNPC4" ENSG00000100461 "RNA binding motif protein 23" Q86U06 14 22893204-22919182 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004144 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" Nucleoplasm "HPA004144: AB_1079747" "unprognostic (5.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (2.14e-2)" "unprognostic (1.06e-1)" "unprognostic (4.27e-2)" "unprognostic (4.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.29e-1)" "prognostic favorable (8.06e-9)" "unprognostic (4.41e-2)" "unprognostic (3.06e-1)" "unprognostic (5.05e-2)" "unprognostic (1.81e-1)" 31.8 37.9 35.8 34.1 38.5 53.2 40.7 55.0 42.0 46.0 48.4 38.3 30.7 53.4 39.3 39.6 59.4 39.1 33.6 35.8 42.9 44.2 40.7 42.0 44.8 38.6 38.5 57.9 39.2 83.2 40.6 46.7 37.0 39.0 41.7 52.2 38.0 40.1 29.1 36.3 37.3 45.9 37.7 45.4 39.2 31.3 43.4 57.9 54.5 40.7 50.6 43.5 37.7 45.0 55.9 86.3 86.6 45.4 46.5 39.6 36.1 59.9 81.3 114.0 88.8 39.6 66.6 93.0 45.8 55.8 54.8 77.3 98.3 50.3 92.2 73.1 81.2 43.7 65.8 2.8 72.9 84.6 68.9 51.0 68.3 65.8 43.4 63.4 64.4 45.5 56.5 58.3 56.6 71.1 93.8 38.0 38.7 84.8 80.3 80.1 71.8 56.6 44.0 78.0 59.5 66.3 89.8 68.8 38.6 56.6 50.8 49.6 59.8 19.3 33.3 47.5 56.1 55.1 77.0 87.6 32.4 48.2 71.7 40.1 47.7 50.7 37.1 37.0 25.1 29.3 26.3 32.2 49.5 34.7 31.5 28.2 136.6 59.7 49.7 24.6 30.0 32.0 35.8 38.5 55.0 42.0 35.8 42.9 38.6 38.5 37.0 37.7 43.4 45.0 36.8 44.8 48.3 12.1 82.3 18.4 44.7 28.4 27.9 66.4 38.7 35.9 24.3 68.6 42.7 33.1 116.7 53.0 53.8 48.8 45.0 36.3 9.5 55.1 36.8 39.5 65.4 54.1 13.5 33.5 48.0 32.0 36.7 41.4 70.9 27.2 53.2 37.2 31.5 50.5 16.1 39.3 20.3 54.9 33.6 11.9 35.4 40.4 16.0 19.7 70.8 52.4 102.0 18.6 15.3 39.7 55.1 28.2 42.2 29.1 57.3 33.1 64.0 164.2 32.9 47.8 32.1 52.0 64.3 22.0 21.0 101.4 64.0 28.1 42.3 27.8 RBM25 "fSAP94, NET52, RNPC7, S164, Snu71" ENSG00000119707 "RNA binding motif protein 25" P49756 14 73058532-73123899 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003025, HPA070713" Supported Enhanced "Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA003025: AB_1079748, HPA070713: AB_2686302" "unprognostic (1.15e-2)" "unprognostic (3.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.28e-1)" "unprognostic (4.85e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.22e-2)" "unprognostic (3.32e-2)" "unprognostic (1.93e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (8.09e-4)" "prognostic unfavorable (4.26e-4)" "unprognostic (6.98e-2)" "unprognostic (2.58e-1)" "unprognostic (2.75e-1)" "unprognostic (1.73e-1)" 31.4 23.2 14.7 36.0 16.2 72.6 30.7 21.5 20.9 28.7 17.2 28.9 23.4 31.4 22.7 28.9 29.5 21.2 22.2 14.5 19.3 20.8 21.2 30.3 40.0 14.9 13.7 31.1 33.2 22.7 25.3 26.7 16.1 22.5 24.0 41.9 31.4 19.8 41.1 33.3 29.9 23.2 12.5 29.7 27.7 28.5 15.9 36.4 29.3 21.9 33.4 28.1 29.8 20.7 97.8 55.6 86.9 66.6 38.1 44.6 76.5 78.4 54.6 59.5 65.2 74.5 61.2 116.7 40.5 54.0 45.1 72.3 100.9 47.2 101.6 73.8 53.3 98.2 43.2 57.7 24.1 87.5 60.0 32.4 33.3 69.7 56.7 51.1 60.0 42.4 102.7 47.6 65.2 73.3 114.4 51.1 73.8 59.6 60.1 97.4 94.8 57.1 49.0 67.4 58.5 55.8 98.5 64.4 35.0 52.2 92.7 37.9 77.2 87.5 85.5 47.3 79.7 50.2 96.0 141.5 39.1 61.3 61.2 17.4 17.2 16.6 19.9 19.2 18.7 22.3 15.8 16.9 18.2 23.7 16.6 17.6 20.3 27.2 17.5 28.7 19.2 11.7 14.7 16.2 21.5 20.9 14.5 19.3 14.9 13.7 16.1 12.5 15.9 20.7 177.8 230.8 319.9 94.7 226.2 227.4 194.3 109.8 198.6 253.8 136.2 139.2 131.5 77.2 191.8 92.0 268.9 151.8 268.4 137.5 17.6 111.0 71.1 160.4 295.6 170.2 155.2 149.3 115.4 122.6 183.5 185.1 146.8 223.2 247.8 183.3 95.3 98.3 113.1 180.0 99.3 146.3 54.9 110.8 180.8 29.2 157.8 169.9 81.8 71.2 176.9 131.2 155.5 84.9 134.1 132.9 111.0 137.7 233.2 236.5 86.3 32.9 137.0 263.0 72.3 234.2 213.4 213.8 212.9 196.7 236.7 185.4 242.9 161.0 162.5 235.1 RBM28 FLJ10377 ENSG00000106344 "RNA binding motif protein 28" Q9NW13 7 128297685-128343908 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019058, HPA026672, HPA031519" Enhanced Supported Nucleoli NA No "Cluster 15: NK-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoli "HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920" "unprognostic (2.34e-1)" "unprognostic (1.87e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.72e-11)" "unprognostic (6.83e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (7.20e-2)" "unprognostic (4.01e-2)" "unprognostic (3.97e-3)" "unprognostic (1.45e-3)" "unprognostic (7.15e-3)" "unprognostic (3.05e-1)" "unprognostic (2.18e-2)" "unprognostic (1.04e-1)" 17.6 13.0 6.1 14.9 9.2 12.2 14.6 7.6 8.6 12.5 7.2 12.2 10.3 12.8 6.3 11.8 11.4 8.2 20.3 6.6 9.2 8.5 15.2 10.6 14.9 7.6 7.7 14.9 12.4 10.5 13.5 11.2 7.9 10.3 9.3 10.4 10.1 7.7 29.6 13.6 9.2 10.7 6.1 10.8 11.9 16.3 8.7 11.3 12.6 17.6 12.5 12.2 11.6 13.1 56.2 60.5 35.9 103.0 25.1 15.9 49.0 50.3 20.7 44.6 48.0 50.7 47.9 74.0 26.8 23.0 64.8 37.0 53.2 42.6 57.4 37.1 51.0 74.4 43.0 47.1 22.3 94.7 63.9 18.1 27.4 59.4 35.5 16.8 41.9 40.3 141.6 42.0 35.1 45.2 68.3 54.0 68.5 38.5 47.0 53.4 42.8 70.7 21.8 37.5 40.0 48.4 65.0 107.2 34.8 42.6 27.6 28.7 40.4 64.4 33.6 57.7 61.9 42.8 39.5 126.0 42.4 78.2 70.8 3.8 11.0 4.6 12.6 9.2 8.7 12.8 10.7 11.6 11.5 13.4 9.7 11.1 9.7 12.3 8.1 14.1 7.4 5.8 6.1 9.2 7.6 8.6 6.6 9.2 7.6 7.7 7.9 6.1 8.7 13.1 22.7 16.0 31.4 33.3 23.2 16.2 17.1 16.2 24.5 54.9 16.3 17.8 28.8 10.0 27.7 12.9 93.8 20.8 27.5 9.1 25.4 22.3 2.5 21.3 50.3 25.3 11.4 20.4 13.1 22.9 26.5 25.7 21.4 22.5 36.7 30.3 9.7 14.8 19.1 40.4 17.6 14.9 14.2 12.9 10.2 3.3 27.7 17.9 5.4 7.5 18.9 18.6 37.0 18.6 15.3 18.7 8.2 20.7 17.7 19.0 8.1 16.7 17.1 56.1 6.6 51.3 26.4 42.6 44.7 19.1 14.5 18.6 24.4 34.6 16.4 14.8 RBM33 "DKFZp434D1319, DKFZp686F102, MGC20460, PRR8" ENSG00000184863 "RNA binding motif protein 33" Q96EV2 7 155644451-155781485 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019232, HPA021497, HPA021768" Approved Approved Nucleoplasm NA NA "Cluster 17: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA019232: AB_1856121, HPA021497: AB_2176261, HPA021768: AB_1856123" "unprognostic (1.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (3.04e-2)" "unprognostic (2.06e-1)" "prognostic favorable (9.63e-5)" "unprognostic (3.48e-2)" "unprognostic (2.07e-2)" "unprognostic (6.85e-2)" "unprognostic (3.89e-2)" "unprognostic (8.90e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.46e-2)" "prognostic favorable (4.29e-4)" 25.4 19.3 14.4 15.2 14.4 62.2 23.3 39.8 18.9 26.8 6.7 24.8 14.0 22.3 17.1 24.3 20.5 8.8 20.1 11.9 20.3 22.7 32.1 30.1 18.8 16.6 11.6 26.1 30.1 8.1 28.3 10.6 14.7 23.0 12.7 33.7 23.0 9.4 30.9 30.5 31.1 9.5 3.7 30.2 26.9 16.9 16.7 31.5 24.5 10.1 15.6 19.4 28.2 23.8 31.9 37.0 22.7 21.1 12.0 15.6 22.9 19.8 14.0 12.0 17.3 34.2 30.0 35.1 25.9 14.7 32.5 22.5 20.8 16.7 15.9 33.3 29.0 33.5 41.7 22.7 13.2 47.7 32.5 15.3 19.3 19.2 27.3 17.4 21.4 38.8 43.6 28.3 17.2 31.1 49.4 40.8 24.4 21.4 23.3 39.2 25.4 29.4 17.4 34.1 23.0 23.5 33.2 21.7 18.0 17.0 16.6 24.8 24.8 20.2 11.9 36.6 26.6 48.8 40.7 52.4 32.7 30.5 26.4 33.5 10.4 23.1 6.6 10.5 5.4 9.5 6.6 8.2 9.1 7.7 6.1 7.8 37.2 9.1 8.3 9.0 9.3 4.2 14.4 14.4 39.8 18.9 11.9 20.3 16.6 11.6 14.7 3.7 16.7 23.8 36.3 32.1 36.4 68.2 52.3 19.6 20.4 19.7 33.6 57.6 22.2 19.8 30.2 14.3 17.0 3.7 83.4 18.1 60.3 32.4 7.9 20.1 25.6 25.9 43.7 27.6 26.3 37.2 86.8 18.0 17.4 26.0 45.3 43.0 39.2 38.9 17.5 30.0 15.9 132.9 85.5 28.1 16.2 28.3 24.4 42.0 26.1 39.3 12.4 87.1 42.9 23.0 42.2 97.0 115.0 23.5 28.5 17.7 93.1 33.3 37.1 18.2 19.2 91.5 13.1 37.5 31.5 29.5 24.4 26.3 23.4 26.1 53.0 33.9 24.0 36.5 RBM39 "CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2" ENSG00000131051 "RNA binding motif protein 39" Q14498 20 35701347-35742312 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001591 Supported Supported "Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite" NA NA 19000 "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "Microtubules, Centriolar satellite" "HPA001591: AB_1079749" "unprognostic (1.37e-2)" "unprognostic (4.97e-1)" "unprognostic (2.72e-2)" "unprognostic (9.09e-2)" "unprognostic (3.47e-1)" "unprognostic (4.99e-2)" "unprognostic (3.55e-3)" "unprognostic (4.56e-2)" "unprognostic (7.83e-2)" "unprognostic (2.65e-1)" "unprognostic (2.04e-2)" "unprognostic (7.65e-3)" "prognostic unfavorable (2.78e-5)" "unprognostic (1.88e-1)" "unprognostic (2.86e-1)" "unprognostic (2.64e-1)" "unprognostic (2.28e-3)" 70.1 55.8 18.4 37.7 17.6 172.0 44.6 33.5 28.0 57.8 22.2 56.0 35.1 54.5 9.2 62.3 61.4 40.8 57.3 16.5 25.0 52.2 47.7 62.2 42.3 24.2 24.0 71.1 41.2 27.3 50.0 40.9 19.4 50.2 16.9 49.5 53.4 22.3 70.3 51.2 46.9 19.2 16.0 56.4 49.7 34.3 16.9 51.1 54.2 33.1 24.1 50.7 62.1 26.5 98.8 87.6 77.0 78.5 48.8 53.8 78.8 131.0 50.6 59.6 60.2 109.3 78.5 137.5 90.6 38.9 67.9 91.2 122.3 67.9 66.5 94.6 96.7 174.6 80.7 101.2 23.4 158.6 99.9 14.4 97.6 68.9 38.4 63.7 57.8 46.4 195.5 117.6 46.3 72.2 194.5 87.9 103.2 87.5 96.8 104.9 136.2 91.7 41.5 56.2 77.9 63.4 91.1 94.7 78.4 109.3 70.6 94.6 91.4 100.8 92.5 90.5 115.8 71.6 164.3 204.0 64.7 123.2 79.2 250.9 120.4 197.5 104.7 111.1 103.6 131.1 91.5 97.6 111.8 140.5 85.7 82.1 427.7 127.2 102.2 160.9 114.7 95.7 18.4 17.6 33.5 28.0 16.5 25.0 24.2 24.0 19.4 16.0 16.9 26.5 302.0 233.9 280.9 144.3 441.7 616.4 521.0 283.0 284.0 258.5 339.1 295.4 189.2 191.6 267.6 200.5 316.9 375.2 624.9 278.1 189.8 203.8 48.1 359.2 496.0 299.7 295.3 214.2 130.1 186.0 389.6 337.9 254.9 540.8 525.8 304.4 215.3 202.1 199.8 220.4 120.9 331.3 215.7 207.7 469.5 41.9 262.5 335.5 270.3 129.3 274.3 208.7 400.6 136.2 160.5 221.3 254.8 214.4 391.0 453.6 271.8 150.6 248.0 386.5 164.3 504.0 410.2 263.5 228.1 215.8 586.9 561.6 490.8 218.2 282.8 532.1 RBM41 FLJ11016 ENSG00000089682 "RNA binding motif protein 41" Q96IZ5 X 107064420-107118823 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042881 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear speckles, Cytosol" "HPA042881: AB_10794536" "unprognostic (1.07e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.39e-1)" "unprognostic (2.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-2)" "unprognostic (1.98e-2)" "unprognostic (2.19e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" "unprognostic (2.80e-2)" "unprognostic (1.92e-1)" 4.6 5.8 2.6 5.0 3.0 3.5 5.7 5.7 3.7 4.2 5.1 5.5 7.7 6.1 6.5 5.6 5.0 4.5 5.5 3.0 2.8 6.8 8.3 4.7 5.8 3.9 3.4 5.5 4.2 9.3 3.4 5.4 3.4 5.5 6.5 5.8 4.5 5.0 6.4 7.1 6.9 5.6 3.2 5.3 5.0 7.3 3.2 6.6 6.9 8.0 6.2 5.0 4.1 3.8 16.9 13.3 8.4 6.8 5.5 9.5 9.7 9.8 9.6 7.1 9.5 8.9 13.8 9.3 18.0 7.2 12.4 13.7 12.3 9.2 10.8 11.5 18.1 11.3 25.2 11.0 6.2 11.6 8.5 6.7 17.7 8.6 8.6 9.9 10.8 8.5 19.8 12.5 8.7 8.2 9.9 6.6 12.4 9.3 15.1 7.9 7.0 8.0 10.5 10.5 6.9 10.9 12.2 8.7 7.9 11.4 8.0 5.4 10.6 9.8 5.7 11.7 7.8 5.8 11.6 9.9 5.5 5.2 7.6 10.5 5.2 8.3 4.5 2.7 2.7 5.1 3.9 4.6 3.5 4.3 2.9 1.9 0.7 6.6 2.9 3.6 3.9 2.3 2.6 3.0 5.7 3.7 3.0 2.8 3.9 3.4 3.4 3.2 3.2 3.8 9.6 12.8 17.0 29.0 11.6 5.2 6.6 8.5 12.0 20.3 7.6 6.7 23.2 11.5 8.3 7.3 27.1 8.7 17.4 10.9 1.9 14.8 8.0 27.1 10.1 9.8 7.8 21.0 38.3 7.8 5.3 10.1 8.2 11.6 13.3 19.5 5.3 10.2 6.6 11.8 46.5 8.6 4.1 10.7 4.6 2.3 14.3 12.5 5.4 45.9 11.7 7.4 14.4 50.8 53.4 13.6 11.9 11.7 12.6 5.6 22.0 9.0 13.1 20.2 0.0 14.7 12.4 11.7 8.0 9.0 7.4 4.5 9.7 13.1 11.4 6.2 RBM45 "DRB1, FLJ44612" ENSG00000155636 "RNA binding motif protein 45" Q8IUH3 2 178112424-178139011 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020448 Approved Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA020448: AB_1856133" "unprognostic (3.11e-2)" "unprognostic (1.91e-1)" "unprognostic (6.56e-2)" "unprognostic (2.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (5.74e-9)" "unprognostic (1.66e-1)" "unprognostic (4.25e-2)" "unprognostic (2.71e-2)" "unprognostic (2.42e-1)" "unprognostic (5.79e-2)" "prognostic unfavorable (5.34e-9)" "unprognostic (3.26e-1)" "unprognostic (2.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.94e-1)" 4.8 6.5 12.5 5.5 12.9 4.1 8.5 12.4 18.4 5.6 12.7 8.3 5.9 6.3 9.2 6.1 7.3 4.7 6.4 12.6 12.9 6.5 8.1 5.4 8.1 12.9 12.5 5.7 7.9 8.8 6.4 3.3 12.8 5.8 9.3 9.8 6.2 5.2 4.8 8.2 6.7 5.7 12.6 7.8 6.5 6.6 12.6 8.9 7.0 3.2 9.9 5.6 5.1 13.3 9.5 10.1 15.7 6.5 13.6 15.7 9.8 12.8 14.5 12.9 14.2 10.7 7.7 15.8 8.4 15.3 12.9 8.4 13.1 16.7 15.7 12.7 11.2 12.2 6.3 16.1 14.3 14.9 11.6 12.7 13.7 13.2 11.0 12.5 13.7 8.7 11.5 12.6 16.2 15.1 15.5 10.0 11.1 14.2 12.8 12.4 11.1 15.7 19.0 21.8 9.7 10.1 9.0 8.8 11.8 17.7 12.9 13.9 11.7 9.1 8.6 10.7 12.7 11.7 14.4 20.3 8.9 11.9 12.8 3.8 5.3 1.9 6.2 8.6 7.1 12.5 6.5 6.8 7.2 8.6 5.9 7.3 1.0 11.3 10.2 7.7 10.9 5.3 12.5 12.9 12.4 18.4 12.6 12.9 12.9 12.5 12.8 12.6 12.6 13.3 5.2 3.2 4.2 8.5 6.3 2.5 3.5 11.3 5.2 7.1 4.3 3.6 4.2 8.6 6.6 1.8 10.4 5.6 8.1 5.0 7.9 7.3 3.8 4.8 5.4 5.9 6.0 8.6 10.2 6.6 10.3 5.7 7.7 3.5 8.2 8.2 3.3 5.1 8.2 10.1 13.1 7.6 4.1 8.1 3.3 4.3 4.4 5.3 1.8 6.5 8.1 7.6 6.2 15.1 13.7 5.2 6.5 5.7 8.0 1.7 6.1 7.0 9.6 9.1 6.6 6.1 6.1 11.4 5.6 6.2 3.4 1.8 6.2 9.1 4.9 2.7 RBM48 "C7orf64, DKFZp564O0523, HSPC304" ENSG00000127993 "RNA binding motif protein 48" Q5RL73 7 92528773-92540481 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021777, HPA025306" Uncertain Enhanced Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA021777: AB_1845763, HPA025306: AB_1845764" "unprognostic (2.79e-2)" "unprognostic (2.15e-1)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (2.81e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.86e-2)" "unprognostic (2.37e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-3)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (2.43e-2)" "unprognostic (8.04e-2)" 8.3 8.6 8.2 5.6 9.4 14.1 8.2 10.1 12.1 9.0 6.5 8.0 5.3 8.2 4.8 7.6 8.4 3.8 10.0 8.5 7.5 7.4 9.0 6.4 8.4 9.0 7.7 9.8 8.5 4.6 7.5 4.6 9.1 8.2 4.6 6.5 8.3 3.3 13.5 8.0 9.0 3.7 7.3 11.3 8.0 8.9 8.5 6.5 8.4 7.0 6.4 7.3 8.3 12.1 5.5 4.0 6.8 11.1 6.5 7.3 5.4 6.5 5.2 6.4 6.1 4.9 6.9 8.0 11.8 4.4 9.9 6.2 6.6 4.6 7.9 7.8 9.4 5.3 12.0 5.8 5.2 10.2 7.1 5.2 8.5 7.2 6.5 8.9 6.9 10.1 11.5 13.1 6.9 5.6 12.1 10.1 6.1 6.9 5.8 6.5 6.1 9.8 5.9 5.9 7.6 9.9 5.7 11.6 8.6 8.3 3.7 8.5 4.4 11.7 6.3 9.1 8.9 8.6 11.1 13.3 5.3 8.6 11.0 67.8 12.4 30.3 23.2 16.3 25.7 28.5 25.1 23.7 12.3 28.7 32.1 27.3 19.2 26.2 13.3 14.3 25.7 16.0 8.2 9.4 10.1 12.1 8.5 7.5 9.0 7.7 9.1 7.3 8.5 12.1 13.5 12.8 7.5 8.1 23.5 8.5 13.2 11.9 12.5 12.7 8.7 7.7 16.7 5.7 10.9 3.7 0.0 10.9 18.8 6.9 7.9 9.2 9.4 9.5 12.3 13.8 0.0 8.6 20.5 6.0 5.8 11.7 6.6 12.9 30.4 11.9 7.9 3.7 6.2 11.8 15.8 4.0 14.2 6.8 6.4 5.9 5.9 8.1 5.4 5.6 9.8 11.5 26.8 11.1 34.3 5.5 6.2 6.4 16.6 10.5 7.0 9.6 7.8 13.2 13.1 15.0 13.7 24.0 15.5 9.9 11.4 15.3 18.9 8.4 5.7 11.8 RBM5 "H37, LUCA-15, LUCA15" ENSG00000003756 "RNA binding motif protein 5" P52756 3 50088919-50119021 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017335, HPA018011" Approved Enhanced Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA017335: AB_1856134, HPA018011: AB_1856135" "unprognostic (4.11e-3)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-1)" "unprognostic (2.61e-3)" "prognostic unfavorable (9.77e-4)" "prognostic favorable (6.46e-4)" "unprognostic (1.16e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.58e-4)" "unprognostic (5.58e-2)" "unprognostic (1.49e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-1)" "unprognostic (3.89e-3)" 70.6 53.9 42.2 44.2 45.4 63.5 69.8 48.4 49.6 96.2 47.9 74.8 37.4 74.6 64.0 57.5 85.8 40.1 58.0 41.1 52.5 66.2 58.1 61.8 66.8 46.5 42.5 120.2 73.1 45.2 84.7 60.1 46.2 85.2 47.7 90.5 63.9 47.2 63.6 81.6 72.1 53.7 40.9 95.2 64.8 62.9 44.1 62.5 80.8 36.4 69.5 66.6 73.2 62.5 31.1 37.3 132.6 58.2 54.3 78.1 31.3 91.9 54.8 67.0 46.9 37.6 34.7 72.4 31.0 60.3 65.6 26.8 90.4 44.5 71.5 67.5 33.2 91.0 136.5 34.2 66.7 84.1 71.0 70.1 49.8 72.7 71.3 114.5 71.9 72.5 63.3 47.4 63.7 27.3 85.6 56.9 47.9 52.3 42.3 46.3 57.9 37.6 48.7 152.1 19.0 43.8 75.6 32.8 46.2 89.5 30.2 79.9 82.0 44.3 45.9 61.7 53.7 64.8 103.2 76.4 32.9 50.8 52.3 54.3 21.4 29.2 24.8 22.2 23.3 20.5 22.2 25.9 18.4 19.6 27.9 22.3 39.0 22.9 22.6 13.9 28.5 17.0 42.2 45.4 48.4 49.6 41.1 52.5 46.5 42.5 46.2 40.9 44.1 62.5 70.1 70.5 103.3 108.7 69.9 32.0 39.8 31.1 27.3 94.4 43.9 44.2 44.5 25.8 68.2 38.6 183.5 52.5 77.0 51.3 11.7 27.3 128.2 52.4 67.9 67.9 73.5 40.2 100.8 20.9 26.2 54.4 74.5 47.8 68.9 85.1 60.3 40.0 32.4 94.2 107.1 53.7 50.8 42.2 48.4 246.2 64.3 56.4 44.4 96.5 66.9 43.2 75.2 117.6 136.0 30.8 45.8 57.9 64.5 49.5 42.4 11.3 84.0 126.1 32.9 62.4 57.1 57.8 33.0 31.1 34.0 81.7 68.1 52.2 44.7 55.5 RBM6 "3G2, DEF-3, DEF3, g16, NY-LU-12" ENSG00000004534 "RNA binding motif protein 6" P78332 3 49940007-50100045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026272, HPA027164" Enhanced Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 72: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Cytoplasmic bodies" "HPA026272: AB_1847592, HPA027164: AB_1847593" "unprognostic (3.81e-3)" "unprognostic (2.13e-1)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (4.53e-2)" "unprognostic (2.88e-2)" "unprognostic (1.40e-2)" "unprognostic (7.97e-3)" "unprognostic (8.84e-3)" "unprognostic (5.09e-2)" "prognostic favorable (1.41e-4)" "unprognostic (4.31e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (7.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.13e-5)" 65.2 75.5 51.4 43.7 50.5 45.8 58.3 56.9 96.4 108.2 53.0 81.5 43.4 70.0 34.5 51.7 81.7 27.6 74.3 51.0 54.8 74.3 78.1 64.7 59.8 53.6 51.0 96.2 89.7 36.7 72.8 30.3 50.0 98.2 39.5 64.3 50.3 36.0 44.0 54.3 78.0 42.2 48.1 103.5 69.3 66.1 53.1 48.6 74.9 25.7 50.1 67.2 68.5 51.7 28.6 18.0 73.0 48.1 70.8 38.4 25.9 47.8 41.0 40.8 42.7 31.0 31.4 147.2 27.0 47.0 41.1 23.6 61.2 40.9 51.3 57.3 23.2 68.6 46.1 41.3 40.0 71.3 69.4 36.0 50.5 45.7 50.9 76.4 52.2 37.0 57.0 36.0 39.3 26.9 66.8 106.0 57.9 34.7 32.0 26.1 31.0 38.0 40.4 57.0 28.8 51.6 43.7 31.0 30.9 62.9 25.3 55.7 48.8 41.2 48.0 33.3 48.6 49.7 123.7 84.9 23.7 58.6 40.6 16.4 8.5 5.2 13.3 4.6 11.2 12.3 9.3 8.2 8.8 11.5 9.3 10.2 5.6 7.2 8.8 9.6 7.0 6.1 51.4 50.5 56.9 96.4 51.0 54.8 53.6 51.0 50.0 48.1 53.1 51.7 76.0 57.7 75.2 172.4 87.4 54.0 43.0 34.2 67.7 120.1 43.5 33.8 35.7 40.0 45.9 62.5 102.2 38.2 91.9 46.4 11.7 33.4 31.9 51.2 69.5 57.2 47.3 51.9 195.6 28.0 33.0 53.9 64.7 46.3 43.0 93.0 45.7 36.0 27.8 92.5 216.8 44.5 36.7 56.1 82.2 25.2 65.6 50.1 60.5 161.1 66.1 43.4 62.8 154.3 177.9 34.3 32.4 60.5 106.9 51.2 60.9 17.7 49.1 145.7 46.0 55.6 63.7 135.3 56.7 46.7 45.3 36.3 66.4 66.3 39.5 35.2 REV1 REV1L ENSG00000135945 "REV1 DNA directed polymerase" Q9UBZ9 2 99400475-99490035 "Predicted intracellular proteins" "DNA damage, DNA repair, DNA synthesis" "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044534, HPA051036" Uncertain Approved Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Cytosol "HPA044534: AB_2678975, HPA051036: AB_2681319" "unprognostic (3.05e-1)" "unprognostic (3.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (7.87e-3)" "unprognostic (1.30e-3)" "unprognostic (3.56e-3)" "unprognostic (2.78e-3)" "unprognostic (1.01e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (3.17e-1)" "unprognostic (1.45e-1)" "unprognostic (4.36e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-3)" 9.8 11.6 7.0 6.1 7.6 7.0 11.2 13.1 9.6 11.9 9.4 9.3 6.1 14.2 17.3 10.5 11.4 7.9 12.4 7.2 8.7 9.0 10.0 11.2 10.0 7.0 7.4 12.1 6.9 8.8 10.4 7.3 6.8 11.2 9.2 12.2 9.4 12.0 15.7 10.3 9.0 10.1 6.9 9.4 8.2 9.6 8.5 9.7 10.3 23.7 10.0 10.5 11.5 8.5 7.9 2.0 12.4 4.7 9.5 9.3 13.0 8.6 10.8 9.9 11.3 4.6 7.5 15.9 6.7 9.2 10.4 10.9 9.3 11.5 15.3 7.0 5.8 8.1 7.7 10.5 10.6 10.6 16.5 9.1 13.7 8.9 13.0 11.1 12.9 8.1 9.4 5.3 11.1 5.2 11.2 19.0 8.9 5.1 5.2 17.4 8.8 7.0 12.3 13.4 8.0 8.5 7.6 6.4 11.2 13.3 6.6 15.2 9.1 11.7 9.7 4.9 5.7 7.2 7.8 12.8 4.8 13.4 9.2 0.0 0.2 0.0 0.3 0.2 0.2 0.1 0.5 0.4 0.3 0.4 0.9 0.7 0.1 0.3 0.1 0.1 0.3 0.1 7.0 7.6 13.1 9.6 7.2 8.7 7.0 7.4 6.8 6.9 8.5 8.5 45.3 70.5 61.9 59.4 27.7 48.3 57.5 37.8 58.6 84.2 21.7 20.4 52.5 20.0 38.6 22.0 39.6 32.9 17.5 24.1 5.9 18.4 29.2 41.6 32.8 31.6 17.5 35.7 71.3 18.1 20.0 33.8 31.6 30.0 25.3 32.4 23.6 18.0 19.1 82.4 78.2 16.3 26.4 17.6 28.3 21.6 27.1 20.6 19.6 53.4 27.3 36.7 14.4 60.3 77.0 16.4 25.6 46.3 23.3 51.0 30.0 12.5 33.7 57.2 26.3 51.2 28.8 52.1 53.8 36.3 35.5 35.2 26.8 39.7 19.3 63.5 RFC1 "A1, MHCBFB, PO-GA, RFC140" ENSG00000035928 "Replication factor C subunit 1" P35251 4 39287456-39366375 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" Neuropathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009520, HPA046116, HPA069306" Supported Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115" "unprognostic (8.23e-2)" "unprognostic (2.30e-1)" "prognostic favorable (4.43e-5)" "unprognostic (4.15e-2)" "unprognostic (4.08e-2)" "unprognostic (3.38e-2)" "unprognostic (7.48e-2)" "unprognostic (3.30e-1)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-2)" "unprognostic (4.14e-2)" "unprognostic (1.62e-3)" "unprognostic (4.48e-2)" "unprognostic (1.31e-1)" "unprognostic (5.41e-2)" "unprognostic (1.47e-2)" 15.6 19.0 13.7 16.7 19.2 33.1 22.2 15.4 15.6 16.9 12.0 15.3 13.3 19.2 17.4 13.8 14.6 12.2 16.5 13.5 14.9 20.8 25.5 18.2 30.2 16.5 15.6 26.1 29.0 31.4 14.7 14.6 18.0 17.8 14.8 24.3 16.6 16.1 11.6 14.9 13.8 17.1 15.4 17.0 14.9 11.8 14.8 28.0 23.1 15.9 30.2 13.5 14.1 25.5 43.5 19.4 53.7 44.1 25.4 32.0 27.5 49.1 44.6 49.2 58.2 37.8 43.1 106.5 32.4 33.2 52.8 20.7 49.8 42.6 78.5 19.5 33.9 48.0 35.6 34.7 30.6 67.5 30.7 24.6 33.8 49.9 55.3 39.1 38.8 52.1 48.0 22.1 37.9 17.5 99.7 43.4 33.0 26.8 24.2 78.1 97.8 33.7 21.4 30.1 37.6 36.4 29.1 11.3 37.6 33.4 29.8 37.5 30.0 40.3 49.6 37.8 63.1 31.0 45.8 101.3 33.1 69.3 41.2 8.2 8.6 3.8 13.7 6.9 10.1 14.6 11.7 11.9 6.9 16.1 13.8 12.2 3.9 12.6 8.9 14.3 11.5 5.5 13.7 19.2 15.4 15.6 13.5 14.9 16.5 15.6 18.0 15.4 14.8 25.5 65.5 64.1 120.6 33.0 62.9 20.6 37.9 26.5 47.3 67.8 60.5 62.4 86.1 45.8 37.0 57.0 60.5 43.1 83.8 30.6 72.4 54.8 73.0 45.9 79.1 56.1 30.0 57.9 22.0 66.0 48.5 54.9 28.1 60.0 25.9 82.2 57.8 82.0 30.7 85.8 32.1 58.2 12.2 44.3 16.6 32.3 82.0 35.1 16.0 22.5 58.1 82.7 107.1 38.7 95.7 51.1 34.2 91.7 75.0 50.0 36.1 124.2 32.6 83.3 59.2 61.6 54.6 49.0 66.5 38.2 21.3 32.2 63.7 70.8 49.1 44.5 RFXAP ENSG00000133111 "Regulatory factor X associated protein" O00287 13 36819222-36829104 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding SCID "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032035 Approved "Nuclear speckles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA032035: AB_2674120" "unprognostic (2.03e-1)" "unprognostic (9.69e-2)" "unprognostic (7.40e-2)" "unprognostic (3.13e-1)" "unprognostic (5.14e-3)" "unprognostic (4.45e-3)" "unprognostic (1.15e-2)" "prognostic favorable (2.26e-5)" "unprognostic (1.45e-1)" "unprognostic (2.94e-1)" "prognostic favorable (4.18e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "prognostic favorable (4.91e-4)" "unprognostic (2.81e-2)" "unprognostic (4.09e-1)" "unprognostic (5.99e-3)" 4.3 3.4 3.8 5.0 4.2 6.0 4.7 6.8 5.2 6.3 2.5 5.1 3.1 6.8 5.1 3.0 5.8 4.1 3.5 3.9 3.5 3.3 2.6 4.3 6.7 3.3 3.7 7.0 4.6 6.2 4.6 3.7 3.5 5.2 4.1 5.5 4.8 3.8 4.3 3.5 4.4 5.8 4.0 5.1 4.2 6.5 3.4 8.3 5.8 3.0 5.4 4.0 3.8 4.3 7.4 1.8 10.4 14.7 3.8 5.2 6.7 5.9 6.2 10.9 6.7 5.2 5.9 32.3 4.8 5.4 9.6 6.7 10.8 3.6 12.2 24.4 17.9 15.5 8.6 10.2 6.9 28.7 10.9 4.8 6.3 5.3 4.0 3.1 8.3 24.4 9.0 6.4 3.3 3.6 28.8 20.5 11.1 6.4 3.2 24.9 19.3 9.8 4.6 4.5 8.5 10.6 5.7 3.8 4.7 6.3 3.9 16.9 6.5 2.8 6.1 9.8 5.5 6.0 5.3 24.2 7.9 19.6 4.5 0.0 0.0 0.5 0.2 0.0 0.1 0.3 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.3 0.2 0.0 3.8 4.2 6.8 5.2 3.9 3.5 3.3 3.7 3.5 4.0 3.4 4.3 6.6 3.2 3.9 11.1 10.4 3.6 3.3 2.5 7.4 14.5 4.9 4.4 3.6 1.5 2.7 3.7 2.1 6.4 11.1 2.0 15.6 4.2 5.3 4.3 7.5 7.0 7.2 16.0 26.4 5.5 2.8 9.8 4.6 3.0 10.2 10.9 7.9 2.2 3.1 23.5 27.5 2.8 2.0 1.9 7.4 4.1 11.1 4.1 7.2 7.5 5.5 20.8 17.5 11.1 23.9 2.8 2.5 10.9 6.4 1.5 3.3 1.4 2.2 18.0 6.6 13.1 10.0 20.1 25.8 2.8 2.0 1.2 11.7 8.2 3.6 0.8 RGPD5 "BS-63, DKFZp686I1842, RGP5" ENSG00000015568 "RANBP2 like and GRIP domain containing 5" Q99666 2 109792758-109857705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 20.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.50e-2)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.23e-1)" "unprognostic (4.23e-2)" "unprognostic (3.19e-1)" "unprognostic (3.19e-3)" "unprognostic (3.19e-1)" 10.2 8.3 12.0 5.8 16.4 13.8 10.3 5.9 21.9 8.1 8.1 8.2 7.4 10.4 17.5 5.4 7.6 7.2 8.9 16.5 14.7 7.3 6.8 10.3 6.0 3.5 3.4 13.0 13.5 14.7 8.2 11.1 4.3 12.3 7.2 22.3 7.0 9.6 6.5 11.6 7.4 7.4 2.7 6.4 7.0 41.2 12.6 3.8 14.4 9.7 5.3 7.5 3.9 14.0 24.3 7.8 26.0 19.5 7.7 8.0 1.2 19.3 16.1 13.8 11.2 20.9 7.8 0.6 12.4 11.7 14.6 8.0 14.3 7.0 17.3 3.7 6.4 18.5 4.1 10.2 8.8 1.5 3.1 8.5 9.5 13.3 14.2 14.5 9.4 7.6 8.8 5.4 10.7 4.5 4.0 0.6 12.7 3.0 9.9 4.3 14.4 0.1 10.4 13.7 31.9 4.5 10.0 1.5 14.0 16.5 0.5 5.4 15.6 14.3 21.1 1.0 14.1 12.2 0.5 0.6 11.7 0.2 4.6 5.4 2.0 2.5 1.9 1.0 3.6 1.7 1.5 2.1 1.4 4.2 2.0 2.1 5.5 2.0 1.2 2.5 1.9 0.6 12.0 16.4 5.9 21.9 16.5 14.7 3.5 3.4 4.3 2.7 12.6 14.0 12.9 3.2 11.8 0.0 9.0 3.4 5.0 0.8 2.8 17.7 2.5 1.4 13.8 0.0 3.7 12.9 16.7 2.4 15.9 1.7 0.0 1.7 4.1 12.3 12.0 7.4 5.3 0.0 7.3 1.0 1.8 7.4 5.1 18.6 0.0 9.4 4.2 0.9 1.8 3.3 4.5 1.4 0.0 2.9 6.5 1.7 2.5 6.6 1.8 1.0 0.9 3.8 0.0 0.0 0.2 1.5 1.7 1.2 10.7 5.5 1.7 0.4 2.6 20.3 0.0 9.7 7.8 4.1 2.9 1.2 3.3 4.4 12.4 1.6 1.0 7.3 RIC3 "AYST720, FLJ11608, PRO1385" ENSG00000166405 "RIC3 acetylcholine receptor chaperone" Q7Z5B4 11 8106056-8169055 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 175.2;Cone photoreceptor cells: 143.9;Rod photoreceptor cells: 204.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 12.8;granulocytes: 4.5;T-cells: 6.7" "Cell line enhanced" "Detected in some" "GAMG: 2.3;HMC-1: 2.6;NTERA-2: 5.0;SCLC-21H: 8.3;SH-SY5Y: 5.8;SuSa: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065016 Approved "Intracellular and membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "HPA065016: AB_2685404" "unprognostic (2.51e-3)" "unprognostic (2.32e-1)" "unprognostic (1.21e-1)" "unprognostic (6.98e-4)" "unprognostic (3.22e-2)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.43e-2)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (4.45e-4)" "unprognostic (1.28e-1)" "unprognostic (2.23e-9)" "unprognostic (4.37e-2)" "unprognostic (5.53e-2)" "unprognostic (1.35e-1)" "unprognostic (2.52e-2)" 3.1 13.5 17.9 5.2 17.8 1.9 6.4 24.6 21.7 8.9 14.8 11.3 1.9 10.9 21.5 5.7 10.1 3.5 9.8 17.0 20.3 10.5 3.5 3.7 7.7 15.5 15.5 19.7 18.0 11.7 31.3 0.3 16.0 16.9 2.1 42.2 16.0 10.3 5.9 14.2 8.2 6.1 14.1 7.3 8.5 7.4 16.2 2.1 22.9 2.4 7.1 10.5 5.9 17.3 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.3 5.8 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.9 0.1 1.2 0.5 0.0 0.0 0.1 0.0 0.1 4.5 0.6 1.3 2.2 0.8 1.4 11.9 4.6 2.4 0.6 12.8 6.7 5.9 1.9 1.8 1.7 1.6 2.6 0.8 17.9 17.8 24.6 21.7 17.0 20.3 15.5 15.5 16.0 14.1 16.2 17.3 1.5 6.4 15.5 56.2 79.1 36.3 55.9 8.2 58.6 175.2 34.8 47.0 14.0 42.9 20.7 23.9 143.9 0.5 7.2 0.1 0.0 33.5 2.9 0.2 1.6 4.2 7.7 4.4 95.3 28.5 0.3 10.8 2.0 0.2 24.6 9.5 6.4 4.9 0.2 95.9 90.1 4.4 8.2 1.0 2.2 4.5 33.5 2.2 12.4 17.8 3.3 52.3 4.1 101.0 50.4 14.6 1.4 46.6 18.6 38.6 3.1 6.6 19.4 204.9 0.0 9.0 7.0 51.0 39.5 15.9 39.6 0.5 19.8 1.1 1.5 38.2 RIF1 "FLJ10599, FLJ12870" ENSG00000080345 "Replication timing regulatory factor 1" Q5UIP0 2 151409883-151508013 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036887, HPA036888" Supported Uncertain "Nucleoplasm,Nuclear bodies,Plasma membrane" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA036887: AB_2675361, HPA036888: AB_2675362" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.71e-1)" "unprognostic (4.71e-3)" "unprognostic (5.87e-2)" "unprognostic (1.79e-2)" "unprognostic (3.73e-2)" "unprognostic (1.86e-1)" "unprognostic (2.51e-2)" "unprognostic (2.84e-2)" "unprognostic (1.80e-3)" "unprognostic (4.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.41e-2)" 6.1 5.0 4.4 7.4 8.4 21.7 10.0 13.8 7.0 6.5 2.6 5.6 4.3 8.2 4.0 5.6 5.6 5.6 3.5 4.6 5.1 5.5 6.7 5.1 8.5 4.4 5.1 11.2 7.0 6.8 3.5 8.0 5.4 6.0 6.1 8.2 7.7 5.0 7.5 7.2 4.6 6.2 4.9 6.5 6.1 11.0 4.5 10.7 9.1 9.5 7.9 7.3 4.6 13.8 20.8 17.4 26.8 20.5 10.7 13.8 25.9 24.8 18.0 21.6 25.5 28.9 16.4 39.2 21.7 17.3 17.9 21.3 41.2 17.1 36.1 27.8 19.8 63.4 21.4 21.0 11.2 64.7 20.2 10.3 11.3 38.8 28.7 12.3 21.3 23.5 52.2 32.6 22.1 13.8 38.3 22.9 43.2 11.2 22.9 38.4 42.1 26.1 11.6 24.9 24.2 18.8 32.0 14.6 16.5 18.8 12.9 23.1 27.0 32.9 22.8 20.3 26.7 16.0 29.6 55.4 15.3 25.5 22.5 6.3 2.5 3.0 4.3 1.7 4.9 4.0 3.6 3.2 1.8 3.1 4.8 3.7 2.8 7.7 3.5 1.6 2.8 1.7 4.4 8.4 13.8 7.0 4.6 5.1 4.4 5.1 5.4 4.9 4.5 13.8 53.1 96.1 49.7 41.1 43.5 49.3 47.5 21.9 33.0 48.2 30.4 29.8 38.2 28.6 38.0 14.7 31.3 39.2 40.3 19.6 1.9 38.5 22.6 38.0 61.7 48.0 25.0 84.3 68.5 21.9 35.9 51.3 34.7 65.0 34.1 88.6 27.1 19.7 23.0 47.1 72.4 30.9 14.2 26.4 27.0 14.0 43.8 37.6 30.2 48.7 44.1 35.8 32.0 73.9 126.3 29.9 23.5 34.3 45.1 53.2 14.9 12.9 21.3 42.8 85.5 106.5 51.2 122.8 113.1 28.9 41.6 40.9 45.3 58.9 34.6 45.4 RMND1 "bA351K16.3, C6orf96, FLJ20627, RMD1" ENSG00000155906 "Required for meiotic nuclear division 1 homolog" Q9NWS8 6 151404762-151452158 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031397, HPA031398, HPA031399" Approved Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156" "unprognostic (1.12e-1)" "unprognostic (4.45e-2)" "unprognostic (9.70e-3)" "unprognostic (6.67e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.50e-3)" "unprognostic (6.56e-2)" "unprognostic (1.02e-1)" "unprognostic (1.73e-1)" "unprognostic (2.03e-1)" "unprognostic (3.57e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (9.74e-2)" "unprognostic (1.04e-1)" 12.6 13.9 7.7 6.4 8.1 4.4 13.6 7.8 8.9 9.9 8.2 10.3 13.4 8.9 11.7 7.5 11.9 8.0 12.1 7.8 8.6 36.9 30.5 7.5 9.2 8.2 8.1 14.6 9.5 8.9 6.3 9.6 8.4 6.8 11.3 7.1 7.1 7.7 10.9 7.7 12.1 7.5 8.0 7.3 8.0 9.1 8.6 8.1 18.6 10.0 10.1 9.2 8.1 8.2 16.0 7.2 15.1 32.3 20.6 46.7 21.3 24.6 23.4 18.6 25.4 21.5 11.7 14.9 17.4 16.1 23.1 13.5 29.3 14.9 32.1 17.7 23.8 24.1 11.0 44.5 43.4 53.9 7.2 33.4 19.5 26.9 39.7 22.8 25.0 22.6 26.3 11.5 29.0 54.1 18.6 18.1 11.1 16.8 14.3 21.0 19.7 18.2 26.7 7.2 26.1 25.5 17.9 22.2 29.5 18.6 36.6 34.8 13.8 14.6 19.0 30.6 20.0 12.1 17.5 17.6 36.7 42.3 17.5 1.9 5.6 7.1 6.4 8.2 10.4 11.6 7.6 9.1 7.0 8.9 10.1 9.3 2.8 13.3 13.3 3.2 11.8 4.5 7.7 8.1 7.8 8.9 7.8 8.6 8.2 8.1 8.4 8.0 8.6 8.2 11.6 0.0 11.2 12.1 6.9 3.8 6.4 10.2 9.1 8.9 15.4 13.7 11.9 5.7 11.9 12.9 12.5 27.0 7.4 7.6 17.6 15.6 9.4 10.9 18.4 7.8 3.0 8.0 22.4 10.7 21.7 8.8 4.1 12.4 9.5 25.0 10.8 16.7 13.7 5.0 20.6 9.7 6.1 12.5 5.7 6.4 6.8 9.8 3.6 8.4 12.3 7.7 10.3 15.6 21.7 9.9 11.2 6.4 5.8 3.6 33.8 45.1 9.3 6.9 0.0 6.7 14.9 13.0 16.8 8.3 2.7 16.8 8.4 27.3 15.3 5.3 RNASEH2C "AGS3, AYP1" ENSG00000172922 "Ribonuclease H2 subunit C" Q8TDP1 11 65714005-65720818 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 388.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065375 Supported Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA065375: AB_2685481" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "unprognostic (2.06e-1)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (7.88e-3)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.68e-5)" "unprognostic (1.48e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.72e-2)" "unprognostic (1.84e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" 17.4 23.8 15.7 9.6 16.4 19.6 16.8 16.8 19.4 30.6 16.4 35.0 8.5 27.3 6.5 14.6 28.2 6.3 18.9 15.9 15.5 27.5 16.8 16.4 13.9 15.3 15.7 34.0 16.9 7.5 32.3 5.5 16.1 34.4 3.9 7.7 16.5 9.6 10.1 11.9 25.0 6.1 14.5 33.1 23.1 13.3 15.8 9.8 22.1 3.6 8.0 27.9 22.2 17.6 13.5 12.9 16.6 13.1 13.3 6.3 5.4 7.4 4.6 18.6 15.4 15.8 15.4 19.9 7.7 6.8 24.1 19.5 14.0 10.3 12.2 13.5 30.2 20.2 40.9 7.4 2.3 3.5 17.7 7.3 3.6 16.7 4.7 11.0 8.0 21.4 10.9 22.7 7.8 19.9 33.9 19.0 10.3 6.4 15.6 27.1 11.3 27.4 4.9 7.8 20.6 20.4 3.5 14.5 8.1 5.1 17.6 7.1 8.2 17.9 15.7 18.3 11.7 20.6 6.3 6.7 26.6 16.8 14.8 3.3 14.6 3.7 9.2 10.7 9.9 12.7 6.2 6.8 9.2 12.8 7.6 5.7 3.0 11.2 8.0 23.3 6.9 9.8 15.7 16.4 16.8 19.4 15.9 15.5 15.3 15.7 16.1 14.5 15.8 17.6 94.0 25.6 39.9 8.5 90.6 31.6 109.5 59.8 23.9 26.7 82.2 102.7 69.8 94.4 44.5 68.0 8.4 73.5 89.5 64.6 105.7 62.6 40.0 34.1 75.5 77.7 128.4 124.2 14.3 46.6 107.8 89.5 32.6 36.7 65.4 168.7 104.6 103.6 128.0 23.5 12.5 52.7 42.7 93.6 51.4 138.2 135.8 73.1 64.0 7.5 90.7 47.5 145.2 8.5 16.9 43.4 83.1 100.1 119.0 74.5 132.5 271.4 37.5 23.5 111.7 66.1 101.7 66.5 68.5 44.1 36.9 208.0 68.6 388.0 53.9 95.9 RNF169 KIAA1991 ENSG00000166439 "Ring finger protein 169" Q8NCN4 11 74748849-74842413 "Enzymes, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038505, HPA046138, HPA047952" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "Nucleoli, Nucleoli rim, Cytosol" "HPA038505: , HPA046138: AB_2679553, HPA047952: " "unprognostic (1.71e-1)" "unprognostic (4.18e-2)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (3.86e-2)" "unprognostic (3.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-1)" "unprognostic (6.47e-2)" "prognostic unfavorable (8.04e-4)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (3.23e-1)" "unprognostic (2.34e-1)" "unprognostic (9.55e-3)" "unprognostic (1.21e-1)" 4.2 2.8 3.8 6.7 6.2 14.4 5.6 6.2 4.4 5.5 5.4 4.4 4.0 7.6 4.2 10.1 5.6 4.8 3.2 4.0 4.4 4.6 5.0 5.9 6.3 5.4 5.0 7.6 4.4 5.6 2.1 4.7 5.4 5.2 5.3 6.1 4.5 4.3 6.8 5.5 4.4 7.6 4.4 7.3 4.6 2.9 4.6 7.7 5.8 5.8 6.7 5.2 5.4 9.2 10.2 7.7 9.1 9.0 5.8 7.7 3.7 7.9 7.4 8.6 7.4 13.0 7.5 18.2 7.9 9.5 5.8 9.6 12.4 9.3 11.2 9.1 8.0 12.6 15.3 5.1 6.6 6.8 10.1 7.1 7.2 9.8 22.1 9.6 14.0 12.2 11.4 14.1 8.7 8.6 11.6 12.0 3.6 12.9 5.0 10.7 21.7 9.9 5.5 10.6 4.1 7.4 10.6 8.0 16.6 7.3 9.9 8.6 9.4 14.2 11.8 9.0 7.1 10.2 5.8 21.1 2.8 7.3 8.4 1.2 0.5 0.4 0.4 0.3 0.3 0.0 0.4 0.2 0.2 0.1 0.3 0.2 1.4 0.3 0.3 0.2 0.3 0.2 3.8 6.2 6.2 4.4 4.0 4.4 5.4 5.0 5.4 4.4 4.6 9.2 18.8 9.6 11.4 51.6 18.4 19.9 30.6 7.1 20.5 58.2 12.6 9.8 3.0 17.2 8.3 3.7 52.1 5.5 24.6 9.8 5.9 10.2 2.8 30.5 26.7 17.2 12.0 18.3 40.8 11.1 6.4 16.0 14.8 30.1 7.0 24.4 10.8 12.3 8.5 37.0 43.2 8.7 2.0 15.6 19.9 3.1 7.5 16.6 10.6 25.3 12.6 22.9 26.8 42.7 68.7 10.1 6.8 10.5 18.5 49.7 6.3 12.1 8.9 33.7 26.3 31.9 18.7 9.4 11.7 16.4 18.6 8.1 22.2 14.0 10.4 42.2 RNF170 "ADSA, DKFZP564A022, SNAX1" ENSG00000120925 "Ring finger protein 170" Q96K19 8 42849637-42897290 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050931, HPA054621" Uncertain NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" "HPA050931: AB_2681279, HPA054621: AB_2682545" "unprognostic (3.06e-2)" "unprognostic (4.20e-1)" "unprognostic (9.54e-2)" "unprognostic (6.37e-2)" "unprognostic (4.59e-2)" "unprognostic (2.84e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.59e-1)" "unprognostic (3.03e-2)" "unprognostic (1.61e-3)" "unprognostic (4.13e-3)" "unprognostic (2.00e-1)" "unprognostic (1.49e-1)" "unprognostic (2.13e-1)" 9.3 11.7 14.5 7.5 15.6 2.4 12.7 16.3 16.8 7.9 11.5 11.1 10.3 9.5 14.9 14.2 9.3 9.2 7.7 14.1 15.8 16.4 19.7 9.3 9.4 15.9 15.5 12.3 8.1 13.5 9.5 19.2 16.2 11.0 11.3 35.6 11.0 10.6 11.9 15.1 11.4 7.6 15.0 9.1 10.7 5.9 15.6 6.1 28.8 9.2 9.9 7.6 8.5 18.3 11.4 18.1 18.2 9.2 29.4 29.7 10.8 13.3 18.1 12.3 13.2 8.5 36.0 13.6 15.7 12.8 22.1 9.6 9.6 13.2 10.8 9.4 10.4 15.9 8.5 9.3 16.1 2.0 10.9 26.0 20.4 9.3 18.8 16.0 13.3 15.0 14.6 15.8 19.9 3.4 17.0 9.5 8.6 24.1 6.5 8.7 24.2 7.7 19.6 10.8 4.7 14.3 12.8 8.9 23.0 17.7 23.1 9.5 19.5 13.2 5.8 17.8 4.3 25.2 26.4 15.7 18.2 6.7 13.6 1.4 5.7 2.1 2.9 5.7 4.2 6.6 4.8 5.3 8.8 3.9 5.6 4.1 0.6 4.9 5.5 8.9 6.7 4.5 14.5 15.6 16.3 16.8 14.1 15.8 15.9 15.5 16.2 15.0 15.6 18.3 13.5 48.1 20.5 41.1 16.1 7.6 13.1 22.3 5.7 44.8 14.9 9.5 11.5 15.7 29.2 23.9 89.6 41.6 9.8 22.1 17.6 21.6 1.7 16.0 14.5 15.2 13.1 5.5 36.7 27.8 19.4 20.0 11.2 13.3 9.5 25.5 21.8 21.7 22.9 21.9 43.7 15.3 20.3 18.5 9.2 2.4 15.2 15.4 8.8 15.9 21.9 31.8 30.9 36.2 75.9 32.2 18.4 20.7 10.7 9.6 34.5 22.1 33.3 72.1 13.1 23.9 12.1 14.9 19.3 12.5 11.5 31.2 12.8 25.7 16.6 12.2 RNF187 "RACO-1, RACO1" ENSG00000168159 "Ring finger protein 187" Q5TA31 1 228487382-228496188 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/70: 189.0" "Low region specificity" "Detected in all" HPA030098 Approved Supported Nucleoplasm,Cytosol Yes No "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA030098: AB_10602923" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (2.83e-4)" "unprognostic (4.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.93e-2)" "unprognostic (3.46e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (5.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.92e-3)" "unprognostic (1.59e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" 26.8 66.6 16.2 7.5 16.2 11.3 25.8 14.8 24.3 40.5 3.4 28.1 8.6 31.8 4.3 59.1 28.7 5.6 35.4 15.9 16.9 40.7 52.0 23.6 7.3 19.4 15.2 39.3 34.5 22.5 47.7 5.5 18.4 33.5 3.7 9.0 39.7 8.2 64.2 45.0 22.5 5.6 15.6 37.0 27.6 20.8 18.5 8.5 36.1 19.8 6.1 29.9 41.2 19.8 26.7 23.1 14.8 28.9 16.8 12.5 26.6 21.5 17.3 15.6 12.7 12.8 19.2 65.9 43.1 28.9 11.4 20.9 19.1 22.1 5.8 25.9 28.5 20.8 13.2 12.6 46.1 22.1 34.4 20.4 44.7 11.6 15.8 18.3 14.0 52.6 35.6 115.2 12.4 17.7 35.2 20.8 30.7 19.1 24.0 27.8 12.5 61.5 11.4 17.2 29.9 30.0 21.9 44.1 62.3 4.3 34.6 50.2 27.8 18.3 16.9 19.6 19.3 189.0 56.7 36.4 46.7 22.7 28.7 0.0 0.5 3.6 0.6 1.0 0.7 0.5 0.7 1.0 0.6 1.0 0.6 0.7 0.1 0.4 1.4 0.7 0.6 0.3 16.2 16.2 14.8 24.3 15.9 16.9 19.4 15.2 18.4 15.6 18.5 19.8 54.0 25.6 15.5 8.1 47.2 36.2 42.9 10.6 38.7 85.2 59.5 58.5 70.8 65.8 14.2 40.5 18.8 19.7 52.2 39.8 113.5 15.2 0.8 35.5 47.2 32.1 40.0 118.4 16.6 24.5 27.1 54.4 34.7 32.0 44.5 45.0 41.7 67.4 27.4 55.5 17.2 36.6 2.0 40.1 30.5 4.2 24.5 35.8 39.2 12.2 29.7 145.3 62.8 7.1 12.6 21.4 23.4 25.9 35.4 44.0 32.9 126.4 10.3 47.7 19.7 52.2 38.4 4.2 21.5 57.0 55.3 17.6 54.6 217.5 38.6 31.7 RNMT RG7MT1 ENSG00000101654 "RNA guanine-7 methyltransferase" O43148 18 13726660-13764556 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039409 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli fibrillar center" "HPA039409: AB_10795289" "unprognostic (3.02e-1)" "unprognostic (1.07e-2)" "unprognostic (3.48e-1)" "unprognostic (1.71e-3)" "unprognostic (3.57e-1)" "unprognostic (3.04e-1)" "unprognostic (6.17e-3)" "unprognostic (1.43e-1)" "unprognostic (3.76e-2)" "unprognostic (1.42e-3)" "unprognostic (9.45e-2)" "unprognostic (9.15e-2)" "unprognostic (1.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.78e-1)" 10.9 9.6 11.8 12.6 12.1 43.3 15.3 12.2 13.0 11.3 17.2 11.6 8.5 14.0 11.5 11.3 11.2 9.0 20.3 12.1 14.2 11.6 11.2 9.5 14.4 13.6 15.2 17.2 12.1 13.0 13.9 15.2 14.8 11.6 10.4 27.4 12.1 10.5 18.4 14.2 10.5 12.5 10.9 12.1 10.6 16.7 11.7 14.9 17.5 15.6 15.2 11.4 10.7 12.6 24.9 14.4 27.4 20.9 20.0 25.1 19.2 19.9 24.7 20.3 27.4 17.3 11.7 27.7 23.9 20.6 31.6 9.8 32.7 28.6 34.0 15.4 17.6 21.0 14.8 16.4 21.9 54.9 17.1 19.4 30.5 21.4 59.9 26.6 15.9 31.1 31.8 26.9 23.3 15.4 35.2 19.7 21.0 50.1 11.2 22.7 29.0 37.9 18.6 19.2 21.1 31.7 22.5 16.4 38.1 27.8 14.3 22.6 16.5 40.6 56.8 33.3 21.5 53.8 63.6 56.9 29.9 20.8 20.6 45.1 17.6 12.8 16.7 14.6 13.6 23.9 15.8 14.2 11.8 25.7 20.5 16.2 9.8 14.1 17.3 29.5 19.0 5.6 11.8 12.1 12.2 13.0 12.1 14.2 13.6 15.2 14.8 10.9 11.7 12.6 62.5 73.7 29.9 48.6 148.5 70.4 67.3 97.9 75.1 115.6 50.7 56.1 56.5 35.8 56.5 46.0 123.0 66.3 143.4 46.5 68.4 51.0 75.4 85.2 88.3 43.7 74.8 37.4 75.3 48.0 59.2 71.6 66.3 113.9 34.9 85.6 40.7 38.5 39.8 106.0 83.9 56.3 85.5 59.4 63.6 21.1 72.7 78.8 49.8 45.0 68.0 51.0 60.8 56.8 78.9 56.1 47.0 60.9 99.7 72.3 49.0 64.8 48.0 148.3 39.5 85.6 60.0 111.4 115.1 50.7 68.3 126.4 113.1 48.8 50.0 50.3 RNPC3 "FLJ20008, KIAA1839, RBM40, SNRNP65" ENSG00000185946 "RNA binding region (RNP1, RRM) containing 3" Q96LT9 1 103525691-103555239 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 133.5;Rod photoreceptor cells: 143.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052434 Supported Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA052434: AB_2681832" "unprognostic (1.87e-2)" "unprognostic (9.61e-2)" "unprognostic (1.04e-1)" "unprognostic (4.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.34e-5)" "unprognostic (9.00e-2)" "prognostic favorable (1.53e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "prognostic favorable (7.82e-4)" "prognostic unfavorable (7.70e-4)" "unprognostic (3.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-1)" "unprognostic (3.19e-1)" "prognostic favorable (5.25e-4)" 31.4 24.8 9.6 22.7 9.5 24.4 30.7 21.3 24.2 35.7 0.7 30.8 23.4 33.8 54.0 16.2 35.6 21.2 30.1 8.1 3.4 29.8 17.0 26.0 33.9 3.4 1.0 37.9 44.9 24.7 33.4 12.5 2.2 25.2 22.2 63.6 37.3 21.4 44.0 37.7 29.2 16.0 0.9 30.0 22.2 15.9 5.8 20.0 55.0 16.9 26.0 26.7 27.4 23.0 10.7 8.7 17.8 8.8 10.4 18.8 11.6 14.4 9.7 11.3 17.1 9.3 17.9 20.0 22.8 7.4 6.7 20.9 11.5 11.1 13.7 13.0 20.3 21.1 52.0 9.5 7.7 28.2 17.4 17.8 16.8 9.9 6.8 16.2 10.4 17.3 13.4 22.4 12.8 5.8 16.8 13.7 11.5 9.8 12.5 22.1 16.7 15.9 14.7 11.7 18.8 9.0 9.9 13.7 14.6 9.7 9.4 12.5 13.9 12.3 12.2 6.5 9.5 17.2 6.4 18.1 21.4 21.5 6.3 249.7 91.0 70.0 53.7 46.1 39.5 109.3 65.0 50.2 28.9 127.7 75.9 69.6 252.6 40.0 53.4 111.9 48.2 15.6 9.6 9.5 21.3 24.2 8.1 3.4 3.4 1.0 2.2 0.9 5.8 23.0 28.8 28.9 43.5 108.0 31.3 7.5 17.4 13.3 30.1 104.6 21.0 26.5 20.2 12.8 30.8 27.6 133.5 7.9 31.1 23.9 15.6 10.6 44.4 20.7 22.1 18.8 16.9 13.9 89.1 10.5 4.1 19.0 34.1 18.5 20.8 22.3 16.1 9.9 7.6 62.2 76.2 19.5 14.2 23.0 10.8 6.5 24.8 22.3 16.0 44.0 37.3 40.5 25.7 64.8 71.2 10.8 19.0 21.4 26.0 10.5 19.9 7.3 41.8 143.1 26.3 35.2 23.4 22.8 11.9 18.9 8.9 10.9 26.3 16.5 14.3 14.0 RPAP1 "DKFZP727M111, FLJ12732, KIAA1403, MGC858" ENSG00000103932 "RNA polymerase II associated protein 1" Q9BWH6 15 41517176-41544269 "Predicted intracellular proteins, Predicted membrane proteins" Transcription "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041739 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA041739: AB_2677647" "unprognostic (8.83e-3)" "unprognostic (2.78e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (1.97e-1)" "unprognostic (8.61e-2)" "unprognostic (1.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-2)" "unprognostic (7.02e-2)" "unprognostic (3.73e-2)" "unprognostic (3.26e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (9.32e-4)" "unprognostic (4.30e-3)" 7.0 5.7 4.9 6.1 5.4 3.5 5.1 4.4 5.2 5.4 3.7 7.2 5.7 6.4 3.2 8.1 6.7 3.9 6.7 5.1 4.2 4.0 4.9 4.7 7.2 5.0 5.1 8.0 5.9 7.2 3.9 5.9 4.8 6.1 4.6 2.8 7.0 5.6 19.0 7.0 5.2 6.6 4.7 6.5 6.1 6.5 5.0 6.9 5.2 11.6 6.8 6.9 5.3 5.9 13.3 15.3 20.8 21.9 17.1 12.3 17.7 12.8 11.0 16.4 15.8 42.3 11.7 10.3 20.6 14.2 26.1 30.5 37.9 18.7 13.8 18.3 18.5 19.6 21.2 18.8 10.7 16.3 11.9 12.6 23.3 19.2 13.3 11.0 18.4 23.1 46.4 11.5 15.2 8.3 17.6 10.0 36.9 20.3 14.3 31.4 18.0 11.2 7.2 30.5 19.0 25.4 16.4 16.9 8.8 18.0 28.1 20.0 16.9 25.3 16.4 25.5 20.6 19.2 57.5 11.6 18.1 17.4 24.4 0.0 1.9 0.0 4.6 2.4 4.0 2.9 2.6 2.8 2.9 3.3 3.7 3.4 0.0 3.1 4.4 1.9 3.1 2.5 4.9 5.4 4.4 5.2 5.1 4.2 5.0 5.1 4.8 4.7 5.0 5.9 4.1 3.2 5.4 10.4 7.7 2.8 4.4 4.6 8.6 10.2 5.1 5.2 9.0 2.8 4.7 5.5 12.5 6.5 6.1 3.9 1.9 5.5 1.5 3.7 6.5 5.8 2.4 11.2 7.7 5.3 5.8 6.1 8.6 5.2 2.5 11.9 5.0 9.6 4.8 16.8 6.7 5.6 6.1 5.2 2.8 1.7 3.7 3.5 1.8 6.5 6.0 5.0 5.2 7.5 9.3 5.3 2.7 9.4 4.4 6.7 4.1 3.0 5.2 7.4 0.0 6.5 4.6 10.6 9.5 6.1 4.1 2.7 7.0 10.8 7.5 3.1 RPAP2 "C1orf82, FLJ13150, Rtr1" ENSG00000122484 "RNA polymerase II associated protein 2" Q8IXW5 1 92299059-92402056 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046443 Approved Supported Nucleoli,Cytosol No No "Cluster 11: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoli, Cytosol" "HPA046443: AB_2679669" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.71e-2)" "unprognostic (4.12e-2)" "unprognostic (4.96e-3)" "unprognostic (5.73e-2)" "unprognostic (1.23e-3)" "unprognostic (3.29e-2)" "unprognostic (8.01e-3)" "unprognostic (4.09e-2)" "unprognostic (2.59e-1)" "unprognostic (6.09e-2)" "unprognostic (7.02e-4)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.62e-3)" "unprognostic (4.10e-2)" 1.4 1.9 3.2 2.2 4.1 3.9 2.2 12.6 8.7 1.6 0.3 1.4 1.8 2.1 3.2 1.3 1.4 1.5 1.6 3.3 0.9 2.2 3.0 1.4 2.6 1.2 0.2 2.1 2.5 2.0 1.7 1.5 1.8 2.1 1.6 9.3 2.1 1.3 3.0 3.2 1.7 1.5 0.2 2.3 1.8 2.0 1.8 2.8 2.7 2.3 1.9 1.4 1.1 8.4 4.0 2.3 4.1 3.8 3.3 4.2 3.4 3.0 2.1 2.0 1.6 1.7 1.7 5.9 5.1 2.3 2.7 2.7 3.4 1.9 3.0 4.0 2.4 3.5 4.6 2.3 1.9 6.3 3.4 2.1 2.4 2.5 2.5 2.9 2.1 3.6 3.7 3.7 3.0 2.0 5.4 3.9 3.1 2.2 2.7 3.9 5.4 2.5 2.6 3.4 3.8 2.7 4.4 4.5 2.5 3.0 2.3 4.7 3.6 2.8 3.7 3.3 4.4 3.7 4.5 3.0 2.0 3.9 1.9 1.9 0.7 0.6 1.3 0.5 1.5 1.1 1.0 1.1 0.6 1.3 1.0 1.2 1.4 1.3 0.7 1.1 1.0 0.4 3.2 4.1 12.6 8.7 3.3 0.9 1.2 0.2 1.8 0.2 1.8 8.4 23.1 64.1 78.5 66.9 20.1 9.2 16.7 15.7 23.9 63.6 16.3 16.5 24.7 10.0 44.5 7.3 110.5 21.3 31.5 6.4 11.7 19.2 68.1 18.8 48.6 23.4 12.6 13.3 97.1 13.6 14.2 24.8 13.3 17.6 62.0 37.7 9.3 8.0 9.7 35.3 91.3 13.3 14.2 8.7 4.6 9.7 19.0 15.6 1.8 43.1 16.6 31.4 42.2 68.3 78.8 13.8 13.6 21.4 28.5 15.9 11.9 15.6 45.0 95.2 26.3 44.4 20.3 27.3 20.0 16.8 9.8 23.7 35.8 42.3 12.1 10.4 RPL7L1 dJ475N16.4 ENSG00000146223 "Ribosomal protein L7 like 1" Q6DKI1 6 42879616-42889925 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046049, HPA050478" Approved Nucleoli,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoli, Mitochondria" "HPA046049: AB_10964167, HPA050478: AB_2681138" "unprognostic (1.03e-3)" "unprognostic (4.37e-2)" "unprognostic (3.37e-1)" "unprognostic (7.97e-2)" "unprognostic (7.73e-3)" "unprognostic (4.26e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (2.56e-1)" "unprognostic (2.98e-2)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.06e-1)" "unprognostic (7.31e-3)" "unprognostic (4.58e-2)" 37.2 39.5 26.1 31.7 28.0 22.6 40.2 27.2 33.5 28.2 20.6 30.4 25.4 30.0 34.0 35.4 34.2 21.5 30.8 28.7 27.3 37.7 48.4 25.2 34.4 23.7 24.1 33.6 32.2 45.4 29.1 31.7 24.2 33.7 34.1 20.0 28.0 27.7 45.5 33.9 23.4 33.4 24.0 27.1 28.6 16.1 26.6 37.1 35.9 44.4 42.8 35.6 27.0 25.9 155.6 48.4 84.2 135.5 77.5 99.5 57.1 121.3 87.8 115.0 94.6 120.4 57.6 231.4 107.0 102.6 93.4 72.5 193.4 147.6 189.4 121.9 144.6 123.7 64.5 109.9 85.2 192.5 91.6 102.5 110.6 151.0 144.7 77.5 114.7 100.2 243.1 77.6 106.2 113.3 110.5 124.2 85.1 472.2 70.3 124.9 94.3 147.1 89.7 96.6 160.1 97.8 103.7 78.2 131.3 66.1 105.0 183.1 110.1 110.5 91.9 88.4 211.3 96.7 163.8 343.2 61.7 178.7 117.7 7.3 13.1 12.4 16.0 15.8 20.3 14.9 15.7 17.0 12.5 17.4 16.5 16.0 2.8 19.7 14.9 14.5 14.3 13.6 26.1 28.0 27.2 33.5 28.7 27.3 23.7 24.1 24.2 24.0 26.6 25.9 56.2 76.9 103.0 12.7 69.3 57.1 89.3 70.6 67.7 62.6 49.2 61.8 42.2 61.5 71.2 42.3 33.3 88.2 77.7 23.9 86.1 92.2 12.6 68.4 96.6 71.6 94.4 73.0 25.9 66.9 84.1 67.5 42.8 44.9 51.2 120.6 51.8 65.0 53.0 72.3 23.3 44.4 54.9 45.0 34.4 12.5 79.2 44.5 30.2 8.4 75.8 78.6 64.9 12.5 15.6 81.3 30.8 71.5 56.1 83.8 25.1 79.8 71.3 69.7 52.6 89.9 64.0 54.9 75.6 65.8 60.2 80.0 65.6 117.8 52.5 58.9 RRAGB ENSG00000083750 "Ras related GTP binding B" Q5VZM2 X 55717749-55758774 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 72.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (2.01e-1)" "unprognostic (2.82e-3)" "prognostic unfavorable (7.60e-4)" "unprognostic (2.44e-2)" "prognostic favorable (3.31e-5)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (3.64e-6)" "unprognostic (8.89e-3)" "unprognostic (1.56e-2)" "unprognostic (1.31e-2)" "unprognostic (2.71e-3)" "unprognostic (2.74e-2)" "unprognostic (3.35e-2)" "unprognostic (6.21e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" 12.6 14.8 13.1 7.1 13.4 8.2 14.7 11.0 12.9 14.0 9.9 12.3 6.9 18.5 34.7 8.9 20.5 13.0 15.2 13.5 14.2 16.2 8.0 11.1 8.3 11.2 14.0 22.2 8.0 23.1 14.9 11.4 12.5 16.4 9.6 17.1 8.9 18.0 12.0 12.1 8.8 17.3 12.4 11.3 9.6 9.2 15.2 10.2 22.9 15.9 8.7 12.0 10.0 12.5 11.9 8.9 10.0 7.6 34.7 32.2 2.6 10.3 19.0 9.1 12.2 5.2 7.7 3.5 72.6 14.4 7.6 7.5 9.1 5.8 8.4 6.5 12.7 5.2 12.1 10.5 24.6 8.4 8.0 38.4 21.9 6.8 8.8 36.8 12.3 9.3 7.3 8.1 15.3 8.8 4.5 11.7 10.4 3.2 14.4 17.0 11.1 10.0 13.9 15.3 10.0 8.9 14.2 4.4 15.6 25.4 12.9 8.8 6.8 11.2 5.2 10.4 5.6 11.1 16.4 6.7 8.5 18.2 5.0 7.1 4.7 4.1 5.0 6.7 7.5 6.8 6.5 6.9 7.3 10.4 7.4 7.5 1.4 6.5 3.9 4.6 7.5 4.0 13.1 13.4 11.0 12.9 13.5 14.2 11.2 14.0 12.5 12.4 15.2 12.5 14.5 12.8 17.4 22.9 16.0 8.7 15.3 16.1 19.4 20.4 9.7 10.2 16.4 4.3 10.4 18.4 14.6 7.4 6.8 4.9 27.4 9.8 1.8 14.3 16.1 12.7 4.2 11.1 32.4 5.0 5.5 15.6 10.7 11.9 17.1 16.7 5.7 2.6 7.3 20.2 29.6 5.1 8.2 5.4 7.8 2.9 9.9 7.9 5.4 23.4 7.8 27.0 2.1 28.6 38.2 4.3 10.8 15.4 6.4 9.0 7.3 19.3 10.4 25.6 0.0 17.9 16.6 7.7 14.6 11.2 7.7 4.8 11.8 26.9 6.9 6.9 RSAD1 "FLJ11164, HemW" ENSG00000136444 "Radical S-adenosyl methionine domain containing 1" Q9HA92 17 50478860-50485974 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA022436, HPA022967, HPA024459" Approved Approved "Mitotic chromosome,Mitochondria" Yes NA "Cluster 39: Non-specific - mRNA processing" "Cluster 39: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Mitochondria "Mitotic chromosome" "HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: " "unprognostic (8.21e-2)" "unprognostic (4.11e-3)" "unprognostic (3.72e-2)" "unprognostic (1.83e-2)" "unprognostic (3.49e-2)" "unprognostic (2.93e-2)" "unprognostic (6.01e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.04e-4)" "unprognostic (1.06e-1)" "unprognostic (1.65e-2)" "unprognostic (4.89e-2)" "unprognostic (2.95e-1)" "unprognostic (7.85e-2)" "unprognostic (3.22e-2)" 23.9 41.4 34.7 16.4 37.8 12.8 23.5 37.5 43.4 36.9 32.9 24.3 17.1 24.2 17.5 17.3 24.5 12.5 43.3 34.4 33.9 40.9 44.0 21.1 19.8 34.5 34.9 31.8 48.9 27.5 23.6 12.4 35.1 25.2 17.6 21.2 27.3 14.9 66.0 22.2 23.9 14.4 34.2 31.8 32.5 14.2 35.4 18.4 29.1 57.0 17.8 26.1 23.6 37.0 13.0 43.2 20.3 33.7 34.0 27.6 7.2 22.2 21.6 27.9 23.5 43.0 16.1 34.9 48.0 15.6 27.6 12.1 23.2 31.0 23.9 38.9 42.0 47.0 20.5 42.4 23.7 28.6 31.7 20.2 33.7 18.6 35.7 23.0 27.5 84.1 36.9 32.3 23.7 30.3 48.1 20.9 8.2 54.6 45.9 19.6 23.2 31.6 34.0 19.4 11.1 37.9 5.7 26.3 29.7 25.6 39.6 28.7 19.6 29.0 30.8 22.3 26.4 50.0 37.6 13.5 21.8 40.3 20.6 1.1 4.2 3.8 8.5 4.4 8.5 4.5 7.3 8.4 4.9 6.9 9.4 9.5 0.0 6.6 4.2 5.4 6.2 5.7 34.7 37.8 37.5 43.4 34.4 33.9 34.5 34.9 35.1 34.2 35.4 37.0 15.1 3.2 13.1 18.3 16.0 10.1 4.4 7.2 19.4 14.8 12.1 12.8 29.4 12.8 7.7 16.5 2.1 21.4 24.1 10.8 23.5 14.4 8.8 5.3 10.4 12.4 25.2 12.0 24.0 29.5 11.1 13.1 12.2 7.4 3.8 15.8 10.0 18.5 16.1 8.4 21.5 11.7 8.2 7.2 6.1 7.4 15.5 9.6 17.8 16.9 12.5 32.1 19.6 13.6 12.4 11.8 6.2 10.9 18.7 6.5 11.1 11.1 3.8 7.8 13.1 16.0 11.3 11.5 21.9 10.6 9.9 10.1 18.7 43.6 12.9 3.4 RSBN1L "FLJ42526, FLJ45813, MGC71764" ENSG00000187257 "Round spermatid basic protein 1 like" Q6PCB5 7 77696459-77783022 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 349.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 60.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 60.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020406, HPA020413" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Plasma membrane" "HPA020406: AB_1856488, HPA020413: AB_2253910" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (2.41e-1)" "unprognostic (1.72e-1)" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (2.43e-2)" "prognostic favorable (3.74e-4)" "unprognostic (1.27e-2)" "unprognostic (3.78e-2)" "unprognostic (1.25e-1)" "unprognostic (9.02e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-3)" "unprognostic (1.53e-3)" 7.3 6.4 8.7 11.5 9.1 8.2 12.1 19.0 12.1 10.3 10.2 11.3 9.0 12.5 10.3 10.8 9.5 7.3 5.6 8.5 10.5 9.1 11.3 10.5 16.1 8.2 9.0 14.5 11.2 10.3 6.9 9.9 8.6 10.3 11.7 30.2 9.6 11.4 8.2 7.8 10.4 11.0 9.0 15.0 11.0 26.3 8.6 18.3 16.5 7.6 15.0 9.6 8.2 11.6 15.8 11.9 19.6 34.5 13.4 17.0 9.5 11.5 12.4 16.0 18.2 14.9 27.6 32.4 4.4 12.0 20.2 13.4 26.8 15.0 22.8 17.7 14.4 25.8 18.4 14.7 11.3 32.1 23.3 12.2 10.7 14.7 16.0 12.1 13.5 21.2 35.7 33.0 16.8 18.2 27.7 32.1 14.0 20.3 10.6 28.3 19.6 34.2 10.0 20.5 22.9 24.0 17.5 31.4 12.6 19.9 19.2 16.9 12.9 23.9 21.9 14.5 17.7 14.7 16.7 51.6 11.4 29.2 16.0 21.6 7.4 13.5 9.5 5.8 7.3 11.0 8.4 7.1 4.4 13.5 7.8 8.6 60.6 6.4 6.7 13.9 9.3 2.6 8.7 9.1 19.0 12.1 8.5 10.5 8.2 9.0 8.6 9.0 8.6 11.6 53.6 57.7 60.3 27.1 85.0 78.8 102.1 76.1 88.8 246.8 52.1 57.3 22.1 61.5 84.4 55.2 235.6 52.7 101.5 77.1 39.2 38.1 271.3 55.5 63.3 60.8 77.5 47.7 44.3 50.4 34.1 55.6 51.5 45.6 70.3 51.3 49.2 56.5 43.7 158.2 47.5 104.6 57.0 48.1 69.0 85.2 101.5 46.4 64.0 34.7 59.0 83.2 132.8 53.8 50.1 35.1 62.7 119.6 74.6 56.7 49.6 28.4 72.0 349.9 72.3 44.2 73.0 108.0 156.7 56.2 75.3 38.7 90.2 61.7 79.1 84.0 RSF1 "HBXAP, p325, RSF-1, XAP8" ENSG00000048649 "Remodeling and spacing factor 1" Q96T23 11 77659996-77821017 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022626, HPA046129, HPA057547, HPA064567" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289" "unprognostic (2.67e-1)" "unprognostic (2.02e-1)" "unprognostic (2.39e-1)" "unprognostic (4.35e-3)" "unprognostic (5.00e-3)" "unprognostic (5.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.19e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.71e-1)" "unprognostic (2.22e-1)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" 12.5 17.9 10.8 16.5 12.9 25.7 15.4 43.9 13.7 17.1 1.5 12.8 9.4 20.0 8.9 14.1 14.5 16.6 14.0 8.7 15.4 14.3 11.7 13.2 15.3 8.3 8.5 26.3 16.9 17.3 6.5 18.5 8.5 15.4 12.6 25.9 10.2 13.4 11.7 9.3 10.8 17.5 8.0 16.3 13.5 23.8 12.0 22.6 22.3 13.4 13.5 17.0 8.4 15.5 27.7 18.2 62.0 33.3 20.6 25.9 23.3 31.7 31.0 25.5 31.4 48.0 37.5 46.7 33.2 22.3 39.4 28.1 36.8 23.8 47.7 33.4 16.3 43.9 25.1 13.0 19.6 42.2 30.0 21.8 17.5 35.0 55.8 29.7 32.7 15.2 72.8 43.0 29.7 18.7 29.7 23.4 36.1 32.9 24.8 49.1 107.5 30.6 13.5 35.5 37.3 37.6 48.8 19.1 18.5 32.2 34.3 20.6 41.2 45.0 38.8 71.0 23.1 25.7 35.7 106.3 11.9 28.1 34.5 49.3 17.8 32.8 27.4 16.9 18.8 34.3 16.6 17.6 14.2 35.0 22.7 22.9 46.4 23.7 30.1 32.0 17.0 7.5 10.8 12.9 43.9 13.7 8.7 15.4 8.3 8.5 8.5 8.0 12.0 15.5 100.3 118.6 113.5 99.6 98.0 90.5 69.3 89.7 93.9 123.0 68.8 85.1 97.1 54.3 84.3 73.5 75.0 57.8 85.1 53.0 46.9 79.2 112.4 72.9 95.2 96.5 85.6 71.8 129.4 55.3 50.6 90.5 51.0 86.0 95.5 132.5 79.9 46.2 45.6 146.4 129.3 64.7 71.2 62.9 68.5 40.3 126.8 66.5 56.9 98.4 93.9 124.6 120.5 157.8 144.7 73.1 63.4 118.1 74.8 97.6 44.1 38.2 69.7 97.6 105.2 99.3 100.4 114.8 109.4 57.2 84.0 67.5 99.9 141.7 58.1 91.6 RTL9 "KIAA1318, Mar9, Mart9, RGAG1, SIRH10" ENSG00000243978 "Retrotransposon Gag like 9" Q8NET4 X 110358816-110456334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.5;choroid plexus: 2.4;testis: 10.3" "Cell type enriched" "Detected in single" 6 "Theca cells: 6.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 2.0;U-2197: 1.5;U-87 MG: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA001242 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 18: U-2197 - ECM organization" "Cluster 52: Non-specific - Transcription" "HPA001242: AB_1079804" "unprognostic (6.03e-2)" "unprognostic (5.59e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-4)" "unprognostic (8.17e-2)" "unprognostic (3.04e-1)" "unprognostic (9.65e-3)" "unprognostic (1.13e-1)" "unprognostic (2.26e-2)" "unprognostic (1.45e-2)" "unprognostic (8.05e-3)" "unprognostic (1.03e-1)" "unprognostic (7.61e-3)" "unprognostic (6.98e-4)" "unprognostic (2.02e-1)" "unprognostic (3.37e-1)" "unprognostic (1.10e-2)" 0.1 0.1 0.5 0.0 0.8 0.0 0.0 0.5 0.7 0.1 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 2.1 0.0 0.2 0.0 0.0 0.7 2.5 0.8 0.0 0.0 0.2 0.7 3.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 10.3 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.5 0.3 0.2 0.7 0.1 0.0 0.0 0.3 0.8 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 2.0 0.3 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.2 1.5 0.5 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.5 0.7 0.2 2.1 0.7 2.5 3.5 0.1 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 S100A13 ENSG00000189171 "S100 calcium binding protein A13" Q99584 1 153618787-153631360 "Predicted intracellular proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 3084.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 28.3" "Group enriched" "Detected in all" 5 "dendritic cells: 11.9;NK-cells: 28.3" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 811.3;SuSa: 896.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019592, CAB025494" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 36000 "Cluster 48: NK-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "CAB025494: , HPA019592: AB_10601499" "unprognostic (1.50e-2)" "unprognostic (9.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (7.77e-2)" "unprognostic (9.72e-3)" "unprognostic (1.75e-3)" "unprognostic (9.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.83e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.43e-2)" "unprognostic (8.10e-2)" "unprognostic (1.82e-3)" "unprognostic (1.72e-2)" 275.3 137.3 237.4 47.7 247.3 4.4 222.4 241.0 347.5 133.7 214.6 198.9 30.6 111.8 72.1 91.7 129.8 103.9 310.1 233.1 240.8 262.2 66.2 138.0 48.8 252.9 245.5 138.2 75.7 317.4 73.9 70.1 249.4 100.9 59.8 25.8 156.1 64.6 250.6 114.0 116.5 68.9 245.8 111.7 94.4 41.2 251.6 21.2 318.7 220.6 49.6 121.2 122.7 258.6 188.7 153.7 174.5 111.4 150.7 437.5 62.7 254.7 400.0 150.6 172.2 150.4 203.7 4.9 471.6 435.5 22.3 174.7 73.5 158.7 132.7 0.8 68.1 12.0 178.0 129.6 99.8 5.9 39.2 355.3 59.4 135.3 145.0 441.9 346.5 1.3 61.4 0.3 475.2 663.4 0.4 3.4 141.0 161.1 460.2 30.0 180.4 1.4 811.3 141.9 53.4 2.0 544.7 277.2 576.7 896.9 226.4 6.8 495.0 103.3 57.9 139.5 312.0 2.0 5.3 9.3 185.5 3.2 62.1 4.1 2.0 0.2 0.4 0.9 0.9 4.1 0.4 0.3 7.0 2.0 0.6 0.5 0.3 28.3 1.4 11.9 1.4 1.1 237.4 247.3 241.0 347.5 233.1 240.8 252.9 245.5 249.4 245.8 251.6 258.6 331.0 28.9 106.1 29.7 9.3 110.5 177.4 105.0 103.0 2.1 311.2 345.6 141.9 164.5 104.0 465.3 0.0 132.4 15.3 148.7 248.4 323.3 8.4 399.3 449.1 251.9 124.7 17.3 1.2 323.6 202.1 450.0 58.6 573.8 23.5 185.5 372.3 51.8 162.3 0.0 0.5 167.5 61.1 31.7 107.7 36.3 771.7 37.1 238.3 13.1 14.8 308.1 1.0 0.0 8.8 488.4 164.7 314.1 6.3 240.0 128.7 521.7 77.1 6.9 0.0 234.2 132.5 12.8 23.4 80.3 75.7 74.7 20.5 3084.7 100.6 244.3 SAFB2 KIAA0138 ENSG00000130254 "Scaffold attachment factor B2" Q14151 19 5586999-5624046 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050894 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA 48000 "Cluster 38: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Vesicles" "HPA050894: AB_2681266" "unprognostic (7.46e-2)" "unprognostic (3.09e-1)" "unprognostic (7.69e-3)" "prognostic favorable (7.10e-4)" "unprognostic (7.95e-2)" "unprognostic (6.76e-3)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.11e-1)" "unprognostic (5.14e-2)" "prognostic favorable (2.53e-4)" "unprognostic (2.23e-2)" "unprognostic (2.82e-3)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "prognostic favorable (2.12e-4)" 26.8 35.8 23.3 22.4 23.8 35.2 25.8 28.0 30.3 48.4 21.0 35.3 22.2 38.2 21.0 23.1 44.0 15.6 30.8 21.7 29.6 40.6 30.7 27.8 24.4 24.2 23.9 56.2 30.5 18.0 48.6 14.2 23.1 43.0 16.1 34.7 27.6 18.6 41.5 25.8 34.3 19.3 17.5 39.9 27.8 32.5 23.9 22.3 38.9 20.4 21.2 31.5 35.0 27.5 44.9 54.8 38.8 30.4 36.7 23.7 47.6 40.9 21.3 24.4 23.3 69.9 31.4 84.9 36.9 19.9 19.6 39.9 47.2 24.9 39.2 59.8 53.5 64.4 59.5 54.6 21.2 53.0 58.2 23.5 25.4 35.2 26.9 23.9 24.6 29.3 63.6 40.6 28.7 48.9 65.7 53.1 69.9 33.1 59.9 82.2 34.2 47.6 27.7 70.5 37.6 35.3 54.7 25.3 35.3 24.4 36.5 33.0 40.5 30.7 32.7 39.3 57.6 55.2 52.2 58.6 31.2 47.1 52.2 42.8 12.6 22.0 14.6 10.8 16.8 13.9 13.2 11.7 11.3 14.9 14.5 11.7 23.4 9.4 12.3 12.5 13.4 7.9 23.3 23.8 28.0 30.3 21.7 29.6 24.2 23.9 23.1 17.5 23.9 27.5 40.6 41.7 45.1 79.7 69.7 46.7 58.1 41.4 47.3 70.2 39.1 30.6 28.7 20.0 39.3 33.1 75.0 46.8 63.0 46.4 23.5 49.7 7.6 44.5 92.6 49.0 43.0 45.8 36.2 44.4 44.7 47.3 44.4 58.3 42.3 45.4 26.7 23.3 30.6 43.7 42.7 46.5 57.0 27.6 49.5 13.3 72.4 46.6 26.6 32.8 52.2 77.5 52.5 29.7 34.6 42.2 48.6 65.8 70.0 50.3 54.1 61.5 55.3 78.4 46.0 75.4 47.9 68.3 78.8 37.3 41.9 32.3 79.1 59.7 44.8 54.2 SAMD8 "FLJ25082, SMSr" ENSG00000156671 "Sterile alpha motif domain containing 8" Q96LT4 10 75099586-75182123 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044402 Supported "Endoplasmic reticulum" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA044402: " "unprognostic (4.32e-1)" "unprognostic (3.14e-1)" "unprognostic (3.24e-2)" "unprognostic (7.87e-2)" "unprognostic (3.37e-2)" "unprognostic (2.77e-2)" "unprognostic (1.61e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (3.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (4.16e-3)" "unprognostic (3.89e-2)" "unprognostic (3.76e-1)" "unprognostic (2.53e-1)" "unprognostic (9.26e-3)" 14.0 10.8 17.1 7.2 22.8 17.0 10.4 20.8 18.7 14.8 10.3 7.2 6.1 11.1 7.2 15.6 10.7 9.2 11.3 17.1 17.8 7.3 7.5 10.1 6.9 23.4 24.9 13.6 5.1 9.6 9.2 11.5 22.5 8.1 4.9 22.6 7.7 8.0 27.1 7.1 6.8 10.1 23.6 7.9 5.6 15.2 21.0 6.3 7.8 14.7 6.1 9.5 12.9 29.7 8.7 7.8 12.7 10.0 28.1 25.8 15.1 14.8 29.9 9.1 11.7 12.8 12.4 5.9 9.4 14.3 10.5 15.3 6.8 11.3 15.9 7.2 8.3 2.6 8.0 8.6 15.6 2.7 6.8 24.4 11.2 18.0 24.8 24.6 14.1 6.7 5.6 10.4 21.0 6.1 5.1 4.1 5.7 6.4 23.9 4.4 10.6 2.8 10.3 7.8 1.8 8.7 13.9 17.8 15.1 13.6 7.4 3.1 22.6 10.5 13.7 12.6 10.4 6.9 6.9 6.0 16.4 7.0 6.7 3.1 3.7 2.5 2.9 4.8 1.8 5.5 3.2 3.4 3.4 5.9 2.7 3.1 19.2 4.0 6.6 3.8 3.0 1.3 17.1 22.8 20.8 18.7 17.1 17.8 23.4 24.9 22.5 23.6 21.0 29.7 24.6 9.6 12.5 25.1 25.0 42.3 28.1 34.2 23.9 20.9 21.4 11.3 26.7 10.0 26.5 14.7 14.6 10.4 18.1 10.0 0.0 10.9 47.6 17.3 29.8 24.3 23.4 4.4 50.9 10.2 12.5 29.4 10.2 23.1 12.7 18.5 23.2 10.9 13.2 18.5 37.2 3.3 26.4 16.3 48.4 10.9 25.1 27.8 12.4 35.6 27.8 20.5 12.3 38.2 77.1 16.3 11.4 25.2 22.2 22.3 11.8 7.7 35.4 32.7 32.9 30.9 23.9 54.7 24.3 42.9 42.9 68.0 20.2 12.4 5.2 40.3 SCAF11 "CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP" ENSG00000139218 "SR-related CTD associated factor 11" Q99590 12 45919131-45992120 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038862, HPA045456, HPA046345" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630" "unprognostic (2.83e-2)" "unprognostic (4.10e-2)" "unprognostic (2.01e-1)" "unprognostic (5.88e-2)" "unprognostic (1.19e-1)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (9.00e-2)" "unprognostic (1.37e-2)" "unprognostic (1.30e-2)" "unprognostic (4.10e-2)" "unprognostic (2.15e-2)" "unprognostic (6.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.76e-1)" "unprognostic (4.30e-2)" "unprognostic (4.13e-2)" 31.1 21.2 22.3 41.7 29.6 89.6 40.1 38.7 23.7 28.0 36.5 31.6 29.4 34.5 41.2 26.7 26.6 30.9 30.0 19.7 25.2 29.9 42.4 31.0 54.7 30.2 26.5 37.7 23.5 39.8 17.2 31.5 32.5 29.4 34.9 60.8 27.0 24.9 35.2 40.3 31.7 29.2 25.9 43.0 29.6 29.0 26.3 44.4 34.7 38.6 49.8 31.8 23.6 38.3 56.4 49.4 60.6 50.7 41.0 55.7 56.0 64.7 52.6 54.8 39.3 180.3 60.1 116.7 71.0 69.3 32.3 54.0 62.4 52.2 61.9 62.1 42.1 108.8 64.5 47.0 32.3 115.6 70.4 46.4 54.7 47.2 71.1 62.9 57.1 50.0 85.1 62.3 70.3 51.9 87.2 63.4 47.0 0.6 67.4 70.2 81.7 57.9 52.4 70.5 34.2 35.0 71.9 60.8 35.0 47.6 56.4 123.4 71.6 55.9 46.3 42.5 34.9 44.4 36.0 187.9 47.0 245.0 21.8 39.4 19.6 29.5 21.7 19.9 19.9 28.6 20.6 21.3 16.0 28.2 22.2 20.0 51.5 21.3 23.5 30.2 20.8 12.9 22.3 29.6 38.7 23.7 19.7 25.2 30.2 26.5 32.5 25.9 26.3 38.3 180.2 176.3 164.0 91.4 200.4 128.5 127.6 87.4 132.1 134.9 101.8 96.8 187.4 88.6 131.7 79.1 127.2 86.3 229.6 96.1 54.8 117.8 57.7 133.3 148.7 146.2 103.3 118.4 75.3 107.9 72.5 135.3 69.3 152.4 222.7 224.7 114.5 138.9 109.8 107.7 81.7 123.3 67.1 158.0 160.9 39.2 121.8 157.3 67.6 141.5 211.7 105.2 185.3 119.6 122.4 103.4 103.4 103.8 126.4 121.6 97.2 83.5 149.6 198.4 124.9 176.3 129.7 157.6 82.5 116.4 120.5 61.0 170.6 114.2 107.5 145.0 SCAP KIAA0199 ENSG00000114650 "SREBF chaperone" Q12770 3 47413681-47477126 "Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 135.2" "Cell type enhanced" "Detected in many" "Theca cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004713 Approved NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA004713: AB_1079868" "unprognostic (4.02e-2)" "unprognostic (2.56e-1)" "unprognostic (1.91e-1)" "unprognostic (4.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.26e-1)" "unprognostic (8.74e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-2)" "unprognostic (7.10e-2)" "prognostic favorable (7.14e-4)" "unprognostic (4.07e-2)" "prognostic favorable (4.33e-5)" "unprognostic (3.15e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (7.06e-3)" 23.4 135.2 30.2 15.8 27.7 17.1 25.8 35.3 37.5 29.0 35.2 36.8 24.5 31.4 17.4 37.5 28.2 14.5 29.8 27.8 26.2 33.3 73.7 22.2 15.9 32.1 27.5 35.4 34.1 28.3 34.0 18.2 30.1 29.1 21.8 27.5 25.1 18.6 27.5 47.0 34.3 20.5 18.8 37.1 32.3 39.2 34.0 18.6 30.6 19.3 15.6 31.7 29.3 26.0 19.7 28.2 28.8 45.6 51.6 26.4 51.3 18.8 27.9 30.0 28.3 38.0 31.9 31.5 26.7 30.4 30.7 20.3 41.1 38.8 31.7 23.6 29.0 54.1 37.7 40.9 51.4 33.4 32.5 33.2 40.1 36.4 42.2 24.9 26.1 32.0 38.5 21.4 24.8 28.9 37.1 49.2 30.7 39.7 40.1 20.1 25.9 37.5 24.4 37.1 19.0 35.1 27.1 33.8 18.8 36.8 29.5 37.6 22.0 27.2 33.1 39.7 26.8 21.2 24.6 18.3 27.6 30.2 20.9 6.0 5.9 6.5 6.6 4.9 8.7 5.5 5.4 6.0 7.0 5.3 6.1 6.1 15.8 6.7 4.2 5.4 7.3 5.0 30.2 27.7 35.3 37.5 27.8 26.2 32.1 27.5 30.1 18.8 34.0 26.0 15.0 0.0 16.0 34.0 11.6 11.6 9.8 14.5 19.9 23.2 20.2 18.9 14.6 11.5 16.2 20.2 29.2 27.6 9.8 55.3 0.0 13.9 13.0 11.5 12.8 12.9 12.0 10.1 39.3 15.1 15.8 16.9 26.5 16.3 7.0 53.5 7.9 46.0 16.3 53.8 39.7 20.7 10.2 13.4 8.3 28.6 19.6 10.4 24.9 15.0 7.7 18.6 14.4 27.6 30.2 10.6 33.8 21.4 18.5 10.2 40.6 9.7 17.9 34.7 32.9 14.0 22.3 14.6 25.0 19.6 11.6 79.1 12.1 100.1 31.4 9.0 SCYL3 "PACE-1, PACE1" ENSG00000000457 "SCY1 like pseudokinase 3" Q8IZE3 1 169849631-169894267 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005624 Approved Uncertain "Nuclear bodies,Microtubules" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" Microtubules "Nuclear bodies" "HPA005624: AB_1854916" "unprognostic (2.35e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (8.36e-2)" "unprognostic (7.13e-2)" "unprognostic (2.72e-3)" "unprognostic (1.31e-1)" "unprognostic (2.12e-2)" "unprognostic (2.85e-2)" "unprognostic (7.17e-2)" "unprognostic (8.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.20e-3)" "unprognostic (3.54e-1)" "unprognostic (1.75e-1)" "unprognostic (4.60e-2)" "prognostic favorable (8.85e-4)" 5.6 5.8 2.7 7.4 3.0 4.0 10.9 4.0 3.5 6.7 5.0 7.8 7.7 7.0 8.3 7.3 6.3 7.6 5.2 3.0 3.0 7.5 11.3 6.2 10.5 2.9 2.8 7.6 6.1 12.0 4.1 8.1 3.1 7.6 9.6 11.4 8.2 6.7 7.9 7.7 6.8 6.2 2.9 7.5 7.7 6.6 3.0 9.7 7.6 9.1 9.8 7.3 6.5 3.9 4.1 5.2 7.9 5.5 9.9 7.2 9.1 6.3 8.1 7.2 6.7 4.8 7.7 8.4 4.5 6.5 4.0 9.4 4.7 5.5 6.4 15.5 4.4 5.8 6.1 3.1 7.0 8.5 7.3 7.0 5.4 5.0 6.8 6.7 6.9 9.2 9.4 10.8 6.9 3.2 6.9 6.5 6.4 27.5 2.5 6.3 4.3 10.1 7.6 7.3 5.9 8.6 5.0 16.3 10.1 11.2 9.1 7.8 5.2 5.1 3.4 6.2 5.1 14.4 13.7 9.9 3.9 6.3 5.7 13.5 3.2 8.6 6.3 3.4 8.5 6.7 8.3 7.0 5.1 6.2 7.0 5.8 6.7 10.7 3.8 11.5 8.1 4.8 2.7 3.0 4.0 3.5 3.0 3.0 2.9 2.8 3.1 2.9 3.0 3.9 5.9 6.4 14.4 11.8 9.6 2.4 2.5 3.6 6.2 10.2 9.6 8.3 4.2 22.8 7.8 1.8 10.4 17.6 19.0 14.0 9.8 7.4 5.1 11.1 8.2 6.6 9.1 4.2 15.8 9.1 5.1 5.1 7.1 5.8 5.7 7.2 11.0 13.2 6.5 10.1 12.5 10.4 8.2 11.4 3.5 2.6 4.4 5.3 1.8 9.4 8.4 10.0 16.5 17.6 14.1 6.2 10.2 5.7 10.5 4.7 13.3 6.4 9.0 19.9 6.6 5.5 5.4 10.9 6.8 8.3 1.8 11.6 11.0 6.3 10.3 3.3 SEC63 "DNAJC23, ERdj2, PRO2507, SEC63L" ENSG00000025796 "SEC63 homolog, protein translocation regulator" Q9UGP8 6 107867756-107958208 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Transport" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 354.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053295, HPA060535" Supported Supported "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA053295: AB_2682105, HPA060535: AB_2684312" "prognostic unfavorable (3.32e-4)" "prognostic unfavorable (4.01e-4)" "unprognostic (4.08e-1)" "unprognostic (1.56e-1)" "unprognostic (4.36e-3)" "unprognostic (1.51e-2)" "unprognostic (8.33e-3)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" "unprognostic (1.04e-1)" "unprognostic (3.27e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (6.16e-4)" "unprognostic (2.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.56e-1)" "unprognostic (4.41e-2)" 27.5 33.0 11.6 22.0 14.3 32.9 23.3 14.4 12.9 30.2 25.7 19.2 16.8 25.2 29.6 19.5 21.8 22.0 19.0 12.4 15.3 20.0 46.6 21.7 16.7 13.3 12.0 40.4 61.2 31.7 14.4 20.9 14.2 27.7 18.6 21.2 77.8 23.3 14.3 15.5 18.0 22.2 12.3 16.1 23.1 33.0 12.1 22.6 52.1 14.1 17.3 21.8 14.0 17.7 28.5 17.1 46.0 57.6 47.1 55.2 41.4 59.2 65.0 27.8 39.2 30.8 34.6 52.8 49.4 53.7 34.4 40.9 32.3 38.3 42.5 63.8 35.7 57.2 25.2 31.6 73.2 65.9 32.5 43.5 61.4 44.5 97.6 50.0 39.3 31.7 48.5 82.8 57.7 22.7 20.6 29.5 36.4 30.0 18.1 65.2 54.4 43.7 33.5 37.1 40.3 45.7 32.9 48.8 59.1 31.2 34.9 95.8 42.5 41.6 25.8 42.2 46.6 31.4 25.0 52.9 45.9 56.4 48.7 5.6 5.2 5.0 4.8 4.7 7.5 4.4 3.9 3.9 5.4 4.0 4.3 3.4 1.7 7.1 9.8 6.9 2.2 3.5 11.6 14.3 14.4 12.9 12.4 15.3 13.3 12.0 14.2 12.3 12.1 17.7 55.6 118.6 143.3 38.2 64.4 85.0 70.5 90.9 42.7 57.7 67.8 54.2 78.8 81.5 125.5 53.3 39.6 80.8 71.6 39.2 11.7 86.0 40.3 48.7 102.8 61.6 53.5 31.5 52.5 125.4 96.4 107.1 46.9 54.8 68.9 84.8 59.6 126.7 62.7 47.1 50.8 80.0 83.4 56.7 78.9 23.9 106.2 54.8 80.0 42.2 54.3 61.0 59.8 60.3 64.8 81.9 53.5 118.8 144.6 91.1 37.2 38.4 116.7 49.9 46.0 108.2 77.2 143.1 75.0 44.7 80.0 91.0 52.3 354.8 60.8 73.8 SETD2 "FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A" ENSG00000181555 "SET domain containing 2, histone lysine methyltransferase" Q9BYW2 3 47016429-47164113 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042451 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA042451: AB_10806239" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (6.08e-2)" "unprognostic (1.01e-1)" "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.40e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.19e-2)" "unprognostic (2.45e-1)" "unprognostic (7.84e-2)" "prognostic favorable (7.99e-6)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (8.79e-2)" "unprognostic (5.43e-2)" 9.9 6.5 8.2 10.7 10.5 23.8 10.3 24.1 8.3 12.6 10.8 9.7 9.1 13.3 6.1 9.8 11.0 8.5 7.2 6.2 6.7 10.8 10.0 9.4 13.5 8.3 8.5 15.3 13.3 16.2 2.2 11.4 8.4 10.2 11.0 10.6 9.6 9.7 11.1 9.0 10.3 11.9 8.1 11.4 10.7 13.1 7.9 19.2 15.5 14.5 13.3 9.8 4.0 12.8 21.1 13.2 25.4 14.5 15.3 18.9 11.3 17.9 17.0 20.8 19.9 15.4 13.8 43.5 11.6 25.5 20.0 12.4 29.5 17.6 27.6 27.5 12.2 47.3 24.8 12.4 11.7 34.1 26.5 15.2 17.3 20.7 24.6 15.3 20.1 22.8 29.9 16.6 17.8 9.5 26.7 8.5 20.6 9.4 15.4 17.5 25.6 23.2 12.4 26.6 10.9 17.6 29.5 11.8 12.0 17.2 12.9 27.5 26.7 24.6 18.1 21.5 29.9 22.0 25.4 43.7 14.2 19.6 14.6 1.3 1.2 2.9 2.0 1.1 1.1 2.2 1.2 1.6 1.4 2.5 1.7 1.6 3.3 3.6 1.1 1.5 0.6 0.6 8.2 10.5 24.1 8.3 6.2 6.7 8.3 8.5 8.4 8.1 7.9 12.8 50.5 48.1 58.8 115.9 58.3 33.3 22.6 15.6 54.1 40.5 31.0 29.1 67.2 27.1 53.2 11.0 41.7 20.3 58.2 32.6 11.7 20.9 26.1 62.8 63.0 41.2 22.1 38.9 131.4 22.4 12.7 39.2 56.6 66.2 58.8 68.9 23.6 29.8 16.8 26.9 129.4 28.2 14.2 28.8 26.5 35.1 30.4 42.7 17.8 148.9 37.9 22.7 43.3 113.1 143.2 23.7 22.3 33.1 54.0 31.2 24.6 11.5 49.7 39.9 13.1 56.1 42.6 71.0 29.3 60.2 35.7 18.5 65.3 57.1 29.5 34.7 SFI1 "KIAA0542, PISD, PPP1R139" ENSG00000198089 "SFI1 centrin binding protein" A8K8P3 22 31488688-31618588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 119.5;Rod photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "unprognostic (7.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.73e-1)" "prognostic favorable (1.10e-4)" "unprognostic (9.82e-3)" "unprognostic (3.51e-2)" "unprognostic (2.56e-1)" "unprognostic (1.77e-1)" "prognostic favorable (5.80e-4)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (2.11e-2)" "prognostic favorable (1.31e-4)" 3.4 6.1 3.3 7.8 2.0 13.0 4.7 10.4 5.0 5.0 1.5 5.6 8.6 4.1 4.1 4.1 5.5 3.4 2.4 1.8 4.0 5.0 2.9 4.6 12.2 2.4 1.5 5.2 5.0 3.9 10.0 2.6 2.4 5.5 2.7 8.5 5.3 3.3 1.4 5.7 9.4 2.2 0.8 9.5 5.5 10.0 3.2 10.6 6.3 0.7 6.5 4.8 4.4 2.9 11.3 7.0 6.4 7.9 3.5 3.3 4.0 8.9 3.7 6.1 7.5 6.4 7.7 17.3 3.4 2.8 3.9 10.4 3.2 5.6 4.2 14.2 10.1 4.2 16.9 7.8 4.6 16.9 13.5 2.5 3.7 6.9 4.5 5.1 5.5 16.0 5.4 8.4 5.1 17.0 11.8 10.3 2.4 8.1 4.2 12.8 7.5 12.5 3.7 11.8 9.6 5.4 7.6 10.8 7.4 2.4 8.1 7.2 10.4 8.6 7.8 7.5 6.4 9.9 7.8 9.2 8.6 8.8 6.9 8.5 1.2 3.1 9.1 1.3 4.1 4.1 7.3 10.6 1.4 3.5 9.9 8.9 5.5 9.3 5.0 1.7 5.9 5.5 3.3 2.0 10.4 5.0 1.8 4.0 2.4 1.5 2.4 0.8 3.2 2.9 7.2 6.4 26.2 17.6 17.6 4.0 7.9 6.8 5.7 45.7 9.7 8.0 2.7 8.6 17.3 16.5 35.5 8.8 21.8 21.7 1.9 7.3 14.2 16.1 5.7 8.9 11.4 17.9 30.5 5.1 2.3 5.6 17.9 18.0 20.3 15.5 7.1 2.9 4.9 119.5 30.9 25.0 6.1 9.1 8.2 5.1 5.3 9.4 3.6 19.7 8.6 7.1 34.0 10.6 17.1 7.6 15.5 1.9 19.1 7.0 34.6 3.2 31.3 68.7 0.0 9.6 5.7 28.9 27.6 2.7 3.3 18.9 35.2 2.6 10.0 6.3 SFSWAP "SFRS8, SWAP" ENSG00000061936 "Splicing factor SWAP" Q12872 12 131711081-131799738 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039362, HPA040063" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane, Cytosol" "HPA039362: AB_10794089, HPA040063: AB_10795413" "unprognostic (1.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.39e-3)" "unprognostic (2.04e-1)" "unprognostic (4.45e-2)" "unprognostic (2.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.44e-1)" "unprognostic (1.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (7.50e-2)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" 26.9 18.3 18.5 10.1 20.8 28.1 26.3 18.5 24.8 27.1 13.7 25.9 10.1 24.6 4.0 23.2 24.5 4.8 20.2 18.2 19.0 24.9 19.4 20.3 11.3 20.4 19.3 29.0 21.9 7.4 21.7 8.1 19.8 21.8 4.3 9.3 20.2 6.8 29.5 32.6 24.6 5.6 16.9 28.4 20.8 16.3 21.2 12.6 24.5 6.7 7.6 22.3 24.3 25.1 26.1 23.0 16.0 17.0 12.6 10.3 35.8 19.7 13.6 22.9 15.6 22.6 12.3 31.9 18.0 14.8 11.9 23.9 22.7 18.1 13.2 9.9 36.0 29.0 12.9 27.0 13.4 37.8 27.4 11.7 20.4 20.8 24.9 18.2 14.3 24.3 40.9 12.3 10.4 32.7 31.9 57.1 41.9 14.0 38.0 36.7 16.2 25.2 13.3 18.8 25.1 28.3 18.7 15.6 25.1 12.5 22.5 29.1 18.6 19.0 24.8 14.8 22.3 35.0 41.2 31.7 18.7 25.5 25.9 2.0 4.1 1.9 3.0 2.7 3.0 2.1 2.8 2.6 2.9 3.7 3.0 3.4 5.6 5.4 3.4 7.2 2.4 1.8 18.5 20.8 18.5 24.8 18.2 19.0 20.4 19.3 19.8 16.9 21.2 25.1 46.4 73.7 44.5 48.6 37.9 38.9 41.5 19.0 42.1 49.7 25.4 25.9 19.3 21.5 38.6 14.7 66.7 30.4 52.6 22.1 0.0 23.1 21.4 27.0 48.8 39.3 21.6 38.7 55.1 26.6 31.8 39.2 37.8 39.7 38.0 47.1 21.4 16.7 22.1 42.1 43.2 24.9 14.2 27.4 21.4 12.9 30.1 30.3 23.2 36.5 35.4 33.7 50.4 58.3 85.1 28.6 24.1 29.7 43.6 44.7 20.8 11.8 30.7 62.4 46.0 52.1 38.1 39.5 42.8 39.7 46.9 43.6 45.9 48.4 22.9 48.2 SGSH "HSS, MPS3A, SFMD" ENSG00000181523 "N-sulfoglucosamine sulfohydrolase" P51688 17 80206716-80220923 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 62.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023436, HPA023451" Enhanced "Intracellular and membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "HPA023436: AB_1856806, HPA023451: AB_1856807" "unprognostic (4.33e-2)" "unprognostic (4.03e-2)" "unprognostic (1.06e-2)" "unprognostic (4.01e-2)" "unprognostic (4.26e-3)" "unprognostic (1.39e-3)" "prognostic unfavorable (7.71e-4)" "prognostic favorable (2.72e-4)" "unprognostic (6.08e-2)" "unprognostic (3.65e-1)" "prognostic favorable (3.10e-4)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.42e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (7.50e-2)" "unprognostic (3.68e-2)" 16.6 45.9 1.7 12.2 2.3 3.6 17.2 0.7 5.2 13.5 8.8 14.8 12.7 17.2 4.6 11.0 16.0 10.6 9.9 2.0 5.4 15.7 9.5 18.1 13.4 4.4 7.6 12.3 20.4 16.0 17.0 12.4 4.2 19.7 6.5 2.8 21.8 11.1 7.0 18.9 16.7 10.6 2.5 28.4 17.8 3.9 5.3 4.2 21.2 4.6 6.9 15.5 11.5 1.8 2.6 7.9 9.8 15.6 22.5 20.2 10.4 16.0 40.4 27.7 24.2 9.0 9.5 0.1 25.7 24.9 13.2 9.9 6.2 11.7 4.7 5.3 9.6 0.0 22.3 25.0 62.2 0.0 5.9 33.9 12.0 9.9 10.5 5.8 50.7 4.7 7.1 26.2 17.9 16.2 0.3 0.2 3.3 10.0 13.2 1.4 3.7 21.1 20.2 18.5 2.0 11.7 18.4 44.1 10.6 4.9 32.8 0.5 32.5 31.9 7.0 11.4 7.4 26.1 3.6 3.9 13.6 0.0 16.3 0.0 20.6 0.0 12.1 8.0 16.0 3.5 10.5 11.3 20.4 3.8 8.2 6.7 2.1 9.3 8.0 1.5 13.5 12.7 1.7 2.3 0.7 5.2 2.0 5.4 4.4 7.6 4.2 2.5 5.3 1.8 7.5 3.2 10.8 4.2 5.5 5.1 3.7 5.9 5.7 3.7 9.3 9.3 1.7 5.7 7.3 7.3 8.4 18.2 5.2 12.0 0.0 8.9 0.2 5.3 9.2 10.1 3.0 2.7 2.6 15.9 8.7 10.1 17.9 10.0 0.0 13.6 9.7 4.5 17.7 0.0 3.4 9.3 4.1 18.2 7.6 0.5 11.5 13.0 1.8 2.8 8.4 4.1 6.2 4.5 1.7 6.8 6.0 14.3 5.5 5.5 8.1 4.9 3.8 3.9 13.1 4.0 5.3 0.3 0.5 6.4 5.5 27.0 7.2 32.0 8.0 2.9 SHPRH "bA545I5.2, FLJ90837, KIAA2023" ENSG00000146414 "SNF2 histone linker PHD RING helicase" Q149N8 6 145864245-145964423 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Helicase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 210.6;Oligodendrocytes: 164.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034854, HPA044852" Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" Cytosol "HPA034854: AB_10964488, HPA044852: " "unprognostic (3.10e-2)" "unprognostic (4.46e-2)" "unprognostic (5.61e-3)" "unprognostic (1.53e-2)" "unprognostic (7.40e-3)" "unprognostic (2.20e-2)" "unprognostic (2.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (5.03e-1)" "unprognostic (7.90e-2)" "unprognostic (6.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" "unprognostic (3.01e-1)" 4.9 4.2 3.1 4.7 3.7 4.2 7.2 18.4 5.1 5.4 3.2 4.3 4.2 7.7 6.0 4.3 5.2 4.6 3.5 3.0 2.5 5.5 4.6 4.2 6.9 2.8 2.6 12.2 3.9 6.7 2.0 4.5 4.5 5.5 5.0 16.3 5.8 5.1 4.2 9.7 4.5 5.7 2.5 6.4 5.4 7.6 2.9 7.2 8.4 5.2 5.8 4.3 3.3 5.5 4.2 3.2 15.3 9.1 7.0 7.3 7.2 4.9 3.9 5.9 7.6 7.0 2.9 14.5 5.9 3.7 4.6 7.0 9.5 6.9 7.7 6.5 10.9 14.6 7.6 6.1 5.2 31.2 8.6 5.2 7.8 5.6 8.0 5.8 6.4 10.0 20.3 7.9 5.1 3.7 19.8 11.6 10.3 6.9 5.4 14.1 23.6 5.0 8.0 4.1 12.6 8.8 8.7 7.9 5.4 10.5 4.2 14.6 7.2 3.7 7.0 7.4 5.8 6.4 9.4 17.1 3.9 13.0 6.0 0.7 0.9 1.9 1.7 0.9 1.5 1.5 1.4 1.1 1.1 2.5 1.5 1.3 0.0 1.5 1.0 2.0 1.4 0.5 3.1 3.7 18.4 5.1 3.0 2.5 2.8 2.6 4.5 2.5 2.9 5.5 31.4 28.9 23.4 106.7 31.0 21.2 17.9 14.5 19.4 117.2 21.5 20.3 17.2 20.0 20.7 22.0 210.6 16.1 34.6 9.1 7.9 18.6 20.4 20.9 52.8 26.0 19.2 15.3 131.0 12.9 7.0 25.9 23.9 18.1 13.3 145.7 15.7 20.5 12.0 94.2 140.3 14.7 6.1 21.4 9.8 8.0 50.7 19.8 14.2 93.7 30.6 40.7 36.0 143.7 164.6 15.9 8.8 34.3 23.5 18.8 17.2 7.5 14.9 158.5 72.3 47.1 39.1 83.2 65.0 16.5 19.7 6.6 26.4 61.5 18.0 12.5 SIMC1 "C5orf25, FLJ44216, OOMA1, PLEIAD" ENSG00000170085 "SUMO interacting motifs containing 1" Q8NDZ2 5 176238367-176345991 "Predicted intracellular proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 47.0" "Cell type enhanced" "Detected in many" "Granulosa cells: 58.2;Inhibitory neurons: 57.4;Spermatocytes: 83.1;Theca cells: 102.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037889, HPA037890" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli fibrillar center" "HPA037889: AB_2675720, HPA037890: AB_2675721" "unprognostic (1.15e-1)" "unprognostic (9.97e-2)" "unprognostic (3.81e-3)" "prognostic unfavorable (2.32e-6)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.20e-2)" "unprognostic (5.59e-2)" "unprognostic (2.75e-1)" "unprognostic (1.97e-3)" "unprognostic (1.60e-1)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-1)" "unprognostic (3.59e-2)" "unprognostic (9.20e-2)" 5.3 28.0 6.8 4.0 6.2 3.8 4.3 7.0 6.8 12.0 7.5 7.1 5.8 12.2 9.9 4.3 13.4 4.0 4.1 6.0 7.3 3.9 8.7 5.0 5.3 4.7 5.0 47.0 6.5 6.0 14.1 5.1 5.3 9.6 6.9 4.6 3.7 6.5 12.1 5.4 7.5 8.5 3.9 10.2 10.2 33.5 8.2 6.8 4.0 4.4 5.5 8.4 6.4 5.9 2.8 6.9 21.6 17.2 11.1 11.3 11.2 9.6 8.7 9.8 11.2 25.7 7.3 0.1 11.5 10.7 20.0 2.5 24.2 18.1 11.9 4.8 17.9 12.7 4.7 3.3 24.5 13.7 9.3 7.4 7.1 6.4 12.1 6.9 9.3 4.6 32.6 11.5 11.5 12.5 13.2 12.3 8.2 3.3 7.5 19.2 15.2 16.6 6.8 5.1 14.3 15.0 11.0 1.7 10.6 8.3 6.1 26.4 6.6 11.6 6.2 10.6 8.4 3.1 3.5 18.9 4.3 9.2 6.9 7.2 3.7 7.0 3.3 3.5 4.0 4.4 4.0 2.6 5.2 4.1 3.3 2.7 0.4 7.3 2.8 2.6 2.9 2.7 6.8 6.2 7.0 6.8 6.0 7.3 4.7 5.0 5.3 3.9 8.2 5.9 4.9 9.6 5.6 24.2 12.6 2.9 5.9 3.2 8.6 18.1 2.1 3.0 4.0 2.8 3.4 1.8 4.2 0.4 15.0 8.9 1.9 3.8 46.5 2.9 15.6 3.6 13.2 2.5 49.1 3.6 2.9 9.2 19.9 4.9 0.0 58.2 5.3 7.2 2.2 18.5 57.4 9.9 0.0 5.7 2.0 14.4 29.8 4.2 5.4 30.9 5.7 6.1 11.3 30.7 7.7 4.7 7.8 34.6 5.7 7.1 12.0 1.9 3.0 5.3 32.9 5.6 6.3 83.1 33.8 5.9 2.6 0.8 7.7 102.8 8.9 3.1 SIN3B KIAA0700 ENSG00000127511 "SIN3 transcription regulator family member B" O75182 19 16829398-16880353 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050329 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 71: Testis - DNA repair" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane" "HPA050329: AB_2681089" "unprognostic (2.71e-3)" "unprognostic (8.89e-2)" "unprognostic (1.32e-3)" "unprognostic (6.22e-2)" "unprognostic (1.24e-1)" "unprognostic (2.05e-2)" "unprognostic (5.44e-2)" "unprognostic (9.89e-2)" "unprognostic (5.42e-3)" "unprognostic (2.77e-1)" "prognostic favorable (4.37e-4)" "prognostic unfavorable (3.58e-4)" "unprognostic (1.18e-3)" "unprognostic (8.45e-2)" "unprognostic (1.49e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" 38.6 31.7 30.1 21.7 28.4 12.6 42.0 8.6 33.3 57.2 12.7 35.9 15.0 59.3 24.1 25.9 49.9 20.4 27.3 30.1 22.7 31.6 19.8 43.6 26.8 19.8 21.8 58.0 25.5 37.8 32.3 29.0 27.0 43.9 12.3 10.0 30.9 35.2 24.7 32.9 36.4 30.6 10.3 43.0 27.2 51.7 24.8 13.2 42.8 14.9 18.1 34.0 43.7 24.5 28.1 14.7 24.4 31.5 19.7 18.1 76.8 23.3 19.2 31.6 27.9 36.4 25.7 25.0 25.5 27.2 26.7 23.6 20.4 20.9 29.1 26.2 36.8 27.0 35.6 16.7 25.9 15.8 20.8 29.9 26.9 21.3 18.2 25.1 29.1 19.7 22.2 15.0 22.4 33.7 21.7 25.5 30.4 14.6 46.6 28.4 22.4 16.6 18.0 23.5 18.0 22.5 29.6 22.5 18.4 32.5 15.9 14.7 38.6 30.5 18.5 44.6 26.5 21.3 16.8 25.0 21.1 20.6 23.1 0.1 4.2 3.9 1.0 3.8 0.6 3.5 0.9 1.1 1.3 2.7 1.1 0.8 2.0 1.2 3.4 1.5 0.3 1.5 30.1 28.4 8.6 33.3 30.1 22.7 19.8 21.8 27.0 10.3 24.8 24.5 45.4 22.4 11.9 30.7 18.9 7.9 11.6 7.4 14.2 20.3 14.4 18.4 8.3 1.5 8.6 3.7 14.6 21.9 9.5 7.0 3.9 10.6 11.4 16.3 34.6 18.8 4.9 6.9 29.9 8.6 29.2 16.0 13.7 36.2 5.1 29.9 10.8 7.0 17.6 10.1 29.8 8.4 0.0 14.6 5.5 24.2 50.7 13.9 5.4 19.7 14.6 8.0 10.3 21.6 26.3 14.5 4.0 66.5 22.0 14.2 4.2 7.5 6.9 14.5 6.6 17.5 13.7 9.7 9.2 14.4 8.1 124.9 11.7 34.5 7.3 17.9 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140980995 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favorable (1.55e-4)" 27.1 22.2 16.6 14.3 16.2 61.6 33.5 16.2 22.7 31.9 13.9 25.7 30.9 34.4 47.7 15.0 32.6 18.4 39.8 16.1 20.1 38.7 4.2 27.5 21.3 17.0 16.4 39.0 45.2 28.9 26.9 26.4 17.5 27.1 19.5 42.6 23.4 20.8 38.4 22.5 22.9 19.2 16.9 20.1 34.0 23.8 18.2 20.6 31.8 20.8 17.6 23.0 23.9 21.5 52.3 11.5 36.0 30.8 33.0 40.7 46.2 19.4 23.6 18.2 27.3 28.6 24.0 42.1 46.9 17.3 31.2 34.9 40.1 15.2 40.6 33.8 36.5 33.9 29.8 20.9 45.9 48.8 21.3 44.1 61.1 15.4 45.8 44.4 22.0 32.0 17.6 27.4 29.2 22.8 30.6 34.1 37.8 12.8 18.4 34.2 32.0 59.6 23.5 17.7 22.4 38.2 26.7 45.1 80.9 30.3 32.6 29.2 24.1 29.5 17.1 52.2 19.0 56.4 36.8 51.2 36.0 21.1 15.0 10.7 9.2 15.1 9.6 11.5 11.8 16.3 9.6 10.2 14.0 15.1 13.5 12.6 1.7 18.3 13.5 9.7 9.9 9.8 16.6 16.2 16.2 22.7 16.1 20.1 17.0 16.4 17.5 16.9 18.2 21.5 60.3 99.3 143.0 85.5 47.6 68.2 68.0 38.1 116.7 106.0 72.2 77.5 90.3 38.6 52.0 71.7 133.5 58.8 58.2 22.7 64.6 26.4 10.6 113.4 78.0 45.8 59.3 27.3 127.7 38.3 38.0 73.9 58.1 106.3 65.9 92.8 35.7 0.5 26.5 92.5 115.6 32.5 30.5 38.2 45.8 16.0 59.7 38.4 56.9 46.9 36.9 68.2 25.7 108.6 109.1 29.3 22.8 59.5 48.2 88.9 44.9 57.5 98.8 121.8 59.2 80.0 59.2 59.4 68.8 61.3 54.4 49.4 49.1 83.2 46.8 78.9 SLC35E3 BLOV1 ENSG00000175782 "Solute carrier family 35 member E3" Q7Z769 12 68746125-68793964 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049403 Uncertain NA NA "Cluster 17: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "HPA049403: AB_2680747" "unprognostic (1.49e-1)" "unprognostic (6.47e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.78e-4)" "unprognostic (1.61e-2)" "unprognostic (2.49e-1)" "unprognostic (1.26e-4)" "unprognostic (2.64e-1)" "unprognostic (2.65e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-2)" "unprognostic (6.98e-2)" "unprognostic (6.85e-3)" "unprognostic (1.48e-1)" "unprognostic (3.22e-2)" "unprognostic (2.89e-3)" "unprognostic (1.80e-1)" 0.9 1.3 1.2 0.6 1.2 1.5 0.7 2.6 1.6 0.8 0.4 0.7 0.4 0.6 0.8 0.9 0.5 0.5 0.7 1.1 0.6 0.7 1.1 0.8 0.7 1.2 0.7 0.7 1.0 0.3 0.6 0.3 1.5 0.8 0.3 1.4 1.0 0.2 0.9 1.5 0.7 0.3 0.3 0.9 0.6 0.4 1.4 0.5 0.6 0.3 0.4 0.8 0.8 2.6 0.4 0.4 0.6 0.5 0.5 0.4 0.7 0.4 0.2 0.3 0.1 0.8 0.4 1.6 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.5 0.5 0.7 1.0 0.9 0.2 0.6 0.5 0.5 0.4 0.4 0.3 0.5 0.3 0.6 0.5 0.9 0.3 0.4 0.3 1.1 0.5 0.2 0.6 2.1 0.8 0.3 0.2 0.7 0.5 0.7 0.6 0.6 0.3 0.3 0.6 0.4 0.5 0.9 0.4 0.7 0.5 1.0 0.5 2.2 0.9 0.6 0.4 2.0 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.3 0.1 0.7 0.3 0.4 1.9 0.6 0.3 0.5 0.4 0.1 1.2 1.2 2.6 1.6 1.1 0.6 1.2 0.7 1.5 0.3 1.4 2.6 15.1 12.8 22.4 10.7 21.5 7.9 23.7 20.7 8.6 72.0 16.9 17.3 18.4 12.8 19.7 18.4 39.6 24.8 22.7 5.0 5.9 18.8 7.8 17.7 15.7 16.2 13.1 15.6 16.0 22.7 23.9 20.7 6.1 15.2 18.3 32.9 16.8 23.7 15.7 43.7 19.1 10.2 12.2 29.6 6.6 2.0 15.2 30.2 7.2 4.7 27.4 29.2 28.8 17.6 40.4 18.9 6.7 23.0 24.3 17.1 11.2 11.7 19.4 68.2 26.3 31.0 16.3 8.8 14.3 19.0 7.5 12.4 20.9 30.3 12.6 17.9 SLC35G1 "C10orf60, FLJ33990, TMEM20" ENSG00000176273 "Solute carrier family 35 member G1" Q2M3R5 10 93893973-93956062 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 68.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 26.9;Peritubular cells: 36.5;Proximal enterocytes: 47.4;Theca cells: 59.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 56: Intestine - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "unprognostic (1.94e-2)" "unprognostic (1.90e-1)" "unprognostic (9.48e-2)" "unprognostic (1.65e-1)" "unprognostic (7.90e-4)" "unprognostic (8.89e-2)" "unprognostic (9.01e-3)" "unprognostic (1.15e-2)" "unprognostic (9.47e-2)" "unprognostic (7.90e-2)" "unprognostic (2.09e-1)" "unprognostic (4.30e-2)" "unprognostic (1.65e-2)" "unprognostic (2.29e-3)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" "unprognostic (2.30e-1)" 0.8 0.8 0.1 1.0 0.1 0.3 0.7 0.2 0.1 0.4 1.0 6.0 68.4 0.8 0.8 1.1 0.4 0.6 1.4 0.1 0.2 0.5 3.7 0.8 0.8 0.3 0.2 1.0 9.5 2.1 1.1 0.8 0.4 0.7 5.8 0.2 1.4 0.8 0.6 1.5 33.4 0.9 0.1 0.6 2.0 3.4 0.2 0.4 1.4 0.2 0.6 1.1 0.7 0.1 6.2 6.1 2.9 3.3 0.9 2.5 3.8 5.4 6.2 5.2 6.5 4.8 4.2 3.9 2.1 3.6 3.4 11.1 6.7 2.1 7.9 4.8 7.0 3.2 3.7 3.6 1.3 6.1 6.1 2.4 2.1 3.9 2.3 1.7 2.3 3.5 3.0 2.2 3.1 2.2 2.9 1.3 3.7 2.2 7.1 0.0 4.6 1.5 2.5 5.3 3.7 3.4 7.2 3.5 4.6 2.4 3.7 2.0 2.9 3.8 6.1 6.8 5.6 2.5 2.4 1.3 2.8 0.0 2.7 0.0 0.1 0.7 0.1 0.1 0.4 0.1 0.8 0.5 0.1 0.1 0.8 0.5 0.0 0.0 0.0 0.1 1.1 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.2 0.4 0.1 0.2 0.1 3.2 3.2 3.9 1.0 2.4 3.1 2.1 2.2 2.2 4.3 1.5 2.7 4.7 5.7 1.6 7.3 4.2 3.0 0.6 26.9 3.9 2.3 20.3 1.8 5.0 4.7 4.2 3.0 2.6 9.7 6.1 4.4 3.1 1.3 0.0 19.9 5.0 5.8 2.3 1.7 6.4 5.0 2.0 3.3 1.2 9.2 17.1 0.9 5.4 1.0 3.1 4.8 0.0 5.0 0.9 3.1 18.3 36.5 2.2 1.3 47.4 1.2 1.3 2.7 0.0 3.6 2.4 19.1 9.2 4.1 1.8 0.8 3.6 59.2 8.3 2.3 SLC7A6OS "FLJ13291, Iwr1" ENSG00000103061 "Solute carrier family 7 member 6 opposite strand" Q96CW6 16 68284503-68310946 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041533 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA041533: AB_10794298" "unprognostic (1.43e-1)" "unprognostic (2.02e-2)" "unprognostic (7.59e-2)" "unprognostic (3.09e-1)" "unprognostic (5.51e-2)" "unprognostic (4.62e-4)" "unprognostic (2.44e-4)" "unprognostic (2.05e-1)" "unprognostic (3.41e-1)" "unprognostic (2.38e-1)" "unprognostic (2.61e-2)" "unprognostic (3.03e-2)" "prognostic favorable (2.35e-4)" "unprognostic (1.84e-1)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" 13.9 8.8 9.6 10.1 11.2 13.9 12.0 11.7 10.8 10.1 9.1 9.8 8.2 9.0 10.1 8.3 9.6 6.1 13.4 9.1 9.6 9.1 6.1 8.5 16.0 11.1 10.7 9.5 8.9 8.1 6.7 9.4 11.2 9.0 7.7 8.8 9.2 6.9 17.0 9.0 11.3 6.8 10.2 13.2 9.5 6.7 10.4 13.0 10.2 8.7 12.3 9.3 8.9 12.5 11.3 11.4 16.4 12.3 9.4 12.8 18.2 14.4 8.1 16.7 14.4 29.3 15.9 19.4 12.6 9.3 10.4 20.0 15.6 12.1 14.5 7.4 10.0 13.1 20.1 24.2 12.1 18.7 13.8 9.9 13.5 13.9 21.7 14.6 12.5 16.6 20.7 8.6 15.2 16.9 24.3 19.1 11.8 13.0 9.7 28.4 10.1 24.3 10.4 14.8 17.3 12.6 27.4 6.1 15.7 12.7 16.5 17.2 18.5 13.0 11.2 12.7 11.3 21.0 18.6 29.2 13.4 22.4 13.8 28.5 12.8 26.3 14.3 15.1 16.6 14.2 14.4 13.3 10.3 15.1 15.5 12.1 11.6 14.8 14.2 12.7 16.2 12.7 9.6 11.2 11.7 10.8 9.1 9.6 11.1 10.7 11.2 10.2 10.4 12.5 15.8 9.6 6.3 2.9 20.6 9.2 13.0 12.4 9.6 22.9 8.3 11.0 1.4 12.8 9.3 12.9 35.5 24.1 24.7 7.0 17.6 13.0 3.0 10.8 16.2 13.6 13.8 8.0 4.8 11.2 12.4 12.7 11.2 10.5 14.0 20.5 13.9 6.2 21.5 16.8 5.2 7.8 12.2 14.1 7.4 2.5 15.8 11.9 12.4 1.0 20.2 25.5 30.9 5.0 4.8 17.0 7.3 16.1 15.7 16.9 10.0 9.8 13.9 23.5 0.0 11.4 11.0 16.7 18.5 10.2 6.7 22.0 21.6 19.7 9.5 14.2 SLC8B1 "FLJ22233, NCKX6, NCLX, SLC24A6" ENSG00000089060 "Solute carrier family 8 member B1" Q6J4K2 12 113298759-113359493 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 75.4" "Cell type enhanced" "Detected in many" "Theca cells: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040668 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" "HPA040668: AB_10793861" "prognostic favorable (9.52e-4)" "unprognostic (1.58e-1)" "unprognostic (1.27e-1)" "unprognostic (4.30e-1)" "unprognostic (1.93e-2)" "unprognostic (2.80e-3)" "unprognostic (1.90e-1)" "unprognostic (6.52e-2)" "unprognostic (1.84e-1)" "unprognostic (2.68e-2)" "unprognostic (2.60e-1)" "unprognostic (5.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.54e-3)" "unprognostic (9.39e-2)" "unprognostic (1.14e-1)" "prognostic favorable (5.02e-4)" 18.5 75.4 7.6 14.8 10.3 17.7 15.1 8.6 8.6 19.3 4.4 15.6 10.6 11.9 7.9 15.8 13.1 11.3 11.0 7.5 8.0 17.2 17.6 20.6 13.8 14.2 9.5 55.5 18.1 7.5 15.3 8.1 10.6 16.9 9.3 1.4 16.9 9.1 10.0 19.4 16.9 6.9 9.3 29.4 12.1 13.6 11.6 18.0 13.1 5.6 9.9 12.7 15.2 11.2 25.3 5.5 3.2 7.0 15.5 10.9 10.6 8.3 23.8 10.6 10.3 5.4 21.1 6.6 18.5 10.8 9.2 20.1 9.8 5.7 5.1 16.3 3.1 13.3 13.1 6.2 25.8 33.9 28.7 11.1 16.9 12.2 5.2 9.1 24.5 24.0 27.7 3.3 6.0 5.9 10.6 27.5 5.7 8.2 14.2 3.9 4.2 8.3 11.4 34.7 0.2 5.4 22.5 45.1 5.4 4.2 8.0 13.1 54.3 7.5 8.8 22.4 5.0 4.5 10.3 5.0 9.6 19.2 6.0 4.1 16.5 32.8 8.0 24.1 10.2 3.3 14.5 7.9 19.1 4.4 28.8 13.5 10.3 6.1 24.8 14.3 19.4 15.8 7.6 10.3 8.6 8.6 7.5 8.0 14.2 9.5 10.6 9.3 11.6 11.2 9.3 12.8 12.6 13.7 5.8 4.5 13.2 8.0 4.6 2.4 8.4 6.5 4.3 8.6 10.9 12.9 10.4 7.8 9.2 30.6 5.9 13.0 1.5 6.0 9.4 9.6 4.9 1.7 7.7 17.4 8.6 13.6 14.3 15.5 21.5 32.4 6.4 12.0 21.6 0.0 3.9 13.3 4.1 21.8 22.6 1.5 24.5 32.4 1.8 22.5 17.8 2.8 5.2 4.0 6.2 22.5 20.7 28.2 3.3 19.1 23.6 3.3 4.5 0.8 32.9 9.9 13.3 1.0 3.9 12.2 7.1 10.7 9.8 96.7 13.3 21.3 SLF2 "C10orf6, FAM178A, FLJ10512, FLJ25012" ENSG00000119906 "SMC5-SMC6 complex localization factor 2" Q8IX21 10 100912963-100965134 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 108.1;Peritubular cells: 105.7;Theca cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 145.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038499, HPA057568" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA038499: AB_10672520, HPA057568: AB_2683471" "unprognostic (9.05e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-2)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.66e-2)" "unprognostic (1.54e-2)" "unprognostic (1.16e-3)" "unprognostic (2.85e-1)" "unprognostic (4.90e-2)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" 9.1 17.2 17.3 10.9 29.2 11.8 8.8 20.4 23.1 14.0 9.3 12.6 7.9 20.8 48.6 8.9 17.6 8.0 10.8 17.0 24.9 11.3 11.6 10.8 14.7 24.5 24.7 25.1 13.1 7.9 23.8 15.4 25.7 15.2 10.1 11.7 9.4 12.9 17.8 13.4 12.7 10.7 19.1 23.1 10.4 25.8 25.3 12.2 11.3 13.3 11.5 11.3 11.2 46.2 25.7 20.6 29.6 31.4 16.1 20.9 11.3 26.3 18.5 24.1 29.0 15.2 17.5 24.1 15.8 11.3 17.9 25.3 20.4 8.8 29.1 26.6 16.6 21.7 14.2 31.0 11.7 28.0 24.9 10.0 13.2 18.6 19.9 25.1 15.7 14.7 15.6 22.5 37.3 17.7 19.1 16.0 13.7 9.9 15.2 18.5 145.7 8.3 10.1 12.8 6.6 12.9 16.5 4.6 30.6 14.1 26.3 10.7 20.6 28.2 23.4 18.0 31.1 18.1 28.5 19.1 20.0 32.9 15.1 6.1 6.6 7.0 9.8 6.7 8.9 8.6 7.8 8.5 5.2 11.0 8.5 7.8 3.6 9.1 7.5 7.5 8.0 4.6 17.3 29.2 20.4 23.1 17.0 24.9 24.5 24.7 25.7 19.1 25.3 46.2 18.4 25.6 18.9 0.0 18.2 0.0 8.4 0.0 12.5 33.8 13.8 12.6 0.0 5.7 8.6 25.8 25.0 17.4 29.4 9.0 13.7 11.0 8.4 22.7 64.8 20.8 12.2 11.3 0.0 8.0 7.1 20.2 10.7 25.0 24.0 32.3 26.7 12.8 17.9 38.7 0.0 10.5 0.0 18.2 0.0 10.4 108.1 18.6 0.0 0.0 19.2 19.7 46.4 0.0 0.0 7.0 8.4 105.7 12.3 9.4 9.3 8.9 13.8 31.4 19.7 44.5 12.8 33.5 43.0 10.4 0.0 5.1 19.7 77.6 8.2 6.0 SMARCC2 "BAF170, CRACC2, Rsc8" ENSG00000139613 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2" Q8TAQ2 12 56162359-56189567 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004321, HPA021213, HPA061788" Supported Enhanced Nucleoplasm NA NA 11000 "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB004321: AB_2286337, HPA021213: AB_1857275, HPA061788: AB_2684608" "unprognostic (7.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.31e-2)" "unprognostic (4.93e-2)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (1.43e-2)" "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.04e-1)" "unprognostic (2.46e-1)" "unprognostic (1.35e-1)" "unprognostic (2.45e-1)" "unprognostic (6.74e-2)" "unprognostic (8.79e-2)" 36.6 33.5 48.1 23.8 52.1 23.5 38.5 48.7 56.3 43.8 19.9 39.3 27.7 42.9 22.8 30.5 40.8 23.3 26.4 49.6 50.9 31.6 19.8 29.7 29.5 44.2 43.8 51.9 32.6 35.5 32.4 25.3 40.2 34.8 23.4 39.2 37.2 33.5 46.7 36.5 34.5 28.4 40.2 31.9 33.0 32.8 49.1 39.0 49.8 30.5 28.7 39.1 37.4 51.6 49.3 74.9 77.2 56.4 47.2 48.9 32.4 42.6 45.3 50.3 48.4 43.5 59.5 71.4 40.0 50.0 47.7 54.8 49.9 42.9 45.1 54.3 47.6 112.2 51.6 27.8 25.6 53.4 79.8 46.4 31.5 47.6 23.7 91.3 65.4 54.7 65.5 57.2 48.1 52.1 90.4 56.0 26.4 39.0 50.4 53.5 62.0 55.0 38.6 63.4 56.6 59.0 72.8 49.4 20.6 40.3 84.3 49.3 56.1 42.5 51.7 38.4 31.8 54.8 41.9 48.4 44.3 35.5 46.9 15.4 8.5 21.0 11.4 10.2 12.3 8.6 8.2 8.6 7.3 9.4 6.0 7.6 7.9 8.3 13.9 6.0 8.6 11.6 48.1 52.1 48.7 56.3 49.6 50.9 44.2 43.8 40.2 40.2 49.1 51.6 40.8 67.3 43.5 40.1 40.9 20.5 43.2 24.5 62.6 59.3 26.6 28.8 25.7 34.3 40.6 42.3 39.6 20.4 39.0 17.9 7.9 25.4 1.6 24.3 42.8 38.5 22.7 51.9 39.5 18.0 11.9 40.2 33.6 36.3 65.1 56.3 33.9 17.3 16.6 38.7 37.5 22.3 32.6 20.6 20.7 7.8 69.0 29.3 19.6 23.4 36.0 42.3 70.0 33.2 23.4 22.7 17.1 55.3 44.6 32.2 19.8 17.3 25.0 66.0 19.7 47.9 42.3 45.5 31.7 55.9 22.6 13.3 49.9 36.6 21.4 37.7 SMC5 "KIAA0594, SMC5L1" ENSG00000198887 "Structural maintenance of chromosomes 5" Q8IY18 9 70258978-70354873 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054900 Supported Supported "Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA054900: AB_2682634" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.24e-2)" "unprognostic (1.40e-1)" "unprognostic (2.72e-1)" "unprognostic (8.04e-3)" "unprognostic (2.15e-2)" "unprognostic (1.20e-1)" "unprognostic (3.80e-2)" "unprognostic (2.23e-1)" "unprognostic (3.36e-2)" "unprognostic (7.30e-2)" "unprognostic (1.71e-2)" "unprognostic (2.73e-2)" "unprognostic (2.54e-1)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" 10.2 7.7 4.3 15.0 4.8 26.0 16.6 10.4 5.0 12.2 9.0 15.0 13.5 15.2 12.8 10.8 12.3 12.9 9.9 4.2 6.1 8.0 14.8 12.8 18.5 5.2 5.7 25.2 19.4 10.4 9.6 14.8 5.7 11.4 16.9 8.3 17.1 8.7 13.8 9.0 13.9 10.7 4.2 12.0 14.5 13.5 4.9 18.2 14.3 8.2 16.1 16.4 11.3 7.8 43.9 10.8 26.6 16.2 15.1 28.3 20.9 29.8 25.8 15.9 17.3 4.1 23.3 43.7 9.5 22.5 13.9 39.3 28.9 19.8 31.7 19.9 10.3 25.5 18.3 13.1 19.2 41.8 25.3 19.9 13.5 21.5 24.5 25.4 16.9 25.8 19.1 17.1 29.9 6.7 55.4 14.7 20.4 33.5 14.9 32.4 43.6 13.7 16.1 21.3 18.9 14.2 29.5 18.7 8.3 19.2 11.2 17.6 18.6 21.3 22.4 29.2 41.2 20.9 29.9 29.9 17.9 21.6 25.9 14.1 5.6 10.4 8.5 6.3 8.0 8.4 7.3 8.1 4.6 8.2 8.0 7.4 3.7 8.1 7.6 8.7 8.4 4.0 4.3 4.8 10.4 5.0 4.2 6.1 5.2 5.7 5.7 4.2 4.9 7.8 48.9 57.7 70.3 61.7 54.6 45.6 102.0 30.3 59.7 26.8 39.2 34.0 34.6 41.5 62.0 20.2 29.2 32.1 65.2 38.8 9.8 61.3 47.9 65.3 58.9 37.6 28.1 29.0 72.2 54.8 37.5 62.1 40.8 89.1 51.8 52.5 16.1 25.9 16.4 38.7 66.4 34.8 20.3 22.9 30.8 15.9 53.4 37.9 24.9 74.0 65.4 17.2 54.6 85.5 94.6 68.3 37.9 59.5 40.6 105.5 23.6 11.7 51.0 35.7 26.3 66.2 52.2 80.0 55.0 52.5 41.9 35.6 56.7 58.4 45.0 105.8 SMG6 "C17orf31, EST1A, KIAA0732, SMG-6" ENSG00000070366 "SMG6 nonsense mediated mRNA decay factor" Q86US8 17 2059839-2303785 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042932 Approved Supported Nucleoli,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 89: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoli Cytosol "HPA042932: AB_10964261" "unprognostic (5.22e-2)" "unprognostic (1.20e-1)" "unprognostic (5.30e-1)" "unprognostic (4.41e-2)" "unprognostic (1.33e-1)" "unprognostic (9.33e-3)" "unprognostic (1.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.75e-2)" "unprognostic (7.63e-2)" "unprognostic (4.78e-2)" "unprognostic (1.31e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.61e-1)" "unprognostic (3.08e-2)" 12.2 13.0 15.5 12.3 14.6 13.6 10.5 17.6 15.0 16.4 13.2 11.4 9.3 26.6 11.1 16.4 21.7 17.2 14.0 13.8 17.8 12.3 7.4 11.9 12.3 19.9 17.3 37.5 7.4 14.4 13.3 10.5 14.3 13.9 9.4 19.2 10.4 12.8 12.9 16.0 10.9 18.9 12.5 9.8 9.6 19.5 16.0 23.1 11.7 9.1 10.9 13.1 12.0 14.8 14.9 22.5 31.7 20.6 33.6 27.0 16.3 23.6 25.9 26.3 22.2 27.6 7.3 15.7 8.3 34.8 12.0 21.3 23.5 20.1 27.4 15.7 14.7 15.3 11.8 13.5 19.2 8.2 10.5 38.5 14.5 21.2 18.6 42.6 24.3 15.3 12.8 18.5 19.9 11.7 20.8 6.6 10.2 8.9 11.7 21.4 20.2 6.2 15.2 13.5 5.3 16.1 24.6 7.1 10.2 22.2 11.1 6.0 32.2 24.0 13.1 25.6 25.1 16.0 10.5 7.2 19.1 9.1 14.0 3.0 0.7 0.8 1.3 0.3 1.3 0.5 1.1 1.3 0.4 0.7 1.5 1.1 0.5 2.0 1.6 1.3 0.6 0.6 15.5 14.6 17.6 15.0 13.8 17.8 19.9 17.3 14.3 12.5 16.0 14.8 17.2 22.4 18.4 41.4 13.2 7.9 13.8 13.1 10.2 35.6 13.8 14.5 8.0 7.2 11.8 14.7 75.0 16.5 17.7 17.9 5.9 13.8 22.5 19.4 37.1 20.3 4.2 12.8 57.1 12.4 10.7 21.0 18.3 21.3 10.8 20.3 17.9 9.1 10.3 47.1 61.7 14.4 16.2 8.7 6.8 36.9 16.8 10.6 8.8 81.5 15.9 24.8 21.6 44.7 64.3 17.2 15.2 19.9 14.6 14.7 10.1 7.6 17.9 50.5 26.3 27.1 20.4 63.7 59.0 15.1 8.7 17.4 24.9 22.4 13.5 14.2 SPG11 "ALS5, FLJ21439, KIAA1840" ENSG00000104133 "SPG11 vesicle trafficking associated, spatacsin" Q96JI7 15 44562696-44663678 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040412, HPA040947" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" Nucleoli "HPA040412: AB_10795418, HPA040947: AB_10796232" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.98e-3)" "unprognostic (1.99e-1)" "unprognostic (9.31e-2)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (2.26e-3)" "unprognostic (2.58e-2)" "unprognostic (9.19e-2)" "prognostic favorable (6.28e-5)" "unprognostic (8.73e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.06e-2)" 21.1 27.1 18.4 18.2 25.7 27.4 21.6 24.4 21.3 21.5 23.9 25.6 17.1 17.9 25.3 25.6 20.2 16.1 25.5 17.5 22.2 25.0 29.8 24.8 28.4 23.8 22.1 21.4 28.6 26.7 21.3 14.9 23.9 25.3 19.9 30.5 24.7 15.0 22.9 30.4 30.1 12.7 19.1 43.0 26.0 25.5 24.6 23.7 30.9 14.3 18.6 23.8 22.6 33.4 13.2 8.8 21.9 21.6 33.7 33.0 15.8 13.4 17.4 13.0 16.6 10.8 12.5 9.7 16.5 18.2 22.5 29.0 15.1 20.8 12.5 29.3 9.0 22.1 21.1 16.4 23.7 22.2 19.2 25.3 23.3 10.7 30.5 20.4 18.6 16.6 28.8 24.2 18.6 11.5 10.1 19.7 11.5 40.3 11.6 12.9 18.5 10.6 28.0 33.6 14.2 16.8 14.6 23.3 13.1 18.0 22.0 30.2 19.9 17.1 8.5 21.4 16.5 23.8 22.6 19.2 17.6 28.8 17.9 5.7 7.7 11.8 6.5 9.2 6.9 10.0 5.4 4.9 6.2 11.3 4.3 5.3 11.6 6.2 12.4 6.3 6.1 3.7 18.4 25.7 24.4 21.3 17.5 22.2 23.8 22.1 23.9 19.1 24.6 33.4 21.0 44.8 22.2 56.2 40.4 9.3 15.6 18.8 14.2 25.1 19.0 12.6 20.1 18.6 31.3 27.6 47.9 16.5 30.1 29.3 5.9 21.3 28.2 31.7 23.2 17.6 20.0 22.3 62.9 16.9 10.1 19.3 37.2 33.6 27.3 31.9 21.8 23.5 20.1 16.8 68.1 31.2 26.4 43.3 23.5 33.2 17.7 40.4 14.2 74.9 88.1 14.0 50.4 68.3 121.4 17.7 24.0 13.9 21.4 19.3 30.8 14.9 53.6 21.7 6.6 24.8 16.3 51.7 31.6 20.1 11.1 9.3 29.5 24.4 27.3 22.2 SPG7 "CAR, CMAR, SPG5C" ENSG00000197912 "SPG7 matrix AAA peptidase subunit, paraplegin" Q9UQ90 16 89490719-89557766 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" "unprognostic (1.42e-1)" "unprognostic (1.72e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.22e-4)" "unprognostic (4.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.54e-1)" "unprognostic (2.33e-1)" "prognostic favorable (4.91e-4)" "unprognostic (3.56e-2)" "unprognostic (7.01e-2)" "unprognostic (1.44e-2)" "unprognostic (2.58e-1)" "unprognostic (1.71e-1)" "prognostic favorable (4.25e-4)" 29.8 44.8 19.3 7.0 18.8 8.2 27.9 21.3 28.6 31.5 18.5 33.3 9.9 31.8 4.0 28.2 26.4 6.8 52.3 19.4 18.3 32.4 47.0 24.9 8.9 19.7 18.6 39.0 31.9 13.8 38.7 5.9 20.3 31.2 8.1 9.9 29.0 9.7 56.7 31.3 35.5 9.0 16.9 34.1 31.1 31.9 18.7 10.5 53.1 31.0 8.0 30.1 26.9 20.0 11.5 28.3 17.3 26.6 33.2 24.2 10.9 27.3 24.6 21.0 10.4 23.0 22.3 16.5 32.5 20.1 16.2 30.5 21.5 24.4 14.7 11.7 25.3 11.4 12.0 43.4 16.2 5.5 10.3 15.2 20.1 12.8 14.1 27.9 25.6 22.0 23.1 5.5 21.7 21.0 14.4 22.5 21.9 23.8 21.4 31.8 26.2 10.8 15.9 17.3 16.4 10.5 44.9 8.3 9.5 15.2 22.6 17.0 33.7 13.9 17.2 12.0 12.2 13.7 19.8 12.8 17.7 19.8 17.7 4.5 2.5 3.9 2.7 2.4 2.6 1.6 1.7 1.3 2.8 3.4 3.1 2.0 2.9 3.7 1.7 2.3 1.8 1.0 19.3 18.8 21.3 28.6 19.4 18.3 19.7 18.6 20.3 16.9 18.7 20.0 53.9 48.1 49.4 39.2 45.6 15.9 27.9 30.1 44.9 57.8 31.2 37.2 45.8 22.8 41.5 35.0 95.9 39.9 47.6 42.3 19.6 40.0 66.0 50.5 41.7 49.9 37.2 27.3 58.5 25.8 28.8 35.9 67.2 54.1 21.5 95.3 51.0 38.1 32.2 40.4 53.1 43.8 30.5 34.8 21.8 22.1 42.9 35.2 21.4 35.6 42.6 30.5 51.5 87.0 46.2 39.5 39.5 33.4 43.5 29.5 68.2 23.8 37.7 73.7 6.6 36.9 36.2 57.5 36.5 36.7 18.0 25.9 45.5 68.3 51.0 28.7 SPICE1 "CCDC52, SPICE" ENSG00000163611 "Spindle and centriole associated protein 1" Q8N0Z3 3 113442718-113515187 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA064843 Approved Supported Centrosome NA NA "Cluster 46: Basophils - DNA binding" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Centrosome "HPA064843: AB_2685367" "unprognostic (2.66e-1)" "unprognostic (1.27e-2)" "unprognostic (1.12e-1)" "unprognostic (4.95e-3)" "unprognostic (2.69e-1)" "unprognostic (1.01e-1)" "unprognostic (4.99e-3)" "unprognostic (1.17e-1)" "unprognostic (6.30e-2)" "unprognostic (2.24e-1)" "unprognostic (1.17e-3)" "unprognostic (1.89e-2)" "unprognostic (4.75e-3)" "unprognostic (6.53e-2)" "unprognostic (4.47e-1)" "unprognostic (3.64e-3)" "unprognostic (2.95e-2)" 4.4 3.8 2.1 4.6 2.3 4.1 7.4 3.2 2.9 8.5 3.4 6.7 4.1 8.6 4.9 6.9 8.0 7.7 4.3 2.4 2.4 4.6 4.1 4.7 4.1 2.2 2.1 7.8 6.3 6.4 8.9 5.5 2.1 6.4 6.6 7.7 8.6 4.9 2.6 6.0 5.3 6.7 1.4 4.2 6.8 7.1 1.9 8.3 6.8 2.3 5.5 6.1 7.2 3.1 17.0 10.4 12.1 10.6 7.5 9.2 7.6 8.2 6.3 10.9 13.6 9.2 9.4 9.9 11.6 7.2 10.7 16.0 6.3 8.0 14.7 5.9 2.8 9.0 9.3 6.1 4.5 18.0 6.8 7.5 7.9 11.3 4.6 9.6 8.0 18.0 5.8 8.2 3.8 17.7 15.6 7.0 13.0 13.4 11.5 10.8 10.3 8.8 4.0 10.7 6.2 10.8 8.7 10.3 4.8 13.4 10.2 7.2 8.0 5.5 8.8 5.1 7.5 7.9 5.8 16.7 11.0 10.5 8.2 3.6 4.1 1.5 3.2 3.0 5.2 5.6 5.0 4.0 3.1 6.1 7.0 5.2 2.1 2.7 2.9 9.7 2.6 2.0 2.1 2.3 3.2 2.9 2.4 2.4 2.2 2.1 2.1 1.4 1.9 3.1 6.7 0.0 4.2 14.4 12.0 6.8 7.9 5.4 9.1 6.4 9.4 5.8 2.5 5.7 5.6 5.5 8.4 4.7 3.5 8.0 0.0 5.4 6.5 22.8 11.9 4.7 3.6 9.9 20.2 4.5 5.9 7.4 16.3 12.7 1.3 10.1 3.3 5.2 4.4 3.3 6.8 10.6 6.1 2.5 3.9 3.5 9.9 4.1 0.0 15.9 2.3 7.9 1.0 16.1 14.4 5.6 3.6 3.4 13.9 4.1 3.9 4.2 15.3 25.0 6.6 6.2 5.4 20.9 16.9 7.7 7.7 3.4 7.5 6.2 7.4 8.5 SRBD1 FLJ10379 ENSG00000068784 "S1 RNA binding domain 1" Q8N5C6 2 45388680-45612165 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030567, HPA030568" Approved Approved Mitochondria,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Mitochondria, Cytosol" "HPA030567: AB_10611244, HPA030568: AB_10601856" "unprognostic (1.16e-2)" "unprognostic (1.27e-1)" "unprognostic (4.97e-3)" "unprognostic (2.46e-1)" "unprognostic (8.20e-3)" "unprognostic (4.14e-1)" "unprognostic (8.69e-3)" "unprognostic (9.74e-2)" "unprognostic (7.11e-2)" "unprognostic (9.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.76e-1)" "unprognostic (3.42e-3)" "unprognostic (3.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (2.29e-1)" 6.8 5.6 1.9 7.2 2.5 6.5 7.6 2.1 1.9 9.8 3.5 7.1 5.7 7.2 11.8 4.7 5.4 5.6 5.8 1.7 2.5 7.6 8.7 6.5 7.5 2.5 2.3 5.4 7.3 12.2 3.7 6.8 2.8 7.4 8.0 3.7 5.2 5.7 3.1 3.8 5.4 6.8 2.4 8.6 8.1 9.0 2.5 11.5 10.2 4.9 7.5 5.3 3.9 2.8 18.7 9.5 19.1 12.9 6.9 15.0 15.1 14.1 12.2 13.2 12.1 8.0 7.8 16.1 10.2 10.1 9.8 8.7 19.0 17.9 24.3 22.1 10.6 21.4 7.4 17.3 8.1 17.9 12.1 9.3 7.2 15.7 18.2 5.8 16.2 5.8 15.6 11.9 19.8 17.0 24.3 13.8 21.9 12.0 10.3 16.5 27.5 14.7 15.0 12.1 16.8 13.7 12.3 13.1 14.0 9.9 8.2 6.4 14.9 18.4 14.7 9.0 12.3 12.5 4.9 9.6 10.4 17.6 13.5 3.9 6.2 13.1 5.4 7.0 4.8 5.3 4.0 6.3 6.1 4.6 5.4 5.0 2.3 8.3 12.3 5.7 4.5 4.3 1.9 2.5 2.1 1.9 1.7 2.5 2.5 2.3 2.8 2.4 2.5 2.8 10.9 19.2 7.7 28.7 13.0 3.6 3.5 6.2 8.6 7.9 8.7 8.0 8.8 8.6 10.6 3.7 4.2 8.4 15.7 5.9 9.8 8.3 3.5 11.5 20.7 9.3 7.2 15.8 22.0 9.1 7.1 10.9 20.9 9.9 8.2 11.0 7.9 13.8 9.6 13.5 32.7 9.7 0.0 22.5 3.9 2.5 7.5 13.8 7.2 46.9 13.7 12.9 13.4 48.2 51.8 4.6 6.3 6.4 19.8 2.9 5.9 10.8 7.8 14.7 13.1 12.9 10.2 37.5 28.4 9.5 3.8 5.6 12.8 16.6 5.1 2.2 SREK1 "DKFZp564B176, SFRS12, SRrp508, SRrp86" ENSG00000153914 "Splicing regulatory glutamic acid and lysine rich protein 1" Q8WXA9 5 66139971-66183615 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037673, HPA037674, HPA059332" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983" "unprognostic (1.38e-1)" "unprognostic (2.51e-1)" "unprognostic (6.16e-2)" "unprognostic (1.52e-1)" "unprognostic (9.40e-2)" "prognostic favorable (2.54e-4)" "unprognostic (1.29e-2)" "unprognostic (7.67e-2)" "unprognostic (5.66e-3)" "unprognostic (2.19e-1)" "unprognostic (2.66e-2)" "unprognostic (5.48e-2)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.63e-1)" "unprognostic (3.08e-1)" "unprognostic (6.76e-2)" "unprognostic (6.69e-2)" 5.6 6.5 6.7 4.4 6.8 20.2 5.9 8.0 8.4 7.4 9.9 6.7 4.5 8.0 5.2 5.4 7.0 4.2 4.9 6.3 7.2 4.8 6.1 6.2 5.9 6.1 6.4 6.4 8.5 6.6 8.1 5.2 6.1 5.4 4.3 9.5 7.0 3.8 4.7 9.0 7.4 3.2 6.0 7.4 6.5 4.8 7.0 5.8 8.0 3.3 4.1 5.5 5.7 7.4 5.5 6.7 8.5 5.5 3.9 7.5 9.5 6.1 3.3 3.1 3.4 9.5 6.3 8.3 7.4 4.5 4.1 7.4 4.3 5.7 5.3 6.0 10.3 7.9 18.0 7.2 3.4 7.0 8.9 4.5 5.6 3.7 4.2 6.4 5.2 4.6 7.4 5.5 3.4 5.6 7.2 16.2 4.8 2.1 3.3 10.2 4.1 6.3 5.6 9.2 10.3 7.3 5.8 2.7 5.1 6.1 7.2 8.7 5.9 5.2 3.3 7.3 6.4 6.0 4.5 8.9 5.1 11.2 5.5 4.9 2.7 2.8 2.4 2.1 2.6 3.2 2.2 2.8 2.3 3.8 2.6 2.6 2.1 3.8 1.9 3.1 2.4 1.5 6.7 6.8 8.0 8.4 6.3 7.2 6.1 6.4 6.1 6.0 7.0 7.4 72.6 93.0 143.5 70.2 67.6 66.0 84.8 69.3 58.6 64.3 64.1 51.4 80.8 60.1 98.8 46.0 116.7 84.6 72.1 59.5 37.2 59.3 46.5 91.2 124.1 83.3 77.8 65.6 71.4 55.4 86.7 80.1 72.4 107.5 97.0 80.5 55.0 68.3 50.2 67.3 73.3 64.2 79.3 54.4 50.2 62.3 83.6 55.4 42.7 40.3 62.3 63.4 53.5 98.0 85.2 54.7 41.8 76.8 70.7 83.7 49.8 32.8 112.2 89.8 46.0 92.3 87.2 78.9 62.0 49.1 69.3 120.7 63.7 85.2 62.5 91.2 SRRM1 "MGC39488, POP101, SRM160" ENSG00000133226 "Serine and arginine repetitive matrix 1" Q8IYB3 1 24631716-24673281 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049941, HPA058612" Supported Enhanced "Nuclear speckles" NA NA 20000 "Cluster 18: Basophils - Vesicular transport" "Cluster 51: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA049941: AB_2680962, HPA058612: AB_2683778" "unprognostic (3.31e-2)" "unprognostic (3.81e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-1)" "unprognostic (1.49e-1)" "unprognostic (7.71e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (3.83e-2)" "unprognostic (1.80e-3)" "unprognostic (2.38e-1)" "unprognostic (9.27e-2)" "unprognostic (5.08e-3)" "unprognostic (4.52e-2)" "unprognostic (4.50e-2)" "unprognostic (2.77e-2)" "unprognostic (1.88e-1)" "unprognostic (3.46e-1)" 43.2 32.8 28.5 30.7 32.9 68.9 45.3 37.2 35.8 62.6 33.8 48.8 27.7 50.7 83.8 37.5 58.4 22.9 40.5 28.3 29.4 31.2 32.1 40.2 40.3 32.6 31.1 79.2 35.7 26.2 37.6 33.3 33.7 53.5 26.9 52.4 40.6 31.9 52.0 54.8 43.2 30.6 27.4 45.7 36.8 39.3 30.7 31.4 39.8 21.5 37.0 41.6 50.3 46.0 52.4 40.4 79.2 74.2 44.4 46.0 78.0 57.7 40.5 59.1 67.4 45.2 88.1 115.0 36.6 50.4 39.2 66.0 82.1 58.2 78.4 39.2 54.3 89.9 83.3 53.0 30.7 101.3 58.5 30.6 34.9 48.4 68.1 66.4 53.7 55.2 92.8 65.5 61.5 44.1 96.3 69.6 139.4 42.9 29.0 89.4 63.3 58.0 52.4 51.6 49.3 43.0 63.5 54.5 45.5 59.8 49.3 50.7 56.7 54.2 53.2 71.4 62.5 54.7 46.0 138.3 58.4 122.4 61.0 32.3 18.1 20.9 21.6 23.3 26.7 19.9 20.4 21.3 20.7 20.0 18.6 21.6 23.2 29.7 27.5 16.8 16.5 16.9 28.5 32.9 37.2 35.8 28.3 29.4 32.6 31.1 33.7 27.4 30.7 46.0 231.5 157.0 165.3 67.9 266.8 302.3 280.8 194.6 271.5 178.4 164.6 188.0 154.8 128.7 172.7 121.4 118.9 152.1 315.1 146.5 199.6 174.1 330.2 211.3 247.6 170.7 118.4 230.1 53.6 147.2 170.0 177.2 142.2 260.0 241.0 148.6 140.7 225.6 149.5 124.5 56.7 174.4 120.1 178.7 311.3 134.1 167.7 205.3 154.7 45.9 286.6 187.1 256.4 58.8 173.2 147.5 149.1 150.8 236.8 329.8 141.8 198.4 145.5 186.9 138.1 252.3 220.3 219.4 223.3 282.5 295.4 241.2 288.6 135.9 194.3 308.9 SRRM2 "Cwc21, KIAA0324, SRL300, SRm300" ENSG00000167978 "Serine/arginine repetitive matrix 2" Q9UQ35 16 2752626-2772538 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 150.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041411, HPA066181" Supported Enhanced "Nuclear speckles" NA NA 17000 "Cluster 11: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA041411: AB_10796671, HPA066181: AB_2685630" "unprognostic (8.48e-2)" "unprognostic (1.80e-1)" "unprognostic (2.44e-1)" "unprognostic (1.81e-1)" "unprognostic (4.23e-2)" "prognostic favorable (6.77e-4)" "prognostic unfavorable (5.08e-4)" "unprognostic (7.39e-2)" "unprognostic (1.64e-1)" "unprognostic (4.74e-2)" "unprognostic (2.72e-1)" "unprognostic (3.50e-3)" "prognostic unfavorable (4.82e-4)" "unprognostic (1.05e-1)" "unprognostic (5.35e-2)" "unprognostic (1.26e-2)" "unprognostic (7.84e-2)" 195.2 215.4 203.8 115.7 211.0 270.4 193.4 229.1 374.7 255.3 232.5 239.3 127.0 219.7 69.9 222.8 253.9 94.3 246.5 205.6 201.2 212.5 252.5 198.6 125.4 222.7 197.7 265.5 315.1 115.9 171.0 89.2 208.7 217.8 102.8 134.1 243.0 86.9 306.6 224.6 261.5 100.3 180.2 250.7 269.6 146.9 227.5 108.4 231.4 96.9 95.2 211.5 211.7 234.5 108.1 134.7 212.9 147.1 147.1 141.9 125.1 119.8 68.1 105.5 93.5 111.5 123.1 192.2 87.3 134.6 88.2 151.6 170.2 153.6 110.9 139.3 177.5 164.8 284.5 192.9 65.6 171.9 229.6 146.3 145.6 155.0 182.8 210.4 110.5 136.5 187.5 184.1 98.7 186.5 162.6 270.9 196.9 76.4 75.1 286.2 84.0 150.4 136.4 109.7 138.1 120.8 158.1 162.0 98.7 141.7 147.2 137.4 157.1 148.8 150.3 97.9 149.8 161.2 131.6 402.9 51.7 124.0 102.2 150.8 24.0 13.3 8.2 10.6 7.9 15.9 10.4 8.1 5.8 22.9 9.1 12.0 48.2 60.5 10.5 31.9 5.9 3.0 203.8 211.0 229.1 374.7 205.6 201.2 222.7 197.7 208.7 180.2 227.5 234.5 286.4 141.1 232.4 134.8 221.3 310.5 430.1 204.0 178.2 416.5 271.8 283.3 139.0 147.3 180.5 167.3 291.9 179.3 289.0 244.4 66.5 156.3 83.1 285.4 457.7 230.3 189.6 191.6 71.1 179.5 204.8 235.0 296.2 379.3 134.8 273.1 158.8 183.8 157.2 439.1 76.7 245.2 162.8 124.5 238.7 77.2 251.6 208.1 120.9 116.2 160.9 239.8 195.7 94.0 109.6 159.9 188.4 192.2 262.3 352.3 192.5 99.3 146.6 358.1 197.2 366.8 391.0 231.8 253.7 219.2 365.1 276.2 237.5 339.5 236.5 377.8 SRSF10 "FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2" ENSG00000188529 "Serine and arginine rich splicing factor 10" O75494 1 23964347-23980927 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053805, HPA053831" Uncertain Supported Nucleoplasm NA Yes 49000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA053805: AB_2682269, HPA053831: AB_2682275" "unprognostic (2.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.34e-2)" "unprognostic (1.77e-1)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (2.05e-2)" "unprognostic (1.68e-3)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.74e-4)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.69e-2)" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (2.40e-2)" 57.0 59.9 22.5 46.3 23.3 119.6 46.9 26.5 30.1 51.7 29.9 48.8 38.0 49.6 40.7 43.8 56.3 29.2 40.0 23.2 24.4 56.3 56.7 49.6 61.0 23.3 23.5 61.1 50.1 37.2 43.6 42.2 24.3 47.9 45.0 46.5 45.4 32.1 37.7 40.1 50.2 41.3 25.0 49.0 47.9 34.7 23.1 55.8 61.3 24.4 57.1 43.0 45.0 28.6 110.7 89.6 142.9 92.9 88.6 68.2 98.0 133.4 53.5 116.8 102.3 83.5 112.8 239.5 82.7 63.5 73.8 99.7 163.4 89.7 140.7 140.9 122.7 134.5 160.3 115.1 62.2 164.3 107.9 44.2 68.5 74.3 72.9 66.8 89.1 92.1 187.2 83.4 99.3 77.2 167.9 118.1 196.2 139.6 84.4 162.9 99.7 127.6 102.1 86.4 104.9 85.5 98.7 88.2 100.1 97.4 94.2 129.5 89.2 94.7 99.5 89.2 126.4 94.6 134.6 189.1 83.4 185.9 112.8 112.8 67.7 74.0 51.3 84.1 65.1 80.2 58.5 60.3 58.1 68.8 62.9 55.8 43.9 74.5 82.0 69.6 75.9 72.3 22.5 23.3 26.5 30.1 23.2 24.4 23.3 23.5 24.3 25.0 23.1 28.6 115.8 112.2 112.1 39.2 188.4 42.6 115.5 23.2 183.2 159.1 104.4 103.4 59.1 97.2 85.5 79.1 160.6 116.8 150.5 85.6 78.2 94.2 115.4 96.7 138.3 109.8 122.0 154.2 54.7 89.2 164.1 111.3 93.8 106.7 93.6 181.0 86.0 63.8 82.0 99.3 50.9 92.4 36.7 51.2 41.3 118.5 127.7 83.4 26.6 44.0 101.5 131.6 111.2 54.8 67.2 78.6 85.9 110.6 169.4 122.6 67.4 74.6 94.6 287.5 105.2 121.8 125.8 188.1 150.5 140.0 45.5 63.3 142.6 335.7 106.3 100.1 SRSF11 "NET2, p54, SFRS11" ENSG00000116754 "Serine and arginine rich splicing factor 11" Q05519 1 70205682-70253052 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008762 Supported Supported "Nuclear speckles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA008762: AB_1856782" "unprognostic (7.82e-3)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (2.85e-1)" "unprognostic (5.32e-3)" "unprognostic (1.30e-3)" "prognostic unfavorable (3.91e-4)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.22e-1)" "unprognostic (6.25e-3)" "prognostic unfavorable (6.53e-6)" "unprognostic (7.79e-2)" "unprognostic (1.63e-1)" "unprognostic (1.90e-1)" "unprognostic (1.43e-2)" 76.4 67.0 39.4 51.4 42.6 136.8 76.9 48.1 64.6 86.6 40.0 73.7 44.7 75.9 70.0 62.1 83.7 45.1 51.9 39.4 46.5 68.8 94.1 70.1 75.8 42.0 40.7 96.3 85.7 43.0 79.8 56.1 43.7 73.7 45.0 57.7 69.5 40.8 66.3 75.9 84.9 39.3 39.7 89.8 72.9 58.4 41.4 75.4 86.2 32.9 64.7 68.5 75.0 47.9 92.8 46.2 118.4 76.2 59.5 79.7 162.4 111.6 57.5 89.0 80.3 81.6 68.0 156.6 74.7 56.5 58.4 77.4 151.5 61.4 120.7 105.9 118.1 159.0 112.4 98.5 71.1 221.0 63.3 64.2 76.0 82.5 83.5 111.3 80.4 79.0 159.1 96.1 88.7 36.4 133.3 163.1 190.9 72.3 76.9 156.1 130.9 99.9 104.3 65.7 99.3 82.1 94.5 101.1 139.8 109.1 80.9 98.1 96.0 97.8 70.4 71.3 102.3 110.4 94.5 169.9 70.2 161.3 87.7 111.7 63.5 103.6 65.7 51.6 74.9 76.3 67.0 65.2 66.1 70.7 72.2 67.8 31.7 85.8 64.6 91.7 80.4 52.7 39.4 42.6 48.1 64.6 39.4 46.5 42.0 40.7 43.7 39.7 41.4 47.9 198.6 211.5 224.9 90.4 208.6 354.0 295.5 229.6 222.5 164.8 166.9 171.7 119.6 115.8 184.5 195.0 118.9 242.0 243.4 123.8 115.4 151.0 64.4 160.0 267.9 186.8 173.8 218.5 219.0 135.3 253.1 228.9 165.6 231.0 194.1 218.1 146.3 152.6 150.4 159.9 183.0 158.3 150.5 124.9 244.4 56.9 255.7 155.4 168.9 126.5 183.1 115.5 145.2 168.9 219.8 144.9 104.7 264.4 234.9 317.8 122.1 101.4 157.8 158.1 170.9 199.1 218.3 270.0 138.0 181.4 353.6 303.7 226.2 195.5 172.9 315.0 STAR STARD1 ENSG00000147465 "Steroidogenic acute regulatory protein" P49675 8 38142700-38150992 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Steroidogenesis, Transport" "Congenital adrenal hyperplasia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "adrenal gland: 5073.8" "Cell type enriched" "Detected in some" 44 "Theca cells: 2243.4" "Group enriched" "Detected in some" 4 "head and neck cancer: 1.0;lung cancer: 0.8;ovarian cancer: 1.4;testis cancer: 3.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "basophil: 2.4" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 5 "K-562: 436.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023644, HPA027318, CAB032598" Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574" "unprognostic (1.60e-4)" "unprognostic (3.20e-2)" "unprognostic (9.17e-2)" "unprognostic (3.28e-2)" "unprognostic (9.22e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.12e-5)" "unprognostic (3.30e-2)" "unprognostic (2.36e-1)" "unprognostic (1.77e-3)" "unprognostic (6.65e-2)" "unprognostic (4.75e-9)" "unprognostic (1.58e-1)" "unprognostic (1.33e-1)" "unprognostic (9.48e-2)" "unprognostic (6.16e-2)" 1.7 5073.8 2.3 3.1 1.6 2.1 0.4 1.6 3.3 1.0 0.7 0.5 0.2 0.5 0.6 2.1 6.3 0.2 0.9 1.5 4.5 0.4 1.2 0.5 0.9 3.8 3.3 497.1 0.9 0.0 2.2 0.5 4.1 0.5 0.1 0.6 1.8 0.3 0.4 5.0 0.6 0.4 1.4 1.0 0.7 88.2 3.0 3.0 0.4 0.0 1.9 0.5 3.2 1.5 0.1 0.0 0.8 0.2 0.3 3.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.1 0.0 88.9 0.8 5.3 1.3 3.8 0.1 12.4 0.3 0.1 0.1 0.8 0.0 0.3 436.1 0.2 0.0 0.0 0.4 43.7 9.6 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.2 0.0 0.2 0.0 0.1 43.0 1.5 0.1 0.0 0.2 0.1 0.2 0.2 0.0 0.3 9.3 0.2 2.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 2.3 1.6 1.6 3.3 1.5 4.5 3.8 3.3 4.1 1.4 3.0 1.5 0.0 0.0 0.0 0.7 0.1 9.4 0.7 0.8 4.0 1.1 0.1 1.1 0.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 1.9 10.7 0.6 0.0 0.0 1.4 0.0 0.0 25.7 0.0 0.3 0.0 1.4 0.0 0.0 0.2 0.0 2.8 0.0 0.0 0.0 0.7 10.2 50.1 0.2 3.6 0.0 0.0 0.6 0.0 0.5 0.3 0.1 0.0 4.1 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.2 3.0 4.8 0.8 1.7 11.2 0.1 0.1 2243.4 0.0 0.1 STX16 "hsyn16, SYN16" ENSG00000124222 "Syntaxin 16" O14662 20 58651253-58679526 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041019, HPA042033" Uncertain Enhanced Vesicles NA NA "Cluster 34: Basophils - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA041019: AB_10964273, HPA042033: AB_10963935" "unprognostic (7.52e-2)" "unprognostic (1.91e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (4.18e-4)" "unprognostic (7.32e-2)" "unprognostic (5.11e-2)" "unprognostic (3.51e-2)" "unprognostic (2.80e-3)" "unprognostic (2.41e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (3.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.56e-1)" "unprognostic (5.89e-2)" 39.5 44.5 42.3 34.7 43.6 54.3 42.7 38.8 45.5 60.9 36.8 56.4 26.2 50.1 44.6 40.8 58.9 24.9 38.5 39.1 39.5 47.6 45.9 44.2 46.3 44.4 42.1 58.9 50.0 21.2 68.7 26.4 44.4 52.7 26.0 38.7 43.5 30.0 33.3 53.7 49.3 27.8 39.4 65.3 44.3 36.3 42.5 33.0 49.2 19.5 32.4 55.5 49.5 50.8 37.2 21.4 27.6 26.9 49.7 52.6 38.2 45.1 30.5 45.3 28.0 41.9 53.0 42.5 61.3 32.4 56.7 53.9 25.5 53.6 37.3 20.2 26.9 26.6 63.9 51.3 49.2 38.2 57.8 58.9 80.4 30.5 46.0 84.6 46.4 49.2 31.3 36.8 36.9 86.9 29.8 45.9 11.2 30.1 35.9 27.3 25.8 29.6 34.6 27.3 18.2 27.7 47.7 82.8 83.2 46.4 33.1 50.1 49.5 74.1 36.0 28.6 50.3 75.7 37.7 23.4 54.7 29.2 31.7 18.2 5.8 5.0 4.3 5.3 4.8 2.3 3.9 3.1 3.8 3.7 5.1 4.9 12.6 5.4 3.9 3.9 4.7 4.1 42.3 43.6 38.8 45.5 39.1 39.5 44.4 42.1 44.4 39.4 42.5 50.8 40.2 22.4 46.6 0.0 27.0 26.9 19.3 22.8 29.0 65.2 44.3 41.5 24.3 41.5 31.2 29.5 85.5 24.2 33.7 23.4 5.9 16.6 6.2 32.6 51.2 36.3 46.1 26.5 0.0 13.7 20.6 28.3 38.2 26.1 19.6 54.8 37.1 30.8 22.2 42.1 0.0 25.4 20.3 42.9 35.9 8.9 22.7 37.1 21.4 0.0 44.0 29.5 33.0 0.0 0.0 19.7 22.5 29.0 16.2 20.1 30.0 12.5 45.6 52.8 13.1 32.1 30.4 47.5 20.2 35.2 42.3 17.5 42.6 27.8 26.0 21.5 SUGP2 "KIAA0365, SFRS14" ENSG00000064607 "SURP and G-patch domain containing 2" Q8IX01 19 18990888-19034023 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 237.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041557, HPA061111" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA041557: AB_10794301, HPA061111: AB_2684432" "unprognostic (1.35e-1)" "unprognostic (2.94e-1)" "unprognostic (3.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-3)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.94e-2)" "unprognostic (4.60e-2)" "unprognostic (3.28e-1)" "unprognostic (4.41e-3)" "unprognostic (2.29e-2)" "unprognostic (1.00e-1)" "unprognostic (1.17e-2)" "unprognostic (1.51e-1)" "unprognostic (5.11e-2)" "unprognostic (3.60e-2)" 24.5 36.2 29.0 18.2 30.1 41.7 28.4 30.8 37.6 37.5 28.0 35.9 17.1 30.2 20.5 25.6 35.5 12.7 36.6 34.5 22.7 36.0 31.7 32.9 23.5 21.5 23.5 39.4 23.9 17.0 54.3 14.2 21.7 46.9 16.4 45.1 32.3 16.1 37.7 22.4 31.6 15.6 18.0 37.4 27.0 87.7 24.4 22.7 60.9 24.3 20.2 30.9 32.8 30.6 27.7 25.7 64.6 46.7 29.7 29.2 32.2 33.8 25.4 38.8 33.1 16.9 24.0 54.3 27.3 27.2 45.8 20.1 53.2 20.6 35.2 19.3 47.0 34.3 42.6 22.2 21.4 29.2 33.3 30.4 21.5 23.7 19.3 51.8 20.6 41.8 52.6 38.1 42.6 23.5 34.3 54.5 33.5 32.4 36.1 33.8 33.2 30.6 19.7 27.5 71.5 29.4 29.9 20.7 14.8 49.5 21.6 26.9 22.6 38.0 22.8 44.6 40.2 48.0 39.1 40.0 38.3 45.0 40.9 4.1 1.4 1.3 2.1 1.5 1.1 1.1 1.3 1.2 1.5 1.8 1.2 1.4 1.3 4.4 1.3 1.9 1.3 0.8 29.0 30.1 30.8 37.6 34.5 22.7 21.5 23.5 21.7 18.0 24.4 30.6 24.5 41.7 45.1 69.9 22.9 17.6 22.6 17.9 18.8 91.2 30.0 23.5 34.7 22.8 33.3 27.6 93.8 16.7 57.0 19.2 9.8 16.2 84.9 44.4 44.7 25.2 41.5 35.3 106.5 10.5 10.2 29.1 31.6 40.7 27.1 94.9 21.8 28.5 23.4 106.0 90.3 22.5 26.4 31.4 19.9 132.0 40.4 29.1 12.4 34.7 31.2 44.5 57.7 42.7 45.2 18.7 23.2 37.6 36.1 26.1 14.5 11.3 42.5 108.6 52.6 33.5 22.8 237.7 56.2 17.2 18.8 7.5 29.3 79.8 26.9 23.6 SULF2 "HSULF-2, KIAA1247, SULF-2" ENSG00000196562 "Sulfatase 2" Q8IWU5 20 47656348-47786616 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 205.8;Oligodendrocyte precursor cells: 247.8;Theca cells: 265.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "basophil: 27.2;classical monocyte: 19.6;intermediate monocyte: 17.2;myeloid DC: 21.3;neutrophil: 31.5;non-classical monocyte: 9.0;plasmacytoid DC: 27.1" "Group enriched" "Detected in many" 84 "dendritic cells: 27.1;granulocytes: 31.5;monocytes: 19.6" "Cell line enhanced" "Detected in many" "EFO-21: 338.0;HaCaT: 230.1;HBEC3-KT: 259.4;hTCEpi: 815.1;MCF7: 695.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002325 Approved "Intracellular and membrane" NA NA 340000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "HPA002325: AB_1080126" "unprognostic (4.06e-2)" "prognostic unfavorable (6.43e-5)" "unprognostic (4.39e-1)" "unprognostic (8.99e-2)" "unprognostic (2.65e-1)" "unprognostic (9.08e-2)" "unprognostic (1.87e-1)" "unprognostic (2.48e-2)" "unprognostic (1.81e-2)" "unprognostic (3.04e-2)" "unprognostic (1.53e-3)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.02e-4)" "unprognostic (7.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.09e-1)" "unprognostic (7.14e-3)" 57.5 12.4 25.8 42.7 30.3 11.5 43.5 21.0 30.7 113.3 20.5 48.0 29.4 152.6 9.8 77.5 73.5 64.3 35.6 45.8 41.4 57.2 38.7 16.5 27.8 56.8 51.1 139.3 9.8 7.1 40.4 26.3 57.1 23.3 43.9 13.6 34.0 22.4 14.7 32.7 26.9 86.5 22.3 15.1 20.6 21.3 30.1 18.2 42.7 22.5 25.1 36.6 62.6 22.6 0.5 20.6 93.4 0.1 19.2 2.3 8.5 16.3 0.0 1.7 2.9 36.7 48.7 3.7 338.0 17.0 5.5 230.1 27.2 259.4 0.7 0.4 20.0 0.0 24.2 82.7 17.4 0.1 4.9 104.1 815.1 1.7 11.2 0.2 18.4 0.0 0.0 151.5 1.9 695.2 0.0 1.4 18.8 0.0 209.0 0.2 0.2 39.8 198.6 1.1 8.2 2.1 32.9 0.3 0.1 122.1 1.3 2.6 17.8 0.0 2.1 0.2 22.5 5.4 1.7 1.6 0.4 0.1 2.8 27.2 19.6 2.2 0.0 17.2 0.2 0.3 0.0 0.1 21.3 0.2 0.0 0.0 31.5 0.1 9.0 27.1 0.0 6.2 25.8 30.3 21.0 30.7 45.8 41.4 56.8 51.1 57.1 22.3 30.1 22.6 62.7 9.6 7.2 2.0 21.9 10.5 7.6 25.4 18.8 8.5 14.0 8.3 8.6 20.0 9.0 16.5 0.0 12.0 34.9 38.4 0.0 5.3 2.7 19.7 205.8 59.2 27.4 7.8 10.3 2.2 10.1 37.0 10.2 30.6 1.3 28.1 62.2 19.0 5.2 35.3 10.8 7.6 16.2 20.6 46.2 6.7 28.9 44.4 10.6 12.2 85.8 8.8 6.2 247.8 1.1 4.9 62.0 76.3 6.2 9.9 3.5 14.1 2.7 6.2 0.0 4.1 13.7 1.2 3.5 24.7 8.4 16.4 11.2 265.0 25.8 12.3 SUPT6H "KIAA0162, SPT6H" ENSG00000109111 "SPT6 homolog, histone chaperone and transcription elongation factor" Q7KZ85 17 28662198-28702679 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012416, HPA036382" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB012416: , HPA036382: AB_2675094" "unprognostic (8.18e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (1.02e-1)" "unprognostic (2.18e-2)" "unprognostic (9.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "prognostic favorable (4.36e-5)" "unprognostic (4.75e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.06e-2)" 31.2 33.5 24.6 25.4 25.8 65.3 28.3 25.0 26.8 27.0 26.8 36.6 20.0 30.6 26.8 26.5 26.6 24.7 28.8 24.0 29.0 25.6 35.8 28.9 28.4 24.0 25.2 31.2 31.4 30.8 34.3 27.8 24.3 28.7 20.9 29.2 29.1 25.6 54.5 39.2 32.2 27.3 21.6 34.4 31.3 21.4 28.7 34.0 28.9 32.6 30.3 32.1 25.6 25.6 49.4 101.3 49.8 57.1 59.1 39.3 38.2 66.2 70.3 76.3 67.8 94.7 21.5 52.1 33.6 66.5 58.7 57.5 73.6 48.1 78.4 97.6 65.4 72.9 83.2 59.4 49.4 77.2 77.9 54.6 28.4 81.2 53.6 50.3 50.8 50.3 72.9 59.7 55.1 59.1 76.9 33.4 38.7 43.2 32.4 38.7 91.2 42.7 37.6 95.9 37.8 49.9 77.6 120.5 41.6 67.9 74.2 54.2 80.6 59.8 49.4 57.5 85.3 75.4 62.2 74.4 67.5 34.4 50.5 14.7 4.5 4.4 3.7 2.9 3.9 4.5 3.1 4.1 3.7 4.5 3.1 2.8 6.8 4.3 5.0 6.2 3.1 3.1 24.6 25.8 25.0 26.8 24.0 29.0 24.0 25.2 24.3 21.6 28.7 25.6 33.9 38.5 51.0 24.2 36.5 22.4 19.2 16.8 43.3 29.5 27.4 26.0 51.6 22.8 28.4 20.2 56.3 24.4 38.4 29.5 5.9 22.1 5.4 31.0 45.3 32.6 31.0 33.0 21.6 21.3 21.3 32.7 46.4 49.1 50.5 36.6 22.9 33.9 23.7 30.3 19.7 23.1 8.2 23.0 22.4 17.8 25.7 41.8 8.8 16.9 29.9 22.0 30.9 17.6 19.4 31.9 18.7 26.7 55.7 20.0 23.4 10.5 25.7 44.4 32.9 32.4 32.0 19.8 19.1 40.1 24.3 49.8 38.3 42.0 22.9 25.7 TAF1C "MGC:39976, SL1, TAFI110, TAFI95" ENSG00000103168 "TATA-box binding protein associated factor, RNA polymerase I subunit C" Q15572 16 84177847-84187070 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072229 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli fibrillar center" "HPA072229: AB_2686499" "unprognostic (9.39e-2)" "unprognostic (1.13e-1)" "unprognostic (6.86e-3)" "unprognostic (8.20e-3)" "unprognostic (4.45e-2)" "unprognostic (3.47e-2)" "unprognostic (6.21e-2)" "unprognostic (1.26e-1)" "unprognostic (2.52e-1)" "unprognostic (3.53e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.06e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (5.60e-2)" "unprognostic (2.22e-1)" "unprognostic (1.82e-1)" "prognostic favorable (3.22e-4)" 19.4 15.8 9.8 7.2 9.9 13.5 20.6 8.1 12.9 25.9 5.4 16.0 7.9 23.5 2.2 15.9 21.4 10.1 18.3 10.9 7.7 20.6 14.8 17.0 11.1 10.5 8.7 31.7 17.9 4.2 20.6 6.2 8.6 21.7 2.9 1.8 15.3 8.3 12.3 17.8 19.3 5.3 7.3 32.2 18.7 13.8 8.9 7.4 23.7 6.7 3.6 18.5 19.1 8.9 11.8 12.7 7.5 23.6 5.7 5.9 34.3 13.8 5.3 11.5 3.7 15.0 8.3 12.7 17.3 5.0 6.1 21.2 4.3 5.4 2.6 11.4 18.2 6.8 21.0 9.7 4.8 7.6 21.8 8.9 6.9 9.1 3.7 5.0 20.4 20.7 17.9 4.1 5.6 25.4 11.3 24.9 27.8 5.1 12.2 29.2 6.1 10.5 4.7 9.5 34.0 16.8 26.3 7.8 43.0 4.6 28.9 8.1 8.9 19.2 16.5 19.2 12.0 19.6 16.9 26.7 9.8 9.2 12.4 0.0 1.3 0.4 1.5 1.3 1.8 0.9 0.6 0.9 1.5 1.1 0.7 1.3 0.0 1.5 0.5 0.6 0.9 1.2 9.8 9.9 8.1 12.9 10.9 7.7 10.5 8.7 8.6 7.3 8.9 8.9 24.9 19.2 15.8 22.5 9.2 6.5 5.1 5.2 5.2 9.3 10.2 10.2 3.0 2.8 8.2 3.7 20.9 9.4 6.5 9.9 5.9 5.1 0.5 6.9 7.4 18.7 7.2 7.4 16.5 7.1 6.7 8.4 20.9 8.8 6.3 24.6 22.9 12.9 6.6 1.7 13.0 8.2 0.0 9.8 6.3 2.5 11.8 7.3 7.2 15.9 6.3 7.8 5.2 13.6 12.5 5.2 5.1 9.1 12.1 3.9 7.6 4.0 6.1 10.4 6.6 8.3 7.8 9.9 10.6 8.7 5.3 7.4 8.0 16.8 10.2 4.4 TAF1D "JOSD3, MGC5306, TAF(I)41" ENSG00000166012 "TATA-box binding protein associated factor, RNA polymerase I subunit D" Q9H5J8 11 93729948-93784391 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030703, HPA055935, HPA060385" Uncertain Supported "Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite" Yes No "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli, Mitotic spindle, Centriolar satellite" "HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271" "unprognostic (9.91e-3)" "unprognostic (4.38e-2)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "unprognostic (5.40e-3)" "unprognostic (6.46e-2)" "unprognostic (3.68e-3)" "unprognostic (9.70e-2)" "unprognostic (5.24e-3)" "unprognostic (3.55e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (3.17e-7)" "unprognostic (1.95e-1)" "unprognostic (2.51e-1)" "unprognostic (2.34e-1)" "unprognostic (6.37e-2)" 10.0 9.3 2.5 18.2 3.0 16.4 12.6 5.0 6.7 7.7 1.2 9.5 13.7 14.1 9.0 9.5 7.7 15.4 7.1 2.9 3.5 6.8 6.9 8.1 20.6 2.3 0.6 13.8 20.9 5.3 4.9 18.0 2.3 9.9 12.5 8.2 10.1 7.3 8.0 11.4 13.3 9.1 0.5 11.9 11.9 5.5 1.7 10.9 10.1 7.1 13.1 13.8 7.2 7.8 18.2 8.6 17.5 17.9 14.0 47.8 29.2 27.0 11.5 18.4 13.8 28.6 38.8 32.6 34.0 15.6 12.6 44.3 21.5 25.9 21.2 10.6 7.8 34.8 55.6 20.2 16.4 31.9 25.1 19.5 25.8 16.0 35.7 35.0 23.7 22.7 24.2 50.4 22.8 5.0 25.8 66.4 12.1 16.7 9.6 23.3 19.1 30.9 22.7 17.4 10.7 19.5 10.8 38.2 16.5 19.3 32.7 12.4 28.7 26.9 30.5 44.2 28.7 22.9 26.2 32.5 11.2 36.9 10.3 44.2 16.7 28.8 17.3 12.5 17.7 39.1 24.9 19.8 12.0 39.8 28.4 24.1 42.7 18.1 10.8 26.1 18.2 5.2 2.5 3.0 5.0 6.7 2.9 3.5 2.3 0.6 2.3 0.5 1.7 7.8 106.7 89.8 95.5 20.9 246.1 244.2 252.4 66.6 255.0 86.6 129.4 130.9 26.2 134.4 105.3 29.5 39.6 176.0 162.5 94.5 45.0 95.2 19.9 144.9 184.9 121.3 110.2 98.4 41.6 146.3 170.2 147.1 125.4 245.6 104.4 257.2 63.1 54.2 69.3 69.0 38.2 148.0 24.4 103.7 153.6 16.5 128.6 112.0 80.0 24.4 102.1 34.8 89.6 35.2 44.0 110.4 87.5 67.7 162.2 269.2 71.1 101.5 67.7 78.2 72.3 187.4 123.1 49.0 71.5 251.4 203.0 160.9 182.3 119.7 174.1 356.8 TAS2R14 "T2R14, TRB1" ENSG00000212127 "Taste 2 receptor member 14" Q9NYV8 12 10937408-11171573 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 7.1;Cone photoreceptor cells: 10.4;Rod photoreceptor cells: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.2" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (4.26e-2)" "unprognostic (1.41e-1)" "unprognostic (6.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.46e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-3)" "unprognostic (1.18e-1)" "unprognostic (1.12e-3)" "unprognostic (1.93e-2)" "unprognostic (1.22e-4)" "unprognostic (2.45e-2)" "unprognostic (1.07e-1)" "unprognostic (9.29e-3)" "unprognostic (4.71e-3)" 1.2 2.1 1.0 0.4 0.5 0.7 1.3 0.5 1.4 2.4 0.6 2.1 0.5 2.1 2.4 1.1 2.1 0.3 1.3 0.9 0.5 1.4 1.7 1.5 0.4 1.1 0.8 3.3 1.7 0.4 3.0 0.4 0.7 1.9 0.5 1.8 1.7 0.4 1.0 1.0 2.0 0.5 0.5 2.0 1.5 0.9 0.6 0.1 2.5 0.2 0.5 1.7 1.8 0.5 0.3 0.2 0.6 0.1 0.1 0.4 0.1 0.3 0.0 0.0 0.1 0.6 0.4 1.0 0.1 0.2 0.3 0.4 0.0 0.3 0.2 0.5 0.5 0.2 0.6 0.3 0.0 0.3 0.1 0.4 0.2 0.8 0.1 0.5 0.4 0.3 0.5 0.0 0.4 0.1 0.2 2.2 0.6 0.1 0.3 0.3 0.3 0.3 0.5 0.6 0.1 0.6 0.5 0.0 0.0 0.5 0.1 0.3 0.5 0.4 0.3 0.2 0.5 0.1 0.1 0.4 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.5 1.4 0.9 0.5 1.1 0.8 0.7 0.5 0.6 0.5 1.4 3.2 1.5 0.0 1.7 0.6 0.7 1.0 0.6 7.1 1.3 1.8 0.5 1.5 0.5 0.0 10.4 2.1 1.3 0.3 3.9 0.6 0.1 1.7 2.6 0.9 3.5 0.8 0.0 0.4 0.6 1.5 0.0 1.0 0.0 4.8 2.2 1.4 1.3 1.7 0.0 0.9 0.0 1.0 0.3 0.0 2.1 1.6 0.0 0.0 1.3 1.4 1.0 0.0 0.0 0.7 0.2 2.6 0.8 1.0 0.4 0.7 0.8 7.7 0.0 2.2 1.8 0.9 0.5 0.4 0.1 0.5 1.2 4.4 1.0 0.4 TAS2R19 "T2R19, T2R23, TAS2R23, TAS2R48" ENSG00000212124 "Taste 2 receptor member 19" P59542 12 11021619-11022620 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 52: Non-specific - Transcription" "unprognostic (1.90e-2)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.84e-1)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (5.73e-2)" "unprognostic (2.35e-1)" "unprognostic (8.76e-2)" "unprognostic (8.26e-2)" "unprognostic (1.94e-2)" "unprognostic (1.57e-8)" "unprognostic (9.08e-2)" "unprognostic (1.58e-1)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" 0.3 0.3 0.1 0.0 0.2 0.0 0.3 0.2 0.3 0.7 0.1 0.4 0.0 0.6 0.0 0.2 0.4 0.0 0.4 0.2 0.3 0.3 0.2 0.4 0.0 0.3 0.2 1.4 0.4 0.0 1.0 0.0 0.2 0.4 0.0 0.2 0.2 0.0 0.5 0.2 0.3 0.0 0.1 0.3 0.3 0.6 0.2 0.1 0.4 0.0 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 TAS2R20 "T2R20, T2R56, TAS2R49" ENSG00000255837 "Taste 2 receptor member 20" P59543 12 10996495-10997875 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 52: Non-specific - Transcription" "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (1.12e-3)" "unprognostic (2.16e-4)" "unprognostic (2.92e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.98e-2)" "unprognostic (5.14e-4)" "unprognostic (6.23e-3)" "unprognostic (1.27e-9)" "unprognostic (2.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-2)" "unprognostic (6.44e-3)" 1.3 1.0 0.2 0.1 0.3 0.1 1.2 0.3 0.5 2.1 0.3 1.2 0.0 1.3 0.0 0.7 1.3 0.0 1.1 0.2 0.2 0.7 1.2 1.3 0.2 0.3 0.2 2.4 1.1 0.0 1.6 0.1 0.5 1.3 0.1 0.8 1.0 0.1 1.4 1.1 1.4 0.1 0.2 1.5 0.8 0.7 0.3 0.2 1.5 0.0 0.0 1.0 1.6 0.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.5 0.2 0.2 0.3 0.2 0.5 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 TAS2R46 T2R54 ENSG00000226761 "Taste 2 receptor member 46" P59540 12 11061365-11062294 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 52: Non-specific - Transcription" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (1.03e-1)" "unprognostic (7.73e-4)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.1 0.3 0.2 0.2 0.3 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TBC1D2B KIAA1055 ENSG00000167202 "TBC1 domain family member 2B" Q9UPU7 15 77984036-78077724 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 90.7;Theca cells: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041833, HPA048174, HPA052663" Approved Enhanced Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" Cytosol "HPA041833: AB_2732494, HPA048174: AB_2680297, HPA052663: AB_2681906" "unprognostic (3.13e-1)" "unprognostic (2.16e-1)" "unprognostic (8.25e-2)" "unprognostic (1.28e-2)" "unprognostic (3.94e-2)" "unprognostic (1.43e-1)" "unprognostic (5.07e-3)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (8.22e-3)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.23e-3)" "unprognostic (6.68e-2)" "unprognostic (3.07e-2)" "unprognostic (3.37e-1)" "unprognostic (3.19e-2)" 23.1 15.4 4.8 20.4 5.1 22.5 17.3 4.6 5.0 25.1 9.3 15.8 12.9 23.3 11.7 11.4 20.8 28.2 10.2 4.1 6.6 7.7 16.3 33.9 23.1 9.7 5.5 46.1 18.3 17.1 5.9 25.0 6.0 11.5 17.4 4.5 8.7 14.3 5.1 13.4 16.0 21.2 6.3 25.5 12.9 12.6 6.7 23.8 12.1 10.8 19.3 19.1 14.9 6.6 12.0 9.4 11.1 10.5 76.2 60.4 19.3 27.1 40.7 24.9 27.3 12.0 4.8 18.5 10.6 23.0 13.8 17.1 24.4 29.9 18.9 35.2 18.8 11.8 9.1 8.2 36.1 30.1 17.3 59.2 20.4 16.5 11.0 36.8 28.6 23.5 6.2 12.5 32.5 13.2 11.2 19.7 8.8 9.3 9.0 16.8 50.9 4.1 12.7 45.1 5.9 16.0 25.3 17.0 31.9 10.2 5.6 31.1 35.5 27.1 17.8 8.6 14.5 20.9 23.8 9.7 9.3 39.8 14.6 0.0 0.8 0.3 1.4 0.6 0.8 0.0 0.9 1.6 0.5 0.1 0.7 0.6 1.4 1.4 0.2 1.2 0.5 0.6 4.8 5.1 4.6 5.0 4.1 6.6 9.7 5.5 6.0 6.3 6.7 6.6 13.9 3.2 17.3 26.4 6.4 9.3 7.3 13.9 1.8 10.7 5.3 4.3 3.3 14.3 9.7 5.5 6.2 20.6 24.0 12.8 0.0 8.8 10.0 7.1 33.7 16.1 7.3 4.4 23.3 10.0 6.9 28.0 17.3 6.3 9.5 6.3 21.4 90.7 19.0 15.2 20.3 19.7 10.2 31.9 29.3 10.3 42.6 21.5 14.2 45.9 23.7 6.2 6.2 12.5 10.4 15.3 13.4 42.2 9.5 6.3 15.3 4.3 10.9 8.9 26.3 19.4 18.2 6.0 7.1 4.5 9.9 28.5 26.0 79.0 15.7 8.1 TBC1D9B "GRAMD9B, KIAA0676" ENSG00000197226 "TBC1 domain family member 9B" Q66K14 5 179862066-179907897 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038350 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 15: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" "Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "HPA038350: AB_10673170" "unprognostic (5.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" "unprognostic (9.53e-2)" "unprognostic (9.45e-3)" "unprognostic (4.25e-1)" "unprognostic (1.06e-1)" "unprognostic (2.84e-1)" "unprognostic (1.10e-1)" "unprognostic (5.08e-2)" "unprognostic (2.01e-1)" "unprognostic (2.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (3.99e-4)" "unprognostic (8.22e-2)" 54.9 61.8 53.9 20.8 62.2 22.8 46.3 58.1 51.1 39.3 38.6 34.1 22.8 38.9 12.0 43.9 34.2 23.8 30.9 51.4 50.1 44.8 55.0 31.7 23.9 60.5 59.8 39.0 46.4 27.0 29.2 17.2 61.6 33.6 12.1 9.1 37.0 25.0 45.9 44.4 34.4 21.1 63.4 39.5 35.5 20.5 57.2 13.1 36.3 18.7 15.3 35.1 35.7 65.9 42.7 64.0 27.4 62.4 69.9 49.0 66.8 51.0 47.2 50.1 48.4 43.8 41.9 29.3 60.2 57.8 56.6 39.6 28.3 115.9 9.8 98.0 39.1 26.0 47.3 27.9 41.5 35.1 85.0 50.6 42.6 39.2 18.9 22.6 48.4 55.3 17.7 28.1 39.5 104.2 22.7 24.5 20.3 17.4 36.5 38.7 22.1 27.8 35.1 66.8 40.1 30.4 48.2 54.5 54.9 11.0 45.0 48.8 57.2 71.2 31.9 34.8 45.2 16.8 23.3 22.7 68.0 41.7 51.7 5.0 7.8 5.5 6.1 9.2 4.8 6.3 4.2 4.9 9.3 5.1 3.9 3.5 0.9 4.2 9.2 9.5 4.0 7.1 53.9 62.2 58.1 51.1 51.4 50.1 60.5 59.8 61.6 63.4 57.2 65.9 24.9 22.4 19.2 20.2 19.7 16.6 10.2 14.6 15.4 27.8 23.9 21.6 9.5 12.8 14.0 27.6 8.4 19.8 20.4 28.4 13.7 21.1 2.4 18.2 20.2 21.0 18.0 17.5 32.1 18.0 23.6 21.1 21.9 27.0 11.4 30.0 24.3 35.2 30.7 62.2 23.6 23.9 10.2 33.5 15.7 8.2 32.3 28.6 16.0 15.9 21.4 17.8 24.7 14.6 27.0 25.2 24.3 28.6 16.4 15.3 24.4 22.6 13.3 18.0 26.3 26.7 16.4 11.1 18.5 25.0 15.6 14.1 17.9 57.1 20.5 13.7 TCAF1 "FAM115A, KIAA0738" ENSG00000198420 "TRPM8 channel associated factor 1" Q9Y4C2 7 143851375-143902198 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 251.7;Syncytiotrophoblasts: 521.5;Theca cells: 377.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011732 Approved Approved "Nuclear bodies,Vesicles,Cell Junctions" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 28: Placenta - Pregnancy" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "Cell Junctions" "Nuclear bodies, Vesicles" "HPA011732: AB_2668526" "unprognostic (1.57e-1)" "unprognostic (7.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.11e-1)" "unprognostic (2.73e-1)" "unprognostic (7.00e-2)" "unprognostic (5.70e-3)" "unprognostic (3.07e-2)" "unprognostic (4.93e-2)" "prognostic favorable (5.93e-4)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (3.95e-3)" "unprognostic (6.45e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.89e-1)" 29.0 46.5 22.7 12.9 51.4 4.7 21.7 15.1 30.3 27.5 2.7 18.8 12.2 32.2 15.2 15.1 22.2 19.3 23.7 29.4 42.7 14.8 29.3 19.0 8.4 15.4 13.4 39.9 19.4 35.1 27.2 81.1 19.8 36.2 20.3 28.0 15.8 19.8 17.5 16.9 15.8 30.6 11.5 11.7 21.7 9.4 31.0 17.1 26.8 55.7 9.0 14.8 13.4 20.1 47.2 29.0 90.1 93.7 57.9 55.7 55.1 54.3 64.9 42.4 56.3 60.5 33.0 0.2 25.2 63.3 54.5 29.7 34.8 35.7 46.5 25.7 26.0 25.7 15.7 54.0 39.7 0.3 16.2 58.2 31.5 50.0 18.4 66.8 53.4 32.2 43.2 4.5 83.2 70.7 42.3 15.9 27.6 52.0 17.4 26.0 60.7 6.2 33.7 37.5 25.6 153.1 55.5 34.2 25.7 63.7 51.5 4.0 48.8 44.6 28.5 42.2 32.7 14.0 19.2 0.4 81.9 7.6 62.3 0.4 1.5 0.9 4.7 1.8 3.3 1.6 2.8 3.1 2.9 1.6 2.4 3.0 0.4 4.4 3.1 1.4 2.3 2.5 22.7 51.4 15.1 30.3 29.4 42.7 15.4 13.4 19.8 11.5 31.0 20.1 36.3 44.8 37.1 30.3 7.3 0.0 15.0 0.0 16.5 47.7 29.4 38.6 43.0 31.5 14.9 3.7 25.0 251.7 15.2 18.7 0.0 30.9 2.4 27.6 62.7 35.1 19.4 22.1 71.2 35.6 43.7 54.6 20.9 40.5 7.6 167.5 34.6 83.6 32.9 30.3 63.1 29.3 0.0 10.5 0.0 3.5 53.1 12.2 0.0 29.0 10.8 27.5 20.6 57.3 43.7 49.9 15.4 56.4 8.4 27.3 20.1 8.9 8.0 26.7 13.1 72.1 53.3 13.3 11.7 14.1 0.0 521.5 10.4 377.5 23.5 24.3 TCEAL4 "FLJ21174, WEX7" ENSG00000133142 "Transcription elongation factor A like 4" Q96EI5 X 103576231-103587729 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Leydig cells: 1524.1;Peritubular cells: 1785.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" "unprognostic (2.21e-1)" "unprognostic (2.21e-1)" "unprognostic (6.17e-3)" "unprognostic (1.47e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.11e-5)" "unprognostic (1.08e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.63e-2)" "unprognostic (5.36e-2)" "unprognostic (4.16e-1)" "unprognostic (2.02e-2)" "unprognostic (7.49e-2)" "unprognostic (3.35e-2)" "unprognostic (5.46e-2)" "unprognostic (7.63e-2)" 167.6 213.2 157.9 44.3 159.0 28.1 156.1 154.5 204.9 517.9 206.4 204.4 32.4 712.6 251.4 113.8 428.0 86.9 179.3 154.9 166.8 144.3 111.4 167.2 30.5 164.6 160.6 855.8 98.1 134.6 180.4 112.1 163.8 318.4 49.5 77.5 88.9 262.6 95.9 146.6 111.8 277.5 157.1 125.7 159.3 118.9 158.0 30.7 134.9 81.5 30.3 423.5 278.9 170.0 153.8 115.2 96.1 85.7 330.5 196.1 96.4 165.0 165.3 101.5 118.2 49.6 112.0 37.9 178.5 181.5 242.6 96.8 107.3 120.2 122.9 0.6 72.4 51.7 179.9 65.0 291.9 0.4 41.2 262.6 182.4 84.5 193.7 253.3 149.2 52.7 0.7 39.9 303.9 376.5 56.5 2.8 87.6 3.6 136.8 55.5 162.8 7.5 155.3 186.4 97.3 95.6 265.4 64.1 224.0 112.0 102.3 25.1 185.3 100.6 39.8 257.3 68.9 11.7 71.7 1.7 138.7 0.7 104.6 12.3 28.5 1.0 12.8 15.3 18.4 36.4 17.5 13.7 37.7 22.8 15.9 16.8 1.1 24.7 11.9 11.8 57.0 13.6 157.9 159.0 154.5 204.9 154.9 166.8 164.6 160.6 163.8 157.1 158.0 170.0 131.6 112.2 159.1 20.9 28.8 130.0 305.9 170.2 117.3 88.5 169.2 191.4 278.7 114.4 130.8 198.6 14.6 222.8 11.7 19.6 385.4 156.6 11.7 117.0 459.5 143.2 104.2 28.6 19.5 95.2 331.5 202.4 46.4 178.9 116.9 167.0 231.0 218.6 148.4 90.9 21.1 44.9 91.6 61.7 80.5 65.2 1524.1 69.9 104.9 11.2 82.3 201.9 4.1 26.2 31.9 68.7 33.7 1785.5 23.3 195.5 7.6 297.2 81.0 60.5 361.6 120.3 192.8 34.8 58.5 91.1 104.3 94.3 29.7 144.7 39.4 135.8 TCF25 "KIAA1049, Nulp1" ENSG00000141002 "Transcription factor 25" Q9BQ70 16 89873570-89913627 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041699, HPA041786" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" "HPA041699: AB_10960254, HPA041786: AB_10960526" "unprognostic (1.33e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "prognostic favorable (6.95e-4)" "unprognostic (6.67e-2)" "unprognostic (4.96e-2)" "unprognostic (2.72e-1)" "unprognostic (6.02e-2)" "unprognostic (2.50e-1)" "unprognostic (3.49e-1)" "unprognostic (1.05e-2)" "unprognostic (1.27e-1)" "unprognostic (7.64e-3)" "unprognostic (1.44e-1)" "unprognostic (1.36e-1)" "unprognostic (6.10e-3)" "unprognostic (1.08e-1)" 71.9 91.2 48.2 51.1 53.7 98.7 71.0 45.6 58.4 72.2 34.6 77.4 61.4 77.4 42.3 69.3 69.0 55.0 73.4 50.7 52.1 65.8 78.4 68.3 63.8 48.2 44.8 85.3 85.9 65.4 85.7 53.3 52.4 70.6 37.2 22.9 72.8 53.7 83.8 71.8 70.9 46.1 35.2 78.0 84.9 76.9 48.8 45.0 77.7 41.4 44.4 73.3 65.4 48.1 51.1 72.9 80.6 107.8 65.4 70.1 89.7 122.4 91.9 91.9 42.9 46.9 75.4 120.2 95.0 88.2 30.7 50.3 45.7 53.8 36.5 50.6 96.7 61.2 71.0 94.4 109.7 72.1 78.7 84.8 55.3 56.6 61.1 90.4 83.1 46.7 113.6 72.4 95.4 166.8 78.4 138.9 52.1 77.3 40.4 122.4 77.2 68.2 78.1 69.0 71.7 42.7 184.5 70.5 67.9 33.6 66.0 75.1 126.6 75.0 81.6 42.7 51.8 91.0 34.7 68.7 72.0 83.0 98.8 124.5 131.5 107.5 97.8 107.4 72.3 74.9 71.2 76.3 91.5 93.2 60.1 63.0 222.6 78.2 102.9 145.3 67.2 81.0 48.2 53.7 45.6 58.4 50.7 52.1 48.2 44.8 52.4 35.2 48.8 48.1 160.7 160.3 154.7 64.3 170.9 102.3 155.7 145.6 124.7 360.0 135.7 142.0 90.7 107.2 148.7 165.5 277.3 249.1 277.8 194.9 148.7 110.8 271.7 165.3 209.1 143.3 148.2 85.0 65.2 152.3 329.5 149.4 181.5 203.1 172.8 153.1 126.7 157.7 156.4 464.4 69.7 233.2 120.1 154.6 161.0 383.9 173.4 160.2 186.7 45.0 195.6 150.8 307.9 38.7 54.7 117.2 179.7 184.3 236.4 175.1 192.8 179.1 162.7 279.4 157.8 119.1 152.1 192.7 74.6 114.9 104.0 538.8 193.8 185.4 185.6 199.4 TCHP "MGC10854, TpMs" ENSG00000139437 "Trichoplein keratin filament binding" Q9BT92 12 109900264-109983841 "Predicted intracellular proteins" "Apoptosis, Cilium biogenesis/degradation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038638, HPA061543" Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Centrosome, Cytosol" "HPA038638: AB_10670785, HPA061543: AB_2684556" "unprognostic (2.21e-1)" "unprognostic (1.51e-2)" "unprognostic (2.58e-1)" "unprognostic (1.04e-1)" "unprognostic (2.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.42e-2)" "unprognostic (7.94e-2)" "unprognostic (1.59e-2)" "unprognostic (9.75e-2)" "unprognostic (1.15e-3)" "unprognostic (4.63e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.52e-4)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" 6.5 7.3 9.7 8.9 10.6 6.8 6.6 10.9 11.3 10.1 8.1 10.4 7.3 9.1 7.5 15.4 7.6 5.9 8.1 9.4 10.5 7.8 5.6 7.3 11.7 10.4 10.5 8.9 10.9 7.4 6.4 7.6 10.5 8.6 6.8 9.2 10.5 7.9 9.1 27.4 8.2 7.6 9.2 11.8 8.2 9.3 10.7 10.4 8.6 7.0 11.6 9.3 13.8 11.0 27.6 24.0 12.7 15.3 11.0 11.9 17.3 25.6 13.4 21.8 12.1 15.2 9.4 38.2 7.2 14.9 11.8 22.5 14.0 16.0 19.5 20.7 13.8 27.6 15.3 15.0 13.3 38.0 20.4 9.8 19.1 22.9 17.1 13.7 19.7 23.8 30.5 7.5 18.2 18.9 35.0 38.4 15.3 6.6 24.2 31.7 24.9 32.4 9.9 24.2 18.8 19.8 18.5 19.8 18.2 9.0 17.9 27.2 21.8 22.2 15.5 14.3 32.7 21.8 29.5 27.0 23.5 31.0 23.7 0.0 2.7 2.3 3.6 1.7 2.6 2.0 3.2 4.5 2.1 1.3 3.2 2.5 2.7 5.9 3.7 1.5 4.7 3.1 9.7 10.6 10.9 11.3 9.4 10.5 10.4 10.5 10.5 9.2 10.7 11.0 11.7 19.2 21.4 18.9 10.4 9.8 7.7 9.5 8.0 28.9 11.3 11.4 13.2 17.2 12.0 7.3 18.8 11.2 14.3 12.8 9.8 20.7 32.5 23.0 19.1 15.2 14.8 15.4 8.3 15.1 8.4 11.4 10.2 13.2 13.3 15.7 7.9 7.4 11.6 25.2 12.3 10.7 10.2 13.0 7.8 47.6 11.1 11.4 7.2 1.9 14.3 13.9 35.0 10.1 19.4 18.8 14.4 27.8 15.0 9.1 14.2 6.6 33.6 24.0 13.1 19.6 12.6 25.1 33.2 14.8 24.7 7.0 15.9 30.9 12.2 30.7 TEFM "C17orf42, FLJ22729" ENSG00000172171 "Transcription elongation factor, mitochondrial" Q96QE5 17 30897336-30906238 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023788, HPA053044" Approved Enhanced Mitochondria No No "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA023788: AB_1848818, HPA053044: AB_2682023" "unprognostic (1.22e-1)" "unprognostic (1.18e-2)" "unprognostic (1.11e-3)" "unprognostic (3.31e-2)" "unprognostic (7.89e-2)" "unprognostic (3.75e-1)" "prognostic unfavorable (9.20e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (2.11e-1)" "unprognostic (6.18e-3)" "unprognostic (9.39e-2)" "unprognostic (4.79e-2)" "unprognostic (7.90e-2)" "unprognostic (1.92e-1)" "unprognostic (2.23e-1)" "unprognostic (8.37e-3)" 4.9 6.0 4.4 5.9 4.6 2.2 6.7 5.7 6.0 4.0 5.5 5.7 5.6 4.9 4.1 5.2 4.8 4.1 8.9 4.6 4.4 9.6 8.8 4.0 7.3 4.5 4.4 4.8 3.3 6.6 3.2 6.8 4.6 5.0 6.6 6.9 5.4 4.8 6.8 5.3 4.6 5.1 4.3 5.7 5.1 4.2 4.6 5.4 5.4 11.7 6.7 5.4 2.9 5.1 12.8 19.2 10.7 14.9 12.7 12.4 10.1 13.1 9.5 23.7 21.4 15.6 7.2 17.4 12.7 8.1 15.5 21.6 18.6 9.1 22.4 5.5 23.9 8.8 15.1 15.5 8.5 18.7 11.2 7.9 11.7 13.4 6.9 7.2 11.9 12.4 19.1 14.3 13.9 11.7 16.0 24.3 8.9 19.6 12.1 10.5 22.9 17.6 19.2 14.4 16.3 7.5 9.8 11.7 15.4 10.9 23.7 14.1 7.8 10.9 14.7 11.2 13.8 7.9 14.0 16.2 7.3 13.8 13.2 2.6 7.7 6.5 6.4 12.2 8.8 9.8 8.2 6.5 8.1 6.3 9.9 9.2 2.3 8.6 9.9 7.0 10.0 7.1 4.4 4.6 5.7 6.0 4.6 4.4 4.5 4.4 4.6 4.3 4.6 5.1 10.1 16.0 10.6 13.7 11.3 4.1 8.0 22.6 9.1 17.8 6.8 6.9 5.8 11.5 13.6 9.2 8.4 26.0 11.5 5.4 25.4 13.4 10.4 12.6 15.3 9.6 5.4 6.9 27.1 8.5 17.3 10.2 5.1 7.8 5.1 17.2 10.4 10.1 20.4 16.8 27.3 7.4 22.4 7.8 3.0 6.3 8.1 9.6 7.2 21.5 14.0 15.0 16.5 27.2 32.2 12.5 5.6 7.5 7.1 5.2 9.4 17.7 17.8 19.4 19.7 11.0 11.6 27.7 17.8 8.7 4.3 17.8 10.0 18.9 7.9 4.7 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria No No "Cluster 26: Non-specific - Mitochondria" "Cluster 35: Non-specific - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: AB_2685782" "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 17.4 24.7 22.1 6.5 22.3 9.6 17.9 23.1 25.8 23.4 18.9 20.1 7.9 18.8 8.3 15.7 19.4 7.7 28.4 20.9 21.3 27.0 29.0 14.1 11.5 23.7 21.8 22.3 24.0 14.0 19.7 7.4 22.2 22.9 4.5 5.1 16.5 9.9 22.8 17.0 15.1 7.0 21.0 21.6 19.2 16.8 21.9 9.7 19.9 13.4 8.6 18.9 18.2 25.0 13.6 12.8 11.2 16.3 18.2 16.3 10.8 12.0 15.6 31.2 19.4 17.1 8.4 11.9 15.7 13.2 11.6 10.5 17.9 10.7 10.8 20.6 30.1 13.7 18.5 15.5 22.8 9.8 13.6 15.3 13.4 19.7 17.2 19.0 13.6 20.5 14.1 14.9 11.7 9.7 17.2 22.2 9.7 15.8 21.7 16.2 13.6 17.3 14.3 3.2 14.7 16.7 14.6 19.9 28.6 9.3 12.8 17.4 12.4 16.5 9.9 11.4 19.0 16.7 19.3 15.9 13.9 20.9 9.5 16.6 19.4 15.2 25.2 16.2 25.7 22.1 25.0 26.8 24.4 31.0 27.3 23.1 12.0 24.7 12.9 22.2 27.1 20.9 22.1 22.3 23.1 25.8 20.9 21.3 23.7 21.8 22.2 21.0 21.9 25.0 12.1 0.0 7.5 5.5 10.8 14.0 12.0 13.2 9.1 11.1 10.4 14.2 7.2 10.0 6.9 9.2 6.2 16.0 9.7 10.7 19.6 10.5 6.5 9.2 11.8 12.8 7.7 11.0 4.6 10.4 17.5 15.8 5.6 9.0 5.7 17.6 11.7 11.6 15.5 5.0 5.8 10.4 10.2 10.9 15.9 4.7 18.6 7.1 10.6 2.8 19.2 12.2 12.3 5.0 7.9 9.8 13.1 23.3 18.1 21.5 21.1 19.3 12.3 8.8 13.1 13.8 15.8 18.2 18.0 8.7 14.8 16.4 9.3 17.7 13.0 15.6 TIA1 TIA-1 ENSG00000116001 "TIA1 cytotoxic granule associated RNA binding protein" P31483 2 70209444-70248660 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Apoptosis RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 172.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056961 Supported Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 51: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA056961: AB_2683289" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "unprognostic (3.68e-2)" "unprognostic (1.07e-1)" "unprognostic (7.64e-3)" "unprognostic (2.51e-3)" "unprognostic (3.37e-3)" "prognostic favorable (6.79e-5)" "unprognostic (5.09e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "prognostic unfavorable (8.05e-7)" "unprognostic (4.00e-1)" "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "prognostic favorable (1.02e-5)" 27.3 34.4 20.0 34.3 23.5 28.0 47.5 27.6 29.2 63.6 25.0 42.3 35.6 68.5 70.2 26.1 50.5 36.6 27.3 20.0 21.4 46.0 33.1 32.8 49.6 22.4 21.1 73.8 41.2 29.7 49.3 36.7 22.7 43.5 39.8 68.0 42.2 35.1 24.6 40.3 45.8 41.0 21.4 51.4 37.0 19.7 21.2 67.6 47.6 25.7 35.8 36.8 39.9 29.7 21.0 22.9 117.4 66.1 32.7 55.1 56.6 36.6 25.8 34.8 34.4 31.0 31.7 47.1 30.7 27.3 20.2 33.8 57.5 20.0 48.9 44.2 25.1 48.9 43.2 74.4 26.1 49.5 26.6 41.2 29.0 20.0 21.9 82.3 65.1 37.5 38.4 41.9 49.4 17.9 91.9 78.0 95.8 30.0 27.0 110.5 63.8 48.0 53.3 40.7 71.0 60.6 43.2 50.8 36.0 60.5 30.4 36.2 53.6 42.5 44.3 20.1 36.6 34.9 36.9 86.7 24.9 62.1 57.6 13.5 5.9 8.4 5.6 5.0 5.4 7.1 5.5 5.8 8.8 5.2 5.0 5.6 2.3 8.2 3.1 4.5 7.6 3.9 20.0 23.5 27.6 29.2 20.0 21.4 22.4 21.1 22.7 21.4 21.2 29.7 45.8 83.3 63.4 91.7 44.7 25.4 31.2 25.1 38.1 52.7 46.9 40.6 30.8 28.6 54.8 20.2 47.9 31.3 40.3 23.0 0.0 31.0 21.0 31.9 70.6 40.1 52.6 42.9 95.0 27.1 34.6 40.8 36.2 34.2 55.7 106.7 33.2 30.6 21.1 35.3 94.5 31.7 32.6 29.4 28.7 9.3 36.1 32.4 16.0 57.1 44.0 31.4 28.8 152.3 172.0 30.1 23.6 35.7 38.2 32.5 24.8 14.0 58.8 51.8 26.3 25.4 45.7 30.0 19.3 26.0 24.0 24.8 43.5 44.3 31.9 29.7 TIAF1 ENSG00000221995 "TGFB1-induced anti-apoptotic factor 1" O95411 17 29073521-29078857 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 37.4" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 70: Brain - Nervous system development" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "unprognostic (1.16e-1)" "unprognostic (8.34e-2)" "unprognostic (7.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.42e-1)" "unprognostic (9.03e-3)" "unprognostic (4.14e-2)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.07e-3)" "unprognostic (1.35e-1)" "unprognostic (3.97e-8)" "unprognostic (1.54e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" 2.4 1.7 7.5 1.1 11.2 1.3 2.2 9.7 11.1 4.4 2.9 3.1 1.5 3.0 2.2 4.2 2.4 1.0 5.9 7.4 9.5 3.3 9.0 2.4 1.4 13.2 10.3 2.8 2.2 0.5 3.0 0.7 14.8 3.4 1.2 3.0 2.1 0.9 6.7 4.0 3.0 1.1 6.9 3.5 2.3 2.3 11.0 1.4 2.1 1.1 1.6 2.4 4.1 16.4 0.6 0.2 1.0 0.5 0.6 0.7 0.7 0.7 0.3 0.4 0.4 0.8 0.8 0.5 0.5 0.9 0.9 1.7 0.7 0.7 0.9 0.7 0.4 0.2 1.4 0.6 0.2 0.9 0.7 0.5 0.4 1.1 0.3 2.0 0.2 1.6 1.9 1.2 0.6 0.5 0.8 1.9 0.1 37.4 0.6 7.0 0.5 0.8 1.2 0.4 0.7 0.3 0.3 3.3 0.3 2.1 0.5 2.9 0.2 0.6 0.6 0.3 0.5 0.4 0.9 0.3 0.8 0.8 0.5 0.2 0.1 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.0 0.3 0.1 0.2 0.5 0.1 0.2 0.4 0.0 0.0 7.5 11.2 9.7 11.1 7.4 9.5 13.2 10.3 14.8 6.9 11.0 16.4 0.5 3.2 2.0 0.0 0.1 0.4 0.3 0.0 0.0 1.6 0.2 0.1 0.9 0.0 0.6 0.0 0.0 0.1 1.7 0.3 0.0 0.1 0.4 0.1 0.3 0.5 0.0 0.0 0.0 0.2 0.3 0.6 1.1 0.1 0.0 1.1 1.1 0.9 0.9 0.0 0.0 0.6 0.0 0.6 0.4 0.2 0.0 0.6 0.0 0.0 0.4 0.2 1.0 0.0 0.0 0.2 0.0 0.0 0.5 0.3 0.5 0.1 0.0 0.9 6.6 0.5 0.4 0.2 0.2 0.5 0.3 0.0 0.3 0.3 0.2 0.8 TIGD1 EEYORE ENSG00000221944 "Tigger transposable element derived 1" Q96MW7 2 232543883-232550557 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041717 Approved Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Cluster 32: T-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies" "HPA041717: AB_2677636" "unprognostic (2.48e-1)" "unprognostic (1.77e-2)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (2.58e-2)" "unprognostic (2.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-2)" "unprognostic (1.20e-2)" "unprognostic (4.40e-2)" "unprognostic (6.86e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (3.77e-2)" "unprognostic (1.85e-2)" "unprognostic (2.77e-1)" "unprognostic (3.21e-3)" 1.8 2.3 6.3 2.3 5.3 6.5 2.7 13.4 7.8 3.2 5.4 2.8 1.9 2.6 2.9 2.8 3.8 1.9 2.4 5.0 4.5 7.4 2.7 2.5 3.4 3.2 2.4 5.7 2.9 1.6 5.0 2.0 4.1 4.4 2.1 10.4 2.7 1.7 4.0 4.2 3.6 1.3 1.5 6.1 3.3 5.2 4.5 3.3 4.7 1.4 2.2 2.8 3.0 9.7 3.1 2.3 4.7 7.5 1.7 2.3 3.6 2.1 1.2 2.6 2.9 2.8 3.6 5.0 1.5 1.6 2.8 3.2 4.1 1.3 3.8 3.0 3.9 4.5 7.7 3.5 1.1 3.6 2.9 2.6 1.2 2.6 1.6 2.5 1.5 6.5 3.6 5.0 2.1 5.3 4.9 8.3 2.8 1.9 2.7 4.7 6.3 2.3 1.5 3.5 6.1 6.0 2.2 2.1 2.3 3.3 3.1 3.9 2.5 4.3 4.5 2.7 2.1 4.8 3.4 4.5 2.5 3.6 2.6 1.6 1.7 1.8 1.9 1.4 1.9 1.7 2.0 1.5 1.1 2.1 3.1 2.5 2.3 1.8 1.5 1.2 1.6 0.7 6.3 5.3 13.4 7.8 5.0 4.5 3.2 2.4 4.1 1.5 4.5 9.7 2.4 9.6 3.9 4.2 5.3 1.3 4.5 2.3 1.8 4.9 2.5 2.2 2.0 1.5 2.9 3.7 8.4 2.2 3.1 1.7 0.0 3.6 4.2 1.0 3.6 1.7 1.2 6.5 4.5 1.5 1.3 3.1 7.7 1.5 0.0 6.4 1.4 0.7 1.4 6.7 5.7 1.5 2.0 1.6 1.7 0.7 4.7 2.4 1.8 1.0 2.8 7.5 5.2 5.0 8.1 2.0 2.4 1.9 5.6 2.6 3.5 1.4 1.7 7.0 6.6 3.7 2.0 3.9 5.7 3.7 2.0 1.4 4.1 4.0 3.0 2.9 TIMM23B bA592B15.7 ENSG00000204152 "Translocase of inner mitochondrial membrane 23 homolog B" Q5SRD1 10 49942049-49974850 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "unprognostic (8.84e-2)" "unprognostic (2.67e-2)" "unprognostic (5.92e-2)" "unprognostic (4.19e-3)" "unprognostic (9.37e-2)" "unprognostic (7.64e-2)" "unprognostic (2.04e-1)" "unprognostic (1.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.43e-3)" "unprognostic (4.03e-2)" "unprognostic (3.30e-3)" "unprognostic (5.39e-2)" "unprognostic (9.66e-2)" "unprognostic (1.62e-1)" "unprognostic (4.90e-3)" "unprognostic (1.18e-1)" 5.0 4.4 3.4 4.2 3.9 15.1 5.9 4.1 4.4 3.1 1.8 3.9 6.0 4.6 4.5 4.2 3.1 2.7 9.0 3.0 4.6 3.2 5.5 3.9 3.8 5.2 4.3 3.9 5.1 3.2 4.0 3.6 5.2 4.3 3.8 5.9 3.8 3.6 18.3 6.4 3.9 4.4 4.3 3.5 4.1 3.8 4.6 3.5 3.9 14.7 3.5 5.2 2.9 5.0 4.0 2.2 2.1 4.6 5.1 7.7 2.2 4.8 10.9 4.0 2.2 3.2 5.6 5.8 2.9 14.6 4.0 3.3 1.8 4.8 8.2 6.8 0.3 0.7 0.0 5.8 8.3 11.6 1.0 11.7 2.6 5.4 13.5 3.6 5.7 5.0 5.3 4.4 7.8 0.6 4.9 4.0 5.3 1.2 3.4 3.7 4.4 4.5 3.7 4.4 4.6 10.6 2.5 7.2 5.6 5.0 5.1 4.1 4.9 3.8 3.5 7.5 8.6 5.4 2.6 13.4 9.1 2.6 3.0 1.5 0.9 1.2 1.2 1.1 2.0 1.5 1.1 1.2 1.4 1.0 1.9 1.3 0.3 2.6 2.4 1.2 0.6 1.3 3.4 3.9 4.1 4.4 3.0 4.6 5.2 4.3 5.2 4.3 4.6 5.0 8.2 19.2 10.9 27.4 11.4 0.0 10.1 0.0 10.2 15.2 5.0 4.3 7.1 7.2 5.6 5.5 29.2 5.0 7.7 2.5 1.9 6.1 1.1 9.2 10.8 6.1 0.0 10.3 30.5 8.2 5.4 7.5 10.7 8.3 7.0 8.7 5.3 10.5 5.6 20.2 39.8 2.8 0.0 3.2 0.0 2.3 5.6 5.8 0.0 19.7 9.2 8.0 7.2 24.6 33.3 9.8 1.1 8.6 13.4 9.1 2.9 3.5 2.9 17.5 6.6 9.4 6.7 15.5 9.1 8.0 0.0 5.9 9.3 9.1 3.7 9.7 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116297-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.7;prostate: 6.6" "Cell type enhanced" "Detected in some" "granulocytes: 1.3;Hofbauer cells: 2.8" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.1;neutrophil: 1.6" "Group enriched" "Detected in many" 7 "granulocytes: 1.6;monocytes: 1.1" "Cell line enhanced" "Detected in some" "AF22: 6.0;SCLC-21H: 14.2;THP-1: 11.9;U-937: 9.8" "Low region specificity" "Detected in all" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: AB_2686036" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 0.3 0.6 6.4 0.9 7.5 1.0 0.7 3.5 7.6 0.2 1.5 0.2 0.2 0.3 0.9 0.3 0.3 0.2 1.2 8.7 3.9 0.3 0.1 0.3 0.1 3.8 3.3 0.2 1.1 0.1 1.6 0.7 3.3 6.6 0.2 1.3 0.4 0.2 1.3 0.5 0.2 0.3 3.6 0.7 0.2 1.9 4.9 0.1 0.1 0.4 0.1 0.3 0.2 5.1 0.0 0.0 6.0 0.8 0.0 0.0 0.0 0.1 0.1 0.2 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.3 0.0 0.8 3.2 2.1 0.0 0.1 0.2 3.0 0.0 0.3 0.1 14.2 2.1 0.0 0.0 0.3 0.8 0.0 11.9 0.6 0.6 0.2 0.2 0.0 0.2 0.4 0.9 0.0 9.8 0.3 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 6.4 7.5 3.5 7.6 8.7 3.9 3.8 3.3 3.3 3.6 4.9 5.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 1.3 0.9 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 TMEM161B MGC33214 ENSG00000164180 "Transmembrane protein 161B" Q8NDZ6 5 88189633-88269476 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 82.1;HMC-1: 85.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044562 Uncertain NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "HPA044562: AB_10794291" "unprognostic (2.08e-1)" "unprognostic (6.02e-2)" "unprognostic (2.06e-2)" "unprognostic (5.64e-2)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" "unprognostic (3.07e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (1.18e-3)" "unprognostic (1.58e-1)" "unprognostic (1.01e-1)" "unprognostic (6.96e-3)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (7.62e-3)" "unprognostic (9.35e-2)" 4.6 5.8 5.0 5.8 4.7 6.2 16.0 7.3 6.3 6.5 3.0 9.7 12.4 6.4 14.2 7.8 7.1 5.6 4.8 4.3 3.8 9.7 11.9 10.1 9.1 3.1 3.1 11.2 14.0 23.0 4.8 8.1 3.2 12.3 11.3 18.2 14.1 8.9 6.4 15.6 11.5 5.8 3.0 6.4 22.9 12.5 4.0 8.6 20.9 7.0 9.5 7.4 6.0 5.6 11.8 8.0 8.7 9.5 5.4 10.3 18.6 10.3 15.4 14.6 21.2 8.9 30.2 18.2 5.2 7.7 26.6 12.3 10.2 13.3 18.4 16.4 10.7 82.1 10.3 5.9 14.0 15.9 85.2 9.2 19.1 12.4 18.3 10.4 6.5 11.9 40.5 16.0 12.7 5.5 11.6 13.9 5.6 8.7 14.3 9.7 10.1 19.9 13.0 16.4 11.1 9.3 5.9 16.3 24.5 7.7 9.8 14.5 5.4 9.5 8.7 13.7 18.9 19.6 33.3 14.9 23.3 15.7 13.4 1.5 1.4 1.0 2.9 2.8 2.9 2.2 2.4 2.1 0.8 2.1 2.4 1.9 0.8 2.9 1.1 2.6 2.1 1.2 5.0 4.7 7.3 6.3 4.3 3.8 3.1 3.1 3.2 3.0 4.0 5.6 9.8 28.9 16.4 37.2 19.2 7.8 8.0 12.0 5.7 15.8 13.6 9.7 16.3 11.5 15.0 9.2 16.7 9.3 17.9 14.7 3.9 8.8 3.6 10.2 11.4 7.7 14.3 10.3 43.4 9.7 4.1 9.8 12.2 14.0 16.5 14.4 15.0 23.1 5.3 6.7 46.3 13.7 6.1 11.8 5.5 3.1 10.5 8.2 0.0 28.1 7.1 15.6 22.6 59.3 55.0 11.3 6.6 12.8 13.1 9.4 11.3 6.4 9.4 22.2 6.6 8.9 8.9 35.8 12.6 9.3 7.1 15.1 15.8 11.3 14.3 7.5 TMEM245 "C9orf5, CG-2" ENSG00000106771 "Transmembrane protein 245" Q9H330 9 109015135-109119947 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023892 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA023892: AB_1845828" "unprognostic (1.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (9.58e-2)" "unprognostic (1.63e-1)" "unprognostic (6.43e-2)" "unprognostic (1.66e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.46e-9)" "unprognostic (6.11e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-1)" "unprognostic (2.24e-2)" 29.2 47.6 18.1 12.4 19.4 7.3 20.2 16.8 19.4 21.0 32.6 22.9 12.6 27.3 26.1 23.1 29.2 19.2 43.1 19.6 21.4 45.9 25.2 28.7 15.1 17.3 19.6 45.3 24.6 65.1 11.3 29.1 17.8 25.5 16.9 27.7 26.2 33.9 35.4 14.2 15.9 34.2 20.6 17.9 17.8 16.8 22.0 17.0 74.2 39.2 11.6 18.9 11.9 18.4 32.3 42.2 30.5 10.3 69.9 39.9 67.0 45.4 35.0 47.9 37.6 56.9 62.9 28.9 45.3 34.7 46.4 49.5 39.1 29.2 56.2 37.8 16.8 36.0 32.2 33.7 30.5 27.5 27.2 42.9 29.2 46.7 42.8 51.5 40.7 31.5 24.4 31.2 55.1 21.2 36.8 12.6 33.9 43.2 37.5 20.8 60.3 18.0 50.8 31.0 16.8 16.4 30.0 29.6 30.2 44.9 39.6 15.4 44.9 37.0 27.7 34.9 52.4 20.6 56.9 9.2 51.5 14.5 54.9 4.4 1.6 1.5 2.4 1.1 2.9 1.5 4.0 3.4 1.6 2.1 5.2 3.6 0.6 3.3 2.4 2.2 4.3 1.8 18.1 19.4 16.8 19.4 19.6 21.4 17.3 19.6 17.8 20.6 22.0 18.4 55.0 115.4 93.1 36.6 22.4 25.2 18.8 27.4 27.3 43.8 34.4 23.0 135.6 74.4 33.8 86.5 106.3 50.7 20.1 27.0 3.9 22.7 6.7 31.6 24.8 51.8 31.2 70.5 71.4 31.1 17.7 31.3 25.5 56.4 31.6 62.8 74.3 98.3 18.0 63.9 62.0 31.1 10.2 28.4 14.3 7.8 41.0 18.9 23.2 46.9 18.3 52.6 16.5 60.8 75.8 30.0 35.6 51.1 19.7 23.1 55.3 33.7 45.6 32.4 46.0 40.7 37.9 27.4 43.8 21.0 28.4 15.1 28.2 81.4 35.6 21.7 TMEM259 "ASBABP1, C19orf6, MBRL, MGC4022" ENSG00000182087 "Transmembrane protein 259" Q4ZIN3 19 1009648-1021179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042669, HPA054801" Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "Nuclear speckles" "HPA042669: AB_10794916, HPA054801: AB_2682604" "unprognostic (1.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "prognostic favorable (1.01e-4)" "unprognostic (4.12e-2)" "unprognostic (6.87e-3)" "unprognostic (2.77e-2)" "unprognostic (1.23e-1)" "unprognostic (2.20e-1)" "unprognostic (2.74e-1)" "unprognostic (4.85e-3)" "unprognostic (4.07e-2)" "unprognostic (4.81e-2)" "prognostic favorable (8.92e-6)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (4.10e-3)" 114.9 119.8 59.6 68.7 62.3 82.4 112.4 59.9 74.5 111.8 71.3 117.4 66.8 108.0 22.3 114.7 110.9 48.0 129.9 57.0 61.3 119.3 162.6 128.5 75.2 72.1 65.6 106.5 127.3 83.2 154.2 50.3 63.7 126.3 33.9 39.1 109.2 45.6 112.7 128.6 135.7 35.2 58.9 191.5 115.5 101.2 66.1 71.9 133.2 48.2 47.8 103.3 113.1 75.5 125.0 78.3 53.6 61.3 64.7 62.2 94.4 101.1 89.5 83.7 89.9 73.2 68.6 84.8 98.5 78.9 39.4 138.9 54.4 102.0 36.9 108.5 88.0 50.4 102.9 81.2 114.6 98.1 122.5 83.7 102.2 67.5 83.6 79.5 73.7 85.6 85.5 168.2 56.8 54.9 106.5 89.9 78.3 63.1 60.2 120.8 40.6 110.1 66.3 115.1 73.7 77.8 64.9 82.2 73.9 43.0 80.9 125.3 87.0 83.0 47.2 118.5 108.2 240.2 95.7 96.2 98.3 79.3 84.6 0.6 1.7 1.0 2.2 1.4 1.6 1.6 1.3 2.2 2.5 1.3 1.3 1.6 1.1 1.2 2.3 2.9 1.4 1.6 59.6 62.3 59.9 74.5 57.0 61.3 72.1 65.6 63.7 58.9 66.1 75.5 73.6 32.1 49.9 64.6 70.1 62.3 54.5 26.0 51.2 118.5 50.3 44.7 14.1 30.0 27.6 66.2 98.0 59.2 90.0 114.1 11.7 28.4 18.3 46.5 56.4 50.4 40.2 21.0 36.3 34.3 51.4 49.6 122.3 63.5 15.2 89.4 40.7 52.0 51.1 104.3 40.8 78.4 18.3 30.0 58.1 11.4 42.6 55.2 44.4 36.5 28.7 65.9 26.8 35.2 58.4 42.9 75.8 34.3 89.1 63.7 56.2 20.7 26.3 170.2 32.9 48.5 51.2 45.4 38.5 53.8 64.9 82.4 69.3 126.4 62.6 66.3 TMEM35A "FLJ14084, NACHO, TMEM35, TUF-1" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078879-101096367 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.9;intestine: 36.8;seminal vesicle: 50.9" "Cell type enriched" "Detected in some" 5 "Theca cells: 37.5" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.1;HUVEC TERT2: 52.5;SH-SY5Y: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported Supported "Vesicles,Focal adhesion sites,Cytosol" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" Vesicles "Focal adhesion sites, Cytosol" "HPA048583: AB_2680451" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.5 6.9 20.8 1.3 20.4 0.0 0.8 18.5 28.5 4.6 2.5 36.8 3.4 7.8 3.6 11.2 4.1 3.4 0.5 28.4 71.9 0.5 0.0 2.3 0.1 21.8 21.3 7.9 0.2 12.7 2.2 0.1 36.8 22.3 9.6 10.2 0.5 50.9 0.8 0.6 7.2 10.3 15.6 0.8 5.2 1.4 47.5 0.2 0.8 2.5 0.3 9.7 4.4 13.5 0.0 0.0 5.4 0.0 3.9 10.1 0.0 1.1 0.7 0.4 0.2 0.0 0.0 0.0 0.1 3.2 0.0 0.0 3.4 0.0 1.0 0.0 0.2 0.0 0.1 0.0 1.2 0.0 0.0 3.5 0.0 1.9 0.0 7.5 52.5 0.0 0.0 0.1 6.6 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 13.2 0.0 0.0 0.0 1.3 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 20.4 18.5 28.5 28.4 71.9 21.8 21.3 36.8 15.6 47.5 13.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 7.4 0.4 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.2 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 37.5 0.0 0.0 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33097146 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 5.5" "Cell type enhanced" "Detected in some" "Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "BEWO: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 0.6 0.5 0.8 1.4 0.7 5.5 0.6 0.7 1.2 0.6 4.3 1.0 1.2 0.5 0.6 0.6 0.9 0.6 0.4 1.5 0.5 1.0 0.6 1.1 1.1 1.4 1.4 0.6 0.7 1.9 0.3 1.2 1.6 0.5 1.2 2.8 0.7 0.6 0.2 1.1 1.1 0.8 0.2 1.5 1.3 0.3 1.7 0.5 1.0 0.3 1.3 0.8 0.4 0.2 1.4 1.9 1.0 1.7 1.2 1.0 27.2 0.6 1.0 1.6 0.9 2.7 3.8 0.8 1.2 1.7 0.9 1.4 1.7 1.5 2.6 4.2 0.6 3.4 1.9 2.1 0.9 3.0 4.7 1.1 1.2 2.0 1.4 0.8 1.9 1.7 2.6 2.9 1.2 1.3 1.2 1.3 1.0 0.4 1.1 1.5 0.6 1.9 1.5 1.9 0.2 0.6 0.9 2.6 0.6 1.3 1.4 4.2 2.7 2.4 3.0 1.3 2.6 2.3 1.6 0.4 3.0 2.2 1.7 0.0 1.1 0.3 0.1 2.4 0.6 0.3 0.2 0.0 1.0 0.1 0.0 0.0 1.9 0.0 1.1 0.2 0.2 0.4 0.8 0.7 0.7 1.2 1.5 0.5 1.4 1.4 1.6 0.2 1.7 0.2 0.3 0.0 1.3 0.0 0.8 0.8 0.1 0.0 0.0 1.2 0.4 0.4 0.4 0.0 0.2 0.0 0.0 1.1 1.9 1.4 0.0 0.4 0.0 0.8 0.6 0.4 0.0 0.4 0.0 0.8 1.7 0.3 0.0 1.1 0.0 0.4 0.4 0.6 0.9 1.7 0.0 0.2 2.0 1.3 1.2 0.0 0.0 1.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.5 1.4 0.4 1.0 0.2 1.4 0.3 0.4 2.2 0.0 0.2 0.7 0.0 0.0 1.5 0.9 0.4 0.6 0.5 0.6 0.2 TNRC6B KIAA1093 ENSG00000100354 "Trinucleotide repeat containing adaptor 6B" Q9UPQ9 22 40044817-40335808 "Metabolic proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 484.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003180 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 6: Brain - Smell perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "HPA003180: AB_1079196" "unprognostic (1.45e-1)" "unprognostic (1.29e-2)" "unprognostic (1.04e-1)" "unprognostic (5.88e-2)" "unprognostic (1.92e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-1)" "unprognostic (2.48e-2)" "unprognostic (9.74e-2)" "unprognostic (4.93e-2)" "unprognostic (2.59e-1)" "unprognostic (8.42e-2)" "unprognostic (1.84e-3)" "unprognostic (8.85e-2)" "unprognostic (7.24e-2)" "unprognostic (7.00e-2)" "unprognostic (1.81e-1)" 4.0 3.6 4.5 4.9 6.2 19.5 3.9 22.0 7.6 4.4 13.2 4.2 3.2 4.0 5.8 3.5 3.7 4.4 4.7 3.6 1.1 3.9 5.4 4.9 5.3 3.7 3.5 4.2 3.9 4.7 5.5 3.6 4.2 3.7 3.5 12.7 4.0 2.8 6.4 5.5 5.2 3.7 1.1 5.6 4.3 14.9 3.9 9.2 5.0 5.1 5.9 3.6 4.2 15.7 6.3 9.3 9.4 9.8 6.1 4.3 5.1 4.2 7.7 6.5 7.9 4.2 4.3 11.9 7.4 5.1 7.6 4.3 11.8 8.6 6.8 13.0 9.3 8.8 9.3 5.3 3.0 10.2 12.5 4.8 4.0 10.2 5.1 3.1 9.0 6.7 7.4 10.8 6.1 6.8 6.3 3.2 12.2 4.8 6.7 7.7 9.0 6.0 6.1 10.6 11.4 2.7 10.2 3.6 5.2 8.5 5.1 3.7 10.3 5.7 20.7 5.8 4.0 8.5 8.2 7.8 3.7 5.1 6.8 228.9 32.8 66.2 48.0 19.2 42.4 100.7 50.5 44.5 16.3 134.6 52.8 53.6 484.5 34.7 29.6 104.9 29.5 12.5 4.5 6.2 22.0 7.6 3.6 1.1 3.7 3.5 4.2 1.1 3.9 15.7 114.0 38.5 54.9 260.8 178.8 74.8 70.2 60.8 92.8 248.7 103.4 85.9 153.6 125.8 56.0 69.9 458.7 36.4 171.1 77.8 70.5 59.8 82.5 142.2 91.0 104.4 141.0 203.1 334.1 59.3 20.7 108.4 61.2 85.0 65.9 78.1 120.7 109.7 39.0 341.6 371.8 76.7 65.1 115.9 80.1 72.4 111.9 71.4 65.8 235.2 117.2 127.2 168.9 255.9 304.0 54.4 76.4 127.9 117.8 79.8 93.0 69.0 91.3 356.9 52.6 175.5 95.1 87.7 88.3 56.6 82.1 7.5 149.0 82.6 83.7 59.1 TOP3A "TOP3, ZGRF7" ENSG00000177302 "DNA topoisomerase III alpha" Q13472 17 18271428-18315007 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, Disease variant, Dwarfism, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002449 Approved NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "CAB002449: AB_564037" "unprognostic (5.49e-2)" "unprognostic (9.04e-2)" "unprognostic (8.99e-2)" "unprognostic (7.24e-3)" "unprognostic (4.01e-2)" "unprognostic (1.95e-2)" "unprognostic (2.33e-3)" "unprognostic (6.54e-2)" "unprognostic (2.34e-1)" "unprognostic (2.74e-1)" "prognostic favorable (1.39e-4)" "prognostic unfavorable (4.59e-4)" "unprognostic (5.58e-2)" "unprognostic (8.80e-2)" "unprognostic (3.53e-2)" "unprognostic (5.05e-2)" "unprognostic (6.05e-2)" 9.4 8.0 1.9 3.3 1.8 5.7 8.6 3.1 2.6 8.6 2.1 7.8 2.3 8.4 1.6 8.6 8.5 2.1 6.0 1.8 1.8 7.0 11.2 7.7 3.6 1.7 1.6 7.5 7.7 2.6 8.9 2.5 1.7 7.7 2.4 2.1 8.1 1.7 10.0 11.3 8.2 2.6 1.4 11.4 7.6 11.7 2.0 4.2 6.7 2.5 3.3 8.5 7.8 2.0 9.3 14.2 9.4 11.1 3.8 4.6 10.9 9.4 4.9 14.2 12.8 22.4 3.4 13.7 6.0 6.5 6.6 11.7 12.6 6.7 11.5 11.6 11.4 13.1 15.2 7.9 4.3 5.8 11.9 2.9 4.6 15.0 8.7 2.9 7.3 11.5 11.3 5.7 6.1 6.4 15.2 5.9 8.7 13.8 6.8 17.4 22.6 14.8 3.2 8.1 7.7 13.6 12.6 8.3 8.4 24.5 16.1 6.5 6.5 10.6 8.1 18.2 15.4 5.8 13.7 10.4 6.6 8.0 10.5 1.1 3.1 3.4 1.8 2.7 1.3 0.7 1.3 1.6 1.3 0.8 1.1 1.2 4.2 2.2 1.5 1.2 1.2 2.0 1.9 1.8 3.1 2.6 1.8 1.8 1.7 1.6 1.7 1.4 2.0 2.0 5.3 6.4 4.8 6.5 9.7 2.0 4.5 4.5 6.8 20.8 6.2 3.9 3.1 5.7 7.4 11.0 39.6 7.4 11.8 4.6 3.9 4.2 7.2 5.0 8.7 6.2 0.0 9.9 16.4 3.7 6.9 6.3 6.6 6.3 5.1 12.1 6.4 7.0 5.4 21.9 17.2 4.2 4.1 12.4 6.3 7.9 8.1 11.6 1.8 12.2 13.9 6.4 15.5 11.6 11.2 3.6 2.8 6.4 12.0 5.8 3.8 2.1 6.5 22.2 13.1 9.3 6.6 26.7 25.5 5.2 3.4 4.4 9.0 13.1 5.9 5.0 TOR2A "FLJ14771, TORP1" ENSG00000160404 "Torsin family 2 member A" "Q5JU69, Q8N2E6" 9 127731524-127735313 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 69.1;Theca cells: 114.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071229 Approved Uncertain "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum, Plasma membrane" "HPA071229: AB_2732175" "unprognostic (1.67e-1)" "unprognostic (9.19e-3)" "unprognostic (1.47e-1)" "unprognostic (1.27e-3)" "unprognostic (3.04e-2)" "unprognostic (6.97e-2)" "unprognostic (2.43e-3)" "unprognostic (4.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.33e-1)" "unprognostic (6.51e-3)" "unprognostic (1.05e-2)" "unprognostic (6.98e-2)" "prognostic favorable (7.51e-4)" "unprognostic (1.72e-1)" "unprognostic (3.27e-1)" "unprognostic (2.82e-2)" 6.8 10.7 9.6 6.8 9.3 26.9 6.7 9.4 13.2 7.9 9.5 12.2 11.2 6.7 3.4 11.4 7.0 4.9 5.4 9.2 9.1 10.2 14.0 8.7 7.7 9.4 9.2 8.2 13.6 3.1 10.0 7.9 8.9 8.1 5.4 2.9 8.7 3.6 3.3 9.5 12.8 2.7 8.6 20.8 11.8 20.4 9.7 8.4 8.7 2.2 4.5 7.1 7.1 9.1 7.4 11.5 9.7 12.2 4.7 4.6 13.0 5.1 6.3 8.0 6.3 7.9 12.6 13.6 7.5 4.4 6.0 23.2 3.0 6.4 2.2 21.1 11.0 5.2 10.6 9.7 7.7 11.0 27.0 7.4 11.8 7.4 3.9 4.0 11.5 16.2 16.2 37.3 4.7 43.4 14.3 34.7 8.7 24.0 9.9 23.4 4.5 30.9 8.3 6.9 21.0 8.3 4.7 16.6 5.3 5.3 37.0 21.4 7.2 5.2 6.0 9.1 6.0 23.4 21.8 5.6 6.4 17.8 5.0 26.5 68.5 96.5 32.8 80.2 26.1 12.1 18.9 32.5 71.6 18.0 14.0 25.2 44.0 26.9 78.3 16.2 32.2 41.5 9.6 9.3 9.4 13.2 9.2 9.1 9.4 9.2 8.9 8.6 9.7 9.1 5.3 3.2 5.1 6.2 12.4 1.5 4.4 16.6 1.2 13.7 8.7 5.8 0.6 15.7 9.6 3.7 0.0 37.9 16.0 26.4 1.9 19.1 69.1 7.0 5.7 8.5 22.8 34.1 5.5 27.4 38.9 10.1 8.2 10.8 5.7 11.7 15.0 7.5 56.9 8.4 4.6 20.4 20.3 33.9 8.3 10.7 11.5 26.2 3.6 2.8 25.2 11.7 30.9 6.0 3.7 15.5 28.7 11.3 21.1 6.0 33.9 8.7 7.7 14.6 0.0 2.5 4.2 30.6 10.9 7.5 1.4 51.9 15.0 114.6 18.3 4.9 TP53BP1 "53BP1, p202, TDRD30" ENSG00000067369 "Tumor protein p53 binding protein 1" Q12888 15 43403061-43510728 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004083, HPA008788, HPA022133, CAB079980" Supported Supported "Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles" Yes No "Cluster 46: Basophils - DNA binding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "Nucleoplasm, Mitotic chromosome, Vesicles" "CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382" "unprognostic (2.12e-1)" "unprognostic (7.96e-2)" "unprognostic (1.11e-1)" "unprognostic (1.85e-2)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.03e-2)" "unprognostic (3.96e-1)" "unprognostic (2.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.34e-2)" "unprognostic (4.07e-1)" "unprognostic (8.06e-2)" "unprognostic (9.11e-2)" "unprognostic (1.52e-1)" "unprognostic (6.99e-2)" "unprognostic (3.38e-2)" 6.9 11.5 17.4 10.1 16.6 11.5 10.7 19.9 14.5 17.7 21.5 9.7 6.4 16.0 15.9 6.1 14.7 10.7 8.8 15.4 26.3 9.1 4.1 8.3 8.6 13.5 16.7 16.8 7.4 22.3 24.1 12.2 15.7 12.1 10.2 22.0 10.1 12.8 7.2 9.2 6.4 16.3 9.6 8.7 7.6 21.6 23.0 15.3 17.9 11.0 12.6 11.2 8.7 12.1 13.5 22.3 63.8 40.1 25.8 31.9 15.8 22.8 33.8 31.0 39.1 19.4 15.8 14.5 19.2 39.0 66.9 32.4 46.3 27.5 36.8 38.9 15.8 27.1 40.1 11.7 16.8 30.2 37.4 24.9 19.0 41.8 31.2 51.7 37.4 24.2 26.9 12.3 36.5 9.6 23.7 14.1 41.1 24.2 13.9 25.1 23.9 9.3 22.9 31.8 57.3 26.8 33.8 14.3 8.5 48.6 29.9 16.9 27.5 33.7 22.3 27.0 20.5 9.8 22.4 33.0 27.6 14.6 17.5 1.4 0.5 1.0 1.6 0.7 1.3 1.9 1.6 1.6 1.2 1.8 1.8 1.6 0.6 0.9 0.5 1.3 1.4 0.7 17.4 16.6 19.9 14.5 15.4 26.3 13.5 16.7 15.7 9.6 23.0 12.1 11.5 22.4 22.3 53.2 17.8 6.4 10.2 10.0 13.6 32.4 17.4 13.2 14.9 5.7 20.8 29.5 47.9 13.4 11.1 7.4 9.8 14.5 38.8 47.0 44.8 16.8 41.9 8.4 66.2 7.1 11.2 23.9 14.8 26.8 26.6 47.0 15.0 3.3 10.8 47.1 81.9 15.7 12.2 3.8 6.9 17.8 23.6 9.3 1.8 17.8 4.0 11.9 7.2 62.8 50.4 7.5 5.8 17.7 17.1 11.0 2.6 8.8 60.7 51.7 13.1 35.2 20.5 33.1 36.2 14.7 5.3 18.5 17.0 29.9 13.4 8.9 TRA2A "AWMS1, htra-2-alpha" ENSG00000164548 "Transformer 2 alpha homolog" Q13595 7 23504780-23532041 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054018 Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoli "Nucleoplasm, Vesicles" "HPA054018: AB_2682344" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.24e-1)" "unprognostic (6.77e-3)" "unprognostic (8.05e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.28e-2)" "unprognostic (2.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.87e-3)" "unprognostic (6.04e-2)" "prognostic unfavorable (1.79e-6)" "unprognostic (1.46e-2)" "unprognostic (1.52e-2)" "unprognostic (8.74e-2)" "unprognostic (1.36e-3)" 35.1 39.1 55.7 37.0 58.2 113.4 32.1 57.4 75.7 47.1 57.9 38.7 26.4 42.8 43.9 47.3 42.7 21.3 30.4 55.3 57.8 45.9 34.9 33.5 47.6 57.2 56.5 53.1 32.6 25.6 40.4 32.9 57.6 41.3 39.2 42.0 33.2 22.1 23.1 42.8 36.8 41.0 56.6 52.8 33.0 30.9 56.8 46.1 35.9 21.3 53.6 37.9 42.9 64.9 57.2 61.2 94.1 148.4 49.1 30.9 60.4 71.4 33.6 70.5 57.4 51.2 76.4 107.4 39.9 53.7 82.3 92.1 115.6 66.9 88.4 64.6 65.7 65.9 67.9 81.8 52.0 78.0 59.2 37.1 44.9 53.1 66.1 62.7 80.9 46.7 129.5 51.0 79.7 55.6 96.5 128.7 84.5 69.5 62.5 106.1 74.8 64.3 81.8 81.0 80.7 65.8 66.0 75.8 49.8 69.1 59.6 85.5 73.8 55.4 79.0 51.0 83.4 56.6 76.1 86.9 47.7 103.8 75.3 16.8 17.1 23.6 24.6 28.8 21.6 17.6 23.3 23.1 20.6 16.1 19.6 23.7 25.4 19.1 27.0 30.0 25.2 10.2 55.7 58.2 57.4 75.7 55.3 57.8 57.2 56.5 57.6 56.6 56.8 64.9 110.6 60.9 72.2 112.3 141.9 104.4 95.6 61.7 94.4 54.5 118.5 74.8 42.5 60.1 60.8 88.3 52.1 83.2 153.3 84.9 25.4 54.8 62.1 155.7 137.1 74.8 118.5 77.5 113.1 43.9 84.6 91.5 89.2 166.7 86.7 62.5 84.6 71.4 54.8 37.0 115.4 100.3 48.8 89.5 125.4 23.7 65.0 88.9 56.9 107.7 71.5 48.1 70.0 203.1 245.1 59.2 92.0 67.7 125.4 97.7 59.7 41.8 71.3 101.8 72.3 119.2 88.2 99.8 65.0 138.6 113.1 117.9 130.4 49.1 112.6 92.1 TRIM32 "BBS11, HT2A, LGMD2H, TATIP" ENSG00000119401 "Tripartite motif containing 32" Q13049 9 116687305-116701300 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Limb-girdle muscular dystrophy, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050060 Approved Approved "Intermediate filaments" No No "Cluster 35: T-regs - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" "HPA050060: AB_2681000" "unprognostic (2.47e-2)" "unprognostic (7.06e-3)" "unprognostic (5.50e-2)" "unprognostic (3.63e-1)" "unprognostic (5.08e-2)" "prognostic unfavorable (4.53e-4)" "prognostic unfavorable (4.72e-4)" "unprognostic (2.41e-3)" "unprognostic (2.92e-1)" "unprognostic (5.01e-2)" "unprognostic (1.79e-2)" "unprognostic (5.63e-2)" "unprognostic (6.03e-2)" "unprognostic (7.06e-2)" "unprognostic (2.73e-1)" "unprognostic (6.64e-3)" "unprognostic (9.77e-2)" 6.7 7.2 4.6 5.4 4.5 1.0 6.8 16.4 5.4 10.1 15.2 6.0 5.9 10.6 6.5 7.4 13.1 6.4 7.9 4.7 6.1 5.2 3.8 5.5 8.1 3.6 2.8 10.1 6.2 8.6 3.5 6.1 3.9 6.9 6.2 7.2 5.2 7.3 18.6 4.6 7.2 10.7 2.1 6.2 5.4 5.2 4.5 7.5 6.3 12.5 7.4 7.6 5.7 3.4 10.9 24.5 14.3 15.7 28.3 20.1 10.8 19.9 21.7 22.1 18.4 16.4 11.7 11.3 8.6 30.7 16.5 22.8 17.5 22.4 20.0 9.9 8.5 6.1 15.4 10.2 14.7 4.1 19.1 17.4 19.7 21.0 12.3 24.4 14.6 12.4 8.6 9.3 26.3 13.9 11.0 0.1 13.0 26.2 14.6 12.7 38.2 7.4 9.0 25.1 14.2 7.2 15.7 10.8 11.4 14.3 29.8 4.0 18.2 20.4 16.2 15.3 15.2 15.1 4.3 17.7 17.0 2.7 20.5 0.0 1.7 0.0 10.9 3.3 8.4 7.3 9.5 8.7 2.3 5.1 9.6 9.8 0.3 7.0 3.0 4.3 20.9 6.0 4.6 4.5 16.4 5.4 4.7 6.1 3.6 2.8 3.9 2.1 4.5 3.4 2.5 6.4 0.6 5.5 4.3 4.2 6.3 9.3 5.7 11.7 3.1 3.7 7.6 7.2 7.3 9.2 0.0 6.7 2.1 1.7 1.9 8.5 3.5 7.1 10.7 3.6 4.2 0.4 7.6 8.0 3.6 6.1 3.6 2.3 2.5 4.5 2.9 4.1 7.2 1.7 10.1 4.0 8.2 2.4 4.7 2.1 5.3 2.2 1.8 1.9 0.8 4.0 3.1 6.6 5.1 5.0 2.6 12.0 3.1 2.8 10.6 3.1 10.8 4.8 0.0 6.0 6.6 17.7 13.1 5.6 3.7 7.4 4.7 5.0 5.3 4.8 TRIM41 "MGC1127, RINCK" ENSG00000146063 "Tripartite motif containing 41" Q8WV44 5 181222499-181235808 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 77.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024204 Approved Supported "Nucleoli,Nuclear bodies" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli, Nuclear bodies" "HPA024204: AB_1858299" "unprognostic (1.13e-1)" "unprognostic (7.05e-2)" "unprognostic (1.23e-2)" "unprognostic (7.93e-2)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (9.56e-2)" "unprognostic (7.24e-2)" "unprognostic (8.66e-2)" "unprognostic (6.87e-2)" "unprognostic (2.21e-3)" "unprognostic (2.07e-1)" "unprognostic (5.17e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (2.68e-2)" 7.9 9.6 52.7 7.5 57.8 8.1 5.8 48.3 50.8 6.9 31.3 6.6 8.4 7.6 5.8 10.1 6.4 3.2 9.4 42.2 44.1 9.5 12.2 6.2 4.9 57.3 57.3 6.0 9.9 11.7 10.9 4.1 53.2 6.8 2.7 7.0 7.6 5.6 26.1 9.8 7.2 3.5 54.5 8.2 8.8 13.2 53.8 10.1 11.7 12.7 5.2 6.8 6.7 54.7 9.3 24.0 8.7 14.6 10.1 10.0 20.6 13.3 7.2 9.6 9.0 20.4 13.8 16.0 21.4 9.1 18.0 17.3 9.1 31.9 5.2 77.8 29.2 17.8 24.9 11.7 9.7 13.3 11.8 8.8 16.1 12.0 4.2 9.3 5.6 23.8 22.7 18.8 5.3 33.8 20.0 14.7 8.3 7.0 11.3 18.7 13.2 20.9 5.5 14.7 13.5 12.7 12.3 14.3 18.7 3.8 28.7 14.8 11.7 13.1 8.9 8.0 10.3 41.2 28.1 21.9 13.7 15.3 11.3 0.2 0.3 0.6 0.6 0.3 0.9 0.5 0.6 1.1 0.4 0.6 0.6 0.8 1.0 0.6 0.7 0.7 0.9 0.4 52.7 57.8 48.3 50.8 42.2 44.1 57.3 57.3 53.2 54.5 53.8 54.7 9.1 3.2 12.4 11.4 10.1 8.0 9.5 7.5 8.0 19.1 10.5 8.9 13.2 12.8 10.0 11.0 18.8 14.6 13.6 12.3 11.7 8.5 8.0 15.8 12.9 10.4 12.7 5.9 5.2 12.1 10.0 7.5 16.8 12.4 2.5 12.3 10.4 21.0 8.8 28.6 5.3 13.1 12.2 15.1 7.3 4.0 5.3 10.1 8.8 5.6 11.8 15.0 14.4 1.5 5.8 9.9 12.3 11.7 11.1 9.5 16.0 8.0 24.1 30.4 0.0 24.4 10.7 33.2 23.7 12.3 11.2 13.0 13.6 10.2 12.6 8.3 TRIM52 RNF102 ENSG00000183718 "Tripartite motif containing 52" Q96A61 5 181254417-181261139 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA054565, HPA056819" Approved Approved "Nucleoli,Intermediate filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoli "Intermediate filaments" "HPA054565: AB_2682525, HPA056819: AB_2683245" "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-2)" "unprognostic (5.23e-1)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.98e-2)" "unprognostic (7.37e-2)" "unprognostic (2.71e-1)" "unprognostic (2.24e-3)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (2.96e-1)" "unprognostic (6.41e-2)" "unprognostic (1.33e-2)" "prognostic favorable (4.07e-4)" 9.3 10.0 10.8 8.6 10.9 8.7 9.0 14.0 14.4 14.2 11.0 12.2 8.1 10.1 9.1 7.0 12.3 5.5 11.0 10.9 10.8 13.7 11.6 12.1 14.2 11.4 10.5 16.0 15.6 9.2 18.9 5.9 11.6 15.2 6.6 21.5 11.5 7.0 6.7 10.0 13.1 5.3 9.6 18.7 11.0 11.6 11.4 10.8 17.3 3.9 9.7 12.0 10.8 11.7 4.3 4.9 7.8 10.0 13.8 8.7 6.9 4.6 4.1 4.4 3.8 7.1 7.7 9.3 4.9 5.0 12.0 7.8 4.2 6.2 5.1 16.0 8.9 3.6 21.4 6.0 3.3 11.0 7.9 8.7 5.1 4.7 2.7 7.2 5.3 13.5 3.8 21.3 4.6 8.1 6.1 10.0 2.7 4.8 6.3 7.1 4.2 6.4 3.7 5.6 8.8 7.1 6.6 4.7 4.4 6.8 8.8 7.4 6.5 8.8 4.6 4.2 4.4 15.5 8.1 6.3 10.0 9.5 3.5 5.8 2.2 5.2 7.1 1.9 7.9 4.9 7.5 7.8 1.8 3.5 9.2 7.5 2.3 5.1 1.9 2.4 5.5 3.3 10.8 10.9 14.0 14.4 10.9 10.8 11.4 10.5 11.6 9.6 11.4 11.7 11.9 19.2 23.6 6.5 20.5 8.8 6.5 3.1 8.0 27.8 6.7 6.7 9.4 8.6 15.0 7.3 39.6 3.7 28.1 7.2 3.9 3.5 27.2 10.3 14.4 14.0 9.0 8.6 9.5 2.5 1.1 12.6 6.6 11.8 17.7 21.2 7.9 3.5 4.2 28.6 10.5 8.3 2.0 6.0 9.7 5.4 12.8 10.3 5.4 9.4 12.5 17.3 35.0 6.6 8.1 2.3 8.1 9.4 24.9 4.5 8.1 3.4 11.6 42.9 0.0 20.3 13.3 25.2 11.0 5.5 6.1 4.2 25.9 19.0 7.8 4.1 TRIM56 RNF109 ENSG00000169871 "Tripartite motif containing 56" Q9BRZ2 7 101085481-101097967 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024358 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA024358: AB_1858308" "unprognostic (6.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.99e-2)" "unprognostic (1.62e-1)" "unprognostic (9.44e-3)" "unprognostic (8.30e-2)" "prognostic unfavorable (3.87e-4)" "unprognostic (2.63e-1)" "unprognostic (4.11e-1)" "unprognostic (3.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.47e-3)" "unprognostic (8.13e-2)" "unprognostic (1.49e-1)" "prognostic favorable (2.13e-4)" 13.6 11.3 12.9 14.4 13.9 6.7 12.9 11.7 12.2 14.8 12.6 11.8 11.7 13.5 13.4 12.4 14.8 7.5 9.9 10.4 11.5 12.9 10.8 17.7 15.4 17.0 13.8 19.0 10.1 9.6 8.6 8.9 14.0 14.8 9.7 2.0 14.0 13.0 11.9 15.7 14.7 8.5 12.7 21.4 12.4 3.8 14.2 12.9 12.7 6.7 12.4 12.6 13.4 16.8 16.4 20.1 8.5 10.9 19.1 19.7 10.2 13.4 11.7 21.2 19.6 9.6 23.0 19.2 14.0 11.1 29.3 18.4 3.5 12.3 14.2 19.2 5.5 12.2 28.9 7.1 17.1 21.6 26.4 12.6 17.3 13.8 22.4 20.7 11.2 12.2 21.6 23.7 14.8 22.4 18.3 24.0 8.5 8.8 16.7 16.8 13.9 12.7 11.1 16.9 0.4 0.3 14.8 40.8 11.6 10.8 9.3 14.0 21.6 29.4 26.1 22.4 14.4 11.7 12.4 14.7 14.6 17.2 23.6 1.7 1.2 1.2 1.8 0.8 1.4 1.1 1.4 1.2 0.4 1.6 1.3 1.7 3.9 4.1 1.2 1.1 0.7 0.6 12.9 13.9 11.7 12.2 10.4 11.5 17.0 13.8 14.0 12.7 14.2 16.8 62.5 73.7 82.7 3.3 45.7 5.2 82.2 6.7 28.5 3.1 30.4 27.2 21.7 108.7 32.8 51.5 2.1 41.6 45.4 51.9 3.9 61.4 2.1 60.8 53.7 80.6 29.1 43.5 0.1 48.1 25.7 40.0 33.1 42.5 15.2 129.9 114.5 48.1 19.3 10.1 0.1 40.9 4.1 48.7 4.5 5.2 132.3 33.3 1.8 8.4 60.0 20.4 141.1 2.5 3.6 56.9 45.4 94.4 24.9 79.9 76.5 11.4 51.0 4.0 65.7 76.7 38.9 5.4 7.2 15.9 3.3 29.8 44.3 64.5 41.1 60.5 TRIP11 "CEV14, GMAP-210, GMAP210, Trip230" ENSG00000100815 "Thyroid hormone receptor interactor 11" Q15643 14 91965991-92040896 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002570, HPA070684" Supported Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoplasm "HPA002570: AB_1078995, HPA070684: AB_2686295" "unprognostic (1.65e-1)" "unprognostic (2.81e-2)" "unprognostic (7.14e-2)" "unprognostic (1.12e-1)" "unprognostic (6.89e-2)" "unprognostic (1.39e-1)" "unprognostic (3.49e-3)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.21e-1)" "prognostic favorable (1.78e-6)" "unprognostic (1.78e-1)" "unprognostic (5.08e-1)" "unprognostic (7.74e-2)" "unprognostic (5.55e-2)" 10.4 10.5 4.7 8.6 8.8 7.6 10.5 10.8 7.4 11.6 13.5 10.1 10.4 9.7 6.7 12.1 7.7 10.1 10.6 3.5 5.4 13.5 12.9 8.0 9.4 6.2 7.3 11.0 25.5 19.2 4.8 11.6 6.8 9.6 9.8 10.6 11.0 8.5 11.8 8.9 7.9 10.2 6.2 8.6 15.3 13.6 6.5 11.2 16.7 15.6 11.4 10.4 5.8 10.7 22.8 22.5 14.4 15.2 24.8 38.1 21.8 35.3 27.0 17.1 19.5 13.8 36.0 15.8 25.3 31.3 13.3 29.1 19.1 17.1 37.0 24.1 5.8 17.9 20.4 13.1 18.9 21.2 17.1 14.7 20.4 30.3 25.8 18.9 27.8 8.7 11.9 17.8 27.0 31.7 12.2 5.2 6.6 22.1 16.0 14.8 27.5 8.0 15.3 36.5 10.5 9.5 28.5 16.6 11.0 14.5 36.2 10.5 36.9 19.8 13.8 20.8 16.1 15.7 25.9 14.2 23.2 11.7 25.3 9.3 9.7 20.2 13.9 9.0 13.6 13.0 14.7 13.1 7.9 23.7 14.2 14.9 9.6 14.8 16.1 14.3 14.5 4.3 4.7 8.8 10.8 7.4 3.5 5.4 6.2 7.3 6.8 6.2 6.5 10.7 66.8 54.5 79.8 57.5 32.5 16.6 30.7 31.7 21.6 61.1 39.9 40.0 115.7 34.3 54.0 38.6 73.0 44.2 41.4 29.8 17.6 72.5 13.6 58.2 81.2 53.9 32.2 30.7 58.1 46.2 32.0 51.7 39.8 56.5 37.9 68.7 32.9 37.5 24.4 43.7 74.7 40.4 32.6 25.7 11.2 14.7 62.1 30.4 7.2 51.5 41.6 56.5 47.4 66.9 92.4 44.7 29.5 54.2 26.3 39.0 31.6 23.4 56.4 70.4 59.2 76.6 50.4 105.0 65.8 19.5 17.0 72.5 30.2 79.8 32.9 35.1 TRMT10B "bA3J10.9, FLJ31455, RG9MTD3" ENSG00000165275 "TRNA methyltransferase 10B" Q6PF06 9 37753803-37778972 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021800 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane" "HPA021800: AB_1856214" "unprognostic (1.00e-2)" "unprognostic (1.78e-1)" "unprognostic (3.35e-2)" "unprognostic (3.89e-2)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (7.78e-2)" "prognostic favorable (3.91e-4)" "unprognostic (5.49e-3)" "unprognostic (1.71e-2)" "prognostic favorable (5.34e-4)" "unprognostic (1.40e-1)" "unprognostic (6.62e-2)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 5.6 6.9 7.3 5.7 8.1 6.0 6.2 10.7 8.0 8.3 5.8 8.3 4.4 7.1 4.4 5.5 7.6 4.1 4.9 6.8 7.3 6.9 6.4 4.9 7.4 7.9 7.6 9.5 7.9 3.9 6.7 3.8 7.1 8.3 3.5 7.3 6.1 4.2 4.4 10.7 7.1 4.0 6.6 8.1 6.7 3.4 7.6 4.0 7.6 2.1 4.2 7.6 7.1 9.8 4.7 5.6 7.0 6.2 4.2 3.3 3.1 4.4 3.3 4.5 3.9 3.3 4.1 8.7 3.3 3.4 2.7 5.3 3.3 5.5 4.1 3.7 5.6 7.8 14.8 3.5 7.6 8.0 5.2 3.8 5.5 4.3 7.4 5.3 4.7 10.4 6.2 3.6 3.4 3.3 8.1 6.2 6.2 5.0 6.7 8.1 2.4 4.6 4.3 4.2 9.4 9.0 3.7 4.7 4.1 4.4 5.0 5.7 4.8 3.6 5.1 5.9 4.0 4.2 6.1 6.9 2.1 6.1 7.3 3.4 2.7 1.5 3.1 2.4 3.8 3.3 2.8 3.1 1.2 4.3 3.3 3.0 2.8 2.4 1.7 2.3 1.9 1.5 7.3 8.1 10.7 8.0 6.8 7.3 7.9 7.6 7.1 6.6 7.6 9.8 13.2 3.2 8.9 30.3 20.3 7.4 11.4 8.9 15.9 16.2 13.5 16.5 7.4 14.3 8.4 3.7 6.2 16.1 11.0 7.9 11.7 11.3 2.1 7.1 14.1 12.8 13.8 13.7 25.4 12.5 8.6 14.0 13.7 9.1 14.5 17.3 13.6 8.1 8.2 16.8 27.5 14.0 8.2 10.4 9.5 0.9 14.6 12.2 10.6 19.7 15.5 15.9 25.7 37.2 45.7 10.0 6.7 23.7 9.1 14.2 11.4 9.0 7.8 13.5 26.3 13.0 11.1 4.2 5.3 9.7 7.5 12.2 16.4 12.3 10.9 9.4 TRMT13 "CCDC76, FLJ10287, FLJ11219" ENSG00000122435 "TRNA methyltransferase 13 homolog" Q9NUP7 1 100133150-100150498 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028494 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Plasma membrane" "Nuclear bodies, Cytosol" "HPA028494: AB_10601254" "unprognostic (1.12e-1)" "unprognostic (3.33e-1)" "unprognostic (5.76e-2)" "unprognostic (2.37e-1)" "unprognostic (9.17e-3)" "unprognostic (4.97e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.16e-3)" "unprognostic (3.28e-2)" "unprognostic (8.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" "prognostic unfavorable (6.89e-6)" "unprognostic (3.12e-2)" "unprognostic (7.71e-2)" "unprognostic (1.99e-2)" "unprognostic (1.70e-3)" 8.8 8.7 6.9 12.2 9.8 5.2 14.5 9.6 9.6 11.2 6.7 9.3 11.2 13.9 11.8 8.5 9.2 7.2 8.0 6.5 9.7 8.8 8.7 7.8 18.2 8.5 9.0 13.5 11.5 12.9 6.8 10.7 8.7 10.4 11.3 21.7 9.1 8.1 13.1 14.7 10.7 10.1 7.0 14.1 10.0 9.4 8.5 11.3 12.0 6.2 14.6 9.5 10.3 14.9 17.5 10.0 16.5 11.5 8.7 16.9 18.0 18.0 7.1 13.4 11.1 11.9 7.0 28.7 21.8 14.4 8.9 15.4 30.6 14.0 23.1 29.0 24.2 17.2 23.1 11.6 15.7 30.0 15.4 11.9 15.5 25.5 33.3 8.4 12.4 21.0 36.6 17.9 13.6 6.7 24.6 15.6 23.0 16.7 19.9 26.0 25.0 15.7 11.1 13.6 10.7 17.9 16.6 15.8 21.6 16.1 9.3 26.1 13.0 17.8 11.9 15.1 24.3 22.8 20.0 34.0 20.1 23.5 7.0 0.2 5.8 3.1 10.5 6.1 13.0 19.9 11.3 10.6 7.0 18.7 16.8 14.0 2.5 7.9 5.1 12.8 8.6 5.6 6.9 9.8 9.6 9.6 6.5 9.7 8.5 9.0 8.7 7.0 8.5 14.9 13.1 25.6 17.0 34.0 29.0 9.7 14.2 14.2 19.9 38.9 10.7 7.9 11.1 12.8 22.2 14.7 29.2 14.2 18.9 8.0 13.7 10.5 20.9 14.3 21.0 15.7 20.4 11.3 23.1 6.1 10.2 13.7 11.7 8.0 21.5 18.7 17.9 11.4 7.6 28.6 32.1 9.9 18.3 10.1 7.0 6.0 24.8 10.3 10.6 25.3 14.7 16.6 41.2 33.7 97.4 8.5 9.6 18.4 9.0 12.6 13.0 10.7 20.4 44.7 19.7 16.0 13.4 47.6 21.9 12.2 11.9 7.3 21.5 15.8 13.6 10.0 TRMT2B "CXorf34, FLJ12687" ENSG00000188917 "TRNA methyltransferase 2 homolog B" Q96GJ1 X 101009346-101052116 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003745, HPA035120, HPA040814" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA003745: AB_2667047, HPA035120: AB_10601702, HPA040814: " "prognostic unfavorable (1.58e-5)" "unprognostic (6.72e-3)" "unprognostic (3.28e-1)" "unprognostic (1.54e-2)" "unprognostic (4.44e-1)" "unprognostic (8.74e-2)" "unprognostic (3.52e-2)" "unprognostic (8.16e-3)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-2)" "prognostic favorable (2.30e-7)" "unprognostic (4.58e-2)" "unprognostic (4.82e-1)" "unprognostic (5.03e-2)" "unprognostic (1.60e-2)" 5.4 6.4 3.3 7.1 3.3 7.8 6.3 3.7 4.0 6.8 5.6 7.8 6.1 4.7 4.0 8.2 5.3 5.4 9.1 3.3 3.8 8.7 6.2 6.5 10.3 4.3 3.9 6.7 6.4 14.7 5.8 3.9 4.7 6.6 9.2 2.4 9.9 5.3 15.0 6.9 9.2 5.0 3.4 10.6 8.7 2.5 4.0 14.7 8.6 14.4 11.3 5.2 6.1 3.3 22.4 18.9 3.8 8.9 8.7 4.5 11.6 11.4 15.4 12.6 18.7 20.6 17.5 19.9 22.3 10.6 25.6 13.7 17.5 16.0 15.7 17.2 10.9 12.6 15.6 9.9 7.6 22.5 19.6 5.8 9.3 18.2 8.4 8.8 24.8 21.2 13.0 18.3 11.7 22.5 28.5 11.6 5.2 27.7 14.0 22.8 18.2 19.1 9.2 12.8 5.5 7.4 19.4 14.0 11.7 10.4 9.1 10.8 14.5 15.7 9.4 14.8 10.3 11.5 18.7 18.1 12.2 25.3 12.4 14.9 10.0 18.8 15.8 8.0 17.0 18.7 18.6 15.8 9.3 20.4 21.8 18.3 5.7 18.7 9.5 10.0 16.8 14.8 3.3 3.3 3.7 4.0 3.3 3.8 4.3 3.9 4.7 3.4 4.0 3.3 3.0 6.4 6.3 22.2 10.5 2.3 5.5 4.1 6.2 0.8 3.0 1.5 10.3 1.5 5.0 14.7 2.1 6.1 5.7 5.4 7.9 4.0 0.1 3.3 1.9 4.0 6.7 5.7 17.2 3.4 3.0 3.4 6.1 2.9 13.3 6.9 3.6 4.1 3.6 1.7 18.5 6.8 2.0 5.3 0.6 0.8 3.4 3.4 1.8 18.7 5.6 4.8 14.4 9.5 11.6 5.3 4.8 3.8 4.2 3.8 5.5 5.7 6.0 1.8 0.0 5.3 3.0 0.2 3.8 6.2 1.6 5.1 8.7 4.4 6.1 5.3 TRMU "FLJ10140, MTO2, MTU1, TRMT" ENSG00000100416 "TRNA mitochondrial 2-thiouridylase" O75648 22 46330875-46357340 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "RNA-binding, Transferase, tRNA-binding" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000824, HPA035273, HPA043300" Uncertain Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415" "unprognostic (2.96e-1)" "unprognostic (1.09e-2)" "unprognostic (8.07e-2)" "unprognostic (4.27e-2)" "unprognostic (2.64e-1)" "unprognostic (3.52e-3)" "prognostic unfavorable (3.04e-5)" "unprognostic (4.72e-2)" "unprognostic (7.14e-2)" "unprognostic (7.89e-2)" "prognostic favorable (6.86e-4)" "unprognostic (4.74e-3)" "prognostic unfavorable (5.63e-6)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (3.56e-1)" "unprognostic (7.44e-3)" 4.2 7.5 7.7 2.3 7.8 2.9 4.0 8.3 9.6 4.3 8.3 4.5 4.7 3.6 7.5 5.6 3.4 2.6 11.2 7.6 8.5 9.1 8.8 3.5 5.0 8.5 8.6 4.0 10.2 8.0 5.3 4.1 8.5 4.4 4.1 2.8 5.5 4.7 6.9 4.8 4.0 3.9 7.9 4.2 4.3 2.3 8.5 3.0 4.6 8.4 4.3 4.2 4.1 7.8 17.8 16.0 6.6 15.1 12.2 8.6 16.6 18.1 12.6 24.9 19.2 22.7 4.5 11.5 12.5 16.2 10.9 15.3 28.5 16.0 21.1 7.5 38.4 13.6 25.0 27.1 10.4 26.5 9.0 8.2 17.6 25.8 8.1 10.3 16.2 5.8 19.3 2.7 15.3 19.1 10.4 21.5 25.5 10.6 27.5 12.2 14.4 21.2 12.5 12.1 15.9 19.0 16.0 18.5 31.7 8.2 10.7 10.9 11.9 11.1 19.8 15.8 20.7 6.5 7.8 12.6 15.7 19.1 22.8 0.0 6.2 3.8 9.4 9.0 8.3 5.4 8.2 8.9 7.1 5.5 7.3 6.9 1.3 8.0 9.8 5.8 11.0 5.9 7.7 7.8 8.3 9.6 7.6 8.5 8.5 8.6 8.5 7.9 8.5 7.8 12.7 9.6 6.1 22.9 13.2 6.2 10.8 16.8 7.4 26.4 10.6 11.8 14.7 10.0 10.7 11.0 16.7 24.9 16.1 14.1 27.4 20.1 1.6 6.3 10.2 14.5 12.5 14.3 19.4 19.6 21.0 11.9 21.9 6.6 9.5 26.8 13.9 16.8 15.9 13.5 18.0 12.3 10.2 9.9 4.0 3.3 15.2 8.8 8.8 5.6 14.9 11.9 20.6 10.1 14.6 19.5 9.9 17.0 13.8 14.2 15.3 27.9 10.2 26.4 6.6 7.6 14.4 18.5 12.9 9.6 9.7 15.3 13.1 21.0 19.3 9.9 TSC2 "LAM, PPP1R160, TSC4, tuberin" ENSG00000103197 "TSC complex subunit 2" P49815 16 2047967-2089491 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "GTPase activation" "Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002225, HPA030409, HPA049679" Approved Enhanced Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Cytosol "CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848" "unprognostic (2.80e-1)" "unprognostic (1.01e-1)" "unprognostic (1.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-3)" "unprognostic (2.04e-2)" "unprognostic (6.05e-3)" "unprognostic (3.43e-1)" "unprognostic (8.94e-2)" "prognostic favorable (5.06e-4)" "unprognostic (4.32e-2)" "unprognostic (3.91e-2)" "unprognostic (2.14e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-2)" "unprognostic (8.96e-2)" 12.6 10.0 3.8 10.2 4.6 10.9 12.6 4.5 6.1 16.7 0.9 15.3 12.4 17.4 7.3 12.0 16.0 10.9 12.6 5.9 1.3 9.6 9.0 12.0 7.7 3.1 1.5 18.4 14.8 14.7 16.5 9.2 2.7 12.4 9.1 17.7 21.3 15.6 31.1 14.4 12.8 11.4 0.1 11.4 15.7 16.2 2.6 11.7 18.6 14.5 7.8 14.0 12.8 12.5 13.5 21.4 28.9 32.5 33.7 28.1 24.3 31.7 21.7 23.4 19.7 25.7 25.4 20.5 27.6 26.2 11.0 22.0 17.5 23.1 17.3 15.5 28.5 19.2 39.6 10.7 23.0 24.0 22.4 33.5 14.3 18.9 13.9 27.9 22.3 14.4 19.0 17.7 21.0 27.0 28.9 7.1 29.8 10.1 21.2 45.3 31.6 25.7 9.4 12.1 22.1 41.3 45.2 29.4 15.3 28.2 26.8 17.5 35.5 24.5 16.5 22.0 16.5 39.0 42.7 40.8 10.2 9.7 29.6 3.2 2.7 2.8 3.1 2.1 2.8 1.8 1.9 1.7 2.5 1.8 1.3 2.1 3.5 1.6 1.7 0.6 1.4 2.2 3.8 4.6 4.5 6.1 5.9 1.3 3.1 1.5 2.7 0.1 2.6 12.5 23.8 25.6 18.9 43.8 16.8 9.2 8.1 10.1 14.8 53.8 23.7 20.2 41.8 21.5 15.3 20.2 93.8 13.0 17.3 34.5 3.9 15.2 13.1 47.8 26.3 25.6 32.5 17.4 22.8 14.1 8.0 19.7 44.9 62.1 8.8 49.0 32.2 38.7 11.4 45.4 22.4 26.6 8.2 17.6 9.9 29.3 28.3 13.8 8.8 15.9 12.1 19.0 36.0 18.6 25.7 21.4 17.5 25.9 14.4 9.4 25.4 8.9 17.8 64.7 13.1 17.2 20.4 18.3 37.7 12.9 9.8 9.3 18.8 31.6 28.9 10.6 TSEN2 "MGC2776, SEN2, SEN2L" ENSG00000154743 "TRNA splicing endonuclease subunit 2" Q8NCE0 3 12484421-12541549 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027120, HPA027125, HPA027268" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Centrosome, Cytosol" "HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347" "unprognostic (5.58e-2)" "unprognostic (4.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.71e-2)" "unprognostic (9.59e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.42e-1)" "unprognostic (5.66e-2)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "unprognostic (6.15e-2)" "unprognostic (1.41e-2)" "unprognostic (6.99e-2)" "unprognostic (4.90e-2)" "unprognostic (6.06e-2)" "prognostic favorable (3.49e-4)" 8.9 9.4 3.4 1.1 3.9 0.3 8.9 4.4 4.8 11.5 3.7 11.5 1.4 10.9 2.6 8.6 12.0 1.8 15.5 3.5 3.7 10.2 8.5 6.0 2.2 3.6 3.5 14.2 12.1 3.2 10.9 0.9 3.6 10.0 2.3 3.4 6.7 3.2 15.9 8.3 6.9 3.2 3.3 6.6 9.7 6.7 3.9 2.6 9.0 3.8 2.2 11.5 9.7 3.8 6.2 11.8 5.5 7.4 6.3 7.7 7.6 5.8 4.3 6.6 5.1 4.2 5.2 5.5 3.3 4.0 5.8 5.8 7.8 9.4 5.4 5.5 9.8 5.1 9.1 5.7 5.4 9.3 2.1 4.9 11.2 10.1 9.7 3.3 4.7 8.8 10.7 3.4 6.5 11.9 9.6 6.1 6.5 10.5 13.5 4.6 2.3 13.5 9.9 4.8 1.5 4.5 6.7 5.0 4.8 3.1 10.1 5.1 4.5 4.2 3.9 4.7 9.7 3.1 8.6 6.2 5.6 11.8 5.4 0.6 1.9 0.0 2.7 1.6 4.4 3.7 4.6 3.8 2.3 3.2 6.2 5.1 0.4 2.5 1.7 3.4 1.6 2.6 3.4 3.9 4.4 4.8 3.5 3.7 3.6 3.5 3.6 3.3 3.9 3.8 5.5 3.2 3.3 26.1 8.9 2.9 11.2 5.6 13.1 28.1 3.7 4.3 7.0 10.0 3.8 11.0 43.8 8.8 2.6 9.2 1.9 6.2 1.6 7.1 7.4 6.2 4.2 8.4 42.8 4.2 4.3 5.7 13.7 3.7 5.1 17.7 3.6 5.0 4.6 10.1 46.4 5.2 4.1 3.5 1.7 2.8 9.0 3.6 3.6 16.9 2.4 8.0 6.2 19.1 31.8 4.5 5.0 10.1 3.8 6.2 2.3 6.9 11.1 34.1 6.6 7.9 6.3 14.0 23.0 7.1 4.8 1.9 4.6 15.3 8.4 8.0 TSHZ1 "NY-CO-33, SDCCAG33, TSH1" ENSG00000179981 "Teashirt zinc finger homeobox 1" Q6ZSZ6 18 75210755-75289950 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 84.9;Peritubular cells: 187.3;Theca cells: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 44.4" "Region enriched" "Detected in all" 5 "olfactory bulb: 115.6" "Low region specificity" "Detected in all" HPA006982 Approved Approved Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA006982: AB_1079886" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (4.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (1.24e-1)" "unprognostic (4.12e-2)" "unprognostic (9.05e-2)" "unprognostic (5.64e-2)" "unprognostic (1.69e-1)" "unprognostic (3.43e-3)" "unprognostic (1.26e-1)" "unprognostic (8.00e-2)" "prognostic unfavorable (1.71e-5)" "unprognostic (3.42e-3)" 12.0 7.7 16.3 7.1 14.1 3.3 12.1 23.5 21.0 17.4 6.3 18.1 13.8 11.4 9.3 10.0 15.9 10.4 10.9 17.0 10.4 12.1 8.2 8.0 7.3 18.8 11.5 35.4 7.2 9.2 9.7 29.7 19.3 8.9 9.3 7.9 12.5 11.1 9.2 10.6 13.7 9.3 20.1 9.4 8.8 6.3 15.5 12.3 8.2 6.4 5.3 10.9 11.0 14.1 5.4 7.0 2.2 12.8 18.8 8.9 2.2 24.2 22.6 4.0 7.4 3.2 12.9 10.8 3.0 21.9 4.5 4.8 2.9 6.9 1.4 44.4 23.2 8.3 14.5 4.3 4.9 20.0 9.4 9.1 7.2 3.3 6.5 6.2 10.1 12.5 4.7 19.1 6.6 5.2 14.3 11.4 0.9 6.3 7.6 12.9 6.6 12.9 7.6 3.9 15.9 12.1 6.8 8.8 6.8 0.8 2.0 10.4 7.6 8.7 5.9 6.0 3.9 6.2 15.9 8.7 8.6 16.6 8.1 0.0 0.5 0.5 2.1 0.2 1.4 0.4 1.0 1.8 0.8 0.6 1.5 2.2 0.3 1.5 0.2 0.8 0.4 0.7 16.3 14.1 23.5 21.0 17.0 10.4 18.8 11.5 19.3 20.1 15.5 14.1 60.2 12.8 14.0 34.3 7.1 17.0 5.6 4.8 27.9 40.8 12.2 12.6 24.4 25.8 7.9 3.7 2.1 4.6 25.6 25.4 3.9 7.5 1.2 12.5 33.9 34.4 16.9 6.9 24.9 10.0 2.2 28.8 4.6 18.2 7.0 22.5 21.0 20.5 6.4 11.8 27.7 15.0 10.2 10.8 30.9 5.9 64.7 14.3 8.8 30.0 11.2 17.9 24.7 84.9 21.3 2.9 14.7 187.3 10.6 7.3 29.7 18.4 9.1 12.1 26.3 21.3 12.2 1.4 4.8 33.1 13.2 3.6 18.2 83.2 17.9 5.4 TSHZ2 "C20orf17, OVC10-2, TSH2, ZABC2, ZNF218" ENSG00000182463 "Teashirt zinc finger homeobox 2" Q9NRE2 20 52972358-53495330 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 395.6;Leydig cells: 468.2;Peritubular cells: 803.8;Theca cells: 396.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 3.0;T-reg: 2.4" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "AN3-CA: 26.7;ASC diff: 11.3;HeLa: 23.6;SiHa: 15.3;U-2197: 13.7" "Low region specificity" "Detected in all" HPA038123 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 89: Fibroblasts - ECM organization" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoplasm "HPA038123: AB_10670657" "unprognostic (9.24e-3)" "unprognostic (1.58e-1)" "unprognostic (9.35e-2)" "unprognostic (1.13e-1)" "unprognostic (1.21e-4)" "unprognostic (3.30e-1)" "unprognostic (4.30e-1)" "unprognostic (1.28e-1)" "unprognostic (2.16e-1)" "unprognostic (3.23e-2)" "unprognostic (3.33e-1)" "unprognostic (3.14e-2)" "unprognostic (9.88e-8)" "unprognostic (6.26e-2)" "unprognostic (3.81e-2)" "unprognostic (3.37e-7)" "unprognostic (2.97e-3)" 21.5 14.8 3.4 4.5 4.7 0.2 10.6 2.9 4.3 9.0 0.0 7.3 2.3 6.8 16.5 8.2 8.7 12.4 3.7 5.7 8.9 3.3 12.6 2.9 3.9 5.9 8.2 18.4 3.5 5.4 2.7 1.3 5.5 5.4 2.0 1.7 12.9 13.6 1.6 5.9 2.8 8.8 10.3 5.1 6.1 4.8 8.1 2.0 5.3 2.6 3.4 7.6 5.7 7.5 0.0 0.0 1.8 26.7 11.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 6.8 0.0 0.1 0.0 0.1 0.0 5.2 1.4 0.0 23.6 0.0 0.3 0.0 0.6 4.1 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.7 4.4 15.3 0.1 0.0 0.7 0.0 0.0 0.0 0.1 2.6 13.7 0.0 0.1 0.3 0.0 2.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.1 0.0 0.4 3.0 0.2 0.6 0.1 0.0 0.1 2.4 0.5 3.4 4.7 2.9 4.3 5.7 8.9 5.9 8.2 5.5 10.3 8.1 7.5 171.4 0.0 0.6 32.7 7.0 45.4 19.9 43.8 37.0 6.7 24.4 161.5 2.8 54.3 41.6 36.8 2.1 1.3 1.3 0.1 0.0 52.2 11.1 32.7 144.4 125.7 6.6 0.0 188.2 9.8 0.5 93.3 3.1 68.9 1.3 395.6 11.7 92.1 1.2 0.0 58.1 1.9 18.3 1.3 16.6 20.3 468.2 2.8 12.4 104.9 1.9 39.0 1.0 23.6 4.9 6.8 2.7 803.8 16.0 27.5 0.8 0.4 19.9 1.9 39.5 10.9 48.2 2.6 1.8 43.9 40.5 0.8 24.2 396.9 2.6 8.2 TSNAX "C3PO, TRAX" ENSG00000116918 "Translin associated factor X" Q99598 1 231528541-231566524 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 194.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024613, HPA031054, HPA031055, CAB034263" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 36000 "Cluster 10: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Golgi apparatus, Cytosol" "CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314" "unprognostic (6.28e-3)" "unprognostic (5.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.12e-1)" "unprognostic (5.55e-2)" "unprognostic (2.27e-1)" "unprognostic (2.96e-2)" "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-3)" "unprognostic (4.51e-2)" "unprognostic (1.91e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-2)" "unprognostic (6.52e-3)" "unprognostic (2.70e-2)" 22.7 31.9 12.2 20.2 12.8 15.1 25.4 11.5 15.1 19.5 17.8 18.4 17.7 21.5 22.8 19.4 18.0 18.7 26.2 13.2 15.2 31.7 26.0 20.8 26.4 11.9 12.7 18.3 16.3 40.0 17.0 20.4 12.3 22.8 19.6 19.9 18.1 20.5 50.5 21.8 17.3 20.7 13.4 28.5 17.7 20.9 13.2 26.6 29.8 40.7 25.7 19.9 14.9 13.7 30.3 24.1 36.7 29.7 27.1 32.6 41.4 33.1 50.9 42.2 36.0 21.4 40.8 42.3 55.0 38.0 15.7 31.9 29.3 31.4 53.9 38.4 51.7 40.7 23.9 28.6 35.8 67.8 82.1 40.4 32.4 40.9 32.3 26.4 30.7 31.6 66.6 28.8 58.0 12.9 44.0 32.9 53.4 26.5 28.3 42.8 39.8 56.8 46.9 33.9 34.1 65.7 35.3 43.3 116.8 14.5 63.2 113.0 28.9 28.3 26.3 57.6 61.0 48.2 68.9 46.4 46.8 52.0 79.7 194.4 34.8 85.6 30.6 40.2 30.3 28.5 33.5 30.6 33.2 28.3 34.6 34.0 37.7 51.9 55.7 22.3 39.4 33.6 12.2 12.8 11.5 15.1 13.2 15.2 11.9 12.7 12.3 13.4 13.2 13.7 48.3 28.9 41.3 0.0 25.5 43.8 21.4 42.4 8.6 59.2 27.2 20.1 24.1 40.0 25.3 42.3 29.2 44.4 36.9 21.8 54.8 30.6 12.6 23.6 20.5 46.1 28.9 59.5 0.0 31.1 51.5 28.1 11.7 19.3 77.3 26.2 31.8 32.8 49.5 65.6 0.0 28.2 38.7 62.2 35.0 9.4 33.5 40.5 26.6 0.0 51.7 72.0 37.0 0.0 0.0 26.5 21.8 36.1 13.4 17.3 22.4 45.8 31.9 47.1 39.5 34.4 30.2 40.8 65.4 13.0 51.4 36.3 30.5 46.8 25.6 14.9 TSTD2 "C9orf97, PP4189" ENSG00000136925 "Thiosulfate sulfurtransferase like domain containing 2" Q5T7W7 9 97600080-97633368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022537, HPA024241, HPA064304" Uncertain Approved Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA022537: AB_1845850, HPA024241: AB_1845851, HPA064304: AB_2685238" "unprognostic (7.24e-2)" "unprognostic (5.56e-2)" "unprognostic (1.88e-1)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-2)" "unprognostic (1.38e-1)" "unprognostic (7.07e-2)" "unprognostic (1.10e-1)" "unprognostic (1.23e-3)" "unprognostic (9.67e-2)" "unprognostic (1.51e-1)" "prognostic favorable (5.75e-4)" "unprognostic (2.21e-2)" "unprognostic (5.31e-2)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" 5.9 5.6 3.4 5.3 4.2 2.5 8.1 4.0 5.1 8.5 3.5 7.0 4.7 8.2 7.4 6.1 7.3 7.1 9.9 3.2 4.1 8.0 9.5 7.3 6.5 3.7 4.3 7.3 10.3 10.1 4.6 7.6 4.1 7.6 7.3 10.3 6.7 8.2 9.1 6.0 4.3 8.6 4.2 6.1 6.2 8.0 4.2 8.9 10.4 12.9 8.1 7.5 3.8 5.5 13.6 10.7 17.3 11.3 11.1 9.2 15.1 8.7 10.7 12.0 12.3 10.9 4.7 14.4 4.1 11.6 14.5 19.0 15.3 9.3 13.3 10.0 6.7 10.1 12.6 8.8 14.4 15.0 13.3 12.3 15.4 11.8 21.0 11.2 9.5 15.0 18.0 10.7 10.6 7.6 17.7 8.2 13.5 17.8 10.6 14.5 24.9 7.7 8.9 6.6 12.3 9.7 11.3 8.0 10.4 13.4 6.1 8.3 9.8 11.1 10.1 12.5 10.0 15.8 21.2 7.5 8.8 7.3 7.7 4.3 2.9 3.9 4.4 5.0 7.3 4.1 4.3 5.4 4.8 4.5 4.8 4.7 1.0 8.6 4.0 2.0 2.6 3.9 3.4 4.2 4.0 5.1 3.2 4.1 3.7 4.3 4.1 4.2 4.2 5.5 11.4 19.2 15.3 23.8 11.7 1.7 4.3 5.7 7.4 27.8 11.1 9.9 17.5 11.5 16.9 1.8 25.0 7.6 12.3 11.1 17.6 8.7 17.9 11.3 17.2 7.8 19.2 12.4 26.0 7.5 3.9 11.3 10.2 10.6 20.8 8.5 5.0 13.4 5.3 21.9 31.5 5.3 4.1 5.4 3.1 9.6 8.1 5.9 5.4 15.0 6.5 13.0 7.2 36.7 36.4 9.2 6.5 10.5 9.5 5.2 4.5 8.9 16.2 23.9 19.7 13.9 9.4 18.8 24.8 7.6 4.1 10.9 9.3 7.6 6.3 3.8 TTC14 "FLJ00166, KIAA1980" ENSG00000163728 "Tetratricopeptide repeat domain 14" Q96N46 3 180602163-180617828 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009295 Uncertain Approved Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA009295: AB_1858425" "unprognostic (2.72e-1)" "unprognostic (4.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (1.54e-1)" "unprognostic (2.43e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (3.63e-1)" "unprognostic (2.22e-3)" "unprognostic (2.27e-3)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-3)" 25.9 23.3 18.2 28.5 20.1 30.7 27.7 13.7 22.7 40.6 27.9 33.7 23.4 35.2 43.7 17.9 38.7 19.5 25.0 20.2 16.2 36.8 21.6 28.0 41.3 17.8 16.2 56.1 35.3 27.3 57.9 21.5 17.1 36.3 22.0 68.6 22.0 23.8 13.7 22.2 31.2 19.7 15.9 33.4 28.0 20.5 16.6 24.1 49.4 7.2 28.9 29.6 32.4 25.2 18.6 15.2 22.7 12.9 29.6 25.9 21.4 26.1 21.0 18.8 30.8 20.3 24.3 27.9 27.4 18.9 43.0 26.2 21.3 13.9 25.4 52.0 21.5 26.5 37.0 46.2 21.8 28.7 23.3 32.9 26.3 18.9 9.4 31.1 15.2 35.2 11.3 5.4 21.1 5.4 21.9 2.1 16.1 23.0 29.6 25.5 14.0 29.9 10.6 14.0 19.4 18.8 24.8 12.5 25.8 22.7 47.0 26.9 24.3 37.6 19.3 17.4 48.7 40.2 66.2 62.0 18.4 35.1 16.7 23.8 9.4 10.6 10.6 10.4 12.7 14.7 11.0 10.6 7.1 10.7 13.3 10.9 7.5 13.9 14.6 17.6 10.7 6.3 18.2 20.1 13.7 22.7 20.2 16.2 17.8 16.2 17.1 15.9 16.6 25.2 33.8 9.6 35.6 135.2 82.1 17.7 33.5 33.6 23.9 98.2 25.8 15.9 14.0 41.5 38.9 66.2 116.7 33.4 114.3 27.8 3.9 28.4 6.2 19.0 41.7 38.7 39.0 41.8 173.1 32.7 19.6 41.8 30.5 19.6 59.6 112.6 45.0 30.4 24.5 80.8 169.9 24.8 30.5 31.7 23.0 11.0 92.6 37.5 30.2 111.5 61.0 49.8 121.5 120.1 160.0 31.9 38.9 81.3 61.5 23.9 42.7 9.4 40.7 123.5 85.5 47.1 40.2 59.6 29.9 16.8 15.3 24.6 68.8 72.2 23.4 23.1 TTC19 "FLJ20343, MGC19520" ENSG00000011295 "Tetratricopeptide repeat domain 19" Q6DKK2 17 15999784-16045015 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 5.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023010, HPA052380" Enhanced Enhanced Mitochondria "Intracellular and membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA023010: AB_1858429, HPA052380: AB_2681806" "unprognostic (1.04e-2)" "unprognostic (4.90e-3)" "unprognostic (2.87e-2)" "unprognostic (4.80e-3)" "unprognostic (8.09e-2)" "unprognostic (2.86e-1)" "unprognostic (1.06e-2)" "unprognostic (2.84e-2)" "unprognostic (8.34e-2)" "unprognostic (1.72e-2)" "unprognostic (2.30e-3)" "unprognostic (5.14e-2)" "prognostic favorable (5.67e-4)" "unprognostic (1.31e-1)" "unprognostic (3.22e-1)" "unprognostic (4.85e-2)" "unprognostic (2.24e-1)" 6.6 11.4 8.1 3.8 7.8 11.2 7.5 19.4 11.6 6.9 8.4 8.0 10.3 6.9 5.2 6.8 5.8 5.2 8.6 8.8 9.6 8.7 7.7 6.6 4.6 7.9 7.4 6.9 12.4 11.2 8.0 5.8 7.9 6.8 5.7 9.9 9.1 4.2 8.8 9.5 9.8 3.8 6.3 4.5 8.4 3.6 8.0 3.9 10.6 4.4 3.3 6.3 6.7 10.5 7.0 4.1 7.6 12.1 6.4 5.6 4.0 3.1 4.6 3.1 3.8 6.5 12.8 8.9 9.8 4.3 4.6 9.1 9.9 8.3 3.8 12.5 10.2 8.2 9.2 6.3 9.1 9.3 11.6 5.6 7.0 2.6 11.4 9.6 7.1 12.4 4.6 7.7 6.8 7.6 7.5 6.8 10.0 11.8 3.0 7.8 8.0 8.2 11.6 10.5 6.6 5.5 7.6 9.8 16.6 24.6 6.9 4.6 13.1 4.2 1.2 6.1 7.5 4.8 1.5 4.2 9.8 9.8 9.5 5.2 0.7 1.8 0.7 0.7 1.2 0.9 0.9 1.2 0.7 1.1 1.0 1.3 0.7 0.6 0.7 1.1 1.0 0.4 8.1 7.8 19.4 11.6 8.8 9.6 7.9 7.4 7.9 6.3 8.0 10.5 51.0 41.7 38.6 69.5 60.8 105.3 83.5 30.8 70.6 147.8 65.1 47.9 34.8 42.9 35.4 46.0 143.9 75.7 62.8 59.7 70.5 50.0 59.4 49.4 41.5 60.3 45.6 32.4 115.1 41.2 41.9 34.2 43.8 67.9 31.1 46.8 42.8 36.0 25.6 129.5 100.9 52.3 26.4 25.8 76.7 7.2 41.0 46.5 55.2 35.6 34.8 73.9 70.0 54.3 57.8 47.7 57.9 33.4 34.5 89.1 75.4 47.1 26.5 180.4 46.0 56.5 40.2 30.2 31.1 56.9 116.8 65.5 68.9 69.9 63.3 72.7 TTC23 "FLJ12572, HCC-8" ENSG00000103852 "Tetratricopeptide repeat domain 23" Q5W5X9 15 99136323-99251223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039806, HPA040369" Uncertain Approved Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" Cytosol "HPA039806: AB_10793921, HPA040369: AB_10795381" "prognostic favorable (3.17e-4)" "unprognostic (5.41e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.40e-2)" "unprognostic (6.53e-2)" "unprognostic (9.25e-3)" "unprognostic (2.56e-1)" "unprognostic (6.18e-2)" "unprognostic (1.76e-3)" "unprognostic (1.88e-1)" "unprognostic (3.24e-1)" "unprognostic (3.21e-2)" "unprognostic (1.11e-2)" "unprognostic (4.31e-1)" "unprognostic (7.99e-2)" "unprognostic (1.23e-1)" 8.3 10.1 5.3 4.3 6.6 1.1 8.0 5.1 6.3 11.6 6.6 17.1 3.5 11.2 6.9 9.8 10.0 8.8 10.6 4.5 6.2 8.9 8.1 6.6 3.1 6.7 5.8 14.9 8.0 8.9 5.3 9.4 6.5 10.7 7.8 7.2 6.7 9.2 8.1 8.4 6.8 10.0 5.7 5.2 9.1 13.0 6.0 3.7 12.7 7.6 3.3 13.2 10.1 8.1 9.9 9.8 15.3 17.8 18.0 20.2 6.4 12.0 14.8 12.6 14.2 8.8 17.0 2.4 23.7 13.7 11.4 19.0 5.0 12.0 13.7 3.3 16.3 10.7 17.1 7.0 10.4 2.4 0.7 14.5 10.5 9.9 9.5 13.7 21.6 4.8 8.3 1.4 11.8 6.0 8.6 2.7 8.4 2.7 7.0 2.7 19.9 3.8 10.0 13.2 6.7 3.0 15.8 6.4 14.7 15.4 10.7 10.9 14.3 16.0 9.4 10.7 15.5 8.1 12.4 3.3 14.3 0.8 9.6 1.8 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.7 0.1 0.0 0.0 0.5 0.5 0.1 0.5 0.1 0.0 5.3 6.6 5.1 6.3 4.5 6.2 6.7 5.8 6.5 5.7 6.0 8.1 5.9 3.2 7.0 27.1 0.6 2.4 4.6 4.4 4.6 1.7 4.6 4.3 9.5 4.3 5.2 5.5 0.0 4.6 0.1 4.3 5.9 6.0 12.5 3.3 10.6 7.0 0.0 0.8 3.3 6.2 4.6 7.4 10.2 4.5 1.3 13.5 9.3 5.3 4.0 8.4 3.5 5.7 6.1 3.8 1.7 8.5 9.0 2.5 1.8 15.9 0.6 11.5 0.0 6.6 13.2 3.9 2.6 10.1 0.1 3.1 3.8 5.5 4.0 5.4 6.6 6.5 5.5 18.0 9.2 7.9 4.0 1.9 0.4 10.9 6.7 2.6 TTC31 FLJ12788 ENSG00000115282 "Tetratricopeptide repeat domain 31" Q49AM3 2 74483073-74494559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041783 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" Cytosol Nucleoplasm "HPA041783: AB_10794306" "unprognostic (2.38e-2)" "unprognostic (7.44e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (2.64e-1)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (6.56e-2)" "unprognostic (7.22e-2)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.46e-3)" "unprognostic (9.61e-2)" "unprognostic (3.24e-1)" "unprognostic (4.83e-2)" "prognostic favorable (2.49e-4)" 6.4 4.8 3.5 8.4 3.9 9.0 4.8 3.4 4.3 5.4 3.8 7.9 11.1 5.9 4.5 6.1 5.9 5.9 5.7 3.3 3.6 6.0 18.7 6.8 9.8 4.3 3.8 6.3 7.9 9.2 3.2 9.2 3.9 5.2 8.2 4.8 4.7 4.5 3.7 8.8 9.9 7.4 3.8 8.2 7.5 3.2 3.8 9.7 4.8 3.9 10.6 5.7 4.6 4.5 16.0 13.1 11.7 6.3 7.3 17.0 12.9 11.2 11.4 16.2 11.9 11.3 13.0 20.6 6.4 9.5 14.2 11.8 9.5 10.5 11.0 23.0 8.3 22.4 12.9 24.9 11.0 10.1 21.5 11.5 13.7 14.0 9.8 14.3 11.0 12.0 15.0 11.5 12.0 13.7 17.4 9.2 7.6 12.2 7.9 13.7 24.0 11.5 11.5 11.8 5.6 16.5 7.9 12.4 10.2 7.4 9.7 6.2 17.6 12.5 18.7 9.5 12.6 13.6 10.8 14.1 13.5 12.5 11.4 4.9 8.3 6.1 6.5 8.1 7.2 7.0 4.9 6.2 8.1 4.7 4.6 5.4 0.8 6.6 8.7 4.4 7.3 7.4 3.5 3.9 3.4 4.3 3.3 3.6 4.3 3.8 3.9 3.8 3.8 4.5 5.4 16.0 9.2 7.2 10.8 2.8 4.1 5.2 4.6 11.1 5.2 5.0 3.5 14.3 7.8 9.2 39.6 8.3 9.8 7.8 1.9 5.8 4.6 3.8 8.0 6.7 6.1 13.3 3.0 5.5 5.3 6.0 7.1 5.9 19.0 8.8 4.6 20.8 8.3 5.0 3.4 5.9 6.1 7.9 3.5 5.0 6.2 7.5 3.6 10.3 13.2 9.2 19.6 2.5 4.4 5.9 9.4 5.7 9.6 3.1 13.9 6.0 4.3 23.6 6.6 7.3 5.3 8.3 10.0 4.2 3.3 8.1 9.8 8.2 6.5 3.8 TTC37 "KIAA0372, THES" ENSG00000198677 "Tetratricopeptide repeat domain 37" Q6PGP7 5 95461755-95554977 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037905 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA037905: AB_10673034" "unprognostic (5.99e-2)" "unprognostic (7.65e-3)" "prognostic favorable (2.62e-4)" "unprognostic (8.48e-2)" "unprognostic (9.49e-2)" "unprognostic (5.39e-2)" "unprognostic (1.40e-2)" "unprognostic (2.18e-1)" "unprognostic (6.88e-2)" "unprognostic (5.97e-2)" "unprognostic (6.81e-3)" "unprognostic (2.51e-1)" "unprognostic (3.30e-3)" "unprognostic (6.88e-3)" "unprognostic (3.91e-1)" "unprognostic (3.98e-2)" "unprognostic (7.90e-3)" 23.6 24.2 10.6 17.9 13.1 10.5 25.7 21.4 15.4 23.8 14.8 20.2 21.4 22.8 19.7 19.9 16.9 18.4 24.3 12.3 11.7 27.5 23.2 17.1 20.5 15.0 12.2 22.6 26.7 46.1 20.2 25.9 15.9 27.2 22.1 21.8 20.7 21.4 34.5 32.7 19.2 22.2 12.7 19.4 26.2 7.8 13.3 25.8 26.2 30.9 21.5 17.0 16.7 18.5 33.1 34.6 43.0 14.9 70.3 94.9 38.2 61.8 49.6 39.3 58.6 37.1 23.6 58.0 39.7 59.0 41.0 31.7 54.5 74.5 65.4 34.0 44.6 39.1 68.8 24.6 60.1 25.7 27.1 63.6 37.3 50.1 69.5 60.3 63.0 19.0 31.2 37.1 75.1 19.0 33.5 20.6 24.3 15.1 28.2 28.1 60.0 61.5 43.2 25.7 53.5 41.8 50.8 24.8 57.0 35.7 38.8 21.7 87.4 53.3 30.5 42.5 47.9 35.4 48.3 53.0 54.0 36.9 70.0 6.1 6.4 2.4 10.1 7.8 12.2 10.3 9.8 8.5 8.1 10.0 10.0 10.6 0.2 9.3 8.0 16.2 9.7 4.4 10.6 13.1 21.4 15.4 12.3 11.7 15.0 12.2 15.9 12.7 13.3 18.5 51.4 76.9 56.1 68.6 38.5 19.5 20.4 26.5 8.6 57.8 33.2 31.8 84.9 25.8 40.9 27.6 50.1 32.5 52.0 22.4 15.6 41.5 2.4 44.8 70.9 39.9 32.5 20.2 146.8 40.5 41.8 43.4 42.8 57.3 41.1 64.6 32.9 36.0 26.9 58.9 130.6 34.3 16.2 28.8 16.7 4.3 62.4 32.2 8.8 68.4 55.4 21.0 41.2 99.5 145.0 38.1 20.2 64.7 41.1 19.0 32.2 30.7 38.2 33.6 39.5 55.1 39.5 10.5 10.0 30.9 32.8 19.8 34.8 52.3 34.2 18.2 TTLL3 "DKFZP434B103, HOTTL" ENSG00000214021 "Tubulin tyrosine ligase like 3" Q9Y4R7 3 9808086-9855138 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 63.9" "Low region specificity" "Detected in all" HPA051413 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 35: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA051413: AB_2681476" "unprognostic (1.51e-2)" "unprognostic (1.91e-1)" "unprognostic (7.23e-3)" "unprognostic (2.08e-1)" "unprognostic (4.96e-1)" "unprognostic (4.04e-4)" "unprognostic (3.14e-2)" "unprognostic (4.39e-2)" "unprognostic (7.71e-2)" "unprognostic (6.83e-2)" "unprognostic (5.46e-3)" "unprognostic (1.08e-2)" "prognostic unfavorable (6.45e-6)" "unprognostic (1.77e-2)" "unprognostic (2.09e-1)" "unprognostic (2.82e-1)" "prognostic favorable (9.51e-6)" 32.2 23.7 24.3 12.4 25.6 30.9 27.5 22.1 30.7 54.5 29.3 31.3 11.5 29.0 16.5 15.9 37.3 25.3 25.6 22.8 25.3 25.2 9.9 24.8 23.0 28.7 28.0 63.0 17.5 11.0 37.5 12.7 26.7 39.7 13.1 8.5 20.1 30.4 11.8 41.0 22.8 20.4 25.6 29.4 19.4 40.8 26.5 13.2 27.2 12.6 15.1 30.8 40.0 30.9 2.0 5.1 10.9 2.1 19.2 36.4 63.9 6.7 6.5 3.6 4.9 8.7 7.7 11.7 5.8 12.5 3.6 3.0 6.9 1.3 2.2 13.6 19.7 14.2 17.6 8.9 6.6 12.9 24.1 23.6 9.2 6.9 2.7 20.8 6.2 17.6 14.0 28.0 8.0 7.0 2.3 20.3 1.4 1.3 2.9 6.7 4.4 5.2 5.4 14.9 5.1 4.6 3.4 1.8 5.8 5.3 4.9 8.9 20.2 9.6 12.4 9.2 3.2 17.8 8.6 16.8 8.0 18.9 3.4 5.9 2.1 6.6 2.3 5.9 1.1 2.8 1.6 1.2 2.7 2.7 1.8 1.5 8.5 2.3 3.5 3.0 2.9 0.9 24.3 25.6 22.1 30.7 22.8 25.3 28.7 28.0 26.7 25.6 26.5 30.9 11.7 12.8 9.1 0.0 5.6 5.2 5.1 6.7 9.1 11.1 6.0 6.5 3.3 1.5 8.5 9.2 25.0 5.4 12.0 11.7 0.0 4.3 29.1 16.5 14.2 10.1 12.0 1.7 0.0 6.7 5.4 14.9 27.0 10.5 8.2 13.6 9.3 1.6 5.3 6.7 0.0 11.9 2.0 14.4 5.7 17.8 22.7 9.2 10.6 0.0 7.9 9.4 11.3 0.0 0.0 7.4 8.2 12.4 4.0 6.6 3.0 2.2 28.7 13.8 13.1 11.6 8.8 15.1 6.7 4.1 4.7 5.1 7.5 9.5 8.5 7.3 TUBGCP5 "GCP5, KIAA1899" ENSG00000275835 "Tubulin gamma complex associated protein 5" Q96RT8 15 22983192-23039572 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039366, HPA040366" Supported Supported Centrosome,Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Centrosome, Cytosol" "HPA039366: AB_10673243, HPA040366: AB_2676942" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "unprognostic (1.30e-1)" "unprognostic (4.27e-3)" "unprognostic (2.94e-1)" "unprognostic (2.79e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.27e-1)" "unprognostic (1.42e-2)" "unprognostic (1.18e-2)" "unprognostic (6.40e-2)" "unprognostic (1.13e-2)" "unprognostic (9.53e-3)" 8.4 9.1 3.5 6.5 4.2 9.0 9.7 3.8 6.6 9.7 1.8 7.3 6.3 9.7 5.7 8.0 6.7 6.0 9.1 3.3 4.7 8.2 9.3 7.0 8.4 4.8 4.1 7.4 10.6 8.4 8.0 6.9 5.1 9.6 7.3 9.8 6.7 7.7 10.7 10.0 6.3 8.7 3.3 7.2 7.8 13.4 4.3 8.9 11.2 10.2 8.7 7.6 7.6 6.5 20.3 20.8 23.9 14.4 18.3 11.9 13.8 24.3 26.6 26.2 22.7 16.1 9.3 16.0 10.3 22.3 13.8 19.8 16.0 18.8 21.8 23.6 6.6 26.9 21.2 8.8 6.4 27.7 11.6 19.4 7.2 17.5 16.2 8.6 16.1 26.4 19.8 23.6 16.9 13.1 18.8 12.1 14.2 19.8 18.8 22.9 26.1 3.2 15.3 30.6 8.3 14.0 19.7 14.2 12.7 11.8 22.2 13.4 13.9 18.4 11.7 14.0 36.6 18.3 19.8 40.0 23.8 18.3 17.3 0.2 1.4 0.6 2.6 2.1 2.7 2.2 4.0 4.4 2.3 4.2 3.5 4.7 1.5 3.9 2.1 2.5 3.7 1.7 3.5 4.2 3.8 6.6 3.3 4.7 4.8 4.1 5.1 3.3 4.3 6.5 7.4 16.0 17.7 16.0 11.0 3.3 3.2 4.2 9.1 27.6 5.2 5.0 13.2 7.2 6.3 5.5 14.6 8.3 11.6 3.0 5.9 6.5 7.8 12.5 13.4 6.4 4.2 3.8 21.4 4.6 7.2 10.4 6.1 6.2 6.3 31.4 5.7 10.2 7.9 10.1 29.7 4.7 4.1 5.2 2.9 13.4 11.1 6.2 3.6 12.2 5.1 11.6 7.2 15.6 26.2 6.6 5.0 12.8 7.9 2.3 2.9 7.1 9.0 18.9 0.0 13.6 10.6 35.0 36.7 8.6 2.7 3.4 9.6 14.1 4.6 2.0 TUBGCP6 "DJ402G11.6, GCP6, KIAA1669" ENSG00000128159 "Tubulin gamma complex associated protein 6" Q96RT7 22 50217689-50245023 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043928 Approved NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 50: Non-specific - Ribosome" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "HPA043928: AB_10960352" "unprognostic (4.26e-2)" "unprognostic (1.62e-3)" "unprognostic (2.86e-2)" "unprognostic (2.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.96e-3)" "unprognostic (2.73e-1)" "unprognostic (2.21e-2)" "unprognostic (2.67e-1)" "unprognostic (1.00e-2)" "prognostic favorable (5.75e-4)" "unprognostic (2.90e-3)" "unprognostic (1.90e-2)" "unprognostic (1.04e-2)" "unprognostic (9.71e-2)" "unprognostic (7.53e-2)" "prognostic favorable (3.18e-5)" 11.1 14.9 10.3 12.3 10.0 13.2 12.2 13.2 14.9 16.6 9.9 12.7 9.8 15.2 6.7 10.1 15.6 10.2 11.3 9.0 8.0 15.1 12.7 11.9 16.4 9.6 7.8 18.3 23.4 12.2 22.2 8.1 7.6 16.4 4.6 5.9 15.9 8.9 14.9 12.9 16.4 6.1 5.7 17.1 15.9 12.4 8.2 15.5 19.7 7.0 10.1 12.7 10.7 11.6 8.0 7.0 12.6 15.2 9.8 9.2 8.6 8.9 5.8 6.2 7.5 5.1 6.6 7.0 6.4 9.1 5.6 9.1 6.3 9.4 2.9 7.2 19.8 6.9 32.7 6.6 6.7 14.6 13.0 13.2 8.4 8.0 6.6 10.5 9.3 14.8 7.2 18.5 5.8 8.3 11.1 12.3 4.2 3.7 4.6 13.4 7.0 14.6 5.2 9.9 4.6 9.1 7.0 12.8 3.7 5.2 6.9 8.3 9.7 9.2 6.6 8.1 6.5 19.4 4.0 8.6 8.0 6.4 6.2 0.7 0.9 0.7 2.2 0.8 1.6 1.0 1.6 2.4 1.0 1.1 1.4 1.7 1.0 1.1 0.7 1.5 2.4 1.2 10.3 10.0 13.2 14.9 9.0 8.0 9.6 7.8 7.6 5.7 8.2 11.6 8.4 9.6 17.2 22.9 10.8 6.4 2.8 6.8 5.2 9.3 9.4 11.0 8.1 7.2 8.3 11.0 16.7 4.6 12.5 8.2 3.9 4.2 2.0 7.2 7.4 6.4 9.0 7.0 13.9 3.6 3.2 8.4 17.9 9.3 6.3 11.5 5.3 7.1 4.4 6.7 12.0 8.1 6.1 9.8 6.2 3.8 9.6 8.6 7.2 9.4 4.6 3.2 9.2 6.6 10.0 4.6 4.9 6.8 11.5 3.9 10.1 2.6 13.2 11.0 6.6 7.8 7.0 10.8 10.0 6.2 5.5 3.4 12.4 10.4 7.7 3.1 UBAP2 "bA176F3.5, FLJ22435, KIAA1491" ENSG00000137073 "Ubiquitin associated protein 2" Q5T6F2 9 33921693-34048949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021684 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Cytosol "HPA021684: AB_2211887" "unprognostic (2.71e-1)" "unprognostic (1.99e-1)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "prognostic favorable (8.59e-4)" "unprognostic (1.75e-1)" "unprognostic (9.76e-3)" "prognostic favorable (1.95e-4)" "unprognostic (8.06e-2)" "unprognostic (2.39e-1)" "unprognostic (2.95e-1)" "unprognostic (8.77e-2)" 12.2 25.7 12.5 8.2 12.9 17.2 12.8 17.3 13.4 15.5 5.3 13.8 8.7 13.0 8.8 19.1 11.4 6.6 15.3 9.5 13.7 14.9 11.1 13.2 10.4 9.4 9.5 15.2 15.4 9.3 11.0 11.8 9.7 14.3 12.1 9.9 13.1 6.7 37.8 22.2 10.8 10.3 6.8 10.9 14.0 32.5 13.6 13.9 15.8 20.5 12.1 12.5 15.2 12.9 40.5 36.5 25.9 32.9 25.2 22.0 31.2 31.8 19.6 32.1 31.0 49.9 21.0 46.8 9.8 26.7 24.7 23.1 43.9 34.9 35.5 34.8 21.5 26.2 47.2 55.0 20.5 59.6 40.3 20.4 28.8 40.8 28.2 16.7 26.3 28.3 36.5 37.6 29.4 26.9 44.6 100.4 27.7 22.6 28.5 34.1 16.0 29.9 31.2 30.1 26.5 18.4 37.6 30.3 9.4 25.8 26.9 26.3 30.9 19.0 25.5 22.8 35.7 14.5 32.3 49.3 20.9 22.5 48.3 1.6 2.7 3.0 2.2 3.1 4.7 2.7 2.7 3.2 3.1 1.4 2.4 3.3 1.6 4.5 7.2 4.1 3.3 2.3 12.5 12.9 17.3 13.4 9.5 13.7 9.4 9.5 9.7 6.8 13.6 12.9 23.8 54.5 23.1 56.8 15.0 28.2 23.8 21.0 27.3 28.7 25.3 26.2 59.9 8.6 32.4 12.9 60.5 44.4 24.7 28.1 3.9 20.0 102.8 52.5 30.3 28.6 25.1 20.8 46.8 19.8 36.3 23.7 32.6 68.8 14.5 36.2 11.7 14.0 16.6 16.8 48.3 30.4 14.2 17.0 21.4 85.0 30.4 17.1 26.6 33.7 19.0 12.5 16.5 50.8 46.3 27.0 26.8 24.5 28.4 24.9 12.3 15.9 24.1 27.0 26.3 27.4 22.6 81.0 70.4 25.9 31.1 72.9 22.3 68.4 29.6 23.7 UBOX5 "KIAA0860, RNF37, Ubce7ip5, UIP5" ENSG00000185019 "U-box domain containing 5" O94941 20 3107573-3160196 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028871 Approved Approved Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA028871: AB_10603140" "unprognostic (4.11e-2)" "unprognostic (2.01e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "prognostic favorable (4.52e-5)" "unprognostic (2.58e-2)" "unprognostic (1.02e-1)" "unprognostic (3.11e-2)" "unprognostic (1.61e-1)" "prognostic favorable (1.80e-5)" "unprognostic (4.02e-2)" "unprognostic (9.71e-3)" "unprognostic (3.33e-1)" "unprognostic (5.58e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-2)" 4.5 4.4 4.3 2.7 5.1 6.9 4.5 5.5 5.1 4.8 2.4 6.2 2.8 5.9 2.7 4.4 4.8 2.6 3.8 4.5 3.8 4.4 3.5 3.7 3.7 3.8 3.7 5.0 6.1 5.4 4.4 3.4 3.5 5.2 2.9 3.8 4.8 4.4 11.2 7.6 4.2 4.1 3.2 4.3 4.7 4.8 3.9 3.8 3.8 6.8 3.0 5.6 4.2 6.1 6.1 6.1 4.8 3.1 6.3 3.5 2.6 4.9 4.7 6.1 6.0 5.8 5.2 4.8 2.0 4.2 7.0 8.5 3.2 7.8 3.6 1.4 2.7 7.9 2.1 5.4 5.0 3.9 2.9 4.5 5.6 4.9 6.2 5.0 3.9 3.7 6.7 4.4 3.5 4.5 7.0 5.0 3.7 6.3 3.7 4.7 5.8 3.3 3.8 6.7 5.9 5.7 3.4 18.8 4.0 3.7 8.1 2.5 4.3 4.0 2.7 4.6 4.4 5.9 9.4 4.2 2.1 3.5 3.0 7.9 5.1 9.4 4.4 5.1 5.0 6.3 5.2 3.6 5.5 4.8 5.3 5.1 8.1 5.2 5.3 3.7 5.6 4.6 4.3 5.1 5.5 5.1 4.5 3.8 3.8 3.7 3.5 3.2 3.9 6.1 2.4 12.8 6.0 6.8 3.6 1.9 4.1 3.4 0.6 6.6 2.8 2.0 1.1 1.5 3.1 0.0 6.2 6.9 1.9 5.6 0.0 4.0 1.4 2.5 2.5 3.6 10.2 0.4 9.6 4.2 4.4 3.5 5.1 2.7 2.5 4.5 4.6 4.3 4.9 6.7 8.5 4.9 6.1 5.0 3.2 1.9 6.8 3.5 3.6 3.7 6.6 4.5 4.1 4.5 10.4 3.9 3.4 3.8 2.3 5.8 4.7 5.2 2.7 5.2 6.6 5.2 2.8 10.2 5.2 1.6 2.4 10.1 3.1 3.8 5.3 5.9 UCMA "C10orf49, GRP" ENSG00000165623 "Upper zone of growth plate and cartilage matrix associated" Q8WVF2 10 13221766-13234374 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2;ovary: 1.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Group enriched" "Detected in some" 6 "amygdala: 1.2;basal ganglia: 2.2;cerebral cortex: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046718 Uncertain "Secreted to extracellular matrix" NA NA 20000 "Cluster 10: Brain - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "HPA046718: AB_2679771" "unprognostic (4.25e-1)" 0.0 0.0 1.2 0.0 2.2 0.0 0.0 0.2 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.2 1.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.2 0.2 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 UGGT1 "HUGT1, UGCGL1" ENSG00000136731 "UDP-glucose glycoprotein glucosyltransferase 1" Q9NYU2 2 128091200-128195677 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012761, HPA015127" Enhanced Uncertain Cytosol NA NA 4000000 "Cluster 24: B-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 52: Non-specific - Transcription" Cytosol "HPA012761: AB_1858597, HPA015127: AB_1858596" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "unprognostic (4.63e-2)" "unprognostic (6.45e-2)" "unprognostic (7.03e-3)" "unprognostic (3.13e-2)" "unprognostic (3.02e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-3)" "unprognostic (7.05e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.86e-1)" "unprognostic (1.50e-1)" "unprognostic (2.23e-2)" "unprognostic (8.38e-3)" 8.1 8.5 4.2 13.7 4.6 21.8 7.6 4.8 6.5 9.1 5.0 12.4 9.0 7.3 19.9 8.0 6.5 6.5 8.0 4.3 4.6 8.2 14.9 8.4 12.3 4.7 4.4 5.1 14.8 8.7 6.5 8.7 5.0 8.7 10.0 9.7 8.6 6.2 13.2 8.8 10.2 6.2 4.0 9.4 10.7 6.4 4.8 11.7 10.4 13.0 12.6 7.5 6.6 5.6 34.8 11.8 22.0 47.6 28.0 22.3 34.3 39.4 16.7 12.7 11.3 26.0 24.9 49.4 15.4 28.3 11.3 25.3 16.8 16.8 25.5 31.5 8.2 43.4 14.9 82.3 28.0 58.6 25.9 16.3 13.0 25.4 23.0 25.0 29.8 19.8 28.4 25.6 26.9 24.4 23.5 33.5 39.5 24.0 12.4 19.2 21.3 20.9 23.8 25.2 11.7 17.4 27.3 36.0 24.4 22.5 14.4 40.2 43.1 34.6 24.4 20.1 28.4 27.3 40.4 22.3 29.3 31.4 32.6 3.8 2.5 2.5 2.3 2.5 2.3 1.6 1.9 2.1 1.9 3.3 1.6 2.3 3.7 1.9 2.5 3.1 1.6 1.4 4.2 4.6 4.8 6.5 4.3 4.6 4.7 4.4 5.0 4.0 4.8 5.6 14.6 35.3 24.7 24.8 14.3 8.2 6.4 11.1 5.7 19.8 11.2 7.1 16.7 12.8 20.7 3.7 22.9 10.5 22.1 21.5 1.9 14.0 9.2 18.4 27.7 16.5 22.8 31.5 40.6 19.5 20.1 16.6 21.9 22.2 11.4 20.8 17.9 39.7 16.6 20.2 37.6 21.9 8.2 25.4 16.4 2.3 14.9 20.0 14.2 32.8 26.0 7.5 15.5 31.2 46.5 19.4 10.4 13.5 31.5 13.3 25.3 8.4 12.7 20.2 6.6 18.5 13.3 10.0 8.5 9.4 10.7 10.8 18.9 16.0 22.8 10.1 UNKL "C16orf28, FLJ23360, ZC3H5L, ZC3HDC5L" ENSG00000059145 "Unk like zinc finger" Q9H9P5 16 1363205-1414751 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055801, HPA073949" Uncertain Supported Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 9: U-2 OS - Unknown function" "Cluster 52: Non-specific - Transcription" Cytosol "HPA055801: AB_2682926, HPA073949: AB_2686647" "unprognostic (5.32e-3)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (8.88e-2)" "unprognostic (4.08e-2)" "unprognostic (1.82e-2)" "unprognostic (3.90e-3)" "unprognostic (8.07e-2)" "unprognostic (5.18e-2)" "unprognostic (8.56e-2)" "unprognostic (4.85e-3)" "unprognostic (1.13e-1)" "unprognostic (3.86e-3)" "unprognostic (1.89e-1)" "unprognostic (6.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.55e-1)" 6.9 7.5 4.5 4.0 3.1 5.6 7.3 9.0 8.3 7.5 0.5 6.5 4.1 8.9 0.7 4.4 8.4 1.8 4.4 4.6 3.5 3.9 4.3 5.3 4.3 8.8 5.4 10.7 4.2 2.0 5.1 3.0 8.9 7.0 1.4 2.6 6.9 3.0 11.5 7.6 7.4 1.7 2.2 8.2 5.6 6.6 6.3 5.4 7.9 2.3 2.8 7.3 6.2 5.2 4.7 12.3 2.8 7.2 2.1 2.6 21.5 12.0 3.6 3.2 2.8 10.1 10.7 1.8 24.4 4.1 5.5 8.6 3.6 1.3 2.2 22.0 10.4 3.7 14.8 8.3 1.6 2.1 7.5 3.4 1.6 5.1 2.1 3.8 5.7 5.4 10.6 6.5 1.5 7.4 5.5 6.0 7.8 2.0 13.4 14.7 3.2 13.7 2.0 1.3 9.4 5.6 7.1 4.4 1.3 2.0 7.1 3.4 6.9 7.1 10.9 6.1 5.1 14.2 8.0 8.4 5.7 4.2 8.3 3.5 1.1 2.7 2.1 0.4 1.0 0.7 0.7 0.5 0.4 0.9 1.5 0.7 4.1 1.4 0.4 1.8 0.9 0.7 4.5 3.1 9.0 8.3 4.6 3.5 8.8 5.4 8.9 2.2 6.3 5.2 7.6 6.4 7.5 18.3 16.0 5.5 6.2 5.0 3.4 30.0 8.1 9.5 2.7 7.2 8.3 5.5 14.6 12.8 16.2 5.3 1.9 5.4 5.7 4.9 6.4 8.9 3.6 6.1 13.3 3.0 6.6 8.7 6.6 7.0 5.1 20.6 12.5 6.8 4.1 6.7 15.7 6.5 6.1 7.3 3.8 20.8 16.4 6.2 7.2 9.4 13.9 16.6 23.7 13.0 17.2 7.3 11.3 15.4 17.1 22.7 11.5 2.0 8.0 37.3 6.6 12.5 8.3 14.2 20.0 4.5 8.2 20.5 11.8 9.4 4.9 11.7 USP22 "KIAA1063, USP3L" ENSG00000124422 "Ubiquitin specific peptidase 22" Q9UPT9 17 20999596-21043760 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044980 Supported Approved "Nuclear speckles" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA044980: AB_10794503" "unprognostic (7.24e-2)" "unprognostic (5.38e-2)" "unprognostic (7.67e-2)" "unprognostic (6.19e-2)" "unprognostic (4.72e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (9.66e-4)" "unprognostic (2.17e-2)" "unprognostic (7.81e-2)" "unprognostic (6.37e-2)" "unprognostic (1.07e-3)" "unprognostic (5.68e-2)" "prognostic favorable (1.53e-7)" "unprognostic (8.95e-2)" "unprognostic (1.93e-1)" "unprognostic (2.91e-1)" "unprognostic (1.79e-2)" 40.7 66.8 91.2 40.3 93.7 53.0 42.5 72.0 90.5 55.3 44.8 48.8 33.6 63.7 48.2 40.7 57.3 40.0 79.8 93.1 112.3 49.5 44.1 46.3 48.3 71.7 78.1 75.6 48.0 68.2 65.2 39.3 85.8 50.2 35.2 57.1 36.3 48.2 108.6 40.3 39.5 54.0 72.4 45.1 49.8 29.3 120.3 63.9 57.0 81.2 50.2 42.3 35.4 68.4 106.9 189.7 179.9 155.5 102.7 105.9 85.9 120.2 91.8 105.6 89.3 220.0 46.9 145.4 112.5 185.2 71.3 111.7 176.7 143.1 157.1 70.0 122.8 120.8 121.5 107.9 121.3 134.2 101.0 117.4 83.9 119.9 125.1 119.8 134.1 93.3 139.7 51.4 151.6 109.5 189.8 63.7 93.1 125.5 61.9 206.2 284.5 99.2 97.7 153.9 86.3 177.8 154.9 63.5 124.9 488.4 106.4 78.0 171.0 107.4 140.8 111.3 164.1 55.0 79.6 476.2 109.0 70.3 169.4 5.5 9.6 10.0 7.9 7.6 7.9 8.0 8.1 7.8 9.2 9.9 10.7 10.2 9.9 7.1 9.7 7.6 6.1 6.0 91.2 93.7 72.0 90.5 93.1 112.3 71.7 78.1 85.8 72.4 120.3 68.4 46.6 41.7 48.8 31.6 47.9 33.0 43.8 33.8 38.7 97.6 80.3 63.8 23.8 45.8 41.5 60.7 93.8 51.4 36.6 59.3 23.5 51.6 36.0 59.3 75.3 56.1 88.2 43.7 53.1 59.0 37.5 51.0 57.6 68.7 30.4 86.5 76.8 68.5 38.1 117.8 66.0 48.8 30.5 53.8 36.1 51.2 51.0 31.7 35.6 43.1 42.2 55.4 28.8 38.7 50.6 69.6 40.3 71.8 36.6 62.2 33.4 48.9 37.4 59.1 13.1 58.6 52.2 15.9 19.7 49.6 29.1 65.8 33.4 77.9 53.3 53.5 USP34 "KIAA0570, KIAA0729" ENSG00000115464 "Ubiquitin specific peptidase 34" Q70CQ2 2 61187463-61471087 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 310.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025815, HPA070764" Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA025815: AB_1858681, HPA070764: AB_2686308" "unprognostic (4.04e-2)" "unprognostic (8.21e-3)" "unprognostic (5.08e-2)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (2.66e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (8.91e-2)" "unprognostic (4.62e-2)" "unprognostic (9.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (6.34e-2)" "unprognostic (7.01e-2)" 32.2 36.0 49.9 21.7 53.9 37.7 35.6 57.7 58.3 36.1 59.9 47.0 14.8 38.4 54.4 35.8 33.3 21.1 33.7 49.7 53.5 43.3 34.8 36.4 44.1 52.1 51.8 43.4 32.4 35.1 45.0 17.4 52.3 38.6 26.8 77.5 27.2 32.4 53.9 41.4 40.8 27.9 50.3 45.8 36.3 45.1 54.5 47.8 32.2 36.8 45.1 36.9 32.8 56.8 43.6 29.9 38.9 40.3 71.8 48.1 32.4 26.3 37.1 23.0 21.7 43.0 16.3 102.2 27.0 56.9 24.3 23.4 30.9 34.4 42.6 36.7 24.4 61.6 29.5 69.6 60.2 46.1 37.8 52.9 43.6 41.9 62.1 55.7 49.0 28.8 42.7 32.2 51.5 40.6 30.6 66.6 26.3 43.9 23.9 32.4 46.5 27.7 67.9 52.2 31.9 34.0 40.5 30.1 48.3 49.4 16.0 33.2 43.6 36.1 48.2 21.5 34.7 37.0 19.7 103.6 33.8 42.5 31.7 2.1 1.2 1.6 3.8 1.1 3.5 2.6 2.6 2.9 1.0 3.1 2.9 3.9 1.8 3.1 2.8 3.2 2.5 1.4 49.9 53.9 57.7 58.3 49.7 53.5 52.1 51.8 52.3 50.3 54.5 56.8 64.5 64.1 68.3 193.6 82.8 61.1 54.2 40.3 46.7 139.7 54.0 46.6 46.0 48.6 54.6 33.1 250.2 33.5 87.3 46.0 9.8 41.4 133.5 59.9 66.9 59.3 48.6 53.2 256.6 33.6 23.8 53.0 73.9 70.6 32.3 78.0 31.8 38.9 21.6 107.7 240.4 37.8 59.0 45.4 48.6 138.0 56.8 56.0 40.9 212.7 55.2 60.0 87.6 232.2 310.0 49.9 41.1 67.0 69.9 79.9 38.3 23.4 44.1 178.1 26.3 78.2 63.9 95.8 115.9 53.1 61.4 53.4 70.5 74.7 35.6 69.9 UVSSA KIAA1530 ENSG00000163945 "UV stimulated scaffold protein A" Q2YD98 4 1345691-1395989 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050824, HPA053496" Approved Supported Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA050824: AB_2681251, HPA053496: AB_2682170" "unprognostic (6.40e-3)" "unprognostic (4.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-2)" "unprognostic (1.67e-1)" "unprognostic (3.85e-4)" "unprognostic (1.89e-1)" "unprognostic (4.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.88e-2)" "unprognostic (2.12e-3)" "unprognostic (3.92e-3)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.76e-3)" "unprognostic (5.19e-2)" "unprognostic (1.02e-2)" "prognostic favorable (6.87e-4)" 4.2 4.3 3.5 5.5 4.1 8.0 4.4 3.4 5.1 4.5 5.5 4.7 5.5 5.0 6.0 4.2 6.4 3.4 2.9 3.3 3.1 3.2 3.9 6.0 3.8 5.7 3.9 5.5 6.7 2.6 9.3 2.8 4.7 4.1 3.5 4.7 5.7 2.7 4.6 9.2 5.3 2.5 3.0 5.6 5.5 9.4 5.4 3.8 7.1 1.5 3.4 4.7 4.5 7.5 3.7 4.1 6.1 5.7 7.0 9.0 4.6 3.4 2.9 3.0 2.6 3.4 7.5 2.7 6.5 3.4 7.9 4.4 3.8 3.9 2.6 3.7 1.6 6.4 7.9 4.0 2.7 3.9 7.6 2.6 7.8 3.4 4.4 3.4 5.0 4.6 6.2 8.9 3.7 2.1 5.8 8.1 6.0 2.9 5.2 5.0 3.1 3.4 2.7 5.4 4.4 5.8 2.6 3.0 3.8 5.3 8.0 2.2 9.5 11.4 2.8 4.2 5.9 13.4 9.0 6.1 8.5 4.4 6.9 0.1 0.6 0.9 0.6 0.5 0.3 0.4 0.5 0.5 1.0 0.4 0.4 0.3 1.0 3.3 0.8 0.8 0.2 0.5 3.5 4.1 3.4 5.1 3.3 3.1 5.7 3.9 4.7 3.0 5.4 7.5 20.7 6.4 26.2 16.3 11.5 5.5 5.2 3.4 5.7 18.2 13.7 10.7 3.6 7.2 8.8 16.5 41.7 3.4 17.1 10.3 3.9 8.0 7.6 23.7 23.1 9.1 6.0 7.4 6.9 8.5 2.9 10.3 21.9 20.1 8.8 16.7 5.3 12.5 6.8 30.3 9.3 10.9 8.2 10.8 6.3 7.3 5.3 13.4 5.4 14.0 7.6 9.0 7.2 5.5 16.5 10.1 6.7 3.8 12.6 5.0 10.7 4.8 23.6 25.3 0.0 13.1 11.4 23.2 9.4 8.0 6.1 3.7 12.0 12.8 6.5 4.5 VPS13C "FLJ10381, FLJ20136, KIAA1421" ENSG00000129003 "Vacuolar protein sorting 13 homolog C" Q709C8 15 61852389-62060473 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 272.2;Oligodendrocytes: 291.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043507 Uncertain Approved Microtubules NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Microtubules "HPA043507: AB_10960840" "unprognostic (1.09e-2)" "unprognostic (5.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-2)" "unprognostic (5.90e-2)" "unprognostic (2.31e-2)" "unprognostic (3.92e-1)" "unprognostic (3.18e-2)" "unprognostic (2.15e-1)" "unprognostic (1.48e-1)" "unprognostic (3.61e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-2)" "unprognostic (3.92e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (5.58e-3)" 9.3 8.3 6.0 13.3 13.8 10.5 9.6 10.2 8.4 11.7 3.1 8.9 6.8 12.0 7.6 4.1 9.4 9.1 6.7 4.4 6.9 8.9 7.2 10.9 17.7 12.9 8.3 16.9 8.6 12.3 5.5 7.9 15.2 7.9 9.1 18.8 8.0 6.1 7.1 5.7 7.7 9.4 8.3 17.8 12.8 6.1 9.9 14.6 11.5 12.8 15.1 9.1 3.5 24.6 8.2 13.9 5.2 5.5 22.8 20.1 6.1 6.4 25.4 6.2 7.5 5.8 5.3 27.9 7.4 12.5 11.6 9.3 18.8 7.2 5.5 20.1 3.4 28.3 7.9 5.4 11.3 13.7 17.6 14.3 4.8 6.7 13.9 14.0 19.2 28.1 8.9 19.5 9.9 3.5 8.1 5.4 3.4 8.7 3.7 19.0 16.1 7.5 10.5 32.5 7.7 9.4 11.5 6.6 7.0 9.1 7.2 19.9 28.9 14.0 7.8 8.5 8.2 9.8 9.4 16.3 11.1 28.8 6.8 3.7 4.2 2.5 3.3 3.1 2.8 4.9 2.7 2.7 3.0 5.3 3.0 2.5 1.1 2.2 5.4 5.9 2.3 1.2 6.0 13.8 10.2 8.4 4.4 6.9 12.9 8.3 15.2 8.3 9.9 24.6 92.5 67.3 61.6 161.6 108.5 18.6 32.3 33.1 26.7 84.9 41.8 24.5 75.2 25.8 83.2 57.0 146.0 14.8 141.1 16.7 9.8 36.7 6.4 92.9 79.6 57.3 53.0 30.7 182.8 29.6 8.3 56.2 83.1 118.9 89.7 51.8 43.2 22.7 31.3 124.5 272.2 29.9 44.7 71.0 58.1 7.3 50.4 107.2 35.6 148.9 118.5 29.6 84.5 217.1 291.3 26.7 21.0 51.6 83.9 25.2 21.6 12.3 113.1 84.5 32.9 86.5 66.9 20.8 20.4 5.9 23.3 8.2 98.8 88.2 23.9 28.3 WDFY2 ZFYVE22 ENSG00000139668 "WD repeat and FYVE domain containing 2" Q96P53 13 51584455-51767709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 301.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050094 Supported Vesicles NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA050094: " "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-3)" "unprognostic (1.59e-1)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (9.58e-2)" "unprognostic (2.28e-1)" "unprognostic (2.59e-2)" "unprognostic (3.87e-2)" "unprognostic (1.14e-1)" "unprognostic (7.49e-4)" "unprognostic (1.47e-1)" "unprognostic (7.04e-2)" "unprognostic (6.36e-2)" "unprognostic (2.48e-1)" 6.7 11.2 8.9 4.5 12.1 15.0 7.6 9.0 8.8 8.4 4.8 3.9 1.9 5.1 5.5 9.5 6.5 2.9 3.8 8.9 10.4 4.5 6.4 5.4 4.7 11.5 9.9 8.1 17.5 15.0 5.2 5.4 12.4 5.1 2.3 6.0 5.6 4.9 1.6 17.7 4.3 3.6 10.0 7.5 6.5 6.5 10.2 4.4 5.9 3.0 5.1 4.3 8.6 15.4 1.4 2.6 11.3 4.6 5.4 11.2 3.6 11.0 7.0 5.6 4.4 1.7 1.5 4.5 1.0 7.6 3.6 5.0 6.3 19.7 10.6 3.7 3.5 9.6 3.8 13.6 4.3 6.5 4.4 9.1 9.3 12.5 14.2 9.1 2.5 4.8 2.7 2.3 9.3 3.1 4.5 14.8 13.4 3.2 3.7 5.9 4.5 3.0 7.2 3.8 3.1 7.5 3.3 4.9 5.0 9.3 2.3 15.5 9.4 10.6 2.0 5.2 7.8 1.5 2.6 3.2 12.1 6.6 13.3 6.1 7.8 4.0 2.2 8.6 3.1 3.8 2.4 1.9 13.0 4.2 2.1 2.7 5.2 4.0 9.5 11.9 3.5 3.5 8.9 12.1 9.0 8.8 8.9 10.4 11.5 9.9 12.4 10.0 10.2 15.4 16.3 16.0 21.9 118.2 36.9 23.3 20.0 10.2 45.5 35.2 25.7 24.0 7.1 8.6 17.5 29.5 127.2 28.5 41.2 7.0 27.4 19.8 46.3 19.3 23.6 13.0 13.8 17.1 47.1 23.5 33.7 20.7 14.8 20.2 29.7 35.3 27.1 18.1 28.1 37.0 47.1 9.2 8.2 63.8 30.8 19.9 39.4 41.3 12.4 96.5 45.9 26.4 16.5 106.6 301.8 15.0 4.5 21.8 17.1 12.2 9.2 6.4 14.9 52.5 26.3 45.1 27.1 32.3 16.5 46.4 27.1 14.0 27.3 41.7 10.0 16.2 WDR11 "BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15" ENSG00000120008 "WD repeat domain 11" Q9BZH6 10 120851305-120909524 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038980 Approved Approved Microtubules,Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Microtubules, Cytosol" "HPA038980: AB_10675955" "unprognostic (8.98e-2)" "unprognostic (8.83e-3)" "unprognostic (1.27e-1)" "unprognostic (5.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.57e-3)" "unprognostic (1.45e-1)" "unprognostic (2.98e-3)" "unprognostic (2.84e-1)" "unprognostic (3.84e-1)" "unprognostic (8.31e-2)" "unprognostic (1.80e-3)" "prognostic favorable (5.04e-4)" "unprognostic (5.09e-2)" "unprognostic (1.87e-1)" "unprognostic (8.99e-2)" "unprognostic (2.38e-2)" 15.2 12.3 5.9 16.9 5.7 6.6 15.3 6.7 5.1 15.4 10.8 15.2 14.2 15.3 10.8 14.8 17.7 15.0 7.8 6.0 7.1 24.4 20.2 15.2 18.6 10.1 6.5 16.0 13.6 38.6 5.3 16.8 10.9 15.6 16.6 15.1 14.4 14.2 3.5 9.7 14.9 16.9 10.3 18.5 16.1 11.5 6.6 17.9 22.5 6.5 20.2 15.7 8.6 14.7 28.5 25.1 24.8 43.4 35.4 42.2 18.0 26.0 52.4 28.3 34.9 14.7 29.1 19.9 13.1 37.5 22.5 26.5 29.1 35.8 35.4 26.5 24.2 20.8 19.9 15.3 33.6 29.6 23.6 36.7 28.5 26.2 42.2 51.7 53.1 14.0 16.9 23.3 30.1 12.1 18.7 12.9 12.8 24.8 16.1 7.7 43.3 17.4 33.7 21.8 12.2 21.8 22.6 24.9 68.8 43.3 18.4 18.7 40.0 18.6 11.6 2.8 25.1 12.9 8.6 24.3 26.4 24.8 9.9 27.4 8.5 3.8 4.5 11.2 3.6 8.5 3.0 4.1 9.7 4.6 3.1 3.3 0.6 5.9 25.3 2.3 4.3 5.2 5.9 5.7 6.7 5.1 6.0 7.1 10.1 6.5 10.9 10.3 6.6 14.7 23.7 6.4 16.4 77.7 42.3 12.0 13.5 15.5 10.8 42.8 16.6 13.6 8.3 27.1 20.1 25.8 98.0 19.3 30.5 24.3 11.7 18.3 3.8 31.7 33.1 24.4 27.1 16.6 57.0 10.5 12.1 21.8 29.6 32.7 9.5 34.2 33.9 33.9 32.2 25.2 54.2 24.5 12.2 43.2 16.5 4.4 43.5 34.9 3.6 30.9 42.4 21.0 20.6 112.1 84.7 25.3 23.4 38.7 25.6 17.9 34.8 19.9 30.1 85.3 19.7 28.9 17.9 25.8 16.3 15.6 14.2 15.2 18.9 41.7 20.6 19.3 WDR6 ENSG00000178252 "WD repeat domain 6" Q9NNW5 3 49007062-49015953 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042622 Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Cytosol "Plasma membrane" "HPA042622: AB_10966784" "unprognostic (2.41e-2)" "unprognostic (2.03e-1)" "unprognostic (2.14e-1)" "unprognostic (1.26e-2)" "unprognostic (4.80e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.97e-6)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (1.01e-3)" "unprognostic (1.94e-2)" "prognostic favorable (4.52e-5)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" 67.5 148.8 108.7 51.9 106.3 41.8 69.8 104.9 124.5 153.1 120.1 130.1 66.5 122.8 83.1 65.1 129.8 59.7 82.7 105.8 116.3 113.7 97.7 77.8 61.2 105.1 112.8 205.9 136.7 91.0 207.4 46.1 108.1 159.3 50.9 49.4 99.2 74.1 71.4 63.7 105.4 68.1 102.0 112.9 93.3 61.2 120.9 54.7 178.2 37.8 53.5 118.8 90.5 107.2 61.4 82.4 133.7 113.7 87.8 71.1 90.1 89.4 73.1 98.7 79.4 73.9 86.2 98.3 55.5 143.2 75.8 68.1 107.8 125.0 70.0 78.3 71.8 93.1 223.0 98.8 88.8 97.3 40.3 128.5 87.3 91.1 68.4 136.2 73.0 101.8 54.0 102.4 90.6 121.7 113.5 109.8 119.1 55.7 75.9 65.5 57.3 61.8 117.6 179.3 64.9 121.0 66.8 54.1 40.6 96.9 94.8 76.7 98.4 72.7 116.1 71.3 121.1 177.3 82.7 84.3 98.7 122.2 53.4 6.4 11.5 12.8 19.0 15.5 21.1 13.0 13.9 14.4 13.5 12.8 15.8 12.2 3.9 14.6 8.0 17.0 12.6 16.8 108.7 106.3 104.9 124.5 105.8 116.3 105.1 112.8 108.1 102.0 120.9 107.2 16.0 22.4 48.5 67.9 28.0 17.8 24.3 32.0 27.9 26.0 48.1 43.1 3.1 42.9 38.5 47.8 47.9 46.5 21.4 18.4 9.8 30.7 4.3 34.6 32.3 20.8 72.3 16.6 9.3 26.0 21.0 24.1 36.7 39.2 29.1 66.7 26.0 44.7 26.8 37.0 17.5 32.3 28.5 19.2 20.2 7.0 38.2 18.7 12.4 22.5 24.7 39.0 12.3 27.2 23.3 28.0 23.5 28.2 29.9 26.2 30.8 31.3 26.2 46.4 26.3 20.0 21.0 43.0 34.9 15.5 11.4 56.5 25.9 44.7 36.4 19.9 WDR73 "FLJ14888, HSPC264" ENSG00000177082 "WD repeat domain 73" Q6P4I2 15 84639285-84654343 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 98.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039357 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 51: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "HPA039357: AB_10673242" "unprognostic (8.49e-2)" "unprognostic (2.16e-1)" "unprognostic (4.77e-2)" "unprognostic (6.86e-2)" "unprognostic (1.74e-1)" "unprognostic (1.48e-1)" "unprognostic (1.18e-2)" "unprognostic (6.59e-2)" "unprognostic (1.02e-1)" "unprognostic (2.32e-2)" "unprognostic (1.26e-2)" "unprognostic (7.19e-4)" "unprognostic (9.21e-4)" "unprognostic (4.12e-1)" "unprognostic (3.16e-2)" "unprognostic (8.58e-2)" "unprognostic (4.02e-2)" 2.2 3.6 1.8 2.2 2.1 2.8 3.3 3.0 2.3 3.2 3.1 3.2 2.3 3.4 4.2 2.7 3.3 1.5 2.2 2.3 2.1 3.2 2.3 2.4 2.3 2.0 2.2 3.3 3.1 3.7 3.2 1.6 2.3 3.5 2.7 3.4 2.9 2.4 2.2 3.0 3.1 2.9 1.8 3.3 2.9 1.8 2.1 3.0 3.9 1.8 2.8 2.9 2.8 2.8 2.8 4.6 5.5 2.7 2.7 3.1 2.8 1.4 2.7 2.4 1.8 4.3 4.7 3.2 1.5 4.7 2.5 6.6 6.4 4.3 2.6 1.7 3.4 2.3 5.5 2.5 3.7 3.4 3.2 5.6 4.0 3.9 5.5 4.5 2.2 3.9 3.9 1.8 1.4 4.7 4.0 5.1 4.7 2.9 1.9 4.2 4.1 2.4 3.7 7.0 3.5 5.8 3.6 5.1 5.8 3.0 8.4 6.5 2.4 2.9 3.3 3.1 4.2 3.4 6.0 2.6 5.1 5.7 4.2 0.4 0.3 0.4 0.4 0.4 0.4 0.3 0.2 0.4 0.1 0.6 0.3 0.3 0.8 0.4 0.2 0.3 0.1 0.4 1.8 2.1 3.0 2.3 2.3 2.1 2.0 2.2 2.3 1.8 2.1 2.8 17.0 25.6 32.8 21.9 17.5 5.4 18.9 18.6 12.5 48.4 16.9 20.1 1.1 27.1 25.9 29.5 73.0 33.6 14.4 13.9 23.5 27.6 4.8 32.2 26.3 14.9 18.0 14.3 13.6 14.0 16.1 18.2 16.3 21.8 17.1 38.0 18.9 9.5 13.2 40.4 15.2 13.8 22.4 10.7 5.1 2.3 22.7 9.8 5.4 15.0 17.4 36.8 21.6 13.6 12.2 17.3 11.5 16.1 8.4 17.7 10.1 20.7 70.1 98.5 6.6 27.2 17.7 44.9 18.0 8.7 5.3 25.7 17.1 44.5 15.0 13.9 WFDC1 PS20 ENSG00000103175 "WAP four-disulfide core domain 1" Q9HC57 16 84294846-84329844 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 99.8;seminal vesicle: 115.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 111.1;Fibroblasts: 72.6;Peritubular cells: 257.3;Smooth muscle cells: 95.8;Theca cells: 325.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 29.8;BJ: 20.5;HEL: 18.2;HeLa: 27.6;THP-1: 9.9;U-937: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031411 Uncertain "Secreted to extracellular matrix" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "HPA031411: AB_10600921" "unprognostic (6.53e-2)" "unprognostic (1.27e-1)" "unprognostic (1.61e-2)" "unprognostic (8.66e-4)" "unprognostic (1.41e-2)" "unprognostic (1.50e-3)" "unprognostic (1.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.60e-1)" "unprognostic (2.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (3.78e-2)" "unprognostic (5.49e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (3.04e-1)" 8.1 26.9 16.5 10.5 16.5 1.9 4.3 19.1 21.2 21.5 12.9 79.3 8.9 17.3 18.8 24.5 7.9 35.1 4.4 16.1 15.5 16.7 5.5 29.5 0.6 17.0 16.2 3.7 1.0 0.4 5.7 99.8 15.3 69.0 17.4 8.4 6.2 115.1 1.2 3.2 14.6 32.2 14.9 3.5 20.8 12.5 16.3 0.3 4.8 1.6 0.8 54.2 13.5 14.9 0.0 0.0 4.4 29.8 0.0 0.1 0.2 20.5 2.5 0.0 0.0 0.0 0.0 0.0 5.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 27.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.5 0.0 0.4 0.0 0.0 2.3 0.0 0.0 5.3 0.1 0.0 0.5 3.2 0.1 0.1 9.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 16.5 19.1 21.2 16.1 15.5 17.0 16.2 15.3 14.9 16.3 14.9 3.4 3.2 0.5 9.1 0.0 1.8 0.9 0.1 0.0 111.1 2.0 0.9 1.4 0.0 0.1 1.8 0.0 2.1 0.1 0.9 11.7 0.0 27.8 0.6 10.6 3.9 4.2 0.0 4.1 0.0 2.0 72.6 7.7 0.5 0.0 0.2 12.5 0.0 6.6 5.0 0.9 4.7 0.0 0.0 3.0 41.1 15.8 2.3 0.0 2.8 0.0 1.4 0.0 29.1 0.6 0.1 0.6 257.3 0.3 1.3 0.4 1.3 0.7 4.2 0.0 1.0 95.8 5.5 0.9 0.1 0.4 3.8 0.5 325.9 3.1 1.0 WFIKKN2 "WFDC20B, WFIKKNRP" ENSG00000173714 "WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2" Q8TEU8 17 50834650-50842353 "Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "choroid plexus: 578.0;ovary: 146.2" "Group enriched" "Detected in some" 11 "Leydig cells: 9.0;Peritubular cells: 24.0" "Group enriched" "Detected in some" 5 "glioma: 0.7;testis cancer: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-87 MG: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "medulla oblongata: 12.6;midbrain: 5.1;thalamus: 6.1" "Secreted in other tissues" NA NA 4500000 "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" "unprognostic (7.31e-2)" "unprognostic (7.31e-2)" "unprognostic (1.31e-2)" "unprognostic (4.80e-2)" "unprognostic (3.46e-2)" "unprognostic (5.72e-2)" "unprognostic (5.42e-3)" "unprognostic (2.54e-3)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.19e-1)" "unprognostic (4.08e-3)" "unprognostic (1.42e-3)" "unprognostic (2.17e-1)" "unprognostic (2.75e-2)" "unprognostic (1.14e-1)" 0.1 1.3 2.6 0.0 1.7 0.0 0.1 5.3 1.7 0.3 578.0 1.0 0.0 1.1 0.5 0.2 0.8 0.2 0.7 8.7 0.8 0.1 0.0 0.2 0.0 1.4 1.1 146.2 0.3 0.0 2.2 0.0 1.5 0.4 0.0 0.3 0.1 0.6 2.1 0.9 0.2 0.3 0.8 0.0 0.2 2.4 6.5 0.5 0.0 0.9 0.0 0.1 0.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.7 5.3 1.7 8.7 0.8 1.4 1.1 1.5 0.8 6.5 1.8 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.0 0.1 0.0 0.0 0.0 1.5 0.0 0.5 0.1 0.0 0.0 24.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 XKR5 ENSG00000275591 "XK related 5" Q6UX68 8 6808517-6835524 "Predicted membrane proteins, Transporters" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.8;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "unprognostic (8.95e-2)" "unprognostic (1.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.46e-2)" "unprognostic (1.78e-1)" "unprognostic (6.73e-2)" "unprognostic (9.91e-2)" "unprognostic (2.16e-3)" "unprognostic (1.30e-1)" "unprognostic (7.91e-3)" "unprognostic (3.13e-2)" "unprognostic (9.19e-2)" "unprognostic (1.03e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-2)" "unprognostic (4.06e-2)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.3 0.2 0.7 0.2 0.0 0.1 0.4 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 2.8 0.5 0.0 0.0 0.1 0.9 0.2 0.5 0.8 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.4 0.0 0.1 0.4 1.7 0.1 0.0 0.1 0.5 0.1 0.1 0.2 1.3 3.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 XPA "XP1, XPAC" ENSG00000136936 "XPA, DNA damage recognition and repair factor" P23025 9 97674909-97697340 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease variant, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000155, HPA056856" Supported Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Cytokinetic bridge" "CAB000155: , HPA056856: AB_2683258" "unprognostic (8.76e-2)" "unprognostic (1.05e-3)" "unprognostic (1.60e-1)" "unprognostic (2.30e-2)" "unprognostic (4.17e-1)" "unprognostic (1.84e-1)" "unprognostic (5.26e-2)" "unprognostic (2.38e-1)" "unprognostic (3.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.97e-3)" "unprognostic (9.55e-3)" "prognostic favorable (4.28e-5)" "unprognostic (2.19e-2)" "unprognostic (1.56e-1)" "unprognostic (3.03e-2)" "unprognostic (1.17e-1)" 15.1 13.4 9.9 9.5 10.3 9.1 13.4 12.0 15.4 13.9 10.8 23.0 15.8 14.0 11.0 14.9 13.1 9.7 9.9 9.7 10.8 18.4 18.8 11.3 14.0 10.2 10.0 13.0 11.8 18.7 9.9 9.7 9.8 14.8 9.9 10.6 12.5 12.7 19.5 12.5 13.1 12.0 9.7 12.5 21.6 5.2 10.7 11.0 23.6 8.6 17.2 15.4 13.5 10.6 35.5 8.2 11.9 14.8 14.3 13.7 8.2 9.4 14.9 16.9 11.4 21.4 28.9 19.9 8.9 10.5 11.3 17.4 9.6 11.4 14.1 13.7 19.2 15.7 17.7 12.0 15.5 18.7 18.2 12.0 12.0 7.9 8.0 11.4 19.1 16.1 22.0 15.2 9.4 11.0 24.4 22.5 8.2 33.5 13.5 24.6 25.4 17.0 27.0 13.7 16.7 16.7 13.4 10.3 12.7 9.0 14.9 11.1 12.0 5.9 14.8 23.4 20.6 26.5 22.7 12.3 14.6 13.2 11.8 12.8 21.6 22.6 25.5 23.0 30.1 34.4 27.9 25.0 23.0 40.5 33.5 29.0 2.6 35.2 29.7 39.8 33.1 19.6 9.9 10.3 12.0 15.4 9.7 10.8 10.2 10.0 9.8 9.7 10.7 10.6 32.4 25.6 37.8 49.0 36.1 17.3 23.3 39.3 31.9 101.4 24.8 31.9 36.2 45.8 39.7 22.0 81.3 32.1 47.2 10.6 121.3 36.3 1.7 22.5 29.1 30.4 22.3 11.1 49.3 38.3 9.7 31.3 22.4 17.2 30.9 28.0 28.2 48.7 36.0 84.1 63.5 24.6 30.5 27.7 20.7 4.0 44.1 24.5 14.2 40.3 49.6 87.0 64.9 74.9 96.0 29.3 19.2 47.4 26.2 18.9 32.1 55.5 28.6 97.5 32.9 38.3 39.4 18.2 17.9 28.5 18.8 14.0 34.9 36.4 24.2 23.5 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178621 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167" "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favorable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favorable (2.46e-4)" 22.9 17.2 14.3 16.4 17.3 10.2 22.9 15.6 14.6 27.2 15.2 20.1 19.0 24.9 17.6 16.1 25.3 16.6 13.1 12.9 17.3 24.8 24.2 20.7 24.5 16.8 17.4 34.6 21.6 24.0 25.8 15.6 17.4 22.9 15.6 15.2 18.5 23.6 21.3 31.9 24.0 17.5 15.2 24.2 17.4 12.4 16.0 21.2 26.7 9.8 21.7 22.9 20.3 18.3 14.3 33.8 36.7 22.6 51.0 35.8 124.8 33.6 88.7 29.9 22.3 11.8 14.7 46.6 14.5 37.5 14.7 15.6 23.6 49.3 23.6 21.5 24.7 24.9 35.7 21.7 45.0 16.8 42.2 50.1 56.4 39.7 77.4 34.2 34.5 19.0 31.2 22.5 32.5 27.2 17.9 16.3 23.5 20.4 21.2 19.3 17.9 33.7 36.2 36.9 8.8 29.9 36.1 27.2 23.5 54.6 29.9 13.8 57.1 11.2 32.1 18.4 15.4 54.5 46.4 25.4 26.5 19.4 41.6 41.4 20.2 26.8 23.2 16.6 22.7 27.1 26.7 23.5 17.9 25.0 28.3 20.8 73.1 24.3 23.3 17.4 24.7 16.9 14.3 17.3 15.6 14.6 12.9 17.3 16.8 17.4 17.4 15.2 16.0 18.3 26.0 60.9 63.2 16.6 39.9 13.8 20.4 25.5 59.2 35.6 19.0 25.9 11.8 31.5 47.7 16.5 39.6 42.5 38.9 13.4 35.2 19.3 2.3 32.2 44.8 29.9 16.3 20.8 18.0 19.2 20.3 29.2 15.3 25.5 47.4 25.0 22.9 40.5 18.2 26.9 22.0 13.9 20.3 23.9 14.9 2.7 30.7 19.6 8.8 15.0 40.1 24.9 54.6 17.1 27.5 19.5 15.0 28.2 29.1 18.9 32.7 66.1 55.0 51.0 26.3 43.3 27.7 28.7 54.9 21.4 11.1 32.0 42.3 26.3 18.1 10.5 YIPF4 "FinGER4, MGC11061" ENSG00000119820 "Yip1 domain family member 4" Q9BSR8 2 32277904-32316594 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "brain: 129.1;choroid plexus: 65.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017884 Supported Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "Vesicles, Plasma membrane" "HPA017884: AB_1853855" "unprognostic (5.61e-3)" "unprognostic (8.50e-2)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (3.05e-1)" "unprognostic (7.64e-2)" "unprognostic (3.45e-2)" "unprognostic (3.61e-2)" "unprognostic (3.69e-1)" "unprognostic (8.70e-2)" "unprognostic (4.15e-1)" "unprognostic (1.54e-1)" "unprognostic (2.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (6.11e-2)" 7.0 6.2 69.9 5.5 66.9 2.5 8.4 69.6 129.1 6.1 65.6 6.9 5.8 6.9 7.2 5.0 5.0 4.5 7.4 71.7 68.8 7.7 9.2 5.6 5.9 69.3 67.7 6.6 14.8 6.5 5.2 5.9 71.9 6.6 6.2 13.1 7.4 5.6 8.0 7.0 5.8 6.5 66.8 6.9 6.4 4.2 67.3 7.9 10.1 6.0 5.1 5.3 5.1 75.4 8.9 4.4 8.6 7.7 9.8 12.4 4.5 7.5 7.5 7.7 5.0 5.9 6.6 4.7 5.1 8.2 7.4 6.8 9.2 6.6 10.0 7.6 14.3 7.6 9.8 10.7 11.5 10.2 6.2 8.7 12.4 6.9 11.0 10.6 6.6 5.2 10.7 9.6 8.5 5.8 8.0 10.6 7.0 9.6 7.5 5.5 12.7 8.9 8.4 3.8 9.6 9.2 6.4 6.4 11.7 5.5 3.5 8.6 7.4 10.1 4.8 7.1 7.2 14.2 19.1 5.8 15.9 9.7 5.7 14.9 5.4 5.7 4.4 5.1 3.7 4.6 4.4 4.1 4.6 4.0 4.5 4.0 14.9 6.4 5.1 5.4 4.6 4.7 69.9 66.9 69.6 129.1 71.7 68.8 69.3 67.7 71.9 66.8 67.3 75.4 61.4 93.0 69.8 13.1 68.5 51.4 56.9 59.5 50.7 113.8 63.3 28.2 88.0 60.1 58.3 42.3 106.3 68.4 81.3 68.8 33.2 45.3 34.7 39.5 57.9 59.0 57.1 86.9 18.8 39.3 69.9 66.6 28.1 40.1 40.0 56.3 67.8 80.9 48.3 101.0 20.1 70.2 50.8 81.7 60.7 21.0 86.6 58.0 81.8 21.5 85.1 53.1 114.4 22.1 31.8 41.8 66.8 74.9 62.6 78.5 62.7 60.1 62.2 122.2 78.9 71.9 66.2 160.2 59.6 41.1 65.9 192.8 60.7 65.4 46.8 74.7 YLPM1 "C14orf170, PPP1R169, ZAP" ENSG00000119596 "YLP motif containing 1" P49750 14 74763316-74859435 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048070, HPA061123" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "HPA048070: AB_2680247, HPA061123: AB_2684435" "unprognostic (2.17e-1)" "unprognostic (3.32e-2)" "unprognostic (3.95e-1)" "unprognostic (2.98e-1)" "unprognostic (3.79e-2)" "unprognostic (7.64e-2)" "unprognostic (3.22e-3)" "unprognostic (8.74e-2)" "unprognostic (3.60e-2)" "unprognostic (2.56e-1)" "unprognostic (7.83e-3)" "unprognostic (6.63e-2)" "prognostic favorable (6.08e-7)" "unprognostic (1.09e-2)" "unprognostic (2.41e-1)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" 13.3 13.0 12.5 10.4 12.8 17.6 13.8 18.1 15.6 18.0 2.8 12.9 7.0 16.1 12.9 12.7 15.9 8.5 11.4 10.9 16.4 10.6 8.5 11.2 13.1 9.5 10.0 22.1 13.1 12.1 15.6 11.2 9.3 14.0 9.2 17.6 15.0 10.3 15.0 15.3 13.4 9.4 4.8 13.4 11.9 18.5 12.3 14.9 16.8 7.4 11.9 14.0 15.0 12.8 28.3 28.9 31.8 7.1 25.2 20.8 18.0 18.3 18.7 18.9 18.9 25.8 19.6 40.9 13.4 20.8 13.7 26.1 28.6 19.6 30.2 24.6 17.3 29.4 19.8 20.0 12.2 22.3 21.9 19.0 13.5 20.9 16.5 23.3 25.3 22.9 24.1 18.9 23.5 29.9 26.4 24.4 20.0 19.2 26.1 40.5 31.8 14.3 16.5 37.2 24.2 23.8 29.4 20.2 8.3 21.8 22.9 17.4 37.0 22.6 28.3 15.6 23.9 23.3 24.8 43.6 19.3 17.3 17.2 0.3 1.4 1.5 1.5 1.6 1.7 1.9 1.3 1.3 1.1 1.9 1.8 1.8 1.0 2.3 1.5 3.4 1.1 1.4 12.5 12.8 18.1 15.6 10.9 16.4 9.5 10.0 9.3 4.8 12.3 12.8 26.8 25.6 34.3 54.2 32.7 19.9 11.2 13.3 27.9 42.0 27.7 25.3 45.9 14.3 25.0 9.2 41.7 19.7 32.4 15.7 1.9 15.7 35.4 26.8 36.0 29.7 20.4 23.5 86.7 15.5 13.5 24.4 23.0 28.6 17.7 54.1 21.8 16.8 19.1 52.2 84.3 18.9 12.2 22.6 12.3 17.7 33.8 19.5 5.4 51.5 28.6 24.6 32.0 68.9 76.5 18.0 13.3 48.5 30.3 18.9 14.0 14.7 33.0 30.8 19.7 35.5 24.8 62.8 49.0 29.2 23.3 15.7 29.3 32.5 21.6 13.2 ZBED8 "Buster3, C5orf54" ENSG00000221886 "Zinc finger BED-type containing 8" Q8IZ13 5 160393148-160400054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 12.6;Sertoli cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045445, HPA055817" Approved Enhanced Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA045445: AB_10959608, HPA055817: AB_2682933" "unprognostic (1.51e-1)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (8.40e-2)" "unprognostic (7.04e-3)" "unprognostic (7.50e-2)" "unprognostic (1.47e-5)" "unprognostic (6.52e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "prognostic favorable (3.72e-4)" "unprognostic (1.16e-1)" "unprognostic (7.44e-2)" "unprognostic (9.74e-2)" "unprognostic (9.25e-2)" "unprognostic (2.50e-1)" "unprognostic (9.96e-3)" 2.6 4.6 5.4 1.1 6.9 0.2 3.9 10.7 7.3 7.5 5.3 5.0 1.6 6.1 7.8 2.1 5.4 2.5 4.2 5.0 6.0 4.1 1.8 2.4 1.6 5.6 5.8 10.9 3.1 3.2 9.9 4.6 5.8 4.7 1.9 8.8 5.0 4.8 2.6 2.8 2.0 3.8 6.0 2.4 2.7 4.3 5.6 2.1 5.6 3.1 1.8 4.9 4.3 9.0 5.7 4.4 10.8 9.6 8.5 6.2 4.4 4.8 4.5 5.8 8.8 4.0 4.4 4.7 9.1 1.6 13.7 6.0 6.2 2.8 7.7 4.8 6.2 3.0 6.7 5.2 3.1 1.9 3.6 2.4 5.8 4.3 2.8 5.3 3.0 4.0 2.1 4.4 6.2 2.3 1.8 3.2 2.6 2.3 4.7 2.3 12.5 3.1 2.7 1.6 11.1 3.7 6.4 1.8 5.5 4.3 4.2 2.0 2.1 8.7 5.7 2.7 4.1 4.0 7.2 1.2 6.2 2.9 8.7 0.0 0.7 0.3 0.7 0.5 0.4 0.2 0.6 0.5 0.9 0.1 0.4 0.3 0.0 1.1 1.0 0.8 0.0 0.4 5.4 6.9 10.7 7.3 5.0 6.0 5.6 5.8 5.8 6.0 5.6 9.0 1.4 0.0 0.5 4.2 0.2 0.0 1.0 0.0 1.8 5.7 1.6 1.3 3.3 0.0 0.6 1.8 2.1 4.0 0.1 0.5 1.9 1.4 1.3 2.6 3.0 1.7 0.0 1.7 4.0 0.4 1.6 3.4 1.1 1.3 0.0 7.2 1.1 0.2 1.5 3.3 5.5 0.7 0.0 0.9 0.0 0.4 6.5 0.6 0.0 1.0 1.1 6.1 0.0 4.5 12.6 0.7 0.7 5.7 0.4 0.7 0.4 1.2 5.1 4.1 13.1 2.4 3.2 3.8 5.1 0.8 0.0 1.4 0.3 2.1 0.7 0.3 ZBTB40 "KIAA0478, ZNF923" ENSG00000184677 "Zinc finger and BTB domain containing 40" Q9NUA8 1 22428838-22531157 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042386 Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA042386: AB_10794649" "unprognostic (2.78e-1)" "unprognostic (3.39e-1)" "unprognostic (2.29e-1)" "unprognostic (5.17e-2)" "unprognostic (6.91e-2)" "prognostic favorable (2.01e-4)" "prognostic unfavorable (7.78e-8)" "unprognostic (8.11e-2)" "unprognostic (1.64e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.12e-5)" "unprognostic (1.52e-1)" "unprognostic (6.74e-2)" "unprognostic (1.98e-2)" "unprognostic (9.51e-2)" "unprognostic (6.66e-2)" "unprognostic (3.34e-2)" 9.1 15.2 6.7 10.9 8.1 8.9 8.1 7.6 7.0 9.7 10.0 10.0 7.8 9.7 7.1 6.4 10.0 8.5 7.5 6.8 7.2 7.4 6.3 8.6 14.2 8.1 8.4 10.7 12.3 8.8 10.6 5.9 7.8 10.1 8.3 12.5 8.2 7.0 10.4 8.3 14.5 7.0 9.9 17.4 9.9 7.3 7.7 9.9 9.5 7.8 15.0 9.6 6.7 9.9 8.6 10.0 15.7 16.6 11.1 9.7 15.2 7.1 8.2 11.4 12.6 8.9 10.8 10.3 8.9 8.6 8.9 10.6 15.6 7.7 13.5 13.3 13.1 22.1 20.0 10.3 9.6 12.4 20.5 7.9 11.1 14.5 10.9 8.5 9.6 13.7 23.5 0.1 9.0 6.4 8.4 16.1 9.7 7.0 8.0 14.7 11.9 11.5 5.4 9.2 12.7 10.8 14.4 10.4 6.1 10.1 19.1 10.2 12.0 13.3 11.2 14.6 7.3 6.5 9.7 9.8 8.0 15.1 9.6 1.0 0.5 0.3 1.0 1.2 1.3 0.8 0.8 0.8 0.8 1.1 0.8 1.0 0.1 2.9 0.5 0.5 1.4 0.4 6.7 8.1 7.6 7.0 6.8 7.2 8.1 8.4 7.8 9.9 7.7 9.9 7.6 12.8 16.7 12.1 12.2 5.7 3.1 4.2 8.0 15.0 7.0 5.0 11.8 8.6 11.7 1.8 31.3 4.6 11.0 3.6 1.9 5.2 4.6 8.9 10.8 8.0 16.2 3.4 15.0 7.4 4.5 7.0 6.6 6.0 16.4 21.1 4.2 3.4 4.8 11.8 20.1 5.1 8.2 5.7 5.7 6.7 5.9 8.1 14.2 25.3 4.1 5.6 13.4 18.6 24.1 6.4 8.2 6.8 12.4 4.8 4.7 2.6 8.8 22.7 13.1 11.9 9.6 7.2 8.2 6.9 4.1 2.9 13.3 13.5 5.8 3.5 ZBTB41 "DKFZp686C06120, FLJ36199, FRBZ1, ZNF924" ENSG00000177888 "Zinc finger and BTB domain containing 41" Q5SVQ8 1 197153682-197201293 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034841, HPA034842" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nuclear membrane, Cytosol" Nucleoplasm "HPA034841: AB_2674355, HPA034842: AB_10669995" "unprognostic (2.36e-1)" "unprognostic (5.58e-3)" "unprognostic (8.01e-3)" "unprognostic (6.07e-2)" "unprognostic (4.14e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.43e-1)" "unprognostic (1.81e-2)" "unprognostic (2.81e-1)" "unprognostic (7.51e-3)" "unprognostic (2.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.58e-1)" 3.5 4.7 5.0 3.0 4.7 1.3 7.0 6.6 5.8 5.2 2.2 3.2 3.2 4.2 4.7 3.4 3.7 4.3 3.2 4.6 5.8 5.3 4.4 3.4 3.9 5.5 6.1 6.8 4.0 4.8 3.9 3.3 5.6 4.2 3.5 7.0 3.9 3.4 3.6 3.5 2.9 3.2 6.0 4.4 4.3 3.8 5.8 5.2 7.5 4.7 3.3 3.9 2.4 6.9 8.1 4.6 5.8 4.7 9.0 13.6 4.6 4.8 7.8 4.9 4.6 2.9 6.7 3.0 6.8 10.9 3.0 6.5 4.1 4.1 7.7 2.7 2.4 2.4 6.0 2.6 8.0 4.8 2.3 5.6 10.6 5.0 8.6 10.0 3.4 3.4 5.7 3.5 12.8 3.9 3.6 2.7 2.3 5.6 1.6 2.5 8.1 5.4 6.0 4.5 8.3 7.4 8.6 14.9 9.3 4.2 11.4 3.6 5.6 9.7 5.6 7.8 6.3 4.0 2.2 3.2 4.6 1.7 13.8 0.3 0.1 0.1 0.2 0.1 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.4 0.0 0.4 0.1 0.1 0.2 0.1 5.0 4.7 6.6 5.8 4.6 5.8 5.5 6.1 5.6 6.0 5.8 6.9 11.6 19.2 8.9 21.2 9.4 7.5 6.9 5.8 11.4 13.6 17.5 10.7 14.7 10.0 10.0 16.5 2.1 4.3 10.6 4.2 1.9 6.3 3.2 14.5 18.0 8.2 13.1 1.7 32.1 5.7 4.0 13.3 7.7 11.3 1.3 18.5 6.8 9.2 4.4 25.2 27.9 7.3 2.0 7.3 5.2 4.6 15.5 8.1 12.4 13.1 9.3 28.5 11.3 19.6 41.0 6.8 2.9 12.0 6.3 9.4 4.3 10.4 12.8 9.1 6.6 13.3 12.7 7.0 4.9 10.8 10.1 3.4 7.7 16.0 7.0 6.0 ZBTB8B "DKFZp547H154, RP1-27O5.1, ZNF916B" ENSG00000273274 "Zinc finger and BTB domain containing 8B" Q8NAP8 1 32465072-32496686 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 6.2;Langerhans cells: 4.7;Oligodendrocyte precursor cells: 9.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "RT4: 1.0" "HPA055553, HPA071427" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA055553: AB_2682848, HPA071427: " "unprognostic (8.32e-4)" "unprognostic (1.23e-1)" "unprognostic (3.83e-1)" "unprognostic (3.83e-5)" "unprognostic (1.86e-2)" "unprognostic (5.65e-2)" "unprognostic (1.67e-4)" "unprognostic (1.57e-2)" "unprognostic (5.94e-2)" "unprognostic (3.43e-3)" "unprognostic (9.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.93e-2)" "unprognostic (3.44e-2)" "unprognostic (6.11e-2)" "unprognostic (3.26e-3)" "unprognostic (5.88e-3)" 0.0 0.1 1.6 0.1 1.1 0.4 0.1 0.8 1.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 1.0 1.9 0.0 0.0 0.0 0.1 1.2 1.9 0.1 0.1 0.1 0.6 0.1 1.1 0.1 0.0 0.5 0.1 0.0 0.6 0.2 0.0 0.0 0.4 0.1 0.0 0.2 1.8 0.0 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.5 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.6 0.0 0.1 0.1 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.1 1.0 0.9 0.5 0.3 0.1 0.0 0.7 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 1.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.5 0.2 0.1 0.2 0.1 0.0 1.6 1.1 0.8 1.2 1.0 1.9 1.2 1.9 1.1 0.4 1.8 0.8 0.4 0.0 1.8 0.3 0.2 1.7 1.1 0.1 0.0 2.6 0.3 0.5 0.8 0.0 0.7 0.0 6.2 1.9 1.4 0.3 0.0 0.0 2.1 0.5 1.6 0.7 0.0 0.0 0.8 0.0 1.3 0.8 0.0 0.5 3.8 2.8 0.7 0.2 0.4 3.3 2.2 0.0 0.0 0.3 4.7 2.1 0.6 0.7 1.8 1.9 0.0 1.4 1.0 9.0 0.4 0.0 0.0 0.0 0.3 0.9 0.0 0.1 1.5 2.4 0.0 1.6 0.7 2.2 1.5 0.0 0.6 0.3 0.7 0.9 0.0 0.9 ZC3H15 LEREPO4 ENSG00000065548 "Zinc finger CCCH-type containing 15" Q8WU90 2 186486253-186509361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031099, HPA031100, HPA031101" Enhanced Enhanced Cytosol NA Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669" "unprognostic (1.51e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (2.24e-1)" "unprognostic (3.11e-3)" "unprognostic (5.92e-2)" "unprognostic (8.15e-2)" "prognostic unfavorable (1.48e-7)" "unprognostic (9.08e-3)" "unprognostic (4.95e-2)" "prognostic favorable (3.98e-4)" "prognostic unfavorable (9.75e-4)" "unprognostic (5.72e-3)" "unprognostic (5.69e-2)" "unprognostic (1.87e-1)" "unprognostic (1.82e-1)" "unprognostic (8.89e-2)" "unprognostic (3.45e-2)" 42.6 47.5 39.2 44.3 42.0 128.8 45.9 43.4 52.5 35.1 38.6 40.8 48.3 39.8 47.0 40.2 26.3 36.5 37.0 42.6 44.5 53.8 67.3 28.4 53.9 42.2 40.9 32.6 47.9 41.2 27.2 48.8 41.7 37.0 46.0 53.0 45.3 32.4 50.3 44.3 46.1 36.9 39.4 38.6 36.8 40.6 41.7 50.2 49.3 44.9 51.4 54.0 29.2 42.4 103.5 68.9 83.3 107.8 93.0 93.4 124.9 112.7 76.7 102.3 91.5 202.9 81.8 140.3 100.2 80.9 130.9 73.6 155.8 137.5 144.0 128.7 118.1 201.9 101.1 221.9 124.9 208.7 118.6 77.2 149.6 111.4 157.2 89.9 111.9 86.0 197.0 106.8 108.4 93.5 133.7 146.5 157.6 135.7 171.8 105.2 113.0 131.6 127.6 124.0 100.3 73.6 71.5 96.4 167.3 124.3 68.1 149.7 95.7 114.7 99.1 70.9 136.4 92.0 167.0 199.8 101.7 145.7 102.3 59.9 47.9 49.1 44.7 61.6 55.8 55.0 54.8 57.4 54.7 42.2 50.5 53.9 28.8 60.4 75.1 48.0 66.6 41.5 39.2 42.0 43.4 52.5 42.6 44.5 42.2 40.9 41.7 39.4 41.7 42.4 107.1 73.7 83.6 26.4 137.0 212.2 169.1 116.6 99.6 75.0 101.9 118.9 95.8 57.2 104.8 115.8 60.5 131.3 116.1 131.4 256.3 112.0 153.1 110.1 125.5 106.4 101.7 98.7 38.0 104.3 167.0 107.4 67.8 127.1 112.2 220.1 62.4 137.0 124.3 57.2 39.8 136.1 87.5 107.4 104.8 307.1 78.6 113.2 64.0 33.7 142.5 82.6 126.7 19.6 32.8 111.6 106.2 87.3 128.0 179.5 164.1 330.2 68.3 130.2 32.9 156.2 127.6 215.6 174.4 116.1 209.1 177.6 117.3 319.6 151.2 163.5 ZC3H18 NHN1 ENSG00000158545 "Zinc finger CCCH-type containing 18" Q86VM9 16 88570403-88631964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040847, HPA041327" Enhanced Enhanced "Nuclear speckles" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA040847: AB_10794865, HPA041327: AB_10795005" "unprognostic (3.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.88e-1)" "unprognostic (2.90e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.06e-4)" "unprognostic (1.10e-2)" "unprognostic (7.37e-2)" "unprognostic (2.89e-2)" "unprognostic (2.79e-1)" "unprognostic (2.07e-3)" "prognostic favorable (3.68e-4)" "unprognostic (5.83e-2)" "unprognostic (1.40e-1)" "unprognostic (4.29e-2)" "unprognostic (4.01e-1)" 14.1 11.0 10.7 18.7 11.3 25.5 13.6 14.4 14.2 14.3 5.7 16.1 14.9 17.4 4.3 14.5 14.2 8.8 14.3 10.6 11.4 10.9 12.0 13.1 18.4 10.1 9.6 14.1 13.7 12.3 10.1 11.9 9.2 11.5 8.1 9.0 13.6 8.2 22.8 15.3 15.6 10.1 7.5 17.4 14.5 25.3 10.2 19.1 13.1 10.1 12.3 15.3 13.7 12.1 45.3 59.6 42.6 42.8 20.7 17.7 68.3 44.5 24.1 40.8 18.5 58.8 38.3 55.1 36.9 21.1 27.3 53.0 40.3 33.7 25.6 32.5 51.2 36.6 29.2 50.6 26.2 28.5 30.7 16.1 25.2 43.3 20.8 16.9 25.5 37.8 101.4 17.8 20.4 87.4 91.6 50.5 66.7 35.3 35.5 111.0 29.3 40.4 18.5 28.3 44.9 38.7 85.2 23.5 25.2 24.8 53.3 38.1 35.1 43.6 45.2 32.0 45.5 39.5 67.2 130.8 38.6 65.7 47.0 2.3 2.0 2.0 2.5 2.3 2.8 2.3 2.4 2.7 1.9 1.9 2.1 1.7 3.4 3.1 5.4 2.8 3.3 2.1 10.7 11.3 14.4 14.2 10.6 11.4 10.1 9.6 9.2 7.5 10.2 12.1 24.9 28.9 24.2 11.1 29.6 16.8 17.0 11.1 13.1 26.6 13.8 14.4 10.2 20.0 23.9 16.5 35.5 24.1 45.6 30.1 7.9 16.5 76.2 21.9 28.7 21.3 25.0 28.6 12.0 16.6 22.1 18.7 22.4 32.1 20.8 26.6 16.4 12.9 18.2 28.6 11.9 18.5 10.2 20.1 21.1 10.0 21.8 30.5 14.2 12.2 23.9 18.1 46.4 7.1 15.7 17.5 21.7 17.0 35.5 20.5 20.3 8.4 13.1 44.0 6.6 28.8 19.5 41.4 37.5 19.6 22.3 25.2 39.2 25.1 24.7 16.6 ZC3H6 "FLJ41410, FLJ45877, KIAA2035, ZC3HDC6" ENSG00000188177 "Zinc finger CCCH-type containing 6" P61129 2 112275597-112340063 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036019, HPA036020, HPA076065" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus" "HPA036019: AB_10673228, HPA036020: AB_2674904, HPA076065: AB_2732300" "unprognostic (1.05e-2)" "unprognostic (3.01e-1)" "unprognostic (2.77e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-3)" "unprognostic (1.83e-1)" "unprognostic (3.99e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.68e-1)" "unprognostic (4.41e-2)" "unprognostic (6.42e-3)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (6.45e-2)" 3.9 2.5 3.1 1.8 4.4 1.7 3.3 5.5 4.1 3.2 0.0 3.0 1.4 2.9 3.4 1.8 3.6 1.8 2.9 2.6 3.1 2.1 1.8 2.4 2.9 3.1 3.3 6.1 2.3 3.0 3.4 1.7 3.0 2.4 1.7 9.4 2.8 2.1 5.8 4.4 2.6 1.8 2.9 3.1 2.2 2.9 3.0 3.8 3.7 5.7 2.6 2.9 2.9 5.4 1.1 0.4 2.3 2.2 2.1 4.1 0.7 1.2 1.9 0.7 1.5 0.2 1.4 1.7 0.9 0.7 2.0 0.6 0.7 0.3 1.0 2.0 0.2 0.3 0.5 0.0 1.9 0.4 0.4 1.6 3.3 0.8 5.5 3.4 1.2 2.2 0.4 3.0 1.7 1.0 1.0 0.6 1.5 0.7 0.5 0.6 0.1 1.6 1.0 0.2 1.7 2.3 1.1 0.6 1.2 1.2 0.7 0.6 1.8 1.1 0.1 1.3 0.5 3.1 0.9 1.5 2.2 1.1 3.0 0.5 0.6 0.8 0.9 0.4 1.0 1.3 1.3 1.0 0.6 1.7 1.4 1.2 1.2 0.6 1.3 1.0 1.2 0.4 3.1 4.4 5.5 4.1 2.6 3.1 3.1 3.3 3.0 2.9 3.0 5.4 33.3 38.5 32.0 33.3 24.4 17.3 30.0 12.1 33.0 69.3 31.9 33.4 68.7 20.0 20.6 22.0 54.2 21.1 17.5 7.8 29.4 13.1 16.8 39.3 16.0 27.7 16.2 14.5 46.7 14.8 7.3 31.7 7.7 16.2 26.6 41.2 25.7 16.7 12.4 114.4 62.2 13.5 6.1 19.5 14.2 12.4 46.3 16.2 5.4 29.0 21.1 47.6 30.9 43.7 114.4 16.0 10.4 36.1 12.2 30.7 12.1 22.3 30.6 89.5 32.9 50.8 31.0 75.2 46.4 13.7 18.5 7.9 28.6 26.9 12.9 20.6 ZC3H7B "DKFZp434K0920, FLJ13787, KIAA1031, RoXaN" ENSG00000100403 "Zinc finger CCCH-type containing 7B" Q9UGR2 22 41301525-41360147 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001784, HPA076092" Uncertain Supported Cytosol NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Cytosol "HPA001784: AB_1080637, HPA076092: " "unprognostic (1.71e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-2)" "unprognostic (3.53e-2)" "unprognostic (3.35e-2)" "unprognostic (5.66e-2)" "unprognostic (3.73e-2)" "unprognostic (7.92e-2)" "unprognostic (7.12e-2)" "unprognostic (7.73e-2)" "unprognostic (1.39e-2)" "unprognostic (3.19e-1)" "prognostic favorable (5.43e-7)" "unprognostic (1.43e-2)" "unprognostic (2.92e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-1)" 29.5 42.9 37.5 20.2 37.1 16.0 22.9 31.9 43.4 25.6 15.1 25.8 24.3 31.1 13.5 20.3 27.2 17.2 26.1 34.1 38.7 31.4 42.1 26.9 21.4 56.0 35.7 41.3 30.9 44.5 30.5 18.5 58.8 26.0 13.2 17.9 44.9 26.7 24.9 20.0 25.9 20.7 30.2 25.6 24.8 11.6 37.2 25.2 45.9 19.1 15.2 23.5 19.7 36.0 59.0 32.2 42.0 25.6 37.6 33.9 49.1 65.8 69.6 53.8 42.1 35.3 23.8 33.1 79.1 92.0 30.1 39.1 35.7 61.8 27.4 76.0 58.9 29.6 40.2 45.4 50.4 57.4 24.9 42.7 34.6 46.3 56.4 45.7 58.9 25.7 60.4 17.9 46.0 59.1 45.4 29.7 30.3 44.2 24.1 68.7 26.4 37.8 45.9 41.5 27.1 20.3 60.5 36.6 31.5 29.0 24.1 38.1 119.0 52.5 54.4 16.3 40.8 30.8 18.4 33.2 44.0 28.0 46.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.0 0.3 0.2 0.1 0.0 0.3 0.0 0.2 0.1 0.0 37.5 37.1 31.9 43.4 34.1 38.7 56.0 35.7 58.8 30.2 37.2 36.0 15.4 12.8 22.2 14.4 13.1 7.1 12.7 13.4 10.2 22.4 18.2 15.6 10.1 20.0 15.7 22.0 18.8 9.0 11.3 13.5 7.9 14.0 0.9 14.2 25.8 17.9 33.6 7.8 20.1 13.3 9.0 16.4 11.2 16.9 8.2 59.0 19.2 44.0 12.0 42.1 20.6 14.6 26.4 12.9 9.8 3.1 33.2 8.2 12.4 13.1 15.2 9.8 20.6 19.1 17.6 18.8 8.1 29.0 7.4 21.2 23.0 18.5 11.7 22.2 19.7 23.1 18.0 2.0 4.9 8.9 5.8 6.2 11.1 46.9 17.1 14.8 ZC3H8 "Fliz1, ZC3HDC8" ENSG00000144161 "Zinc finger CCCH-type containing 8" Q8N5P1 2 112211529-112255136 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034803, HPA034804" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA034803: AB_2674338, HPA034804: AB_10670284" "unprognostic (2.45e-1)" "unprognostic (1.64e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.12e-6)" "unprognostic (4.93e-2)" "unprognostic (1.01e-1)" "unprognostic (4.29e-3)" "unprognostic (8.76e-2)" "unprognostic (1.20e-2)" "unprognostic (5.04e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (2.74e-2)" "unprognostic (3.49e-2)" "unprognostic (8.02e-3)" "unprognostic (4.88e-3)" 3.6 3.9 4.7 5.7 4.8 6.2 8.0 6.5 6.2 5.4 3.1 4.6 5.2 4.6 4.4 8.6 5.1 2.6 8.6 5.0 4.7 5.7 5.9 2.9 8.5 4.5 4.1 6.0 9.0 11.2 6.6 3.7 4.5 5.6 6.0 5.9 7.1 3.9 11.0 7.6 4.6 4.4 4.0 6.1 4.4 9.0 4.1 9.1 7.2 11.0 8.6 4.9 6.1 4.8 22.1 10.5 13.2 13.7 7.4 8.0 20.6 6.8 5.8 9.5 7.9 25.3 8.3 45.6 12.4 4.8 13.3 13.1 19.4 13.7 12.5 16.2 9.0 30.3 11.8 12.9 11.7 28.6 13.4 10.0 27.0 18.4 28.4 7.0 7.2 27.3 39.2 12.2 7.5 14.6 31.0 25.7 12.2 23.1 29.2 21.2 22.5 18.8 8.7 9.7 19.8 15.4 12.9 13.7 29.9 11.5 10.9 15.1 9.6 12.3 15.9 8.8 17.4 21.9 27.9 44.4 8.8 23.4 4.9 2.7 2.5 0.8 4.0 2.0 8.4 5.9 4.2 4.3 2.5 6.1 7.1 5.9 1.4 7.2 2.6 4.1 4.7 2.4 4.7 4.8 6.5 6.2 5.0 4.7 4.5 4.1 4.5 4.0 4.1 4.8 15.5 9.6 15.2 17.0 35.6 12.6 18.2 16.6 30.7 50.2 28.7 28.6 35.4 12.8 22.8 7.3 41.7 18.1 38.7 13.4 27.4 15.2 30.9 25.5 28.0 15.4 14.9 19.8 35.8 18.6 16.8 16.4 12.2 15.1 35.4 20.2 13.6 11.3 11.4 38.7 46.2 27.4 22.4 15.7 7.8 40.6 22.1 13.7 1.8 12.2 18.1 16.1 43.3 41.2 27.8 19.5 11.3 20.3 14.3 21.2 12.7 24.3 17.4 53.5 13.1 20.9 16.2 60.9 39.0 34.3 17.8 14.2 31.6 24.4 24.0 12.5 ZDHHC8 "KIAA1292, ZNF378" ENSG00000099904 "Zinc finger DHHC-type palmitoyltransferase 8" Q9ULC8 22 20129456-20148007 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003422 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Cytosol Nucleoplasm "HPA003422: AB_1080640" "unprognostic (1.00e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (3.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.43e-3)" "unprognostic (9.34e-3)" "unprognostic (3.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (1.11e-1)" "unprognostic (1.02e-1)" "unprognostic (9.88e-2)" "unprognostic (9.57e-2)" 31.6 31.2 13.8 18.6 15.1 10.7 30.4 11.3 26.4 32.6 0.0 22.8 12.1 31.2 7.5 29.3 27.7 13.0 31.6 13.9 7.0 30.4 36.1 31.0 17.1 12.2 10.0 34.6 35.6 14.4 41.3 16.9 9.9 28.1 7.0 7.4 27.6 15.4 23.6 32.2 24.7 13.1 6.6 35.7 26.4 14.9 12.3 13.7 37.3 10.3 11.7 25.3 30.9 12.8 30.0 18.7 29.3 38.7 42.0 25.0 26.3 55.1 37.3 36.6 32.6 9.8 15.2 0.1 22.3 46.0 19.8 40.2 15.5 42.2 18.0 43.2 59.4 14.5 57.2 23.0 34.5 0.0 19.5 43.7 27.9 28.2 23.6 22.5 41.4 21.0 101.4 22.8 33.0 14.7 17.8 39.1 14.9 13.2 29.4 37.8 25.6 10.9 15.6 35.9 46.9 23.7 22.4 10.7 26.6 13.1 0.7 20.4 48.0 82.5 59.8 46.8 25.0 32.6 11.5 11.7 24.2 18.7 24.8 1.3 0.4 0.1 0.8 0.5 0.4 0.2 0.2 0.4 0.1 0.5 0.4 0.5 0.0 0.4 0.2 1.3 0.7 0.2 13.8 15.1 11.3 26.4 13.9 7.0 12.2 10.0 9.9 6.6 12.3 12.8 17.4 3.2 3.1 17.6 3.7 9.1 3.8 3.6 5.7 11.9 8.2 8.1 7.1 4.3 3.5 11.0 14.6 3.6 9.2 4.3 1.9 5.2 0.5 4.3 15.7 11.5 4.2 0.8 16.6 4.5 8.5 9.3 10.2 8.7 5.7 8.7 10.4 9.8 4.9 13.5 9.9 5.9 10.2 5.0 5.0 2.1 10.8 5.7 5.4 9.4 3.7 7.4 1.0 13.0 13.3 7.7 5.4 14.7 2.7 7.6 2.7 2.1 1.5 10.8 6.6 10.5 6.8 1.4 3.8 5.5 9.8 3.4 4.2 8.0 5.0 3.4 ZFP14 "KIAA1559, ZNF531" ENSG00000142065 "ZFP14 zinc finger protein" Q9HCL3 19 36334453-36379201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 63.2;Rod photoreceptor cells: 105.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030637 Uncertain Approved "Nuclear speckles" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA030637: AB_10602353" "unprognostic (1.89e-1)" "unprognostic (3.80e-2)" "unprognostic (9.61e-2)" "unprognostic (3.53e-1)" "unprognostic (2.20e-2)" "unprognostic (3.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.23e-2)" "unprognostic (1.96e-2)" "unprognostic (1.17e-1)" "unprognostic (3.18e-3)" "unprognostic (1.91e-1)" "unprognostic (5.51e-2)" "unprognostic (1.86e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "prognostic favorable (2.75e-5)" 1.8 2.6 4.0 2.5 5.2 1.1 4.1 6.2 4.7 2.9 6.9 2.3 2.8 3.3 5.2 1.6 3.1 1.9 1.7 3.8 5.4 3.2 2.0 1.9 3.7 4.3 4.5 4.2 1.9 4.7 3.8 2.1 4.7 3.0 2.0 9.0 2.2 3.0 1.5 3.2 2.5 2.2 3.7 3.6 2.5 1.1 4.4 3.9 4.4 1.5 3.5 2.4 2.4 8.6 1.5 2.5 5.1 4.7 4.3 2.1 1.2 0.7 2.2 1.4 2.2 1.7 1.2 4.2 1.8 1.0 1.1 0.5 2.1 0.3 1.5 1.6 1.6 3.7 2.5 1.4 1.4 3.0 3.8 0.9 0.9 0.6 0.1 2.6 1.9 4.8 1.1 0.0 2.2 1.0 4.8 1.2 3.8 2.2 1.1 3.8 2.9 1.2 1.5 2.9 2.8 4.2 2.6 0.8 1.5 2.6 1.6 2.4 1.3 1.4 3.2 1.5 0.7 1.1 1.9 2.1 0.2 0.4 2.5 5.6 2.8 4.1 4.1 3.4 4.4 8.1 4.7 5.6 2.8 6.0 6.5 6.6 1.7 4.5 2.9 4.2 4.8 1.3 4.0 5.2 6.2 4.7 3.8 5.4 4.3 4.5 4.7 3.7 4.4 8.6 12.0 0.0 5.3 17.9 25.5 3.2 6.7 4.5 8.0 63.2 8.5 6.1 6.5 20.0 5.9 12.9 52.1 8.2 18.5 8.2 7.9 8.9 2.8 6.5 7.9 11.2 13.2 10.3 32.9 4.5 2.4 9.3 7.7 4.6 13.3 22.1 12.5 4.3 8.6 47.1 39.5 8.3 6.1 8.5 4.6 0.8 15.5 8.8 3.6 17.8 15.6 16.9 44.3 41.2 56.2 4.9 13.0 19.5 4.9 7.0 13.9 12.4 11.3 105.3 32.9 10.4 9.1 7.9 8.3 3.0 2.6 2.5 17.3 15.2 7.7 7.2 ZFP28 "KIAA1431, mkr5" ENSG00000196867 "ZFP28 zinc finger protein" Q8NHY6 19 56538948-56556808 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028879 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 13: T-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA028879: AB_10603841" "unprognostic (5.02e-3)" "unprognostic (3.67e-3)" "unprognostic (1.78e-1)" "unprognostic (1.90e-1)" "unprognostic (1.89e-1)" "unprognostic (4.24e-3)" "unprognostic (1.73e-1)" "unprognostic (7.00e-2)" "unprognostic (4.26e-3)" "unprognostic (3.16e-2)" "unprognostic (3.32e-4)" "unprognostic (1.15e-3)" "unprognostic (2.36e-5)" "unprognostic (6.77e-3)" "unprognostic (1.53e-1)" "unprognostic (1.07e-1)" "unprognostic (1.34e-1)" 4.2 4.2 6.7 2.3 7.0 1.3 4.4 8.0 7.8 5.4 5.0 4.8 1.9 6.4 4.8 2.9 4.6 3.9 4.6 7.7 7.4 4.2 0.9 4.3 2.6 6.9 6.9 10.7 3.5 6.2 6.1 3.8 7.8 4.9 2.2 11.0 3.2 4.6 2.9 3.5 2.7 5.1 6.0 3.8 3.2 7.5 6.8 3.4 5.3 3.9 2.7 4.6 4.3 8.4 0.0 1.7 7.9 2.4 2.6 2.5 4.1 5.2 5.0 4.1 6.7 0.0 1.1 0.0 2.6 6.2 7.9 0.2 3.9 1.7 6.2 0.0 6.7 5.4 0.3 0.0 7.4 0.2 6.0 6.9 2.2 6.2 0.1 8.1 0.8 2.8 1.1 0.1 5.3 0.0 2.7 1.0 3.6 0.0 1.7 4.2 10.3 0.0 5.5 3.4 0.0 7.2 0.0 0.3 1.2 7.2 3.0 5.4 2.0 3.8 4.1 0.4 6.4 0.1 0.2 0.5 0.1 0.1 0.4 0.0 0.1 1.4 0.1 0.1 0.8 0.6 0.8 0.6 0.4 1.1 0.6 0.5 0.1 0.8 0.1 0.5 1.3 0.3 6.7 7.0 8.0 7.8 7.7 7.4 6.9 6.9 7.8 6.0 6.8 8.4 5.1 9.6 3.6 6.2 1.0 5.7 2.8 2.0 4.0 7.6 3.3 2.5 5.6 1.5 2.1 5.5 4.2 0.8 1.2 0.6 7.9 2.7 4.2 2.7 3.5 4.3 2.4 1.7 6.7 0.8 0.8 3.5 1.1 3.6 3.8 3.8 2.2 0.5 0.7 10.1 6.7 0.4 4.1 0.3 3.1 2.0 4.1 1.6 5.4 3.7 1.7 6.0 0.0 6.0 8.1 1.1 1.8 4.9 0.2 3.1 0.1 2.7 2.5 5.9 0.0 6.7 4.6 9.7 5.7 2.1 3.8 0.7 3.0 3.9 0.8 1.8 ZFP90 "KIAA1954, NK10, ZNF756" ENSG00000184939 "ZFP90 zinc finger protein" Q8TF47 16 68530090-68576072 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029017 Uncertain Supported "Vesicles,Plasma membrane,Centrosome" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Vesicles, Plasma membrane, Centrosome" "HPA029017: AB_10669653" "unprognostic (3.27e-1)" "unprognostic (1.71e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (2.47e-1)" "unprognostic (3.68e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (7.33e-2)" "unprognostic (1.35e-3)" "unprognostic (3.43e-1)" "prognostic favorable (1.78e-4)" "unprognostic (1.47e-2)" "unprognostic (2.37e-1)" "unprognostic (1.33e-1)" "unprognostic (9.60e-2)" 7.0 6.3 19.4 7.2 18.6 6.1 11.1 27.0 31.1 11.7 9.9 8.2 2.9 10.8 12.2 5.9 9.5 6.5 8.0 18.2 18.1 8.6 5.4 6.7 9.5 15.2 14.6 12.7 7.4 15.7 13.5 5.8 15.3 9.2 6.2 12.7 6.3 8.8 8.2 9.3 7.3 9.3 11.0 10.5 8.1 9.7 18.2 13.4 8.2 9.0 11.3 7.5 8.0 20.3 10.6 11.4 20.9 19.9 18.1 19.2 9.7 9.7 11.0 13.2 15.2 8.0 7.0 11.5 12.7 12.6 11.1 9.7 12.9 12.5 15.0 10.1 4.7 3.0 2.2 13.4 14.0 0.0 10.3 17.2 20.2 12.1 16.8 23.5 10.7 21.2 5.8 4.1 16.3 18.8 11.6 10.7 7.8 6.3 8.5 21.0 6.5 7.6 9.0 7.2 23.5 17.9 28.1 2.1 10.5 15.4 16.8 14.9 8.4 12.2 7.2 10.4 5.8 8.1 15.9 14.0 4.1 4.0 9.9 7.9 1.5 2.5 5.2 1.6 6.7 4.5 4.9 6.0 2.0 3.3 6.7 5.9 0.3 4.3 1.0 2.3 5.8 2.7 19.4 18.6 27.0 31.1 18.2 18.1 15.2 14.6 15.3 11.0 18.2 20.3 13.1 19.2 8.9 18.6 15.1 3.4 6.4 10.5 14.8 21.1 8.5 9.4 10.5 10.0 9.0 20.2 14.6 3.4 11.8 1.5 7.9 10.2 20.6 9.8 14.4 10.9 16.1 13.2 34.0 6.1 1.7 14.7 5.1 6.5 12.0 30.3 11.0 5.2 6.9 18.5 41.4 4.7 4.1 7.9 5.7 13.2 16.4 8.3 3.6 11.2 6.4 13.0 19.6 31.2 35.5 6.5 3.2 17.7 7.2 5.9 1.3 8.1 24.2 17.3 0.0 12.4 11.0 12.1 19.1 8.6 4.5 1.4 18.7 13.7 4.5 4.0 ZFYVE16 "KIAA0305, PPP1R69" ENSG00000039319 "Zinc finger FYVE-type containing 16" Q7Z3T8 5 80408013-80483379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 620.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 21.2;neutrophil: 21.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 80.7" "Low region specificity" "Detected in all" "HPA035935, HPA035936" Supported Enhanced Vesicles,Cytosol No No "Cluster 6: Non-specific - Transcription" "Cluster 82: Adipose tissue - ECM organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" "Vesicles, Cytosol" "HPA035935: AB_10672076, HPA035936: AB_10669662" "unprognostic (1.11e-1)" "unprognostic (3.98e-2)" "unprognostic (1.78e-2)" "unprognostic (3.26e-1)" "unprognostic (7.19e-2)" "unprognostic (2.57e-2)" "unprognostic (7.25e-3)" "unprognostic (6.91e-2)" "unprognostic (4.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.15e-1)" "unprognostic (3.04e-1)" "unprognostic (4.64e-2)" "unprognostic (4.95e-2)" "unprognostic (6.91e-2)" "unprognostic (4.23e-2)" 8.4 8.7 5.1 8.1 12.0 5.2 8.7 5.7 6.4 15.1 4.3 6.4 5.1 12.7 2.5 7.2 7.2 11.2 14.0 4.1 8.2 9.5 10.3 9.1 5.6 7.0 8.5 12.3 6.4 9.0 3.9 13.0 7.6 8.5 6.3 8.6 5.0 6.6 6.1 4.3 6.8 9.9 6.5 9.0 6.6 9.3 8.3 5.0 9.5 8.4 4.5 9.5 4.7 15.5 11.9 13.4 23.4 21.9 14.0 14.3 15.5 17.6 15.2 15.4 20.7 9.9 16.5 7.9 12.5 14.6 16.4 11.9 17.2 14.4 16.9 5.1 10.9 8.6 16.3 11.3 11.6 2.6 6.3 15.4 7.5 12.9 12.4 12.4 18.0 7.3 8.5 12.0 16.8 14.9 5.7 2.5 5.3 6.1 6.5 11.7 48.3 8.4 12.9 22.1 8.8 19.5 25.3 11.6 80.7 14.1 20.2 7.7 16.0 9.2 10.3 14.3 14.6 3.6 7.6 7.8 12.1 8.0 21.0 21.2 4.5 2.5 1.8 2.8 1.0 3.6 0.9 1.6 1.8 3.2 0.7 0.9 21.3 3.0 5.4 3.0 1.0 0.4 5.1 12.0 5.7 6.4 4.1 8.2 7.0 8.5 7.6 6.5 8.3 15.5 49.3 25.6 22.2 127.0 25.8 18.2 14.0 16.4 15.4 94.9 23.4 18.2 52.3 14.3 33.8 31.3 114.7 22.1 28.9 20.3 9.8 16.2 7.4 47.6 85.6 33.1 21.6 7.8 87.7 12.3 11.8 33.7 23.9 37.5 10.1 59.7 35.7 16.8 26.5 80.8 114.0 11.3 2.0 59.8 71.5 7.0 37.9 71.4 19.6 64.6 34.7 26.3 17.5 182.0 620.2 16.4 20.2 44.4 19.0 16.5 16.3 13.6 49.9 75.3 32.9 58.6 43.3 49.0 22.0 15.6 25.4 37.4 17.5 44.7 12.9 20.1 ZIK1 ZNF762 ENSG00000171649 "Zinc finger protein interacting with K protein 1" Q3SY52 19 57578456-57593890 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 5.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 28.8;NTERA-2: 34.3;REH: 25.6;U-266/84: 34.8" "Low region specificity" "Detected in all" HPA059975 Uncertain Approved "Intermediate filaments" NA NA "Cluster 30: Non-specific - Translation" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" "HPA059975: AB_2684184" "unprognostic (2.14e-2)" "unprognostic (9.03e-3)" "unprognostic (9.42e-2)" "unprognostic (1.83e-1)" "unprognostic (3.77e-2)" "unprognostic (1.34e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (1.02e-1)" "unprognostic (4.18e-6)" "unprognostic (6.21e-2)" "unprognostic (5.15e-1)" "unprognostic (5.21e-2)" "unprognostic (3.50e-1)" 1.9 1.9 2.0 2.6 2.5 4.6 3.2 5.6 2.1 2.9 2.1 2.1 0.6 2.4 4.3 1.3 4.9 1.9 3.1 1.9 2.3 2.2 0.7 2.5 5.9 1.5 1.7 6.0 1.1 6.7 2.6 3.3 1.4 3.2 1.4 6.9 1.7 4.0 1.8 2.1 2.2 2.7 1.7 4.6 1.6 5.2 2.6 7.1 5.6 2.4 6.4 2.0 1.1 2.3 0.1 0.0 22.5 0.1 0.9 0.9 0.0 7.9 7.4 11.3 10.2 0.1 0.2 0.0 5.6 4.0 8.9 0.6 0.0 12.6 16.0 0.0 28.8 4.6 0.1 2.5 2.6 0.1 8.5 4.6 0.0 8.7 0.0 1.0 0.8 1.8 0.2 0.0 3.7 0.0 17.8 2.4 34.3 0.0 2.8 25.6 0.1 5.6 3.2 0.0 16.4 16.5 0.1 0.0 0.7 17.4 0.1 0.3 0.1 10.2 5.2 0.0 9.3 0.2 34.8 8.8 0.1 0.0 10.1 1.8 1.6 8.1 1.8 1.9 3.5 6.8 3.5 2.2 2.6 9.4 6.5 3.2 0.3 4.1 1.7 2.8 4.4 2.6 2.0 2.5 5.6 2.1 1.9 2.3 1.5 1.7 1.4 1.7 2.6 2.3 1.4 0.0 0.0 3.3 4.5 1.0 1.4 1.8 1.2 3.7 1.7 1.4 3.0 5.7 1.9 5.5 0.0 2.0 1.1 0.0 3.9 3.0 2.9 0.3 1.5 1.8 0.0 4.2 2.3 0.2 1.0 1.7 2.0 0.3 3.8 5.4 2.9 0.3 1.9 3.3 1.9 0.1 4.1 0.8 1.8 3.4 2.1 1.2 0.0 1.0 1.0 4.8 0.0 4.0 0.7 0.2 0.1 2.2 2.6 0.7 0.0 0.5 0.9 5.0 6.6 1.5 1.9 1.0 5.6 0.7 0.9 1.2 2.3 1.7 0.1 1.1 ZMAT1 KIAA1789 ENSG00000166432 "Zinc finger matrin-type 1" Q5H9K5 X 101882288-101932079 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 190.3;Oligodendrocyte precursor cells: 111.1;Oligodendrocytes: 112.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 8.2;U-266/70: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012827 Enhanced Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA012827: AB_1859070" "unprognostic (9.30e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-5)" "unprognostic (1.20e-3)" "unprognostic (2.22e-2)" "unprognostic (3.70e-2)" "unprognostic (6.09e-2)" "prognostic favorable (1.72e-5)" "unprognostic (6.33e-3)" "unprognostic (1.72e-2)" "unprognostic (3.05e-1)" "unprognostic (5.28e-2)" "unprognostic (2.21e-1)" "unprognostic (1.38e-2)" 6.4 9.3 11.1 2.8 11.5 6.3 7.5 10.5 15.1 8.0 10.6 7.3 1.8 5.5 21.2 2.4 10.0 2.1 7.9 10.7 10.7 18.3 9.7 5.7 6.6 11.5 10.9 15.2 10.3 4.3 34.8 0.7 11.0 10.7 1.3 9.4 6.7 3.7 2.6 3.0 7.5 1.3 11.1 13.8 5.8 6.7 10.9 3.2 25.0 1.5 2.6 6.0 4.8 12.1 0.2 0.0 1.0 1.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 1.2 1.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.2 0.7 1.9 0.0 8.2 0.6 0.0 0.1 0.1 1.3 0.0 0.1 1.5 0.0 0.1 2.3 0.0 0.4 1.1 0.7 0.0 0.1 1.1 1.4 2.1 2.0 0.6 0.0 0.0 0.1 4.1 0.3 0.0 0.4 2.0 0.6 0.8 0.3 0.5 0.2 0.1 0.4 0.6 0.3 0.4 0.0 0.9 0.4 0.3 0.2 0.1 0.1 0.9 0.2 0.1 11.1 11.5 10.5 15.1 10.7 10.7 11.5 10.9 11.0 11.1 10.9 12.1 18.9 16.0 31.2 190.3 30.2 4.1 7.6 0.2 7.4 38.1 18.2 12.3 25.4 11.5 14.4 14.7 43.8 0.1 16.5 0.6 3.9 5.0 14.9 28.2 3.7 16.8 10.3 6.9 30.7 2.7 0.0 10.3 2.0 21.6 15.8 51.5 13.6 10.6 3.3 16.8 32.8 2.8 0.0 9.7 11.1 9.7 1.8 11.7 7.2 71.2 10.7 25.8 10.3 111.1 112.8 1.5 1.6 1.2 7.4 6.1 2.7 5.7 13.0 57.5 0.0 27.5 9.0 22.4 10.2 3.2 2.8 0.1 16.3 5.4 2.6 4.3 ZMYM3 "DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261" ENSG00000147130 "Zinc finger MYM-type containing 3" Q14202 X 71239624-71255146 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 38.8;Theca cells: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003211, HPA075255" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA003211: AB_1080661, HPA075255: AB_2732287" "unprognostic (2.17e-1)" "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.69e-3)" "unprognostic (2.03e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.18e-4)" "unprognostic (5.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-2)" "unprognostic (4.07e-2)" "unprognostic (1.17e-1)" "unprognostic (2.93e-1)" "unprognostic (2.73e-1)" "unprognostic (5.50e-2)" "unprognostic (4.42e-2)" "unprognostic (1.30e-3)" 10.0 29.2 19.5 8.6 18.9 7.1 10.2 10.7 18.2 17.3 9.5 15.5 7.1 15.9 18.6 9.9 19.2 9.9 9.6 17.8 20.4 13.2 13.6 11.0 12.1 12.8 14.4 37.1 10.8 11.6 18.1 7.9 14.2 15.5 7.8 13.3 11.6 17.1 10.8 11.4 12.0 14.6 13.0 15.5 12.2 20.5 25.9 16.0 15.8 5.7 10.9 13.3 13.3 13.7 15.4 27.9 66.2 35.2 18.8 18.9 16.7 14.0 20.8 29.7 27.8 31.1 22.9 39.0 34.1 25.3 26.8 14.2 57.1 21.2 22.3 13.1 30.6 33.9 25.6 27.9 8.7 31.9 20.3 22.3 12.1 21.6 13.4 52.8 25.2 30.8 39.7 20.9 22.0 25.5 38.6 40.6 65.9 19.0 24.2 47.7 20.3 28.7 22.0 18.6 31.5 21.7 23.8 14.7 13.7 47.8 21.7 20.7 19.5 14.6 26.7 21.5 12.8 18.9 12.1 32.9 17.6 42.9 16.4 6.1 5.2 4.3 4.2 4.8 4.8 7.1 4.8 3.9 4.8 6.6 4.0 4.0 0.3 4.9 4.2 10.1 4.8 4.0 19.5 18.9 10.7 18.2 17.8 20.4 12.8 14.4 14.2 13.0 25.9 13.7 5.6 12.8 11.9 14.7 6.9 3.8 2.7 12.2 6.8 12.9 9.2 10.0 10.6 7.2 15.0 31.3 10.4 8.5 4.7 3.3 1.9 6.7 1.1 12.0 8.5 7.5 4.8 7.6 15.8 8.9 7.0 7.0 6.6 9.4 2.5 38.8 8.9 15.3 9.8 13.5 17.3 9.2 6.1 11.9 6.7 4.0 13.7 6.6 3.6 6.5 11.2 9.5 7.2 7.1 12.3 5.5 8.8 23.3 4.9 1.9 4.5 15.1 12.0 7.7 6.6 5.3 9.9 1.5 4.0 9.3 3.8 4.2 5.2 40.0 7.1 2.0 ZMYM6 "Buster2, MYM, ZBED7, ZNF198L4, ZNF258" ENSG00000163867 "Zinc finger MYM-type containing 6" O95789 1 34986165-35031945 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011004, HPA071865" Approved Approved Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA011004: AB_1859075, HPA071865: AB_2686464" "prognostic favorable (1.30e-5)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" "unprognostic (3.92e-2)" "unprognostic (2.11e-6)" "unprognostic (1.77e-3)" "unprognostic (4.83e-3)" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.70e-2)" "unprognostic (9.29e-2)" "unprognostic (7.15e-2)" "unprognostic (2.28e-1)" "unprognostic (1.72e-1)" "unprognostic (4.84e-3)" 5.7 7.5 3.2 8.4 4.5 15.2 6.9 5.2 4.6 5.3 3.3 6.2 6.4 7.1 8.5 6.9 4.8 6.4 6.8 3.3 4.0 6.8 4.6 6.4 9.5 3.8 3.7 9.2 5.0 7.6 6.8 4.9 4.4 6.5 7.5 9.2 5.2 5.4 3.5 8.2 7.1 6.6 3.2 10.6 7.3 9.6 4.5 8.2 9.4 4.8 8.6 5.5 4.9 5.4 8.3 4.8 7.9 8.0 9.3 10.8 5.1 7.5 10.7 7.8 8.6 3.4 8.9 11.3 7.2 10.4 5.8 7.7 9.2 7.3 9.8 7.7 5.4 9.6 6.4 4.4 8.1 14.7 11.8 9.9 9.9 9.3 7.2 5.8 9.2 9.5 15.9 12.2 8.3 3.0 6.5 10.0 7.7 4.8 7.6 8.9 10.9 6.5 7.2 6.1 8.4 8.4 8.1 7.8 9.5 8.0 5.2 7.9 9.7 10.0 8.0 11.0 10.6 7.6 13.0 8.5 10.5 13.6 8.9 3.0 5.5 5.7 5.3 4.6 4.6 4.6 3.6 3.0 5.0 5.5 5.2 3.5 3.1 4.0 5.9 7.7 4.3 2.6 3.2 4.5 5.2 4.6 3.3 4.0 3.8 3.7 4.4 3.2 4.5 5.4 9.2 12.8 16.5 30.0 11.1 6.0 5.5 7.2 10.2 12.0 7.8 6.1 15.7 8.6 7.9 16.5 20.9 3.9 13.5 8.9 5.9 5.1 2.0 5.6 7.7 6.9 3.6 3.4 34.4 5.6 3.3 8.0 13.3 7.1 10.1 10.6 5.0 8.8 7.8 13.5 37.9 8.0 6.1 20.6 15.7 1.8 8.4 15.6 1.8 30.9 19.0 8.5 15.5 22.6 41.4 5.8 7.4 11.3 7.0 4.0 7.5 7.3 8.3 20.9 13.1 8.0 12.0 24.7 18.8 9.0 6.5 5.3 8.5 8.6 8.2 5.7 ZNF112 "ZFP112, ZNF228" ENSG00000062370 "Zinc finger protein 112" Q9UJU3 19 44326555-44367217 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 10.8;Inhibitory neurons: 9.9;Oligodendrocyte precursor cells: 10.6;Oligodendrocytes: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 17.3" "Low region specificity" "Detected in all" HPA023856 Approved Approved Centrosome NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 21: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 52: Non-specific - Transcription" Centrosome "HPA023856: AB_1859018" "unprognostic (1.99e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "unprognostic (1.04e-1)" "unprognostic (4.58e-2)" "unprognostic (1.95e-1)" "unprognostic (1.34e-2)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (2.53e-2)" "unprognostic (1.65e-3)" "prognostic favorable (1.54e-5)" "unprognostic (1.65e-1)" "unprognostic (9.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.57e-3)" 1.7 3.0 4.1 0.8 4.7 0.1 4.3 8.1 4.7 2.3 4.5 3.0 2.6 3.8 3.8 2.6 3.9 2.3 3.4 4.1 4.7 2.8 1.6 2.5 0.9 4.6 4.5 4.4 2.5 4.5 3.4 2.5 4.7 3.8 2.9 5.2 3.0 3.9 1.9 2.8 2.7 2.8 4.7 2.0 3.2 7.5 4.5 1.4 4.1 2.5 1.5 2.3 2.2 6.0 4.4 2.7 7.5 4.4 4.4 3.9 1.8 4.1 6.8 3.8 5.7 1.9 3.1 0.0 2.9 3.5 3.5 3.9 4.5 2.8 6.0 0.0 5.5 5.1 4.6 1.8 3.5 0.0 0.0 4.1 4.9 2.9 6.0 6.5 4.5 0.0 1.9 11.9 4.5 1.0 0.0 0.0 4.1 1.1 1.6 0.0 8.1 2.3 3.6 4.8 3.6 5.8 5.4 1.0 2.9 6.3 2.2 0.0 6.2 6.0 4.5 17.3 3.4 0.0 0.0 0.1 3.6 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 4.1 4.7 8.1 4.7 4.1 4.7 4.6 4.5 4.7 4.7 4.5 6.0 2.8 0.0 0.5 6.2 0.1 0.4 1.1 1.7 0.6 6.9 1.7 1.9 4.4 1.5 1.7 0.0 0.0 1.2 0.0 1.5 1.9 1.7 5.5 1.2 1.8 1.7 1.2 1.3 10.8 1.2 0.7 1.8 0.0 0.9 0.0 6.1 1.8 0.2 0.5 8.4 9.9 1.6 0.0 0.0 0.4 1.0 0.6 0.5 0.0 7.5 0.4 4.3 0.0 10.6 13.4 0.7 0.5 1.5 0.0 0.7 1.3 1.2 2.8 2.5 0.0 2.3 1.5 2.9 2.0 2.1 0.4 0.3 0.1 3.5 1.1 0.3 ZNF117 "H-plk, HPF9" ENSG00000152926 "Zinc finger protein 117" Q03924 7 64971772-65006684 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 21.0;SuSa: 21.9;THP-1: 21.9" HPA031148 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Nucleoli fibrillar center, Cytosol" "HPA031148: AB_2673759" "unprognostic (1.04e-1)" "unprognostic (3.04e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.35e-2)" "unprognostic (1.45e-2)" "unprognostic (1.24e-1)" "unprognostic (6.13e-2)" "unprognostic (2.30e-1)" "unprognostic (3.35e-1)" "unprognostic (7.10e-2)" "prognostic unfavorable (2.17e-11)" "unprognostic (1.08e-1)" "unprognostic (9.19e-2)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" 20.6 28.1 3.8 7.1 3.0 5.4 17.0 3.2 4.5 13.1 4.3 6.8 2.2 8.3 11.2 12.0 8.2 10.2 7.6 3.2 3.7 6.8 3.5 10.8 6.0 4.4 4.3 10.6 5.2 3.7 9.3 10.1 3.1 7.6 4.7 11.8 7.8 4.9 2.8 8.2 4.9 5.7 3.2 8.9 4.6 12.3 3.7 4.7 8.5 1.4 5.6 6.7 11.6 4.1 1.7 0.1 20.0 21.0 7.4 3.4 11.2 4.4 1.0 1.1 2.1 0.9 8.6 7.6 3.6 2.2 3.2 1.3 2.3 0.5 2.4 2.3 2.0 3.5 0.5 4.2 0.6 0.0 2.0 4.3 0.8 0.8 0.8 8.0 3.4 8.8 14.4 5.1 5.0 3.8 8.0 7.9 8.4 2.5 0.3 10.4 1.3 1.5 2.7 3.3 3.1 16.9 2.2 0.9 0.9 21.9 3.8 21.9 10.2 6.0 0.7 3.6 2.8 3.4 6.7 3.9 2.2 9.7 3.7 0.2 0.2 0.3 0.2 0.7 0.2 0.3 0.1 0.1 0.2 0.3 0.1 0.1 2.4 0.3 0.2 0.2 0.1 0.1 3.8 3.0 3.2 4.5 3.2 3.7 4.4 4.3 3.1 3.2 3.7 4.1 10.3 3.2 43.0 35.6 4.2 3.3 5.8 6.2 0.6 14.3 15.5 10.7 7.3 12.8 23.2 5.5 0.0 5.4 5.4 3.3 11.7 10.9 3.1 7.5 10.4 10.9 5.3 2.1 11.4 28.5 2.5 9.6 3.1 8.9 10.8 21.1 17.5 4.2 6.6 28.6 11.6 4.1 10.2 7.9 7.5 3.1 8.7 11.8 5.4 9.4 4.1 7.1 7.2 19.6 7.2 17.7 1.7 5.3 2.3 4.6 1.6 3.3 20.2 7.7 6.6 7.1 7.9 7.2 8.4 3.2 4.7 11.1 3.8 10.3 2.4 12.3 ZNF12 "GIOT-3, KOX3, ZNF325" ENSG00000164631 "Zinc finger protein 12" P17014 7 6688433-6706947 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 8.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063402 Supported Nucleoplasm,Centrosome NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Centrosome "HPA063402: AB_2685005" "unprognostic (2.68e-1)" "unprognostic (6.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.84e-1)" "unprognostic (8.32e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-3)" "unprognostic (1.41e-1)" "unprognostic (6.67e-2)" "unprognostic (2.89e-3)" "unprognostic (5.52e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" "unprognostic (2.10e-2)" "unprognostic (4.36e-2)" "unprognostic (8.46e-3)" 9.2 8.7 9.0 8.2 8.7 8.5 13.6 12.5 8.9 12.1 10.3 9.7 10.0 13.8 13.8 10.4 10.3 9.2 8.9 8.3 8.2 9.7 10.2 8.5 13.4 9.0 9.1 14.3 9.0 18.5 8.7 13.3 9.4 11.3 10.4 15.3 10.0 12.1 6.7 10.5 11.2 9.8 8.3 13.3 10.2 5.2 9.7 12.3 13.9 10.0 13.4 9.8 10.0 9.2 16.5 7.7 15.0 18.9 15.1 15.2 14.4 10.2 18.3 12.8 13.3 10.5 9.4 12.5 6.9 12.7 28.8 19.3 12.5 9.9 19.4 4.7 9.4 12.6 11.9 10.6 14.1 20.2 13.1 16.7 21.6 9.2 14.8 19.0 9.4 9.9 20.3 11.2 17.1 13.1 7.8 18.6 18.2 5.2 11.7 10.2 21.5 7.7 10.4 16.2 13.7 24.2 11.8 21.2 12.4 18.7 13.5 22.7 9.4 14.3 18.0 11.5 13.7 10.6 7.3 12.6 11.7 13.4 19.4 8.8 0.5 0.7 1.4 0.4 1.9 1.1 1.1 1.6 0.5 1.1 1.5 1.9 0.5 1.2 0.4 1.1 1.0 0.2 9.0 8.7 12.5 8.9 8.3 8.2 9.0 9.1 9.4 8.3 9.7 9.2 15.1 9.6 8.9 16.3 14.1 26.9 16.3 8.0 11.4 27.9 16.3 15.1 17.2 12.8 10.7 3.7 16.7 11.7 15.3 8.3 1.9 8.7 1.2 10.4 15.8 13.9 7.7 12.4 15.9 6.8 9.0 14.9 6.6 12.7 11.4 27.3 15.4 10.3 10.1 37.0 16.7 11.9 2.0 13.0 10.9 2.7 22.4 8.4 5.4 18.7 11.3 20.9 15.5 9.5 19.9 9.1 8.8 22.6 11.6 13.3 10.1 7.0 12.6 18.9 26.3 17.6 16.7 12.7 7.8 16.7 22.4 8.6 11.2 23.9 12.1 18.1 ZNF134 pHZ-15 ENSG00000213762 "Zinc finger protein 134" P52741 19 57614233-57624724 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA009064 Supported Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA009064: AB_1080668" "unprognostic (3.60e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.88e-1)" "unprognostic (4.29e-2)" "unprognostic (9.62e-2)" "prognostic unfavorable (5.21e-4)" "unprognostic (6.34e-2)" "unprognostic (1.35e-1)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (3.39e-2)" "unprognostic (1.17e-2)" "prognostic favorable (2.61e-4)" "unprognostic (1.56e-2)" "unprognostic (3.40e-1)" "unprognostic (2.52e-2)" "unprognostic (1.34e-1)" 4.6 5.4 4.9 4.7 5.2 12.5 7.5 8.7 5.3 5.7 4.0 6.5 3.5 5.5 6.0 5.3 6.5 4.5 6.0 4.9 5.5 5.6 4.9 5.8 7.5 3.9 4.0 7.6 3.8 12.0 5.7 7.9 3.7 7.3 4.5 10.6 5.4 8.3 6.3 7.1 4.9 6.0 3.6 7.1 6.0 6.6 5.5 11.1 8.3 7.2 8.5 6.1 4.1 4.7 2.5 6.6 15.5 8.4 6.8 9.1 7.7 6.8 11.1 9.8 4.9 2.2 2.9 5.0 4.7 8.5 7.5 2.1 7.2 12.6 16.8 0.1 33.2 15.8 7.0 6.2 9.9 10.6 11.2 12.3 12.1 7.4 16.7 12.9 6.6 8.2 2.1 5.7 14.8 3.7 21.0 4.4 21.8 1.6 13.6 12.2 22.5 7.9 7.3 21.5 12.4 14.5 11.3 4.9 7.2 17.0 6.9 8.4 8.7 14.7 6.3 3.5 9.0 15.3 21.8 6.9 7.7 1.8 9.9 2.3 4.2 7.4 6.3 3.0 8.3 9.5 6.5 6.7 4.6 8.3 7.5 7.5 3.4 11.9 3.4 3.5 4.4 5.5 4.9 5.2 8.7 5.3 4.9 5.5 3.9 4.0 3.7 3.6 5.5 4.7 6.0 9.6 4.1 1.0 14.4 5.4 12.7 4.4 8.6 8.4 9.8 8.0 11.2 11.5 5.6 3.7 12.5 8.2 11.1 1.2 7.9 7.8 1.7 6.0 7.8 8.3 1.2 13.0 1.0 3.7 4.3 6.2 1.1 7.3 6.3 10.6 9.7 4.1 5.3 8.4 0.9 4.0 6.1 5.1 3.2 1.5 7.2 4.4 3.6 0.0 7.0 11.3 9.2 1.0 1.6 3.8 2.6 14.7 5.0 9.3 2.8 4.6 5.1 11.9 6.6 6.6 8.5 2.2 15.2 6.7 7.7 16.3 8.8 8.0 3.6 13.8 ZNF135 "pHZ-17, ZNF61, ZNF78L1" ENSG00000176293 "Zinc finger protein 135" P52742 19 58059239-58086310 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 21.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 5.5;HSkMC: 5.5;MOLT-4: 6.3;NTERA-2: 5.5;T-47d: 7.0" "Low region specificity" "Detected in all" HPA006961 Approved Approved Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA006961: AB_1080670" "unprognostic (4.87e-2)" "unprognostic (7.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.96e-1)" "unprognostic (1.01e-1)" "unprognostic (6.54e-2)" "unprognostic (1.70e-1)" "unprognostic (5.85e-2)" "unprognostic (9.18e-3)" "unprognostic (1.20e-2)" "unprognostic (1.01e-3)" "unprognostic (2.34e-1)" "prognostic favorable (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (1.93e-1)" "unprognostic (1.64e-1)" "unprognostic (1.25e-1)" 3.6 2.5 5.2 2.1 5.1 1.3 6.2 3.8 5.0 6.5 4.3 4.6 1.3 8.7 7.9 2.7 6.2 4.2 3.5 4.4 5.2 6.2 0.8 2.7 2.2 4.7 4.3 11.4 2.3 10.6 8.3 3.9 4.5 6.0 2.0 10.0 2.3 5.2 2.0 4.6 2.1 6.8 3.0 3.9 2.6 6.5 4.9 7.1 8.0 1.8 2.3 4.8 3.8 7.8 0.0 0.0 1.4 0.0 0.1 0.0 0.0 3.3 0.0 4.3 0.2 0.0 0.2 0.0 3.6 4.7 2.6 0.2 0.0 0.0 4.7 0.0 5.1 0.0 0.0 0.0 1.9 0.0 5.5 5.5 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 6.3 0.0 5.5 0.0 0.0 0.0 0.0 0.0 2.2 3.8 5.2 0.1 0.0 0.0 0.0 4.8 7.0 0.0 0.0 0.0 2.9 0.0 0.0 0.2 2.3 0.0 0.0 0.0 2.6 0.0 0.0 1.9 0.0 0.1 0.0 0.4 0.1 0.1 0.8 1.7 1.7 1.0 0.0 2.6 0.0 2.0 0.1 0.4 5.2 5.1 3.8 5.0 4.4 5.2 4.7 4.3 4.5 3.0 4.9 7.8 2.7 0.0 1.1 5.5 3.2 2.3 2.5 0.8 2.8 11.9 7.9 7.6 5.3 11.5 1.2 9.2 16.7 0.9 0.8 0.1 21.5 6.4 13.3 7.8 5.6 3.3 2.4 1.7 8.1 0.7 0.2 4.1 0.0 3.6 5.1 12.3 4.2 0.3 0.6 15.2 9.3 1.2 2.0 0.3 0.3 11.5 7.8 0.5 1.8 1.9 0.3 8.0 1.0 6.0 13.7 0.6 0.3 6.8 0.0 2.1 0.2 2.5 4.2 14.0 0.0 3.3 5.3 12.7 11.5 1.0 3.1 0.7 1.0 4.6 0.9 1.6 ZNF154 pHZ-92 ENSG00000179909 "Zinc finger protein 154" Q13106 19 57697367-57709194 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 11.8;granulocytes: 10.8;Oligodendrocyte precursor cells: 10.6;Rod photoreceptor cells: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 5.2;HSkMC: 2.9;MOLT-4: 4.4;NTERA-2: 2.9;SuSa: 6.1" "Low region specificity" "Detected in all" HPA076284 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli fibrillar center" "HPA076284: " "unprognostic (3.32e-2)" "unprognostic (3.43e-1)" "unprognostic (1.26e-2)" "unprognostic (1.33e-1)" "unprognostic (5.81e-2)" "unprognostic (5.17e-3)" "unprognostic (2.25e-1)" "unprognostic (1.41e-2)" "unprognostic (1.27e-3)" "unprognostic (1.57e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.20e-3)" "unprognostic (9.39e-2)" "unprognostic (3.35e-1)" "unprognostic (8.38e-3)" "unprognostic (1.11e-1)" 1.3 2.8 2.4 3.2 2.8 1.2 2.1 6.4 2.8 1.4 4.9 3.6 1.1 0.8 1.5 2.1 0.9 2.0 2.9 2.6 2.8 2.2 0.7 1.6 4.9 1.6 2.2 1.4 1.4 3.6 5.1 3.1 1.2 2.2 1.3 4.6 2.4 3.5 1.6 0.8 2.5 1.4 0.9 4.6 1.2 0.9 3.1 6.1 5.8 1.5 4.4 2.4 0.8 1.5 0.1 0.2 5.2 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.1 0.2 0.3 0.1 1.3 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.2 0.8 0.1 1.8 0.3 0.4 2.9 0.0 0.3 0.0 1.8 0.1 0.2 0.2 0.3 1.2 0.1 4.4 0.2 2.9 0.1 0.1 0.2 0.1 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.0 6.1 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.3 0.1 0.2 0.0 0.2 0.0 0.8 0.1 2.0 0.2 0.0 0.6 0.4 0.2 0.4 0.1 1.0 0.3 0.3 0.6 0.5 0.0 0.5 0.0 0.2 2.4 2.8 6.4 2.8 2.6 2.8 1.6 2.2 1.2 0.9 3.1 1.5 2.0 0.0 1.9 11.8 7.5 0.4 1.5 0.5 0.6 8.1 1.9 2.2 4.2 1.5 1.0 1.8 8.4 0.2 5.5 0.1 0.0 2.5 0.0 0.5 1.4 2.7 0.0 0.4 7.3 0.2 0.2 1.2 2.0 0.8 10.8 2.2 3.6 0.2 1.6 8.4 7.2 0.0 2.0 0.6 1.7 0.2 0.3 1.2 0.0 1.9 0.7 3.4 4.1 10.6 1.4 0.1 0.0 1.5 2.5 1.3 0.0 0.2 1.3 10.3 0.0 1.5 3.6 0.6 1.1 0.5 0.4 0.3 2.6 0.3 0.0 2.0 ZNF16 KOX9 ENSG00000170631 "Zinc finger protein 16" P17020 8 144930358-144950888 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035782, HPA061835" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 15: NK-cells - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA035782: AB_10603243, HPA061835: AB_2684621" "unprognostic (4.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.87e-2)" "unprognostic (2.45e-1)" "unprognostic (2.69e-1)" "prognostic favorable (2.39e-4)" "unprognostic (7.53e-3)" "unprognostic (1.10e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.70e-2)" "unprognostic (2.96e-1)" "unprognostic (9.75e-2)" "unprognostic (4.17e-3)" 4.6 3.6 4.6 2.4 4.7 2.6 6.3 4.4 5.0 6.0 5.9 6.5 4.7 6.2 6.9 5.9 7.1 5.7 4.4 4.5 4.4 5.3 3.9 3.7 3.2 4.2 4.2 11.0 7.5 8.6 4.0 3.9 4.3 5.4 4.7 5.1 4.6 5.6 8.3 9.3 4.8 5.5 4.5 3.4 5.0 7.5 4.8 4.4 7.0 8.3 3.9 5.7 6.0 4.6 4.5 3.9 7.7 4.2 6.4 9.0 5.5 4.0 8.9 8.0 7.2 3.1 4.5 7.1 5.2 5.2 4.3 3.5 5.4 8.9 7.2 3.1 4.5 8.2 4.4 4.5 10.7 3.0 4.6 10.9 8.8 5.1 13.2 7.9 4.4 5.3 5.7 4.7 6.4 6.2 6.1 3.0 4.7 6.9 8.8 7.5 4.5 4.5 6.8 6.7 6.4 4.7 8.5 5.1 6.9 5.8 9.5 5.6 4.7 3.6 7.5 4.3 4.5 3.4 3.1 6.4 4.1 4.0 5.8 2.6 3.0 2.2 4.9 2.9 5.6 2.8 3.8 4.5 4.8 4.4 3.8 3.5 0.4 9.2 3.0 2.5 5.8 3.2 4.6 4.7 4.4 5.0 4.5 4.4 4.2 4.2 4.3 4.5 4.8 4.6 3.6 3.2 4.4 4.9 3.4 2.7 6.9 6.8 5.2 11.4 4.3 2.9 3.7 5.7 3.1 9.2 12.5 5.9 7.0 3.2 1.9 7.3 10.3 2.0 3.5 3.7 4.2 3.0 6.8 4.4 3.6 3.8 5.1 3.9 7.0 9.4 5.0 4.5 3.6 6.7 6.3 5.6 6.1 3.5 2.4 3.7 6.2 2.1 1.8 6.5 5.4 6.2 7.2 6.6 7.2 3.6 4.9 6.4 3.2 4.2 10.6 4.8 3.4 25.1 0.0 3.4 4.0 13.6 18.1 4.5 4.5 5.5 5.1 6.6 5.4 5.5 ZNF160 "F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18" ENSG00000170949 "Zinc finger protein 160" Q9HCG1 19 53066606-53103436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 67.7;Theca cells: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 48.6" HPA023599 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 1: Thyroid gland - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA023599: AB_2218442" "unprognostic (1.18e-2)" "unprognostic (4.75e-2)" "unprognostic (1.16e-2)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (8.31e-3)" "unprognostic (2.65e-5)" "unprognostic (5.20e-2)" "unprognostic (4.11e-3)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (6.03e-3)" "unprognostic (2.71e-3)" "unprognostic (2.87e-1)" "unprognostic (4.63e-1)" "unprognostic (1.71e-1)" "prognostic favorable (2.67e-5)" 19.3 29.0 7.3 7.8 10.2 7.4 17.6 12.2 11.6 19.6 4.9 17.4 8.0 18.9 13.7 11.0 17.9 13.9 15.9 6.9 11.9 22.5 13.8 15.0 11.6 9.0 9.5 20.8 12.7 18.1 10.2 13.7 10.3 15.3 10.7 14.2 14.2 13.5 8.4 12.4 12.5 14.1 6.7 33.3 13.7 14.9 9.6 13.5 29.3 9.0 10.4 17.2 15.5 17.1 9.8 8.6 11.6 17.8 19.1 13.4 19.7 10.4 13.9 8.3 13.2 7.4 6.0 11.1 8.8 9.7 11.0 7.0 11.1 10.7 16.4 8.3 13.4 17.2 6.6 4.2 10.5 0.0 11.3 16.7 10.8 8.9 12.5 20.9 9.0 12.9 8.8 0.0 15.8 6.7 14.5 10.6 10.9 2.6 13.7 9.1 12.2 8.6 13.0 48.6 9.8 12.8 0.0 8.2 1.6 37.0 8.8 10.0 17.3 23.0 8.2 6.9 7.7 6.1 27.4 15.9 4.0 4.2 11.1 10.9 3.1 11.4 6.7 4.2 10.0 8.6 6.9 9.2 4.4 9.9 10.4 8.3 6.6 17.6 6.6 4.2 7.9 5.5 7.3 10.2 12.2 11.6 6.9 11.9 9.0 9.5 10.3 6.7 9.6 17.1 46.5 22.4 30.5 23.8 18.5 4.0 10.0 14.7 9.6 23.2 9.4 9.5 20.6 15.7 14.1 9.2 29.2 8.3 16.8 8.0 5.9 8.2 31.0 12.4 21.6 29.8 8.4 9.9 17.1 6.8 9.5 15.4 20.4 16.0 18.3 67.7 34.2 5.0 6.4 47.1 18.8 8.3 8.2 11.3 6.4 10.2 10.8 13.0 1.8 15.9 7.1 13.8 19.6 21.6 29.4 8.1 6.3 14.3 12.7 12.6 11.1 5.9 12.7 19.1 13.1 13.9 18.4 8.3 8.3 8.1 4.0 10.4 18.5 66.0 5.7 13.0 ZNF169 MGC51961 ENSG00000175787 "Zinc finger protein 169" Q14929 9 94259298-94301829 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 18.4;Inhibitory neurons: 16.7;NK-cells: 15.5;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041769, HPA061185" Uncertain Approved "Nucleoplasm,Nuclear speckles,Vesicles,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "Vesicles, Cytosol" "HPA041769: AB_2677662, HPA061185: " "unprognostic (1.07e-1)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (3.27e-2)" "unprognostic (9.08e-3)" "unprognostic (1.18e-3)" "unprognostic (7.33e-2)" "unprognostic (2.27e-1)" "unprognostic (7.45e-2)" "unprognostic (6.79e-2)" "unprognostic (1.69e-2)" "unprognostic (1.49e-4)" "unprognostic (6.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (2.15e-4)" 3.0 2.7 3.8 4.4 4.4 3.2 3.9 4.3 4.8 5.4 3.4 4.3 2.9 3.9 4.2 2.6 4.8 1.7 2.6 3.8 2.4 3.7 2.1 3.2 6.0 3.7 2.6 5.4 3.3 2.3 2.7 2.1 3.8 4.2 5.5 4.2 3.9 2.6 4.6 5.2 5.7 2.8 1.8 6.1 4.1 2.6 3.5 3.8 4.8 1.8 5.1 4.0 4.1 5.7 3.0 2.6 2.8 4.9 1.5 3.4 3.1 1.1 2.0 2.2 2.3 1.8 4.3 7.3 1.4 1.7 2.2 5.8 5.7 2.7 2.9 4.0 6.3 5.1 6.5 3.3 1.8 7.8 5.0 3.0 2.9 1.8 2.8 2.8 2.7 6.8 4.6 2.1 2.8 2.9 3.7 4.4 4.6 6.2 3.2 3.1 2.0 2.3 1.9 2.5 2.9 3.5 1.9 3.5 1.4 2.7 2.2 3.2 3.1 2.0 2.6 2.6 2.2 3.9 1.5 1.4 1.9 5.2 1.9 2.2 3.0 3.2 2.4 3.4 3.1 3.0 2.9 1.7 2.1 4.0 3.0 4.1 2.5 3.3 2.6 2.0 3.1 1.7 3.8 4.4 4.3 4.8 3.8 2.4 3.7 2.6 3.8 1.8 3.5 5.7 2.0 3.2 0.5 10.4 8.0 0.3 2.2 1.3 1.2 4.8 1.0 1.3 1.2 1.5 2.6 1.8 4.2 0.5 3.9 2.5 0.0 1.1 1.0 0.6 1.4 2.3 1.2 3.8 18.4 0.9 0.8 1.8 2.6 0.5 0.0 6.3 2.5 0.8 0.7 5.0 16.7 4.1 0.0 4.4 1.6 1.0 5.9 4.1 0.0 7.5 7.8 2.3 15.5 14.1 19.9 1.2 3.1 3.4 2.6 2.6 4.3 1.0 2.4 4.5 0.0 2.9 1.7 5.2 3.6 0.7 0.4 0.4 4.7 3.7 2.1 2.4 ZNF180 HHZ168 ENSG00000167384 "Zinc finger protein 180" Q9UJW8 19 44474428-44500524 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028979, HPA028980" Uncertain Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA028979: AB_10600328, HPA028980: AB_10611524" "unprognostic (2.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.34e-3)" "unprognostic (1.37e-2)" "unprognostic (1.82e-1)" "unprognostic (7.13e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-2)" "unprognostic (4.09e-3)" "unprognostic (1.33e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-2)" "unprognostic (6.49e-2)" "unprognostic (2.21e-1)" "unprognostic (2.02e-2)" "unprognostic (3.38e-3)" 2.8 2.8 1.7 2.4 1.8 2.7 4.5 2.3 2.2 3.2 2.4 2.9 2.4 3.5 2.6 2.7 4.1 1.6 2.4 1.8 1.8 2.9 3.3 3.0 3.2 1.8 2.0 4.7 3.3 8.1 2.4 2.7 1.9 5.2 3.4 4.7 2.4 3.0 2.6 3.0 3.0 3.2 1.8 3.2 3.1 2.8 1.8 3.9 4.5 2.2 4.0 2.7 2.8 2.2 7.0 2.0 9.1 6.5 2.1 3.9 5.5 4.0 4.3 6.3 7.4 3.6 0.9 0.6 3.1 5.5 4.5 2.2 5.5 8.0 7.8 8.0 3.3 7.7 1.6 2.7 2.0 11.7 4.8 3.8 3.3 3.8 4.8 5.8 4.4 3.4 3.7 5.6 4.4 1.3 6.2 4.1 6.0 6.5 4.4 3.7 4.9 5.2 6.1 11.4 7.5 6.4 7.1 6.8 3.3 5.8 3.6 9.8 3.5 10.8 4.3 1.4 5.7 1.5 5.7 3.2 2.4 5.0 5.6 2.1 1.1 2.3 1.1 0.6 1.6 1.8 1.7 2.0 1.7 1.7 1.9 1.8 0.3 1.7 1.2 0.4 4.6 1.3 1.7 1.8 2.3 2.2 1.8 1.8 1.8 2.0 1.9 1.8 1.8 2.2 3.4 6.4 1.5 4.2 4.3 2.5 2.2 2.4 4.0 6.7 3.2 2.4 4.5 2.8 4.1 1.8 4.2 5.5 4.2 3.5 7.9 4.2 5.8 3.0 4.7 2.8 4.2 8.2 5.7 4.2 4.0 3.5 4.1 2.9 1.3 5.7 5.3 3.7 3.4 1.7 5.8 4.9 6.1 4.6 1.1 1.3 2.8 2.6 5.4 8.4 5.4 6.0 7.2 6.6 9.0 3.9 5.7 4.5 1.7 2.2 4.3 3.5 4.3 4.4 6.6 4.3 3.5 2.7 4.6 2.5 1.3 3.1 4.0 3.5 4.0 1.7 ZNF195 ENSG00000005801 "Zinc finger protein 195" O14628 11 3339261-3379222 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA030605 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA030605: AB_10602686" "unprognostic (2.30e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (5.40e-2)" "unprognostic (4.02e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (3.10e-2)" "unprognostic (1.39e-2)" "unprognostic (5.94e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (4.24e-4)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.79e-7)" 9.3 10.1 12.1 6.6 12.0 10.8 13.7 13.1 16.0 12.3 11.8 11.1 9.4 8.5 15.6 9.1 8.5 7.1 7.7 12.1 13.7 13.0 13.1 8.7 11.3 13.9 12.5 6.8 13.1 6.2 10.2 6.4 13.7 13.7 12.1 14.1 10.3 6.2 11.8 8.3 12.4 7.5 11.9 16.5 10.3 4.9 12.8 17.1 10.2 9.5 11.0 10.3 9.2 13.4 15.8 18.6 32.0 38.2 9.9 11.8 37.7 16.7 14.1 16.4 22.6 19.4 24.3 26.7 11.1 10.8 24.2 21.1 34.5 20.0 24.6 14.2 28.4 18.3 15.6 19.1 12.5 32.3 28.7 14.7 17.9 13.4 21.7 12.1 21.7 35.0 32.8 17.3 17.9 12.7 37.6 25.1 66.4 18.4 19.1 35.8 20.4 14.2 27.4 38.3 47.8 49.5 18.5 21.2 15.9 27.8 10.7 29.0 17.2 9.1 14.2 11.6 14.0 14.9 25.5 43.8 7.7 23.6 13.8 2.4 11.6 14.7 15.4 13.0 20.0 18.8 19.0 19.5 17.3 17.8 17.9 20.3 1.8 18.7 11.6 14.5 28.4 11.3 12.1 12.0 13.1 16.0 12.1 13.7 13.9 12.5 13.7 11.9 12.8 13.4 13.8 16.0 21.9 15.0 16.6 12.1 16.9 18.6 14.2 15.3 9.7 12.8 18.3 11.5 20.8 7.3 10.4 9.7 17.3 9.0 9.8 25.1 3.3 10.3 18.7 12.7 20.4 12.0 19.8 18.9 10.5 12.0 23.4 13.3 6.3 33.9 8.2 7.5 10.9 18.5 24.3 14.0 14.2 12.3 8.4 0.8 5.9 8.8 7.2 6.5 9.8 17.9 15.5 20.1 27.9 25.3 13.5 5.7 16.9 13.6 10.0 12.5 15.6 13.7 0.0 12.6 12.3 12.3 9.6 12.4 6.8 4.0 15.9 15.2 15.8 17.5 ZNF197 "D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41" ENSG00000186448 "Zinc finger protein 197" O14709 3 44584888-44648471 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054567 Uncertain Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA054567: AB_2682527" "unprognostic (1.06e-1)" "unprognostic (6.35e-2)" "unprognostic (6.10e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (7.49e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.49e-2)" "unprognostic (3.14e-1)" "unprognostic (7.83e-2)" "unprognostic (1.23e-1)" "unprognostic (2.85e-2)" 6.2 5.8 2.8 1.9 3.0 1.1 5.7 4.6 3.0 6.3 2.1 7.2 2.1 6.3 2.7 4.5 6.1 2.2 5.4 2.8 3.3 5.6 6.3 4.6 2.4 3.1 3.0 7.4 5.9 3.3 7.4 2.7 2.9 6.0 2.4 5.7 5.2 2.9 11.6 4.8 5.0 2.7 2.7 4.8 5.2 5.7 3.1 3.2 7.6 4.2 2.3 6.9 5.6 3.5 2.6 1.2 10.4 3.4 5.5 6.4 0.4 5.0 6.5 4.3 4.6 2.1 2.3 2.1 3.1 4.0 2.6 1.7 4.8 4.0 4.4 0.4 1.2 9.0 4.0 1.7 5.7 6.8 2.4 6.7 5.2 4.9 7.3 5.6 3.2 2.8 6.1 3.7 6.3 0.6 3.9 4.9 7.2 2.8 3.4 1.5 7.3 2.9 3.9 2.6 4.2 7.3 4.5 2.3 6.0 5.5 6.2 6.8 3.1 4.5 3.6 7.0 4.2 4.9 5.6 1.4 3.5 2.3 4.5 0.4 0.7 0.5 0.7 0.3 0.6 0.5 0.6 0.6 1.0 1.7 0.7 0.4 0.3 1.3 4.7 1.7 0.8 0.3 2.8 3.0 4.6 3.0 2.8 3.3 3.1 3.0 2.9 2.7 3.1 3.5 7.3 16.0 8.7 13.1 3.8 2.5 4.6 4.1 5.7 12.4 4.5 3.9 12.3 1.5 9.7 0.0 8.4 1.1 5.7 7.2 1.9 7.4 16.7 4.6 8.0 5.4 6.1 3.0 13.5 8.9 0.7 6.2 3.6 4.5 3.8 10.9 6.8 7.6 4.6 16.8 17.1 6.5 2.0 5.1 3.4 4.5 5.6 5.1 5.4 12.2 8.5 13.2 7.2 14.6 20.1 6.8 5.2 5.3 5.4 5.0 6.4 4.5 4.6 8.5 6.6 6.6 6.4 11.2 5.7 3.3 3.4 0.4 4.6 13.5 5.1 3.6 ZNF2 "A1-5, Zfp661, ZNF661" ENSG00000275111 "Zinc finger protein 2" Q9BSG1 2 95165432-95184317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041358 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" Nucleoplasm "HPA041358: AB_10795539" "unprognostic (1.18e-1)" "unprognostic (6.41e-3)" "unprognostic (5.81e-2)" "unprognostic (9.29e-2)" "unprognostic (4.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.13e-3)" "prognostic favorable (4.69e-5)" "unprognostic (1.47e-2)" "unprognostic (1.78e-1)" "unprognostic (2.37e-2)" "unprognostic (2.63e-2)" "unprognostic (2.66e-3)" "unprognostic (2.57e-2)" "unprognostic (6.78e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" 2.1 2.6 2.3 2.3 2.5 0.7 2.5 2.7 2.9 3.2 2.0 2.4 2.1 2.4 3.2 2.3 2.9 1.5 3.1 2.2 2.2 2.7 1.9 2.4 3.1 2.3 2.3 3.9 2.1 3.8 1.9 2.2 2.4 2.6 1.7 3.0 2.3 3.2 3.4 2.9 1.8 2.6 2.1 2.9 2.5 3.0 2.3 3.2 3.1 3.6 3.2 2.3 1.8 3.0 4.1 3.7 4.5 7.6 6.2 5.1 2.8 4.0 5.7 6.1 7.7 3.9 2.5 2.2 3.0 4.1 4.3 3.0 5.1 3.2 6.1 5.8 4.0 5.8 2.9 4.9 5.1 2.8 3.4 4.4 4.3 5.5 7.8 6.3 5.1 4.6 3.9 1.9 5.9 3.1 4.2 4.1 1.8 3.3 4.9 4.1 7.4 3.3 3.4 2.3 4.0 5.2 4.1 5.7 4.9 3.8 3.6 4.4 4.0 7.0 4.2 5.4 3.6 3.4 3.3 3.0 4.4 3.7 5.2 5.6 3.4 12.9 6.3 4.8 4.4 5.4 4.9 5.5 4.0 5.1 6.3 6.2 2.6 3.5 4.0 3.1 6.2 4.0 2.3 2.5 2.7 2.9 2.2 2.2 2.3 2.3 2.4 2.1 2.3 3.0 2.1 0.0 1.7 3.3 2.0 1.0 0.7 1.1 1.8 3.3 2.3 1.5 2.6 5.7 2.1 1.8 0.0 1.8 2.9 0.8 5.9 1.8 2.7 1.3 2.0 1.9 0.0 1.3 7.7 2.0 1.4 2.1 1.5 1.2 1.3 4.7 2.5 1.6 2.5 1.7 6.2 0.7 0.0 2.5 1.2 0.8 2.1 2.2 0.0 3.7 0.5 4.2 4.1 7.1 5.7 0.9 0.5 3.0 1.4 0.9 1.5 2.8 2.5 2.7 6.6 1.6 2.0 5.5 7.5 0.9 1.1 1.6 1.6 2.8 1.1 0.7 ZNF207 BuGZ ENSG00000010244 "Zinc finger protein 207" O43670 17 32350132-32381885 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017013, HPA063908" Enhanced Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA017013: AB_1859124, HPA063908: AB_2685149" "unprognostic (8.40e-3)" "unprognostic (1.84e-1)" "prognostic favorable (2.81e-4)" "unprognostic (7.57e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.30e-8)" "unprognostic (2.68e-1)" "unprognostic (4.75e-3)" "unprognostic (8.53e-2)" "unprognostic (5.18e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.17e-8)" "unprognostic (1.28e-2)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" 71.8 65.5 36.8 74.0 40.2 239.5 67.8 50.3 45.3 72.0 44.4 68.7 55.1 70.6 72.0 111.1 62.3 58.5 60.5 38.6 37.7 63.2 63.4 72.3 101.0 39.3 37.2 71.7 55.3 72.0 61.3 78.7 40.7 57.2 81.3 61.9 71.6 56.4 84.5 76.3 63.6 77.8 40.7 69.3 63.6 66.3 39.4 103.8 63.0 62.1 128.6 93.2 78.2 48.0 169.9 203.5 215.8 122.4 113.0 121.3 172.6 165.5 231.9 230.1 205.3 195.2 157.3 231.5 124.8 204.6 178.5 170.6 282.1 200.6 258.1 120.0 188.9 237.9 183.8 202.9 118.2 305.0 209.4 141.3 118.3 162.0 89.6 129.4 215.9 115.5 245.9 173.2 223.9 154.6 245.2 142.5 187.1 160.8 114.8 217.5 193.5 217.0 191.5 324.9 150.6 167.7 155.8 113.2 148.1 183.9 204.8 178.7 154.1 129.4 153.4 132.5 227.8 146.7 235.6 369.5 110.6 141.9 204.9 110.5 75.7 78.1 67.6 84.8 70.2 59.7 61.7 62.7 99.8 44.7 50.8 59.1 38.6 83.9 92.5 47.1 86.9 90.6 36.8 40.2 50.3 45.3 38.6 37.7 39.3 37.2 40.7 40.7 39.4 48.0 119.3 80.1 114.7 135.8 131.1 149.4 195.5 120.8 149.1 134.2 108.8 64.1 32.9 65.8 146.1 64.4 225.2 123.3 191.1 118.2 54.8 94.9 62.0 101.9 116.9 110.1 115.9 125.1 171.2 105.7 175.5 101.3 124.9 144.2 75.3 152.8 85.3 58.4 98.7 101.0 163.0 95.2 93.6 98.8 130.2 26.1 107.2 133.1 55.2 123.7 175.8 55.0 168.9 215.7 257.4 146.5 91.2 97.8 144.9 160.3 101.7 57.7 115.0 141.0 124.9 146.3 145.6 136.3 113.5 175.9 148.5 178.7 143.8 90.0 109.9 250.3 ZNF221 ENSG00000159905 "Zinc finger protein 221" Q9UK13 19 43951223-43967709 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA059435 Uncertain Approved "Nuclear bodies" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "HPA059435: AB_2684016" "unprognostic (2.06e-1)" "unprognostic (8.35e-2)" "unprognostic (2.65e-2)" "unprognostic (1.63e-1)" "unprognostic (3.17e-3)" "unprognostic (2.11e-1)" "unprognostic (1.81e-2)" "unprognostic (3.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.17e-2)" "unprognostic (5.02e-2)" "unprognostic (1.91e-1)" "unprognostic (1.84e-2)" "unprognostic (3.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" 0.9 1.2 1.3 0.6 1.5 0.6 1.2 4.8 1.5 1.0 1.0 0.7 0.5 1.1 0.8 0.8 1.3 0.6 1.2 1.1 1.5 1.1 1.1 1.0 0.7 1.1 1.3 1.9 0.7 2.3 0.9 1.3 1.7 1.5 0.8 3.0 0.7 1.1 0.4 1.2 0.8 1.3 0.8 1.0 0.8 1.1 1.5 1.2 1.8 0.7 0.7 1.0 0.7 3.5 1.4 1.2 3.6 2.8 1.2 2.4 1.0 1.5 2.3 1.3 2.0 1.6 0.5 0.0 0.8 1.5 0.9 0.6 1.4 1.0 2.3 0.0 2.9 3.8 5.1 0.6 1.2 0.4 1.6 3.5 0.9 2.2 0.8 2.7 2.4 0.0 0.2 0.0 1.7 0.1 0.0 0.6 3.3 0.5 1.2 0.1 4.0 0.4 0.8 4.6 2.9 2.5 3.0 0.2 0.3 2.1 1.0 3.5 4.1 1.6 3.6 0.8 1.2 1.9 2.6 0.0 0.5 1.5 1.9 0.3 0.1 0.2 0.2 0.2 0.2 0.1 0.3 0.3 0.3 0.2 0.2 0.1 0.3 0.6 0.1 0.3 0.1 0.1 1.3 1.5 4.8 1.5 1.1 1.5 1.1 1.3 1.7 0.8 1.5 3.5 1.4 0.0 2.0 1.0 0.2 0.0 0.1 1.1 0.6 2.8 0.5 0.3 0.7 0.0 0.4 0.0 2.1 0.3 0.2 0.1 0.0 0.4 0.3 0.8 1.8 0.8 0.0 1.3 2.7 0.4 0.2 1.4 1.5 0.8 1.3 1.3 0.7 0.1 0.3 0.0 2.1 0.0 0.0 0.0 0.3 0.5 1.2 0.2 1.8 0.0 0.0 1.3 1.0 2.5 2.6 0.5 0.0 0.4 0.4 0.1 0.0 0.4 0.3 2.3 0.0 0.9 1.1 0.9 0.7 0.7 0.1 0.3 0.4 1.3 0.1 0.4 ZNF224 "BMZF-2, KOX22, ZNF255, ZNF27" ENSG00000267680 "Zinc finger protein 224" Q9NZL3 19 44094339-44109886 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054045 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear membrane" Nucleoplasm "HPA054045: AB_2682354" "unprognostic (1.01e-3)" "unprognostic (4.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.40e-3)" "unprognostic (8.47e-2)" "unprognostic (4.25e-4)" "unprognostic (9.61e-2)" "unprognostic (6.35e-3)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.81e-3)" "unprognostic (2.64e-2)" "prognostic unfavorable (5.32e-4)" "unprognostic (1.68e-1)" "unprognostic (1.67e-1)" "unprognostic (1.16e-1)" "prognostic favorable (1.53e-7)" 15.5 15.4 12.5 17.6 14.2 9.6 17.0 15.9 13.9 16.2 16.0 15.0 18.1 17.8 23.1 9.4 16.1 13.8 12.5 12.3 13.3 14.3 15.8 16.3 22.4 13.1 13.2 20.6 14.7 14.1 19.5 14.8 13.7 17.1 21.2 17.8 15.6 15.7 7.5 24.6 22.2 13.3 12.6 27.2 16.0 6.4 13.4 18.3 19.8 5.9 22.6 12.7 13.0 16.7 8.5 13.9 14.7 12.1 14.4 15.0 12.0 10.5 15.6 7.1 16.2 7.0 6.6 10.2 11.3 13.9 5.4 9.5 8.1 9.0 9.4 10.5 16.4 19.7 26.5 7.3 7.6 14.3 22.0 18.6 16.0 8.8 13.1 22.6 13.1 10.1 6.1 12.0 12.0 2.2 12.6 17.2 6.4 4.7 9.5 7.4 15.9 6.3 10.8 26.9 7.5 17.1 14.4 6.2 5.0 14.4 6.1 18.5 13.8 15.7 10.1 7.1 7.4 16.2 16.3 5.8 8.4 11.0 7.4 49.6 9.1 22.0 18.4 6.3 20.3 16.9 15.5 18.7 9.7 17.8 19.5 15.1 6.9 16.7 13.7 8.7 19.5 10.4 12.5 14.2 15.9 13.9 12.3 13.3 13.1 13.2 13.7 12.6 13.4 16.7 16.0 22.4 14.6 16.3 26.2 5.6 7.3 14.7 10.8 26.8 9.1 5.7 4.7 18.6 11.3 25.8 18.8 13.1 30.4 14.5 1.9 8.1 14.5 7.9 9.9 12.2 9.6 12.0 26.2 5.3 8.1 12.4 8.6 8.2 21.0 20.5 16.1 7.6 7.3 26.9 23.4 11.2 20.3 13.9 8.9 4.4 16.1 10.4 5.4 14.0 19.8 11.8 47.4 14.1 29.0 8.6 13.3 13.9 12.1 10.4 29.8 3.3 7.4 22.1 13.1 10.9 9.3 5.4 4.1 6.8 6.8 8.2 27.3 19.9 11.0 9.3 ZNF229 ENSG00000278318 "Zinc finger protein 229" Q9UJW7 19 44417519-44448578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.9" HPA001494 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Vesicles "Plasma membrane" "HPA001494: AB_1080692" "unprognostic (2.59e-1)" "unprognostic (7.41e-4)" "unprognostic (2.13e-1)" "unprognostic (1.08e-1)" "unprognostic (3.90e-1)" "unprognostic (2.17e-1)" "unprognostic (3.34e-2)" "unprognostic (7.18e-3)" "unprognostic (1.17e-2)" "unprognostic (4.66e-2)" "unprognostic (4.18e-2)" "unprognostic (5.04e-3)" "prognostic favorable (8.43e-5)" "unprognostic (3.66e-3)" "unprognostic (2.01e-2)" "unprognostic (2.18e-1)" "unprognostic (4.34e-1)" 0.5 1.7 1.3 0.1 1.4 0.1 1.0 1.3 1.6 1.0 1.7 0.9 0.7 1.1 1.1 0.7 1.9 0.5 1.4 1.4 1.4 0.8 0.7 0.6 0.3 1.3 1.3 2.3 0.8 2.7 1.3 1.1 1.3 1.2 0.1 4.5 0.7 0.8 0.8 0.3 0.4 0.8 1.2 0.6 0.6 0.7 1.5 1.1 2.0 1.2 0.3 0.8 0.5 1.6 0.0 3.7 2.7 0.0 2.9 2.4 0.0 4.4 1.4 2.1 2.8 0.0 0.6 0.0 1.7 2.5 3.4 1.3 0.0 2.8 1.4 0.0 1.4 0.4 1.2 0.3 5.0 0.0 0.0 3.4 0.0 1.7 6.9 2.9 2.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 3.4 0.0 1.0 0.0 0.0 1.3 2.1 5.5 0.7 1.0 1.9 0.3 0.0 2.0 0.0 0.0 1.9 1.3 0.1 0.5 0.1 3.1 2.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.3 0.1 0.0 1.5 0.0 0.0 0.0 0.1 1.3 1.4 1.3 1.6 1.4 1.4 1.3 1.3 1.3 1.2 1.5 1.6 1.4 0.0 0.0 5.9 0.4 0.1 0.7 2.0 1.8 5.8 2.1 2.2 3.7 0.0 1.3 0.0 4.2 0.9 0.0 0.2 3.9 1.7 0.7 1.6 1.7 1.3 0.0 2.1 3.1 1.2 0.6 1.0 2.6 1.0 0.0 3.4 1.4 0.2 0.7 1.7 4.5 0.3 0.0 0.6 0.0 0.5 0.9 0.3 0.0 1.0 0.1 4.7 0.0 7.5 2.2 2.0 0.3 1.9 0.0 1.6 0.3 1.6 4.5 6.9 0.0 1.0 1.5 1.8 2.4 1.4 0.0 0.8 0.2 3.4 0.5 0.9 ZNF230 FDZF2 ENSG00000159882 "Zinc finger protein 230" Q9UIE0 19 44002957-44013924 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA006172 Approved Mitochondria No No "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA006172: AB_2667532" "unprognostic (3.55e-3)" "unprognostic (5.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-2)" "unprognostic (3.89e-2)" "unprognostic (3.79e-2)" "unprognostic (1.35e-1)" "unprognostic (4.08e-4)" "unprognostic (2.45e-2)" "unprognostic (1.14e-2)" "unprognostic (8.59e-2)" "unprognostic (1.68e-1)" "unprognostic (4.62e-2)" "unprognostic (1.42e-5)" 2.0 2.1 1.1 2.2 1.3 3.2 3.2 2.8 2.0 2.3 1.5 2.0 1.3 2.3 2.1 1.4 2.5 1.6 1.8 1.1 1.4 1.7 2.1 2.4 3.4 1.2 1.3 4.2 1.4 2.7 2.7 2.4 1.4 2.2 2.0 4.6 1.9 2.5 0.8 2.9 2.4 1.8 1.3 3.9 1.9 1.8 1.3 4.0 3.0 1.9 3.9 2.0 1.7 1.8 2.1 1.7 3.4 3.5 2.7 3.3 1.3 2.9 2.9 2.6 4.7 1.0 1.1 1.7 1.9 2.1 1.6 1.7 2.9 2.6 3.9 2.1 3.6 2.9 4.1 1.2 1.5 3.8 2.4 2.5 2.4 2.9 3.0 3.5 1.8 2.0 0.5 0.0 2.7 1.1 4.3 2.7 2.0 1.4 1.6 3.1 4.7 0.8 1.5 2.4 1.9 4.3 4.1 1.4 2.1 2.3 1.2 8.7 2.3 4.1 3.0 1.2 2.2 2.1 2.2 0.3 2.0 2.8 2.6 6.2 3.3 8.7 3.6 4.0 3.8 4.2 4.1 3.7 3.6 4.2 4.5 4.2 11.5 2.9 2.0 2.2 3.7 2.9 1.1 1.3 2.8 2.0 1.1 1.4 1.2 1.3 1.4 1.3 1.3 1.8 4.7 0.0 2.2 1.6 8.3 2.8 2.6 3.0 4.6 8.5 3.3 3.9 6.0 10.0 3.5 3.7 16.7 4.0 9.9 2.7 3.9 3.0 2.7 2.9 3.3 4.2 1.2 2.1 4.6 2.4 3.2 4.4 2.6 1.7 1.3 4.8 3.9 2.7 3.2 8.4 3.8 2.4 10.2 4.4 3.3 1.7 6.5 3.6 3.6 3.7 7.9 5.4 7.2 2.5 4.0 1.2 0.8 4.5 1.4 2.0 4.1 1.6 2.9 9.6 6.6 3.9 4.3 13.7 7.9 2.8 2.7 3.1 6.7 3.7 3.2 2.0 ZNF234 "HZF4, ZNF269" ENSG00000263002 "Zinc finger protein 234" Q14588 19 44141554-44160313 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA001664 Approved Approved "Nuclear bodies" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "HPA001664: AB_1080694" "unprognostic (9.03e-2)" "unprognostic (8.56e-2)" "unprognostic (5.31e-2)" "unprognostic (4.97e-2)" "unprognostic (2.53e-2)" "unprognostic (2.96e-1)" "unprognostic (7.77e-3)" "unprognostic (2.22e-1)" "unprognostic (5.07e-2)" "unprognostic (3.43e-1)" "unprognostic (3.77e-2)" "unprognostic (2.57e-2)" "unprognostic (8.04e-2)" "unprognostic (1.48e-1)" "unprognostic (1.70e-1)" "unprognostic (7.31e-2)" "prognostic favorable (4.34e-5)" 3.5 4.8 2.1 4.0 2.9 0.7 4.8 3.7 3.0 3.6 3.2 3.6 3.7 3.7 2.7 3.0 3.2 3.3 4.5 2.1 2.6 3.7 3.1 3.2 4.7 2.4 2.5 5.2 2.9 4.7 3.5 4.7 3.1 4.0 3.6 5.3 3.6 3.5 3.3 4.4 4.0 4.2 1.8 5.7 3.9 2.1 2.7 4.8 4.2 2.9 5.1 3.3 3.3 4.5 5.1 3.5 8.4 8.0 9.8 9.9 3.8 6.5 4.7 5.0 8.3 4.4 3.1 0.1 4.3 5.9 4.7 3.8 6.4 4.1 6.0 0.0 7.7 10.1 8.1 5.8 4.6 0.0 6.8 5.7 9.1 5.4 6.2 6.9 5.7 0.0 0.6 0.1 7.6 1.6 6.8 2.4 5.6 3.3 3.3 0.0 9.6 1.6 3.1 9.7 4.7 7.8 4.7 3.8 3.4 8.6 4.3 4.1 5.8 9.3 7.6 1.7 6.0 5.2 4.7 0.1 1.0 0.0 7.6 1.4 2.0 3.1 3.6 2.6 3.0 2.2 2.1 2.5 2.4 3.4 3.9 3.8 0.7 4.4 1.8 1.6 1.2 1.7 2.1 2.9 3.7 3.0 2.1 2.6 2.4 2.5 3.1 1.8 2.7 4.5 5.0 0.0 2.0 6.2 4.7 3.1 2.4 3.1 2.8 4.8 2.8 2.8 8.3 0.0 4.7 1.8 2.1 5.8 4.2 2.2 5.9 4.1 11.0 3.2 4.7 4.5 3.6 9.1 5.6 2.0 2.5 6.6 3.6 2.5 3.8 7.5 6.8 0.9 2.8 5.0 4.1 2.8 2.0 2.7 2.8 6.3 6.8 2.3 1.8 8.4 3.4 2.9 10.3 7.5 14.2 2.3 5.0 5.7 0.9 2.4 3.3 2.2 2.1 5.7 6.6 4.7 4.3 4.0 4.8 2.7 2.8 3.1 4.8 7.9 2.2 2.2 ZNF236 ENSG00000130856 "Zinc finger protein 236" Q9UL36 18 76822557-76972901 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008600 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cell Junctions" Cytosol "HPA008600: AB_1080696" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (3.13e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (9.88e-3)" "unprognostic (5.51e-2)" "unprognostic (1.77e-1)" "unprognostic (2.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "unprognostic (2.95e-2)" "unprognostic (9.40e-2)" "unprognostic (1.74e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" 2.5 2.2 3.2 2.2 5.3 4.9 2.4 9.2 4.4 3.0 0.0 2.8 1.9 3.2 2.8 2.5 2.9 2.0 2.3 3.4 4.3 2.0 2.1 2.1 2.6 2.3 3.5 4.3 2.8 3.1 3.6 2.2 2.6 2.6 1.5 2.4 2.7 2.3 2.5 4.1 2.5 2.1 1.4 2.3 2.8 6.8 3.5 4.1 2.6 3.1 2.4 2.6 2.9 5.7 2.5 2.4 4.7 3.4 3.7 3.4 1.9 1.8 2.6 2.9 2.4 2.3 2.3 3.6 0.9 2.5 3.2 4.6 3.0 2.8 2.5 3.8 3.1 3.4 3.9 2.8 2.1 5.7 3.7 3.4 3.1 2.8 4.4 3.4 3.0 5.5 3.3 2.9 3.1 2.2 6.9 3.2 2.5 0.6 2.6 4.3 4.9 2.4 2.4 3.8 2.6 2.8 3.6 2.2 2.5 2.2 2.5 3.9 3.2 5.3 2.0 1.3 2.9 2.0 3.0 4.4 3.6 3.0 3.9 0.7 2.0 3.9 3.1 1.9 3.0 5.9 2.3 2.1 1.4 4.4 2.6 2.7 2.1 1.9 1.8 2.8 2.7 0.9 3.2 5.3 9.2 4.4 3.4 4.3 2.3 3.5 2.6 1.4 3.5 5.7 9.3 9.6 7.9 39.5 11.9 7.1 8.5 5.4 10.8 15.3 8.0 7.6 9.5 12.8 6.7 7.3 10.4 8.4 12.9 5.6 1.9 5.4 6.9 10.8 12.6 9.3 6.0 12.8 37.7 3.9 7.2 8.8 9.2 10.5 1.3 15.8 10.0 6.8 6.0 25.2 25.3 5.0 6.1 7.2 7.2 6.0 10.5 8.7 7.2 16.9 8.4 9.7 9.2 41.7 39.7 4.7 3.1 7.2 9.1 6.8 5.9 3.0 10.9 15.9 6.6 14.2 10.4 26.7 26.2 8.8 8.4 6.0 12.4 7.8 5.7 6.3 ZNF24 "KOX17, Zfp191, ZNF191, ZSCAN3" ENSG00000172466 "Zinc finger protein 24" P17028 18 35332227-35345482 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024062, CAB025642" Supported Supported Nucleoplasm NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB025642: , HPA024062: AB_1859150" "unprognostic (1.19e-1)" "unprognostic (3.25e-1)" "unprognostic (1.16e-3)" "unprognostic (2.42e-2)" "unprognostic (2.09e-1)" "unprognostic (1.49e-2)" "unprognostic (3.12e-2)" "unprognostic (2.79e-2)" "unprognostic (6.01e-2)" "unprognostic (7.69e-2)" "unprognostic (5.68e-2)" "unprognostic (2.44e-2)" "prognostic favorable (1.44e-4)" "unprognostic (5.25e-2)" "unprognostic (1.74e-2)" "unprognostic (9.27e-2)" "unprognostic (5.30e-3)" 19.4 21.9 32.1 22.4 40.0 25.0 35.3 34.9 34.8 21.6 29.7 19.7 20.5 23.8 22.2 17.8 18.2 18.1 20.9 28.7 33.1 23.8 30.9 21.5 28.8 36.4 36.8 26.1 25.8 32.3 12.5 23.4 37.3 25.5 21.4 38.0 23.7 18.3 23.7 15.4 21.4 18.2 33.4 25.6 25.1 19.9 33.4 34.0 33.3 27.6 26.4 19.2 12.6 54.4 19.3 19.1 60.0 31.5 24.9 26.7 16.9 25.9 29.1 31.3 35.7 12.4 15.5 43.7 28.4 21.7 25.0 34.8 44.7 24.3 53.5 40.1 24.3 31.3 40.2 26.7 26.2 66.9 48.6 22.6 41.0 28.0 30.2 36.0 30.2 27.2 48.2 27.6 32.8 22.8 51.3 28.5 31.2 12.8 12.8 38.0 38.8 35.1 31.5 44.0 51.0 43.7 31.6 29.2 54.7 31.0 27.4 50.3 25.7 44.8 20.1 10.8 26.1 69.7 60.6 44.4 25.0 27.0 41.8 30.2 21.0 24.8 24.4 20.3 23.5 30.5 24.1 20.8 19.3 30.2 23.0 21.4 40.9 22.4 30.3 29.7 20.0 15.2 32.1 40.0 34.9 34.8 28.7 33.1 36.4 36.8 37.3 33.4 33.4 54.4 49.0 57.7 63.0 30.0 66.1 32.9 65.9 44.2 29.0 57.2 62.6 55.4 46.9 52.9 60.7 25.8 43.8 41.4 52.7 37.7 27.4 46.4 126.1 47.6 37.6 50.2 55.6 43.1 26.9 41.1 33.6 47.5 29.6 41.1 43.6 40.0 42.8 48.3 35.3 79.1 26.4 39.2 44.7 38.2 25.4 33.8 54.3 38.6 23.2 33.7 43.1 101.3 56.7 33.2 71.7 42.3 37.8 50.0 34.0 67.2 29.8 30.4 59.1 85.5 46.0 50.1 53.9 59.0 51.6 32.7 32.5 70.7 45.6 50.9 32.2 76.5 ZNF253 "BMZF-1, FLJ90391, ZNF411" ENSG00000256771 "Zinc finger protein 253" O75346 19 19865882-19894674 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 25.6;Oligodendrocytes: 33.7;Rod photoreceptor cells: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "unprognostic (3.03e-2)" "unprognostic (3.54e-1)" "unprognostic (7.10e-2)" "unprognostic (1.41e-2)" "prognostic favorable (8.39e-5)" "unprognostic (4.75e-2)" "unprognostic (4.77e-2)" "unprognostic (2.80e-2)" "unprognostic (5.26e-3)" "prognostic favorable (2.19e-4)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "prognostic favorable (9.69e-5)" "unprognostic (4.88e-2)" "unprognostic (3.68e-1)" "unprognostic (1.84e-3)" "unprognostic (4.54e-3)" 3.1 4.5 1.3 4.2 3.1 2.5 8.3 7.4 4.5 6.3 0.4 4.8 4.4 5.0 4.5 2.5 6.1 3.2 4.7 1.1 4.3 7.0 4.3 3.9 8.7 2.1 1.8 13.0 4.4 8.4 3.5 4.4 2.6 6.0 5.3 19.8 5.5 5.4 7.4 3.4 4.3 2.5 1.1 6.2 5.4 3.9 2.6 9.0 14.5 10.5 8.6 4.4 3.0 4.9 0.0 0.1 17.5 14.0 2.4 2.4 7.4 2.4 1.1 4.8 5.5 2.2 4.2 12.2 8.8 2.3 4.2 2.2 0.0 0.6 6.9 1.4 4.1 0.9 1.1 3.6 2.9 0.1 0.3 3.6 3.2 3.2 0.4 6.7 0.2 0.3 7.8 6.2 7.0 5.5 20.6 4.2 18.5 0.0 2.3 19.7 10.1 10.1 6.4 9.6 10.0 10.3 10.2 2.3 2.9 13.5 6.3 14.8 0.2 6.1 0.2 4.4 3.2 9.0 8.1 19.7 0.3 0.4 3.1 13.5 1.5 4.1 5.7 2.1 7.6 9.1 7.9 7.9 3.4 9.8 15.4 10.3 1.4 7.5 1.9 4.5 6.0 4.7 1.3 3.1 7.4 4.5 1.1 4.3 2.1 1.8 2.6 1.1 2.6 4.9 3.7 9.6 3.6 7.8 9.4 0.4 1.9 1.1 1.8 12.2 3.7 4.3 5.9 4.3 4.1 5.5 6.2 5.6 6.8 2.6 17.6 6.1 12.2 4.3 5.6 5.3 7.7 4.2 16.3 2.9 3.3 4.6 1.5 5.2 2.5 9.0 3.9 2.5 2.9 13.5 22.3 2.1 0.0 2.5 1.8 1.0 5.0 2.6 1.8 8.4 1.4 12.6 11.3 25.6 33.7 2.3 2.7 4.5 6.4 1.7 1.9 6.4 6.8 26.7 0.0 4.0 4.8 7.2 7.1 1.0 0.4 4.9 7.3 9.4 3.7 1.5 ZNF256 BMZF-3 ENSG00000152454 "Zinc finger protein 256" Q9Y2P7 19 57940833-57947706 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 32.8" HPA055390 Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA055390: AB_2682803" "unprognostic (2.47e-2)" "unprognostic (3.43e-2)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (2.95e-2)" "unprognostic (1.42e-1)" "unprognostic (3.03e-1)" "unprognostic (3.38e-1)" "unprognostic (3.49e-3)" "unprognostic (2.32e-2)" "unprognostic (4.73e-3)" "unprognostic (2.83e-2)" "unprognostic (6.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-1)" "unprognostic (1.27e-1)" "unprognostic (3.28e-3)" 3.5 2.5 2.3 2.3 2.6 10.8 5.6 5.6 3.3 2.9 2.4 3.3 2.3 3.5 4.4 2.7 3.9 1.9 6.0 2.5 1.9 3.1 1.8 3.2 4.9 1.6 1.8 5.5 2.1 4.4 2.8 4.6 1.6 3.8 2.9 9.1 3.3 4.0 3.6 7.1 3.5 3.5 1.6 4.6 2.6 4.3 1.7 5.4 3.9 4.2 5.3 3.1 2.8 2.3 3.9 1.3 9.6 9.7 2.0 3.3 8.3 3.3 3.5 5.2 3.5 0.8 2.1 0.0 2.9 4.3 8.0 0.5 2.2 7.4 8.5 0.0 32.8 9.5 0.0 2.6 3.7 0.0 7.4 6.5 2.0 3.8 0.0 5.4 3.2 9.1 0.7 0.0 5.3 0.9 13.2 0.0 11.6 0.4 8.2 4.2 12.0 5.9 3.8 16.8 4.8 6.9 0.0 3.0 2.4 11.8 7.2 3.0 1.3 10.7 6.3 0.0 6.5 4.4 4.7 16.9 0.3 0.0 4.7 1.3 1.0 1.3 3.3 3.4 6.1 4.7 5.6 5.0 4.2 5.6 5.4 6.4 0.5 3.9 3.6 2.0 4.9 2.2 2.3 2.6 5.6 3.3 2.5 1.9 1.6 1.8 1.6 1.6 1.7 2.3 2.4 0.0 0.0 2.0 4.0 2.7 4.8 3.5 2.2 4.5 2.4 1.4 3.2 1.5 1.7 1.8 0.0 3.1 2.2 0.4 3.9 3.5 0.2 1.2 1.1 2.7 1.2 5.2 1.6 0.8 1.7 2.0 1.1 1.3 0.0 2.2 0.7 0.7 1.4 1.7 1.4 0.9 8.2 0.8 1.0 0.3 1.8 0.8 0.0 1.0 1.7 3.8 1.0 3.5 0.6 0.8 0.3 0.4 0.3 2.7 0.8 0.9 3.4 7.2 0.0 2.6 2.1 4.9 8.7 1.6 3.4 2.6 3.1 2.3 1.2 3.7 ZNF26 "FLJ20755, KOX20" ENSG00000198393 "Zinc finger protein 26" P17031 12 132986365-133032952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018329, HPA042406" Uncertain Approved "Nuclear bodies,Mitochondria" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Mitochondria "Nuclear bodies" "HPA018329: AB_1859157, HPA042406: AB_2677982" "unprognostic (7.31e-3)" "unprognostic (7.60e-3)" "unprognostic (7.26e-4)" "unprognostic (5.52e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (1.52e-3)" "unprognostic (3.00e-2)" "unprognostic (9.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "unprognostic (3.67e-3)" "unprognostic (2.66e-12)" "unprognostic (8.24e-2)" "unprognostic (7.20e-2)" "unprognostic (1.94e-3)" "unprognostic (7.64e-4)" 0.8 0.7 1.2 0.9 1.2 1.6 0.8 1.9 1.7 1.0 2.2 0.7 0.8 0.9 1.5 0.6 1.2 0.5 0.6 1.4 0.9 0.8 0.6 1.0 0.9 1.2 0.9 0.9 0.8 0.4 0.7 0.5 0.9 0.7 0.6 1.4 0.8 0.5 1.1 1.4 0.8 0.6 0.4 0.9 0.8 1.1 1.4 0.6 0.8 0.2 0.8 0.7 0.8 2.0 1.3 0.3 1.0 2.0 0.4 0.5 3.4 0.9 0.7 0.9 0.5 0.4 1.0 0.9 1.8 0.8 0.6 1.4 0.4 0.4 0.5 1.1 3.1 2.0 1.2 0.4 0.2 2.7 3.2 0.8 0.7 0.6 1.3 0.8 0.4 1.4 1.3 0.3 0.6 1.4 2.5 1.7 2.2 0.4 2.4 3.0 2.6 2.7 0.3 2.5 2.6 4.2 0.8 1.3 1.1 0.5 2.9 2.4 2.4 1.5 1.1 0.7 1.2 0.7 0.1 3.5 0.9 1.6 1.8 5.9 1.2 3.2 4.0 1.4 4.0 2.1 3.4 2.9 1.8 3.8 4.3 3.8 0.9 3.4 1.3 1.5 3.3 2.8 1.2 1.2 1.9 1.7 1.4 0.9 1.2 0.9 0.9 0.4 1.4 2.0 10.7 22.4 16.0 6.5 15.7 0.0 9.0 0.1 7.4 26.6 9.1 6.7 5.2 11.5 8.2 5.5 25.0 6.4 18.9 3.3 3.9 7.5 1.1 8.8 9.5 10.1 8.4 3.8 11.6 5.7 4.2 8.2 9.2 8.4 9.5 20.3 11.4 5.6 5.3 26.9 8.8 7.0 0.0 6.6 0.0 1.5 8.1 7.5 0.0 11.2 6.5 5.6 17.5 9.5 10.3 8.4 4.9 6.0 10.7 8.1 5.9 2.8 3.0 23.2 0.0 19.1 7.4 12.1 10.9 5.3 0.0 4.8 15.8 14.0 7.2 7.8 ZNF266 HZF1 ENSG00000174652 "Zinc finger protein 266" Q14584 19 9412461-9435571 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 74.2" "Low region specificity" "Detected in all" "HPA026836, HPA054110" Uncertain Supported "Nucleoplasm,Vesicles,Rods & Rings" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Vesicles "Nucleoplasm, Rods & Rings" "HPA026836: AB_2672018, HPA054110: AB_2682383" "unprognostic (2.50e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (7.60e-2)" "prognostic favorable (3.94e-6)" "unprognostic (1.72e-2)" "prognostic favorable (4.47e-4)" "unprognostic (4.59e-2)" "unprognostic (9.00e-3)" "prognostic favorable (3.03e-5)" "unprognostic (2.92e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" "prognostic favorable (9.15e-5)" 21.0 17.6 8.7 12.7 9.1 17.5 22.8 10.5 10.7 26.3 10.1 22.8 10.2 20.6 53.3 17.5 21.7 9.7 15.3 8.4 8.9 16.3 15.4 21.8 23.8 8.9 8.9 24.2 15.1 15.7 20.1 15.0 9.0 31.5 15.9 12.6 19.0 14.6 11.4 25.1 29.4 14.0 8.8 44.1 19.4 16.7 9.1 27.6 26.3 8.6 27.9 20.0 20.3 9.9 21.5 5.4 13.0 26.6 10.8 15.3 10.3 19.4 18.9 19.1 27.5 10.1 7.1 22.5 12.6 10.7 7.4 6.3 19.3 10.8 22.1 6.8 29.6 27.1 21.8 13.9 9.2 16.9 17.3 16.4 16.0 9.6 14.3 15.5 14.2 25.7 18.0 0.0 16.7 2.1 25.8 74.2 16.6 9.9 16.5 9.6 16.4 16.9 13.6 22.2 13.0 19.5 10.5 11.0 14.0 14.0 8.8 14.2 13.7 16.6 6.9 23.1 11.8 32.1 55.6 28.0 4.5 14.8 11.3 4.0 3.5 4.9 9.6 4.1 6.8 4.8 5.7 7.4 2.9 5.3 7.5 8.1 2.0 11.1 5.4 2.7 7.5 4.8 8.7 9.1 10.5 10.7 8.4 8.9 8.9 8.9 9.0 8.8 9.1 9.9 8.8 0.0 14.3 10.4 15.3 4.0 5.9 5.3 11.4 8.0 9.0 8.8 5.5 4.3 8.7 3.7 12.5 4.8 22.4 7.2 3.9 5.5 0.7 5.0 5.4 7.5 9.5 14.3 12.5 3.7 3.3 6.6 11.2 6.5 12.0 12.9 10.8 3.1 4.8 8.4 12.0 7.1 6.1 11.4 7.2 1.4 6.2 9.1 5.4 14.0 11.3 4.2 20.6 14.1 15.1 4.7 5.2 4.5 10.5 5.6 7.6 1.4 6.6 9.5 6.6 7.2 6.2 5.5 8.7 6.4 4.7 4.7 17.1 6.5 7.4 6.4 ZNF268 HZF3 ENSG00000090612 "Zinc finger protein 268" Q14587 12 133181409-133214832 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001794 Approved Supported Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA001794: AB_2666437" "unprognostic (7.65e-2)" "unprognostic (2.78e-1)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (1.16e-1)" "unprognostic (1.94e-1)" "unprognostic (4.91e-3)" "unprognostic (2.21e-1)" "unprognostic (7.63e-3)" "unprognostic (2.57e-2)" "unprognostic (6.59e-3)" "unprognostic (5.69e-2)" "unprognostic (2.30e-1)" "unprognostic (8.79e-2)" "unprognostic (1.53e-3)" 5.6 6.6 2.8 4.0 3.9 3.6 9.5 5.0 3.9 7.4 4.9 5.5 4.4 7.5 7.4 6.5 8.7 4.3 4.4 2.7 3.3 9.3 12.8 5.6 6.2 3.4 3.5 9.7 5.3 13.1 3.9 9.5 3.3 8.1 5.4 12.0 5.6 6.9 2.4 5.1 5.2 5.8 3.2 6.0 7.1 5.8 3.2 7.3 10.7 4.9 7.1 6.3 3.7 4.2 6.9 10.1 21.4 19.0 9.0 11.5 14.6 10.2 10.8 9.3 7.4 10.6 4.6 5.9 15.5 10.3 9.4 6.3 10.5 12.8 11.8 0.2 8.5 14.6 5.3 13.4 9.6 14.1 12.6 16.9 12.6 11.1 17.4 12.5 10.8 5.6 11.2 7.8 15.9 8.2 5.7 6.4 15.8 8.7 0.6 5.7 6.6 7.3 5.3 15.9 15.3 12.9 20.9 7.0 9.1 18.2 17.0 12.0 11.6 10.6 13.2 3.7 9.3 2.8 4.2 12.9 5.9 7.3 11.3 1.9 5.1 6.0 8.2 5.0 5.5 9.6 9.3 10.4 7.6 7.2 14.2 10.2 1.6 10.8 8.6 6.0 5.2 5.0 2.8 3.9 5.0 3.9 2.7 3.3 3.4 3.5 3.3 3.2 3.2 4.2 8.0 19.2 22.3 6.8 10.0 1.8 5.6 5.7 5.2 24.3 10.0 8.4 8.4 12.8 13.6 7.3 20.9 14.9 3.2 2.8 5.9 8.8 15.5 7.1 9.0 9.5 3.6 15.8 8.4 6.4 9.4 9.7 4.6 7.5 2.5 19.1 14.6 11.0 9.8 21.9 10.0 6.9 4.1 6.7 3.0 4.3 10.5 7.7 5.4 10.3 5.5 15.8 8.2 11.6 12.9 7.7 7.6 11.3 5.2 6.3 5.5 11.5 7.1 19.1 6.6 17.4 8.8 14.9 17.3 6.4 2.8 8.6 7.5 12.4 6.9 4.4 ZNF274 "ZKSCAN19, ZSCAN51" ENSG00000171606 "Zinc finger protein 274" Q96GC6 19 58183029-58213562 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 77.1" "Low region specificity" "Detected in all" HPA028880 Uncertain Approved Nucleoplasm,Centrosome NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Centrosome "HPA028880: AB_10601929" "unprognostic (2.38e-3)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (3.84e-1)" "prognostic favorable (6.16e-4)" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (6.57e-2)" "unprognostic (2.19e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" "unprognostic (8.85e-2)" "unprognostic (2.58e-3)" 12.0 11.5 10.1 9.9 11.1 13.1 13.0 13.5 10.3 11.3 15.2 14.4 8.6 10.2 13.6 14.9 14.5 8.8 18.0 9.6 9.5 16.4 19.2 13.1 14.0 10.8 10.5 21.7 8.7 21.7 14.4 9.4 11.0 12.9 7.5 17.3 10.3 10.7 17.7 15.1 14.8 8.9 10.0 17.3 11.4 14.4 10.7 11.5 18.9 14.6 14.3 12.7 11.8 14.5 18.5 12.3 20.9 8.5 12.9 19.1 20.3 14.3 7.9 15.9 14.1 7.5 13.1 6.2 9.4 9.3 16.9 5.1 10.1 20.3 21.8 12.7 77.1 29.5 12.8 12.1 20.8 20.9 46.1 15.0 25.7 19.6 37.2 16.6 12.8 9.7 22.5 26.8 12.0 12.0 11.5 19.1 20.0 10.6 12.2 26.0 5.3 26.8 11.9 7.4 13.6 6.1 19.6 8.6 16.9 15.7 20.4 39.4 12.5 8.5 12.8 10.0 16.9 12.5 14.1 20.9 3.8 23.3 18.4 23.0 7.3 36.9 13.5 8.0 21.1 20.5 17.7 19.7 10.3 26.3 26.1 18.5 26.1 22.1 13.4 5.0 24.4 13.2 10.1 11.1 13.5 10.3 9.6 9.5 10.8 10.5 11.0 10.0 10.7 14.5 15.2 16.0 19.6 17.6 33.5 10.5 40.1 12.8 8.0 32.6 10.2 8.3 14.5 15.7 14.1 18.4 43.8 11.3 12.7 10.4 1.9 13.5 18.5 8.3 8.1 13.9 6.6 10.8 4.4 5.6 11.7 9.2 13.7 11.9 29.2 11.2 13.2 9.9 7.1 20.2 3.7 9.0 4.1 13.0 15.9 10.7 12.2 11.9 7.2 10.3 10.4 22.3 18.6 16.6 21.0 12.3 17.9 12.0 7.8 26.7 18.0 10.3 12.4 67.0 19.7 14.1 16.6 21.6 14.6 8.8 12.1 16.7 23.7 5.5 8.3 25.5 ZNF302 "ZNF135L, ZNF140L, ZNF327" ENSG00000089335 "Zinc finger protein 302" Q9NR11 19 34677639-34686397 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 203.2;choroid plexus: 142.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059503 Approved "Vesicles,Cytokinetic bridge" Yes No "Cluster 6: Non-specific - Transcription" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Vesicles, Cytokinetic bridge" "HPA059503: AB_2684043" "unprognostic (3.52e-1)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (2.25e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-1)" "unprognostic (1.50e-2)" "unprognostic (4.33e-3)" "unprognostic (1.82e-2)" "unprognostic (4.63e-2)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.41e-4)" "unprognostic (2.34e-1)" "unprognostic (1.21e-1)" "unprognostic (3.94e-2)" "prognostic favorable (9.85e-5)" 13.7 18.1 139.4 10.2 142.4 4.6 24.0 142.8 203.2 17.5 142.3 20.0 12.4 19.5 21.6 9.1 18.5 11.1 25.4 139.0 140.3 19.8 19.0 14.6 17.8 140.2 141.5 28.0 24.4 21.5 16.7 11.9 141.4 18.0 15.4 45.2 13.5 18.8 37.2 12.8 15.7 14.8 140.7 19.4 14.9 15.5 140.7 17.2 19.1 30.4 16.7 18.0 12.1 147.3 10.5 16.0 33.3 13.2 30.8 23.6 11.6 17.8 21.8 16.0 17.3 11.9 9.5 16.3 21.7 13.5 12.0 8.5 16.3 10.4 17.1 1.3 13.6 31.2 18.0 0.3 16.5 0.3 2.4 22.3 15.0 9.9 1.8 20.0 13.8 11.4 0.3 0.9 25.2 5.5 16.9 16.7 15.1 18.9 10.6 12.5 27.0 9.1 16.9 14.0 14.8 24.1 16.2 6.0 21.9 17.7 12.7 24.8 13.6 7.4 17.6 6.8 8.9 18.6 35.1 5.1 6.8 2.4 33.9 28.1 10.1 17.2 14.9 10.0 20.7 23.3 17.0 14.0 8.8 25.0 28.0 22.3 7.5 19.4 13.4 20.3 14.9 9.1 139.4 142.4 142.8 203.2 139.0 140.3 140.2 141.5 141.4 140.7 140.7 147.3 32.2 28.9 27.6 41.8 33.2 26.8 34.0 16.0 19.9 56.5 24.4 30.9 58.9 25.8 22.1 22.0 52.1 16.8 26.6 10.4 45.0 17.5 31.3 12.7 29.7 34.3 19.9 20.8 41.5 11.4 6.8 41.0 21.4 11.8 29.1 63.0 28.5 11.8 10.1 48.8 42.4 13.4 14.2 14.5 44.9 6.3 59.4 15.7 24.9 29.0 17.8 73.5 42.2 54.8 76.1 10.0 16.4 51.1 14.8 40.1 20.6 14.3 25.6 88.8 52.6 73.5 40.5 67.0 40.2 15.7 21.5 5.5 29.3 44.8 11.6 30.8 ZNF316 "ENST00000305834, MZF-3" ENSG00000205903 "Zinc finger protein 316" A6NFI3 7 6637318-6658279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 18: Non-specific - Mitochondria" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "unprognostic (2.74e-1)" "unprognostic (2.82e-3)" "unprognostic (9.69e-3)" "unprognostic (4.56e-2)" "unprognostic (7.06e-2)" "unprognostic (3.41e-1)" "unprognostic (7.22e-2)" "unprognostic (2.49e-2)" "unprognostic (2.30e-2)" "unprognostic (4.21e-3)" "prognostic favorable (6.03e-5)" "unprognostic (1.38e-2)" "unprognostic (8.60e-2)" "unprognostic (3.69e-2)" "unprognostic (2.26e-1)" "unprognostic (6.08e-2)" "unprognostic (1.43e-3)" 16.1 15.2 13.3 18.0 12.2 20.7 13.4 9.9 13.8 19.1 11.6 19.7 13.0 18.6 17.1 15.4 17.6 8.9 13.0 12.6 10.3 15.0 16.6 15.7 16.3 14.5 11.6 16.4 17.2 21.0 17.9 11.0 11.2 17.5 8.3 8.9 13.7 8.8 26.1 19.7 17.8 12.7 10.3 28.2 15.6 12.8 11.7 13.2 23.4 6.6 12.1 17.0 14.8 13.2 26.6 23.0 28.5 27.3 15.0 7.7 17.2 20.5 9.8 9.0 9.3 21.6 18.6 35.3 13.7 15.0 35.5 26.6 14.0 13.9 8.6 10.8 15.7 24.3 39.6 12.3 16.2 30.6 26.7 11.0 14.4 14.0 16.8 18.1 8.0 16.0 46.0 17.1 10.3 44.2 11.6 38.7 16.0 18.1 17.0 21.0 21.9 15.3 9.1 59.5 32.9 53.7 15.0 55.0 16.7 24.1 31.8 33.2 15.2 17.8 35.2 25.5 28.1 37.3 37.7 27.5 14.0 25.0 36.4 0.7 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.5 0.2 0.6 0.2 0.1 13.3 12.2 9.9 13.8 12.6 10.3 14.5 11.6 11.2 10.3 11.7 13.2 9.6 6.4 9.3 15.7 8.6 0.0 3.1 0.0 12.5 13.3 12.8 11.8 9.0 10.0 3.7 14.7 10.4 3.4 10.1 13.2 3.9 4.6 1.0 10.3 9.2 8.4 16.7 4.8 9.8 6.0 2.0 6.5 15.8 11.4 1.3 12.0 9.3 13.6 7.3 18.5 9.8 9.9 0.0 10.3 0.0 0.9 6.5 13.1 0.0 7.5 9.7 5.0 9.2 7.5 9.2 6.1 6.6 7.2 10.8 7.6 5.7 3.8 1.5 7.5 0.0 11.5 8.4 4.3 3.2 15.7 0.0 2.2 7.6 12.5 9.4 5.3 ZNF333 KIAA1806 ENSG00000160961 "Zinc finger protein 333" Q96JL9 19 14689801-14733746 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043973, HPA054680" Uncertain Supported Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA043973: AB_10961277, HPA054680: AB_2682571" "unprognostic (8.16e-2)" "unprognostic (2.80e-4)" "unprognostic (5.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-2)" "unprognostic (1.45e-3)" "unprognostic (2.98e-2)" "unprognostic (2.17e-3)" "unprognostic (2.12e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-3)" "unprognostic (3.46e-2)" "unprognostic (1.32e-5)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.62e-1)" "unprognostic (7.06e-3)" 6.3 3.8 4.5 3.7 5.0 6.3 5.2 5.9 5.4 6.8 3.5 6.1 1.9 6.4 4.6 2.3 6.7 2.9 3.5 4.5 4.3 3.2 2.2 4.2 3.5 4.8 4.7 7.3 4.3 3.1 3.0 3.4 5.1 4.3 2.5 5.6 3.0 3.6 7.8 3.6 3.7 5.2 4.6 6.8 3.6 3.8 4.9 3.5 3.3 4.1 3.0 5.7 4.7 6.6 1.2 0.8 4.6 6.1 6.6 6.2 1.8 2.7 4.0 2.5 3.6 0.1 0.9 1.8 3.3 3.5 0.6 1.0 1.2 0.9 3.6 4.9 1.3 8.5 1.9 1.8 5.5 3.2 4.6 5.4 3.2 2.1 6.6 3.3 3.6 2.2 1.5 3.9 3.2 0.5 1.7 8.1 1.7 2.8 1.5 3.1 2.6 1.9 2.4 1.4 2.5 5.1 2.6 0.3 4.9 1.8 1.1 5.5 5.8 4.1 1.9 6.9 3.0 1.7 0.9 1.7 4.3 5.8 5.0 8.6 3.4 5.3 3.5 4.5 4.6 2.3 3.0 2.9 4.3 2.2 3.5 3.3 6.4 13.8 4.6 2.7 3.2 2.2 4.5 5.0 5.9 5.4 4.5 4.3 4.8 4.7 5.1 4.6 4.9 6.6 8.8 6.4 8.7 9.1 6.6 3.1 5.4 1.6 6.2 12.7 4.5 5.6 3.7 0.0 2.7 3.7 4.2 3.0 4.7 2.2 1.9 2.7 5.8 2.3 9.0 7.5 2.4 3.4 12.6 3.0 3.0 9.1 3.1 3.1 16.5 12.0 5.0 2.2 5.1 8.4 15.7 1.0 4.1 9.1 6.0 3.7 9.9 8.0 1.8 11.2 9.5 5.5 12.3 13.6 22.9 2.3 2.1 9.1 4.1 4.1 2.0 2.1 3.5 17.4 13.1 10.8 9.8 11.9 7.3 2.6 2.7 1.4 5.5 4.3 2.3 3.5 ZNF33A "FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK" ENSG00000189180 "Zinc finger protein 33A" Q06730 10 38010650-38065088 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: AB_2683199" "unprognostic (1.85e-2)" "unprognostic (1.19e-1)" "unprognostic (7.68e-3)" "unprognostic (1.48e-1)" "unprognostic (3.42e-2)" "unprognostic (1.69e-3)" "unprognostic (7.96e-3)" "unprognostic (4.89e-3)" "unprognostic (6.73e-2)" "unprognostic (9.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (6.83e-2)" "unprognostic (7.39e-3)" 9.2 12.6 5.8 12.2 7.0 12.2 17.9 17.1 7.6 14.5 9.6 12.2 13.4 15.1 10.9 9.3 14.9 11.8 9.0 5.0 7.8 15.3 16.3 10.1 14.8 9.5 7.1 14.8 16.9 17.1 14.0 11.4 9.9 15.1 15.8 20.6 14.9 14.3 13.9 13.9 13.7 10.3 6.7 14.2 16.7 4.3 6.8 14.0 15.7 15.8 16.2 11.0 10.3 8.4 16.3 9.1 16.2 14.1 7.8 9.8 12.8 7.3 7.1 9.1 10.2 9.7 14.5 31.5 7.7 9.8 5.2 10.6 19.3 12.6 8.5 18.9 22.0 25.2 18.6 13.2 7.9 36.0 20.2 8.6 22.5 6.9 10.1 17.0 7.5 17.7 13.5 16.5 9.3 10.6 15.0 8.2 16.4 8.2 10.5 12.9 11.2 14.8 12.8 15.0 12.6 19.8 11.3 12.3 6.4 11.2 14.8 9.5 7.3 8.0 11.7 9.0 5.8 13.0 17.1 18.5 7.4 19.7 3.7 12.7 3.6 6.1 5.4 5.0 4.7 6.4 4.7 3.6 3.4 6.2 5.8 4.6 15.9 4.7 6.6 6.3 3.6 3.1 5.8 7.0 17.1 7.6 5.0 7.8 9.5 7.1 9.9 6.7 6.8 8.4 28.4 60.9 73.0 39.8 47.5 11.9 33.0 25.6 19.4 38.2 33.4 28.6 70.6 31.5 49.0 27.6 33.3 28.4 43.1 27.1 25.4 34.9 4.6 62.8 19.3 31.6 34.1 30.3 47.4 29.2 20.0 23.5 25.5 37.7 33.6 47.6 21.4 39.6 19.4 30.3 63.9 28.2 18.3 22.8 16.8 6.7 23.9 26.1 10.6 58.1 46.9 21.1 38.1 56.3 81.5 32.0 29.6 24.0 32.1 38.9 22.0 39.3 80.8 31.8 26.3 32.7 22.7 15.3 18.9 18.7 12.8 35.6 34.6 33.2 27.5 38.4 ZNF33B "KOX2, KOX31, ZNF11B" ENSG00000196693 "Zinc finger protein 33B" Q06732 10 42574185-42638570 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: AB_2683199" "unprognostic (3.01e-3)" "unprognostic (2.20e-1)" "unprognostic (2.93e-2)" "unprognostic (8.34e-2)" "unprognostic (5.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.90e-3)" "unprognostic (3.71e-1)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (1.61e-2)" 4.7 9.8 3.9 5.9 4.9 3.1 20.6 9.8 5.1 9.5 9.5 9.1 8.9 11.7 7.6 7.4 18.6 8.6 5.3 4.8 6.6 18.5 10.3 8.9 9.4 4.9 4.0 23.5 34.1 15.2 10.0 7.2 5.1 12.6 10.4 10.4 18.6 10.4 3.9 12.2 9.7 5.2 2.5 10.3 14.3 4.7 5.3 8.0 18.3 4.9 8.9 9.0 9.0 3.7 13.2 3.3 8.5 8.8 3.1 0.4 10.6 8.1 6.2 5.1 7.1 7.3 14.9 19.9 4.8 3.1 7.7 10.9 16.5 5.6 5.7 11.8 12.4 7.9 12.7 11.9 3.6 18.8 6.2 5.1 20.1 3.1 17.0 13.4 4.4 10.8 10.9 14.7 3.1 5.7 7.5 4.5 9.3 6.5 7.7 8.0 8.5 8.5 13.4 17.2 15.3 14.9 5.1 10.5 5.1 7.7 13.4 5.7 5.3 2.6 12.3 4.5 8.6 9.5 15.5 6.1 1.8 13.9 2.4 19.4 7.5 7.1 10.7 6.7 15.1 20.1 15.4 10.8 6.7 15.4 19.5 13.7 2.4 8.3 5.5 11.1 13.4 9.0 3.9 4.9 9.8 5.1 4.8 6.6 4.9 4.0 5.1 2.5 5.3 3.7 10.0 80.1 37.8 14.0 17.7 4.8 18.0 5.5 18.2 15.4 26.0 27.8 31.5 34.3 30.0 20.2 10.4 18.6 13.4 9.7 21.5 27.0 2.4 37.2 6.0 14.1 25.3 17.1 25.6 36.1 16.8 10.0 14.8 14.5 8.2 23.8 16.4 10.8 8.4 10.1 48.2 17.6 4.1 13.6 3.6 3.8 20.5 9.3 7.2 36.5 17.9 10.2 21.6 30.7 14.1 25.8 21.4 11.7 15.2 13.0 21.2 27.0 47.6 9.6 0.0 9.0 8.5 9.0 11.3 11.8 4.0 11.5 17.0 22.6 18.5 12.8 ZNF347 ZNF1111 ENSG00000197937 "Zinc finger protein 347" Q96SE7 19 53124072-53159075 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023448 Uncertain Approved Microtubules NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 6: Brain - Smell perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Microtubules "HPA023448: AB_1859214" "unprognostic (1.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.98e-1)" "unprognostic (1.48e-1)" "unprognostic (6.48e-2)" "unprognostic (3.01e-3)" "unprognostic (6.20e-2)" "unprognostic (3.82e-2)" "unprognostic (3.65e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (8.39e-2)" "unprognostic (3.22e-3)" "unprognostic (3.60e-1)" "unprognostic (1.05e-1)" "unprognostic (8.99e-2)" "unprognostic (7.59e-3)" 4.8 4.7 6.7 5.7 5.3 19.3 5.1 17.5 6.8 4.7 0.8 3.6 2.7 6.2 5.5 3.8 3.9 6.0 4.5 6.0 7.7 3.5 2.0 5.0 5.8 6.9 5.3 6.3 5.3 4.6 2.9 5.0 6.4 4.4 3.7 14.9 4.4 4.8 3.6 6.8 3.1 4.9 1.9 9.5 4.2 3.8 5.8 5.7 6.8 3.6 4.1 3.7 3.5 15.8 0.8 0.8 7.9 13.2 5.0 5.4 7.4 8.6 8.6 10.0 11.8 1.3 2.2 7.6 3.3 7.3 11.2 3.7 0.9 1.5 12.8 1.5 5.8 1.4 5.1 2.4 3.1 1.7 7.7 6.1 0.6 7.4 0.0 3.5 2.5 4.6 6.4 2.3 5.2 0.9 12.9 3.9 9.6 0.4 4.0 3.5 0.3 1.7 4.0 20.1 5.7 5.9 1.3 2.6 3.4 10.1 7.1 3.5 4.2 12.5 8.1 6.8 12.4 1.1 7.1 13.4 2.0 1.4 7.1 3.8 1.1 1.6 1.8 0.9 1.8 1.9 1.5 1.6 1.1 3.0 1.9 1.6 6.8 3.7 1.5 1.9 1.8 0.8 6.7 5.3 17.5 6.8 6.0 7.7 6.9 5.3 6.4 1.9 5.8 15.8 16.2 19.2 12.4 5.9 6.0 2.0 4.9 1.0 3.4 10.5 3.5 4.2 7.3 4.3 6.8 3.7 4.2 3.1 1.5 3.8 1.9 2.9 0.3 5.5 7.8 15.9 1.2 3.0 7.7 4.0 3.7 6.5 4.6 6.1 3.8 11.7 11.7 1.3 2.7 8.4 10.8 2.5 2.0 3.8 2.8 0.8 5.3 3.5 1.8 4.7 3.4 4.0 8.2 8.5 14.9 3.5 1.1 3.8 2.0 4.6 2.9 1.4 18.6 14.3 0.0 11.4 5.9 3.0 5.4 4.2 2.0 3.4 3.9 16.9 2.8 3.0 ZNF354C KID3 ENSG00000177932 "Zinc finger protein 354C" Q86Y25 5 179060373-179083977 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 16.8;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.8" "Low region specificity" "Detected in all" "HPA030904, HPA068570" Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA030904: AB_10603842, HPA068570: " "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (6.56e-4)" "unprognostic (4.76e-1)" "unprognostic (2.40e-3)" "unprognostic (2.61e-2)" "unprognostic (2.83e-2)" "unprognostic (1.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (5.57e-2)" "unprognostic (1.62e-1)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "unprognostic (4.00e-2)" "unprognostic (2.83e-1)" 3.2 2.2 2.7 2.4 3.7 0.6 4.0 6.1 2.9 3.6 1.8 3.1 1.2 5.1 1.8 2.0 3.6 2.6 2.8 2.3 2.6 2.1 1.4 2.6 3.4 3.0 3.5 7.0 2.0 3.1 1.2 3.2 3.2 3.5 1.6 6.4 2.1 3.3 2.2 1.9 2.0 3.8 2.9 3.3 2.0 2.2 3.4 4.4 4.7 4.3 3.4 2.5 2.3 4.4 1.0 1.4 11.1 17.8 5.6 9.0 0.0 5.0 4.3 5.4 6.1 0.0 2.2 0.0 5.9 5.4 9.0 3.4 0.0 1.7 10.2 0.0 0.1 0.0 0.5 0.0 5.3 0.0 2.4 6.8 1.6 5.4 0.0 1.7 2.6 0.0 0.1 0.0 6.5 0.6 10.6 0.0 7.7 0.8 0.0 0.0 0.0 0.0 2.0 0.4 6.7 11.2 7.8 0.1 5.2 4.7 4.6 4.2 3.3 0.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.2 0.1 0.1 0.5 0.2 0.5 0.3 0.7 0.5 0.2 0.3 0.7 0.6 0.0 0.3 0.6 0.0 0.5 0.3 2.7 3.7 6.1 2.9 2.3 2.6 3.0 3.5 3.2 2.9 3.4 4.4 6.4 3.2 3.1 10.4 2.6 0.9 0.6 1.4 2.8 10.5 1.7 3.0 6.1 4.3 2.3 0.0 0.0 2.2 2.2 0.1 0.0 1.3 0.4 1.3 5.5 4.3 0.0 2.1 8.0 0.9 1.4 5.1 0.5 1.3 1.3 7.4 4.6 0.9 1.7 16.8 2.5 0.5 2.0 1.6 2.2 0.4 3.1 1.7 1.8 4.7 0.6 5.4 1.0 17.6 16.2 0.7 0.1 5.7 0.7 0.6 0.2 0.6 1.3 5.0 6.6 7.0 3.9 2.3 1.3 2.2 0.9 0.5 2.2 4.3 0.7 0.3 ZNF37A "KOX21, ZNF37" ENSG00000075407 "Zinc finger protein 37A" P17032 10 38094334-38150293 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003172 Approved Approved Vesicles NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Vesicles "HPA003172: AB_1080709" "unprognostic (8.64e-2)" "unprognostic (1.24e-1)" "unprognostic (3.22e-1)" "unprognostic (6.87e-2)" "unprognostic (1.17e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.83e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (4.39e-2)" "unprognostic (1.29e-1)" "unprognostic (3.43e-2)" "unprognostic (3.09e-2)" 4.9 5.6 5.9 6.2 6.0 3.1 5.7 11.3 7.8 6.3 4.3 5.6 4.8 7.2 5.8 3.7 5.2 4.5 4.3 6.3 8.0 5.8 4.9 4.8 5.9 5.5 5.0 7.5 8.7 9.7 8.6 4.8 5.9 5.7 4.8 16.6 7.6 5.6 3.7 6.3 4.6 5.6 3.6 6.0 5.6 2.4 6.7 5.8 8.1 5.1 6.0 4.4 4.2 8.8 15.8 7.9 7.0 13.2 10.5 10.2 7.6 11.9 4.5 5.4 7.2 6.4 4.5 23.1 3.5 6.6 7.4 6.3 13.2 10.0 8.4 14.9 12.5 23.3 9.7 9.1 9.0 24.7 14.4 7.8 16.4 9.3 7.7 10.8 7.2 10.8 15.4 15.9 11.7 3.7 14.0 3.7 6.1 5.5 13.0 10.0 19.0 4.6 5.7 6.1 5.6 9.6 8.2 6.6 6.7 7.4 12.1 7.6 12.4 10.1 10.9 9.8 11.6 17.8 20.5 8.9 6.7 17.3 6.5 1.3 1.0 1.0 1.5 0.8 2.0 1.5 1.8 1.6 1.0 2.6 2.1 1.8 0.7 2.7 2.3 1.2 1.1 0.7 5.9 6.0 11.3 7.8 6.3 8.0 5.5 5.0 5.9 3.6 6.7 8.8 21.8 25.6 43.6 31.6 26.0 8.2 14.7 11.0 18.8 66.1 14.4 16.4 29.6 15.7 18.8 11.0 54.2 10.2 23.2 7.6 1.9 18.1 3.7 15.0 30.0 26.3 41.9 26.3 46.7 11.8 6.8 27.0 16.3 14.9 40.5 56.9 22.9 10.4 7.1 42.1 57.7 10.4 10.2 11.3 6.4 1.4 28.3 13.8 5.4 40.3 16.6 27.4 30.9 64.3 85.5 11.9 8.3 28.2 34.4 17.0 12.6 7.3 12.6 55.1 13.1 53.5 25.7 22.2 15.2 14.7 6.0 3.8 18.5 48.5 12.5 9.3 ZNF383 "FLJ35863, Zfp383" ENSG00000188283 "Zinc finger protein 383" Q8NA42 19 37217926-37248738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063945 Approved Supported "Nucleoplasm,Nuclear membrane" No No "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" "HPA063945: AB_2685158" "unprognostic (1.92e-1)" "unprognostic (1.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.26e-2)" "unprognostic (3.72e-3)" "unprognostic (1.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.27e-3)" "unprognostic (1.66e-2)" "unprognostic (1.27e-1)" "prognostic favorable (9.97e-4)" "unprognostic (7.40e-2)" "unprognostic (5.44e-2)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.01e-3)" "prognostic favorable (3.71e-4)" 3.6 3.2 2.5 3.4 4.4 3.5 5.1 8.5 3.4 4.1 1.5 3.3 3.5 3.8 3.6 3.6 3.7 2.9 4.9 2.7 3.5 4.4 3.2 3.5 6.1 3.7 3.1 5.8 2.9 4.4 2.8 3.2 3.8 4.1 3.5 5.4 4.0 3.9 7.4 5.4 3.4 3.8 2.0 5.1 3.9 3.9 3.7 5.7 5.3 9.0 6.0 3.4 3.4 7.1 2.9 6.8 4.6 7.1 5.7 5.8 3.1 4.1 5.6 4.0 5.9 3.1 3.6 4.0 5.9 3.9 3.8 3.0 3.6 5.5 5.9 5.4 4.2 5.7 5.2 2.6 6.1 6.9 6.2 7.1 4.6 3.9 7.6 5.1 3.7 5.5 3.2 2.1 5.0 1.4 6.3 3.2 4.2 5.8 1.9 4.4 8.4 3.7 3.6 8.2 5.2 4.1 6.6 3.8 5.7 5.8 4.6 4.1 2.3 5.0 3.5 3.7 4.0 6.5 6.4 7.9 0.7 3.2 4.7 3.7 3.2 5.3 5.8 3.9 8.2 8.0 5.4 7.1 3.3 10.7 8.6 6.9 3.5 4.8 4.9 3.1 6.0 3.9 2.5 4.4 8.5 3.4 2.7 3.5 3.7 3.1 3.8 2.0 3.7 7.1 7.2 3.2 4.4 7.5 10.2 2.7 4.0 3.4 5.7 9.8 3.7 5.2 12.8 7.2 2.5 1.8 14.6 3.8 7.5 3.8 1.9 3.5 8.9 3.6 5.4 5.1 2.4 11.0 7.4 3.6 4.8 5.8 4.6 3.7 5.7 7.8 6.4 2.2 3.8 15.2 8.7 3.8 2.0 6.3 3.5 3.0 6.5 4.5 8.8 4.7 5.5 6.2 10.3 9.5 10.4 2.7 3.6 7.5 3.8 5.1 5.8 3.9 2.5 9.9 13.1 9.9 6.1 5.8 5.2 3.9 3.3 4.9 8.5 6.6 4.8 4.1 ZNF397 "MGC13250, ZNF47, ZSCAN15" ENSG00000186812 "Zinc finger protein 397" Q8NF99 18 35241030-35267133 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026087 Uncertain Approved "Nucleoli,Plasma membrane,Microtubules,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli, Plasma membrane, Cytosol" Microtubules "HPA026087: AB_1859243" "unprognostic (1.97e-1)" "unprognostic (2.82e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-1)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.74e-3)" "unprognostic (1.45e-2)" "unprognostic (1.48e-2)" "unprognostic (3.28e-2)" "prognostic favorable (9.44e-4)" "unprognostic (2.46e-2)" "unprognostic (2.17e-3)" "unprognostic (3.83e-2)" "unprognostic (4.44e-2)" "unprognostic (1.06e-1)" "unprognostic (2.09e-3)" 12.9 13.4 17.6 14.4 23.4 5.0 16.1 19.1 20.0 13.5 14.9 12.8 10.6 15.7 12.4 9.8 11.7 10.1 10.5 16.4 20.7 11.3 10.6 10.4 16.2 20.5 20.9 17.8 12.4 14.8 12.0 11.9 20.1 13.9 13.9 25.0 12.4 12.1 11.7 13.6 12.6 11.5 15.4 16.1 13.3 9.9 20.3 13.1 15.7 11.0 15.8 11.9 11.8 34.4 4.2 7.9 18.7 17.1 20.3 17.0 8.9 8.4 8.3 4.1 5.4 3.0 5.7 21.2 7.4 6.7 5.6 11.1 12.2 9.2 5.7 13.5 7.5 0.9 11.7 8.6 6.7 10.3 7.4 7.7 12.1 4.9 14.1 14.6 2.6 16.1 12.7 14.4 10.7 9.1 17.4 7.8 16.1 3.2 3.2 18.2 5.4 15.1 8.4 11.0 20.2 17.4 13.7 7.2 8.2 16.2 12.5 7.6 4.2 13.6 7.6 4.6 3.8 23.2 9.3 11.9 12.0 7.1 13.1 10.1 4.6 8.3 5.7 7.5 4.1 10.6 5.3 4.7 3.3 11.3 7.8 5.4 11.0 4.7 9.4 7.5 3.0 2.2 17.6 23.4 19.1 20.0 16.4 20.7 20.5 20.9 20.1 15.4 20.3 34.4 15.5 35.3 21.0 24.5 35.3 4.1 19.4 8.0 10.2 51.0 11.8 10.4 16.4 15.7 17.3 14.7 35.5 22.6 15.8 14.1 13.7 18.7 66.0 10.8 20.4 17.6 31.0 20.4 17.4 10.9 13.4 18.4 12.8 8.9 11.4 31.7 31.1 12.6 10.8 33.7 19.5 11.5 12.2 20.5 5.4 49.6 18.6 11.8 8.8 23.4 20.3 24.6 15.5 30.2 94.1 10.7 18.3 22.6 6.1 15.8 24.3 11.4 16.4 46.1 32.9 25.3 16.6 29.7 23.4 7.8 4.5 14.6 13.9 22.1 16.1 11.1 ZNF418 "FLJ31551, KIAA1956" ENSG00000196724 "Zinc finger protein 418" Q8TF45 19 57921882-57935402 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 9.1;Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 11.1;SuSa: 7.6;T-47d: 6.9" "HPA043800, HPA053762, HPA072145" Approved Uncertain Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (4.41e-2)" "unprognostic (3.20e-1)" "unprognostic (1.91e-1)" "unprognostic (4.27e-1)" "unprognostic (2.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-1)" "unprognostic (2.20e-1)" "unprognostic (2.96e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.63e-2)" "unprognostic (4.77e-2)" "unprognostic (1.66e-1)" "unprognostic (1.29e-1)" "unprognostic (1.36e-3)" 2.2 2.8 4.9 2.4 5.7 2.0 5.9 10.3 5.0 3.2 0.2 4.5 1.0 4.1 5.3 2.0 4.7 2.4 8.7 4.5 5.6 4.1 2.3 2.6 5.2 2.6 3.3 6.2 4.5 6.2 5.3 5.7 2.5 4.7 1.5 12.4 3.5 5.6 3.3 9.0 2.5 4.0 1.4 5.1 3.5 4.4 4.9 4.6 6.7 4.9 4.5 3.6 2.9 9.2 0.3 1.3 11.1 3.6 1.7 3.6 1.2 3.4 1.1 2.5 0.2 0.2 1.2 0.4 2.3 1.7 3.3 1.0 0.0 2.8 3.0 0.3 1.0 0.2 0.7 0.1 1.0 0.3 2.3 3.0 0.8 3.1 0.0 0.0 0.5 1.0 0.9 0.8 2.1 0.4 0.6 0.4 5.7 0.1 0.4 0.5 0.8 4.0 2.1 1.4 0.2 0.5 0.1 2.0 0.1 7.6 6.9 1.2 0.0 0.7 0.5 0.4 0.6 1.8 4.7 2.9 0.3 1.3 2.2 1.3 0.5 0.5 0.1 1.3 0.4 3.2 1.1 0.7 1.0 5.5 1.8 0.5 0.6 4.3 0.5 1.8 0.0 0.8 4.9 5.7 10.3 5.0 4.5 5.6 2.6 3.3 2.5 1.4 4.9 9.2 1.7 0.0 0.6 4.2 2.9 0.4 0.8 0.4 0.6 4.3 1.8 1.4 9.1 1.5 1.0 0.0 4.2 1.0 0.8 0.0 1.9 1.2 0.1 1.8 0.9 1.9 0.0 2.5 4.1 0.6 0.6 1.9 1.1 1.1 5.7 2.5 2.5 0.8 0.8 3.3 3.5 0.0 0.0 0.3 0.7 0.9 0.3 0.6 0.0 1.9 0.2 4.3 1.0 4.0 6.3 0.2 1.2 1.5 0.1 1.1 0.0 1.1 5.6 5.9 13.1 0.7 1.3 2.6 5.6 0.7 0.4 0.8 0.7 0.3 0.2 0.8 ZNF419 "ZAPHIR, ZNF419A" ENSG00000105136 "Zinc finger protein 419" Q96HQ0 19 57487711-57496098 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 31.9" "HPA003152, HPA003274" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716, HPA003274: AB_1080714" "unprognostic (3.50e-2)" "unprognostic (1.40e-5)" "unprognostic (1.12e-1)" "unprognostic (2.63e-2)" "unprognostic (2.55e-2)" "unprognostic (8.26e-2)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (3.18e-1)" "unprognostic (1.33e-1)" "unprognostic (8.55e-5)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.20e-1)" "unprognostic (2.42e-1)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.53e-5)" 6.0 8.7 10.0 4.6 10.1 3.0 6.2 10.7 12.6 4.8 9.9 6.3 3.8 5.3 9.7 4.7 6.2 3.5 8.2 10.0 10.1 8.1 6.6 7.0 7.4 9.4 8.9 7.8 4.6 9.1 13.4 6.1 8.8 8.9 3.6 11.1 6.4 6.3 10.4 7.4 6.2 4.0 8.9 10.6 5.3 5.3 10.2 8.0 10.8 7.8 8.9 5.4 4.6 10.1 5.4 6.0 10.3 10.5 4.7 7.1 8.9 6.4 8.8 5.8 31.9 3.8 3.4 1.8 5.1 4.5 5.2 1.6 4.9 13.3 8.0 0.5 22.4 8.3 9.1 4.2 16.8 6.5 6.0 9.7 19.3 5.8 13.8 12.0 6.4 8.0 0.9 1.3 7.3 0.9 10.9 6.7 6.8 0.7 7.9 10.1 9.9 7.6 6.3 11.5 8.4 9.4 6.5 6.0 6.2 8.8 5.3 9.7 6.6 7.0 7.7 2.5 5.6 15.2 18.0 4.5 5.6 3.5 5.7 4.5 2.7 6.1 5.2 3.3 8.9 14.3 8.9 6.6 4.7 15.8 13.8 7.4 3.2 9.7 2.7 3.4 6.5 4.4 10.0 10.1 10.7 12.6 10.0 10.1 9.4 8.9 8.8 8.9 10.2 10.1 3.1 0.0 5.3 3.6 7.2 4.1 5.7 4.9 2.8 8.1 4.3 5.2 5.3 4.3 5.2 7.3 6.2 5.0 4.2 1.3 0.0 5.8 0.3 2.0 2.1 4.8 1.2 2.5 3.3 1.8 2.4 3.7 0.5 1.7 4.5 7.4 5.7 4.6 3.2 10.1 2.8 1.8 8.2 3.2 1.7 0.5 1.8 1.8 5.4 0.0 4.1 6.8 7.2 3.5 1.9 2.5 2.8 5.7 1.6 9.0 2.0 1.9 1.8 9.5 6.6 2.9 3.3 4.9 10.4 2.1 3.8 8.3 4.8 4.2 1.8 5.6 ZNF420 FLJ32191 ENSG00000197050 "Zinc finger protein 420" Q8TAQ5 19 37007857-37130368 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059675 Approved Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA059675: AB_2684101" "unprognostic (1.00e-2)" "unprognostic (5.00e-2)" "unprognostic (2.30e-2)" "unprognostic (5.40e-3)" "prognostic favorable (3.57e-5)" "unprognostic (7.94e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (7.14e-3)" "unprognostic (1.64e-1)" "unprognostic (5.24e-2)" "unprognostic (7.59e-2)" "prognostic favorable (1.83e-4)" "unprognostic (2.42e-1)" "unprognostic (7.23e-2)" "unprognostic (7.35e-3)" "unprognostic (1.63e-2)" 3.0 4.2 4.9 2.5 5.2 1.6 5.6 6.7 6.2 5.0 5.0 3.9 2.5 4.5 3.9 3.0 5.1 2.7 3.3 4.9 5.0 4.2 3.3 2.8 4.2 4.5 4.8 8.0 3.2 6.3 3.4 3.3 5.5 4.2 2.5 7.3 3.4 4.0 5.5 3.4 2.7 4.1 5.0 4.4 3.1 9.8 4.9 5.7 6.6 6.5 4.6 3.4 3.2 5.4 0.0 6.8 6.4 6.7 5.8 3.8 3.2 4.2 4.1 4.7 7.1 1.5 1.4 3.3 8.1 2.9 2.9 1.2 6.6 2.1 5.5 10.8 5.0 7.5 3.6 2.8 6.0 6.3 3.2 4.0 4.5 5.1 3.5 5.4 2.7 5.6 4.1 0.3 5.5 2.3 10.7 2.4 7.4 2.7 4.1 6.1 12.9 6.8 2.7 4.5 8.7 9.7 6.1 2.5 3.4 4.5 4.0 4.9 3.1 5.0 7.7 4.6 4.9 9.9 12.9 8.2 0.0 1.3 4.4 2.1 2.9 6.8 9.9 4.0 10.6 9.8 11.0 10.4 5.6 13.7 11.1 12.3 0.5 12.3 4.3 3.0 14.3 5.9 4.9 5.2 6.7 6.2 4.9 5.0 4.5 4.8 5.5 5.0 4.9 5.4 7.1 12.8 8.6 11.1 11.0 9.9 3.3 4.0 7.4 18.7 7.4 6.3 6.1 4.3 6.6 3.7 0.0 9.2 6.2 2.1 7.9 4.1 31.4 4.6 4.1 6.7 6.0 4.2 32.8 1.3 4.1 7.0 0.5 2.9 12.7 15.3 10.0 4.2 4.2 16.8 24.2 2.8 8.2 3.8 2.3 34.5 9.6 3.5 7.2 26.2 2.8 5.9 12.3 28.1 26.4 1.9 2.9 9.4 5.9 4.2 2.7 5.3 10.7 9.0 26.3 10.5 6.5 15.5 7.4 6.4 8.7 4.0 10.4 6.6 4.3 2.6 ZNF429 ENSG00000197013 "Zinc finger protein 429" Q86V71 19 21496682-21556270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004139 Approved Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA004139: AB_2667147" "unprognostic (1.06e-1)" "unprognostic (1.88e-1)" "unprognostic (2.77e-1)" "unprognostic (1.75e-2)" "unprognostic (1.45e-2)" "unprognostic (3.13e-1)" "unprognostic (3.39e-2)" "unprognostic (1.95e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.96e-8)" "prognostic favorable (7.30e-4)" "unprognostic (5.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.48e-1)" 2.8 4.7 5.1 2.8 4.7 2.4 5.2 7.4 6.1 4.2 6.4 3.2 2.6 3.3 6.1 2.1 4.9 2.8 2.1 4.5 3.3 5.4 5.6 3.3 4.9 4.2 3.1 6.8 5.1 5.4 3.5 3.6 4.4 4.3 4.1 5.4 3.6 2.9 2.2 6.8 3.1 2.2 2.1 5.9 4.4 4.5 4.4 5.7 7.8 2.2 3.5 2.2 2.6 7.3 0.3 0.6 3.7 5.2 2.7 2.4 4.0 2.0 1.5 2.7 3.6 0.4 2.7 3.5 5.6 1.3 2.4 1.3 2.1 0.9 4.9 0.9 2.7 0.8 0.9 1.3 1.5 3.6 1.4 2.5 1.2 1.7 0.6 2.5 0.2 4.9 5.5 0.9 4.4 2.4 8.5 3.4 4.1 0.1 1.3 4.1 2.1 1.8 3.2 4.2 6.5 2.9 0.3 0.2 1.6 7.1 4.9 3.2 0.6 0.4 0.9 3.5 1.7 0.7 3.0 4.4 0.2 0.4 1.4 8.9 1.3 6.7 3.5 1.7 3.8 5.5 4.8 4.7 1.2 4.9 6.7 6.2 6.9 7.1 2.2 1.9 3.2 1.9 5.1 4.7 7.4 6.1 4.5 3.3 4.2 3.1 4.4 2.1 4.4 7.3 6.1 28.9 13.6 14.7 13.6 2.8 6.5 3.8 8.6 15.9 8.6 8.0 6.0 18.6 10.8 7.3 6.2 9.1 5.1 3.8 21.5 8.7 39.2 9.6 8.7 7.7 6.7 10.1 17.5 4.9 6.9 9.5 9.2 7.8 3.8 19.0 7.1 8.5 3.4 3.3 20.8 5.1 8.2 3.1 4.0 7.6 11.5 5.4 5.4 12.2 4.5 11.4 23.7 20.6 20.4 4.4 6.1 6.0 3.7 5.0 10.9 13.6 12.2 8.1 19.7 6.0 7.5 14.0 17.3 9.4 2.0 6.8 10.3 37.2 5.8 4.6 ZNF430 FLJ13659 ENSG00000118620 "Zinc finger protein 430" Q9H8G1 19 21020634-21060050 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059135 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA059135: AB_2683918" "unprognostic (2.47e-1)" "unprognostic (4.29e-1)" "unprognostic (1.38e-1)" "unprognostic (4.14e-2)" "unprognostic (1.11e-1)" "unprognostic (4.75e-3)" "unprognostic (5.86e-2)" "unprognostic (1.91e-1)" "unprognostic (1.51e-4)" "unprognostic (2.03e-3)" "unprognostic (2.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.19e-1)" "unprognostic (2.31e-1)" "unprognostic (1.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.24e-3)" 3.2 3.0 3.0 5.4 4.4 12.0 5.2 7.3 3.5 4.0 0.0 3.1 3.7 4.3 8.5 6.8 3.8 3.5 1.9 1.8 2.7 2.7 1.2 3.8 10.3 3.8 2.7 12.7 4.1 7.9 1.9 3.4 3.8 4.9 4.2 2.9 3.5 3.8 1.5 7.0 3.4 3.5 1.9 6.7 4.9 3.0 3.1 9.8 8.6 2.7 7.8 4.5 4.7 5.9 6.6 1.9 8.0 5.7 6.0 11.2 7.7 6.0 6.4 8.6 8.2 3.7 6.0 10.4 5.7 5.2 5.4 3.7 0.3 6.0 13.0 3.8 7.7 7.3 4.3 3.5 2.9 2.5 14.4 5.9 7.3 5.4 9.9 6.1 6.2 10.8 8.2 12.0 7.8 3.0 17.4 7.8 8.0 3.4 12.8 11.2 10.8 6.0 6.3 9.6 8.9 5.8 1.7 0.8 5.1 7.7 3.5 12.9 4.3 4.6 2.9 8.9 7.4 6.2 7.0 13.1 2.1 7.2 4.6 19.6 4.4 15.9 8.5 5.2 10.4 10.2 10.6 10.1 3.6 13.0 13.9 11.2 10.3 10.4 5.5 6.6 11.4 4.8 3.0 4.4 7.3 3.5 1.8 2.7 3.8 2.7 3.8 1.9 3.1 5.9 16.8 9.6 12.8 16.3 48.2 28.7 23.7 13.2 21.6 33.1 11.4 11.0 4.0 5.7 9.8 18.4 20.9 12.3 50.8 8.3 1.9 11.9 0.8 11.6 17.8 14.4 10.7 16.2 13.8 8.0 10.6 15.1 13.7 33.3 17.7 45.6 16.1 0.8 10.2 23.5 18.6 7.7 12.2 16.9 17.7 1.8 15.2 20.6 3.6 11.2 19.0 8.6 28.8 23.1 31.1 13.9 7.5 11.3 27.9 26.8 7.0 1.9 12.1 19.7 0.0 13.9 14.8 18.4 16.8 33.5 35.5 9.9 40.9 32.8 9.6 50.4 ZNF431 KIAA1969 ENSG00000196705 "Zinc finger protein 431" Q8TF32 19 21142024-21196053 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 121.8;Granulosa cells: 132.7;Theca cells: 185.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059135 Uncertain NA NA "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA059135: AB_2683918" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (1.39e-1)" "unprognostic (2.94e-2)" "unprognostic (1.37e-2)" "unprognostic (9.08e-2)" "unprognostic (2.30e-2)" "unprognostic (7.86e-2)" "unprognostic (1.97e-3)" "unprognostic (2.93e-3)" "unprognostic (5.91e-2)" "unprognostic (9.37e-3)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (2.77e-1)" "unprognostic (2.29e-2)" "unprognostic (3.01e-3)" 5.0 10.3 2.5 6.1 3.4 14.6 7.3 7.5 3.4 8.3 0.4 4.0 3.4 5.7 6.9 19.2 4.9 3.1 7.6 2.1 2.8 3.7 1.2 6.7 9.4 2.9 3.8 21.9 7.1 4.9 3.5 5.6 4.3 5.1 5.0 7.1 6.7 3.3 5.2 11.6 4.8 4.6 1.5 6.7 6.4 8.3 2.8 9.6 12.3 5.7 8.3 4.5 11.3 5.9 11.0 3.1 9.7 11.4 2.7 5.4 14.7 5.6 4.9 10.5 10.4 6.0 7.7 13.9 9.6 3.8 4.9 7.2 8.5 6.1 12.8 5.0 10.7 10.6 8.3 3.7 2.6 5.3 10.7 3.9 10.9 6.6 6.3 5.9 8.2 12.3 19.5 8.1 6.3 4.7 16.9 5.9 11.3 4.2 9.2 9.2 12.4 3.9 4.1 12.6 9.3 7.8 14.5 0.1 5.1 15.3 6.0 9.3 5.0 6.6 0.5 9.1 8.2 6.4 12.9 18.1 1.6 9.2 4.5 4.1 3.4 7.1 2.8 3.1 4.1 8.1 4.9 3.8 2.4 8.0 6.0 4.7 5.0 8.6 4.3 5.8 4.1 1.8 2.5 3.4 7.5 3.4 2.1 2.8 2.9 3.8 4.3 1.5 2.8 5.9 17.5 121.8 22.1 7.2 32.0 12.6 15.0 8.0 15.4 32.8 13.6 13.7 17.3 12.8 20.1 23.9 37.5 17.6 34.4 9.0 3.9 12.6 3.7 23.2 30.5 16.5 16.9 19.3 12.5 8.8 18.4 19.9 24.5 52.5 20.3 132.7 17.5 0.6 10.7 15.2 12.5 10.2 12.2 17.9 11.3 5.4 32.6 16.4 3.6 19.7 16.0 11.3 43.3 16.6 24.0 14.0 3.1 21.4 21.2 17.8 5.5 4.5 11.9 30.8 19.7 25.2 23.2 26.7 16.1 26.0 15.5 11.6 27.1 185.6 10.4 31.7 ZNF439 DKFZp571K0837 ENSG00000171291 "Zinc finger protein 439" Q8NDP4 19 11848726-11883750 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 52.1;Rod photoreceptor cells: 49.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 26.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 15.4;U-138 MG: 15.6" HPA047845 Approved Uncertain Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (4.83e-2)" "unprognostic (3.55e-3)" "unprognostic (2.93e-2)" "unprognostic (1.19e-3)" "unprognostic (8.26e-3)" "unprognostic (7.54e-2)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "unprognostic (9.66e-4)" "unprognostic (1.00e-1)" "unprognostic (8.68e-2)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.29e-2)" 2.6 3.5 3.8 3.5 4.7 4.2 5.7 8.2 5.2 4.2 4.3 5.0 1.1 5.2 5.0 3.2 4.0 2.4 3.5 4.0 4.0 6.3 1.3 5.1 7.3 4.5 4.1 8.1 4.1 16.5 10.1 5.2 5.0 6.2 3.8 14.7 5.3 4.4 0.8 8.0 8.0 2.6 4.0 9.4 3.9 5.7 4.1 10.0 7.3 1.1 7.6 5.6 4.8 6.7 0.1 0.0 4.2 12.2 0.4 0.3 0.0 5.2 1.8 6.2 4.2 3.0 0.2 4.5 2.2 2.9 1.8 0.1 0.0 0.4 7.2 0.0 0.1 4.4 0.0 1.8 1.2 0.0 4.2 1.2 0.3 1.3 0.0 2.7 0.0 4.2 0.8 0.0 0.4 0.4 6.2 15.4 5.1 0.0 1.2 7.3 1.2 0.0 4.6 2.6 7.5 8.0 0.0 0.1 5.6 4.3 3.2 10.0 0.0 15.6 1.4 1.3 3.1 6.0 10.1 10.1 0.2 0.0 4.3 26.1 0.6 5.7 1.7 1.6 2.3 8.9 3.0 1.7 2.8 8.6 5.4 3.1 1.6 2.2 3.5 2.7 1.4 1.9 3.8 4.7 8.2 5.2 4.0 4.0 4.5 4.1 5.0 4.0 4.1 6.7 3.1 3.2 10.4 15.0 23.9 0.5 2.5 1.6 3.4 26.2 3.9 4.6 3.5 11.5 6.8 0.0 52.1 32.8 8.3 9.2 3.9 8.2 4.5 6.5 5.1 4.6 6.1 3.0 19.2 1.8 22.2 3.8 4.1 4.4 29.8 11.2 6.1 0.2 4.2 16.8 8.7 2.3 2.0 1.9 3.1 3.8 4.4 2.7 5.4 14.0 2.4 10.4 25.7 31.7 28.3 3.0 6.0 7.9 4.1 2.1 6.5 2.1 5.8 49.9 13.1 1.8 5.9 21.7 5.8 1.1 1.8 13.5 7.4 2.8 3.1 1.3 ZNF445 "ZKSCAN15, ZNF168, ZSCAN47" ENSG00000185219 "Zinc finger protein 445" P59923 3 44431705-44477670 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006678 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 72: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Mitochondria, Cytosol" "HPA006678: AB_10603329" "unprognostic (7.72e-2)" "unprognostic (2.55e-1)" "unprognostic (1.12e-2)" "unprognostic (1.42e-1)" "unprognostic (7.14e-2)" "unprognostic (1.67e-2)" "unprognostic (1.79e-2)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.62e-1)" "unprognostic (1.03e-2)" "unprognostic (4.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.76e-1)" "unprognostic (2.48e-1)" "unprognostic (4.40e-3)" "unprognostic (1.05e-1)" 4.2 3.0 2.3 1.8 2.5 1.3 3.9 4.3 2.4 6.0 1.1 4.7 1.4 5.1 2.0 2.7 5.0 1.6 3.6 2.4 2.4 3.3 4.9 4.1 1.9 2.1 2.1 7.0 4.4 2.8 5.0 2.0 2.2 4.4 1.7 4.2 3.6 2.1 4.4 3.7 3.5 2.2 1.7 3.9 3.9 3.1 2.2 3.3 3.8 2.7 2.1 4.1 4.4 2.9 1.9 2.1 6.4 5.1 3.5 3.6 2.9 2.5 2.1 3.7 3.7 3.2 1.6 3.3 1.5 2.6 2.3 1.5 4.4 1.7 4.5 3.6 1.6 6.1 4.7 3.2 2.2 7.8 4.9 2.5 2.1 4.2 2.6 3.1 2.6 4.6 4.8 2.4 3.0 1.2 7.5 5.2 4.4 1.2 1.9 3.3 4.0 1.6 2.0 3.8 3.2 3.9 3.9 2.0 1.0 4.7 3.7 3.4 3.2 5.2 4.6 3.2 3.2 1.9 1.5 2.7 1.9 3.8 3.2 1.0 0.3 0.6 0.3 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.3 0.2 1.0 0.5 0.8 0.3 0.1 0.1 2.3 2.5 4.3 2.4 2.4 2.4 2.1 2.1 2.2 1.7 2.2 2.9 11.7 12.8 17.4 19.2 8.4 4.1 4.4 2.9 9.6 36.0 4.8 4.4 11.1 5.7 7.6 11.0 37.5 4.1 15.7 3.8 1.9 5.8 2.5 6.3 14.1 9.7 7.2 10.3 21.7 8.4 1.7 9.0 7.1 6.8 11.4 26.6 13.2 10.1 5.7 28.6 24.3 6.3 2.0 16.4 4.7 2.2 9.3 10.5 0.0 9.4 11.6 10.1 22.6 11.6 19.5 4.9 6.0 9.8 9.5 5.6 4.3 2.8 9.6 28.4 13.1 14.5 10.6 6.7 6.9 5.6 2.6 1.4 9.8 9.3 7.2 3.8 ZNF471 "KIAA1396, Z1971, Zfp78" ENSG00000196263 "Zinc finger protein 471" Q9BX82 19 56507850-56530221 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 24.8;Oligodendrocytes: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 8.5;hTERT-RPE1: 12.6;SuSa: 9.0" "Low region specificity" "Detected in all" HPA066695 Uncertain Supported Nucleoplasm NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA066695: AB_2685704" "unprognostic (2.89e-2)" "unprognostic (2.79e-4)" "unprognostic (1.58e-1)" "unprognostic (2.90e-2)" "unprognostic (2.22e-1)" "unprognostic (2.42e-3)" "unprognostic (1.45e-1)" "unprognostic (8.44e-2)" "unprognostic (1.01e-2)" "unprognostic (4.14e-2)" "unprognostic (4.47e-4)" "unprognostic (9.36e-2)" "prognostic favorable (2.37e-4)" "unprognostic (3.84e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-2)" "unprognostic (3.44e-3)" 5.7 6.3 13.6 2.4 16.1 2.8 7.1 14.0 14.8 10.3 7.4 8.9 1.8 13.3 15.9 4.8 10.5 6.8 5.7 13.4 16.6 5.3 2.4 5.6 3.0 14.8 13.1 22.4 3.6 10.4 8.4 6.2 13.7 8.2 4.5 28.5 6.0 7.5 4.9 9.5 3.2 7.9 9.9 4.4 4.5 8.5 14.7 2.7 9.8 6.3 2.0 7.0 7.6 25.5 0.4 0.5 4.8 0.6 4.1 4.5 0.5 4.5 1.6 2.1 1.8 0.6 0.6 0.6 3.0 5.0 4.0 0.3 0.6 0.4 2.0 1.0 1.8 3.6 1.3 0.5 4.0 1.0 3.1 8.5 1.6 2.6 0.2 12.6 0.2 0.5 1.1 1.3 2.3 0.5 0.4 0.6 1.1 0.3 1.9 0.4 3.1 0.4 3.5 3.7 0.6 2.9 0.4 0.1 0.2 9.0 0.6 0.7 0.7 7.6 3.2 0.6 3.5 1.0 1.1 0.3 0.6 0.5 0.4 1.5 0.4 0.3 0.6 0.3 0.4 0.4 0.5 0.4 0.2 0.9 0.5 0.7 1.8 1.0 0.4 0.5 0.3 0.1 13.6 16.1 14.0 14.8 13.4 16.6 14.8 13.1 13.7 9.9 14.7 25.5 5.7 19.2 18.4 24.8 0.6 0.6 2.4 1.6 2.2 11.2 4.1 4.6 10.9 2.8 7.8 5.5 6.2 1.0 1.7 0.9 3.9 2.1 10.2 8.2 5.9 6.0 1.2 0.4 15.0 1.0 0.4 4.6 1.5 6.7 2.5 8.4 5.0 0.8 0.5 6.7 14.4 0.9 0.0 0.6 0.3 3.6 5.0 1.9 1.8 5.6 0.6 7.9 2.1 20.1 32.3 0.7 0.2 7.2 0.0 2.5 0.5 1.6 11.9 9.5 6.6 7.9 6.7 9.9 8.2 1.6 0.6 0.8 0.9 3.6 1.2 1.6 ZNF493 FLJ36504 ENSG00000196268 "Zinc finger protein 493" Q6ZR52 19 21397119-21427577 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 21.7" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (3.49e-1)" "unprognostic (5.80e-3)" "unprognostic (1.28e-1)" "unprognostic (2.83e-2)" "unprognostic (2.54e-2)" "unprognostic (2.71e-3)" "unprognostic (5.90e-2)" "unprognostic (1.75e-3)" "unprognostic (2.30e-2)" "unprognostic (1.82e-3)" "unprognostic (4.13e-3)" "unprognostic (6.03e-3)" "unprognostic (2.08e-1)" "unprognostic (1.34e-2)" "unprognostic (4.80e-1)" "unprognostic (3.55e-1)" "unprognostic (6.00e-4)" 5.1 7.5 9.0 6.2 11.2 11.1 8.6 34.2 11.1 8.3 4.7 6.5 5.7 9.0 8.8 4.6 7.9 5.4 6.5 7.3 9.0 10.1 3.9 7.6 11.5 11.0 7.6 22.2 9.5 10.8 9.9 5.0 11.1 8.1 6.8 17.7 8.4 5.1 6.1 9.2 6.6 5.5 3.9 9.4 9.0 6.1 8.9 13.6 20.3 3.9 8.6 6.7 6.7 14.7 0.9 0.3 7.4 11.6 4.8 4.7 9.0 2.8 3.0 3.9 5.5 1.5 5.2 9.0 5.5 2.5 2.9 2.2 5.8 1.9 4.0 0.7 9.7 5.0 6.0 3.6 2.9 0.1 0.8 4.1 2.2 2.9 2.0 5.3 1.0 17.9 6.3 2.3 4.6 1.5 21.7 10.4 8.5 0.1 2.6 11.2 6.0 3.8 4.0 7.8 10.2 5.6 0.4 0.8 2.7 11.2 8.1 5.0 2.8 3.1 0.6 5.2 2.6 7.1 11.0 7.4 0.4 0.5 1.4 10.4 3.7 10.4 11.6 3.1 11.6 16.4 10.7 12.9 3.1 16.3 15.2 14.0 34.1 14.1 4.7 9.1 8.8 2.0 9.0 11.2 34.2 11.1 7.3 9.0 11.0 7.6 11.1 3.9 8.9 14.7 16.2 41.7 16.8 37.9 33.1 9.9 12.0 10.4 31.3 41.1 19.6 15.4 7.4 17.2 18.6 29.5 41.7 10.3 26.6 10.5 7.9 11.0 1.6 9.9 14.0 17.1 13.1 32.2 65.4 8.2 10.6 18.8 14.3 14.3 5.7 56.5 20.7 4.0 4.9 50.5 74.3 9.2 20.3 11.1 9.6 2.7 22.1 8.1 8.8 30.9 7.4 17.7 41.2 69.9 81.5 7.7 6.7 15.4 13.0 15.1 11.3 6.1 17.9 24.0 26.3 22.4 12.4 10.9 12.8 19.7 11.8 10.0 24.7 43.8 13.1 19.2 ZNF500 "KIAA0557, ZKSCAN18, ZSCAN50" ENSG00000103199 "Zinc finger protein 500" O60304 16 4748239-4767624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035498, HPA057963" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA035498: AB_10602356, HPA057963: AB_2683565" "unprognostic (3.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.57e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (3.61e-3)" "unprognostic (8.72e-3)" "unprognostic (7.77e-3)" "unprognostic (1.45e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (4.07e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.41e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (3.19e-2)" 4.1 3.2 1.7 2.5 1.9 2.2 4.1 4.4 3.1 5.4 1.8 4.7 2.8 6.0 1.6 3.2 4.9 1.9 3.0 2.4 1.1 3.0 2.7 3.1 3.1 2.3 1.7 6.6 3.6 2.6 4.0 2.2 1.1 4.8 1.7 1.7 4.2 2.6 3.3 4.5 3.5 1.5 0.5 4.7 3.6 3.8 1.4 2.4 4.6 1.4 2.2 4.8 4.4 3.0 1.8 7.2 2.3 6.2 2.7 2.4 10.7 5.2 5.7 6.4 4.3 3.2 3.4 3.8 4.4 2.8 2.3 4.0 4.5 2.7 4.6 2.8 7.4 3.1 10.8 4.4 3.8 2.3 3.3 2.9 6.5 2.9 5.3 6.2 3.6 4.8 4.7 5.9 2.5 4.0 4.7 4.0 3.0 1.4 2.6 8.1 5.6 7.6 2.1 2.0 8.7 5.7 4.5 6.6 2.0 1.6 4.3 3.6 4.1 6.0 4.4 6.7 2.5 5.6 4.1 3.4 1.8 1.9 3.8 1.3 1.0 1.5 1.5 1.0 1.2 2.1 0.9 1.1 0.5 1.9 1.5 1.9 1.1 1.2 0.7 2.6 1.7 1.0 1.7 1.9 4.4 3.1 2.4 1.1 2.3 1.7 1.1 0.5 1.4 3.0 4.8 12.8 2.7 5.5 5.8 2.4 3.2 3.6 1.8 19.1 3.7 3.0 5.3 5.7 3.0 7.3 25.0 6.8 10.1 4.6 1.9 4.6 8.9 5.1 6.4 5.5 8.4 5.7 8.8 3.1 4.4 5.9 4.6 2.9 7.0 12.0 12.1 4.1 3.3 18.5 6.3 6.8 4.1 4.8 3.8 1.8 11.5 3.4 1.8 3.7 8.4 11.1 6.2 6.0 5.9 3.5 2.3 11.3 4.3 5.2 7.3 3.3 6.6 20.8 0.0 8.0 4.8 13.2 8.8 1.7 2.3 4.5 5.0 9.8 5.5 1.8 ZNF506 DKFZp761G1812 ENSG00000081665 "Zinc finger protein 506" Q5JVG8 19 19785839-19821751 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (1.88e-3)" "unprognostic (4.12e-2)" "unprognostic (1.75e-1)" "unprognostic (1.33e-2)" "unprognostic (6.26e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (3.68e-3)" "unprognostic (4.74e-3)" "unprognostic (7.95e-2)" "unprognostic (1.52e-3)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (4.39e-2)" "unprognostic (2.37e-1)" "unprognostic (1.28e-2)" "unprognostic (2.51e-3)" 9.8 6.0 7.1 7.4 9.2 9.1 10.4 11.2 15.7 9.6 6.7 8.4 7.8 8.7 11.6 7.8 8.7 8.2 9.9 6.8 7.2 10.8 4.3 7.0 11.2 7.3 6.6 12.7 10.7 10.7 5.9 7.7 7.2 9.5 8.5 12.0 7.1 7.6 7.8 14.0 8.9 6.5 6.1 11.4 9.9 5.7 8.2 9.8 16.8 5.6 12.9 10.5 3.5 13.4 1.3 0.8 7.6 1.2 6.9 9.3 11.9 4.5 2.6 4.2 2.8 3.5 8.9 13.1 10.4 4.2 7.8 8.0 6.2 0.4 5.8 1.9 8.7 1.7 2.8 1.5 9.6 2.2 1.6 7.0 7.1 4.5 0.5 3.5 0.8 7.0 1.2 2.4 6.4 1.2 22.6 4.7 11.2 2.3 1.9 7.1 12.5 6.2 11.1 4.8 12.6 8.5 9.2 4.8 4.9 9.4 9.3 13.3 3.5 5.3 0.8 10.9 5.0 4.3 2.4 7.2 0.5 6.2 7.1 7.7 4.2 9.4 6.4 4.7 7.5 10.6 6.7 6.1 3.3 12.5 12.5 10.7 8.2 7.3 6.7 11.9 7.1 4.2 7.1 9.2 11.2 15.7 6.8 7.2 7.3 6.6 7.2 6.1 8.2 13.4 18.1 16.0 12.6 19.6 30.3 6.2 10.0 7.5 10.2 18.1 12.6 11.9 10.0 15.7 11.7 36.8 27.1 10.3 34.4 11.4 35.2 10.0 35.7 19.3 14.6 14.0 10.3 1.7 24.4 11.6 6.5 14.6 11.2 22.9 9.5 20.0 13.9 2.8 8.1 26.9 29.5 11.2 12.2 8.7 11.4 7.4 12.2 9.2 8.8 25.3 8.0 14.2 35.0 33.7 42.0 13.3 9.0 9.8 17.2 14.3 11.4 37.0 12.1 19.8 6.6 11.6 14.4 7.5 5.3 7.6 8.5 14.6 25.2 14.3 9.8 12.1 ZNF507 "KIAA1084, Zfp507" ENSG00000168813 "Zinc finger protein 507" Q8TCN5 19 32345594-32387667 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030964, HPA049728" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoli Cytosol "HPA030964: AB_10670562, HPA049728: AB_2680864" "unprognostic (3.39e-1)" "unprognostic (3.78e-2)" "unprognostic (6.84e-2)" "unprognostic (2.61e-2)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (1.41e-3)" "unprognostic (1.20e-1)" "unprognostic (3.24e-2)" "unprognostic (4.28e-3)" "unprognostic (7.24e-2)" "unprognostic (7.44e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (1.46e-2)" 5.1 4.2 4.3 4.6 5.7 6.8 6.8 6.4 5.6 5.9 3.4 4.9 5.7 6.8 4.3 5.1 5.9 4.3 5.6 4.4 4.8 4.7 6.3 4.4 6.7 4.7 5.3 9.5 5.3 6.2 3.7 7.0 5.0 5.9 5.3 8.1 6.4 4.7 9.2 4.7 5.9 6.0 4.8 5.2 5.2 13.1 4.7 8.6 10.7 8.7 5.8 4.3 4.1 7.3 10.0 16.2 13.5 8.2 9.3 14.6 11.4 8.5 8.1 7.3 8.1 9.8 7.6 15.1 10.5 7.8 8.3 5.9 19.4 10.5 14.8 10.6 15.3 14.8 8.7 7.7 11.0 12.8 8.0 9.5 8.9 9.0 15.4 8.6 10.9 11.9 21.0 10.7 8.6 5.8 13.5 5.2 14.9 15.0 5.8 14.0 16.1 6.4 5.5 9.9 11.9 10.5 11.2 7.8 10.2 10.7 5.9 9.5 10.4 12.6 13.3 8.0 11.9 10.4 12.9 14.1 8.7 9.3 11.5 0.2 0.0 0.5 1.0 0.0 1.1 0.7 0.8 0.8 0.0 1.0 1.1 0.9 0.5 0.6 0.0 0.1 0.6 0.4 4.3 5.7 6.4 5.6 4.4 4.8 4.7 5.3 5.0 4.8 4.7 7.3 13.3 9.6 17.7 22.5 13.2 2.8 8.8 5.3 13.6 22.2 9.3 7.6 16.1 5.7 9.0 0.0 14.6 10.9 7.7 7.6 1.9 5.6 22.1 10.0 22.7 11.0 9.0 12.4 31.3 5.5 5.3 11.9 12.2 11.4 3.8 17.1 13.6 12.1 3.7 58.9 36.0 11.5 4.1 0.3 1.8 11.0 9.3 0.8 1.8 16.9 0.4 17.2 10.3 31.2 46.6 4.9 8.0 7.2 6.4 12.0 15.6 4.2 16.1 23.5 0.0 16.1 13.9 25.8 18.9 10.9 2.7 8.8 11.3 12.6 11.2 7.6 ZNF510 KIAA0972 ENSG00000081386 "Zinc finger protein 510" Q9Y2H8 9 96754553-96778129 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 21.5;Inhibitory neurons: 22.7;Oligodendrocytes: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049139 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 77: Retina - Visual perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Plasma membrane" "HPA049139: AB_2680651" "unprognostic (2.70e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.92e-2)" "unprognostic (2.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.02e-2)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (2.18e-2)" 3.6 3.8 4.8 3.3 4.7 2.3 4.8 8.3 6.1 5.2 2.4 3.9 2.6 4.7 3.5 2.7 4.0 2.7 3.6 4.9 5.2 3.8 3.8 3.3 4.3 3.6 4.2 5.7 5.1 5.0 4.6 3.1 3.7 4.3 3.3 11.7 3.3 4.3 4.3 3.4 2.9 4.1 4.0 4.2 3.4 3.3 5.2 5.5 4.7 4.8 4.7 3.7 3.2 5.2 4.2 4.3 8.1 7.2 6.7 6.3 4.0 3.7 6.5 6.1 6.4 3.7 2.7 5.7 2.2 3.7 5.8 8.7 3.2 3.3 5.8 6.5 3.7 6.0 7.0 2.5 3.5 3.5 5.2 4.3 5.8 4.5 6.9 6.5 5.3 8.2 6.8 4.5 7.8 3.9 9.3 5.2 6.6 5.9 3.6 5.6 14.4 2.4 4.3 3.2 9.9 7.8 7.0 3.9 3.8 5.4 3.1 6.2 4.1 4.4 4.5 5.6 5.9 8.8 9.8 3.5 2.7 2.0 4.6 0.4 0.2 0.6 0.7 0.3 1.2 0.9 1.2 0.9 0.2 1.0 1.3 0.9 0.1 1.4 0.8 0.3 0.8 0.4 4.8 4.7 8.3 6.1 4.9 5.2 3.6 4.2 3.7 4.0 5.2 5.2 5.5 3.2 3.2 13.4 4.5 1.7 1.6 1.7 0.6 11.0 2.6 2.5 5.1 1.5 2.9 3.7 2.1 2.2 3.2 1.4 1.9 2.2 5.7 3.5 6.3 4.2 1.2 4.0 21.5 2.6 1.4 5.7 2.0 4.0 1.3 5.7 3.6 1.3 2.0 16.8 22.7 2.1 2.0 2.5 0.5 6.9 5.9 2.2 5.4 10.3 2.0 4.5 8.2 18.1 20.5 1.8 2.8 4.1 3.1 2.0 1.0 1.9 3.2 6.5 6.6 4.6 3.3 3.6 5.6 1.8 1.4 0.8 4.6 4.3 1.5 1.1 ZNF512 KIAA1805 ENSG00000243943 "Zinc finger protein 512" Q96ME7 2 27582969-27623217 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031430 Approved Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA031430: AB_10603844" "prognostic favorable (9.79e-4)" "unprognostic (4.19e-2)" "unprognostic (1.87e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (7.75e-3)" "prognostic favorable (5.08e-9)" "unprognostic (6.08e-2)" "unprognostic (2.33e-1)" "prognostic favorable (5.19e-4)" "unprognostic (1.10e-2)" "unprognostic (8.09e-3)" "unprognostic (4.44e-2)" "unprognostic (1.85e-1)" "unprognostic (5.66e-2)" "unprognostic (5.60e-3)" 11.3 13.1 8.8 10.7 9.4 6.1 16.6 9.1 12.6 19.5 8.1 16.5 7.8 25.0 14.9 8.3 21.4 10.9 13.1 9.1 12.5 12.4 7.0 13.8 16.9 8.6 10.3 34.3 7.7 20.1 13.6 13.0 9.1 18.1 12.0 26.4 11.1 19.2 7.4 7.2 12.9 16.9 8.7 17.0 11.0 13.2 11.5 27.0 20.5 10.5 17.5 16.4 13.0 11.1 26.2 22.8 46.2 20.6 22.4 25.2 0.0 12.7 17.9 23.6 27.7 17.7 16.2 22.8 14.0 14.6 19.6 8.7 41.3 12.0 25.0 21.2 33.0 47.9 18.4 27.0 17.3 31.4 20.8 23.2 12.9 18.4 5.3 18.9 37.9 39.3 42.0 16.2 35.0 3.3 3.3 24.0 32.1 17.2 0.0 52.2 65.0 19.8 16.8 7.2 45.0 44.8 12.0 7.6 36.0 21.9 9.3 17.8 31.5 8.3 20.0 8.6 16.8 16.2 12.1 38.9 12.5 38.4 17.3 24.5 5.5 9.8 10.2 6.7 14.1 12.4 12.9 15.0 8.2 11.1 17.1 14.6 1.7 22.1 5.5 5.9 9.8 10.8 8.8 9.4 9.1 12.6 9.1 12.5 8.6 10.3 9.1 8.7 11.5 11.1 8.9 9.6 14.2 16.6 10.0 3.8 10.4 4.3 6.8 22.8 8.1 7.6 15.6 7.2 7.8 18.4 16.7 1.6 9.7 2.2 9.8 6.8 11.9 5.2 12.7 11.5 9.0 14.7 22.5 1.9 1.1 11.6 8.2 5.2 6.3 25.5 11.7 4.4 5.3 18.5 28.9 6.3 6.1 7.2 7.1 5.7 14.9 6.2 1.8 23.4 8.9 17.0 9.2 25.1 27.2 4.6 3.3 17.3 9.0 5.8 2.3 4.2 8.9 15.7 19.7 14.6 13.4 8.3 9.0 6.6 3.0 1.2 10.3 13.6 5.0 6.9 ZNF512B "GM632, MGC149845, MGC149846" ENSG00000196700 "Zinc finger protein 512B" Q96KM6 20 63956704-63969930 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 22.4;Cone photoreceptor cells: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006688, HPA008731" Approved Enhanced Nucleoplasm NA NA "Cluster 18: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA006688: AB_10963053, HPA008731: " "unprognostic (7.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-3)" "unprognostic (7.19e-3)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (5.30e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (6.99e-3)" "unprognostic (5.03e-3)" "unprognostic (2.12e-1)" "unprognostic (7.72e-2)" "unprognostic (5.52e-2)" "unprognostic (1.95e-3)" "unprognostic (3.72e-2)" 8.6 11.4 8.4 5.5 8.4 5.9 10.4 4.8 11.4 12.9 0.9 10.9 4.4 13.8 2.8 17.2 12.2 5.9 9.6 8.8 7.0 12.4 21.3 8.4 6.2 5.1 5.5 14.2 15.0 9.1 20.8 7.9 4.5 13.0 1.4 4.5 12.6 7.7 12.1 14.4 7.2 5.9 2.9 10.3 10.3 10.2 6.3 8.3 19.7 5.2 4.1 11.4 10.9 5.8 10.2 16.8 18.6 19.8 8.1 5.9 17.0 14.4 11.2 42.3 13.8 33.1 16.8 6.6 34.5 12.6 7.8 12.8 14.1 21.4 10.1 11.0 20.3 16.4 26.4 31.9 12.9 8.9 18.9 12.5 17.3 14.7 8.4 11.1 13.3 29.4 23.1 9.9 8.5 24.3 43.6 19.2 12.9 12.9 21.8 19.8 1.7 20.1 7.6 16.9 27.2 15.8 11.9 19.4 9.8 8.8 40.9 21.4 18.8 40.4 6.2 10.3 12.6 23.6 12.1 18.3 14.5 0.1 17.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 8.4 8.4 4.8 11.4 8.8 7.0 5.1 5.5 4.5 2.9 6.3 5.8 6.7 3.2 5.6 1.6 3.1 5.4 3.5 5.3 4.6 22.4 10.3 9.5 2.9 5.7 6.5 1.8 22.9 7.8 6.1 0.1 1.9 3.7 0.1 5.2 12.0 5.8 6.0 3.4 1.1 6.1 2.9 6.7 3.6 9.6 0.0 14.0 8.6 19.4 3.9 13.5 1.4 0.8 8.2 1.9 2.5 1.3 6.5 1.7 5.4 1.0 2.3 7.3 4.1 1.5 0.6 3.2 0.2 6.8 5.2 3.5 2.2 5.7 2.6 10.6 0.0 8.7 5.6 6.5 4.1 11.1 7.0 5.1 3.6 14.3 1.2 2.8 ZNF518A "KIAA0335, ZNF518" ENSG00000177853 "Zinc finger protein 518A" Q6AHZ1 10 96129715-96205288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029049 Approved Nucleoplasm Yes No "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA029049: AB_2672885" "unprognostic (1.48e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-2)" "unprognostic (4.66e-2)" "unprognostic (7.61e-2)" "unprognostic (3.38e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-2)" "unprognostic (6.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" "unprognostic (8.38e-3)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (3.09e-2)" "unprognostic (1.16e-3)" 4.1 3.2 3.8 4.4 4.5 7.6 7.3 5.7 4.7 4.3 2.1 7.1 5.0 5.6 7.8 4.3 4.3 4.1 3.4 3.5 5.1 5.1 4.6 4.5 6.1 5.0 4.5 7.4 4.5 4.0 4.1 4.4 5.4 4.8 7.0 9.3 4.1 4.2 1.9 6.0 6.4 4.4 4.5 5.4 6.7 16.1 4.7 8.1 7.7 2.3 6.1 3.8 2.8 6.8 4.2 9.4 10.3 0.0 5.1 5.8 12.4 4.4 2.5 4.7 4.8 8.9 10.0 15.5 4.1 2.8 6.7 5.9 11.8 4.2 4.3 7.1 6.3 23.2 3.2 14.5 4.5 25.3 13.5 3.8 10.1 4.9 7.8 3.4 5.7 17.8 20.1 10.1 4.7 4.2 15.0 15.3 15.9 4.7 0.6 16.7 11.8 6.2 5.6 8.5 3.0 7.2 6.2 5.8 4.5 17.0 6.9 16.0 3.7 2.2 8.5 3.0 4.8 9.3 24.9 8.8 1.5 19.0 2.4 9.8 2.6 3.2 1.8 2.8 2.7 2.5 2.1 1.8 1.7 2.2 3.0 2.1 2.5 2.3 5.3 2.9 2.5 1.4 3.8 4.5 5.7 4.7 3.5 5.1 5.0 4.5 5.4 4.5 4.7 6.8 31.1 57.7 28.2 136.8 26.1 0.0 17.1 0.0 13.1 65.0 32.5 21.2 26.5 30.0 14.9 40.5 43.8 49.1 31.6 51.0 19.6 24.1 23.6 42.6 38.8 24.0 61.2 17.1 63.9 25.5 30.8 21.6 32.6 41.3 9.5 57.9 35.3 28.3 28.1 75.7 90.5 35.8 0.0 32.8 0.0 15.0 35.1 31.3 0.0 81.5 48.7 29.1 47.4 150.3 173.0 32.9 52.4 25.2 18.3 20.8 39.5 20.4 10.2 56.9 19.7 33.8 23.2 73.1 131.2 16.2 0.0 43.8 23.3 40.9 35.2 17.6 ZNF518B KIAA1729 ENSG00000178163 "Zinc finger protein 518B" Q9C0D4 4 10439880-10457426 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031215, HPA031216" Approved Approved Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA031215: AB_10600200, HPA031216: AB_10601449" "unprognostic (2.69e-1)" "unprognostic (1.68e-1)" "unprognostic (2.89e-1)" "unprognostic (7.74e-3)" "unprognostic (2.11e-1)" "unprognostic (7.99e-2)" "unprognostic (1.01e-1)" "unprognostic (4.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.07e-1)" "unprognostic (2.24e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (1.27e-1)" "unprognostic (5.44e-2)" "unprognostic (1.02e-1)" "unprognostic (1.89e-3)" 6.3 4.4 4.7 6.4 5.2 3.9 7.0 7.8 4.7 3.7 4.9 3.9 3.7 4.9 3.6 4.2 2.9 4.3 6.4 5.6 6.4 3.3 2.2 4.3 6.7 2.5 4.0 7.8 1.5 3.7 2.9 7.0 3.6 6.9 2.9 7.0 7.4 7.1 6.0 3.7 5.0 5.6 3.9 6.7 3.5 9.0 7.7 8.6 7.9 8.7 8.7 4.2 3.7 4.0 8.2 5.5 20.8 6.1 2.7 3.9 0.1 9.1 2.3 5.7 6.6 0.0 0.0 0.1 9.2 13.7 16.1 0.2 4.8 10.4 12.6 0.0 8.8 26.2 0.0 0.0 11.9 0.0 11.2 11.7 6.0 9.0 0.0 11.6 19.6 19.3 28.9 0.0 4.7 0.0 18.2 0.6 20.4 4.1 12.5 15.5 8.6 3.0 0.3 11.2 15.5 4.6 4.3 0.0 2.8 16.6 3.4 7.0 14.9 0.0 18.7 0.1 8.8 10.7 8.5 15.1 1.1 1.4 1.1 2.2 2.0 9.6 2.1 1.9 2.6 7.9 3.3 2.4 3.5 3.5 3.4 3.2 4.9 5.0 4.7 1.2 2.6 1.7 4.7 5.2 7.8 4.7 5.6 6.4 2.5 4.0 3.6 3.9 7.7 4.0 15.7 3.2 6.3 4.2 12.1 15.9 22.8 8.0 8.6 9.6 5.7 5.1 26.3 4.3 9.5 0.0 10.4 8.9 3.7 3.6 3.9 2.5 13.1 5.0 9.2 13.1 1.2 4.6 12.1 4.0 9.3 11.9 4.6 10.2 16.5 22.5 12.8 1.8 9.2 11.8 10.6 3.5 14.2 10.2 8.0 20.8 16.1 7.3 1.8 7.5 6.5 6.1 6.2 4.5 3.5 1.6 3.3 21.4 5.3 20.0 6.2 1.3 6.7 10.3 0.0 6.7 8.6 13.7 11.2 6.8 14.2 9.2 8.1 19.7 4.3 19.5 ZNF527 KIAA1829 ENSG00000189164 "Zinc finger protein 527" Q8NB42 19 37371061-37393066 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037740, HPA037741" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Golgi apparatus" "HPA037740: AB_10672284, HPA037741: AB_2675642" "unprognostic (4.36e-2)" "unprognostic (5.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-2)" "unprognostic (1.30e-2)" "unprognostic (9.26e-2)" "unprognostic (8.70e-3)" "unprognostic (6.47e-3)" "unprognostic (1.91e-1)" "unprognostic (6.05e-4)" "unprognostic (8.34e-3)" "unprognostic (8.92e-2)" "unprognostic (6.83e-2)" "unprognostic (1.44e-2)" "unprognostic (1.52e-3)" "unprognostic (3.17e-4)" 2.0 2.1 1.9 1.3 1.8 2.5 2.0 2.1 2.4 2.8 1.6 2.5 0.8 2.2 1.7 1.5 2.2 1.3 2.3 1.7 2.1 2.2 1.7 1.5 2.1 1.9 1.6 3.3 1.7 2.7 2.3 1.2 2.0 2.3 1.5 3.2 1.9 1.7 2.3 1.7 1.7 1.9 1.5 1.9 1.7 2.4 1.9 2.5 2.5 3.0 1.5 2.3 2.3 2.3 2.3 2.3 2.1 2.8 1.6 3.3 0.8 2.2 2.2 1.9 2.6 2.1 0.6 2.1 2.6 2.1 1.4 0.9 3.1 1.9 2.5 4.9 1.4 1.7 2.8 0.2 2.3 4.1 2.5 2.6 2.7 2.1 3.6 2.3 2.0 3.4 0.9 1.5 2.4 0.8 2.7 2.2 1.6 2.6 1.0 3.4 2.6 1.7 1.7 2.3 4.1 1.8 3.4 1.0 1.5 1.8 2.3 3.6 3.6 2.0 2.7 2.5 2.4 4.0 5.4 6.4 0.1 3.1 1.7 2.2 1.0 3.4 3.3 1.4 2.9 3.5 2.1 3.0 1.3 2.8 3.0 3.7 1.0 2.4 0.9 1.5 2.3 2.3 1.9 1.8 2.1 2.4 1.7 2.1 1.9 1.6 2.0 1.5 1.9 2.3 2.6 9.6 4.8 5.2 2.5 2.7 1.9 3.3 3.4 6.1 2.4 1.8 8.7 1.5 3.5 0.0 12.5 2.3 5.8 1.2 3.9 1.9 1.3 2.0 2.9 3.0 1.2 2.5 5.8 1.5 1.3 3.5 1.1 2.4 1.3 4.5 2.2 1.9 1.7 6.7 6.9 1.9 4.1 0.8 1.3 0.8 2.5 2.0 0.0 2.8 1.7 3.8 6.2 6.6 7.0 0.5 0.6 1.5 1.8 1.9 1.4 2.4 4.0 10.2 0.0 4.1 3.7 5.3 2.7 2.0 1.6 2.1 4.6 3.3 1.9 1.3 ZNF528 KIAA1827 ENSG00000167555 "Zinc finger protein 528" Q3MIS6 19 52397849-52418412 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 51.2;U-266/84: 69.0" HPA065435 Approved "Nuclear speckles,Cytosol" No No "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA065435: " "unprognostic (1.90e-2)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (3.73e-1)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "unprognostic (9.60e-2)" "unprognostic (4.81e-3)" "unprognostic (1.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.42e-2)" "unprognostic (2.98e-3)" "unprognostic (3.26e-3)" "unprognostic (2.78e-2)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" 8.9 9.2 7.9 5.4 10.1 5.7 10.9 16.8 8.6 9.9 9.6 8.6 4.9 13.5 18.8 8.9 13.6 10.1 10.1 6.6 10.3 9.6 4.7 8.0 9.1 9.2 7.6 18.2 5.2 12.7 9.2 9.9 11.2 11.6 8.8 19.7 10.7 9.3 6.4 11.4 6.7 8.3 4.0 11.3 9.3 13.1 9.8 9.8 17.7 5.7 10.7 9.8 8.5 13.6 0.2 0.0 6.1 36.5 13.6 16.9 15.0 13.6 22.3 8.2 18.1 0.2 6.9 0.3 3.3 16.9 20.4 4.1 0.0 8.6 10.5 0.1 9.8 5.7 2.0 3.5 20.4 0.1 15.2 17.2 15.5 9.0 0.0 2.5 19.7 0.3 3.8 0.6 11.9 0.2 21.5 2.9 15.9 0.3 9.4 0.2 24.5 6.5 10.1 51.2 25.1 20.8 0.0 1.1 9.1 21.2 24.2 3.3 23.3 14.2 16.3 5.6 18.8 0.6 69.0 12.9 7.1 0.2 22.5 7.6 5.1 11.8 6.6 5.4 12.7 7.8 8.2 10.2 5.4 11.1 7.7 6.9 1.4 17.6 5.5 8.8 9.6 3.9 7.9 10.1 16.8 8.6 6.6 10.3 9.2 7.6 11.2 4.0 9.8 13.6 9.8 6.4 3.2 8.8 5.8 3.7 4.1 5.2 1.2 19.6 8.6 7.1 12.2 2.8 7.4 1.8 14.6 4.1 6.0 4.1 3.9 5.6 2.9 13.1 7.7 8.8 1.2 0.8 13.2 1.9 4.5 6.0 2.0 13.2 8.8 16.7 6.1 1.3 3.5 21.9 12.7 4.0 4.1 3.8 4.7 3.1 5.0 4.7 1.8 7.5 0.7 12.3 11.3 20.6 10.3 7.1 6.3 4.1 1.5 4.7 4.0 3.9 10.4 21.8 0.0 6.1 6.9 17.6 10.2 2.3 3.1 3.1 7.6 7.3 3.0 4.1 ZNF529 KIAA1615 ENSG00000186020 "Zinc finger protein 529" Q6P280 19 36534774-36605276 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 46.6;Horizontal cells: 75.7;Inhibitory neurons: 45.7;Oligodendrocytes: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA031311 Uncertain Approved Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA031311: AB_10604158" "unprognostic (2.19e-2)" "unprognostic (4.89e-2)" "unprognostic (8.51e-2)" "unprognostic (7.94e-2)" "unprognostic (1.83e-3)" "unprognostic (2.61e-3)" "unprognostic (8.67e-2)" "unprognostic (1.30e-2)" "unprognostic (3.84e-3)" "unprognostic (7.10e-2)" "unprognostic (1.05e-3)" "unprognostic (6.61e-3)" "unprognostic (3.37e-2)" "unprognostic (1.45e-2)" "unprognostic (1.00e-1)" "unprognostic (9.64e-2)" "prognostic favorable (1.39e-5)" 5.7 5.8 8.1 5.1 11.5 10.1 6.0 9.6 10.4 6.2 6.5 5.1 3.1 6.9 5.5 3.3 8.0 3.8 7.3 7.1 9.8 5.9 4.4 5.8 7.4 8.9 9.5 8.9 3.6 6.0 5.7 4.8 9.8 5.1 3.0 20.1 4.2 3.4 5.4 6.6 5.1 4.5 9.0 6.0 3.9 9.2 9.1 6.3 5.7 5.5 6.4 4.7 5.2 14.9 4.0 8.1 11.5 12.3 5.4 6.6 4.5 6.1 3.3 3.4 8.6 4.1 3.1 10.7 7.7 4.9 4.4 1.5 8.7 3.9 6.2 14.4 9.7 13.1 7.6 3.0 6.4 9.9 7.9 8.0 5.0 4.6 6.7 5.8 2.9 8.1 5.5 0.7 7.1 1.1 10.0 3.4 7.5 0.2 3.3 2.9 6.9 4.9 3.0 10.6 5.1 10.4 8.5 2.7 2.6 4.4 3.5 6.0 7.0 7.4 5.3 6.1 7.6 13.2 8.5 9.0 0.2 3.3 5.7 4.7 1.1 1.5 2.3 0.6 3.1 2.9 2.5 2.4 1.2 2.2 2.8 2.2 0.5 2.1 0.7 1.4 3.1 1.2 8.1 11.5 9.6 10.4 7.1 9.8 8.9 9.5 9.8 9.0 9.1 14.9 10.0 3.2 3.3 23.8 14.1 9.8 5.3 2.9 10.2 19.0 12.3 8.1 14.7 5.7 5.7 7.3 25.0 3.6 11.0 1.4 5.9 3.5 4.5 10.1 8.0 10.0 3.0 14.1 46.6 1.6 2.8 7.9 5.1 9.9 2.5 15.2 7.9 6.9 4.0 75.7 45.7 3.5 4.1 5.1 8.4 2.3 6.5 4.3 5.4 19.7 3.1 7.8 6.2 36.2 61.5 2.2 2.5 6.8 7.2 7.0 1.4 4.5 8.8 22.4 0.0 9.1 7.5 18.0 10.3 8.2 9.1 3.3 11.2 9.9 2.8 6.5 ZNF549 FLJ34917 ENSG00000121406 "Zinc finger protein 549" Q6P9A3 19 57527325-57557542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Rod photoreceptor cells: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 11.2" "Group enriched" "Detected in all" 4 "B-cells: 4.5;NK-cells: 11.2;T-cells: 4.6" "Low cell line specificity" "Detected in many" HPA039511 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA039511: AB_10671998" "unprognostic (6.27e-2)" "unprognostic (9.03e-3)" "unprognostic (2.02e-2)" "unprognostic (1.20e-2)" "unprognostic (4.28e-2)" "unprognostic (2.80e-1)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (2.14e-1)" "unprognostic (7.07e-2)" "unprognostic (4.01e-4)" "unprognostic (4.03e-3)" "unprognostic (2.51e-8)" "unprognostic (2.88e-2)" "unprognostic (9.92e-2)" "unprognostic (9.89e-3)" "unprognostic (9.11e-3)" 2.5 3.3 4.3 3.4 4.3 3.6 4.3 9.9 4.1 2.9 3.3 3.3 1.9 3.3 3.9 2.0 4.1 2.7 3.5 4.6 3.6 3.9 1.3 3.3 5.0 2.9 2.8 5.6 2.4 5.5 4.9 3.7 2.7 4.2 2.3 11.8 3.0 3.3 3.0 3.9 3.3 3.2 2.0 5.6 2.9 4.0 3.6 5.9 4.7 2.4 5.3 3.3 2.4 4.5 1.5 2.0 7.9 6.6 2.4 1.9 1.9 3.8 4.5 3.6 17.5 2.1 1.4 2.2 2.6 3.5 4.5 0.9 2.5 5.5 5.9 0.2 14.7 10.2 1.9 3.1 3.3 8.6 7.0 3.4 4.2 3.7 5.1 5.2 2.3 5.7 0.1 0.3 6.6 0.9 9.8 3.6 6.8 0.2 5.3 6.8 6.6 4.7 1.4 3.9 3.3 5.7 0.1 0.5 4.4 6.6 4.5 6.7 1.9 6.9 4.7 0.3 5.5 3.7 11.6 7.0 1.1 2.9 6.4 0.6 0.8 1.5 2.4 0.7 3.2 2.2 3.3 3.8 1.5 4.5 4.6 3.0 0.5 11.2 1.2 1.4 2.2 1.9 4.3 4.3 9.9 4.1 4.6 3.6 2.9 2.8 2.7 2.0 3.6 4.5 2.2 0.0 2.8 5.9 7.0 1.7 1.7 1.3 0.6 7.5 2.2 1.7 3.2 4.3 0.8 1.8 14.6 1.6 5.6 0.4 3.9 1.4 0.6 2.2 2.3 3.6 3.6 5.7 9.8 0.7 0.8 2.2 1.1 1.9 6.3 6.1 3.9 0.6 1.5 8.4 7.9 0.5 0.0 3.2 0.4 0.4 3.1 2.3 5.4 6.5 1.5 3.9 7.2 8.0 4.1 0.7 1.8 2.2 1.3 1.8 0.7 0.8 5.8 14.8 6.6 2.6 2.3 1.2 4.7 0.6 1.6 1.1 4.0 2.3 0.9 1.2 ZNF550 MGC41917 ENSG00000251369 "Zinc finger protein 550" Q7Z398 19 57535257-57559863 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003251 Uncertain Approved Vesicles,Microtubules NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles Microtubules "HPA003251: AB_1080736" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-2)" "unprognostic (1.43e-1)" "unprognostic (2.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.61e-2)" "unprognostic (2.66e-3)" "unprognostic (3.46e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.33e-2)" "unprognostic (1.59e-1)" "unprognostic (2.69e-2)" "unprognostic (6.68e-3)" "unprognostic (1.52e-1)" 2.8 3.7 1.8 5.1 2.0 5.2 6.0 5.8 2.7 5.5 3.2 2.8 2.2 4.6 3.9 3.1 4.6 3.1 5.6 1.7 2.9 2.9 3.0 3.4 6.7 1.5 1.8 9.1 2.4 7.8 2.5 6.5 2.3 6.0 2.9 7.3 4.2 4.4 2.2 4.0 3.6 3.3 1.1 7.7 3.5 2.8 1.7 7.4 4.8 3.3 5.4 3.6 1.3 2.9 4.3 3.0 8.4 8.0 2.8 6.9 0.0 5.7 4.8 5.0 2.1 3.7 3.9 1.2 3.9 4.2 4.0 3.6 4.4 5.0 6.3 0.1 23.2 11.5 10.9 4.9 4.1 10.1 4.3 5.8 3.0 3.9 11.2 6.9 4.2 10.6 1.8 0.1 5.4 1.0 15.5 4.4 9.2 1.3 5.8 12.3 8.7 12.1 2.7 7.6 7.8 11.0 7.2 4.8 3.5 5.9 5.5 6.6 4.8 6.9 4.2 2.6 5.6 24.0 24.0 10.0 2.8 5.8 6.1 0.4 1.4 2.0 3.6 1.9 4.5 1.8 4.5 2.5 2.0 2.6 5.8 3.4 0.4 5.2 0.6 0.7 4.5 2.3 1.8 2.0 5.8 2.7 1.7 2.9 1.5 1.8 2.3 1.1 1.7 2.9 4.5 0.0 1.1 4.2 8.9 5.1 3.9 2.6 5.7 4.5 4.7 3.6 7.2 2.8 3.4 0.0 6.2 4.2 4.9 0.5 1.9 2.8 1.0 3.4 4.7 5.8 3.6 5.0 4.8 1.2 4.4 3.9 0.5 2.9 5.1 8.3 5.0 3.2 2.3 11.8 5.3 2.8 4.1 1.9 2.2 0.6 4.7 1.4 3.6 2.8 2.5 3.0 12.3 4.0 3.7 2.2 0.8 0.7 3.4 6.7 1.2 0.9 6.5 5.1 0.0 3.3 4.4 3.2 5.0 4.4 6.8 5.2 6.2 4.4 2.7 4.3 ZNF551 DKFZp686H1038 ENSG00000204519 "Zinc finger protein 551" Q7Z340 19 57681969-57717301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "cerebellum: 6.4" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038187 Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 30: Non-specific - Translation" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "HPA038187: AB_2675884" "unprognostic (1.96e-1)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (6.24e-3)" "unprognostic (1.30e-1)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (2.92e-1)" "unprognostic (5.89e-2)" "unprognostic (4.83e-3)" "prognostic favorable (1.32e-4)" "unprognostic (4.70e-2)" "unprognostic (2.73e-1)" "unprognostic (1.26e-2)" "unprognostic (1.54e-1)" 1.9 2.3 0.9 3.4 1.0 7.9 4.0 6.4 1.1 2.3 2.9 2.4 2.2 1.9 1.8 2.2 2.9 1.7 2.2 1.1 0.7 2.4 1.7 1.9 5.0 0.6 0.9 3.3 2.5 3.3 6.3 2.6 0.4 2.7 2.5 4.9 2.5 2.4 2.0 3.7 2.4 2.4 0.7 3.6 2.7 4.3 1.1 5.1 6.1 1.8 4.9 2.6 1.6 1.2 3.9 8.4 10.2 7.5 1.9 2.4 10.8 4.6 3.2 6.3 2.9 7.2 3.7 7.0 2.9 3.4 4.6 4.3 6.9 10.4 9.7 0.0 30.3 12.4 0.3 3.2 1.8 8.8 10.8 4.1 3.8 6.4 5.8 3.5 2.6 7.2 8.6 0.0 5.6 3.6 18.3 3.4 21.6 7.4 13.5 11.4 17.7 9.3 2.5 22.0 9.9 8.1 6.9 4.3 3.5 9.7 5.5 11.5 3.2 7.2 7.4 2.4 8.6 7.3 17.0 15.7 1.3 4.3 6.9 1.2 1.2 1.3 1.8 1.9 3.3 3.8 2.7 2.9 2.8 2.8 4.3 4.1 0.6 3.1 1.0 2.2 2.3 2.3 0.9 1.0 6.4 1.1 1.1 0.7 0.6 0.9 0.4 0.7 1.1 1.2 2.2 6.4 3.9 2.6 5.4 5.2 6.3 2.6 1.8 7.7 4.7 2.8 1.8 2.8 6.3 1.8 8.4 4.1 4.5 2.3 1.9 3.1 13.8 2.0 3.3 3.3 2.4 11.2 1.1 1.0 3.0 2.8 2.0 3.8 1.3 6.0 4.6 2.4 2.6 3.3 1.4 4.1 4.1 4.4 2.1 4.1 3.4 2.4 1.8 1.0 1.7 2.7 3.1 2.0 0.9 1.9 1.7 4.9 3.3 5.0 1.6 0.7 4.5 13.8 0.0 2.3 2.4 8.7 12.8 4.6 7.1 2.9 4.8 3.3 4.7 7.6 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069703-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments" No No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Intermediate filaments" "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favorable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favorable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 1.5 1.9 1.2 1.8 1.5 3.9 1.9 3.1 1.7 1.6 1.5 1.5 1.1 1.7 1.6 1.7 1.9 1.3 1.2 1.3 1.0 1.8 2.2 1.4 2.6 1.4 1.1 2.4 1.8 1.7 1.5 1.5 1.5 1.5 1.4 1.9 1.4 1.4 1.4 2.0 1.7 1.6 0.9 2.3 1.8 2.1 1.4 2.4 2.1 1.0 2.5 1.6 1.5 3.1 2.1 2.2 2.3 5.0 3.1 2.1 1.9 2.1 2.2 2.3 2.8 2.8 1.3 4.4 3.6 2.3 1.8 2.9 4.0 2.3 2.3 4.0 2.6 5.6 4.7 1.5 2.1 6.0 5.9 3.0 2.3 2.4 3.7 2.3 2.0 3.8 2.2 6.7 3.1 3.0 5.0 2.1 2.2 2.0 3.0 3.6 3.6 2.4 1.7 4.9 2.7 3.2 3.1 2.4 2.3 2.0 1.9 3.1 3.9 2.2 1.7 5.0 2.3 6.8 5.8 3.9 2.4 3.1 2.0 5.6 3.1 3.8 4.6 2.9 4.7 4.1 5.0 4.0 3.1 5.4 5.8 4.9 3.5 5.9 2.7 5.7 4.3 1.7 1.2 1.5 3.1 1.7 1.3 1.0 1.4 1.1 1.5 0.9 1.4 3.1 5.5 3.2 4.4 5.2 8.3 1.5 6.9 2.7 2.2 9.4 6.1 5.8 5.4 7.2 6.1 7.3 0.0 5.9 5.8 5.4 15.6 6.2 0.9 3.4 8.9 6.9 5.4 6.1 9.2 6.2 4.2 5.6 4.6 4.6 8.2 9.4 8.6 3.8 6.1 16.8 8.9 5.8 2.0 9.8 2.9 0.5 4.4 6.0 0.0 5.6 9.0 6.1 14.4 3.5 8.8 6.1 6.2 5.7 5.9 6.8 6.1 8.1 4.3 6.8 0.0 7.8 6.7 23.2 19.9 3.6 1.3 5.7 7.7 6.7 5.5 6.9 ZNF558 FLJ30932 ENSG00000167785 "Zinc finger protein 558" Q96NG5 19 8806170-8832314 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003151 Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "HPA003151: AB_1859344" "unprognostic (2.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.90e-1)" "unprognostic (2.09e-2)" "unprognostic (1.84e-1)" "prognostic favorable (1.04e-4)" "unprognostic (1.61e-2)" "unprognostic (1.58e-2)" "unprognostic (1.69e-2)" "unprognostic (1.09e-2)" "unprognostic (3.20e-1)" "unprognostic (5.89e-3)" "prognostic unfavorable (1.23e-6)" "unprognostic (2.28e-2)" "unprognostic (6.92e-2)" "unprognostic (1.09e-1)" "prognostic favorable (9.30e-5)" 9.3 10.1 7.8 6.5 8.0 4.6 9.5 8.6 9.3 15.0 8.3 11.2 6.0 13.6 9.4 7.9 14.7 5.4 6.6 7.6 8.1 11.4 11.0 8.3 7.3 8.3 8.2 15.1 11.5 10.3 8.5 5.5 8.1 11.5 8.0 14.5 8.3 8.7 6.9 10.1 9.2 10.3 8.0 9.7 9.5 6.2 8.3 7.9 12.2 6.6 8.0 9.9 10.7 8.6 8.1 2.8 12.8 17.6 11.8 13.2 10.9 5.6 8.5 8.2 12.8 4.1 4.9 4.0 14.5 6.4 10.0 7.2 10.9 0.8 11.5 9.6 0.5 0.3 5.0 2.1 9.4 5.9 9.3 12.7 18.5 5.2 0.0 20.0 0.0 12.3 8.6 15.4 10.8 3.3 5.4 31.4 8.0 3.0 4.0 2.8 10.1 3.5 15.2 8.9 2.7 12.7 6.5 3.7 11.5 15.0 7.9 8.5 0.1 10.4 5.9 16.5 6.7 7.0 6.4 8.8 2.4 5.8 3.5 0.4 0.6 0.3 1.0 0.6 0.8 0.3 0.7 1.1 0.7 1.0 1.2 1.5 0.7 2.0 0.5 1.0 0.5 0.5 7.8 8.0 8.6 9.3 7.6 8.1 8.3 8.2 8.1 8.0 8.3 8.6 3.8 9.6 5.6 8.1 3.2 3.6 2.9 3.1 9.1 4.8 5.5 5.5 3.6 2.8 5.5 3.7 8.4 4.0 3.9 3.6 1.9 4.5 9.6 4.5 9.3 4.0 1.2 4.0 4.0 3.3 3.7 4.6 11.2 5.0 3.8 5.1 2.9 5.3 2.9 8.4 3.3 3.3 0.0 4.7 1.3 5.2 2.1 2.9 0.0 3.7 2.4 5.9 5.2 5.5 7.9 4.2 2.7 2.6 1.8 3.3 2.8 1.9 3.6 8.6 0.0 5.2 4.8 4.1 3.9 5.4 2.7 1.5 3.9 2.8 3.9 1.5 ZNF559 MGC13105 ENSG00000188321 "Zinc finger protein 559" Q9BR84 19 9323772-9351162 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA059632, HPA065485" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA059632: AB_2684089, HPA065485: AB_2685497" "unprognostic (1.35e-3)" "unprognostic (1.98e-1)" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.64e-3)" "prognostic favorable (6.99e-4)" "unprognostic (7.28e-3)" "unprognostic (4.04e-2)" "unprognostic (8.48e-2)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-3)" 14.8 14.2 12.5 9.2 13.7 4.0 16.8 19.7 14.0 23.5 17.8 16.7 6.4 22.4 21.5 7.4 23.1 9.9 19.7 12.4 12.9 19.1 11.1 12.4 16.0 12.7 12.3 32.7 10.6 22.2 25.9 12.1 12.4 20.5 11.0 20.4 12.3 12.9 4.7 10.7 14.8 19.1 11.8 22.1 12.9 16.3 13.7 22.7 19.7 10.6 13.1 17.0 15.6 19.4 15.4 8.3 15.6 19.3 9.2 8.3 4.2 9.3 18.6 13.3 11.4 3.8 1.8 12.4 10.8 13.7 18.4 5.4 9.5 8.8 16.9 19.9 13.5 16.2 14.0 5.7 16.0 15.0 18.3 17.3 15.6 14.7 18.7 11.4 11.3 18.8 12.7 42.8 8.7 0.0 20.4 46.8 25.4 2.6 13.4 10.0 18.8 16.7 8.1 21.5 17.8 14.7 17.9 2.9 22.6 22.9 12.7 11.5 9.6 24.6 5.6 20.1 14.2 3.5 0.1 12.6 4.6 9.4 16.0 40.7 4.8 11.4 12.1 4.7 16.4 17.4 13.0 13.3 7.7 17.0 21.0 17.2 2.7 20.9 6.5 6.4 12.6 9.0 12.5 13.7 19.7 14.0 12.4 12.9 12.7 12.3 12.4 11.8 13.7 19.4 9.8 3.2 3.3 0.0 12.9 3.8 6.7 6.2 5.7 30.2 7.0 7.1 8.8 10.0 5.1 3.7 27.1 7.0 12.4 2.2 1.9 7.3 9.1 6.1 8.3 11.0 3.0 3.0 0.0 3.2 5.3 9.8 1.5 3.8 2.5 17.8 12.8 2.7 4.9 26.9 0.0 4.0 2.0 7.0 3.7 2.9 12.8 4.7 3.6 0.0 7.7 17.3 29.9 0.0 0.0 3.2 3.0 13.5 1.8 4.6 2.2 3.4 5.7 27.2 6.6 14.1 10.1 27.0 40.4 2.9 3.0 2.9 10.0 8.5 4.1 2.8 ZNF566 "FLJ14779, MGC12515" ENSG00000186017 "Zinc finger protein 566" Q969W8 19 36445119-36489902 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023456 Uncertain Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA023456: AB_2221143" "unprognostic (1.68e-1)" "unprognostic (6.34e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (3.89e-3)" "unprognostic (5.71e-4)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (1.92e-2)" "unprognostic (7.56e-2)" "unprognostic (8.19e-4)" "unprognostic (7.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (9.48e-2)" "unprognostic (3.00e-1)" "unprognostic (5.47e-3)" 4.1 5.0 5.0 3.6 5.0 3.2 4.2 7.9 6.6 4.5 4.5 4.7 3.2 4.6 4.4 2.8 5.0 2.9 4.7 4.5 5.0 3.9 5.7 3.7 4.2 4.6 4.7 6.3 3.9 4.7 5.0 2.6 4.9 4.0 2.6 5.5 3.0 3.1 4.7 3.8 4.0 4.1 4.5 4.4 3.7 2.4 5.1 3.4 4.7 6.0 4.3 4.2 3.6 5.9 3.7 9.1 10.3 11.5 7.6 7.6 7.1 7.3 6.2 9.0 9.5 3.8 1.5 7.3 7.7 4.6 4.0 2.6 9.5 2.5 10.1 11.7 7.1 7.3 6.2 3.2 5.4 7.9 8.5 6.6 3.8 4.8 7.3 4.2 3.5 7.5 10.8 0.1 6.3 6.0 10.3 3.8 12.5 6.7 4.0 6.7 8.2 4.9 2.7 7.3 9.7 14.4 8.9 4.9 7.0 4.9 4.4 10.7 3.7 7.8 10.8 3.2 7.0 2.8 8.4 10.0 0.3 5.0 10.5 6.5 1.1 1.6 3.9 1.2 6.5 6.5 5.0 4.9 2.3 5.3 6.0 6.1 1.0 4.0 1.3 1.6 5.6 2.5 5.0 5.0 7.9 6.6 4.5 5.0 4.6 4.7 4.9 4.5 5.1 5.9 7.6 9.6 7.7 14.0 9.3 3.3 4.2 4.4 7.4 22.3 4.5 3.0 10.2 4.3 7.4 5.5 35.5 6.7 8.4 1.6 11.7 4.5 4.1 4.2 8.1 8.1 3.0 8.0 24.0 2.5 3.2 10.5 3.1 4.0 2.5 10.6 10.0 4.3 4.4 32.0 26.9 4.5 6.1 3.2 3.9 0.6 8.4 3.5 10.6 11.2 2.5 8.6 8.2 14.1 20.7 2.3 4.7 14.7 5.2 5.1 2.8 6.8 4.0 22.2 19.7 12.2 9.6 11.4 5.7 5.7 3.3 1.9 9.3 9.6 4.9 2.8 ZNF568 DKFZp686B0797 ENSG00000198453 "Zinc finger protein 568" Q3ZCX4 19 36916329-36998700 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 40.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024541, HPA052061" Uncertain Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA024541: , HPA052061: AB_2681713" "unprognostic (3.62e-2)" "unprognostic (2.73e-1)" "unprognostic (9.97e-2)" "unprognostic (1.99e-3)" "unprognostic (5.07e-2)" "unprognostic (2.81e-2)" "unprognostic (8.64e-2)" "unprognostic (2.65e-2)" "unprognostic (5.83e-5)" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (2.05e-5)" "unprognostic (2.03e-2)" "unprognostic (1.81e-1)" "unprognostic (5.06e-3)" "unprognostic (9.98e-3)" 4.1 6.5 5.5 3.6 5.4 3.7 5.6 12.4 6.4 6.3 7.3 4.5 2.4 7.3 4.9 3.4 5.9 3.4 5.2 5.4 8.4 4.5 3.3 4.2 4.1 5.9 6.9 9.3 4.4 8.3 5.3 5.2 5.8 4.9 2.9 11.8 4.8 5.4 5.5 4.1 3.2 5.9 3.9 6.1 4.3 6.0 6.9 4.8 7.7 5.7 4.5 4.4 4.1 9.9 0.2 5.0 8.4 2.5 7.8 8.8 2.6 7.4 7.4 6.0 8.1 0.6 2.9 0.3 8.3 9.3 4.3 1.4 0.1 4.3 6.3 1.1 6.5 2.8 0.9 1.0 10.1 0.4 6.5 10.7 5.1 6.1 0.2 7.3 2.9 3.7 0.3 0.8 9.2 0.2 1.6 1.3 6.9 0.0 0.3 0.7 6.7 2.6 5.7 11.0 8.2 10.7 0.3 0.2 6.2 8.3 6.7 1.1 4.7 3.5 11.9 6.1 4.8 9.0 13.1 6.0 0.2 0.2 12.5 19.6 1.7 6.4 7.1 1.3 6.3 9.0 6.8 5.9 2.9 6.9 8.4 6.4 1.4 7.4 2.1 2.7 6.4 3.0 5.5 5.4 12.4 6.4 5.4 8.4 5.9 6.9 5.8 3.9 6.9 9.9 7.7 3.2 7.0 12.7 7.5 5.1 3.4 4.5 2.8 18.9 5.7 6.5 6.6 10.0 3.1 9.2 14.6 5.0 6.3 0.5 3.9 7.1 28.9 5.1 7.1 7.4 0.0 1.3 22.4 3.7 4.1 7.8 2.6 3.8 16.5 13.9 6.4 1.4 3.5 40.4 22.6 1.4 14.2 2.5 3.4 19.5 6.5 3.5 1.8 10.3 3.5 9.4 12.3 25.6 25.7 2.8 0.3 9.8 3.4 3.9 0.7 5.1 5.2 17.0 6.6 13.6 6.6 18.1 12.6 3.4 4.1 2.9 7.9 7.2 1.0 2.6 ZNF573 FLJ30921 ENSG00000189144 "Zinc finger protein 573" Q86YE8 19 37735833-37817300 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 37.9;Inhibitory neurons: 28.1;Oligodendrocytes: 22.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042776 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" Cytosol "HPA042776: AB_10961399" "unprognostic (3.79e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (3.72e-2)" "unprognostic (3.29e-2)" "unprognostic (8.26e-2)" "unprognostic (1.10e-1)" "unprognostic (3.62e-2)" "unprognostic (3.69e-1)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (9.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (3.11e-2)" "unprognostic (2.60e-2)" 1.6 1.7 0.5 1.1 1.2 2.1 2.0 4.0 1.4 1.0 0.2 0.9 1.3 1.9 2.7 0.7 1.2 1.7 0.9 0.6 2.6 1.3 0.7 1.4 1.2 0.7 0.6 2.1 1.3 1.4 0.8 1.5 0.9 1.3 1.2 2.7 0.8 0.9 0.9 2.1 1.0 0.9 0.2 1.7 2.0 1.3 0.6 1.1 2.5 0.7 1.6 0.7 0.8 2.4 0.5 1.8 1.4 1.3 0.7 1.5 0.6 1.2 1.3 0.4 1.0 1.8 1.2 1.8 1.1 1.0 0.5 1.1 1.4 1.9 1.7 0.4 1.2 2.0 2.8 0.9 0.6 1.7 1.6 1.4 0.6 2.5 1.0 0.9 1.3 1.0 0.8 0.8 0.3 0.7 1.4 1.0 2.0 0.5 0.2 1.4 2.8 0.6 0.0 1.3 1.8 1.6 2.2 0.6 0.2 0.9 1.7 1.5 0.5 1.6 1.5 1.4 1.9 2.1 2.8 2.6 0.3 0.2 1.3 2.1 0.4 1.6 1.9 0.6 1.5 1.5 1.6 2.1 0.9 2.8 2.6 2.0 0.2 1.7 1.3 1.5 1.0 0.5 0.5 1.2 4.0 1.4 0.6 2.6 0.7 0.6 0.9 0.2 0.6 2.4 3.1 0.0 3.9 7.2 7.4 1.8 2.6 2.1 1.8 15.7 2.1 2.4 11.8 2.8 1.9 3.7 12.5 4.0 7.1 0.8 1.9 2.5 37.9 1.4 3.8 4.7 1.2 3.4 22.2 0.7 3.2 4.0 1.1 1.3 0.0 7.6 5.0 1.4 4.0 16.8 28.1 1.3 0.0 1.3 2.5 16.8 8.7 2.2 3.6 12.2 3.2 7.3 7.2 21.1 22.9 1.3 1.6 6.4 1.8 1.9 2.6 2.9 2.4 12.0 0.0 5.2 3.8 7.7 7.6 2.8 2.6 1.6 5.7 3.6 2.1 1.2 ZNF578 FLJ31384 ENSG00000258405 "Zinc finger protein 578" Q96N58 19 52453553-52516882 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 6.3" "Cell type enhanced" "Detected in many" "Horizontal cells: 6.7;NK-cells: 8.2;Oligodendrocyte precursor cells: 10.1;Rod photoreceptor cells: 8.2" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 5.5;U-266/84: 9.4" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "unprognostic (6.57e-3)" "unprognostic (1.43e-2)" "unprognostic (1.56e-2)" "unprognostic (3.77e-2)" "unprognostic (1.60e-3)" "unprognostic (2.96e-3)" "unprognostic (5.42e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-2)" "unprognostic (8.14e-2)" "unprognostic (9.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.81e-1)" "unprognostic (2.64e-1)" "unprognostic (1.82e-1)" "unprognostic (3.96e-2)" "unprognostic (2.42e-1)" 0.7 0.6 2.1 0.7 3.1 0.8 0.8 5.1 2.7 0.9 1.4 0.5 0.4 1.1 1.8 0.4 1.3 0.6 1.2 2.0 3.0 0.9 0.3 0.7 0.7 2.5 2.2 1.7 0.7 1.0 0.3 1.3 2.4 1.4 0.7 3.1 0.7 1.2 0.9 1.2 0.4 0.9 1.6 1.2 0.6 6.3 2.6 1.0 1.7 0.6 0.7 0.5 0.2 3.2 0.5 0.3 2.1 2.7 1.2 0.7 1.2 1.3 0.7 0.5 0.9 0.9 0.7 0.9 0.5 2.0 2.5 0.7 1.1 0.6 0.6 0.2 1.5 0.8 1.6 0.5 1.1 0.2 2.7 1.9 0.3 0.9 0.8 1.0 0.9 0.8 0.6 0.6 2.6 0.8 0.9 1.2 4.1 0.6 0.7 0.8 0.8 0.3 1.8 2.7 0.6 1.5 0.6 0.6 0.2 5.5 2.0 0.6 1.3 0.6 0.7 0.8 0.7 0.5 9.4 0.8 0.1 0.2 1.7 1.4 0.3 0.4 0.9 0.3 0.7 0.5 0.6 0.5 0.1 0.8 0.7 0.8 0.5 1.1 0.3 0.5 0.3 0.3 2.1 3.1 5.1 2.7 2.0 3.0 2.5 2.2 2.4 1.6 2.6 3.2 3.9 0.0 0.0 4.9 1.3 0.9 1.7 0.2 0.0 4.4 0.5 0.5 4.1 0.0 0.2 0.0 4.2 0.7 4.0 0.0 0.0 0.2 5.9 0.9 1.4 1.6 0.0 0.8 3.9 0.2 0.8 1.4 0.0 2.1 1.3 3.9 0.7 0.0 0.2 6.7 5.8 0.1 0.0 0.3 0.6 6.1 0.6 0.4 0.0 0.0 0.4 1.8 8.2 10.1 6.2 0.0 0.0 0.0 0.4 1.0 0.2 0.8 0.1 8.2 0.0 0.7 1.8 0.2 2.3 0.1 0.4 0.8 1.8 2.6 0.1 1.7 ZNF587 "FLJ14710, FLJ20813, UBF-fl, ZF6" ENSG00000198466 "Zinc finger protein 587" Q96SQ5 19 57849859-57865117 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "RT4: 41.5" "HPA042125, HPA043288, HPA056213" Uncertain Uncertain Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 4: Stomach - Digestion" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069" "unprognostic (1.61e-2)" "unprognostic (5.39e-2)" "unprognostic (3.92e-2)" "unprognostic (1.91e-1)" "unprognostic (2.42e-1)" "unprognostic (2.12e-2)" "unprognostic (6.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.29e-1)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.98e-4)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (7.30e-2)" "unprognostic (3.68e-3)" 5.0 5.1 3.9 6.4 3.6 6.8 10.1 4.5 5.3 6.4 5.9 8.5 8.2 5.9 5.6 6.1 6.0 3.7 6.0 3.7 3.8 6.5 6.2 6.2 5.4 2.9 2.9 7.1 9.1 4.9 11.5 8.0 2.9 9.6 13.1 11.4 12.1 6.5 4.5 5.9 7.9 5.5 2.1 6.1 8.9 4.4 3.3 5.4 7.7 4.1 6.8 6.2 7.3 4.7 8.6 7.8 7.0 5.7 7.5 10.9 10.5 7.5 9.5 11.2 9.8 11.2 5.7 5.7 3.9 5.9 4.4 5.1 10.1 11.1 20.8 5.3 21.5 11.1 28.6 8.0 4.3 11.1 10.6 10.8 5.1 11.0 10.4 8.6 12.1 7.8 14.1 7.5 8.4 3.6 6.7 4.1 2.1 2.2 7.1 5.3 6.6 3.8 6.7 41.5 11.1 5.2 8.7 7.9 2.7 9.2 6.8 6.3 5.7 8.3 5.1 2.1 10.7 12.0 9.8 6.0 3.8 4.7 5.0 1.4 0.5 0.4 0.4 0.4 0.4 0.5 0.5 0.4 0.5 0.7 0.4 0.7 1.2 0.5 0.4 0.4 0.7 0.3 3.9 3.6 4.5 5.3 3.7 3.8 2.9 2.9 2.9 2.1 3.3 4.7 6.9 3.2 6.8 13.1 8.4 9.2 13.6 7.3 1.8 20.0 10.4 5.8 7.1 30.0 9.6 7.3 31.3 10.8 7.4 12.2 11.7 9.1 9.5 16.9 10.0 7.8 23.4 3.8 19.9 3.7 9.8 7.3 19.4 22.6 12.7 18.3 12.5 9.4 6.5 20.2 19.3 18.2 4.1 7.1 5.5 1.3 4.7 7.0 0.0 10.3 7.2 7.6 7.2 17.6 14.1 7.6 15.9 9.1 8.7 13.4 14.8 8.5 13.3 24.7 0.0 9.2 6.3 4.2 6.7 5.4 6.7 10.1 8.7 9.5 15.5 15.4 ZNF587B ENSG00000269343 "Zinc finger protein 587B" E7ETH6 19 57819721-57846238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 36.2" "HPA043800, HPA053762, HPA072145" Uncertain Uncertain Nucleoplasm NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 59: Non-specific - Translation" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (4.13e-3)" "unprognostic (1.43e-1)" "unprognostic (1.36e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (5.69e-2)" "unprognostic (3.22e-3)" "unprognostic (3.80e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (5.47e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.16e-1)" "unprognostic (3.57e-2)" "unprognostic (2.94e-1)" "unprognostic (7.48e-2)" "unprognostic (8.70e-2)" 3.6 3.1 1.2 3.4 1.6 9.4 5.3 4.0 1.1 2.5 3.4 4.0 5.7 3.2 2.5 3.8 3.2 2.6 3.1 1.3 0.8 4.0 6.6 3.8 4.8 0.7 0.7 3.3 5.6 3.0 3.0 3.0 0.4 4.0 4.4 2.0 6.0 2.3 9.9 6.9 5.6 2.2 0.1 6.4 4.7 5.3 1.3 2.8 4.0 2.0 5.0 3.7 2.9 0.8 5.6 16.3 6.0 13.0 1.5 1.7 7.0 4.5 3.5 4.4 3.0 9.6 8.9 11.9 2.4 6.1 2.4 4.7 5.9 14.1 10.5 2.0 13.8 8.8 15.3 10.1 5.2 15.4 8.3 5.0 2.7 6.8 7.1 1.2 3.7 8.5 10.3 5.5 2.8 6.2 7.2 2.6 15.7 5.2 7.2 5.9 6.5 5.6 5.3 36.2 3.7 6.2 5.0 6.6 4.3 9.4 9.1 5.5 5.1 6.0 6.9 1.4 6.6 7.7 6.6 9.1 4.9 4.5 6.7 2.0 1.8 0.8 1.1 1.6 1.2 1.2 1.2 1.3 1.1 1.2 1.6 1.5 3.0 1.1 0.9 1.2 1.0 1.8 1.2 1.6 4.0 1.1 1.3 0.8 0.7 0.7 0.4 0.1 1.3 0.8 1.7 6.4 1.5 6.5 3.4 3.2 3.4 2.4 1.2 4.2 2.2 0.6 2.7 4.3 5.4 0.0 0.0 3.5 3.9 1.3 1.9 3.9 4.6 3.1 2.2 2.8 4.2 1.3 11.6 2.0 3.3 2.8 3.1 3.3 0.0 5.8 5.7 3.4 1.4 3.3 12.2 3.7 4.1 2.2 1.0 0.9 0.6 1.9 1.8 4.7 1.8 0.8 2.1 11.1 4.6 2.1 1.4 0.7 2.2 2.9 1.4 3.3 3.2 3.6 6.6 2.3 2.5 4.2 5.8 1.3 3.8 2.5 2.2 4.4 2.4 3.1 ZNF594 KIAA1871 ENSG00000180626 "Zinc finger protein 594" Q96JF6 17 5179535-5191868 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 17.8;Horizontal cells: 15.2;Inhibitory neurons: 15.7;Oligodendrocytes: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060283, HPA067178, HPA069360, HPA074493, HPA077596" Approved Enhanced Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: " "unprognostic (6.67e-2)" "unprognostic (1.07e-2)" "unprognostic (6.93e-2)" "unprognostic (7.92e-3)" "unprognostic (1.11e-1)" "unprognostic (8.24e-3)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (6.67e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-5)" "unprognostic (4.09e-3)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.99e-1)" "unprognostic (5.21e-2)" "unprognostic (6.59e-2)" 1.8 3.3 2.8 4.2 3.9 0.7 4.9 6.0 3.8 4.4 4.5 3.9 1.6 5.1 4.2 1.9 4.4 2.2 2.9 3.0 2.7 4.2 2.2 2.2 6.2 3.8 2.8 10.7 3.3 5.4 6.2 3.2 3.1 5.1 2.7 11.7 3.8 4.3 4.0 2.1 4.0 3.0 2.0 5.1 2.9 4.5 3.4 5.1 5.6 2.9 5.9 3.6 2.9 6.8 5.8 2.5 10.5 8.3 1.6 1.8 8.9 3.8 1.9 6.6 6.2 7.3 2.1 13.1 5.9 3.0 4.9 6.2 6.8 0.2 8.3 7.0 6.9 4.2 10.2 3.7 2.4 0.0 4.0 1.4 1.1 4.0 0.0 1.7 0.7 7.5 1.7 3.2 2.2 5.7 3.6 1.8 4.9 0.9 3.5 7.6 8.9 1.7 1.9 1.5 6.2 8.4 2.8 1.5 5.8 4.6 3.4 3.1 0.1 0.1 3.7 3.4 2.7 2.0 4.5 3.0 0.6 0.0 4.1 0.2 0.4 0.5 1.4 0.5 1.0 1.6 1.5 1.4 0.4 2.5 2.3 1.6 0.2 1.3 0.5 2.2 2.4 0.6 2.8 3.9 6.0 3.8 3.0 2.7 3.8 2.8 3.1 2.0 3.4 6.8 1.8 6.4 3.9 14.0 3.6 1.1 1.3 0.4 1.2 9.5 2.5 2.2 5.5 4.3 2.8 5.5 6.2 1.4 1.3 0.7 7.9 1.6 0.8 0.8 3.1 2.1 1.2 2.5 17.8 1.1 0.7 2.7 1.5 0.8 3.8 9.9 3.9 0.7 1.1 15.2 15.7 1.5 0.0 1.4 0.6 4.3 3.4 1.2 0.0 8.4 1.5 7.7 3.1 14.6 20.3 0.7 1.5 2.6 0.8 0.9 0.6 1.0 5.0 9.2 0.0 3.3 2.4 2.5 4.1 0.9 0.3 0.3 1.8 5.2 1.3 0.5 ZNF605 ENSG00000196458 "Zinc finger protein 605" Q86T29 12 132918306-132956306 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061970, HPA062655" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA061970: AB_2684649, HPA062655: AB_2684820" "unprognostic (2.38e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-2)" "unprognostic (6.38e-2)" "unprognostic (3.83e-2)" "unprognostic (1.16e-6)" "unprognostic (3.62e-1)" "unprognostic (1.15e-1)" "unprognostic (4.03e-1)" "unprognostic (2.13e-2)" "unprognostic (1.10e-2)" "unprognostic (2.89e-1)" "unprognostic (6.58e-2)" "unprognostic (1.10e-1)" "unprognostic (7.53e-2)" "unprognostic (9.06e-3)" 2.9 4.1 5.7 2.5 5.7 1.4 5.2 7.3 6.8 4.6 6.6 5.1 2.8 4.3 5.4 3.5 4.6 2.7 4.4 5.6 4.7 4.7 4.3 2.9 3.2 5.4 5.0 5.4 3.9 6.2 6.7 3.3 5.5 5.2 2.8 8.4 4.5 3.8 4.2 5.0 4.2 3.2 4.3 3.9 4.0 2.1 5.4 4.0 6.9 5.2 2.9 4.4 4.2 6.4 4.8 3.8 9.7 9.2 5.2 10.7 7.2 6.5 3.7 2.9 2.1 0.6 0.6 2.0 3.4 5.6 3.6 2.6 4.2 1.6 3.6 1.6 7.2 9.2 3.4 3.0 3.9 3.9 9.7 6.8 7.0 2.0 4.4 9.0 2.2 4.7 1.4 0.1 7.4 1.3 5.1 5.4 7.5 1.3 5.2 4.7 6.3 1.4 5.0 8.1 6.2 7.1 2.9 1.7 4.5 5.7 10.6 11.1 4.4 3.6 5.8 5.4 2.6 0.0 0.0 1.6 0.1 3.2 2.2 0.4 0.2 0.2 0.2 0.1 0.1 0.5 0.2 0.3 0.1 0.3 0.5 0.3 0.3 0.3 0.1 0.2 0.0 0.1 5.7 5.7 7.3 6.8 5.6 4.7 5.4 5.0 5.5 4.3 5.4 6.4 8.4 19.2 33.5 21.9 9.3 3.4 8.1 3.3 18.8 33.6 10.5 11.2 22.5 15.7 25.1 9.2 29.2 7.5 5.0 7.3 9.8 7.2 2.2 8.1 15.0 12.7 6.1 7.6 24.9 3.3 3.6 12.6 15.3 7.1 10.1 20.2 13.6 4.9 3.9 40.4 25.2 10.1 6.1 7.3 2.7 2.5 15.8 6.1 0.0 11.2 8.9 16.4 13.4 28.1 15.8 7.5 4.5 13.5 5.8 9.5 5.8 5.2 13.7 35.2 13.1 16.2 11.5 6.8 7.9 9.4 4.5 5.6 10.8 23.0 7.1 6.2 ZNF606 "FLJ14260, KIAA1852, ZNF328" ENSG00000166704 "Zinc finger protein 606" Q8WXB4 19 57977053-58003349 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 25.0;Rod photoreceptor cells: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041712, HPA043584" Uncertain Supported Nucleoplasm NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA041712: AB_10960410, HPA043584: AB_2678565" "unprognostic (1.05e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (6.21e-2)" "unprognostic (1.10e-1)" "unprognostic (6.83e-2)" "unprognostic (3.48e-3)" "unprognostic (4.26e-2)" "unprognostic (1.29e-3)" "unprognostic (4.09e-2)" "unprognostic (1.03e-1)" "unprognostic (5.00e-2)" "unprognostic (3.21e-2)" "unprognostic (4.01e-2)" "prognostic favorable (4.75e-6)" 4.4 5.3 7.3 5.0 9.2 4.0 8.0 10.5 8.1 8.3 11.8 5.7 5.6 8.1 8.9 5.0 10.0 3.5 5.7 6.8 7.2 9.7 5.7 5.3 8.1 8.4 9.1 10.4 6.4 9.3 11.3 4.3 8.2 8.9 4.5 10.0 7.9 6.0 3.9 7.2 8.4 3.5 8.1 9.0 6.7 7.6 7.8 8.5 13.3 2.8 6.6 6.3 6.0 12.1 1.7 3.1 13.1 10.9 3.9 5.4 9.4 4.0 1.4 3.9 2.4 4.1 4.7 2.7 3.1 2.7 4.2 4.0 1.7 3.9 5.2 0.0 23.5 6.6 1.3 3.7 3.0 0.0 5.1 6.4 1.9 3.4 1.9 6.1 2.8 7.7 3.4 0.1 5.0 1.6 9.0 1.5 7.9 2.1 5.8 9.9 4.8 4.0 4.2 8.2 12.1 8.0 7.2 0.2 3.0 6.3 6.3 6.3 3.3 3.1 4.4 1.1 1.3 7.8 9.1 1.9 0.2 0.7 4.1 10.2 2.3 6.5 2.2 2.0 3.2 6.5 3.6 2.7 2.1 7.4 6.4 3.7 6.2 5.5 2.3 6.5 2.6 1.8 7.3 9.2 10.5 8.1 6.8 7.2 8.4 9.1 8.2 8.1 7.8 12.1 4.3 6.4 7.8 9.1 9.6 1.0 3.5 2.5 5.2 15.4 3.5 2.9 10.8 2.8 5.6 12.9 25.0 3.2 6.2 1.7 3.9 4.0 2.8 8.6 4.6 5.9 0.0 9.0 8.4 1.6 1.1 3.9 6.1 2.2 5.1 14.4 5.3 2.6 2.0 11.8 9.8 2.4 4.1 0.8 3.0 1.2 8.1 2.5 0.0 7.5 2.2 8.6 10.3 10.1 12.9 2.2 2.4 3.4 3.0 4.1 4.2 2.2 22.6 29.2 6.6 2.9 4.6 12.3 12.7 3.1 2.0 3.4 4.4 6.8 2.2 3.2 ZNF613 FLJ13590 ENSG00000176024 "Zinc finger protein 613" Q6PF04 19 51927147-51948759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 19.4" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "prostate cancer: 10.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026833 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA026833: AB_1859377" "unprognostic (1.10e-1)" "unprognostic (2.57e-1)" "unprognostic (9.27e-2)" "unprognostic (2.84e-1)" "unprognostic (9.31e-3)" "unprognostic (1.79e-1)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-2)" "unprognostic (1.91e-1)" "unprognostic (2.73e-1)" "unprognostic (5.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-3)" "prognostic favorable (1.92e-6)" 3.2 3.2 3.4 2.6 3.8 1.4 7.0 4.6 4.2 3.1 3.2 5.2 2.2 3.5 3.8 3.4 3.2 2.8 3.5 3.5 5.1 4.9 2.9 3.8 4.2 4.0 4.2 3.8 2.5 6.0 3.2 6.6 3.9 19.4 5.0 7.2 2.9 4.0 2.7 3.6 2.9 4.1 3.5 4.3 2.8 2.8 4.0 5.6 4.3 3.5 4.2 3.6 2.8 4.2 2.9 3.8 6.2 6.3 5.5 5.7 1.5 5.0 7.8 6.4 8.1 1.3 3.5 2.7 2.6 6.1 5.8 3.2 6.3 6.1 6.9 0.1 8.2 5.4 2.8 3.7 5.5 0.3 7.2 4.6 7.1 6.2 5.0 7.7 7.1 6.2 2.5 0.0 6.6 0.5 8.9 4.1 4.5 1.3 5.9 4.7 7.0 2.8 6.5 9.9 4.2 4.0 8.0 5.8 4.6 9.8 6.3 6.4 4.6 2.7 5.3 2.2 5.3 5.5 0.0 4.9 0.1 0.0 8.5 5.7 5.2 10.5 7.1 5.3 6.5 6.0 7.4 8.3 7.0 9.0 7.6 9.9 5.4 7.7 9.4 3.5 7.7 5.4 3.4 3.8 4.6 4.2 3.5 5.1 4.0 4.2 3.9 3.5 4.0 4.2 2.0 3.2 2.6 2.0 0.9 0.5 0.6 0.8 0.6 2.4 1.6 1.0 4.6 1.5 2.7 3.7 0.0 6.1 1.5 1.9 3.9 2.5 2.3 1.2 1.2 3.0 1.2 0.0 2.4 2.2 1.7 1.2 1.5 1.6 1.3 4.9 3.3 1.5 3.2 0.0 2.0 3.7 6.1 1.6 1.5 1.2 1.2 1.2 0.0 4.7 3.0 2.3 3.1 4.5 4.6 1.8 2.1 1.5 0.5 1.6 1.0 1.4 0.5 4.0 0.0 1.6 1.5 1.9 2.1 1.5 0.6 7.1 1.4 2.3 2.1 0.7 ZNF618 "KIAA1952, NEDD10" ENSG00000157657 "Zinc finger protein 618" Q5T7W0 9 113876282-114056591 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 33.0;REH: 31.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023116, HPA061732" Uncertain Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 1: Thyroid gland - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA023116: AB_10964204, HPA061732: AB_2684596" "unprognostic (1.92e-1)" "unprognostic (3.22e-2)" "unprognostic (2.29e-2)" "unprognostic (4.17e-3)" "prognostic unfavorable (6.34e-4)" "unprognostic (3.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.61e-1)" "unprognostic (6.43e-2)" "unprognostic (2.38e-2)" "unprognostic (1.56e-2)" "unprognostic (8.24e-2)" "prognostic favorable (5.22e-7)" "unprognostic (4.57e-2)" "unprognostic (2.79e-1)" "unprognostic (1.04e-1)" "unprognostic (3.51e-2)" 3.3 4.6 2.5 2.1 2.4 2.7 3.7 4.5 2.3 5.8 4.5 1.8 2.2 6.4 2.9 2.3 5.4 4.0 2.0 1.8 3.1 7.3 5.5 3.5 1.2 3.4 2.9 9.6 5.5 6.9 3.9 2.1 2.9 3.0 1.6 1.9 3.4 2.8 2.3 2.2 1.6 4.5 2.1 3.9 4.2 2.5 3.7 3.5 5.4 1.8 1.1 2.0 2.6 2.1 7.4 22.5 33.0 14.4 7.8 9.1 1.6 4.8 7.9 9.5 8.4 0.2 5.2 4.1 4.5 8.4 2.7 0.2 16.6 8.3 3.7 0.1 6.6 0.0 1.7 0.1 5.8 4.4 7.4 8.8 3.3 10.1 2.2 8.6 24.2 0.5 0.0 0.0 4.3 12.1 0.2 5.6 16.4 0.6 4.9 31.8 19.2 0.1 10.2 8.1 10.2 24.2 13.7 8.7 8.7 9.4 0.7 8.9 19.8 12.6 9.9 7.1 5.9 0.0 0.0 0.0 0.9 6.6 9.0 1.6 0.4 0.2 0.3 0.2 0.1 0.0 0.0 0.3 1.4 0.5 0.2 0.2 0.0 1.1 0.3 1.7 0.0 0.4 2.5 2.4 4.5 2.3 1.8 3.1 3.4 2.9 2.9 2.1 3.7 2.1 9.1 3.2 13.2 4.9 2.1 2.0 4.8 3.7 12.0 14.9 12.6 17.1 2.7 24.3 4.2 11.0 4.2 0.2 3.1 0.5 7.9 16.0 7.6 7.4 22.8 10.0 2.4 7.6 14.6 8.2 0.1 12.7 10.7 12.2 21.0 26.9 11.0 10.9 3.4 58.9 30.6 2.1 2.0 5.4 8.5 4.8 15.2 7.2 0.0 38.4 12.1 10.1 4.1 24.1 8.7 9.7 1.9 15.4 0.4 1.8 0.1 10.8 2.3 1.6 26.3 10.1 19.2 0.4 11.4 3.6 3.7 0.3 2.0 40.0 2.8 1.9 ZNF619 FLJ90764 ENSG00000177873 "Zinc finger protein 619" Q8N2I2 3 40477113-40491053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045094 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Intermediate filaments" "HPA045094: AB_10959900" "unprognostic (7.16e-2)" "unprognostic (5.94e-1)" "unprognostic (8.38e-3)" "unprognostic (5.42e-2)" "unprognostic (8.16e-3)" "unprognostic (1.32e-2)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (5.46e-2)" "unprognostic (2.65e-1)" "unprognostic (7.99e-2)" "unprognostic (6.15e-3)" "unprognostic (8.28e-6)" "unprognostic (1.94e-1)" "unprognostic (1.69e-1)" "unprognostic (6.56e-2)" "unprognostic (1.38e-2)" 1.7 1.6 2.3 2.0 3.5 3.1 2.9 3.0 2.8 2.0 2.5 2.0 2.3 2.0 2.1 1.4 2.5 1.3 1.8 2.2 2.6 2.2 2.4 2.0 2.4 3.0 3.0 2.6 2.5 3.1 1.2 2.0 3.0 2.1 2.6 4.1 2.7 2.2 2.5 2.4 2.0 2.3 2.2 2.9 2.4 1.1 3.0 1.5 3.0 2.2 2.9 1.7 1.5 4.6 1.9 2.5 2.9 2.8 4.5 4.3 1.3 2.7 3.1 4.5 3.9 0.9 2.6 0.2 1.4 2.2 2.2 2.1 3.2 5.0 4.8 3.6 1.1 6.1 2.2 1.4 4.6 4.2 5.0 3.4 3.9 4.7 6.6 3.9 3.8 0.2 3.9 2.9 2.9 2.3 0.1 2.1 1.6 2.2 2.8 1.2 3.0 3.3 2.1 4.2 2.1 2.2 2.4 4.1 2.0 2.9 3.4 2.7 3.6 3.3 2.7 2.0 2.8 1.6 2.2 0.2 2.1 2.6 3.7 0.8 0.7 1.1 0.7 0.9 0.7 0.7 0.6 0.8 1.0 0.8 0.6 0.9 0.8 1.3 1.0 0.6 1.2 0.7 2.3 3.5 3.0 2.8 2.2 2.6 3.0 3.0 3.0 2.2 3.0 4.6 1.5 0.0 1.1 1.0 2.3 0.3 0.8 0.6 1.2 3.6 1.0 1.0 1.3 0.0 0.3 3.7 2.1 1.4 1.0 0.7 0.0 1.4 0.1 1.4 1.6 1.6 0.0 2.1 0.5 1.5 0.9 1.2 1.5 1.1 0.0 2.4 1.8 0.9 1.1 0.0 1.0 1.3 0.0 1.6 0.4 0.0 1.2 1.2 0.0 2.8 1.6 2.5 2.1 1.0 2.3 0.6 0.2 0.4 1.7 0.5 1.6 1.3 1.0 3.6 0.0 2.0 1.1 1.2 1.4 1.7 0.1 0.4 1.5 2.5 0.8 0.6 ZNF621 FLJ45246 ENSG00000172888 "Zinc finger protein 621" Q6ZSS3 3 40524878-40574685 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065518, HPA071440" Enhanced "Nuclear speckles" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA065518: AB_2685501, HPA071440: AB_2686395" "unprognostic (1.09e-1)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (9.50e-3)" "unprognostic (3.06e-2)" "unprognostic (3.14e-2)" "unprognostic (2.62e-1)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.19e-1)" "unprognostic (5.33e-2)" "unprognostic (8.76e-2)" "unprognostic (2.50e-2)" "unprognostic (2.01e-3)" 13.0 10.0 15.7 5.9 18.9 7.1 12.9 15.0 16.5 12.7 13.4 11.2 5.3 11.2 8.1 9.5 11.5 5.7 9.4 13.2 17.1 15.2 12.4 13.2 6.2 19.4 16.3 12.0 12.2 7.7 14.6 5.5 19.4 14.4 5.7 7.4 12.1 6.9 7.2 10.0 11.7 6.1 17.0 12.7 10.7 7.6 17.5 5.5 13.2 5.6 6.1 11.0 11.5 21.0 8.9 5.0 12.2 12.0 7.8 13.4 6.9 9.5 11.1 11.7 11.6 11.1 4.8 3.7 6.9 12.4 8.8 3.1 12.2 7.2 13.7 14.9 15.1 12.4 20.8 10.1 13.6 11.6 11.8 10.4 14.9 12.2 19.0 12.7 9.9 4.4 13.3 10.8 10.1 5.6 2.9 13.8 7.7 3.5 10.2 1.1 8.2 4.4 6.1 11.0 4.3 10.9 10.2 6.9 12.0 11.7 11.4 9.4 13.1 20.2 9.8 10.2 13.4 16.1 17.4 8.3 9.9 8.6 12.5 2.5 1.0 0.9 1.3 1.3 0.8 2.3 1.3 1.8 0.9 3.3 1.6 1.2 1.2 1.8 0.7 1.3 1.3 0.7 15.7 18.9 15.0 16.5 13.2 17.1 19.4 16.3 19.4 17.0 17.5 21.0 13.2 9.6 12.3 22.5 9.6 1.5 5.2 2.3 9.1 13.8 6.3 5.0 12.1 10.0 7.7 11.0 12.5 5.5 9.5 4.9 5.9 7.7 10.8 11.1 16.4 12.0 10.2 12.4 4.1 5.6 3.5 9.0 7.7 12.2 3.8 15.0 5.0 5.6 3.7 15.2 4.2 7.1 4.1 8.1 3.0 7.9 7.5 6.9 3.6 11.2 9.4 7.1 10.3 19.1 26.1 7.5 4.9 12.0 8.8 6.6 6.7 3.2 4.6 16.7 0.0 13.6 9.1 10.6 6.3 7.5 1.8 5.5 8.1 12.9 5.8 4.4 ZNF623 KIAA0628 ENSG00000183309 "Zinc finger protein 623" O75123 8 143636019-143656418 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "PC-3: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044372 Uncertain Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA044372: AB_10966790" "unprognostic (1.06e-3)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (4.00e-3)" "unprognostic (6.95e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (2.08e-1)" "unprognostic (1.82e-1)" "unprognostic (5.21e-2)" "unprognostic (8.03e-2)" 5.8 5.0 2.5 1.8 2.3 0.6 5.5 1.8 3.0 7.4 1.2 7.4 2.3 7.0 1.7 6.2 6.6 1.5 6.0 2.6 2.7 5.2 5.7 5.2 2.3 2.2 2.1 8.5 5.4 2.8 5.9 1.8 2.5 5.9 2.0 1.7 6.0 1.3 7.2 7.8 6.4 2.1 1.5 6.8 5.4 7.2 2.7 2.1 5.2 1.8 1.9 7.6 6.5 2.3 3.0 6.9 2.6 2.5 4.1 8.0 2.5 2.9 3.8 4.7 3.3 2.4 2.5 1.8 3.6 6.5 3.2 1.9 3.0 1.9 3.7 5.1 2.3 7.5 7.3 2.2 3.2 1.7 2.1 3.3 3.8 2.0 8.7 5.1 3.3 4.9 6.1 3.3 3.4 6.6 5.8 2.4 3.4 3.7 18.3 4.0 2.3 2.8 2.6 4.0 6.4 6.2 11.9 2.4 4.0 2.6 5.4 5.2 1.5 4.4 1.5 1.8 2.4 1.9 2.3 2.8 3.2 2.8 3.6 1.1 0.2 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.5 0.4 0.4 0.4 0.2 0.5 0.5 0.4 0.2 2.5 2.3 1.8 3.0 2.6 2.7 2.2 2.1 2.5 1.5 2.7 2.3 4.6 6.4 3.9 3.9 5.8 1.7 3.1 1.6 7.4 5.9 4.4 4.2 10.3 7.2 1.5 7.3 6.2 5.9 4.7 5.8 3.9 5.9 5.4 3.0 8.1 5.8 5.4 9.9 7.5 3.8 6.0 5.6 4.6 5.0 1.3 9.2 7.1 6.6 5.8 15.2 5.3 5.3 2.0 6.6 2.4 4.5 8.4 4.6 3.6 4.7 8.3 7.2 7.2 5.5 5.4 4.4 2.3 13.9 2.8 4.5 5.4 3.9 1.3 7.0 19.7 8.2 5.1 10.8 13.9 6.2 2.6 4.8 5.8 5.8 5.2 1.7 ZNF626 ENSG00000188171 "Zinc finger protein 626" Q68DY1 19 20619939-20661596 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 19.8" HPA045631 Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 1: Thyroid gland - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear membrane, Vesicles" Nucleoplasm "HPA045631: AB_2679397" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-2)" "unprognostic (2.18e-2)" "unprognostic (6.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-2)" "unprognostic (6.51e-3)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (5.10e-2)" "unprognostic (1.73e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (2.31e-1)" 7.4 8.9 3.0 5.4 4.7 3.8 16.1 4.8 4.5 8.4 4.8 3.7 1.6 11.2 7.8 6.3 12.2 9.3 10.0 3.0 3.8 11.0 5.7 5.2 12.2 2.5 3.4 25.9 7.2 21.4 3.6 7.3 2.7 11.0 3.2 7.5 7.0 9.7 4.6 9.3 2.4 9.4 3.1 7.0 8.0 5.0 3.8 8.6 23.7 5.9 9.7 14.8 4.1 5.8 0.1 0.0 5.9 0.4 6.8 8.7 0.3 6.5 0.6 9.1 7.9 0.1 0.1 0.5 3.0 8.3 10.7 1.1 0.0 0.2 11.6 0.1 0.2 0.0 0.2 2.3 12.1 0.1 0.0 16.6 2.6 5.5 2.8 0.1 4.3 0.1 4.1 0.6 9.6 0.1 0.4 1.1 12.0 0.0 2.9 5.7 4.1 2.1 8.4 6.4 1.6 10.6 0.1 0.7 6.0 10.6 13.7 0.1 0.1 4.2 0.2 16.4 0.5 9.0 19.8 8.6 0.1 0.1 0.5 0.9 1.1 6.3 7.2 1.1 6.8 8.4 7.6 8.2 3.2 10.5 7.0 6.3 11.2 9.8 4.8 4.2 3.8 3.8 3.0 4.7 4.8 4.5 3.0 3.8 2.5 3.4 2.7 3.1 3.8 5.8 14.0 3.2 8.2 26.4 18.5 9.4 13.7 4.2 10.2 11.1 18.2 18.8 9.8 12.8 6.7 27.6 10.4 17.5 11.1 1.4 31.3 8.7 1.3 19.3 15.0 11.6 2.4 1.7 29.3 9.5 24.9 13.9 6.1 20.8 7.0 19.7 17.2 7.4 11.0 13.5 27.6 1.3 6.1 4.7 9.8 1.7 18.6 5.1 5.4 15.9 2.9 16.2 19.6 37.7 43.0 9.1 0.4 15.4 3.9 17.2 0.1 30.8 12.3 9.5 13.1 11.4 11.9 10.1 16.2 6.1 12.6 43.4 12.3 39.8 0.8 15.5 ZNF630 "BC037316, dJ54B20.2, FLJ20573, MGC138344" ENSG00000221994 "Zinc finger protein 630" Q2M218 X 47983356-48071658 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 5.0;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 5.3" "Low region specificity" "Detected in all" "HPA001053, HPA068130" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 21: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA001053: AB_2666183, HPA068130: AB_2685961" "unprognostic (1.03e-1)" "unprognostic (2.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (8.09e-2)" "unprognostic (5.86e-3)" "unprognostic (5.83e-2)" "unprognostic (9.06e-3)" "unprognostic (8.68e-2)" "unprognostic (5.83e-2)" "unprognostic (2.14e-2)" "unprognostic (7.92e-2)" "unprognostic (6.07e-3)" "unprognostic (5.92e-2)" "unprognostic (1.31e-1)" "unprognostic (3.27e-1)" "unprognostic (7.51e-5)" 1.9 2.2 3.8 1.5 4.0 0.9 2.8 5.0 4.8 3.6 4.1 2.5 1.8 2.6 2.8 2.1 2.6 2.5 2.7 3.6 3.8 2.4 1.4 2.1 1.8 4.0 4.1 4.7 3.2 4.2 2.6 1.6 4.2 3.8 2.5 3.7 2.3 2.8 1.0 1.9 1.8 2.4 3.8 2.3 2.9 0.7 4.2 0.9 3.7 1.2 1.5 3.0 2.7 4.6 1.0 0.7 0.2 0.0 0.1 0.0 0.0 1.4 0.5 1.1 0.6 2.3 4.0 0.1 0.8 1.4 1.6 1.8 0.0 0.8 0.9 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 1.0 4.0 2.3 0.0 2.6 0.7 0.0 0.0 4.2 2.5 4.3 0.0 0.0 1.5 3.5 1.2 0.5 1.0 0.0 1.7 2.2 2.3 1.8 5.3 3.7 1.4 3.2 4.3 0.9 1.3 0.0 1.8 1.8 0.0 0.0 3.7 0.0 0.0 0.1 3.3 2.3 0.8 2.0 0.8 0.3 0.9 1.0 0.7 0.7 1.5 0.6 0.9 1.0 0.9 0.7 0.3 0.4 0.5 0.9 3.8 4.0 5.0 4.8 3.6 3.8 4.0 4.1 4.2 3.8 4.2 4.6 0.8 0.0 0.0 2.6 1.4 0.1 1.0 0.8 3.4 2.5 1.6 1.3 1.6 0.0 0.8 1.8 0.0 0.1 0.4 0.9 1.9 1.4 0.0 1.2 1.9 1.2 4.2 0.8 2.2 1.1 0.9 1.4 1.1 1.3 0.0 4.0 1.8 0.3 0.9 0.0 2.6 1.6 0.0 0.0 0.0 0.2 0.3 0.7 0.0 1.0 1.3 0.7 0.0 5.0 3.2 1.0 0.6 0.4 1.0 0.9 1.1 0.7 0.5 1.0 6.6 1.4 1.4 0.2 0.4 1.7 0.3 0.3 1.1 4.0 1.0 0.8 ZNF638 "MGC26130, NP220, ZFML, Zfp638" ENSG00000075292 "Zinc finger protein 638" Q14966 2 71276561-71435069 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 342.3;Oligodendrocytes: 619.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036784, HPA057395" Supported Enhanced Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA036784: AB_10672478, HPA057395: AB_2683426" "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (7.57e-2)" "unprognostic (1.26e-3)" "unprognostic (2.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-2)" "unprognostic (5.68e-3)" "unprognostic (2.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (2.66e-3)" "unprognostic (3.28e-1)" "unprognostic (7.68e-2)" "unprognostic (1.93e-2)" "prognostic favorable (8.73e-5)" 21.1 22.1 35.7 21.6 48.9 28.2 24.6 77.6 52.3 23.0 37.7 22.0 15.6 29.2 18.4 19.8 22.1 19.1 41.0 35.7 41.3 24.2 30.9 21.2 25.0 41.9 36.8 37.3 21.9 27.9 24.9 23.2 41.9 22.2 19.5 48.6 21.0 19.5 51.5 16.8 19.0 22.9 34.8 23.1 21.8 29.7 38.9 30.9 29.8 33.7 22.6 21.3 17.1 82.5 36.2 51.0 77.0 36.1 44.4 48.3 59.2 40.4 46.6 33.6 30.0 49.2 34.6 59.2 36.6 37.1 52.3 29.9 72.1 41.4 48.7 60.5 40.1 77.8 54.8 45.4 38.3 72.0 50.6 30.8 39.5 36.1 66.7 47.8 52.5 39.2 79.4 33.8 49.6 36.1 50.9 52.9 66.7 54.1 32.4 43.0 116.5 41.7 36.0 54.3 59.0 38.7 49.8 34.7 52.8 76.3 32.3 43.7 54.3 41.4 60.0 31.1 41.2 27.6 45.7 57.4 34.8 46.3 45.8 64.1 17.0 33.5 18.1 16.3 17.2 25.4 17.1 17.2 14.0 26.0 22.5 16.7 29.1 21.5 24.1 17.7 16.0 10.8 35.7 48.9 77.6 52.3 35.7 41.3 41.9 36.8 41.9 34.8 38.9 82.5 63.1 67.3 112.4 227.9 63.9 31.7 56.8 40.8 46.1 111.5 36.8 35.4 107.0 27.1 59.0 40.5 123.0 42.5 46.7 39.2 19.6 43.0 15.7 54.2 63.7 65.9 38.4 57.2 286.9 40.9 29.0 83.5 50.0 59.2 79.1 112.8 38.6 48.6 32.5 67.3 268.4 34.2 32.6 41.9 33.3 15.8 75.2 49.6 23.2 225.8 71.6 56.4 56.7 342.3 619.5 39.6 35.7 63.9 50.5 60.0 38.1 21.6 74.7 104.0 32.9 98.3 73.1 110.1 78.3 37.4 30.3 50.2 56.1 74.0 36.8 58.9 ZNF641 FLJ31295 ENSG00000167528 "Zinc finger protein 641" Q96N77 12 48337180-48351414 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035189 Uncertain Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA035189: AB_10603333" "unprognostic (1.79e-1)" "unprognostic (1.85e-1)" "unprognostic (2.70e-2)" "unprognostic (9.82e-3)" "unprognostic (3.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.90e-2)" "unprognostic (1.35e-3)" "unprognostic (7.82e-3)" "prognostic favorable (3.91e-4)" "prognostic favorable (8.30e-5)" "unprognostic (3.67e-1)" "unprognostic (2.68e-2)" "unprognostic (7.61e-2)" "unprognostic (1.51e-1)" "unprognostic (5.76e-2)" "unprognostic (7.85e-3)" 9.0 22.9 8.3 10.7 9.0 6.9 7.8 8.9 9.5 11.3 4.2 8.2 9.4 14.1 10.1 6.6 10.7 9.9 9.1 7.6 9.5 9.2 9.9 10.9 12.5 10.0 10.1 19.6 12.1 14.1 9.8 14.8 9.8 8.8 8.0 16.9 7.4 9.2 16.6 6.2 7.5 13.3 9.1 12.6 9.3 11.9 10.9 14.7 14.7 17.3 12.9 10.7 7.1 9.5 3.2 5.4 8.3 13.9 8.0 2.2 6.1 8.1 5.5 4.3 2.8 9.1 9.1 6.2 11.4 7.3 8.1 5.3 3.1 5.3 1.4 14.2 5.2 10.2 9.9 2.6 7.4 11.0 14.2 3.5 7.9 2.9 6.7 6.9 3.8 7.9 10.4 6.1 3.9 4.1 5.1 4.7 1.8 3.4 2.3 3.4 8.0 5.0 7.0 16.6 3.4 5.2 9.4 4.0 5.9 7.2 10.2 11.2 1.5 4.7 7.5 4.6 3.9 6.6 6.5 4.8 2.8 12.8 4.7 1.6 2.9 7.2 2.7 2.7 1.6 0.4 1.5 2.5 3.1 0.6 1.4 2.6 6.5 4.5 4.0 1.3 0.7 2.4 8.3 9.0 8.9 9.5 7.6 9.5 10.0 10.1 9.8 9.1 10.9 9.5 8.4 6.4 16.1 19.2 9.9 3.1 13.5 4.4 14.2 14.7 7.9 5.6 9.1 11.5 5.7 7.3 10.4 1.4 12.7 4.3 7.9 8.8 2.2 3.8 8.7 9.2 5.4 7.4 16.8 10.4 0.9 12.8 4.6 5.0 3.8 33.0 15.7 8.6 7.6 18.5 38.7 1.7 0.0 18.3 13.5 2.7 15.5 12.3 0.0 15.0 15.3 16.9 27.8 10.1 4.7 7.2 1.3 24.0 3.7 5.9 4.8 5.1 5.0 18.4 19.7 9.3 17.9 5.2 6.0 6.2 2.3 0.5 11.8 45.3 2.7 5.2 ZNF652 KIAA0924 ENSG00000198740 "Zinc finger protein 652" Q9Y2D9 17 49289206-49362473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 18.0" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044408 Uncertain Approved Nucleoplasm No No "Cluster 38: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA044408: AB_2678932" "unprognostic (1.33e-2)" "unprognostic (5.54e-2)" "unprognostic (1.15e-1)" "prognostic favorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (7.31e-3)" "unprognostic (2.34e-1)" "unprognostic (4.52e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-1)" "unprognostic (4.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.30e-2)" 2.1 2.3 4.6 2.8 11.4 3.7 9.6 6.7 4.7 3.2 1.5 2.8 2.6 2.1 2.0 2.0 2.1 2.2 1.6 3.6 6.2 2.5 4.0 2.8 2.9 10.7 8.2 2.8 2.4 3.6 1.0 2.6 11.4 3.3 2.9 4.5 4.4 2.4 10.5 6.6 2.1 2.7 5.2 4.6 3.4 3.7 7.9 3.4 3.6 2.5 3.0 2.1 1.1 18.0 4.3 2.9 3.2 4.1 4.3 2.3 4.3 1.6 2.6 1.8 2.1 6.8 2.7 9.7 5.0 3.3 1.4 3.0 2.9 3.1 2.9 3.3 2.6 3.5 5.0 4.7 1.6 2.9 5.3 3.2 2.8 1.6 2.9 1.8 2.2 4.8 2.7 8.1 1.8 6.0 4.3 1.6 3.2 2.5 2.1 3.4 6.6 4.6 2.4 5.7 5.9 4.0 2.8 3.9 4.2 4.8 7.1 4.1 3.6 5.9 4.4 2.6 2.6 10.3 7.6 6.3 3.2 2.6 2.2 7.7 3.0 3.2 2.6 2.6 3.5 1.9 1.9 2.0 2.1 2.6 1.8 1.9 5.9 2.1 3.4 1.9 0.9 2.5 4.6 11.4 6.7 4.7 3.6 6.2 10.7 8.2 11.4 5.2 7.9 18.0 28.8 19.2 19.8 37.5 38.6 16.4 14.2 7.8 18.8 56.5 63.7 50.2 16.6 21.5 15.2 29.5 64.6 24.0 60.6 22.7 13.7 18.6 19.2 56.6 45.1 24.3 12.1 22.3 49.2 19.6 18.2 24.4 16.8 59.1 5.1 24.0 29.6 41.6 12.8 43.7 70.9 20.4 14.2 41.6 32.4 17.3 48.4 25.1 26.6 65.6 37.0 30.1 45.3 76.9 152.6 18.4 18.5 44.4 21.9 24.6 17.9 12.4 21.3 47.1 0.0 30.0 22.8 60.4 29.9 15.6 24.3 13.4 33.7 27.7 24.0 12.6 ZNF655 "VIK, VIK-1" ENSG00000197343 "Zinc finger protein 655" Q8N720 7 99558406-99576453 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029534, HPA050750" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane" "HPA029534: AB_10603008, HPA050750: AB_2681225" "prognostic favorable (7.12e-4)" "unprognostic (3.03e-2)" "unprognostic (9.62e-2)" "unprognostic (5.00e-1)" "unprognostic (1.51e-1)" "unprognostic (5.42e-2)" "unprognostic (3.31e-2)" "unprognostic (3.93e-3)" "prognostic unfavorable (7.24e-4)" "unprognostic (2.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (2.16e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-2)" "unprognostic (1.12e-1)" 11.6 11.9 7.0 14.3 6.2 8.9 12.8 8.3 7.8 13.2 5.9 15.5 15.9 10.1 11.0 26.9 11.5 10.2 8.4 6.3 6.1 13.8 14.9 15.3 19.7 5.0 5.5 13.9 21.1 14.4 8.2 12.5 6.4 11.4 11.8 8.5 16.7 11.3 12.7 18.4 13.8 11.7 5.1 14.2 18.0 7.4 6.3 22.6 11.8 13.5 17.3 18.8 14.9 9.6 40.5 35.9 16.5 23.9 15.8 25.4 12.4 24.0 45.8 40.7 37.8 20.1 37.0 31.8 0.4 33.2 52.0 25.2 18.0 29.6 40.6 34.5 23.6 18.9 16.0 27.8 24.1 38.1 35.9 21.1 32.8 35.8 50.6 21.4 17.3 26.4 54.4 39.7 24.4 0.1 53.9 36.6 21.1 0.1 0.0 19.9 14.0 52.9 25.9 42.8 17.4 37.6 25.1 0.7 27.2 24.0 12.2 20.2 13.3 24.3 60.2 43.4 43.6 47.3 72.7 63.4 23.5 18.2 39.9 147.8 43.2 74.4 47.8 47.2 45.1 32.7 44.1 55.7 40.3 31.3 35.0 43.8 50.3 37.0 55.2 23.3 61.3 55.4 7.0 6.2 8.3 7.8 6.3 6.1 5.0 5.5 6.4 5.1 6.3 9.6 19.5 96.1 82.8 51.2 53.2 44.7 46.5 36.5 42.1 48.8 34.4 25.1 36.1 31.5 44.3 23.9 41.7 31.6 76.3 46.3 33.2 31.6 12.8 25.8 33.9 20.4 41.5 12.8 53.4 36.2 42.7 32.7 37.2 33.0 18.9 70.8 19.2 24.6 37.4 50.5 57.4 40.4 18.3 63.4 31.6 9.7 25.4 56.0 23.2 44.0 59.2 24.9 106.1 61.3 75.3 48.2 55.2 25.2 55.4 44.5 48.1 41.1 26.0 45.8 13.1 39.9 31.7 39.0 29.8 55.6 48.9 73.6 62.5 30.0 28.1 64.0 ZNF662 FLJ45880 ENSG00000182983 "Zinc finger protein 662" Q6ZS27 3 42906142-42919334 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.4;SH-SY5Y: 3.2;THP-1: 3.3;U-2 OS: 4.6" "Low region specificity" "Detected in all" "HPA039116, HPA040377" Uncertain NA NA "Cluster 32: T-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "HPA039116: AB_2676355, HPA040377: AB_2676949" "unprognostic (2.37e-2)" "unprognostic (2.71e-1)" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.14e-1)" "unprognostic (2.55e-4)" "unprognostic (1.80e-3)" "unprognostic (1.09e-2)" "unprognostic (7.99e-2)" "unprognostic (2.96e-2)" "unprognostic (1.37e-1)" "unprognostic (2.69e-1)" "unprognostic (5.39e-3)" "unprognostic (7.18e-4)" "unprognostic (1.19e-1)" "unprognostic (3.60e-1)" "unprognostic (6.62e-2)" 5.9 4.8 3.5 1.4 3.9 0.9 7.3 6.8 6.5 11.3 5.2 7.3 2.0 9.2 4.5 5.8 8.2 2.6 5.1 3.4 3.6 6.9 5.1 4.3 1.6 3.6 3.3 14.2 10.7 1.3 7.2 2.0 3.6 10.4 3.4 11.1 8.3 4.0 3.5 10.9 4.4 4.1 3.0 4.7 6.2 7.4 3.4 1.1 8.2 2.8 1.5 7.9 8.1 5.2 0.1 0.0 0.2 0.0 0.0 0.0 2.4 1.0 0.0 0.7 0.5 2.4 1.4 0.2 1.7 1.1 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.5 0.5 0.0 0.9 0.1 0.4 2.3 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.3 2.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.7 0.1 1.7 3.2 0.0 1.1 0.0 0.6 0.0 3.3 0.1 0.8 4.6 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.2 0.0 0.1 0.3 0.2 0.1 0.4 0.3 1.3 1.3 0.4 0.5 0.1 0.4 0.2 0.2 3.5 3.9 6.8 6.5 3.4 3.6 3.6 3.3 3.6 3.0 3.4 5.2 4.2 12.8 4.6 7.2 0.2 2.4 2.5 0.2 2.2 6.5 4.4 3.9 2.9 4.3 3.9 1.8 6.2 1.9 0.2 1.4 1.9 1.8 2.0 1.3 5.6 3.4 5.4 1.3 4.3 3.2 2.4 4.6 12.2 2.3 0.0 9.7 3.6 3.4 0.1 6.7 6.5 2.4 2.0 0.8 2.6 4.4 11.5 0.8 5.4 6.5 0.0 4.1 0.0 16.1 8.0 2.9 1.2 4.5 0.1 1.9 0.4 1.7 1.3 10.9 13.1 6.0 3.3 18.5 11.0 0.9 1.8 2.9 0.4 2.2 4.0 2.1 ZNF669 FLJ12606 ENSG00000188295 "Zinc finger protein 669" Q96BR6 1 247099962-247104372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA044043 Uncertain NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA044043: AB_10964039" "unprognostic (1.88e-1)" "unprognostic (6.57e-2)" "unprognostic (2.01e-2)" "unprognostic (1.32e-1)" "unprognostic (3.80e-2)" "unprognostic (6.04e-2)" "unprognostic (1.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (5.98e-2)" "unprognostic (1.09e-1)" "prognostic favorable (4.59e-7)" "unprognostic (2.60e-2)" "unprognostic (1.47e-1)" "unprognostic (3.11e-2)" "unprognostic (4.81e-2)" 3.4 1.8 2.0 2.6 1.7 11.7 5.5 4.8 2.2 3.8 1.5 3.7 2.9 4.7 3.2 2.5 4.0 3.0 2.5 1.6 1.7 3.8 2.1 3.4 5.5 1.7 1.5 4.6 4.3 4.3 1.6 2.8 1.9 3.1 3.6 5.1 2.9 3.2 2.0 2.8 2.4 3.7 1.1 4.0 3.3 4.7 2.0 8.8 5.0 3.7 5.6 2.7 1.6 3.3 4.2 2.9 9.4 10.9 5.4 4.8 9.6 6.1 6.2 8.1 8.3 7.1 4.3 5.9 8.9 4.2 5.8 5.3 9.2 7.2 9.0 3.1 2.2 0.4 6.4 5.2 4.3 5.7 6.9 4.5 7.4 6.6 4.8 3.9 4.9 15.1 10.4 4.1 8.6 3.7 14.6 5.7 22.1 8.7 5.9 11.6 9.1 4.3 6.0 12.0 10.1 17.9 7.8 4.1 3.1 10.5 8.0 20.3 5.6 5.7 6.4 5.3 11.4 10.2 20.1 12.0 1.5 2.9 5.8 10.7 2.4 8.9 4.4 1.6 5.8 6.4 5.2 4.2 3.1 5.1 5.9 5.8 5.8 4.3 2.4 4.2 6.2 2.9 2.0 1.7 4.8 2.2 1.6 1.7 1.7 1.5 1.9 1.1 2.0 3.3 10.2 3.2 8.3 1.6 17.5 9.7 6.2 4.8 7.4 27.1 5.1 5.6 1.6 12.8 4.5 1.8 12.5 3.6 11.3 2.3 7.9 5.1 11.5 9.0 7.2 8.3 7.8 8.6 3.0 7.7 4.9 5.4 3.6 11.5 15.2 9.7 8.6 2.5 4.8 16.8 3.3 2.6 2.0 6.0 19.8 7.4 7.2 7.3 12.4 3.7 4.7 9.9 18.6 3.0 2.4 8.1 1.2 3.8 8.1 3.3 2.8 3.6 7.5 31.1 0.0 5.9 6.2 10.4 9.5 5.1 8.5 2.3 10.5 9.7 2.5 4.1 ZNF671 FLJ23506 ENSG00000083814 "Zinc finger protein 671" Q8TAW3 19 57719751-57727624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 10.1" "Low region specificity" "Detected in all" "HPA046099, HPA056043" Uncertain Approved Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA046099: AB_10962484, HPA056043: " "prognostic favorable (2.20e-4)" "unprognostic (4.16e-3)" "unprognostic (6.02e-2)" "unprognostic (5.91e-3)" "unprognostic (8.76e-2)" "unprognostic (3.97e-3)" "unprognostic (6.12e-2)" "unprognostic (5.56e-3)" "unprognostic (8.26e-3)" "unprognostic (2.04e-1)" "prognostic favorable (3.57e-4)" "unprognostic (2.14e-1)" "unprognostic (1.92e-3)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.02e-1)" "unprognostic (4.22e-1)" 2.9 6.8 6.8 3.7 7.1 4.4 4.3 11.0 7.7 3.4 7.1 6.5 1.8 2.5 5.3 2.0 4.5 2.8 6.8 6.6 7.7 6.0 2.8 4.0 7.9 6.7 7.1 3.3 3.4 9.4 9.7 4.0 6.8 5.8 2.3 8.3 3.8 5.8 7.7 2.2 6.4 2.7 7.3 13.5 2.7 6.4 7.8 13.7 8.3 6.9 8.5 4.8 2.0 7.4 0.1 0.2 2.2 0.0 0.4 0.1 0.0 2.5 1.4 4.8 1.7 0.3 0.4 5.2 0.8 3.6 1.5 0.1 1.9 2.1 5.6 5.7 3.6 0.1 0.8 0.0 4.2 0.0 7.3 6.2 1.5 3.0 1.7 5.6 0.7 5.4 0.8 2.5 4.4 0.1 10.1 0.1 3.2 0.0 5.1 3.9 6.8 3.2 1.8 0.2 0.2 0.0 0.0 0.1 3.5 5.4 1.4 7.3 0.0 0.5 2.6 0.0 1.9 4.5 0.1 2.8 0.5 1.2 1.6 19.4 10.5 19.3 8.0 9.5 21.4 22.7 17.0 14.1 14.9 30.4 24.2 19.7 7.3 20.9 15.1 13.7 18.9 15.0 6.8 7.1 11.0 7.7 6.6 7.7 6.7 7.1 6.8 7.3 7.8 7.4 1.1 0.0 0.6 5.9 5.2 0.6 0.7 0.9 0.0 5.8 1.3 1.0 5.4 4.3 1.2 3.7 0.0 2.3 2.0 0.0 1.9 3.7 0.2 0.8 0.4 1.7 0.0 3.4 3.4 0.0 1.1 0.7 0.0 0.7 2.5 2.9 1.1 1.2 3.8 6.7 4.1 0.2 6.1 2.7 0.8 0.7 0.0 2.3 1.8 2.8 1.9 8.4 6.2 4.0 2.8 0.3 0.1 0.4 3.8 0.5 0.9 1.6 0.9 7.8 0.0 0.2 1.6 7.0 5.0 0.4 0.4 0.8 4.1 0.6 0.5 0.1 ZNF681 FLJ31526 ENSG00000196172 "Zinc finger protein 681" Q96N22 19 23739195-23758891 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 13.2;Spermatogonia: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 16.2;RPMI-8226: 10.7" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (1.48e-1)" "unprognostic (4.49e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (6.22e-2)" "unprognostic (1.01e-1)" "unprognostic (2.45e-3)" "unprognostic (8.55e-2)" "unprognostic (1.61e-2)" "unprognostic (5.24e-2)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (7.98e-2)" "unprognostic (2.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.55e-2)" 0.6 1.3 0.7 0.9 0.7 0.7 2.0 2.2 1.0 1.4 0.0 1.6 1.0 1.1 1.6 1.9 1.3 0.7 0.5 0.8 0.9 0.7 0.2 0.9 2.8 0.7 0.8 2.0 1.9 0.8 0.3 1.0 0.8 1.1 1.9 0.9 0.6 0.7 0.1 2.2 0.6 0.8 0.4 1.8 1.0 2.5 0.8 3.9 1.8 0.2 2.2 1.6 1.0 0.7 0.8 0.0 5.0 9.7 0.3 0.0 2.7 0.6 0.1 1.5 1.6 1.4 2.6 1.3 4.5 0.9 2.2 2.4 4.6 0.2 2.5 16.2 1.7 2.5 0.0 0.0 0.7 0.0 0.6 1.1 0.9 0.6 0.6 0.3 0.0 3.5 7.0 0.0 2.6 2.2 8.8 2.2 7.2 0.1 2.2 6.8 3.5 10.7 1.3 4.9 0.4 5.1 0.0 0.0 0.8 6.9 5.3 0.4 0.0 1.0 0.1 3.1 3.6 0.0 9.7 7.9 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.2 1.6 1.2 1.8 1.5 0.6 2.1 3.6 3.2 0.2 0.9 0.2 0.9 2.0 0.8 0.7 0.7 2.2 1.0 0.8 0.9 0.7 0.8 0.8 0.4 0.8 0.7 2.9 3.2 0.0 3.3 5.8 1.1 1.2 0.2 1.8 3.4 4.0 4.6 1.1 2.8 3.4 1.8 0.0 3.6 3.8 3.9 1.9 1.9 9.7 1.9 3.6 2.6 2.4 2.5 5.9 2.3 4.2 2.5 1.5 2.8 0.0 9.1 1.4 0.0 2.4 1.7 7.4 2.5 0.0 2.6 0.8 5.2 0.6 1.3 1.8 2.8 1.1 2.7 11.3 12.1 5.4 1.2 1.9 3.0 0.6 1.1 0.4 1.8 5.4 1.2 0.0 1.9 2.1 13.2 16.7 3.3 1.3 3.7 3.8 4.9 2.2 1.1 ZNF682 BC39498_3 ENSG00000197124 "Zinc finger protein 682" O95780 19 19997058-20039505 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 22.2" "Cancer enhanced" "Detected in many" "testis cancer: 7.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 14.4;AN3-CA: 21.8" HPA055998 Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA055998: AB_2683002" "unprognostic (8.96e-2)" "unprognostic (3.93e-2)" "unprognostic (4.78e-2)" "unprognostic (1.10e-1)" "unprognostic (6.16e-2)" "unprognostic (6.95e-3)" "unprognostic (1.69e-2)" "unprognostic (1.71e-2)" "unprognostic (6.44e-2)" "unprognostic (1.24e-3)" "unprognostic (7.70e-4)" "unprognostic (1.77e-3)" "unprognostic (4.06e-7)" "unprognostic (2.07e-1)" "unprognostic (2.10e-1)" "unprognostic (1.19e-1)" "prognostic favorable (3.51e-4)" 2.0 2.5 4.0 2.4 4.5 2.1 3.4 4.5 7.2 2.7 1.9 2.4 1.5 2.4 3.5 3.3 3.0 2.2 6.2 4.5 5.2 5.1 4.1 3.7 3.9 4.3 4.4 2.0 3.0 3.0 4.1 3.0 4.4 4.8 2.5 3.2 1.8 4.0 3.4 6.5 2.9 1.3 3.6 4.0 3.0 3.3 4.1 3.1 8.0 1.6 4.5 3.5 3.1 6.0 0.0 0.0 14.4 21.8 1.1 1.5 0.6 3.1 1.4 5.1 8.1 2.5 3.1 0.1 5.2 4.4 1.5 2.6 5.9 0.5 5.7 0.0 6.3 0.0 0.1 1.6 2.0 0.0 5.1 2.1 1.7 2.8 0.0 0.8 0.0 5.7 0.0 0.1 3.9 4.3 8.7 1.3 7.9 0.0 1.9 5.3 7.5 0.1 2.7 9.7 7.9 8.5 0.0 2.8 0.0 7.8 5.4 2.9 0.0 7.5 1.2 12.7 5.4 0.0 9.0 1.4 0.0 0.0 2.4 7.1 0.4 0.9 2.5 0.5 1.8 4.1 3.7 2.0 1.5 2.7 4.0 4.1 1.5 1.4 0.7 1.3 4.2 1.3 4.0 4.5 4.5 7.2 4.5 5.2 4.3 4.4 4.4 3.6 4.1 6.0 5.2 9.6 15.1 7.2 7.0 3.4 2.1 0.6 5.2 5.4 4.6 5.2 10.3 4.3 4.6 3.7 0.0 6.8 8.2 2.7 5.9 4.0 1.8 1.8 2.9 4.4 1.2 4.4 9.8 7.5 6.8 3.5 2.6 3.0 2.5 5.9 5.0 3.0 2.9 3.3 10.1 2.8 0.0 3.5 2.7 0.9 1.8 2.3 1.8 6.5 0.6 4.0 5.2 6.6 22.2 4.8 1.2 4.5 3.1 1.5 1.7 3.8 1.5 2.3 0.0 3.1 3.4 4.3 4.2 3.7 3.4 2.5 6.9 9.2 2.1 2.5 ZNF687 KIAA1441 ENSG00000143373 "Zinc finger protein 687" Q8N1G0 1 151281618-151292176 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 13.5" "Group enriched" "Detected in many" 8 "granulocytes: 13.5;monocytes: 4.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021193, HPA023948" Approved Enhanced Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA021193: AB_1859415, HPA023948: AB_2671380" "unprognostic (2.23e-1)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (9.64e-3)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.39e-1)" "unprognostic (9.91e-2)" "unprognostic (8.69e-3)" "unprognostic (2.10e-1)" "unprognostic (5.82e-3)" "unprognostic (1.36e-1)" "unprognostic (1.41e-1)" "unprognostic (8.54e-2)" "unprognostic (7.99e-2)" 8.5 10.9 9.0 8.2 9.9 31.2 8.7 12.6 10.2 9.9 6.9 10.7 8.6 10.5 5.5 11.0 9.7 7.0 8.9 8.5 8.4 10.2 9.7 8.6 10.1 10.5 9.6 11.7 16.0 14.1 13.0 7.1 9.5 11.3 5.7 9.4 12.0 8.6 10.9 12.3 11.3 6.1 8.9 14.4 10.8 14.5 9.7 9.3 10.8 6.9 7.5 10.4 8.7 10.5 14.8 21.5 20.4 12.6 11.3 9.5 26.3 7.6 12.9 13.8 13.1 18.1 19.6 12.6 18.7 12.3 14.7 22.3 18.1 15.2 6.1 17.3 18.3 11.9 18.8 20.1 12.1 14.3 16.7 14.7 15.3 11.6 12.1 12.3 9.4 13.4 19.5 22.6 7.8 44.8 19.2 16.8 27.6 19.8 16.5 16.9 16.1 22.8 11.6 22.1 18.5 27.7 20.8 24.6 19.7 19.2 32.2 30.1 9.2 11.0 12.1 13.9 11.6 26.2 24.1 31.3 14.0 9.4 14.2 0.5 1.8 13.5 0.5 2.3 0.5 1.0 0.5 0.4 0.9 1.1 0.7 0.8 8.8 0.4 4.5 0.8 0.4 1.2 9.0 9.9 12.6 10.2 8.5 8.4 10.5 9.6 9.5 8.9 9.7 10.5 4.3 3.2 4.6 3.6 5.8 4.7 2.8 4.9 5.7 6.7 6.0 5.5 1.4 10.0 3.5 1.8 10.4 6.7 3.8 9.3 3.9 5.5 3.1 4.3 3.7 4.4 2.4 3.0 1.6 6.0 5.3 4.2 7.7 5.3 0.0 8.5 2.9 4.5 5.3 8.4 1.9 5.6 8.2 5.2 4.1 2.8 6.2 5.8 0.0 2.8 6.0 5.2 5.2 3.0 1.7 7.3 3.5 7.2 5.8 4.7 10.2 4.1 3.4 10.8 13.1 4.4 3.9 6.9 6.8 4.3 3.4 9.4 4.3 6.5 7.3 5.1 ZNF696 FLJ14129 ENSG00000185730 "Zinc finger protein 696" Q9H7X3 8 143289676-143299952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057855, HPA072473" Uncertain Approved Nucleoplasm,Nucleoli No No "Cluster 48: NK-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 9: U-2 OS - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA057855: AB_2683545, HPA072473: AB_2686524" "unprognostic (3.23e-2)" "prognostic unfavorable (6.63e-5)" "unprognostic (3.62e-2)" "prognostic unfavorable (3.52e-5)" "unprognostic (2.58e-1)" "unprognostic (7.86e-2)" "unprognostic (2.76e-3)" "unprognostic (8.82e-2)" "unprognostic (3.16e-1)" "unprognostic (3.02e-1)" "prognostic favorable (1.41e-4)" "unprognostic (6.57e-2)" "unprognostic (8.22e-2)" "unprognostic (7.99e-2)" "unprognostic (2.86e-1)" "unprognostic (3.42e-3)" "unprognostic (8.09e-3)" 4.0 3.3 3.9 3.3 3.7 3.5 3.2 5.9 6.1 3.4 0.0 3.3 6.0 4.5 2.5 2.6 3.4 2.1 2.8 4.2 2.5 3.3 4.6 2.8 3.8 5.6 3.0 4.7 5.0 4.3 3.2 2.7 5.0 3.1 1.9 3.6 5.7 2.3 3.9 6.6 3.7 2.3 0.9 4.0 3.3 3.5 3.4 2.1 3.7 2.4 3.0 3.7 2.8 4.9 8.2 7.4 7.8 8.8 3.2 2.5 14.9 6.3 2.4 4.4 2.7 4.3 6.3 0.7 8.2 2.5 2.5 5.8 8.5 3.8 4.5 9.1 17.9 10.8 8.8 6.7 3.4 4.5 13.5 2.4 6.1 3.0 6.8 3.3 2.2 6.4 22.2 5.3 3.1 17.3 4.6 8.8 10.2 9.7 17.1 9.8 4.4 8.1 3.0 6.3 11.6 16.1 9.3 6.7 8.2 5.3 10.3 8.1 4.5 6.2 13.4 5.5 10.9 9.7 7.3 10.0 4.2 9.2 7.5 1.2 2.0 1.7 2.9 1.1 3.0 2.4 2.1 3.1 2.1 3.2 3.9 3.5 1.2 3.5 2.0 3.8 0.7 1.9 3.9 3.7 5.9 6.1 4.2 2.5 5.6 3.0 5.0 0.9 3.4 4.9 2.2 0.0 0.0 3.6 3.0 2.9 2.3 0.6 0.0 5.3 1.5 1.3 2.8 2.8 0.3 3.7 6.2 1.7 1.8 2.1 3.9 2.4 1.2 0.8 2.3 2.5 0.0 1.3 3.4 2.0 1.8 1.9 2.0 1.0 0.0 2.9 2.2 2.2 1.2 3.3 3.9 1.0 2.0 0.9 0.7 2.4 4.1 0.7 1.8 1.0 0.9 1.8 6.2 4.5 3.1 1.5 0.3 1.2 2.3 1.7 2.7 1.9 0.3 4.5 6.6 1.7 2.2 3.0 5.7 1.1 2.0 0.4 2.5 2.7 2.0 0.6 ZNF7 "HF.16, KOX4" ENSG00000147789 "Zinc finger protein 7" P17097 8 144827464-144847509 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059090 Approved Approved Mitochondria NA NA "Cluster 42: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA059090: AB_2683901" "unprognostic (1.11e-1)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-2)" "unprognostic (2.52e-1)" "unprognostic (2.97e-1)" "unprognostic (8.42e-3)" "unprognostic (3.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.95e-2)" "prognostic unfavorable (8.46e-8)" "unprognostic (1.15e-1)" "unprognostic (5.00e-1)" "unprognostic (5.43e-2)" "unprognostic (6.53e-2)" 18.4 14.1 10.4 10.7 11.0 14.4 18.3 18.6 12.8 20.2 10.7 18.2 10.4 18.0 15.2 14.8 17.5 10.5 14.3 10.5 9.8 18.3 15.5 14.5 15.0 11.6 10.8 19.4 17.4 15.3 16.8 14.3 11.1 20.5 12.7 13.9 16.4 13.6 26.6 21.1 17.2 12.7 9.0 21.7 15.2 17.0 11.2 15.9 19.3 17.5 15.6 18.3 17.2 13.4 16.7 22.2 21.4 21.1 17.9 27.2 19.6 17.4 22.0 23.1 19.7 11.4 20.9 23.1 19.9 19.0 12.6 14.2 19.5 25.4 25.1 15.4 16.2 41.3 30.6 13.3 20.7 12.1 18.5 26.1 30.3 18.1 44.2 22.4 14.5 19.2 41.9 16.1 26.0 27.3 33.0 13.1 21.8 22.0 26.6 22.6 19.0 18.4 16.1 22.6 21.0 25.6 38.1 21.6 21.3 20.4 26.1 19.1 16.4 17.3 30.9 13.2 16.9 13.0 9.9 25.0 18.0 15.4 21.7 34.3 10.7 10.9 13.5 10.0 16.9 18.1 15.4 12.0 12.2 17.4 20.1 13.8 10.4 16.6 19.2 9.6 16.3 9.2 10.4 11.0 18.6 12.8 10.5 9.8 11.6 10.8 11.1 9.0 11.2 13.4 11.9 19.2 11.6 6.2 16.4 7.0 18.2 12.7 8.6 34.2 9.1 8.0 11.4 7.2 11.3 3.7 29.2 17.3 16.6 6.6 5.9 14.1 18.4 6.3 10.4 10.6 9.6 15.6 11.3 11.2 12.9 14.7 10.2 7.7 3.8 16.7 15.0 8.2 9.1 28.6 10.7 9.1 6.1 9.0 11.1 4.9 17.7 10.2 8.8 3.7 12.9 20.0 22.6 10.6 11.4 13.7 5.6 15.8 7.8 18.6 12.4 7.1 9.2 30.1 6.6 19.3 10.4 44.1 26.7 9.1 9.2 19.4 16.9 19.8 10.2 13.8 ZNF70 "Cos17, MGC48959" ENSG00000187792 "Zinc finger protein 70" Q9UC06 22 23738682-23751112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018821 Uncertain Approved Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 14: REH - Unknown function" "Cluster 52: Non-specific - Transcription" Cytosol "HPA018821: AB_1859423" "unprognostic (3.17e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" "unprognostic (8.49e-3)" "unprognostic (1.08e-1)" "unprognostic (2.80e-2)" "unprognostic (6.07e-3)" "unprognostic (2.18e-3)" "unprognostic (9.93e-2)" "unprognostic (6.20e-2)" "unprognostic (1.73e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-2)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (4.36e-2)" "unprognostic (5.69e-2)" 1.4 1.2 1.0 1.3 1.4 1.6 1.3 2.8 1.1 1.9 2.2 1.4 0.8 1.9 2.3 0.8 1.9 1.1 1.6 0.9 1.0 1.0 0.7 1.2 1.4 2.0 1.4 3.9 1.8 2.1 1.6 1.2 1.1 1.5 1.2 3.0 2.0 1.5 2.6 1.1 1.2 1.6 0.8 1.4 1.3 1.2 1.6 1.2 1.8 2.1 1.6 1.4 1.3 2.5 1.2 1.5 2.9 3.0 4.2 2.0 0.9 1.1 2.2 2.5 3.5 1.5 0.8 1.7 0.7 2.4 1.6 1.3 2.0 1.5 3.1 1.1 1.8 3.3 3.0 1.3 2.5 3.0 2.7 2.0 0.9 3.3 2.7 3.2 2.0 1.3 1.2 2.4 1.8 1.6 1.7 1.4 0.7 1.1 0.6 7.2 2.8 0.4 0.9 1.6 1.6 2.0 1.6 2.0 1.2 2.0 1.0 1.4 2.6 2.7 3.4 1.8 1.2 2.4 0.4 1.5 2.4 1.3 2.4 1.5 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.3 0.2 0.3 0.8 0.5 0.2 0.4 0.1 0.1 1.0 1.4 2.8 1.1 0.9 1.0 2.0 1.4 1.1 0.8 1.6 2.5 1.2 0.0 2.8 0.7 1.0 0.4 1.1 0.0 1.2 3.8 1.1 1.4 2.6 2.8 1.8 3.7 10.4 0.4 2.1 0.3 0.0 1.1 1.4 1.6 3.9 1.7 1.2 0.8 0.8 1.1 0.6 3.2 0.5 1.0 1.3 3.8 4.2 0.5 0.8 6.7 1.2 0.6 0.0 1.6 0.6 3.3 6.2 1.0 0.0 0.0 0.8 2.1 0.0 0.0 1.6 0.4 0.0 4.1 1.5 0.7 0.8 0.9 3.6 4.0 6.6 5.4 2.7 2.7 2.5 1.0 0.0 0.3 1.2 2.8 0.7 0.9 ZNF701 FLJ10891 ENSG00000167562 "Zinc finger protein 701" Q9NV72 19 52555457-52587174 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 28.6" HPA005532 Uncertain Approved "Nucleoplasm,Centriolar satellite" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Centriolar satellite" "HPA005532: AB_1080746" "unprognostic (1.21e-1)" "unprognostic (4.98e-3)" "unprognostic (5.58e-2)" "unprognostic (3.40e-1)" "unprognostic (7.74e-2)" "unprognostic (1.13e-2)" "unprognostic (8.86e-2)" "unprognostic (4.67e-2)" "unprognostic (5.46e-4)" "unprognostic (3.75e-1)" "unprognostic (2.86e-1)" "unprognostic (1.16e-2)" "unprognostic (8.17e-3)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (2.79e-1)" "prognostic favorable (4.89e-5)" 5.1 4.1 3.9 6.4 5.6 10.1 7.9 6.7 4.5 5.7 7.4 5.6 5.0 5.7 7.2 4.3 6.2 5.0 5.7 4.8 4.2 6.3 2.7 5.7 8.0 5.3 4.4 6.2 4.7 6.2 4.4 7.6 6.0 6.5 6.7 6.3 5.8 4.7 5.7 7.3 6.4 4.7 3.2 7.3 6.4 6.1 4.9 9.3 9.4 5.7 7.1 5.5 5.7 8.3 2.3 0.3 5.0 8.9 5.5 6.5 9.2 5.9 5.8 7.8 8.1 4.6 5.5 11.0 3.3 4.6 7.6 3.5 2.3 6.3 8.3 0.4 6.6 3.0 9.3 1.1 5.6 0.4 14.1 6.8 5.0 6.0 10.1 4.0 7.4 5.8 15.0 1.4 7.2 1.8 11.3 5.2 4.8 2.9 8.0 11.8 6.6 4.6 6.2 28.6 4.9 5.4 3.9 10.1 3.1 10.1 12.9 6.2 7.3 6.2 3.1 3.0 10.7 1.1 7.1 14.4 0.2 12.4 10.1 21.6 9.0 18.1 9.3 9.8 7.9 9.2 7.3 8.2 6.7 9.0 8.5 9.1 23.0 14.2 7.7 6.6 9.1 7.0 3.9 5.6 6.7 4.5 4.8 4.2 5.3 4.4 6.0 3.2 4.9 8.3 7.2 0.0 6.1 4.6 11.1 2.2 6.7 6.0 0.6 5.4 6.3 7.6 4.8 4.3 7.7 14.7 14.6 13.5 13.8 8.9 3.9 6.8 2.3 9.2 7.8 7.3 2.4 5.2 2.1 3.9 9.7 5.5 5.6 9.7 2.5 13.6 6.4 0.6 5.3 3.3 2.4 6.2 8.2 5.5 8.2 1.2 6.2 6.8 3.6 3.7 9.9 3.8 15.5 3.5 5.9 5.5 8.8 3.8 3.0 8.2 13.1 3.7 9.7 6.0 0.0 3.7 7.0 3.8 10.8 3.0 3.7 23.5 9.9 7.2 3.8 11.7 ZNF708 "KOX8, ZNF15, ZNF15L1" ENSG00000182141 "Zinc finger protein 708" P17019 19 21291160-21329425 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 58.8;Oligodendrocytes: 211.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "unprognostic (4.18e-2)" "unprognostic (3.67e-1)" "unprognostic (1.96e-2)" "unprognostic (3.98e-2)" "prognostic favorable (7.16e-4)" "unprognostic (2.96e-3)" "unprognostic (1.11e-2)" "unprognostic (1.67e-3)" "unprognostic (2.05e-2)" "prognostic favorable (3.53e-4)" "unprognostic (4.00e-3)" "unprognostic (1.22e-2)" "unprognostic (5.39e-2)" "unprognostic (2.94e-2)" "unprognostic (9.30e-2)" "unprognostic (8.21e-2)" "unprognostic (1.22e-3)" 2.6 3.8 4.8 6.0 18.7 5.2 6.0 12.9 9.6 5.1 0.5 3.3 3.6 3.9 3.9 2.2 3.8 3.2 3.5 6.9 9.9 2.7 1.8 4.0 8.2 17.5 13.7 10.8 4.8 2.8 3.3 3.2 17.4 5.3 3.2 6.2 4.4 3.2 2.4 2.7 3.6 2.0 8.7 4.8 5.1 3.9 13.1 6.1 6.5 3.7 6.1 3.1 2.9 31.6 1.8 1.3 11.5 6.4 3.3 2.9 10.1 3.4 1.5 2.1 3.8 3.4 2.8 0.1 4.9 2.5 2.0 1.8 4.0 2.2 3.5 1.5 6.3 9.6 4.7 2.6 1.5 8.6 2.5 2.5 2.4 1.4 2.1 3.3 3.0 4.8 6.7 0.7 3.9 2.5 7.3 6.6 15.9 0.5 3.8 8.9 5.7 4.5 1.4 12.1 9.0 5.3 3.1 0.0 2.9 6.4 4.3 5.9 4.7 3.0 1.8 4.1 3.7 5.5 5.3 11.8 0.2 3.4 2.4 13.6 2.1 4.8 4.0 2.0 5.9 4.4 5.3 6.2 2.5 4.9 6.4 5.8 8.6 5.1 2.0 2.3 4.0 2.9 4.8 18.7 12.9 9.6 6.9 9.9 17.5 13.7 17.4 8.7 13.1 31.6 11.6 32.1 8.4 34.6 19.2 1.3 6.1 4.2 4.0 11.2 5.7 5.8 3.3 2.8 4.2 9.2 10.4 3.7 20.2 3.2 5.9 7.6 0.8 9.6 22.5 8.8 7.2 8.0 38.4 5.3 2.6 16.8 13.7 12.2 12.0 52.7 7.5 1.8 2.6 16.8 43.9 3.1 2.0 2.4 1.6 1.2 8.4 5.8 3.6 30.0 3.8 12.9 20.6 58.8 211.2 6.6 1.0 6.8 8.3 4.6 2.0 2.2 5.9 15.6 6.6 19.5 12.7 8.4 6.1 3.4 0.6 3.4 18.8 36.6 2.6 3.7 ZNF714 ENSG00000160352 "Zinc finger protein 714" 19 21082159-21125270 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 17.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Granulosa cells: 49.8;Oligodendrocyte precursor cells: 40.2;Theca cells: 40.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 49.5" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (2.72e-1)" "unprognostic (3.04e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (5.47e-4)" "unprognostic (4.75e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (1.02e-1)" "unprognostic (2.20e-2)" "prognostic favorable (4.27e-5)" "unprognostic (1.21e-1)" "unprognostic (6.88e-3)" "unprognostic (6.32e-2)" "unprognostic (3.15e-2)" "unprognostic (2.73e-1)" "unprognostic (5.40e-3)" "unprognostic (7.86e-2)" 1.5 4.4 2.9 3.2 4.6 6.9 3.3 7.4 3.4 2.1 0.0 2.1 2.6 3.1 3.4 5.3 2.6 1.6 1.4 3.0 2.9 1.7 0.6 2.1 4.9 2.6 2.8 17.3 3.8 1.6 1.2 2.9 3.2 2.4 3.7 3.2 2.1 1.6 2.9 6.7 3.3 1.7 2.0 2.4 2.8 3.9 3.5 5.7 14.4 1.8 4.3 1.6 2.2 3.4 18.3 3.5 26.9 12.5 1.3 3.8 21.2 10.2 6.0 21.8 20.3 8.2 14.1 7.6 14.8 5.5 7.9 4.6 0.1 8.9 32.4 6.1 18.6 1.3 12.9 8.2 2.1 10.3 8.2 2.2 1.6 15.0 6.1 5.5 7.3 39.3 20.0 9.4 13.0 4.3 49.5 7.0 25.8 3.9 5.8 17.1 1.8 7.3 5.9 10.7 23.6 13.9 16.1 0.2 4.8 20.8 0.5 1.0 3.4 9.7 0.3 8.9 6.7 7.6 22.6 1.4 0.4 2.9 3.4 5.4 2.0 4.9 2.3 2.4 2.3 1.9 2.4 3.3 3.1 2.9 4.4 3.9 1.4 2.7 1.8 7.8 3.6 1.3 2.9 4.6 7.4 3.4 3.0 2.9 2.6 2.8 3.2 2.0 3.5 3.4 3.9 44.8 9.1 27.4 8.0 4.1 4.3 4.6 13.1 22.3 4.6 5.5 4.9 5.7 6.3 5.5 16.7 7.7 7.3 6.6 1.9 4.2 1.6 4.7 8.7 4.9 6.7 9.7 28.8 3.8 13.6 7.4 6.6 7.0 1.3 49.8 5.3 0.1 4.9 16.8 37.0 3.3 4.1 6.0 8.2 1.5 5.3 5.2 3.6 13.1 2.6 6.2 6.2 40.2 19.6 3.3 2.2 3.8 11.5 6.3 4.1 1.1 3.0 14.5 6.6 4.9 6.9 36.3 15.6 7.5 4.0 4.7 6.7 40.0 5.5 7.7 ZNF721 KIAA1982 ENSG00000182903 "Zinc finger protein 721" Q8TF20 4 425815-499156 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA065313 Approved "Centriolar satellite,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Cytosol "Centriolar satellite" "HPA065313: AB_2685464" "unprognostic (2.23e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" "unprognostic (1.57e-1)" "unprognostic (6.91e-2)" "unprognostic (7.66e-2)" "unprognostic (1.51e-2)" "unprognostic (3.26e-2)" "unprognostic (3.48e-2)" "unprognostic (1.96e-2)" "unprognostic (3.43e-2)" "unprognostic (1.25e-1)" "unprognostic (5.12e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-3)" "prognostic favorable (2.76e-4)" 12.5 10.9 8.3 14.4 9.2 18.0 18.8 18.9 12.7 12.1 4.4 10.9 10.5 12.9 14.2 10.4 14.7 10.0 8.2 9.2 8.7 11.8 12.8 12.6 22.6 5.0 5.2 15.3 15.1 15.5 11.2 10.0 6.1 11.5 12.0 19.9 11.1 10.0 10.5 18.5 11.4 10.3 4.6 14.9 12.9 14.2 7.1 19.1 16.8 16.1 22.0 10.9 11.9 12.5 17.2 10.4 20.2 25.0 14.5 19.9 12.7 15.2 13.1 16.4 14.5 15.4 17.1 28.8 16.3 14.9 23.6 11.3 20.9 19.0 22.0 10.4 24.4 51.0 10.7 10.4 14.2 21.5 2.4 17.5 16.3 18.0 27.3 25.6 17.1 40.4 29.9 19.7 23.0 16.4 35.3 32.4 32.1 11.3 22.1 28.6 30.1 16.4 17.9 22.8 29.6 18.9 20.2 11.6 19.3 17.3 21.2 22.4 22.0 14.5 5.3 11.5 27.3 22.7 22.2 68.7 11.1 5.2 13.9 8.0 8.3 12.9 12.1 8.7 12.2 16.6 13.3 12.0 8.4 15.9 20.8 16.5 11.4 13.5 8.2 10.3 16.7 7.3 8.3 9.2 18.9 12.7 9.2 8.7 5.0 5.2 6.1 4.6 7.1 12.5 44.4 25.6 31.9 29.7 44.9 21.0 26.4 18.6 25.6 38.0 25.0 27.3 16.7 25.8 24.8 18.4 31.3 16.9 33.0 10.9 15.6 12.9 34.5 29.6 31.9 30.7 12.7 33.2 37.6 14.9 10.6 26.0 29.0 29.0 26.0 32.0 28.5 17.6 10.9 23.5 30.1 16.4 4.1 18.8 19.1 12.3 19.6 18.8 12.4 11.2 14.8 24.7 46.4 24.6 32.7 13.8 11.3 12.0 23.4 27.8 12.4 14.5 24.9 35.1 19.7 30.5 20.1 35.2 34.3 23.1 23.2 17.4 40.9 29.5 15.8 31.0 ZNF724 ZNF724P ENSG00000196081 "Zinc finger protein 724" A8MTY0 19 23221599-23250394 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 2.5;esophagus: 2.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 2.1;Extravillous trophoblasts: 5.0;Glandular and luminal cells: 3.0;granulocytes: 2.5;Granulosa cells: 3.4;Syncytiotrophoblasts: 2.7;Theca cells: 3.1" "Cancer enhanced" "Detected in many" "testis cancer: 2.5" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 13.6" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "unprognostic (2.02e-1)" "unprognostic (1.65e-1)" "unprognostic (1.78e-2)" "unprognostic (3.80e-2)" "unprognostic (2.27e-2)" "unprognostic (2.33e-1)" "unprognostic (1.94e-2)" "unprognostic (1.19e-2)" "unprognostic (1.03e-2)" "unprognostic (1.92e-1)" "unprognostic (4.32e-2)" "unprognostic (5.34e-2)" "unprognostic (3.07e-2)" "unprognostic (2.73e-2)" "unprognostic (3.20e-1)" "unprognostic (3.76e-1)" "unprognostic (3.30e-2)" 0.3 0.2 0.7 0.6 0.5 2.5 0.4 2.1 0.8 0.3 0.4 0.5 0.1 0.5 0.4 2.6 0.3 0.3 0.1 0.7 0.7 0.3 0.4 0.2 0.6 0.6 0.7 0.4 0.3 0.2 0.0 0.6 1.0 0.3 0.6 0.8 0.5 0.1 0.6 0.6 0.4 0.3 0.4 0.7 1.7 1.0 0.9 0.8 0.5 0.1 0.8 0.1 0.2 1.2 3.4 1.6 5.7 7.1 0.5 0.6 6.6 1.6 1.4 4.2 5.1 3.7 1.1 3.4 3.8 1.7 1.5 2.2 6.2 2.4 7.8 0.4 5.5 3.4 1.2 1.4 0.1 0.1 3.2 0.4 0.3 5.1 3.6 0.5 0.2 4.8 5.4 0.3 2.6 5.1 8.5 2.1 13.6 0.1 4.5 4.8 7.4 2.6 0.6 3.6 3.2 2.8 0.0 0.1 0.8 4.5 2.0 2.2 0.1 1.6 0.2 4.8 4.6 0.0 1.5 7.4 0.0 1.0 1.4 2.2 0.6 0.3 1.0 0.6 0.5 1.6 0.6 0.7 0.5 1.9 0.8 1.0 2.6 2.0 0.5 1.4 0.4 0.2 0.7 0.5 2.1 0.8 0.7 0.7 0.6 0.7 1.0 0.4 0.9 1.2 1.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.6 0.0 0.0 2.1 0.8 0.0 0.0 0.8 0.0 1.2 1.9 0.7 0.0 0.0 0.0 0.2 5.0 0.6 0.0 3.0 2.5 3.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.7 0.4 3.1 0.0 0.0 ZNF75A FLJ31529 ENSG00000162086 "Zinc finger protein 75a" Q96N20 16 3305406-3318852 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001665 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 21: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli fibrillar center" "HPA001665: AB_1080751" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (1.64e-1)" "unprognostic (7.79e-3)" "unprognostic (6.32e-2)" "unprognostic (4.45e-1)" "unprognostic (2.67e-2)" "unprognostic (5.93e-2)" "unprognostic (4.66e-3)" "unprognostic (2.75e-3)" "unprognostic (6.79e-3)" "unprognostic (4.71e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-2)" "unprognostic (8.97e-3)" 5.4 7.3 8.3 8.5 8.6 7.7 10.1 11.0 11.6 8.3 9.3 6.9 6.7 8.6 16.7 5.4 11.5 5.6 8.3 8.4 8.4 9.4 9.1 7.7 13.4 8.8 8.0 14.5 7.9 15.4 8.1 8.1 8.9 11.3 10.0 16.9 6.9 7.7 7.8 9.9 7.7 7.1 8.0 11.0 7.8 11.0 8.8 12.4 10.7 7.4 12.3 5.6 4.9 9.7 7.4 8.8 18.5 8.4 9.3 9.6 17.6 10.6 5.4 9.6 11.4 0.0 10.0 12.3 7.9 8.2 13.0 5.0 10.2 6.1 15.8 4.8 12.6 23.5 10.4 0.9 6.2 16.4 21.3 9.7 8.7 9.0 8.9 10.4 8.1 9.9 15.0 18.8 14.3 9.9 26.3 9.5 30.1 7.4 8.1 49.4 10.0 14.5 10.9 11.7 16.5 11.8 16.3 6.9 9.0 23.1 22.5 19.2 9.9 6.3 17.8 7.0 10.0 13.2 10.9 31.1 2.4 17.2 11.9 29.5 11.7 29.3 22.2 11.9 27.4 33.7 26.1 23.8 9.5 44.1 39.4 29.0 8.8 34.5 17.3 25.8 23.5 6.4 8.3 8.6 11.0 11.6 8.4 8.4 8.8 8.0 8.9 8.0 8.8 9.7 14.5 22.4 14.0 22.5 40.5 4.1 30.6 17.5 6.8 40.4 12.0 9.1 13.3 14.3 15.9 16.5 33.3 19.4 23.8 10.7 5.9 22.0 3.5 8.6 16.7 15.7 6.0 12.4 20.4 10.2 9.4 12.4 13.3 8.4 13.9 27.0 16.8 11.5 10.7 48.8 18.0 10.8 12.2 11.7 5.4 3.6 23.3 12.5 8.8 14.0 19.8 26.8 58.7 27.6 28.7 13.7 8.5 26.7 12.7 24.1 28.6 7.8 12.9 66.5 26.3 19.7 15.4 53.0 48.3 8.3 3.4 15.7 27.1 16.0 13.5 14.5 ZNF76 "D6S229E, Zfp523, ZNF523" ENSG00000065029 "Zinc finger protein 76" P36508 6 35258909-35295985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030090, HPA030091" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA030090: AB_10603334, HPA030091: AB_10602593" "unprognostic (8.29e-3)" "unprognostic (3.61e-2)" "unprognostic (7.71e-2)" "unprognostic (8.70e-3)" "unprognostic (2.76e-1)" "unprognostic (6.51e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.18e-4)" "prognostic favorable (5.09e-4)" "unprognostic (3.66e-3)" "unprognostic (1.20e-3)" "unprognostic (5.31e-3)" "unprognostic (1.14e-1)" "unprognostic (3.76e-1)" "unprognostic (1.20e-3)" 15.7 33.0 17.9 11.7 18.3 10.0 18.2 17.5 18.6 22.4 20.7 21.2 12.6 17.4 18.5 15.5 20.9 9.9 30.3 17.4 17.7 27.5 25.6 17.7 17.5 18.8 18.2 30.9 23.4 21.5 45.2 11.0 18.2 27.8 10.4 22.9 21.3 14.5 54.7 13.1 23.1 10.7 17.2 33.7 20.3 24.7 18.6 15.3 39.1 31.7 14.6 20.2 18.0 18.3 10.7 9.6 20.7 23.0 8.6 13.2 14.8 9.0 15.1 14.9 11.9 7.3 14.0 23.1 13.1 13.5 14.2 5.9 17.5 13.6 8.6 34.5 26.7 22.2 15.7 11.6 17.1 11.2 12.6 16.2 8.5 17.2 16.0 9.1 13.7 23.1 16.6 23.7 13.7 23.5 19.1 13.1 10.2 8.5 9.2 18.1 10.7 21.4 13.5 14.7 32.5 11.9 11.0 13.9 27.3 6.8 20.8 36.1 10.6 10.4 8.9 7.2 13.2 23.8 17.8 21.6 9.0 17.4 28.0 5.2 7.2 6.3 16.8 9.5 13.2 10.9 12.1 12.0 8.2 10.4 12.6 13.2 2.2 10.8 10.9 4.1 10.3 10.3 17.9 18.3 17.5 18.6 17.4 17.7 18.8 18.2 18.2 17.2 18.6 18.3 9.6 16.0 9.6 16.3 19.3 5.7 8.3 10.2 15.9 28.5 14.0 10.2 20.3 8.6 9.7 9.2 50.1 23.7 11.6 13.4 21.5 12.5 20.6 9.2 7.7 10.5 12.1 6.9 19.7 15.5 12.4 10.0 7.7 10.1 12.7 19.5 10.0 8.7 11.3 30.3 22.0 13.9 8.2 7.2 6.9 13.4 11.1 7.6 5.4 21.5 6.1 15.3 16.5 24.1 23.9 7.6 13.1 6.0 16.1 6.8 12.1 12.5 9.2 31.2 19.7 8.8 10.2 21.9 10.4 8.7 6.3 22.7 12.6 14.8 10.1 7.9 ZNF766 ENSG00000196214 "Zinc finger protein 766" Q5HY98 19 52269587-52296046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 83.6;Late spermatids: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044882, HPA063496" Uncertain Supported Centrosome NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Centrosome "HPA044882: AB_10965173, HPA063496: AB_2685024" "unprognostic (1.47e-1)" "unprognostic (1.04e-2)" "unprognostic (4.15e-1)" "unprognostic (1.20e-1)" "unprognostic (9.45e-2)" "unprognostic (9.28e-3)" "unprognostic (6.85e-3)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (6.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (3.26e-2)" "unprognostic (2.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.75e-1)" "unprognostic (3.85e-3)" 7.6 5.8 5.1 8.5 5.3 16.2 12.5 7.2 5.4 9.5 5.7 9.2 6.2 9.7 7.4 7.2 9.6 6.4 7.0 4.7 6.2 7.9 5.5 8.7 12.6 6.4 5.8 14.6 5.6 9.3 6.1 6.4 6.1 9.4 8.3 5.6 8.3 7.2 6.9 8.7 7.0 6.8 4.4 11.2 8.4 23.8 5.2 14.1 14.0 7.2 11.3 8.1 6.3 7.8 11.8 18.8 13.8 16.0 13.5 19.4 10.2 11.2 11.0 7.2 14.2 5.0 9.2 19.4 10.4 11.9 11.1 11.5 13.0 11.1 12.7 15.1 17.6 20.2 11.0 5.7 7.9 22.7 13.3 15.3 15.8 8.3 19.5 14.0 11.3 25.4 13.7 10.7 12.7 8.0 29.9 9.5 15.6 16.9 20.8 20.7 23.8 17.3 9.2 34.2 17.0 14.1 17.3 13.4 9.7 20.9 15.9 14.2 13.8 6.7 9.5 5.7 11.9 18.6 56.9 29.4 6.4 11.6 13.2 51.4 14.8 30.1 26.1 21.3 36.3 32.7 27.8 29.8 15.1 29.2 43.7 34.6 15.4 31.7 22.9 10.6 32.3 20.9 5.1 5.3 7.2 5.4 4.7 6.2 6.4 5.8 6.1 4.4 5.2 7.8 12.0 22.4 8.7 3.9 17.7 5.5 17.0 13.1 5.2 15.1 8.6 12.2 20.2 14.3 12.7 14.7 4.2 13.3 11.4 4.4 15.6 18.7 83.6 8.9 16.1 12.8 9.1 17.9 8.4 10.3 10.7 12.6 4.1 9.3 10.1 21.1 11.7 5.9 6.5 15.2 10.0 10.5 18.3 8.2 6.4 53.2 11.5 7.6 3.6 7.5 16.5 11.2 21.6 8.5 11.7 11.3 11.2 10.5 5.8 19.2 4.7 8.9 9.7 10.5 0.0 15.7 10.6 13.7 30.8 4.5 7.7 11.9 15.7 12.7 7.5 18.2 ZNF772 DKFZp686I1569 ENSG00000197128 "Zinc finger protein 772" Q68DY9 19 57466663-57477570 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 16.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 26.4" "Low region specificity" "Detected in all" HPA031312 Uncertain Approved Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA031312: AB_10603941" "unprognostic (2.30e-2)" "unprognostic (5.96e-2)" "unprognostic (1.12e-1)" "unprognostic (1.82e-1)" "unprognostic (1.83e-1)" "unprognostic (3.73e-2)" "unprognostic (2.24e-1)" "unprognostic (2.35e-1)" "unprognostic (6.31e-3)" "unprognostic (1.27e-1)" "unprognostic (2.50e-2)" "unprognostic (5.01e-2)" "prognostic favorable (1.02e-6)" "unprognostic (7.99e-2)" "unprognostic (3.75e-1)" "unprognostic (1.43e-1)" "unprognostic (7.93e-2)" 1.8 3.8 2.8 1.7 3.2 1.5 4.8 12.9 3.6 2.9 5.6 1.6 1.7 2.3 5.5 2.4 5.3 2.6 6.9 2.5 3.8 4.1 2.6 2.9 3.4 2.0 2.9 6.2 2.9 11.0 4.5 4.4 1.1 4.5 1.6 14.0 4.1 4.1 5.6 4.3 1.9 2.0 1.4 4.8 2.5 3.7 2.5 6.1 9.1 7.9 4.1 1.9 1.4 3.5 2.9 1.9 11.7 4.9 3.0 6.3 4.8 5.1 6.0 7.8 26.4 0.8 2.6 0.3 3.7 4.4 3.4 0.4 2.5 6.4 9.5 0.0 18.5 9.6 1.1 3.1 4.0 1.2 9.7 4.8 3.0 5.5 10.2 7.1 5.7 3.8 2.9 1.8 7.4 2.1 1.4 2.5 7.4 0.7 5.2 2.6 14.4 9.6 3.7 7.5 12.1 7.5 0.2 2.6 3.7 7.9 7.6 6.2 2.7 7.1 4.6 1.6 5.1 11.5 22.2 3.4 1.5 0.2 7.3 0.2 1.2 1.1 0.3 0.8 1.3 2.1 1.0 0.4 1.5 3.7 1.9 1.0 0.6 1.6 0.9 0.8 0.2 1.0 2.8 3.2 12.9 3.6 2.5 3.8 2.0 2.9 1.1 1.4 2.5 3.5 1.5 6.4 2.6 6.5 2.7 0.6 0.5 0.9 0.6 7.0 2.2 1.5 5.3 2.8 1.6 16.5 6.2 2.3 0.4 1.0 0.0 2.0 0.0 1.0 0.8 2.6 2.4 1.7 4.3 0.4 0.9 1.3 1.1 1.2 2.5 3.8 4.2 3.3 2.6 6.7 4.2 1.4 4.1 4.1 0.5 1.2 0.6 1.6 0.0 1.0 1.2 5.4 1.0 7.5 4.5 0.7 0.5 2.2 0.8 1.2 1.0 2.1 1.7 8.8 0.0 1.1 1.9 0.6 1.3 2.3 1.1 1.8 0.7 1.9 1.5 0.8 ZNF773 "MGC4728, ZNF419B" ENSG00000152439 "Zinc finger protein 773" Q6PK81 19 57499915-57518404 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003152 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716" "unprognostic (6.53e-2)" "unprognostic (3.79e-3)" "unprognostic (2.09e-1)" "unprognostic (1.29e-1)" "unprognostic (6.06e-2)" "unprognostic (2.07e-1)" "unprognostic (3.21e-2)" "unprognostic (5.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (9.50e-4)" "unprognostic (2.97e-2)" "unprognostic (3.56e-4)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (1.14e-1)" "unprognostic (3.71e-3)" 4.0 4.4 4.6 3.1 4.1 6.6 6.0 6.7 5.1 2.9 3.2 3.6 4.5 3.3 5.6 2.8 4.3 2.8 3.3 4.2 4.8 4.1 2.4 3.8 4.8 4.0 4.1 6.0 2.4 6.9 4.4 4.5 3.5 4.8 3.6 5.1 3.8 3.8 4.5 5.2 3.5 3.8 2.5 5.7 3.6 4.4 3.9 5.3 6.1 3.2 5.5 3.2 2.7 5.0 2.3 4.3 7.0 9.7 4.9 6.4 0.4 7.1 10.0 6.1 24.8 4.3 3.6 4.5 3.7 4.3 4.6 1.8 3.6 7.6 9.0 0.2 22.8 8.0 0.6 2.7 8.9 5.9 6.2 14.0 9.9 4.5 15.8 7.8 4.4 8.2 0.3 0.8 7.8 0.6 11.3 4.3 7.7 1.2 12.8 6.4 11.6 6.9 4.3 8.7 7.4 9.4 1.3 3.2 6.9 6.6 5.4 10.7 3.7 9.5 4.3 2.5 7.5 10.9 12.7 7.3 3.8 5.7 8.3 30.4 6.4 10.7 10.6 5.0 17.7 15.3 13.2 11.7 8.8 19.2 21.4 17.2 2.8 13.0 4.4 9.3 10.1 7.9 4.6 4.1 6.7 5.1 4.2 4.8 4.0 4.1 3.5 2.5 3.9 5.0 3.2 0.0 2.6 2.9 6.6 1.0 2.7 1.8 1.8 5.2 2.0 2.0 1.3 2.8 3.9 0.0 6.2 3.0 2.3 0.0 3.9 2.4 0.6 1.3 1.7 3.4 0.0 2.1 6.2 0.7 0.9 2.0 1.5 1.0 1.3 3.9 3.6 0.9 0.9 6.7 5.1 0.9 4.1 1.6 1.2 0.3 1.2 1.5 1.8 0.0 1.7 4.2 3.1 3.5 3.6 1.1 1.7 3.8 2.1 2.3 1.0 0.8 0.8 7.5 13.1 2.3 2.6 4.5 7.7 2.0 0.6 2.9 5.3 4.8 0.9 2.3 ZNF776 FLJ38288 ENSG00000152443 "Zinc finger protein 776" Q68DI1 19 57746815-57758148 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA046653, HPA068553" Uncertain Approved Nucleoplasm,Cytosol No No "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA046653: AB_10961126, HPA068553: AB_2686002" "unprognostic (6.73e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (3.99e-2)" "unprognostic (3.26e-1)" "unprognostic (6.35e-2)" "unprognostic (2.73e-2)" "unprognostic (1.62e-1)" "unprognostic (2.69e-2)" "unprognostic (2.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (7.45e-3)" "unprognostic (1.71e-3)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (6.41e-2)" "unprognostic (6.86e-2)" 4.4 6.5 4.5 5.2 5.5 17.2 9.1 10.6 6.3 6.6 5.4 6.4 6.4 5.0 21.6 5.0 7.0 4.0 7.2 5.4 4.9 7.7 6.8 6.3 8.3 4.4 3.8 8.3 4.7 10.8 8.3 7.7 4.7 8.5 6.7 20.7 7.8 7.7 9.1 6.4 5.9 4.2 3.7 8.2 7.6 6.6 4.4 12.6 9.3 10.3 8.2 5.5 5.3 8.2 6.2 5.3 16.7 11.2 2.6 8.2 7.2 5.0 8.3 8.7 5.6 3.2 6.8 7.2 4.4 4.6 4.6 4.1 8.8 8.7 13.8 6.5 32.1 9.8 12.6 3.7 6.2 5.5 7.5 9.5 7.1 5.8 6.2 9.2 6.7 11.6 6.6 5.0 11.2 2.9 18.2 4.9 9.7 2.8 11.0 11.6 12.7 8.3 6.4 20.0 18.7 13.7 9.3 7.7 5.5 9.0 7.9 7.7 6.2 9.2 4.9 0.8 7.6 13.8 16.8 12.1 5.5 5.1 7.7 6.6 1.8 8.9 1.1 1.3 2.7 2.4 1.9 2.4 1.7 3.7 2.8 2.2 4.6 5.6 1.7 1.9 1.8 1.6 4.5 5.5 10.6 6.3 5.4 4.9 4.4 3.8 4.7 3.7 4.4 8.2 3.3 3.2 4.1 7.2 7.1 2.7 4.1 3.9 1.8 8.7 7.7 5.3 12.3 11.5 3.2 9.2 2.1 3.1 2.5 3.9 5.9 3.3 1.4 8.3 3.7 6.5 8.4 8.6 7.1 1.3 2.3 2.8 4.1 6.9 3.8 6.9 10.4 8.1 3.5 11.8 7.7 4.1 6.1 6.0 1.8 0.6 1.2 3.6 0.0 6.5 3.1 12.0 5.2 8.0 9.1 2.5 2.1 4.9 3.9 4.1 3.9 2.8 6.0 7.5 0.0 2.6 3.9 2.9 4.8 3.1 1.7 2.9 3.3 2.9 3.2 5.5 ZNF783 DKFZp667J212 ENSG00000204946 "Zinc finger family member 783" Q6ZMS7 7 149262171-149297302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020375 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA020375: AB_1859453" "unprognostic (3.17e-3)" "unprognostic (2.54e-1)" "unprognostic (8.40e-3)" "unprognostic (1.16e-1)" "unprognostic (6.13e-2)" "unprognostic (1.08e-3)" "unprognostic (4.28e-3)" "unprognostic (1.05e-1)" "unprognostic (4.24e-3)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "unprognostic (3.29e-2)" "prognostic unfavorable (2.24e-7)" "unprognostic (2.49e-2)" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "prognostic favorable (4.11e-4)" 7.1 5.4 6.6 5.3 6.5 3.0 7.4 6.6 7.4 10.8 5.0 7.7 4.0 8.9 3.6 6.0 10.1 3.0 5.4 6.2 6.6 9.9 3.4 6.2 7.3 7.1 6.6 11.7 7.1 2.9 7.1 2.9 6.7 9.4 3.8 2.9 5.8 4.0 6.4 7.0 9.2 4.5 6.1 12.8 6.6 6.6 6.8 4.0 8.3 3.3 6.4 8.1 7.8 8.0 3.5 3.5 5.7 4.1 3.7 6.9 5.3 2.1 1.1 5.0 2.2 5.6 6.5 11.9 5.5 3.5 1.1 2.3 4.0 4.3 2.2 3.3 3.5 7.6 8.7 1.1 8.5 5.1 9.2 7.4 8.7 4.5 5.5 3.1 3.4 4.2 6.2 6.0 4.2 7.6 7.6 7.8 12.8 8.1 4.7 1.6 0.5 10.6 5.6 5.8 4.5 9.5 8.5 4.0 6.0 3.0 4.4 10.1 5.0 4.0 0.9 2.1 4.9 9.1 6.2 0.1 5.6 1.8 8.7 0.1 0.4 0.1 1.0 0.7 0.8 0.7 0.6 0.6 0.4 1.3 0.8 0.7 0.1 0.5 1.7 0.9 0.4 0.4 6.6 6.5 6.6 7.4 6.2 6.6 7.1 6.6 6.7 6.1 6.8 8.0 6.7 3.2 2.7 5.5 6.1 2.5 2.5 4.6 1.8 13.3 7.5 7.6 2.2 7.2 3.2 0.0 10.4 3.0 6.1 3.4 3.9 2.1 5.3 3.2 7.9 4.3 3.6 1.7 5.7 2.7 2.0 7.0 7.1 6.2 0.0 6.4 5.0 6.6 4.2 6.7 6.3 4.7 4.1 7.9 4.6 5.0 8.7 3.9 5.4 11.2 5.2 3.8 8.2 4.0 8.5 3.0 1.6 5.7 3.9 4.0 3.0 1.1 5.5 8.8 13.1 7.4 5.0 16.3 6.9 3.6 3.0 1.1 5.0 6.9 4.3 2.4 ZNF785 FLJ32130 ENSG00000197162 "Zinc finger protein 785" A8K8V0 16 30573740-30585769 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004010 Approved Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Cytosol "HPA004010: " "unprognostic (2.85e-2)" "unprognostic (1.29e-1)" "unprognostic (8.25e-2)" "unprognostic (2.47e-1)" "unprognostic (2.35e-1)" "unprognostic (4.15e-2)" "unprognostic (2.54e-4)" "prognostic favorable (8.99e-4)" "unprognostic (1.55e-1)" "unprognostic (2.08e-1)" "prognostic favorable (2.03e-5)" "unprognostic (3.37e-2)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (3.13e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-2)" 5.2 5.7 5.7 4.9 6.4 3.1 6.1 9.1 8.3 10.9 2.9 8.1 8.4 9.6 5.4 6.2 8.8 4.4 5.6 5.6 6.2 8.2 5.8 5.8 5.5 6.1 4.7 11.0 8.3 5.7 9.5 3.6 4.8 10.2 4.7 6.5 8.2 5.1 6.0 7.4 8.2 4.2 2.6 7.6 7.5 3.3 6.3 4.4 8.0 3.6 3.9 9.0 8.5 9.8 5.7 0.5 5.4 7.1 6.5 7.2 1.7 4.9 4.3 5.0 3.7 7.5 8.9 5.9 5.6 4.7 0.3 8.0 0.1 3.2 2.9 4.0 1.4 7.2 17.4 1.8 4.8 0.6 11.8 4.8 6.7 3.3 3.1 4.2 5.3 1.0 6.9 7.1 4.6 9.8 7.3 6.7 3.0 2.2 3.2 18.8 6.1 2.9 4.6 5.8 14.7 10.4 4.0 5.0 3.0 3.2 6.3 6.1 8.1 1.9 5.2 4.4 0.4 0.9 3.3 2.4 6.3 4.3 8.1 2.8 1.1 0.4 0.9 0.6 0.9 2.7 1.1 0.7 0.8 1.1 1.3 1.0 1.9 1.3 2.4 2.3 1.5 0.5 5.7 6.4 9.1 8.3 5.6 6.2 6.1 4.7 4.8 2.6 6.3 9.8 5.3 0.0 3.4 11.1 5.3 1.0 7.6 3.4 6.8 10.7 4.1 2.4 1.8 4.3 2.5 7.3 20.9 1.3 14.3 4.7 5.9 3.9 0.1 3.5 11.1 7.1 12.0 3.4 14.1 3.7 1.1 5.2 3.6 4.5 0.0 14.8 3.6 3.5 2.6 13.5 13.6 5.2 0.0 5.0 3.1 0.8 13.4 3.3 5.4 6.5 6.0 5.8 15.5 6.6 11.4 4.2 8.1 13.2 1.4 7.0 6.6 2.4 4.0 12.0 0.0 6.2 4.6 5.3 3.1 3.1 2.6 0.8 4.7 6.8 7.4 5.1 ZNF791 FLJ90396 ENSG00000173875 "Zinc finger protein 791" Q3KP31 19 12610918-12633840 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021537 Uncertain Approved Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA021537: AB_2670741" "unprognostic (1.95e-1)" "unprognostic (4.88e-3)" "unprognostic (1.73e-2)" "unprognostic (7.58e-2)" "unprognostic (2.30e-2)" "unprognostic (1.04e-3)" "unprognostic (6.86e-2)" "prognostic favorable (9.07e-4)" "unprognostic (1.88e-2)" "unprognostic (1.59e-2)" "unprognostic (3.38e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-2)" "unprognostic (2.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" "prognostic favorable (1.39e-5)" 8.3 5.9 4.9 7.4 5.7 13.3 9.3 11.6 6.1 8.6 6.7 7.2 5.7 8.2 7.6 6.9 7.8 5.1 6.3 4.7 6.4 6.3 6.7 8.6 8.6 6.0 6.2 10.2 7.2 9.6 7.3 6.5 5.8 7.2 6.4 13.6 7.3 6.7 6.9 8.6 7.8 5.7 4.8 7.8 6.7 2.7 5.4 5.2 12.1 8.2 10.1 8.2 8.1 8.3 7.2 4.0 7.6 7.7 8.6 11.3 6.4 9.7 10.1 5.8 8.3 5.0 4.5 1.6 9.1 9.8 3.8 6.7 7.1 8.7 10.6 4.8 7.7 7.6 10.0 6.9 6.9 9.7 6.7 9.9 9.6 8.5 11.4 10.4 7.3 4.4 8.6 11.2 7.2 10.9 6.2 3.5 8.2 4.3 11.9 4.4 13.0 6.2 5.9 14.3 8.5 10.3 7.9 6.6 8.5 8.9 6.5 8.1 7.5 13.2 5.3 11.8 7.3 15.6 22.8 5.0 8.9 6.8 8.3 9.9 2.6 4.7 5.5 1.9 5.5 6.2 4.8 5.6 2.4 8.6 5.4 6.6 4.6 9.2 3.5 8.3 4.2 2.2 4.9 5.7 11.6 6.1 4.7 6.4 6.0 6.2 5.8 4.8 5.4 8.3 34.2 12.8 28.2 4.9 56.1 29.2 31.2 18.1 35.9 75.5 28.3 25.7 21.8 27.1 22.6 18.4 98.0 30.5 56.7 29.0 19.6 23.8 5.5 35.6 29.3 41.2 37.1 16.8 9.1 17.6 19.4 31.6 15.8 34.2 9.5 58.7 48.9 26.5 14.0 35.3 9.4 26.3 16.2 21.8 33.5 3.9 39.1 24.9 14.2 1.0 19.8 36.2 49.4 3.0 10.9 26.3 15.4 39.1 69.5 37.6 33.0 13.3 27.9 98.0 39.5 34.8 34.6 13.4 12.7 22.1 27.7 39.1 41.5 33.2 24.1 36.8 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 31.3;Early spermatids: 39.6;Horizontal cells: 48.8;Rod photoreceptor cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 11.6;RT4: 10.0;U-266/70: 18.4;U-266/84: 12.7" "Low region specificity" "Detected in all" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 1.8 4.4 6.1 2.4 5.7 1.2 3.6 10.0 5.9 4.9 4.3 3.7 1.8 5.3 3.8 3.3 4.6 2.5 4.2 5.5 5.5 5.3 0.8 2.1 3.7 4.4 4.4 8.1 2.5 6.0 9.2 2.7 4.2 4.6 3.3 14.7 2.8 3.2 2.4 6.4 2.5 3.3 3.2 3.6 3.0 9.0 5.3 2.8 6.5 2.3 2.8 3.7 4.5 6.0 0.1 0.2 4.5 11.6 0.9 0.9 0.3 3.7 0.2 0.7 0.4 0.2 1.5 3.4 5.6 1.9 1.0 0.5 0.3 2.9 0.3 0.8 4.2 0.4 0.4 0.3 2.4 0.2 2.9 3.5 2.2 0.7 0.1 0.3 0.1 0.4 0.1 0.5 0.5 3.2 0.4 0.4 7.3 0.0 0.2 0.1 0.1 0.8 3.3 10.0 3.4 6.8 0.1 0.1 0.0 8.2 6.7 0.3 0.4 0.1 1.8 0.2 3.5 18.4 12.7 0.2 0.0 0.2 0.6 4.0 0.6 0.5 0.6 0.2 0.9 0.9 1.1 1.0 0.4 1.4 0.7 0.9 1.6 1.6 0.2 0.9 1.0 0.7 6.1 5.7 10.0 5.9 5.5 5.5 4.4 4.4 4.2 3.2 5.3 6.0 6.5 3.2 5.8 24.2 4.0 3.3 3.8 2.6 6.2 29.1 5.0 5.8 9.7 7.2 5.0 12.9 31.3 5.5 2.9 1.7 3.9 3.6 39.6 5.0 8.7 7.0 9.0 2.1 14.9 1.5 4.1 4.6 1.1 3.9 2.5 21.5 6.4 0.5 0.9 48.8 16.3 2.9 0.0 0.3 3.4 11.2 5.0 0.9 0.0 2.8 1.5 13.6 8.2 19.6 16.7 2.0 1.0 10.1 1.1 2.8 1.0 2.7 5.7 33.6 0.0 8.7 5.3 6.0 6.9 4.0 3.3 1.9 4.0 12.7 3.7 1.9 ZNF8 "HF.18, Zfp128" ENSG00000278129 "Zinc finger protein 8" P17098 19 58278955-58302791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034797, HPA034798" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA034797: AB_10696364, HPA034798: AB_10602785" "unprognostic (1.41e-1)" "unprognostic (7.27e-2)" "unprognostic (6.66e-2)" "unprognostic (3.03e-2)" "unprognostic (1.52e-2)" "unprognostic (4.16e-3)" "unprognostic (1.09e-2)" "unprognostic (9.20e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (4.14e-3)" "unprognostic (4.98e-2)" "unprognostic (7.16e-3)" "unprognostic (8.56e-2)" "unprognostic (7.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.28e-2)" 1.5 1.8 2.3 1.1 1.8 3.6 1.6 4.6 3.2 1.5 1.0 1.7 1.1 1.8 1.5 1.6 1.7 1.1 2.2 2.8 1.5 1.9 1.1 2.1 1.4 1.7 1.7 1.8 1.6 2.0 2.3 1.5 1.7 1.6 1.1 4.0 1.7 1.3 0.9 2.5 1.7 1.4 0.9 1.8 1.6 1.4 2.1 2.1 1.8 1.4 1.3 1.6 1.6 2.8 1.8 2.6 3.7 6.9 2.3 1.9 3.1 0.9 1.4 0.9 1.0 2.8 1.3 2.3 1.1 1.5 0.8 1.6 2.7 3.0 1.2 1.8 11.4 4.5 6.0 2.5 2.1 1.5 3.5 3.7 1.8 1.6 3.1 2.7 1.7 3.7 2.4 0.9 1.9 2.1 3.5 2.0 3.3 1.3 1.8 3.9 3.5 1.6 1.8 6.3 6.5 3.5 2.8 1.9 0.9 2.8 1.9 2.8 2.5 6.9 1.7 1.0 1.9 3.4 2.9 3.0 1.1 0.0 1.8 1.4 0.7 0.4 0.4 0.3 0.5 0.4 0.3 0.3 0.4 0.5 0.3 0.4 1.3 0.5 0.3 0.3 0.2 0.7 2.3 1.8 4.6 3.2 2.8 1.5 1.7 1.7 1.7 0.9 2.1 2.8 4.2 0.0 4.1 2.3 2.3 0.0 2.9 0.0 2.8 11.0 2.5 2.3 3.1 0.0 1.8 5.5 12.5 2.1 1.2 1.4 3.9 4.0 4.0 4.7 5.3 4.5 5.4 10.3 4.2 2.3 1.6 2.8 4.1 3.9 1.3 5.9 6.8 1.7 2.5 11.8 4.3 2.1 0.0 1.9 0.0 0.9 4.1 2.4 0.0 1.9 3.0 3.5 2.1 3.0 3.3 3.1 0.5 1.9 1.7 4.4 1.0 2.5 2.2 10.2 6.6 6.6 2.6 8.0 3.4 2.8 0.0 2.6 3.4 5.1 1.9 2.8 ZNF805 ENSG00000204524 "Zinc finger protein 805" Q5CZA5 19 57240632-57262728 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA046330, HPA058895" Uncertain Approved Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA046330: , HPA058895: AB_2683846" "unprognostic (2.18e-1)" "unprognostic (1.10e-1)" "unprognostic (8.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.22e-1)" "unprognostic (2.62e-3)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.20e-1)" "unprognostic (1.95e-1)" "unprognostic (1.58e-2)" "unprognostic (3.51e-1)" "unprognostic (3.68e-2)" "unprognostic (7.16e-3)" "unprognostic (1.64e-1)" 1.5 1.9 2.6 1.5 3.0 6.7 2.0 2.6 2.5 1.6 3.3 1.3 1.0 1.7 1.6 1.1 1.4 1.2 1.5 2.1 2.7 1.3 1.9 1.6 1.5 3.1 3.1 2.1 1.3 2.2 1.3 1.8 2.7 1.3 1.6 2.7 1.4 1.5 1.8 2.0 1.1 1.8 2.5 2.1 1.5 2.2 3.2 1.6 1.7 2.1 2.0 1.3 1.1 3.7 1.3 1.8 2.1 3.0 3.9 2.7 2.6 1.2 2.6 2.1 4.2 1.9 1.1 2.5 0.9 2.9 1.4 0.8 2.1 2.3 3.5 1.3 5.3 2.6 1.8 2.2 3.0 2.5 2.3 3.1 2.6 2.7 4.7 1.9 1.9 2.7 0.9 3.5 1.7 0.9 2.9 1.3 1.6 1.2 2.1 1.3 3.9 2.1 1.6 3.9 1.7 1.9 3.2 1.9 2.1 2.5 1.2 2.5 2.2 3.3 2.1 1.3 1.6 3.2 2.4 2.4 2.0 1.3 1.6 1.0 0.8 2.4 1.6 0.4 1.8 1.5 1.3 2.0 0.8 0.7 1.3 1.4 0.9 2.8 0.6 0.8 1.6 0.9 2.6 3.0 2.6 2.5 2.1 2.7 3.1 3.1 2.7 2.5 3.2 3.7 4.1 3.2 0.5 7.2 2.3 1.7 2.2 1.3 2.8 6.3 2.1 2.2 2.0 0.0 0.7 1.8 8.4 1.1 3.5 0.7 1.9 1.6 5.3 2.8 4.2 2.3 1.2 3.2 7.4 1.1 1.6 2.9 2.0 2.7 4.5 2.6 2.9 0.6 0.9 3.3 7.1 1.1 0.0 0.8 0.4 0.8 1.2 1.9 0.0 10.3 0.0 2.5 2.1 7.5 9.7 1.4 0.2 0.7 3.9 2.1 0.9 0.8 1.6 5.4 0.0 4.4 3.7 7.8 2.8 1.8 1.1 2.3 2.7 5.1 0.7 2.4 ZNF816 ZNF816A ENSG00000180257 "Zinc finger protein 816" Q0VGE8 19 52949379-52962911 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 52.6" HPA042466 Uncertain Approved "Nucleoli rim" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoli rim" "HPA042466: AB_10797497" "unprognostic (1.83e-2)" "unprognostic (1.90e-1)" "unprognostic (1.64e-1)" "unprognostic (4.81e-2)" "unprognostic (3.12e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-4)" "unprognostic (1.69e-1)" "unprognostic (1.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (3.72e-2)" "unprognostic (5.36e-3)" "unprognostic (6.21e-2)" "unprognostic (5.45e-1)" "unprognostic (8.59e-2)" "unprognostic (1.39e-2)" 2.8 3.2 2.5 4.6 2.9 3.3 7.9 6.7 3.5 9.5 3.7 9.1 4.8 5.8 8.4 4.3 11.7 5.3 4.6 2.2 2.8 6.0 2.7 5.5 7.7 2.9 2.5 8.4 5.7 6.0 2.9 6.6 3.3 12.5 10.1 5.9 4.6 6.9 1.8 5.2 4.9 4.6 2.3 6.8 10.0 4.4 2.8 9.6 7.2 3.0 8.8 8.2 4.5 3.1 6.5 0.2 5.8 14.5 10.2 11.6 17.0 5.4 5.5 6.8 10.1 4.7 4.1 17.8 11.2 4.8 10.5 3.9 8.5 6.3 6.6 8.9 17.1 8.3 7.0 7.7 3.5 0.0 12.3 5.5 7.8 4.3 7.9 8.0 5.8 8.1 13.4 0.6 8.7 5.3 14.4 9.6 6.8 3.8 8.0 7.9 12.2 8.6 10.7 52.6 4.4 8.1 0.2 9.1 3.6 11.3 5.7 9.6 5.0 5.0 4.9 3.4 6.1 6.0 18.4 16.1 0.6 8.8 6.0 15.2 8.6 17.3 14.4 7.5 19.5 11.3 13.5 14.3 10.0 11.6 18.5 14.5 3.9 21.3 9.6 9.3 13.9 8.9 2.5 2.9 6.7 3.5 2.2 2.8 2.9 2.5 3.3 2.3 2.8 3.1 2.0 3.2 1.5 0.0 2.8 0.9 2.8 4.3 2.2 1.6 1.4 1.3 2.2 2.8 7.0 1.8 6.2 4.9 2.5 1.8 7.9 3.8 3.3 4.8 1.8 2.1 0.0 7.8 0.0 1.6 3.7 1.7 2.0 3.7 7.6 3.8 1.4 0.7 2.4 0.0 0.0 3.2 4.1 1.0 1.7 2.3 1.5 1.8 5.4 0.0 3.7 1.0 8.2 0.0 0.0 2.0 2.5 1.2 1.9 1.4 1.6 0.9 4.8 0.9 0.0 1.3 1.8 1.5 5.0 1.6 1.6 3.6 3.3 2.3 3.3 4.1 ZNF83 "FLJ11015, HPF1, ZNF816B" ENSG00000167766 "Zinc finger protein 83" P51522 19 52594060-52690496 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA025970 Approved Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA025970: AB_1859463" "unprognostic (6.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "prognostic favorable (3.83e-4)" "unprognostic (3.38e-3)" "unprognostic (3.67e-1)" "prognostic unfavorable (9.20e-4)" "prognostic favorable (9.06e-4)" "unprognostic (6.08e-2)" "unprognostic (3.85e-3)" "prognostic unfavorable (3.13e-5)" "unprognostic (2.81e-2)" "unprognostic (1.14e-1)" "unprognostic (3.33e-1)" "prognostic favorable (6.92e-6)" 42.7 54.4 35.4 24.7 49.8 30.1 45.6 53.3 47.7 82.9 35.5 55.6 14.9 50.8 92.0 28.7 88.2 28.2 36.5 33.9 40.8 99.3 13.1 42.8 36.2 43.7 38.0 100.8 36.5 26.1 77.3 30.0 44.8 81.2 24.2 67.4 33.3 40.5 9.8 30.8 40.4 29.3 36.8 48.9 34.2 22.1 40.2 19.1 71.5 8.9 29.6 50.2 61.0 51.0 19.6 1.0 27.0 19.6 23.7 47.4 15.0 29.9 20.4 17.6 23.7 7.2 16.5 20.2 14.9 20.3 13.0 8.6 16.3 20.1 24.5 2.7 18.4 16.5 18.9 9.3 19.5 12.3 23.1 38.4 24.2 14.7 73.0 61.8 19.9 22.6 19.3 15.7 29.2 13.2 17.4 20.5 7.4 3.4 18.3 17.3 23.2 13.5 45.0 39.1 15.2 12.5 19.2 18.6 7.7 42.9 19.8 12.7 27.0 17.7 10.7 8.5 31.1 1.4 18.3 27.5 1.0 12.8 14.2 4.1 3.0 7.5 5.7 3.2 6.1 5.7 7.0 7.5 3.6 9.3 6.0 6.7 2.7 10.9 4.7 2.5 3.8 3.2 35.4 49.8 53.3 47.7 33.9 40.8 43.7 38.0 44.8 36.8 40.2 51.0 28.1 35.3 20.0 53.8 20.3 10.3 52.9 23.6 11.4 25.2 23.1 20.7 15.4 12.8 38.1 40.5 35.5 48.4 22.6 10.6 19.6 21.2 24.5 35.2 30.7 28.9 10.8 14.1 26.9 6.9 20.8 32.9 16.3 47.4 37.2 130.5 23.2 1.1 13.5 48.8 57.2 11.3 18.3 5.7 15.8 17.3 42.6 12.0 30.2 46.9 14.6 16.6 37.0 56.8 80.0 10.7 18.5 34.6 9.9 90.8 8.2 23.9 34.9 38.3 6.6 43.3 21.4 15.4 15.8 6.4 9.7 64.0 26.0 62.5 8.8 116.2 ZNF891 ENSG00000214029 "Zinc finger protein 891" A8MT65 12 133104779-133130274 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 31.4;Early spermatids: 70.4;Horizontal cells: 40.4;Rod photoreceptor cells: 32.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040301 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA040301: AB_10795380" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" "unprognostic (3.29e-1)" "unprognostic (3.72e-1)" "unprognostic (7.51e-3)" "unprognostic (5.98e-3)" "unprognostic (1.94e-2)" "unprognostic (7.90e-2)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.60e-2)" "unprognostic (6.09e-2)" "unprognostic (5.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (2.07e-3)" "unprognostic (6.68e-2)" 0.9 1.7 1.4 1.0 1.6 1.3 2.0 3.8 1.7 1.3 1.1 0.9 0.8 2.1 1.4 1.2 1.3 0.9 0.8 1.6 1.1 1.2 0.8 0.9 1.3 1.4 1.3 2.3 0.9 1.3 1.4 1.0 1.2 1.1 1.1 4.7 1.1 1.1 1.0 1.7 0.9 1.5 1.0 1.2 1.0 4.2 1.4 1.3 1.8 1.4 1.3 0.8 0.9 2.8 1.1 1.4 4.1 0.1 1.4 1.9 3.5 0.8 1.2 2.2 1.7 0.9 0.6 0.1 1.1 1.2 2.6 1.6 3.0 1.8 1.6 0.0 2.3 3.7 3.7 1.2 1.4 2.3 1.9 1.4 0.9 2.0 2.0 2.0 1.4 3.0 2.4 0.3 2.2 0.8 3.4 2.6 3.5 2.2 2.0 3.4 3.8 2.4 1.0 2.2 3.5 1.5 3.0 0.6 1.0 3.0 2.9 1.3 0.8 2.0 2.4 1.5 1.5 0.2 0.1 3.4 0.5 0.9 1.5 0.5 0.3 0.6 0.9 0.3 0.7 1.1 0.7 0.9 0.3 1.3 1.3 1.3 0.4 1.0 0.3 0.6 0.9 0.4 1.4 1.6 3.8 1.7 1.6 1.1 1.4 1.3 1.2 1.0 1.4 2.8 6.4 3.2 5.3 2.0 14.3 1.8 5.9 2.3 2.8 31.4 3.2 3.9 5.7 5.7 6.7 11.0 29.2 3.4 5.2 1.1 0.0 3.9 70.4 6.6 11.9 5.9 6.7 4.0 2.8 1.9 2.3 6.2 3.6 5.6 1.3 16.7 6.8 2.0 2.0 40.4 3.4 2.4 0.0 2.8 0.8 10.0 5.3 4.3 1.8 1.9 2.7 10.6 10.3 3.5 3.6 1.8 2.1 6.0 2.7 3.7 2.4 2.2 9.5 32.4 19.7 11.2 8.4 14.2 14.1 3.0 1.7 2.3 6.5 8.9 3.2 2.4 ZNHIT6 "BCD1, C1orf181, FLJ20729, NY-BR-75" ENSG00000117174 "Zinc finger HIT-type containing 6" Q9NWK9 1 85649417-85708433 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018132 Uncertain Approved "Nuclear speckles,Vesicles" No No "Cluster 21: B-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles, Vesicles" "HPA018132: AB_1848789" "unprognostic (1.37e-1)" "unprognostic (4.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.27e-3)" "unprognostic (1.61e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.08e-6)" "unprognostic (1.11e-1)" "unprognostic (3.89e-2)" "unprognostic (8.48e-2)" "unprognostic (9.91e-3)" "unprognostic (2.92e-2)" "unprognostic (1.27e-3)" "unprognostic (5.91e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (7.37e-2)" 10.3 6.6 7.2 5.2 8.2 5.2 10.1 6.8 7.7 14.6 5.3 9.7 2.9 11.0 4.4 11.8 9.6 3.6 7.7 6.8 7.9 9.0 6.7 6.9 6.4 7.7 7.4 10.4 7.2 4.2 7.5 4.7 7.6 8.9 4.2 3.3 9.5 4.4 7.8 11.1 7.9 5.5 8.1 8.1 6.9 6.1 7.6 5.5 8.5 3.9 6.0 11.6 11.3 9.1 13.5 9.1 8.9 8.1 19.2 17.4 11.3 17.0 16.3 11.5 11.0 9.2 6.8 10.4 19.7 10.4 24.7 11.2 15.9 10.9 18.6 14.3 13.7 21.6 10.3 10.7 16.2 35.4 8.3 17.2 10.0 15.3 13.4 11.4 13.7 16.4 20.2 13.3 17.6 5.1 20.9 9.2 13.5 11.0 16.5 16.6 19.7 12.0 18.7 25.2 8.6 5.6 13.3 20.3 19.3 9.3 9.0 8.9 15.6 14.8 10.0 12.5 24.7 8.5 9.3 28.2 3.4 22.0 13.1 0.6 0.7 0.1 1.8 0.7 2.0 1.9 1.6 2.0 1.2 2.4 2.0 2.0 0.1 1.8 0.7 2.1 1.8 0.8 7.2 8.2 6.8 7.7 6.8 7.9 7.7 7.4 7.6 8.1 7.6 9.1 22.0 16.0 22.5 22.5 20.3 16.2 14.4 12.5 13.1 31.8 10.6 9.9 17.6 11.5 38.0 31.3 33.3 9.0 21.0 25.6 3.9 11.9 4.2 15.5 47.4 20.9 9.5 8.4 40.4 8.8 13.7 22.2 6.1 16.1 27.8 22.4 14.3 10.6 7.5 15.2 30.0 20.9 16.2 13.5 7.4 3.8 13.4 9.1 7.2 22.5 11.0 17.6 27.8 34.2 45.3 12.2 11.6 12.8 11.1 11.1 15.5 6.3 18.0 38.8 19.7 22.4 20.7 35.8 21.6 14.0 16.3 2.7 20.1 25.8 20.5 10.8 ZRANB2 "ZIS, ZIS1, ZIS2, ZNF265" ENSG00000132485 "Zinc finger RANBP2-type containing 2" O95218 1 71063291-71081289 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053960, HPA061949, HPA063298" Supported Enhanced Nucleoplasm NA Yes 13000 "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979" "unprognostic (2.10e-1)" "unprognostic (7.54e-2)" "unprognostic (4.15e-3)" "unprognostic (8.11e-2)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (4.25e-3)" "unprognostic (1.24e-2)" "unprognostic (7.79e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (1.57e-8)" "unprognostic (3.96e-2)" "unprognostic (8.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-3)" 41.0 39.4 29.7 45.3 31.1 60.0 52.6 36.9 47.0 45.0 36.8 40.8 35.5 70.7 67.6 29.3 45.4 29.6 42.7 30.7 29.1 35.3 30.2 40.4 62.5 32.0 27.7 56.7 33.8 33.2 64.5 36.3 31.6 44.2 42.9 62.1 39.5 38.0 58.9 43.4 37.9 50.1 29.3 42.6 35.6 50.4 30.3 47.6 48.5 38.9 49.3 37.9 35.2 38.8 86.8 31.1 122.3 73.0 46.5 79.8 71.0 103.2 55.6 89.2 113.2 58.7 55.5 177.6 89.0 64.2 82.7 53.5 111.1 63.9 133.4 127.5 79.9 154.5 127.3 50.0 70.8 171.5 62.7 61.7 80.3 86.1 73.5 98.1 76.3 90.3 165.1 93.6 69.6 29.3 145.0 58.4 128.7 52.9 59.6 159.8 92.3 108.4 60.5 72.6 93.8 58.3 88.7 58.8 91.4 63.7 74.7 76.8 102.5 65.9 62.1 51.9 103.8 75.7 100.6 193.8 96.4 160.3 94.6 99.1 33.4 32.1 44.5 32.3 51.2 68.8 47.5 44.0 26.8 63.1 61.2 48.7 30.7 48.2 33.8 73.4 49.6 31.2 29.7 31.1 36.9 47.0 30.7 29.1 32.0 27.7 31.6 29.3 30.3 38.8 86.9 99.3 154.5 83.6 109.8 50.6 94.4 66.1 59.7 166.5 61.4 66.5 99.9 50.1 68.4 49.7 129.3 55.1 136.9 85.8 49.0 60.2 190.3 79.9 123.5 63.5 73.0 87.1 135.3 68.2 50.4 92.6 62.7 85.7 87.4 132.8 50.7 41.8 45.4 213.7 114.7 64.5 54.9 34.5 39.7 46.2 185.4 55.7 48.0 73.1 74.8 116.6 139.0 90.5 131.9 69.2 76.5 115.5 127.5 54.8 41.2 41.1 76.5 202.2 118.3 88.1 99.2 218.7 113.0 55.3 46.5 63.5 89.6 96.4 55.1 68.5 ZSCAN26 "SRE-ZBP, ZNF187" ENSG00000197062 "Zinc finger and SCAN domain containing 26" Q16670 6 28267058-28278224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027521 Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 44: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "HPA027521: AB_2672314" "unprognostic (1.07e-1)" "unprognostic (4.10e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-2)" "unprognostic (1.38e-3)" "unprognostic (4.60e-3)" "prognostic unfavorable (7.81e-5)" "unprognostic (1.00e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-2)" "unprognostic (2.49e-3)" "unprognostic (9.01e-2)" "prognostic unfavorable (6.79e-5)" "unprognostic (4.45e-2)" "unprognostic (1.44e-1)" "unprognostic (3.10e-1)" "prognostic favorable (1.68e-4)" 9.9 11.1 18.5 10.3 19.1 6.8 15.1 24.3 23.0 20.2 14.4 16.2 8.9 18.9 13.5 9.6 14.3 12.7 13.0 19.5 20.4 12.1 9.9 10.3 11.0 19.0 17.9 30.2 11.9 14.0 16.4 9.3 18.6 17.1 10.0 26.6 10.2 18.1 11.9 9.9 11.6 16.3 17.3 17.5 10.9 7.8 18.7 11.4 14.4 10.4 12.2 13.6 12.2 22.4 8.1 6.6 18.8 16.2 19.0 18.5 4.2 16.2 15.0 19.9 19.8 4.9 5.7 4.6 22.9 10.1 15.1 5.7 8.6 11.3 21.5 9.8 9.6 12.2 10.6 9.9 13.2 10.1 7.1 15.5 10.7 15.4 14.0 25.8 20.5 7.0 10.2 9.2 16.0 6.7 10.9 13.3 5.6 4.3 10.5 10.7 16.1 7.8 17.2 7.9 13.6 10.3 9.6 4.0 13.2 15.2 6.5 6.9 13.7 16.3 11.7 5.8 19.2 9.9 14.5 8.7 5.8 11.0 14.3 17.9 7.9 14.0 16.1 6.4 19.0 16.3 16.0 17.6 12.5 19.9 19.4 16.0 5.8 22.5 5.5 6.0 15.6 12.5 18.5 19.1 24.3 23.0 19.5 20.4 19.0 17.9 18.6 17.3 18.7 22.4 8.8 0.0 5.6 15.3 9.2 0.0 2.7 0.0 4.0 8.9 4.7 8.3 10.4 2.8 6.2 0.0 4.2 4.9 9.2 1.8 3.9 5.6 5.9 3.8 7.8 7.0 6.7 7.8 23.5 5.0 2.8 8.1 2.0 3.1 6.3 11.1 4.6 1.8 5.9 1.7 26.1 2.6 0.0 5.1 0.0 2.5 9.0 4.3 0.0 8.4 2.3 12.8 14.4 30.7 28.8 3.6 4.0 13.2 3.5 2.2 4.9 4.6 1.5 9.6 19.7 7.7 7.5 7.5 8.7 2.9 0.0 1.4 7.2 8.1 3.4 0.8 ZSCAN30 "ZNF397OS, ZNF917" ENSG00000186814 "Zinc finger and SCAN domain containing 30" Q86W11 18 35251058-35290245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007289 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA007289: AB_1079726" "unprognostic (6.02e-3)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (8.94e-2)" "unprognostic (3.56e-3)" "unprognostic (7.02e-3)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (3.05e-3)" "unprognostic (2.78e-3)" "unprognostic (8.27e-3)" "unprognostic (1.15e-1)" "unprognostic (8.44e-3)" "unprognostic (8.75e-2)" "unprognostic (1.36e-1)" 9.2 14.1 12.1 7.9 14.4 7.5 10.1 26.1 16.2 12.3 9.3 11.2 8.6 10.7 10.9 7.1 11.7 7.3 17.5 11.0 15.8 12.1 8.4 9.2 11.0 12.9 9.6 11.1 10.7 13.1 16.7 8.1 12.6 11.3 6.8 28.0 9.3 7.0 16.9 9.9 11.2 7.6 7.7 12.9 9.3 10.0 14.5 11.1 14.6 8.7 7.9 9.7 9.1 26.9 6.2 1.7 13.4 18.2 9.1 17.8 9.3 11.9 15.9 6.7 13.1 5.1 7.6 11.3 7.7 12.5 11.5 4.1 6.5 12.4 18.0 11.5 3.7 7.1 8.9 3.6 9.3 5.9 6.8 11.6 9.6 17.9 15.5 17.5 13.2 15.7 12.1 12.8 18.0 2.8 9.1 10.5 8.9 1.8 5.7 13.6 4.6 8.4 10.4 4.2 19.4 9.9 11.7 3.7 4.8 14.1 5.8 8.3 15.5 24.6 5.2 3.8 4.6 23.4 10.7 10.0 18.4 6.8 13.9 1.4 0.6 2.3 2.1 0.8 1.3 2.5 2.0 1.2 1.1 3.3 2.3 2.6 2.3 2.0 1.0 2.6 2.0 1.2 12.1 14.4 26.1 16.2 11.0 15.8 12.9 9.6 12.6 7.7 14.5 26.9 8.4 9.6 8.7 22.2 7.5 1.8 2.0 3.2 13.6 30.5 4.8 5.5 15.5 10.0 9.1 1.8 20.9 3.3 6.4 3.4 5.9 5.2 9.3 7.0 11.9 10.7 7.2 7.8 21.8 3.4 1.5 6.0 7.7 6.5 8.8 18.8 10.0 5.2 2.6 20.2 18.4 4.0 2.0 4.7 1.7 9.0 5.9 3.3 0.0 23.4 2.3 12.2 7.2 26.2 52.1 3.1 4.0 7.9 3.3 2.0 5.9 4.5 6.2 19.3 0.0 10.3 6.3 13.5 5.3 4.2 1.0 1.8 5.3 15.4 3.1 1.6 ZSWIM8 "4832404P21Rik, KIAA0913" ENSG00000214655 "Zinc finger SWIM-type containing 8" A7E2V4 10 73785606-73801797 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041244 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA041244: AB_10794269" "unprognostic (8.83e-2)" "unprognostic (2.86e-1)" "unprognostic (2.89e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-2)" "prognostic favorable (5.61e-4)" "unprognostic (3.11e-1)" "unprognostic (1.64e-1)" "unprognostic (2.97e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-3)" "unprognostic (1.31e-1)" "unprognostic (1.52e-1)" "unprognostic (2.41e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-1)" "unprognostic (2.52e-1)" 60.4 97.0 86.7 19.7 88.1 42.8 59.3 85.1 110.5 77.1 88.3 77.7 27.2 63.8 43.4 105.6 62.5 24.9 65.1 87.5 85.5 97.3 143.6 68.9 25.1 87.9 86.4 69.8 64.4 35.4 145.0 24.8 87.1 91.1 17.8 27.5 70.9 28.4 62.2 88.9 70.1 28.1 83.7 109.8 68.1 96.4 87.8 25.1 87.6 22.4 21.6 74.5 77.1 90.4 14.0 23.3 28.4 46.9 65.6 31.2 16.3 17.5 48.1 24.3 29.1 20.7 11.3 7.9 12.3 28.6 23.6 20.6 10.1 19.9 12.2 12.6 21.3 11.2 26.1 27.7 49.2 7.7 41.4 51.4 36.2 30.2 35.0 66.0 28.5 16.4 16.0 14.9 28.3 21.2 11.7 22.8 8.4 11.2 72.8 13.9 13.5 4.7 34.9 29.6 6.8 30.9 14.5 42.1 25.9 24.5 28.5 15.8 29.6 26.7 16.0 12.2 18.1 37.6 21.6 5.1 29.5 11.3 14.1 2.4 2.2 1.9 3.0 1.5 1.7 1.8 1.3 1.3 1.8 1.2 0.6 1.9 4.9 1.1 2.5 3.8 1.8 1.0 86.7 88.1 85.1 110.5 87.5 85.5 87.9 86.4 87.1 83.7 87.8 90.4 17.2 3.2 11.5 49.6 7.2 12.4 7.4 15.1 11.4 32.8 20.2 17.7 1.4 20.0 12.8 20.2 68.8 13.4 27.2 21.7 1.9 13.7 5.5 14.0 19.0 17.1 20.4 11.4 34.0 14.8 8.4 13.2 24.5 22.2 0.0 18.8 29.6 35.0 19.0 35.3 30.2 18.3 14.2 24.2 15.7 2.2 22.1 17.1 16.0 21.5 19.2 19.6 15.5 26.7 36.5 17.5 19.5 24.0 8.2 17.7 41.3 11.7 15.4 45.3 13.1 21.1 18.3 35.8 15.9 14.9 14.2 28.7 13.9 19.3 12.1 17.9